Citrus Sinensis ID: 010512
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 508 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LV37 | 510 | Mitogen-activated protein | yes | no | 0.986 | 0.982 | 0.844 | 0.0 | |
| Q5Z9J0 | 580 | Mitogen-activated protein | yes | no | 0.994 | 0.870 | 0.799 | 0.0 | |
| Q9C9U4 | 576 | Mitogen-activated protein | no | no | 0.972 | 0.857 | 0.788 | 0.0 | |
| Q9LM33 | 589 | Mitogen-activated protein | no | no | 0.964 | 0.831 | 0.809 | 0.0 | |
| Q6L5F7 | 582 | Mitogen-activated protein | no | no | 0.968 | 0.845 | 0.769 | 0.0 | |
| Q5VP69 | 501 | Mitogen-activated protein | no | no | 0.966 | 0.980 | 0.758 | 0.0 | |
| Q0E459 | 506 | Mitogen-activated protein | no | no | 0.978 | 0.982 | 0.756 | 0.0 | |
| A2X0M1 | 506 | Mitogen-activated protein | N/A | no | 0.978 | 0.982 | 0.756 | 0.0 | |
| Q53N72 | 498 | Mitogen-activated protein | no | no | 0.954 | 0.973 | 0.737 | 0.0 | |
| Q75KK8 | 542 | Mitogen-activated protein | no | no | 0.789 | 0.739 | 0.847 | 0.0 |
| >sp|Q9LV37|MPK9_ARATH Mitogen-activated protein kinase 9 OS=Arabidopsis thaliana GN=MPK9 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 874 bits (2258), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 428/507 (84%), Positives = 466/507 (91%), Gaps = 6/507 (1%)
Query: 4 ALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI 63
ALETEFFTEYGEASRYQIQEVIGKGSYGVV SA+DTH+GE+VAIKKINDVFEHVSDATRI
Sbjct: 8 ALETEFFTEYGEASRYQIQEVIGKGSYGVVASAIDTHSGEKVAIKKINDVFEHVSDATRI 67
Query: 64 LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ 123
LREIKLLRLLRHPDIVEIKH+MLPPSRREF+DIYVVFELMESDLHQVIKANDDLTPEHYQ
Sbjct: 68 LREIKLLRLLRHPDIVEIKHVMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHYQ 127
Query: 124 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY 183
FFLYQLLRGLK+IHTANVFHRDLKPKNILAN+DCKLKICDFGLARVSFNDAPSAIFWTDY
Sbjct: 128 FFLYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKICDFGLARVSFNDAPSAIFWTDY 187
Query: 184 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 243
VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD+MTDLLGT
Sbjct: 188 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDIMTDLLGT 247
Query: 244 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 303
P E+I+RIRNEKARRYLG+MR+K PVPF+HKFP+ DPLAL LL RLLAFDPKDRP+AEE
Sbjct: 248 PPPEAIARIRNEKARRYLGNMRRKPPVPFTHKFPHVDPLALRLLHRLLAFDPKDRPSAEE 307
Query: 304 ALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLR 363
ALADPYF+GLANVDREPSTQPI KLEFEFERRK+ K+DVRE+IYREILEYHPQMLQEYLR
Sbjct: 308 ALADPYFYGLANVDREPSTQPIPKLEFEFERRKITKEDVRELIYREILEYHPQMLQEYLR 367
Query: 364 GGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQNN 423
GGEQTSFMYPSGVDRFKRQFAHLEE+YGKGE+ +PLQRQHASLPRERVPAPK EN N+
Sbjct: 368 GGEQTSFMYPSGVDRFKRQFAHLEENYGKGEKGSPLQRQHASLPRERVPAPKKENGSHNH 427
Query: 424 DY-GRTADSVAATLQSPPT-ENANTEEQNGINRPNCSARSLLKSASISASKCVGVKDRTD 481
D R+ S+ TL+SPPT ++ ++ +NG ++ SARSLLKSASISASKC+G+K R
Sbjct: 428 DIENRSIASLVTTLESPPTSQHEGSDYRNGTSQTGYSARSLLKSASISASKCIGMKPRNK 487
Query: 482 REPGEAIAEVNDEAVDGLSQKVAALHA 508
E GE+ N++ VD LSQKVAALH
Sbjct: 488 SEYGES----NNDTVDALSQKVAALHT 510
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4 |
| >sp|Q5Z9J0|MPK12_ORYSJ Mitogen-activated protein kinase 12 OS=Oryza sativa subsp. japonica GN=MPK12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 826 bits (2133), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/513 (79%), Positives = 452/513 (88%), Gaps = 8/513 (1%)
Query: 2 QSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDAT 61
++ +E EFFTEYGEAS+YQIQEVIGKGSYGVV +AVDT TGERVAIKKINDVFEHVSDAT
Sbjct: 70 KNTVEMEFFTEYGEASQYQIQEVIGKGSYGVVAAAVDTRTGERVAIKKINDVFEHVSDAT 129
Query: 62 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH 121
RILREIKLLRLLRHPDIVEIKHIMLPPSRREF+DIYVVFELMESDLHQVI+ANDDLTPEH
Sbjct: 130 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFQDIYVVFELMESDLHQVIRANDDLTPEH 189
Query: 122 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 181
YQFFLYQLLR LKYIH ANVFHRDLKPKNILAN+DCKLKICDFGLAR SFNDAPSAIFWT
Sbjct: 190 YQFFLYQLLRALKYIHAANVFHRDLKPKNILANSDCKLKICDFGLARASFNDAPSAIFWT 249
Query: 182 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 241
DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTG+PLFPGKNVVHQLD++TDLL
Sbjct: 250 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGKNVVHQLDIITDLL 309
Query: 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA 301
GTPS+E++SRIRNEKARRYL +MRKK VPFS KF N DPLAL LLERLLAFDPKDR +A
Sbjct: 310 GTPSSETLSRIRNEKARRYLSTMRKKHAVPFSQKFRNTDPLALRLLERLLAFDPKDRSSA 369
Query: 302 EEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEY 361
EEALADPYF LANV+REPS PISKLEFEFERRKL KDDVRE+IYREILEYHPQMLQEY
Sbjct: 370 EEALADPYFASLANVEREPSRHPISKLEFEFERRKLTKDDVRELIYREILEYHPQMLQEY 429
Query: 362 LRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQ 421
++GGEQ SF+YPSGVDRFKRQFAHLEE+Y KGER +PLQR+HASLPRERV KD Q
Sbjct: 430 MKGGEQISFLYPSGVDRFKRQFAHLEENYSKGERGSPLQRKHASLPRERVGVSKDGYNQQ 489
Query: 422 N-NDYGRTADSVAATLQSPP----TENANTEEQNGINRPNCSARSLLKSASISASKCVGV 476
N ND R+ADSVA T SPP + + QNG+ + S+RS LKSASISASKCV V
Sbjct: 490 NTNDQERSADSVARTTVSPPMSQDAQQHGSAGQNGVTSTDLSSRSYLKSASISASKCVAV 549
Query: 477 KDRTDREP-GEAIAEVNDEAVDGLSQKVAALHA 508
KD ++EP + I+E + +VDGLS++V+ +H+
Sbjct: 550 KD--NKEPEDDYISEEMEGSVDGLSEQVSRMHS 580
|
May be involved in defense signaling pathway. Phosphorylates EREBP1 transcriptional activator in vitro. Enhances DNA-binding activity of EREBP1 to the GCC box element of pathogenesis-related (PR) gene promoters. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9C9U4|MPK15_ARATH Mitogen-activated protein kinase 15 OS=Arabidopsis thaliana GN=MPK15 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 820 bits (2118), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/502 (78%), Positives = 441/502 (87%), Gaps = 8/502 (1%)
Query: 8 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREI 67
EFFTEYGEA+RYQIQEV+GKGSYGVVGSA+DTHTGERVAIKKINDVF+H+SDATRILREI
Sbjct: 79 EFFTEYGEANRYQIQEVVGKGSYGVVGSAIDTHTGERVAIKKINDVFDHISDATRILREI 138
Query: 68 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 127
KLLRLL HPD+VEIKHIMLPPSRREF+D+YVVFELMESDLHQVIKANDDLTPEH+QFFLY
Sbjct: 139 KLLRLLLHPDVVEIKHIMLPPSRREFRDVYVVFELMESDLHQVIKANDDLTPEHHQFFLY 198
Query: 128 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 187
QLLRGLKY+H ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP+AIFWTDYVATR
Sbjct: 199 QLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFWTDYVATR 258
Query: 188 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247
WYRAPELCGSFFSKYTPAIDIWS+GCIFAEML GKPLFPGKNVVHQLD+MTD LGTP E
Sbjct: 259 WYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDIMTDFLGTPPPE 318
Query: 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307
+IS+IRN+KARRYLG+MRKKQPVPFS KFP ADP AL LLERL+AFDPKDRP+AEEALAD
Sbjct: 319 AISKIRNDKARRYLGNMRKKQPVPFSKKFPKADPSALRLLERLIAFDPKDRPSAEEALAD 378
Query: 308 PYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQ 367
PYF+GL++ REPSTQPISKLEFEFER+KL KDD+RE+IYREILEYHPQML+EYLRGG Q
Sbjct: 379 PYFNGLSSKVREPSTQPISKLEFEFERKKLTKDDIRELIYREILEYHPQMLEEYLRGGNQ 438
Query: 368 TSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQ--NNDY 425
SFMYPSGVDRF+RQFAHLEE+ G G RS LQRQHASLPRERVPA K+E + N+
Sbjct: 439 LSFMYPSGVDRFRRQFAHLEENQGPGGRSNALQRQHASLPRERVPASKNETVEERSNDIE 498
Query: 426 GRTADSVAATLQSPPTENANTEEQNGINRPNCSARSLLKSASISASKCVGVKDRTDREPG 485
RT +VA+TL SP + E SAR+L+KS+SIS SKC+GV+ +T+ E
Sbjct: 499 RRTTAAVASTLDSPKA-SQQAEGTENGGGGGYSARNLMKSSSISGSKCIGVQSKTNIE-- 555
Query: 486 EAIAEVNDEAVDGLSQKVAALH 507
++I E DE V + KVA+LH
Sbjct: 556 DSIVEEQDETV---AVKVASLH 574
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9LM33|MPK8_ARATH Mitogen-activated protein kinase 8 OS=Arabidopsis thaliana GN=MPK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 810 bits (2093), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/509 (80%), Positives = 447/509 (87%), Gaps = 19/509 (3%)
Query: 6 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILR 65
ETEFFTEYGEA+RYQIQEV+GKGSYGVV SAVD+HTGERVAIKKINDVFEHVSDATRILR
Sbjct: 91 ETEFFTEYGEANRYQIQEVVGKGSYGVVASAVDSHTGERVAIKKINDVFEHVSDATRILR 150
Query: 66 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFF 125
EIKLLRLLRHPD+VEIKHIMLPPSRREF+DIYVVFELMESDLHQVIKANDDLTPEHYQFF
Sbjct: 151 EIKLLRLLRHPDVVEIKHIMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHYQFF 210
Query: 126 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVA 185
LYQLLRGLKY+H ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP+AIFWTDYVA
Sbjct: 211 LYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFWTDYVA 270
Query: 186 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245
TRWYRAPELCGSFFSKYTPAIDIWS+GCIFAEML GKPLFPGKNVVHQLDLMTD LGTP
Sbjct: 271 TRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDLMTDFLGTPP 330
Query: 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 305
ESISRIRNEKARRYL SMRKKQPVPFSHKFP ADPLAL LLERLLAFDPKDR +AE+AL
Sbjct: 331 PESISRIRNEKARRYLSSMRKKQPVPFSHKFPKADPLALRLLERLLAFDPKDRASAEDAL 390
Query: 306 ADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGG 365
ADPYF GL+N +REP+TQPISKLEF+FER+KL KDDVRE+IYREILEYHPQML+EYLRGG
Sbjct: 391 ADPYFSGLSNSEREPTTQPISKLEFDFERKKLVKDDVRELIYREILEYHPQMLEEYLRGG 450
Query: 366 EQTSFMYPSGVDRFKRQFAHLEEHYGK-----GERSTPLQRQHASLPRERVPAPKDENAG 420
+Q SFMYPSGVDRFKRQFAHLEE+ GK G RST L R HASLPRERVPAP E A
Sbjct: 451 DQLSFMYPSGVDRFKRQFAHLEENQGKPGAAGGGRSTALHRHHASLPRERVPAPNGETAE 510
Query: 421 QNNDYG-RTADSVAATLQSPPTENANTEEQNGINRPNCSARSLLKSASISASKCVGVKDR 479
+++D R A +VA+TL+S +N SAR+L+KSASIS SKC+GV+ +
Sbjct: 511 ESSDVERRAAAAVASTLESEEADNGG----------GYSARNLMKSASISGSKCIGVQSK 560
Query: 480 TDREPGEAIAEVND-EAVDGLSQKVAALH 507
TD+E + IAE D E V L+ KVA+LH
Sbjct: 561 TDKE--DTIAEEEDNETVAELTDKVASLH 587
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q6L5F7|MPK17_ORYSJ Mitogen-activated protein kinase 17 OS=Oryza sativa subsp. japonica GN=MPK17 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 803 bits (2074), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/504 (76%), Positives = 431/504 (85%), Gaps = 12/504 (2%)
Query: 3 SALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR 62
S E +FFTEYGEA+RY++ EVIGKGSYGVV +AVDT TGERVAIKKINDVF+HVSDATR
Sbjct: 89 SKKEPDFFTEYGEANRYKVSEVIGKGSYGVVAAAVDTQTGERVAIKKINDVFDHVSDATR 148
Query: 63 ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY 122
ILREIKLLRLLRHPDIVEIKHIMLPPSRREF+DIYV+FELMESDLHQVIKANDDLTPEH+
Sbjct: 149 ILREIKLLRLLRHPDIVEIKHIMLPPSRREFRDIYVIFELMESDLHQVIKANDDLTPEHH 208
Query: 123 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 182
QFFLYQLLRG+KYIH A+VFHRDLKPKNILANADCKLK+CDFGLARVSFND PSAIFWTD
Sbjct: 209 QFFLYQLLRGMKYIHAASVFHRDLKPKNILANADCKLKVCDFGLARVSFNDTPSAIFWTD 268
Query: 183 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 242
YVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+LTGKPLFPGKNVVHQLDLMTDLLG
Sbjct: 269 YVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAELLTGKPLFPGKNVVHQLDLMTDLLG 328
Query: 243 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 302
TPS ES+++IRNEKARRYL +MRKK VPF+ KFP DP+ALHLLERLLAFDPKDRP+AE
Sbjct: 329 TPSAESLAKIRNEKARRYLSNMRKKPRVPFTKKFPGVDPMALHLLERLLAFDPKDRPSAE 388
Query: 303 EALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYL 362
EAL DPYF+GLAN +REP QPISKLEFEFE+RKLAKDDVRE+IYREILEYHP MLQEYL
Sbjct: 389 EALTDPYFNGLANSEREPIAQPISKLEFEFEKRKLAKDDVRELIYREILEYHPHMLQEYL 448
Query: 363 RGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQN 422
RGG+Q SFMYPSGVDRFKRQFAHLEE KGE+S+P RQ+ASLPRER
Sbjct: 449 RGGDQMSFMYPSGVDRFKRQFAHLEEGVSKGEKSSPQLRQNASLPRER---------AIG 499
Query: 423 NDYGRTADSVAATLQSPPTENANTEEQNGINRPNCSARSLLKSASISASKCVGVKDRTDR 482
N +G + P + T +GI++P SARSLLKS SISASKC+G K + DR
Sbjct: 500 NKHGDDEYHAKLNVGEKPCHASVT---DGISKPLMSARSLLKSESISASKCIGEKPKQDR 556
Query: 483 EPGEAIAEVNDEAVDGLSQKVAAL 506
+ +++ E DE D +S+KVA L
Sbjct: 557 DQEDSLTESMDETADEVSEKVAQL 580
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5VP69|MPK16_ORYSJ Mitogen-activated protein kinase 16 OS=Oryza sativa subsp. japonica GN=MPK16 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 792 bits (2045), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/501 (75%), Positives = 434/501 (86%), Gaps = 10/501 (1%)
Query: 6 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILR 65
E EFF+EYG+ASRY++ EV+GKGSYGVV +AVDTHTG RVAIKKINDVFEH+SDATRILR
Sbjct: 9 EPEFFSEYGDASRYEVTEVVGKGSYGVVAAAVDTHTGGRVAIKKINDVFEHISDATRILR 68
Query: 66 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFF 125
EIKLLRLLRHPDIVEIKHIMLPPSRREF+DIY++FELMESDLHQVIKANDDLTPEH+QFF
Sbjct: 69 EIKLLRLLRHPDIVEIKHIMLPPSRREFRDIYIIFELMESDLHQVIKANDDLTPEHHQFF 128
Query: 126 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVA 185
LYQLLRG+KYIH A+VFHRDLKPKNILANADCK+KICDFGLARVSF+D PSAIFWTDYVA
Sbjct: 129 LYQLLRGMKYIHAASVFHRDLKPKNILANADCKVKICDFGLARVSFDDTPSAIFWTDYVA 188
Query: 186 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245
TRWYRAPELCGSFFSKYTPAIDIWS+GCIFAEML GKPLFPGKNVVHQLDLMTDLLG+PS
Sbjct: 189 TRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLMGKPLFPGKNVVHQLDLMTDLLGSPS 248
Query: 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 305
E+ISRIRNEKARRYLG+MRKK VPFS KFP ADP+ALHLLERLLAFDPKDRPTA EAL
Sbjct: 249 GETISRIRNEKARRYLGNMRKKPRVPFSQKFPGADPMALHLLERLLAFDPKDRPTAAEAL 308
Query: 306 ADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGG 365
DPYF GLAN +REP QPISKLEFEFERRKLAKDDVRE+IYREILEYHPQM+Q+YLRGG
Sbjct: 309 TDPYFTGLANSEREPIAQPISKLEFEFERRKLAKDDVRELIYREILEYHPQMMQKYLRGG 368
Query: 366 EQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQNNDY 425
+Q++F+YPSGVDRFKRQFAHLEE +G++++P RQH SLPRERV DE DY
Sbjct: 369 DQSNFLYPSGVDRFKRQFAHLEEGVAQGDKTSPQLRQHVSLPRERVVRNGDE-PDPTADY 427
Query: 426 GRTADSVAATLQSPPTENANTEEQNGINRPNCSARSLLKSASISASKCVGVKDRTDREPG 485
+ + P ++ T +G+N+P SAR+ LKS SI AS+CV +K++ +++
Sbjct: 428 -----CIKLHVGEQPGHSSVT---DGLNKPLLSARNFLKSESIGASQCVVIKEKREKDE- 478
Query: 486 EAIAEVNDEAVDGLSQKVAAL 506
E+++E +EA DG+ K+A L
Sbjct: 479 ESMSEYMNEAADGVPHKIAQL 499
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q0E459|MPK13_ORYSJ Mitogen-activated protein kinase 13 OS=Oryza sativa subsp. japonica GN=MPK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 767 bits (1980), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/505 (75%), Positives = 431/505 (85%), Gaps = 8/505 (1%)
Query: 8 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREI 67
EFFTEYGEAS+YQIQEV+GKGSYGVV +AVDTHTGERVAIKKINDVFEHVSDA RILREI
Sbjct: 2 EFFTEYGEASQYQIQEVVGKGSYGVVAAAVDTHTGERVAIKKINDVFEHVSDAIRILREI 61
Query: 68 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 127
K+LRLLRHPDIV IKHIMLPP+RREF+DIYVVFELMESDLHQVI+AN DL+PEH++FFLY
Sbjct: 62 KVLRLLRHPDIVVIKHIMLPPTRREFRDIYVVFELMESDLHQVIEANHDLSPEHHRFFLY 121
Query: 128 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 187
QLL LKYIH+ANVFHRDLKPKNILAN+DCKLKICDFGLARV+FND+PS IFWTDYVATR
Sbjct: 122 QLLCALKYIHSANVFHRDLKPKNILANSDCKLKICDFGLARVAFNDSPSTIFWTDYVATR 181
Query: 188 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247
WYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTG+PLFPG+NVVHQLDL+TDLLGTPS+E
Sbjct: 182 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEILTGRPLFPGRNVVHQLDLITDLLGTPSSE 241
Query: 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307
++SRIRNE AR YL M++K P+PFSHKF NADPLAL LLERLLAFDPKDRPTAEEALAD
Sbjct: 242 TLSRIRNENARGYLTGMQRKHPIPFSHKFHNADPLALRLLERLLAFDPKDRPTAEEALAD 301
Query: 308 PYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQ 367
PYF G++ + REPS P+SK EFEFERRKL KDDVREMIYREILEYHPQMLQEY+RGGEQ
Sbjct: 302 PYFRGISKLSREPSRLPVSKFEFEFERRKLTKDDVREMIYREILEYHPQMLQEYIRGGEQ 361
Query: 368 TSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKD-ENAGQNNDYG 426
SF+YPSGVDRFKRQFAHLEE+Y +GERSTPL+RQHASLPRERV + D N +N+
Sbjct: 362 ISFLYPSGVDRFKRQFAHLEENYSRGERSTPLRRQHASLPRERVCSSVDSNNQDSDNEER 421
Query: 427 RTADSVAATLQSPP-----TENANTEEQNGINRPNCSARSLLKSASISASKCVGVKDRTD 481
R S+A T+ SPP +N + NGI N + + LKSASISAS C+ ++
Sbjct: 422 RAISSIARTMISPPRSQEKGKNRASAYPNGIINLNSNPKIYLKSASISASTCIIRGNKGP 481
Query: 482 REPGEAIAEVNDEAVDGLSQKVAAL 506
+E G I+E +E V LS V +
Sbjct: 482 KENG--ISEDMEEVVYELSDNVTRM 504
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|A2X0M1|MPK13_ORYSI Mitogen-activated protein kinase 13 OS=Oryza sativa subsp. indica GN=MPK13 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 767 bits (1980), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/505 (75%), Positives = 431/505 (85%), Gaps = 8/505 (1%)
Query: 8 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREI 67
EFFTEYGEAS+YQIQEV+GKGSYGVV +AVDTHTGERVAIKKINDVFEHVSDA RILREI
Sbjct: 2 EFFTEYGEASQYQIQEVVGKGSYGVVAAAVDTHTGERVAIKKINDVFEHVSDAIRILREI 61
Query: 68 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 127
K+LRLLRHPDIV IKHIMLPP+RREF+DIYVVFELMESDLHQVI+AN DL+PEH++FFLY
Sbjct: 62 KVLRLLRHPDIVVIKHIMLPPTRREFRDIYVVFELMESDLHQVIEANHDLSPEHHRFFLY 121
Query: 128 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 187
QLL LKYIH+ANVFHRDLKPKNILAN+DCKLKICDFGLARV+FND+PS IFWTDYVATR
Sbjct: 122 QLLCALKYIHSANVFHRDLKPKNILANSDCKLKICDFGLARVAFNDSPSTIFWTDYVATR 181
Query: 188 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247
WYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTG+PLFPG+NVVHQLDL+TDLLGTPS+E
Sbjct: 182 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEILTGRPLFPGRNVVHQLDLITDLLGTPSSE 241
Query: 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307
++SRIRNE AR YL M++K P+PFSHKF NADPLAL LLERLLAFDPKDRPTAEEALAD
Sbjct: 242 TLSRIRNENARGYLTGMQRKHPIPFSHKFHNADPLALRLLERLLAFDPKDRPTAEEALAD 301
Query: 308 PYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQ 367
PYF G++ + REPS P+SK EFEFERRKL KDDVREMIYREILEYHPQMLQEY+RGGEQ
Sbjct: 302 PYFRGISKLSREPSRLPVSKFEFEFERRKLTKDDVREMIYREILEYHPQMLQEYIRGGEQ 361
Query: 368 TSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKD-ENAGQNNDYG 426
SF+YPSGVDRFKRQFAHLEE+Y +GERSTPL+RQHASLPRERV + D N +N+
Sbjct: 362 ISFLYPSGVDRFKRQFAHLEENYSRGERSTPLRRQHASLPRERVCSSVDSNNQDSDNEER 421
Query: 427 RTADSVAATLQSPP-----TENANTEEQNGINRPNCSARSLLKSASISASKCVGVKDRTD 481
R S+A T+ SPP +N + NGI N + + LKSASISAS C+ ++
Sbjct: 422 RAISSIARTMISPPRSQEKGKNRASAYPNGIINLNSNPKIYLKSASISASTCIIRGNKGP 481
Query: 482 REPGEAIAEVNDEAVDGLSQKVAAL 506
+E G I+E +E V LS V +
Sbjct: 482 KENG--ISEDMEEVVYELSDNVTRM 504
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q53N72|MPK15_ORYSJ Mitogen-activated protein kinase 15 OS=Oryza sativa subsp. japonica GN=MPK15 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 753 bits (1944), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/491 (73%), Positives = 406/491 (82%), Gaps = 6/491 (1%)
Query: 8 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREI 67
+FFTEYGE +RY+I+EVIGKGSYGVV SA+DTHTGE+VAIKKIND+FEHVSDATRILREI
Sbjct: 2 DFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGEKVAIKKINDIFEHVSDATRILREI 61
Query: 68 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 127
KLLRLLRHPDIVEIKHI+LPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY
Sbjct: 62 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 121
Query: 128 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 187
QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV+F+D P+AIFWTDYVATR
Sbjct: 122 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYVATR 181
Query: 188 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247
WYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLD++TDLLGTPSTE
Sbjct: 182 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPSTE 241
Query: 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307
+ISRIRNEKARRYL SMR+K+P+PF+ KFPNADPLAL LLER+L+F+PKDRP AEEALAD
Sbjct: 242 AISRIRNEKARRYLSSMRRKKPIPFTQKFPNADPLALRLLERMLSFEPKDRPNAEEALAD 301
Query: 308 PYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQ 367
PYF +ANVDREPS QP++KLEFEFERR++ K+D+RE+IYR+ILEYHP ML+EYL G E
Sbjct: 302 PYFRNIANVDREPSAQPVTKLEFEFERRRITKEDIRELIYRDILEYHPNMLREYLEGTES 361
Query: 368 TSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDE-----NAGQN 422
FMYPS VD FK+QFA+LEEHY KG + P +RQH SLPR V D N ++
Sbjct: 362 AGFMYPSAVDHFKKQFAYLEEHYAKGSTAAPPERQHNSLPRPSVLYSDDRPQNTANIAED 421
Query: 423 NDYGRTADSVAATLQSPPTENANTEEQNGINRPNCSARSLLKSASISASKCVGVKD-RTD 481
D+ Q + AN Q G RP S L+ + S S + RTD
Sbjct: 422 LSKCVLGDNTQKMHQGSASVCANRVPQGGAARPGKVVGSALRYGNCSTSTAEQYEHRRTD 481
Query: 482 REPGEAIAEVN 492
R P A V+
Sbjct: 482 RNPALATNTVS 492
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q75KK8|MPK14_ORYSJ Mitogen-activated protein kinase 14 OS=Oryza sativa subsp. japonica GN=MPK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 743 bits (1918), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 340/401 (84%), Positives = 378/401 (94%)
Query: 8 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREI 67
+FFTEYGE +RY+I+EVIGKGSYGVV SA+DTHTG++VAIKKIND+FEHVSDATRILREI
Sbjct: 2 DFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGDKVAIKKINDIFEHVSDATRILREI 61
Query: 68 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 127
KLLRLLRHPDIVEIKHI+LPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY
Sbjct: 62 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 121
Query: 128 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 187
QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV+F+D P+AIFWTDY+ATR
Sbjct: 122 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYIATR 181
Query: 188 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247
WYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLD++TDLLGTPS E
Sbjct: 182 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPSPE 241
Query: 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307
+ISRIRNEKARRYL SMR+K+P+PF+ KFPNADPLA+ LLER+LAFDPKDRP+AEEALAD
Sbjct: 242 TISRIRNEKARRYLNSMRRKKPIPFTQKFPNADPLAMRLLERMLAFDPKDRPSAEEALAD 301
Query: 308 PYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQ 367
PYF +ANVDREPS QPI+KLEFEFERR++ K+D+RE+IYREILEYHP+ML+E+L G E
Sbjct: 302 PYFKNIANVDREPSAQPITKLEFEFERRRITKEDIRELIYREILEYHPKMLREFLEGTES 361
Query: 368 TSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPR 408
T FMYPS VD FK+QFA+LEEHY KG + P +RQH SLPR
Sbjct: 362 TGFMYPSAVDHFKKQFAYLEEHYAKGSTAAPPERQHNSLPR 402
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 508 | ||||||
| 449497497 | 647 | PREDICTED: mitogen-activated protein kin | 0.988 | 0.775 | 0.881 | 0.0 | |
| 449439123 | 647 | PREDICTED: mitogen-activated protein kin | 0.988 | 0.775 | 0.881 | 0.0 | |
| 359491016 | 601 | PREDICTED: mitogen-activated protein kin | 0.984 | 0.831 | 0.870 | 0.0 | |
| 399106776 | 594 | MAP kinase [Nicotiana tabacum] | 0.984 | 0.841 | 0.858 | 0.0 | |
| 297830442 | 510 | hypothetical protein ARALYDRAFT_898157 [ | 0.990 | 0.986 | 0.850 | 0.0 | |
| 224118686 | 519 | predicted protein [Populus trichocarpa] | 0.992 | 0.971 | 0.854 | 0.0 | |
| 356512988 | 594 | PREDICTED: mitogen-activated protein kin | 0.988 | 0.845 | 0.866 | 0.0 | |
| 9294059 | 619 | MAP kinase [Arabidopsis thaliana] | 0.986 | 0.809 | 0.844 | 0.0 | |
| 224135517 | 548 | predicted protein [Populus trichocarpa] | 0.990 | 0.917 | 0.847 | 0.0 | |
| 18401750 | 510 | mitogen-activated protein kinase 9 [Arab | 0.986 | 0.982 | 0.844 | 0.0 |
| >gi|449497497|ref|XP_004160419.1| PREDICTED: mitogen-activated protein kinase 9-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 910 bits (2352), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/514 (88%), Positives = 478/514 (92%), Gaps = 12/514 (2%)
Query: 2 QSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDAT 61
+ LETEFFTEYGEASRYQ+QE+IGKGSYGVVGSAVDTHT E+VAIKKINDVFEHVSDAT
Sbjct: 139 KGGLETEFFTEYGEASRYQVQEIIGKGSYGVVGSAVDTHTDEKVAIKKINDVFEHVSDAT 198
Query: 62 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH 121
RILREIKLLRLLRHPDIVEIKHIMLPPSRREF+DIYVVFELMESDLHQVIKANDDLTPEH
Sbjct: 199 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEH 258
Query: 122 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 181
+QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT
Sbjct: 259 HQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 318
Query: 182 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 241
DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTD+L
Sbjct: 319 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDVL 378
Query: 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA 301
GTPS+ESI+RIRNEKARRYL +MR+KQPVP + KFPNADPLAL LL+RLLAFDPKDRPTA
Sbjct: 379 GTPSSESIARIRNEKARRYLSNMRRKQPVPLTQKFPNADPLALRLLQRLLAFDPKDRPTA 438
Query: 302 EEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEY 361
EEALADPYF GLANVDREPSTQPISKLEFEFERRKL KDDVRE+IYREILEYHPQMLQEY
Sbjct: 439 EEALADPYFQGLANVDREPSTQPISKLEFEFERRKLTKDDVRELIYREILEYHPQMLQEY 498
Query: 362 LRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQ 421
LR GEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRER+PAPKDE AGQ
Sbjct: 499 LRSGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERIPAPKDE-AGQ 557
Query: 422 NNDY-GRTADSVAATLQSPP------TENANTEEQNGINRPNCSARSLLKSASISASKCV 474
+ND GR +VA +LQSPP +ENAN EQNG N+PN SARSLLKSASISASKC+
Sbjct: 558 HNDLEGR---NVATSLQSPPKSQGDGSENANGNEQNGQNKPNYSARSLLKSASISASKCI 614
Query: 475 GVKDRTDREPGEAIAEVNDEAVDGLSQKVAALHA 508
GVK R D E E I+E NDEAVDG+S K++ALH
Sbjct: 615 GVKPRKDLEE-EPISETNDEAVDGVSHKMSALHT 647
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439123|ref|XP_004137337.1| PREDICTED: mitogen-activated protein kinase 9-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 910 bits (2352), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/514 (88%), Positives = 478/514 (92%), Gaps = 12/514 (2%)
Query: 2 QSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDAT 61
+ LETEFFTEYGEASRYQ+QE+IGKGSYGVVGSAVDTHT E+VAIKKINDVFEHVSDAT
Sbjct: 139 KGGLETEFFTEYGEASRYQVQEIIGKGSYGVVGSAVDTHTDEKVAIKKINDVFEHVSDAT 198
Query: 62 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH 121
RILREIKLLRLLRHPDIVEIKHIMLPPSRREF+DIYVVFELMESDLHQVIKANDDLTPEH
Sbjct: 199 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEH 258
Query: 122 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 181
+QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT
Sbjct: 259 HQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 318
Query: 182 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 241
DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTD+L
Sbjct: 319 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDVL 378
Query: 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA 301
GTPS+ESI+RIRNEKARRYL +MR+KQPVP + KFPNADPLAL LL+RLLAFDPKDRPTA
Sbjct: 379 GTPSSESIARIRNEKARRYLSNMRRKQPVPLTQKFPNADPLALRLLQRLLAFDPKDRPTA 438
Query: 302 EEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEY 361
EEALADPYF GLANVDREPSTQPISKLEFEFERRKL KDDVRE+IYREILEYHPQMLQEY
Sbjct: 439 EEALADPYFQGLANVDREPSTQPISKLEFEFERRKLTKDDVRELIYREILEYHPQMLQEY 498
Query: 362 LRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQ 421
LR GEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRER+PAPKDE AGQ
Sbjct: 499 LRSGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERIPAPKDE-AGQ 557
Query: 422 NNDY-GRTADSVAATLQSPP------TENANTEEQNGINRPNCSARSLLKSASISASKCV 474
+ND GR +VA +LQSPP +ENAN EQNG N+PN SARSLLKSASISASKC+
Sbjct: 558 HNDLEGR---NVATSLQSPPKSQGDGSENANGNEQNGQNKPNYSARSLLKSASISASKCI 614
Query: 475 GVKDRTDREPGEAIAEVNDEAVDGLSQKVAALHA 508
GVK R D E E I+E NDEAVDG+S K++ALH
Sbjct: 615 GVKPRKDLEE-EPISETNDEAVDGVSHKMSALHT 647
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491016|ref|XP_003634202.1| PREDICTED: mitogen-activated protein kinase 9-like [Vitis vinifera] gi|297734305|emb|CBI15552.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 908 bits (2347), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/508 (87%), Positives = 470/508 (92%), Gaps = 8/508 (1%)
Query: 6 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILR 65
ETEFFTEYGEASRYQ+QEV+GKGSYGVVGSA+DTHTGE+VAIKKINDVFEHVSDATRILR
Sbjct: 97 ETEFFTEYGEASRYQVQEVVGKGSYGVVGSAIDTHTGEKVAIKKINDVFEHVSDATRILR 156
Query: 66 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFF 125
EIKLLRLLRHPDIVEIKHIMLPPSRREF+DIYVVFELMESDLHQVIKANDDLTPEHYQFF
Sbjct: 157 EIKLLRLLRHPDIVEIKHIMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHYQFF 216
Query: 126 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVA 185
LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVA
Sbjct: 217 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVA 276
Query: 186 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245
TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS
Sbjct: 277 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 336
Query: 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 305
ESI+RIRNEKARRYL +MRKK +PFS KFP+ADPLALHL+ERLLAFDPKDRPTAEEAL
Sbjct: 337 AESIARIRNEKARRYLSTMRKKPSIPFSQKFPDADPLALHLVERLLAFDPKDRPTAEEAL 396
Query: 306 ADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGG 365
ADPYF GLANVDREPSTQPISKLEFEFERRKL KDDVRE+IYREILEYHPQMLQEYLRGG
Sbjct: 397 ADPYFDGLANVDREPSTQPISKLEFEFERRKLTKDDVRELIYREILEYHPQMLQEYLRGG 456
Query: 366 EQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQNNDY 425
+QTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERV AP +E A +N ++
Sbjct: 457 DQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVCAPINEAADENKEF 516
Query: 426 -GRTADSVAATLQSPPT----ENANTEEQNGINRPNCSARSLLKSASISASKCVGVKDRT 480
R+A SVA TL+SPP E N E NG ++PN SARSLLKSASISASKC+GVK++
Sbjct: 517 EKRSAASVATTLESPPKAEGLEKGNVE--NGPSKPNQSARSLLKSASISASKCIGVKEQK 574
Query: 481 DREPGEAIAEVNDEAVDGLSQKVAALHA 508
D E E I E +DE V+GLS +AAL++
Sbjct: 575 DVEE-ETIVEHDDEGVNGLSHDLAALNS 601
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|399106776|gb|AFP20221.1| MAP kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 888 bits (2295), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 438/510 (85%), Positives = 464/510 (90%), Gaps = 10/510 (1%)
Query: 6 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILR 65
E EFFTEYGEASRYQIQEVIGKGSYGVV SAVDT TGERVAIKKI+DVFEHVSDATRILR
Sbjct: 88 EAEFFTEYGEASRYQIQEVIGKGSYGVVASAVDTKTGERVAIKKIHDVFEHVSDATRILR 147
Query: 66 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFF 125
EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFF
Sbjct: 148 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFF 207
Query: 126 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVA 185
LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND PSAIFWTDYVA
Sbjct: 208 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDTPSAIFWTDYVA 267
Query: 186 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245
TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP
Sbjct: 268 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPP 327
Query: 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 305
E++++IRNEKARRYL +MRKK PVPFS KFP+ DP AL LLE LLAFDPKDRP+AEEAL
Sbjct: 328 PETVAKIRNEKARRYLSNMRKKPPVPFSQKFPHVDPFALRLLECLLAFDPKDRPSAEEAL 387
Query: 306 ADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGG 365
DPYF GL+NVDREPST PISKLEFEFERRKLAK+DVRE+IYREILEYHPQMLQEYLRGG
Sbjct: 388 GDPYFRGLSNVDREPSTHPISKLEFEFERRKLAKEDVRELIYREILEYHPQMLQEYLRGG 447
Query: 366 EQTS-FMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQNND 424
+QTS FMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDE + QN+D
Sbjct: 448 DQTSGFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDETSSQNDD 507
Query: 425 Y-GRTADSVAATLQSPP-----TENANTEEQNGINRPNCSARSLLKSASISASKCVGVKD 478
+ RT+ SVA+TLQSPP +EN++ QNG N+ N SARSLLKSASISASKC+ VK
Sbjct: 508 FEKRTSASVASTLQSPPGQSEGSENSDANMQNGPNKANYSARSLLKSASISASKCIEVK- 566
Query: 479 RTDREPGEAIAEVNDEAVDGLSQKVAALHA 508
R++ E + D VDGL+QKVAALHA
Sbjct: 567 RSNTEEEPIEEQSED--VDGLAQKVAALHA 594
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297830442|ref|XP_002883103.1| hypothetical protein ARALYDRAFT_898157 [Arabidopsis lyrata subsp. lyrata] gi|297328943|gb|EFH59362.1| hypothetical protein ARALYDRAFT_898157 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 884 bits (2284), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 433/509 (85%), Positives = 469/509 (92%), Gaps = 6/509 (1%)
Query: 2 QSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDAT 61
Q ALETEFFTEYGEASRYQIQEVIGKGSYGVV SA+DTH+GE+VAIKKINDVFEHVSDAT
Sbjct: 6 QVALETEFFTEYGEASRYQIQEVIGKGSYGVVASAIDTHSGEKVAIKKINDVFEHVSDAT 65
Query: 62 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH 121
RILREIKLLRLLRHPDIVEIKH+MLPPSRREF+DIYVVFELMESDLHQVIKANDDLTPEH
Sbjct: 66 RILREIKLLRLLRHPDIVEIKHVMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEH 125
Query: 122 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 181
YQFFLYQLLRGLK+IHTANVFHRDLKPKNILAN+DCKLKICDFGLARVSFNDAPSAIFWT
Sbjct: 126 YQFFLYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKICDFGLARVSFNDAPSAIFWT 185
Query: 182 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 241
DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD+MTDLL
Sbjct: 186 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDIMTDLL 245
Query: 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA 301
GTP E+ISRIRNEKARRYLG+MR+K PVPF+HKFP+ DPLAL LL RLLAFDPKDRPTA
Sbjct: 246 GTPPPEAISRIRNEKARRYLGNMRRKPPVPFTHKFPHVDPLALRLLHRLLAFDPKDRPTA 305
Query: 302 EEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEY 361
EEALADPYF+GLANVDREPSTQPI KLEFEFERRK+ K+DVRE+IYREILEYHPQMLQEY
Sbjct: 306 EEALADPYFYGLANVDREPSTQPIPKLEFEFERRKITKEDVRELIYREILEYHPQMLQEY 365
Query: 362 LRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQ 421
LRGGEQTSFMYPSGVDRFKRQFAHLEE+YGKGER +PLQRQHASLPRERVPAPK EN
Sbjct: 366 LRGGEQTSFMYPSGVDRFKRQFAHLEENYGKGERGSPLQRQHASLPRERVPAPKKENGSH 425
Query: 422 NNDY-GRTADSVAATLQSPPT-ENANTEEQNGINRPNCSARSLLKSASISASKCVGVKDR 479
N+D R+ S+A TL+SPPT ++ ++ +NG+++ +ARSLLKSASISASKC+GVK R
Sbjct: 426 NHDIENRSTASLATTLESPPTSQHEGSDYRNGVSQTGYNARSLLKSASISASKCIGVKQR 485
Query: 480 TDREPGEAIAEVNDEAVDGLSQKVAALHA 508
E GE+ N++ VD LSQKVAALH
Sbjct: 486 NKSEHGES----NNDTVDALSQKVAALHT 510
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224118686|ref|XP_002317882.1| predicted protein [Populus trichocarpa] gi|222858555|gb|EEE96102.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 882 bits (2278), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 440/515 (85%), Positives = 467/515 (90%), Gaps = 11/515 (2%)
Query: 2 QSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDAT 61
+ + E +FFTEYGE +RYQ+QEV+GKGSYGVVGSA+DTHTGE+VAIKKINDVFEHVSDAT
Sbjct: 6 KGSAEADFFTEYGEGNRYQVQEVVGKGSYGVVGSAIDTHTGEKVAIKKINDVFEHVSDAT 65
Query: 62 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH 121
RILREIKLLRLLRHPDIVEIKHIMLPPSRREF+DIYVVFELMESDLHQVIKANDDLTPEH
Sbjct: 66 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEH 125
Query: 122 YQFFLYQLLRGLKYIHT--ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179
YQFFLYQLLRGLKYIHT +NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF
Sbjct: 126 YQFFLYQLLRGLKYIHTGMSNVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 185
Query: 180 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTD 239
WTDYVATRWYRAPELCGSFFSKYTPAID WSIGCIFAEMLTGKPLFPGKNVVHQLDLM+D
Sbjct: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDTWSIGCIFAEMLTGKPLFPGKNVVHQLDLMSD 245
Query: 240 LLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP 299
LLGTPS ES+SRIRNEKARRYL SMRKK PVPFS KFPN DPLAL LLERLLAFDPKDRP
Sbjct: 246 LLGTPSPESLSRIRNEKARRYLSSMRKKPPVPFSQKFPNVDPLALRLLERLLAFDPKDRP 305
Query: 300 TAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQ 359
+AEEALADPYF+GL+NV+REPSTQPISKLEFEFERRKL KDDVRE+IYREILEYHPQMLQ
Sbjct: 306 SAEEALADPYFNGLSNVEREPSTQPISKLEFEFERRKLTKDDVRELIYREILEYHPQMLQ 365
Query: 360 EYLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENA 419
EYLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGE++TPLQRQHASLPRERVPAPKDE A
Sbjct: 366 EYLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGEKNTPLQRQHASLPRERVPAPKDETA 425
Query: 420 GQNNDY-GRTADSVAATLQSPP-------TENANTEEQNGINRPNCSARSLLKSASISAS 471
+N D GRTA SVA +LQS P +E+A QNG ++PN S RSLLKSASISAS
Sbjct: 426 ARNTDIEGRTAASVATSLQSLPGSQQPDGSEDATAAAQNGSSKPNYSNRSLLKSASISAS 485
Query: 472 KCVGVKDRTDREPGEAIAEVNDEAVDGLSQKVAAL 506
KCV VK D E E I E NDE V+ LS+KVAAL
Sbjct: 486 KCVVVKPEGDTEE-ETITEANDEVVNDLSEKVAAL 519
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356512988|ref|XP_003525196.1| PREDICTED: mitogen-activated protein kinase 15-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 879 bits (2271), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 440/508 (86%), Positives = 467/508 (91%), Gaps = 6/508 (1%)
Query: 2 QSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDAT 61
+ A ETEFFTEYGEAS+YQIQEV+GKGSYGVVGSA+DTHTGE+VAIKKINDVFEHVSDAT
Sbjct: 92 KGAPETEFFTEYGEASQYQIQEVVGKGSYGVVGSAIDTHTGEKVAIKKINDVFEHVSDAT 151
Query: 62 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH 121
RILREIKLLRLLRHPDIVEIKHIMLPPSRREF+DIYVVFELMESDLHQVIKANDDLTPEH
Sbjct: 152 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEH 211
Query: 122 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 181
+QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT
Sbjct: 212 HQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 271
Query: 182 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 241
DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL
Sbjct: 272 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 331
Query: 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA 301
GTP ESI+RIRNEKA+RYL SMRKKQP+PFS KFPNADPLAL LLERLLAFDPKDRP+A
Sbjct: 332 GTPPPESIARIRNEKAKRYLNSMRKKQPIPFSQKFPNADPLALRLLERLLAFDPKDRPSA 391
Query: 302 EEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEY 361
EEAL+DPYF GLAN+DREPSTQPISKLEFEFERRKL KDDVRE+IYREILEYHPQMLQEY
Sbjct: 392 EEALSDPYFTGLANMDREPSTQPISKLEFEFERRKLTKDDVRELIYREILEYHPQMLQEY 451
Query: 362 LRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERST-PLQRQHASLPRERVPAPKDENAG 420
LRGG+QTSFMYPSGVDRFKRQFAHLEEHYGKGERST PLQRQHASLPR+RV APKDE +
Sbjct: 452 LRGGDQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPPLQRQHASLPRQRVCAPKDE-SK 510
Query: 421 QNNDYGRTADSVAATLQSPPTENANTEEQNGINRPNCSARSLLKSASISASKCVGVKDRT 480
QNND + + S LQ P + T QNG ++PN SARSLLKSASISASKCV +K
Sbjct: 511 QNNDSEKPSGS---NLQQSPPGSDETGAQNGTSKPNYSARSLLKSASISASKCVVLKQNK 567
Query: 481 DREPGEAIAEVNDEAVDGLSQKVAALHA 508
D E E I EVNDEAVDG++ ++AALHA
Sbjct: 568 DPE-QEPITEVNDEAVDGVTGEIAALHA 594
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|9294059|dbj|BAB02016.1| MAP kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 877 bits (2265), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 428/507 (84%), Positives = 466/507 (91%), Gaps = 6/507 (1%)
Query: 4 ALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI 63
ALETEFFTEYGEASRYQIQEVIGKGSYGVV SA+DTH+GE+VAIKKINDVFEHVSDATRI
Sbjct: 117 ALETEFFTEYGEASRYQIQEVIGKGSYGVVASAIDTHSGEKVAIKKINDVFEHVSDATRI 176
Query: 64 LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ 123
LREIKLLRLLRHPDIVEIKH+MLPPSRREF+DIYVVFELMESDLHQVIKANDDLTPEHYQ
Sbjct: 177 LREIKLLRLLRHPDIVEIKHVMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHYQ 236
Query: 124 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY 183
FFLYQLLRGLK+IHTANVFHRDLKPKNILAN+DCKLKICDFGLARVSFNDAPSAIFWTDY
Sbjct: 237 FFLYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKICDFGLARVSFNDAPSAIFWTDY 296
Query: 184 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 243
VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD+MTDLLGT
Sbjct: 297 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDIMTDLLGT 356
Query: 244 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 303
P E+I+RIRNEKARRYLG+MR+K PVPF+HKFP+ DPLAL LL RLLAFDPKDRP+AEE
Sbjct: 357 PPPEAIARIRNEKARRYLGNMRRKPPVPFTHKFPHVDPLALRLLHRLLAFDPKDRPSAEE 416
Query: 304 ALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLR 363
ALADPYF+GLANVDREPSTQPI KLEFEFERRK+ K+DVRE+IYREILEYHPQMLQEYLR
Sbjct: 417 ALADPYFYGLANVDREPSTQPIPKLEFEFERRKITKEDVRELIYREILEYHPQMLQEYLR 476
Query: 364 GGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQNN 423
GGEQTSFMYPSGVDRFKRQFAHLEE+YGKGE+ +PLQRQHASLPRERVPAPK EN N+
Sbjct: 477 GGEQTSFMYPSGVDRFKRQFAHLEENYGKGEKGSPLQRQHASLPRERVPAPKKENGSHNH 536
Query: 424 DY-GRTADSVAATLQSPPT-ENANTEEQNGINRPNCSARSLLKSASISASKCVGVKDRTD 481
D R+ S+ TL+SPPT ++ ++ +NG ++ SARSLLKSASISASKC+G+K R
Sbjct: 537 DIENRSIASLVTTLESPPTSQHEGSDYRNGTSQTGYSARSLLKSASISASKCIGMKPRNK 596
Query: 482 REPGEAIAEVNDEAVDGLSQKVAALHA 508
E GE+ N++ VD LSQKVAALH
Sbjct: 597 SEYGES----NNDTVDALSQKVAALHT 619
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224135517|ref|XP_002322093.1| predicted protein [Populus trichocarpa] gi|222869089|gb|EEF06220.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 875 bits (2261), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/513 (84%), Positives = 463/513 (90%), Gaps = 10/513 (1%)
Query: 2 QSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDAT 61
+ + E +FFTEYGEAS+YQ+QEVIGKGSYGVVGSA+D+HTGERVAIKKINDVFEHVSDAT
Sbjct: 38 KGSAEADFFTEYGEASQYQVQEVIGKGSYGVVGSAIDSHTGERVAIKKINDVFEHVSDAT 97
Query: 62 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH 121
RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH
Sbjct: 98 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH 157
Query: 122 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 181
YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI WT
Sbjct: 158 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAILWT 217
Query: 182 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 241
DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL
Sbjct: 218 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 277
Query: 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA 301
GTP ESIS+IRNEKARRYL +MRKK PVPF KFPN DPLAL LLE LLAFDPKDRPTA
Sbjct: 278 GTPPPESISKIRNEKARRYLSNMRKKPPVPFPQKFPNVDPLALRLLEGLLAFDPKDRPTA 337
Query: 302 EEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEY 361
EEALA+PYF+GL+NV+ EPSTQPISKLEFEFERRK+ KDDVRE+IYREILEYHPQML+EY
Sbjct: 338 EEALANPYFNGLSNVECEPSTQPISKLEFEFERRKITKDDVRELIYREILEYHPQMLKEY 397
Query: 362 LRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQ 421
LRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDE A Q
Sbjct: 398 LRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDETAAQ 457
Query: 422 NNDYGR-TADSVAATLQSPP-------TENANTEEQNGINRPNCSARSLLKSASISASKC 473
+ D R TA S+A +L+S P +E+ QNG ++PN S RSLLKS+SISASKC
Sbjct: 458 STDIERQTAPSIAKSLKSLPGLQQADGSEDVTVAAQNGSSKPNYSNRSLLKSSSISASKC 517
Query: 474 VGVKDRTDREPGEAIAEVNDEAVDGLSQKVAAL 506
V VK + D E E I EV+DE V+ LSQKVA L
Sbjct: 518 VVVKPKGDSE--EMIKEVSDEDVNDLSQKVATL 548
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18401750|ref|NP_566595.1| mitogen-activated protein kinase 9 [Arabidopsis thaliana] gi|110287681|sp|Q9LV37.2|MPK9_ARATH RecName: Full=Mitogen-activated protein kinase 9; Short=AtMPK9; Short=MAP kinase 9 gi|332642517|gb|AEE76038.1| mitogen-activated protein kinase 9 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 874 bits (2258), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 428/507 (84%), Positives = 466/507 (91%), Gaps = 6/507 (1%)
Query: 4 ALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI 63
ALETEFFTEYGEASRYQIQEVIGKGSYGVV SA+DTH+GE+VAIKKINDVFEHVSDATRI
Sbjct: 8 ALETEFFTEYGEASRYQIQEVIGKGSYGVVASAIDTHSGEKVAIKKINDVFEHVSDATRI 67
Query: 64 LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ 123
LREIKLLRLLRHPDIVEIKH+MLPPSRREF+DIYVVFELMESDLHQVIKANDDLTPEHYQ
Sbjct: 68 LREIKLLRLLRHPDIVEIKHVMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHYQ 127
Query: 124 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY 183
FFLYQLLRGLK+IHTANVFHRDLKPKNILAN+DCKLKICDFGLARVSFNDAPSAIFWTDY
Sbjct: 128 FFLYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKICDFGLARVSFNDAPSAIFWTDY 187
Query: 184 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 243
VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD+MTDLLGT
Sbjct: 188 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDIMTDLLGT 247
Query: 244 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 303
P E+I+RIRNEKARRYLG+MR+K PVPF+HKFP+ DPLAL LL RLLAFDPKDRP+AEE
Sbjct: 248 PPPEAIARIRNEKARRYLGNMRRKPPVPFTHKFPHVDPLALRLLHRLLAFDPKDRPSAEE 307
Query: 304 ALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLR 363
ALADPYF+GLANVDREPSTQPI KLEFEFERRK+ K+DVRE+IYREILEYHPQMLQEYLR
Sbjct: 308 ALADPYFYGLANVDREPSTQPIPKLEFEFERRKITKEDVRELIYREILEYHPQMLQEYLR 367
Query: 364 GGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQNN 423
GGEQTSFMYPSGVDRFKRQFAHLEE+YGKGE+ +PLQRQHASLPRERVPAPK EN N+
Sbjct: 368 GGEQTSFMYPSGVDRFKRQFAHLEENYGKGEKGSPLQRQHASLPRERVPAPKKENGSHNH 427
Query: 424 DY-GRTADSVAATLQSPPT-ENANTEEQNGINRPNCSARSLLKSASISASKCVGVKDRTD 481
D R+ S+ TL+SPPT ++ ++ +NG ++ SARSLLKSASISASKC+G+K R
Sbjct: 428 DIENRSIASLVTTLESPPTSQHEGSDYRNGTSQTGYSARSLLKSASISASKCIGMKPRNK 487
Query: 482 REPGEAIAEVNDEAVDGLSQKVAALHA 508
E GE+ N++ VD LSQKVAALH
Sbjct: 488 SEYGES----NNDTVDALSQKVAALHT 510
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 508 | ||||||
| TAIR|locus:2092717 | 510 | MPK9 "MAP kinase 9" [Arabidops | 0.984 | 0.980 | 0.774 | 4.2e-214 | |
| TAIR|locus:2194040 | 589 | ATMPK8 [Arabidopsis thaliana ( | 0.964 | 0.831 | 0.746 | 5.2e-200 | |
| TAIR|locus:2027814 | 576 | MPK15 "MAP kinase 15" [Arabido | 0.972 | 0.857 | 0.733 | 1.1e-197 | |
| TAIR|locus:2179609 | 567 | MPK16 "mitogen-activated prote | 0.801 | 0.717 | 0.789 | 3e-179 | |
| TAIR|locus:2052357 | 606 | MPK20 "MAP kinase 20" [Arabido | 0.875 | 0.734 | 0.715 | 7.4e-176 | |
| TAIR|locus:2049552 | 486 | MPK17 "MAP kinase 17" [Arabido | 0.864 | 0.903 | 0.715 | 1.4e-172 | |
| TAIR|locus:2089576 | 598 | MPK19 "MAP kinase 19" [Arabido | 0.797 | 0.677 | 0.741 | 6.2e-165 | |
| TAIR|locus:2024887 | 615 | MPK18 "mitogen-activated prote | 0.854 | 0.705 | 0.682 | 2.1e-164 | |
| DICTYBASE|DDB_G0286353 | 529 | erkA "mitogen-activated protei | 0.653 | 0.627 | 0.492 | 1.7e-84 | |
| TAIR|locus:2124943 | 376 | MPK4 "MAP kinase 4" [Arabidops | 0.669 | 0.904 | 0.446 | 6.6e-81 |
| TAIR|locus:2092717 MPK9 "MAP kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2069 (733.4 bits), Expect = 4.2e-214, P = 4.2e-214
Identities = 392/506 (77%), Positives = 430/506 (84%)
Query: 4 ALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATXX 63
ALETEFFTEYGEASRYQIQEVIGKGSYGVV SA+DTH+GE+VAIKKINDVFEHVSDAT
Sbjct: 8 ALETEFFTEYGEASRYQIQEVIGKGSYGVVASAIDTHSGEKVAIKKINDVFEHVSDATRI 67
Query: 64 XXXXXXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ 123
HPDIVEIKH+MLPPSRREF+DIYVVFELMESDLHQVIKANDDLTPEHYQ
Sbjct: 68 LREIKLLRLLRHPDIVEIKHVMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHYQ 127
Query: 124 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY 183
FFLYQLLRGLK+IHTANVFHRDLKPKNILAN+DCKLKICDFGLARVSFNDAPSAIFWTDY
Sbjct: 128 FFLYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKICDFGLARVSFNDAPSAIFWTDY 187
Query: 184 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 243
VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD+MTDLLGT
Sbjct: 188 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDIMTDLLGT 247
Query: 244 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKDRPTAEE 303
P E+I+RIRNEKARRYLG+MR+K PVPF+HKFP+ DP AFDPKDRP+AEE
Sbjct: 248 PPPEAIARIRNEKARRYLGNMRRKPPVPFTHKFPHVDPLALRLLHRLLAFDPKDRPSAEE 307
Query: 304 ALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLR 363
ALADPYF+GLANVDREPSTQPI KLEFEFERRK+ K+DVRE+IYREILEYHPQMLQEYLR
Sbjct: 308 ALADPYFYGLANVDREPSTQPIPKLEFEFERRKITKEDVRELIYREILEYHPQMLQEYLR 367
Query: 364 GGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQNN 423
GGEQTSFMYPSGVDRFKRQFAHLEE+YGKGE+ +PLQRQHASLPRERVPAPK EN N+
Sbjct: 368 GGEQTSFMYPSGVDRFKRQFAHLEENYGKGEKGSPLQRQHASLPRERVPAPKKENGSHNH 427
Query: 424 DY-GRTADSVAATLQSPPT-ENANTEEQNGINRPNCXXXXXXXXXXXXXXXCVGVKDRTD 481
D R+ S+ TL+SPPT ++ ++ +NG ++ C+G+K R
Sbjct: 428 DIENRSIASLVTTLESPPTSQHEGSDYRNGTSQTGYSARSLLKSASISASKCIGMKPRNK 487
Query: 482 REPGEAIAEVNDEAVDGLSQKVAALH 507
E GE+ N++ VD LSQKVAALH
Sbjct: 488 SEYGES----NNDTVDALSQKVAALH 509
|
|
| TAIR|locus:2194040 ATMPK8 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1936 (686.6 bits), Expect = 5.2e-200, P = 5.2e-200
Identities = 380/509 (74%), Positives = 414/509 (81%)
Query: 6 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATXXXX 65
ETEFFTEYGEA+RYQIQEV+GKGSYGVV SAVD+HTGERVAIKKINDVFEHVSDAT
Sbjct: 91 ETEFFTEYGEANRYQIQEVVGKGSYGVVASAVDSHTGERVAIKKINDVFEHVSDATRILR 150
Query: 66 XXXXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFF 125
HPD+VEIKHIMLPPSRREF+DIYVVFELMESDLHQVIKANDDLTPEHYQFF
Sbjct: 151 EIKLLRLLRHPDVVEIKHIMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHYQFF 210
Query: 126 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVA 185
LYQLLRGLKY+H ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP+AIFWTDYVA
Sbjct: 211 LYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFWTDYVA 270
Query: 186 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245
TRWYRAPELCGSFFSKYTPAIDIWS+GCIFAEML GKPLFPGKNVVHQLDLMTD LGTP
Sbjct: 271 TRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDLMTDFLGTPP 330
Query: 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKDRPTAEEAL 305
ESISRIRNEKARRYL SMRKKQPVPFSHKFP ADP AFDPKDR +AE+AL
Sbjct: 331 PESISRIRNEKARRYLSSMRKKQPVPFSHKFPKADPLALRLLERLLAFDPKDRASAEDAL 390
Query: 306 ADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGG 365
ADPYF GL+N +REP+TQPISKLEF+FER+KL KDDVRE+IYREILEYHPQML+EYLRGG
Sbjct: 391 ADPYFSGLSNSEREPTTQPISKLEFDFERKKLVKDDVRELIYREILEYHPQMLEEYLRGG 450
Query: 366 EQTSFMYPSGVDRFKRQFAHLEEHYGK-----GERSTPLQRQHASLPRERVPAPKDENAG 420
+Q SFMYPSGVDRFKRQFAHLEE+ GK G RST L R HASLPRERVPAP E A
Sbjct: 451 DQLSFMYPSGVDRFKRQFAHLEENQGKPGAAGGGRSTALHRHHASLPRERVPAPNGETAE 510
Query: 421 QNNDYGR-TADSVAATLQSPPTENANTEEQNGINRPNCXXXXXXXXXXXXXXXCVGVKDR 479
+++D R A +VA+TL+S +N G + N C+GV+ +
Sbjct: 511 ESSDVERRAAAAVASTLESEEADNGG-----GYSARNLMKSASISGSK-----CIGVQSK 560
Query: 480 TDREPGEAIAEVND-EAVDGLSQKVAALH 507
TD+E + IAE D E V L+ KVA+LH
Sbjct: 561 TDKE--DTIAEEEDNETVAELTDKVASLH 587
|
|
| TAIR|locus:2027814 MPK15 "MAP kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1914 (678.8 bits), Expect = 1.1e-197, P = 1.1e-197
Identities = 368/502 (73%), Positives = 409/502 (81%)
Query: 8 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATXXXXXX 67
EFFTEYGEA+RYQIQEV+GKGSYGVVGSA+DTHTGERVAIKKINDVF+H+SDAT
Sbjct: 79 EFFTEYGEANRYQIQEVVGKGSYGVVGSAIDTHTGERVAIKKINDVFDHISDATRILREI 138
Query: 68 XXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 127
HPD+VEIKHIMLPPSRREF+D+YVVFELMESDLHQVIKANDDLTPEH+QFFLY
Sbjct: 139 KLLRLLLHPDVVEIKHIMLPPSRREFRDVYVVFELMESDLHQVIKANDDLTPEHHQFFLY 198
Query: 128 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 187
QLLRGLKY+H ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP+AIFWTDYVATR
Sbjct: 199 QLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFWTDYVATR 258
Query: 188 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247
WYRAPELCGSFFSKYTPAIDIWS+GCIFAEML GKPLFPGKNVVHQLD+MTD LGTP E
Sbjct: 259 WYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDIMTDFLGTPPPE 318
Query: 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKDRPTAEEALAD 307
+IS+IRN+KARRYLG+MRKKQPVPFS KFP ADP AFDPKDRP+AEEALAD
Sbjct: 319 AISKIRNDKARRYLGNMRKKQPVPFSKKFPKADPSALRLLERLIAFDPKDRPSAEEALAD 378
Query: 308 PYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQ 367
PYF+GL++ REPSTQPISKLEFEFER+KL KDD+RE+IYREILEYHPQML+EYLRGG Q
Sbjct: 379 PYFNGLSSKVREPSTQPISKLEFEFERKKLTKDDIRELIYREILEYHPQMLEEYLRGGNQ 438
Query: 368 TSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQ-NNDYG 426
SFMYPSGVDRF+RQFAHLEE+ G G RS LQRQHASLPRERVPA K+E + +ND
Sbjct: 439 LSFMYPSGVDRFRRQFAHLEENQGPGGRSNALQRQHASLPRERVPASKNETVEERSNDIE 498
Query: 427 R-TADSVAATLQSPPTENANTEEQNGINRPNCXXXXXXXXXXXXXXXCVGVKDRTDREPG 485
R T +VA+TL SP +NG C+GV+ +T+ E
Sbjct: 499 RRTTAAVASTLDSPKASQQAEGTENG-GGGGYSARNLMKSSSISGSKCIGVQSKTNIE-- 555
Query: 486 EAIAEVNDEAVDGLSQKVAALH 507
++I E DE V + KVA+LH
Sbjct: 556 DSIVEEQDETV---AVKVASLH 574
|
|
| TAIR|locus:2179609 MPK16 "mitogen-activated protein kinase 16" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1740 (617.6 bits), Expect = 3.0e-179, P = 3.0e-179
Identities = 322/408 (78%), Positives = 357/408 (87%)
Query: 2 QSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDAT 61
+S++E +FFTEYGE SRY+I+EVIGKGSYGVV SA DTHTGE+VAIKKIND+FEHVSDAT
Sbjct: 8 KSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIFEHVSDAT 67
Query: 62 XXXXXXXXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH 121
HPDIVEIKHI+LPPSRREF+DIYVVFELMESDLHQVIKANDDLTPEH
Sbjct: 68 RILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEH 127
Query: 122 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 181
YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV+FND P+AIFWT
Sbjct: 128 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 187
Query: 182 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 241
DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLDLMTD+L
Sbjct: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDLMTDML 247
Query: 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKDRPTA 301
GTPS E+I R+RNEKARRYL SMRKK+P+PFSHKFP+ DP +F+PKDRPTA
Sbjct: 248 GTPSAEAIGRVRNEKARRYLSSMRKKKPIPFSHKFPHTDPLALRLLEKMLSFEPKDRPTA 307
Query: 302 EEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEY 361
EEALAD YF GLA V+REPS QP++KLEFEFERR++ K+DVRE+IYRE LEYHP+ML+EY
Sbjct: 308 EEALADVYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDVRELIYRESLEYHPKMLKEY 367
Query: 362 LRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQ-HASLPR 408
L G E T+FMYPS V+ FK+QFA+LEEHY G P +RQ HASLPR
Sbjct: 368 LDGSEPTNFMYPSAVEHFKKQFAYLEEHYKNGTSHNPPERQQHASLPR 415
|
|
| TAIR|locus:2052357 MPK20 "MAP kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1691 (600.3 bits), Expect = 7.4e-176, Sum P(2) = 7.4e-176
Identities = 319/446 (71%), Positives = 366/446 (82%)
Query: 5 LETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATXXX 64
LE EFF++YG+A+R+++QEVIGKGSYGVV SA+DT TGE+VAIKKI+D+FEH+SDA
Sbjct: 11 LEMEFFSDYGDANRFKVQEVIGKGSYGVVCSAIDTLTGEKVAIKKIHDIFEHISDAARIL 70
Query: 65 XXXXXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQF 124
HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLT EHYQF
Sbjct: 71 REIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTREHYQF 130
Query: 125 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 184
FLYQLLR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARV+FND P+ IFWTDYV
Sbjct: 131 FLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYV 190
Query: 185 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244
ATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAE+L GKPLFPGKNVVHQLDLMTDLLGTP
Sbjct: 191 ATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGKPLFPGKNVVHQLDLMTDLLGTP 250
Query: 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKDRPTAEEA 304
S ++ISR+RNEKARRYL SMRKK P+PF+ KFPNADP AFDPKDRPTAEEA
Sbjct: 251 SLDTISRVRNEKARRYLTSMRKKPPIPFAQKFPNADPLSLKLLERLLAFDPKDRPTAEEA 310
Query: 305 LADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRG 364
LADPYF GLA V+REPS QPI+K+EFEFERRK+ K+D+RE+I REILEYHPQ+L++++ G
Sbjct: 311 LADPYFKGLAKVEREPSCQPITKMEFEFERRKVTKEDIRELISREILEYHPQLLKDHMNG 370
Query: 365 GEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERV-PAPKDENAGQNN 423
++ SF+YPS VD+F+RQFAHLEE+ GK PL+R+HASLPR V + GQ
Sbjct: 371 ADKASFLYPSAVDQFRRQFAHLEENSGKTGPVAPLERKHASLPRSTVIHSTAVARGGQPK 430
Query: 424 DYGRTADSVAATLQSPPTENANTEEQ 449
T T Q+ P +A + Q
Sbjct: 431 LMNNTNTLNPETTQNIPFNHATIQAQ 456
|
|
| TAIR|locus:2049552 MPK17 "MAP kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1677 (595.4 bits), Expect = 1.4e-172, P = 1.4e-172
Identities = 319/446 (71%), Positives = 367/446 (82%)
Query: 5 LETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATXXX 64
LE EFFTEYGEAS+YQIQEV+GKGSYGVV SA HTG +VAIKK+ +VFEHVSDA
Sbjct: 2 LEKEFFTEYGEASQYQIQEVVGKGSYGVVASAECPHTGGKVAIKKMTNVFEHVSDAIRIL 61
Query: 65 XXXXXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQF 124
HPDIVEIKHIMLPP R+EFKDIYVVFELMESDLH V+K NDDLTP+H+QF
Sbjct: 62 REIKLLRLLRHPDIVEIKHIMLPPCRKEFKDIYVVFELMESDLHHVLKVNDDLTPQHHQF 121
Query: 125 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 184
FLYQLLRGLK++H+A+VFHRDLKPKNILANADCK+KICD GLARVSF D+PSA+FWTDYV
Sbjct: 122 FLYQLLRGLKFMHSAHVFHRDLKPKNILANADCKIKICDLGLARVSFTDSPSAVFWTDYV 181
Query: 185 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244
ATRWYRAPELCGSF+S YTPAID+WS+GCIFAEMLTGKPLFPGKNVVHQL+L+TDLLGTP
Sbjct: 182 ATRWYRAPELCGSFYSNYTPAIDMWSVGCIFAEMLTGKPLFPGKNVVHQLELVTDLLGTP 241
Query: 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKDRPTAEEA 304
S ++SRIRNEKAR+YLG+MR+K PVPF+HKFPN DP AFDPKDRP+AEEA
Sbjct: 242 SPITLSRIRNEKARKYLGNMRRKDPVPFTHKFPNIDPVALKLLQRLIAFDPKDRPSAEEA 301
Query: 305 LADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRG 364
LADPYF GLANVD EPS QPISKLEFEFERRKL +DDVRE++YREILEYHPQMLQEYL+G
Sbjct: 302 LADPYFQGLANVDYEPSRQPISKLEFEFERRKLTRDDVRELMYREILEYHPQMLQEYLQG 361
Query: 365 GEQTS--FMYPSGVDRFKRQFAHLEEHYGKGER--STPLQRQHASLPRERVPAPKDENAG 420
E + F+YPSGVD+FK++FA LEEH E S P QR++ SLPRERV + +DE G
Sbjct: 362 EENINSHFLYPSGVDQFKQEFARLEEHNDDEEEHNSPPHQRKYTSLPRERVCSSEDE--G 419
Query: 421 QNNDYGRTADSVAATLQSPPTENANT 446
++ + +++ S + P T N T
Sbjct: 420 SDSVHAQSS-SASVVFTPPQTPNTAT 444
|
|
| TAIR|locus:2089576 MPK19 "MAP kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1605 (570.0 bits), Expect = 6.2e-165, P = 6.2e-165
Identities = 301/406 (74%), Positives = 341/406 (83%)
Query: 6 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATXXXX 65
E EFFTEYG+A+RY+I EVIGKGSYGVV +A+DT TGE+VAIKKINDVFEHVSDA
Sbjct: 12 EMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTQTGEKVAIKKINDVFEHVSDALRILR 71
Query: 66 XXXXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFF 125
HPDIVEIK IMLPPS+REFKDIYVVFELMESDLHQVIKANDDLT EH+QFF
Sbjct: 72 EVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFF 131
Query: 126 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVA 185
LYQ+LR LKY+HTANV+HRDLKPKNILANA+CKLK+CDFGLARVSFND P+ +FWTDYVA
Sbjct: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVSFNDTPTTVFWTDYVA 191
Query: 186 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245
TRWYRAPELCGSF SKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQLDL+TDLLGTP
Sbjct: 192 TRWYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPK 251
Query: 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKDRPTAEEAL 305
+E+I+ +RNEKAR+YL MRKK VPFS KFPNADP AFDPKDRPTA EAL
Sbjct: 252 SETIAGVRNEKARKYLNEMRKKNLVPFSQKFPNADPLALRLLQRLLAFDPKDRPTAAEAL 311
Query: 306 ADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGG 365
ADPYF LA V+REPS QPISK+EFEFERR+L KDD+RE+IYREILEYHPQ+L++Y+
Sbjct: 312 ADPYFKCLAKVEREPSCQPISKMEFEFERRRLTKDDIRELIYREILEYHPQLLKDYMNS- 370
Query: 366 EQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERV 411
E +SF+YPS + ++QFA+LEE+ GK P R+HASLPR V
Sbjct: 371 EGSSFLYPSAIGHLRKQFAYLEENSGKSGPVIPPDRKHASLPRSAV 416
|
|
| TAIR|locus:2024887 MPK18 "mitogen-activated protein kinase 18" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1600 (568.3 bits), Expect = 2.1e-164, P = 2.1e-164
Identities = 299/438 (68%), Positives = 356/438 (81%)
Query: 6 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATXXXX 65
E EFFTEYG+A+RY+I EVIGKGSYGVV +A+DTHTGE+VAIKKINDVFEH+SDA
Sbjct: 12 EMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTHTGEKVAIKKINDVFEHISDALRILR 71
Query: 66 XXXXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFF 125
HPDIVEIK IMLPPS+REFKDIYVVFELMESDLHQVIKANDDLT EH+QFF
Sbjct: 72 EVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFF 131
Query: 126 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVA 185
LYQ+LR LK++HTANV+HRDLKPKNILANA+CKLK+CDFGLARV+FND P+ +FWTDYVA
Sbjct: 132 LYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDTPTTVFWTDYVA 191
Query: 186 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245
TRWYRAPELCGSFFSKYTPAID+WSIGCIFAE+LTGKPLFPGK+VVHQL+L+TDLLGTP
Sbjct: 192 TRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQLELITDLLGTPK 251
Query: 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKDRPTAEEAL 305
+E+IS +RN+KAR+YL MRKK PV FS KF ADP AFDPKDRPT EAL
Sbjct: 252 SETISGVRNDKARKYLTEMRKKNPVTFSQKFSKADPLALRLLQRLLAFDPKDRPTPAEAL 311
Query: 306 ADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGG 365
ADPYF GL+ ++REPS+Q ISK+EFEFERR+L KDD+RE+IYREILEYHPQ+L++Y+ G
Sbjct: 312 ADPYFKGLSKIEREPSSQQISKMEFEFERRRLTKDDIRELIYREILEYHPQLLKDYMSGS 371
Query: 366 EQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQNNDY 425
E ++F+YPS + ++QF +LEE+ + PL+R+HASLPR V + + Q N
Sbjct: 372 EGSNFVYPSAIGHLRQQFTYLEENSSRNGPVIPLERKHASLPRSTVHSTVVHSTSQPN-L 430
Query: 426 GRTADSVAATLQSPPTEN 443
G T DS + + P++N
Sbjct: 431 GAT-DSRRVSFE--PSKN 445
|
|
| DICTYBASE|DDB_G0286353 erkA "mitogen-activated protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 846 (302.9 bits), Expect = 1.7e-84, P = 1.7e-84
Identities = 168/341 (49%), Positives = 226/341 (66%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATXXXXXXXXXXXXXHPD 77
RY I + IG G+YGVV SA D TGE+VAIKKI+ F+++ D H +
Sbjct: 148 RYSIVKCIGHGAYGVVCSAKDNLTGEKVAIKKISKAFDNLKDTKRTLREIHLLRHFKHEN 207
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
++ IK I+ P S+ +F+D+Y+V ELM++DLHQ+I + L+ +H Q+F+YQ+LRGLK+IH
Sbjct: 208 LISIKDILKPNSKEQFEDVYIVSELMDTDLHQIITSPQPLSDDHCQYFVYQMLRGLKHIH 267
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 197
+ANV HRDLKP N+L N DC LKICD GLARV DA F T+YVATRWYRAPE+ S
Sbjct: 268 SANVLHRDLKPSNLLINEDCLLKICDLGLARVE--DATHQGFMTEYVATRWYRAPEVILS 325
Query: 198 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 257
+ +KYT AIDIWS+GCIFAE+L KPLF GK+ +HQ+ L+ + +G+PS E I I NE+A
Sbjct: 326 W-NKYTKAIDIWSVGCIFAELLGRKPLFQGKDYIHQITLIIETIGSPSEEDICNIANEQA 384
Query: 258 RRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKDRPTAEEALADPYFHGLANVD 317
R+++ +M + V F++ FP A+P FDP R T EEALA PYF L
Sbjct: 385 RQFIRNMGNQPKVNFANMFPKANPDAIDLLERMLYFDPSKRLTVEEALAHPYFQSL---- 440
Query: 318 REPSTQPIS--KLEFEFERRKLAKDDVREMIYREILEYHPQ 356
+PS +PI K FE L +D ++E+IY E+L YHP+
Sbjct: 441 HDPSDEPICLHKFSLNFEAWDLNRDLLKELIYNEMLAYHPE 481
|
|
| TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 812 (290.9 bits), Expect = 6.6e-81, P = 6.6e-81
Identities = 157/352 (44%), Positives = 227/352 (64%)
Query: 10 FTEYG---EASRYQIQEV--IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATXXX 64
+ YG E SR + + IG+G+YG+V +A ++ TGE VAIKKI + F+++ DA
Sbjct: 29 YNVYGNLFEVSRKYVPPLRPIGRGAYGIVCAATNSETGEEVAIKKIGNAFDNIIDAKRTL 88
Query: 65 XXXXXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQF 124
H +++ +K I+ PP R F D+Y+V+ELM++DLHQ+I++N LT +H +F
Sbjct: 89 REIKLLKHMDHENVIAVKDIIKPPQRENFNDVYIVYELMDTDLHQIIRSNQPLTDDHCRF 148
Query: 125 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 184
FLYQLLRGLKY+H+ANV HRDLKP N+L NA+C LK+ DFGLAR F T+YV
Sbjct: 149 FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKLGDFGLARTK----SETDFMTEYV 204
Query: 185 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244
TRWYRAPEL + S+YT AIDIWS+GCI E +T +PLFPGK+ VHQL L+T+L+G+P
Sbjct: 205 VTRWYRAPELLLNC-SEYTAAIDIWSVGCILGETMTREPLFPGKDYVHQLRLITELIGSP 263
Query: 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKDRPTAEEA 304
S+ +R++ ARRY+ + + F+ +FPN FDP R T +EA
Sbjct: 264 DDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSAGAVDLLEKMLVFDPSRRITVDEA 323
Query: 305 LADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQ 356
L PY L +++ EP + F+FE+ L +++++E+IYRE ++++PQ
Sbjct: 324 LCHPYLAPLHDINEEPVC--VRPFNFDFEQPTLTEENIKELIYRETVKFNPQ 373
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LV37 | MPK9_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.8441 | 0.9862 | 0.9823 | yes | no |
| Q5Z9J0 | MPK12_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7992 | 0.9940 | 0.8706 | yes | no |
| Q5VP69 | MPK16_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7584 | 0.9665 | 0.9800 | no | no |
| Q53N72 | MPK15_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7372 | 0.9547 | 0.9738 | no | no |
| Q6L5F7 | MPK17_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7698 | 0.9685 | 0.8453 | no | no |
| P42525 | ERK1_DICDI | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5229 | 0.6673 | 0.6408 | yes | no |
| Q9C9U4 | MPK15_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7888 | 0.9724 | 0.8576 | no | no |
| Q84M93 | MPK17_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7166 | 0.9291 | 0.9711 | no | no |
| A2X0M1 | MPK13_ORYSI | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7564 | 0.9783 | 0.9822 | N/A | no |
| Q0E459 | MPK13_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7564 | 0.9783 | 0.9822 | no | no |
| Q9LM33 | MPK8_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.8094 | 0.9645 | 0.8319 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.24 | 0.994 |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.998 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00017805001 | SubName- Full=Chromosome chr17 scaffold_16, whole genome shotgun sequence; (586 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 508 | |||
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.0 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.0 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-162 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-150 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-142 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-126 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-124 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-123 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-110 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-108 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-104 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-102 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-95 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-94 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-92 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-91 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-90 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-89 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-89 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-86 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-85 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-84 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-83 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-81 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-81 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-76 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-73 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-72 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-71 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-71 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-70 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-70 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-69 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-68 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-65 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-65 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-65 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-64 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-64 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-63 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-63 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-63 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-62 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-61 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-60 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-60 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-59 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-56 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-55 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-55 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-55 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-50 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-49 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-49 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-47 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-47 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-46 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-46 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-46 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-44 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-43 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-41 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-40 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-39 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-38 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-38 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-37 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-36 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-35 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-34 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-33 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-33 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-31 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-30 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-30 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-30 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-27 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-27 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-27 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-25 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-25 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-24 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-23 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-23 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-23 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-22 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-22 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-22 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-21 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-21 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-20 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-19 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-16 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-16 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-15 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-15 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-15 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-15 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-13 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-12 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 0.001 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.002 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 741 bits (1914), Expect = 0.0
Identities = 312/338 (92%), Positives = 327/338 (96%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
RY+IQEVIGKGSYGVV SA+DTHTGE+VAIKKINDVFEHVSDATRILREIKLLRLLRHPD
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH+QFFLYQLLR LKYIH
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 197
TANVFHRDLKPKNILANADCKLKICDFGLARV+FND P+AIFWTDYVATRWYRAPELCGS
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 198 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 257
FFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLDL+TDLLGTPS E+ISR+RNEKA
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240
Query: 258 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 317
RRYL SMRKKQPVPFS KFPNADPLAL LLERLLAFDPKDRPTAEEALADPYF GLA V+
Sbjct: 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE 300
Query: 318 REPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 355
REPS QPI+KLEFEFERR+L K+DVRE+IYREILEYHP
Sbjct: 301 REPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP 338
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 532 bits (1373), Expect = 0.0
Identities = 188/332 (56%), Positives = 244/332 (73%), Gaps = 2/332 (0%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
RY++ + IG G+YGVV SAVD TG +VAIKKI++VF+ + DA RILREIKLLR LRH +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
I+ + I+ PPS +F D+Y+V ELME+DLH+VIK+ LT +H Q+FLYQ+LRGLKY+H
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 197
+ANV HRDLKP NIL N++C LKICDFGLAR D F T+YV TRWYRAPEL S
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180
Query: 198 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 257
S+YT AIDIWS+GCIFAE+LT KPLFPG++ + QL+L+ ++LGTPS E + I +EKA
Sbjct: 181 -SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239
Query: 258 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 317
R YL S+ KK P S FP A P A+ LLE++L FDPK R TA+EALA PY L + +
Sbjct: 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299
Query: 318 REPSTQPISKLEFEFERRKLAKDDVREMIYRE 349
EP +P +F F+ +L +++++E+IY E
Sbjct: 300 DEPVAKPPFDFDF-FDDDELTEEELKELIYEE 330
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 463 bits (1193), Expect = e-162
Identities = 187/339 (55%), Positives = 246/339 (72%), Gaps = 6/339 (1%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
++Y + IG+G+YG+V SA ++ T E+VAIKKI + F++ DA R LREIKLLR L H
Sbjct: 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHE 64
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 136
+++ IK IM PP R F D+Y+V+ELM++DLHQ+I+++ L+ +H Q+FLYQLLRGLKYI
Sbjct: 65 NVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
H+ANV HRDLKP N+L NA+C LKICDFGLAR + F T+YV TRWYRAPEL
Sbjct: 125 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD---FMTEYVVTRWYRAPELLL 181
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256
+ S+YT AID+WS+GCIFAE+L KPLFPGK+ VHQL L+T+LLG+PS E + IRNEK
Sbjct: 182 N-CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240
Query: 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 316
ARRY+ S+ F+ FP+A+PLA+ LLE++L FDP R T EEALA PY L +
Sbjct: 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300
Query: 317 DREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 355
EP Q + F+FE L ++D++E+IY E+L YHP
Sbjct: 301 SDEPVCQ--TPFSFDFEEDALTEEDIKELIYNEMLAYHP 337
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 431 bits (1111), Expect = e-150
Identities = 173/342 (50%), Positives = 236/342 (69%), Gaps = 16/342 (4%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 75
RYQ IG+G+YG+V SA TG +VAIKKI+ FEH + R LREIK+LR +H
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP-FEHQTFCQRTLREIKILRRFKH 62
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
+I+ I I+ PPS F D+Y+V ELME+DL+++IK L+ +H Q+FLYQ+LRGLKY
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH-LSNDHIQYFLYQILRGLKY 121
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 195
IH+ANV HRDLKP N+L N +C LKICDFGLAR++ + F T+YVATRWYRAPE+
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
+ YT AIDIWS+GCI AEML+ +PLFPGK+ +HQL+L+ +LGTPS E ++ I +
Sbjct: 182 LNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240
Query: 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY---FHG 312
+AR Y+ S+ K VP++ FPNADP AL LL+++L F+P R T EEALA PY +H
Sbjct: 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH- 299
Query: 313 LANVDREPSTQPISKLEFEFE---RRKLAKDDVREMIYREIL 351
+PS +P+++ F F+ L K+ ++E+I+ EI+
Sbjct: 300 ------DPSDEPVAEEPFPFDFELFDDLPKEKLKELIFEEIM 335
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 412 bits (1062), Expect = e-142
Identities = 175/334 (52%), Positives = 241/334 (72%), Gaps = 5/334 (1%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
SRY+ E IG G+YGVV SA+DT +G++VAIKKI F+ + A R LRE+K+LR +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 136
+I+ I+ I+ PP +FKD+YVV +LMESDLH +I ++ LT EH ++FLYQLLRGLKYI
Sbjct: 65 NIIAIRDILRPPGA-DFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLAR-VSFNDAPSAIFWTDYVATRWYRAPELC 195
H+ANV HRDLKP N+L N DC+L+I DFG+AR +S + F T+YVATRWYRAPEL
Sbjct: 124 HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
S +YT AID+WS+GCIFAEML + LFPGKN VHQL L+ +LG+PS E ++RI ++
Sbjct: 184 LSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242
Query: 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315
+ R+Y+ ++ +KQPVP+S FP A P AL LL ++L FDP++R T E+AL P+ +
Sbjct: 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302
Query: 316 VDREPSTQPISKLEFEFERRKLAKDDVREMIYRE 349
D EP+ P +F+FE +L+++ ++E I +E
Sbjct: 303 PDDEPTCPP--PFDFDFEAIELSREQLKEAIVKE 334
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 370 bits (952), Expect = e-126
Identities = 155/339 (45%), Positives = 212/339 (62%), Gaps = 13/339 (3%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-H 75
+Y+I + +GKG+YG+V A+D T E VA+KKI D F + +DA R REI L+ L H
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDH 66
Query: 76 PDIVEIKHIMLPPSRREF-KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 134
P+IV++ +++ + E KDIY+VFE ME+DLH VI+AN L H ++ +YQLL+ LK
Sbjct: 67 PNIVKLLNVI----KAENDKDIYLVFEYMETDLHAVIRANI-LEDVHKRYIMYQLLKALK 121
Query: 135 YIHTANVFHRDLKPKNILANADCKLKICDFGLARV--SFNDAPSAIFWTDYVATRWYRAP 192
YIH+ NV HRDLKP NIL N+DC++K+ DFGLAR + P TDYVATRWYRAP
Sbjct: 122 YIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181
Query: 193 E-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251
E L GS ++YT +D+WS+GCI EML GKPLFPG + ++QL+ + +++G PS E I
Sbjct: 182 EILLGS--TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239
Query: 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311
I++ A L S+ + P P A AL LL++LL F+P R TAEEAL PY
Sbjct: 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299
Query: 312 GLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREI 350
N EP + + + KL+ + R +Y EI
Sbjct: 300 QFHNPSDEPVLPYPITIPLD-DNVKLSVAEYRNKLYEEI 337
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 366 bits (941), Expect = e-124
Identities = 152/346 (43%), Positives = 216/346 (62%), Gaps = 12/346 (3%)
Query: 11 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 70
T + RYQ +G G+YG V SA DT TG +VAIKK++ F+ A R RE++LL
Sbjct: 9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLL 68
Query: 71 RLLRHPDIVEIKHIMLPPSRRE-FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 129
+ + H +++ + + P S E F+D+Y+V LM +DL+ ++K L+ +H QF +YQ+
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK-LSDDHIQFLVYQI 127
Query: 130 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
LRGLKYIH+A + HRDLKP NI N DC+LKI DFGLAR + ++ T YVATRWY
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM------TGYVATRWY 181
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
RAPE+ ++ Y +DIWS+GCI AE+LTGK LFPG + + QL + +L+GTP E +
Sbjct: 182 RAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309
+I +E AR Y+ S+ + F F A+PLA+ LLE++L DP R TA EALA PY
Sbjct: 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300
Query: 310 FHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 355
+ + EP P + FE R L D+ +E++Y+EI+ + P
Sbjct: 301 LAEYHDPEDEPVAPPYDQS---FESRDLTVDEWKELVYKEIMNFKP 343
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 362 bits (932), Expect = e-123
Identities = 170/337 (50%), Positives = 223/337 (66%), Gaps = 9/337 (2%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHT--GERVAIKKINDVFEHVSDATRILREIKLLRLLR- 74
RY++ + +G+G+YG+V SA + T E VAIKKI +VF A R LRE+KLLR R
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 134
H +I + + M F ++Y+ ELME+DLHQ+I++ LT H+Q F+YQ+L GLK
Sbjct: 61 HKNITCL-YDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLK 119
Query: 135 YIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VSFNDAPSAIFWTDYVATRWYRAPE 193
YIH+ANV HRDLKP N+L NADC+LKICDFGLAR S N +A F T+YVATRWYRAPE
Sbjct: 120 YIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179
Query: 194 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253
+ SF YT AID+WS+GCI AE+L KP+F GK+ V QL+ + +LGTP E++SRI
Sbjct: 180 IMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238
Query: 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313
+ KA+ Y+ S+ PF FPNA+PLAL LLE+LLAFDP R + EEAL PY
Sbjct: 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298
Query: 314 ANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREI 350
+ D EP Q FE E + +++R+MI E+
Sbjct: 299 HDPDDEPVCQKPFDFSFESED---SMEELRDMIIEEV 332
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 330 bits (847), Expect = e-110
Identities = 162/346 (46%), Positives = 224/346 (64%), Gaps = 24/346 (6%)
Query: 9 FFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK 68
F T + +RY + +G G++G+V SA D TG+ VAIKKI F A R RE+K
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 69 LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQ 128
LL+ LRH +I+ + I + P +DIY V EL+ +DLH+++ + L + Q+FLYQ
Sbjct: 62 LLKHLRHENIISLSDIFISP----LEDIYFVTELLGTDLHRLLTSRP-LEKQFIQYFLYQ 116
Query: 129 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 188
+LRGLKY+H+A V HRDLKP NIL N +C LKICDFGLAR+ T YV+TR+
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM------TGYVSTRY 170
Query: 189 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248
YRAPE+ ++ KY +DIWS GCIFAEML GKPLFPGK+ V+Q ++TDLLGTP +
Sbjct: 171 YRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229
Query: 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308
I+ I +E R++ S+ K++PVPFS KF NADP A+ LLE++L FDP+ R +A EALA P
Sbjct: 230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289
Query: 309 Y---FHGLANVDREPSTQPISKLEFE--FERRKLAKDDVREMIYRE 349
Y +H +P+ +P+++ +F+ F L D + M+Y E
Sbjct: 290 YLAPYH-------DPTDEPVAEEKFDWSFNDADLPVDTWKVMMYSE 328
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 323 bits (831), Expect = e-108
Identities = 136/294 (46%), Positives = 178/294 (60%), Gaps = 13/294 (4%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 78
YQ IG+G+YGVV A D TGE VAIKKI FE LREIKLL+ L HP+I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 79 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIH 137
+++ + D+Y+VFE M++DL+++IK L + +LYQLL+GL + H
Sbjct: 61 IKLLDVFRHK-----GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCG 196
+ + HRDLKP+N+L N + LK+ DFGLAR +T YV TRWYRAPE L G
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSF---GSPVRPYTHYVVTRWYRAPELLLG 172
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256
Y+ +DIWS+GCIFAE+L+ +PLFPGK+ + QL + LGTP E + +
Sbjct: 173 DKG--YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS-L 229
Query: 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
AR Y S KK +P FPNA P AL LL ++L +DP R TAE+ALA PYF
Sbjct: 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 312 bits (803), Expect = e-104
Identities = 126/296 (42%), Positives = 174/296 (58%), Gaps = 18/296 (6%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRHP 76
Y+ E +G+G+YGVV A D TGE VA+KKI ++ + LREI LL+ L+HP
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHP 58
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKY 135
+IV++ ++ + +Y+VFE + DL + + L+P + +YQLLRGL Y
Sbjct: 59 NIVKLLDVIHTERK-----LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-L 194
H+ + HRDLKP+NIL N D LK+ DFGLAR +F +T V T WYRAPE L
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLAR-AFGIPLRT--YTHEVVTLWYRAPEIL 170
Query: 195 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254
GS Y+ A+DIWS+GCIFAEM+TGKPLFPG + + QL + +LGTP+ ES +
Sbjct: 171 LGS--KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV-- 226
Query: 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
K Y + K P P DP + LL ++L ++P R +A+EAL PYF
Sbjct: 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 311 bits (798), Expect = e-102
Identities = 148/354 (41%), Positives = 211/354 (59%), Gaps = 32/354 (9%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 84
IG G++GVV S D G+RVA+KK+ +VF+++ R+ RE+K+L +H +++ I
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 85 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 144
+ PP F++IYVV ELM+SDLH++I + L+ +H + FLYQ+LRGLKY+H+A + HR
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHR 127
Query: 145 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFSKYT 203
D+KP N+L N++C LKICDFGLARV D + T V T++YRAPE L GS YT
Sbjct: 128 DIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEVVTQYYRAPEILMGS--RHYT 183
Query: 204 PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGS 263
A+DIWS+GCIFAE+L + LF ++ + QLDL+TDLLGTPS E++ E AR ++
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC-EGARAHILR 242
Query: 264 MRKKQP---VPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY-------FHG- 312
K P V ++ A+HLL R+L FDP R +A +ALA PY +H
Sbjct: 243 GPHKPPSLPVLYTLSSQATHE-AVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTC 301
Query: 313 ------------LANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYH 354
+ D EPS P E+E + V+E +++ ILE
Sbjct: 302 MCKCCYTTSGGRVYTSDFEPSANPPFDDEYEKNLTSV--RQVKEELHQFILEQQ 353
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 291 bits (747), Expect = 5e-95
Identities = 147/339 (43%), Positives = 215/339 (63%), Gaps = 12/339 (3%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
RYQ +G G+YG V +A DT TG RVA+KK++ F+ + A R RE++LL+ ++H +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77
Query: 78 IVEIKHIMLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 136
++ + + P S EF D+Y+V LM +DL+ ++K LT +H QF +YQ+LRGLKYI
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYI 136
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
H+A++ HRDLKP N+ N DC+LKI DFGLAR + ++ T YVATRWYRAPE+
Sbjct: 137 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM------TGYVATRWYRAPEIML 190
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256
++ Y +DIWS+GCI AE+LTG+ LFPG + + QL L+ L+GTP E + +I +E
Sbjct: 191 NWM-HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249
Query: 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 316
AR Y+ S+ + + F++ F A+PLA+ LLE++L D R TA +ALA YF +
Sbjct: 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309
Query: 317 DREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 355
D EP P + FE R L D+ + + Y E++ + P
Sbjct: 310 DDEPVADPYDQ---SFESRDLLIDEWKSLTYDEVISFVP 345
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 286 bits (734), Expect = 7e-94
Identities = 116/302 (38%), Positives = 172/302 (56%), Gaps = 29/302 (9%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLLRHPD 77
Y++ + +G G++G V A + TGE VAIKK+ F + LRE+K L +L HP+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPN 59
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKY 135
IV++K + RE ++Y VFE ME +L+Q++K + + +YQ+L+GL +
Sbjct: 60 IVKLKEV-----FRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL- 194
IH FHRDLKP+N+L + +KI DFGLAR + P +TDYV+TRWYRAPE+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----YTDYVSTRWYRAPEIL 170
Query: 195 --CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252
S Y+ +DIW++GCI AE+ T +PLFPG + + QL + +LGTP+ +
Sbjct: 171 LRSTS----YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE- 225
Query: 253 RNEKARRYLGSMR----KKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308
+ + + P PNA P A+ L++ +L +DPK RPTA +AL P
Sbjct: 226 ----GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281
Query: 309 YF 310
YF
Sbjct: 282 YF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 281 bits (721), Expect = 7e-92
Identities = 119/302 (39%), Positives = 174/302 (57%), Gaps = 25/302 (8%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRHP 76
Y+ IG+G+YG V A + TGE VA+KKI E+ + I +REIKLL+ LRHP
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHP 58
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLRGLKY 135
+IV +K I+ + IY+VFE M+ DL ++ T + ++ QLL GL+Y
Sbjct: 59 NIVRLKEIVTSKGK---GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-L 194
+H+ + HRD+K NIL N D LK+ DFGLAR + SA + T+ V T WYR PE L
Sbjct: 116 LHSNGILHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADY-TNRVITLWYRPPELL 173
Query: 195 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254
G+ ++Y P +D+WS+GCI AE+ GKP+F G + QL+ + +L G+P+ E+ +
Sbjct: 174 LGA--TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231
Query: 255 EKARRYLGSMRKKQPVP------FSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308
+ +++ K+P F H DP AL LL++LL DPK R +A++AL
Sbjct: 232 LP---WFENLKPKKPYKRRLREFFKHLI---DPSALDLLDKLLTLDPKKRISADQALQHE 285
Query: 309 YF 310
YF
Sbjct: 286 YF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 279 bits (716), Expect = 1e-91
Identities = 109/293 (37%), Positives = 150/293 (51%), Gaps = 40/293 (13%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 78
Y+I E +G+GS+G V A D TG+ VAIK I D RILREIK+L+ L+HP+I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI-KKDRERILREIKILKKLKHPNI 59
Query: 79 VEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
V + + +Y+V E E DL ++K L+ + +F+L Q+L L+Y+H
Sbjct: 60 VRLYDVFEDE-----DKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLH 114
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 197
+ + HRDLKP+NIL + D +K+ DFGLAR T +V T Y APE+
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL----TTFVGTPEYMAPEVLLG 170
Query: 198 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 257
Y A+DIWS+G I E+LTGKP FPG + QL + +G P
Sbjct: 171 --KGYGKAVDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKP------------- 212
Query: 258 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
PF + P A L+ +LL DP+ R TAEEAL P+F
Sbjct: 213 -----------KPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 280 bits (718), Expect = 1e-90
Identities = 140/339 (41%), Positives = 202/339 (59%), Gaps = 13/339 (3%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
RY + +G G+YG V SA+D TGE+VAIKK++ F+ A R RE+ LL+ ++H +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 78 IVEIKHIMLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 136
++ + + S EF+D Y+V M++DL +++ L+ + Q+ +YQ+L GLKYI
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYI 133
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
H+A + HRDLKP N+ N DC+LKI DFGLAR + DA T YV TRWYRAPE+
Sbjct: 134 HSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA--DAE----MTGYVVTRWYRAPEVIL 187
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256
++ Y +DIWS+GCI AEMLTGK LF GK+ + QL + + G P E + ++ ++
Sbjct: 188 NWM-HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246
Query: 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 316
A+ Y+ S+ K FS FP A P A+ LLE++L D R TA EAL PYF +
Sbjct: 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306
Query: 317 DREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 355
D E QP E KL+ D+ ++ IY+E+ + P
Sbjct: 307 DEETEQQPYDD---SLENEKLSVDEWKKHIYKEVKSFSP 342
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 276 bits (706), Expect = 5e-89
Identities = 136/340 (40%), Positives = 209/340 (61%), Gaps = 12/340 (3%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
RY+ + +G G+YG V SA+D TG +VAIKK+ F+ A R RE++LL+ ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 77 DIVEIKHIMLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
+++ + + P S F D Y+V M +DL +++K ++ L+ + QF +YQ+L+GLKY
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKY 133
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 195
IH A + HRDLKP N+ N DC+LKI DFGLAR + ++ T YV TRWYRAPE+
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM------TGYVVTRWYRAPEVI 187
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
++ YT +DIWS+GCI AEMLTGKPLF G + + QL + + GTPS E + ++++E
Sbjct: 188 LNWM-HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246
Query: 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315
A+ Y+ + + + F PNA+PLA+++LE++L D + R TA EALA PYF +
Sbjct: 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306
Query: 316 VDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 355
+ E P + F+ + ++ + + + EIL + P
Sbjct: 307 PEDETEAPP---YDDSFDEVDQSLEEWKRLTFTEILSFQP 343
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 275 bits (705), Expect = 9e-89
Identities = 138/339 (40%), Positives = 209/339 (61%), Gaps = 12/339 (3%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
RYQ +G G+YG V SA DT ++VA+KK++ F+ + A R RE++LL+ ++H +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN 75
Query: 78 IVEIKHIMLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 136
++ + + P S F ++Y+V LM +DL+ ++K L+ EH QF +YQLLRGLKYI
Sbjct: 76 VIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK-LSDEHVQFLIYQLLRGLKYI 134
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
H+A + HRDLKP N+ N DC+L+I DFGLAR + ++ T YVATRWYRAPE+
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM------TGYVATRWYRAPEIML 188
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256
++ Y +DIWS+GCI AE+L GK LFPG + + QL + +++GTPS E + +I +E
Sbjct: 189 NWM-HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247
Query: 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 316
AR+Y+ S+ F A+PLA+ LLE++L D R +A EALA PYF +
Sbjct: 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP 307
Query: 317 DREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 355
+ EP +P + E ++ ++ +E+ Y E+ + P
Sbjct: 308 EDEPEAEPYDE---SPENKERTIEEWKELTYEEVSSFKP 343
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 266 bits (683), Expect = 5e-86
Identities = 125/300 (41%), Positives = 168/300 (56%), Gaps = 20/300 (6%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEHVSDATRI--LREIKLLRLLR 74
RY+ + +G+G+Y VV A D TG VAIKKI + D LREIKLL+ L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGL 133
HP+I+ + + S I +VFE ME+DL +VIK LTP + ++ LRGL
Sbjct: 61 HPNIIGLLDVFGHKSN-----INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGL 115
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 193
+Y+H+ + HRDLKP N+L +D LK+ DFGLAR SF P+ T V TRWYRAPE
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR-SFGS-PNRKM-THQVVTRWYRAPE 172
Query: 194 LCGSFF--SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251
L F Y +D+WS+GCIFAE+L P PG + + QL + + LGTP+ E+
Sbjct: 173 L---LFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229
Query: 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311
+ + Y+ + P P FP A AL LL+RLL +P R TA +AL PYF
Sbjct: 230 VTSLP--DYV-EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 263 bits (675), Expect = 5e-85
Identities = 121/299 (40%), Positives = 174/299 (58%), Gaps = 20/299 (6%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
RY+I IG+G++G+V A D TGE VA+KK+ + LREIK L+ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYI 136
+V++ + S +V E M SDL +V++ + L + ++ LL+G+ Y+
Sbjct: 61 VVKLLDVFPHGSG-----FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC- 195
H + HRDLKP N+L +AD LKI DFGLAR+ + P ++ VATRWYRAPEL
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL--YSHQVATRWYRAPELLY 173
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN- 254
G+ KY P +D+W++GCIFAE+L G PLFPG+N + QL ++ LGTP+ E+ + +
Sbjct: 174 GA--RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231
Query: 255 ---EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
K + +P+P FP+A P AL LL+ LL +DP R +A EAL PYF
Sbjct: 232 PDYNKIT-----FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 263 bits (673), Expect = 7e-84
Identities = 132/348 (37%), Positives = 202/348 (58%), Gaps = 24/348 (6%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
RYQ + IG G+ G+V +A DT TG+ VAIKK++ F++V+ A R RE+ L++L+ H
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 77 DIVEIKHIMLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
+I+ + ++ P S EF+D+Y+V ELM+++L QVI DL E + LYQ+L G+K+
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI--QMDLDHERMSYLLYQMLCGIKH 133
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 195
+H+A + HRDLKP NI+ +DC LKI DFGLAR A ++ T YV TR+YRAPE+
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYVVTRYYRAPEVI 189
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
Y +DIWS+GCI EM+ G LFPG + + Q + + + LGTPS E +SR+
Sbjct: 190 LGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL-QP 246
Query: 256 KARRYLGSMRKKQPVPFSHKFP---------NADPL----ALHLLERLLAFDPKDRPTAE 302
R Y+ + K F FP + + L A LL ++L DP+ R + +
Sbjct: 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306
Query: 303 EALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREI 350
+AL PY + + E P + + + R+ ++ +E+IY+E+
Sbjct: 307 DALQHPYIN-VWYDPSEVEAPPPAPYDHSIDEREHTVEEWKELIYKEV 353
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 258 bits (662), Expect = 4e-83
Identities = 116/296 (39%), Positives = 168/296 (56%), Gaps = 12/296 (4%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+Y++ V+G+G+YGVV + TGE VAIKK + + LRE+K+LR LRH +
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYI 136
IV +K RR+ + +Y+VFE +E L ++++A+ L P+ + +++QLL+ + Y
Sbjct: 62 IVNLKEAF----RRKGR-LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LC 195
H+ N+ HRD+KP+NIL + LK+CDFG AR A A TDYVATRWYRAPE L
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFAR--ALRARPASPLTDYVATRWYRAPELLV 174
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
G + Y +D+W+IGCI AE+L G+PLFPG + + QL L+ LG +
Sbjct: 175 GD--TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232
Query: 256 KARRYLGSMRKKQPVPFSHKFPNA-DPLALHLLERLLAFDPKDRPTAEEALADPYF 310
+ QP ++P AL L+ L DPK+R T +E L PYF
Sbjct: 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 254 bits (650), Expect = 1e-81
Identities = 97/293 (33%), Positives = 144/293 (49%), Gaps = 34/293 (11%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 78
Y++ +G GS+G V A TG+ VA+K + E REI++LR L HP+I
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 79 VEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
V + + +Y+V E E DL + L+ + + Q+LRGL+Y+H
Sbjct: 61 VRLIDAF-----EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 197
+ + HRDLKP+NIL + + +KI DFGLA+ + S T +V T WY APE+
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL---TTFVGTPWYMAPEVL-L 171
Query: 198 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 257
+ Y P +D+WS+G I E+LTGKP F G+N++ QL + I RI
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQL------------QLIRRI----- 214
Query: 258 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
+ ++ A L+++ L DP RPTAEE L P+F
Sbjct: 215 ------LGPPLEFDEPKWSSGSEE-AKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 257 bits (657), Expect = 1e-81
Identities = 143/359 (39%), Positives = 192/359 (53%), Gaps = 52/359 (14%)
Query: 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI---LREIKL 69
+ SRY +G GS G+V SAVD+ +RVA+KKI ++D + LREIK+
Sbjct: 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIV-----LTDPQSVKHALREIKI 55
Query: 70 LRLLRHPDIVEIKHIMLPPSRR---------EFKDIYVVFELMESDLHQVIKANDDLTPE 120
+R L H +IV++ ++ P E +Y+V E ME+DL V++ L+ E
Sbjct: 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP-LSEE 114
Query: 121 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSFNDAPSAIF 179
H + F+YQLLRGLKYIH+ANV HRDLKP N+ N D LKI DFGLAR+ +
Sbjct: 115 HARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 180 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTD 239
++ + T+WYR+P L S + YT AID+W+ GCIFAEMLTGKPLF G H+L+ M
Sbjct: 175 LSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGA---HELEQMQL 230
Query: 240 LLGTPSTESISRIRNE-----------KARRYLGSMRKKQPVPFSHKFPNADPLALHLLE 288
+L ES+ +R E R G R+ P P +P AL LE
Sbjct: 231 IL-----ESVPVVREEDRNELLNVIPSFVRNDGGEPRR----PLRDLLPGVNPEALDFLE 281
Query: 289 RLLAFDPKDRPTAEEALADPYFHGLANVDREP-STQPISKLEFEFERRKLAKDDVREMI 346
++L F+P DR TAEEAL PY + EP S P +E E DD+ M
Sbjct: 282 QILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFH-IEDEL-------DDILLMT 332
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 242 bits (619), Expect = 2e-76
Identities = 120/302 (39%), Positives = 164/302 (54%), Gaps = 25/302 (8%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRHP 76
Y+ I +G+YGVV A D TGE VA+KK+ E + I LREI +L L+HP
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK--MEKEKEGFPITSLREINILLKLQHP 64
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKY 135
+IV +K +++ IY+V E +E DL +++ + + QLL G+ +
Sbjct: 65 NIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-L 194
+H + HRDLK N+L N LKICDFGLAR + +T V T WYRAPE L
Sbjct: 122 LHDNWILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKP--YTQLVVTLWYRAPELL 178
Query: 195 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES---ISR 251
G+ +Y+ AID+WS+GCIFAE+LT KPLFPGK+ + QL+ + LLGTP+ + S
Sbjct: 179 LGA--KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236
Query: 252 IRNEKARRYLGSMRKKQPV-PFSHKFPNA--DPLALHLLERLLAFDPKDRPTAEEALADP 308
+ K + K P KFP LL RLL +DP R +AE+AL P
Sbjct: 237 LPGAKKKT-----FTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHP 291
Query: 309 YF 310
YF
Sbjct: 292 YF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 234 bits (599), Expect = 2e-73
Identities = 113/316 (35%), Positives = 165/316 (52%), Gaps = 34/316 (10%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLR 74
Y+I +G+G++G V A TG VA+KKI + + D I LREIK+L+ L+
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI--LMHNEKDGFPITALREIKILKKLK 65
Query: 75 HPDIVEIKHIML---PPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLL 130
HP++V + + + S+R+ +Y+V M+ DL +++ LT + ++ QLL
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125
Query: 131 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP--------SAIFWTD 182
G+ Y+H ++ HRD+K NIL + LKI DFGLAR P +T+
Sbjct: 126 EGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185
Query: 183 YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 241
V TRWYR PEL G +YT A+DIW IGC+FAEM T +P+ GK+ + QL L+ L
Sbjct: 186 LVVTRWYRPPELLLGE--RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243
Query: 242 GTPSTESISRIR-------NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFD 294
GTP+ E+ R Y ++ + +F P L LL +LL+ D
Sbjct: 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE--------RFGKLGPEGLDLLSKLLSLD 295
Query: 295 PKDRPTAEEALADPYF 310
P R TA +AL PYF
Sbjct: 296 PYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 232 bits (593), Expect = 1e-72
Identities = 116/308 (37%), Positives = 161/308 (52%), Gaps = 37/308 (12%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA---TRILREIKLLRLLR- 74
Y+ IG+G+YG V A D +TG VA+KK+ +S+ LREI LL+ L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLKQLES 57
Query: 75 --HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK--ANDDLTPEHYQFFLYQLL 130
HP+IV + + P + +VFE ++ DL + L PE + + QLL
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 131 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV-SFNDAPSAIFWTDYVATRWY 189
RG+ ++H+ + HRDLKP+NIL +D ++KI DFGLAR+ SF A+ T V T WY
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE---MAL--TSVVVTLWY 172
Query: 190 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE- 247
RAPE L S Y +D+WS+GCIFAE+ +PLF G + QLD + D++G PS E
Sbjct: 173 RAPEVLLQ---SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229
Query: 248 -----SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 302
S+ R S P F P L LL+++L F+P R +A
Sbjct: 230 WPRNVSLPRS----------SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAF 279
Query: 303 EALADPYF 310
EAL PYF
Sbjct: 280 EALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 229 bits (587), Expect = 1e-71
Identities = 127/295 (43%), Positives = 167/295 (56%), Gaps = 25/295 (8%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRHPDIVEIK 82
IG+G+YG+V A DT +GE VA+KK+ ++ D I LREI LL LRHP+IVE+K
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVR--MDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 83 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANV 141
+++ + I++V E E DL ++ + + + QLLRGL+Y+H +
Sbjct: 73 EVVVG---KHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFI 129
Query: 142 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFS 200
HRDLK N+L LKI DFGLAR + + T V T WYRAPE L G +
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLART-YGLPAKPM--TPKVVTLWYRAPELLLGC--T 184
Query: 201 KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI----SRIRNEK 256
YT AID+W++GCI AE+L KPL PGK+ + QLDL+ LLGTP+ ESI S +
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN-ESIWPGFSDLPL-- 241
Query: 257 ARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
++ KQP HKFP L LL LL +DPK R TAEEAL YF
Sbjct: 242 VGKF---TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 227 bits (582), Expect = 3e-71
Identities = 113/297 (38%), Positives = 173/297 (58%), Gaps = 20/297 (6%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPD 77
Y+I IG+G++ V A TG+ AIK + F+ + LREI+ LR L HP+
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPN 59
Query: 78 IVEIKHIML-PPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLRGLKY 135
I+ + ++ + R + +VFELM+ +L+++IK PE + ++YQLL+ L +
Sbjct: 60 ILRLIEVLFDRKTGR----LALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-- 193
+H +FHRD+KP+NIL D LK+ DFG R ++ P +T+Y++TRWYRAPE
Sbjct: 116 MHRNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPP----YTEYISTRWYRAPECL 170
Query: 194 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253
L + Y P +DIW++GC+F E+L+ PLFPG N + Q+ + D+LGTP E + + R
Sbjct: 171 LTDGY---YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227
Query: 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
+ Y + K+ PNA L LL++LLA+DP +R TA++AL PYF
Sbjct: 228 KSRHMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 226 bits (577), Expect = 2e-70
Identities = 122/298 (40%), Positives = 167/298 (56%), Gaps = 21/298 (7%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSD---ATRILREIKLLRLLRH 75
YQ E IG+G+YGVV A D TGE VA+KKI E + +T I REI LL+ L H
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIR--LETEDEGVPSTAI-REISLLKELNH 57
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVI--KANDDLTPEHYQFFLYQLLRGL 133
P+IV + ++ ++ +Y+VFE ++ DL + + L P + +LYQLL+G+
Sbjct: 58 PNIVRLLDVVHSENK-----LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 193
Y H+ V HRDLKP+N+L + + LK+ DFGLAR +F +T V T WYRAPE
Sbjct: 113 AYCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR-AFGVPVRT--YTHEVVTLWYRAPE 169
Query: 194 -LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252
L GS Y+ +DIWSIGCIFAEM+ +PLFPG + + QL + LGTP + +
Sbjct: 170 ILLGSRQ--YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV 227
Query: 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
Y + K S PN D L LL ++L +DP R +A+ AL PYF
Sbjct: 228 --TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 225 bits (574), Expect = 5e-70
Identities = 115/296 (38%), Positives = 171/296 (57%), Gaps = 17/296 (5%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 78
++ E +G+G+Y V + TGE VA+K+I+ E + +T I REI L++ L+H +I
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-REISLMKELKHENI 60
Query: 79 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD---LTPEHYQFFLYQLLRGLKY 135
V + ++ ++ + +VFE M+ DL + + + L P + F YQLL+G+ +
Sbjct: 61 VRLHDVIHTENK-----LMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-L 194
H V HRDLKP+N+L N +LK+ DFGLAR +F P F + V T WYRAP+ L
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGELKLADFGLAR-AFG-IPVNTFSNE-VVTLWYRAPDVL 172
Query: 195 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254
GS Y+ +IDIWS+GCI AEM+TG+PLFPG N QL + ++GTP+ + I
Sbjct: 173 LGS--RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230
Query: 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
Y + + P FP+ADPL + LL RLL +P+ R +A +AL P+F
Sbjct: 231 --LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 226 bits (577), Expect = 1e-69
Identities = 129/369 (34%), Positives = 210/369 (56%), Gaps = 29/369 (7%)
Query: 3 SALETEFFT-EYGEAS-----RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH 56
S +++F++ + +++ RYQ + IG G+ G+V +A DT G VA+KK++ F++
Sbjct: 1 SEEDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN 60
Query: 57 VSDATRILREIKLLRLLRHPDIVEIKHIMLP-PSRREFKDIYVVFELMESDLHQVIKAND 115
+ A R RE+ LL+ + H +I+ + ++ P S EF+D+Y+V ELM+++L QVI
Sbjct: 61 QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM-- 118
Query: 116 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175
+L E + LYQ+L G+K++H+A + HRDLKP NI+ +DC LKI DFGLAR A
Sbjct: 119 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AC 174
Query: 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD 235
+ T YV TR+YRAPE+ Y +DIWS+GCI E++ G +F G + + Q +
Sbjct: 175 TNFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN 232
Query: 236 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPN--------ADPL----A 283
+ + LGTPS E ++R++ R Y+ + + + F FP+ D L A
Sbjct: 233 KVIEQLGTPSAEFMNRLQ-PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQA 291
Query: 284 LHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVR 343
LL ++L DP R + +EAL PY + E P + + E R+ A ++ +
Sbjct: 292 RDLLSKMLVIDPDKRISVDEALRHPYITVWYD-PAEAEAPPPQIYDAQLEEREHAIEEWK 350
Query: 344 EMIYREILE 352
E+IY+E+++
Sbjct: 351 ELIYKEVMD 359
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 222 bits (567), Expect = 2e-68
Identities = 117/324 (36%), Positives = 168/324 (51%), Gaps = 39/324 (12%)
Query: 18 RYQIQEVIGKGSYGVVGSAV--DTHTGERVAIKKI---NDVFEHVSDATRILREIKLLRL 72
+Y+I+ IG+G+YG V A + G+ AIKK + + +S + REI LLR
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA--CREIALLRE 58
Query: 73 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK-----ANDDLTPEHYQFFLY 127
L+H ++V + + L + + +Y++F+ E DL Q+IK + P + L+
Sbjct: 59 LKHENVVSLVEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 128 QLLRGLKYIHTANVFHRDLKPKNILANADCK----LKICDFGLARVSFNDAPSAIFWTD- 182
Q+L G+ Y+H+ V HRDLKP NIL + +KI D GLAR+ FN + D
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL-FNAPLKPLADLDP 174
Query: 183 YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV---------VH 232
V T WYRAPEL G+ YT AIDIW+IGCIFAE+LT +P+F G+
Sbjct: 175 VVVTIWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232
Query: 233 QLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFS------HKFPNADPLALHL 286
QL+ + ++LGTP+ + I+ L K + P + K D L
Sbjct: 233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL 292
Query: 287 LERLLAFDPKDRPTAEEALADPYF 310
L +LL +DP R TAEEAL PYF
Sbjct: 293 LRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 212 bits (542), Expect = 3e-65
Identities = 117/304 (38%), Positives = 170/304 (55%), Gaps = 30/304 (9%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI----LREIKLLRLL 73
+Y+ IG+GSYGVV + TG+ VAIKK F D I LREI++L+ L
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKK----FVESEDDPVIKKIALREIRMLKQL 57
Query: 74 RHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRG 132
+HP++V + + RR+ K +++VFE + + ++ N PEH + ++Q L+
Sbjct: 58 KHPNLVNLIEVF----RRKRK-LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQA 112
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 192
+ + H N HRD+KP+NIL ++K+CDFG AR+ +TDYVATRWYRAP
Sbjct: 113 VNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL---TGPGDDYTDYVATRWYRAP 169
Query: 193 EL-CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG--TPSTESI 249
EL G ++Y P +D+W+IGC+FAE+LTG+PL+PGK+ V QL L+ LG P + I
Sbjct: 170 ELLVGD--TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227
Query: 250 SRIRNEKARRYLGSMRKKQP---VPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306
++ + +P P KFPN AL L+ L DP +R + EE L
Sbjct: 228 FS-----TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282
Query: 307 DPYF 310
PYF
Sbjct: 283 HPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 212 bits (542), Expect = 3e-65
Identities = 114/304 (37%), Positives = 170/304 (55%), Gaps = 19/304 (6%)
Query: 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 72
+G+ Y+ + +G+GSY V TG+ VA+K+I E + T I RE LL+
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-REASLLKD 59
Query: 73 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLR 131
L+H +IV + I+ K + +VFE +++DL Q + L+ + + FL+QLLR
Sbjct: 60 LKHANIVTLHDII-----HTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR 114
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 191
GL Y H V HRDLKP+N+L + +LK+ DFGLAR PS + ++ V T WYR
Sbjct: 115 GLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARA--KSVPSKTY-SNEVVTLWYRP 171
Query: 192 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG-KNVVHQLDLMTDLLGTPSTESI 249
P+ L GS ++Y+ ++D+W +GCIF EM TG+PLFPG +V QL + +LGTP+ E+
Sbjct: 172 PDVLLGS--TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETW 229
Query: 250 SRI-RNEKARRYLGSMRKKQPVPFSHKFPNAD--PLALHLLERLLAFDPKDRPTAEEALA 306
+ N + + Y S P P + P D P L + L ++PK R +A EA+
Sbjct: 230 PGVSSNPEFKPY--SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287
Query: 307 DPYF 310
PYF
Sbjct: 288 HPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 213 bits (545), Expect = 5e-65
Identities = 120/324 (37%), Positives = 169/324 (52%), Gaps = 43/324 (13%)
Query: 16 ASRY-QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR------------ 62
+ RY Q +G+G+YG V A DT TG+ VAIKK+ + E +D T+
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKII-EISNDVTKDRQLVGMCGIHF 65
Query: 63 -ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH 121
LRE+K++ ++H +I+ + + + +F I +V ++M SDL +V+ LT
Sbjct: 66 TTLRELKIMNEIKHENIMGLVDVYV---EGDF--INLVMDIMASDLKKVVDRKIRLTESQ 120
Query: 122 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF-- 179
+ L Q+L GL +H HRDL P NI N+ KI DFGLAR S
Sbjct: 121 VKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 180 ---------WTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 229
T V T WYRAPEL G+ KY A+D+WS+GCIFAE+LTGKPLFPG+N
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGA--EKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238
Query: 230 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGS---MRKKQPVPFSHKFPNADPLALHL 286
+ QL + +LLGTP+ + N + L ++P FPNA A+ L
Sbjct: 239 EIDQLGRIFELLGTPNED------NWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDL 292
Query: 287 LERLLAFDPKDRPTAEEALADPYF 310
L+ LL +P +R +A+EAL YF
Sbjct: 293 LQSLLKLNPLERISAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 211 bits (539), Expect = 6e-64
Identities = 128/352 (36%), Positives = 200/352 (56%), Gaps = 29/352 (8%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
RYQ + IG G+ G+V +A D VAIKK++ F++ + A R RE+ L++ + H +
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 78 IVEIKHIMLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 136
I+ + ++ P S EF+D+Y+V ELM+++L QVI+ +L E + LYQ+L G+K++
Sbjct: 85 IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHL 142
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
H+A + HRDLKP NI+ +DC LKI DFGLAR A ++ T YV TR+YRAPE+
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYVVTRYYRAPEVIL 198
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256
Y +DIWS+GCI EM+ G LFPG + + Q + + + LGTP E + +++
Sbjct: 199 GM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ-PT 255
Query: 257 ARRYLGSMRKKQPVPFSHKFPN----AD--------PLALHLLERLLAFDPKDRPTAEEA 304
R Y+ + K F FP+ AD A LL ++L D R + +EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 305 LADPYFHGLANVDREPS--TQPISKL-EFEFERRKLAKDDVREMIYREILEY 353
L PY NV +PS P K+ + + + R+ ++ +E+IY+E+++
Sbjct: 316 LQHPYI----NVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDL 363
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 208 bits (532), Expect = 7e-64
Identities = 116/295 (39%), Positives = 166/295 (56%), Gaps = 15/295 (5%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 78
+Q E IG+G+YGVV A + TGE VA+KKI E + +REI LL+ L HP+I
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 79 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYI 136
V++ ++ +Y+VFE + DL + + A+ + + +L+QLL+GL +
Sbjct: 62 VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LC 195
H+ V HRDLKP+N+L N + +K+ DFGLAR +F P + T V T WYRAPE L
Sbjct: 117 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFG-VPVRTY-THEVVTLWYRAPEILL 173
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
G + Y+ A+DIWS+GCIFAEM+T + LFPG + + QL + LGTP + +
Sbjct: 174 GCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231
Query: 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
Y S K FS P D LL ++L +DP R +A+ ALA P+F
Sbjct: 232 P--DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 208 bits (531), Expect = 1e-63
Identities = 118/302 (39%), Positives = 174/302 (57%), Gaps = 27/302 (8%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI--NDVFEHV-SDATRILREIKLLRLLR 74
+Y+ E IG+G+YG V A + T E VA+K++ +D E V S A LREI LL+ L+
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA---LREICLLKELK 57
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGL 133
H +IV + ++ + + +VFE + DL + + N D+ PE + F++QLL+GL
Sbjct: 58 HKNIVRLYDVLHSDKK-----LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGL 112
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 193
+ H+ NV HRDLKP+N+L N + +LK+ DFGLAR +F P + + V T WYR P+
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR-AFG-IPVRCYSAE-VVTLWYRPPD 169
Query: 194 -LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES--- 248
L G+ Y+ +ID+WS GCIFAE+ G+PLFPG +V QL + LLGTP+ ES
Sbjct: 170 VLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPG 227
Query: 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308
+S++ + K + + P + LL+ LL +P R +AEEAL P
Sbjct: 228 VSKLPDYKPYPMYPAT-----TSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP 282
Query: 309 YF 310
YF
Sbjct: 283 YF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 208 bits (531), Expect = 1e-63
Identities = 119/308 (38%), Positives = 178/308 (57%), Gaps = 38/308 (12%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI-LREIKLLRLLRHP 76
+Y+ ++G+GSYG+V TG+ VAIKK + E +I +REI++L+ LRH
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLES-EDDKMVKKIAMREIRMLKQLRHE 60
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY---------QFFLY 127
++V ++ RR+ K +Y+VFE ++ H V+ DDL E Y + +L+
Sbjct: 61 NLVN----LIEVFRRK-KRLYLVFEFVD---HTVL---DDL--EKYPNGLDESRVRKYLF 107
Query: 128 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 187
Q+LRG+++ H+ N+ HRD+KP+NIL + +K+CDFG AR AP ++ TDYVATR
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVY-TDYVATR 164
Query: 188 WYRAPEL-CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246
WYRAPEL G +KY A+DIW++GC+ EMLTG+PLFPG + + QL + LG
Sbjct: 165 WYRAPELLVGD--TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGN--- 219
Query: 247 ESISRIRNEKARRYLGS-MR---KKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 302
I R + + L + MR K+ P +FP L L L ++ L DP DRP++
Sbjct: 220 -LIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSS 278
Query: 303 EALADPYF 310
+ L +F
Sbjct: 279 QLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 210 bits (535), Expect = 2e-63
Identities = 125/350 (35%), Positives = 199/350 (56%), Gaps = 29/350 (8%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
RYQ + IG G+ G+V +A D VAIKK++ F++ + A R RE+ L++ + H +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 78 IVEIKHIMLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 136
I+ + ++ P S EF+D+Y+V ELM+++L QVI+ +L E + LYQ+L G+K++
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHL 135
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
H+A + HRDLKP NI+ +DC LKI DFGLAR A ++ T YV TR+YRAPE+
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYVVTRYYRAPEVIL 191
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256
Y +DIWS+GCI EM+ K LFPG++ + Q + + + LGTP E + +++
Sbjct: 192 GM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 248
Query: 257 ARRYLGSMRKKQPVPFSHKFPNA------------DPLALHLLERLLAFDPKDRPTAEEA 304
R Y+ + K + F FP++ A LL ++L DP R + +EA
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308
Query: 305 LADPYFHGLANVDREPS---TQPISKLEFEFERRKLAKDDVREMIYREIL 351
L PY NV +P+ P + + + R+ ++ +E+IY+E++
Sbjct: 309 LQHPYI----NVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM 354
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 205 bits (523), Expect = 2e-62
Identities = 112/292 (38%), Positives = 167/292 (57%), Gaps = 16/292 (5%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 82
E IG+G+YGVV + TG+ VA+KKI E + +REI LL+ L+HP+IV ++
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 83 HIMLPPSRREFKDIYVVFELMESDLHQ---VIKANDDLTPEHYQFFLYQLLRGLKYIHTA 139
+++ SR +Y++FE + DL + + + E + +LYQ+L+G+ + H+
Sbjct: 66 DVLMQESR-----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 140 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSF 198
V HRDLKP+N+L + +K+ DFGLAR +F P ++ T V T WYRAPE L GS
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFG-IPVRVY-THEVVTLWYRAPEVLLGS- 176
Query: 199 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 258
+Y+ +DIWSIG IFAEM T KPLF G + + QL + +LGTP+ + +
Sbjct: 177 -PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV--TSLP 233
Query: 259 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
Y + K + N D L LLE++L +DP R +A++AL PYF
Sbjct: 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 5e-61
Identities = 114/308 (37%), Positives = 154/308 (50%), Gaps = 19/308 (6%)
Query: 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRL 72
E S+Y+ IG+G++G V A T + VA+KK+ + E+ + I LREIK+L+L
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKILQL 67
Query: 73 LRHPDIV---EIKHIMLPPSRREFKDIYVVFELMESDLHQVIK-ANDDLTPEHYQFFLYQ 128
L+H ++V EI P R Y+VFE E DL ++ N T + +
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 129 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV-SFNDAPSAIFWTDYVATR 187
LL GL YIH + HRD+K NIL D LK+ DFGLAR S + +T+ V T
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 188 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246
WYR PE L G Y P ID+W GCI AEM T P+ G HQL L++ L G+ +
Sbjct: 188 WYRPPELLLGE--RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245
Query: 247 ESISRIRN----EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 302
E + +K G RK V K DP AL L+++LL DP R A+
Sbjct: 246 EVWPGVDKLELFKKMELPQGQKRK---VKERLKPYVKDPHALDLIDKLLVLDPAKRIDAD 302
Query: 303 EALADPYF 310
AL +F
Sbjct: 303 TALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 199 bits (507), Expect = 6e-60
Identities = 111/301 (36%), Positives = 161/301 (53%), Gaps = 18/301 (5%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 78
+ I IG+G+YG V A D TGE VA+KK+ E +REIK+LR L H +I
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 79 VEIKHIMLPPS-----RREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRG 132
V +K I+ +++ Y+VFE M+ DL ++++ + +H + F+ QLL G
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEG 128
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 192
L Y H N HRD+K NIL N ++K+ DFGLAR ++ + +T+ V T WYR P
Sbjct: 129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR--LYNSEESRPYTNKVITLWYRPP 186
Query: 193 E-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE---S 248
E L G +Y PAID+WS GCI E+ T KP+F + QL+L++ L G+P
Sbjct: 187 ELLLGE--ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD 244
Query: 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308
+ ++ + R++ FS P AL LL+ +L DP R TAEEAL P
Sbjct: 245 VIKLPYFNTMKPKKQYRRRLREEFSF-IP---TPALDLLDHMLTLDPSKRCTAEEALNSP 300
Query: 309 Y 309
+
Sbjct: 301 W 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 198 bits (506), Expect = 6e-60
Identities = 111/300 (37%), Positives = 164/300 (54%), Gaps = 16/300 (5%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH-PD 77
Y+ E IG+G+YG V A D +TG+ VA+KK + LREI LL++L
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN-----DDLTPEHYQFFLYQLLRG 132
IV + + + +Y+VFE ++SDL + + +N L + + F+YQLL+G
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 133 LKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 191
+ + H V HRDLKP+N+L + LKI D GL R +F+ + +T + T WYRA
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIPVKS--YTHEIVTLWYRA 179
Query: 192 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250
PE L GS + Y+ +DIWS+GCIFAEM +PLFPG + + QL + LLGTP+ +
Sbjct: 180 PEVLLGS--THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237
Query: 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
+ R + +P S P+ P L LL+++L +DP R +A+ AL PYF
Sbjct: 238 GVSK---LRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 198 bits (504), Expect = 1e-59
Identities = 116/303 (38%), Positives = 170/303 (56%), Gaps = 16/303 (5%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+Y+ E IG+G+YGVV A D T E +A+KKI E + +REI LL+ ++H +
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY--QFFLYQLLRGLKY 135
IV ++ ++ R +Y+VFE ++ DL + + ++ D + +LYQ+LRG+ Y
Sbjct: 63 IVRLQDVVHSEKR-----LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 136 IHTANVFHRDLKPKNILANADCK-LKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE- 193
H+ V HRDLKP+N+L + LK+ DFGLAR +F P F T V T WYRAPE
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFG-IPVRTF-THEVVTLWYRAPEI 174
Query: 194 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253
L GS Y+ +DIWS+GCIFAEM+ KPLFPG + + +L + +LGTP+ E+ +
Sbjct: 175 LLGS--RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232
Query: 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313
+ Y + K P + P +P + LL ++L DP R TA AL YF L
Sbjct: 233 S--LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290
Query: 314 ANV 316
+
Sbjct: 291 GDA 293
|
Length = 294 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 6e-56
Identities = 84/294 (28%), Positives = 129/294 (43%), Gaps = 35/294 (11%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+ E++G+GS+G V A+D TGE +A+K + + + + REI++L L+HP+
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 136
IV E + + E + L ++K L + + Q+L GL Y+
Sbjct: 61 IVRYYGSER---DEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
H+ + HRD+K NIL ++D +K+ DFG A+ D + T ++ APE+
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFGCAK-RLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256
+Y A DIWS+GC EM TGKP + + M L S+ I
Sbjct: 177 G--EEYGRAADIWSLGCTVIEMATGKPPWS-----ELGNPMAALYKIGSSGEPPEI---- 225
Query: 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
P S A L + L DPK RPTA+E L P+
Sbjct: 226 ------------PEHLS-------EEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 3e-55
Identities = 115/301 (38%), Positives = 169/301 (56%), Gaps = 16/301 (5%)
Query: 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 72
+G+ Y + +G+G+Y V T VA+K+I E + T I RE+ LL+
Sbjct: 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKN 59
Query: 73 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLR 131
L+H +IV + I+ + + +VFE ++SDL Q + +L H + F++QLLR
Sbjct: 60 LKHANIVTLHDII-----HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLR 114
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 191
GL Y H + HRDLKP+N+L N +LK+ DFGLAR P+ + ++ V T WYR
Sbjct: 115 GLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARA--KSVPTKTY-SNEVVTLWYRP 171
Query: 192 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250
P+ L GS ++Y+ ID+W +GCI EM TG+P+FPG V +L L+ LLGTP+ E+
Sbjct: 172 PDVLLGS--TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP 229
Query: 251 RI-RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309
I NE+ R YL + QP+ +H P D + LL LL ++ K R +AE AL Y
Sbjct: 230 GITSNEEFRSYLFPQYRAQPL-INHA-PRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287
Query: 310 F 310
F
Sbjct: 288 F 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 187 bits (475), Expect = 3e-55
Identities = 116/305 (38%), Positives = 167/305 (54%), Gaps = 16/305 (5%)
Query: 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 72
+G+ Y + +G+G+Y V T VA+K+I E + T I RE+ LL+
Sbjct: 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKD 60
Query: 73 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLR 131
L+H +IV + I+ K + +VFE ++ DL Q + + H + FL+QLLR
Sbjct: 61 LKHANIVTLHDII-----HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLR 115
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 191
GL Y H V HRDLKP+N+L N +LK+ DFGLAR P+ + ++ V T WYR
Sbjct: 116 GLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA--KSIPTKTY-SNEVVTLWYRP 172
Query: 192 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250
P+ L GS + Y+ ID+W +GCIF EM TG+PLFPG V QL + +LGTP+ E+
Sbjct: 173 PDILLGS--TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWP 230
Query: 251 RI-RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309
I NE+ + Y + K + + P D LL +LL F+ + R +AEEA+ PY
Sbjct: 231 GILSNEEFKSY--NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288
Query: 310 FHGLA 314
FH L
Sbjct: 289 FHCLG 293
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 187 bits (475), Expect = 3e-55
Identities = 116/305 (38%), Positives = 170/305 (55%), Gaps = 16/305 (5%)
Query: 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 72
+G+ Y E +G+G+Y V T VA+K+I E + T I RE+ LL+
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKD 60
Query: 73 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLR 131
L+H +IV + I+ K + +VFE ++ DL Q + ++ H + FLYQ+LR
Sbjct: 61 LKHANIVTLHDIV-----HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILR 115
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 191
GL Y H V HRDLKP+N+L N +LK+ DFGLAR P+ + ++ V T WYR
Sbjct: 116 GLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA--KSVPTKTY-SNEVVTLWYRP 172
Query: 192 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250
P+ L GS S+Y+ ID+W +GCIF EM +G+PLFPG V +L L+ LLGTP+ E+
Sbjct: 173 PDVLLGS--SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230
Query: 251 RI-RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309
I N++ + Y + K +P P + P D + LL + L ++ K R +AEEA+ Y
Sbjct: 231 GISSNDEFKNY--NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288
Query: 310 FHGLA 314
F L
Sbjct: 289 FRSLG 293
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 2e-51
Identities = 102/296 (34%), Positives = 169/296 (57%), Gaps = 11/296 (3%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
+++++ V+G+G+YGVV T E VAIKK D E+ LRE+K+LR L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKY 135
+IVE+K RR K +Y+VFE +E ++ ++++ + + PE + ++YQL++ + +
Sbjct: 61 NIVELKEAF----RRRGK-LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 195
H ++ HRD+KP+N+L + + LK+CDFG AR + ++ +A + T+YVATRWYR+PEL
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFAR-NLSEGSNANY-TEYVATRWYRSPELL 173
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
+ Y A+D+WS+GCI E+ G+PLFPG++ + QL + +LG E + +
Sbjct: 174 --LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231
Query: 256 KARRYLGSMRKKQPVPFSHKFPNA-DPLALHLLERLLAFDPKDRPTAEEALADPYF 310
L P ++ + L L++ LL +P DR E+ L P F
Sbjct: 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 5e-50
Identities = 69/197 (35%), Positives = 108/197 (54%), Gaps = 13/197 (6%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 84
+G+G +G V A D TG++VAIK I S +LREI++L+ L HP+IV++ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS-SLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 85 MLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVF 142
+ +Y+V E E L ++K N+ L+ + L Q+L GL+Y+H+ +
Sbjct: 60 FEDENH-----LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 143 HRDLKPKNIL-ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK 201
HRDLKP+NIL + + K+K+ DFGL+++ +D V T Y APE+
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLKTIVGTPAYMAPEVL-LGKGY 170
Query: 202 YTPAIDIWSIGCIFAEM 218
Y+ DIWS+G I E+
Sbjct: 171 YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 1e-49
Identities = 116/306 (37%), Positives = 173/306 (56%), Gaps = 23/306 (7%)
Query: 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 72
+G A+ Y E +G+GSY V + G+ VA+K I+ E T I RE LL+
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-REASLLKG 59
Query: 73 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQ-VIKANDDLTPEHYQFFLYQLLR 131
L+H +IV + I+ F VFE M +DL Q +I+ L P + + F++QLLR
Sbjct: 60 LKHANIVLLHDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR 114
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 191
GL YIH ++ HRDLKP+N+L + +LK+ DFGLAR PS + ++ V T WYR
Sbjct: 115 GLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSSE-VVTLWYRP 171
Query: 192 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG-KNVVHQLDLMTDLLGTPSTES- 248
P+ L G+ + Y+ A+DIW GCIF EML G+P FPG +V QL+ + +LG P+ ++
Sbjct: 172 PDVLLGA--TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTW 229
Query: 249 --ISRIRNEKARRYLGSMRKKQPVPFSH--KFPNADPLALHLLERLLAFDPKDRPTAEEA 304
+S++ N K +L ++ V + + P A+ LA ++L PKDR +A++A
Sbjct: 230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLA----SQMLMMFPKDRISAQDA 285
Query: 305 LADPYF 310
L PYF
Sbjct: 286 LLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 173 bits (439), Expect = 3e-49
Identities = 83/303 (27%), Positives = 131/303 (43%), Gaps = 35/303 (11%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA-TRILREIKLLRLLRHPD 77
Y+I +G+GS+G V A D + VA+K + E S R LREI++L L HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 78 -IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD---LTPEHYQFFLYQLLRGL 133
IV++ V+ + L ++K L+ F L Q+L L
Sbjct: 59 NIVKLYDFFQDEGS----LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 134 KYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARV---SFNDAPSAIFWTDYVATRWY 189
+Y+H+ + HRD+KP+NIL + D +K+ DFGLA++ + + + V T Y
Sbjct: 115 EYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 190 RAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248
APE+ G + + + DIWS+G E+LTG P F G+ ++
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS-----------QT 223
Query: 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308
+ I + P A LL++LLA DPK+R ++ L+
Sbjct: 224 LKIILELPTPSLASPLSPSNP-------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 309 YFH 311
Sbjct: 277 LLA 279
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 164 bits (419), Expect = 1e-47
Identities = 91/303 (30%), Positives = 143/303 (47%), Gaps = 55/303 (18%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRH 75
+Y+I + IGKGS+G V G+ +K+I+ ++S+ R L E+K+L+ L H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEID--LSNMSEKEREDALNEVKILKKLNH 58
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKA---NDDLTPEHYQ--FFLYQL 129
P+I IK+ S E + +V E + DL Q IK PE Q + QL
Sbjct: 59 PNI--IKYYE---SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE-QILDWFVQL 112
Query: 130 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
LKY+H+ + HRD+KP+NI ++ +K+ DFG+++V + A V T +Y
Sbjct: 113 CLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA---KTVVGTPYY 169
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
+PELC + Y DIWS+GC+ E+ T K F G+N L+L
Sbjct: 170 LSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELAL----------- 213
Query: 250 SRIRNEKARRYLGSMRKKQPVP--FSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307
+I + P+P +S + N L+ LL DP++RP+ + L
Sbjct: 214 -KILKG----------QYPPIPSQYSSELRN-------LVSSLLQKDPEERPSIAQILQS 255
Query: 308 PYF 310
P+
Sbjct: 256 PFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 2e-47
Identities = 108/302 (35%), Positives = 162/302 (53%), Gaps = 22/302 (7%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGER-VAIKKINDVFEHVSDATRILREIKLLRLLR-- 74
+Y+ IG+G+YG V A D G R VA+K++ +RE+ +LR L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 75 -HPDIVEIKHI-MLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLL 130
HP++V + + + + RE K + +VFE ++ DL + + + E + ++QLL
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETK-LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 131 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV-SFNDAPSAIFWTDYVATRWY 189
RGL ++H+ V HRDLKP+NIL + ++K+ DFGLAR+ SF A +++ V T WY
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-----VVTLWY 175
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
RAPE+ S Y +D+WS+GCIFAEM KPLF G + V QL + D++G P E
Sbjct: 176 RAPEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233
Query: 250 SRIRNEKA-RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308
+ A R + QP+ + D L LL + L F+P R +A AL+ P
Sbjct: 234 P---RDVALPRQAFHSKSAQPI--EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 288
Query: 309 YF 310
YF
Sbjct: 289 YF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 3e-46
Identities = 79/299 (26%), Positives = 129/299 (43%), Gaps = 55/299 (18%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 78
++I E IGKG +G V A TG+ VAIK I + +I+ EI++L+ +HP+I
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNI 59
Query: 79 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPE-HYQFFLYQLLRGLKYI 136
V+ L +++V E L ++K+ + E + +LL+GL+Y+
Sbjct: 60 VKYYGSYLKKDE-----LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYL 114
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
H+ + HRD+K NIL +D ++K+ DFGL+ +D + V T ++ APE+
Sbjct: 115 HSNGIIHRDIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNTM---VGTPYWMAPEVI- 169
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256
Y DIWS+G E+ GKP +
Sbjct: 170 -NGKPYDYKADIWSLGITAIELAEGKPPY------------------------------- 197
Query: 257 ARRYLGSMR------KKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309
L M+ P + +D L++ L +P+ RPTAE+ L P+
Sbjct: 198 --SELPPMKALFKIATNGPPGLRNPEKWSDEFK-DFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 3e-46
Identities = 109/337 (32%), Positives = 176/337 (52%), Gaps = 29/337 (8%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 78
Y++ +IG GS+GVV A+ T E+VAIKK+ + D RE+ +++ L H +I
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV------LQDPQYKNRELLIMKNLNHINI 121
Query: 79 VEIKHIMLPPS-RREFKDIY--VVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLR 131
+ +K ++ K+I+ VV E + +H+ +K N L + + YQL R
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCR 181
Query: 132 GLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 190
L YIH+ + HRDLKP+N+L + + LK+CDFG A+ S Y+ +R+YR
Sbjct: 182 ALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS----VSYICSRFYR 237
Query: 191 APEL-CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
APEL G+ + YT ID+WS+GCI AEM+ G P+F G++ V QL + +LGTP+ + +
Sbjct: 238 APELMLGA--TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADP-LALHLLERLLAFDPKDRPTAEEALADP 308
+ A ++ K FP P A++ + + L ++P R EALADP
Sbjct: 296 KEMNPNYADIKFPDVKPKD---LKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352
Query: 309 YFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREM 345
+F L R+P + ++ + +++EM
Sbjct: 353 FFDDL----RDPCIKLPKYIDKLPDLFNFCDAEIKEM 385
|
Length = 440 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 6e-46
Identities = 93/296 (31%), Positives = 142/296 (47%), Gaps = 45/296 (15%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
YQ+ ++IG+G++GVV ++ TG+ VAIK+I+ I++EI LL+ L+HP+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHY-QFFLYQLLRGLKY 135
IV K+I S +Y++ E E+ L Q+IK PE ++YQ+L+GL Y
Sbjct: 61 IV--KYI---GSIETSDSLYIILEYAENGSLRQIIKKFGPF-PESLVAVYVYQVLQGLAY 114
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLA-RVSFNDAPSAIFWTDYVATRWYRAPEL 194
+H V HRD+K NIL D +K+ DFG+A +++ V T ++ APE+
Sbjct: 115 LHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD----ASVVGTPYWMAPEV 170
Query: 195 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254
S + A DIWS+GC E+LTG P + + L+ M L RI
Sbjct: 171 IE--MSGASTASDIWSLGCTVIELLTGNPPY------YDLNPMAALF---------RIVQ 213
Query: 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
+ P+P P L + DP RPTA++ L P+
Sbjct: 214 D----------DHPPLP-----EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 2e-44
Identities = 102/305 (33%), Positives = 147/305 (48%), Gaps = 29/305 (9%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR--- 74
+Y+ IG G+YG V A D H+G VA+K + +RE+ LL+ L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRG 132
HP+IV + + + +VFE ++ DL + L E + + Q LRG
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV-SFNDAPSAIFWTDYVATRWYRA 191
L ++H + HRDLKP+NIL + ++K+ DFGLAR+ S A T V T WYRA
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-----LTPVVVTLWYRA 175
Query: 192 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE---- 247
PE+ S Y +D+WS+GCIFAEM KPLF G + QL + DL+G P +
Sbjct: 176 PEVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233
Query: 248 --SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 305
++ R G+ + P P P + LL +L F+P R +A AL
Sbjct: 234 DVTLPR----------GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283
Query: 306 ADPYF 310
P+F
Sbjct: 284 QHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 1e-43
Identities = 112/310 (36%), Positives = 171/310 (55%), Gaps = 25/310 (8%)
Query: 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 72
+G+A Y+ E +G+GSY V G+ VA+K I E + T I RE LL+
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKG 59
Query: 73 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLR 131
L+H +IV + I+ + + +VFE + +DL Q + K L PE+ + FL+QLLR
Sbjct: 60 LKHANIVLLHDII-----HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR 114
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 191
GL YIH + HRDLKP+N+L + +LK+ DFGLAR PS + ++ V T WYR
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTY-SNEVVTLWYRP 171
Query: 192 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG-KNVVHQLDLMTDLLGTPSTE-- 247
P+ L GS ++Y+ +D+W +GCIF EM+ G FPG K++ QL+ + +LGTP+ +
Sbjct: 172 PDVLLGS--TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229
Query: 248 ----SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 303
S+ + E+ Y ++ S+ +A+ LA +LL PK+R +A+
Sbjct: 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSY-VNHAEDLA----SKLLQCFPKNRLSAQA 284
Query: 304 ALADPYFHGL 313
AL+ YF L
Sbjct: 285 ALSHEYFSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 3e-41
Identities = 91/305 (29%), Positives = 141/305 (46%), Gaps = 56/305 (18%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHP 76
Y++ E IGKGS+G V G+ + K+I+ + ++++ + ++ E+ +LR L+HP
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHP 59
Query: 77 DIVE-IKHIMLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEHY--QFFLYQL 129
+IV I+ ++ +Y+V E E DL Q+I K E + + QL
Sbjct: 60 NIVRYYDRIIDRSNQT----LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT-QL 114
Query: 130 LRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 184
L L H + V HRDLKP NI +A+ +K+ DFGLA++ +D+ A YV
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA---KTYV 171
Query: 185 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244
T +Y +PE Y DIWS+GC+ E+ P F +N QL L
Sbjct: 172 GTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQL-------- 218
Query: 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 304
S+I+ K RR P +S L +++ +L DP RP+ EE
Sbjct: 219 ----ASKIKEGKFRRI--------PYRYS------SELNE-VIKSMLNVDPDKRPSTEEL 259
Query: 305 LADPY 309
L P
Sbjct: 260 LQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 2e-40
Identities = 115/320 (35%), Positives = 164/320 (51%), Gaps = 45/320 (14%)
Query: 25 IGKGSYGVVGSAV--DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 82
+G+G+YG V A D A+K+I E + REI LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64
Query: 83 HIMLPPSRREFKDIYVVFELMESDL------HQVIKAND---DLTPEHYQFFLYQLLRGL 133
+ L + R+ ++++F+ E DL H+ KAN L + LYQ+L G+
Sbjct: 65 KVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 134 KYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVSFNDAPSAIFWTD-YVATRW 188
Y+H V HRDLKP NIL + ++KI D G AR+ FN + D V T W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-FNSPLKPLADLDPVVVTFW 180
Query: 189 YRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK-------NVVH--QLDLMT 238
YRAPEL G+ YT AIDIW+IGCIFAE+LT +P+F + N H QLD +
Sbjct: 181 YRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238
Query: 239 DLLGTPSTESISRIRNEKARRYL-GSMRKKQPVPFS-------HKFPNADPLALHLLERL 290
+++G P+ + I+ L R+ S HK D A HLL++L
Sbjct: 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV-KPDSKAFHLLQKL 297
Query: 291 LAFDPKDRPTAEEALADPYF 310
L DP R T+E+A+ DPYF
Sbjct: 298 LTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-39
Identities = 115/320 (35%), Positives = 162/320 (50%), Gaps = 45/320 (14%)
Query: 25 IGKGSYGVVGSA--VDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 82
+G+G+YG V A D + A+K+I E + REI LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64
Query: 83 HIMLPPSRREFKDIYVVFELMESDL------HQVIKAND---DLTPEHYQFFLYQLLRGL 133
+ L S R+ ++++F+ E DL H+ KAN L + LYQ+L G+
Sbjct: 65 KVFLSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 134 KYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVSFNDAPSAIFWTD-YVATRW 188
Y+H V HRDLKP NIL + ++KI D G AR+ FN + D V T W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-FNSPLKPLADLDPVVVTFW 180
Query: 189 YRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK-------NVVH--QLDLMT 238
YRAPEL G+ YT AIDIW+IGCIFAE+LT +P+F + N H QLD +
Sbjct: 181 YRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238
Query: 239 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFS--------HKFPNADPLALHLLERL 290
++G P+ + IR L ++ S HK D LL++L
Sbjct: 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKV-KPDSKVFLLLQKL 297
Query: 291 LAFDPKDRPTAEEALADPYF 310
L DP R T+E+AL DPYF
Sbjct: 298 LTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 1e-38
Identities = 89/307 (28%), Positives = 139/307 (45%), Gaps = 69/307 (22%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI---NDVFEHVSDATRILREIKLLRLLRH 75
Y+ E IG+G+ G V A D TG+ VAIKK+ E I+ EI +++ +H
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKE------LIINEILIMKDCKH 74
Query: 76 PDIVE-IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRG 132
P+IV+ S +++VV E M+ L +I N + + ++L+G
Sbjct: 75 PNIVDYYD------SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQG 128
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFNDAPSAIFWTDY 183
L+Y+H+ NV HRD+K NIL + D +K+ DFG A R S
Sbjct: 129 LEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV------------ 176
Query: 184 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 243
V T ++ APE+ Y P +DIWS+G + EM G+P + + + L L+T G
Sbjct: 177 VGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGI 233
Query: 244 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 303
P ++N + +S +F + L + L DP+ RP+AEE
Sbjct: 234 P------PLKNPEK--------------WSPEFKD-------FLNKCLVKDPEKRPSAEE 266
Query: 304 ALADPYF 310
L P+
Sbjct: 267 LLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 3e-38
Identities = 90/295 (30%), Positives = 135/295 (45%), Gaps = 35/295 (11%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
R+Q IG G++G V +AV+ TGE +A+K+I I E+K+L LL+HP+
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 78 IVEIKHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 136
+V+ + + RE +Y+ E L ++++ L + + QLL GL Y+
Sbjct: 61 LVKYYGVEV---HRE--KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYL 115
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLA-RVSFNDAPSAIFWTDYVATRWYRAPEL- 194
H+ + HRD+KP NI + + +K+ DFG A ++ N T Y APE+
Sbjct: 116 HSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 195 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254
G + A DIWS+GC+ EM TGK + +LD N
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPW------SELD------------------N 211
Query: 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309
E + K P+P S + P L+R L DPK RPTA E L P+
Sbjct: 212 EFQIMFHVGAGHKPPIPDSLQ---LSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 5e-38
Identities = 82/296 (27%), Positives = 129/296 (43%), Gaps = 56/296 (18%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKIN--DVFEHVSDATRILREIKLLRLLRHPDIVEIK 82
+GKGS+G V TG+ A+K + + + + L E +L + HP IV++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR-KEVEHTLTERNILSRINHPFIVKLH 59
Query: 83 HIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 138
F+ +Y+V E +L + + E +F+ +++ L+Y+H+
Sbjct: 60 --------YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHS 111
Query: 139 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 198
+ +RDLKP+NIL +AD +K+ DFGLA+ ++ + T Y APE+
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT---NTFCGTPEYLAPEVLLG- 167
Query: 199 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 258
Y A+D WS+G + EMLTGKP F ++ E +I
Sbjct: 168 -KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---------------EIYEKI------ 205
Query: 259 RYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDRPT---AEEALADPYF 310
K P+ +FP P A L+ LL DP R AEE A P+F
Sbjct: 206 -------LKDPL----RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 3e-37
Identities = 84/299 (28%), Positives = 128/299 (42%), Gaps = 69/299 (23%)
Query: 23 EVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHP 76
+ +G+G++G V VA+K + E S+ LRE +++R L HP
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK---EDASEQQIEEFLREARIMRKLDHP 61
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLK 134
++V++ + +Y+V E ME DL ++ N L+ F Q+ RG++
Sbjct: 62 NVVKLLGVCTEEEP-----LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGME 116
Query: 135 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------R 187
Y+ + N HRDL +N L + +KI DFGL+R ++D DY R
Sbjct: 117 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--------DYYRKRGGKLPIR 168
Query: 188 WYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPS 245
W APE S K+T D+WS G + E+ T G+ +PG +
Sbjct: 169 WM-APE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS---------------- 208
Query: 246 TESISRIRNEKARRYLGS-MRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 303
NE+ YL + R QP PN P L+ + A DP+DRPT E
Sbjct: 209 --------NEEVLEYLKNGYRLPQP-------PNCPPELYDLMLQCWAEDPEDRPTFSE 252
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 6e-36
Identities = 80/300 (26%), Positives = 124/300 (41%), Gaps = 70/300 (23%)
Query: 23 EVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHP 76
+ +G+G++G V VA+K + + S+ LRE +++R L HP
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKE---DASEQQIEEFLREARIMRKLDHP 61
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGL 133
+IV++ + + +V E M DL ++ N L+ F Q+ RG+
Sbjct: 62 NIVKLLGVCTEEEP-----LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGM 116
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------- 186
+Y+ + N HRDL +N L + +KI DFGL+R ++D DY
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--------DYYKVKGGKLPI 168
Query: 187 RWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTP 244
RW APE S K+T D+WS G + E+ T G+ +PG +
Sbjct: 169 RWM-APE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS--------------- 209
Query: 245 STESISRIRNEKARRYLGS-MRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 303
N + YL R +P PN P L+ + A DP+DRPT E
Sbjct: 210 ---------NAEVLEYLKKGYRLPKP-------PNCPPELYKLMLQCWAEDPEDRPTFSE 253
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 89/327 (27%), Positives = 140/327 (42%), Gaps = 84/327 (25%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK---------- 68
++ ++IG+GS+ V A + T + AIK + D ++++E K
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIK--------ILDKRQLIKEKKVKYVKIEKEV 54
Query: 69 LLRLLRHPDIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQF 124
L RL HP I+++ + F+D +Y V E + +L Q I+ L + +F
Sbjct: 55 LTRLNGHPGIIKLYY--------TFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF 106
Query: 125 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV--------------- 169
+ ++L L+Y+H+ + HRDLKP+NIL + D +KI DFG A+V
Sbjct: 107 YAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 170 --SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 227
+ + +V T Y +PEL + D+W++GCI +MLTGKP F G
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRG 224
Query: 228 KNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLL 287
N L +I + F FP P A L+
Sbjct: 225 SN--------EYLT-------FQKILKLE-------------YSFPPNFP---PDAKDLI 253
Query: 288 ERLLAFDPKDRPTA----EEALADPYF 310
E+LL DP+DR +E A P+F
Sbjct: 254 EKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 5e-34
Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 39/291 (13%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79
+ +V+G+GS GVV TG+ A+KKI+ V ++LRE+K LR P +V
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 80 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 138
+ I +V E M+ L ++K + + Q+L+GL Y+HT
Sbjct: 63 KCYGAFYKEGE-----ISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 139 -ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 197
++ HRD+KP N+L N+ ++KI DFG+++V + T +V T Y +PE
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNT-FVGTVTYMSPERIQG 174
Query: 198 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 257
Y+ A DIWS+G E GK F +LM + P + + +
Sbjct: 175 --ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232
Query: 258 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308
R + L DPK RP+A E L P
Sbjct: 233 R--------------------------DFISACLQKDPKKRPSAAELLQHP 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 86/300 (28%), Positives = 140/300 (46%), Gaps = 51/300 (17%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN------DVFEHVSDATRILREIKLLR 71
R++ E++G GS+G V ++ G+ A+K+++ E V ++ +EI LL
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVK---QLEQEIALLS 57
Query: 72 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLL 130
L+HP+IV+ + RE ++Y+ EL+ L +++K + + Q+L
Sbjct: 58 KLQHPNIVQYLG-----TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL 112
Query: 131 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VSFNDAPSAIFWTDYVATRWY 189
GL+Y+H N HRD+K NIL + + +K+ DFG+A+ V F + + ++
Sbjct: 113 LGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-----FAKSFKGSPYW 167
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
APE+ Y A DIWS+GC EM TGKP + QL E +
Sbjct: 168 MAPEVIAQ-QGGYGLAADIWSLGCTVLEMATGKPPW------SQL------------EGV 208
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309
+ + +G ++ P+P H A L L+R DP RPTA E L P+
Sbjct: 209 AAVFK------IGRSKELPPIP-DHLSDEAKDFILKCLQR----DPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 6e-33
Identities = 84/307 (27%), Positives = 128/307 (41%), Gaps = 62/307 (20%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIKKI--------NDVFEHVSDATRILREIKLLRLLR 74
E+IGKG+YG V A++ TGE +A+K++ + EI+ L+ L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLH------------QVIKANDDLTPEHY 122
H +IV+ Y+ FE E L ++ +
Sbjct: 67 HLNIVQ----------------YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLV 110
Query: 123 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 182
+FF Q+L GL Y+H+ + HRDLK N+L +AD KI DFG+++ S +D
Sbjct: 111 RFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS-DDIYDNDQNMS 169
Query: 183 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 242
+ ++ APE+ S+ Y+ +DIWS+GC+ EM G+
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR-------------------- 209
Query: 243 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 302
S A LG+ R P+P N P+AL L +P +RPTA
Sbjct: 210 ----RPWSDEEAIAAMFKLGNKRSAPPIP-PDVSMNLSPVALDFLNACFTINPDNRPTAR 264
Query: 303 EALADPY 309
E L P+
Sbjct: 265 ELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 73/288 (25%), Positives = 125/288 (43%), Gaps = 53/288 (18%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS-DATR-ILREIKLLRLLRHP 76
+++ VIGKG++G V T + A+K +N + V + R +L E ++L+ L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ-KCVEKGSVRNVLNERRILQELNHP 60
Query: 77 DIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 132
+V + F+D +Y+V +L+ DL + + E +F++ +++
Sbjct: 61 FLVNL--------WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLA 112
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 192
L+Y+H+ + HRD+KP NIL + + I DF +A D + T T Y AP
Sbjct: 113 LEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT----TSTSGTPGYMAP 168
Query: 193 ELCGSFFSK-YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251
E+ + Y+ A+D WS+G E L GK + G S +
Sbjct: 169 EV---LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGH----------------SRTIRDQ 209
Query: 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPL-ALHLLERLLAFDPKDR 298
IR ++ V +P A+ + +LL DP+ R
Sbjct: 210 IRA---------KQETADVL----YPATWSTEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSD-ATRILREIKLLRLLRH 75
+ + E IGKGS+G V A+D T + VAIK I+ E D I +EI+ L R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID--LEEAEDEIEDIQQEIQFLSQCRS 58
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLR 131
P I + L S+ ++++ E DL + K L + F L ++L
Sbjct: 59 PYITKYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKPGK----LDETYIAFILREVLL 109
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-RVSFNDAPSAIFWTDYVATRWYR 190
GL+Y+H HRD+K NIL + + +K+ DFG++ +++ + F V T ++
Sbjct: 110 GLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF----VGTPFWM 165
Query: 191 APELCGSFFSKYTPAIDIWSIGCIFAEMLTGKP 223
APE+ S Y DIWS+G E+ G+P
Sbjct: 166 APEVIKQ--SGYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 81/301 (26%), Positives = 136/301 (45%), Gaps = 50/301 (16%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKIND---VFEHVSDATRILREIKLLRLLRHPDIVEI 81
I KG+YG V A TG+ AIK I + ++ D ++L E +L + P +V++
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVD--QVLTERDILSQAQSPYVVKL 58
Query: 82 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 140
+ S + K++Y+V E + DL +++ L + + ++ +++ L+Y+H+
Sbjct: 59 YY-----SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG 113
Query: 141 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY-----VATRWYRAPELC 195
+ HRDLKP NIL +++ LK+ DFGL++V + + V T Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
++ +D WS+GCI E L G P F G+ E I N
Sbjct: 174 LG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETP---------------EEIFQNILNG 216
Query: 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA---EEALADPYFHG 312
K + + + A+ L+ +LL DP+ R A EE P+F G
Sbjct: 217 K-------------IEWP-EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
Query: 313 L 313
+
Sbjct: 263 I 263
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 117 bits (297), Expect = 4e-30
Identities = 60/233 (25%), Positives = 109/233 (46%), Gaps = 33/233 (14%)
Query: 20 QIQEVIGKGSYGVV--GSAVDTH--TGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 75
++ + +G+G++G V G+ T +VA+K + + + L E +++ L H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASE-EEREEFLEEASIMKKLSH 60
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 133
P+IV + + + + +Y+V E M DL ++ + + LT + Q+ +G+
Sbjct: 61 PNIVRLLGVCT-----QGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------- 186
+Y+ + N HRDL +N L + +KI DFGL+R + D Y
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD-------YYRKRGGGKLPI 168
Query: 187 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 235
+W APE K+T D+WS G + E+ T G+ +PG + V+ L+
Sbjct: 169 KWM-APESL--KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLE 218
|
Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 4e-28
Identities = 71/208 (34%), Positives = 113/208 (54%), Gaps = 20/208 (9%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHP 76
++I++ IGKG + VV A+ G VA+KK+ +FE + R L+EI LL+ L HP
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKV-QIFEMMDAKARQDCLKEIDLLKQLDHP 62
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIK---ANDDLTPEH--YQFFLYQLL 130
++ IK++ S E ++ +V EL ++ DL ++IK L PE +++F QL
Sbjct: 63 NV--IKYL---ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF-VQLC 116
Query: 131 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 190
L+++H+ + HRD+KP N+ A +K+ D GL R F+ +A V T +Y
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAH--SLVGTPYYM 173
Query: 191 APELCGSFFSKYTPAIDIWSIGCIFAEM 218
+PE + Y DIWS+GC+ EM
Sbjct: 174 SPERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 85/299 (28%), Positives = 136/299 (45%), Gaps = 54/299 (18%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 78
+ I E +G+GSYG V A+ TG+ VAIK + V E + + I++EI +L+ P I
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQE---IIKEISILKQCDSPYI 60
Query: 79 VEIKHIMLPPSRREFKDIYVVFELME-------SDLHQVIKANDDLTPEHYQFFLYQLLR 131
V+ S + D+++V ME SD+ ++ N LT E LYQ L+
Sbjct: 61 VKYY-----GSYFKNTDLWIV---MEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLK 110
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 191
GL+Y+H+ HRD+K NIL N + + K+ DFG++ + + T ++ A
Sbjct: 111 GLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR---NTVIGTPFWMA 167
Query: 192 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251
PE+ Y DIWS+G EM GKP P ++ +I
Sbjct: 168 PEVIQE--IGYNNKADIWSLGITAIEMAEGKP--PYSDI-------------HPMRAIFM 210
Query: 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
I N+ P +S +F + +++ L DP++RP+A + L P+
Sbjct: 211 IPNKPPPTL------SDPEKWSPEFND-------FVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 76/306 (24%), Positives = 123/306 (40%), Gaps = 75/306 (24%)
Query: 23 EVIGKGSYGVV--GSAVDTHTGER-VAIKKINDVFEHVSDATR--ILREIKLLRLLRHPD 77
+ +G+G++G V G VA+K + E S+ R L+E ++++ L HP+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK---EDASEEERKDFLKEARVMKKLGHPN 57
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAN---------DDLTPEHYQFFLY 127
+V + + E + +Y+V E ME DL ++ + L+ + F
Sbjct: 58 VVRLLGVCT-----EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112
Query: 128 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT- 186
Q+ +G++Y+ + HRDL +N L D +KI DFGL+R ++D Y
Sbjct: 113 QIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD-------DYYRKKT 165
Query: 187 ------RWYRAPELCGSFFS-KYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMT 238
RW APE S +T D+WS G + E+ T G +PG
Sbjct: 166 GGKLPIRWM-APE---SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG----------- 210
Query: 239 DLLGTPSTESISRIRNEKARRYLGS-MRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD 297
+ NE+ YL R +P + L+ DP+D
Sbjct: 211 -------------LSNEEVLEYLRKGYRLPKPEYCPDELYE-------LMLSCWQLDPED 250
Query: 298 RPTAEE 303
RPT E
Sbjct: 251 RPTFSE 256
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 77/303 (25%), Positives = 124/303 (40%), Gaps = 45/303 (14%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
Y++ EVIG G+ VV +A+ E+VAIK+I D+ + + + +E++ + HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKA--NDDLTPEHY-QFFLYQLLRG 132
++V+ S ++++V + L ++K+ E L ++L+G
Sbjct: 60 NVVKYY-----TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP-SAIFWTDYVATRWYRA 191
L+Y+H+ HRD+K NIL D +KI DFG++ + + +V T + A
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 192 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKP----LFPGKNVVHQLDLMTDLLGTPSTE 247
PE+ Y DIWS G E+ TG P K LM L P +
Sbjct: 175 PEVMEQ-VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV------LMLTLQNDPPSL 227
Query: 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307
+S F ++ L DP RPTAEE L
Sbjct: 228 ETGA----------------DYKKYSKSFRK-------MISLCLQKDPSKRPTAEELLKH 264
Query: 308 PYF 310
+F
Sbjct: 265 KFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 5e-27
Identities = 83/299 (27%), Positives = 128/299 (42%), Gaps = 53/299 (17%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRH 75
Y V+GKG++G T V K++N +S+ R L EI +L LL+H
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVN--LTRLSEKERRDALNEIVILSLLQH 58
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDD-LTPEHY-QFFLYQL 129
P+I+ + F D + ME L+ I L E ++L+Q+
Sbjct: 59 PNIIAYYN--------HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQI 110
Query: 130 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
+ + YIH A + HRD+K NI +K+ DFG++++ ++ A V T +Y
Sbjct: 111 VSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA---ETVVGTPYY 167
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
+PELC KY DIW++GC+ E+LT K F N L+L+ ++ T +
Sbjct: 168 MSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKIVQGNYTPVV 222
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308
S Y + L+ LL DP+ RPTA+E L P
Sbjct: 223 S--------VYSSELIS-------------------LVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 80/294 (27%), Positives = 119/294 (40%), Gaps = 48/294 (16%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS----DATRILREIKLLRLLRHPDIV 79
+G G+ GVV + TG+ +A+K I + +ILRE+ +L P IV
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTI-----RLEINEAIQKQILRELDILHKCNSPYIV 62
Query: 80 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHY-QFFLYQLLRGLKYIH 137
DI + E M+ L +++K PE +L+GL Y+H
Sbjct: 63 GFYGAFY----NN-GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 138 TA-NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
+ HRD+KP NIL N+ ++K+CDFG++ N +V T Y APE
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-----TFVGTSSYMAPERIQ 172
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256
+ Y+ DIWS+G E+ TG+ FP E + I NE
Sbjct: 173 G--NDYSVKSDIWSLGLSLIELATGR--FPYPP--ENDPPDGIF------ELLQYIVNEP 220
Query: 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
P S KF P + L DP++RP+ +E L P+
Sbjct: 221 P-----------PRLPSGKFS---PDFQDFVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 80/290 (27%), Positives = 128/290 (44%), Gaps = 48/290 (16%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR---ILREIKLLRLLRHPDIVEI 81
IG+GS G+V A D TG +VA+KK++ + R + E+ ++R +HP+IVE+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD-----LRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 82 KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 141
L +++VV E +E I + + E +L+ L ++H V
Sbjct: 82 YSSYLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGV 136
Query: 142 FHRDLKPKNILANADCKLKICDFGL-ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 200
HRD+K +IL +D ++K+ DFG A+VS + P V T ++ APE+
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVS-KEVPRR---KSLVGTPYWMAPEVISR--L 190
Query: 201 KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 260
Y +DIWS+G + EM+ G+P + P +++ RIR+
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPY---------------FNEPPLQAMKRIRDNLP--- 232
Query: 261 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
P P L+R+L DP R TA E L P+
Sbjct: 233 ----------PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 9e-27
Identities = 77/293 (26%), Positives = 127/293 (43%), Gaps = 43/293 (14%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 78
++I IGKGS+GVV V A+K+I+ + + + E ++L L I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 79 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGLKY 135
I++ S + + +V E E+ DLH+++K L + F Q+L GL +
Sbjct: 62 --IRYY---ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 195
+H+ + HRD+K N+ +A +KI D G+A++ + + F V T +Y +PELC
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC 173
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
Y D+W++G + E TGK F N Q L I +I
Sbjct: 174 ED--KPYNEKSDVWALGVVLYECCTGKHPFDANN---QGAL------------ILKI--- 213
Query: 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308
+R P P S + L+++ L D + RP + L +P
Sbjct: 214 --------IRGVFP-PVSQMY---SQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 88/308 (28%), Positives = 126/308 (40%), Gaps = 63/308 (20%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
Y++ + IG G+YG V A D TGE VAIK I E D I +EI +L+ RHP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK--LEPGDDFEIIQQEISMLKECRHP 60
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRG 132
+IV L RR+ +++V E D++QV L+ + + L+G
Sbjct: 61 NIVAYFGSYL---RRD--KLWIVMEYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKG 113
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFNDAPSAIFWTDY 183
L Y+H HRD+K NIL D +K+ DFG++ R SF
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF------------ 161
Query: 184 VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 242
+ T ++ APE Y DIW++G E+ +P P M DL
Sbjct: 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP--P----------MFDL-- 207
Query: 243 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNA-DPLALHLLERLLAFDPKDRPTA 301
R L + K P K P+ +++ L DPK RPTA
Sbjct: 208 -------------HPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTA 254
Query: 302 EEALADPY 309
+ L P+
Sbjct: 255 TKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 83/299 (27%), Positives = 131/299 (43%), Gaps = 53/299 (17%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRH 75
+++ + +GKGSYG V + A+K+++ +S R + EI++L + H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVD--LGSMSQKEREDAVNEIRILASVNH 58
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVI---KANDDLTPEH--YQFFLYQL 129
P+I+ K L ++ + +V E DL + I K L PE ++ F+ QL
Sbjct: 59 PNIISYKEAFLDGNK-----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QL 112
Query: 130 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
LRGL+ +H + HRDLK NIL A+ +KI D G+++V + + T Y
Sbjct: 113 LRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-----IGTPHY 167
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
APE+ Y+ DIWS+GC+ EM T P F ++ M DL
Sbjct: 168 MAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARS-------MQDL--------- 209
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308
R K P P + + D + + +L PK RP ++ LA P
Sbjct: 210 ----------RYKVQRGKYP-PIPPIY-SQD--LQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 75/299 (25%), Positives = 133/299 (44%), Gaps = 46/299 (15%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR-----ILREIKLLRLL 73
++ +++G+G++G V D TG +A+K++ F+ S T+ + EI+LL+ L
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVP--FDPDSPETKKEVNALECEIQLLKNL 61
Query: 74 RHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 132
+H IV+ + R+ + + + E M + +KA LT + + Q+L G
Sbjct: 62 QHERIVQYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEG 116
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 192
++Y+H+ + HRD+K NIL ++ +K+ DFG ++ S T ++ +P
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 193 ELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252
E+ Y D+WS+GC EMLT KP P E+++ I
Sbjct: 177 EVISG--EGYGRKADVWSVGCTVVEMLTEKP--PWAEF----------------EAMAAI 216
Query: 253 RNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
+ + P + P + P A + L R + K RP+AEE L +
Sbjct: 217 FK---------IATQPTNP---QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 89/305 (29%), Positives = 132/305 (43%), Gaps = 64/305 (20%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKK--INDVFEHVSDATRIL-----REIKLLRLLRHP 76
+IG GS+G V ++ +GE +A+K+ + V D R + REI LL+ L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 136
+IV+ L YV + + L+ + L + F+ Q+L+GL Y+
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLV----RNFVRQILKGLNYL 122
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLA-RVSFN--------DAPS---AIFWTDYV 184
H + HRD+K NIL + +KI DFG++ ++ N PS ++FW
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM--- 179
Query: 185 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244
APE+ + YT DIWS+GC+ EMLTGK FP T L
Sbjct: 180 ------APEVVKQ--TSYTRKADIWSLGCLVVEMLTGKHPFPD---------CTQL---- 218
Query: 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 304
++I +I E A P S+ A LE+ D RPTA E
Sbjct: 219 --QAIFKI-GENAS----------PEIPSNISSEAI----DFLEKTFEIDHNKRPTAAEL 261
Query: 305 LADPY 309
L P+
Sbjct: 262 LKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 73/286 (25%), Positives = 129/286 (45%), Gaps = 40/286 (13%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 84
IG+GS G+V A + H+G +VA+K ++ + E+ ++R +H ++VE+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 85 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 144
L ++++V+ E ++ I + L E +L+ L Y+H+ V HR
Sbjct: 87 YLVG-----EELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHR 141
Query: 145 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP 204
D+K +IL D ++K+ DFG D P V T ++ APE+ + Y
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVISR--TPYGT 196
Query: 205 AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSM 264
+DIWS+G + EM+ G+P + + V +++ R+R+
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPV---------------QAMKRLRDS--------- 232
Query: 265 RKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
P P P+ LER+L +P++R TA+E L P+
Sbjct: 233 ----PPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 71/215 (33%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN---DVFEHVSDATRILREIKLLRLL 73
S YQ E+IG+G+YG V TG VA+K IN + VSD I RE+ LL L
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSD---IQREVALLSQL 56
Query: 74 RHPDIVEIKH----IMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQ 128
R I + P ++++ E E + ++KA + ++ + +
Sbjct: 57 RQSQPPNITKYYGSYLKGPR------LWIIMEYAEGGSVRTLMKAGP-IAEKYISVIIRE 109
Query: 129 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 188
+L LKYIH V HRD+K NIL +K+CDFG+A N S + +V T +
Sbjct: 110 VLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVA-ALLNQNSSK--RSTFVGTPY 166
Query: 189 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKP 223
+ APE+ Y DIWS+G EM TG P
Sbjct: 167 WMAPEVITE-GKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 82/305 (26%), Positives = 131/305 (42%), Gaps = 46/305 (15%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-R 74
+++ EVIG+G+YG V A TG+ VAIK ++ + + I E +LR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE---EEEIKEEYNILRKYSN 61
Query: 75 HPDIVEIKHIMLPPSRREFKD-IYVVFELME----SDLHQ-VIKANDDLTPEHYQFFLYQ 128
HP+I + + D +++V EL +DL + + K L E + L +
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 129 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 188
LRGL Y+H V HRD+K +NIL + ++K+ DFG++ D+ T ++ T +
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNT-FIGTPY 178
Query: 189 YRAPE--LCG-SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245
+ APE C + Y D+WS+G E+ GKP D+
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL--------CDM-------HP 223
Query: 246 TESISRI-RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 304
++ +I RN K P +S KF + L + + RP EE
Sbjct: 224 MRALFKIPRNP-------PPTLKSPENWSKKFN-------DFISECLIKNYEQRPFMEEL 269
Query: 305 LADPY 309
L P+
Sbjct: 270 LEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-24
Identities = 82/299 (27%), Positives = 129/299 (43%), Gaps = 53/299 (17%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRH 75
+Y+ V+G+G++G+V + V IK+I E ++ R E ++L+LL H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIP--VEQMTKDERLAAQNECQVLKLLSH 58
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVI-KANDDLTPEH--YQFFLYQLLR 131
P+I+E L E K + +V E L + I K + L E FF+ Q+L
Sbjct: 59 PNIIEYYENFL-----EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV-QILL 112
Query: 132 GLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARV-SFNDAPSAIFWTDYVATRWY 189
L ++HT + HRDLK +NIL + +KI DFG++++ S + V T Y
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV-----VGTPCY 167
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
+PELC Y DIW++GC+ E+ + K F N+ P+
Sbjct: 168 ISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANL-------------PAL--- 209
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308
L M P S ++ P L+ +L DP RP + +A P
Sbjct: 210 ----------VLKIMSGTF-APISDRY---SPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 93/318 (29%), Positives = 131/318 (41%), Gaps = 68/318 (21%)
Query: 8 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREI 67
E+ EY E + V+GKG+YG+V +A D T R+AIK+I + + EI
Sbjct: 2 EYEYEYDENGE---RVVLGKGTYGIVYAARDLSTQVRIAIKEIPE--RDSRYVQPLHEEI 56
Query: 68 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-------SDLHQV----IKANDD 116
L L+H +IV+ + S F I+ ME S L + +K N+
Sbjct: 57 ALHSYLKHRNIVQY---LGSDSENGFFKIF-----MEQVPGGSLSALLRSKWGPLKDNEQ 108
Query: 117 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFG----LARVSF 171
F+ Q+L GLKY+H + HRD+K N+L N +KI DFG LA ++
Sbjct: 109 TI----IFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN- 163
Query: 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 231
P + T Y APE+ Y DIWS+GC EM TGKP F
Sbjct: 164 ---PCT---ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF------ 211
Query: 232 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLL 291
+ LG P +A + M K P A + + R
Sbjct: 212 IE-------LGEP-----------QAAMFKVGMFKIHP-EIPESLSAE---AKNFILRCF 249
Query: 292 AFDPKDRPTAEEALADPY 309
DP R +A + L DP+
Sbjct: 250 EPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 2e-23
Identities = 73/223 (32%), Positives = 112/223 (50%), Gaps = 15/223 (6%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
RY+I + IG+GS+G + A E IK+I+ V + +E+ LL ++HP+
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLY--QLLRGLK 134
IV S +E +++V E + DL + I + Q + Q+ GLK
Sbjct: 61 IVTFFA-----SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 135 YIHTANVFHRDLKPKNILANADCKL-KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 193
+IH + HRD+K +NI + + + K+ DFG+AR ND S V T +Y +PE
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LND--SMELAYTCVGTPYYLSPE 172
Query: 194 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 236
+C + Y DIWS+GC+ E+ T K F G N +HQL L
Sbjct: 173 ICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 2e-23
Identities = 76/286 (26%), Positives = 128/286 (44%), Gaps = 40/286 (13%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 84
IG+GS G+V A + HTG++VA+KK++ + E+ ++R H ++V++ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD--LRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 85 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 144
L +++VV E +E I + + E +LR L Y+H V HR
Sbjct: 88 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHR 142
Query: 145 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP 204
D+K +IL +D ++K+ DFG + P V T ++ APE+ Y
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR---KSLVGTPYWMAPEVISRL--PYGT 197
Query: 205 AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSM 264
+DIWS+G + EM+ G+P + P +++ RIR+ R
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPY---------------FNEPPLQAMRRIRDNLPPR----- 237
Query: 265 RKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
V SHK + + L+ +L +P R TA+E L P+
Sbjct: 238 -----VKDSHKVSS---VLRGFLDLMLVREPSQRATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 4e-23
Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA---TRILREIKLLRLLRHPDIVEI 81
+G G +G V A+K + H+ + I E ++L HP IV++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKR--HIVETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 82 KHIMLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
R FKD ++ LME +L +++ +F++ ++ +Y+H
Sbjct: 59 --------YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLH 110
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 197
+ +RDLKP+N+L +++ +K+ DFG A+ + + WT + T Y APE+
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT---WT-FCGTPEYVAPEII-- 164
Query: 198 FFSK-YTPAIDIWSIGCIFAEMLTGKPLF 225
+K Y ++D WS+G + E+LTG+P F
Sbjct: 165 -LNKGYDFSVDYWSLGILLYELLTGRPPF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 2e-22
Identities = 81/295 (27%), Positives = 132/295 (44%), Gaps = 43/295 (14%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+Y + IG+GS+G G++ IK+IN + +E+ +L ++HP+
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQF--FLYQLLRGLK 134
IV+ + S E ++Y+V + E DL++ I A + Q + Q+ LK
Sbjct: 61 IVQYQE-----SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 135 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 194
++H + HRD+K +NI D +K+ DFG+ARV + A + T +Y +PE+
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA---RTCIGTPYYLSPEI 172
Query: 195 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254
C + Y DIW++GC+ EM T K F N M +L+ + IR
Sbjct: 173 CEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGN-------MKNLV-------LKIIR- 215
Query: 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309
GS PV SH + L L +R +P+DRP+ L +
Sbjct: 216 -------GSY---PPVS-SHYSYDLRNLVSQLFKR----NPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 7e-22
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 21/217 (9%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR-ILREIKLLRLLRHPD 77
+QI +G+G YG V A TGE VA+K++ + R +L E +L +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRGL 133
+V++ + F+D ++ ME D ++ L+ +H +F++ ++ +
Sbjct: 63 LVKLLY--------AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAV 114
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 193
+H HRDLKP+N L +A +K+ DFGL++ A S + DY+ APE
Sbjct: 115 DALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYM------APE 168
Query: 194 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV 230
+ Y +D WS+GC+ E L G P F G
Sbjct: 169 VLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 8e-22
Identities = 77/303 (25%), Positives = 126/303 (41%), Gaps = 56/303 (18%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR----ILREIKLLRLLRHPDI 78
+ +G G++ A D TG +A+K++ V S+ + +EI+L+ L HP I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 79 VEIKHIMLPPSRREFKDIYVVF-ELM-----ESDLHQVIKANDDLTPEHYQFFLYQLLRG 132
+ ML + + +F E M L + + + + QLLRG
Sbjct: 66 IR----MLGATCE--DSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN----YTEQLLRG 115
Query: 133 LKYIHTANVFHRDLKPKNILANADCK-LKICDFGLA-RVSFNDAPSAIFWTDYVATRWYR 190
L Y+H + HRD+K N+L ++ + L+I DFG A R++ + F + T +
Sbjct: 116 LSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 191 APELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL---LGTPSTE 247
APE+ +Y + D+WS+GC+ EM T KP + + + L L+ + P
Sbjct: 176 APEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP--- 230
Query: 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307
+P H P + L LE P+DRP + E L
Sbjct: 231 ---------------------SIP-EHLSPGLRDVTLRCLEL----QPEDRPPSRELLKH 264
Query: 308 PYF 310
P F
Sbjct: 265 PVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 8e-22
Identities = 71/213 (33%), Positives = 109/213 (51%), Gaps = 18/213 (8%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 76
+Y + V+G+GS+G ++ ++ A+K+I + +R +E LL ++HP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR--KEAVLLAKMKHP 58
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIK-ANDDLTPEH--YQFFLYQLLRG 132
+IV K S +Y+V E + DL Q IK L PE Q+F+ Q+ G
Sbjct: 59 NIVAFKE-----SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV-QMCLG 112
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 192
+++IH V HRD+K KNI + K+K+ DFG AR+ + P A + YV T +Y P
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGA-YACTYVGTPYYVPP 169
Query: 193 ELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 225
E+ + Y DIWS+GCI E+ T K F
Sbjct: 170 EIWENM--PYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 40/286 (13%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 84
IG+GS G+V A +G+ VA+KK++ + E+ ++R +H ++VE+ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 85 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 144
L +++VV E +E I + + E +L+ L +H V HR
Sbjct: 86 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 145 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP 204
D+K +IL D ++K+ DFG + P V T ++ APEL Y P
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPELISRL--PYGP 195
Query: 205 AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSM 264
+DIWS+G + EM+ G+P + P +++ IR+ + L ++
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPY---------------FNEPPLKAMKMIRDNLPPK-LKNL 239
Query: 265 RKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
K P L+RLL DP R TA E L P+
Sbjct: 240 HK------------VSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 4e-21
Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 37/220 (16%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIK--KINDVF-----EHVSDATRILREIKLLR 71
++ + +G GS+G V +G+ A+K + EHV L E ++L+
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHV------LNEKRILQ 56
Query: 72 LLRHPDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLY 127
+RHP +V + F+D +Y+V E + +L ++ + +F+
Sbjct: 57 SIRHPFLVNLYG--------SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA 108
Query: 128 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-RVSFNDAPSAIFWTDYVAT 186
Q++ L+Y+H+ ++ +RDLKP+N+L ++D +KI DFG A RV +T T
Sbjct: 109 QVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT------YT-LCGT 161
Query: 187 RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLTGKPLF 225
Y APE+ SK Y A+D W++G + EML G P F
Sbjct: 162 PEYLAPEI---ILSKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 83/329 (25%), Positives = 129/329 (39%), Gaps = 70/329 (21%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
+++ +VIG+G++G V D TG+ A+K + + +R + +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDI------ 54
Query: 77 DIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 132
+ + + F+D +Y+V E M DL ++ D E +F++ +L+
Sbjct: 55 -LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA 113
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLA----------------RVSFNDAPS 176
L +H HRD+KP NIL +AD +K+ DFGL
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 177 AIFWTDY----------VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 225
+ D+ V T Y APE L G+ Y D WS+G I EML G P F
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT---PYGLECDWWSLGVILYEMLYGFPPF 230
Query: 226 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH 285
E+ ++I N K L P P A+
Sbjct: 231 YSDT---------------LQETYNKIINWK--ESLR-------FPPDPPVS---PEAID 263
Query: 286 LLERLLAFDPKDR-PTAEEALADPYFHGL 313
L+ RLL DP+DR + EE + P+F G+
Sbjct: 264 LICRLLC-DPEDRLGSFEEIKSHPFFKGI 291
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 5e-21
Identities = 78/300 (26%), Positives = 132/300 (44%), Gaps = 46/300 (15%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI----NDVFEHVSDATRILREIKLLRLLR 74
+ EV+GKG+YG V + T+ G+ +A+K++ ++V + ++ E+ LL+ L+
Sbjct: 2 WTKGEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGL 133
H +IV+ L + I + E + + ++ L + + Q+L G+
Sbjct: 61 HVNIVQYLGTCL-----DDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGV 115
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGLAR----VSFNDAPSAIFWTDYVATRWY 189
Y+H V HRD+K N++ + +K+ DFG AR V + S + + + T ++
Sbjct: 116 AYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH-GTPYW 174
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
APE+ S Y DIWSIGC EM TGKP S+
Sbjct: 175 MAPEVINE--SGYGRKSDIWSIGCTVFEMATGKPPL---------------------ASM 211
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309
R+ A Y+G+ R P F A A+ + L D +RP+A + L +
Sbjct: 212 DRL---AAMFYIGAHRGLMP-RLPDSFSAA---AIDFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 8e-21
Identities = 86/303 (28%), Positives = 129/303 (42%), Gaps = 55/303 (18%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHT--GERVAIKKINDVFE-HVSDATRILREIKLLRLLR 74
RY +Q+ +GKGS+G V D ER+ + K V E + ++ + +E +LL L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLH---QVIKANDDLTPEHYQF-FLYQL 129
HP IV+ L E ++ E E DL + +K E+ + QL
Sbjct: 61 HPAIVKFHASFL-----ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 130 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
L G+ Y+H + HRDLK KNI + LKI DFG++R+ A T + T +Y
Sbjct: 116 LLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLA---TTFTGTPYY 171
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL--GTPSTE 247
+PE Y DIWS+GCI EM F G+N L ++ ++ TPS
Sbjct: 172 MSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPTPS-- 224
Query: 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH-LLERLLAFDPKDRPTAEEALA 306
P L+ +++ +L DP RP+A E L
Sbjct: 225 ----------------------------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256
Query: 307 DPY 309
+P+
Sbjct: 257 NPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 56/221 (25%), Positives = 105/221 (47%), Gaps = 27/221 (12%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN--DVF-----EHVSDATRILREIKL 69
+ + +G G++G V D + A+K + +V +HV + R+L+E+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-- 58
Query: 70 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQ 128
HP I+ L + + + +Y++ E + +L ++ + + F+ +
Sbjct: 59 ----SHPFIIR-----LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE 109
Query: 129 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 188
++ L+Y+H+ + +RDLKP+NIL + + +K+ DFG A+ + WT T
Sbjct: 110 IVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----WT-LCGTPE 163
Query: 189 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 229
Y APE+ S + A+D W++G + EML G P F N
Sbjct: 164 YLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 1e-20
Identities = 77/294 (26%), Positives = 132/294 (44%), Gaps = 42/294 (14%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+Y E IG+G+ G V +A+D TG+ VAIK+IN + I+ EI +++ L++P+
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN--LQKQPKKELIINEILVMKELKNPN 77
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
IV L +++VV E + + + + L+ L+++H
Sbjct: 78 IVNFLDSFLVGD-----ELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH 132
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGL-ARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
V HRD+K N+L D +K+ DFG A+++ P + V T ++ APE+
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT----PEQSKRSTMVGTPYWMAPEVVT 188
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256
Y P +DIWS+G + EM+ G+P + +N + L L+ GTP ++ ++
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPEKL---- 241
Query: 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
P+ L R L D + R +A+E L P+
Sbjct: 242 -----------------------SPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 67/217 (30%), Positives = 103/217 (47%), Gaps = 42/217 (19%)
Query: 25 IGKGSYGVVGSA----VDTHTGERVAIKKIN--DVFEHVSDATRILREIKLLRLLRHPDI 78
+G+G +G V + +TGE+VA+K +N +H SD REI++LR L H +I
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD---FEREIEILRTLDHENI 68
Query: 79 VEIKHIMLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLY--QLLRG 132
V+ K + P R + ++ E + S D Q + + + L+ Q+ +G
Sbjct: 69 VKYKGVCEKPGGRSLR---LIMEYLPSGSLRDYLQRHRDQIN----LKRLLLFSSQICKG 121
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV---------SFNDAPSAIFWTDY 183
+ Y+ + HRDL +NIL ++ +KI DFGLA+V S IFW Y
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW--Y 179
Query: 184 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 220
APE C SK++ A D+WS G E+ T
Sbjct: 180 -------APE-CLR-TSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 88/300 (29%), Positives = 134/300 (44%), Gaps = 54/300 (18%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHP 76
Y V+GKGSYG V G++ IKK+N + S R +E +LL L+HP
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLN--LRNASRRERKAAEQEAQLLSQLKHP 59
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DL-HQVIKANDDLTPEH--YQFFLYQLLRG 132
+IV + E +Y+V E DL H++ + L PE+ ++F+ Q+
Sbjct: 60 NIVAYRE----SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV-QIAMA 114
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV--SFNDAPSAIFWTDYVATRWYR 190
L+Y+H ++ HRDLK +N+ +K+ D G+ARV + D S + T Y Y
Sbjct: 115 LQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPY-----YM 169
Query: 191 APELCGSFFSK-YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
+PEL F +K Y D+W++GC EM T K F K+ M L +
Sbjct: 170 SPEL---FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-------MNSL--------V 211
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309
RI K P+P + P L+ +L+ P+ RP+ + L PY
Sbjct: 212 YRIIEGKL----------PPMPKDY-----SPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 68/228 (29%), Positives = 113/228 (49%), Gaps = 15/228 (6%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+Y E IG+G+ G V +A+D TG+ VAIK++N + I+ EI ++R +HP+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN--LQQQPKKELIINEILVMRENKHPN 77
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
IV L +++VV E + + + + L+ L+++H
Sbjct: 78 IVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 132
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGL-ARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
+ V HRD+K NIL D +K+ DFG A+++ P + V T ++ APE+
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT----PEQSKRSTMVGTPYWMAPEVVT 188
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244
Y P +DIWS+G + EM+ G+P + +N + L L+ GTP
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP 233
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 97/350 (27%), Positives = 148/350 (42%), Gaps = 74/350 (21%)
Query: 8 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRI 63
E F++ + IG GS+G V A D T E VAIKK++ E D I
Sbjct: 6 ELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD---I 62
Query: 64 LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME------SDLHQVIKANDDL 117
++E++ L+ LRHP+ +E K L RE + + +ME SD+ +V K L
Sbjct: 63 IKEVRFLQQLRHPNTIEYKGCYL----RE----HTAWLVMEYCLGSASDILEVHK--KPL 112
Query: 118 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 177
+ L+GL Y+H+ HRD+K NIL +K+ DFG A + +P+
Sbjct: 113 QEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV---SPAN 169
Query: 178 IFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLD 235
F V T ++ APE+ + +Y +D+WS+G E+ K PLF ++
Sbjct: 170 SF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-------NMN 218
Query: 236 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDP 295
M+ L +S + +S F N ++ L P
Sbjct: 219 AMSALYHIAQNDSPTL----------------SSNDWSDYFRN-------FVDSCLQKIP 255
Query: 296 KDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREM 345
+DRP++EE L + V RE I L +R KD VRE+
Sbjct: 256 QDRPSSEELLKHRF------VLRERPPTVIIDL---IQR---TKDAVREL 293
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-20
Identities = 68/210 (32%), Positives = 112/210 (53%), Gaps = 20/210 (9%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLR 74
+ +QI++ IG+G + V A + VA+KK+ +FE + R ++EI LL+ L
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQ-IFEMMDAKARQDCVKEIDLLKQLN 60
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEH--YQFFLYQ 128
HP++ IK++ S E ++ +V EL ++ DL Q+I K L PE +++F+ Q
Sbjct: 61 HPNV--IKYL---DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV-Q 114
Query: 129 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 188
L ++++H+ V HRD+KP N+ A +K+ D GL R + +A V T +
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPY 171
Query: 189 YRAPELCGSFFSKYTPAIDIWSIGCIFAEM 218
Y +PE + Y DIWS+GC+ EM
Sbjct: 172 YMSPERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 2e-20
Identities = 68/236 (28%), Positives = 116/236 (49%), Gaps = 15/236 (6%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+Y E IG+G+ G V +A+D TG+ VAIK++N + I+ EI ++R ++P+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNPN 77
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
IV L +++VV E + + + + L+ L ++H
Sbjct: 78 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH 132
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGL-ARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
+ V HRD+K NIL D +K+ DFG A+++ P + V T ++ APE+
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT----PEQSKRSTMVGTPYWMAPEVVT 188
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252
Y P +DIWS+G + EM+ G+P + +N + L L+ GTP ++ R+
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPERL 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 29/230 (12%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGER-VAIKKIN--------DVFEHVSDATRILREIKL 69
Y + E +G G++G V + G+ +A+K+IN D E I+ E+ +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 70 LR-LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEH--Y 122
++ LRHP+IV L R +Y+V +L+E + +K E +
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDR-----LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW 116
Query: 123 QFFLYQLLRGLKYIHTAN-VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 181
F+ Q++ L+Y+H + HRDL P NI+ D K+ I DFGLA+ ++ T
Sbjct: 117 NIFV-QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES----KLT 171
Query: 182 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 231
V T Y PE+ + Y D+W+ GCI +M T +P F N++
Sbjct: 172 SVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNML 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-20
Identities = 66/236 (27%), Positives = 117/236 (49%), Gaps = 15/236 (6%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+Y E IG+G+ G V +A+D TG+ VAI+++N + I+ EI ++R ++P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
IV L +++VV E + + + + L+ L+++H
Sbjct: 79 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGL-ARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
+ V HRD+K NIL D +K+ DFG A+++ P + V T ++ APE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT----PEQSKRSTMVGTPYWMAPEVVT 189
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252
Y P +DIWS+G + EM+ G+P + +N + L L+ GTP ++ ++
Sbjct: 190 R--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKL 242
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 7e-20
Identities = 84/285 (29%), Positives = 136/285 (47%), Gaps = 42/285 (14%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR-ILREIKLLRLLRHPDIVEIKH 83
IG GS+G V A ++HT E VA+KK++ + ++ + I++E+K L+ L+HP+ +E K
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 84 IMLPPSRREFKDIYVVFELME------SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
L K+ + + +ME SDL +V K L + L+GL Y+H
Sbjct: 89 CYL-------KE-HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH 138
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 197
+ N+ HRD+K NIL ++K+ DFG A S +P+ +V T ++ APE+ +
Sbjct: 139 SHNMIHRDIKAGNILLTEPGQVKLADFGSASKS---SPA----NSFVGTPYWMAPEVILA 191
Query: 198 F-FSKYTPAIDIWSIGCIFAEMLTGKP-LFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
+Y +D+WS+G E+ KP LF ++ M+ L +S + NE
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLF-------NMNAMSALYHIAQNDSPTLQSNE 244
Query: 256 KARRYLGSMRKKQPVPFS-HKFPNADPLALHLLERLLAFDPKDRP 299
+ G V + K P P + LL F +DRP
Sbjct: 245 WTDSFRGF------VDYCLQKIPQERPASAELLRH--DFVRRDRP 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 1e-19
Identities = 70/221 (31%), Positives = 112/221 (50%), Gaps = 33/221 (14%)
Query: 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGER---VAIKKINDVFEHVSDATR--ILREIKL 69
+AS +I++VIG G +G V S G+R VAIK + + ++ R L E +
Sbjct: 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASI 58
Query: 70 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQ 128
+ HP+I+ ++ ++ + K + +V E ME+ L ++ +D QF + Q
Sbjct: 59 MGQFDHPNIIHLEGVV-----TKSKPVMIVTEYMENGSLDAFLRKHDG------QFTVIQ 107
Query: 129 L---LRG----LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 181
L LRG +KY+ HRDL +NIL N++ K+ DFGL+RV D P A + T
Sbjct: 108 LVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDPEAAYTT 166
Query: 182 D--YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 220
+ RW APE + K+T A D+WS G + E+++
Sbjct: 167 RGGKIPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 58/208 (27%), Positives = 105/208 (50%), Gaps = 7/208 (3%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN---DVFEHVSDATRILREIKLLRLLRH 75
+++ +++G+G++G V D TG +A+K++ D E + + EI+LL+ LRH
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
IV+ + P ++ I+V + + + +KA LT + + Q+L+G+ Y
Sbjct: 64 DRIVQYYGCLRDPEEKKLS-IFVEY-MPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 195
+H+ + HRD+K NIL ++ +K+ DFG ++ S T ++ +PE+
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKP 223
Y D+WS+ C EMLT KP
Sbjct: 182 SG--EGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 3e-19
Identities = 93/347 (26%), Positives = 147/347 (42%), Gaps = 50/347 (14%)
Query: 2 QSALETEFFTEYGE-----ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH 56
QS E F+ GE R++I ++G+G++G V A D E A+K + +V ++
Sbjct: 109 QSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY 168
Query: 57 VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD----IYVVFELMESDLHQVIK 112
DA +I EI+ + +R D + +M +R F++ + +V L I
Sbjct: 169 TRDA-KI--EIQFMEKVRQADPADRFPLM--KIQRYFQNETGHMCIVMPKYGPCLLDWIM 223
Query: 113 ANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANAD--------------- 156
+ + H ++Q L Y HT ++ H DLKP+NIL
Sbjct: 224 KHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPD 283
Query: 157 -CKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 215
C+++ICD G + +AI V+TR YR+PE+ Y+ D+WS+GCI
Sbjct: 284 PCRVRICDLG-GCCDERHSRTAI-----VSTRHYRSPEVVLGLGWMYS--TDMWSMGCII 335
Query: 216 AEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHK 275
E+ TGK L+ + + L LM LG +E R E+AR S + +P
Sbjct: 336 YELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKH 395
Query: 276 FPN-----------ADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311
D L L+ LL +D + R A + PY
Sbjct: 396 LARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVL 442
|
Length = 467 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 5e-19
Identities = 87/294 (29%), Positives = 128/294 (43%), Gaps = 52/294 (17%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV---SDATRILREIKLLRLLRHPDIVEI 81
IGKGS+G V T A+K I H+ S+ T L E +L + P IV +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRK--AHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58
Query: 82 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 140
K P + +Y+V + +L ++ +F+ +LL L+ +H N
Sbjct: 59 KFSFQSPEK-----LYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN 113
Query: 141 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 200
V +RDLKP+NIL + + +CDFGL +++ D + T Y APEL
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT---NTFCGTPEYLAPELLLGH-- 168
Query: 201 KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 260
YT A+D W++G + EMLTG P F +NV NE R+
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----------------------NEMYRKI 205
Query: 261 LGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR---PTAEEALADPYF 310
L ++P+ +FP D A LL LL+ DP R A+E P+F
Sbjct: 206 L-----QEPL----RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF 250
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-19
Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 9/211 (4%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN---DVFEHVSDATRILREIKLLRLL 73
+ +++ +++G+G++G V D TG +A+K++ + E + + EI+LL+ L
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 74 RHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQFFLYQLLRG 132
H IV+ + P R + E M + +K+ LT + + Q+L G
Sbjct: 62 LHERIVQYYGCLRDPMERTLS---IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEG 118
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 192
+ Y+H+ + HRD+K NIL ++ +K+ DFG ++ S T ++ +P
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 193 ELCGSFFSKYTPAIDIWSIGCIFAEMLTGKP 223
E+ Y DIWS+GC EMLT KP
Sbjct: 179 EVISG--EGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-19
Identities = 66/219 (30%), Positives = 113/219 (51%), Gaps = 20/219 (9%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLR 74
+ ++I++ IG+G + V A G VA+KK+ +F+ + R ++EI LL+ L
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQ-IFDLMDAKARADCIKEIDLLKQLN 60
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEH--YQFFLYQ 128
HP++++ + E ++ +V EL ++ DL ++I K L PE +++F+ Q
Sbjct: 61 HPNVIKYYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV-Q 114
Query: 129 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 188
L L+++H+ V HRD+KP N+ A +K+ D GL R + +A V T +
Sbjct: 115 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPY 171
Query: 189 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 227
Y +PE + Y DIWS+GC+ EM + F G
Sbjct: 172 YMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 7e-19
Identities = 91/303 (30%), Positives = 142/303 (46%), Gaps = 51/303 (16%)
Query: 9 FFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR-ILREI 67
FF E E ++E IG GS+G V A D T E VAIKK++ + ++ + I++E+
Sbjct: 18 FFKEDPEKLFTDLRE-IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEV 76
Query: 68 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM---ESDLHQVIKANDDLTPEHYQF 124
K L+ ++HP+ +E K L RE ++V E SDL +V K L
Sbjct: 77 KFLQRIKHPNSIEYKGCYL----RE-HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAA 129
Query: 125 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 184
+ L+GL Y+H+ N+ HRD+K NIL ++K+ DFG A ++ +P+ +V
Sbjct: 130 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA---SPA----NSFV 182
Query: 185 ATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLMTDLLG 242
T ++ APE+ + +Y +D+WS+G E+ K PLF ++ M+ L
Sbjct: 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-------NMNAMSALYH 235
Query: 243 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 302
ES + NE +S F N L + P+DRPT+E
Sbjct: 236 IAQNESPTLQSNE----------------WSDYFRNFVDSCLQKI-------PQDRPTSE 272
Query: 303 EAL 305
E L
Sbjct: 273 ELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 79/299 (26%), Positives = 135/299 (45%), Gaps = 61/299 (20%)
Query: 25 IGKGSYGVVG----SAVDTHTGERVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPDIV 79
+GKG++G V + +TGE VA+KK+ + EH+ D REI++L+ L+H +IV
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRD---FEREIEILKSLQHDNIV 68
Query: 80 EIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHYQFFLY--QLLRGLKYI 136
+ K + RR + +V E L L ++ + + +H + LY Q+ +G++Y+
Sbjct: 69 KYKGVCYSAGRRNLR---LVMEYLPYGSLRDYLQKHRERL-DHRKLLLYASQICKGMEYL 124
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFND---------APSAIFWTDYVATR 187
+ HRDL +NIL ++ ++KI DFGL +V D S IFW
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY------ 178
Query: 188 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247
APE SK++ A D+WS G + E+ T +D +P E
Sbjct: 179 ---APESLTE--SKFSVASDVWSFGVVLYELFT----------------YSDKSCSPPAE 217
Query: 248 SISRIRNEKAR-----RYLGSMRKKQPVPFSHKFPNADPLALH-LLERLLAFDPKDRPT 300
+ + N+K + ++ +P P P ++ +++ DP RP+
Sbjct: 218 FMRMMGNDKQGQMIVYHLIELLKNNGRLP----APPGCPAEIYAIMKECWNNDPSQRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 70/243 (28%), Positives = 116/243 (47%), Gaps = 24/243 (9%)
Query: 23 EVIGKGSYG---VVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79
+V+G+GS+G +V G+ A+K + V D R E +L + HP IV
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 80 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 138
++ + + +Y++ + + DL + T E +F+L +L L ++H+
Sbjct: 62 KLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 116
Query: 139 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 198
+ +RDLKP+NIL + + +K+ DFGL++ S + A + T Y APE+
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVNR- 172
Query: 199 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL----LGTP---STESISR 251
+T + D WS G + EMLTG F GK + + MT + LG P S E+ S
Sbjct: 173 -RGHTQSADWWSFGVLMFEMLTGSLPFQGK---DRKETMTMILKAKLGMPQFLSPEAQSL 228
Query: 252 IRN 254
+R
Sbjct: 229 LRA 231
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 22 QEVIGKGSYGVVGSAVDTHTGER---VAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 78
Q+VIG G +G V + G + VAIK + + L E ++ H +I
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFSHHNI 68
Query: 79 VEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKAND-DLTPEHYQFFLYQLLRGLKYI 136
+ ++ ++ +FK ++ E ME+ L + ++ +D + + L + G+KY+
Sbjct: 69 IRLEGVV-----TKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD--YVATRWYRAPEL 194
N HRDL +NIL N++ + K+ DFGL+RV D P + T + RW APE
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRV-LEDDPEGTYTTSGGKIPIRW-TAPEA 181
Query: 195 CGSFFSKYTPAIDIWSIGCIFAEMLT 220
+ K+T A D+WS G + E+++
Sbjct: 182 IA--YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 22/209 (10%)
Query: 21 IQEVIGKGSYGVVGSAVDTHTGER---VAIKKINDVFEHVSDATRI--LREIKLLRLLRH 75
I++VIG G +G V G++ VAIK + SD R+ L E ++ H
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFDH 64
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 133
P+I+ ++ ++ ++ + + ++ E ME+ L + ++ ND T L + G+
Sbjct: 65 PNIIRLEGVV---TKS--RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGM 119
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD--YVATRWYRA 191
KY+ N HRDL +NIL N++ K+ DFGL+R + A + T + RW A
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL--EDSEATYTTKGGKIPIRW-TA 176
Query: 192 PELCGSFFSKYTPAIDIWSIGCIFAEMLT 220
PE + K+T A D+WS G + E+++
Sbjct: 177 PEAIA--YRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 6e-18
Identities = 67/241 (27%), Positives = 106/241 (43%), Gaps = 42/241 (17%)
Query: 15 EASRYQIQ--EVIGKGSYGVVGSAV-DTHTGERVAIKKINDVFEHVSDATRILREIKLLR 71
E R ++ +G G +G V + T +VA+K + L+E ++++
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTT--KVAVKTLK---PGTMSPEAFLQEAQIMK 56
Query: 72 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQ 128
LRH +V++ + S E IY+V E M L +K+ + L Q
Sbjct: 57 KLRHDKLVQLYAVC---SEEE--PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQ 111
Query: 129 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWT 181
+ G+ Y+ + N HRDL +NIL + KI DFGLAR+ +D +A I WT
Sbjct: 112 IAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT 171
Query: 182 DYVATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 235
APE G F K D+WS G + E++T G+ +PG V+ Q++
Sbjct: 172 ---------APEAANYGRFTIKS----DVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE 218
Query: 236 L 236
Sbjct: 219 R 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 7e-18
Identities = 76/302 (25%), Positives = 122/302 (40%), Gaps = 67/302 (22%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 84
I KG++G V A TG+ AIK +L++ ++ + ++ + I
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIK--------------VLKKSDMIAKNQVTNVKAERAI 49
Query: 85 MLPPSRREF----------KD-IYVVFE-LMESDLHQVIKANDDLTPEHYQFFLYQLLRG 132
M+ + KD +Y+V E L D +IK L + + ++ +++ G
Sbjct: 50 MMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLG 109
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 192
++ +H + HRD+KP+N+L + LK+ DFGL+R + +V T Y AP
Sbjct: 110 VEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-------KKFVGTPDYLAP 162
Query: 193 E-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251
E + G D WS+GC+ E L G P F TP
Sbjct: 163 ETILG---VGDDKMSDWWSLGCVIFEFLFGYPPFHA--------------ETPD-AVFDN 204
Query: 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA---EEALADP 308
I +RR K+ P A+ L+ RLL DP R A +E + P
Sbjct: 205 I---LSRRINWPEEVKE---------FCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP 252
Query: 309 YF 310
+F
Sbjct: 253 FF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 9e-18
Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 23/229 (10%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEHVSDATRILREIKLLRLLRH 75
+ ++ +G G +G V + RVAIK + +D D + E++ L+ LRH
Sbjct: 6 EEFTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQK---EVQALKRLRH 61
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRG 132
++ + + +Y++ ELME L +++ + L Q+ G
Sbjct: 62 KHLISL-FAVCSVGE----PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD--YVATRWYR 190
+ Y+ N HRDL +NIL D K+ DFGLAR+ D ++ + + +W
Sbjct: 117 MAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED----VYLSSDKKIPYKW-T 171
Query: 191 APELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMT 238
APE ++ D+WS G + EM T G+ +PG N D +T
Sbjct: 172 APEAAS--HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 77/299 (25%), Positives = 119/299 (39%), Gaps = 49/299 (16%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKH 83
+GKG +G V + TG+ A KK++ + L E K+L + IV + +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 84 IMLPPSRREFKDIYVVFELMES-DLH-QVIKANDDLTPE-HYQFFLYQLLRGLKYIHTAN 140
D+ +V LM DL + + PE F+ Q++ GL+++H
Sbjct: 61 AFETKD-----DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115
Query: 141 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 200
+ +RDLKP+N+L + ++I D GLA V T Y APE+
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKI---KGRAGTPGYMAPEVLQG--E 169
Query: 201 KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 260
Y ++D +++GC EM+ G+ F R R EK +
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF-------------------------RQRKEKVEKE 204
Query: 261 -LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYFHGL 313
L + V + KF P A L E LL DP+ R +A+E P F L
Sbjct: 205 ELKRRTLEMAVEYPDKF---SPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 80/308 (25%), Positives = 124/308 (40%), Gaps = 77/308 (25%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDT-HTGER--VAIK--KINDVFEHVSDATRILREIKLLR 71
+ IG+G +G V V E+ VA+K K S + L+E ++R
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMR 62
Query: 72 LLRHPDIVE-IKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQ 128
HP IV+ I I P +++V EL +L ++ N L + YQ
Sbjct: 63 QFDHPHIVKLIGVITENP-------VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQ 115
Query: 129 LLRGLKYIHTANVFHRDLKPKNIL-ANADCKLKICDFGLARVSFNDAPSAIFWTD----Y 183
L L Y+ + HRD+ +N+L ++ DC +K+ DFGL+R + + Y
Sbjct: 116 LSTALAYLESKRFVHRDIAARNVLVSSPDC-VKLGDFGLSR-----------YLEDESYY 163
Query: 184 VATR------WYRAPELCGSFFSKYTPAIDIWSIG-CIFAEMLTG-KPLFPGKNVVHQLD 235
A++ W APE F ++T A D+W G C++ ++ G KP
Sbjct: 164 KASKGKLPIKWM-APESIN--FRRFTSASDVWMFGVCMWEILMLGVKPFQ---------- 210
Query: 236 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDP 295
G + + I RI E R P+P PN P L+ + A+DP
Sbjct: 211 ------GVKNNDVIGRI--ENGERL--------PMP-----PNCPPTLYSLMTKCWAYDP 249
Query: 296 KDRPTAEE 303
RP E
Sbjct: 250 SKRPRFTE 257
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 67/218 (30%), Positives = 109/218 (50%), Gaps = 25/218 (11%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR-ILREIKLLRLLRHPDIVEIKH 83
IG GS+G V A D E VAIKK++ + ++ + I++E++ L+ LRHP+ ++ +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 84 IMLPPSRREFKDIYVVFELME------SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
L RE + + +ME SDL +V K L + L+GL Y+H
Sbjct: 83 CYL----RE----HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH 132
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 197
+ N+ HRD+K NIL + +K+ DFG A + AP+ +V T ++ APE+ +
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APA----NXFVGTPYWMAPEVILA 185
Query: 198 F-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQL 234
+Y +D+WS+G E+ KP N + L
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 72/293 (24%), Positives = 128/293 (43%), Gaps = 41/293 (13%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 84
+G+G+ G V +TG A+K I + +ILRE+++ + + P IV+
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTIT-TDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 85 MLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLYQ-LLRGLKYIHTA 139
L S I + E E +++ +K E + + +L+GL Y+H+
Sbjct: 68 FLDESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124
Query: 140 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSF 198
+ HRD+KP NIL ++K+CDFG++ N + T +Y APE + G
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-----FTGTSFYMAPERIQG-- 177
Query: 199 FSKYTPAIDIWSIGCIFAEMLTGKPLFP--GKNVVHQLDLMTDLLGTPSTESISRIRNEK 256
Y+ D+WS+G E+ + FP G+ + ++L++ I + N +
Sbjct: 178 -KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS---------YIVNMPNPE 227
Query: 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309
+ G+ K +S +F +++ L DP RPT + L P+
Sbjct: 228 LKDEPGNGIK-----WSEEFK-------DFIKQCLEKDPTRRPTPWDMLEHPW 268
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 3e-17
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 9/205 (4%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIKKIN---DVFEHVSDATRILREIKLLRLLRHPDIV 79
+++G+G++G V D TG +A K++ + E + + + EI+LL+ L+H IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 80 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 138
+ + R K + + E M + +KA LT + + Q+L G+ Y+H+
Sbjct: 68 QYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 139 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 198
+ HRD+K NIL ++ +K+ DFG ++ S T ++ +PE+
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG- 183
Query: 199 FSKYTPAIDIWSIGCIFAEMLTGKP 223
Y D+WS+GC EMLT KP
Sbjct: 184 -EGYGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-17
Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 41 TGERVAIKKINDVFEHVSDA---TRILREIKLLRLLRHPDIVE-IKHIMLPPSRREFKDI 96
TG VAIK + + + R RE L L HP+IV + PP +
Sbjct: 2 TGHEVAIKLLRT--DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-----L 54
Query: 97 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI-LAN 154
+ VFE + L +V+ A+ L + Q+L L H + HRDLKP+NI ++
Sbjct: 55 FAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQ 114
Query: 155 ADCK--LKICDFGLAR----VSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAID 207
+ K+ DFG+ V D + T+ + T Y APE L G TP D
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG---EPVTPNSD 171
Query: 208 IWSIGCIFAEMLTGKPLFPGKNV 230
+++ G IF E LTG+ + G +V
Sbjct: 172 LYAWGLIFLECLTGQRVVQGASV 194
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 83/304 (27%), Positives = 126/304 (41%), Gaps = 57/304 (18%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 78
++I +G G++G V A TG A K I E + + EI +L +HP+I
Sbjct: 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQ--IESEEELEDFMVEIDILSECKHPNI 64
Query: 79 VEIKH---------IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 129
V + I++ EF D + +M + LT ++ Q+
Sbjct: 65 VGLYEAYFYENKLWILI-----EFCDGGALDSIML-------ELERGLTEPQIRYVCRQM 112
Query: 130 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
L L ++H+ V HRDLK NIL D +K+ DFG VS + + ++ T ++
Sbjct: 113 LEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFG---VSAKNKSTLQKRDTFIGTPYW 169
Query: 190 RAPEL--CGSFFSK-YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246
APE+ C +F Y DIWS+G E+ +P P H+L+ M LL +
Sbjct: 170 MAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP--PH----HELNPMRVLLKILKS 223
Query: 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306
E + QP +S F + L+ L DP DRPTA E L
Sbjct: 224 EPPTL---------------DQPSKWSSSFND-------FLKSCLVKDPDDRPTAAELLK 261
Query: 307 DPYF 310
P+
Sbjct: 262 HPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 7e-17
Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 25 IGKGSYGVVGSAVDTHTGE-----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79
+G G +GVV H G+ +VAIK IN+ D + E K++ L HP +V
Sbjct: 12 LGSGQFGVV------HLGKWRAQIKVAIKAINEGAMSEED---FIEEAKVMMKLSHPKLV 62
Query: 80 EIKHIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
++ + + K +Y+V E ME+ L+ + + L+ + + G++Y+
Sbjct: 63 QLYGVCT-----QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 197
+ HRDL +N L ++ +K+ DFG+ R +D ++ + +W PE+
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKW-SPPEVFN- 174
Query: 198 FFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 229
FSKY+ D+WS G + E+ T GK F K+
Sbjct: 175 -FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 9e-17
Identities = 71/267 (26%), Positives = 111/267 (41%), Gaps = 37/267 (13%)
Query: 64 LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ 123
L E LL+ + HP ++ +K ++ + V SDL+ + P
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLV---SGAITCM--VLPHYSSDLYTYLTKRSRPLPIDQA 159
Query: 124 FFLY-QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 182
+ Q+L GL+Y+H + HRD+K +NI N ++ I D G A+ AP+ +
Sbjct: 160 LIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV-APAFLGLAG 218
Query: 183 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT----------GKPLFPGKNV-V 231
V T APE+ KY DIWS G + EML P K+
Sbjct: 219 TVET---NAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHS 273
Query: 232 HQLDLMTDLLGTPS---TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH--- 285
H L +++ L P + SR+ Y R+ P++ ++P + L
Sbjct: 274 HLLKIISTLKVHPEEFPRDPGSRLVRGFI-EYASLERQ----PYT-RYPCFQRVNLPIDG 327
Query: 286 --LLERLLAFDPKDRPTAEEALADPYF 310
L+ ++L FD RP+AEE L P F
Sbjct: 328 EFLVHKMLTFDAAMRPSAEEILNYPMF 354
|
Length = 357 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 25 IGKGSYGVVGSAVDTHTGE-----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79
+G G +GVV H G+ VAIK I E + E K++ L HP++V
Sbjct: 12 LGSGQFGVV------HLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLV 62
Query: 80 EIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFL---YQLLRGLKY 135
++ + + + I++V E M + L ++ ++ L + ++Y
Sbjct: 63 QLYGVCT-----KQRPIFIVTEYMANGCLLNYLRERKGK--LGTEWLLDMCSDVCEAMEY 115
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 195
+ + HRDL +N L D +K+ DFGLAR +D ++ T + +W PE+
Sbjct: 116 LESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF-PVKW-APPEVF 173
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGK 228
+S+++ D+WS G + E+ + GK +
Sbjct: 174 D--YSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIK--------KINDVFEHVSDATRILREIK 68
S +++ E +G GS+G V A TGE AIK K+ V +HV+ IL E
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQV-QHVAQEKSILME-- 74
Query: 69 LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQ 128
L HP IV + +R F +VV + + L + + +D+ +F+ +
Sbjct: 75 ----LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVA----KFYHAE 126
Query: 129 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 188
L+ +Y+H+ ++ +RDLKP+N+L + +K+ DFG A+ P F T
Sbjct: 127 LVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRTF--TLCGTPE 180
Query: 189 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 225
Y APE+ S + A+D W++G + E + G P F
Sbjct: 181 YLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 77/318 (24%), Positives = 125/318 (39%), Gaps = 85/318 (26%)
Query: 20 QIQEVIGKGSYGVV--GSA---VDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 74
I+E +G+GS+G+V G A V RVAIK +N+ + + L E +++
Sbjct: 10 LIRE-LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-ASMRERIEFLNEASVMKEFN 67
Query: 75 HPDIVEIKHIML---PPSRREFKDIYVVFELM-ESDLHQVIKA-------NDDLTPEHYQ 123
+V + ++ P VV ELM + DL +++ N L P Q
Sbjct: 68 CHHVVRLLGVVSTGQPT--------LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 124 FFLY---QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 180
F+ ++ G+ Y+ HRDL +N + D +KI DFG+ R I+
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--------DIYE 171
Query: 181 TDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVV 231
TDY + RW APE +T D+WS G + EM T + + G +
Sbjct: 172 TDYYRKGGKGLLPVRWM-APESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-- 226
Query: 232 HQLDLMTDLLGTPSTESISRIRNEKARRYLGS---MRKKQPVPFSHKFPNADPLALHLLE 288
NE+ +++ + + P D L L L+
Sbjct: 227 ----------------------NEEVLKFVIDGGHLDLPENCP--------DKL-LELMR 255
Query: 289 RLLAFDPKDRPTAEEALA 306
++PK RPT E ++
Sbjct: 256 MCWQYNPKMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 79/288 (27%), Positives = 124/288 (43%), Gaps = 33/288 (11%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 84
+G G+ G V TG +A KK+ + S +ILRE++++ R P IV
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 85 MLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN-VF 142
L + +I + E M+ L ++ K + E ++ GL Y++ + +
Sbjct: 72 FLNEN-----NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIM 126
Query: 143 HRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKY 202
HRD+KP NIL N+ ++K+CDFG++ N +V T Y +PE KY
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT-----FVGTSTYMSPERIQG--GKY 179
Query: 203 TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLG 262
T D+WS+G E+ GK FP D D +G + + +I E R
Sbjct: 180 TVKSDVWSLGISIIELALGK--FPFAFSNIDDDGQDDPMGI--LDLLQQIVQEPPPR--- 232
Query: 263 SMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
+P S FP ++ L DP +RPT ++ A P F
Sbjct: 233 -------LP-SSDFP---EDLRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 33/217 (15%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGER---VAIKKINDVFEHVSDATR--ILREIKLLRLLR 74
+I+EVIG G +G V G+R VAIK + + ++ R L E ++
Sbjct: 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFD 63
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQL---L 130
HP+I+ ++ + + SR + ++ E ME+ L ++ ND QF + QL L
Sbjct: 64 HPNIIHLEGV-VTKSR----PVMIITEFMENGALDSFLRQNDG------QFTVIQLVGML 112
Query: 131 RG----LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY--- 183
RG +KY+ N HRDL +NIL N++ K+ DFGL+R +D + +
Sbjct: 113 RGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGK 172
Query: 184 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 220
+ RW APE + K+T A D+WS G + E+++
Sbjct: 173 IPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEHVSDATRILREIKLLRLL-RHPDIVEI 81
V+GKGS+G V A T E A+K + DV D + E ++L L +HP + ++
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 82 KHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
R +F +ME DL I+ + +F+ +++ GL+++H
Sbjct: 62 HSCFQTKDR--------LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGLARVSF-NDAPSAIFWTDYVATRWYRAPELCG 196
+ +RDLK N+L +++ +KI DFG+ + ++ F T Y APE+
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF----CGTPDYIAPEILS 169
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 229
+ Y PA+D W++G + EML G+ F G +
Sbjct: 170 --YQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 76/294 (25%), Positives = 128/294 (43%), Gaps = 40/294 (13%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 78
+++ + IG G+YG V A + +TGE AIK I E D + +EI +++ +H +I
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 79 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
V L RR+ +++ E L + L+ + + L+GL Y+H
Sbjct: 69 VAYFGSYL---RRD--KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGL-ARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
+ HRD+K NIL + +K+ DFG+ A+++ A F + T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF----IGTPYWMAPEVAA 179
Query: 197 -SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
Y DIW++G E+ +P + + L LMT P
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP---------- 229
Query: 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309
+ K + +S+ F H ++ L +PK RPTAE+ L P+
Sbjct: 230 ---------KLKDKMKWSNSFH-------HFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 25/209 (11%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHPDIVEI 81
+G G+ GVV + +G +A K I+ E + A R I+RE+K+L P IV
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIH--LE-IKPAIRNQIIRELKVLHECNSPYIVGF 64
Query: 82 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFL-YQLLRGLKYIHTA 139
+I + E M+ L QV+K + PE+ + +LRGL Y+
Sbjct: 65 YGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRI-PENILGKISIAVLRGLTYLREK 118
Query: 140 -NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGS 197
+ HRD+KP NIL N+ ++K+CDFG++ + ++ +V TR Y +PE L G
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQG- 172
Query: 198 FFSKYTPAIDIWSIGCIFAEMLTGKPLFP 226
+ YT DIWS+G EM G+ +P
Sbjct: 173 --THYTVQSDIWSLGLSLVEMAIGR--YP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 19/216 (8%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIK---KINDVFEHVSDATRILREIKLLRLLRH 75
++I E IGKG+YG V + G A+K I+DV E + IL+ L H
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQS-----LPNH 78
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMESD-----LHQVIKANDDLTPEHYQFFLYQLL 130
P++V+ + + +++V EL + ++ L + LY L
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 131 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 190
GL+++H + HRD+K NIL + +K+ DFG VS + + V T ++
Sbjct: 139 LGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRRNTSVGTPFWM 195
Query: 191 APELCG---SFFSKYTPAIDIWSIGCIFAEMLTGKP 223
APE+ + Y D+WS+G E+ G P
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIK---KINDVFEHVSDATRILREIKLLRLLRH 75
++I E IGKG+YG V ++ G + A+K I+D+ E + IL+ L H
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKA-----LSDH 74
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQ-VIKANDDLTPEHYQFFLYQLL 130
P++V+ + + +++V EL +DL + +K + + + L++ L
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 131 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 190
GL+++H HRD+K NIL + +K+ DFG VS + + V T ++
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRRNTSVGTPFWM 191
Query: 191 APELCG---SFFSKYTPAIDIWSIGCIFAEMLTGKP 223
APE+ S Y D+WS+G E+ G P
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 64/249 (25%), Positives = 101/249 (40%), Gaps = 62/249 (24%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIKKI--NDVFE-----HVSDATRILREIKLLRLLRH 75
+VIG+G++G V TG A+KK+ +++ E HV IL E +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD------N 60
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLR 131
P +V++ + F+D ++ +ME D+ ++ D T E +F++ + +
Sbjct: 61 PWVVKLYY--------SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETIL 112
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGL------------ARVSFNDAPSAIF 179
+ IH HRD+KP N+L +A +K+ DFGL R+ + PS
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 180 WTDY-----------------------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA 216
V T Y APE+ + Y D WS+G I
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMY 230
Query: 217 EMLTGKPLF 225
EML G P F
Sbjct: 231 EMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 5e-16
Identities = 76/296 (25%), Positives = 123/296 (41%), Gaps = 50/296 (16%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDI 78
Q QE++G G+ G V A T +A+K I D+ + +I+ E+++L P I
Sbjct: 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDSPYI 61
Query: 79 VEIKHIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTPEH-YQFFLYQLLRGLK 134
+ +R I + E M+ D+++ I PEH +++GL
Sbjct: 62 IGFYGAFFVENR-----ISICTEFMDGGSLDVYRKI-------PEHVLGRIAVAVVKGLT 109
Query: 135 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 194
Y+ + + HRD+KP N+L N ++K+CDFG++ N YV T Y APE
Sbjct: 110 YLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA-----KTYVGTNAYMAPER 164
Query: 195 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254
+Y D+WS+G F E+ G+ +P + LL E +
Sbjct: 165 ISG--EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL-- 220
Query: 255 EKARRYLGSMRKKQPV-PFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309
PV FS KF +H + + + PK+RP E + P+
Sbjct: 221 --------------PVGQFSEKF-------VHFITQCMRKQPKERPAPENLMDHPF 255
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 6e-16
Identities = 81/307 (26%), Positives = 129/307 (42%), Gaps = 53/307 (17%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 84
+GKG+YG V + TG +A+K+I + S +I+ E+ +L P IV+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE-SKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 85 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLT---PEH-YQFFLYQLLRGLKYIHTA- 139
+Y+ E M++ + A T PE + Y +++GLK++
Sbjct: 68 FFIEGA-----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122
Query: 140 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE----LC 195
N+ HRD+KP N+L N + ++K+CDFG VS N S + T+ + + Y APE
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFG---VSGNLVAS-LAKTN-IGCQSYMAPERIKSGG 177
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK---NVVHQLDLMTDLLGTPSTESISRI 252
+ YT D+WS+G EM G+ +P + N+ QL + D G P T
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT------ 229
Query: 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312
P +S A + + L P RPT + L P+
Sbjct: 230 ---------------LPSGYS-------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267
Query: 313 LANVDRE 319
N D +
Sbjct: 268 YKNADVD 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 55/216 (25%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 23 EVIGKGSYGVV--GSAVDTHTGER-VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79
VIGKG +G V G+ +D+ + A+K +N + + + + L+E +++ HP+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 80 EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHT 138
+ I LP E + V+ + DL I++ + T + F Q+ +G++Y+ +
Sbjct: 60 SLLGICLPS---EGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS 116
Query: 139 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 198
HRDL +N + + +K+ DFGLAR I+ +Y + + +L +
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLAR--------DIYDKEYYSVHNHTGAKLPVKW 168
Query: 199 FS-------KYTPAIDIWSIGCIFAEMLT-GKPLFP 226
+ K+T D+WS G + E++T G P +P
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 13/209 (6%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 82
V+GKGS+G V A T E AIK + DV D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 83 HIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 141
H R +Y V E + DL I+ H F+ ++ GL ++H+ +
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 142 FHRDLKPKNILANADCKLKICDFGLARVS-FNDAPSAIFWTDYVATRWYRAPELCGSFFS 200
+RDLK N++ +A+ +KI DFG+ + + F + F T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTF----CGTPDYIAPEIIA--YQ 176
Query: 201 KYTPAIDIWSIGCIFAEMLTGKPLFPGKN 229
Y ++D W+ G + EML G+P F G++
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 82
E IGKGS+G V +D T E VAIK I D+ E + I +EI +L P I
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 83 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF 142
L ++ ++++ E + + L + L ++L+GL Y+H+
Sbjct: 69 GSYLKGTK-----LWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKI 123
Query: 143 HRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKY 202
HRD+K N+L + +K+ DFG+A D + I +V T ++ APE+ S Y
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAG-QLTD--TQIKRNTFVGTPFWMAPEVIKQ--SAY 178
Query: 203 TPAIDIWSIGCIFAEMLTGKP 223
DIWS+G E+ G+P
Sbjct: 179 DFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 76/328 (23%), Positives = 127/328 (38%), Gaps = 78/328 (23%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEI 81
+++GKG G V TG+ A+K ++ + R+L E ++L L HP + +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 82 KHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHT 138
S + + +V + +L ++++ L+ E +F+ ++L L+Y+H
Sbjct: 67 YA-----SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL 121
Query: 139 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT----------------- 181
+ +RDLKP+NIL + + + DF L++ S + P +
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQS-DVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 182 ----------DYVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK 228
+V T Y APE+ G + A+D W++G + EML G F G
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDG-----HGSAVDWWTLGILLYEMLYGTTPFKGS 235
Query: 229 NVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLE 288
N R+E L K+ V F P A L+
Sbjct: 236 N-----------------------RDETFSNIL-----KKEVTF-PGSPPVSSSARDLIR 266
Query: 289 RLLAFDPKDR----PTAEEALADPYFHG 312
+LL DP R A E P+F G
Sbjct: 267 KLLVKDPSKRLGSKRGAAEIKQHPFFRG 294
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 80/269 (29%), Positives = 117/269 (43%), Gaps = 39/269 (14%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKI-------NDVFEHVSDATRILREIKLLRLLRHP 76
V+G+G +G V A TGE AIK + D E + RI + RHP
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIF---ETANSERHP 62
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
+V + + V E DL I + P F+ ++ GL+Y
Sbjct: 63 FLVNLFACFQTEDH-----VCFVMEYAAGGDLMMHIHTDVFSEPRA-VFYAACVVLGLQY 116
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLAR--VSFNDAPSAIFWTDYVATRWYRAPE 193
+H + +RDLK N+L + + +KI DFGL + + F D S + T + APE
Sbjct: 117 LHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-----FCGTPEFLAPE 171
Query: 194 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD-LMTDLLGTP---STESI 249
+ + YT A+D W +G + EML G+ FPG + D ++ D + P S E+I
Sbjct: 172 VLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAI 229
Query: 250 SRIRNEKAR---RYLGSMR------KKQP 269
S +R R R LGS KKQP
Sbjct: 230 SIMRRLLRRNPERRLGSGEKDAEDVKKQP 258
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 17/212 (8%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPDIVEI 81
+V+GKGS+G V A T E AIK + DV D + E ++L L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA------- 53
Query: 82 KHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
KH L F+ +F +ME DL I+ + +F+ ++ L ++H
Sbjct: 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 197
V +RDLK NIL +A+ K+ DFG+ + + + T + T Y APE+
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQE 170
Query: 198 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 229
+Y P++D W++G + EM+ G+P F N
Sbjct: 171 L--EYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 43/228 (18%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79
++ IGKG +G V + + G++VA+K + D + A L E ++ LRHP++V
Sbjct: 9 KLGATIGKGEFGDV--MLGDYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTLRHPNLV 63
Query: 80 EIKHIMLPPSRREFKDIYVVFELME---------SDLHQVIKANDDLTPEHYQFFLYQLL 130
++ ++L + +Y+V E M S VI L F +
Sbjct: 64 QLLGVVL-----QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLG------FALDVC 112
Query: 131 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF---WTDYVATR 187
G++Y+ N HRDL +N+L + D K+ DFGLA+ + S WT
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT------ 166
Query: 188 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GK---PLFPGKNVV 231
APE K++ D+WS G + E+ + G+ P P K+VV
Sbjct: 167 ---APEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKIND-VFEHVSDATRILREIKLLR---LLRHPDIVE 80
IGKG++G V T A+K ++ + + E +L L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 81 IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 139
+K S D+Y+V + M +L ++ + + +F++ +L+ L+++H
Sbjct: 61 LKFSFQTDS-----DLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 140 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFF 199
++ +RDLKP+NIL +A + +CDFGL++ + D + + T Y APE+
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT---NTFCGTTEYLAPEVLLD-E 171
Query: 200 SKYTPAIDIWSIGCIFAEMLTG 221
YT +D WS+G + EM G
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 36/237 (15%)
Query: 15 EASRYQIQEV--IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 72
E R IQ + +G G +G V + +T VA+K + D L E ++++
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLK---PGTMDPKDFLAEAQIMKK 57
Query: 73 LRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQL 129
LRHP ++++ + + E IY+V ELM+ L + ++ L Q+
Sbjct: 58 LRHPKLIQLYAVC---TLEE--PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 130 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWTD 182
G+ Y+ N HRDL +N+L + K+ DFGLARV D A I WT
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT- 171
Query: 183 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 235
APE + +++++ D+WS G + E++T G+ +PG V+ Q+D
Sbjct: 172 --------APE--AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-15
Identities = 84/328 (25%), Positives = 131/328 (39%), Gaps = 64/328 (19%)
Query: 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 74
E + + I E G+ G + +D T E V IK + AT E +LR +
Sbjct: 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIK----AGQRGGTAT----EAHILRAIN 141
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 134
HP I+++K ++ ++DL+ + A ++ +LR ++
Sbjct: 142 HPSIIQLKGTFTYNKF-----TCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQ 196
Query: 135 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY----- 189
Y+H + HRD+K +NI N + + DFG +A F D A ++Y
Sbjct: 197 YLHENRIIHRDIKAENIFINHPGDVCLGDFG----------AACFPVDINANKYYGWAGT 246
Query: 190 ---RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNV------VHQLDLMTD 239
APEL Y PA+DIWS G + EM T LF + Q+ L+
Sbjct: 247 IATNAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR 304
Query: 240 LLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLE----------R 289
GT E + Y+G +K S + P + PL +L E +
Sbjct: 305 RSGTHPNEFPIDAQANLDEIYIGLAKK------SSRKPGSRPLWTNLYELPIDLEYLICK 358
Query: 290 LLAFDPKDRPTAE--------EALADPY 309
+LAFD RP+AE + + DPY
Sbjct: 359 MLAFDAHHRPSAEALLDFAAFQDIPDPY 386
|
Length = 391 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 7e-15
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLR-HPDIVE 80
V+GKGS+G V A +G A+K + DV D + E ++L L R HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 81 IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 139
+ P R ++ V E + DL I+ + +F+ ++ L ++H
Sbjct: 61 LYCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115
Query: 140 NVFHRDLKPKNILANADCKLKICDFGLARVS-FNDAPSAIFWTDYVATRWYRAPELCGSF 198
+ +RDLK N+L + + K+ DFG+ + FN ++ F T Y APE+
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF----CGTPDYIAPEILQEM 171
Query: 199 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 229
Y P++D W++G + EML G F +N
Sbjct: 172 L--YGPSVDWWAMGVLLYEMLCGHAPFEAEN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 77/320 (24%), Positives = 122/320 (38%), Gaps = 59/320 (18%)
Query: 24 VIGKGSYG--VVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVE 80
+IGK +V A T VA+KKIN D D + +EI R L+HP+I+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSK-EDLKLLQQEIITSRQLQHPNILP 63
Query: 81 IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY---------QFFLYQLLR 131
+ S ++YVV LM + +DL H+ F L +L
Sbjct: 64 YVTSFIVDS-----ELYVVSPLMA------YGSCEDLLKTHFPEGLPELAIAFILKDVLN 112
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDF---------GLARVSFNDAP-SAIF-- 179
L YIH+ HR +K +IL + D K+ + G + +D P S++
Sbjct: 113 ALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172
Query: 180 -WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMT 238
W +PE+ Y DI+S+G E+ G P K++ L+
Sbjct: 173 PWL---------SPEVLQQNLQGYNEKSDIYSVGITACELANG--HVPFKDMPATQMLLE 221
Query: 239 DLLGTP------ST--ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERL 290
+ GT ST + ++ + R P++ F +E
Sbjct: 222 KVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTF---SEHFHQFVELC 278
Query: 291 LAFDPKDRPTAEEALADPYF 310
L DP+ RP+A + L +F
Sbjct: 279 LQRDPESRPSASQLLNHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 11/208 (5%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 82
V+GKGS+G V A T E AIK + DV D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 83 HIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 141
H R +Y V E + DL I+ H F+ ++ GL ++H+ +
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 142 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK 201
+RDLK N++ +++ +KI DFG+ + + D + + T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT---KTFCGTPDYIAPEIIA--YQP 177
Query: 202 YTPAIDIWSIGCIFAEMLTGKPLFPGKN 229
Y ++D W+ G + EML G+ F G++
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 13/209 (6%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRL-LRHPDIVEI 81
V+GKGS+G V A T E AIK + DV D + E ++L L HP +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLT-- 59
Query: 82 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 140
H+ +E ++ V E + DL I+++ +F+ +++ GL+++H
Sbjct: 60 -HLFCTFQTKEH--LFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116
Query: 141 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 200
+ +RDLK N+L + D +KI DFG+ + + N A + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA---STFCGTPDYIAPEILKG--Q 171
Query: 201 KYTPAIDIWSIGCIFAEMLTGKPLFPGKN 229
KY ++D WS G + EML G+ F G++
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 8e-15
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 16/212 (7%)
Query: 24 VIGKGSYGVVGSAVDTH---TGERVAIK--KINDVFEHVSDATRILREIKLLRLLRHPDI 78
V+GKG YG V TG+ A+K K + + D E +L ++HP I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 79 VEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
V++ + + +Y++ E L +L ++ + F+L ++ L+++H
Sbjct: 63 VDLIYAFQTGGK-----LYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH 117
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 197
+ +RDLKP+NIL +A +K+ DFGL + S ++ + T Y APE+
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE---GTVTHTFCGTIEYMAPEILMR 174
Query: 198 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 229
S + A+D WS+G + +MLTG P F +N
Sbjct: 175 --SGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 9e-15
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 21 IQEVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 78
+QE IG G +G+V G ++ +VAIK I + D + E +++ L HP +
Sbjct: 9 VQE-IGSGQFGLVWLGYWLEK---RKVAIKTIREGAMSEED---FIEEAQVMMKLSHPKL 61
Query: 79 VEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKAND-DLTPEHYQFFLYQLLRGLKYI 136
V++ + E I +VFE ME L ++A + E + G+ Y+
Sbjct: 62 VQLYGVCT-----ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL 116
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
++NV HRDL +N L + +K+ DFG+ R +D ++ T + +W +PE+
Sbjct: 117 ESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF-PVKW-SSPEVFS 174
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLT 220
FSKY+ D+WS G + E+ +
Sbjct: 175 --FSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 71/300 (23%), Positives = 127/300 (42%), Gaps = 52/300 (17%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPDIVEI 81
+++GKG++G V + TG+ A+K + +V + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 82 KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 141
K+ R F Y +L + + + +F+ +++ L Y+H+ +V
Sbjct: 61 KYSFQTHDRLCFVMEYA----NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDV 116
Query: 142 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK 201
+RDLK +N++ + D +KI DFGL + +D + + T Y APE+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--ND 171
Query: 202 YTPAIDIWSIGCIFAEMLTGKPLFPGK--NVVHQLDLMTDLLGTPSTESISRIRNEKARR 259
Y A+D W +G + EM+ G+ F + + +L LM ++
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI------------------- 212
Query: 260 YLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR-----PTAEEALADPYFHGL 313
+FP P A LL LL DPK R A+E + +F +
Sbjct: 213 ---------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 75/310 (24%), Positives = 128/310 (41%), Gaps = 58/310 (18%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLLRHPD 77
+ ++ ++G+G +G V + TG+ A+K + + E + +L + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 78 IVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHY-QFFLYQLLRG 132
I ++++ F+D +Y+V E DL ++ +D E QF+L +L+
Sbjct: 63 IPQLQY--------AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA 114
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFG-LARVSFNDAPSAIFWTDYVATRWYRA 191
+ +H HRD+KP+N+L + +K+ DFG AR++ N + V T Y A
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN---KMVNSKLPVGTPDYIA 171
Query: 192 PELC----GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247
PE+ G Y D WS+G I EM+ G+ F +
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA---------------K 216
Query: 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLA----LHLLERLLAFDPKDRPTAEE 303
+ + I N + R+L KFP DP L L++ LL K+R E
Sbjct: 217 TYNNIMNFQ--RFL-------------KFP-EDPKVSSDFLDLIQSLLC-GQKERLGYEG 259
Query: 304 ALADPYFHGL 313
P+F +
Sbjct: 260 LCCHPFFSKI 269
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 64/250 (25%), Positives = 118/250 (47%), Gaps = 19/250 (7%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEI 81
+++GKG++G V + +G+ A+K + +V + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 82 KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 141
K+ R F YV + L + ++D T +F+ +++ L Y+H+ +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRT----RFYGAEIVSALDYLHSGKI 116
Query: 142 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK 201
+RDLK +N++ + D +KI DFGL + DA + + T Y APE+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM---KTFCGTPEYLAPEVLED--ND 171
Query: 202 YTPAIDIWSIGCIFAEMLTGKPLFPGKN--VVHQLDLMTDLLGTPSTESISRIRNEKARR 259
Y A+D W +G + EM+ G+ F ++ + +L LM D+ R + A+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI-------KFPRTLSADAKS 224
Query: 260 YLGSMRKKQP 269
L + K P
Sbjct: 225 LLSGLLIKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 1e-14
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 82
E IGKGS+G V +D T + VAIK I D+ E + I +EI +L P + +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 83 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF 142
L ++ ++++ E + + L L ++L+GL Y+H+
Sbjct: 69 GSYLKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI 123
Query: 143 HRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKY 202
HRD+K N+L + ++K+ DFG+A D + I +V T ++ APE+ S Y
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAG-QLTD--TQIKRNTFVGTPFWMAPEVIKQ--SAY 178
Query: 203 TPAIDIWSIGCIFAEMLTGKP 223
DIWS+G E+ G+P
Sbjct: 179 DSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 15/211 (7%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLL-RHPDIVE 80
+++GKGS+G V A T + AIK + DV D + E ++L L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT- 59
Query: 81 IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 139
H+ +E +++ V E + DL I++ F+ +++ GL+++H+
Sbjct: 60 --HLYCTFQTKE--NLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115
Query: 140 NVFHRDLKPKNILANADCKLKICDFGLARVS-FNDAPSAIFWTDYVATRWYRAPELCGSF 198
+ +RDLK NIL + D +KI DFG+ + + DA + F T Y APE+
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF----CGTPDYIAPEIL--L 169
Query: 199 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 229
KY ++D WS G + EML G+ F G +
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 29/225 (12%)
Query: 25 IGKGSYGVVGSAVDTHTGER---VAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVE 80
+G G++G V V + VA+K + EH + LRE ++ L HP IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ--EHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 81 IKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 139
+ + + +V EL L + +K ++ + +Q+ G+ Y+ +
Sbjct: 61 LIGVCKGEP------LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114
Query: 140 NVFHRDLKPKNILANADCKLKICDFGLAR-VSFND----APSAIFWTDYVATRWYRAPEL 194
+ HRDL +N+L + KI DFG++R + A +A W +WY APE
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRW----PLKWY-APE- 168
Query: 195 CGSFFSKYTPAIDIWSIGCIFAEMLT--GKPL--FPGKNVVHQLD 235
C ++ K++ D+WS G E + KP G V+ L+
Sbjct: 169 CINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE 212
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKL-LRLLRHPDI 78
++ E +G+G+YGVV TG +A+K+I R+L ++ + +R + P
Sbjct: 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYT 62
Query: 79 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK---ANDDLTPEHYQFFL----YQLLR 131
V + RE D+++ E+M++ L + K PE L +++
Sbjct: 63 VTFYGALF----RE-GDVWICMEVMDTSLDKFYKKVYDKGLTIPED---ILGKIAVSIVK 114
Query: 132 GLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 190
L+Y+H+ +V HRD+KP N+L N + ++K+CDFG++ + + T + Y
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS----VAKTIDAGCKPYM 170
Query: 191 APELCGSFFSK--YTPAIDIWSIGCIFAEMLTGKPLFP 226
APE ++ Y D+WS+G E+ TG+ FP
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGR--FP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 13/216 (6%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIKKIND-VFEHVSDATRILREIK-LLRLLRHPDIVE 80
+VIGKGS+G V A G+ A+K + + + + I+ E LL+ ++HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 81 IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 139
+ + S + + +Y V + + +L ++ +F+ ++ L Y+H+
Sbjct: 61 LHY-----SFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115
Query: 140 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFF 199
N+ +RDLKP+NIL ++ + + DFGL + + + T + T Y APE+
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVIRK-- 170
Query: 200 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD 235
Y +D W +G + EML G P F ++V D
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 31/212 (14%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHPDIVEIK 82
IG G+ G V + TG A+K I + + D R I REI++LR + HP++V+
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVI---YGNHEDTVRRQICREIEILRDVNHPNVVKC- 137
Query: 83 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF 142
H M + +I V+ E M+ + D+ Q+L G+ Y+H ++
Sbjct: 138 HDMFDHN----GEIQVLLEFMDGGSLEGTHIADEQFLADVAR---QILSGIAYLHRRHIV 190
Query: 143 HRDLKPKNILANADCKLKICDFGLARV---SFNDAPSAIFWTDYVATRWYRAPE-----L 194
HRD+KP N+L N+ +KI DFG++R+ + + S+ V T Y +PE L
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS------VGTIAYMSPERINTDL 244
Query: 195 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFP 226
+ Y A DIWS+G E G+ FP
Sbjct: 245 NHGAYDGY--AGDIWSLGVSILEFYLGR--FP 272
|
Length = 353 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 83/298 (27%), Positives = 122/298 (40%), Gaps = 51/298 (17%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIK 82
V+GKG +G V + TG+ A KK+ + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66
Query: 83 HIMLPPSRREFKD-IYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 138
+ E KD + +V LM DL H N E F+ ++ GL+ +H
Sbjct: 67 YAY------ETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR 120
Query: 139 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 198
+ +RDLKP+NIL + ++I D GLA + P V T Y APE+ +
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLA----VEIPEGETIRGRVGTVGYMAPEVVKN- 175
Query: 199 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 258
+YT + D W +GC+ EM+ GK F R R EK +
Sbjct: 176 -ERYTFSPDWWGLGCLIYEMIEGKSPF-------------------------RQRKEKVK 209
Query: 259 RYLGSMR-KKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYF 310
R R K+ +S KF A + +LL DP R AEE A P+F
Sbjct: 210 REEVERRVKEDQEEYSEKF---SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 17/228 (7%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATRILREIKLLRL 72
+ + +V+G G++G V V GE+ VAIK + + ++ IL E ++
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKAN-KEILDEAYVMAS 65
Query: 73 LRHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLL 130
+ HP +V + I L + ++ +LM L V D++ ++ + Q+
Sbjct: 66 VDHPHVVRLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIA 119
Query: 131 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 190
+G+ Y+ + HRDL +N+L +KI DFGLA++ D V +W
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM- 178
Query: 191 APELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLM 237
A E YT D+WS G E++T G + G V DL+
Sbjct: 179 ALESI--LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 82
E IGKGS+G V +D T + VAIK I D+ E + I +EI +L P + +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 83 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFF-----LYQLLRGLKYIH 137
L ++ ++++ E + A D L + F L ++L+GL Y+H
Sbjct: 69 GSYLKGTK-----LWIIMEYLGGG-----SALDLLRAGPFDEFQIATMLKEILKGLDYLH 118
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 197
+ HRD+K N+L + +K+ DFG+A D + I +V T ++ APE+
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAG-QLTD--TQIKRNTFVGTPFWMAPEVIQQ 175
Query: 198 FFSKYTPAIDIWSIGCIFAEMLTGKP 223
S Y DIWS+G E+ G+P
Sbjct: 176 --SAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 4e-14
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 34/219 (15%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRH 75
+ + E+IG+G +G V +TG++VA+K I DV A L E ++ L H
Sbjct: 6 QKLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHH 58
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDL---TPEHYQFFLYQLLR 131
++V + ++L +Y+V ELM + +L ++ + QF L +
Sbjct: 59 KNLVRLLGVIL------HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL-DVAE 111
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF---WTDYVATRW 188
G++Y+ + + HRDL +NIL + D K+ DFGLARV ++ WT
Sbjct: 112 GMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT------- 164
Query: 189 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFP 226
APE K++ D+WS G + E+ + G+ +P
Sbjct: 165 --APEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 11/208 (5%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 82
V+GKGS+G V A T E AIK + DV D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 83 HIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 141
H R +Y V E + DL I+ F+ ++ GL ++H +
Sbjct: 67 HSCFQTVDR----LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGI 122
Query: 142 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK 201
+RDLK N++ +++ +KI DFG+ + D + + T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT---RTFCGTPDYIAPEIIA--YQP 177
Query: 202 YTPAIDIWSIGCIFAEMLTGKPLFPGKN 229
Y ++D W+ G + EML G+P F G++
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 4e-14
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIK--KINDVFEHVSDATRILREIKLLRLLRHPDIVE 80
E IGKG++G V V VA+K + + + L+E ++L+ HP+IV+
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPD---LKRKFLQEAEILKQYDHPNIVK 56
Query: 81 IKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 138
+ + + + + IY+V EL+ S L + K + LT + G++Y+ +
Sbjct: 57 LIGVCV-----QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111
Query: 139 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 198
N HRDL +N L + LKI DFG++R + + +W APE
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-TAPEALN-- 168
Query: 199 FSKYTPAIDIWSIGCIFAEMLTG 221
+ +YT D+WS G + E +
Sbjct: 169 YGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 5e-14
Identities = 77/302 (25%), Positives = 123/302 (40%), Gaps = 51/302 (16%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIK 82
V+GKG +G V + TG+ A K++ + + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 83 HIMLPPSRREFKD-IYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 138
+ E KD + +V +M DL H N E F+ ++L GL+ +H
Sbjct: 67 YAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 139 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 198
N +RDLKP+NIL + ++I D GLA P V T Y APE+ +
Sbjct: 121 ENTVYRDLKPENILLDDYGHIRISDLGLAV----KIPEGESIRGRVGTVGYMAPEVLNN- 175
Query: 199 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 258
+YT + D W +GC+ EM+ G+ F G+ +++ E+
Sbjct: 176 -QRYTLSPDYWGLGCLIYEMIEGQSPFRGRK--------------------EKVKREEVD 214
Query: 259 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDR 318
R + + FS + A + + LL DPK R +E G V R
Sbjct: 215 RRVLETEEVYSAKFSEE-------AKSICKMLLTKDPKQRLGCQE-------EGAGEVKR 260
Query: 319 EP 320
P
Sbjct: 261 HP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 6e-14
Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 42/224 (18%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79
++ + +G G +G V +VAIK + + L E L++ L+HP +V
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGH-TKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 80 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL-------R 131
+ ++ + IY++ E ME+ L +K TPE + + +L+
Sbjct: 65 RLYAVVTQ------EPIYIITEYMENGSLVDFLK-----TPEGIKLTINKLIDMAAQIAE 113
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWTDYV 184
G+ +I N HRDL+ NIL + KI DFGLAR+ ++ +A I WT
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT--- 170
Query: 185 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG 227
APE + +T D+WS G + E++T G+ +PG
Sbjct: 171 ------APEAIN--YGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 75/291 (25%), Positives = 124/291 (42%), Gaps = 40/291 (13%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 78
Y++ + +G G+YG V A + HTGE A+K I E D + I +EI +++ +H +I
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 79 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
V L SR + +++ E L + L+ + + L+GL Y+H
Sbjct: 69 VAYFGSYL--SREK---LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH 123
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGL-ARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
+ HRD+K NIL + +K+ DFG+ A+++ A F + T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF----IGTPYWMAPEVAA 179
Query: 197 -SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
Y DIW++G E+ +P + + L LM+ P
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP---------- 229
Query: 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306
+ K +S F N ++ L +PK RPTAE L
Sbjct: 230 ---------KLKDKTKWSSTFHNFVKIS-------LTKNPKKRPTAERLLT 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 70/240 (29%), Positives = 111/240 (46%), Gaps = 38/240 (15%)
Query: 15 EASRYQIQEV--IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 72
E R I+ V +G G +G V + +VA+K + V L E L++
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQ---AFLEEANLMKT 57
Query: 73 LRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDD---LTPEHYQFFLYQ 128
L+H +V + ++ ++ E IY++ E M + L +K+++ L P+ F Q
Sbjct: 58 LQHDKLVRLYAVV---TKEE--PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA-Q 111
Query: 129 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWT 181
+ G+ YI N HRDL+ N+L + KI DFGLARV ++ +A I WT
Sbjct: 112 IAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT 171
Query: 182 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDL 240
APE F +T D+WS G + E++T GK +PG + D+M+ L
Sbjct: 172 ---------APEAIN--FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS---NSDVMSAL 217
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 65/253 (25%), Positives = 118/253 (46%), Gaps = 25/253 (9%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPDIVEI 81
+++GKG++G V + TG A+K + +V + + E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 82 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 140
K+ R F V E +L + T E +F+ +++ L+Y+H+ +
Sbjct: 61 KYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115
Query: 141 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 200
V +RD+K +N++ + D +KI DFGL + +D + + T Y APE+ +
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--N 170
Query: 201 KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH----QLDLMTDLLGTPSTESISRIRNEK 256
Y A+D W +G + EM+ G+ P N H +L LM ++ R + +
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELILMEEI-------RFPRTLSPE 221
Query: 257 ARRYLGSMRKKQP 269
A+ L + KK P
Sbjct: 222 AKSLLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 32/221 (14%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79
Q+ + +G G +G V +VA+K + L E ++++ LRH +V
Sbjct: 9 QLIKKLGNGQFGEVWMGTWNGN-TKVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKLV 64
Query: 80 EIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQF--FLYQLLRGLKYI 136
++ ++ S IY+V E M + L +K + + Q+ G+ YI
Sbjct: 65 QLYAVV---SEEP---IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWTDYVATRWY 189
N HRDL+ NIL KI DFGLAR+ ++ +A I WT
Sbjct: 119 ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT-------- 170
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 229
APE + + ++T D+WS G + E++T G+ +PG N
Sbjct: 171 -APE--AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 67/257 (26%), Positives = 110/257 (42%), Gaps = 52/257 (20%)
Query: 23 EVIGKGSYGVV-----GSAVDTHTGERVAIKKINDVFEHVSDATR-ILREIKLLRLLRHP 76
+G+G++G V + E VA+K + + +DA + RE +LL +H
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET--ASNDARKDFEREAELLTNFQHE 68
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND--------------DLTPEH 121
+IV+ + E +VFE ME DL++ ++++ +LT
Sbjct: 69 NIVKFYGVCT-----EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQ 123
Query: 122 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 181
Q+ G+ Y+ + + HRDL +N L D +KI DFG++R ++ T
Sbjct: 124 LLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--------DVYTT 175
Query: 182 DY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GK-PLFPGKN-- 229
DY + RW PE + K+T D+WS G + E+ T GK P + N
Sbjct: 176 DYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232
Query: 230 VVHQLDLMTDLLGTPST 246
V+ + LL P T
Sbjct: 233 VIECITQGR-LLQRPRT 248
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 36/221 (16%)
Query: 20 QIQEVIGKGSYGVVGSAV-DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 78
++++ +G G +G V A + HT +VA+K + V L E +++ L+H +
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVE---AFLAEANVMKTLQHDKL 63
Query: 79 VEIKHIMLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLYQLLRGLK 134
V++ ++ + IY++ E M D + + + P+ F Q+ G+
Sbjct: 64 VKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA-QIAEGMA 116
Query: 135 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWTDYVATR 187
+I N HRDL+ NIL +A KI DFGLARV ++ +A I WT
Sbjct: 117 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT------ 170
Query: 188 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG 227
APE F +T D+WS G + E++T G+ +PG
Sbjct: 171 ---APEAIN--FGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 66/254 (25%), Positives = 116/254 (45%), Gaps = 26/254 (10%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEI 81
+++GKG++G V + TG A+K + +V + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 82 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA- 139
K+ R F V E +L + + + +F+ +++ L Y+H+
Sbjct: 61 KYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115
Query: 140 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFF 199
NV +RDLK +N++ + D +KI DFGL + D + + T Y APE+
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVLED-- 170
Query: 200 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH----QLDLMTDLLGTPSTESISRIRNE 255
+ Y A+D W +G + EM+ G+ P N H +L LM ++ R +
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELILMEEI-------RFPRTLSP 221
Query: 256 KARRYLGSMRKKQP 269
+A+ L + KK P
Sbjct: 222 EAKSLLSGLLKKDP 235
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-13
Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 84
+G G YG V V VA+K + E + L+E +++ ++HP++V++ +
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 85 ML--PPSRREFKDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTA 139
PP Y++ E M +L ++ + ++ + Q+ ++Y+
Sbjct: 71 CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 123
Query: 140 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWTDYVATRWYRAP 192
N HRDL +N L + +K+ DFGL+R+ D +A I WT AP
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT---------AP 174
Query: 193 ELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 235
E ++K++ D+W+ G + E+ T G +PG V L+
Sbjct: 175 E--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 219
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 33/213 (15%)
Query: 23 EVIGKGSYGVVGSAV-DTHTGER--VAIKKINDVFEHVSDATR-ILREIKLLRLLRHPDI 78
+ +G GS+GVV T G+ VA+K + + +SD L+E ++ L H ++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS--DKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 79 VEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQF-FLYQLLRGLKY 135
+ + ++L + +V EL S L ++ K + Q+ G++Y
Sbjct: 59 IRLYGVVLTHP------LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRY 112
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLAR-VSFNDAPSAIFWTDYVATRWYR---- 190
+ + HRDL +NIL +D K+KI DFGL R + N+ D+ +
Sbjct: 113 LESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE--------DHYVMEEHLKVPF 164
Query: 191 ---APELCGSFFSKYTPAIDIWSIGCIFAEMLT 220
APE ++ A D+W G EM T
Sbjct: 165 AWCAPESLR--TRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 20/219 (9%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 75
A +++ EV+G G+YG V TG+ AIK + DV E + I EI +L+ H
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTE--DEEEEIKLEINMLKKYSH 71
Query: 76 PDIVEIKHIML----PPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLY 127
+ + PP + +++V E +DL + K N L + +
Sbjct: 72 HRNIATYYGAFIKKSPPGHDD--QLWLVMEFCGAGSVTDLVKNTKGNA-LKEDWIAYICR 128
Query: 128 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 187
++LRGL ++H V HRD+K +N+L + ++K+ DFG VS + ++ T
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFIGTP 185
Query: 188 WYRAPELCG---SFFSKYTPAIDIWSIGCIFAEMLTGKP 223
++ APE+ + + Y DIWS+G EM G P
Sbjct: 186 YWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 13/210 (6%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEI 81
+V+GKGS+G V A GE A+K + DV D + E ++L L +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPF--L 58
Query: 82 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 140
H+ +E ++ V E + DL I+ F+ +++ GL+++H+
Sbjct: 59 THLYCTFQTKE--HLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG 116
Query: 141 VFHRDLKPKNILANADCKLKICDFGLARVS-FNDAPSAIFWTDYVATRWYRAPELCGSFF 199
+ +RDLK N++ + D +KI DFG+ + + F D ++ F T Y APE+
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF----CGTPDYIAPEILQGL- 171
Query: 200 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 229
KYT ++D WS G + EML G+ F G +
Sbjct: 172 -KYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 81/314 (25%), Positives = 128/314 (40%), Gaps = 62/314 (19%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKI--NDVFEHVSDATRILREIKLLRLLRH-- 75
+ IG G+ G V TG +A+K++ E RIL ++ ++ L H
Sbjct: 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENK---RILMDLDVV-LKSHDC 73
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL-YQLLRGLK 134
P IV+ + S D+++ ELM + L +++K PE + +++ L
Sbjct: 74 PYIVKCYGYFITDS-----DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALH 128
Query: 135 YIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVA-TR----- 187
Y+ V HRD+KP NIL +A +K+CDFG++ D A TR
Sbjct: 129 YLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG----------RLVDSKAKTRSAGCA 178
Query: 188 WYRAPELCG--SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245
Y APE KY D+WS+G E+ TG+ FP KN + +++T
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTEFEVLT------- 229
Query: 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 305
+I E+ + FS F + ++ L D + RP E L
Sbjct: 230 -----KILQEEPPSLPPNEG------FSPDFCS-------FVDLCLTKDHRKRPKYRELL 271
Query: 306 ADPYF--HGLANVD 317
P+ + A VD
Sbjct: 272 QHPFIRRYETAEVD 285
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 21/201 (10%)
Query: 25 IGKGSYGVVGSAV-DTHTGER-VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 82
+G G++G V + E+ VA+K + + + +LRE +++ L +P IV +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 83 HIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 141
I E + +V EL E L++ ++ N +T ++ ++Q+ G+KY+ N
Sbjct: 63 GIC------EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 142 FHRDLKPKNILANADCKLKICDFGLARVSFND-----APSAIFWTDYVATRWYRAPELCG 196
HRDL +N+L KI DFGL++ D A + W +WY APE C
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW----PVKWY-APE-CM 170
Query: 197 SFFSKYTPAIDIWSIGCIFAE 217
+++ K++ D+WS G + E
Sbjct: 171 NYY-KFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 77/308 (25%), Positives = 135/308 (43%), Gaps = 49/308 (15%)
Query: 19 YQIQEVIGKGSYG---VVGSAVDTHTGERVAIKKINDVF----EHVSDATRILREIKLLR 71
+++ +V+G G+YG +V TG+ A+K + + TR R + L
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNV--LE 59
Query: 72 LLRH-PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLL 130
+R P +V + + ++ YV M + L+Q D+ + + +F+ +++
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEII 115
Query: 131 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 190
L+++H + +RD+K +NIL +++ + + DFGL++ ++ + + T Y
Sbjct: 116 LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY--SFCGTIEYM 173
Query: 191 APELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250
APE+ + A+D WS+G + E+LTG F L G +T+S
Sbjct: 174 APEIIRG-KGGHGKAVDWWSLGILIFELLTGASPF-------------TLEGERNTQS-- 217
Query: 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEAL 305
E +RR L + P P P A LL +LL DPK R A E
Sbjct: 218 ----EVSRRIL---KCDPPFP-----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIK 265
Query: 306 ADPYFHGL 313
P+F GL
Sbjct: 266 EHPFFKGL 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 5e-13
Identities = 73/309 (23%), Positives = 132/309 (42%), Gaps = 52/309 (16%)
Query: 19 YQIQEVIGKGSYG---VVGSAVDTHTGERVAIKKINDV--------FEHVSDATRILREI 67
+++ V+G G+YG +V G+ A+K + EH TR R++
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEH----TRTERQV 57
Query: 68 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 127
L + R P +V + + ++ YV + + L+Q + T + ++
Sbjct: 58 -LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIA 112
Query: 128 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 187
+++ L ++H + +RD+K +NIL +++ + + DFGL++ + + + T
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY--SFCGTI 170
Query: 188 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247
Y APE+ + A+D WS+G + E+LTG F T E
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF-----------------TVDGE 213
Query: 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR---PTAEEA 304
S ++E +RR L K +P PF A +++LL DPK R A+E
Sbjct: 214 QNS--QSEISRRIL----KSKP-PFPKTM---SAEARDFIQKLLEKDPKKRLGANGADEI 263
Query: 305 LADPYFHGL 313
P+F G+
Sbjct: 264 KNHPFFQGI 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 85/320 (26%), Positives = 135/320 (42%), Gaps = 52/320 (16%)
Query: 20 QIQEVIGK---GSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
++ E+IG+ G++G V A + TG A K I E + + EI++L HP
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYMVEIEILATCNHP 69
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLK 134
IV+ +L + K ++++ E I D LT Q Q+L L+
Sbjct: 70 YIVK----LLGAFYWDGK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQ 124
Query: 135 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 194
Y+H+ + HRDLK N+L D +K+ DFG VS + + ++ T ++ APE+
Sbjct: 125 YLHSMKIIHRDLKAGNVLLTLDGDIKLADFG---VSAKNVKTLQRRDSFIGTPYWMAPEV 181
Query: 195 CGSFFSKYTP---AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251
K TP DIWS+G EM +P H+L+ M LL +E +
Sbjct: 182 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH------HELNPMRVLLKIAKSEPPTL 235
Query: 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311
QP +S +F + L+ L P+ RP+A + L P+
Sbjct: 236 ---------------SQPSKWSMEFRD-------FLKTALDKHPETRPSAAQLLEHPF-- 271
Query: 312 GLANVDREPSTQPISKLEFE 331
V S +P+ +L E
Sbjct: 272 ----VSSVTSNRPLRELVAE 287
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-13
Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 19/220 (8%)
Query: 18 RYQIQEVIGKGSYGVVGSAV-----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 72
+ +G G++G V A + +VA+K + H S+ ++ E+K++
Sbjct: 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT-AHSSEREALMSELKIMSH 94
Query: 73 L-RHPDIVEIKHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDD--LTPEHYQFFLYQ 128
L H +IV L + I V+ E DL ++ + LT E F YQ
Sbjct: 95 LGNHENIVN-----LLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ 149
Query: 129 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 188
+ +G+ ++ + N HRDL +N+L +KICDFGLAR ND+ + + +W
Sbjct: 150 VAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209
Query: 189 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG 227
APE F YT D+WS G + E+ + G +PG
Sbjct: 210 M-APE--SIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 78/300 (26%), Positives = 124/300 (41%), Gaps = 49/300 (16%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIK 82
V+GKG +G V + TG+ A KK+ + + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 83 HIMLPPSRREFKD-IYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 138
+ E KD + +V LM DL H F+ ++ GL+ +H
Sbjct: 67 YAY------ETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 139 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 198
+ +RDLKP+NIL + ++I D GLA P V T Y APE+ +
Sbjct: 121 ERIVYRDLKPENILLDDHGHIRISDLGLAV----HVPEGQTIKGRVGTVGYMAPEVVKN- 175
Query: 199 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 258
+YT + D W++GC+ EM+ G+ +P + +I+ E+
Sbjct: 176 -ERYTFSPDWWALGCLLYEMIAGQ--------------------SPFQQRKKKIKREEVE 214
Query: 259 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYFHGL 313
R + K+ +S KF P A L + LL DPK+R A E P F +
Sbjct: 215 RLV----KEVQEEYSEKF---SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 8e-13
Identities = 76/310 (24%), Positives = 124/310 (40%), Gaps = 66/310 (21%)
Query: 18 RY-QIQEVIGKGSYGVVG----SAVDTHTGERVAIKKINDVFEHVSDATRILR-----EI 67
RY + V+G+G +G V + TGE VA+K + + + EI
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK------RECGQQNTSGWKKEI 57
Query: 68 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFF 125
+L+ L H +IV+ K S + K + ++ E + S + K +L F
Sbjct: 58 NILKTLYHENIVKYKGCC---SEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLA--QLLLF 112
Query: 126 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA----------RVSFNDAP 175
Q+ G+ Y+H+ + HRDL +N+L + D +KI DFGLA RV D
Sbjct: 113 AQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR-EDGD 171
Query: 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT--GKPLFPGKNVVHQ 233
S +FW A E K++ A D+WS G E+LT P K
Sbjct: 172 SPVFWY---------AVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-- 218
Query: 234 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLAL-HLLERLLA 292
+++G P ++ + R + + + +P P P + L++
Sbjct: 219 -----EMIG-PKQGQMTVV------RLIELLERGMRLP----CPKNCPQEVYILMKNCWE 262
Query: 293 FDPKDRPTAE 302
+ K RPT
Sbjct: 263 TEAKFRPTFR 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 9e-13
Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 12/185 (6%)
Query: 40 HTGERVAIK--KINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97
+TGE+VA+K K H++D + +EI++LR L H +IV+ K I K
Sbjct: 31 NTGEQVAVKSLKPESGGNHIAD---LKKEIEILRNLYHENIVKYKGICTEDGGNGIK--- 84
Query: 98 VVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 155
++ E + S L + + N + + + + Q+ +G+ Y+ + HRDL +N+L +
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES 144
Query: 156 DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 215
+ ++KI DFGL + D D + ++ APE SK+ A D+WS G
Sbjct: 145 EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL--IQSKFYIASDVWSFGVTL 202
Query: 216 AEMLT 220
E+LT
Sbjct: 203 YELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 9e-13
Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 11/142 (7%)
Query: 87 PPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDL 146
P S + D V L+ D + + D L+ F YQ+ RG++++ + N HRDL
Sbjct: 211 PASYKGSNDSEVK-NLLSDDGSEGLTTLDLLS------FTYQVARGMEFLASKNCVHRDL 263
Query: 147 KPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAI 206
+N+L +KICDFGLAR +D+ + ++ +W APE F + YT
Sbjct: 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWM-APE--SIFDNLYTTLS 320
Query: 207 DIWSIGCIFAEMLT-GKPLFPG 227
D+WS G + E+ + G +PG
Sbjct: 321 DVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 12/221 (5%)
Query: 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV--SDATRILREIKLLRL 72
+A Y + +VIG+G++G V V + ++V K+ FE + SD+ E ++
Sbjct: 41 KAEDYDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 73 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRG 132
P +V+ L + ++ K +Y+V E M + +N D+ + +F+ +++
Sbjct: 100 ANSPWVVQ-----LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLA 154
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 192
L IH+ + HRD+KP N+L + LK+ DFG D + V T Y +P
Sbjct: 155 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVRCDTAVGTPDYISP 212
Query: 193 ELCGSFFSK--YTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 231
E+ S Y D WS+G EML G F ++V
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 18/222 (8%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRH---PDIV 79
+IG+G +G V TG+ A+K ++ + T L E +L L+ P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 80 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 138
+ + P + F + +LM DLH + + + + +F+ +++ GL+++H
Sbjct: 61 CMTYAFHTPDKLCF-----ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN 115
Query: 139 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 198
V +RDLKP NIL + ++I D GLA P A V T Y APE+
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYMAPEVLQK- 169
Query: 199 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV--VHQLDLMT 238
+ Y + D +S+GC+ ++L G F H++D MT
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 13/216 (6%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIKKIND-VFEHVSDATRILREIK-LLRLLRHPDIVE 80
+VIGKGS+G V A G A+K + + I+ E LL+ L+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 81 IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 139
+ + + +Y V + + +L ++ +F+ ++ + Y+H+
Sbjct: 61 LHYSFQTAEK-----LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL 115
Query: 140 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFF 199
N+ +RDLKP+NIL ++ + + DFGL + + + + T Y APE+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPEVLRK-- 170
Query: 200 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD 235
Y +D W +G + EML G P F ++V D
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 20/219 (9%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 75
A +++ E++G G+YG V TG+ AIK ++ + + I +EI +L+ H
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSH 61
Query: 76 PDIVEIKHIML----PPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLY 127
+ + PP + +++V E +DL + K N L E +
Sbjct: 62 HRNIATYYGAFIKKNPPGMDD--QLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICR 118
Query: 128 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 187
++LRGL ++H V HRD+K +N+L + ++K+ DFG VS + ++ T
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFIGTP 175
Query: 188 WYRAPELCG---SFFSKYTPAIDIWSIGCIFAEMLTGKP 223
++ APE+ + + Y D+WS+G EM G P
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 70/232 (30%), Positives = 98/232 (42%), Gaps = 37/232 (15%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEHVSDATRILREIKLLRLLRHP 76
RY I +IGKG G V A D RVA+KKI D+ E+ R LRE K+ L HP
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLR----- 131
IV + I + Y+ ++S L V + + + L
Sbjct: 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 132 --GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-----------VSFNDA---- 174
++Y+H+ V HRDLKP NIL ++ I D+G A + ++
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 175 -----PSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLT 220
P I V T Y APE L G S+ T DI+++G I +MLT
Sbjct: 183 SSMTIPGKI-----VGTPDYMAPERLLGVPASEST---DIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 21/219 (9%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV---SDATRILREIK-LLRLLRHPDIV 79
VIGKGS+G V A G+ A+K + + + + I+ E LL+ ++HP +V
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQK--KAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 80 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 138
+ + S + +Y V + + +L ++ +F+ ++ L Y+H+
Sbjct: 60 GLHY-----SFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS 114
Query: 139 ANVFHRDLKPKNILANADCKLKICDFGLAR--VSFNDAPSAIFWTDYVATRWYRAPELCG 196
N+ +RDLKP+NIL ++ + + DFGL + + + S + T Y APE+
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-----FCGTPEYLAPEVLR 169
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD 235
Y +D W +G + EML G P F ++ D
Sbjct: 170 K--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 69/307 (22%), Positives = 136/307 (44%), Gaps = 46/307 (14%)
Query: 19 YQIQEVIGKGSYGVVG--SAVDTH-TGERVAIKKINDVF----EHVSDATRILREIKLLR 71
+++ +V+G G+YG V V H +G+ A+K + ++ TR R++ L
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQV-LEH 60
Query: 72 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLR 131
+ + P +V + + ++ Y+ + + L Q + + Q + +++
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER----FKEQEVQIYSGEIVL 116
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 191
L+++H + +RD+K +NIL +++ + + DFGL++ D + + T Y A
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY--SFCGTIEYMA 174
Query: 192 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251
P++ + A+D WS+G + E+LTG F + +
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF-------------------TVDGEKN 215
Query: 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR----PT-AEEALA 306
+ E +RR L K +P P+ + LA +++RLL DPK R P+ A+E
Sbjct: 216 SQAEISRRIL----KSEP-PYPQEM---SALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267
Query: 307 DPYFHGL 313
P+F +
Sbjct: 268 HPFFQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 34/224 (15%)
Query: 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 74
E+ R +++ +G+G +G V T RVAIK + L+E ++++ LR
Sbjct: 6 ESLRLEVK--LGQGCFGEVWMGTWNGT-TRVAIKTLK---PGTMSPEAFLQEAQVMKKLR 59
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQF--FLYQLLR 131
H +V++ ++ + IY+V E M + L +K Q Q+
Sbjct: 60 HEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 113
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWTDYV 184
G+ Y+ N HRDL+ NIL + K+ DFGLAR+ ++ +A I WT
Sbjct: 114 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT--- 170
Query: 185 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG 227
APE + + ++T D+WS G + E+ T G+ +PG
Sbjct: 171 ------APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 58/223 (26%), Positives = 109/223 (48%), Gaps = 25/223 (11%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79
++ + IGKG +G V + + G +VA+K I ++ + A L E ++ LRH ++V
Sbjct: 9 KLLQTIGKGEFGDV--MLGDYRGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLV 62
Query: 80 EIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYI 136
++ +++ E +Y+V E M + L +++ L + F + ++Y+
Sbjct: 63 QLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
N HRDL +N+L + D K+ DFGL + + S+ T + +W APE
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKW-TAPEALR 172
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLT-GK---PLFPGKNVVHQLD 235
K++ D+WS G + E+ + G+ P P K+VV +++
Sbjct: 173 E--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 213
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 61/222 (27%), Positives = 108/222 (48%), Gaps = 19/222 (8%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA-TRILREIKLLRLLRHPD 77
++I +VIG+G++G V HT ER+ KI + +E + A T RE + +L + D
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHT-ERIYAMKILNKWEMLKRAETACFREER--NVLVNGD 59
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHY-QFFLYQLLRG 132
I + F+D ++ +M+ DL ++ +D PE +F++ +++
Sbjct: 60 CQWITTL-----HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA 114
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 192
+ IH + HRD+KP N+L + + +++ DFG D + + V T Y +P
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--TVQSSVAVGTPDYISP 172
Query: 193 ELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 231
E+ + KY P D WS+G EML G+ F +++V
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 18/222 (8%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRH---PDIV 79
+IG+G +G V TG+ A+K ++ + T L E +L L+ P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 80 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 138
+ + P + F + +LM DLH + + + +F+ +++ GL+++H
Sbjct: 61 CMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN 115
Query: 139 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 198
V +RDLKP NIL + ++I D GLA P A V T Y APE+
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYMAPEVLQKG 170
Query: 199 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV--HQLDLMT 238
+ Y + D +S+GC+ ++L G F H++D MT
Sbjct: 171 VA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 23/228 (10%)
Query: 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 74
E+ R ++ +G+G +G V T +VAIK + L+E ++++ LR
Sbjct: 6 ESLRLDVK--LGQGCFGEVWMGTWNGT-TKVAIKTLK---PGTMMPEAFLQEAQIMKKLR 59
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQF--FLYQLLR 131
H +V + ++ + IY+V E M + L +K D + Q Q+
Sbjct: 60 HDKLVPLYAVV------SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIAD 113
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 191
G+ YI N HRDL+ NIL + KI DFGLAR+ ++ +A + +W A
Sbjct: 114 GMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKW-TA 171
Query: 192 PELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 235
PE + + ++T D+WS G + E++T G+ +PG + V+ Q++
Sbjct: 172 PE--AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 18/210 (8%)
Query: 23 EVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVE 80
E++GKG++G V G+ D VA+K + + L E ++L+ HP+IV+
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTP---VAVKTCKEDLPQ-ELKIKFLSEARILKQYDHPNIVK 56
Query: 81 IKHIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 138
+ + ++R+ IY+V EL+ L + K D+L + F G+ Y+ +
Sbjct: 57 LIGVC---TQRQ--PIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES 111
Query: 139 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 198
N HRDL +N L + LKI DFG++R +D + + +W APE
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSRQE-DDGIYSSSGLKQIPIKW-TAPEALN-- 167
Query: 199 FSKYTPAIDIWSIGCIFAEMLT-GKPLFPG 227
+ +Y+ D+WS G + E + G +PG
Sbjct: 168 YGRYSSESDVWSYGILLWETFSLGVCPYPG 197
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 4e-12
Identities = 78/330 (23%), Positives = 129/330 (39%), Gaps = 56/330 (16%)
Query: 17 SRYQIQEVIGKGSYG-VVGSAVDTHTGERVAIKKINDVFEHVSDATRIL----------- 64
+ +++ + + G++G + A+ T E A + +N + R++
Sbjct: 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAA 207
Query: 65 ----REIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND---DL 117
EI L L H +I++I+ I+ + + Y++ + + DL+ +
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEA-----NTYMITQKYDFDLYSFMYDEAFDWKD 262
Query: 118 TPEHYQF--FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND-A 174
P Q + QLL ++YIH + HRD+K +NI N D K+ + DFG A +
Sbjct: 263 RPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE 322
Query: 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFP----GKNV 230
W VAT +PE+ Y DIWS G I +ML+ P G
Sbjct: 323 AFDYGWVGTVAT---NSPEILAG--DGYCEITDIWSCGLILLDMLS-HDFCPIGDGGGKP 376
Query: 231 VHQLDLMTDLLGTPSTE----------SISRIRNEKARRYLGSMRKKQPVPFSHKFPNAD 280
QL + D L E I + A + + + +P ++P
Sbjct: 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYP--- 433
Query: 281 PLALHLLERLLAFDPKDRPTAEEALADPYF 310
L ++L FD RP A E LA P F
Sbjct: 434 ------LVKMLTFDWHLRPGAAELLALPLF 457
|
Length = 501 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 66/285 (23%), Positives = 119/285 (41%), Gaps = 50/285 (17%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 82
E IG+G++G V S VA+K + A + L+E ++L+ HP+IV +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-KFLQEARILKQYSHPNIVRLI 59
Query: 83 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLR-------GLKY 135
+ + + IY+V EL++ L E + + +L++ G++Y
Sbjct: 60 GVC-----TQKQPIYIVMELVQGGDFLTF-----LRTEGPRLKVKELIQMVENAAAGMEY 109
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 195
+ + + HRDL +N L LKI DFG++R + ++ + +W APE
Sbjct: 110 LESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPEAL 168
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
+ +Y+ D+WS G + E + LG ++S N+
Sbjct: 169 N--YGRYSSESDVWSFGILLWEAFS--------------------LGAVPYANLS---NQ 203
Query: 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 300
+ R + + +P P+A L+ER +DP RP+
Sbjct: 204 QTREAI---EQGVRLPCPELCPDA---VYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 66/246 (26%), Positives = 113/246 (45%), Gaps = 55/246 (22%)
Query: 17 SRYQIQEVIGKGSYG--VVGSAVDTHTGER---VAIKKI-NDVFEHVSDATRILREIKLL 70
R + + +G+G++G V AV VA+K + +D E D + ++ E++++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK--DLSDLVSEMEMM 69
Query: 71 RLL-RHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKAN-------------- 114
+++ +H +I+ +L +E +YVV E +L ++A
Sbjct: 70 KMIGKHKNIIN----LLGVCTQEGP-LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 115 --DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172
+ LT + F YQ+ RG++++ + HRDL +N+L D +KI DFGLAR
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR---- 180
Query: 173 DAPSAIFWTDY--------VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLT--G 221
I DY + +W APE + F + YT D+WS G + E+ T G
Sbjct: 181 ----DIHHIDYYRKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLLWEIFTLGG 232
Query: 222 KPLFPG 227
P +PG
Sbjct: 233 SP-YPG 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-12
Identities = 78/307 (25%), Positives = 121/307 (39%), Gaps = 62/307 (20%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKINDV-------FEHVSDATRILREIKLLRLLRHPD 77
+GKG +G V + TG+ A KK+N +E RIL ++ H
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-------HSR 53
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTP---EHYQ-FFLYQLLRG 132
+ + L + + D+ +V +M DL I D+ P E F+ Q++ G
Sbjct: 54 FI----VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG 109
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 192
L+++H + +RDLKP+N+L + D ++I D GLA V D S Y T + AP
Sbjct: 110 LEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKT--KGYAGTPGFMAP 166
Query: 193 ELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252
EL +Y ++D +++G EM+ + F R
Sbjct: 167 ELLQG--EEYDFSVDYFALGVTLYEMIAARGPF-------------------------RA 199
Query: 253 RNEKA-RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALA 306
R EK + L V + KF A + E LLA DP+ R +
Sbjct: 200 RGEKVENKELKQRILNDSVTYPDKFSPA---SKSFCEALLAKDPEKRLGFRDGNCDGLRT 256
Query: 307 DPYFHGL 313
P F L
Sbjct: 257 HPLFRDL 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 13/216 (6%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIKKIND-VFEHVSDATRILREIK-LLRLLRHPDIVE 80
+VIGKGS+G V A + A+K + + I+ E LL+ ++HP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 81 IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 139
+ + +Y V + + +L ++ +F+ ++ L Y+H+
Sbjct: 61 LHFSFQTADK-----LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL 115
Query: 140 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFF 199
N+ +RDLKP+NIL ++ + + DFGL + N + T + T Y APE+
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTST-FCGTPEYLAPEVLHK-- 170
Query: 200 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD 235
Y +D W +G + EML G P F +N D
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 8e-12
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERV----AIKKINDVFEHVSDATRILREIKLLRLLRHPDI 78
+V+G G++G V + GE V AIK +N+ ++ + E ++ + HP +
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN-VEFMDEALIMASMDHPHL 71
Query: 79 VEIKHIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYI 136
V + + L P+ I +V +LM L V + D++ + + Q+ +G+ Y+
Sbjct: 72 VRLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
+ HRDL +N+L + +KI DFGLAR+ D + +W L
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM---ALEC 182
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLT--GKP 223
+ K+T D+WS G E++T GKP
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 8e-12
Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 20/128 (15%)
Query: 112 KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171
+ LT E + +Q+ RG++++ + HRDL +NIL + + +KICDFGLAR +
Sbjct: 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 172 NDAPSAIFWTDYVAT-------RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLT-GK 222
D DYV +W APE S F K YT D+WS G + E+ + G
Sbjct: 225 KDP-------DYVRKGDARLPLKWM-APE---SIFDKVYTTQSDVWSFGVLLWEIFSLGA 273
Query: 223 PLFPGKNV 230
+PG +
Sbjct: 274 SPYPGVQI 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 34/236 (14%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGER-----VAIKKINDVFEHVSDATRILREIKLLRLLR 74
+ + +G+G +G V A R VA+K + + S+ +L E LL+ +
Sbjct: 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN-ASSSELRDLLSEFNLLKQVN 61
Query: 75 HPDIVEI-----------------KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD- 116
HP ++++ K+ L RE + + + + + + N D
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 117 --LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174
LT F +Q+ RG++Y+ + HRDL +N+L K+KI DFGL+R + +
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 175 PSAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLT--GKPLFPG 227
+ +W A E S F YT D+WS G + E++T G P +PG
Sbjct: 182 SYVKRSKGRIPVKWM-AIE---SLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHPDIVEIK 82
+G G+ GVV +G +A K I+ + A R I+RE+++L P IV
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIH---LEIKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 83 HIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN- 140
+I + E M+ L QV+K + E +LRGL Y+ +
Sbjct: 70 GAFYSDG-----EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 124
Query: 141 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFF 199
+ HRD+KP NIL N+ ++K+CDFG++ + ++ +V TR Y +PE L G+ +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQGTHY 179
Query: 200 SKYTPAIDIWSIGCIFAEMLTGKPLFP 226
S + DIWS+G E+ G+ P
Sbjct: 180 SVQS---DIWSMGLSLVELAIGRYPIP 203
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 40/212 (18%)
Query: 96 IYVVFELMESDLHQVIKANDDL-----TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 150
++ F+ S + DDL T E + +Q+ RG++++ + HRDL +N
Sbjct: 145 LFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARN 204
Query: 151 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIW 209
IL + + +KICDFGLAR + D + + +W APE S F K YT D+W
Sbjct: 205 ILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM-APE---SIFDKVYTTQSDVW 260
Query: 210 SIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQ 268
S G + E+ + G +PG +I E +R R +
Sbjct: 261 SFGVLLWEIFSLGASPYPG----------------------VQINEEFCQRLKDGTRMRA 298
Query: 269 PVPFSHKFPNADPLALHLLERLLAFDPKDRPT 300
P NA P ++ DPK+RPT
Sbjct: 299 P-------ENATPEIYRIMLACWQGDPKERPT 323
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 21/234 (8%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 78
++I +G G++G V A + TG A K I+ E + + EI +L HP+I
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNI 64
Query: 79 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVI--KANDDLTPEHYQFFLYQLLRGLKYI 136
V+ +L E +++++ E + + LT + Q L L Y+
Sbjct: 65 VK----LLDAFYYE-NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
H + HRDLK NIL D +K+ DFG VS + + ++ T ++ APE+
Sbjct: 120 HENKIIHRDLKAGNILFTLDGDIKLADFG---VSAKNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 197 SFFSKYTP---AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247
SK P D+WS+G EM +P H+L+ M LL +E
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEPPH------HELNPMRVLLKIAKSE 224
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 57/236 (24%), Positives = 102/236 (43%), Gaps = 48/236 (20%)
Query: 18 RYQIQEVIGKGSYGVV--------------GSAVDTHTGERVAIKKINDVFEHVSDATR- 62
+ +++E +G+G +G V G+ VA+K + +D T+
Sbjct: 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR------ADVTKT 59
Query: 63 ----ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVI------ 111
L+EIK++ L++P+I+ + + + + ++ E ME+ DL+Q +
Sbjct: 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDD-----PLCMITEYMENGDLNQFLSQREIE 114
Query: 112 ----KANDDLTPEHYQFFLY---QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 164
AN+ + LY Q+ G+KY+ + N HRDL +N L +KI DF
Sbjct: 115 STFTHANN-IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADF 173
Query: 165 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 220
G++R ++ I + RW + K+T A D+W+ G EM T
Sbjct: 174 GMSRNLYSGDYYRIQGRAVLPIRWMAWESI---LLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 44/130 (33%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 104 ESDLHQVIKANDDLT--PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 161
+ D+ I D+L E F YQ+ +G+ ++ + N HRDL +NIL KI
Sbjct: 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKI 255
Query: 162 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT- 220
CDFGLAR ND+ + + +W APE F YT D+WS G + E+ +
Sbjct: 256 CDFGLARDIRNDSNYVVKGNARLPVKWM-APE--SIFNCVYTFESDVWSYGILLWEIFSL 312
Query: 221 GKPLFPGKNV 230
G +PG V
Sbjct: 313 GSSPYPGMPV 322
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 18/224 (8%)
Query: 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV--SDATRILREIKLLRL 72
+A Y++ +VIG+G++G V T + A+K ++ FE + SD+ E ++
Sbjct: 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK-FEMIKRSDSAFFWEERDIMAF 99
Query: 73 LRHPDIVEIKHIMLPPSRREFKD---IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 129
P +V++ + F+D +Y+V E M + +N D+ + +F+ ++
Sbjct: 100 ANSPWVVQLFY--------AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEV 151
Query: 130 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
+ L IH+ HRD+KP N+L + LK+ DFG + + V T Y
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG--MVRCDTAVGTPDY 209
Query: 190 RAPELCGSFFSK--YTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 231
+PE+ S Y D WS+G EML G F ++V
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 52/224 (23%), Positives = 98/224 (43%), Gaps = 31/224 (13%)
Query: 24 VIGKGSYGVVGSA---VDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVE 80
++GKG +G V A + + ++VA+K + SD LRE ++ HP++++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 81 IKHIMLPPSRREFKDI-YVVFELME-SDLHQVIKAND------DLTPEHYQFFLYQLLRG 132
+ + L + I V+ M+ DLH + + L + F+ + G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY--------V 184
++Y+ + N HRDL +N + N + + + DFGL++ I+ DY +
Sbjct: 126 MEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK--------KIYSGDYYRQGCASKL 177
Query: 185 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG 227
+W L + YT D+W+ G E++T G+ + G
Sbjct: 178 PVKWLALESLADNV---YTTHSDVWAFGVTMWEIMTRGQTPYAG 218
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 69/318 (21%), Positives = 125/318 (39%), Gaps = 77/318 (24%)
Query: 17 SRYQIQE--VIGKGSYGVV----GSAVDTHTGERVAIKKINDVFEHVSDATRIL---REI 67
R +QE +G+G +G V ++ GE + + K + D RE+
Sbjct: 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVK---ALQKTKDENLQSEFRREL 59
Query: 68 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD---------L 117
+ R L H ++V + + RE + Y++ E + DL Q ++A L
Sbjct: 60 DMFRKLSHKNVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114
Query: 118 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 177
+ + Q+ G+ ++ A HRDL +N L ++ ++K+ L++ +N
Sbjct: 115 STKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS---- 170
Query: 178 IFWTDY-------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 229
+Y + RW APE ++ D+WS G + E+ T G+ F G
Sbjct: 171 ----EYYKLRNALIPLRWL-APE--AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG-- 221
Query: 230 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH-LLE 288
++D E ++R++ K P P L+ L+
Sbjct: 222 -------LSD------EEVLNRLQAGKLEL---------------PVPEGCPSRLYKLMT 253
Query: 289 RLLAFDPKDRPTAEEALA 306
R A +PKDRP+ E ++
Sbjct: 254 RCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 13/219 (5%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA-TRILREIKLLRLLRHPD 77
++I +VIG+G++G V + V ++V KI + +E + A T RE + + +
Sbjct: 3 FEILKVIGRGAFGEV-AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 78 IVEIKHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKY 135
+ H ++ ++Y+V + + DL ++ +D PE +F+L +++ +
Sbjct: 62 WITTLHYAF----QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 195
+H + HRD+KP NIL + + +++ DFG D + + V T Y +PE+
Sbjct: 118 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSVAVGTPDYISPEIL 175
Query: 196 GSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 231
+ KY P D WS+G EML G+ F +++V
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 38/115 (33%), Positives = 61/115 (53%), Gaps = 6/115 (5%)
Query: 115 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174
LT E + +Q+ +G++++ + HRDL +NIL + + +KICDFGLAR + D
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD- 232
Query: 175 PSAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLT-GKPLFPG 227
P + D + APE + F + YT D+WS G + E+ + G +PG
Sbjct: 233 PDYVRKGDARLPLKWMAPE---TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHPDIVEIK 82
+G G+ GVV +G +A K I+ + A R I+RE+++L P IV
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIH---LEIKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 83 HIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN- 140
+I + E M+ L QV+K + + +++GL Y+ +
Sbjct: 70 GAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 124
Query: 141 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFF 199
+ HRD+KP NIL N+ ++K+CDFG++ + ++ +V TR Y +PE L G+ +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQGTHY 179
Query: 200 SKYTPAIDIWSIGCIFAEMLTGK-PLFP 226
S + DIWS+G EM G+ P+ P
Sbjct: 180 SVQS---DIWSMGLSLVEMAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 47/226 (20%)
Query: 23 EVIGKGSYGVVGSAVDTHTGER-----VAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
E +G+G++G V T ER VAIK + + E +E +L+ L+HP+
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFRQEAELMSDLQHPN 69
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQ----------VIKANDDLTPEH---YQ 123
IV + + + + ++FE + DLH+ V + D T +
Sbjct: 70 IVCLLGVCT-----KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCS 124
Query: 124 FFL---YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 180
FL Q+ G++Y+ + + HRDL +N L +KI DFGL+R I+
Sbjct: 125 DFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSR--------DIYS 176
Query: 181 TDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEM 218
DY + RW PE + K+T DIWS G + E+
Sbjct: 177 ADYYRVQSKSLLPVRWM-PPE--AILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 37/218 (16%)
Query: 106 DLHQVIKA--NDDLTPEHYQ--FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 161
DL++ IK + L + Y+ YQ++ L +H+ + HRDLK NI +K+
Sbjct: 151 DLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKL 210
Query: 162 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG 221
DFG ++ ++D+ S + + T +Y APEL +Y+ D+WS+G I E+LT
Sbjct: 211 GDFGFSK-QYSDSVSLDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTL 267
Query: 222 KPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADP 281
F G + Q ++M +L K P P P +
Sbjct: 268 HRPFKGPS---QREIMQQVL----------------------YGKYDPFP----CPVSSG 298
Query: 282 LALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDRE 319
+ LL+ LL+ +P RPT ++ L + +AN+ ++
Sbjct: 299 MKA-LLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQD 335
|
Length = 478 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 65/236 (27%), Positives = 104/236 (44%), Gaps = 53/236 (22%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH--------- 75
IG+G++G V + +G +A+K+I +T +E K RLL
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIR--------STVDEKEQK--RLLMDLDVVMRSSD 61
Query: 76 -PDIVEIKHIMLPPSRREFK--DIYVVFELMESDL-------HQVIKANDDLTPEHYQFF 125
P IV+ + F+ D ++ ELM+ L ++V+K+ PE
Sbjct: 62 CPYIVKFYGAL-------FREGDCWICMELMDISLDKFYKYVYEVLKSV---IPEE---I 108
Query: 126 L----YQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 180
L ++ L Y+ + HRD+KP NIL + + +K+CDFG++ + +I
Sbjct: 109 LGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD----SIAK 164
Query: 181 TDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG-KNVVHQL 234
T R Y APE + S Y D+WS+G E+ TGK +P +V QL
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 26/209 (12%)
Query: 23 EVIGKGSYGVVGSAVDTHTGER----VAIKKIND-----VFEHVSDATRILREIKLLRLL 73
+++G G +G V + G+ VAIK I D F+ ++D + + L
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITD------HMLAMGSL 66
Query: 74 RHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLR 131
H IV + I S + +V +L S L V + D L P+ + Q+ +
Sbjct: 67 DHAYIVRLLGICPGAS------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAK 120
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 191
G+ Y+ + HR+L +NIL +D ++I DFG+A + + D + +W
Sbjct: 121 GMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM-- 178
Query: 192 PELCGSFFSKYTPAIDIWSIGCIFAEMLT 220
L F +YT D+WS G EM++
Sbjct: 179 -ALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 66/267 (24%), Positives = 104/267 (38%), Gaps = 44/267 (16%)
Query: 65 REIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQF 124
REI +L+ + H I+ + H + R + +V + DL + + L E
Sbjct: 135 REIDILKTISHRAIINLIH-----AYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAIT 189
Query: 125 FLYQLLRGLKYIHTANVFHRDLKPKNILAN-----------ADCKLKICDFGLARVSFND 173
+LL L Y+H + HRD+K +NI + A CKL D
Sbjct: 190 IQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP---------D 240
Query: 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV--- 230
P W+ + T +PEL Y DIWS G + EM GK V
Sbjct: 241 TPQCYGWSGTLET---NSPEL--LALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS 295
Query: 231 VHQLD-----LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVP--FSHKFPNADPLA 283
QL + L P S + ++ K +Y +R +P + D
Sbjct: 296 SSQLRSIIRCMQVHPLEFPQNGSTNLCKHFK--QYAIVLRPPYTIPPVIRKYGMHMD--V 351
Query: 284 LHLLERLLAFDPKDRPTAEEALADPYF 310
+L+ ++L FD + RP+A++ L+ P F
Sbjct: 352 EYLIAKMLTFDQEFRPSAQDILSLPLF 378
|
Length = 392 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 25 IGKGSYGVVGSAVDTHTGER--VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 82
+G G++G V V ++ VAIK + + E S ++RE +++ L +P IV +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK-SVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 83 HIMLPPSRREFKDIYVVFELMESD-LHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTAN 140
+ E + + +V E+ L++ + D++T + ++Q+ G+KY+ N
Sbjct: 62 GVC------EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 141 VFHRDLKPKNILANADCKLKICDFGLARV-----SFNDAPSAIFWTDYVATRWYRAPELC 195
HRDL +N+L KI DFGL++ S+ A SA W +WY APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW----PLKWY-APECI 170
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLT--GKP 223
F K++ D+WS G E + KP
Sbjct: 171 N--FRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 36/104 (34%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 125 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 184
F Q+ +G+ ++ + N HRD+ +N+L KICDFGLAR ND+ + +
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276
Query: 185 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG 227
+W APE F YT D+WS G + E+ + GK +PG
Sbjct: 277 PVKWM-APE--SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 72/298 (24%), Positives = 126/298 (42%), Gaps = 55/298 (18%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEI-- 81
+GKG +G V + +TG+ A KK++ + S L E ++L + P IV +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 82 -----KHIMLPPSRREFKDI-YVVFELMES--DLHQVIKANDDLTPEHYQFFLYQLLRGL 133
H+ L S D+ Y ++ + E ++ +VI + Q+ G+
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVI------------HYSAQITCGI 108
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 193
++H+ ++ +RD+KP+N+L + ++ D GLA V D + T T Y APE
Sbjct: 109 LHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTI---TQRAGTNGYMAPE 164
Query: 194 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253
+ Y+ +D +++GC EM+ G+ P K+ ++ +
Sbjct: 165 ILKE--EPYSYPVDWFAMGCSIYEMVAGRT--PFKDHKEKVA-----------------K 203
Query: 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311
E RR L + V F H+ N + + LA P+DR + E DP H
Sbjct: 204 EELKRRTL-----EDEVKFEHQ--NFTEESKDICRLFLAKKPEDRLGSREKNDDPRKH 254
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 9e-11
Identities = 78/306 (25%), Positives = 135/306 (44%), Gaps = 41/306 (13%)
Query: 11 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 70
T +A +Y I V+G G+ G V A GE A+K ++ +D R E+ L
Sbjct: 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCL 85
Query: 71 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLT---PEHYQ 123
IV+ R +++ ++ +++ DL Q IK+ EH
Sbjct: 86 LNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEA 145
Query: 124 FFLY-QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 182
L+ Q+L + ++H+ ++ HRD+K NIL ++ +K+ DFG +++ + T
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT- 204
Query: 183 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 242
+ T +Y APE+ Y+ D++S+G + E+LT K F G+N+ ++M L
Sbjct: 205 FCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENME---EVMHKTL- 258
Query: 243 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 302
A RY P+P P+ P ++ LL+ DPK RP++
Sbjct: 259 --------------AGRY-------DPLP-----PSISPEMQEIVTALLSSDPKRRPSSS 292
Query: 303 EALADP 308
+ L P
Sbjct: 293 KLLNMP 298
|
Length = 496 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 64/247 (25%), Positives = 102/247 (41%), Gaps = 53/247 (21%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN--DVFE-----HVSDATRILREIKLLR 71
++ +VIG+G++G V TG A+K + D+ E H+ IL E L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 72 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL 130
+++ + S ++ ++Y++ E + D+ ++ D LT E QF++ + +
Sbjct: 63 VVK-----------MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETV 111
Query: 131 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-------RVSF------------ 171
+ IH HRD+KP N+L ++ +K+ DFGL R F
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 172 -----NDAPSAIFWT--------DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEM 218
N A W V T Y APE+ + Y D WS+G I EM
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEM 229
Query: 219 LTGKPLF 225
L G P F
Sbjct: 230 LIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 62/246 (25%), Positives = 103/246 (41%), Gaps = 59/246 (23%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 82
+VIG+G++G V TG A+K ILR+ +L + I +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMK--------------ILRKADMLEKEQVAHIRAER 52
Query: 83 HIMLPP----------SRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLR 131
I++ S ++ +++Y++ E + D+ ++ D L+ E QF++ + +
Sbjct: 53 DILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL 112
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-------RVSF-----NDAPSAIF 179
+ IH HRD+KP N+L +A +K+ DFGL R F ++ PS
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 180 WTDYVATR----W----------------YRAPELCGSFFSKYTPAIDIWSIGCIFAEML 219
+ + + R W Y APE+ + Y D WS+G I EML
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEML 230
Query: 220 TGKPLF 225
G P F
Sbjct: 231 IGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 36/101 (35%), Positives = 54/101 (53%), Gaps = 5/101 (4%)
Query: 125 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 184
F YQ+ G++++ + N HRDL +N+L +KICDFGLAR D+ + ++
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 185 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT--GKP 223
+W APE F + YT D+WS G + E+ T G P
Sbjct: 304 PLKWM-APE--SIFNNLYTTLSDVWSFGILLWEIFTLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 70/235 (29%), Positives = 104/235 (44%), Gaps = 49/235 (20%)
Query: 25 IGKGSYGVV--GSAVD---THTGE-RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 78
+G G++G V G+A D +G RVA+K + + L+E L+ HP+I
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK-GATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 79 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL------- 130
V++ + L + Y++ ELME DL ++ L +LL
Sbjct: 62 VKLLGVCL-----LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 131 RGLKYIHTANVFHRDLKPKNILA-----NADCKLKICDFGLARVSFNDAPSAIFWTDY-- 183
+G Y+ + HRDL +N L +AD +KI DFGLAR I+ +DY
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--------DIYKSDYYR 168
Query: 184 ------VATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 229
+ RW APE L G F T D+WS G + E+LT G+ +P N
Sbjct: 169 KEGEGLLPVRWM-APESLLDGKF----TTQSDVWSFGVLMWEILTLGQQPYPALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 56/199 (28%), Positives = 88/199 (44%), Gaps = 43/199 (21%)
Query: 45 VAIKKINDVFEHVSDATRI--LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 102
VA+K + SD R L+E+K+L L P+I + L + + ++ E
Sbjct: 49 VAVKVLRP---DASDNAREDFLKEVKILSRLSDPNIARL----LGVCTVD-PPLCMIMEY 100
Query: 103 ME-SDLHQVIKANDDLTPEH--------YQFFLY---QLLRGLKYIHTANVFHRDLKPKN 150
ME DL+Q ++ + T + LY Q+ G++Y+ + N HRDL +N
Sbjct: 101 MENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160
Query: 151 ILANADCKLKICDFGLARVSF-ND-------APSAIFWTDYVATRWYRAPELCGSFF-SK 201
L + +KI DFG++R + +D AP I RW A E S K
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPI--------RWM-AWE---SVLLGK 208
Query: 202 YTPAIDIWSIGCIFAEMLT 220
+T D+W+ G E+LT
Sbjct: 209 FTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 20/169 (11%)
Query: 64 LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTP 119
L+EIK++ L+ P+I+ + + + + ++ E ME+ DL+Q + + +
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEK 121
Query: 120 EHYQFFLY--------QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171
Y Q+ G+KY+ + N HRDL +N L + +KI DFG++R +
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 220
+ I + RW + K+T A D+W+ G E+LT
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESI---LLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 72/305 (23%), Positives = 123/305 (40%), Gaps = 48/305 (15%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 82
+I G+YG V T +R A+KKIN + ++ E +L +P +V
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVS-- 65
Query: 83 HIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 141
+ S + + +V E +E D ++K L + + + + + L+Y+H +
Sbjct: 66 ---MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122
Query: 142 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF-WTDYVATRWYRAPELCGS--- 197
HRDLKP N+L + +K+ DFGL+++ + ++ TR + ++CG+
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182
Query: 198 ------FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251
Y +D W++G I E L G F G D +L G ++ I
Sbjct: 183 IAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-------DTPEELFGQVISDDIEW 235
Query: 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR---PTAEEALADP 308
++A AD A L+ RLL +P +R A E
Sbjct: 236 PEGDEA-------------------LPAD--AQDLISRLLRQNPLERLGTGGAFEVKQHR 274
Query: 309 YFHGL 313
+F GL
Sbjct: 275 FFLGL 279
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 66/300 (22%), Positives = 115/300 (38%), Gaps = 65/300 (21%)
Query: 23 EVIGKGSYGVVGSA---VDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDI 78
+++G+G +G V D + +VA+K + D+ + S+ L E ++ HP++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFDHPNV 63
Query: 79 VEIKHIMLPPSRRE-FKDIYVVFELME-SDLHQ-VIKANDDLTPEHYQF-----FLYQLL 130
+++ + S + V+ M+ DLH ++ + PE F+ +
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 131 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY------- 183
G++Y+ N HRDL +N + D + + DFGL++ I+ DY
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK--------KIYSGDYYRQGRIA 175
Query: 184 -VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLL 241
+ +W L YT D+W+ G E+ T G+ +PG
Sbjct: 176 KMPVKWIAIESLADRV---YTSKSDVWAFGVTMWEIATRGQTPYPG-------------- 218
Query: 242 GTPSTESISRIRNEKARRYL-GSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 300
+ N + YL R KQP + L+ DPKDRPT
Sbjct: 219 ----------VENHEIYDYLRHGNRLKQP-------EDCLDELYDLMYSCWRADPKDRPT 261
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 64/293 (21%), Positives = 113/293 (38%), Gaps = 46/293 (15%)
Query: 23 EVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVE 80
+ +G+G +G V G + +VA+K + S+ L E ++ HP+++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 81 IKHIMLPPSRRE-FKDIYVVFELME-SDLHQVI---KANDD---LTPEHYQFFLYQLLRG 132
+ + L E + V+ M+ DLH + + D L + F+ + G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 192
++Y+ + + HRDL +N + N + + + DFGL++ +N + +W
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184
Query: 193 ELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251
L YT D+WS G E+ T G+ +PG
Sbjct: 185 SLADRV---YTTKSDVWSFGVTMWEIATRGQTPYPG------------------------ 217
Query: 252 IRNEKARRYL-GSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 303
+ N + YL R KQP P+ L+ +PKDRP+ E
Sbjct: 218 VENSEIYDYLRQGNRLKQP-------PDCLDGLYSLMSSCWLLNPKDRPSFET 263
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 30/204 (14%)
Query: 96 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 154
+++V E + DL ++ L EH +F+ ++ L ++H + +RDLK N+L +
Sbjct: 71 LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130
Query: 155 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 214
AD +K+ D+G+ + + + + T Y APE+ +Y ++D W++G +
Sbjct: 131 ADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRG--EEYGFSVDWWALGVL 185
Query: 215 FAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSH 274
EM+ G+ F D++TD + + + ++ EK R + K
Sbjct: 186 MFEMMAGRSPF---------DIITDNPDMNTEDYLFQVILEKPIRIPRFLSVK------- 229
Query: 275 KFPNADPLALHLLERLLAFDPKDR 298
A H+L+ L DPK+R
Sbjct: 230 --------ASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIK 82
V+GKG +G V + TG+ A KK+ + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 83 HIMLPPSRREFKD-IYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 138
+ E KD + +V +M DL H N + F+ +L GL+ +
Sbjct: 67 YAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 139 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 198
+ +RDLKP+NIL + ++I D GLA P V T Y APE+ +
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINN- 175
Query: 199 FSKYTPAIDIWSIGCIFAEMLTGKPLF 225
KYT + D W +GC+ EM+ G+ F
Sbjct: 176 -EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 47/225 (20%)
Query: 25 IGKGSYGVVGSAVDTH---TGER--VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79
+G+G++G V A + ++ VA+K + + E S RE +LL +L+H IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTVLQHQHIV 70
Query: 80 EIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND---------------DLTPEHYQ 123
+ E + + +VFE M DL++ ++++ LT
Sbjct: 71 RFYGVC-----TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 124 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY 183
Q+ G+ Y+ + + HRDL +N L +KI DFG++R I+ TDY
Sbjct: 126 AIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--------DIYSTDY 177
Query: 184 --------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 220
+ RW PE + K+T DIWS G + E+ T
Sbjct: 178 YRVGGRTMLPIRWM-PPE--SILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 5e-10
Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 20/203 (9%)
Query: 25 IGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 82
+G G +GVV G + VAIK I E + E K++ L H +V++
Sbjct: 12 LGTGQFGVVKYGKWRGQYD---VAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQLY 65
Query: 83 HIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 140
+ + + IY+V E M + L+ + + P + G+ Y+ +
Sbjct: 66 GVC-----TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 141 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 200
HRDL +N L + +K+ DFGL+R +D ++ + + RW PE+ +S
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF-PVRW-SPPEVL--LYS 176
Query: 201 KYTPAIDIWSIGCIFAEMLT-GK 222
K++ D+W+ G + E+ + GK
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 30/211 (14%)
Query: 25 IGKGSYG-VVGSAVDTHTGERVAIKKINDVFEHVS-----DATRILREIKLLRLLRHPDI 78
+G GS+G V+ + VAIK+ FE + E K+L + HP
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKR----FEKSKIIKQKQVDHVFSERKILNYINHPFC 93
Query: 79 VEIKHIMLPPSRREFKD---IYVVFE-LMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 134
V + FKD +Y+V E ++ + ++ N + F+ Q++ +
Sbjct: 94 VNL--------YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFE 145
Query: 135 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 194
Y+ + N+ +RDLKP+N+L + D +K+ DFG A+V + T Y APE+
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT------LCGTPEYIAPEI 199
Query: 195 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 225
+ + A D W++G E+L G P F
Sbjct: 200 LLNV--GHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 6e-10
Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 28/192 (14%)
Query: 45 VAIKKINDVFEHVSDATR--ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 102
VA+K + D SD R RE +LL L+H IV+ + + E + +VFE
Sbjct: 38 VAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EGDPLIMVFEY 88
Query: 103 ME-SDLHQVIKAN-------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKP 148
M+ DL++ ++A+ +LT Q+ G+ Y+ + + HRDL
Sbjct: 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLAT 148
Query: 149 KNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 208
+N L + +KI DFG++R ++ + + RW PE + K+T D+
Sbjct: 149 RNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDV 205
Query: 209 WSIGCIFAEMLT 220
WS+G + E+ T
Sbjct: 206 WSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 39/115 (33%), Positives = 57/115 (49%), Gaps = 6/115 (5%)
Query: 127 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 186
YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR N +
Sbjct: 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV 200
Query: 187 RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTD 239
+W APE + F + YT D+WS G + E+ T G +PG V L+ +
Sbjct: 201 KWM-APE---ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 13/205 (6%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLL-RHPDIVEI 81
VIG+GSY V T A+K I ++ D + E + HP +V +
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 82 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 140
SR ++ V E + DL ++ L EH +F+ ++ L ++H
Sbjct: 62 HSCFQTESR-----LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG 116
Query: 141 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 200
+ +RDLK N+L +A+ +K+ D+G+ + + + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 201 KYTPAIDIWSIGCIFAEMLTGKPLF 225
Y ++D W++G + EM+ G+ F
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 55/212 (25%), Positives = 84/212 (39%), Gaps = 26/212 (12%)
Query: 25 IGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 82
IG G +G V G A + RV +K++ + L+E++ R L HP++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNV---- 57
Query: 83 HIMLPPSRREFKDIYVVFELME-SDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYI 136
+ E +V E DL +++N + Q ++ GL ++
Sbjct: 58 -LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD---YVATRWYRAPE 193
H A+ H DL +N AD +KI D+GLA P + T V RW APE
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLA---LEQYPEDYYITKDCHAVPLRWL-APE 172
Query: 194 LCGSFFS-----KYTPAIDIWSIGCIFAEMLT 220
L T +IWS+G E+ T
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 39/112 (34%), Positives = 56/112 (50%), Gaps = 24/112 (21%)
Query: 127 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY--- 183
YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR + DY
Sbjct: 141 YQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR--------GVHDIDYYKK 192
Query: 184 -----VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLT--GKPLFPG 227
+ +W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 193 TSNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGILMWEIFTLGGSP-YPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 40/112 (35%), Positives = 56/112 (50%), Gaps = 24/112 (21%)
Query: 127 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY--- 183
YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR I DY
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--------DIHHIDYYKK 198
Query: 184 -----VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLT--GKPLFPG 227
+ +W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 199 TTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV--SDATRILREIKLLRLLRHP 76
+ + +VIG+G++G V + + A+K ++ FE + SD+ E ++
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK-FEMIKRSDSAFFWEERDIMAHANSE 103
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
IV++ + K +Y+V E M DL ++ +N D+ + +F+ +++ L
Sbjct: 104 WIVQLHYAFQDD-----KYLYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTAEVVLALDA 157
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLA-RVSFNDAPSAIFWTDYVATRWYRAPEL 194
IH+ HRD+KP N+L + LK+ DFG ++ DA + V T Y +PE+
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM---DANGMVRCDTAVGTPDYISPEV 214
Query: 195 CGS--FFSKYTPAIDIWSIGCIFAEMLTGKPLF 225
S Y D WS+G EML G F
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 39/116 (33%), Positives = 58/116 (50%), Gaps = 8/116 (6%)
Query: 127 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 186
YQ+ RG++Y+ + HRDL +N+L + +KI DFGLAR N +
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV 203
Query: 187 RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLT--GKPLFPGKNVVHQLDLMTD 239
+W APE + F + YT D+WS G + E+ T G P +PG V L+ +
Sbjct: 204 KWM-APE---ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLLKE 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 33/186 (17%)
Query: 59 DATR-----ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIK 112
DA + L+E+K+L L+ P+I+ + + + + + ++ E ME+ DL+Q +
Sbjct: 57 DANKNARNDFLKEVKILSRLKDPNIIRLLGVCV-----DEDPLCMITEYMENGDLNQFLS 111
Query: 113 A----------NDDLTPEH------YQFFLY---QLLRGLKYIHTANVFHRDLKPKNILA 153
+ ND + P H Y L+ Q+ G+KY+ + N HRDL +N L
Sbjct: 112 SHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLV 171
Query: 154 NADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC 213
+ +KI DFG++R + I + RW A E K+T A D+W+ G
Sbjct: 172 GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWM-AWECI--LMGKFTTASDVWAFGV 228
Query: 214 IFAEML 219
E+L
Sbjct: 229 TLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLL-RLLRHPDIVEI 81
VIG+GSY V T A+K + ++ D + E + + HP +V +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 82 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 140
SR ++ V E + DL ++ L EH +F+ ++ L Y+H
Sbjct: 62 HSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 116
Query: 141 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 200
+ +RDLK N+L +++ +K+ D+G+ + + + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 201 KYTPAIDIWSIGCIFAEMLTGKPLF 225
Y ++D W++G + EM+ G+ F
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 5e-09
Identities = 64/248 (25%), Positives = 105/248 (42%), Gaps = 38/248 (15%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
+ Y++ + IG G +G V T E K I+ + ++++ E+ ++R L+H
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDL---TPEHYQF-FLYQLLR 131
+IV L + ++ +Y++ E ++ DL + I+ + EH QLL
Sbjct: 73 NIVRYIDRFLNKANQK---LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 132 GLKYIHT-------ANVFHRDLKPKNILANADCK-----------------LKICDFGLA 167
L Y H V HRDLKP+NI + + KI DFGL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 168 R-VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFP 226
+ + + V T +Y +PEL Y D+W++GCI E+ +GK F
Sbjct: 190 KNIGIESMAHSC-----VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244
Query: 227 GKNVVHQL 234
N QL
Sbjct: 245 KANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 57/201 (28%), Positives = 82/201 (40%), Gaps = 26/201 (12%)
Query: 128 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG---LARVSFNDAPSAIFWTDYV 184
QLL + YIH + HRD+K +N+L N + + DFG AR S+ S F
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW----STPFHYGIA 323
Query: 185 ATRWYRAPELCGSFFSKYTPAIDIWSIG-CIFAEMLTGKPLFPGKN-------------V 230
T APE+ YTP++DIWS G IF + LF +
Sbjct: 324 GTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRI 381
Query: 231 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERL 290
+ Q + D + SR+ ++ R + R P ++ D +L+ R
Sbjct: 382 IRQAQVHVDEF---PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRA 438
Query: 291 LAFDPKDRPTAEEALADPYFH 311
L FD RP+A E L P F
Sbjct: 439 LTFDGARRPSAAELLRLPLFQ 459
|
Length = 461 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 34/226 (15%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERV--AIKKINDVFEHVSDATRILREIKLL-RLLRHP 76
+ Q+VIG+G++G V A G R+ AIK++ + + D E+++L +L HP
Sbjct: 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHP 68
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFE---------------LMESDLHQVI--KANDDLTP 119
+I+ +++ R + +Y+ E ++E+D I L+
Sbjct: 69 NII---NLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123
Query: 120 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179
+ F + RG+ Y+ HRDL +NIL + KI DFGL+R +
Sbjct: 124 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM- 182
Query: 180 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEM--LTGKP 223
+ RW L +S YT D+WS G + E+ L G P
Sbjct: 183 --GRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 59/229 (25%), Positives = 109/229 (47%), Gaps = 33/229 (14%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 78
++I +VIG+G++G V AV V +K V+ A +IL + ++L+
Sbjct: 3 FEILKVIGRGAFGEV--AV-------VKMKNTGQVY-----AMKILNKWEMLKRAETACF 48
Query: 79 VEIKHIMLPPSRR-------EFKD---IYVVFEL-MESDLHQVI-KANDDLTPEHYQFFL 126
E + +++ RR F+D +Y+V + + DL ++ K D L + +F+L
Sbjct: 49 REERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL 108
Query: 127 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG----LARVSFNDAPSAIFWTD 182
+++ + +H HRD+KP N+L + + +++ DFG L + A+ D
Sbjct: 109 AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD 168
Query: 183 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 231
Y++ +A E +Y P D WS+G EML G+ F +++V
Sbjct: 169 YISPEILQAME---DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 59/246 (23%), Positives = 97/246 (39%), Gaps = 59/246 (23%)
Query: 15 EASRYQIQEV--IGKGSYGVVGSA-----VDTHTGERVAIKKINDVFEHVSDATR--ILR 65
E R I+ V IG+G++G V A + VA+K + E S + R
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQR 57
Query: 66 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND--------- 115
E L+ HP+IV++ + K + ++FE M DL++ ++
Sbjct: 58 EAALMAEFDHPNIVKLLGVCA-----VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSH 112
Query: 116 -------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 162
L+ Q+ G+ Y+ HRDL +N L + +KI
Sbjct: 113 STSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 172
Query: 163 DFGLARVSFNDAPSAIFWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCI 214
DFGL+R I+ DY + RW PE F+++YT D+W+ G +
Sbjct: 173 DFGLSR--------NIYSADYYKASENDAIPIRWM-PPE--SIFYNRYTTESDVWAYGVV 221
Query: 215 FAEMLT 220
E+ +
Sbjct: 222 LWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 48/230 (20%)
Query: 21 IQEVIGKGSYGVVGSA-----VDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 75
++ +G+G++G V A T VA+K + D ++ RE +LL L+H
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQH 66
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKA----------------NDDLT 118
IV+ + + + +VFE M+ DL++ ++A +L
Sbjct: 67 EHIVKFYGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121
Query: 119 PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 178
Q+ G+ Y+ + + HRDL +N L A+ +KI DFG++R +
Sbjct: 122 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--------DV 173
Query: 179 FWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 220
+ TDY + RW PE + K+T D+WS G I E+ T
Sbjct: 174 YSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 23/222 (10%)
Query: 17 SRYQIQEVIGKGSYGVV--GSAVDTHTGER---VAIKKINDVFEHVSDATRILREIKLLR 71
S + E +G+ +G V G T GE+ VAIK + D E E +
Sbjct: 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRS 63
Query: 72 LLRHPDIVEI-------KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD------LT 118
L+HP+IV + + + + S D++ F +M S V +DD L
Sbjct: 64 RLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHE-FLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 119 PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 178
P + + Q+ G++++ + +V H+DL +N+L +KI D GL R + +
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182
Query: 179 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 220
+ RW +PE + K++ DIWS G + E+ +
Sbjct: 183 MGNSLLPIRWM-SPE--AIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 51/221 (23%), Positives = 94/221 (42%), Gaps = 29/221 (13%)
Query: 17 SRYQIQEVIGKGSYGVV--GSAVDTHTG--ERVAIKKINDVFEHVSDA--TRILREIKLL 70
R + +++ +G++G + G +D G E V +K + D H S+ T +L+E LL
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD---HASEIQVTLLLQESCLL 62
Query: 71 RLLRHPDIVEIKH----------IMLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTP 119
L H +I+ I H ++ P + K L E++ Q + +
Sbjct: 63 YGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH- 121
Query: 120 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179
Q+ G+ Y+H V H+D+ +N + + + ++KI D L+R F +
Sbjct: 122 -----MAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176
Query: 180 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 220
+ +W L +S A D+WS G + E++T
Sbjct: 177 DNENRPVKWMALESLVNKEYSS---ASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 14/203 (6%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIK-KINDVFEHVSDAT--RILREIKLLRLLRHPDIV 79
+V+G G++G V + GE+V I I ++ E S IL E ++ + +P +
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 80 EIKHIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
+ I L + + ++ +LM L V + D++ ++ + Q+ +G+ Y+
Sbjct: 73 RLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 126
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 197
+ HRDL +N+L +KI DFGLA++ D V +W +
Sbjct: 127 ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI--- 183
Query: 198 FFSKYTPAIDIWSIGCIFAEMLT 220
YT D+WS G E++T
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 5e-08
Identities = 63/234 (26%), Positives = 102/234 (43%), Gaps = 47/234 (20%)
Query: 15 EASRYQIQEV--IGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LR 65
E SR +I + +G+GS+G+V G+A D GE RVA+K +N E S RI L
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN---ESASLRERIEFLN 58
Query: 66 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKA-------NDDL 117
E +++ +V + ++ + + VV ELM DL +++ N
Sbjct: 59 EASVMKGFTCHHVVRLLGVV-----SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 113
Query: 118 TPEHYQFFLY---QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174
P Q + ++ G+ Y++ HRDL +N + D +KI DFG+ R
Sbjct: 114 PPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR------ 167
Query: 175 PSAIFWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 220
I+ TDY + RW L F+ + D+WS G + E+ +
Sbjct: 168 --DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSS---DMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 40/152 (26%), Positives = 58/152 (38%), Gaps = 47/152 (30%)
Query: 119 PEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL----------- 166
PE +F++ +L ++ +H HRD+KP NIL + D +K+ DFGL
Sbjct: 99 PEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158
Query: 167 -----ARVSFNDAPSAIFWTD----------------------------YVATRWYRAPE 193
+ + + + W D V T Y APE
Sbjct: 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPE 218
Query: 194 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 225
+ YT D WS+G I EML G+P F
Sbjct: 219 VL--LRKGYTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 18/216 (8%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIK-KINDVFEHVSDAT--RILREIKLLRLLRHPDIVE 80
V+G G++G V + GE V I I + E+ S IL E ++ + P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 81 IKHIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 138
+ I L + + +V +LM L V + D + + + Q+ +G+ Y+
Sbjct: 74 LLGICLTST------VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE 127
Query: 139 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 198
+ HRDL +N+L + +KI DFGLAR+ D V +W +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI---L 184
Query: 199 FSKYTPAIDIWSIGCIFAEMLT--GKPL--FPGKNV 230
++T D+WS G E++T KP P + +
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 40/160 (25%), Positives = 72/160 (45%), Gaps = 25/160 (15%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI-------NDVFEHVSDATRILREIKLLR 71
+ +VIGKG++G V TG+ A+K + D HV +L E
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD--- 59
Query: 72 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLY 127
P +V + + F+D ++ +ME DL ++ D + + +F++
Sbjct: 60 ---SPWVVSLYY--------SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA 108
Query: 128 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 167
+ + ++ +H HRD+KP NIL + +K+ DFGL+
Sbjct: 109 ECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 41/220 (18%)
Query: 25 IGKGSYGVV-----GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79
+G+GS+G+V V RVAIK +N+ + + L E +++ +V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVV 72
Query: 80 EIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKA-------NDDLTPEHYQFFLY---Q 128
+ ++ + + V+ ELM DL +++ N P + + +
Sbjct: 73 RLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 129 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY----- 183
+ G+ Y++ HRDL +N + D +KI DFG+ R I+ TDY
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--------DIYETDYYRKGG 179
Query: 184 ---VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 220
+ RW L F+ Y+ D+WS G + E+ T
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 41/150 (27%), Positives = 57/150 (38%), Gaps = 47/150 (31%)
Query: 119 PEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL----------- 166
E +F++ +L ++ +H HRD+KP NIL + D +K+ DFGL
Sbjct: 99 EEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158
Query: 167 -------ARV-SFNDAPSAIFWT-----------------------DYVATRWYRAPELC 195
R S PS + V T Y APE+
Sbjct: 159 YYQKGDHHRQDSME--PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL 216
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 225
+ YT D WS+G I EML G+P F
Sbjct: 217 LR--TGYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 74/319 (23%), Positives = 118/319 (36%), Gaps = 45/319 (14%)
Query: 24 VIGKG--SYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 81
VIG+G V A TGE V +++IN T + E+ + +L HP+IV
Sbjct: 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPY 64
Query: 82 KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ---------FFLYQLLRG 132
+ + + +++VV M + DL H+ + L +L+
Sbjct: 65 RATFIADN-----ELWVVTSFM------AYGSAKDLICTHFMDGMSELAIAYILQGVLKA 113
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY----VATRW 188
L YIH HR +K +IL + D K+ + N D+ V
Sbjct: 114 LDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP 173
Query: 189 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT----- 243
+ +PE+ Y DI+S+G E+ G P K++ L+ L GT
Sbjct: 174 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGH--VPFKDMPATQMLLEKLNGTVPCLL 231
Query: 244 -----PSTESISRIRNEKARRYLG------SMRKKQPVPFSHKFPNA-DPLALHLLERLL 291
P+ E + A LG + R SH + P H +E+ L
Sbjct: 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCL 291
Query: 292 AFDPKDRPTAEEALADPYF 310
+P RP+A L +F
Sbjct: 292 QRNPDARPSASTLLNHSFF 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 50/194 (25%), Positives = 87/194 (44%), Gaps = 27/194 (13%)
Query: 45 VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE-LM 103
VAIK + D + +E L+ L HP+IV +L +E + + ++FE L
Sbjct: 37 VAIKTLKD-INNPQQWGEFQQEASLMAELHHPNIV----CLLGVVTQE-QPVCMLFEYLN 90
Query: 104 ESDLHQVI-----------KANDDLTP----EHYQFF--LYQLLRGLKYIHTANVFHRDL 146
+ DLH+ + +++D T +H F Q+ G++Y+ + H+DL
Sbjct: 91 QGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDL 150
Query: 147 KPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAI 206
+NIL +KI D GL+R ++ + + RW PE + K++
Sbjct: 151 AARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWM-PPE--AIMYGKFSSDS 207
Query: 207 DIWSIGCIFAEMLT 220
DIWS G + E+ +
Sbjct: 208 DIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 8e-07
Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 20/208 (9%)
Query: 25 IGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 82
IG G +G V G +T +V +K++ V V + + L E + R L+H ++++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELR-VSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 83 HIMLPPSRREFKDIYVVFELME-SDLH---QVIKANDDLTPE--HYQFFLYQLLRGLKYI 136
E +V E DL + + + +TP+ Q ++ GL ++
Sbjct: 62 GQC-----TEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL 116
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
H N H DL +N L AD +KI D+GL+ + + +V RW APEL
Sbjct: 117 HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI-APELVD 175
Query: 197 SFFSKY-----TPAIDIWSIGCIFAEML 219
T ++WS+G E+
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 36/119 (30%), Positives = 61/119 (51%), Gaps = 12/119 (10%)
Query: 106 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDF 164
DL ++K L+ + + QL+ L +H N+ H D+K +N+L + A ++ +CD+
Sbjct: 95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDY 154
Query: 165 GLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGK 222
GL ++ PS Y T Y +PE + G Y + D W++G + E+LTGK
Sbjct: 155 GLCKII--GTPSC-----YDGTLDYFSPEKIKGHN---YDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 39/147 (26%), Positives = 56/147 (38%), Gaps = 46/147 (31%)
Query: 123 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA--------------- 167
+F++ +L ++ +H HRD+KP NIL + D +K+ DFGL
Sbjct: 104 RFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSG 163
Query: 168 -RVSFNDAPSAIFWTD----------------------------YVATRWYRAPELCGSF 198
V + + W D V T Y APE+
Sbjct: 164 DHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL--L 221
Query: 199 FSKYTPAIDIWSIGCIFAEMLTGKPLF 225
+ YT D WS+G I EML G+P F
Sbjct: 222 RTGYTQLCDWWSVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERV--AIKKINDVFEHVSDATRILREIKLL-RLLRHP 76
+ ++VIG+G++G V A+ G ++ AIK + + F +D E+++L +L HP
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHP 63
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFE----------LMESDLHQVIKANDDLTPEH---YQ 123
+I+ +++ R + +Y+ E L +S +V++ + EH
Sbjct: 64 NII---NLLGACENRGY--LYIAIEYAPYGNLLDFLRKS---RVLETDPAFAKEHGTAST 115
Query: 124 FFLYQLLR-------GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 176
QLL+ G++Y+ HRDL +N+L + KI DFGL+R
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175
Query: 177 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEM--LTGKP 223
+ + RW L +S YT D+WS G + E+ L G P
Sbjct: 176 TM---GRLPVRWMAIESLN---YSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 61/255 (23%), Positives = 98/255 (38%), Gaps = 52/255 (20%)
Query: 15 EASRYQIQ--EVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREI 67
E R I +G G++G V + +VA+K + + D + L E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-QDESDFLMEA 60
Query: 68 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFL 126
++ H +IV + + R +++ ELM DL ++ N +
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPR-----FILLELMAGGDLKSFLRENRPRPERPSSLTM 115
Query: 127 YQLLR-------GLKYIHTANVFHRDLKPKNILANADCK-----LKICDFGLARVSFNDA 174
LL G KY+ + HRD+ +N L CK KI DFG+AR
Sbjct: 116 KDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLT--CKGPGRVAKIADFGMAR------ 167
Query: 175 PSAIFWTDY--------VATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKP 223
I+ Y + +W PE L G F SK D+WS G + E+ + G
Sbjct: 168 --DIYRASYYRKGGRAMLPIKWM-PPEAFLDGIFTSK----TDVWSFGVLLWEIFSLGYM 220
Query: 224 LFPGKNVVHQLDLMT 238
+PG+ ++ +T
Sbjct: 221 PYPGRTNQEVMEFVT 235
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 20/210 (9%)
Query: 22 QEVIGKGSYG-VVGSAVDTHTG-ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79
QE IG G +G V+ S + T TG RV +K++ + L++ R+L+HP+I+
Sbjct: 1 QE-IGNGWFGKVLLSEIYTDTGVARVVVKELK-ANASSKEQNEFLQQGDPYRILQHPNIL 58
Query: 80 EIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLY----QLLRGLK 134
+ + E +VFE E DL + L ++ G+
Sbjct: 59 QCLGQCV-----EAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVT 113
Query: 135 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 194
++H N H DL +N +D +K+ D+G+ + + V RW APEL
Sbjct: 114 HMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-APEL 172
Query: 195 CGSFF-----SKYTPAIDIWSIGCIFAEML 219
G F ++ T ++W++G E+
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 19/42 (45%), Positives = 29/42 (69%)
Query: 126 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 167
+ Q+L GL+ +H + HRD+KP+N+L D ++KI DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 30/221 (13%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERV--AIKKINDVFEHVSDATRILREIKLL-RLLRHPDIV 79
+VIG+G++G V A G R+ AIK++ + + D E+++L +L HP+I+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 80 EIKHIMLPPSRREFKDIYVVFELMESDL-----HQVIKANDDLTPEH---YQFFLYQLLR 131
+++ R + + + + + L +V++ + + QLL
Sbjct: 60 ---NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 132 -------GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 184
G+ Y+ HRDL +NIL + KI DFGL+R + +
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM---GRL 173
Query: 185 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEM--LTGKP 223
RW L +S YT D+WS G + E+ L G P
Sbjct: 174 PVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 17/155 (10%)
Query: 25 IGKGSYGVVGSAVDTHTGERVAIK------KINDVFEHVSDATRILREIKLLRLLRHPDI 78
I +G++G V + + A+K IN H A R L L + P I
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAER-----DALALSKSPFI 66
Query: 79 VEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
V + + S + ++Y+V E L+ D+ ++ E ++ ++ L Y+H
Sbjct: 67 VHLYY-----SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172
+ HRDLKP N+L + + +K+ DFGL++V+ N
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 30/101 (29%), Positives = 45/101 (44%), Gaps = 16/101 (15%)
Query: 128 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG----LARVSFNDAPSAIFWTDY 183
+++ L +H + RDL P NIL + +++ F + +A
Sbjct: 93 EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVE------- 145
Query: 184 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL 224
Y APE+ G S+ T A D WS+G I E+LTGK L
Sbjct: 146 ---NMYCAPEVGG--ISEETEACDWWSLGAILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 74/326 (22%), Positives = 132/326 (40%), Gaps = 50/326 (15%)
Query: 20 QIQEVIGKG--SYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILR-EIKLLRLLRHP 76
++Q IG+G + V A T TG V ++ I D+ + + L+ E+ L RHP
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVR-ITDLENCTEEHLKALQNEVVLSHFFRHP 59
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGL 133
+I+ + S ++V+ M + ++K + ++ L+ LRGL
Sbjct: 60 NIMTSWTVFTTGSW-----LWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGL 114
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY----VATRWY 189
Y+H HR++K +IL + D + + + A D+ + +
Sbjct: 115 NYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPW 174
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST--- 246
+PEL Y DI+S+G E+ TG+ P ++++ L+ L G P +
Sbjct: 175 LSPELLRQDLYGYNVKSDIYSVGITACELATGR--VPFQDMLRTQMLLQKLKGPPYSPLD 232
Query: 247 -----ESISRIRNEKA---------------RRYLGSMRKKQPVP--FSHKFPNADPLAL 284
SR++N ++ + + S R + P FS F N
Sbjct: 233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQN------ 286
Query: 285 HLLERLLAFDPKDRPTAEEALADPYF 310
L+E L DP+ RP+A L+ +F
Sbjct: 287 -LVELCLQQDPEKRPSASSLLSHAFF 311
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 58/224 (25%), Positives = 82/224 (36%), Gaps = 60/224 (26%)
Query: 123 QFFLYQLLRGLKYIHTANVFHRDLKPKNIL-ANADCKLKICDFGLA---RVSFNDAPSAI 178
Q + Q+L L +H+ + HRD+KP+NI+ + KI D G A RV N P
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPK-- 315
Query: 179 FWTDYVATRWYRAPELCGSFFSKYTPA----------------------IDIWSIGCIFA 216
+++ Y APE S TP+ DI+S G IF
Sbjct: 316 ---EFLLDPRYAAPE--QYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370
Query: 217 EMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY-LGSMRKKQPVPFSHK 275
+M FP L +D + I R K Y L + RK S
Sbjct: 371 QM-----AFPN--------LRSD------SNLIQFNRQLKRNDYDLVAWRKLVEPRASPD 411
Query: 276 FPNA-------DPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312
LL+ ++ F + R +A+ ALA PYF
Sbjct: 412 LRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDR 455
|
Length = 566 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 48/214 (22%), Positives = 87/214 (40%), Gaps = 21/214 (9%)
Query: 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGER---VAIKKINDVFEHVSDATR--ILREIKL 69
+ +I+ ++G G +G + +R VAI + SD R L E
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRA---GCSDKQRRGFLAEALT 59
Query: 70 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKAND-DLTPEHYQFFLY 127
L H +IV ++ ++ + + +V E M + L ++ ++ L L
Sbjct: 60 LGQFDHSNIVRLEGVITRGN-----TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLP 114
Query: 128 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT-DYVAT 186
L G+KY+ H+ L +L N+D KI F + D AI+ T +
Sbjct: 115 GLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ---EDKSEAIYTTMSGKSP 171
Query: 187 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 220
+ APE + ++ A D+WS G + E+++
Sbjct: 172 VLWAAPEAIQ--YHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 28/205 (13%)
Query: 22 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 81
+ VI +G G G + +K+INDV + EI + L+HP+IV++
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDV------NSIPSSEIADMGKLQHPNIVKL 748
Query: 82 KHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH--- 137
+ R K Y++ E +E +L +V++ +L+ E + + + L+++H
Sbjct: 749 IGLC-----RSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRC 800
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 197
+ V +L P+ I+ + + + L + D I + Y APE +
Sbjct: 801 SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFI-------SSAYVAPETRET 852
Query: 198 FFSKYTPAIDIWSIGCIFAEMLTGK 222
T DI+ G I E+LTGK
Sbjct: 853 --KDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 508 | |||
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.67 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.57 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.49 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.44 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.42 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.26 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.17 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.13 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.07 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.0 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.97 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.95 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.77 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.77 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.75 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.64 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.56 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.41 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.41 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.39 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.36 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.26 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.24 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.23 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.05 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.0 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 98.0 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.99 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.88 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.83 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.7 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.66 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.58 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.53 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.53 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.5 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.48 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.42 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.34 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.32 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.26 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.14 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.89 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.89 | |
| PLN02236 | 344 | choline kinase | 96.64 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.62 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.56 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.51 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.23 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.2 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.13 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.55 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.12 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.09 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.03 | |
| PTZ00296 | 442 | choline kinase; Provisional | 93.42 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 93.41 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 92.75 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 92.48 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 92.21 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 92.15 |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-78 Score=591.15 Aligned_cols=341 Identities=60% Similarity=0.986 Sum_probs=322.6
Q ss_pred cccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 11 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 11 ~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
+.|....+|..++.||+|+||+|++|.++.||+.||||||.+.+.+...+++.+||+++|+.++|+||+.+++++.++..
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 34667788888999999999999999999999999999999999999999999999999999999999999999999887
Q ss_pred CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 91 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 91 ~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
+.++++|+|+|+|+.||.++|+.+..|+++++++|++|||+||+|+|+.||+||||||.|+|+|.+|.+||||||+|+..
T Consensus 96 ~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 96 DKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred cccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence 88999999999999999999999988999999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
... .....+|.|+.|+||+|||++... ..|+.++||||+||||+|||+|++.|+|++..+|+.+|..++|+|+.+.+.
T Consensus 176 ~~~-~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 176 DKF-FEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred ccc-CcccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 655 556678999999999999999874 899999999999999999999999999999999999999999999999999
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccchhh
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEF 330 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~~~ 330 (508)
.+.+++++.|+.+++..++.+|...|+++++.+++||++||.+||.+|+|++|+|+||||..++++++||.+++....
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~-- 331 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDS-- 331 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999988776543
Q ss_pred HHHHhhcCHHHHHHHHHHHHHHhChhh
Q 010512 331 EFERRKLAKDDVREMIYREILEYHPQM 357 (508)
Q Consensus 331 ~~~~~~~~~~~~~~~i~~ei~~~~~~~ 357 (508)
++.. ++.+++++++|+|++.++|+.
T Consensus 332 -~~~~-~~~~~~r~~i~~e~~~~~~~~ 356 (359)
T KOG0660|consen 332 -FEHE-LTEEELRELIYKEILDFHPDV 356 (359)
T ss_pred -cccc-ccHHHHHHHHHHHHHhhCccc
Confidence 4445 889999999999999999864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-65 Score=486.26 Aligned_cols=289 Identities=36% Similarity=0.666 Sum_probs=255.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|+.+..+|+|+||+||+|+++.||+.||||++.....+....+-.+|||++|++|+|||+|.++++| +....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence 579999999999999999999999999999999987666666677789999999999999999999999 555679
Q ss_pred EEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 97 YVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 97 ylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
++|||||+.++.+.+... ..++++.++.+++|++.|+.|||+++++||||||+||||+.+|.+||||||+|+....
T Consensus 77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--- 153 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--- 153 (396)
T ss_pred EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC---
Confidence 999999998888777765 4699999999999999999999999999999999999999999999999999998653
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
....+|+|+.|+||+|||++.+. ..|+..+||||+||+++||++|.++|||+++.+|+..|...+|...+...+-+...
T Consensus 154 pgd~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred CcchhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 22347999999999999999874 79999999999999999999999999999999999999999999888776655433
Q ss_pred HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
..-.-+.......+.++...+++++..++||+++||..||.+|++.+|+|.||||.++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~ 291 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI 291 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence 32222222334456677888999999999999999999999999999999999997653
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-63 Score=497.63 Aligned_cols=289 Identities=39% Similarity=0.677 Sum_probs=258.4
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~ 92 (508)
...+||.+++.||.|+||.||+|+...+|+.||||++++.+....+... +||++.|++|. |||||+|++++.+..
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~--- 82 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDND--- 82 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccC---
Confidence 4557999999999999999999999999999999999988777666554 59999999999 999999999996433
Q ss_pred CccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 93 FKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
..+|+|||||+.+|+++++.+ ..|++..++.|++||++||+|+|.+|++||||||||||+..+..|||+|||+||...
T Consensus 83 -~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 83 -RILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred -ceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence 379999999999999999875 469999999999999999999999999999999999999999999999999999764
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
... .+|+||.|+||+|||++... ..|+.++||||+|||++|+.+-+|+|||.++.+|+.+|.+++|+|..+.|..
T Consensus 162 Skp----PYTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 162 SKP----PYTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred cCC----CcchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 433 47999999999999998863 7899999999999999999999999999999999999999999999988766
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
. ..-+...-..++...+.++...++++++++.+||.+||.+||.+||||+|+|+||||+.-
T Consensus 237 g-~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 237 G-YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred H-HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 3 122333333566677888889999999999999999999999999999999999999843
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-62 Score=507.83 Aligned_cols=413 Identities=25% Similarity=0.370 Sum_probs=329.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
.+-|++++.||+|+.|.|.+|+|..||+.+|||+|.+. .........+.+||-||+.|.||||+.+++++ ++..
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCc
Confidence 45699999999999999999999999999999999876 33445567899999999999999999999999 5567
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
++|+|.||++ |.|++++..+++|++.++.+||+||+.|+.|||..+||||||||+|+|++.++++||+|||+|....++
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 8999999998 799999999999999999999999999999999999999999999999999999999999999875433
Q ss_pred CCCcccccccccCcccccccccccccCCCC-cchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~-~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
. .+.+.||+|+|+|||++.| .+|+ .++||||+|||||.||+|+.||.++|....+.++....-
T Consensus 166 k----lLeTSCGSPHYA~PEIV~G--~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f---------- 229 (786)
T KOG0588|consen 166 K----LLETSCGSPHYAAPEIVSG--RPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF---------- 229 (786)
T ss_pred c----cccccCCCcccCCchhhcC--CCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc----------
Confidence 3 3577899999999999998 5665 899999999999999999999998887666655543211
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCc--cchhh
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPI--SKLEF 330 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~--~~~~~ 330 (508)
+.-.++++++++||.+||.+||.+|+|.+||++|||+.+........+..+. ...-.
T Consensus 230 ---------------------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~~~~~~~i~s 288 (786)
T KOG0588|consen 230 ---------------------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKSLRPPVSVPILS 288 (786)
T ss_pred ---------------------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChhhhcCCCcccceee
Confidence 1114688999999999999999999999999999999987765443221111 11111
Q ss_pred HHHHhhcCHHHHHHHHHHHHHHhChhhHHHHhhcCC-ccccccCCcchhhHHHHHHhhhhcCCCCCCCCccccCCCCCCc
Q 010512 331 EFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGE-QTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRE 409 (508)
Q Consensus 331 ~~~~~~~~~~~~~~~i~~ei~~~~~~~~~~~~~~~~-~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 409 (508)
......++...++.|....+......+++.++..++ +++++|...++++++-..++.+....--+ .-.+.++.||+
T Consensus 289 ~ps~~~IDp~Il~~l~iLwc~~d~~kl~~kLls~~~n~EK~~Y~LLl~~k~r~~~~~~~~~~~kk~---~~~s~~~~p~k 365 (786)
T KOG0588|consen 289 IPSIQEIDPLILQHLCILWCGRDPEKLVEKLLSPDDNDEKTLYFLLLRRKRRDSSQLDDFDENKKD---LLGSAADPPRK 365 (786)
T ss_pred cCCcccCCHHHHhhhhheeecCChHHHHHHHcCCCcchhHHHHHHHHHhhccchhhhhhhhhhhhh---hhccccCCchh
Confidence 223456778888888888888888888888888877 77999999999987766666543222111 12377899999
Q ss_pred cCC---------CCCCCC-CCCCCCCCcchhhhhhcC-----CCCCCCCcccccccC--CCCCcccccccccccCcccce
Q 010512 410 RVP---------APKDEN-AGQNNDYGRTADSVAATL-----QSPPTENANTEEQNG--INRPNCSARSLLKSASISASK 472 (508)
Q Consensus 410 ~~~---------~~~~~~-~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 472 (508)
||+ ||+.++ +++.+.++.+++-.+..+ +..++.....+++++ ++++.+++++.++..++++..
T Consensus 366 ~~~~~~~~~~~~s~~s~r~~~~~~a~~~~~si~t~s~~~~~~St~~~~~~~~~~~~~qr~~rs~~s~rss~s~~p~s~~~ 445 (786)
T KOG0588|consen 366 RVDEEIESAINISPLSSRKLIKDNASSTSSSILTTSLVSSRVSTNSAFSSSFSAELAQRISRSPSSARSSNSQLPKSIPV 445 (786)
T ss_pred hhhhhhhhhcccCccccccccccccccccccccccCCccCCCCccccccCCccchhhhhhccccchhhcccccCcccCCc
Confidence 999 888887 577777777766333222 223334444555554 478888999998888887665
Q ss_pred e
Q 010512 473 C 473 (508)
Q Consensus 473 ~ 473 (508)
-
T Consensus 446 s 446 (786)
T KOG0588|consen 446 S 446 (786)
T ss_pred c
Confidence 3
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-62 Score=458.70 Aligned_cols=287 Identities=41% Similarity=0.701 Sum_probs=251.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
.+|..++.||+|.||+||+|+|..||+.||||+|+............+|||+.|+.++|+||+.++++|. ....+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~-----~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFP-----HKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhcc-----CCCce
Confidence 5899999999999999999999999999999999865444444567889999999999999999999994 34569
Q ss_pred EEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 97 YVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 97 ylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
.||+|||+.||..+|+.+. .+++.+++.|+.++++||+|||+++|+||||||.|+|++++|.+||+|||+|+.+.....
T Consensus 77 ~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9999999999999998754 699999999999999999999999999999999999999999999999999998754332
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
..+..+.|+||+|||++.|. ..|+..+||||+|||++||+.|.|.|+|+++.+|+..|...+|+|.++.|..+..-
T Consensus 157 ---~~~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 ---IQTHQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred ---ccccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 23455999999999999874 78999999999999999999999999999999999999999999999998876532
Q ss_pred HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
. .|.. +...+..+....|+.++.+++||+.+||.+||.+|+|+.|+|+|+||.....
T Consensus 233 p--dY~~-~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~ 289 (318)
T KOG0659|consen 233 P--DYVK-IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL 289 (318)
T ss_pred c--cHHH-HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence 2 1211 1123344455689999999999999999999999999999999999997543
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-59 Score=478.11 Aligned_cols=338 Identities=92% Similarity=1.454 Sum_probs=307.3
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
+|++.+.||+|+||.||+|++..+|..||||+++..........++.+|+.+|+.++||||+++++++..........+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 69999999999999999999999999999999976555555567789999999999999999999998766555566799
Q ss_pred EEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCc
Q 010512 98 VVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 177 (508)
Q Consensus 98 lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~ 177 (508)
+|||||+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 160 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998654433333
Q ss_pred ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHH
Q 010512 178 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 257 (508)
Q Consensus 178 ~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 257 (508)
..+...+||++|+|||++.+....++.++|||||||++|+|++|++||.+.+...++..+.+.+|.|....+..+.....
T Consensus 161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 240 (338)
T cd07859 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240 (338)
T ss_pred ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence 34566789999999999876435789999999999999999999999999999999999999999999999999888888
Q ss_pred HHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccchhhHHHHhhc
Q 010512 258 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKL 337 (508)
Q Consensus 258 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (508)
..++..+....+.++...++..++.+.+||.+||..||.+|||++|+|+||||+++......+..+++...++.++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (338)
T cd07859 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRL 320 (338)
T ss_pred HHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCccccccccHHHHhc
Confidence 88888888888888888888999999999999999999999999999999999999888888888999999999999999
Q ss_pred CHHHHHHHHHHHHHHhCh
Q 010512 338 AKDDVREMIYREILEYHP 355 (508)
Q Consensus 338 ~~~~~~~~i~~ei~~~~~ 355 (508)
..++++..+++++++|||
T Consensus 321 ~~~~~~~~~~~~~~~~~~ 338 (338)
T cd07859 321 TKEDVRELIYREILEYHP 338 (338)
T ss_pred CHHHHHHHHHHHHHhcCC
Confidence 999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-60 Score=483.06 Aligned_cols=290 Identities=38% Similarity=0.611 Sum_probs=251.8
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
.-...+.|+.+++||+|+||.||+|++..||+.||+|++..............|||+||++|.||||++|.+++...
T Consensus 112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~--- 188 (560)
T KOG0600|consen 112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK--- 188 (560)
T ss_pred cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---
Confidence 33556789999999999999999999999999999999976555556677788999999999999999999999764
Q ss_pred CCccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 92 EFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 92 ~~~~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
..+.+|||||||+.||.-++...+ .|++.+++.||+||+.||.|||++||+|||||.+|||||.+|.+||+|||||+++
T Consensus 189 ~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 189 LSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred CCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 346799999999999999998744 7999999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
..... ..+|..|.|+||+|||++.|. ..|+.++|+||+||||.||++|++.|+|.++.+|++.|.+++|.|....|.
T Consensus 269 ~~~~~--~~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 269 TPSGS--APYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred cCCCC--cccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence 54432 237889999999999999984 899999999999999999999999999999999999999999999999876
Q ss_pred HHhhHHHHHHHhhcccCC--CCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010512 251 RIRNEKARRYLGSMRKKQ--PVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~ 311 (508)
...-..+ ..+.... ...+.+.|...++.+++|+..||..||.+|.||.++|.|+||.
T Consensus 346 ~~kLP~~----~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 346 VSKLPHA----TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred cccCCcc----cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 3221111 1111111 2223455778899999999999999999999999999999994
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-60 Score=459.86 Aligned_cols=294 Identities=38% Similarity=0.610 Sum_probs=256.7
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
.....+.|+.+..|++|+||+||+|+|+.|++.||+|+++.........-..+|||.+|.+++|||||.+.++.....
T Consensus 71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~-- 148 (419)
T KOG0663|consen 71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN-- 148 (419)
T ss_pred CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc--
Confidence 344557899999999999999999999999999999999866555445556789999999999999999999996543
Q ss_pred CCccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 92 EFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 92 ~~~~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
...+|||||||+.||..++...+ ++.+.+++.++.|+|+||+|||.++|+||||||+|+|++..|.+||+|||+||.+
T Consensus 149 -~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 149 -MDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred -cceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhh
Confidence 46699999999999999998865 8999999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.... ..+|..+.|.||+|||++.+. ..|+.++|+||+|||++||++++|.|+|++..+|+++|.+++|+|+...|.
T Consensus 228 gsp~---k~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 228 GSPL---KPYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred cCCc---ccCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence 5432 247889999999999999884 789999999999999999999999999999999999999999999999988
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCC--CHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNA--DPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~--~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.+....+.+.+ .+...+...+...|+.. +....+|+..+|.+||.+|.||+|+|+|.||...
T Consensus 304 g~~~lp~~k~~-~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 304 GYSELPAVKKM-TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred Cccccchhhcc-ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 77654443321 22334445556666654 4899999999999999999999999999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-58 Score=458.79 Aligned_cols=263 Identities=35% Similarity=0.567 Sum_probs=221.3
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh-----hHHHHHHHHHHHHHhCCCCCcceeeeeecCCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-----SDATRILREIKLLRLLRHPDIVEIKHIMLPPS 89 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~-----~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 89 (508)
..+.|.+.+.||+|+||.|.+|.++.||+.||||+|++..... .....+.+|+++|++|+|||||+++++|.
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~--- 246 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE--- 246 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee---
Confidence 4577999999999999999999999999999999997643222 12344689999999999999999999994
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC---CcEEEcccc
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFG 165 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~---~~lkL~DFG 165 (508)
.....|||||||+ |+|++.+..++.+.++..+.+++||+.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus 247 --~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 247 --VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred --cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence 4455799999998 6999999999999999999999999999999999999999999999999877 889999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccccCC-CCcchhhhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhcCC
Q 010512 166 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH-QLDLMTDLLGT 243 (508)
Q Consensus 166 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~-y~~~~DIWSlG~il~eLltG~~pF~~~~~~~-~l~~i~~~~g~ 243 (508)
+|++.. ...++.+.||||.|.|||++.+.... |..++||||+|||+|.+|+|.+||.+..... ..++|..
T Consensus 325 lAK~~g----~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~---- 396 (475)
T KOG0615|consen 325 LAKVSG----EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK---- 396 (475)
T ss_pred hhhccc----cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc----
Confidence 999764 23356789999999999999764333 3458999999999999999999998765322 2222321
Q ss_pred CChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 244 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 244 p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
......+..|..++.++++||.+||..||++|||++|+|+||||+..
T Consensus 397 -----------------------G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 397 -----------------------GRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred -----------------------CcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 11122234566788999999999999999999999999999999853
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-57 Score=446.52 Aligned_cols=286 Identities=39% Similarity=0.674 Sum_probs=248.6
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
.|+-.+++|+|+||+||.|....+++.||||++-.. .+.-.+|+++|+.+.|||||+++.+|......+.-++.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d------~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD------KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCC------CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 588899999999999999999999999999998421 11234799999999999999999998765433344677
Q ss_pred EEEecCCccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC-CcEEEccccccccccC
Q 010512 98 VVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVSFN 172 (508)
Q Consensus 98 lV~E~~~g~L~~~i~~----~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~-~~lkL~DFGla~~~~~ 172 (508)
+|||||+.+|.++++. +..++.-+++.+.+||++||+|||+.|||||||||+|||+|.+ |.+||||||.|+....
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 8999999999999974 5679999999999999999999999999999999999999987 9999999999998766
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
..++ ..|..|+.|+|||++.+. ..|+.++||||.|||++||+.|++.|+|++..+|+..|.+++|+|+.+.+..+
T Consensus 179 ~epn----iSYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 179 GEPN----ISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred CCCc----eeEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 5554 568899999999999884 88999999999999999999999999999999999999999999999999887
Q ss_pred hhHHHHHHHhhcccCCCCCCCC-CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSH-KFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 317 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~ 317 (508)
..... ....+.-.+.+|.. .+...++++.+|+.++|+++|.+|.++-|+|.||||..+.+++
T Consensus 254 n~~y~---~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~ 316 (364)
T KOG0658|consen 254 NPNYT---EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN 316 (364)
T ss_pred Ccccc---cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence 65432 12233344555555 5678899999999999999999999999999999999888764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-55 Score=456.65 Aligned_cols=263 Identities=32% Similarity=0.553 Sum_probs=231.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.+|+..+.||+|||+.||.+++..+|+.||+|+|.+. ........++.+||+|.+.|+|||||+++++| ++..+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence 7899999999999999999999999999999999753 34455677899999999999999999999999 67788
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|||+|+|. ++|..++++...++|.++++|++||+.||.|||+.+|+|||||..||+++++.+|||+|||||.....+.
T Consensus 93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999999 7999999999999999999999999999999999999999999999999999999999999999875443
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
.. -.+.||||.|.|||++.. ..++..+||||+|||||.||.|+|||..++..+.+..|..---.
T Consensus 173 Er---k~TlCGTPNYIAPEVl~k--~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~----------- 236 (592)
T KOG0575|consen 173 ER---KKTLCGTPNYIAPEVLNK--SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS----------- 236 (592)
T ss_pred cc---cceecCCCcccChhHhcc--CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc-----------
Confidence 32 246899999999999987 78999999999999999999999999998888777776531100
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCC
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREP 320 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~ 320 (508)
.-..++..|.+||.+||+.||.+|||++++|.|+||....-+...|
T Consensus 237 --------------------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp 282 (592)
T KOG0575|consen 237 --------------------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLP 282 (592)
T ss_pred --------------------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCC
Confidence 0125788999999999999999999999999999996544444433
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-56 Score=435.33 Aligned_cols=294 Identities=39% Similarity=0.681 Sum_probs=251.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC-cceeeeeecCCC-cCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD-IVEIKHIMLPPS-RREF 93 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~Hpn-Iv~l~~v~~~~~-~~~~ 93 (508)
...|+.++.||+|+||+||+|+++.+|+.||+|++.-............||+.+|+.|+|+| |+.+++++.... .+..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45688888999999999999999999999999999765444334556789999999999999 999999997643 2334
Q ss_pred ccEEEEEecCCccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 94 KDIYVVFELMESDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 94 ~~lylV~E~~~g~L~~~i~~~~----~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
+.+|+||||++.+|..++.... .++...++.|++||++||+|||++||+||||||+||||+.+|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 5799999999999999998755 588889999999999999999999999999999999999999999999999996
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
..-.. ..++..++|.||+|||++.+. ..|+..+||||+|||++||+++++.|+|.++.+|+..|..++|+|+.+.|
T Consensus 170 ~~ip~---~~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 170 FSIPM---RTYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hcCCc---ccccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 53222 236778999999999999884 57999999999999999999999999999999999999999999999988
Q ss_pred HHHhhHHHHHHHhhcccCC-CCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 250 SRIRNEKARRYLGSMRKKQ-PVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
.....- ..+-...+... +.++....++.++.+.+|+.+||+.||.+|.|+..+|.||||..+..
T Consensus 246 p~v~~~--~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 246 PGVSSL--PDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred CCcccc--ccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 765421 11111333333 66667777888899999999999999999999999999999987643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-54 Score=425.15 Aligned_cols=260 Identities=27% Similarity=0.478 Sum_probs=221.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++.+.++.||+|+.|+||+|+|+.|++.+|+|+|. ........+++.+|+++++.++||+||+++++|.... ..+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~----~~i 153 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG----EEI 153 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC----ceE
Confidence 36788899999999999999999999999999994 3344567788999999999999999999999996532 159
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-cCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 97 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs-~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+||||+ |+|.++++..++++|.....+++++++||.|||. .+||||||||+|||+|.+|.|||||||.+....+.
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999 7999999988999999999999999999999995 99999999999999999999999999999876543
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCC--ChHHHHHHHHhhcCCCChHHHHHH
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK--NVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~--~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
...+++||..|||||.+.+ ..|+.++||||||+.++||++|+.||+.. .....+.++..+
T Consensus 233 ----~a~tfvGT~~YMsPERi~g--~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I------------ 294 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISG--ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI------------ 294 (364)
T ss_pred ----hcccccccccccChhhhcC--CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH------------
Confidence 3577899999999999998 79999999999999999999999999874 112222222111
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
...+|..+... .+++++.+||..||++||.+|||+.|+|+|||++...
T Consensus 295 ------------v~~ppP~lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 295 ------------VDEPPPRLPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred ------------hcCCCCCCCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 11122222111 4789999999999999999999999999999998654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-53 Score=418.71 Aligned_cols=262 Identities=29% Similarity=0.498 Sum_probs=228.7
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
..-.++|+++++||+|+||+||.++.+.|++.||+|++++.. ....+...+.+|..||..++||+||+++-.| +
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Q 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----Q 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----c
Confidence 345688999999999999999999999999999999998653 2334677889999999999999999999988 5
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
+..++|+|+||+. |+|+..|++++.++++.+++|+..|+.||.|||++||+||||||+|||+|.+|.++|+|||+|+..
T Consensus 96 t~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 96 TEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred cCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 5567999999998 599999999999999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
...... ..+.|||+.|||||++.+ ..|+.++|.||||+++|+|++|.+||.+.+.....+.|...-
T Consensus 176 ~~~~~~---t~tfcGT~eYmAPEil~~--~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k--------- 241 (357)
T KOG0598|consen 176 LKDGDA---TRTFCGTPEYMAPEILLG--KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK--------- 241 (357)
T ss_pred ccCCCc---cccccCCccccChHHHhc--CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc---------
Confidence 433222 245799999999999998 799999999999999999999999999999777666664311
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCC-CCHHHHHHHHHhccCCCCCCC----CHHHHhcCCcccCCCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPN-ADPLALHLLERLLAFDPKDRP----TAEEALADPYFHGLAN 315 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~~Ll~~mL~~DP~~Rp----ta~eiL~hp~f~~~~~ 315 (508)
....+. .+..+++||+++|+.||.+|. .++++-+||||.++..
T Consensus 242 ----------------------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 242 ----------------------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred ----------------------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 011233 678999999999999999995 7999999999997654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-53 Score=431.12 Aligned_cols=264 Identities=31% Similarity=0.539 Sum_probs=228.1
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~ 92 (508)
...+|.+++.||+|+|++|++|+++.+++.||||++.+..- .....+.+.+|-.+|.+| .||.|++|+-.| .+
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----QD 145 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----QD 145 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----ec
Confidence 35789999999999999999999999999999999875432 222345577899999999 799999999999 45
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
...+|+|+||++ |+|.++|.+.+.|++..+++|+.||+.||+|||++|||||||||+|||+|.||++||+|||.|..+.
T Consensus 146 ~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 146 EESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred ccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 567999999998 8999999999999999999999999999999999999999999999999999999999999999864
Q ss_pred CCCCC----------cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Q 010512 172 NDAPS----------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 241 (508)
Q Consensus 172 ~~~~~----------~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~ 241 (508)
..... ......+|||..|.+||+|.. ...++.+|||+||||+|+|+.|.|||.+.|+...+..|.++-
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~ 303 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND--SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD 303 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcC--CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence 32211 111255899999999999987 678899999999999999999999999999888877776532
Q ss_pred CCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCC
Q 010512 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 316 (508)
Q Consensus 242 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~ 316 (508)
..|. ++.++.+.|||+++|..||.+|+|+++|-+||||.++...
T Consensus 304 ----------------------------y~fp---~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 304 ----------------------------YEFP---EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred ----------------------------ccCC---CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence 1122 3456899999999999999999999999999999987643
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-52 Score=436.38 Aligned_cols=286 Identities=35% Similarity=0.615 Sum_probs=239.9
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-C-----CCcceeeeeecC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-H-----PDIVEIKHIMLP 87 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-H-----pnIv~l~~v~~~ 87 (508)
.++.||+|+++||+|+||.|.+|.|..|++.||||+|++. .....+...||.+|..|+ | -|+|+++++|..
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 3456999999999999999999999999999999999853 445667788999999997 4 479999999955
Q ss_pred CCcCCCccEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC--CcEEEcc
Q 010512 88 PSRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--CKLKICD 163 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~--~~lkL~D 163 (508)
. +++|||+|+++-+|+++|+.+. +|+...++.|+.|||.||.+||..||||+||||||||+..- ..|||+|
T Consensus 260 r-----~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVID 334 (586)
T KOG0667|consen 260 R-----NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVID 334 (586)
T ss_pred c-----cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEe
Confidence 4 5699999999999999999875 68999999999999999999999999999999999999864 5699999
Q ss_pred ccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC
Q 010512 164 FGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 243 (508)
Q Consensus 164 FGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~ 243 (508)
||.++..... ...|+-++.|+|||++.| .+|+.++||||||||++||++|.|+|+|+++.+|+..|.+++|.
T Consensus 335 FGSSc~~~q~------vytYiQSRfYRAPEVILG--lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~ 406 (586)
T KOG0667|consen 335 FGSSCFESQR------VYTYIQSRFYRAPEVILG--LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGL 406 (586)
T ss_pred cccccccCCc------ceeeeeccccccchhhcc--CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCC
Confidence 9999864221 237899999999999999 79999999999999999999999999999999999999999999
Q ss_pred CChHHHHHHhhHHHHHHHhh----------------------------cccC--C---CCCCCCCCC-CCCHHHHHHHHH
Q 010512 244 PSTESISRIRNEKARRYLGS----------------------------MRKK--Q---PVPFSHKFP-NADPLALHLLER 289 (508)
Q Consensus 244 p~~~~~~~~~~~~~~~~l~~----------------------------~~~~--~---~~~~~~~~~-~~~~~~~~Ll~~ 289 (508)
|+...+...... ..|+.. .... . ...+..... .....+.|||++
T Consensus 407 Pp~~mL~~~~~~--~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~ 484 (586)
T KOG0667|consen 407 PPPKMLDTAKKA--HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR 484 (586)
T ss_pred CCHHHHHhcccc--ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH
Confidence 999988765421 222222 0111 1 112222333 234557999999
Q ss_pred hccCCCCCCCCHHHHhcCCcccCCCCCC
Q 010512 290 LLAFDPKDRPTAEEALADPYFHGLANVD 317 (508)
Q Consensus 290 mL~~DP~~Rpta~eiL~hp~f~~~~~~~ 317 (508)
||.+||.+|+|+.++|+||||.+.....
T Consensus 485 ~L~~dP~~R~tp~qal~Hpfl~~~~~~~ 512 (586)
T KOG0667|consen 485 CLEWDPAERITPAQALNHPFLTGTSLER 512 (586)
T ss_pred HhccCchhcCCHHHHhcCcccccccccc
Confidence 9999999999999999999999766543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-52 Score=413.29 Aligned_cols=259 Identities=33% Similarity=0.481 Sum_probs=222.2
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|.+.+.||+|+||+||+|+++.++..||||.|.+........+.+..||++|+.|+|||||.++++... .+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-----~~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED-----DD 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec-----CC
Confidence 4578999999999999999999999999999999998765566667778999999999999999999999944 45
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC------CcEEEcccccc
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD------CKLKICDFGLA 167 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~------~~lkL~DFGla 167 (508)
++|+|||||. |||.++|++.+.+++..++.|+.||+.||++||+++||||||||+|||+..+ -.+||+|||+|
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 7999999999 7999999999999999999999999999999999999999999999999875 45899999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChH
Q 010512 168 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 168 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
+..... ....+.||++.|||||++.. ..|+.|+|+||+|+|+|+|++|++||...+..+.+..+.+.-..
T Consensus 163 R~L~~~----~~a~tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~---- 232 (429)
T KOG0595|consen 163 RFLQPG----SMAETLCGSPLYMAPEVIMS--QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI---- 232 (429)
T ss_pred hhCCch----hHHHHhhCCccccCHHHHHh--ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc----
Confidence 986532 23567899999999999976 79999999999999999999999999988876665544321100
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
.+. .-...+....+|+...|+.+|.+|.+..+-+.|+++..
T Consensus 233 --------------------~~~----~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 233 --------------------VPV----LPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred --------------------cCc----hhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 000 00123455679999999999999999999999999864
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-51 Score=418.37 Aligned_cols=337 Identities=55% Similarity=0.989 Sum_probs=290.2
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
|....+|.+.+.||+|+||+||+|.+..+|..||||++............+.+|+.+|+.++||||+++++++.......
T Consensus 1 ~~~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 1 FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80 (337)
T ss_pred CccccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence 34678999999999999999999999999999999999765444445667889999999999999999999887654445
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 93 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
...+|+||||+.++|.+++...+.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 81 FNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred cCcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 56799999999999999998888899999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
.. .....+.++.+|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+....+..+...+|.+..+.+..+
T Consensus 161 ~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 161 KG---DFMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred Cc---ccccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 21 223456789999999988652 45889999999999999999999999999988888899999999988888777
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccchhhHH
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEF 332 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 332 (508)
.......++..........+...++++++.+.+||.+||+.||.+|||++++|+||||..+......+..+. .+.+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~~--~~~~~~ 314 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQT--PFSFDF 314 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCCC--ccchhh
Confidence 777777777666655555555566788999999999999999999999999999999999887776666544 457778
Q ss_pred HHhhcCHHHHHHHHHHHHHHhCh
Q 010512 333 ERRKLAKDDVREMIYREILEYHP 355 (508)
Q Consensus 333 ~~~~~~~~~~~~~i~~ei~~~~~ 355 (508)
+...+..+++++.++.|.+.|||
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~ 337 (337)
T cd07858 315 EEDALTEEDIKELIYNEMLAYHP 337 (337)
T ss_pred hhhhcCHHHHHHHHHHHHhhcCC
Confidence 88889999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-51 Score=418.06 Aligned_cols=331 Identities=41% Similarity=0.792 Sum_probs=273.3
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc-
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR- 90 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~- 90 (508)
.+...++|++++.||+|+||+||+|.+..++..||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 4567899999999999999999999999999999999997654444455678899999999999999999998864322
Q ss_pred CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 91 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 91 ~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
.....+|+++++++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~~~~~~~~~~~~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 90 ENFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cccCcEEEEeecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 33456899999999999887754 56999999999999999999999999999999999999999999999999999864
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
... .+.++||++|+|||++.+. ..++.++|||||||++|+|++|+.||++.+..+.+..+....+.+..+.+.
T Consensus 169 ~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 169 DDE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred CCC------cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 321 2456899999999998762 568899999999999999999999999999989999999999999988888
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccchhh
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEF 330 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~~~ 330 (508)
.+.......++..++......+...+...++.+.+||.+||..||.+|||+.|+|+||||.....+...+...+ ...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~---~~~ 318 (343)
T cd07878 242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEP---YDE 318 (343)
T ss_pred hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCccccccCc---ccc
Confidence 88777777777766655555566666778899999999999999999999999999999998766554433322 222
Q ss_pred HHHHhhcCHHHHHHHHHHHHHHh
Q 010512 331 EFERRKLAKDDVREMIYREILEY 353 (508)
Q Consensus 331 ~~~~~~~~~~~~~~~i~~ei~~~ 353 (508)
.........+++++..+.+....
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~ 341 (343)
T cd07878 319 SPENKERTIEEWKELTYEEVSSF 341 (343)
T ss_pred chhhhhccHHHHHHHHHHHHHhc
Confidence 22334455577777766665443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=403.11 Aligned_cols=334 Identities=36% Similarity=0.687 Sum_probs=287.2
Q ss_pred cccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 11 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 11 ~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
+-|.+..||.-+..+|.|.- .|..|.|..+++.||||++...+.+....++..+|..++..++|+||++++.+|++...
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT 89 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence 34567889999999999999 99999999999999999998777777778899999999999999999999999987632
Q ss_pred -CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 91 -REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 91 -~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
.++.++|+|||+|..+|.+++.. .++.+.+.++++|++.|++|||++||+||||||+||+++.+|.+||+|||+|+.
T Consensus 90 l~~~~e~y~v~e~m~~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 90 LEEFQEVYLVMELMDANLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHhHHHHHHhhhhHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence 45678999999999999999983 488899999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
...+ ...++|+.|+.|+|||++.+ ..|...+||||+|||+.||++|...|+|++..+|..+|.+.+|+|.....
T Consensus 168 e~~~----~~mtpyVvtRyyrapevil~--~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 168 EDTD----FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred cCcc----cccCchhheeeccCchheec--cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 3222 45789999999999999998 45999999999999999999999999999999999999999999999998
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCC------------CCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPN------------ADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 317 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------------~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~ 317 (508)
..+. +.++.|+...++.+...++..||+ -...+.+|+.+||..||++|.+++++|+||||+-|.. +
T Consensus 242 ~qL~-~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~-~ 319 (369)
T KOG0665|consen 242 KQLQ-PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYD-P 319 (369)
T ss_pred HHhh-HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecc-c
Confidence 8875 456677776666666666666553 2346889999999999999999999999999995543 3
Q ss_pred CCCCCCCccchhhHHHHhhcCHHHHHHHHHHHHHHhCh
Q 010512 318 REPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 355 (508)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ei~~~~~ 355 (508)
.++..++.......++.+..+.++|+++|++|+.++.+
T Consensus 320 ~ev~ap~pe~~d~~~d~~~~t~~e~ke~If~ev~~f~~ 357 (369)
T KOG0665|consen 320 DEVEAPPPEIYDKQLDEREHTIEEWKELIFKEVQRFEE 357 (369)
T ss_pred ccccCCCCchhhhhcccccCCHHHHHHHHHHHHHhhcc
Confidence 33333333344455666777799999999999998876
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-54 Score=399.50 Aligned_cols=262 Identities=31% Similarity=0.496 Sum_probs=229.2
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
....+.|++.++||+|.|++|++|.+..||+.+|+|+|+-......+.+.+.+|+.|-+.|+||||+++.+.+ ..
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~ 81 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QE 81 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cc
Confidence 3445789999999999999999999999999999999986555556788999999999999999999999987 55
Q ss_pred CccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC---CcEEEccccccc
Q 010512 93 FKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLAR 168 (508)
Q Consensus 93 ~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~---~~lkL~DFGla~ 168 (508)
.+..|||||+|+| +|+.-|.+..-+++..+-.+++|||+||.|||.+||+|||+||+|+|+-+. .-+||||||+|.
T Consensus 82 ~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 82 ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred cceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEE
Confidence 5678999999995 898888777778999999999999999999999999999999999998654 349999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
... ....+...+|||.|||||++.. .+|+..+|||+.|+|||-||.|.+||.+++..+..+.|...
T Consensus 162 ~l~----~g~~~~G~~GtP~fmaPEvvrk--dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g-------- 227 (355)
T KOG0033|consen 162 EVN----DGEAWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG-------- 227 (355)
T ss_pred EeC----CccccccccCCCcccCHHHhhc--CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc--------
Confidence 764 2335788999999999999988 79999999999999999999999999998876666665431
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
.....+..|+++++.+++|+++||..||.+|+|+.|+|+|||+.+
T Consensus 228 -------------------~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 228 -------------------AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred -------------------ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 112223468899999999999999999999999999999999975
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-53 Score=404.51 Aligned_cols=291 Identities=40% Similarity=0.651 Sum_probs=240.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCc----EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGE----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~----~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
..|++++.||+|.||.||+|....++. .||||+|+.............||+.+++.|+||||+.+..+++..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~---- 99 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH---- 99 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence 469999999999999999997665543 799999986544444556678999999999999999999999864
Q ss_pred CccEEEEEecCCccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC----CcEEEcc
Q 010512 93 FKDIYVVFELMESDLHQVIKAN-----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD----CKLKICD 163 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~~-----~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~----~~lkL~D 163 (508)
...+++++||.+.||.++|+-. ..++...++.|++||+.|+.|||++.|+||||||.|||+..+ |.|||+|
T Consensus 100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 3679999999999999999643 358999999999999999999999999999999999999988 8999999
Q ss_pred ccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCC---------hHHHH
Q 010512 164 FGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN---------VVHQL 234 (508)
Q Consensus 164 FGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~---------~~~~l 234 (508)
||+||.+.+....-......+.|.||+|||++.|. ..|++++||||+|||++|||+-.|.|.++. ..+|+
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99999876544333334567899999999999884 789999999999999999999999997753 36789
Q ss_pred HHHHhhcCCCChHHHHHHhhHHH-HHHHhhcccCCCCC-----CCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 010512 235 DLMTDLLGTPSTESISRIRNEKA-RRYLGSMRKKQPVP-----FSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308 (508)
Q Consensus 235 ~~i~~~~g~p~~~~~~~~~~~~~-~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp 308 (508)
..|..++|+|..+.|..+.+... ...+..++...... +.+....-++.+.+||.+||++||.+|+|++++|+|+
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 99999999999999887654222 23344444322222 1223344566799999999999999999999999999
Q ss_pred cccC
Q 010512 309 YFHG 312 (508)
Q Consensus 309 ~f~~ 312 (508)
||..
T Consensus 339 yF~~ 342 (438)
T KOG0666|consen 339 YFTE 342 (438)
T ss_pred cccc
Confidence 9985
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-51 Score=422.55 Aligned_cols=259 Identities=32% Similarity=0.539 Sum_probs=221.5
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC---hhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH---VSDATRILREIKLLRLLR-HPDIVEIKHIMLPPS 89 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~---~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~ 89 (508)
...++|++.+.||+|+||+|+.|.+..+|..||||++++.... ......+.+|+.+|+.++ ||||+++++++...
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~- 92 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP- 92 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-
Confidence 4567999999999999999999999999999999988764111 134556779999999999 99999999999554
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC-CcEEEcccccc
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLA 167 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~-~~lkL~DFGla 167 (508)
.++|+|||||. |+|++++...+++.+.+++.+|+||+.||+|||+.||+||||||+|||++.+ +++||+|||++
T Consensus 93 ----~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 93 ----TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred ----CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 44999999999 5999999999999999999999999999999999999999999999999999 99999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCC-CC-cchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC
Q 010512 168 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK-YT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245 (508)
Q Consensus 168 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~-y~-~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~ 245 (508)
.... .......+.+||+.|+|||++.+ .. |+ .++||||+|+|||.|++|+.||...+.......|..
T Consensus 169 ~~~~---~~~~~l~t~cGsp~Y~aPEvl~~--~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~------ 237 (370)
T KOG0583|consen 169 AISP---GEDGLLKTFCGSPAYAAPEVLSG--KGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK------ 237 (370)
T ss_pred cccC---CCCCcccCCCCCcccCCHHHhCC--CCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc------
Confidence 8763 12234678899999999999988 34 75 889999999999999999999998776655554422
Q ss_pred hHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 246 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
....+...+. ++.+.+||.+||..||.+|+|+.+++.||||+.
T Consensus 238 ----------------------~~~~~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 238 ----------------------GEFKIPSYLL--SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ----------------------CCccCCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 1111111111 899999999999999999999999999999985
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-50 Score=414.96 Aligned_cols=292 Identities=45% Similarity=0.770 Sum_probs=243.7
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
+|++++.||+|+||+||+|.+..+|+.||||++..........+++.+|+.+|+.++||||+++++++..........+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47899999999999999999999999999999976555555667889999999999999999999998765433445799
Q ss_pred EEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCc
Q 010512 98 VVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 177 (508)
Q Consensus 98 lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~ 177 (508)
+||||+.++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~--~ 158 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE--S 158 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc--c
Confidence 99999999999999888889999999999999999999999999999999999999999999999999998643222 1
Q ss_pred ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHH
Q 010512 178 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 257 (508)
Q Consensus 178 ~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 257 (508)
...+..++|++|+|||++.+. ..|+.++||||+|||+|+|++|++||.+.+..+++..|.+.+|.++.+.+..... ..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~ 236 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE-GA 236 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH-HH
Confidence 223456789999999998762 4588999999999999999999999999999999999999999999877655433 22
Q ss_pred HHHHhhcccCCCC--CCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 258 RRYLGSMRKKQPV--PFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 258 ~~~l~~~~~~~~~--~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
..++.......+. .........++.+.+||.+||++||.+|||+.|+|+||||.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 3333222222211 0112234568899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-50 Score=410.13 Aligned_cols=335 Identities=51% Similarity=0.882 Sum_probs=278.1
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
|..+++|++.+.||+|+||.||+|.+..+|..||||+++.. .......++.+|+.+++.++||||+++++++.......
T Consensus 1 ~~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 1 FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred CccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 35678999999999999999999999999999999998642 22334566789999999999999999999987665555
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 93 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
...+|+|+||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 80 FNDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred cceEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 667999999999999988754 4699999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
...........+||+.|+|||++.+. ..++.++||||+||++|+|++|++||.+.+...++..+...++.+..+.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 32222233456889999999987642 56889999999999999999999999999998999999999999998888877
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccchhhHH
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEF 332 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 332 (508)
.....+.++...+.....++....+..++.+.+||.+||+.||.+|||+.++++||||..+..+..++..++...++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 317 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFEL 317 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChhhcc
Confidence 77777777766665555555556677889999999999999999999999999999999888766665554433344433
Q ss_pred HHhhcCHHHHHHHHHHHHH
Q 010512 333 ERRKLAKDDVREMIYREIL 351 (508)
Q Consensus 333 ~~~~~~~~~~~~~i~~ei~ 351 (508)
. ..+.++.+++.|..+|+
T Consensus 318 ~-~~~~~~~~~~~~~~~~~ 335 (336)
T cd07849 318 F-DDLPKEKLKELIFEEIM 335 (336)
T ss_pred c-cccCHHHHHHHHHHHhc
Confidence 3 45567888888887764
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-50 Score=403.15 Aligned_cols=286 Identities=36% Similarity=0.656 Sum_probs=236.5
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
|+.-++|++.+.||.|+||+||+|.+..++..||+|+++.... ......+.+|+.+|+.++||||+++++++..
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 74 (288)
T cd07871 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHT----- 74 (288)
T ss_pred CCccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-----
Confidence 5677889999999999999999999999999999999864322 2233467799999999999999999999843
Q ss_pred CccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 93 FKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
...+|+||||++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 75 ERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 35689999999999999887654 57999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
... .......+|+.|+|||++.+. ..++.++||||+||++|+|++|++||.+.+..+.+..+...++.|..+.+..
T Consensus 155 ~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07871 155 VPT---KTYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG 230 (288)
T ss_pred CCC---ccccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc
Confidence 221 123446789999999998652 5689999999999999999999999999999999999999999998887765
Q ss_pred HhhH-HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 252 IRNE-KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 252 ~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
+... ....++ .+.....++....+..++++++||.+||++||.+|||++|+|+||||
T Consensus 231 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 231 ITSNEEFRSYL--FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccchhhhccc--cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 4321 111111 11111222223345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=421.63 Aligned_cols=257 Identities=32% Similarity=0.574 Sum_probs=229.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|.+.+.||+|+||+||+|+.+.|.+.||||.+.+......+.+.+.+|++|++.|+|||||.+++.| +...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 589999999999999999999999999999999998878888889999999999999999999999988 666789
Q ss_pred EEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCC
Q 010512 97 YVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 176 (508)
Q Consensus 97 ylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~ 176 (508)
++|+|||.|+|+.++...+.++++.++.|.+|++.||.|||+++|+|||+||.|||+..+|.+|+||||+|+.+.. +
T Consensus 77 ~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~---~ 153 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST---N 153 (808)
T ss_pred EEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc---C
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999997643 3
Q ss_pred cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHH
Q 010512 177 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256 (508)
Q Consensus 177 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 256 (508)
....+...|||.|||||++.+ .+|+..+|+||+|||+|||+.|+|||...+..+....|..
T Consensus 154 t~vltsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~----------------- 214 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK----------------- 214 (808)
T ss_pred ceeeeeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc-----------------
Confidence 344677889999999999997 8999999999999999999999999977665444443321
Q ss_pred HHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 257 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
. +..+. ..++..+.+||+.+|.+||.+|+|..+++.|||+++-.
T Consensus 215 ----------d-~v~~p---~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 215 ----------D-PVKPP---STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred ----------C-CCCCc---ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 1 11111 26788999999999999999999999999999998643
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=411.24 Aligned_cols=295 Identities=38% Similarity=0.700 Sum_probs=243.1
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc-CC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-RE 92 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-~~ 92 (508)
...++|++.+.||+|+||.||+|.+..+|..||+|++............+.+|+.+++.++||||+++++++..... ..
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 45689999999999999999999999999999999997655555566778899999999999999999999865432 33
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 93 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
...+|+||||++++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred cceeEEEEeCCCcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 456899999999999888753 488999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
. ...+...||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+++..+...+|+|..+.+...
T Consensus 176 ~----~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 176 N----FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred C----ccCCCCcccCCCCCchhccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 1 12345688999999999987 68999999999999999999999999999988888889999999988776654
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCC------------CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKF------------PNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 317 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~------------~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~ 317 (508)
.. ....+....+......+...+ ...++.+.+||.+||..||.+|||+.|+|+||||..+.++.
T Consensus 250 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~ 325 (359)
T cd07876 250 QP-TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPA 325 (359)
T ss_pred HH-HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcc
Confidence 32 233333332222222222221 12467789999999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=410.97 Aligned_cols=327 Identities=36% Similarity=0.658 Sum_probs=258.9
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC-cCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RRE 92 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~-~~~ 92 (508)
...++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 4568999999999999999999999999999999999866555556678889999999999999999999886543 233
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 93 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
...+|+||||++++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 101 FQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred cCeEEEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 456899999999999888864 488999999999999999999999999999999999999999999999999975422
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...+|.|..+.+..+
T Consensus 179 ~----~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 179 S----FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred C----CcccCCcccCCcCCHHHHhC--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 1 12345689999999999987 68999999999999999999999999999999999999999999888766554
Q ss_pred hhHHHHHHHhhcccCCCCCCCCC------------CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHK------------FPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREP 320 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~------------~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~ 320 (508)
... ...+....+......+... ....+..+++||.+||+.||.+|||++++|+||||..+.++...+
T Consensus 253 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~ 331 (364)
T cd07875 253 QPT-VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAE 331 (364)
T ss_pred hHH-HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCC
Confidence 332 2333332222211111111 122356789999999999999999999999999998766544333
Q ss_pred CCCC-ccchhhHHHHhhcCHHHHHHHHHHHHH
Q 010512 321 STQP-ISKLEFEFERRKLAKDDVREMIYREIL 351 (508)
Q Consensus 321 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~ei~ 351 (508)
...+ +.. ...+.+....+++++.++.+++
T Consensus 332 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 361 (364)
T cd07875 332 APPPKIPD--KQLDEREHTIEEWKELIYKEVM 361 (364)
T ss_pred CCCCCCCC--ccchhhhccHHHHHHHHHHHHH
Confidence 2222 211 1223345666778887777764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-52 Score=370.10 Aligned_cols=279 Identities=39% Similarity=0.685 Sum_probs=241.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
.+|.-.+.||+|.||+||+|++..|++.||+|.+.-...+.......+|||-+|+.|+|.|||+++++.. ..+.+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh-----sdkkl 76 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc-----cCcee
Confidence 3577788999999999999999999999999999765555566678899999999999999999999983 44679
Q ss_pred EEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 97 YVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 97 ylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
.+|+|||..+|..+..+ ++.++.+.++.++.|+++||.|+|++++.||||||+|+|||.+|.+||+|||+++.+.- +
T Consensus 77 tlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi--p 154 (292)
T KOG0662|consen 77 TLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI--P 154 (292)
T ss_pred EEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC--c
Confidence 99999999999988876 67899999999999999999999999999999999999999999999999999997532 1
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
. ..++..+.|.||++|.++.+. .-|+..+|+||.|||++|+.. |+|.|+|.+..+|+..|..++|+|+.+.|..+..
T Consensus 155 v-rcysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 155 V-RCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred e-EeeeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 1 124556889999999999873 679999999999999999986 8999999999999999999999999988765432
Q ss_pred HHHHHHHhhcccCCC-------CCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 255 EKARRYLGSMRKKQP-------VPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
++...+ ..|++..|+.+....||++++|.-+|.+|++++++|+||||...
T Consensus 233 ---------lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 233 ---------LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ---------CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 222222 23445556777888999999999999999999999999999864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=387.00 Aligned_cols=255 Identities=26% Similarity=0.496 Sum_probs=224.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++++.||.|+||.|.+++++.+|..||+|++++. .......+...+|..+|+.+.||+++++++.+ .+..+
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~~ 118 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNSN 118 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCCe
Confidence 6799999999999999999999999999999999753 22334556678999999999999999999988 55677
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+||||++ |.|+.++++.+++++.++++++.||+.||+|||+.+|++|||||||||+|.+|.+||+|||+|......
T Consensus 119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 999999998 699999999999999999999999999999999999999999999999999999999999999865322
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
..+.||||.|+|||++.+ .+|+.++|.|||||++|||+.|.+||.+.+.....++|...-
T Consensus 198 -----T~TlCGTPeYLAPEii~s--k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~------------- 257 (355)
T KOG0616|consen 198 -----TWTLCGTPEYLAPEIIQS--KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK------------- 257 (355)
T ss_pred -----EEEecCCccccChHHhhc--CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc-------------
Confidence 245799999999999998 899999999999999999999999999999877777775321
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCC-----CCHHHHhcCCcccCCCC
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYFHGLAN 315 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~R-----pta~eiL~hp~f~~~~~ 315 (508)
..+. +-.++.+++||.++|++|-.+| ....+|..||||+++..
T Consensus 258 ---------------v~fP---~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W 305 (355)
T KOG0616|consen 258 ---------------VKFP---SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDW 305 (355)
T ss_pred ---------------ccCC---cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccH
Confidence 0111 2357889999999999999999 45789999999997653
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-50 Score=409.15 Aligned_cols=266 Identities=29% Similarity=0.467 Sum_probs=225.5
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
..++|+++++||+|+||.||+|+.+.||+.||+|++++.. ........+..|-.+|.....|.||+|+-.| .+.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence 4578999999999999999999999999999999998653 2334567788999999999999999999999 555
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
.++||||||++ ||+..+|.+.+.|+++++++++.+++.|+.-||..|+|||||||+|+|||.+|++||+||||+.....
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 67999999998 69999999999999999999999999999999999999999999999999999999999999965311
Q ss_pred C-------------------CCCc-c------------------------cccccccCcccccccccccccCCCCcchhh
Q 010512 173 D-------------------APSA-I------------------------FWTDYVATRWYRAPELCGSFFSKYTPAIDI 208 (508)
Q Consensus 173 ~-------------------~~~~-~------------------------~~~~~~gT~~Y~APE~l~~~~~~y~~~~DI 208 (508)
. .+.. . .....+|||-|+|||++.+ ..|+..+|.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~--kgY~~~cDw 371 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG--KGYGKECDW 371 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--CCCCccccH
Confidence 0 0000 0 0123589999999999998 789999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHH
Q 010512 209 WSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLE 288 (508)
Q Consensus 209 WSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~ 288 (508)
||||||+||||.|.|||.+++......+|..+--+ + .+. .-..+++++.|||.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~-----------------l---------~fP-~~~~~s~eA~DLI~ 424 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET-----------------L---------KFP-EEVDLSDEAKDLIT 424 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh-----------------c---------cCC-CcCcccHHHHHHHH
Confidence 99999999999999999999988888777543110 0 000 01234689999999
Q ss_pred HhccCCCCCCCC---HHHHhcCCcccCCCC
Q 010512 289 RLLAFDPKDRPT---AEEALADPYFHGLAN 315 (508)
Q Consensus 289 ~mL~~DP~~Rpt---a~eiL~hp~f~~~~~ 315 (508)
+||. ||.+|.. ++||-+||||+++..
T Consensus 425 rll~-d~~~RLG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 425 RLLC-DPENRLGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred HHhc-CHHHhcCcccHHHHhcCCccccCCc
Confidence 9999 9999975 999999999998765
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=399.38 Aligned_cols=289 Identities=34% Similarity=0.604 Sum_probs=227.8
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
||..++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+|+.++||||+++++++..
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 74 (303)
T cd07869 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHT----- 74 (303)
T ss_pred CCccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEec-----
Confidence 6888999999999999999999999999999999999974322 2223457789999999999999999999843
Q ss_pred CccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 93 FKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
...+|+||||+.++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 75 KETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 3569999999999999888764 568999999999999999999999999999999999999999999999999987532
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhhcCCCChHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN-VVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~-~~~~l~~i~~~~g~p~~~~~~ 250 (508)
... ......++|+.|+|||++.+. ..++.++||||+||++|+|++|.+||.+.. ..+++..+...++.|....+.
T Consensus 155 ~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 155 VPS---HTYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred CCC---ccCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence 211 123456789999999998652 568899999999999999999999998754 456677777777877665543
Q ss_pred HHhhHHHHHHH-hhcccCCCCCCCCCCC--CCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 251 RIRNEKARRYL-GSMRKKQPVPFSHKFP--NADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 251 ~~~~~~~~~~l-~~~~~~~~~~~~~~~~--~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
...... .+. .......+..+...+. ..++.+.+||.+||++||.+|||+.|+|+||||+++
T Consensus 231 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 231 GVHSLP--HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred chhhcc--ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 321100 000 0000001111111111 245789999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-51 Score=390.77 Aligned_cols=257 Identities=31% Similarity=0.467 Sum_probs=217.2
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeee-eecCCCcCCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH-IMLPPSRREF 93 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~-v~~~~~~~~~ 93 (508)
.-..|+|++.||+|+||.||+|.+..+|..||.|+|+-...+....+.+..|+.+|++|+|||||++++ .+. ++.
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~----~~~ 92 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI----EDN 92 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh----ccc
Confidence 345699999999999999999999999999999999855556666778999999999999999999988 342 233
Q ss_pred ccEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHh--cC--ceecCCCCCceeeCCCCcEEEccc
Q 010512 94 KDIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHT--AN--VFHRDLKPKNILANADCKLKICDF 164 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~Qil~aL~yLHs--~g--IiHrDLKPeNILl~~~~~lkL~DF 164 (508)
.-++||||||+ |||.++|+. +..+++..++.++.|+++||..||+ .. |+||||||.||+++.+|.+||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 45899999999 899999863 3569999999999999999999999 45 999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC
Q 010512 165 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244 (508)
Q Consensus 165 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p 244 (508)
|+++..... ..+...++|||.||+||++.+ .+|+.++||||+||++|||+.-++||.|++......+|.+.--.|
T Consensus 173 GL~r~l~s~---~tfA~S~VGTPyYMSPE~i~~--~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~ 247 (375)
T KOG0591|consen 173 GLGRFLSSK---TTFAHSLVGTPYYMSPERIHE--SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP 247 (375)
T ss_pred hhHhHhcch---hHHHHhhcCCCcccCHHHHhc--CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC
Confidence 999986433 335678999999999999998 899999999999999999999999999998877777775431111
Q ss_pred ChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
-+ - .-.+..+..||..|+.+||..||+. +|++..+.
T Consensus 248 ~p-------------------------~----~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~ 283 (375)
T KOG0591|consen 248 LP-------------------------D----EHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQ 283 (375)
T ss_pred Cc-------------------------H----HHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHH
Confidence 11 0 1245778999999999999999997 66665443
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=402.97 Aligned_cols=293 Identities=38% Similarity=0.688 Sum_probs=240.5
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc-CC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-RE 92 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-~~ 92 (508)
...++|++.+.||+|+||+||+|.+..+++.||||++............+.+|+.+++.++||||+++++++..... ..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34689999999999999999999999999999999998665555566788899999999999999999999865432 33
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 93 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
...+|+||||++++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred cceeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 456899999999999888764 488999999999999999999999999999999999999999999999999985422
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+..+.+...
T Consensus 172 ~----~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 172 S----FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred c----cccCCccccCCccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 1 12345689999999999987 68999999999999999999999999999988888888888898888776654
Q ss_pred hhHHHHHHHhhcccCCCCCCC------------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 253 RNEKARRYLGSMRKKQPVPFS------------HKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~------------~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
... ...++...+......+. ......+..+.+||.+||..||.+|||+.|+|+||||..+.+
T Consensus 246 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 246 QPT-VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred cHH-HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 432 23333222211111111 111224567899999999999999999999999999986654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-49 Score=402.83 Aligned_cols=329 Identities=52% Similarity=0.934 Sum_probs=280.3
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
...++|++.+.||.|+||.||+|.+..+|..||+|++............+.+|+.+|+.++||||+++++++.... ...
T Consensus 2 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 80 (334)
T cd07855 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADF 80 (334)
T ss_pred chhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCC
Confidence 4568999999999999999999999999999999999765444445677889999999999999999999876543 345
Q ss_pred ccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 94 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 94 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
..+|+||||+.++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 81 KDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred ceEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 67999999999999999988888999999999999999999999999999999999999999999999999999765332
Q ss_pred CC-CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 174 AP-SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 174 ~~-~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
.. ........+++.+|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+...++..+...+|.|+...+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred CcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 21 11122346889999999998652 46889999999999999999999999999999999999999999999988887
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccchhhHH
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEF 332 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 332 (508)
.......+........+.++...++..++.+.+||.+||+.||.+|||+++++.||||.+......++.. ...+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~~--~~~~~~~~ 317 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTC--PPPFDFDF 317 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccccC--CCCCCCCh
Confidence 7777777777777777777777778889999999999999999999999999999999988876665543 34566777
Q ss_pred HHhhcCHHHHHHHH
Q 010512 333 ERRKLAKDDVREMI 346 (508)
Q Consensus 333 ~~~~~~~~~~~~~i 346 (508)
+......+.+.+.|
T Consensus 318 ~~~~~~~~~~~~~~ 331 (334)
T cd07855 318 EAIELSREQLKEAI 331 (334)
T ss_pred hhhhcChhhHHHHh
Confidence 77777777665554
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=400.43 Aligned_cols=333 Identities=45% Similarity=0.836 Sum_probs=285.7
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc-
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR- 90 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~- 90 (508)
.+...++|++.+.||+|+||.||+|.+..++..||||++............+.+|+.+++.+.||||+++.+++.....
T Consensus 10 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred eecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 4456789999999999999999999999999999999987544444455678899999999999999999998765432
Q ss_pred CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 91 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 91 ~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
.....+|+|+||++++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 90 ~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 90 EDFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cccccEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 33456899999999999998875 46999999999999999999999999999999999999999999999999999864
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
... ...+.+|.+|+|||++.+. ..++.++|||||||++|+|++|++||++.+....+..+...++.+....+.
T Consensus 169 ~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 169 DDE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred ccc------ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence 321 2446788999999998652 467899999999999999999999999999888888888889999988888
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccchhh
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEF 330 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~~~ 330 (508)
++.......++..+.......+...+...++.+.+||.+||..||.+|||+.++++||||..+.....++.. ...+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~---~~~~~ 318 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVA---PPYDQ 318 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcccccc---cccCc
Confidence 888777777877777666666666667789999999999999999999999999999999988776554432 23456
Q ss_pred HHHHhhcCHHHHHHHHHHHHHHhCh
Q 010512 331 EFERRKLAKDDVREMIYREILEYHP 355 (508)
Q Consensus 331 ~~~~~~~~~~~~~~~i~~ei~~~~~ 355 (508)
+++...++.++|+++++.++.++.|
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07851 319 SFESRDLTVDEWKELVYKEIMNFKP 343 (343)
T ss_pred chhhhhcCHHHHHHHhHHHHHhccC
Confidence 7788999999999999999998865
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-49 Score=391.32 Aligned_cols=285 Identities=34% Similarity=0.643 Sum_probs=226.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|++.+.||+|+||+||+|++..+++.||+|++............+.+|+.+++.++||||+++++++. ..+.+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR-----RRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEe-----cCCEE
Confidence 4799999999999999999999999999999999754444444567889999999999999999999883 44579
Q ss_pred EEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 97 YVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 97 ylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
|+||||+++++.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99999999766555544 45799999999999999999999999999999999999999999999999999986532221
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|++||++.+..+.+..+....+..+...+......
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 156 --ANYTEYVATRWYRSPELLLG--APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred --ccccccccccccCCcHHHcC--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence 12345679999999999977 67899999999999999999999999999888888888887777665544322110
Q ss_pred HHHHHHhhcccCCCCCC-CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 256 KARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
.............+... ......+++.+.+||.+||++||.+|||++++|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00000000000000000 11123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-49 Score=391.71 Aligned_cols=284 Identities=36% Similarity=0.604 Sum_probs=230.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECC-CCcEEEEEEecCccCChhHHHHHHHHHHHHHhC---CCCCcceeeeeecCCCcCC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTH-TGERVAIKKINDVFEHVSDATRILREIKLLRLL---RHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~-tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L---~HpnIv~l~~v~~~~~~~~ 92 (508)
.+|++++.||+|+||+||+|.+.. +|..||+|+++...........+.+|+.+++.+ .||||+++++++.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999864 578899999875443333345566788877766 6999999999986543344
Q ss_pred CccEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 93 FKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
...+|+||||+.++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 5679999999999999998764 35899999999999999999999999999999999999999999999999999864
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.|....+.
T Consensus 161 ~~~----~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 161 SFQ----MALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred cCC----cccccccccccccChHHHhC--CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 322 12345678999999999976 678999999999999999999999999999999999998888877765443
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
..... . ........+.++....+.+++.+.+||.+||+.||++|||+.++|+||||
T Consensus 235 ~~~~~--~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVAL--P--RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcc--c--chhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 21100 0 00111223333444456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-49 Score=399.28 Aligned_cols=329 Identities=57% Similarity=0.961 Sum_probs=283.4
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
+|++.+.||.|+||.||+|.+..+|..||||++..........+.+.+|+.+++.++||||+++.+++..........+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 69999999999999999999999999999999986554455567889999999999999999999998765434456799
Q ss_pred EEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCc
Q 010512 98 VVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 177 (508)
Q Consensus 98 lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~ 177 (508)
+||||++++|.+++.....+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++..........
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~ 160 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999998754432211
Q ss_pred ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHH
Q 010512 178 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 257 (508)
Q Consensus 178 ~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 257 (508)
.......+|++|+|||++.+. ..++.++|+||+||++|+|++|.+||.+.+....+..+...+|.+..+.+..+.....
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 161 GFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred ccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 223556789999999999872 3789999999999999999999999999999999999999999999888877777777
Q ss_pred HHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccchhhHHHHhhc
Q 010512 258 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKL 337 (508)
Q Consensus 258 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (508)
..++.........++...++.+++.+.+||.+||++||.+|||+++++.||||+++..+..++..+....+ ..++...+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 318 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDF-DFFDDDEL 318 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCcccc-cccchhhc
Confidence 77777777777777777788899999999999999999999999999999999998877766655443322 14566778
Q ss_pred CHHHHHHHHHH
Q 010512 338 AKDDVREMIYR 348 (508)
Q Consensus 338 ~~~~~~~~i~~ 348 (508)
.+++.++.|+.
T Consensus 319 ~~~~~~~~~~~ 329 (330)
T cd07834 319 TEEELKELIYE 329 (330)
T ss_pred CHHHHhHHhhc
Confidence 88888888764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-51 Score=384.44 Aligned_cols=293 Identities=43% Similarity=0.739 Sum_probs=252.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
..+.+-.+.||-|+||+||.+.|..+|+.||+||+.+.+.+....+++.+|+++|-.++|.|++..+++..++....+..
T Consensus 52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred cccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 34556678999999999999999999999999999988888888899999999999999999999999998887667788
Q ss_pred EEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 96 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 96 lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
+|+|+|+|..||+..|.+-..|+.++++-|++||++||+|||+.||.||||||.|+|+|+||.+||||||+|+....+.
T Consensus 132 iYV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~- 210 (449)
T KOG0664|consen 132 LYVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD- 210 (449)
T ss_pred HHHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999754333
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
...++..+.|..|+|||++.|. ..|+.++||||+||||.|||..+.+|...+..+|+++|.+++|+|+.+.+......
T Consensus 211 -~~hMTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 211 -RLNMTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred -hhhhHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 3346777899999999999884 78999999999999999999999999999999999999999999999987654433
Q ss_pred HHHHHHhhcccCCCCCCCCCCC-----CCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 256 KARRYLGSMRKKQPVPFSHKFP-----NADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~-----~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.-.-.+..-. ++..+...+. ....++.+++.+||.+||++|++.++++.|+|....
T Consensus 289 Ak~H~LR~~~--k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 289 AKNHVLRAGL--RAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hHHHhhccCC--CCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 2222222211 1222222222 234568899999999999999999999999998643
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=411.68 Aligned_cols=288 Identities=34% Similarity=0.616 Sum_probs=231.5
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc---
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR--- 90 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~--- 90 (508)
....+|++++.||+|+||+||+|.+..+++.||||++... .....+|+.+|+.++||||+++++++.....
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC------cchHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 3456899999999999999999999999999999998532 1234579999999999999999998754321
Q ss_pred CCCccEEEEEecCCccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC-cEEEcccc
Q 010512 91 REFKDIYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFG 165 (508)
Q Consensus 91 ~~~~~lylV~E~~~g~L~~~i~----~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~-~lkL~DFG 165 (508)
.....+|+||||++++|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||
T Consensus 137 ~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 2223578999999999887775 345799999999999999999999999999999999999999765 69999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC
Q 010512 166 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245 (508)
Q Consensus 166 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~ 245 (508)
+|+...... ....++||+.|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+..+++..+...+|+|.
T Consensus 217 la~~~~~~~----~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 217 SAKNLLAGQ----RSVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291 (440)
T ss_pred cchhccCCC----CcccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 998653322 12356889999999998652 5789999999999999999999999999999999999999999998
Q ss_pred hHHHHHHhhHHHHHHHhhcccCCCCCCCCCCC-CCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 246 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
.+.+......... . .++...+..+...++ ..++++++||.+||++||.+|||+.|+|+||||..+.+
T Consensus 292 ~~~~~~~~~~~~~-~--~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 292 EDQLKEMNPNYAD-I--KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHHHHhchhhhc-c--cCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 8766543221100 0 011111122222233 46789999999999999999999999999999988765
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-49 Score=392.21 Aligned_cols=275 Identities=29% Similarity=0.435 Sum_probs=228.2
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
...+.|++.++||.|..++||+|+...+++.||||+++-...+ .+...+.+|++.|+.++||||++++..|...
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~-~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~----- 96 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN-NDLDALRKEVQTMSLIDHPNIVTYHCSFVVD----- 96 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh-hhHHHHHHHHHHhhhcCCCCcceEEEEEEec-----
Confidence 4468899999999999999999999999999999999754333 3478899999999999999999999999654
Q ss_pred ccEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 94 KDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
..+|+||.||. |+++++++.. ..+.|..+..|++++|+||.|||.+|.||||||+.||||+.+|.|||+|||.....
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 45999999998 7999999874 45999999999999999999999999999999999999999999999999998876
Q ss_pred cCCCCCcccc-cccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 171 FNDAPSAIFW-TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 171 ~~~~~~~~~~-~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
.......... ...+||++|||||++......|+.|+||||||++..||.+|..||..-.....+ +..+-|.|+.-..
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l~tLqn~pp~~~t 254 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--LLTLQNDPPTLLT 254 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--HHHhcCCCCCccc
Confidence 6554433333 678999999999997665678999999999999999999999999776554433 3444455442221
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
.....+ .....+..+..+|..||++||.+||||+++|+|+||+....
T Consensus 255 ~~~~~d-------------------~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 255 SGLDKD-------------------EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred ccCChH-------------------HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 111111 11234557899999999999999999999999999987654
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-48 Score=391.48 Aligned_cols=291 Identities=37% Similarity=0.657 Sum_probs=240.8
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
|+..++|++.+.||+|+||.||+|++..++..||+|+++.... ......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 75 (309)
T cd07872 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHT----- 75 (309)
T ss_pred CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEee-----
Confidence 6777899999999999999999999999999999999864322 2233457789999999999999999999843
Q ss_pred CccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 93 FKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
....|+||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 76 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 76 DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence 3568999999999999888764 458999999999999999999999999999999999999999999999999997542
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.... ......+|+.|+|||++.+. ..++.++|||||||++|+|++|++||++.+..+.+..+...+|.|....+..
T Consensus 156 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07872 156 VPTK---TYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG 231 (309)
T ss_pred CCcc---ccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence 2211 12345789999999998652 5688999999999999999999999999999999999999999998887765
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
+........ ...+...+.++....+.+++.+.+||.+||..||.+|||+.|+|+||||+.+.
T Consensus 232 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 232 ISSNDEFKN-YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hcchhhhhh-hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 543221111 11222233333445567889999999999999999999999999999999765
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=386.33 Aligned_cols=283 Identities=35% Similarity=0.608 Sum_probs=228.8
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC---CCCCcceeeeeecCCCcCCCc
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL---RHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L---~HpnIv~l~~v~~~~~~~~~~ 94 (508)
+|++.+.||+|+||+||+|.+..+|+.||+|.++...........+.+|+.+++.+ .||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 69999999999999999999999999999999875433333334556777777665 699999999998654434456
Q ss_pred cEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 95 DIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 95 ~lylV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
.+++||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 78999999999999988764 3489999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
.. ..+...||..|+|||++.+ ..++.++||||+||++|+|++|++||.+.+..+.+..+....+.+....+...
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 161 QM----ALTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cc----cCCCccccccccCchHhhC--CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 21 1244678999999999976 67999999999999999999999999999888888888888777765443221
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
.... ........+..+....+.++..+.+||.+||++||.+|||+.+++.||||
T Consensus 235 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLP----RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccc----ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0000 00111222333344556788899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-48 Score=403.48 Aligned_cols=282 Identities=27% Similarity=0.378 Sum_probs=221.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
.+|++++.||+|+||.||+|.+..+++.||||+.. ...+.+|+.+|+.|+||||+++++++.. ....
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~ 158 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTY-----NKFT 158 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-----CCee
Confidence 67999999999999999999999999999999753 2346789999999999999999999843 3468
Q ss_pred EEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCC
Q 010512 97 YVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 176 (508)
Q Consensus 97 ylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~ 176 (508)
|+|||++.++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 159 ~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-- 236 (391)
T PHA03212 159 CLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-- 236 (391)
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc--
Confidence 999999999999999888889999999999999999999999999999999999999999999999999997532211
Q ss_pred cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHhhcCCCChHHH
Q 010512 177 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK-------NVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 177 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~-------~~~~~l~~i~~~~g~p~~~~~ 249 (508)
.......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+. ....++..+...+|.++.+..
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ccccccccCccCCCChhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 112345689999999999987 68999999999999999999999776432 234567777777777654321
Q ss_pred HHHhhHHHHHHHhhcccCC--C--CCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 250 SRIRNEKARRYLGSMRKKQ--P--VPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~--~--~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
..........+........ + .+.......++..+.+||.+||++||.+|||++|+|+||||+.+..
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 384 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD 384 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence 1110000011111111111 1 0101111245678999999999999999999999999999987643
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=391.53 Aligned_cols=327 Identities=39% Similarity=0.701 Sum_probs=257.2
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC-cC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RR 91 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~-~~ 91 (508)
|...++|++.+.||+|+||.||+|.+..+|..||||++.+..........+.+|+.+++.++||||+++++++.... ..
T Consensus 12 ~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 12 FTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 45678999999999999999999999999999999999765545555667889999999999999999999986543 23
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 92 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 92 ~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
+....|+||||+.++|.+.+... +++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 92 ~~~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 92 EFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred ccCcEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 44578999999999999988654 8999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
... ......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||++.+...++..+...+|.|..+....
T Consensus 170 ~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 170 TSF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred CCC----CCCCCcccccccCHHHHhC--CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 221 1234578899999999987 6899999999999999999999999999998889999999999998876665
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCC-------------CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKF-------------PNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDR 318 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~-------------~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~ 318 (508)
+... ...+..........++...+ ...++.+.+||.+||+.||.+|||+.|+|.||||+.+.....
T Consensus 244 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~ 322 (353)
T cd07850 244 LQPT-VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSE 322 (353)
T ss_pred hhhh-hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCcc
Confidence 4422 22222222222222222221 234567899999999999999999999999999987665433
Q ss_pred CCCCCCccchhhHHHHhhcCHHHHHHHHHHH
Q 010512 319 EPSTQPISKLEFEFERRKLAKDDVREMIYRE 349 (508)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~e 349 (508)
.....+ ...+.+.+.+....++|+..++.+
T Consensus 323 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T cd07850 323 VEAPPP-APYDHSIDEREHTVEEWKELIYKE 352 (353)
T ss_pred CCCCCC-CccccccccccccHHHHHHHHHhh
Confidence 322222 112233344555667777666554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=408.55 Aligned_cols=285 Identities=28% Similarity=0.433 Sum_probs=226.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCC------CcceeeeeecCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP------DIVEIKHIMLPPS 89 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~Hp------nIv~l~~v~~~~~ 89 (508)
.++|++++.||+|+||+||+|.+..+++.||||+++... ........|+.+++.++|. +|+.+++++..
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~-- 202 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN-- 202 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc--
Confidence 478999999999999999999999999999999996421 2233456688888777654 47888887743
Q ss_pred cCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-cCceecCCCCCceeeCCCC-----------
Q 010512 90 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADC----------- 157 (508)
Q Consensus 90 ~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs-~gIiHrDLKPeNILl~~~~----------- 157 (508)
...++|+||++++++|.+++...+.+++..++.|+.||+.||.|||+ .||+||||||+|||++.++
T Consensus 203 --~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 203 --ETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred --CCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 23568999999999999999888899999999999999999999998 5999999999999998765
Q ss_pred -----cEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHH
Q 010512 158 -----KLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH 232 (508)
Q Consensus 158 -----~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~ 232 (508)
.+||+|||++..... ..+..+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLG--LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred CCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhc--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 499999998864211 1345789999999999987 689999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCC----C-----CC--CCCCHHHHHHHHHhccCCCCCCCCH
Q 010512 233 QLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFS----H-----KF--PNADPLALHLLERLLAFDPKDRPTA 301 (508)
Q Consensus 233 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~----~-----~~--~~~~~~~~~Ll~~mL~~DP~~Rpta 301 (508)
++..|...+|.++............+.+........+.... . .+ ...++.+.|||.+||++||.+|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 99999999998877655443222223332222211110000 0 00 0124678899999999999999999
Q ss_pred HHHhcCCcccCCCC
Q 010512 302 EEALADPYFHGLAN 315 (508)
Q Consensus 302 ~eiL~hp~f~~~~~ 315 (508)
+|+|+||||..+..
T Consensus 433 ~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 433 RQMTTHPYVLKYYP 446 (467)
T ss_pred HHHhcCccccccCC
Confidence 99999999987654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=402.01 Aligned_cols=256 Identities=31% Similarity=0.525 Sum_probs=223.5
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
...+|.....||+|+.|.||.|....+++.||||+++...+. ..+-+++|+.+|+.++|+|||.+++.|+-. .
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----d 343 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLVG-----D 343 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhccc-----c
Confidence 346789999999999999999999999999999999754443 345588999999999999999999998654 5
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
.+|+|||||+ |+|.+++... .++|.++..+++++++||+|||.+||+|||||.+|||++.+|.+||+|||+|......
T Consensus 344 eLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred eeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 6999999999 5888877654 5999999999999999999999999999999999999999999999999999876554
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
.. .....+|||.|||||++.. ..|++++||||||++++||+-|+|||-.++...-+.+|.. .|+|..
T Consensus 423 ~~---KR~TmVGTPYWMAPEVvtr--k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~l------- 489 (550)
T KOG0578|consen 423 QS---KRSTMVGTPYWMAPEVVTR--KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKL------- 489 (550)
T ss_pred cC---ccccccCCCCccchhhhhh--cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCc-------
Confidence 43 4577899999999999987 7999999999999999999999999998888777777653 233221
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~ 311 (508)
.....+++.+++||.+||++|+.+|++|.|+|+||||+
T Consensus 490 --------------------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 490 --------------------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred --------------------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence 12346789999999999999999999999999999995
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=391.96 Aligned_cols=270 Identities=28% Similarity=0.455 Sum_probs=219.7
Q ss_pred cccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC------------hhHHHHHHHHHHHHHhCCCCCc
Q 010512 11 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH------------VSDATRILREIKLLRLLRHPDI 78 (508)
Q Consensus 11 ~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~------------~~~~~~i~~Ei~iL~~L~HpnI 78 (508)
+....-++|++++.||+|.||.|.+|++..+++.||||++.+.... ....+++.+||.||++|.||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 3445668999999999999999999999999999999999643211 1223578999999999999999
Q ss_pred ceeeeeecCCCcCCCccEEEEEecCC-ccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC
Q 010512 79 VEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 156 (508)
Q Consensus 79 v~l~~v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~~-l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~ 156 (508)
|+|+++.-++ ...++|||+|||. |.+. +.-...+ |++.++++|++.++.||.|||.+|||||||||+|+|++++
T Consensus 171 V~LiEvLDDP---~s~~~YlVley~s~G~v~-w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 171 VKLIEVLDDP---ESDKLYLVLEYCSKGEVK-WCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD 246 (576)
T ss_pred eEEEEeecCc---ccCceEEEEEeccCCccc-cCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC
Confidence 9999998543 4578999999999 5543 3333445 9999999999999999999999999999999999999999
Q ss_pred CcEEEccccccccccCC--CCCcccccccccCccccccccccccc--CCCCcchhhhhHHHHHHHHHhCCCCCCCCChHH
Q 010512 157 CKLKICDFGLARVSFND--APSAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH 232 (508)
Q Consensus 157 ~~lkL~DFGla~~~~~~--~~~~~~~~~~~gT~~Y~APE~l~~~~--~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~ 232 (508)
|++||+|||.+...... ......+...+|||.|+|||.|.+.. ...+.+.||||+||+||.|+.|+.||-++...+
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 99999999999764222 11222344579999999999997621 224578999999999999999999999988877
Q ss_pred HHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 233 QLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 233 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
..++|.. .|..| ...+.+...++|||.+||.+||.+|+++.++..|||...
T Consensus 327 l~~KIvn----------------------------~pL~f-P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 327 LFDKIVN----------------------------DPLEF-PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred HHHHHhc----------------------------CcccC-CCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 7777643 11111 123456788999999999999999999999999999875
Q ss_pred C
Q 010512 313 L 313 (508)
Q Consensus 313 ~ 313 (508)
-
T Consensus 378 ~ 378 (576)
T KOG0585|consen 378 D 378 (576)
T ss_pred C
Confidence 3
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=387.04 Aligned_cols=333 Identities=40% Similarity=0.757 Sum_probs=277.3
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc-
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR- 90 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~- 90 (508)
-+...++|++++.||+|+||.||+|.+..+|..||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3567899999999999999999999999999999999986544333445678899999999999999999999865432
Q ss_pred CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 91 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 91 ~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
.....+|+||||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 90 ~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 90 DRFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred cccceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 22345799999998899888764 57999999999999999999999999999999999999999999999999999754
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
... .....+++.|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.+....+..+....+.+..+...
T Consensus 169 ~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 169 DSE------MTGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred ccC------ccccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 221 2345678999999998752 458899999999999999999999999988888888888888888777777
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccchhh
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEF 330 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~~~ 330 (508)
.+.......+...++...+..+....+.+++.+.+||.+||..||.+|||+.+++.||||+.......++... .+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~---~~~~ 318 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAP---PYDD 318 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCC---Cccc
Confidence 7766666667666665555555556678899999999999999999999999999999999887655544332 3556
Q ss_pred HHHHhhcCHHHHHHHHHHHHHHhCh
Q 010512 331 EFERRKLAKDDVREMIYREILEYHP 355 (508)
Q Consensus 331 ~~~~~~~~~~~~~~~i~~ei~~~~~ 355 (508)
.+++.....++++.+...||+.+.|
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07880 319 SFDEVDQSLEEWKRLTFTEILSFQP 343 (343)
T ss_pred cHHhhccchHHHHHHHHHHHHhcCC
Confidence 6777788889999999999988764
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=387.48 Aligned_cols=264 Identities=30% Similarity=0.467 Sum_probs=213.1
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
...+|...+.||+|+||.||++.+..+|..+|||.+... +......+.+|+.+|+.|+|||||++++...... . .
T Consensus 15 ~~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~--~-~ 89 (313)
T KOG0198|consen 15 EISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE--N-D 89 (313)
T ss_pred ccchhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc--C-e
Confidence 356789999999999999999999999999999998653 2222677899999999999999999999753321 1 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC-CCcEEEcccccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSF 171 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~-~~~lkL~DFGla~~~~ 171 (508)
.++|.|||+. |+|.+++...+ .|++..++.+.+||++||+|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 90 ~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 90 EYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 6899999998 69999999877 7999999999999999999999999999999999999999 7999999999998654
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhhcCCCChHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK-NVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~-~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.............||+.|||||++... .....++|||||||++.||+||.+||... .....+-.+
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~i------------- 235 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLI------------- 235 (313)
T ss_pred cccccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHH-------------
Confidence 311121223457899999999999851 22335999999999999999999999763 211111111
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.... ..| .....+++.+.+||.+||.+||.+||||+++|.|||.++.
T Consensus 236 -------------g~~~-~~P--~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 236 -------------GRED-SLP--EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred -------------hccC-CCC--CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 0011 011 2234588999999999999999999999999999999764
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=386.46 Aligned_cols=332 Identities=44% Similarity=0.815 Sum_probs=276.9
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc-C
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-R 91 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-~ 91 (508)
+...++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++..... .
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 456799999999999999999999999999999999997644444445678899999999999999999998864321 2
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 92 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 92 ~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
....+|+|+++++++|.+++... .+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 93 ~~~~~~lv~~~~~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 93 EFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred ccccEEEEehhcccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 34568999999989998887654 69999999999999999999999999999999999999999999999999987532
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
. ......+|++|+|||++.+. ..++.++||||+||++|+|++|++||++.+....+..+....+.+.......
T Consensus 172 ~------~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 172 D------EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred c------cccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 2 12345789999999998652 5688999999999999999999999999888888888888889888888777
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccchhhH
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFE 331 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~ 331 (508)
+.....+.++..+.......+...+...++.+.+||.+||..||.+|||+.+++.||||.++..+..++... .....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~---~~~~~ 321 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD---PYDQS 321 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCC---CccCc
Confidence 776666677666665555556555667889999999999999999999999999999999887766555332 34555
Q ss_pred HHHhhcCHHHHHHHHHHHHHHhCh
Q 010512 332 FERRKLAKDDVREMIYREILEYHP 355 (508)
Q Consensus 332 ~~~~~~~~~~~~~~i~~ei~~~~~ 355 (508)
+..+.+..+++....|.++..+.|
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~ 345 (345)
T cd07877 322 FESRDLLIDEWKSLTYDEVISFVP 345 (345)
T ss_pred chhcccCHHHHHHHHHHHHHhcCC
Confidence 666677778888899998877654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=391.60 Aligned_cols=262 Identities=31% Similarity=0.512 Sum_probs=226.5
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-VSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~-~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~ 91 (508)
.....|++.+.||+|.||+||+|+++.||+.||+|+|++.... ......+.+|+.+|+++. |||||.++++|.
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e----- 106 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE----- 106 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE-----
Confidence 4557899999999999999999999999999999999765433 234567899999999999 999999999994
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC----CcEEEccccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD----CKLKICDFGL 166 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~----~~lkL~DFGl 166 (508)
....+|+|||+|. |+|++.|... .+++..+..++.||+.|+.|||+.||+||||||+|+|+... +.+|++|||+
T Consensus 107 ~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 107 DPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred cCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 4457999999999 6999999887 49999999999999999999999999999999999998654 4799999999
Q ss_pred cccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCh
Q 010512 167 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246 (508)
Q Consensus 167 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 246 (508)
+..... .......+||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.+.......|..
T Consensus 186 a~~~~~----~~~~~~~~Gtp~y~APEvl~~--~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~------- 252 (382)
T KOG0032|consen 186 AKFIKP----GERLHTIVGTPEYVAPEVLGG--RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR------- 252 (382)
T ss_pred ceEccC----CceEeeecCCccccCchhhcC--CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc-------
Confidence 987643 223577899999999999987 7999999999999999999999999999886555443322
Q ss_pred HHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 247 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.........|+.++..+.+||.+||.+||.+|+|+.++|+|||+++..
T Consensus 253 --------------------~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 253 --------------------GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred --------------------CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 122333456788999999999999999999999999999999998753
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=380.91 Aligned_cols=256 Identities=29% Similarity=0.522 Sum_probs=225.6
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
....-||++.+.||+|.||.|.+|.+...|+.||||.|++. ..+..+...+.|||.||..|+||||+.++++| +
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----E 123 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----E 123 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----c
Confidence 34557899999999999999999999999999999999754 45566778899999999999999999999999 5
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
....+.|||||.. |+|+++|...+.|++.+++.||+||+.|+.|||.++++|||||.+|||+|.|+++||+|||++..+
T Consensus 124 NkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 124 NKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred CCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhh
Confidence 5567999999998 799999999999999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCC-cchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~-~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
... .+++++||+|.|.+||++.| .+|. +.+|-||||++||-|+.|..||.|.+....+.+|...--
T Consensus 204 ~~~----kfLqTFCGSPLYASPEIvNG--~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaY------- 270 (668)
T KOG0611|consen 204 ADK----KFLQTFCGSPLYASPEIVNG--TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAY------- 270 (668)
T ss_pred ccc----cHHHHhcCCcccCCccccCC--CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccc-------
Confidence 433 35788999999999999998 5665 899999999999999999999999987666665543110
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~ 311 (508)
.-|..+..+.-||+.||.+||++|.|+++|-.|=|.+
T Consensus 271 -------------------------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 271 -------------------------REPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred -------------------------cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 0123346688999999999999999999999998875
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=385.65 Aligned_cols=330 Identities=41% Similarity=0.752 Sum_probs=268.5
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc-
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR- 90 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~- 90 (508)
.|....+|.+.+.||+|+||.||+|++..+|+.||||++.+..........+.+|+.+++.++||||+++++++.....
T Consensus 10 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 89 (342)
T cd07879 10 VWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG 89 (342)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccC
Confidence 4566789999999999999999999999999999999997644333445568899999999999999999999865421
Q ss_pred CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 91 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 91 ~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
.....+|+|+||+..+|..++ ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++..
T Consensus 90 ~~~~~~~lv~e~~~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 90 DEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred CCCceEEEEecccccCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 233567999999998887765 346899999999999999999999999999999999999999999999999998753
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.. ......+|++|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+....+..+....|.+......
T Consensus 168 ~~------~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 168 DA------EMTGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred CC------CCCCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 21 12346788999999998652 468899999999999999999999999999888888888888888887776
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccchhh
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEF 330 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~~~ 330 (508)
.+.......+...++......+...++..++.+.+||.+||+.||.+||+++++|.||||..+.+.+.++..++ +..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~---~~~ 317 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQP---YDD 317 (342)
T ss_pred HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCCc---ccc
Confidence 66554445555544444445555666788999999999999999999999999999999999876555444332 344
Q ss_pred HHHHhhcCHHHHHHHHHHHHHHh
Q 010512 331 EFERRKLAKDDVREMIYREILEY 353 (508)
Q Consensus 331 ~~~~~~~~~~~~~~~i~~ei~~~ 353 (508)
..+...+..+++..-||.+....
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~ 340 (342)
T cd07879 318 SLENEKLSVDEWKKHIYKEVKSF 340 (342)
T ss_pred hhhhhhCCHHHHHHHhhhhhhcc
Confidence 44555667788888888775443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=383.08 Aligned_cols=254 Identities=24% Similarity=0.393 Sum_probs=214.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++. +...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH-----DQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc-----cCCe
Confidence 47999999999999999999999999999999986432 12234556889999999999999999998873 4467
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 999999998 699999998889999999999999999999999999999999999999999999999999999864321
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 155 -----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-------------- 213 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-------------- 213 (291)
T ss_pred -----cccccCChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 123579999999999987 67899999999999999999999999887654433332210
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCC
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLA 314 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt-----a~eiL~hp~f~~~~ 314 (508)
. ..+ ....++.+.+||++||+.||.+||+ ++++++||||..+.
T Consensus 214 ------------~--~~~---~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 214 ------------K--LEF---PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred ------------C--cCC---CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence 0 011 1235788999999999999999995 99999999998643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=383.74 Aligned_cols=327 Identities=51% Similarity=0.837 Sum_probs=267.4
Q ss_pred CeEEeeeeeecCceEEEEEEECCC--CcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCCc
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHT--GERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~t--g~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~ 94 (508)
+|++.+.||+|+||.||+|.+..+ +..||||++..........+.+.+|+.+++.+ .||||+++++...... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 589999999999999999999888 99999999875444444456788999999999 5999999998754322 2345
Q ss_pred cEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 95 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 95 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
.+|+++++++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 80 ~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 80 ELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred cEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 68999999999999999888889999999999999999999999999999999999999999999999999998643221
Q ss_pred CC-cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 175 PS-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 175 ~~-~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
.. .......+||+.|+|||++.+. ..++.++||||+||++|+|++|.+||.+.+..+.+..+...+|.|..+.+..+.
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred ccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 1122346799999999987652 568999999999999999999999999999999999999999999988887777
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccchhhHHH
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFE 333 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 333 (508)
......+...+.......+....+..+..+.+|+.+||+.||.+|||+.+++.||||+.++++...+.+.......|+.|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFESE 318 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCcccc
Confidence 66666666666555556666667778999999999999999999999999999999998887665555544333333222
Q ss_pred HhhcCHHHHHHHHHHH
Q 010512 334 RRKLAKDDVREMIYRE 349 (508)
Q Consensus 334 ~~~~~~~~~~~~i~~e 349 (508)
-+.++++.+|..+
T Consensus 319 ---~~~~~~~~~~~~~ 331 (332)
T cd07857 319 ---DSMEELRDMIIEE 331 (332)
T ss_pred ---ccHHHHHHHHhhc
Confidence 2456677766543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=383.84 Aligned_cols=281 Identities=36% Similarity=0.608 Sum_probs=216.9
Q ss_pred eeeeeecCceEEEEEEEC--CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEE
Q 010512 22 QEVIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 99 (508)
Q Consensus 22 ~~~LG~G~~g~V~~a~~~--~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV 99 (508)
.+.||+|+||+||+|.+. .++..||+|++.... ....+.+|+.+|+.++||||+++++++... ....+|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEE
Confidence 357999999999999965 477899999986432 234567899999999999999999998643 23568999
Q ss_pred EecCCccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceee----CCCCcEEEccccc
Q 010512 100 FELMESDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFGL 166 (508)
Q Consensus 100 ~E~~~g~L~~~i~~~---------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl----~~~~~lkL~DFGl 166 (508)
|||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 999999999887632 258999999999999999999999999999999999999 4567899999999
Q ss_pred cccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCCh---------HHHHHHH
Q 010512 167 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV---------VHQLDLM 237 (508)
Q Consensus 167 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~---------~~~l~~i 237 (508)
++...............+||++|+|||++.+. ..|+.++||||+||++|+|++|++||.+.+. ..++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 98654322222223456899999999998762 4689999999999999999999999976542 4677888
Q ss_pred HhhcCCCChHHHHHHhhHHH-HHHHhhcccCCC------CCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 238 TDLLGTPSTESISRIRNEKA-RRYLGSMRKKQP------VPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 238 ~~~~g~p~~~~~~~~~~~~~-~~~l~~~~~~~~------~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
...+|.|....+..+..... ...+........ ..+.......+..+.+||.+||++||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 89999988877665432110 001111110000 00111112346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-47 Score=379.67 Aligned_cols=291 Identities=36% Similarity=0.642 Sum_probs=234.8
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
|+.-++|++++.||+|+||.||+|.+..++..||+|.+...... .....+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~----- 75 (301)
T cd07873 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT----- 75 (301)
T ss_pred CccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEec-----
Confidence 56678999999999999999999999999999999998643222 233457789999999999999999999843
Q ss_pred CccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 93 FKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
...+|+||||++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++....
T Consensus 76 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 76 EKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred CCeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 3569999999999999988764 468999999999999999999999999999999999999999999999999997542
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.... ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||++.+..+++..+...++.+....+..
T Consensus 156 ~~~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 156 IPTK---TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231 (301)
T ss_pred CCCC---cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh
Confidence 2211 12345678999999998652 4688899999999999999999999999998888888999888887766544
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
+...... .....+......+....+.+++.+.+||.+||++||.+|||++|+|+||||+.+.
T Consensus 232 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 232 ILSNEEF-KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred hhccccc-cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 3211000 0000111111111223356788999999999999999999999999999998765
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=387.40 Aligned_cols=250 Identities=26% Similarity=0.455 Sum_probs=210.1
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEe
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 101 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 101 (508)
+.||+|+||.||+|.+..+|+.||||++++... .......+.+|+.+|+.++||||+++++++. ....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQ-----THDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----cCCEEEEEEe
Confidence 479999999999999999999999999975322 2334567789999999999999999999984 3457999999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcccc
Q 010512 102 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 180 (508)
Q Consensus 102 ~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~ 180 (508)
|+. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~---~~~ 152 (323)
T cd05571 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG---ATM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC---Ccc
Confidence 998 6999999888899999999999999999999999999999999999999999999999999997532211 123
Q ss_pred cccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHH
Q 010512 181 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 260 (508)
Q Consensus 181 ~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~ 260 (508)
...+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--------------------- 209 (323)
T cd05571 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------------- 209 (323)
T ss_pred cceecCccccChhhhcC--CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc---------------------
Confidence 45689999999999987 6899999999999999999999999987665433332211
Q ss_pred HhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCC
Q 010512 261 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGL 313 (508)
Q Consensus 261 l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~ 313 (508)
.. .. ....+++.+.+||.+||..||.+|| ++.++++||||.++
T Consensus 210 -----~~--~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 210 -----EE--IR---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred -----CC--CC---CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 00 01 1134678999999999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=387.28 Aligned_cols=253 Identities=26% Similarity=0.439 Sum_probs=214.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
.++|++.+.||+|+||.||+|.+..+|+.||||+++... ........+.+|+.+|+.++||||+++++++.. ..
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-----EN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-----CC
Confidence 478999999999999999999999999999999996432 222345668899999999999999999999843 45
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
.+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 6999999998 699999998889999999999999999999999999999999999999999999999999999864321
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 172 ------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~-------------- 229 (329)
T PTZ00263 172 ------TFTLCGTPEYLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA-------------- 229 (329)
T ss_pred ------cceecCChhhcCHHHHcC--CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc--------------
Confidence 123579999999999987 6789999999999999999999999987765443333221
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHG 312 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt-----a~eiL~hp~f~~ 312 (508)
.. ..+ ...++..+.+||.+||+.||.+||+ +++++.||||.+
T Consensus 230 ------------~~--~~~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 230 ------------GR--LKF---PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred ------------CC--cCC---CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 00 011 1236788999999999999999997 799999999985
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=372.03 Aligned_cols=302 Identities=34% Similarity=0.537 Sum_probs=248.0
Q ss_pred ccccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCC-
Q 010512 10 FTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP- 88 (508)
Q Consensus 10 ~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~- 88 (508)
+.-..+.++|+-+..||+|.||.||+|+.+.+|+.||+|++--..+........++|+++|..|+|+|++.+++++...
T Consensus 10 ~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 10 EPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred CCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence 4445788999999999999999999999999999999998743222333445678999999999999999999988643
Q ss_pred --CcCCCccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccc
Q 010512 89 --SRREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 165 (508)
Q Consensus 89 --~~~~~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFG 165 (508)
.......+|+||++|+.||..++... .+++..+++.++.+++.||.|||++.|+|||+||.|+||+.+|.+||+|||
T Consensus 90 Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred CCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccc
Confidence 22344569999999999999999765 589999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC
Q 010512 166 LARVSFNDA-PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244 (508)
Q Consensus 166 la~~~~~~~-~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p 244 (508)
+|+.+.... .....++..+.|.||++||.+.|. ..|+++.|||..|||+++|++|.+.|.+....+++..|..++|..
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 998754322 222336778999999999999984 889999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHhhHHHHHHHhh--cccCCCCCCCCCCC--CCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 245 STESISRIRNEKARRYLGS--MRKKQPVPFSHKFP--NADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~--~~~~~~~~~~~~~~--~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
+.+.|....+...-.-+.. +++.+......... .-++.+.||+++||..||.+|+++.++|.|.||..
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 9988877655433332211 11111111111111 12578999999999999999999999999999963
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=383.56 Aligned_cols=260 Identities=27% Similarity=0.486 Sum_probs=227.6
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
.+++=|.+.+.||+|.|.+|.+|+|..||+.||||+|.+...+......+..|++.|+..+|||||+||++. ...
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQ 89 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQ 89 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----ccc
Confidence 456789999999999999999999999999999999998777666667899999999999999999999998 344
Q ss_pred ccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC-CCcEEEccccccccc
Q 010512 94 KDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVS 170 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~-~~~lkL~DFGla~~~ 170 (508)
..+|+|+|+-+ |+|+++|.+. ..+.++.+++||.||+.|+.|||...++||||||+|+++-+ -|-|||.|||++..+
T Consensus 90 TKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 90 TKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred ceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 56999999998 6999999875 47999999999999999999999999999999999987654 588999999999765
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCC-cchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~-~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
.... .+++.||+..|-|||++.| ..|+ +++||||||||||-|++|++||..-|+.+.+-.|.+..-+-
T Consensus 170 ~PG~----kL~TsCGSLAYSAPEILLG--DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtv----- 238 (864)
T KOG4717|consen 170 QPGK----KLTTSCGSLAYSAPEILLG--DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTV----- 238 (864)
T ss_pred CCcc----hhhcccchhhccCchhhhc--CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccC-----
Confidence 4332 3678899999999999998 5676 88999999999999999999999999888887776532221
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
-..++.++++||..||..||++|.+.++|..|+|++....
T Consensus 239 --------------------------PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 239 --------------------------PSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred --------------------------chhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 1246788999999999999999999999999999997643
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=367.66 Aligned_cols=262 Identities=29% Similarity=0.499 Sum_probs=219.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC--hh----HHHHHHHHHHHHHhCC-CCCcceeeeeecCCC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH--VS----DATRILREIKLLRLLR-HPDIVEIKHIMLPPS 89 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~--~~----~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~ 89 (508)
.+|+-.++||.|..++|.+|.++.||..+|+|+|...... .. ..+.-.+|+.||+++. ||+|+++.++|..++
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 3466678999999999999999999999999999643211 11 1234567999999985 999999999996554
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
.+++|+|+|. |.|++++.+.-.+++...+.|++||+.|+.|||..+|+||||||+|||++++.++||+|||+|+
T Consensus 97 -----F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 97 -----FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred -----hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceee
Confidence 4899999998 8999999999899999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccc----cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~----~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p 244 (508)
..... ..+...||||.|+|||.+... ...|+..+|+||+|+|+|-||.|.+||-.....-++..|..
T Consensus 172 ~l~~G----ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime----- 242 (411)
T KOG0599|consen 172 QLEPG----EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME----- 242 (411)
T ss_pred ccCCc----hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh-----
Confidence 65332 346788999999999998542 25689999999999999999999999976554444444432
Q ss_pred ChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.+...-+..|.+++..++|||.+||++||.+|+|++|+|.||||..+.
T Consensus 243 ----------------------GkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 243 ----------------------GKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred ----------------------cccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 112222345678889999999999999999999999999999997654
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=385.10 Aligned_cols=261 Identities=25% Similarity=0.465 Sum_probs=218.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++++.||+|+||.||+|++..+|+.||||++++... .......+.+|+.+|+.++||||+++++++. ...+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ-----DDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE-----cCCE
Confidence 479999999999999999999999999999999975422 2234566889999999999999999999984 4457
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999998 69999999888899999999999999999999999999999999999999999999999999975432
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+......
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------- 216 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET----------- 216 (333)
T ss_pred ----ccCCcccCccccChhHhcC--CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc-----------
Confidence 2345689999999999987 68999999999999999999999999987765554433221100
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
+ ..+ .+......+++.+.+||.+||..+|.+||+++++++||||.+.
T Consensus 217 ---------~--~~~-~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 217 ---------L--QRP-VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred ---------c--cCC-CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 0 000 0111113568899999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=389.11 Aligned_cols=262 Identities=26% Similarity=0.428 Sum_probs=214.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++++.||+|+||+||+|++..+|+.||||++.... ........+.+|+.+|+.++||||+++++.+. ....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ-----DENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-----cCCe
Confidence 47999999999999999999999999999999996432 22234456788999999999999999999984 3457
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999998 6999999988889999999999999999999999999999999999999999999999999987542211
Q ss_pred CC-----------------------------------cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHH
Q 010512 175 PS-----------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEML 219 (508)
Q Consensus 175 ~~-----------------------------------~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLl 219 (508)
.. .......+||+.|+|||++.+ ..|+.++|||||||++|+|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--CCCCCeeeeecchhHHHHhh
Confidence 00 001123479999999999977 68999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 010512 220 TGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP 299 (508)
Q Consensus 220 tG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp 299 (508)
+|.+||.+.+....+..+.... ....+. ....+++.+.+||.+||. ||.+|+
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~~--------------------------~~~~~~-~~~~~s~~~~~li~~ll~-~p~~R~ 285 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINWK--------------------------ETLQFP-DEVPLSPEAKDLIKRLCC-EAERRL 285 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcCC--------------------------CccCCC-CCCCCCHHHHHHHHHHcc-CHhhcC
Confidence 9999998877554443332110 001111 112467899999999997 999999
Q ss_pred C---HHHHhcCCcccCC
Q 010512 300 T---AEEALADPYFHGL 313 (508)
Q Consensus 300 t---a~eiL~hp~f~~~ 313 (508)
+ ++++|+||||++.
T Consensus 286 ~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 286 GNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHhcCCCcCCC
Confidence 8 9999999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=387.98 Aligned_cols=262 Identities=25% Similarity=0.385 Sum_probs=213.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++++.||+|+||+||+|.+..+|+.||||++++... .......+.+|+.+++.++||||+++++.+. +...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~-----~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ-----DKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCCe
Confidence 479999999999999999999999999999999965322 2233456788999999999999999999984 4457
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+|||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999998 6999999988899999999999999999999999999999999999999999999999999997532111
Q ss_pred CC--------------------------------cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCC
Q 010512 175 PS--------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK 222 (508)
Q Consensus 175 ~~--------------------------------~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~ 222 (508)
.. .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--CCCCCchhhhhhHHHHHHHHhCC
Confidence 00 001134589999999999987 68999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCC---CC
Q 010512 223 PLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD---RP 299 (508)
Q Consensus 223 ~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~---Rp 299 (508)
+||.+.+.......+..... ...+.. ...+++.+.+||.+|+. +|.+ ||
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~~--------------------------~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~ 285 (363)
T cd05628 234 PPFCSETPQETYKKVMNWKE--------------------------TLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAP 285 (363)
T ss_pred CCCCCCCHHHHHHHHHcCcC--------------------------cccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCC
Confidence 99988776555444432110 001111 12367889999999876 5554 58
Q ss_pred CHHHHhcCCcccCC
Q 010512 300 TAEEALADPYFHGL 313 (508)
Q Consensus 300 ta~eiL~hp~f~~~ 313 (508)
+++|+++||||++.
T Consensus 286 ~~~ei~~hp~f~~~ 299 (363)
T cd05628 286 GVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHHhCCCCCCCC
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=389.51 Aligned_cols=263 Identities=23% Similarity=0.335 Sum_probs=212.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
+.|++++.||+|+||+||+|++..++..||||++.... ........+.+|+.+|+.++||||+++++++.. ...
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-----~~~ 75 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-----KDN 75 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-----CCE
Confidence 46999999999999999999999999999999996532 233445678899999999999999999999943 456
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+||||++ |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999998 6999999988889999999999999999999999999999999999999999999999999986421100
Q ss_pred C--------------------------------------------CcccccccccCcccccccccccccCCCCcchhhhh
Q 010512 175 P--------------------------------------------SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 210 (508)
Q Consensus 175 ~--------------------------------------------~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWS 210 (508)
. ........+||+.|+|||++.+ ..|+.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwS 233 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--KGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--CCCCCccceee
Confidence 0 0001124589999999999987 67999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHh
Q 010512 211 IGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERL 290 (508)
Q Consensus 211 lG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~m 290 (508)
||||+|+|++|.+||.+.+.......+..... ... + .....+++.+.+||.+|
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~~~------------------------~~~--~-~~~~~~s~~~~dli~~l 286 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKVINWEN------------------------TLH--I-PPQVKLSPEAVDLITKL 286 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHHHcccc------------------------ccC--C-CCCCCCCHHHHHHHHHH
Confidence 99999999999999987665443332221100 000 0 11234689999999996
Q ss_pred ccC--CCCCCCCHHHHhcCCcccCC
Q 010512 291 LAF--DPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 291 L~~--DP~~Rpta~eiL~hp~f~~~ 313 (508)
|.. +|..|++++++++||||.++
T Consensus 287 l~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 287 CCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred ccCcccccCCCCHHHHhcCcccCCC
Confidence 654 44459999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=381.46 Aligned_cols=329 Identities=45% Similarity=0.768 Sum_probs=266.0
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~ 93 (508)
..++|++.+.||+|+||.||+|.+..+|..||+|++............+.+|+.+++.+ +||||+++++++... +.
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~---~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE---ND 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC---CC
Confidence 45789999999999999999999999999999999865544445556778999999999 999999999988542 23
Q ss_pred ccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 94 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 94 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
..+|+||||+.++|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 82 KDIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred ceEEEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 468999999999999998776 7899999999999999999999999999999999999999999999999999865432
Q ss_pred CCC--cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 174 APS--AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 174 ~~~--~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
... ......++||++|+|||++.+. ..++.++|||||||++|+|++|++||++....+.+..+....+.+..+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred cccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 211 1223456899999999988652 5678999999999999999999999999998899999999899988888777
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccchhhH
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFE 331 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~ 331 (508)
+........+..........+...++.++..+.+||.+||+.||.+|||+.++++||||+++.....++.........+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~- 318 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPL- 318 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCccCCc-
Confidence 7666666666655555555566667778999999999999999999999999999999998866555543322111111
Q ss_pred HHHhhcCHHHHHHHHHHH
Q 010512 332 FERRKLAKDDVREMIYRE 349 (508)
Q Consensus 332 ~~~~~~~~~~~~~~i~~e 349 (508)
...+++...+.+..+|.|
T Consensus 319 ~~~~~~~~~~~~~~~~~~ 336 (337)
T cd07852 319 DDNVKLSVAEYRNKLYEE 336 (337)
T ss_pred cccceeeHHHHHhhhhhc
Confidence 123445555555555544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=390.09 Aligned_cols=263 Identities=24% Similarity=0.360 Sum_probs=213.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++++.||+|+||+||+|++..+++.||||++.+.. ........+.+|+.+|+.++||||+++++.+. +...
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~ 75 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDN 75 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCE
Confidence 46999999999999999999999999999999996432 12234567889999999999999999999984 3456
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+|||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999985321000
Q ss_pred C--------------------------------------------CcccccccccCcccccccccccccCCCCcchhhhh
Q 010512 175 P--------------------------------------------SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 210 (508)
Q Consensus 175 ~--------------------------------------------~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWS 210 (508)
. ........+||+.|+|||++.+ ..|+.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwS 233 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--CCCCCeeeEEe
Confidence 0 0000123579999999999987 68999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHh
Q 010512 211 IGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERL 290 (508)
Q Consensus 211 lG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~m 290 (508)
|||++|+|++|++||.+.+.......+.... ..... .....+++.+.+||.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------------~~~~~---p~~~~~s~~~~~li~~l 286 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQ------------------------TSLHI---PPQAKLSPEASDLIIKL 286 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHHccC------------------------CCcCC---CCcccCCHHHHHHHHHH
Confidence 9999999999999998876544433332110 00011 11235689999999998
Q ss_pred ccCCCCCCCC---HHHHhcCCcccCCC
Q 010512 291 LAFDPKDRPT---AEEALADPYFHGLA 314 (508)
Q Consensus 291 L~~DP~~Rpt---a~eiL~hp~f~~~~ 314 (508)
+. ||.+|++ ++++++||||++..
T Consensus 287 ~~-~p~~R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 287 CR-GPEDRLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred cc-CHhHcCCCCCHHHHhcCCCcCCcC
Confidence 74 9999997 99999999998653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=376.45 Aligned_cols=322 Identities=49% Similarity=0.863 Sum_probs=270.8
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
+...++|++.+.||.|+||.||+|.+..+|..||||++.+........+.+.+|+.+++.++||||+++.+++...
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---- 81 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP---- 81 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----
Confidence 5678899999999999999999999999999999999865443334556788999999999999999999988532
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 93 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
....|+||||++++|.+++.. .++++..+..++.||+.||.|||+.||+||||||.||+++.++.++|+|||++.....
T Consensus 82 ~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 82 LEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred CCcEEEEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 246899999999999888764 4688999999999999999999999999999999999999999999999999875321
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
......++..|+|||.+.+. ..++.++|||||||++|+|++|++||++.........+.+.+|.++.+....+
T Consensus 161 ------~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 161 ------QMTGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred ------CcCCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 12345778899999987542 46889999999999999999999999998888888888899999998887776
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccchhhHH
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEF 332 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 332 (508)
.......++.......+.++...++.+++.+.++|.+||+.||.+|||+++++.||||.....+..++.. -..+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~--~~~~~~~~ 311 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVA--EEKFDWSF 311 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCc--hhhcCCch
Confidence 6655555666666566666666777889999999999999999999999999999999987766554432 23667788
Q ss_pred HHhhcCHHHHHHHHHH
Q 010512 333 ERRKLAKDDVREMIYR 348 (508)
Q Consensus 333 ~~~~~~~~~~~~~i~~ 348 (508)
....+..+.|+-|.|.
T Consensus 312 ~~~~~~~~~~~~~~~~ 327 (328)
T cd07856 312 NDADLPVDTWKVMMYS 327 (328)
T ss_pred hcccCCHHHHHHHhcC
Confidence 8888888988887764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=368.52 Aligned_cols=282 Identities=38% Similarity=0.638 Sum_probs=228.5
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
+|++.+.||+|+||.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-----ESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-----CCeEE
Confidence 5899999999999999999999999999999987543333345678899999999999999999999853 45689
Q ss_pred EEEecCCccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 98 VVFELMESDLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 98 lV~E~~~g~L~~~i~~~---~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 99999999998888653 468999999999999999999999999999999999999999999999999997542211
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
.......+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+...++.+....+.....
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 ---RVYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred ---ccccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 122345678999999988652 4678999999999999999999999999888877777777777766655543221
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
...+...........+......+++++.+||.+||..||.+|||+.+++.||||
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 --LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred --hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 111222222212222233345688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=372.61 Aligned_cols=259 Identities=24% Similarity=0.352 Sum_probs=210.7
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
.|++.+.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.+|+.++|+||+.+++++. +...+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~-----~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc-----cCCeE
Confidence 38899999999999999999999999999999864322 2223345789999999999999999999984 34569
Q ss_pred EEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 97 YVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
|+|||||. |+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999998 6898777543 36899999999999999999999999999999999999999999999999999764222
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 156 ~----~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~------------- 216 (285)
T cd05631 156 E----TVRGRVGTVGYMAPEVINN--EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR------------- 216 (285)
T ss_pred C----eecCCCCCCCccCHhhhcC--CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH-------------
Confidence 1 1245679999999999987 68999999999999999999999999876543222111110
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLA 314 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt-----a~eiL~hp~f~~~~ 314 (508)
.. ... .......++.+.+||.+||..||.+||+ ++++++||||.++.
T Consensus 217 ----------~~-~~~---~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 217 ----------VK-EDQ---EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred ----------hh-ccc---ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 00 000 1122356789999999999999999997 99999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-47 Score=395.15 Aligned_cols=256 Identities=25% Similarity=0.457 Sum_probs=221.1
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCCCc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~-~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~ 94 (508)
.+|.++++||+|+||+|++|..+.+++.||||.+++. .....+......|..|+.... ||.++.++..|. ...
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQ-----T~~ 442 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQ-----TKE 442 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccc-----cCC
Confidence 6799999999999999999999999999999999864 334456778889999998886 999999999994 446
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
++|+||||+.| | ...+...+.+++..+++|+..|+.||.|||++||||||||.+|||+|.+|.+||+|||+++.....
T Consensus 443 ~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 443 HLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred eEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 79999999985 6 444455578999999999999999999999999999999999999999999999999999864322
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
. ...+++||||.|||||++.+ ..|+.++|.|||||+|||||.|++||+|+++.+..+.|..-
T Consensus 522 g---~~TsTfCGTpey~aPEil~e--~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d------------- 583 (694)
T KOG0694|consen 522 G---DRTSTFCGTPEFLAPEVLTE--QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND------------- 583 (694)
T ss_pred C---CccccccCChhhcChhhhcc--CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------
Confidence 2 23467899999999999998 89999999999999999999999999999998887766431
Q ss_pred hHHHHHHHhhcccCCCCCCCCCC-CCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLAN 315 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~Ll~~mL~~DP~~Rpt-----a~eiL~hp~f~~~~~ 315 (508)
...+ ..++.++.++++++|.+||.+|.. +++|..||||+.+..
T Consensus 584 -------------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w 632 (694)
T KOG0694|consen 584 -------------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW 632 (694)
T ss_pred -------------------CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence 0111 246789999999999999999976 588999999998764
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=384.60 Aligned_cols=263 Identities=30% Similarity=0.480 Sum_probs=217.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++++.||+|+||+||+|.+..+|+.||||+++.... .......+.+|+.+|+.++||||+++++++. +...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ-----DEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee-----cCCe
Confidence 479999999999999999999999999999999975322 2234566889999999999999999999884 4457
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999997 6999999888889999999999999999999999999999999999999999999999999998653322
Q ss_pred --------------------------CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCC
Q 010512 175 --------------------------PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK 228 (508)
Q Consensus 175 --------------------------~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~ 228 (508)
.........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--TPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcC--CCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 00112334679999999999987 68999999999999999999999999887
Q ss_pred ChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-HHHHhcC
Q 010512 229 NVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-AEEALAD 307 (508)
Q Consensus 229 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt-a~eiL~h 307 (508)
+.......+..... ....+ ....+++.+.+||.+||. ||.+||+ ++++|+|
T Consensus 234 ~~~~~~~~i~~~~~------------------------~~~~p---~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKIINWKE------------------------SLRFP---PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHHhccCC------------------------cccCC---CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 75444433322110 00011 112368999999999998 9999999 9999999
Q ss_pred CcccCCC
Q 010512 308 PYFHGLA 314 (508)
Q Consensus 308 p~f~~~~ 314 (508)
|||+++.
T Consensus 286 p~~~~~~ 292 (350)
T cd05573 286 PFFKGID 292 (350)
T ss_pred CCcCCCC
Confidence 9998653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=388.70 Aligned_cols=262 Identities=25% Similarity=0.407 Sum_probs=212.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++++.||+|+||.||+|.+..+|+.||||++.+... .......+.+|+.+|+.++||||+++++++. +...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ-----DAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCe
Confidence 479999999999999999999999999999999864321 2234566889999999999999999999984 3456
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+||||++ |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999997 6999999888889999999999999999999999999999999999999999999999999996321100
Q ss_pred CC------------c--------------------------------ccccccccCcccccccccccccCCCCcchhhhh
Q 010512 175 PS------------A--------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 210 (508)
Q Consensus 175 ~~------------~--------------------------------~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWS 210 (508)
.. . ......+||+.|+|||++.+ ..|+.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwS 233 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--QGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc--CCCCCceeeEe
Confidence 00 0 00012579999999999977 68999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHh
Q 010512 211 IGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERL 290 (508)
Q Consensus 211 lG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~m 290 (508)
|||++|+|++|.+||.+.+..+.+..+.... . ...+. ....+++.+.+||.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------------~--~~~~p-~~~~~s~~~~dli~~l 286 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINWR------------------------E--TLYFP-DDIHLSVEAEDLIRRL 286 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHccC------------------------C--ccCCC-CCCCCCHHHHHHHHHH
Confidence 9999999999999998877655444332210 0 00111 1124678999999999
Q ss_pred ccCCCCCC---CCHHHHhcCCcccCC
Q 010512 291 LAFDPKDR---PTAEEALADPYFHGL 313 (508)
Q Consensus 291 L~~DP~~R---pta~eiL~hp~f~~~ 313 (508)
|. +|.+| +|+.+++.||||.+.
T Consensus 287 L~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 287 IT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 98 77765 599999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=370.45 Aligned_cols=282 Identities=37% Similarity=0.608 Sum_probs=226.3
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
+|++.+.||+|+||.||+|++..+|..||+|+++...........+.+|+.+++.++||||+++++++. +...+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH-----SDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc-----cCCceE
Confidence 699999999999999999999999999999998654333333456778999999999999999999984 345699
Q ss_pred EEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCC
Q 010512 98 VVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 176 (508)
Q Consensus 98 lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~ 176 (508)
+|+||++++|.+++.. .+.+++..++.++.||++||.|||++||+||||||+||+++.++.++|+|||+++......
T Consensus 76 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-- 153 (284)
T cd07839 76 LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-- 153 (284)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--
Confidence 9999999999988865 5679999999999999999999999999999999999999999999999999997542211
Q ss_pred cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 177 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL-FPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 177 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~p-F~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
.......+++.|+|||++.+. ..++.++|||||||++|+|++|..| |++.+...++..+...++.+....+..+...
T Consensus 154 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 -RCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred -CCcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 123445788999999998662 4578999999999999999998765 6777777888888888888776655432211
Q ss_pred HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
...... ........+....+.+++.+.+||.+||..||.+|||+++++.||||
T Consensus 232 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYKPY--PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccc--CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 000000 00001112233446688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=388.32 Aligned_cols=262 Identities=24% Similarity=0.356 Sum_probs=212.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++++.||+|+||.||+|.+..+|+.||||++.+.. ........+.+|+.+|+.++||||+++++.+. +.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ-----DKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCE
Confidence 47999999999999999999999999999999986432 12233456789999999999999999999984 4457
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+|||||+ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999998 6999999988889999999999999999999999999999999999999999999999999985321000
Q ss_pred C----------------------------------------CcccccccccCcccccccccccccCCCCcchhhhhHHHH
Q 010512 175 P----------------------------------------SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 214 (508)
Q Consensus 175 ~----------------------------------------~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~i 214 (508)
. ........+||+.|+|||++.+ ..++.++|||||||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvi 233 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--CCCCcceeeeeccce
Confidence 0 0000123579999999999987 688999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCC
Q 010512 215 FAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFD 294 (508)
Q Consensus 215 l~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~D 294 (508)
+|+|++|+.||.+.+..+....+.... ..... .....+++.+.+||.+|+ .|
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~------------------------~~~~~---~~~~~~s~~~~~li~~l~-~~ 285 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWE------------------------TTLHI---PSQAKLSREASDLILRLC-CG 285 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccC------------------------ccccC---CCCCCCCHHHHHHHHHHh-cC
Confidence 999999999998877544433222110 00001 112357889999999987 49
Q ss_pred CCCCC---CHHHHhcCCcccCC
Q 010512 295 PKDRP---TAEEALADPYFHGL 313 (508)
Q Consensus 295 P~~Rp---ta~eiL~hp~f~~~ 313 (508)
|.+|+ |+.++++||||.++
T Consensus 286 p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 286 AEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred HhhcCCCCCHHHHhCCCCcCCC
Confidence 99999 99999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=377.47 Aligned_cols=248 Identities=32% Similarity=0.492 Sum_probs=207.8
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEecC
Q 010512 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 103 (508)
Q Consensus 25 LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~ 103 (508)
||+|+||.||+|.+..+++.||+|+++... ........+.+|+.+|+.++||||+++++++. ....+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-----SPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-----cCCeEEEEEcCC
Confidence 799999999999999999999999996432 22344567889999999999999999999884 345699999999
Q ss_pred C-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcccccc
Q 010512 104 E-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 182 (508)
Q Consensus 104 ~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~ 182 (508)
. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ....
T Consensus 76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~ 152 (312)
T cd05585 76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNT 152 (312)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC---cccc
Confidence 8 69999998888899999999999999999999999999999999999999999999999999975322221 2345
Q ss_pred cccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHh
Q 010512 183 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLG 262 (508)
Q Consensus 183 ~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~ 262 (508)
.+||+.|+|||++.+ ..|+.++||||+||++|+|++|++||.+.+.......+..
T Consensus 153 ~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~----------------------- 207 (312)
T cd05585 153 FCGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ----------------------- 207 (312)
T ss_pred ccCCcccCCHHHHcC--CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc-----------------------
Confidence 689999999999987 6899999999999999999999999987765433322211
Q ss_pred hcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC---CHHHHhcCCcccCC
Q 010512 263 SMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP---TAEEALADPYFHGL 313 (508)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp---ta~eiL~hp~f~~~ 313 (508)
.+.. ....+++.+.+||.+||..||.+|| ++.++|.||||...
T Consensus 208 -----~~~~---~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 208 -----EPLR---FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred -----CCCC---CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 0111 1135678999999999999999997 58999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=382.76 Aligned_cols=256 Identities=24% Similarity=0.366 Sum_probs=213.8
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCC-cEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTG-ERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg-~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
..++|++.+.||+|+||.||+|.+..++ ..||+|++.... ........+.+|+.+|+.++||||+++++++..
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~----- 102 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD----- 102 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe-----
Confidence 3467999999999999999999876655 689999986432 222345678899999999999999999999843
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
...+|+||||+. |+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 456999999997 6999999988899999999999999999999999999999999999999999999999999998642
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+...
T Consensus 183 ~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~----------- 243 (340)
T PTZ00426 183 TR------TYTLCGTPEYIAPEILLN--VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG----------- 243 (340)
T ss_pred CC------cceecCChhhcCHHHHhC--CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC-----------
Confidence 21 234679999999999987 67899999999999999999999999877654333332210
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 314 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~~ 314 (508)
. .. ..+.+++.+.+||++||+.||.+|+ +++++++||||.++.
T Consensus 244 ---------------~--~~---~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 244 ---------------I--IY---FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID 291 (340)
T ss_pred ---------------C--CC---CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 0 00 1134578899999999999999995 899999999998753
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=378.28 Aligned_cols=250 Identities=25% Similarity=0.449 Sum_probs=209.1
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEe
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 101 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 101 (508)
++||+|+||.||+|.+..+|..||+|++.+... .......+.+|+.+|+.++||||+++++.+. ....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ-----TKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-----cCCEEEEEEe
Confidence 479999999999999999999999999975422 2334567889999999999999999999884 3456999999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcccc
Q 010512 102 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 180 (508)
Q Consensus 102 ~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~ 180 (508)
|++ |+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~---~~~ 152 (328)
T cd05593 76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA---ATM 152 (328)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc---ccc
Confidence 998 6999999888889999999999999999999999999999999999999999999999999987532221 123
Q ss_pred cccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHH
Q 010512 181 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 260 (508)
Q Consensus 181 ~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~ 260 (508)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--------------------- 209 (328)
T cd05593 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------------- 209 (328)
T ss_pred ccccCCcCccChhhhcC--CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc---------------------
Confidence 45679999999999987 6889999999999999999999999987665433322210
Q ss_pred HhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCC
Q 010512 261 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGL 313 (508)
Q Consensus 261 l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~ 313 (508)
.. .. ....+++.+.+||.+||..||.+|+ ++.++++||||.+.
T Consensus 210 -----~~--~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 210 -----ED--IK---FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred -----CC--cc---CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 00 01 1134678899999999999999997 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=376.61 Aligned_cols=250 Identities=26% Similarity=0.447 Sum_probs=209.2
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEe
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 101 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 101 (508)
+.||+|+||.||+|.+..+|..||+|+++.... .......+.+|+.+|+.++||||+++++++.. ...+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCEEEEEEe
Confidence 479999999999999999999999999975322 22345567889999999999999999999843 356999999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcccc
Q 010512 102 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 180 (508)
Q Consensus 102 ~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~ 180 (508)
|++ ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~---~~~ 152 (323)
T cd05595 76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC---Ccc
Confidence 998 6999999888889999999999999999999999999999999999999999999999999987532221 123
Q ss_pred cccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHH
Q 010512 181 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 260 (508)
Q Consensus 181 ~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~ 260 (508)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~--------------------- 209 (323)
T cd05595 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------------- 209 (323)
T ss_pred ccccCCcCcCCcccccC--CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------------
Confidence 44679999999999977 6889999999999999999999999987665443333211
Q ss_pred HhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCC
Q 010512 261 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGL 313 (508)
Q Consensus 261 l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~ 313 (508)
... . ....+++.+.+||.+||..||.+|+ ++.++++||||.+.
T Consensus 210 -----~~~--~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 210 -----EEI--R---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred -----CCC--C---CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 000 0 1134678999999999999999998 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=371.17 Aligned_cols=293 Identities=41% Similarity=0.634 Sum_probs=234.9
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++.+.||.|+||.||+|.+..+|+.||+|++............+.+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCC
Confidence 45789999999999999999999999999999999864433333334567899999999999999999998643 235
Q ss_pred cEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
.+|+||||++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 82 SIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred eEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 68999999999998888763 57999999999999999999999999999999999999999999999999999865332
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
. ...+...+++.|+|||++.+. ..++.++||||+||++|+|++|++||.+.+..+++..+...++.+....+..+.
T Consensus 162 ~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 162 A---KPMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred c---CCCCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 2 122344668899999998652 568899999999999999999999999999999999999999888776554332
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
........ .........+...+...++.+.+||.+||.+||.+|||++++|.||||.+..-
T Consensus 238 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 238 DLPLVGKF-TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred cccccccc-cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 21100000 00111111222334456889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=383.45 Aligned_cols=257 Identities=29% Similarity=0.456 Sum_probs=223.4
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
....|..++.||+|+||.||+|.+..|++.||||+++-. ....+...+.+|+.+|..++++||.++++.|+...
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le-~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~----- 84 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE-EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT----- 84 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechh-hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc-----
Confidence 345788889999999999999999999999999999743 33445678899999999999999999999997654
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
.++++||||. |++.++++....+.+.++..++++++.||.|||+.+.+|||||+.|||+..+|.+||+|||.+......
T Consensus 85 ~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 85 KLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred cHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech
Confidence 4899999998 699999998888899999999999999999999999999999999999999999999999999865433
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
.. ...+++||+.|||||++.+ ..|+.++||||||++.+||++|.|||......
T Consensus 165 ~~---rr~tfvGTPfwMAPEVI~~--~~Y~~KADIWSLGITaiEla~GePP~s~~hPm---------------------- 217 (467)
T KOG0201|consen 165 VK---RRKTFVGTPFWMAPEVIKQ--SGYDTKADIWSLGITAIELAKGEPPHSKLHPM---------------------- 217 (467)
T ss_pred hh---ccccccccccccchhhhcc--ccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------------
Confidence 32 2367899999999999996 79999999999999999999999999876532
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
+++..+++..|..+.. .+++.+++|+..||.+||+.||+|.++|+|+|++.
T Consensus 218 -----rvlflIpk~~PP~L~~---~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 218 -----RVLFLIPKSAPPRLDG---DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred -----eEEEeccCCCCCcccc---ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 2333444455544443 67889999999999999999999999999999985
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=368.48 Aligned_cols=264 Identities=27% Similarity=0.410 Sum_probs=223.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
+.|++++.||.|.-|+||+|..+.++..+|+|++.+... ......++..|-.||..+.||.+..|+..+ +...+
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~~~ 151 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETDKY 151 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----eccce
Confidence 568899999999999999999999999999999986533 344567788899999999999999999999 55567
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 96 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
+|+|||||. |+|+.+.+++ ..++++.+++|+..++-||+|||..|||+||||||||||.++|+|.|+||.|+.....
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 999999998 6999999875 4699999999999999999999999999999999999999999999999999854210
Q ss_pred C----------------------------------C-------------------CCcccccccccCccccccccccccc
Q 010512 173 D----------------------------------A-------------------PSAIFWTDYVATRWYRAPELCGSFF 199 (508)
Q Consensus 173 ~----------------------------------~-------------------~~~~~~~~~~gT~~Y~APE~l~~~~ 199 (508)
. . +.......+|||-.|.|||++.|
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-- 309 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-- 309 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec--
Confidence 0 0 00011124689999999999998
Q ss_pred CCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCC
Q 010512 200 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNA 279 (508)
Q Consensus 200 ~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 279 (508)
...+.++|.|+|||++||||.|.-||.|.+...++..|.. ++..|.. .+.+
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~----------------------------~~l~Fp~-~~~v 360 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG----------------------------QPLKFPE-EPEV 360 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc----------------------------CCCcCCC-CCcc
Confidence 7889999999999999999999999999998877766642 1111111 1256
Q ss_pred CHHHHHHHHHhccCCCCCCCC----HHHHhcCCcccCCCCC
Q 010512 280 DPLALHLLERLLAFDPKDRPT----AEEALADPYFHGLANV 316 (508)
Q Consensus 280 ~~~~~~Ll~~mL~~DP~~Rpt----a~eiL~hp~f~~~~~~ 316 (508)
+..++|||+++|.+||.+|.. |.||-+||||+++...
T Consensus 361 s~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 361 SSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred hhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 788999999999999999998 9999999999998764
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=377.28 Aligned_cols=262 Identities=24% Similarity=0.404 Sum_probs=214.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++.+.||+|+||+||+|.+..+|+.||||+++.... .......+.+|+.+++.++||||+++++++. +...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~-----~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ-----DKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCe
Confidence 479999999999999999999999999999999975432 2234456788999999999999999999884 3456
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 96 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999997 6999999876 67999999999999999999999999999999999999999999999999999865332
Q ss_pred CCCcccccccccCcccccccccccc----cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~----~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
... .....+||+.|+|||++... ...++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--------- 224 (330)
T cd05601 156 KMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--------- 224 (330)
T ss_pred Cce--eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC---------
Confidence 211 22345799999999998631 146789999999999999999999999877655444333221
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.....+ ...+.+++.+.+||.+||. ||.+|||++++++||||..+
T Consensus 225 -----------------~~~~~~-~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 225 -----------------QRFLKF-PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred -----------------CCccCC-CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 000011 1123578899999999998 99999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=373.44 Aligned_cols=255 Identities=25% Similarity=0.419 Sum_probs=211.8
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCC-CcceeeeeecCCCcCCCcc
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHP-DIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~Hp-nIv~l~~v~~~~~~~~~~~ 95 (508)
+|++++.||+|+||.||+|.+..+++.||||++.+... .......+..|+.++..+.|+ +|+.+++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----MDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-----CCE
Confidence 58999999999999999999999999999999975322 233456778899999999865 57788888743 356
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+||||++ |+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999987432211
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
. .....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+....+..+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------------- 216 (324)
T cd05587 156 K---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------------- 216 (324)
T ss_pred C---ceeeecCCccccChhhhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------
Confidence 1 1234679999999999987 67899999999999999999999999887755444333211
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH-----HHHhcCCcccCC
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA-----EEALADPYFHGL 313 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta-----~eiL~hp~f~~~ 313 (508)
. .. ....+++.+.+||.+||..||.+|++. +++++||||...
T Consensus 217 ------------~--~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 217 ------------N--VS---YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred ------------C--CC---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 0 00 112467889999999999999999986 899999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=362.52 Aligned_cols=285 Identities=41% Similarity=0.715 Sum_probs=234.2
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
+|++.+.||+|+||.||+|.+..+|..||+|++............+.+|+.+++.++||||+++++++.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-----GSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeE
Confidence 6999999999999999999999999999999997654334445678899999999999999999999844 45689
Q ss_pred EEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCC
Q 010512 98 VVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 176 (508)
Q Consensus 98 lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~ 176 (508)
+||||+.++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 76 ~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 76 LVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9999997799999865 45699999999999999999999999999999999999999999999999999986533221
Q ss_pred cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHH
Q 010512 177 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256 (508)
Q Consensus 177 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 256 (508)
.......++.+|+|||.+.+. ..++.++||||+||++|+|++|.+||.+.+....+..+...++.+....+.......
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred -CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 123445789999999998652 457899999999999999999999999998888888888888888776554432111
Q ss_pred HHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010512 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 257 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~ 311 (508)
.... .......+..+...+++.+..+.+||.+||..||.+|||++++|+||||.
T Consensus 233 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 233 DYNK-ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhhc-ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0000 01122223334445567789999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=371.36 Aligned_cols=279 Identities=24% Similarity=0.389 Sum_probs=217.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++++.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+++|+.++||||+++++++.. .+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 77 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE 77 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCE
Confidence 478999999999999999999999999999999987432 23345678999999999999999999999843 356
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhc-CceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~-gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
+|+||||++ ++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999998 59999998888899999999999999999999986 6999999999999999999999999999754322
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHH-----
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES----- 248 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~----- 248 (508)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+ +.+....
T Consensus 158 ~-----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~----~~~~~~~~~~~~ 226 (331)
T cd06649 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF----GRPVVDGEEGEP 226 (331)
T ss_pred c-----cccCCCCcCcCCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh----cccccccccCCc
Confidence 1 234679999999999987 67999999999999999999999999876654332222 1111000
Q ss_pred -------------H-----HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 249 -------------I-----SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 249 -------------~-----~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
. ...........+..+....+... .....++.+.+||.+||++||++|||++++|+||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 227 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKL--PNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cccCcccccccccccccccccccchhHHHHHHHHHhCCCcCC--CCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 0 00000000111111111111111 113467899999999999999999999999999999
Q ss_pred cCC
Q 010512 311 HGL 313 (508)
Q Consensus 311 ~~~ 313 (508)
+..
T Consensus 305 ~~~ 307 (331)
T cd06649 305 KRS 307 (331)
T ss_pred hhc
Confidence 853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=362.17 Aligned_cols=282 Identities=40% Similarity=0.645 Sum_probs=229.2
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
.|++++.||.|++|.||+|++..+|..||||+++...........+.+|+++++.++||||+++++++. ....+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEE
Confidence 489999999999999999999999999999998754333334457889999999999999999999984 345689
Q ss_pred EEEecCCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 98 VVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 98 lV~E~~~g~L~~~i~~--~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
+||||+.++|..++.. ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++.......
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 9999999899988865 3468999999999999999999999999999999999999999999999999987543221
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
.......+++.|+|||++.+. ..++.++|||||||++|+|++|+.||++.+....+..+...++.+....+.....
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (284)
T cd07860 155 --RTYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS- 230 (284)
T ss_pred --cccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH-
Confidence 112344678999999988652 4468899999999999999999999999998888888888888887655433221
Q ss_pred HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
...+...........+....+.+++.+.+||.+||+.||.+|||++++|+||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 231 -LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred -HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 111212222222222333345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=373.99 Aligned_cols=251 Identities=24% Similarity=0.414 Sum_probs=209.0
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCCccEEEEE
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV~ 100 (508)
+.||+|+||+||+|.+..+++.||||++.+.. ........+.+|+.++..+ +||||+++++++. ....+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~-----~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ-----TPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE-----cCCEEEEEE
Confidence 47999999999999999999999999997532 2223455677899998876 6999999999984 345699999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCccc
Q 010512 101 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179 (508)
Q Consensus 101 E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~ 179 (508)
||++ |+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~---~~ 152 (320)
T cd05590 76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---KT 152 (320)
T ss_pred cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC---Cc
Confidence 9998 6999999888899999999999999999999999999999999999999999999999999987532211 12
Q ss_pred ccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHH
Q 010512 180 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259 (508)
Q Consensus 180 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 259 (508)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~------------------- 211 (320)
T cd05590 153 TSTFCGTPDYIAPEILQE--MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND------------------- 211 (320)
T ss_pred ccccccCccccCHHHHcC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-------------------
Confidence 344679999999999987 68899999999999999999999999887765544433210
Q ss_pred HHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH------HHHhcCCcccCCC
Q 010512 260 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA------EEALADPYFHGLA 314 (508)
Q Consensus 260 ~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta------~eiL~hp~f~~~~ 314 (508)
. .. ....+++.+.+||.+||+.||.+||++ +++++||||.++.
T Consensus 212 --------~-~~---~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 212 --------E-VV---YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred --------C-CC---CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 0 00 112367889999999999999999998 9999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=376.04 Aligned_cols=250 Identities=27% Similarity=0.475 Sum_probs=208.4
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEe
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 101 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 101 (508)
+.||+|+||.||+|.+..+|..||+|++.+... .......+.+|+++++.++||||+++++++. ....+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~-----~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----THDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEE-----cCCEEEEEEe
Confidence 479999999999999999999999999975422 2234566788999999999999999999884 3456999999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-cCceecCCCCCceeeCCCCcEEEccccccccccCCCCCccc
Q 010512 102 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179 (508)
Q Consensus 102 ~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs-~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~ 179 (508)
|++ |+|..++.....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~---~~ 152 (325)
T cd05594 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---AT 152 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC---cc
Confidence 998 6899999888889999999999999999999997 799999999999999999999999999987532221 12
Q ss_pred ccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHH
Q 010512 180 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259 (508)
Q Consensus 180 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 259 (508)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-------------------- 210 (325)
T cd05594 153 MKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-------------------- 210 (325)
T ss_pred cccccCCcccCCHHHHcc--CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc--------------------
Confidence 344679999999999977 6889999999999999999999999987665433332211
Q ss_pred HHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCC
Q 010512 260 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGL 313 (508)
Q Consensus 260 ~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~ 313 (508)
....+ -..+++.+.+||.+||+.||.+|+ ++.++++||||.+.
T Consensus 211 --------~~~~~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 211 --------EEIRF---PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred --------CCCCC---CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 00001 124678999999999999999997 99999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=368.84 Aligned_cols=280 Identities=36% Similarity=0.599 Sum_probs=213.7
Q ss_pred eeeeecCceEEEEEEECC--CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEE
Q 010512 23 EVIGKGSYGVVGSAVDTH--TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~--tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~ 100 (508)
..||+|+||.||+|.+.. ++..||+|.+.... ....+.+|+.+|+.++||||+++++++... ....+|+||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~ 79 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLF 79 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEE
Confidence 579999999999998654 66899999986432 234567899999999999999999998653 235689999
Q ss_pred ecCCccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceee----CCCCcEEEcccccc
Q 010512 101 ELMESDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFGLA 167 (508)
Q Consensus 101 E~~~g~L~~~i~~~---------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl----~~~~~lkL~DFGla 167 (508)
||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 80 DYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 99999998887532 248899999999999999999999999999999999999 56678999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCCh---------HHHHHHHH
Q 010512 168 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV---------VHQLDLMT 238 (508)
Q Consensus 168 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~---------~~~l~~i~ 238 (508)
+...............+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+... ..++..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 8654332222223456889999999998752 4689999999999999999999999976442 35677788
Q ss_pred hhcCCCChHHHHHHhhHH-HHHHHhhcccC--CCC----CCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 239 DLLGTPSTESISRIRNEK-ARRYLGSMRKK--QPV----PFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 239 ~~~g~p~~~~~~~~~~~~-~~~~l~~~~~~--~~~----~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
..+|.+....+..+.... ........... ... .........+..+.+||.+||..||.+|||++|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 888888777665542110 00000000000 000 0011112346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=373.83 Aligned_cols=261 Identities=24% Similarity=0.406 Sum_probs=209.0
Q ss_pred CeEEeeeeeecCceEEEEEEEC---CCCcEEEEEEecCcc--CChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcC
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVF--EHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~---~tg~~vAIKki~~~~--~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~ 91 (508)
+|++++.||+|+||+||+|.+. .+|..||+|++.+.. ........+.+|+.+|+.++ ||||+.+++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----- 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ----- 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe-----
Confidence 5999999999999999999864 578999999986432 12233456788999999995 899999999884
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
....+|+||||+. |+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 3456899999998 699999988888999999999999999999999999999999999999999999999999999864
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
...... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...........+.
T Consensus 156 ~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~------------ 220 (332)
T cd05614 156 LSEEKE--RTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS------------ 220 (332)
T ss_pred cccCCC--ccccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH------------
Confidence 322211 12346899999999998762 457889999999999999999999997543211111110
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGL 313 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~ 313 (508)
.... .... .....+++.+.+||.+||..||.+|| +++++++||||++.
T Consensus 221 -------~~~~---~~~~-----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 221 -------RRIL---KCDP-----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred -------HHHh---cCCC-----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 0000 0011 11234678999999999999999999 89999999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=379.47 Aligned_cols=263 Identities=25% Similarity=0.374 Sum_probs=214.0
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
..++|++.+.||+|+||.||+|.+..+|..||+|++++.. ........+.+|+.+|+.++||||+++++++. +.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~-----~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ-----DD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence 3478999999999999999999999999999999996432 12233455778999999999999999999884 44
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
..+|+|||||+ |+|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 56999999998 6899888654 689999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCcccccccccccc--cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~--~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.. .......+||+.|+|||++.+. ...++.++|||||||++|+|++|++||.+.+....+..+...
T Consensus 195 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~---------- 262 (370)
T cd05596 195 NG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH---------- 262 (370)
T ss_pred CC--cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC----------
Confidence 21 1122346799999999998652 134889999999999999999999999987755444333210
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHhcCCcccC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD--RPTAEEALADPYFHG 312 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~--Rpta~eiL~hp~f~~ 312 (508)
.....+. ....++..+.+||.+||..+|.+ |+|++++++||||++
T Consensus 263 ----------------~~~~~~~-~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 263 ----------------KNSLTFP-DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred ----------------CCcCCCC-CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 0111111 12356899999999999999988 999999999999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=379.16 Aligned_cols=263 Identities=25% Similarity=0.404 Sum_probs=214.1
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
+.|++++.||+|+||.||+|.+..+|+.||||+++... ........+.+|+.++..++||||+++++.+. +...
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-----~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ-----DKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence 47999999999999999999999999999999996432 12234567788999999999999999999984 4457
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999998 6999999988889999999999999999999999999999999999999999999999999987532111
Q ss_pred CC--------------------------------cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCC
Q 010512 175 PS--------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK 222 (508)
Q Consensus 175 ~~--------------------------------~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~ 222 (508)
.. .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--CCCCCcceeccccceeeecccCC
Confidence 00 001124579999999999987 68999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC---
Q 010512 223 PLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP--- 299 (508)
Q Consensus 223 ~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp--- 299 (508)
+||.+.+.......+... .....+.. ...+++.+.+||.+|+. ||.+|+
T Consensus 234 ~Pf~~~~~~~~~~~i~~~--------------------------~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~ 285 (360)
T cd05627 234 PPFCSETPQETYRKVMNW--------------------------KETLVFPP-EVPISEKAKDLILRFCT-DSENRIGSN 285 (360)
T ss_pred CCCCCCCHHHHHHHHHcC--------------------------CCceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCC
Confidence 999887755444333211 00011111 12367899999999875 999998
Q ss_pred CHHHHhcCCcccCCC
Q 010512 300 TAEEALADPYFHGLA 314 (508)
Q Consensus 300 ta~eiL~hp~f~~~~ 314 (508)
+++++++||||+++.
T Consensus 286 ~~~ei~~hp~f~~~~ 300 (360)
T cd05627 286 GVEEIKSHPFFEGVD 300 (360)
T ss_pred CHHHHhcCCCCCCCC
Confidence 489999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=371.45 Aligned_cols=253 Identities=27% Similarity=0.434 Sum_probs=207.7
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHH---HhCCCCCcceeeeeecCCCcCCCc
Q 010512 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLL---RLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL---~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
|++++.||+|+||.||+|.+..+|+.||||++++.. ........+.+|+.++ +.++||||+++++++. ...
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-----~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-----TED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-----cCC
Confidence 789999999999999999999999999999997532 1223345677777665 5667999999999984 345
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
.+|+||||+. ++|...+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 7999999998 588877754 57999999999999999999999999999999999999999999999999998753221
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 155 ~---~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------------- 216 (324)
T cd05589 155 G---DRTSTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND------------- 216 (324)
T ss_pred C---CcccccccCccccCHhHhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence 1 12245689999999999987 67899999999999999999999999887755444333210
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGL 313 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~ 313 (508)
.+ .....+++.+.+||.+||..||.+|| ++.++++||||.++
T Consensus 217 --------------~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 217 --------------EV----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred --------------CC----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 00 01124678899999999999999999 79999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=361.01 Aligned_cols=282 Identities=37% Similarity=0.676 Sum_probs=220.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|++.+.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++. ....+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEE
Confidence 4799999999999999999999999999999998643333233456789999999999999999999984 34568
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 97 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 97 ylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
|+||||+++ .|..++.....+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999999996 5555555566799999999999999999999999999999999999999999999999999986533221
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
......++.+|+|||.+.+. ..++.++|||||||++|+|++|.+||++.+..+.+..+...++.............
T Consensus 156 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 156 ---DYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred ---cccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 12345688999999998652 46789999999999999999999999998877777666665554333211111000
Q ss_pred HHHHHHhhcccC---CCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 256 KARRYLGSMRKK---QPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 256 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
.+...+... ...+....++.++..+.+||.+||..||++|||+.|++.||||
T Consensus 232 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 232 ---QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ---cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000001001 1111222345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=362.92 Aligned_cols=287 Identities=41% Similarity=0.671 Sum_probs=234.1
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC---hhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH---VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~---~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
+|++.+.||+|+||.||+|.+..+|..||||++...... ......+..|+.+++.++|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence 599999999999999999999999999999999754332 2234567789999999999999999999844 45
Q ss_pred cEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
.+|+||||+.++|.+++.... .+++..+..++.||++||.|||++||+|+||||+||+++.++.++|+|||+++.....
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 799999999889999998776 7999999999999999999999999999999999999999999999999999865332
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
.. ......+++.|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.+..+.+..+...++.+....+....
T Consensus 156 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NR---KMTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred Cc---cccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 21 12334678899999988542 567899999999999999999999999988888888887777777665544322
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 316 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~ 316 (508)
.. ..+. ......+.+....+...+..+.+||.+||.+||++|||+.|+|.||||++...+
T Consensus 232 ~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~ 291 (298)
T cd07841 232 SL--PDYV-EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP 291 (298)
T ss_pred cc--cccc-cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence 11 0111 111222333444556778899999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=370.97 Aligned_cols=250 Identities=25% Similarity=0.419 Sum_probs=208.7
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCCccEEEEE
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV~ 100 (508)
+.||+|+||.||+|.+..+|+.||||++.+.. ........+..|+.++..+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-----~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-----KDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCeEEEEE
Confidence 46999999999999999999999999997532 2233455677899999876 79999999999843 45699999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCccc
Q 010512 101 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179 (508)
Q Consensus 101 E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~ 179 (508)
||++ ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~---~~ 152 (321)
T cd05591 76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---VT 152 (321)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC---cc
Confidence 9998 6999999888889999999999999999999999999999999999999999999999999997532221 12
Q ss_pred ccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHH
Q 010512 180 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259 (508)
Q Consensus 180 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 259 (508)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~------------------- 211 (321)
T cd05591 153 TTTFCGTPDYIAPEILQE--LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD------------------- 211 (321)
T ss_pred ccccccCccccCHHHHcC--CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 345679999999999987 68999999999999999999999999988765554433210
Q ss_pred HHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-------CHHHHhcCCcccCC
Q 010512 260 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-------TAEEALADPYFHGL 313 (508)
Q Consensus 260 ~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-------ta~eiL~hp~f~~~ 313 (508)
.. . ....+++.+.+||.+||..||.+|| +++++++||||..+
T Consensus 212 -------~~--~---~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 212 -------DV--L---YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred -------CC--C---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 00 0 0123578899999999999999999 99999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=347.01 Aligned_cols=258 Identities=26% Similarity=0.387 Sum_probs=222.9
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
.....++|++.+.||+|-||.||.|+.+.++..||+|++.+.. .......++.||+.|...|+||||++++++|.+
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd--- 93 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD--- 93 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec---
Confidence 4456688999999999999999999999999999999986542 222334568899999999999999999999954
Q ss_pred CCCccEEEEEecCC-ccHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccc
Q 010512 91 REFKDIYVVFELME-SDLHQVIK--ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 167 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~--~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla 167 (508)
...+|+++||.. |+|+..+. ...++++.....+++|++.||.|||..+|+||||||+|+|++.++.+||+|||-+
T Consensus 94 --~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGws 171 (281)
T KOG0580|consen 94 --SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWS 171 (281)
T ss_pred --cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCce
Confidence 456999999998 89999998 5668999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChH
Q 010512 168 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 168 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
.... .......|||.-|.+||...+ ..++..+|+|++|++.||++.|.+||...+..+....|.+.-
T Consensus 172 V~~p-----~~kR~tlcgt~dyl~pEmv~~--~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~------ 238 (281)
T KOG0580|consen 172 VHAP-----SNKRKTLCGTLDYLPPEMVEG--RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD------ 238 (281)
T ss_pred eecC-----CCCceeeecccccCCHhhcCC--CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc------
Confidence 6532 223567899999999999988 789999999999999999999999998887666666554321
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
-..| ..++..+.|||.+||.++|.+|.+..|++.|||+..
T Consensus 239 ------------------~~~p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 239 ------------------LKFP-------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ------------------ccCC-------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 0011 467889999999999999999999999999999864
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=370.25 Aligned_cols=251 Identities=29% Similarity=0.480 Sum_probs=207.8
Q ss_pred eeeeeecCceEEEEEEEC---CCCcEEEEEEecCcc--CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 22 QEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 22 ~~~LG~G~~g~V~~a~~~---~tg~~vAIKki~~~~--~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++.||+|+||.||+|.+. .+++.||||++++.. ........+.+|+.+|+.++||||+++++++.. .+.+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-----GGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-----CCeE
Confidence 368999999999999864 578999999986432 122334567789999999999999999999843 4569
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 97 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
|+||||+. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999998 59999999888899999999999999999999999999999999999999999999999999875322221
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+...
T Consensus 156 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--------------- 215 (323)
T cd05584 156 ---VTHTFCGTIEYMAPEILMR--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--------------- 215 (323)
T ss_pred ---cccccCCCccccChhhccC--CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------------
Confidence 1234679999999999987 67889999999999999999999999887654443333210
Q ss_pred HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCC
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGL 313 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~ 313 (508)
.. ...+.+++.+.+||.+||+.||.+|| +++++++||||...
T Consensus 216 -----------~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 216 -----------KL-----NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred -----------CC-----CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 00 11234678899999999999999999 89999999999753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=378.07 Aligned_cols=264 Identities=25% Similarity=0.374 Sum_probs=212.9
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
..++|++.+.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.+++.++||||+++++++. ..
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-----~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ-----DD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cC
Confidence 3478999999999999999999999999999999986422 22234456788999999999999999999984 34
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
..+|+|||||+ |+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 56999999998 6999988654 689999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCcccccccccCccccccccccccc--CCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~--~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.. .......+||+.|+|||++.+.. ..++.++||||+||++|+|++|++||.+.+....+..+....
T Consensus 195 ~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~--------- 263 (370)
T cd05621 195 TG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK--------- 263 (370)
T ss_pred CC--ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------
Confidence 11 11234568999999999986521 237899999999999999999999998877655444332211
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHhcCCcccCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD--RPTAEEALADPYFHGL 313 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~--Rpta~eiL~hp~f~~~ 313 (508)
....+. ....++..+.+||.+||..++.+ |+|++|+++||||+..
T Consensus 264 -----------------~~~~~p-~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 264 -----------------NSLNFP-EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred -----------------cccCCC-CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 001111 11246788999999999866644 8999999999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=369.35 Aligned_cols=255 Identities=24% Similarity=0.410 Sum_probs=212.3
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCCcc
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
+|++++.||+|+||.||+|.+..++..||||++++... .......+..|+.++..+ .|++|+.+++++. ....
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ-----TMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe-----cCCE
Confidence 58999999999999999999999999999999975422 223345577888888887 4789999999884 3456
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+||||++ |+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999997532211
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 156 ---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------- 217 (323)
T cd05616 156 ---VTTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN------------- 217 (323)
T ss_pred ---CccccCCCChhhcCHHHhcC--CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence 12345679999999999987 689999999999999999999999998877655444332210
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCC
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGL 313 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt-----a~eiL~hp~f~~~ 313 (508)
.. ....++..+.+|+.+||+.||.+|++ ..++++||||+.+
T Consensus 218 ---------------~~---~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 218 ---------------VA---YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred ---------------CC---CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 00 11246788999999999999999998 4899999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=369.61 Aligned_cols=264 Identities=23% Similarity=0.416 Sum_probs=212.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++++.||+|+||+||+|.+..+++.||+|++++.. ........+.+|+.+++.++|+||+.+++++. ...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ-----DENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe-----cCCe
Confidence 47999999999999999999999999999999996421 22233456788999999999999999999984 4467
Q ss_pred EEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 96 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
+|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999997 699999976 457999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccCcccccccccccc---cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.. ......+||+.|+|||++.+. ...++.++||||+||++|+|++|+.||.+.+..+....+...
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~---------- 223 (331)
T cd05597 156 GT--VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH---------- 223 (331)
T ss_pred CC--ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC----------
Confidence 21 112235799999999998631 145788999999999999999999999887655444333211
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHhcCCcccCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD--RPTAEEALADPYFHGL 313 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~--Rpta~eiL~hp~f~~~ 313 (508)
.....+....+.+++.+.+||.+||..++.+ |++++++++||||.+.
T Consensus 224 ----------------~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 224 ----------------KEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred ----------------CCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 1111222333457899999999999765554 7899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=360.12 Aligned_cols=287 Identities=37% Similarity=0.659 Sum_probs=226.6
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
||..++|++.+.||+|+||.||+|.+..+++.||||.+...... .....+.+|+.+++.++||||+++++++. .
T Consensus 1 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~ 74 (291)
T cd07844 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIH-----T 74 (291)
T ss_pred CCCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEe-----c
Confidence 57789999999999999999999999999999999998643222 12234678999999999999999999984 3
Q ss_pred CccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 93 FKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
....|+||||+.++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 75 KKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred CCeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence 4579999999999999988764 468999999999999999999999999999999999999999999999999987532
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhhcCCCChHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN-VVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~-~~~~l~~i~~~~g~p~~~~~~ 250 (508)
... .......++..|+|||++.+. ..++.++||||+||++|+|++|++||.+.. ..+++..+.+.++.+....+.
T Consensus 155 ~~~---~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 155 VPS---KTYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred CCC---ccccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhh
Confidence 211 112334578899999998652 468899999999999999999999998766 566777788888887766554
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCC--HHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNAD--PLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~--~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
.+....... ........+.+.....+..+ ..+.+||.+||..||.+|||+.++|.||||
T Consensus 231 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 231 GVSSNPEFK-PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhhccccc-cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 332110000 00000111112222333444 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=357.91 Aligned_cols=258 Identities=34% Similarity=0.589 Sum_probs=212.9
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEE
Q 010512 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 98 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 98 (508)
|++++.||+|+||+||+|.+..+++.||+|++..............+|+.+++.++||||+++++++.. ...+|+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 899999999999999999999999999999997654333333445679999999999999999999954 466899
Q ss_pred EEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCc
Q 010512 99 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 177 (508)
Q Consensus 99 V~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~ 177 (508)
|||++.+ +|.+++.....+++..+..++.||++||.|||+.||+|+||||+||+++.++.++|+|||.+... ....
T Consensus 76 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~---~~~~ 152 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL---SENN 152 (260)
T ss_dssp EEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES---TSTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccc
Confidence 9999996 99999997788999999999999999999999999999999999999999999999999999754 1112
Q ss_pred ccccccccCcccccccccc-cccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHH
Q 010512 178 IFWTDYVATRWYRAPELCG-SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256 (508)
Q Consensus 178 ~~~~~~~gT~~Y~APE~l~-~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 256 (508)
.......+|..|+|||++. + ..++.++||||||+++++|++|..||...+..+....+...........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 222 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQG--KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS-------- 222 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTT--SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH--------
T ss_pred ccccccccccccccccccccc--ccccccccccccccccccccccccccccccchhhhhhhhhccccccccc--------
Confidence 2345678999999999987 4 6789999999999999999999999988755555444433221110000
Q ss_pred HHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 257 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
.. ........+.+||.+||+.||.+|||+.++++||||
T Consensus 223 -------~~---------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 223 -------SQ---------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp -------TT---------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred -------cc---------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 00 000112679999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=360.87 Aligned_cols=288 Identities=37% Similarity=0.632 Sum_probs=229.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.+. ||||+++++++..........
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4799999999999999999999999999999998654433334567889999999995 699999999986544333445
Q ss_pred EEEEEecCCccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC-CCcEEEcccccccc
Q 010512 96 IYVVFELMESDLHQVIKAN-----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARV 169 (508)
Q Consensus 96 lylV~E~~~g~L~~~i~~~-----~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~-~~~lkL~DFGla~~ 169 (508)
+|+||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 8999999999999888653 35799999999999999999999999999999999999998 88999999999975
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
...... ..+...++++|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+....+..+...++.|....+
T Consensus 161 ~~~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 161 FSIPVK---SYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cCCCcc---ccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 432211 12334678999999988652 46789999999999999999999999999888888888787787776654
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~ 311 (508)
.......... ..+...+.......+.++..+.+||.+||..||.+||++.++|.||||+
T Consensus 237 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWH---EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchh---hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 3322111100 0111122223333456789999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=368.77 Aligned_cols=250 Identities=26% Similarity=0.427 Sum_probs=205.9
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCCccEEEEE
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV~ 100 (508)
+.||+|+||.||+|.+..+|..||+|+++.... .......+..|+.++..+ +||||+++++++. ..+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ-----TKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE-----eCCEEEEEE
Confidence 479999999999999999999999999975322 123345667788888764 8999999999984 445799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCccc
Q 010512 101 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179 (508)
Q Consensus 101 E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~ 179 (508)
||+. ++|..++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++...... ..
T Consensus 76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~ 152 (316)
T cd05620 76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---NR 152 (316)
T ss_pred CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC---Cc
Confidence 9998 6999999888889999999999999999999999999999999999999999999999999987432111 12
Q ss_pred ccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHH
Q 010512 180 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259 (508)
Q Consensus 180 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 259 (508)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~-------------------- 210 (316)
T cd05620 153 ASTFCGTPDYIAPEILQG--LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV-------------------- 210 (316)
T ss_pred eeccCCCcCccCHHHHcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------------
Confidence 345689999999999987 6899999999999999999999999987765443332211
Q ss_pred HHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH-HHHhcCCcccCC
Q 010512 260 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA-EEALADPYFHGL 313 (508)
Q Consensus 260 ~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta-~eiL~hp~f~~~ 313 (508)
..+ .....++..+.+||.+||..||.+||++ +++++||||...
T Consensus 211 -------~~~----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 211 -------DTP----HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred -------CCC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 000 0112367889999999999999999997 589999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=379.63 Aligned_cols=280 Identities=23% Similarity=0.298 Sum_probs=218.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC--CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~--~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
..+|++++.||+|+||.||+|... .++..||+|.+... ....+|+.+|+.++||||+++++++. ..
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~-----~~ 158 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYR-----WK 158 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEe-----eC
Confidence 357999999999999999999754 46788999988532 23468999999999999999999884 34
Q ss_pred ccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 94 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 94 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
..+|+|||++.++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 159 ~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 159 STVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred CEEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 56899999999999999977788999999999999999999999999999999999999999999999999999764332
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhhcCCCChHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN---VVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~---~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.. .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.. ...++..+...++..+.+...
T Consensus 239 ~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 239 PD-TPQCYGWSGTLETNSPELLAL--DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred cc-cccccccccccCccCHhHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 21 112335689999999999987 689999999999999999999999997754 345566666666654332211
Q ss_pred HHhh---HHHHHHHhhcccCCCCCCCCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 251 RIRN---EKARRYLGSMRKKQPVPFSHKF--PNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 251 ~~~~---~~~~~~l~~~~~~~~~~~~~~~--~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
.... .....+... ...+..+...+ ...+..+.+||.+||.+||.+|||+.|+|.||||..
T Consensus 316 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 316 NGSTNLCKHFKQYAIV--LRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred ccchhHHHHHHhhccc--ccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 1100 111111111 11111222211 245678999999999999999999999999999975
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=369.15 Aligned_cols=302 Identities=42% Similarity=0.678 Sum_probs=231.7
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc--
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-- 90 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-- 90 (508)
|...++|++.+.||.|+||.||+|.+..+|..||+|++.... ......+.+|+.+|+.++||||+++++++.....
T Consensus 1 ~~~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred CCcCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 345789999999999999999999999999999999986432 2345668899999999999999999988765331
Q ss_pred -------CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC-CCcEEEc
Q 010512 91 -------REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKIC 162 (508)
Q Consensus 91 -------~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~-~~~lkL~ 162 (508)
.+...+|+||||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++|+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 11246899999999999888764 46999999999999999999999999999999999999974 5678999
Q ss_pred cccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC
Q 010512 163 DFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 242 (508)
Q Consensus 163 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g 242 (508)
|||+++...............+++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+.......+.+...
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999997643222211222334688999999987542 5688999999999999999999999998887777666655554
Q ss_pred CCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCC
Q 010512 243 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDRE 319 (508)
Q Consensus 243 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~ 319 (508)
.+.........+.... ...........++....+..+..+.+||.+||..||.+|||++++|+||||+.+..+..+
T Consensus 237 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~ 312 (342)
T cd07854 237 VVREEDRNELLNVIPS-FVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDE 312 (342)
T ss_pred CCChHHhhhhhhhhhh-hhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCccc
Confidence 4444333322221111 111111122222333445788999999999999999999999999999999977554333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=355.07 Aligned_cols=273 Identities=31% Similarity=0.476 Sum_probs=224.3
Q ss_pred ccccCCCCCeEEe-eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecC
Q 010512 10 FTEYGEASRYQIQ-EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLP 87 (508)
Q Consensus 10 ~~~~~~~~rY~i~-~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~ 87 (508)
|.+|.+.++|.|- ++||-|-.|.|..|.++.||+++|+|++. +..+..||+.+.-.. .|||||.++++|..
T Consensus 54 ~k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-------Ds~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 54 FKEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-------DSPKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hhcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-------cCHHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 4889999999995 48999999999999999999999999984 345567899887655 59999999999854
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC---CCcEEE
Q 010512 88 PSRREFKDIYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKI 161 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~-g~L~~~i~~~~~--l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~---~~~lkL 161 (508)
++.....+.||||.|+ |+|+..|+.++. +++.++..|+.||..|+.|||+.+|.||||||+|+|... |..+||
T Consensus 127 -s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 127 -SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred -hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEe
Confidence 3355678999999999 699999998765 999999999999999999999999999999999999875 467999
Q ss_pred ccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Q 010512 162 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 241 (508)
Q Consensus 162 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~ 241 (508)
+|||+|+.... ...+.+.+.||.|.|||+++. .+|+...|+||+|||+|.||+|.|||.......
T Consensus 206 tDfGFAK~t~~----~~~L~TPc~TPyYvaPevlg~--eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a--------- 270 (400)
T KOG0604|consen 206 TDFGFAKETQE----PGDLMTPCFTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--------- 270 (400)
T ss_pred cccccccccCC----CccccCCcccccccCHHHhCc--hhcCCCCCccchhHHHHHhhcCCCcccccCCcc---------
Confidence 99999986432 233567799999999999987 789999999999999999999999997654211
Q ss_pred CCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCC
Q 010512 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDRE 319 (508)
Q Consensus 242 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~ 319 (508)
.+...-.+ ++..+.......|..++..++|+|+.+|..+|.+|.|+++++.|||+.+...+...
T Consensus 271 --ispgMk~r------------I~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~t 334 (400)
T KOG0604|consen 271 --ISPGMKRR------------IRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQT 334 (400)
T ss_pred --CChhHHhH------------hhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCC
Confidence 00100011 11222233345567788999999999999999999999999999999886655443
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=361.05 Aligned_cols=296 Identities=35% Similarity=0.546 Sum_probs=228.9
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc--
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-- 90 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-- 90 (508)
....++|++.+.||+|+||.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++.....
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 345678999999999999999999999999999999986543333334556789999999999999999999865431
Q ss_pred -CCCccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 91 -REFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 91 -~~~~~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
......|+||||+.++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.
T Consensus 88 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 88 NRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred cCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 2235679999999999988887653 68999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCC-cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChH
Q 010512 169 VSFNDAPS-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 169 ~~~~~~~~-~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
........ ........++..|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+...++..+..+.|..+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 65332211 1122345788999999988652 457889999999999999999999999998888888888888776655
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCC--CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSH--KFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
.+...........+. ........... .....++.+.+||.+||..||.+|||++++|+||||
T Consensus 247 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 247 VWPGVDKLELFKKME-LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hcccccchhhhhhcc-CCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 433321111100000 00000000000 011245778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=369.73 Aligned_cols=250 Identities=28% Similarity=0.476 Sum_probs=205.9
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHH-HHHhCCCCCcceeeeeecCCCcCCCccEEEEE
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIK-LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~-iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~ 100 (508)
+.||+|+||+||+|.+..+|+.||||++.+.. ........+.+|.. +++.++||||+++++.+. ....+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-----~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-----eCCEEEEEE
Confidence 47999999999999999999999999996432 12233455666665 568899999999999884 345689999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCccc
Q 010512 101 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179 (508)
Q Consensus 101 E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~ 179 (508)
||+. |+|..++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~ 152 (323)
T cd05575 76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS---KT 152 (323)
T ss_pred cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC---Cc
Confidence 9998 5999999888889999999999999999999999999999999999999999999999999987532211 12
Q ss_pred ccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHH
Q 010512 180 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259 (508)
Q Consensus 180 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 259 (508)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~-------------------- 210 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN-------------------- 210 (323)
T ss_pred cccccCChhhcChhhhcC--CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 345679999999999987 6799999999999999999999999988765443333211
Q ss_pred HHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH----HHHhcCCcccCC
Q 010512 260 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA----EEALADPYFHGL 313 (508)
Q Consensus 260 ~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta----~eiL~hp~f~~~ 313 (508)
.+. ...+..++.+.+||.+||+.||.+||++ .++++||||...
T Consensus 211 --------~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 211 --------KPL---RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred --------CCC---CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 000 1124568899999999999999999997 699999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=367.23 Aligned_cols=250 Identities=28% Similarity=0.461 Sum_probs=205.3
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHh-CCCCCcceeeeeecCCCcCCCccEEEEE
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRL-LRHPDIVEIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~-L~HpnIv~l~~v~~~~~~~~~~~lylV~ 100 (508)
+.||+|+||+||+|.+..+++.||||+++.... .......+..|..++.. ++||||+++++++. ....+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ-----TKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence 479999999999999999999999999975322 22334556677777765 47999999999984 345699999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCccc
Q 010512 101 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179 (508)
Q Consensus 101 E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~ 179 (508)
||++ |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---~~ 152 (316)
T cd05592 76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GK 152 (316)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---Cc
Confidence 9998 6999999888889999999999999999999999999999999999999999999999999997543222 12
Q ss_pred ccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHH
Q 010512 180 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259 (508)
Q Consensus 180 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 259 (508)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------------------- 211 (316)
T cd05592 153 ASTFCGTPDYIAPEILKG--QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND------------------- 211 (316)
T ss_pred cccccCCccccCHHHHcC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 345679999999999987 67899999999999999999999999987754443332210
Q ss_pred HHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH-HHHhcCCcccCC
Q 010512 260 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA-EEALADPYFHGL 313 (508)
Q Consensus 260 ~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta-~eiL~hp~f~~~ 313 (508)
.+ ..-..++..+.+||.+||..||.+||++ .+++.||||...
T Consensus 212 --------~~----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 212 --------RP----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred --------CC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 00 0112467889999999999999999986 588899999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=366.15 Aligned_cols=282 Identities=33% Similarity=0.563 Sum_probs=227.7
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCC--CC----cceeeeeecC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH--PD----IVEIKHIMLP 87 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~H--pn----Iv~l~~v~~~ 87 (508)
-..+||+|++.+|+|.||.|..|.|..++..||||+|+... ......+-||++|.+|.+ |+ +|.+.+.|
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-- 160 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-- 160 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh--
Confidence 34789999999999999999999999999999999997431 223345679999999953 22 55555555
Q ss_pred CCcCCCccEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC----------
Q 010512 88 PSRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---------- 155 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~---------- 155 (508)
+..++++||+|.++-++++++.++. +++..+++.+.+||+++++|||+.+++|.||||+|||+.+
T Consensus 161 ---dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 161 ---DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred ---hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccC
Confidence 5567899999999999999999875 6899999999999999999999999999999999999643
Q ss_pred ----------CCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCC
Q 010512 156 ----------DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 225 (508)
Q Consensus 156 ----------~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF 225 (508)
+..|+|+|||.|+...... +..+.|+.|+|||++.+ -+++..+||||+||||+||.+|..+|
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEViLg--LGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEVILG--LGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchheec--cCcCCccCceeeeeEEEEeeccceec
Confidence 2348999999998754332 55789999999999998 68999999999999999999999999
Q ss_pred CCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccC---------------CCCCCCCCCCCCC---HHHHHHH
Q 010512 226 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKK---------------QPVPFSHKFPNAD---PLALHLL 287 (508)
Q Consensus 226 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~---------------~~~~~~~~~~~~~---~~~~~Ll 287 (508)
.+....+.++.|..++|..+...+.+.. ..+|+...+-. .+.++.......+ ..+.|||
T Consensus 310 qtHen~EHLaMMerIlGp~P~~mi~r~~---~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl 386 (415)
T KOG0671|consen 310 QTHENLEHLAMMERILGPIPSRMIKKTR---KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL 386 (415)
T ss_pred ccCCcHHHHHHHHHhhCCCcHHHhhhhh---hHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence 9999999999999999987777776653 22232222111 1222222222222 3477999
Q ss_pred HHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 288 ERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 288 ~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
++||.+||.+|+|+.|+|.||||+.+.
T Consensus 387 ~~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 387 RRMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred HHHHccCccccccHHHHhcCHHhhcCC
Confidence 999999999999999999999998753
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=357.93 Aligned_cols=285 Identities=36% Similarity=0.659 Sum_probs=223.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+|+.++||||+++++++. .....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR-----RKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc-----cCCeE
Confidence 4799999999999999999999999999999998654433334556789999999999999999999984 44579
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 97 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 97 ylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
|+||||+++ .|..+......+++..++.++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 999999996 566666556679999999999999999999999999999999999999999999999999997643322
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
...+.+.++.+|+|||++.+. ..++.++|||||||++|+|++|++||++.+..+.+..+....+.............
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred --cccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 223456789999999998652 45788999999999999999999999988877777777666665433221111100
Q ss_pred HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
...............+....+++++..+.+|+.+||..||.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000000000011112223356788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=367.38 Aligned_cols=264 Identities=23% Similarity=0.413 Sum_probs=213.5
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++.+.||+|+||.||++.+..+++.||+|++.+.. ........+.+|+.++..++|+||+.+++.+. ....
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ-----DENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cCCE
Confidence 47999999999999999999999999999999986422 12223345778999999999999999999984 3456
Q ss_pred EEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 96 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
+|+||||+. |+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999997 699999977 467999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccCcccccccccccc---cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.. ......+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~----------- 222 (332)
T cd05623 156 GT--VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN----------- 222 (332)
T ss_pred Cc--ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC-----------
Confidence 11 112345799999999998631 24688999999999999999999999988775554443321
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHhcCCcccCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD--RPTAEEALADPYFHGL 313 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~--Rpta~eiL~hp~f~~~ 313 (508)
......+......+++.+.+||.+||..++.+ |++++++++||||.++
T Consensus 223 ---------------~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 223 ---------------HKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred ---------------CCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 11111223334567899999999999776555 6899999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=362.12 Aligned_cols=296 Identities=38% Similarity=0.633 Sum_probs=232.9
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc-
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR- 90 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~- 90 (508)
+....++|++.+.||.|+||.||+|.+..++..||||++............+.+|+++++.++||||+++++++.....
T Consensus 3 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (311)
T cd07866 3 GCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDK 82 (311)
T ss_pred CCcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccc
Confidence 3455789999999999999999999999999999999986433332233456789999999999999999998765432
Q ss_pred --CCCccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccc
Q 010512 91 --REFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 167 (508)
Q Consensus 91 --~~~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla 167 (508)
.....+|+||||+.++|...+... ..+++..++.++.||++||.|||++||+|+||||+||+++.++.++|+|||++
T Consensus 83 ~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 83 SKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred ccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 234568999999999888887653 47999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC--------cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 010512 168 RVSFNDAPS--------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTD 239 (508)
Q Consensus 168 ~~~~~~~~~--------~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~ 239 (508)
+........ ....+..++++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 864332211 1123445788999999988652 4688999999999999999999999999998888888888
Q ss_pred hcCCCChHHHHHHhhHHHHHHHh-hcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 240 LLGTPSTESISRIRNEKARRYLG-SMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 240 ~~g~p~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
..+.+....+...... ..... ......+..+...+....+.+.+||.+||..||.+|||+.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 242 LCGTPTEETWPGWRSL--PGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HhCCCChhhchhhhhc--ccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 8777665544321110 00000 011111222223345567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=370.20 Aligned_cols=251 Identities=29% Similarity=0.453 Sum_probs=208.6
Q ss_pred eeeeeecCceEEEEEEE---CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEE
Q 010512 22 QEVIGKGSYGVVGSAVD---THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 98 (508)
Q Consensus 22 ~~~LG~G~~g~V~~a~~---~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 98 (508)
++.||+|+||.||++.+ ..+|..||+|++............+.+|+.+|+.++||||+++++++.. .+.+|+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~l 75 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-----EGKLYL 75 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCEEEE
Confidence 36899999999999976 3588999999997543333345567889999999999999999999843 456999
Q ss_pred EEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCc
Q 010512 99 VFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 177 (508)
Q Consensus 99 V~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~ 177 (508)
||||++ ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 999998 69999998888899999999999999999999999999999999999999999999999999976432211
Q ss_pred ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHH
Q 010512 178 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 257 (508)
Q Consensus 178 ~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 257 (508)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 154 -~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~----------------- 213 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA----------------- 213 (318)
T ss_pred -ceecccCChhhcCHHHHcC--CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 1234679999999999987 67899999999999999999999999887654444333210
Q ss_pred HHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCC
Q 010512 258 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGL 313 (508)
Q Consensus 258 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt-----a~eiL~hp~f~~~ 313 (508)
.. .....+++.+.+||.+||+.||.+||+ +++++.||||...
T Consensus 214 ---------~~-----~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 214 ---------KL-----GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred ---------CC-----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 00 011246788999999999999999999 7889999999853
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=367.31 Aligned_cols=259 Identities=23% Similarity=0.395 Sum_probs=205.1
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCCccEEEEE
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV~ 100 (508)
++||+|+||.||+|.+..+++.||||++++... .......+.+|+.+++.+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-----~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-----ESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-----CCEEEEEE
Confidence 479999999999999999999999999975432 223455678899999998 69999999999843 45699999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCccc
Q 010512 101 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179 (508)
Q Consensus 101 E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~ 179 (508)
|||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (329)
T cd05588 76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC---c
Confidence 9998 59999998888999999999999999999999999999999999999999999999999999874322111 2
Q ss_pred ccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHH
Q 010512 180 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259 (508)
Q Consensus 180 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 259 (508)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+...... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~----------~~~~~~~~-----~~~~ 215 (329)
T cd05588 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD----------NPDQNTED-----YLFQ 215 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceechHHHHHHHHHCCCCcccccccc----------cccccchH-----HHHH
Confidence 345689999999999987 688999999999999999999999996422100 00000000 0000
Q ss_pred HHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC------HHHHhcCCcccCC
Q 010512 260 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT------AEEALADPYFHGL 313 (508)
Q Consensus 260 ~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt------a~eiL~hp~f~~~ 313 (508)
. +... ... ....+++.+.+||.+||..||.+|+| ++++++||||..+
T Consensus 216 ~---~~~~-~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 216 V---ILEK-QIR---IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred H---HHcC-CCC---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 0 0111 111 11346788999999999999999987 7999999999754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=369.16 Aligned_cols=253 Identities=31% Similarity=0.437 Sum_probs=208.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcE-EEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGER-VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~-vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
.....+.+.||+|+||+||++... |.. ||||++............+.+|+.+|.+++|||||++++++..+..
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~---- 113 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG---- 113 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----
Confidence 445566777999999999999654 666 9999998655444447789999999999999999999999965431
Q ss_pred cEEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhcC-ceecCCCCCceeeCCCC-cEEEcccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTAN-VFHRDLKPKNILANADC-KLKICDFGLARV 169 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~Qil~aL~yLHs~g-IiHrDLKPeNILl~~~~-~lkL~DFGla~~ 169 (508)
.+.||||||+ |+|.+++.. +..++...+..|+.||++|+.|||+++ ||||||||+|||++.++ ++||||||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 5899999998 799999987 578999999999999999999999999 99999999999999998 999999999987
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
..... ...+...||+.|||||++.+....|+.++||||||+++|||+||+.||.+.........+....
T Consensus 194 ~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~-------- 262 (362)
T KOG0192|consen 194 KVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGG-------- 262 (362)
T ss_pred ecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC--------
Confidence 54321 2245578999999999998411589999999999999999999999999887633332222111
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.+.+.+ ..+++.+..|+++||..||.+||+..+++.
T Consensus 263 ----------------~Rp~~p-----~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 263 ----------------LRPPIP-----KECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ----------------CCCCCC-----ccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 011111 127788999999999999999999999876
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=358.52 Aligned_cols=287 Identities=39% Similarity=0.672 Sum_probs=229.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|++.+.||+|++|.||+|.+..+|+.||||++............+.+|+++++.++||||+++++++.. ....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-----EKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-----CCeE
Confidence 57999999999999999999999999999999986543333344567889999999999999999999843 4579
Q ss_pred EEEEecCCccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC-CCcEEEccccccccccCC
Q 010512 97 YVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSFND 173 (508)
Q Consensus 97 ylV~E~~~g~L~~~i~~~~~--l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~-~~~lkL~DFGla~~~~~~ 173 (508)
|+||||++++|.+.+..... +++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 99999999999888876543 578889999999999999999999999999999999985 567999999999754322
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
. ...+...+++.|+|||++.+. ..++.++||||+||++|+|++|.+||.+....+.+..+...++.|....+....
T Consensus 157 ~---~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 V---RTFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred c---cccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 1 123445788999999998652 468899999999999999999999999988888888888888887766554321
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.. ..+........+.......+..++.+.+||.+||+.||.+||++.++++||||.++.
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 233 SL--PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred cc--hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 11 111111111111222223456788999999999999999999999999999998764
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=383.70 Aligned_cols=269 Identities=25% Similarity=0.369 Sum_probs=220.3
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc--
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-- 90 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-- 90 (508)
-...++|++.+.||+|+||+||+|.+..+|+.||||++............+.+|+.+|..++|+||+++++.+.....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 345689999999999999999999999999999999997654455566778899999999999999999887754321
Q ss_pred -CCCccEEEEEecCC-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccc
Q 010512 91 -REFKDIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 164 (508)
Q Consensus 91 -~~~~~lylV~E~~~-g~L~~~i~~~----~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DF 164 (508)
.....+++||||+. |+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 11224789999998 6999988653 46899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC
Q 010512 165 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244 (508)
Q Consensus 165 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p 244 (508)
|+++........ ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 188 Gls~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~--~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~----- 259 (496)
T PTZ00283 188 GFSKMYAATVSD-DVGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA----- 259 (496)
T ss_pred ccCeeccccccc-cccccccCCcceeCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-----
Confidence 999865332211 12245689999999999987 6799999999999999999999999988765443332211
Q ss_pred ChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.. .....+.+++.+.+|+.+||..||.+||++.++++|||++.+.
T Consensus 260 ----------------------~~---~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~ 304 (496)
T PTZ00283 260 ----------------------GR---YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI 304 (496)
T ss_pred ----------------------CC---CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence 00 0112245788999999999999999999999999999987543
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=360.01 Aligned_cols=287 Identities=40% Similarity=0.655 Sum_probs=232.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.+.|++.+.||.|+||.||+|.+..++..||||+++...........+.+|+.+++.++||||+++++++.... ...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCc
Confidence 35799999999999999999999999999999999754333333446778999999999999999999885432 367
Q ss_pred EEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+||||+.++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 81 IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99999999999999887644 59999999999999999999999999999999999999999999999999998654321
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
.......+++.|+|||.+.+. ..++.++||||+||++|+|++|.+||.+....+.+..+...++.|....+..+..
T Consensus 161 ---~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 161 ---KPYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred ---cccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 123445678999999998752 4578899999999999999999999999998888888888888888776654322
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCC--CHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNA--DPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~--~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
-..... ..........+...++.. ++.+.+||.+||+.||++|||+.|+|.||||
T Consensus 237 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 237 LPGAKK-KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cchhcc-cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 111000 011111222233445554 8889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=366.13 Aligned_cols=250 Identities=25% Similarity=0.440 Sum_probs=207.8
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCCccEEEEE
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV~ 100 (508)
+.||+|+||+||+|.+..++..||||++++.. ........+.+|+.+++.+ +||||+++++++. ....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence 47999999999999999999999999997532 2223455677899999888 6999999999984 345699999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCccc
Q 010512 101 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179 (508)
Q Consensus 101 E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~ 179 (508)
||+. ++|...+...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (318)
T cd05570 76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---T 152 (318)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC---c
Confidence 9998 69999998888899999999999999999999999999999999999999999999999999875322111 1
Q ss_pred ccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHH
Q 010512 180 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259 (508)
Q Consensus 180 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 259 (508)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~-------------------- 210 (318)
T cd05570 153 TSTFCGTPDYIAPEILSY--QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-------------------- 210 (318)
T ss_pred ccceecCccccCHHHhcC--CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc--------------------
Confidence 234579999999999987 6899999999999999999999999987765443332211
Q ss_pred HHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH-----HHHhcCCcccCC
Q 010512 260 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA-----EEALADPYFHGL 313 (508)
Q Consensus 260 ~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta-----~eiL~hp~f~~~ 313 (508)
... . ....++..+.+||.+||..||.+|||+ .++++||||...
T Consensus 211 -------~~~-~---~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 211 -------DEV-R---YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred -------CCC-C---CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 000 0 112467889999999999999999999 999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=356.48 Aligned_cols=281 Identities=38% Similarity=0.688 Sum_probs=228.1
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
+|++.+.||.|++|.||+|.+..+|..||||+++.... ......+.+|+.+++.++||||+++++.+.. .+..|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEE
Confidence 59999999999999999999999999999999975322 2234567789999999999999999999843 35689
Q ss_pred EEEecCCccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 98 VVFELMESDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 98 lV~E~~~g~L~~~i~~~~---~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+||||++++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||+++......
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 75 LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred EEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 999999999999887643 58999999999999999999999999999999999999999999999999997542211
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
. ......+|..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+....+.|....+..+..
T Consensus 155 ~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 155 N---TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred c---ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 1 12345678999999988652 4578999999999999999999999999988888888888888887776654431
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
. ..+....+...........+..++.+.++|.+||+.||.+||++.++++||||
T Consensus 231 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 231 L--PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred C--chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 1 11111111111111222334567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=354.74 Aligned_cols=281 Identities=41% Similarity=0.687 Sum_probs=230.6
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEE
Q 010512 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 98 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 98 (508)
|++.+.||.|++|.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++.. ....|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-----~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-----ENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-----CCeEEE
Confidence 788999999999999999999999999999987543333344567889999999999999999999843 357899
Q ss_pred EEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCC
Q 010512 99 VFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 176 (508)
Q Consensus 99 V~E~~~g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~ 176 (508)
||||++++|.+++.... .+++..+..++.||+.||.|||+.+++||||+|+||+++.++.++|+|||++.......
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-- 153 (283)
T cd07835 76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-- 153 (283)
T ss_pred EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--
Confidence 99999999999998765 68999999999999999999999999999999999999999999999999997542211
Q ss_pred cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHH
Q 010512 177 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256 (508)
Q Consensus 177 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 256 (508)
.......++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+.+.+++|....+..+...
T Consensus 154 -~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (283)
T cd07835 154 -RTYTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL- 230 (283)
T ss_pred -cccCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc-
Confidence 112334678899999988652 45788999999999999999999999998888888888888888887665443211
Q ss_pred HHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 257 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
..+................+..+..+.+||.+||+.||.+|||+++++.||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 231 -PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred -hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 12222222222223334456778999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=372.29 Aligned_cols=263 Identities=25% Similarity=0.377 Sum_probs=212.0
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
..++|++.+.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.+++.++||||+++++++. ..
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-----~~ 115 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-----DD 115 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----cC
Confidence 3489999999999999999999999999999999986422 22233455778999999999999999999984 34
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
..+|+|||||+ |+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 56999999998 6899888654 589999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCccccccccccccc--CCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~--~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.. .......+||+.|+|||++.+.. ..++.++|||||||++|+|++|.+||.+.+.......|...
T Consensus 195 ~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~---------- 262 (371)
T cd05622 195 EG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH---------- 262 (371)
T ss_pred CC--cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC----------
Confidence 21 11224568999999999986521 23889999999999999999999999987765444333211
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHhcCCcccC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD--RPTAEEALADPYFHG 312 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~--Rpta~eiL~hp~f~~ 312 (508)
.....+. ....++..+.+||.+||..++.+ |++++++++||||.+
T Consensus 263 ----------------~~~~~~~-~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 263 ----------------KNSLTFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred ----------------CCcccCC-CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 0011111 12457889999999999844443 789999999999976
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=371.56 Aligned_cols=279 Identities=26% Similarity=0.343 Sum_probs=208.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
...|++++.||+|+||.||+|.+..++..||+|+.... ....|+.+|+.++||||+++++++.. ...
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 131 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVS-----GAI 131 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEe-----CCe
Confidence 35699999999999999999999999999999985421 23569999999999999999999854 346
Q ss_pred EEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
.|+|||++.++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 132 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 132 TCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred eEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 899999999999998865 4579999999999999999999999999999999999999999999999999997532211
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCC-CCCCCCCh---------HHHHHHHHhhcCCC
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNV---------VHQLDLMTDLLGTP 244 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~-~pF~~~~~---------~~~l~~i~~~~g~p 244 (508)
......||+.|+|||++.+ ..|+.++|||||||++|+|+++. ++|..... ..++..+...++..
T Consensus 212 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 285 (357)
T PHA03209 212 ----AFLGLAGTVETNAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH 285 (357)
T ss_pred ----ccccccccccccCCeecCC--CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence 1234679999999999987 68999999999999999999854 55544221 12233333334433
Q ss_pred ChHHHHHHhhHHHHHHHhhcc-cCCCCCCC--CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 245 STESISRIRNEKARRYLGSMR-KKQPVPFS--HKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~--~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
+..............++.... .+.+.... ....+++..+.+||.+||++||.+|||+.|+|+||||+++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 286 PEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred hhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 222110000111111111100 01111100 0112466788899999999999999999999999999863
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=364.00 Aligned_cols=255 Identities=24% Similarity=0.407 Sum_probs=210.4
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCCCcc
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ 95 (508)
+|++.+.||+|+||.||+|.+..+|+.||||++++... .......+..|+.+++.+. |++|+.+++++. ....
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ-----TVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe-----cCCE
Confidence 48899999999999999999999999999999975322 2234456778999998886 567778888874 3356
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+||||++ |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999987532211
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
......+||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+.......+...
T Consensus 156 ---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------------- 216 (323)
T cd05615 156 ---VTTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------------- 216 (323)
T ss_pred ---ccccCccCCccccCHHHHcC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 11234579999999999987 67899999999999999999999999887654444333210
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCC
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGL 313 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt-----a~eiL~hp~f~~~ 313 (508)
.. .....++..+.+|+.+||..||.+|++ .+++++||||..+
T Consensus 217 ------------~~-----~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 217 ------------NV-----SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred ------------CC-----CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 00 011246788999999999999999997 5899999999865
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=363.71 Aligned_cols=251 Identities=25% Similarity=0.432 Sum_probs=205.8
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHh-CCCCCcceeeeeecCCCcCCCccEEEEE
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRL-LRHPDIVEIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~-L~HpnIv~l~~v~~~~~~~~~~~lylV~ 100 (508)
+.||+|+||+||+|.+..+++.||||+++.... ..........|..++.. +.||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-----KENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-----CCEEEEEE
Confidence 479999999999999999999999999975422 12234556778888876 489999999999843 35699999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCccc
Q 010512 101 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179 (508)
Q Consensus 101 E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~ 179 (508)
||++ |+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (316)
T cd05619 76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---K 152 (316)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---c
Confidence 9998 69999998888899999999999999999999999999999999999999999999999999875322111 1
Q ss_pred ccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHH
Q 010512 180 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259 (508)
Q Consensus 180 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 259 (508)
....+||+.|+|||++.+ ..|+.++||||+||++|+|++|..||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~-------------------- 210 (316)
T cd05619 153 TCTFCGTPDYIAPEILLG--QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM-------------------- 210 (316)
T ss_pred eeeecCCccccCHHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------------
Confidence 234679999999999987 6799999999999999999999999987765433332211
Q ss_pred HHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHH-HHhcCCcccCCC
Q 010512 260 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE-EALADPYFHGLA 314 (508)
Q Consensus 260 ~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~-eiL~hp~f~~~~ 314 (508)
..+. + ...++..+.+||.+||..||.+||++. ++++||||..+.
T Consensus 211 -------~~~~-~---~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 211 -------DNPC-Y---PRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred -------CCCC-C---CccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 0000 0 123578899999999999999999996 899999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=356.24 Aligned_cols=258 Identities=27% Similarity=0.374 Sum_probs=209.6
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
.|++.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+.+++.+.. ...+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-----KDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC-----CCeE
Confidence 48999999999999999999999999999999964322 22233457789999999999999999998843 3469
Q ss_pred EEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 97 YVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
|+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||+++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999998 6898877653 46999999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
. .....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+...
T Consensus 156 ~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~------------- 216 (285)
T cd05605 156 E----TIRGRVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR------------- 216 (285)
T ss_pred C----ccccccCCCCccCcHHhcC--CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH-------------
Confidence 1 1234578999999999976 67899999999999999999999999876543322222110
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGL 313 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~ 313 (508)
+ .... ......+++.+.+||.+||..||.+|| +++++++||||...
T Consensus 217 -------~---~~~~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 217 -------V---KEDQ----EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred -------h---hhcc----cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 0 0000 011234678899999999999999999 99999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=379.65 Aligned_cols=281 Identities=26% Similarity=0.321 Sum_probs=211.1
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
....|.+.+.||+|+||.||+|.+..++..||||... ...+.+|+++|+.|+|+||+++++++.. .+
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~ 233 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVV-----GG 233 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEE-----CC
Confidence 3568999999999999999999999999999999643 2335689999999999999999998843 35
Q ss_pred cEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
..|+|||++.++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 234 ~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 234 LTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred EEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 68999999999999988764 46999999999999999999999999999999999999999999999999999865332
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCC-CCCCC------hHHHHHHHHhhcCCCCh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL-FPGKN------VVHQLDLMTDLLGTPST 246 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~p-F~~~~------~~~~l~~i~~~~g~p~~ 246 (508)
.. .......+||+.|+|||++.+ ..++.++||||||||+|||++|..+ |.... ...++..+....+....
T Consensus 314 ~~-~~~~~~~~GT~~Y~APE~~~~--~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 314 WS-TPFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred cc-cccccccCCCcCCcCHHHHcC--CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 21 111234579999999999987 6799999999999999999998754 43321 12334444333222111
Q ss_pred HH----HHHHhhHHHHHHHhhccc-CCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 247 ES----ISRIRNEKARRYLGSMRK-KQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 247 ~~----~~~~~~~~~~~~l~~~~~-~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
+. ..++.............. .....| ..+...+..+.+||.+||++||.+|||+.|+|+||||++
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAW-TRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcch-hhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 10 001110000000001111 111112 222356778999999999999999999999999999974
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=356.92 Aligned_cols=286 Identities=38% Similarity=0.680 Sum_probs=224.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|++.+.||+|+||.||+|.+..+++.||+|+++...........+.+|+++++.++|+||+++++++.. .+..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence 47999999999999999999999999999999987544444445778899999999999999999999854 4568
Q ss_pred EEEEecCCccHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 97 YVVFELMESDLHQ-VIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 97 ylV~E~~~g~L~~-~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
|+||||+++++.. ++.....+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++........
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9999999975554 444556799999999999999999999999999999999999999999999999999986543322
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
.....++++.+|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.............
T Consensus 156 --~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 156 --SPLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred --ccccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 123457889999999999872 37889999999999999999999999998888777777777766554332221100
Q ss_pred HHHHHHhhcccCCCCCCCCCCCC-CCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPN-ADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
....-........+..+...++. +++.+.+||++||..||++|||++++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00000000000011111112233 47889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=366.83 Aligned_cols=250 Identities=29% Similarity=0.496 Sum_probs=205.2
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHH-HHHhCCCCCcceeeeeecCCCcCCCccEEEEE
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIK-LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~-iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~ 100 (508)
+.||+|+||+||+|.+..+|+.||||++.+... .......+.+|.. +++.++||||+++++.+. ....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----cCCEEEEEE
Confidence 469999999999999999999999999964321 2233455666665 577899999999999884 345699999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCccc
Q 010512 101 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179 (508)
Q Consensus 101 E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~ 179 (508)
||+. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---~ 152 (325)
T cd05604 76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---T 152 (325)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---C
Confidence 9998 58999998888999999999999999999999999999999999999999999999999999875322211 2
Q ss_pred ccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHH
Q 010512 180 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259 (508)
Q Consensus 180 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 259 (508)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~-------------------- 210 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRK--QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH-------------------- 210 (325)
T ss_pred cccccCChhhCCHHHHcC--CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 345679999999999987 6889999999999999999999999987765443332211
Q ss_pred HHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH----HHHhcCCcccCC
Q 010512 260 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA----EEALADPYFHGL 313 (508)
Q Consensus 260 ~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta----~eiL~hp~f~~~ 313 (508)
. .. ...+..+..+.++|.+||..||.+||++ .++++||||.+.
T Consensus 211 -------~-~~---~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 211 -------K-PL---VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred -------C-Cc---cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 0 00 1123567889999999999999999976 599999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=353.19 Aligned_cols=280 Identities=39% Similarity=0.726 Sum_probs=223.1
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCCCccEE
Q 010512 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
|++.+.||+|+||.||+|.+..++..||+|+++....... .....+|+.+++++. |+||+++++++... ..+.+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEE
Confidence 7899999999999999999999999999999875443322 234568999999986 99999999998643 225689
Q ss_pred EEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCC
Q 010512 98 VVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 176 (508)
Q Consensus 98 lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~ 176 (508)
+||||++++|.+.+... ..+++..+..++.||+.||.|||+.||+||||||+||+++. +.+||+|||+++.......
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 77 LVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 99999999999888764 57899999999999999999999999999999999999999 9999999999986533221
Q ss_pred cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHH
Q 010512 177 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256 (508)
Q Consensus 177 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 256 (508)
.....++..|+|||++... ..++.++||||+||++|+|++|.+||++.+..+.+..+...+|.+............
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 ---YTEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred ---cCCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 2345788999999986542 457889999999999999999999999999888888888888887765532221111
Q ss_pred HHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 257 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
...+ ..+......+....+.++..+.+||.+||.+||.+|||++++++||||
T Consensus 231 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 231 HMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccc--cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0000 000001111112234568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=356.78 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=203.0
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEecC
Q 010512 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 103 (508)
Q Consensus 25 LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~ 103 (508)
||+|+||+||+|.+..+|+.||+|++..... .......+..|+.+|+.++||||+++.+++. ....+|+|||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ-----TKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc-----CCCeEEEEEeCC
Confidence 7999999999999999999999999864322 2223456778999999999999999999884 345689999999
Q ss_pred C-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcc
Q 010512 104 E-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 178 (508)
Q Consensus 104 ~-g~L~~~i~~----~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~ 178 (508)
+ |+|..++.. +..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--- 152 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--- 152 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc---
Confidence 8 688877642 34699999999999999999999999999999999999999999999999999976433221
Q ss_pred cccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHH
Q 010512 179 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 258 (508)
Q Consensus 179 ~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 258 (508)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..
T Consensus 153 ~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~------------------- 211 (280)
T cd05608 153 KTKGYAGTPGFMAPELLQG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ------------------- 211 (280)
T ss_pred cccccCCCcCccCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH-------------------
Confidence 1234679999999999987 6889999999999999999999999976543211111100
Q ss_pred HHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCC
Q 010512 259 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 314 (508)
Q Consensus 259 ~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~~ 314 (508)
... ..+. .....+++.+.+|+.+||+.||.+|| |++++++||||+++.
T Consensus 212 ----~~~-~~~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 212 ----RIL-NDSV---TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred ----hhc-ccCC---CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 000 0011 11235778999999999999999999 899999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=364.76 Aligned_cols=259 Identities=23% Similarity=0.397 Sum_probs=204.2
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCCccEEEEE
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV~ 100 (508)
+.||+|+||.||+|.+..+++.||+|++++... .......+.+|+.++..+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-----CCEEEEEE
Confidence 479999999999999999999999999975432 233455678899998776 79999999999843 45699999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCccc
Q 010512 101 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179 (508)
Q Consensus 101 E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~ 179 (508)
||+. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---~ 152 (329)
T cd05618 76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---c
Confidence 9998 69999988888899999999999999999999999999999999999999999999999999975322111 1
Q ss_pred ccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHH
Q 010512 180 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259 (508)
Q Consensus 180 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 259 (508)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+...... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----------~~~~~~~~-----~~~~ 215 (329)
T cd05618 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD----------NPDQNTED-----YLFQ 215 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceecccHHHHHHhhCCCCCccCCCcC----------CcccccHH-----HHHH
Confidence 234679999999999987 688999999999999999999999995321100 00000000 0000
Q ss_pred HHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC------HHHHhcCCcccCC
Q 010512 260 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT------AEEALADPYFHGL 313 (508)
Q Consensus 260 ~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt------a~eiL~hp~f~~~ 313 (508)
.+.... . ......+..+.+||.+||..||.+||+ ++++++||||.+.
T Consensus 216 ---~i~~~~-~---~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 216 ---VILEKQ-I---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred ---HHhcCC-C---CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 000010 1 112356788999999999999999998 5899999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=364.39 Aligned_cols=264 Identities=23% Similarity=0.404 Sum_probs=213.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++.+.||+|+||.||+|++..+++.||+|++.+.. ........+.+|+.+++.+.|+||+.+++++. ..+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~-----~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ-----DENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence 57999999999999999999999999999999986421 12233445778999999999999999999984 4467
Q ss_pred EEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 96 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
+|+||||+. |+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999998 699999987 467999999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcccccccccCcccccccccccc---cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.. ......+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~----------- 222 (331)
T cd05624 156 GT--VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN----------- 222 (331)
T ss_pred Cc--eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc-----------
Confidence 21 112335799999999998642 13578899999999999999999999987765444433321
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHhcCCcccCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD--RPTAEEALADPYFHGL 313 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~--Rpta~eiL~hp~f~~~ 313 (508)
.....++...+..++..+.+||.+||..++.+ |++++++++||||++.
T Consensus 223 ---------------~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 223 ---------------HEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred ---------------CCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 11112233344567899999999999976655 5799999999999853
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=369.11 Aligned_cols=258 Identities=27% Similarity=0.363 Sum_probs=203.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++|+||+++++++ ...+.
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 146 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGE 146 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCe
Confidence 357889999999999999999999999999999986432 223456788999999999999999999998 34467
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+|||||.+ +|.+ ...+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 147 IQVLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEEEEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999999984 6643 2346778889999999999999999999999999999999999999999999998653221
Q ss_pred CCcccccccccCcccccccccccc---cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
. .....+||..|+|||++... ...++.++|||||||++|+|++|+.||......+....+..
T Consensus 223 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~------------ 287 (353)
T PLN00034 223 D---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA------------ 287 (353)
T ss_pred c---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH------------
Confidence 1 13456899999999987431 12345689999999999999999999974332111111110
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.....+ ......++..+.+||.+||..||.+|||+.|+|+||||.+-
T Consensus 288 ------------~~~~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 288 ------------ICMSQP---PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred ------------HhccCC---CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 000000 11223567889999999999999999999999999999864
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=347.00 Aligned_cols=258 Identities=26% Similarity=0.427 Sum_probs=211.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh---hHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV---SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~---~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
+.|++.+.||+|++|.||.|.+..++..||+|.+....... .....+.+|+.+++.++||||+++++++. ..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cC
Confidence 56999999999999999999999999999999986432221 23456889999999999999999999984 34
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
..+|+||||++ ++|.+++.....+++..+..+++||+.||.|||+.||+||||||+||+++.++.++|+|||+++....
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 57999999998 59999998888899999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
............++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------- 221 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISG--EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT------------- 221 (263)
T ss_pred cccccccccCCCcCccccCcceecc--CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc-------------
Confidence 2211111134568899999999987 5689999999999999999999999976543322211110
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
.... ......++..+.+||.+||..||.+|||+.++|+||||
T Consensus 222 -------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 222 -------------QPTN---PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred -------------cCCC---CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0000 11123567889999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=372.10 Aligned_cols=259 Identities=30% Similarity=0.448 Sum_probs=226.1
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++++++|+|+||.++.++++..+..|++|+|+-.............|+.++++++|||||.+++.|... ..
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~----~~ 77 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED----GQ 77 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC----Cc
Confidence 45789999999999999999999999999999999986655555556788999999999999999999999532 23
Q ss_pred cEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
.++|||+||+ |+|.+.|.... .++++.+..|+.||+.||.|||+++|+|||||+.||+++.++.|||.|||+|+...
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 4999999999 69999997654 58999999999999999999999999999999999999999999999999999875
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
... .....++||+.||+||++.+ .+|+.++|||||||++|||++-+++|.+.+....+..|......|-.
T Consensus 158 ~~~---~~a~tvvGTp~YmcPEil~d--~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp----- 227 (426)
T KOG0589|consen 158 PED---SLASTVVGTPYYMCPEILSD--IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP----- 227 (426)
T ss_pred Cch---hhhheecCCCcccCHHHhCC--CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC-----
Confidence 543 13467899999999999998 79999999999999999999999999999987777766654433221
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
...+.++..||+.||..+|..||++.++|.+|.+..
T Consensus 228 -------------------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 228 -------------------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred -------------------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 245678999999999999999999999999988763
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=363.33 Aligned_cols=250 Identities=27% Similarity=0.435 Sum_probs=203.9
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHH-HHHhCCCCCcceeeeeecCCCcCCCccEEEEE
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIK-LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~-iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~ 100 (508)
++||+|+||.||+|++..+|+.||+|++.+... .......+.+|+. +++.++||||+++++++. ....+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~-----~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ-----TAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCEEEEEE
Confidence 479999999999999999999999999864321 2223445666664 678899999999999884 345699999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCccc
Q 010512 101 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179 (508)
Q Consensus 101 E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~ 179 (508)
||++ ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~ 152 (321)
T cd05603 76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE---ET 152 (321)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC---Cc
Confidence 9998 5999888888889999999999999999999999999999999999999999999999999987532221 12
Q ss_pred ccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHH
Q 010512 180 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259 (508)
Q Consensus 180 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 259 (508)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-------------------- 210 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRK--EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH-------------------- 210 (321)
T ss_pred cccccCCcccCCHHHhcC--CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc--------------------
Confidence 345679999999999977 6799999999999999999999999988765443332211
Q ss_pred HHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH----HHHhcCCcccCC
Q 010512 260 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA----EEALADPYFHGL 313 (508)
Q Consensus 260 ~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta----~eiL~hp~f~~~ 313 (508)
.+.. ..+..+..+.+||.+||+.||.+||++ .++++|+||..+
T Consensus 211 --------~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 211 --------KPLQ---LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred --------CCCC---CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 0111 113457889999999999999999875 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=363.83 Aligned_cols=283 Identities=23% Similarity=0.365 Sum_probs=215.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++.+.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+++|+.++||||+++++++.. .+.
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 77 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE 77 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCE
Confidence 478999999999999999999999999999999986532 23345678899999999999999999999854 356
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhc-CceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~-gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999998 69999998888899999999999999999999975 7999999999999999999999999999754322
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHH-hhcCCCChHHHH--
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMT-DLLGTPSTESIS-- 250 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~-~~~g~p~~~~~~-- 250 (508)
. .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+. ...+.+......
T Consensus 158 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred c-----cccCCCCccccCHHHhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 1 234578999999999987 678999999999999999999999998765433222111 111111110000
Q ss_pred ---------HHh-----hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 251 ---------RIR-----NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 251 ---------~~~-----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
... ...............+..+. ....+.++.+||.+||++||.+|||++|++.||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLP--SGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCC--CCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 000 00000001111111111111 12357889999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=356.60 Aligned_cols=288 Identities=39% Similarity=0.650 Sum_probs=220.1
Q ss_pred CeEEeeeeeecCceEEEEEEECC--CCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTH--TGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~--tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
+|++.+.||+|+||.||+|.+.. ++..||+|.+.... ........+.+|+.+++.++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 69999999999999999999988 89999999997532 1222345678899999999999999999999653 225
Q ss_pred cEEEEEecCCccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC----CCcEEEcccc
Q 010512 95 DIYVVFELMESDLHQVIKAN-----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA----DCKLKICDFG 165 (508)
Q Consensus 95 ~lylV~E~~~g~L~~~i~~~-----~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~----~~~lkL~DFG 165 (508)
.+|+||||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 69999999999888877532 26899999999999999999999999999999999999999 8999999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChH---------HHHHH
Q 010512 166 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV---------HQLDL 236 (508)
Q Consensus 166 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~---------~~l~~ 236 (508)
++.................+|++|+|||++.+. ..++.++|||||||++|+|++|++||.+.... ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 998653322212223345789999999988652 46889999999999999999999999866532 34555
Q ss_pred HHhhcCCCChHHHHHHhhHH-HHHHHhhcccCCCCC------CCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCc
Q 010512 237 MTDLLGTPSTESISRIRNEK-ARRYLGSMRKKQPVP------FSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309 (508)
Q Consensus 237 i~~~~g~p~~~~~~~~~~~~-~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~ 309 (508)
+...++.+....+....... ........ .....+ +...+...+..+.++|.+||..||.+|||+.|++.|||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDF-KTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhc-cCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 66666666555443222110 00000000 000000 00111256788999999999999999999999999999
Q ss_pred c
Q 010512 310 F 310 (508)
Q Consensus 310 f 310 (508)
|
T Consensus 316 f 316 (316)
T cd07842 316 F 316 (316)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=363.05 Aligned_cols=250 Identities=28% Similarity=0.469 Sum_probs=204.8
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHH-HHHhCCCCCcceeeeeecCCCcCCCccEEEEE
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIK-LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~-iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~ 100 (508)
+.||+|+||+||+|++..++..||+|++..... .......+.+|.. +++.++||||+++++++. ....+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~-----~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE-----cCCeEEEEE
Confidence 479999999999999999999999999864321 1222344555554 568899999999999984 345699999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCccc
Q 010512 101 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179 (508)
Q Consensus 101 E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~ 179 (508)
||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---~ 152 (325)
T cd05602 76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---T 152 (325)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---C
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999975322221 2
Q ss_pred ccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHH
Q 010512 180 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259 (508)
Q Consensus 180 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 259 (508)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-------------------- 210 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN-------------------- 210 (325)
T ss_pred cccccCCccccCHHHHcC--CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh--------------------
Confidence 345679999999999987 6899999999999999999999999988775444333211
Q ss_pred HHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHH----HHhcCCcccCC
Q 010512 260 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE----EALADPYFHGL 313 (508)
Q Consensus 260 ~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~----eiL~hp~f~~~ 313 (508)
.+. ...+.+++.+.+||.+||+.||.+|+++. ++++|+||...
T Consensus 211 --------~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 211 --------KPL---QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred --------CCc---CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 001 12246788999999999999999999876 89999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=350.20 Aligned_cols=286 Identities=36% Similarity=0.622 Sum_probs=221.3
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
+|..++|++.+.||+|+||.||+|.+..+|..||||.+..... ......+.+|+.+|+.++|+||+++++++..
T Consensus 1 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----- 74 (291)
T cd07870 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHT----- 74 (291)
T ss_pred CCccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-----
Confidence 4667899999999999999999999999999999999864322 2223456789999999999999999999843
Q ss_pred CccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 93 FKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
....|+||||+.++|.+.+... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 75 KETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred CCeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 3568999999998888877653 568899999999999999999999999999999999999999999999999997532
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhhcCCCChHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV-VHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~-~~~l~~i~~~~g~p~~~~~~ 250 (508)
... .......+++.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+. .+++..+...+|.|....+.
T Consensus 155 ~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 155 IPS---QTYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred CCC---CCCCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence 211 112344678999999998652 4578899999999999999999999976553 45566666777777665543
Q ss_pred HHhhHHHHHHHhh-cccCCCCCCCCCCC--CCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 251 RIRNEKARRYLGS-MRKKQPVPFSHKFP--NADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 251 ~~~~~~~~~~l~~-~~~~~~~~~~~~~~--~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
.... ...+... .....+..+...+. ..++.+.+|+.+||..||.+|||+.|++.||||
T Consensus 231 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 231 GVSK--LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhhh--cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 3321 0011000 00011111111111 136789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=366.20 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=202.8
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhC---CCCCcceeeeeecCCCcCCCccEEEEE
Q 010512 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLL---RHPDIVEIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 25 LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L---~HpnIv~l~~v~~~~~~~~~~~lylV~ 100 (508)
||+|+||+||+|++..+|+.||||++.+.. ...........|..++..+ .||||+.+++++. ....+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~-----~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ-----TDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe-----cCCeEEEEE
Confidence 799999999999999999999999986432 1223344556777777665 6999999999984 345699999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCccc
Q 010512 101 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179 (508)
Q Consensus 101 E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~ 179 (508)
||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++....... .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---~ 152 (330)
T cd05586 76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---T 152 (330)
T ss_pred cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---C
Confidence 9998 69999998888999999999999999999999999999999999999999999999999999975322211 2
Q ss_pred ccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHH
Q 010512 180 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259 (508)
Q Consensus 180 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 259 (508)
....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------- 212 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG------------------- 212 (330)
T ss_pred ccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 3456899999999998652 45889999999999999999999999877654433322110
Q ss_pred HHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC----CHHHHhcCCcccCC
Q 010512 260 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP----TAEEALADPYFHGL 313 (508)
Q Consensus 260 ~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp----ta~eiL~hp~f~~~ 313 (508)
... +. ...+++.+.+||.+||..||.+|| +++++++||||...
T Consensus 213 -------~~~--~~--~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 213 -------KVR--FP--KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred -------CCC--CC--CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 000 00 123578899999999999999998 79999999999753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=360.76 Aligned_cols=294 Identities=38% Similarity=0.601 Sum_probs=233.9
Q ss_pred ccCCCCCeEE-eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChh------------HHHHHHHHHHHHHhCCCCCc
Q 010512 12 EYGEASRYQI-QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS------------DATRILREIKLLRLLRHPDI 78 (508)
Q Consensus 12 ~~~~~~rY~i-~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~------------~~~~i~~Ei~iL~~L~HpnI 78 (508)
.+...+||.. .+.||.|+||+||+|.+..+|+.||||++........ ....+.+|+.+++.++||||
T Consensus 3 ~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 82 (335)
T PTZ00024 3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI 82 (335)
T ss_pred ccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce
Confidence 3567789975 5779999999999999999999999999864322210 01246789999999999999
Q ss_pred ceeeeeecCCCcCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCc
Q 010512 79 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 158 (508)
Q Consensus 79 v~l~~v~~~~~~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~ 158 (508)
+++++++.. ...+|+||||+.++|.+++.....+++..+..++.||+.||.|||+.||+|+||||+||+++.++.
T Consensus 83 v~~~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 83 MGLVDVYVE-----GDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI 157 (335)
T ss_pred eeeeEEEec-----CCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC
Confidence 999999853 356899999999999999988888999999999999999999999999999999999999999999
Q ss_pred EEEccccccccccCCC-----------CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCC
Q 010512 159 LKICDFGLARVSFNDA-----------PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 227 (508)
Q Consensus 159 lkL~DFGla~~~~~~~-----------~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~ 227 (508)
++|+|||+++...... ..........+++.|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999997653111 011122334678899999998762 4578999999999999999999999999
Q ss_pred CChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 228 KNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 228 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.+..+++..+...++.|....+...... ..+ .......+..+...++..+..+.+||.+||..||.+|||++++|.|
T Consensus 237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 237 ENEIDQLGRIFELLGTPNEDNWPQAKKL--PLY-TEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred CCHHHHHHHHHHHhCCCchhhCcchhhc--ccc-cccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 9998888888888888776543321110 000 0011112222333455678889999999999999999999999999
Q ss_pred CcccCCC
Q 010512 308 PYFHGLA 314 (508)
Q Consensus 308 p~f~~~~ 314 (508)
|||++..
T Consensus 314 ~~~~~~~ 320 (335)
T PTZ00024 314 EYFKSDP 320 (335)
T ss_pred cccCCCC
Confidence 9998654
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=349.73 Aligned_cols=282 Identities=48% Similarity=0.775 Sum_probs=233.9
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEE
Q 010512 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 98 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 98 (508)
|++.+.||.|++|.||+|.+..+|+.+|+|+++...........+.+|+.+|+.++|+||+++++++.. ...+|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-----KGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-----CCCEEE
Confidence 778899999999999999999999999999997654443455678899999999999999999999844 356999
Q ss_pred EEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCc
Q 010512 99 VFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 177 (508)
Q Consensus 99 V~E~~~g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~ 177 (508)
||||++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+.......
T Consensus 76 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 76 VFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred EEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 9999999999888764 579999999999999999999999999999999999999999999999999997654332
Q ss_pred ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHH
Q 010512 178 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 257 (508)
Q Consensus 178 ~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 257 (508)
.......++.+|+|||.+.+. ..++.++|+||+||++|+|++|++||++.+..+++..+...++.+....+..+... .
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 230 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL-A 230 (283)
T ss_pred ccccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh-h
Confidence 123445788999999998762 37899999999999999999999999999998888888888888877665554331 1
Q ss_pred HHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 258 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 258 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
...................+.++..+.+||.+||..||.+||++.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 11111222223333334456778999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=367.45 Aligned_cols=269 Identities=26% Similarity=0.399 Sum_probs=226.3
Q ss_pred chhhhccccccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCccee
Q 010512 3 SALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEI 81 (508)
Q Consensus 3 ~~~~~~~~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l 81 (508)
.+.-+++|........|.=++.||+|+||-||.|+|..|.+.||||++.... ........|+.||.+|+.|+|||+|.+
T Consensus 12 DPeiA~LF~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieY 91 (948)
T KOG0577|consen 12 DPEIADLFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEY 91 (948)
T ss_pred CchHHHHHccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccc
Confidence 3445677887777788999999999999999999999999999999997653 334556789999999999999999999
Q ss_pred eeeecCCCcCCCccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEE
Q 010512 82 KHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLK 160 (508)
Q Consensus 82 ~~v~~~~~~~~~~~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lk 160 (508)
.++|+-.. ..|+|||||-|+-.+++.- ..++-+.++..|..+.|.||+|||+.+.||||||..|||+.+.|.||
T Consensus 92 kgCyLre~-----TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VK 166 (948)
T KOG0577|consen 92 KGCYLREH-----TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVK 166 (948)
T ss_pred cceeeccc-----hHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeee
Confidence 99997543 4799999999877776654 35799999999999999999999999999999999999999999999
Q ss_pred EccccccccccCCCCCcccccccccCcccccccccccc-cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 010512 161 ICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTD 239 (508)
Q Consensus 161 L~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~ 239 (508)
|+|||.|..... ...++|||+|||||++... .+.|+-++||||||+++.||.-.+||+-+.|....+.-|..
T Consensus 167 LaDFGSAsi~~P-------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ 239 (948)
T KOG0577|consen 167 LADFGSASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 239 (948)
T ss_pred eccccchhhcCc-------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh
Confidence 999999986422 3568999999999998653 25799999999999999999999999877776555544432
Q ss_pred hcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 240 LLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 240 ~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
+.+..+. -+.++..+..|+..||++-|.+|||.+++|+|+|...
T Consensus 240 ---------------------------NesPtLq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 240 ---------------------------NESPTLQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred ---------------------------cCCCCCC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 1111111 2346778999999999999999999999999999863
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=359.54 Aligned_cols=258 Identities=22% Similarity=0.389 Sum_probs=205.1
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCCccEEEEE
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV~ 100 (508)
+.||+|+||.||+|.+..++..||+|++.+... .......+.+|+.++..+ +||||+.+++++. ....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ-----TTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE-----eCCEEEEEE
Confidence 479999999999999999999999999975422 223456678999999888 5999999999984 345699999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCccc
Q 010512 101 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179 (508)
Q Consensus 101 E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~ 179 (508)
||+. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~ 152 (327)
T cd05617 76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---DT 152 (327)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC---Cc
Confidence 9998 6999999888889999999999999999999999999999999999999999999999999987532211 11
Q ss_pred ccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHH
Q 010512 180 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259 (508)
Q Consensus 180 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 259 (508)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||......... ...+. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~---------~~~~~--------~-- 211 (327)
T cd05617 153 TSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM---------NTEDY--------L-- 211 (327)
T ss_pred eecccCCcccCCHHHHCC--CCCCchheeehhHHHHHHHHhCCCCCCccCCCccc---------ccHHH--------H--
Confidence 345689999999999987 68899999999999999999999999643210000 00000 0
Q ss_pred HHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC------HHHHhcCCcccCCC
Q 010512 260 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT------AEEALADPYFHGLA 314 (508)
Q Consensus 260 ~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt------a~eiL~hp~f~~~~ 314 (508)
...+. ..+..+ ...++..+.+||.+||..||.+|++ ++++++||||.++.
T Consensus 212 -~~~~~-~~~~~~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 212 -FQVIL-EKPIRI---PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred -HHHHH-hCCCCC---CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 00000 111111 1246788999999999999999998 57999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=364.21 Aligned_cols=261 Identities=27% Similarity=0.478 Sum_probs=223.7
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..+-|.+.+.||+|.|+.|.+|++..||..||||.|++...+......+.+|+++|+.|+|||||+++.++.. ..
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-----~~ 128 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-----EA 128 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-----cc
Confidence 3467999999999999999999999999999999999887777777779999999999999999999999944 45
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
.+|+||||+. |++++++.++++..+..++.+|.|+++|++|||+++|+|||||++|||++.+.++||+|||++..+...
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc
Confidence 6999999997 799999999999999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
....+++|++.|.|||++.+. ...++.+|+||+|+++|.|+.|..||.|.+....-...
T Consensus 209 ----~~lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv---------------- 267 (596)
T KOG0586|consen 209 ----LMLQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV---------------- 267 (596)
T ss_pred ----ccccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCcccccccchh----------------
Confidence 245678999999999999983 34458999999999999999999999987632211110
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 316 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~ 316 (508)
+..+..+++ -++-++.+||+++|..+|.+|++.+++..|.|...+...
T Consensus 268 ----------l~gk~rIp~-----~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 268 ----------LRGKYRIPF-----YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred ----------eeeeecccc-----eeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 011111221 245678999999999999999999999999999865543
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=391.37 Aligned_cols=270 Identities=26% Similarity=0.391 Sum_probs=217.9
Q ss_pred ccccccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecC
Q 010512 8 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLP 87 (508)
Q Consensus 8 ~~~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~ 87 (508)
.+.+.-...++|++++.||+|+||+||+|.+..++..||+|++............+.+|+.+|+.|+|||||+++++|..
T Consensus 4 ~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred cccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 34455566689999999999999999999999999999999997654455566778999999999999999999998864
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhc-------CceecCCCCCceeeCC
Q 010512 88 PSRREFKDIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTA-------NVFHRDLKPKNILANA 155 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~Qil~aL~yLHs~-------gIiHrDLKPeNILl~~ 155 (508)
. ....+||||||+. ++|.++|.. ...+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 84 e---~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 84 K---ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred c---CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 3 2356899999998 699998865 35799999999999999999999985 4999999999999964
Q ss_pred -----------------CCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHH
Q 010512 156 -----------------DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEM 218 (508)
Q Consensus 156 -----------------~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eL 218 (508)
.+.+||+|||++....... .....+||+.|+|||++.+....++.++||||||||||+|
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYEL 236 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCccccccccc----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHH
Confidence 2348999999997643221 1234579999999999865335689999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 010512 219 LTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR 298 (508)
Q Consensus 219 ltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~R 298 (508)
++|..||...+...++.... ...... .....++.+.+||..||.+||.+|
T Consensus 237 LTGk~PF~~~~~~~qli~~l--------------------------k~~p~l----pi~~~S~eL~dLI~~~L~~dPeeR 286 (1021)
T PTZ00266 237 CSGKTPFHKANNFSQLISEL--------------------------KRGPDL----PIKGKSKELNILIKNLLNLSAKER 286 (1021)
T ss_pred HHCCCCCCcCCcHHHHHHHH--------------------------hcCCCC----CcCCCCHHHHHHHHHHhcCChhHC
Confidence 99999997655433321111 001111 123457889999999999999999
Q ss_pred CCHHHHhcCCcccCCC
Q 010512 299 PTAEEALADPYFHGLA 314 (508)
Q Consensus 299 pta~eiL~hp~f~~~~ 314 (508)
|++.|+|.||||..+.
T Consensus 287 PSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 287 PSALQCLGYQIIKNVG 302 (1021)
T ss_pred cCHHHHhccHHHhhcC
Confidence 9999999999998654
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=339.23 Aligned_cols=254 Identities=29% Similarity=0.460 Sum_probs=210.5
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
.|++++.||+|++|.||+|.+..+++.||+|++............+.+|+.+++.++|+|++++++.+.. ....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence 5999999999999999999999999999999997544444456678899999999999999999887632 224589
Q ss_pred EEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 98 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 98 lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+||||++ ++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999998 6899988763 458999999999999999999999999999999999999999999999999998653222
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
. ......+++.|+|||++.+ ..++.++|+||+||++++|++|+.||.+.+.......+...
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~-------------- 217 (257)
T cd08223 157 D---MASTLIGTPYYMSPELFSN--KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG-------------- 217 (257)
T ss_pred C---ccccccCCcCccChhHhcC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--------------
Confidence 1 2344578899999999987 67889999999999999999999999876643332221110
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
.. .......++.+.+|+.+||..||.+|||+.++++||||
T Consensus 218 ------------~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 218 ------------KL----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ------------CC----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 01113467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=359.12 Aligned_cols=287 Identities=23% Similarity=0.309 Sum_probs=208.7
Q ss_pred EEeeeeeec--CceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 20 QIQEVIGKG--SYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 20 ~i~~~LG~G--~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
+++++||+| +||+||++.+..+|+.||||+++...........+.+|+.+++.++||||+++++++.. ...+|
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~~~~ 75 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----DNELW 75 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-----CCEEE
Confidence 357899999 78899999999999999999997554444455677889999999999999999999854 35689
Q ss_pred EEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 98 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 98 lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+||||++ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+.......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 9999998 6999998653 458999999999999999999999999999999999999999999999998765432111
Q ss_pred CCc----ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChH-HH
Q 010512 175 PSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE-SI 249 (508)
Q Consensus 175 ~~~----~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~-~~ 249 (508)
... .......++..|+|||++.+....|+.++|||||||++|+|++|+.||............. .+..... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~ 233 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL--NGTVPCLLDT 233 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh--cCCccccccc
Confidence 100 0112235778899999987533468999999999999999999999998765433322211 1111100 00
Q ss_pred HHHhhHHHHHHH------hhcc----------cCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 250 SRIRNEKARRYL------GSMR----------KKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 250 ~~~~~~~~~~~l------~~~~----------~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
..+..+...... .... .............+++.+.+||.+||+.||.+|||++++|+||||+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 000000000000 0000 000000111223467889999999999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=348.03 Aligned_cols=281 Identities=43% Similarity=0.732 Sum_probs=234.2
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEE
Q 010512 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 98 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 98 (508)
|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++|+||+++++++.. ...+|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-----ERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-----CCceEE
Confidence 778899999999999999999999999999997654334445677899999999999999999999853 356999
Q ss_pred EEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCc
Q 010512 99 VFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 177 (508)
Q Consensus 99 V~E~~~g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~ 177 (508)
||||++++|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||+++.......
T Consensus 76 v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 76 VFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred EecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 9999999999999876 5799999999999999999999999999999999999999999999999999976432221
Q ss_pred ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHH
Q 010512 178 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 257 (508)
Q Consensus 178 ~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 257 (508)
......++..|+|||.+.+. ..++.++|||||||++++|++|.+||.+.+....+..+...++.+....+..+.+..
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP- 230 (282)
T ss_pred -ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-
Confidence 12334567889999998762 478899999999999999999999999999999998898888888877665543321
Q ss_pred HHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 258 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 258 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
.+-..++..........++..+..+.++|.+||..||.+||++++++.||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 -DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred -cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1111122222333344556678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=347.42 Aligned_cols=283 Identities=40% Similarity=0.682 Sum_probs=228.1
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEE
Q 010512 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 98 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 98 (508)
|++.+.||.|+||.||+|.+..+|+.||+|++............+.+|+.+++.++|||++++++++.... .+.+|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 78999999999999999999999999999999765433344567889999999999999999999985431 367999
Q ss_pred EEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCc
Q 010512 99 VFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 177 (508)
Q Consensus 99 V~E~~~g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~ 177 (508)
||||++++|.+++... ..+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 78 VFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred EeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 9999999999988765 5799999999999999999999999999999999999999999999999999986543321
Q ss_pred ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHH
Q 010512 178 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 257 (508)
Q Consensus 178 ~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 257 (508)
...+...++..|+|||.+.+. ..++.++|||||||++++|++|++||...+....+..+....+.+....+..+.....
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred ccccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 123345678899999987652 4688999999999999999999999999998888888888888776655433221100
Q ss_pred HHHHhhcccC--CCCCCCCCCCC-CCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 258 RRYLGSMRKK--QPVPFSHKFPN-ADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 258 ~~~l~~~~~~--~~~~~~~~~~~-~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
....... .+..+...+.. .++.+.++|.+||..||.+||+++++++||||
T Consensus 235 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 235 ---FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ---hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0000000 01111122333 38899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=351.31 Aligned_cols=283 Identities=24% Similarity=0.378 Sum_probs=215.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|++.+.||+|+||.||+|.+..+|..||+|.++... ......++.+|+++++.++||||+++++++.. .+.+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEE
Confidence 46999999999999999999999999999999986432 23345568899999999999999999999843 4579
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-cCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 97 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs-~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.++|+|||++.......
T Consensus 75 ~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred EEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999998 5999999888889999999999999999999997 599999999999999999999999999987542221
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHH------
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES------ 248 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~------ 248 (508)
....++++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.......+...........
T Consensus 155 -----~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 155 -----ANSFVGTRSYMSPERLQG--THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred -----cccCCCCcCccChhHhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCccccc
Confidence 234678999999999876 5788999999999999999999999987664332222211100000000
Q ss_pred ---HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 249 ---ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 249 ---~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
....................+. ......++..+.+|+.+||..||++|||+.++++||||.+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEPPP--KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCCCc--cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence 0000000000001111111110 011123678899999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=373.94 Aligned_cols=257 Identities=23% Similarity=0.326 Sum_probs=211.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCC-CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHT-GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~t-g~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
..|.+.+.||+|+||.||+|.+..+ +..||+|++.. ........+.+|+.+|+.++||||+++++.+. ..+.
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~ 139 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML--NDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDK 139 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCE
Confidence 3499999999999999999998877 78899998743 23344556788999999999999999999984 3457
Q ss_pred EEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 96 IYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
+||||||++ |+|.+++.. ..++++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 999999998 699887753 346899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 220 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~---------- 286 (478)
T PTZ00267 220 SDSVS-LDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG---------- 286 (478)
T ss_pred CCccc-cccccccCCCccccCHhHhCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------
Confidence 33221 112345679999999999987 68999999999999999999999999876654433332110
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
...+ ....+++.+.+||.+||..||.+||+++++|.|+|++.+
T Consensus 287 ---------------~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 287 ---------------KYDP-----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred ---------------CCCC-----CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 0001 112467889999999999999999999999999998753
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=350.95 Aligned_cols=290 Identities=37% Similarity=0.628 Sum_probs=229.2
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC-----
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS----- 89 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~----- 89 (508)
..++|++.+.||+|+||.||+|.+..+|+.||||+++...........+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 457899999999999999999999999999999999754333334456778999999999999999999886532
Q ss_pred cCCCccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 90 RREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 90 ~~~~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
......+|+||||++++|...+... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 1123479999999999888888764 469999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
....... .......++..|+|||.+.+. ..++.++|||||||++++|++|++||...+....+..+....+.+....
T Consensus 165 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 165 LYNSEES--RPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241 (302)
T ss_pred cccCCcc--cccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 6533221 122334567889999988652 4578899999999999999999999999888888888888887776654
Q ss_pred HHHHhhHHHHHHHhhccc--CCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 249 ISRIRNEKARRYLGSMRK--KQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
+..+..... ...... .....+...+..++..+.+||.+||..||.+|||+.+++.||||
T Consensus 242 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 242 WPDVIKLPY---FNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccc---ccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 332211000 000000 00011222344578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=349.29 Aligned_cols=258 Identities=26% Similarity=0.393 Sum_probs=207.5
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
.|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+|+.++|+||+.+++.+.. ...+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-----KDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-----CCEE
Confidence 48899999999999999999999999999999864322 22233457789999999999999999998843 3569
Q ss_pred EEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 97 YVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
|+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999998 6898888643 35899999999999999999999999999999999999999999999999998754222
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
. ......||..|+|||++.+ ..++.++||||+||++|+|++|++||.+..........
T Consensus 156 ~----~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---------------- 213 (285)
T cd05630 156 Q----TIKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---------------- 213 (285)
T ss_pred c----cccCCCCCccccChHHHcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH----------------
Confidence 1 1234578999999999977 67999999999999999999999999764321111000
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGL 313 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt-----a~eiL~hp~f~~~ 313 (508)
......... .....+++.+.+|+.+||+.||.+||| ++|+++||||+.+
T Consensus 214 ----~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 214 ----ERLVKEVQE-------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred ----Hhhhhhhhh-------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 000000000 112346788999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=353.32 Aligned_cols=256 Identities=26% Similarity=0.439 Sum_probs=217.1
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
-|.|++.||+|+||.||+|+|+.+|..+|||++.. ..+.+.+..||.||++++.|++|++|+.|.- ..++|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK-----~sDLW 104 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFK-----HSDLW 104 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhcc-----CCceE
Confidence 47788999999999999999999999999999863 4678999999999999999999999999854 35699
Q ss_pred EEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 98 VVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 98 lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
||||||+ |++.+.+.. +.+|+++++..+++..|.||.|||...-+|||||..|||+|.+|..||+|||.|........
T Consensus 105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 9999999 899999875 46899999999999999999999999999999999999999999999999999976543322
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
...+.+|||.|||||++.. -.|+.++||||||+...||..|+|||..-.....+
T Consensus 185 ---KRNTVIGTPFWMAPEVI~E--IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI--------------------- 238 (502)
T KOG0574|consen 185 ---KRNTVIGTPFWMAPEVIEE--IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI--------------------- 238 (502)
T ss_pred ---hhCccccCcccccHHHHHH--hccchhhhHhhhcchhhhhhcCCCCccccccccee---------------------
Confidence 2456799999999999987 68999999999999999999999999764432211
Q ss_pred HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
..++.++|..|. .-..++.++.||++.||.++|++|.||-++++|||+++-..
T Consensus 239 ------FMIPT~PPPTF~-KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g 291 (502)
T KOG0574|consen 239 ------FMIPTKPPPTFK-KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPG 291 (502)
T ss_pred ------EeccCCCCCCCC-ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence 112223332222 12245678899999999999999999999999999986543
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=344.05 Aligned_cols=282 Identities=39% Similarity=0.651 Sum_probs=224.4
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC---CCCCcceeeeeecCCCcCCCcc
Q 010512 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL---RHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L---~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
|++.+.||.|+||.||+|.+..+|..||+|+++...........+.+|+.+++.+ .||||+++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999998999999999975443333345566788887766 5999999999997654333345
Q ss_pred EEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 96 IYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 96 lylV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
+|+||||+.++|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 89999999999999887643 5899999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
.. .....++..|+|||++.+ ..++.++|+||+||++|+|++|.+||.+.+..+.+..+.+..+.+....+....
T Consensus 161 ~~----~~~~~~~~~~~~PE~~~~--~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 161 MA----LTSVVVTLWYRAPEVLLQ--SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred cc----cccccccccccChHHhcc--CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 21 234467899999999987 678999999999999999999999999999888888877766655433222111
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
.... ..........+....+..++.+.+||.+||+.||.+||++++++.||||
T Consensus 235 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPR----SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccch----hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0000 0111222223333445667889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=356.57 Aligned_cols=254 Identities=26% Similarity=0.456 Sum_probs=200.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 89 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~-----~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~ 89 (508)
.++|++.+.||+|+||.||+|.+ ..++..||+|+++.. ........+.+|+.+|+.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 36899999999999999999975 245678999998743 2233456788999999999 899999999988532
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC------------------------------------------------------
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 114 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------------------------------------ 114 (508)
...+|+||||++ |+|.+++...
T Consensus 84 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 84 ---NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 245899999998 6999988652
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcccccccccC
Q 010512 115 --------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 186 (508)
Q Consensus 115 --------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT 186 (508)
.++++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... ........++
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~ 239 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARLP 239 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc-hhcccCCCCC
Confidence 2477888999999999999999999999999999999999999999999999986432211 1112233566
Q ss_pred cccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcc
Q 010512 187 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMR 265 (508)
Q Consensus 187 ~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~ 265 (508)
+.|+|||++.+ ..|+.++|||||||++|+|++ |.+||++......+.... .
T Consensus 240 ~~y~aPE~~~~--~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~--------------------------~ 291 (338)
T cd05102 240 LKWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL--------------------------K 291 (338)
T ss_pred ccccCcHHhhc--CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH--------------------------h
Confidence 78999999976 679999999999999999997 999998755322211110 0
Q ss_pred cCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 266 KKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..... .....+++.+.+|+.+||..||.+|||+.++++
T Consensus 292 ~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 292 DGTRM---RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred cCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 00000 012356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=346.25 Aligned_cols=253 Identities=25% Similarity=0.371 Sum_probs=200.7
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEecC
Q 010512 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 103 (508)
Q Consensus 25 LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~ 103 (508)
||+|+||.||+|.+..+|+.||+|++..... .......+..|+.+|+.++||||+++.+++. ....+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~-----~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE-----SKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe-----cCCeEEEEEecC
Confidence 7999999999999999999999999964322 1222344567999999999999999999884 345689999999
Q ss_pred C-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcccc
Q 010512 104 E-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 180 (508)
Q Consensus 104 ~-g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~ 180 (508)
. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... ..
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~ 151 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TI 151 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----ee
Confidence 8 68988876543 58899999999999999999999999999999999999999999999999987643221 12
Q ss_pred cccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHH
Q 010512 181 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 260 (508)
Q Consensus 181 ~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~ 260 (508)
....||..|+|||++.+ ..++.++||||+||++|+|++|+.||.+.........+. ...
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~-------------------~~~ 210 (277)
T cd05607 152 TQRAGTNGYMAPEILKE--EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK-------------------RRT 210 (277)
T ss_pred eccCCCCCccCHHHHcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH-------------------HHh
Confidence 34578999999999987 569999999999999999999999997643211100000 000
Q ss_pred HhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH----HHHhcCCcccCCC
Q 010512 261 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA----EEALADPYFHGLA 314 (508)
Q Consensus 261 l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta----~eiL~hp~f~~~~ 314 (508)
+ ... .......+++.+.+||.+||+.||.+||++ ++++.||||+++.
T Consensus 211 ~---~~~----~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 211 L---EDE----VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred h---ccc----cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence 0 000 011123568899999999999999999999 7788999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=336.07 Aligned_cols=253 Identities=27% Similarity=0.421 Sum_probs=211.6
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
.|.+.+.||+|++|.||+|.+..+|..|++|.+............+.+|+.+++.++||||+++++.+.. ....|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-----KGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-----CCEEE
Confidence 4899999999999999999999999999999987544445566778899999999999999999999854 35689
Q ss_pred EEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 98 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 98 lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999997 6999998774 568999999999999999999999999999999999999999999999999988653322
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
. ......|+++|+|||++.+ ..++.++|+|||||++++|++|+.||...+.......+..
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 215 (256)
T cd08529 156 N---FANTIVGTPYYLSPELCED--KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR--------------- 215 (256)
T ss_pred c---hhhccccCccccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---------------
Confidence 1 1234578899999999987 6788999999999999999999999987764333222211
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
... ......++..+.++|.+||+.+|++||++.++++|||+
T Consensus 216 ------------~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 216 ------------GVF---PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ------------CCC---CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 000 01112467889999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=344.80 Aligned_cols=258 Identities=26% Similarity=0.387 Sum_probs=209.9
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
.|++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+|+.++|+||+.+.+.+.. ...+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-----KDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-----CCEE
Confidence 48889999999999999999999999999999864322 22234557889999999999999999998843 3568
Q ss_pred EEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 97 YVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
|+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999998 5888877543 36999999999999999999999999999999999999999999999999999754221
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
. ......|+..|+|||++.+ ..++.++|+||+||++|+|++|..||.+.........+....
T Consensus 156 ~----~~~~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~------------ 217 (285)
T cd05632 156 E----SIRGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRV------------ 217 (285)
T ss_pred C----cccCCCCCcCccChHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh------------
Confidence 1 1234578999999999976 678999999999999999999999998766443332221100
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGL 313 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt-----a~eiL~hp~f~~~ 313 (508)
.... ....+..++.+.+|+.+||..||.+||+ +.+++.|+||...
T Consensus 218 -----------~~~~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 218 -----------LETE----EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred -----------hccc----cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 0000 0112356788999999999999999999 8999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=340.29 Aligned_cols=260 Identities=26% Similarity=0.421 Sum_probs=207.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC---hhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH---VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~---~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
..|++.+.||+|+||.||+|.+..+|..||+|++...... ......+.+|+.+++.++||||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence 4699999999999999999999999999999998643222 23345688999999999999999999987542 23
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
..+|+||||+. ++|.+++...+.+++.....++.||+.||.|||+.||+||||||+||+++.++.++|+|||+++....
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 56899999998 59999998888899999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
............++..|+|||.+.+ ..++.++||||+||++|+|++|++||........+..+.. .
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~--------- 224 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---Q--------- 224 (266)
T ss_pred ccccCCccccCCccccccCHHHhCC--CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---C---------
Confidence 2111111233568899999999976 6789999999999999999999999976543222211110 0
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~ 311 (508)
... + ..-..+++.+.+|| +||..||.+||+++|+++||||+
T Consensus 225 ------------~~~-~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 225 ------------PTN-P----QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ------------CCC-C----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 000 0 01123567788898 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=332.10 Aligned_cols=287 Identities=31% Similarity=0.620 Sum_probs=234.0
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCc
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSR 90 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~ 90 (508)
.||..++|+|.+.+|+|-|+.||.|++..+.++++||+++. -..+.+.|||+||+.|. ||||++++++..++.
T Consensus 33 ~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~- 106 (338)
T KOG0668|consen 33 DWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPE- 106 (338)
T ss_pred eccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcc-
Confidence 68999999999999999999999999999999999999974 34678999999999998 999999999997653
Q ss_pred CCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC-CcEEEccccccc
Q 010512 91 REFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLAR 168 (508)
Q Consensus 91 ~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~-~~lkL~DFGla~ 168 (508)
.....+|+||++. +...+. +.|+.-.++.+++|||.||.|||++||+|||+||.|++||.. -.++|+|||+|.
T Consensus 107 --SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 107 --SKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred --ccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHh
Confidence 3556899999995 555544 358899999999999999999999999999999999999975 469999999999
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCC-CCCCCCChHHHHHHHHhhcCCCChH
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~-~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
++..... ..-.+.++.|--||++.. ...|+..-|+|||||+|+.|+..+ |.|.|.+..+|+-+|.+++|+....
T Consensus 182 FYHp~~e----YnVRVASRyfKGPELLVd-y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~ 256 (338)
T KOG0668|consen 182 FYHPGKE----YNVRVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELY 256 (338)
T ss_pred hcCCCce----eeeeeehhhcCCchheee-chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHH
Confidence 8755433 344688899999999987 478999999999999999999976 5678999999999999999985433
Q ss_pred H-HHHHhhHHHHHHHhhcccCCCCCCCCCCC-----CCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 248 S-ISRIRNEKARRYLGSMRKKQPVPFSHKFP-----NADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 248 ~-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-----~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
. +.+..-.-..++-..+......+|+.... -++++++|||.++|..|..+|+||.|++.||||..+.
T Consensus 257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 2 11111111122222233333444443332 3579999999999999999999999999999998654
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=344.06 Aligned_cols=254 Identities=27% Similarity=0.477 Sum_probs=213.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+++|+.+.||||+++++++. ....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCe
Confidence 47999999999999999999999999999999986432 22234567889999999999999999999984 3456
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+.||+|+||+|.|||++.++.+||+|||++......
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999995 799999998889999999999999999999999999999999999999999999999999999865332
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
.....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+..
T Consensus 155 -----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 212 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILS--KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--------------- 212 (290)
T ss_pred -----CCCCCCCccccChhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------
Confidence 234578899999999876 5788999999999999999999999987664333222211
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCC
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 314 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~~ 314 (508)
.. ..+ ....++.+.++|.+||..||.+|+ +++++++||||..+.
T Consensus 213 -----------~~--~~~---~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 213 -----------GK--VRF---PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred -----------CC--ccC---CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 00 011 123478899999999999999999 999999999997653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=341.26 Aligned_cols=275 Identities=26% Similarity=0.402 Sum_probs=219.6
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCCCccEEEEEe
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIYVVFE 101 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~lylV~E 101 (508)
+.||+|+|+.|--|+...||..||||+|.+. ......+++||+.++.+++ |+||++|+++| ++...+|+|||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FYLVfE 156 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFYLVFE 156 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEEEEEe
Confidence 6899999999999999999999999999764 3345778999999999997 99999999999 55667999999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC---cEEEccccccccccCCCC--
Q 010512 102 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARVSFNDAP-- 175 (508)
Q Consensus 102 ~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~---~lkL~DFGla~~~~~~~~-- 175 (508)
-|. |.|.+.|.+...+++.++..+...|+.||.|||.+||.||||||+|||..... -||||||.++........
T Consensus 157 Km~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 157 KMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred cccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 998 69999999999999999999999999999999999999999999999987654 489999998875422211
Q ss_pred --CcccccccccCcccccccccc---cccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 176 --SAIFWTDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 176 --~~~~~~~~~gT~~Y~APE~l~---~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
....+.+.+|+..|||||+.. +....|+.+.|.||||+|+|.||.|.+||.|....+--.. -|.+.
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd----rGe~C----- 307 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD----RGEVC----- 307 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc----CCCcc-----
Confidence 122345678999999999863 3235699999999999999999999999987653110000 00000
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 316 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~ 316 (508)
+.. -..++..+...........|..++.+++|||..+|..|+.+|.++.++++|||++.....
T Consensus 308 r~C---Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 308 RVC---QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHH---HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 000 012233344444444556677889999999999999999999999999999999876543
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=342.11 Aligned_cols=259 Identities=26% Similarity=0.414 Sum_probs=209.0
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++.+.||+|+||.||+|.+..+++.||+|+++.. .......+.+|+.+++.++||||+++++.+.. ..
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-----~~ 79 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-----RD 79 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----CC
Confidence 346899999999999999999999999999999998643 22344567889999999999999999999843 45
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
.+|+||||++ ++|.+++...+.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 6899999998 599999988889999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccCccccccccccc-ccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~-~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
.. ......||..|+|||++.. ....++.++|+|||||++|+|++|.+||........+..+..
T Consensus 160 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~------------- 223 (267)
T cd06645 160 IA---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK------------- 223 (267)
T ss_pred cc---ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc-------------
Confidence 11 1234578999999999742 124688999999999999999999999865543222211110
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCc
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~ 309 (508)
....+..+ .....++..+.+||.+||..||.+|||++++++|||
T Consensus 224 ------------~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 224 ------------SNFQPPKL-KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ------------cCCCCCcc-cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 00001111 111245678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=346.99 Aligned_cols=263 Identities=27% Similarity=0.433 Sum_probs=214.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.+|++.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+++|+.++||||+++++.+. ....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ-----TETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee-----cCCE
Confidence 4799999999999999999999999999999999754322 234567889999999999999999999984 3457
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 96 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 899999998 5999998764 4699999999999999999999999999999999999999999999999999875422
Q ss_pred CCCC--------------------------cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCC
Q 010512 173 DAPS--------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFP 226 (508)
Q Consensus 173 ~~~~--------------------------~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~ 226 (508)
.... .......+||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--DGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--CCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 1110 011123578999999999987 678999999999999999999999998
Q ss_pred CCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC----HH
Q 010512 227 GKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT----AE 302 (508)
Q Consensus 227 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt----a~ 302 (508)
+.+....+..+.. .. ..+. .....+..+.+||.+||..||.+||| ++
T Consensus 234 ~~~~~~~~~~~~~--------------------------~~--~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 234 GSNRDETFSNILK--------------------------KE--VTFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred CCchHHHHHHHhc--------------------------CC--ccCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 7765443322210 00 0111 11226789999999999999999999 99
Q ss_pred HHhcCCcccCCCC
Q 010512 303 EALADPYFHGLAN 315 (508)
Q Consensus 303 eiL~hp~f~~~~~ 315 (508)
++|.||||++...
T Consensus 285 ~ll~~~~~~~~~~ 297 (316)
T cd05574 285 EIKQHPFFRGVNW 297 (316)
T ss_pred HHHcCchhhcCCh
Confidence 9999999987653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=344.11 Aligned_cols=258 Identities=26% Similarity=0.419 Sum_probs=222.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|..+++||+|.||.|-+|+.+.+|+.||||++++.. -.......-+.|-++|+..+||.+..+.-.|.. ...
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt-----~dr 242 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT-----QDR 242 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc-----Cce
Confidence 67899999999999999999999999999999998653 233445667789999999999999999888744 456
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+++||||+. |+|+-.+.....++++..+++-..|+.||.|||+.+|++||||.+|+|+|.||.+||+|||+++......
T Consensus 243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999998543322
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
.....+||||.|+|||++.. ..|+.++|.|.+||++|||++|+.||.+.+......+|.-- .
T Consensus 323 ---~t~kTFCGTPEYLAPEVleD--nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e----------d--- 384 (516)
T KOG0690|consen 323 ---DTTKTFCGTPEYLAPEVLED--NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME----------D--- 384 (516)
T ss_pred ---ceeccccCChhhcCchhhcc--ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh----------h---
Confidence 23467899999999999988 79999999999999999999999999998877766665320 0
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCCC
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLAN 315 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt-----a~eiL~hp~f~~~~~ 315 (508)
. ..-..++++++.||..+|.+||.+|.. +.||.+|+||.++..
T Consensus 385 ---------------~---kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W 432 (516)
T KOG0690|consen 385 ---------------L---KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDW 432 (516)
T ss_pred ---------------c---cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCH
Confidence 0 111357899999999999999999964 899999999997654
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=336.34 Aligned_cols=262 Identities=26% Similarity=0.429 Sum_probs=212.1
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|++.+.||.|+||+||+|.+..++..||+|++....... ....+.+|+.+|+.++|+||+++++.+.. ....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEE
Confidence 47999999999999999999998899999999986433322 56778999999999999999999998843 4568
Q ss_pred EEEEecCC-ccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 97 YVVFELME-SDLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~---~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
|+|||++. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 99999998 5899998764 3589999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCc-ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSA-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
..... ......+|+..|+|||.+... ..++.++|+|||||++++|++|+.||...+....+..+..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~------------ 221 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ------------ 221 (267)
T ss_pred CccccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc------------
Confidence 32221 112345789999999998762 3688999999999999999999999976554322221111
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
. ..........+..+++.+.+|+.+||..||.+|||++++++||||
T Consensus 222 -----------~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 222 -----------N--DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred -----------C--CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0 001111111234678899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=359.78 Aligned_cols=262 Identities=27% Similarity=0.438 Sum_probs=207.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~ 94 (508)
+..|++++.||+||.+.||++... ....||+|++.....+.....-+.+||.+|.+|+ |.+||+|+++-.. .+
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-----d~ 433 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-----DG 433 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-----Cc
Confidence 457999999999999999999754 4467888888766666677788999999999997 8999999998754 46
Q ss_pred cEEEEEecCCccHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELMESDLHQVIKANDDL-TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~g~L~~~i~~~~~l-~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
++|||||+-+.||..+|++.... ..-.++++.+|+|.|+.++|.+||||.||||.|+|+- +|.+||+|||.|.....+
T Consensus 434 ~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 434 YLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred eEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 79999999999999999887643 3348899999999999999999999999999999986 679999999999987655
Q ss_pred CCCcccccccccCcccccccccccccC---------CCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFS---------KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~---------~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p 244 (508)
. ..+.....+||+.||+||.+..... +.+.++||||||||||+|+.|++||.. ...+++++..+ -+|
T Consensus 513 T-TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~--~~n~~aKl~aI-~~P 588 (677)
T KOG0596|consen 513 T-TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ--IINQIAKLHAI-TDP 588 (677)
T ss_pred c-cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH--HHHHHHHHHhh-cCC
Confidence 4 3444567899999999999854211 266899999999999999999999943 22222222111 011
Q ss_pred ChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
...+.|...-+ ..+++++++.||+.||++|||+.++|+|||++.
T Consensus 589 ----------------------~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 589 ----------------------NHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ----------------------CccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 11112211111 123899999999999999999999999999874
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=343.10 Aligned_cols=263 Identities=29% Similarity=0.499 Sum_probs=215.2
Q ss_pred ccC-CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 12 EYG-EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 12 ~~~-~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
+++ ...+|++.+.||.|+||.||+|.+..+|+.||||++.... ......+.+|+.+++.++||||+++++.+..
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 87 (296)
T cd06655 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLV--- 87 (296)
T ss_pred hcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEec---
Confidence 344 4578999999999999999999999999999999986432 2345678899999999999999999999843
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 91 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
...+|+|+||+. ++|..++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 88 --~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 88 --GDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred --CceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchh
Confidence 356999999998 588887765 4689999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
...... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+....+..+... +
T Consensus 165 ~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~------- 231 (296)
T cd06655 165 ITPEQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-G------- 231 (296)
T ss_pred cccccc---cCCCcCCCccccCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-C-------
Confidence 432221 1234578899999999876 67889999999999999999999999887654433222110 0
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
.+.......+++.+.+||.+||..||.+|||+.+++.||||+....
T Consensus 232 --------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 232 --------------------TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred --------------------CcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 0001112356788999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=336.74 Aligned_cols=256 Identities=29% Similarity=0.489 Sum_probs=208.8
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh-------hHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-------SDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~-------~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
+|.+.+.||.|+||.||+|.+..++..||+|.+....... .....+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence 5888999999999999999999999999999986432221 123567899999999999999999998843
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 91 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
....++||||++ ++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.
T Consensus 78 --~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 78 --ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred --CCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 456899999998 59999998888899999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCc---ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCh
Q 010512 170 SFNDAPSA---IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246 (508)
Q Consensus 170 ~~~~~~~~---~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 246 (508)
........ .......|+..|+|||.+.+ ..++.++|+||+||++|+|++|+.||.+.+....+..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------- 226 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQ--TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE------- 226 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhcc--CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-------
Confidence 54221111 11123468899999999876 6788999999999999999999999987554322221111
Q ss_pred HHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 247 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
. .........+..+.+||.+||+.||.+||++.++++||||
T Consensus 227 --------------------~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 227 --------------------N---ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred --------------------c---CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 0 0001123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=340.58 Aligned_cols=280 Identities=40% Similarity=0.704 Sum_probs=227.0
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCCCccEE
Q 010512 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
|++.+.||.|+||+||+|.+..+++.||||++...... .......+|+..++.++ ||||+++++++.. ....|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~ 74 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELY 74 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEE
Confidence 78999999999999999999989999999998754332 22334567999999999 9999999999844 45689
Q ss_pred EEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 98 VVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 98 lV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
+||||+.++|.+++.... .+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 75 FVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred EEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 999999999999988764 78999999999999999999999999999999999999999999999999997643222
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
..+...++..|+|||++.+. ..++.++|+||||+++++|++|++||++.+..+++..+...++.+....+......
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 154 ---PYTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred ---CcCCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 23456789999999988642 56889999999999999999999999999998999888888888876654332110
Q ss_pred HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
. ...-..+....+......++..+..+.+||.+||+.||.+|||++|++.||||
T Consensus 230 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 230 A-SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred h-ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0 00000111111222233344557889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=332.55 Aligned_cols=253 Identities=28% Similarity=0.495 Sum_probs=213.4
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
+|++++.||.|+||.||.+.+..++..|++|++............+.+|+.+|++++|+||+++++++.. ...++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence 6999999999999999999999999999999987554445556778899999999999999999999943 45699
Q ss_pred EEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 98 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 98 lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.......
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999998 6999999775 468999999999999999999999999999999999999999999999999998653322
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
. ......+++.|+|||++.+ ..++.++|+||+||++++|++|..||.+.+.......+.. +.
T Consensus 156 ~---~~~~~~~~~~y~ape~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~----------- 217 (256)
T cd08221 156 S---MAETVVGTPYYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--GN----------- 217 (256)
T ss_pred c---cccccCCCccccCHhhcCC--CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CC-----------
Confidence 1 2345678999999999887 5688999999999999999999999987665443333221 00
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
+......++..+.++|.+||..||.+||++.++|+|||+
T Consensus 218 -----------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 218 -----------------YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -----------------CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 011114567889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=338.25 Aligned_cols=260 Identities=24% Similarity=0.410 Sum_probs=208.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcC-CC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRR-EF 93 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~-~~ 93 (508)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++...... ..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 467999999999999999999999999999999986432 2345678899999998 699999999998654322 13
Q ss_pred ccEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 94 KDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
..+|+||||+. ++|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++.++|+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 46899999998 5999988763 36899999999999999999999999999999999999999999999999999754
Q ss_pred cCCCCCcccccccccCcccccccccccc---cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
.... .......|+..|+|||++.+. ...|+.++||||+||++|+|++|..||...........+.
T Consensus 162 ~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~--------- 229 (272)
T cd06637 162 DRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP--------- 229 (272)
T ss_pred cccc---ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh---------
Confidence 3221 123456789999999998631 2468889999999999999999999996544222111110
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
.... .......++..+.+||.+||..||.+|||+.++++||||
T Consensus 230 ------------------~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 230 ------------------RNPA--PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ------------------cCCC--CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0000 001122467889999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=340.59 Aligned_cols=263 Identities=24% Similarity=0.383 Sum_probs=211.5
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
...+.|++++.||.|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++||||+++++.+.. .
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 81 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYW-----D 81 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-----C
Confidence 4457899999999999999999999999999999998642 33456678899999999999999999999843 3
Q ss_pred ccEEEEEecCCc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 94 KDIYVVFELMES-DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 94 ~~lylV~E~~~g-~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
+.+|+||||+++ +|..++.+ ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus 82 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 82 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 568999999984 77777654 4568999999999999999999999999999999999999999999999999987532
Q ss_pred CCCCCcccccccccCcccccccccccc---cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
... .......+++.|+|||++.+. ...++.++|+|||||++|+|++|.+||...+.......+...
T Consensus 162 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-------- 230 (292)
T cd06644 162 KTL---QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-------- 230 (292)
T ss_pred ccc---cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC--------
Confidence 211 112345688999999998531 145788999999999999999999999765533222211100
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.. +.......++..+.+||.+||..||.+||+++++++||||..+.
T Consensus 231 ------------------~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 231 ------------------EP--PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred ------------------CC--ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 00 00111234677899999999999999999999999999998654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=333.11 Aligned_cols=255 Identities=31% Similarity=0.525 Sum_probs=212.2
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
+|++++.||.|+||.||+|.+..+|..||+|.++..........++.+|+.+++.++||||+++++.+... ....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence 59999999999999999999999999999999875544455667788999999999999999999987543 235689
Q ss_pred EEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhH-----hcCceecCCCCCceeeCCCCcEEEcccccc
Q 010512 98 VVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIH-----TANVFHRDLKPKNILANADCKLKICDFGLA 167 (508)
Q Consensus 98 lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~Qil~aL~yLH-----s~gIiHrDLKPeNILl~~~~~lkL~DFGla 167 (508)
+||||++ ++|.+++.. ..++++..+..++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999998 599988865 357999999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChH
Q 010512 168 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 168 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
........ ......+++.|+|||.+.+ ..++.++|+||||+++++|++|..||.+.+.......+..
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------- 224 (265)
T cd08217 158 KILGHDSS---FAKTYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE-------- 224 (265)
T ss_pred ccccCCcc---cccccccCCCccChhhhcC--CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc--------
Confidence 86533221 1234578999999999977 6688999999999999999999999987663332222211
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
.. +...-...+..+.+|+.+||..||.+|||+.++|+|||+
T Consensus 225 -------------------~~---~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 225 -------------------GK---FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred -------------------CC---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 00 011123567889999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=335.33 Aligned_cols=257 Identities=25% Similarity=0.416 Sum_probs=208.1
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC----hhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH----VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~----~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
+|++.+.||+|+||.||+|.+ .+|..||+|++...... ......+.+|+.+|+.++|+||+++++++.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-----D 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-----C
Confidence 588999999999999999986 48899999998643221 2234568899999999999999999999843 4
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
..+|+||||+. ++|.+++.+...+++..+..++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 67999999998 59999998888899999999999999999999999999999999999999999999999999975421
Q ss_pred CC---CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 173 DA---PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 173 ~~---~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
.. ..........|+..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------- 224 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINE--SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHR-------- 224 (265)
T ss_pred ccccccccccccccCCCccccChhhhcC--CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhcc--------
Confidence 11 11112234578999999999987 678899999999999999999999997654332221111100
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
.........++..+.+||.+||..||.+||++.++|+||||
T Consensus 225 --------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 225 --------------------GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred --------------------CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00111123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=360.37 Aligned_cols=259 Identities=25% Similarity=0.410 Sum_probs=214.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
+-|+|+..||.|+||.||+|.++.++-..|.|+|. .........++-||.||..+.||+||+|++.|+.. +.+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe--tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e-----nkL 104 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE--TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE-----NKL 104 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc--ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-----Cce
Confidence 45788999999999999999999999999999985 34456678889999999999999999999998543 569
Q ss_pred EEEEecCCc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 97 YVVFELMES-DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 97 ylV~E~~~g-~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+.|||+| -...++.. ...|++.+++.+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+.....
T Consensus 105 wiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-- 182 (1187)
T KOG0579|consen 105 WILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-- 182 (1187)
T ss_pred EEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh--
Confidence 999999996 45555444 45799999999999999999999999999999999999999999999999998764321
Q ss_pred CCcccccccccCcccccccccccc---cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.......++|||+|||||+.... ..+|++++||||||++|.||..+.||-...+....+-+|.+.-
T Consensus 183 -t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe---------- 251 (1187)
T KOG0579|consen 183 -TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---------- 251 (1187)
T ss_pred -HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC----------
Confidence 12234568999999999997432 2689999999999999999999999998888777666554311
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
+|..+ .-..++..+.|||.+||.+||..||++.++|+||||++.
T Consensus 252 ----------------PPTLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 252 ----------------PPTLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred ----------------CCccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 11100 012356678999999999999999999999999999864
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=338.37 Aligned_cols=259 Identities=26% Similarity=0.399 Sum_probs=207.9
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++.+.||+|+||.||+|.+..+|..||+|++... .......+.+|+.+++.++||||+++++.+.. ..
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~~ 79 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----RE 79 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC--ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----CC
Confidence 346799999999999999999999999999999998643 22344567899999999999999999999843 35
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
.+|+||||++ ++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 80 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 80 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 6899999998 599999988888999999999999999999999999999999999999999999999999999865322
Q ss_pred CCCcccccccccCcccccccccccc-cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
.. ......|++.|+|||.+... ...++.++|+||+||++|+|++|++||...+.......+..
T Consensus 160 ~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~------------- 223 (267)
T cd06646 160 IA---KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK------------- 223 (267)
T ss_pred cc---ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec-------------
Confidence 11 12345788999999987431 24578899999999999999999999865442221111100
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCc
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~ 309 (508)
....+..+ .....++..+.+||.+||..||.+|||++++|+|+|
T Consensus 224 ------------~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 224 ------------SNFQPPKL-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ------------CCCCCCCC-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 00000001 112346788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=342.71 Aligned_cols=261 Identities=28% Similarity=0.456 Sum_probs=213.4
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
.-+...+|++.+.||+|+||.||+|++..++..||+|++..... .....+.+|+.+++.+.||||+++++.+..
T Consensus 15 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~---- 88 (296)
T cd06654 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLV---- 88 (296)
T ss_pred cCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEe----
Confidence 33556899999999999999999999999999999999864322 345678899999999999999999998854
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
....|+||||+. ++|.+++.. ..+++.++..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++...
T Consensus 89 -~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 89 -GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (296)
T ss_pred -CCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhc
Confidence 346899999998 589998864 46899999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
..... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|++||...+....+..+..
T Consensus 167 ~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~----------- 230 (296)
T cd06654 167 TPEQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT----------- 230 (296)
T ss_pred ccccc---ccCcccCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-----------
Confidence 32211 1234578899999999876 6788999999999999999999999987654332221110
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.. .+.......+++.+.+||.+||..||.+|||+.++++||||...
T Consensus 231 ---------------~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 231 ---------------NG--TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred ---------------CC--CCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 00 00011123467889999999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=372.91 Aligned_cols=287 Identities=25% Similarity=0.295 Sum_probs=205.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC-CcEEEEEEec--------------C-ccCChhHHHHHHHHHHHHHhCCCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHT-GERVAIKKIN--------------D-VFEHVSDATRILREIKLLRLLRHPDIV 79 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~t-g~~vAIKki~--------------~-~~~~~~~~~~i~~Ei~iL~~L~HpnIv 79 (508)
.++|++++.||+|+||+||+|..+.. +..+++|.++ + ..........+.+|+.+|+.++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 36899999999999999999876543 2223322111 1 111222345678999999999999999
Q ss_pred eeeeeecCCCcCCCccEEEEEecCCccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeC
Q 010512 80 EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 154 (508)
Q Consensus 80 ~l~~v~~~~~~~~~~~lylV~E~~~g~L~~~i~~~~-----~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~ 154 (508)
++++++.. ....|+|++++.++|..++.... ......++.|+.||+.||.|||++||+||||||+|||++
T Consensus 227 ~l~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 227 KIEEILRS-----EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred cEeEEEEE-----CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 99999843 35689999999999988875432 344677889999999999999999999999999999999
Q ss_pred CCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCC-CCCCC--ChH
Q 010512 155 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKP-LFPGK--NVV 231 (508)
Q Consensus 155 ~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~-pF~~~--~~~ 231 (508)
.++.+||+|||+++....... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.. ||.+. +..
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred CCCCEEEEeCCCceecCcccc--cccccccCCcCCCCchhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 999999999999986532211 12234689999999999987 689999999999999999999875 44322 344
Q ss_pred HHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcc-cCCCCCCCCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 010512 232 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMR-KKQPVPFSHKF--PNADPLALHLLERLLAFDPKDRPTAEEALADP 308 (508)
Q Consensus 232 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~~--~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp 308 (508)
.++..+...++.+..+.... ......++.... ...+..+...+ ...+..+.++|.+||++||.+|||+.|+|.||
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDP--PCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHHHhcccChhhcCCc--HHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 55555555554433221100 001111111110 00111111111 13567789999999999999999999999999
Q ss_pred cccCC
Q 010512 309 YFHGL 313 (508)
Q Consensus 309 ~f~~~ 313 (508)
||...
T Consensus 456 ~f~~~ 460 (501)
T PHA03210 456 LFSAE 460 (501)
T ss_pred hhhcC
Confidence 99753
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=336.69 Aligned_cols=261 Identities=26% Similarity=0.445 Sum_probs=209.4
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC----hhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH----VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~----~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
+|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+++|+.++|+||+++++++. +.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC-----ED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec-----cC
Confidence 488899999999999999999999999999998643211 123567889999999999999999999984 44
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC-cEEEcccccccccc
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVSF 171 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~-~lkL~DFGla~~~~ 171 (508)
+.+++||||+. ++|.+++...+++++..+..++.||+.||.|||++|++|+||||+||+++.++ .++|+|||++....
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 56899999998 59999998888899999999999999999999999999999999999998876 59999999997654
Q ss_pred CCCCCc-ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 172 NDAPSA-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 172 ~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
...... .......+|..|+|||.+.+ ..++.++|+||+||++++|++|..||...........+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 224 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA--------- 224 (268)
T ss_pred cccccCCccccccccccceeCHhHhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh---------
Confidence 322111 11123468899999999876 678999999999999999999999997554322222211100
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~ 311 (508)
.... ........++.+.+++.+||..||.+|||+.++++||||+
T Consensus 225 --------------~~~~---~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 225 --------------SATT---APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred --------------ccCC---CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 0000 0111234678899999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=333.46 Aligned_cols=260 Identities=26% Similarity=0.449 Sum_probs=208.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC---ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE---HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~---~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
..|++.+.||+|+||.||.|.+..+|..||||++..... .......+.+|+.+++.+.||||+++++++.... .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM---E 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC---C
Confidence 579999999999999999999999999999999853221 1233567889999999999999999999874421 2
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
..+|+||||++ ++|.+++.....+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||+++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 46899999998 59999998877899999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
............++..|+|||++.+ ..++.++|+|||||++|+|++|+.||.+......+..+. ..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~-------- 225 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISG--EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQP-------- 225 (265)
T ss_pred ccccccccccCCCCccccChhhhcC--CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCC--------
Confidence 2111112234568899999999876 678999999999999999999999997654322221111 000
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~ 311 (508)
.. .......+..+.++|.+||. +|.+||+++++++|||++
T Consensus 226 --------------~~----~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 226 --------------TN----PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred --------------CC----CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 00 00112456778999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=341.11 Aligned_cols=261 Identities=25% Similarity=0.425 Sum_probs=209.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|++++.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.+++.++||||+++++.+.. .+.+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFI-----EGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-----CCeE
Confidence 47999999999999999999999999999999986432 23345678899999999999999999998843 4579
Q ss_pred EEEEecCC-ccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHhHh-cCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 97 YVVFELME-SDLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~---~~l~~~~~~~i~~Qil~aL~yLHs-~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.++|+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999998 4888888763 379999999999999999999997 599999999999999999999999999987542
Q ss_pred CCCCCcccccccccCccccccccccccc----CCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~----~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
... .....+++.|+|||.+.+.. ..++.++|||||||++|+|++|..||...........+...
T Consensus 155 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~------- 222 (286)
T cd06622 155 ASL-----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI------- 222 (286)
T ss_pred CCc-----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHH-------
Confidence 211 23346888999999985421 24688999999999999999999999765432222111110
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
.... .....+.+++.+.+||.+||..||.+||++++++.||||.....
T Consensus 223 -----------------~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 223 -----------------VDGD---PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred -----------------hhcC---CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 0011 11123357889999999999999999999999999999986643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=332.56 Aligned_cols=253 Identities=27% Similarity=0.467 Sum_probs=210.0
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
+|++.+.||+|+||.||++.+..+|..||+|.+............+.+|+.+++.++||||+++.+.+. ..+..|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE-----ENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec-----CCCeEE
Confidence 699999999999999999999999999999998754333445567889999999999999999999883 445799
Q ss_pred EEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 98 VVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 98 lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+||||+. ++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999998 59999887643 58899999999999999999999999999999999999999999999999997643321
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
. ......|++.|+|||++.+ ..++.++|+|||||++++|++|..||...+..+....+.. +
T Consensus 156 ~---~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~------------ 216 (256)
T cd08218 156 E---LARTCIGTPYYLSPEICEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--G------------ 216 (256)
T ss_pred h---hhhhccCCccccCHHHhCC--CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc--C------------
Confidence 1 1223468889999999877 6788999999999999999999999976654443322211 0
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
.. .......+..+.++|.+||..||.+||++.++++||||
T Consensus 217 ------------~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 217 ------------SY----PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ------------CC----CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 00 01123457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=386.34 Aligned_cols=265 Identities=25% Similarity=0.401 Sum_probs=226.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
+++|+|+++||+|+||.|..++++.|++.||+|++++... ...+...|..|-.+|..-..+=|+.++-.| .+..
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~~ 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDER 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCcc
Confidence 5789999999999999999999999999999999986322 233455677888999988899999998888 6667
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
++|+|||||. |||..++.+-++++++.+++|+..|+.||.-||+.|+|||||||+|||+|..|+|||+|||.|-.+..+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 8999999998 699999998889999999999999999999999999999999999999999999999999999766433
Q ss_pred CCCcccccccccCcccccccccccc--c-CCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSF--F-SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~--~-~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
........||||-|.+||++... . +.|++.+|.||+||++|||+.|..||..++..+++-+|.+.
T Consensus 229 --G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h---------- 296 (1317)
T KOG0612|consen 229 --GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH---------- 296 (1317)
T ss_pred --CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch----------
Confidence 23345667999999999998542 1 56999999999999999999999999998887777766542
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC---HHHHhcCCcccCCCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT---AEEALADPYFHGLAN 315 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt---a~eiL~hp~f~~~~~ 315 (508)
+....|+. -..++..+++||+++|. +|..|.. ++++-.||||.++.+
T Consensus 297 ----------------k~~l~FP~-~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 297 ----------------KESLSFPD-ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred ----------------hhhcCCCc-ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 22223332 22489999999999888 8899988 999999999998765
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=332.23 Aligned_cols=258 Identities=29% Similarity=0.440 Sum_probs=209.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++.+.||.|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++.+.. ...
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~ 74 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDK 74 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCE
Confidence 468999999999999999999999999999999986432 2356778899999999999999999998843 456
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 96 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
+|+||||++ ++|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 999999998 5898888776 78999999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcccccccccCcccccccccccc-cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
.. ......++..|+|||.+.+. ...++.++|+|||||++|+|++|.+||.+.+.......+...-
T Consensus 155 ~~---~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~----------- 220 (262)
T cd06613 155 IA---KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN----------- 220 (262)
T ss_pred hh---ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----------
Confidence 11 12345788999999998651 1268889999999999999999999998766443332221100
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCc
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~ 309 (508)
+ .+. ........+..+.+||.+||..||.+|||+.+++.|+|
T Consensus 221 -----------~---~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 221 -----------F---PPP-KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred -----------C---CCc-cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0 000 00111234577899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=341.04 Aligned_cols=263 Identities=25% Similarity=0.394 Sum_probs=211.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
+.|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++.+. ....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE-----TKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe-----cCCE
Confidence 469999999999999999999999999999999865322 2234557889999999999999999999884 3456
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+||||++ ++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 899999998 5999999888889999999999999999999999999999999999999999999999999987421110
Q ss_pred CC------------cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC
Q 010512 175 PS------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 242 (508)
Q Consensus 175 ~~------------~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g 242 (508)
.. ........++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+....+..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~-- 231 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD-- 231 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--
Confidence 00 001123467889999999876 67899999999999999999999999876543322222110
Q ss_pred CCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC---HHHHhcCCcccCCC
Q 010512 243 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT---AEEALADPYFHGLA 314 (508)
Q Consensus 243 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt---a~eiL~hp~f~~~~ 314 (508)
. ..+......+++.+.+||.+||..||.+||+ +.++|+||||.+..
T Consensus 232 ------------------------~--~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 232 ------------------------D--IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred ------------------------c--cCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 0 0011111246788999999999999999998 79999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=337.36 Aligned_cols=262 Identities=24% Similarity=0.411 Sum_probs=209.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~ 94 (508)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+... ......+.+|+.+++.+ +||||+++++++.........
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 57899999999999999999999999999999998642 12345677899999999 799999999998755433345
Q ss_pred cEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
.+|+||||++ ++|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 7899999998 589888753 45789999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCcccccccccCccccccccccccc---CCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCh
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~---~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 246 (508)
...... ......|+..|+|||++.... ..++.++|||||||++|+|++|++||...+....+..+..
T Consensus 178 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~------- 247 (291)
T cd06639 178 LTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR------- 247 (291)
T ss_pred cccccc---cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc-------
Confidence 432211 123357889999999975421 2368899999999999999999999977654333322211
Q ss_pred HHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010512 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 247 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~ 311 (508)
..+..+ ......+..+.+||.+||+.||.+||++.++++||||+
T Consensus 248 --------------------~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 248 --------------------NPPPTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred --------------------CCCCCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 000000 01123557799999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=342.73 Aligned_cols=261 Identities=29% Similarity=0.472 Sum_probs=212.9
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
+...+|++++.||.|+||.||+|.+..+|..||+|.+.... ......+.+|+.+++.++||||+++++.+.. .
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~ 88 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLV-----G 88 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEec-----C
Confidence 45589999999999999999999999999999999986432 2334667899999999999999999999843 4
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
...|+||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred CEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 56899999998 589888865 4689999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+....+..+.. .+.+
T Consensus 168 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~-------- 233 (297)
T cd06656 168 EQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP-------- 233 (297)
T ss_pred Ccc---CcCcccCCccccCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCC--------
Confidence 221 1234578899999999987 6788999999999999999999999977554322211110 0000
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
........+..+.+|+.+||..||.+||+++++++||||.....
T Consensus 234 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 234 -------------------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred -------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 01112345678999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=357.93 Aligned_cols=256 Identities=29% Similarity=0.548 Sum_probs=214.8
Q ss_pred CCeEE--eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 17 SRYQI--QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 17 ~rY~i--~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
.-|+| .++||+|.||+||-|+++.||+.||||+|.+..-.......+.+|+.||+.+.||.||.+--.|.. ..
T Consensus 562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET-----~e 636 (888)
T KOG4236|consen 562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET-----PE 636 (888)
T ss_pred HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC-----Cc
Confidence 33444 379999999999999999999999999998765444555778899999999999999999888844 45
Q ss_pred cEEEEEecCCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC---CcEEEcccccccc
Q 010512 95 DIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARV 169 (508)
Q Consensus 95 ~lylV~E~~~g~L~~~i~~--~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~---~~lkL~DFGla~~ 169 (508)
.+++|||-+.||..+.|.. .++|++...++++.|||.||.|||-+||+|+||||+|||+.+. -++||||||+|++
T Consensus 637 rvFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 637 RVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred eEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence 6999999999999888864 5689999999999999999999999999999999999999765 4699999999998
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhhcCCCChHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV-VHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~-~~~l~~i~~~~g~p~~~~ 248 (508)
..+. .+....+|||.|+|||++.. ..|+..-|+||+|+|+|.-|.|..||..+.+ .+|+....
T Consensus 717 IgEk----sFRrsVVGTPAYLaPEVLrn--kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa---------- 780 (888)
T KOG4236|consen 717 IGEK----SFRRSVVGTPAYLAPEVLRN--KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA---------- 780 (888)
T ss_pred cchh----hhhhhhcCCccccCHHHHhh--ccccccccceeeeEEEEEEecccccCCCccchhHHhhccc----------
Confidence 6443 24567899999999999998 7999999999999999999999999965432 22221110
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
| -.++ ..|..+++.++|||..+|++.-.+|.|.+..|.|||+++.
T Consensus 781 -----------F-----MyPp----~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 781 -----------F-----MYPP----NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred -----------c-----ccCC----CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 0 0122 3356788999999999999999999999999999999863
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=337.34 Aligned_cols=256 Identities=28% Similarity=0.444 Sum_probs=211.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|++.+.||.|+||.||+|.+..+|..||+|.+.... .......+.+|+.+++.++|+||+++.+.+.. ...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-----GSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-----CCeE
Confidence 47999999999999999999999999999999986432 23345668899999999999999999998853 3568
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 97 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
|+|+||+. ++|.+++... ++++..+..++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||+++.......
T Consensus 75 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 99999998 5899998765 799999999999999999999999999999999999999999999999999987543221
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+..
T Consensus 154 ---~~~~~~~~~~y~~PE~~~~--~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~---------------- 212 (274)
T cd06609 154 ---KRNTFVGTPFWMAPEVIKQ--SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK---------------- 212 (274)
T ss_pred ---ccccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh----------------
Confidence 1234578899999999987 5699999999999999999999999976553222211110
Q ss_pred HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
..+..+. ...+++.+.++|.+||..||++|||++++++||||...
T Consensus 213 -----------~~~~~~~--~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 213 -----------NNPPSLE--GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred -----------cCCCCCc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 0010010 11267889999999999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=330.55 Aligned_cols=261 Identities=31% Similarity=0.484 Sum_probs=211.9
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
||++.+.||+|+||.||+|.+..++..||+|.++...........+.+|+.+++.++|+||++++++.. ....++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV-----HREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe-----cCCEEE
Confidence 699999999999999999999999999999999755443446778999999999999999999999874 335689
Q ss_pred EEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCC
Q 010512 98 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 176 (508)
Q Consensus 98 lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~ 176 (508)
+|+||++ ++|.+++.....+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.........
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999998 699999988778999999999999999999999999999999999999999999999999999875433322
Q ss_pred ccc-ccccccCccccccccccccc-CCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 177 AIF-WTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 177 ~~~-~~~~~gT~~Y~APE~l~~~~-~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
... .....++..|+|||++.+.. ..++.++|||||||++++|++|+.||.+............
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~--------------- 220 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG--------------- 220 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh---------------
Confidence 111 22456888999999987631 2378999999999999999999999976532211111100
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
...... ......+++.+.+||.+||+.||.+|||+.+++.|||+
T Consensus 221 ---------~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 221 ---------AGHKPP---IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ---------cCCCCC---CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000001 11123457889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=329.78 Aligned_cols=252 Identities=29% Similarity=0.470 Sum_probs=209.0
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
+|++.+.||+|+||.||+|.+..++..||||.+............+.+|+.+|+.++||||+++++.+. ....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEE
Confidence 699999999999999999999999999999999765444455678899999999999999999999884 335689
Q ss_pred EEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC-cEEEccccccccccCC
Q 010512 98 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVSFND 173 (508)
Q Consensus 98 lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~-~lkL~DFGla~~~~~~ 173 (508)
+||||++ ++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++ .++|+|||++......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999998 5999999764 3589999999999999999999999999999999999998654 5899999999865332
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
.. .....++..|+|||.+.+ ..++.++||||+||++|+|++|..||.+.+.......+..
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-------------- 215 (256)
T cd08220 156 SK----AYTVVGTPCYISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-------------- 215 (256)
T ss_pred cc----ccccccCCcccCchhccC--CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh--------------
Confidence 21 233578899999999976 6788999999999999999999999987664333322211
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
.. .......+++.+.+|+.+||..||.+|||+.|+++||||
T Consensus 216 -------------~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 216 -------------GT---FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred -------------cC---CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 00 001113467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=337.10 Aligned_cols=258 Identities=24% Similarity=0.431 Sum_probs=203.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHH-HHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKL-LRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~i-L~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++++.||+|+||.||+|.+..+|+.||||+++...... ...++..|+.+ ++.+.||||+++++.+.. .+.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~ 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGD 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCc
Confidence 47999999999999999999999999999999997543332 33456667665 677889999999999843 356
Q ss_pred EEEEEecCCccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhc-CceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 96 IYVVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 96 lylV~E~~~g~L~~~i~~----~~~l~~~~~~~i~~Qil~aL~yLHs~-gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
+|+||||++++|.+++.. ...+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|||++...
T Consensus 75 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 75 VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred EEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999998887754 34689999999999999999999997 9999999999999999999999999999864
Q ss_pred cCCCCCcccccccccCcccccccccccc--cCCCCcchhhhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhhcCCCChH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN-VVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~--~~~y~~~~DIWSlG~il~eLltG~~pF~~~~-~~~~l~~i~~~~g~p~~~ 247 (508)
.... ..+...++..|+|||++.+. ...++.++|+|||||++|+|++|+.||.... ....+..+.
T Consensus 155 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------- 221 (283)
T cd06617 155 VDSV----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV--------- 221 (283)
T ss_pred cccc----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH---------
Confidence 3221 12334688999999988542 1357889999999999999999999996422 111111110
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.... .. .....++..+.+||.+||..||.+||++.++++||||...
T Consensus 222 --------------~~~~----~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 222 --------------EEPS----PQ--LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred --------------hcCC----CC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 0000 00 0112367889999999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=338.26 Aligned_cols=257 Identities=24% Similarity=0.353 Sum_probs=207.7
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEE
Q 010512 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 98 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 98 (508)
|++.+.||.|+||.||+|.+..++..+|+|.+... .......+.+|+.+++.++||||+++++++.. ....|+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~ 79 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWI 79 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEE
Confidence 78899999999999999999999999999998542 23445678899999999999999999999854 346899
Q ss_pred EEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCC
Q 010512 99 VFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 176 (508)
Q Consensus 99 V~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~ 176 (508)
||||+. ++|..++.. ..++++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 999998 577777654 45799999999999999999999999999999999999999999999999999875432211
Q ss_pred cccccccccCccccccccccc---ccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 177 AIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 177 ~~~~~~~~gT~~Y~APE~l~~---~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
......+|..|+|||++.. ....++.++||||+||++|+|++|++||...+.......+....
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~------------ 224 (282)
T cd06643 159 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE------------ 224 (282)
T ss_pred --ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcC------------
Confidence 1234578999999999842 12457889999999999999999999998766433332221100
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.+ .......++..+.+||.+||..||.+||+++++++||||...
T Consensus 225 --------------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 225 --------------PP--TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred --------------CC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 00 001112456889999999999999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=338.93 Aligned_cols=258 Identities=24% Similarity=0.405 Sum_probs=204.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|+++++||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+|+.++||||+++++.+.. ....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 74 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRI 74 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEE
Confidence 46899999999999999999999999999999986432 23345678899999999999999999999854 3568
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 97 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 97 ylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
++||||+++ +|..+ ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++......
T Consensus 75 ~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 75 SICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred EEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 999999995 55433 35788999999999999999999999999999999999999999999999999754322
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
.....+||..|+|||++.+ ..++.++|+|||||++|+|++|+.||.......... .......
T Consensus 149 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~--------~~~~~~~----- 210 (279)
T cd06619 149 ---IAKTYVGTNAYMAPERISG--EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL--------MPLQLLQ----- 210 (279)
T ss_pred ---cccCCCCChhhcCceeecC--CCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc--------chHHHHH-----
Confidence 1234689999999999987 678999999999999999999999996532111000 0000000
Q ss_pred HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
......+. .......++.+.+|+.+||+.||.+||++++++.||||...
T Consensus 211 -------~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 211 -------CIVDEDPP--VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred -------HHhccCCC--CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 00000010 11123467889999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=339.13 Aligned_cols=260 Identities=27% Similarity=0.422 Sum_probs=211.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++++.||.|+||.||+|.+..++..||+|.+.. ........+.+|+.+++.++||||+++++.+.. ...
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI--ESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-----ENK 76 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee--CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-----CCe
Confidence 4679999999999999999999998999999999863 234455678899999999999999999999854 356
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 96 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
+|+||||++ ++|.+++... ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 899999998 5898888764 56999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccCcccccccccccc---cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.. ......+|+.|+|||++... ...++.++|+|||||++|+|++|++||.+.+....+..+..
T Consensus 157 ~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------- 222 (280)
T cd06611 157 LQ---KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK----------- 222 (280)
T ss_pred cc---ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc-----------
Confidence 11 12345789999999997521 14577899999999999999999999987654333222211
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
..+ +.......++..+.+||.+||..||.+||+++++|+||||...
T Consensus 223 ----------------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 223 ----------------SEP-PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred ----------------CCC-CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 000 0001112457789999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=336.41 Aligned_cols=267 Identities=24% Similarity=0.424 Sum_probs=210.9
Q ss_pred ccccC-CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecC
Q 010512 10 FTEYG-EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLP 87 (508)
Q Consensus 10 ~~~~~-~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~ 87 (508)
|..+. ..++|++.+.||+|+||.||+|.+..+|..||+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 45554 5689999999999999999999999999999999886421 2235677899999999 69999999999865
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEc
Q 010512 88 PSRREFKDIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 162 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~ 162 (508)
........+|+||||++ ++|.+++.. ...+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence 44344567999999998 589887753 3468899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCcccccccccCcccccccccccc---cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 010512 163 DFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTD 239 (508)
Q Consensus 163 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~ 239 (508)
|||+++...... .......|++.|+|||++... ...++.++||||+||++|+|++|+.||...+....+..+..
T Consensus 167 dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 243 (286)
T cd06638 167 DFGVSAQLTSTR---LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR 243 (286)
T ss_pred cCCceeecccCC---CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc
Confidence 999987643211 112345789999999998531 14588999999999999999999999976553322211100
Q ss_pred hcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 240 LLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 240 ~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
..+... ..-..++..+.+||.+||+.||.+|||+.|+++|+||
T Consensus 244 ---------------------------~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 244 ---------------------------NPPPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ---------------------------cCCCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 000000 0011246789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=334.20 Aligned_cols=254 Identities=26% Similarity=0.452 Sum_probs=210.2
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
+|++.+.||.|+||.||+|.+..++..||+|++.+... .......+.+|++++++++||||+++++.+ .+...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 59999999999999999999999999999999975432 224567789999999999999999999988 344679
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 97 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
|+|+||+. ++|.+++....++++..+..++.||++||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999998 5999999887789999999999999999999999999999999999999999999999999998653322
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.........
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----------------- 212 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCR--QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA----------------- 212 (258)
T ss_pred ---cccccCCChhhcCHHHHcc--cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH-----------------
Confidence 1234568889999999987 568999999999999999999999998765311100000
Q ss_pred HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH--HHHhcCCcc
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA--EEALADPYF 310 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta--~eiL~hp~f 310 (508)
.... .. .......+..+.++|.+||..||.+||++ .|+++||||
T Consensus 213 -------~~~~-~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 213 -------KQET-AD---VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -------Hhcc-cc---ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 0000 00 01113456889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=333.04 Aligned_cols=262 Identities=27% Similarity=0.446 Sum_probs=210.0
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCc-CC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSR-RE 92 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~-~~ 92 (508)
..++|++.+.||.|+||.||+|.+..+++.|++|++.... .....+.+|+.+++.+ .|+||+++++++..... ..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4589999999999999999999999999999999986432 2345688999999999 69999999999876442 33
Q ss_pred CccEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 167 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla 167 (508)
...+|+||||++ ++|.+++.. +..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 567899999999 588888764 357999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccc---cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC
Q 010512 168 RVSFNDAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244 (508)
Q Consensus 168 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p 244 (508)
....... .......|+..|+|||++... ...++.++|||||||++|+|++|++||...+....+..+..
T Consensus 161 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----- 232 (275)
T cd06608 161 AQLDSTL---GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR----- 232 (275)
T ss_pred eecccch---hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc-----
Confidence 7643222 122345789999999987531 13577899999999999999999999976543333222211
Q ss_pred ChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
..+..+ ......+..+.+||.+||..||.+|||+.++++|||+
T Consensus 233 ----------------------~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 233 ----------------------NPPPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ----------------------cCCCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 000000 0112356789999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=332.79 Aligned_cols=262 Identities=28% Similarity=0.479 Sum_probs=208.5
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC--------hhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH--------VSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 89 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~--------~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 89 (508)
+|.+.+.||.|+||.||+|.+..+|+.||+|.++..... ....+.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 689999999999999999999999999999988532111 1123457789999999999999999998843
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
...+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||+++
T Consensus 80 ---~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 80 ---EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ---CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 456899999998 6999999888889999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
...... .........++..|+|||++......++.++|+|||||++++|++|..||...+....+..+.
T Consensus 157 ~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---------- 225 (272)
T cd06629 157 KSDDIY-DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLG---------- 225 (272)
T ss_pred cccccc-cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhh----------
Confidence 643211 111223456889999999987632348899999999999999999999996544322211110
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
.. ...+.......+.++..+.+||.+||..||.+|||++++|+||||
T Consensus 226 --------------~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 226 --------------NK-RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred --------------cc-ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 00 001111112234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=339.72 Aligned_cols=262 Identities=24% Similarity=0.436 Sum_probs=205.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|+..+.||+|+||.||++.+..+|..||||++...... .....+.+|+.++.++. ||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~ 77 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGD 77 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCc
Confidence 4677788999999999999999999999999998753322 34567889999999996 9999999998843 356
Q ss_pred EEEEEecCCccHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHhHhc-CceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 96 IYVVFELMESDLHQVIK-----ANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 96 lylV~E~~~g~L~~~i~-----~~~~l~~~~~~~i~~Qil~aL~yLHs~-gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
.|+||||+.++|.++.. ....+++..+..++.|++.||+|||+. ||+||||||+||+++.++.++|+|||+++.
T Consensus 78 ~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 78 CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 89999999876654432 235799999999999999999999975 999999999999999999999999999975
Q ss_pred ccCCCCCcccccccccCccccccccccccc-CCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~-~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
...... .....|++.|+|||++.+.. ..++.++||||+||++|+|++|++||...+. ....+...
T Consensus 158 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~-------- 223 (288)
T cd06616 158 LVDSIA----KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQV-------- 223 (288)
T ss_pred hccCCc----cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhh--------
Confidence 432221 13346889999999987621 2688999999999999999999999975431 11111111
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.....+.........++..+.+||.+||..||.+|||++++++||||+..
T Consensus 224 ---------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 224 ---------------VKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred ---------------cCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 00111111111224578899999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=336.13 Aligned_cols=262 Identities=25% Similarity=0.423 Sum_probs=209.1
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCc-C
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSR-R 91 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~-~ 91 (508)
...+.|++.+.||.|+||.||+|.+..+++.||+|++... ......+..|+.+++.+ +|+||+++++++..... .
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 4557899999999999999999999999999999998542 23345678899999998 69999999999865321 2
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
....+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 3457899999998 5999988753 358899999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCcccccccccCcccccccccccc---cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~ 245 (508)
....... ......|++.|+|||++... ...++.++|+|||||++|+|++|.+||........+..+.
T Consensus 170 ~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~------- 239 (282)
T cd06636 170 QLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP------- 239 (282)
T ss_pred hhhcccc---CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh-------
Confidence 5422111 12346789999999998531 2468889999999999999999999997544322211110
Q ss_pred hHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 246 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
.. .........++..+.+||.+||..||.+|||+.|+|+||||
T Consensus 240 --------------------~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 240 --------------------RN--PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred --------------------hC--CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 00 01111123567899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=329.92 Aligned_cols=253 Identities=31% Similarity=0.524 Sum_probs=208.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++.+.||+|+||.||+|.+..++..||+|.+... .....+.+|+.+++.++||||+++++.+.. ...
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~ 72 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYFK-----NTD 72 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCc
Confidence 46899999999999999999999988999999998643 126678899999999999999999999854 356
Q ss_pred EEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 96 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
+|+|+||+. ++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 73 ~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 73 LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred EEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 899999999 599998875 457899999999999999999999999999999999999999999999999999865332
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
.. ......++..|+|||.+.+ ..++.++||||||||+++|++|++||...+.......+.
T Consensus 153 ~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~--------------- 212 (256)
T cd06612 153 MA---KRNTVIGTPFWMAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP--------------- 212 (256)
T ss_pred cc---ccccccCCccccCHHHHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc---------------
Confidence 21 1233568889999999877 678999999999999999999999997654322221110
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
.... ........++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 213 ------------~~~~-~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 213 ------------NKPP-PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ------------cCCC-CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0000 0011112456789999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=335.11 Aligned_cols=258 Identities=28% Similarity=0.482 Sum_probs=210.1
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|++.+.||.|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.+.||||+++++++... ..+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEE
Confidence 468999999999999999999999999999999875433 24456788999999999999999999998543 569
Q ss_pred EEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHh-cCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 97 YVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs-~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
|+|+||++ ++|.+++... ..+++..+..++.||+.||+|||+ .|++|+||||+||+++.++.++|+|||.+......
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999 6999999876 789999999999999999999999 99999999999999999999999999998754322
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhhcCCCChHHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV--VHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~--~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.. ....++..|+|||.+.+ ..++.++|||||||++++|++|..||...+. ......+..
T Consensus 155 ~~-----~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 215 (265)
T cd06605 155 LA-----KTFVGTSSYMAPERIQG--NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY------------ 215 (265)
T ss_pred Hh-----hcccCChhccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH------------
Confidence 11 12678889999999977 6889999999999999999999999975431 000111100
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.+ ...+.... ...+++.+.+||.+||..||.+|||+.+++.||||+.+
T Consensus 216 --------~~----~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 216 --------IV----NEPPPRLP--SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred --------Hh----cCCCCCCC--hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 00 01110000 01167889999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=328.18 Aligned_cols=254 Identities=29% Similarity=0.491 Sum_probs=208.7
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC---ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE---HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~---~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
+|+..+.||+|+||.||+|.+..++..|++|.+..... .......+.+|+.+++.++|+||+++++++. ...
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----EED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCC
Confidence 68889999999999999999998999999999864321 1234567889999999999999999999884 335
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
.+|+||||++ ++|.+++.....+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 6899999998 599999988878999999999999999999999999999999999999999999999999998864332
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
. ......++..|+|||.+... ..++.++|+|||||++|+|++|++||...........+...
T Consensus 156 ~----~~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~------------- 217 (258)
T cd06632 156 S----FAKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS------------- 217 (258)
T ss_pred c----cccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc-------------
Confidence 2 12345788999999998762 23889999999999999999999999765432222111100
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
.........+++.+.+|+.+||..||.+||++.+++.|||+
T Consensus 218 ----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 218 ----------------KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ----------------ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 00111223567889999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=328.08 Aligned_cols=259 Identities=31% Similarity=0.465 Sum_probs=213.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
+.|++.+.||+|++|.||+|.+..+|+.||+|++...... .....+.+|+..+..++|+||+++++++... ..+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeE
Confidence 3699999999999999999999999999999998754322 4467789999999999999999999998543 569
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-cCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 97 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs-~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
|+||||++ ++|.+++.....+++..+..++.||++||.|||+ .|++||||+|+||+++.++.++|+|||++.......
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999 6999999888889999999999999999999999 999999999999999999999999999998654322
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
.. .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+..
T Consensus 155 ~~---~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~--------------- 214 (264)
T cd06623 155 DQ---CNTFVGTVTYMSPERIQG--ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA--------------- 214 (264)
T ss_pred Cc---ccceeecccccCHhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH---------------
Confidence 21 234578899999999877 6788999999999999999999999976642111111110
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCC-CCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPN-ADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
. ....... .... ++..+.++|.+||..+|++|||+.++++||||+..
T Consensus 215 -----~----~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 215 -----I----CDGPPPS---LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred -----H----hcCCCCC---CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 0 0111111 1123 67889999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=337.83 Aligned_cols=259 Identities=21% Similarity=0.329 Sum_probs=199.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECC----------------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTH----------------TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~----------------tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv 79 (508)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+|+.++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 4689999999999999999997532 34579999987532 233456788999999999999999
Q ss_pred eeeeeecCCCcCCCccEEEEEecCC-ccHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHhHhc
Q 010512 80 EIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND-------------------DLTPEHYQFFLYQLLRGLKYIHTA 139 (508)
Q Consensus 80 ~l~~v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~-------------------~l~~~~~~~i~~Qil~aL~yLHs~ 139 (508)
++++++.. ....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.
T Consensus 83 ~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 83 RLLGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred EEEEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 99999854 345899999998 69999886532 367788999999999999999999
Q ss_pred CceecCCCCCceeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHH
Q 010512 140 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEML 219 (508)
Q Consensus 140 gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLl 219 (508)
||+||||||+|||++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY-RIQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCcee-EecCcCCCCccccCHHHHhc--CCCCchhhhHHHHHHHHHHH
Confidence 9999999999999999999999999999864322211 11223456788999999876 67999999999999999998
Q ss_pred h--CCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCC
Q 010512 220 T--GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD 297 (508)
Q Consensus 220 t--G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~ 297 (508)
+ +..||.+.+....+..+...+ .... ...+....+.++..+.+|+.+||..||.+
T Consensus 235 ~~~~~~p~~~~~~~~~~~~~~~~~--------------------~~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~ 291 (304)
T cd05096 235 MLCKEQPYGELTDEQVIENAGEFF--------------------RDQG---RQVYLFRPPPCPQGLYELMLQCWSRDCRE 291 (304)
T ss_pred HccCCCCCCcCCHHHHHHHHHHHh--------------------hhcc---ccccccCCCCCCHHHHHHHHHHccCCchh
Confidence 7 567887665444333222111 0000 00011112356788999999999999999
Q ss_pred CCCHHHHhc
Q 010512 298 RPTAEEALA 306 (508)
Q Consensus 298 Rpta~eiL~ 306 (508)
|||++++.+
T Consensus 292 RPs~~~i~~ 300 (304)
T cd05096 292 RPSFSDIHA 300 (304)
T ss_pred CcCHHHHHH
Confidence 999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=335.43 Aligned_cols=246 Identities=20% Similarity=0.247 Sum_probs=200.5
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccCChh-HHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEe
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS-DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 101 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~-~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 101 (508)
..||+|++|.||+|.. +|+.||||+++....... ....+.+|+.+|++++||||+++++++.... .....+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 5799999999999976 689999999975433222 2456779999999999999999999986411 22356899999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-cCceecCCCCCceeeCCCCcEEEccccccccccCCCCCccc
Q 010512 102 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179 (508)
Q Consensus 102 ~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs-~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~ 179 (508)
|+. |+|.+++.....+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----
Confidence 999 6999999988889999999999999999999998 499999999999999999999999999998643211
Q ss_pred ccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHH
Q 010512 180 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259 (508)
Q Consensus 180 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 259 (508)
...+||..|+|||++.+....|+.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~------------------ 238 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKN------------------ 238 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC------------------
Confidence 2347889999999987644679999999999999999999999998776544433322110
Q ss_pred HHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 260 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 260 ~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
...++ ...+++.+.+|+.+||+.||.+|||+.++++
T Consensus 239 --------~~~~~---~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 239 --------NSLKL---PLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred --------CCCCC---CCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 01111 1246788999999999999999999999986
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=327.02 Aligned_cols=253 Identities=29% Similarity=0.493 Sum_probs=207.9
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
+|.+.+.||+|+||.||+|.+..+|..||+|.+............+.+|+.+++.++|+||+++++.+.. ...+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-----NGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-----CCeEE
Confidence 6999999999999999999999999999999986533333445677899999999999999999998843 45689
Q ss_pred EEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCc-EEEccccccccccCC
Q 010512 98 VVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-LKICDFGLARVSFND 173 (508)
Q Consensus 98 lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~-lkL~DFGla~~~~~~ 173 (508)
+|+||+. ++|.+++.... .+++..+..++.|++.||.|||+.+|+|+||||+||+++.++. ++|+|||.+......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999997 59999887643 4799999999999999999999999999999999999998864 699999999765332
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
.. ......|++.|+|||++.+ ..++.++|+|||||++++|++|..||.+.+.......+..
T Consensus 156 ~~---~~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------- 216 (257)
T cd08225 156 ME---LAYTCVGTPYYLSPEICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-------------- 216 (257)
T ss_pred cc---cccccCCCccccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--------------
Confidence 21 1233568899999999876 5788999999999999999999999977654333221110
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
..+....+..+..+.++|.+||..+|++|||+.++++||||
T Consensus 217 ----------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 217 ----------------GYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ----------------ccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 00112234567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=336.60 Aligned_cols=264 Identities=27% Similarity=0.407 Sum_probs=214.1
Q ss_pred ccccccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeec
Q 010512 8 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIML 86 (508)
Q Consensus 8 ~~~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~ 86 (508)
+.+.......+|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++.+++.
T Consensus 6 ~~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~ 85 (307)
T cd06607 6 ELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85 (307)
T ss_pred HhhcCCCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence 344555666889999999999999999999999999999999864322 2334567889999999999999999999985
Q ss_pred CCCcCCCccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccc
Q 010512 87 PPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 165 (508)
Q Consensus 87 ~~~~~~~~~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFG 165 (508)
. ....|+||||+.|+|.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||
T Consensus 86 ~-----~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg 160 (307)
T cd06607 86 R-----EHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFG 160 (307)
T ss_pred e-----CCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecC
Confidence 4 345899999999998888764 4579999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccc-cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC
Q 010512 166 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244 (508)
Q Consensus 166 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p 244 (508)
++..... .....+++.|+|||++.+. ...++.++|||||||++|+|++|.+||.+.+....+..+..
T Consensus 161 ~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~----- 228 (307)
T cd06607 161 SASLVSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----- 228 (307)
T ss_pred cceecCC-------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-----
Confidence 9875421 1235678899999998531 24688999999999999999999999977664333222210
Q ss_pred ChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
..+. ......++..+.+||.+||..||.+||++.+++.||||..
T Consensus 229 ----------------------~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 229 ----------------------NDSP--TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred ----------------------CCCC--CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 0000 0001235678999999999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=329.62 Aligned_cols=251 Identities=20% Similarity=0.288 Sum_probs=201.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC---CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~---~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
..+|++.+.||+|+||.||+|.+. ..+..||+|.++.... ......+.+|+.+|+.++||||+++++++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 77 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITR----- 77 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----
Confidence 467999999999999999999765 4567899999875422 2344568899999999999999999999853
Q ss_pred CccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
...+|+||||++ |+|.+++... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.++++|||.+...
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 356899999998 5898888764 57899999999999999999999999999999999999999999999999987653
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
...... ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+....+..+.+..
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-------- 225 (266)
T cd05064 158 KSEAIY--TTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF-------- 225 (266)
T ss_pred cccchh--cccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC--------
Confidence 211110 0112235678999999876 689999999999999999775 999998776544443332111
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..+ ....++..+.+++.+||+.||.+||+++++++
T Consensus 226 -------------------~~~---~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 226 -------------------RLP---APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -------------------CCC---CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 011 12346788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=338.87 Aligned_cols=258 Identities=27% Similarity=0.486 Sum_probs=209.1
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
+.|.....||.|+||.||++.+..++..||||++... .......+.+|+.+++.++||||+++++.+.. ....
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~ 94 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-----GDEL 94 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-----CCeE
Confidence 4556677899999999999999999999999998642 22345668899999999999999999998843 3568
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 97 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 97 ylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
|+||||+++ +|.+++. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 95 ~lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 95 WVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred EEEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 999999984 7877775 45699999999999999999999999999999999999999999999999999875432221
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
......|+..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+....+..+...+
T Consensus 174 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-------------- 234 (292)
T cd06658 174 ---KRKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL-------------- 234 (292)
T ss_pred ---cCceeecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--------------
Confidence 1234678999999999876 678999999999999999999999998766443332221100
Q ss_pred HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
.. ........+..+.+||.+||..||.+|||++++++||||.....
T Consensus 235 ---------~~-----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 235 ---------PP-----RVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred ---------CC-----ccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 00 00111245778999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=325.79 Aligned_cols=249 Identities=28% Similarity=0.437 Sum_probs=205.6
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
+|++.+.||.|+||.||++.+..++..||+|.++... .......+.+|+.+++.++||||+++++.+. ....+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFE-----ADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEE
Confidence 5899999999999999999999999999999986432 2345667889999999999999999999984 445799
Q ss_pred EEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 98 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 98 lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++......
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 9999998 6899888653 458999999999999999999999999999999999999999999999999997653221
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
. ......|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 155 ~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~--------------- 214 (255)
T cd08219 155 A---YACTYVGTPYYVPPEIWEN--MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ--------------- 214 (255)
T ss_pred c---ccccccCCccccCHHHHcc--CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc---------------
Confidence 1 2234678999999999977 6789999999999999999999999987664333322211
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.... .....++..+.+||.+||..||.+|||+.+++.-
T Consensus 215 ------------~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 215 ------------GSYK---PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ------------CCCC---CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0000 1113456789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=325.58 Aligned_cols=259 Identities=26% Similarity=0.438 Sum_probs=209.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc---CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF---EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~---~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
.+|++.+.||+|+||.||+|.+..+|..||+|.+.... ........+.+|+.+++.++||||+++++.+.... .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE---E 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC---C
Confidence 57999999999999999999999999999999875321 12234567889999999999999999999875432 2
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
..+++||||+. ++|.+++...+.+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||+++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 46899999998 58999998877899999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
........+...++..|+|||++.+ ..++.++|+|||||++|+|++|++||........+..+ ...+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~-------- 225 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISG--EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---ATQP-------- 225 (264)
T ss_pred ccccCccccccCCcccccCHhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---HcCC--------
Confidence 2111112234678999999999987 67889999999999999999999999765433222111 1000
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
.. ......+++.+.++|.+||. +|..|||+.+++.|||.
T Consensus 226 ---------------~~---~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 226 ---------------TK---PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ---------------CC---CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 00 11123567889999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=328.14 Aligned_cols=250 Identities=24% Similarity=0.420 Sum_probs=205.5
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEecC
Q 010512 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 103 (508)
Q Consensus 25 LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~ 103 (508)
||.|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++.+. +...+|+||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence 6999999999999999999999999975332 2234567889999999999999999999884 345689999999
Q ss_pred C-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcccccc
Q 010512 104 E-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 182 (508)
Q Consensus 104 ~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~ 182 (508)
+ ++|.+++.....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~~~~ 151 (262)
T cd05572 76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWT 151 (262)
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----cccc
Confidence 8 6999999888889999999999999999999999999999999999999999999999999998653322 1234
Q ss_pred cccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhhcCCCChHHHHHHhhHHHHHH
Q 010512 183 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN--VVHQLDLMTDLLGTPSTESISRIRNEKARRY 260 (508)
Q Consensus 183 ~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~--~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~ 260 (508)
..++..|+|||.+.+ ..++.++|+||+||++|+|++|..||.... .......+..
T Consensus 152 ~~~~~~~~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------- 208 (262)
T cd05572 152 FCGTPEYVAPEIILN--KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK--------------------- 208 (262)
T ss_pred ccCCcCccChhHhcC--CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc---------------------
Confidence 578899999999876 678999999999999999999999997655 2211111110
Q ss_pred HhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCC
Q 010512 261 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLA 314 (508)
Q Consensus 261 l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt-----a~eiL~hp~f~~~~ 314 (508)
......+ -...++.+.+||.+||..||.+||+ ++|+++||||+++.
T Consensus 209 -----~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 209 -----GNGKLEF---PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred -----cCCCCCC---CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 0001111 1223688999999999999999999 99999999998753
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=356.55 Aligned_cols=263 Identities=29% Similarity=0.497 Sum_probs=221.9
Q ss_pred cccccCCCCCe-EEeeeeeecCceEEEEEEECCCCcEEEEEEec--CccCChhHHHHHHHHHHHHHhCCCCCcceeeeee
Q 010512 9 FFTEYGEASRY-QIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN--DVFEHVSDATRILREIKLLRLLRHPDIVEIKHIM 85 (508)
Q Consensus 9 ~~~~~~~~~rY-~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~--~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~ 85 (508)
.|-+-...+|| +...+||+|+|-+||+|.|..+|..||+-.++ +........+++..|+.+|+.|+|||||++++.+
T Consensus 31 ~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW 110 (632)
T KOG0584|consen 31 EFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSW 110 (632)
T ss_pred cccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeehe
Confidence 34455667788 55679999999999999999999999986553 4455666778999999999999999999999999
Q ss_pred cCCCcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcC--ceecCCCCCceeeCCC-CcEEE
Q 010512 86 LPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANAD-CKLKI 161 (508)
Q Consensus 86 ~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~g--IiHrDLKPeNILl~~~-~~lkL 161 (508)
.+... ..+-+|+|+|. |+|..++++.+.++...++.|++|||+||.|||++. |||||||.+||+||.+ |.|||
T Consensus 111 ~d~~n---~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKI 187 (632)
T KOG0584|consen 111 VDTDN---KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKI 187 (632)
T ss_pred ecCCC---ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceee
Confidence 77543 67899999998 899999999999999999999999999999999995 9999999999999986 89999
Q ss_pred ccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHH-HHhh
Q 010512 162 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL-MTDL 240 (508)
Q Consensus 162 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~-i~~~ 240 (508)
+|+|||+...... ....+|||.|||||++. ..|+..+||||||++++||+|+..||.......|+.+ +..
T Consensus 188 GDLGLAtl~r~s~-----aksvIGTPEFMAPEmYE---E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S- 258 (632)
T KOG0584|consen 188 GDLGLATLLRKSH-----AKSVIGTPEFMAPEMYE---ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS- 258 (632)
T ss_pred cchhHHHHhhccc-----cceeccCccccChHHHh---hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc-
Confidence 9999999764332 24479999999999986 4899999999999999999999999987665555433 221
Q ss_pred cCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 241 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 241 ~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
| .+|..|+. --+|++++||++||.. ..+|+|+.|+|.||||..
T Consensus 259 -G------------------------iKP~sl~k---V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 259 -G------------------------IKPAALSK---VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred -C------------------------CCHHHhhc---cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 1 12222222 2368899999999999 999999999999999985
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=331.13 Aligned_cols=258 Identities=29% Similarity=0.511 Sum_probs=211.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
.+|...+.||+|++|.||+|.+..++..||||+++.. .......+.+|+.+++.+.||||+++++.+.. ....
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~ 91 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDEL 91 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeE
Confidence 4566678999999999999999999999999998532 22334568899999999999999999998853 3568
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 97 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
|+|+||+. ++|.+++.. .++++..+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||++........
T Consensus 92 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 99999997 599988877 6799999999999999999999999999999999999999999999999998875433222
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
. .....|++.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+....+..+...
T Consensus 171 ~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~--------------- 230 (285)
T cd06648 171 R---RKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN--------------- 230 (285)
T ss_pred c---cccccCCccccCHHHhcC--CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc---------------
Confidence 1 233568999999999876 67899999999999999999999999776644333322210
Q ss_pred HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
. .+.......++..+.+|+.+||..||.+|||+.++++||||.....
T Consensus 231 ------------~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 231 ------------L-PPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred ------------C-CCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 0 0111112236788999999999999999999999999999987553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=331.47 Aligned_cols=252 Identities=23% Similarity=0.370 Sum_probs=203.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCC-----cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTG-----ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg-----~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
++|++.+.||+|+||.||+|.+...+ ..||+|.++... .......+.+|+.+|+.++||||+++++++..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---- 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK---- 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC----
Confidence 57999999999999999999876555 689999986432 23345568899999999999999999999843
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeC
Q 010512 92 EFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 154 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~ 154 (508)
....|++|||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 80 -~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 80 -EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 345899999998 6999999764 4578899999999999999999999999999999999999
Q ss_pred CCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHH
Q 010512 155 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQ 233 (508)
Q Consensus 155 ~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 233 (508)
.++.++|+|||+++....... ........+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADY-YRVQSKSLLPVRWMPPEAILY--GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEECCCcceeecccccc-ccccCCCcccccccCHHHhcc--CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999976432221 112234567889999999876 678999999999999999998 9999987664433
Q ss_pred HHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 234 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 234 l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
...+.. ..... ....+++.+.+|+.+||+.||.+||++.+++++
T Consensus 236 ~~~i~~---------------------------~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 236 IEMIRS---------------------------RQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHc---------------------------CCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 322211 11111 123567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=355.74 Aligned_cols=252 Identities=32% Similarity=0.515 Sum_probs=208.0
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEecC
Q 010512 24 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 103 (508)
Q Consensus 24 ~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~ 103 (508)
+||+|.||+||.|+|..|...+|||.|... +....+-+..||.+.+.|+|.|||++++.+ .+.+.+-|.||-+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqV 654 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQV 654 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecC
Confidence 699999999999999999999999999642 334566788999999999999999999987 4556788999999
Q ss_pred C-ccHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC-CCcEEEccccccccccCCCCCcc
Q 010512 104 E-SDLHQVIKAN-DDL--TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSFNDAPSAI 178 (508)
Q Consensus 104 ~-g~L~~~i~~~-~~l--~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~-~~~lkL~DFGla~~~~~~~~~~~ 178 (508)
+ |+|.+++... +++ .+..+-++.+||++||+|||.+.|+|||||-+|+|||. .|.+||+|||-++....-.+.
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~-- 732 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC-- 732 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcc--
Confidence 8 6999999864 777 88999999999999999999999999999999999986 588999999999876443332
Q ss_pred cccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHH
Q 010512 179 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 258 (508)
Q Consensus 179 ~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 258 (508)
..++.||..|||||++......|+.++|||||||++.||.||+|||-.....+ ...+.
T Consensus 733 -TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-------------AAMFk-------- 790 (1226)
T KOG4279|consen 733 -TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-------------AAMFK-------- 790 (1226)
T ss_pred -ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-------------Hhhhh--------
Confidence 34678999999999997766789999999999999999999999996543221 11110
Q ss_pred HHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 259 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 259 ~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
+.....-+++ -..++.+++.||.+|+..||.+||+|.++|.+||++..
T Consensus 791 --VGmyKvHP~i-----Peelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 791 --VGMYKVHPPI-----PEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred --hcceecCCCC-----cHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 0111111111 12457889999999999999999999999999999754
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=329.16 Aligned_cols=256 Identities=32% Similarity=0.540 Sum_probs=211.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCCCc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~ 94 (508)
++|.+.+.||+|+||.||+|.+..+|..||+|++.+.. ........+.+|+.+++.+. ||||+++++++. ...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ-----DEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc-----CCc
Confidence 47999999999999999999999999999999987532 22334567889999999999 999999999884 345
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
.+|+|||++. ++|.+++...+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 6899999995 799999998888999999999999999999999999999999999999999999999999999865432
Q ss_pred CCC-----------------cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 010512 174 APS-----------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 236 (508)
Q Consensus 174 ~~~-----------------~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~ 236 (508)
... ........++..|+|||++.+ ..++.++|||||||++++|++|+.||...+....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCC--CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 211 011233567899999999876 5688999999999999999999999987653322222
Q ss_pred HHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH----HHHhcCCcc
Q 010512 237 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA----EEALADPYF 310 (508)
Q Consensus 237 i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta----~eiL~hp~f 310 (508)
+.. ... .....+++.+.+||.+||..||.+|||+ +++++||||
T Consensus 234 ~~~--------------------------~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILK--------------------------LEY-----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHh--------------------------cCC-----CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 110 000 1112457889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=331.66 Aligned_cols=252 Identities=27% Similarity=0.383 Sum_probs=197.0
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEecCccCCh-hHHHHHHHHHHHHH---hCCCCCcceeeeeecCCCcCCCccEEEE
Q 010512 24 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-SDATRILREIKLLR---LLRHPDIVEIKHIMLPPSRREFKDIYVV 99 (508)
Q Consensus 24 ~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~-~~~~~i~~Ei~iL~---~L~HpnIv~l~~v~~~~~~~~~~~lylV 99 (508)
+||+|+||.||+|.+..+|..||+|.+.+..... .......+|..+++ ...||||+.+++.+.. .+..|+|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence 4899999999999999999999999986543221 12233445554444 4479999999998843 3468999
Q ss_pred EecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcc
Q 010512 100 FELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 178 (508)
Q Consensus 100 ~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~ 178 (508)
|||+. ++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 99998 6999999888889999999999999999999999999999999999999999999999999987542211
Q ss_pred cccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHH
Q 010512 179 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 258 (508)
Q Consensus 179 ~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 258 (508)
.....||..|+|||.+... ..++.++||||+||++|+|++|..||......... .+..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-------------~~~~------- 209 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-------------EIDR------- 209 (279)
T ss_pred -ccCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-------------HHHH-------
Confidence 1235789999999998641 56889999999999999999999999754321110 0000
Q ss_pred HHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCC
Q 010512 259 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 314 (508)
Q Consensus 259 ~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~~ 314 (508)
... ..+. ...+.+++.+.+||.+||..||.+|| |+.++++||||+++.
T Consensus 210 -~~~----~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 210 -MTL----TVNV---ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred -Hhh----cCCc---CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 000 0000 11235678999999999999999999 699999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=332.22 Aligned_cols=267 Identities=26% Similarity=0.385 Sum_probs=211.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++++.||+|+||+||+|.+..+|..||+|++.... .......+.+|+++++.++||||+++++.+.. ...
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~ 77 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLN-----ENN 77 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEec-----CCE
Confidence 367999999999999999999999999999999986432 23345678899999999999999999999854 356
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-cCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs-~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
+|+||||++ ++|.+++...+.+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 899999998 5898998888889999999999999999999997 69999999999999999999999999998654221
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
. ....+|+..|+|||++.+ ..++.++|||||||++|+|++|..||...+....... ...
T Consensus 158 ~-----~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~--------~~~------ 216 (284)
T cd06620 158 I-----ADTFVGTSTYMSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD--------DPM------ 216 (284)
T ss_pred c-----cCccccCcccCCHHHHcc--CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh--------hhh------
Confidence 1 123578999999999876 6788999999999999999999999986553211000 000
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.....+..+....+..+. ...++..+.+||.+||..||.+|||+.|+++|+||...
T Consensus 217 --~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 217 --GILDLLQQIVQEPPPRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred --HHHHHHHHHhhccCCCCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 000111111111111111 11256789999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=320.89 Aligned_cols=253 Identities=30% Similarity=0.513 Sum_probs=212.0
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
+|++.+.||+|+||.||+|.+..++..||+|++............+.+|+++++.++|||++++.+.+... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence 69999999999999999999999999999999976544445667789999999999999999999998543 5689
Q ss_pred EEEecCC-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 98 VVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 98 lV~E~~~-g~L~~~i~~~----~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
+|+|+++ ++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 9999998 5999988763 6799999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
.. .......|++.|+|||.+.+ ..++.++|+||+|+++++|++|..||...+.......+..
T Consensus 156 ~~---~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------- 217 (258)
T cd08215 156 TV---DLAKTVVGTPYYLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK------------- 217 (258)
T ss_pred Cc---ceecceeeeecccChhHhcc--CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc-------------
Confidence 32 12234578899999999876 6788999999999999999999999977653322221110
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
....+ .....+..+.+++.+||..||.+|||+.++|+||||
T Consensus 218 --------------~~~~~---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 218 --------------GQYPP---IPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred --------------CCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 00111 112567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=333.97 Aligned_cols=259 Identities=29% Similarity=0.481 Sum_probs=211.3
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++.+.||+|+||.||++.+..++..||+|++... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~ 89 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLV-----GD 89 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeee-----CC
Confidence 347999999999999999999999999999999998632 22345678899999999999999999998844 34
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
..|+|+||++ ++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred cEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 6899999998 5999888654 5889999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
. .......+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+...++..+..
T Consensus 169 ~---~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-------------- 229 (293)
T cd06647 169 Q---SKRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-------------- 229 (293)
T ss_pred c---cccccccCChhhcCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc--------------
Confidence 1 12234578899999999876 6789999999999999999999999987654333221110
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.....+ .....++..+.+||.+||..||.+||++.+++.|+||+...
T Consensus 230 -------------~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 230 -------------NGTPEL-QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred -------------CCCCCC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 000000 11223567899999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=325.74 Aligned_cols=251 Identities=26% Similarity=0.413 Sum_probs=200.8
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHH-HhCCCCCcceeeeeecCCCcCCCccEEEEE
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLL-RLLRHPDIVEIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL-~~L~HpnIv~l~~v~~~~~~~~~~~lylV~ 100 (508)
+.||.|+||.||+|.+..+|+.||+|.+.+... .......+..|..++ ..+.|+||+++++++. ....+|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence 679999999999999999999999999864321 112233445555544 4568999999999984 345699999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCccc
Q 010512 101 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179 (508)
Q Consensus 101 E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~ 179 (508)
||+. ++|.+++...+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++.....
T Consensus 77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875422
Q ss_pred ccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHH
Q 010512 180 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259 (508)
Q Consensus 180 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 259 (508)
.....++..|+|||.+.+ ..++.++||||+|+++|+|++|.+||...+.......+..
T Consensus 150 ~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------------- 207 (260)
T cd05611 150 NKKFVGTPDYLAPETILG--VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS-------------------- 207 (260)
T ss_pred cccCCCCcCccChhhhcC--CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--------------------
Confidence 123468889999999887 4589999999999999999999999987664333322211
Q ss_pred HHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC---HHHHhcCCcccCCC
Q 010512 260 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT---AEEALADPYFHGLA 314 (508)
Q Consensus 260 ~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt---a~eiL~hp~f~~~~ 314 (508)
............+++.+.++|.+||..||++||+ ++|+|+||||....
T Consensus 208 -------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 208 -------RRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred -------cccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 0000011122356789999999999999999995 58999999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=330.59 Aligned_cols=252 Identities=27% Similarity=0.380 Sum_probs=203.0
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccCC-hhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEecC
Q 010512 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 103 (508)
Q Consensus 25 LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~ 103 (508)
||+|+||+||+|.+..+|+.||+|++...... ......+.+|+.+|+.++||||+++++++. ..+.+|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE-----TKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe-----cCCeEEEEEecC
Confidence 69999999999999999999999998643222 223455678999999999999999999884 345689999999
Q ss_pred C-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcccc
Q 010512 104 E-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 180 (508)
Q Consensus 104 ~-g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~ 180 (508)
+ ++|.+++.... .+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++....... ..
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~----~~ 151 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK----KI 151 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC----cc
Confidence 8 69999987765 79999999999999999999999999999999999999999999999999987643211 12
Q ss_pred cccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHH
Q 010512 181 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 260 (508)
Q Consensus 181 ~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~ 260 (508)
....++..|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.........+.. .
T Consensus 152 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------------~ 209 (277)
T cd05577 152 KGRAGTPGYMAPEVLQG--EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR--------------------R 209 (277)
T ss_pred ccccCCCCcCCHHHhcC--CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh--------------------c
Confidence 34567889999999876 5689999999999999999999999976543111111110 0
Q ss_pred HhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCC
Q 010512 261 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 314 (508)
Q Consensus 261 l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~~ 314 (508)
....+. ...+..++.+.+||.+||+.||.+|| ++.+++.||||..+.
T Consensus 210 ----~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 210 ----TLEMAV---EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred ----cccccc---cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence 000111 11234588999999999999999999 999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=319.95 Aligned_cols=253 Identities=33% Similarity=0.538 Sum_probs=212.2
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
+|++.+.||+|++|.||+|.+..++..||+|.+............+.+|+++++.++|||++++++++.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-----SDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-----CCEEE
Confidence 6999999999999999999999999999999997654444566788999999999999999999999843 35689
Q ss_pred EEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCC
Q 010512 98 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 176 (508)
Q Consensus 98 lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~ 176 (508)
+||||++ ++|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.........
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred EEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999998 599999988888999999999999999999999999999999999999999999999999999865432221
Q ss_pred cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHH
Q 010512 177 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256 (508)
Q Consensus 177 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 256 (508)
.....++..|+|||.+.+ ..++.++|+||+|+++++|++|..||...+.......+.
T Consensus 156 ---~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~------------------ 212 (254)
T cd06627 156 ---DASVVGTPYWMAPEVIEM--SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV------------------ 212 (254)
T ss_pred ---ccccccchhhcCHhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh------------------
Confidence 234568899999999877 458899999999999999999999997654322221110
Q ss_pred HHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 257 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
... .....+.++..+.+++.+||..||++|||+.++++||||
T Consensus 213 ---------~~~---~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 213 ---------QDD---HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ---------ccC---CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 000 011123567889999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=328.39 Aligned_cols=265 Identities=25% Similarity=0.393 Sum_probs=207.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|++.+.||.|++|.||+|.+..++..||+|.+..... .....++.+|+++++.++||||+++++++... ....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeE
Confidence 479999999999999999999999999999999874322 24456788999999999999999999988543 23468
Q ss_pred EEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 97 YVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999998 588877643 3468999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhhcCCCChHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV--VHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~--~~~l~~i~~~~g~p~~~~~ 249 (508)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||..... ........
T Consensus 157 ~~~-----~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------- 218 (287)
T cd06621 157 NSL-----AGTFTGTSFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS----------- 218 (287)
T ss_pred ccc-----cccccCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHH-----------
Confidence 221 123467889999999876 6889999999999999999999999976532 00011000
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
++..............-...++.+.+||.+||..||.+|||+.|++.||||...
T Consensus 219 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 219 ----------YIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred ----------HHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 000000000000000001245778999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=335.82 Aligned_cols=260 Identities=28% Similarity=0.506 Sum_probs=211.2
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
+...-|.....||+|+||.||+|.+..++..||||++.... ......+.+|+.+++.+.||||+++++.+.. .
T Consensus 18 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~ 90 (297)
T cd06659 18 DPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----G 90 (297)
T ss_pred cchhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheee-----C
Confidence 33455667778999999999999999999999999986432 2234568899999999999999999998843 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
...|+||||++ ++|..++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 91 ~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 91 EELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred CeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 56899999998 588776654 5689999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
... ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..+..
T Consensus 170 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------- 231 (297)
T cd06659 170 DVP---KRKSLVGTPYWMAPEVISR--TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD------------- 231 (297)
T ss_pred ccc---cccceecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------
Confidence 221 1234678999999999977 6789999999999999999999999977664443322211
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
. +.........++..+.+||.+||+.||.+||+++++++||||.+..
T Consensus 232 --------------~-~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 232 --------------S-PPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred --------------c-CCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 0 0111122345678899999999999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=330.68 Aligned_cols=256 Identities=27% Similarity=0.412 Sum_probs=209.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
...|+.++.||.|+||.||+|.+..++..||||.+... ........+.+|+.+++.+.||||+++++++.. ...
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----GTK 76 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCE
Confidence 35688899999999999999999999999999998643 223445678899999999999999999999843 456
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
.|+||||++ ++|.+++.. +++++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 77 LWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999998 589988865 578999999999999999999999999999999999999999999999999997643222
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
. ......++..|+|||++.+ ..++.++|+|||||++|+|++|.+||...+.......+.
T Consensus 156 ~---~~~~~~~~~~y~apE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~---------------- 214 (277)
T cd06640 156 I---KRNTFVGTPFWMAPEVIQQ--SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP---------------- 214 (277)
T ss_pred c---ccccccCcccccCHhHhcc--CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh----------------
Confidence 1 1233568889999999876 678999999999999999999999997655332221110
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
...+ ......++..+.+|+.+||..||.+||+++++++|+||...
T Consensus 215 -----------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 215 -----------KNNP---PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred -----------cCCC---CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 0000 11223456789999999999999999999999999999653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=347.21 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=198.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC-----CcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHT-----GERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 89 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~t-----g~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~ 89 (508)
.++|++.+.||+|+||.||+|++..+ +..||+|+++... .......+.+|+.+|+.+ +|+||+++++.+..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~-- 113 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTH-- 113 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecC--
Confidence 35799999999999999999986544 3579999997532 223456788999999999 89999999999843
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC------------------------------------------------------
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 114 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------------------------------------ 114 (508)
...+|+|||||. |+|.+++...
T Consensus 114 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 114 ---GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ---CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 356899999998 6999888542
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcc
Q 010512 115 ----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 178 (508)
Q Consensus 115 ----------------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~ 178 (508)
.++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~-~ 269 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY-V 269 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce-e
Confidence 24788899999999999999999999999999999999999999999999999764332211 1
Q ss_pred cccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHH
Q 010512 179 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 257 (508)
Q Consensus 179 ~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 257 (508)
......++..|+|||++.+ ..|+.++|||||||++|+|++ |+.||+.......+..+..
T Consensus 270 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~------------------ 329 (374)
T cd05106 270 VKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK------------------ 329 (374)
T ss_pred eccCCCCccceeCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH------------------
Confidence 1122345677999999976 689999999999999999997 9999986543222111110
Q ss_pred HHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 258 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 258 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
...... .....++.+.+|+.+||+.||.+|||+.++++
T Consensus 330 --------~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 330 --------RGYQMS---RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred --------cccCcc---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000000 01235788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=325.22 Aligned_cols=256 Identities=21% Similarity=0.358 Sum_probs=202.9
Q ss_pred eEEeeeeeecCceEEEEEEECC---CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc-CCCc
Q 010512 19 YQIQEVIGKGSYGVVGSAVDTH---TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 94 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~~---tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-~~~~ 94 (508)
|.+.+.||+|+||.||+|.+.. ++..||||+++...........+.+|+.+|+.++||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6788999999999999998764 44889999997544444556678999999999999999999998865432 3345
Q ss_pred cEEEEEecCC-ccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccc
Q 010512 95 DIYVVFELME-SDLHQVIKAN------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 167 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla 167 (508)
..++||||+. ++|..++... ..+++..+..++.|++.||.|||+.||+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 6899999998 6998887542 35899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCCh
Q 010512 168 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPST 246 (508)
Q Consensus 168 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~ 246 (508)
+........ .......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+..
T Consensus 161 ~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~------- 230 (273)
T cd05035 161 KKIYSGDYY-RQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH------- 230 (273)
T ss_pred eeccccccc-cccccccCCccccCHhhccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------
Confidence 865332211 11112234678999999876 678999999999999999999 8999987664433322211
Q ss_pred HHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 247 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.... .....++..+.+++.+||+.||.+|||+.+++++
T Consensus 231 --------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 231 --------------------GNRL---KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred --------------------CCCC---CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000 1123567889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=315.71 Aligned_cols=267 Identities=25% Similarity=0.408 Sum_probs=209.5
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
.+.-.+||+|.+.||+|||+.||++.+..++..||+|+|.. ....+.+..++|+...++++||||+++++..+.....
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c--~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILC--HSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeec--cchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 34557899999999999999999999999999999999964 3456788899999999999999999999987765444
Q ss_pred CCccEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhcC--ceecCCCCCceeeCCCCcEEEccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDF 164 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~Qil~aL~yLHs~g--IiHrDLKPeNILl~~~~~lkL~DF 164 (508)
.....||+++|.. |+|.+.|.. +..+++.++..|+.+|++||.+||+.. ++||||||.|||+.+.+.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 5567999999998 899998864 236999999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCc------ccccccccCcccccccccccc-cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 010512 165 GLARVSFNDAPSA------IFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLM 237 (508)
Q Consensus 165 Gla~~~~~~~~~~------~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i 237 (508)
|.++...-..... ..|.....|..|+|||++.-. ....+.++|||||||+||.|+.|..||.. +
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~---------~ 244 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER---------I 244 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH---------H
Confidence 9998642211111 123344678999999997531 24567899999999999999999999942 1
Q ss_pred HhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 238 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 238 ~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.. -|..-.- .+ ......+... +..+..+.+||+.||+.||.+||++.+++.+
T Consensus 245 ~~-~GgSlaL---------------Av-~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 245 YQ-QGGSLAL---------------AV-QNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred hh-cCCeEEE---------------ee-eccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11 0100000 00 0001111111 2367889999999999999999999999874
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=327.10 Aligned_cols=254 Identities=21% Similarity=0.370 Sum_probs=201.3
Q ss_pred CCCCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 89 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~-----~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 89 (508)
..++|++.+.||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--- 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--- 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc---
Confidence 4578999999999999999999864 24578999998643 22334566889999999999999999999983
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCc
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKAND----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 158 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~~----------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~ 158 (508)
.....++||||+. ++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.
T Consensus 80 --~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 80 --QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred --CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC
Confidence 3456899999998 69999987532 3577888999999999999999999999999999999999999
Q ss_pred EEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 010512 159 LKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLM 237 (508)
Q Consensus 159 lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i 237 (508)
++|+|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+....+..+
T Consensus 158 ~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (277)
T cd05062 158 VKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234 (277)
T ss_pred EEECCCCCccccCCccee-ecCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999998754322211 11122355788999999876 678999999999999999998 78999877654433322
Q ss_pred HhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 238 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 238 ~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
... ... .....++..+.+|+.+||+.||.+|||+.|++++
T Consensus 235 ~~~---------------------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 235 MEG---------------------------GLL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HcC---------------------------CcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 110 000 1113456789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=327.76 Aligned_cols=260 Identities=22% Similarity=0.356 Sum_probs=204.3
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 89 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~-----tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 89 (508)
..++|++.+.||+|+||.||+|.++. .+..||+|.++... .......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK-- 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--
Confidence 35789999999999999999997642 35589999986432 22344567889999999999999999999843
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCc
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKAN----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 158 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~----------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~ 158 (508)
....|+||||+. |+|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 81 ---GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred ---CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc
Confidence 345899999998 7999999753 23466788999999999999999999999999999999999999
Q ss_pred EEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 010512 159 LKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLM 237 (508)
Q Consensus 159 lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i 237 (508)
++|+|||+++........ .......++..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.+.+..+....+
T Consensus 158 ~~L~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~--~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (288)
T cd05061 158 VKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKD--GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234 (288)
T ss_pred EEECcCCccccccccccc-cccCCCcccccccCHHHhcc--CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999854322211 11122345678999999876 678999999999999999998 78999776543333222
Q ss_pred HhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc------CCccc
Q 010512 238 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA------DPYFH 311 (508)
Q Consensus 238 ~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~------hp~f~ 311 (508)
... ... ......++.+.+++.+||+.||.+|||+.++++ ||||.
T Consensus 235 ~~~---------------------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~ 284 (288)
T cd05061 235 MDG---------------------------GYL---DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284 (288)
T ss_pred HcC---------------------------CCC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence 110 000 011245688999999999999999999999987 99998
Q ss_pred CC
Q 010512 312 GL 313 (508)
Q Consensus 312 ~~ 313 (508)
++
T Consensus 285 ~~ 286 (288)
T cd05061 285 EV 286 (288)
T ss_pred CC
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=327.17 Aligned_cols=257 Identities=31% Similarity=0.493 Sum_probs=208.9
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC---CCCcceeeeeecCCCcCCCc
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR---HPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~v~~~~~~~~~~ 94 (508)
.|++.+.||+|+||.||+|.+..+|..||+|.++... .......+.+|+.+++.++ ||||+++++++.. ..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-----~~ 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-----GP 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-----CC
Confidence 5888999999999999999999999999999986432 2334567889999999997 9999999998843 35
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
..|+||||+. ++|.+++.. +.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 76 RLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 6899999998 589888865 47999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
.. ......|+..|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.........+.
T Consensus 155 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~--------------- 215 (277)
T cd06917 155 SS---KRSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP--------------- 215 (277)
T ss_pred cc---ccccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc---------------
Confidence 21 23445789999999988652 457899999999999999999999997655322211110
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
...+..+. ....+..+.+|+.+||..||.+||++.+++.|+||+...
T Consensus 216 ------------~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 216 ------------KSKPPRLE--DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred ------------cCCCCCCC--cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 00111111 112678899999999999999999999999999997643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=345.69 Aligned_cols=247 Identities=28% Similarity=0.421 Sum_probs=203.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
..+.+++.||+|.||.||.|.... ...||+|.++... .....+++|+++|+.|+|+|||++++++.. ..-+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~---m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-----~~pi 276 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS---MSPEAFLREAQIMKKLRHEKLVKLYGVCTK-----QEPI 276 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccc---cChhHHHHHHHHHHhCcccCeEEEEEEEec-----CCce
Confidence 345678899999999999997642 3489999997542 234667899999999999999999999953 2359
Q ss_pred EEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 97 YVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
|||||||. |+|.++|+. ...+.......|+.||++|++||+++++|||||-..||||+++..+||+|||||+...++
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 99999998 899999997 456899999999999999999999999999999999999999999999999999954332
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
... ...+.-...-|.|||.+.- ..++.++|||||||+|+||+| |+.||++.+..+.+..+.....-|.
T Consensus 357 ~Y~--~~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~------- 425 (468)
T KOG0197|consen 357 EYT--ASEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR------- 425 (468)
T ss_pred cee--ecCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC-------
Confidence 211 1122223345889999986 789999999999999999998 9999999998888777754332221
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
-.++++.+.+++..||..+|++|||++.+..
T Consensus 426 -----------------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 426 -----------------------PEGCPDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred -----------------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 1368899999999999999999999986554
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=332.39 Aligned_cols=255 Identities=29% Similarity=0.415 Sum_probs=207.5
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
..|++.+.||+|+||.||+|.+..+|..||+|.+..... ......+.+|+.+++.++||||+++++.+.. ...+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLK-----GTKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhccccc-----CCce
Confidence 457788999999999999999999999999999864322 2345678899999999999999999998853 3568
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 97 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred EEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence 99999998 588888764 578999999999999999999999999999999999999999999999999997643221
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
.......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...........+.
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~----------------- 214 (277)
T cd06642 156 --IKRNTFVGTPFWMAPEVIKQ--SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP----------------- 214 (277)
T ss_pred --hhhhcccCcccccCHHHhCc--CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-----------------
Confidence 11233468899999999987 678899999999999999999999997544322211110
Q ss_pred HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
...+. .....++..+.+||.+||..+|.+|||+.++++||||..+
T Consensus 215 ----------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 215 ----------KNSPP---TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred ----------cCCCC---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 00010 1112456789999999999999999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=339.62 Aligned_cols=288 Identities=21% Similarity=0.268 Sum_probs=205.7
Q ss_pred eeeeeec--CceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEE
Q 010512 22 QEVIGKG--SYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 99 (508)
Q Consensus 22 ~~~LG~G--~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV 99 (508)
...||+| +||+||+|.+..+|+.||||++..........+.+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~~~~~~v 77 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-----GSWLWVI 77 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-----CCceEEE
Confidence 3457777 99999999999999999999987544444455778899999999999999999999954 3568999
Q ss_pred EecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCC
Q 010512 100 FELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 176 (508)
Q Consensus 100 ~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~ 176 (508)
|||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++++|||.+.........
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99998 5999988764 35899999999999999999999999999999999999999999999999866433211111
Q ss_pred c-cc---ccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHH----
Q 010512 177 A-IF---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES---- 248 (508)
Q Consensus 177 ~-~~---~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~---- 248 (508)
. .. .....++..|+|||++.+....++.++||||+||++|+|++|++||.+......+..+.......+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccc
Confidence 0 00 011235667999999876334588999999999999999999999987765444333222111100000
Q ss_pred --HHHHhhH--HHHH-HHhhccc-----CCC-CCC-CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 249 --ISRIRNE--KARR-YLGSMRK-----KQP-VPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 249 --~~~~~~~--~~~~-~l~~~~~-----~~~-~~~-~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.....+. .... ....... ... ..+ .......++.+.+||.+||+.||.+|||+.++|+||||....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 0000000 0000 0000000 000 000 001123567899999999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=323.12 Aligned_cols=251 Identities=31% Similarity=0.463 Sum_probs=199.4
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEe
Q 010512 22 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 101 (508)
Q Consensus 22 ~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 101 (508)
...||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.+++.++|+||+++++++.. ...+|+|||
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e 85 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE-----NGFFKIFME 85 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-----CCEEEEEEe
Confidence 35899999999999999999999999998643 23456678899999999999999999999843 356899999
Q ss_pred cCC-ccHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC-CCcEEEccccccccccCCCCC
Q 010512 102 LME-SDLHQVIKAN-DDL--TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSFNDAPS 176 (508)
Q Consensus 102 ~~~-g~L~~~i~~~-~~l--~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~-~~~lkL~DFGla~~~~~~~~~ 176 (508)
|+. ++|.+++... ..+ ++..+..++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~- 164 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP- 164 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-
Confidence 998 6999988764 455 88889999999999999999999999999999999986 67899999999875432221
Q ss_pred cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHH
Q 010512 177 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256 (508)
Q Consensus 177 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 256 (508)
......|+..|+|||++.+....++.++|+||+||++|+|++|++||.............
T Consensus 165 --~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~------------------ 224 (268)
T cd06624 165 --CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV------------------ 224 (268)
T ss_pred --ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh------------------
Confidence 123346889999999986533458899999999999999999999996533211100000
Q ss_pred HHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 257 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
. ..... ......+++.+.+|+.+||..+|.+|||+.+++.||||
T Consensus 225 -----~-~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 225 -----G-MFKIH----PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -----h-hhccC----CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 0 00000 01123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=344.72 Aligned_cols=253 Identities=27% Similarity=0.405 Sum_probs=198.4
Q ss_pred CCeEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~-----~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~ 90 (508)
++|++.+.||+|+||.||+|.+ ..++..||+|+++... .......+.+|+.+|+.+ +||||+++++++..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~--- 110 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTV--- 110 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc---
Confidence 5799999999999999999974 3567789999986432 233456788999999999 89999999999844
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC------------------------------------------------------
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAND------------------------------------------------------ 115 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~------------------------------------------------------ 115 (508)
....|+|||||+ |+|.+++....
T Consensus 111 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 111 --GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred --CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 356899999998 69998886431
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 116 ---------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 116 ---------------------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 46788899999999999999999999999999999999999999999999998653322
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
.. .......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+......+..+..
T Consensus 269 ~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~-------------- 331 (375)
T cd05104 269 NY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK-------------- 331 (375)
T ss_pred cc-cccCCCCCCcceeChhHhcC--CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH--------------
Confidence 11 11122345667999999987 689999999999999999998 8999977543322211100
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.... .. .....+..+.+||.+||..||.+|||+.++++.
T Consensus 332 --------~~~~----~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 332 --------EGYR----ML---SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred --------hCcc----CC---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0000 00 012346789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=327.40 Aligned_cols=252 Identities=27% Similarity=0.388 Sum_probs=197.1
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEecCccCCh-hHHHHHHHH---HHHHHhCCCCCcceeeeeecCCCcCCCccEEEE
Q 010512 24 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-SDATRILRE---IKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 99 (508)
Q Consensus 24 ~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~-~~~~~i~~E---i~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV 99 (508)
+||+|+||.||+|.+..+|+.||||++.+..... ........| +.+++...||||+.+++.+.. ...+|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-----PDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCEEEEE
Confidence 4899999999999999999999999986532221 111223334 345555689999999998843 3568999
Q ss_pred EecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcc
Q 010512 100 FELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 178 (508)
Q Consensus 100 ~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~ 178 (508)
|||+. ++|.+++...+.+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++.......
T Consensus 76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 99998 5899999888889999999999999999999999999999999999999999999999999987542211
Q ss_pred cccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHH
Q 010512 179 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 258 (508)
Q Consensus 179 ~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 258 (508)
....+|+..|+|||++.+. ..++.++||||+||++|+|++|+.||.+..........
T Consensus 152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~--------------------- 208 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--------------------- 208 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---------------------
Confidence 1235789999999998752 46889999999999999999999999765321111000
Q ss_pred HHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCC
Q 010512 259 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 314 (508)
Q Consensus 259 ~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~~ 314 (508)
.... ..... .....+..+.+||.+||..||.+|| ++.++++||||....
T Consensus 209 ~~~~----~~~~~---~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 209 RMTL----TMAVE---LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred HHhh----ccCCC---CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 0000 00111 1123578999999999999999999 999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=370.03 Aligned_cols=264 Identities=33% Similarity=0.480 Sum_probs=203.5
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCC--------
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP-------- 88 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~-------- 88 (508)
.+|+.+++||+||||.||+|+++-+|..||||+|.-.. ......++.+|+++|.+|+|||||+++..+...
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 45688999999999999999999999999999998655 566778899999999999999999987654100
Q ss_pred ----------------------------------------------C-------cC------------------------
Q 010512 89 ----------------------------------------------S-------RR------------------------ 91 (508)
Q Consensus 89 ----------------------------------------------~-------~~------------------------ 91 (508)
. .+
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0 00
Q ss_pred -----------------------------CCccEEEEEecCCcc-HHHHHHhCCCC-CHHHHHHHHHHHHHHHHHhHhcC
Q 010512 92 -----------------------------EFKDIYVVFELMESD-LHQVIKANDDL-TPEHYQFFLYQLLRGLKYIHTAN 140 (508)
Q Consensus 92 -----------------------------~~~~lylV~E~~~g~-L~~~i~~~~~l-~~~~~~~i~~Qil~aL~yLHs~g 140 (508)
..-.+||-||||+.+ |.+++..+... ....++.+|+||+.||+|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 002489999999965 55555555443 47889999999999999999999
Q ss_pred ceecCCCCCceeeCCCCcEEEcccccccccc------C---------CCCCcccccccccCcccccccccccccC-CCCc
Q 010512 141 VFHRDLKPKNILANADCKLKICDFGLARVSF------N---------DAPSAIFWTDYVATRWYRAPELCGSFFS-KYTP 204 (508)
Q Consensus 141 IiHrDLKPeNILl~~~~~lkL~DFGla~~~~------~---------~~~~~~~~~~~~gT~~Y~APE~l~~~~~-~y~~ 204 (508)
||||||||.||++++++.|||+|||+|+... . ........|..+||..|+|||++.+... .|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999998721 0 0111123577899999999999987422 6999
Q ss_pred chhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhccc-CCCCCCCCCCCCCCHHH
Q 010512 205 AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRK-KQPVPFSHKFPNADPLA 283 (508)
Q Consensus 205 ~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~-~~~~~~~~~~~~~~~~~ 283 (508)
|+||||||+||+||+. ||...-+ ... .+..++. ..|.+ ...+.+--+..
T Consensus 798 KiDmYSLGIVlFEM~y---PF~TsME--Ra~------------------------iL~~LR~g~iP~~-~~f~~~~~~~e 847 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTSME--RAS------------------------ILTNLRKGSIPEP-ADFFDPEHPEE 847 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCchHH--HHH------------------------HHHhcccCCCCCC-cccccccchHH
Confidence 9999999999999995 4643221 111 1122221 12222 22333444667
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010512 284 LHLLERLLAFDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 284 ~~Ll~~mL~~DP~~Rpta~eiL~hp~f~ 311 (508)
..+|++||+.||.+||||.|+|++.||-
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 8999999999999999999999999985
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=359.57 Aligned_cols=258 Identities=24% Similarity=0.416 Sum_probs=204.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeee-eecCCCcCC-C
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKH-IMLPPSRRE-F 93 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~-v~~~~~~~~-~ 93 (508)
-+++|.+.|.+|||+.||+|.+...|..||+|++-. .+......+.+||.+|++|+ |+|||.+++ ......... .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~--~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV--NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec--CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 468999999999999999999998889999999853 35566778899999999998 999999999 443332222 2
Q ss_pred ccEEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhcC--ceecCCCCCceeeCCCCcEEEccccccc
Q 010512 94 KDIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~Qil~aL~yLHs~g--IiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
-.++|+||||. |.|-+++.. ...|++.++.+||+|+++||.+||... |||||||-|||||+.+|..||||||.|+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 45889999999 699999985 346999999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCCccc---cc---ccccCcccccccccccc-cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Q 010512 169 VSFNDAPSAIF---WT---DYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 241 (508)
Q Consensus 169 ~~~~~~~~~~~---~~---~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~ 241 (508)
-.......... .. ....|+.|+|||.|.-. ....+.|+|||+|||+||-|+....||.+......+
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl------- 267 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL------- 267 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE-------
Confidence 54332211100 00 12468999999987321 156889999999999999999999999765311100
Q ss_pred CCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCc
Q 010512 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309 (508)
Q Consensus 242 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~ 309 (508)
..+..+ ..++.++..+.+||..||+.||.+||++-|++.+-+
T Consensus 268 -----------------------ng~Y~~---P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 268 -----------------------NGNYSF---PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred -----------------------eccccC---CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 001111 123667888999999999999999999999988433
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=323.57 Aligned_cols=256 Identities=21% Similarity=0.374 Sum_probs=201.6
Q ss_pred eEEeeeeeecCceEEEEEEECCCCc--EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc-CCCcc
Q 010512 19 YQIQEVIGKGSYGVVGSAVDTHTGE--RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFKD 95 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~~tg~--~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-~~~~~ 95 (508)
|.+.+.||+|+||.||+|.+..++. .||+|.++...........+.+|+.+|+.++||||+++++++..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4577899999999999999887775 69999987654455567788899999999999999999998754321 22346
Q ss_pred EEEEEecCC-ccHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 96 IYVVFELME-SDLHQVIKA------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~------~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
.++||||+. |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 799999998 699888742 1348899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChH
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
........ .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |++||++.........+..
T Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-------- 229 (272)
T cd05075 161 KIYNGDYY-RQGRIAKMPVKWIAIESLAD--RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ-------- 229 (272)
T ss_pred ccCcccce-ecCCcccCCcccCCHHHccC--CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--------
Confidence 65332211 01122345678999999987 678999999999999999999 8999987654332222211
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.... ...+.++..+.++|.+||+.||.+|||+.+++++
T Consensus 230 -------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 230 -------------------GNRL---KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -------------------CCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0000 1123567789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=322.45 Aligned_cols=249 Identities=22% Similarity=0.430 Sum_probs=202.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
...|.+.+.||+|+||.||+|.+..++..||+|++... ......+.+|+.+|+.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPP 76 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcC-----CCC
Confidence 35699999999999999999999999999999998642 2345678899999999999999999999843 356
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 96 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
+|+||||++ ++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 899999997 6999998764 3589999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||++.+..+....+...
T Consensus 157 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~----------- 221 (263)
T cd05052 157 DTYTA--HAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG----------- 221 (263)
T ss_pred ceeec--cCCCCCccccCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-----------
Confidence 22111 112234567999999876 678999999999999999998 99999887654333222110
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
... .....+++.+.+||.+||..||++|||+.++++
T Consensus 222 ----------------~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 222 ----------------YRM---ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ----------------CCC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 000 112346789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=365.13 Aligned_cols=148 Identities=23% Similarity=0.412 Sum_probs=133.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
.++|.+++.||+|+||+||+|.+..+++.||||+++... ........+.+|+.+++.++||||+++++++. ...
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ-----SAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE-----ECC
Confidence 468999999999999999999999999999999997532 23334567889999999999999999998883 345
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
++||||||+. ++|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 7999999997 6999999888889999999999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=316.38 Aligned_cols=259 Identities=29% Similarity=0.452 Sum_probs=212.5
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
+|.+.+.||+|++|.||+|.+..++..|++|++............+.+|+.++++++||||+++++.+.... ...+|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 588999999999999999999999999999999765443455678889999999999999999999985432 25689
Q ss_pred EEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCC
Q 010512 98 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 176 (508)
Q Consensus 98 lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~ 176 (508)
+|+||++ ++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999996 699999988878999999999999999999999999999999999999999999999999999875443321
Q ss_pred cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHH
Q 010512 177 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256 (508)
Q Consensus 177 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 256 (508)
.......++..|+|||.+.+ ..++.++|||||||++++|++|..||..... ....+....
T Consensus 158 -~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~--------------- 217 (260)
T cd06606 158 -EGTGSVRGTPYWMAPEVIRG--EEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIG--------------- 217 (260)
T ss_pred -ccccCCCCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhcc---------------
Confidence 01234568899999999877 5688999999999999999999999977651 111111100
Q ss_pred HHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 257 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
. ...........+..+.+||.+||..||.+||++.+++.||||
T Consensus 218 ---------~--~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 218 ---------S--SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ---------c--cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 0 000111123447889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=326.29 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=203.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~-----~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
.++|.+.+.||+|+||.||+|.+. .++..||||+++.... ......+.+|+++|+.++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 79 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTE--- 79 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEec---
Confidence 467999999999999999999874 3468899999875322 2245678899999999999999999999854
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAND--------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 155 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~--------------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~ 155 (508)
....|+||||+. ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 80 --~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~ 157 (280)
T cd05049 80 --GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157 (280)
T ss_pred --CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence 356899999998 69999997643 4788999999999999999999999999999999999999
Q ss_pred CCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 010512 156 DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQL 234 (508)
Q Consensus 156 ~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l 234 (508)
++.++|+|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.....
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~ 234 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI 234 (280)
T ss_pred CCeEEECCcccceecccCcce-ecCCCCcccceecChhhhcc--CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999999754322211 11223456788999999987 679999999999999999998 99999876654433
Q ss_pred HHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 235 DLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 235 ~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..+... .. ......++..+.+|+.+||..||.+|||+.|+++
T Consensus 235 ~~~~~~---------------------------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 235 ECITQG---------------------------RL---LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHcC---------------------------Cc---CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 332210 00 0111346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=335.60 Aligned_cols=275 Identities=24% Similarity=0.296 Sum_probs=200.7
Q ss_pred CceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEecCC-ccH
Q 010512 29 SYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDL 107 (508)
Q Consensus 29 ~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~-g~L 107 (508)
++|.||.+++..+|..||||+++...........+.+|+.+|+.++||||+++++++.. ....|++|||+. ++|
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-----~~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-----DSELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-----CCeEEEEEeccCCCCH
Confidence 45566666667799999999997653445567789999999999999999999999854 356899999998 689
Q ss_pred HHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCC----ccccc
Q 010512 108 HQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS----AIFWT 181 (508)
Q Consensus 108 ~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~----~~~~~ 181 (508)
.+++... ..+++..+..+++||+.||.|||++||+||||||+||+++.++.+||+|||.+......... .....
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 9988763 46899999999999999999999999999999999999999999999999998754322111 11123
Q ss_pred ccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHH
Q 010512 182 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYL 261 (508)
Q Consensus 182 ~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l 261 (508)
...++..|+|||++.+....|+.++||||+||++++|++|..||........+. ....+...... ... ......
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~-~~~---~~~~~~ 240 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL--EKVRGTVPCLL-DKS---TYPLYE 240 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhccCcccc-ccC---chhhhc
Confidence 346788999999987633468899999999999999999999998765433321 11111111000 000 000000
Q ss_pred hhccc--------CCCCCC-CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 262 GSMRK--------KQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 262 ~~~~~--------~~~~~~-~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
..+.. ...... .......+..+.+|+.+||..||.+|||++++|+||||+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00000 000000 011123456788999999999999999999999999998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=321.24 Aligned_cols=245 Identities=23% Similarity=0.347 Sum_probs=197.5
Q ss_pred eeeecCceEEEEEEE--CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEe
Q 010512 24 VIGKGSYGVVGSAVD--THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 101 (508)
Q Consensus 24 ~LG~G~~g~V~~a~~--~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 101 (508)
.||+|+||.||+|.. ..++..||+|+++...........+.+|+.+++.+.||||+++++++.. ...++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence 589999999999964 4578899999987554444456778899999999999999999998732 34699999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcccc
Q 010512 102 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 180 (508)
Q Consensus 102 ~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~ 180 (508)
|+. ++|.+++.....+++..+..++.|++.||.|||++||+||||||.||+++.++.+||+|||+++............
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 998 6899999887789999999999999999999999999999999999999999999999999998653322211111
Q ss_pred cccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHH
Q 010512 181 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259 (508)
Q Consensus 181 ~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 259 (508)
....++..|+|||.+.. ..++.++|||||||++|+|++ |.+||.+.+.......+..
T Consensus 156 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~-------------------- 213 (257)
T cd05116 156 THGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-------------------- 213 (257)
T ss_pred CCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC--------------------
Confidence 22334578999999876 678899999999999999997 9999987665443333221
Q ss_pred HHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 260 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 260 ~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
....+ ....+++.+.+||.+||+.||.+||++.+|..
T Consensus 214 -------~~~~~---~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 214 -------GERME---CPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred -------CCCCC---CCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 00011 11356789999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=332.15 Aligned_cols=252 Identities=23% Similarity=0.384 Sum_probs=201.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcE----EEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~----vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
..+|++.+.||+|+||.||+|.+..+|.. ||||+++.. .......++.+|+.+++.++||||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---
Confidence 45799999999999999999998766654 899998642 2234456788999999999999999999998543
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
..++|++|+. |+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ---~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 82 ---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred ---CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence 3689999998 7999999875 4688999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
....... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+.
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~---------- 225 (316)
T cd05108 159 LGADEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---------- 225 (316)
T ss_pred ccCCCcc-eeccCCccceeecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh----------
Confidence 5432211 11122334678999999977 688999999999999999997 999998755332211111
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.....+ ..+.++..+.+++.+||..||.+||++.+++.+
T Consensus 226 -----------------~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 226 -----------------KGERLP---QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred -----------------CCCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 000011 113456789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=331.20 Aligned_cols=263 Identities=26% Similarity=0.403 Sum_probs=212.7
Q ss_pred cccccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecC
Q 010512 9 FFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLP 87 (508)
Q Consensus 9 ~~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~ 87 (508)
+|......+.|...+.||+|+||+||+|.+..+|..||||++..... .......+.+|+.+++.++|||++++++++..
T Consensus 13 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 92 (313)
T cd06633 13 LFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK 92 (313)
T ss_pred HhccCCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 44445555668888999999999999999999999999999864322 22344578899999999999999999999854
Q ss_pred CCcCCCccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccc
Q 010512 88 PSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 166 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGl 166 (508)
....|+||||+.++|.+++.. ..++++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||+
T Consensus 93 -----~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~ 167 (313)
T cd06633 93 -----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGS 167 (313)
T ss_pred -----CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCC
Confidence 356899999999998888765 45789999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCcccccccccccc-cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC
Q 010512 167 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245 (508)
Q Consensus 167 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~ 245 (508)
+..... .....|+..|+|||++... ...++.++|||||||++|+|++|.+||.+.+....+..+...
T Consensus 168 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~----- 235 (313)
T cd06633 168 ASKSSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----- 235 (313)
T ss_pred CcccCC-------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-----
Confidence 864211 2345788999999998531 146888999999999999999999999876644433322110
Q ss_pred hHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 246 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
..+ ......++..+.+|+.+||+.||.+||++.+++.||||..
T Consensus 236 ---------------------~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 236 ---------------------DSP---TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred ---------------------CCC---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 000 0112345677999999999999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=327.08 Aligned_cols=263 Identities=22% Similarity=0.395 Sum_probs=208.9
Q ss_pred CeEEeeeeeecCceEEEEEEEC---CCCcEEEEEEecCccC--ChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcC
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFE--HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~---~tg~~vAIKki~~~~~--~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~ 91 (508)
.|++.+.||.|+||.||.|.+. .+|..||+|.++.... .......+.+|+++|+.+ +|+||+.+++.+.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----- 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ----- 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee-----
Confidence 4899999999999999999874 4789999999864321 223346678899999999 5899999998884
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
....+|+||||++ ++|.+++....++++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++...
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 3456899999998 599999988888999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
..... .......|+..|+|||.+.+....++.++|||||||++|+|++|..||...+.......+..
T Consensus 156 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~----------- 222 (290)
T cd05613 156 HEDEV--ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR----------- 222 (290)
T ss_pred ccccc--cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH-----------
Confidence 32211 11234578999999999875334578899999999999999999999965432211111110
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 314 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~~ 314 (508)
... ....+ + ...+++.+.+|+.+||..||.+|| ++++++.||||+.+.
T Consensus 223 --------~~~---~~~~~--~---~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 223 --------RIL---KSEPP--Y---PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred --------Hhh---ccCCC--C---CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 000 00111 1 134678899999999999999997 899999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=321.94 Aligned_cols=252 Identities=26% Similarity=0.395 Sum_probs=201.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++.+.||+|+||.||+|++..+|..||||+++... ........+.+|+.+++.++||||+++++++.. .+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence 57999999999999999999999999999999886422 233445568899999999999999999998853 356
Q ss_pred EEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 96 IYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
.|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 899999999 589887753 345899999999999999999999999999999999999999999999999998864
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHhhcCCCChHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV-HQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~-~~l~~i~~~~g~p~~~~~ 249 (508)
..... ......+++.|+|||.+.+ ..++.++|+||+||++|+|++|+.||...... ..+.......+
T Consensus 157 ~~~~~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------- 224 (267)
T cd08228 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD------- 224 (267)
T ss_pred cchhH---HHhcCCCCccccChhhhcc--CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC-------
Confidence 32211 1234578899999999876 67889999999999999999999998654321 11110000000
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..+ ......+..+.+|+.+||..||.+||++.++++
T Consensus 225 -----------------~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 225 -----------------YPP----LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred -----------------CCC----CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 000 011235678999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=338.68 Aligned_cols=255 Identities=25% Similarity=0.426 Sum_probs=200.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 89 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~-----~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~ 89 (508)
.++|++.+.||+|+||.||+|.+. .+++.||+|+++... .......+.+|+.+++.+ +|+||+++++.+...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~- 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP- 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-
Confidence 368999999999999999999743 356889999987432 233456788999999999 799999999988533
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC------------------------------------------------------
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 114 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------------------------------------ 114 (508)
...+|+||||+. ++|.+++...
T Consensus 84 ---~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 84 ---GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ---CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 346899999998 6998888542
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcccccccccCc
Q 010512 115 -------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 187 (508)
Q Consensus 115 -------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~ 187 (508)
.++++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++....... ........++.
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-~~~~~~~~~~~ 239 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARLPL 239 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-hhhccCCCCCc
Confidence 2578999999999999999999999999999999999999999999999999986533221 11123345677
Q ss_pred ccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhccc
Q 010512 188 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRK 266 (508)
Q Consensus 188 ~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~ 266 (508)
.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.+.... ..
T Consensus 240 ~y~aPE~~~~--~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~--------------------------~~ 291 (337)
T cd05054 240 KWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL--------------------------KE 291 (337)
T ss_pred cccCcHHhcC--CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH--------------------------hc
Confidence 8999999977 689999999999999999997 999998654322211110 00
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 267 KQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
..... .....++.+.+++.+||+.+|.+||+++++++|
T Consensus 292 ~~~~~---~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 292 GTRMR---APEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred cCCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00000 012456889999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=321.97 Aligned_cols=253 Identities=30% Similarity=0.496 Sum_probs=206.0
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEecC
Q 010512 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 103 (508)
Q Consensus 25 LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~ 103 (508)
||.|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++.+. ....+|+||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ-----GKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee-----cCcEEEEEEecC
Confidence 6899999999999999999999999864322 2244567889999999999999999998874 345689999999
Q ss_pred C-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCC-----c
Q 010512 104 E-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS-----A 177 (508)
Q Consensus 104 ~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~-----~ 177 (508)
. ++|.+++...+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......... .
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 8 599999988778999999999999999999999999999999999999999999999999998864332110 1
Q ss_pred ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHH
Q 010512 178 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 257 (508)
Q Consensus 178 ~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 257 (508)
.......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------------ 215 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN------------------ 215 (265)
T ss_pred ccccCcccCccccCHHHhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------------
Confidence 11234568889999999876 5688999999999999999999999987664333322211
Q ss_pred HHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH---HHHhcCCcccCC
Q 010512 258 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA---EEALADPYFHGL 313 (508)
Q Consensus 258 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta---~eiL~hp~f~~~ 313 (508)
....+.. ....+..+.+|+.+||+.||.+|||+ .++|+||||+++
T Consensus 216 ----------~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 216 ----------GKIEWPE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred ----------CCcCCCc-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 0001111 11247889999999999999999999 999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=318.08 Aligned_cols=251 Identities=27% Similarity=0.449 Sum_probs=209.5
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
+|++.+.||.|+||.||++.+..+|+.||+|++............+.+|+.+++.++|+||+++.+++... ...|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEE
Confidence 59999999999999999999999999999999976544445566788999999999999999999988543 5689
Q ss_pred EEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 98 VVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 98 lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
+||||++ ++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 9999997 589988866 35689999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
. ......++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||...+.......+..
T Consensus 156 ~-----~~~~~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------- 215 (256)
T cd08530 156 N-----MAKTQIGTPHYMAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR------------- 215 (256)
T ss_pred C-----CcccccCCccccCHHHHCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------
Confidence 3 1233568899999999977 6788999999999999999999999987664322211110
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
.. +.......+..+.++|.+||..||.+|||+.++++||++
T Consensus 216 --------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 216 --------------GK---YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred --------------CC---CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 00 011112456889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=325.68 Aligned_cols=263 Identities=32% Similarity=0.526 Sum_probs=216.5
Q ss_pred ccccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC
Q 010512 10 FTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 89 (508)
Q Consensus 10 ~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 89 (508)
...-.....|++.+.||+|+||.||+|.+..++..||+|++..... ....+.+|+.+++.++|+||+++++.+...
T Consensus 12 ~~~~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 87 (286)
T cd06614 12 VSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG- 87 (286)
T ss_pred cCCCCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-
Confidence 3344667889999999999999999999998999999999964322 456788999999999999999999998543
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccc
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 167 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla 167 (508)
..+|+|+||++ ++|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++
T Consensus 88 ----~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~ 163 (286)
T cd06614 88 ----DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFA 163 (286)
T ss_pred ----CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchh
Confidence 56899999999 69999998876 8999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChH
Q 010512 168 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 168 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
........ ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+..
T Consensus 164 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~-------- 230 (286)
T cd06614 164 AQLTKEKS---KRNSVVGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-------- 230 (286)
T ss_pred hhhccchh---hhccccCCcccCCHhHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------
Confidence 75432211 1233457889999999876 6789999999999999999999999977654433222211
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
..... ......++..+.+||.+||+.||.+|||+.+++.|+||...
T Consensus 231 -------------------~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 231 -------------------KGIPP-LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred -------------------cCCCC-CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 00001 11123367889999999999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=313.88 Aligned_cols=251 Identities=31% Similarity=0.532 Sum_probs=208.0
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
.|++.+.||+|++|.||+|.+..++..|++|++..... .....+.+|+.+++.++|+||+++++.+... ...|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEE
Confidence 48899999999999999999998999999999975332 3567788999999999999999999998543 5689
Q ss_pred EEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 98 VVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 98 lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
+|+||++ ++|.+++... ..+++..+..++.|++.||.|||.+|++||||+|+||+++.++.++|+|||.+........
T Consensus 74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999 6999998776 5799999999999999999999999999999999999999999999999999976543221
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
.....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+....+..+..
T Consensus 154 ----~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------- 211 (253)
T cd05122 154 ----RNTMVGTPYWMAPEVING--KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---------------- 211 (253)
T ss_pred ----ccceecCCcccCHHHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----------------
Confidence 234578899999999887 5688999999999999999999999987653333222211
Q ss_pred HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCc
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~ 309 (508)
...+ .+ .....++..+.+||.+||..||.+|||+.++|+|||
T Consensus 212 ----------~~~~-~~-~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 212 ----------NGPP-GL-RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ----------cCCC-Cc-CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0000 00 001123678999999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=317.44 Aligned_cols=246 Identities=26% Similarity=0.434 Sum_probs=203.1
Q ss_pred eeeeecCceEEEEEEECCC---CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEE
Q 010512 23 EVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 99 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~t---g~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV 99 (508)
+.||+|+||.||+|.+... +..||+|.++...... ....+.+|+.+++.++|+||+++++++.. ...+|+|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEE
Confidence 4799999999999999865 8999999997543332 46778899999999999999999999854 4568999
Q ss_pred EecCC-ccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 100 FELME-SDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 100 ~E~~~-g~L~~~i~~~---------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
|||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||.+..
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccc
Confidence 99996 7999999875 7799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
...... ........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 155 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--------- 222 (262)
T cd00192 155 VYDDDY-YRKKTGGKLPIRWMAPESLKD--GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--------- 222 (262)
T ss_pred cccccc-cccccCCCcCccccCHHHhcc--CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------
Confidence 543321 112334567889999999877 578999999999999999999 6999987754443333221
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.... .....+++.+.+++.+||..||.+|||+.+++++
T Consensus 223 ------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 223 ------------------GYRL---PKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ------------------CCCC---CCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0000 1123457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=323.96 Aligned_cols=252 Identities=21% Similarity=0.376 Sum_probs=201.0
Q ss_pred CCeEEeeeeeecCceEEEEEEE----CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVD----THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~----~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
..|++.+.||+|+||+||+|.. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---- 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE---- 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC----
Confidence 5789999999999999999985 3456899999997432 233456788999999999999999999998443
Q ss_pred CccEEEEEecCC-ccHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeC
Q 010512 93 FKDIYVVFELME-SDLHQVIKAN-----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 154 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~-----------------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~ 154 (508)
...|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 80 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 80 -QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred -CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 45899999998 6999988532 2478889999999999999999999999999999999999
Q ss_pred CCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHH
Q 010512 155 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQ 233 (508)
Q Consensus 155 ~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 233 (508)
.++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.+.+....
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYR-VQPKSLLPIRWMPPEAIMY--GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEeccccccccccCCccee-cccCCCccceecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999998653322111 1233445678999999876 678999999999999999998 9999987654333
Q ss_pred HHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 234 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 234 l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
...+.. .... .....+++.+.+|+.+||+.||.+||++.+++++
T Consensus 236 ~~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVRK---------------------------RQLL---PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHc---------------------------CCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 222211 1111 1123567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=323.49 Aligned_cols=254 Identities=27% Similarity=0.425 Sum_probs=207.5
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
-|++.+.||+|+||.||+|.+..++..||||.+.... .......+.+|+.+++.++||||+++++.+. .....|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 78 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLW 78 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEE
Confidence 4778899999999999999999999999999986432 2234567889999999999999999999984 345689
Q ss_pred EEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCC
Q 010512 98 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 176 (508)
Q Consensus 98 lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~ 176 (508)
+||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06641 79 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence 9999998 588888764 468999999999999999999999999999999999999999999999999987543221
Q ss_pred cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHH
Q 010512 177 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256 (508)
Q Consensus 177 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 256 (508)
.......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...+.......+..
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----------------- 215 (277)
T cd06641 156 -IKRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK----------------- 215 (277)
T ss_pred -hhhccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc-----------------
Confidence 11234578899999999876 5778899999999999999999999976543222221110
Q ss_pred HHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 257 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
..+ ......++..+.+++.+||..||.+||++.++++||||...
T Consensus 216 ----------~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 216 ----------NNP---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ----------CCC---CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 000 11123467889999999999999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=324.47 Aligned_cols=251 Identities=23% Similarity=0.345 Sum_probs=202.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~-----~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
...|.+.+.||+|+||.||++.+ ..++..||+|.+... .......+.+|+.+|+.++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 78 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE--- 78 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---
Confidence 46799999999999999999985 335677999998643 23345678899999999999999999999843
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAND-------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 156 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~-------------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~ 156 (508)
...+|+||||+. ++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 79 --~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 79 --GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 156 (288)
T ss_pred --CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 356899999998 69999987543 48999999999999999999999999999999999999999
Q ss_pred CcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 010512 157 CKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLD 235 (508)
Q Consensus 157 ~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~ 235 (508)
+.++|+|||+++....... ........++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+....+.
T Consensus 157 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~ 233 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233 (288)
T ss_pred CcEEeccCCccccccCCce-eecCCCCCccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999985432221 111233456788999999876 678999999999999999998 999998766544333
Q ss_pred HHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 236 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 236 ~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.+.. ..... .....++.+.+|+.+||+.||.+|||+.++++
T Consensus 234 ~i~~---------------------------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 234 CITQ---------------------------GRVLQ---RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHc---------------------------CCcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3321 00001 11245688999999999999999999999966
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=322.90 Aligned_cols=253 Identities=21% Similarity=0.365 Sum_probs=200.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~-----tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--- 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc---
Confidence 3679999999999999999999977 78899999886432 22334568899999999999999999998854
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC---cE
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAND-------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KL 159 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~-------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~---~l 159 (508)
....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++.++ .+
T Consensus 81 --~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 81 --RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred --CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence 345799999997 69999997653 488999999999999999999999999999999999998765 59
Q ss_pred EEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 010512 160 KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMT 238 (508)
Q Consensus 160 kL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~ 238 (508)
||+|||+++........ ........+..|+|||++.+ ..++.++|||||||++|+|++ |..||++.+.......+.
T Consensus 159 kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~ 235 (277)
T cd05036 159 KIADFGMARDIYRASYY-RKGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235 (277)
T ss_pred EeccCccccccCCccce-ecCCCCCccHhhCCHHHHhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999999865222111 01112233567999999976 679999999999999999997 999998776544332221
Q ss_pred hhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 239 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 239 ~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.. .... ....++..+.+|+.+||+.||++|||+.++++|
T Consensus 236 ~~---------------------------~~~~---~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 236 GG---------------------------GRLD---PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred cC---------------------------CcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 10 0000 113457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=323.30 Aligned_cols=247 Identities=21% Similarity=0.353 Sum_probs=196.6
Q ss_pred CCeEEeeee--eecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCC
Q 010512 17 SRYQIQEVI--GKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 17 ~rY~i~~~L--G~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~ 93 (508)
++|++.+.+ |+|+||.||++.+..+|..||+|.+....... .|+.....+ +||||+++++.+...
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~----- 81 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTL----- 81 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecC-----
Confidence 467777766 99999999999999999999999986432111 123233222 699999999999543
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC-cEEEcccccccccc
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVSF 171 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~-~lkL~DFGla~~~~ 171 (508)
..+|+||||++ ++|.+++..+..+++..+..++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++....
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 46899999997 69999998888899999999999999999999999999999999999999998 99999999987542
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHhhcCCCChHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQ-LDLMTDLLGTPSTESIS 250 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~-l~~i~~~~g~p~~~~~~ 250 (508)
.. ....++..|+|||++.+ ..++.++|+||+||++|+|++|..||........ ...+
T Consensus 162 ~~-------~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~------------- 219 (267)
T PHA03390 162 TP-------SCYDGTLDYFSPEKIKG--HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL------------- 219 (267)
T ss_pred CC-------ccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHH-------------
Confidence 21 23468899999999987 6789999999999999999999999975432110 0000
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-HHHHhcCCcccC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-AEEALADPYFHG 312 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt-a~eiL~hp~f~~ 312 (508)
.... . . .....+..++.+.+||.+||+.||.+||+ ++++|+||||.+
T Consensus 220 ----------~~~~-~-~---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 220 ----------LKRQ-Q-K---KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred ----------HHhh-c-c---cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 0000 0 0 11122367899999999999999999996 599999999963
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=317.29 Aligned_cols=245 Identities=23% Similarity=0.390 Sum_probs=193.7
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEec
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 102 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~ 102 (508)
+.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.+|+.++||||+++++++.. ...+|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEee
Confidence 46999999999999999999999999886432 23345678899999999999999999999843 3568999999
Q ss_pred CC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcccc
Q 010512 103 ME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 180 (508)
Q Consensus 103 ~~-g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~ 180 (508)
+. ++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......... ...
T Consensus 75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~ 153 (252)
T cd05084 75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA-STG 153 (252)
T ss_pred ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccccc-ccC
Confidence 98 59999987644 6899999999999999999999999999999999999999999999999998754321110 001
Q ss_pred cccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHH
Q 010512 181 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259 (508)
Q Consensus 181 ~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 259 (508)
.....+..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...........+..
T Consensus 154 ~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-------------------- 211 (252)
T cd05084 154 GMKQIPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-------------------- 211 (252)
T ss_pred CCCCCceeecCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc--------------------
Confidence 11123456999999876 678999999999999999997 8899976543222211111
Q ss_pred HHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 260 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 260 ~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..+.. .....+..+.+|+.+||..||.+|||+.++++
T Consensus 212 -------~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 212 -------GVRLP---CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -------CCCCC---CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01111 11245788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=327.32 Aligned_cols=257 Identities=28% Similarity=0.503 Sum_probs=208.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
..|.....||+|+||.||++.+..+|..||||++... .......+.+|+.+++.++|+||+++++.+.. ..+.
T Consensus 20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~ 92 (292)
T cd06657 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDEL 92 (292)
T ss_pred HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----CCEE
Confidence 4455567899999999999999999999999998532 22345568899999999999999999999843 4568
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 97 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 97 ylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
|+||||+++ +|.+++. ...+++..+..++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 93 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 93 WVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred EEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence 999999984 7877664 45689999999999999999999999999999999999999999999999999875432221
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
......+++.|+|||.+.+ ..++.++|+||+||++|+|++|.+||.+.+....+..+...
T Consensus 172 ---~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~--------------- 231 (292)
T cd06657 172 ---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--------------- 231 (292)
T ss_pred ---cccccccCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh---------------
Confidence 1234578899999999876 67889999999999999999999999876654433322110
Q ss_pred HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.+..+ .....+++.+.+|+.+||..||.+||++.++|+||||....
T Consensus 232 ------------~~~~~-~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 232 ------------LPPKL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred ------------CCccc-CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 01111 11245678899999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=318.52 Aligned_cols=248 Identities=23% Similarity=0.376 Sum_probs=201.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++++.||+|+||.||+|.+. ++..||+|.+... ......+.+|+.+++.++|+||+++++++. ....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 75 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVT-----KEEP 75 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCC
Confidence 468999999999999999999864 5678999988642 223567889999999999999999999884 3456
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 96 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
.|+||||+. ++|.+++... ..+++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||+++....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 899999997 6999998753 4688999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||++.........+...
T Consensus 156 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~----------- 220 (261)
T cd05072 156 NEY--TAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG----------- 220 (261)
T ss_pred Cce--eccCCCccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-----------
Confidence 211 11223346678999999876 678999999999999999998 99999876644433322211
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
... .....++..+.+|+.+||..||++||+++++++
T Consensus 221 ----------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 221 ----------------YRM---PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ----------------CCC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 000 112346788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=328.80 Aligned_cols=257 Identities=27% Similarity=0.409 Sum_probs=208.8
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
....|.+.+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++|||++++++++.. .
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 97 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----E 97 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----C
Confidence 33458999999999999999999999999999999864322 23345678899999999999999999999854 3
Q ss_pred ccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
...|+||||+.|+|.+++.. ..++++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++.....
T Consensus 98 ~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 98 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 45899999999998887754 45799999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCcccccccccCcccccccccccc-cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.....|++.|+|||++... ...++.++|||||||++|+|++|.+||.+.+....+..+....
T Consensus 178 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~---------- 240 (317)
T cd06635 178 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE---------- 240 (317)
T ss_pred -------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcc----------
Confidence 1234688999999997431 2468899999999999999999999997655433333222100
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
.+. ......++.+.+||.+||+.||.+||++.++++|+|+..
T Consensus 241 ----------------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 241 ----------------SPT---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ----------------CCC---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 000 011245678999999999999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=317.23 Aligned_cols=248 Identities=25% Similarity=0.391 Sum_probs=199.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++.+.||+|+||.||+|... .+..+|+|.+.... .....+.+|+.+|+.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 73 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-----QKP 73 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEcc-----CCC
Confidence 357999999999999999999875 45689999886432 224567889999999999999999999843 456
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 96 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
+|+||||++ |+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 74 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 74 LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 899999998 6999988753 46899999999999999999999999999999999999999999999999999864322
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
... ......++..|+|||++.+ ..++.++|||||||++|+|++ |++||.+.+..+.+..+....
T Consensus 154 ~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~----------- 218 (256)
T cd05114 154 EYT--SSSGAKFPVKWSPPEVFNF--SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF----------- 218 (256)
T ss_pred cee--ccCCCCCchhhCChhhccc--CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-----------
Confidence 211 1122345567999999876 678999999999999999999 899998877554444432210
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..... ...+..+.+|+.+||..||.+||+++++++
T Consensus 219 ----------------~~~~~---~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 219 ----------------RLYRP---KLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ----------------CCCCC---CCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00000 124577999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=337.59 Aligned_cols=262 Identities=28% Similarity=0.426 Sum_probs=215.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
.+.|..-++||+|+||.||-|+.+.||+-||.|++.+.-. ........++|-+||.++..+.||.+--.| +...
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----eTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----ETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----cCCC
Confidence 3678889999999999999999999999999999864321 122234578999999999999999998888 4455
Q ss_pred cEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
.+++||..|. |||.-.|-..+ .+++..+.+++.+|+.||.+||..+|++|||||+|||+|+.|+++|+|+|+|....
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 6999999998 69988887655 79999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
...+ ....+||.+|||||++.+ ..|+...|.|||||++|+|+.|+.||.....-..
T Consensus 339 ~g~~----~~~rvGT~GYMAPEvl~n--e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk------------------ 394 (591)
T KOG0986|consen 339 EGKP----IRGRVGTVGYMAPEVLQN--EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK------------------ 394 (591)
T ss_pred CCCc----cccccCcccccCHHHHcC--CcccCCccHHHHHhHHHHHHcccCchhhhhhhhh------------------
Confidence 4443 355699999999999988 6799999999999999999999999965432111
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLAN 315 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~~~ 315 (508)
.+.+. .+....+..++ ...++++++|.+.+|++||.+|. .++++-+||||+++..
T Consensus 395 --~eEvd----rr~~~~~~ey~---~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 395 --REEVD----RRTLEDPEEYS---DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred --HHHHH----HHHhcchhhcc---cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence 11111 11112222222 35689999999999999999996 4789999999998654
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=325.73 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=197.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCc--EEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGE--RVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~--~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~ 93 (508)
++|++.+.||+|+||.||+|.+..+|. .+++|.++. .........+.+|+.++.++ +||||+++++++.. .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~ 75 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-----R 75 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc-cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-----C
Confidence 579999999999999999999877765 478888763 22334456788999999999 79999999998843 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC
Q 010512 94 KDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 156 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~ 156 (508)
..+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN 155 (297)
T ss_pred CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC
Confidence 56899999998 69999997542 48889999999999999999999999999999999999999
Q ss_pred CcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 010512 157 CKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLD 235 (508)
Q Consensus 157 ~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~ 235 (508)
+.+||+|||++........ ......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 156 ~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~ 229 (297)
T cd05089 156 LASKIADFGLSRGEEVYVK----KTMGRLPVRWMAIESLNY--SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229 (297)
T ss_pred CeEEECCcCCCccccceec----cCCCCcCccccCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999864211110 111123456999999876 678999999999999999997 999998766543332
Q ss_pred HHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 236 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 236 ~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.+.. .... .....++..+.+||.+||..||.+|||++++++.
T Consensus 230 ~~~~---------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 230 KLPQ---------------------------GYRM---EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHhc---------------------------CCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2211 0000 1113467889999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=318.60 Aligned_cols=253 Identities=24% Similarity=0.364 Sum_probs=202.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC---CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~t---g~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
.++|++.+.||+|+||+||+|.+..+ ...||||+++... .......+.+|+.+++.++||||+++++.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 76 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK----- 76 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-----
Confidence 46799999999999999999988654 4589999986533 23345678899999999999999999998843
Q ss_pred CccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
...+|+||||+. ++|.+++... +.+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||+++..
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 356899999998 5999998764 46899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
...... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+....
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~~Pe~~~~--~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-------- 225 (266)
T cd05033 157 EDSEAT-YTTKGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY-------- 225 (266)
T ss_pred cccccc-eeccCCCCCccccChhhhcc--CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC--------
Confidence 421111 11112344678999999876 678999999999999999997 999997655433332221110
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
..+. ....++.+.+|+.+||+.||.+||++++++++
T Consensus 226 -------------------~~~~---~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 226 -------------------RLPP---PMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred -------------------CCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0011 12467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=328.25 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=198.2
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcE--EEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGER--VAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~--vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~ 91 (508)
.-++|++.+.||+|+||.||+|.+..+|.. +|+|.++.. ........+.+|+.++.++ +||||+++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~----- 78 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACE----- 78 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC-----
Confidence 346799999999999999999998877764 577776532 2233456788999999999 8999999999984
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeC
Q 010512 92 EFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 154 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~ 154 (508)
..+.+|+||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~ 158 (303)
T cd05088 79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 158 (303)
T ss_pred CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec
Confidence 3456899999998 69999987542 478999999999999999999999999999999999999
Q ss_pred CCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHH
Q 010512 155 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQ 233 (508)
Q Consensus 155 ~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 233 (508)
.++.+||+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+.
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 232 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 232 (303)
T ss_pred CCCcEEeCccccCcccchhhh----cccCCCcccccCHHHHhc--cCCcccccchhhhhHHHHHHhcCCCCcccCChHHH
Confidence 999999999999864211110 111234567999999876 578999999999999999998 9999977654332
Q ss_pred HHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 234 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 234 l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
...+.. .... ......++.+.+||.+||+.||.+||+++++|.+
T Consensus 233 ~~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 233 YEKLPQ---------------------------GYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHHHhc---------------------------CCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 222110 0000 0112357889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=319.64 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=202.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCc---EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~---~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
..+|++.+.||+|+||.||+|.+..++. .||+|.++.... ......+.+|+.+++.++||||+++++++. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 76 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----K 76 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----c
Confidence 4689999999999999999999865544 799999865322 334567889999999999999999999984 3
Q ss_pred CccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
...+|+||||++ ++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++...
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 356899999998 5899998765 46899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
..............++..|+|||.+.+ ..++.++|+|||||++|++++ |..||.+.+..+....+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-------- 226 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-------- 226 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhcc--CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC--------
Confidence 432221111122233568999999976 678999999999999999886 999997765444333332111
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..+ ....+++.+.+|+.+||+.+|.+||++.++++
T Consensus 227 -------------------~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 227 -------------------RLP---APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -------------------cCC---CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 001 11345788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=324.33 Aligned_cols=253 Identities=27% Similarity=0.444 Sum_probs=201.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC-----CcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHT-----GERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 89 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~t-----g~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~ 89 (508)
.++|++.+.||+|+||.||+|.+... ...||+|.+.... .......+.+|+.+++.+ +|+||+++++++..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 87 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-- 87 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--
Confidence 36899999999999999999987643 3789999987532 233456788999999999 79999999999843
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCcee
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL 152 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNIL 152 (508)
.+.+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 88 ---~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 88 ---EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred ---CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 356899999998 6999998642 35889999999999999999999999999999999999
Q ss_pred eCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChH
Q 010512 153 ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVV 231 (508)
Q Consensus 153 l~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~ 231 (508)
++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||++.+..
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYY-RKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred EcCCCeEEeCccccccccccccce-eccCCCCCCccccCHHHhcc--CCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 999999999999999865332211 11122334567999999876 678999999999999999997 99999877654
Q ss_pred HHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 232 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 232 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
+....+.. .... .....++..+.+|+.+||..||.+|||+.+++++
T Consensus 242 ~~~~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 242 ELFKLLKE---------------------------GYRM---EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHc---------------------------CCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 43322211 0000 1112457889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=361.17 Aligned_cols=256 Identities=28% Similarity=0.382 Sum_probs=201.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++.+.||+|+||.||+|.+..+|+.||||++...... .....++.+|+.+++.++||||+++++++. +.+.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence 6899999999999999999999999999999999754332 334567899999999999999999999984 3456
Q ss_pred EEEEEecCC-ccHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcc
Q 010512 96 IYVVFELME-SDLHQVIKAN-----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 163 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~-----------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~D 163 (508)
.|+||||++ ++|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.++.++|+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 899999998 5999888641 2355667888999999999999999999999999999999999999999
Q ss_pred ccccccccCCCC---------------CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCC
Q 010512 164 FGLARVSFNDAP---------------SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK 228 (508)
Q Consensus 164 FGla~~~~~~~~---------------~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~ 228 (508)
||+++....... ........+||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--CCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 999986521110 0001123579999999999987 68899999999999999999999999765
Q ss_pred ChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 229 NVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 229 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
........ ... ..+... ..+..+++.+.+++.+||..||++|++..+.+.+
T Consensus 235 ~~~ki~~~--~~i-------------------------~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 235 KGRKISYR--DVI-------------------------LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred chhhhhhh--hhc-------------------------cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 43211110 000 000000 1124577889999999999999999887766654
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=323.77 Aligned_cols=259 Identities=22% Similarity=0.314 Sum_probs=203.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCC----------------cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTG----------------ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg----------------~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv 79 (508)
.++|++++.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+.+|+.++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 468999999999999999999876544 568999987432 234566788999999999999999
Q ss_pred eeeeeecCCCcCCCccEEEEEecCC-ccHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCC
Q 010512 80 EIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND-----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 147 (508)
Q Consensus 80 ~l~~v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~-----------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLK 147 (508)
++++++.. ....++|||++. ++|.+++.... .+++..+..++.|++.||.|||++||+|||||
T Consensus 83 ~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 83 RLLGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred EEEEEEec-----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 99999843 356899999998 69999987765 68999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh--CCCCC
Q 010512 148 PKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT--GKPLF 225 (508)
Q Consensus 148 PeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt--G~~pF 225 (508)
|+||+++.++.++|+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYY-RVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcce-eecCcCCCCceecCHHHhhc--CCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence 99999999999999999999764322211 11233456788999999876 678999999999999999998 67888
Q ss_pred CCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHh
Q 010512 226 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 305 (508)
Q Consensus 226 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL 305 (508)
...+....+..+...+. ...........+.++..+.+|+.+||+.||.+|||+.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~ 291 (296)
T cd05051 235 EHLTDQQVIENAGHFFR-----------------------DDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIH 291 (296)
T ss_pred CCcChHHHHHHHHhccc-----------------------cccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHH
Confidence 76554443333221110 0000011111234678899999999999999999999997
Q ss_pred c
Q 010512 306 A 306 (508)
Q Consensus 306 ~ 306 (508)
+
T Consensus 292 ~ 292 (296)
T cd05051 292 L 292 (296)
T ss_pred H
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=317.86 Aligned_cols=253 Identities=25% Similarity=0.399 Sum_probs=201.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCc---EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~---~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
.++|+..+.||+|+||.||+|.+..++. .+|+|++.... .......+.+|+.+++.++||||+++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 77 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK----- 77 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc-----
Confidence 4578999999999999999999876665 79999986432 23345678899999999999999999999843
Q ss_pred CccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
....|+||||++ ++|.+++... +.+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 356899999998 5899888764 57899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
...............+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~-------- 227 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-------- 227 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhc--CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC--------
Confidence 332221111111223457999999876 678999999999999999997 999997766544433332211
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..+. ....+..+.+|+.+||+.||.+||++.++++
T Consensus 228 -------------------~~~~---~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 228 -------------------RLPA---PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -------------------CCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1111 1245678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=319.42 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=201.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC-----CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHT-----GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~t-----g~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
.++|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+|+.++||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--- 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVST--- 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC---
Confidence 46899999999999999999988644 4889999986432 23345668899999999999999999999854
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcE
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAND----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 159 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~----------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~l 159 (508)
....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+
T Consensus 81 --~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 81 --GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred --CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence 356899999997 79999986532 36788999999999999999999999999999999999999999
Q ss_pred EEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 010512 160 KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMT 238 (508)
Q Consensus 160 kL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~ 238 (508)
||+|||+++........ .......+|..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+.......+.
T Consensus 159 kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 159 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred EECCcccchhhccCccc-ccCCCCCccccccCHHHHhc--CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 99999999865332211 11233456788999999876 678999999999999999998 999998766443332221
Q ss_pred hhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 239 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 239 ~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
. ..... .....+..+.+|+.+||+.||.+|||+.++++
T Consensus 236 ~---------------------------~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 236 D---------------------------GGHLD---LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred c---------------------------CCCCC---CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 00011 11234788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=316.26 Aligned_cols=248 Identities=26% Similarity=0.406 Sum_probs=200.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++.+.||+|+||.||+|.+. ++..||+|.++... .....+.+|+.+++.++||||+++++++. ..+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 75 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEP 75 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCC
Confidence 367999999999999999999875 45789999986432 23456889999999999999999999884 3356
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 96 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
.|+||||+. ++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 899999995 79999997654 689999999999999999999999999999999999999999999999999987542
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
..... ......+..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+...
T Consensus 156 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~----------- 220 (261)
T cd05068 156 DIYEA--REGAKFPIKWTAPEAALY--NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG----------- 220 (261)
T ss_pred Ccccc--cCCCcCceeccCcccccc--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------
Confidence 21111 111223457999999876 678999999999999999999 99999877654443333211
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
...+ .....+..+.+|+.+||..||.+||++.++++
T Consensus 221 ----------------~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 221 ----------------YRMP---CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ----------------CCCC---CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 0001 11345688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=316.50 Aligned_cols=245 Identities=22% Similarity=0.327 Sum_probs=196.1
Q ss_pred eeeeecCceEEEEEEECCCC---cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEE
Q 010512 23 EVIGKGSYGVVGSAVDTHTG---ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 99 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg---~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV 99 (508)
+.||+|+||.||+|....++ ..||+|.+...... .....+.+|+++++.+.||||+++++++.. ...++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEE
Confidence 47999999999999876544 78999998754332 455678899999999999999999998732 347999
Q ss_pred EecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcc
Q 010512 100 FELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 178 (508)
Q Consensus 100 ~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~ 178 (508)
|||+. ++|.+++.....+++..+..++.|++.||.|||..||+|+||||+|||++.++.+||+|||+++..........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99998 69999998888899999999999999999999999999999999999999999999999999986533222111
Q ss_pred cccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHH
Q 010512 179 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 257 (508)
Q Consensus 179 ~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 257 (508)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~----------------- 214 (257)
T cd05060 154 ATTAGRWPLKWYAPECINY--GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG----------------- 214 (257)
T ss_pred cccCccccccccCHHHhcC--CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-----------------
Confidence 1111123457999999876 678999999999999999997 99999776543333222110
Q ss_pred HHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 258 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 258 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.+. .....+++.+.+||.+||..||.+||++.++++
T Consensus 215 ----------~~~---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 215 ----------ERL---PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ----------CcC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 000 112346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=319.52 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=201.0
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCc----EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGE----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~----~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
...+|++++.||+|+||+||+|.+..+|. .||+|+++.. ........+.+|+.+++.+.||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-- 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC--
Confidence 35689999999999999999999877776 4899998643 2233456788999999999999999999988542
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
..+++|+|++ |+|.+++..+ +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 82 ----~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 82 ----TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred ----CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCcee
Confidence 3689999998 7999998764 469999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChH
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
........ .......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||...........+..
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-------- 226 (279)
T cd05109 158 LLDIDETE-YHADGGKVPIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-------- 226 (279)
T ss_pred ecccccce-eecCCCccchhhCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC--------
Confidence 65322211 11122345678999999876 678999999999999999998 8999976543222211111
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.... ......++.+.+++.+||..||.+||++.+++.
T Consensus 227 -------------------~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 227 -------------------GERL---PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred -------------------CCcC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0001 112346788999999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=340.21 Aligned_cols=283 Identities=31% Similarity=0.511 Sum_probs=227.5
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCC------CCcceeeeeecCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH------PDIVEIKHIMLPP 88 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~H------pnIv~l~~v~~~~ 88 (508)
..++|.|....|+|-||+|..|.|..-|..||||+|.+. ..-.+.=++|+.||+.|+. -++++++..|.
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~-- 504 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK-- 504 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh--
Confidence 358999999999999999999999999999999999642 2234455789999999963 46888877773
Q ss_pred CcCCCccEEEEEecCCccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC-CcEEEccc
Q 010512 89 SRREFKDIYVVFELMESDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDF 164 (508)
Q Consensus 89 ~~~~~~~lylV~E~~~g~L~~~i~~~~---~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~-~~lkL~DF 164 (508)
..+++|||||.+.-+|.+++++-+ .|....++.|..||+-||..|-..||+|.||||+|||||+. ..+|||||
T Consensus 505 ---hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 505 ---HKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred ---hcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccC
Confidence 446799999999999999998754 58899999999999999999999999999999999999986 56899999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC
Q 010512 165 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244 (508)
Q Consensus 165 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p 244 (508)
|.|...... ..++|..++.|+|||++.| -.|+...|+||+||+||||.||+..|||...-+++.+.+++-|..
T Consensus 582 GSA~~~~en-----eitPYLVSRFYRaPEIiLG--~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~ 654 (752)
T KOG0670|consen 582 GSASFASEN-----EITPYLVSRFYRAPEIILG--LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF 654 (752)
T ss_pred ccccccccc-----cccHHHHHHhccCcceeec--CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence 999865332 2578899999999999999 699999999999999999999999999999999999999999998
Q ss_pred ChHHHHHHhh--HHHHHHHh----------------hcccCCC-CCCCC------CCCC----CCHHHHHHHHHhccCCC
Q 010512 245 STESISRIRN--EKARRYLG----------------SMRKKQP-VPFSH------KFPN----ADPLALHLLERLLAFDP 295 (508)
Q Consensus 245 ~~~~~~~~~~--~~~~~~l~----------------~~~~~~~-~~~~~------~~~~----~~~~~~~Ll~~mL~~DP 295 (508)
+...+.+-.- .-+..-+. -|..-.| ..+.. .++. +-..+.+||.+||..||
T Consensus 655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP 734 (752)
T KOG0670|consen 655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP 734 (752)
T ss_pred cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence 8877654221 10000000 0001111 11111 1111 12346799999999999
Q ss_pred CCCCCHHHHhcCCcccC
Q 010512 296 KDRPTAEEALADPYFHG 312 (508)
Q Consensus 296 ~~Rpta~eiL~hp~f~~ 312 (508)
.+|.|+.++|+||||++
T Consensus 735 ~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 735 EKRITVNQALKHPFITE 751 (752)
T ss_pred hhcCCHHHHhcCCcccC
Confidence 99999999999999974
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=316.20 Aligned_cols=251 Identities=27% Similarity=0.461 Sum_probs=202.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++.+.||+|+||.||+|.+..+|..||+|.++.. .........+.+|+++++.++|+||+++++.+.. .+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence 5899999999999999999999999999999998642 2223345678899999999999999999999854 356
Q ss_pred EEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 96 IYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
.|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 899999998 599988864 245899999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChH--HHHHHHHhhcCCCChHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV--HQLDLMTDLLGTPSTES 248 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~--~~l~~i~~~~g~p~~~~ 248 (508)
..... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...... .....+..
T Consensus 157 ~~~~~---~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 222 (267)
T cd08224 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK--------- 222 (267)
T ss_pred cCCCc---ccceecCCccccCHHHhcc--CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc---------
Confidence 32221 1234568899999999876 67899999999999999999999999654311 11100000
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
....+.+ ....+..+.++|.+||..+|.+|||+.++++
T Consensus 223 ----------------~~~~~~~----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 223 ----------------CDYPPLP----ADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ----------------CCCCCCC----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0001111 1245678999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=323.13 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=200.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCC-----CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHT-----GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~t-----g~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
.+|++.+.||+|+||.||+|.+..+ +..||||+++.... ......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--- 80 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE--- 80 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC---
Confidence 4688999999999999999987543 57899999974322 23345688999999999999999999998543
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeC
Q 010512 92 EFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 154 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~ 154 (508)
..+++++||+. ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus 81 --~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 81 --QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF 158 (283)
T ss_pred --CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence 45899999998 6898888532 3478889999999999999999999999999999999999
Q ss_pred CCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHH
Q 010512 155 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQ 233 (508)
Q Consensus 155 ~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 233 (508)
.++.+||+|||+++....... ........+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+....+.
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADY-YKLMGNSLLPIRWMSPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred CCCceEecccccccccccchh-eeeccCccCCccccCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999886432221 111233456789999999876 678999999999999999998 8899987665444
Q ss_pred HHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 234 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 234 l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
+..+... ... .....++..+.+|+.+||+.||.+||++.+++.
T Consensus 236 ~~~i~~~---------------------------~~~---~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 236 IEMIRNR---------------------------QVL---PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHHHHcC---------------------------CcC---CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 4333221 000 111356788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=316.67 Aligned_cols=249 Identities=22% Similarity=0.347 Sum_probs=199.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
..+|++.+.||+|+||.||+|.+. ++..+|+|++..... ....+.+|+.+++.++||||+++++++. ....
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 73 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRP 73 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCc
Confidence 356899999999999999999875 567899999864322 2345778999999999999999999884 3356
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 96 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
.|+||||++ ++|.+++..+ ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 74 IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred eEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 899999997 5899998764 46899999999999999999999999999999999999999999999999999865322
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+.......+...
T Consensus 154 ~~~--~~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~------------ 217 (256)
T cd05059 154 QYT--SSQGTKFPVKWAPPEVFDY--SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG------------ 217 (256)
T ss_pred ccc--ccCCCCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC------------
Confidence 111 1112233457999999886 678999999999999999998 89999876544333222110
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
... .....++..+.+|+.+||..+|.+|||+.++++.
T Consensus 218 ---------------~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 218 ---------------YRL---YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ---------------CcC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 000 1113467889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=324.29 Aligned_cols=260 Identities=26% Similarity=0.396 Sum_probs=209.7
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
-....+|...+.||+|+||.||+|++..++..||+|++.... .......++.+|+.+++.++|+|++++.+++...
T Consensus 11 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 87 (308)
T cd06634 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--- 87 (308)
T ss_pred CCcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC---
Confidence 345667999999999999999999999999999999986432 2233456788999999999999999999998543
Q ss_pred CCccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 92 EFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 92 ~~~~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
...|+||||+.|+|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...
T Consensus 88 --~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 88 --HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred --CeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceee
Confidence 46899999999988887754 456899999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCcccccccccCcccccccccccc-cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
.. .....+++.|+|||.+.+. ...++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 166 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---------- 228 (308)
T cd06634 166 AP-------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---------- 228 (308)
T ss_pred cC-------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh----------
Confidence 22 1235688999999997531 14578899999999999999999999876543322221110
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
...+ .......+..+.+||.+||.++|.+||+++++++|||+...
T Consensus 229 ----------------~~~~---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 229 ----------------NESP---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ----------------cCCC---CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 0000 00112466789999999999999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=338.52 Aligned_cols=253 Identities=25% Similarity=0.392 Sum_probs=198.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPS 89 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~-----tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~ 89 (508)
.++|++++.||+|+||.||+|.+.. ++..||||+++.. ........+.+|+.+|+.+. ||||+++++++.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~--- 111 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGACT--- 111 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc---
Confidence 4688999999999999999998743 3457999999643 22334567899999999996 999999999984
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC------------------------------------------------------
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 114 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------------------------------------ 114 (508)
....+|||||||. |+|.+++..+
T Consensus 112 --~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 112 --KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred --cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 3456999999998 6998887642
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCcee
Q 010512 115 ------------------------------------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL 152 (508)
Q Consensus 115 ------------------------------------------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNIL 152 (508)
..+++..+..++.||+.||.|||+.||+||||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 23778888999999999999999999999999999999
Q ss_pred eCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChH
Q 010512 153 ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVV 231 (508)
Q Consensus 153 l~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~ 231 (508)
++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||++....
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFD--NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 999999999999999865332211 11223456788999999977 678999999999999999997 99999765432
Q ss_pred HHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 232 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 232 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..+.... ....... ....++..+.+|+.+||..||++|||+.++.+
T Consensus 347 ~~~~~~~--------------------------~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 347 STFYNKI--------------------------KSGYRMA---KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHH--------------------------hcCCCCC---CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 2111100 0000000 11346788999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=315.88 Aligned_cols=248 Identities=27% Similarity=0.394 Sum_probs=199.2
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++.+.||+|+||.||+|.+..+ ..||+|+++.... ....+.+|+.+++.++||||+++++.+.. .
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~ 73 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------E 73 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC------C
Confidence 457899999999999999999988655 4699999874322 23567899999999999999999987632 3
Q ss_pred cEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
..|+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++...
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~ 153 (262)
T cd05071 74 PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 153 (262)
T ss_pred CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecc
Confidence 4799999998 6999999763 358899999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
..... ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+......+..+...
T Consensus 154 ~~~~~--~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~---------- 219 (262)
T cd05071 154 DNEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---------- 219 (262)
T ss_pred ccccc--cccCCcccceecCHhHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC----------
Confidence 22211 1123346678999999876 678999999999999999999 88999876644333322110
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.+.+ ....++..+.+|+.+||+.||.+||++.++++
T Consensus 220 -----------------~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 220 -----------------YRMP---CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred -----------------CCCC---CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0001 11346788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=318.81 Aligned_cols=253 Identities=25% Similarity=0.401 Sum_probs=202.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++.+.||+|+||.||+|.+..+|..||||++.... ........+.+|+.+++.++||||+++++.+.. ...
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCe
Confidence 57999999999999999999999999999999886432 233345678899999999999999999998853 356
Q ss_pred EEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 96 IYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
+|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 899999998 589888863 346899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
..... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+...... ...
T Consensus 157 ~~~~~---~~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~------------- 217 (267)
T cd08229 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLC------------- 217 (267)
T ss_pred ccCCc---ccccccCCcCccCHHHhcC--CCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HHh-------------
Confidence 32221 1234578899999999976 6788999999999999999999999976542110 000
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
......... .......++.+.+||.+||..||.+|||+.++++
T Consensus 218 -----------~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 218 -----------KKIEQCDYP--PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred -----------hhhhcCCCC--CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 000000000 0111246788999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=318.22 Aligned_cols=248 Identities=26% Similarity=0.418 Sum_probs=203.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
..+|++.+.||.|+||.||+|.+.. +..+|+|++... .......+.+|+.+|+.++||||+++++++.. ...
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 76 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSV-----GEP 76 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEec-----CCC
Confidence 3569999999999999999999887 899999998643 22345678899999999999999999998843 356
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 96 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
.|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 899999998 5999999763 4689999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+....
T Consensus 157 ~~~~---~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~---------- 221 (261)
T cd05148 157 DVYL---SSDKKIPYKWTAPEAASH--GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY---------- 221 (261)
T ss_pred cccc---ccCCCCceEecCHHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC----------
Confidence 2111 123345678999999876 678999999999999999998 899998876544443332110
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..+ .....++.+.+++.+||+.||.+|||+.++++
T Consensus 222 ---------------~~~-----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 222 ---------------RMP-----CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ---------------cCC-----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 001 11356788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=343.38 Aligned_cols=254 Identities=24% Similarity=0.309 Sum_probs=207.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.+...+...||+|+||+||+|+.-. .||||+++.........+.|.+|+.+|++-+|.||+-+.+++..+.
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~------ 461 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP------ 461 (678)
T ss_pred HHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc------
Confidence 3667889999999999999997643 4999999877777778889999999999999999999999996554
Q ss_pred EEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 96 IYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 96 lylV~E~~~g-~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
+.||+.+|+| +|+.+|+-. ..|.......|+.||++|+.|||.++|||||||..||++.++++|||+|||++.....-
T Consensus 462 ~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 462 LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 4999999997 899888653 46889999999999999999999999999999999999999999999999999864322
Q ss_pred CCCcccccccccCcccccccccccc-cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHH-HhhcCCCChHHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLM-TDLLGTPSTESISR 251 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i-~~~~g~p~~~~~~~ 251 (508)
. .........|...|||||++... ..+|+..+|||||||++|||++|..||.. +..+|+-.+ -...+
T Consensus 542 ~-g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIifmVGrG~l--------- 610 (678)
T KOG0193|consen 542 S-GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQIIFMVGRGYL--------- 610 (678)
T ss_pred c-cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheEEEeccccc---------
Confidence 1 11123345677889999999642 24699999999999999999999999994 444443222 11111
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.........+++.++++|+..||.+++++||.+.+||.
T Consensus 611 -----------------~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 611 -----------------MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred -----------------CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 12233344567779999999999999999999999987
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=321.05 Aligned_cols=251 Identities=23% Similarity=0.331 Sum_probs=201.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~-----~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
..+|.+.+.||+|+||.||+|.+. .++..+++|.+... .......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 78 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGD--- 78 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc---
Confidence 356999999999999999999853 34567999988532 23344668899999999999999999999843
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceee
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA 153 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl 153 (508)
....++||||++ ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 79 --~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~ 156 (291)
T cd05094 79 --GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV 156 (291)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE
Confidence 346899999998 69999997543 37899999999999999999999999999999999999
Q ss_pred CCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHH
Q 010512 154 NADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVH 232 (508)
Q Consensus 154 ~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~ 232 (508)
+.++.++|+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+...
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 233 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 233 (291)
T ss_pred ccCCcEEECCCCcccccCCCce-eecCCCCCcceeecChHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999975433221 111234567789999999887 678999999999999999998 999997766543
Q ss_pred HHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 233 QLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 233 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.+..+.. ... .......+..+.+|+.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~---------------------------~~~---~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 234 VIECITQ---------------------------GRV---LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHHhC---------------------------CCC---CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 3322211 000 0112345778999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=315.02 Aligned_cols=249 Identities=21% Similarity=0.332 Sum_probs=199.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++.+.||+|+||+||+|.... +..||+|.+..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 73 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTK-----QRP 73 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEcc-----CCC
Confidence 4679999999999999999997653 45699999864322 23568899999999999999999999843 345
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 96 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||+++.....
T Consensus 74 ~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 74 IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred cEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 899999998 6899998764 46899999999999999999999999999999999999999999999999998765332
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+.......+...
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~------------ 217 (256)
T cd05113 154 EYT--SSVGSKFPVRWSPPEVLLY--SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG------------ 217 (256)
T ss_pred cee--ecCCCccChhhCCHHHHhc--CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC------------
Confidence 211 1112345678999999976 678999999999999999998 99999776644333322211
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.... .....+..+.+++.+||..||.+|||+.+++.+
T Consensus 218 ---------------~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 218 ---------------LRLY---RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ---------------CCCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0000 112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=312.78 Aligned_cols=258 Identities=23% Similarity=0.398 Sum_probs=210.4
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCCCccE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~l 96 (508)
+.+++..||+|+.|+|++++.+.+|...|||.+.+. .+..+.++++..+.++.... +|+||+.+++|.... ++
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-----dV 166 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-----DV 166 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-----hH
Confidence 345678899999999999999999999999999764 45567889999998876654 999999999997643 58
Q ss_pred EEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHh-cCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 97 YVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 97 ylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs-~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|.||.|..-+..+++. .++++|..+-++...++.||.||.. +||+|||+||+|||+|+.|++||||||.+.......
T Consensus 167 ~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 167 FICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 99999998666666554 4679999999999999999999975 599999999999999999999999999998765444
Q ss_pred CCcccccccccCcccccccccccc-cCCCCcchhhhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhhcCCCChHHHHHH
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV-VHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~-~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
.. +...|-+.|||||.+.-. ...|+..+||||||+.++||.||+.||++.+. .+.+-.|.+
T Consensus 247 Ah----trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln------------- 309 (391)
T KOG0983|consen 247 AH----TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN------------- 309 (391)
T ss_pred cc----ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-------------
Confidence 32 445788999999998653 36799999999999999999999999998652 333333321
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
..|..+. .-.+.++.+.+|+..||++|+.+||...++|+|||+...
T Consensus 310 --------------~ePP~L~-~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 310 --------------EEPPLLP-GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred --------------cCCCCCC-cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 1111111 112378999999999999999999999999999998754
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=317.77 Aligned_cols=268 Identities=23% Similarity=0.406 Sum_probs=201.0
Q ss_pred CCCeEEeeeeeecCceEEEEEE----ECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~----~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
..+|++++.||+|+||.||+|. +..++..||||++... .......+.+|+++|+.++||||+++++++....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 78 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG-- 78 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC--
Confidence 4589999999999999999997 4567899999998643 2344567889999999999999999999875432
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
...+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 79 -~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 79 -RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred -CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 245899999997 6999998764 4689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCh--H
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST--E 247 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~--~ 247 (508)
...............++..|+|||++.+ ..++.++|||||||++|+|++|..++..... .... ..+.... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~----~~~~~~~~~~ 230 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMR----MMGNDKQGQM 230 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhcc--CCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhh----hccccccccc
Confidence 5332211111112234456999999876 6789999999999999999999877643321 1111 1111100 0
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
... .....+...... .....++..+.+|+.+||..||.+|||+.++++
T Consensus 231 ~~~--------~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 231 IVY--------HLIELLKNNGRL---PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred chH--------HHHHHHhcCCcC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 000 001111111111 122456788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=315.59 Aligned_cols=253 Identities=25% Similarity=0.403 Sum_probs=201.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCc---EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~---~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
.++|++.+.||+|+||.||+|.+..+|. .||||++.... .......+.+|+.+++.++||||+++++++. .
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~ 76 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----K 76 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEEC-----C
Confidence 4579999999999999999999887665 69999986532 3345667899999999999999999999984 3
Q ss_pred CccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
...+|+||||++ ++|.+++... +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++...
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 456899999998 5899888764 56899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCccccccc--ccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChH
Q 010512 171 FNDAPSAIFWTDY--VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 171 ~~~~~~~~~~~~~--~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
............. ..+..|+|||.+.+ ..++.++||||+||++|||++ |..||.+.+..+....+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~------- 227 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD------- 227 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhcc--CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-------
Confidence 3322111111111 12457999999876 688999999999999999886 99999776644333322111
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
...+. ...++..+.+++.+||..||.+||++++++.
T Consensus 228 --------------------~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 228 --------------------YRLPP---PMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred --------------------CcCCC---cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01111 1345788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=314.91 Aligned_cols=248 Identities=26% Similarity=0.389 Sum_probs=199.8
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++.+.||+|+||.||+|.+. .+..||+|++..... ....+.+|+.+++.++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~ 73 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVSE------E 73 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEECC------C
Confidence 3468999999999999999999865 567799999865322 23568899999999999999999988732 3
Q ss_pred cEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
..|+||||+. ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 74 PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIE 153 (260)
T ss_pred CcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeecc
Confidence 4799999998 6999998763 358999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
..... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+....
T Consensus 154 ~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~--------- 220 (260)
T cd05070 154 DNEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY--------- 220 (260)
T ss_pred Ccccc--cccCCCCCccccChHHHhc--CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------
Confidence 22211 1122345668999999876 678999999999999999999 899998776544443332110
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
+.+ .....+..+.+|+.+||..||.+|||+.++++
T Consensus 221 ------------------~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 221 ------------------RMP---CPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred ------------------CCC---CCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 001 12346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=320.92 Aligned_cols=261 Identities=24% Similarity=0.387 Sum_probs=205.3
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~ 93 (508)
..+.|++.+.||+|+||.||+|.+..+|..||||.++.... ......+.+|+.++..+. ||||+++++++.. .
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~ 86 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-----D 86 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeec-----C
Confidence 34779999999999999999999998999999999975322 233456777887776665 9999999999843 4
Q ss_pred ccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHh-cCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 94 KDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 94 ~~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs-~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
..+|+||||+++.|.+++.. ...+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++....
T Consensus 87 ~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 87 SDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred CeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 56999999999888887765 4579999999999999999999997 599999999999999999999999999987543
Q ss_pred CCCCCcccccccccCccccccccccccc--CCCCcchhhhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhhcCCCChHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV-VHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~--~~y~~~~DIWSlG~il~eLltG~~pF~~~~~-~~~l~~i~~~~g~p~~~~ 248 (508)
.... .....++..|+|||.+.+.. ..++.++|||||||++|+|++|+.||..... .+.+..+.
T Consensus 167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---------- 232 (296)
T cd06618 167 DSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL---------- 232 (296)
T ss_pred CCCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHh----------
Confidence 2221 12345788999999987521 3478899999999999999999999965322 11111110
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.. ..+ .+ .....++..+.+|+.+||..||.+||++++++.||||...
T Consensus 233 -------------~~---~~~-~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 233 -------------QE---EPP-SL-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred -------------cC---CCC-CC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 00 000 00 0112467889999999999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=315.92 Aligned_cols=252 Identities=29% Similarity=0.492 Sum_probs=201.9
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC---ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE---HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~---~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
||.+.+.||+|+||.||+|.+..++..+++|.++.... .......+.+|+.+++.++||||+++++.+.. ..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-----RD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-----CC
Confidence 69999999999999999999988888787777654221 22344567789999999999999999998854 34
Q ss_pred cEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
..|+||||+. ++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++. +.++|+|||++..
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence 5899999998 588887753 356999999999999999999999999999999999999975 5799999999976
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
...... ......|++.|+|||.+.+ ..++.++|+||+|+++++|++|..||.+.+.......+.. +
T Consensus 155 ~~~~~~---~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~--~------- 220 (260)
T cd08222 155 LMGSCD---LATTFTGTPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE--G------- 220 (260)
T ss_pred cCCCcc---cccCCCCCcCccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--C-------
Confidence 533221 1234568889999999876 6788899999999999999999999976554332222110 0
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
. .......++..+.+||.+||..||.+||++.++++||||
T Consensus 221 ------------------~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 221 ------------------P---TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ------------------C---CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0 001123467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=323.46 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=199.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECC-------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTH-------TGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLP 87 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~-------tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~ 87 (508)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.++... .......+.+|+.+++.+ +||||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3789999999999999999998643 33579999987432 234456788999999999 79999999999843
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCc
Q 010512 88 PSRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 150 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeN 150 (508)
...+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++|++||||||+|
T Consensus 96 -----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 96 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred -----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 356899999998 69999997642 47889999999999999999999999999999999
Q ss_pred eeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCC
Q 010512 151 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 229 (508)
Q Consensus 151 ILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~ 229 (508)
||++.++.++|+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchh-hccccCCCccceeChHHhcc--CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 99999999999999998754321111 11112234568999999876 678999999999999999998 889997765
Q ss_pred hHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 230 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 230 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
..+....+.. .... .....++..+.+|+.+||..+|.+|||+.+++++
T Consensus 248 ~~~~~~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 248 VEELFKLLKE---------------------------GHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHHc---------------------------CCCC---CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 4332222211 0000 1123467889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=321.17 Aligned_cols=259 Identities=23% Similarity=0.366 Sum_probs=199.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCC--------------cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCccee
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTG--------------ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 81 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg--------------~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l 81 (508)
.++|++.+.||+|+||.||+|.+..++ ..||+|+++... .......+.+|+++|+.++||||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 368999999999999999999875432 359999987532 23344568899999999999999999
Q ss_pred eeeecCCCcCCCccEEEEEecCC-ccHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCC
Q 010512 82 KHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKP 148 (508)
Q Consensus 82 ~~v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~------------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKP 148 (508)
++++.. ....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++|++||||||
T Consensus 83 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp 157 (295)
T cd05097 83 LGVCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLAT 157 (295)
T ss_pred EEEEcC-----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccCh
Confidence 999843 356899999998 59999886532 367888999999999999999999999999999
Q ss_pred CceeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh--CCCCCC
Q 010512 149 KNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT--GKPLFP 226 (508)
Q Consensus 149 eNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt--G~~pF~ 226 (508)
+||+++.++.+||+|||++........ ........++..|+|||++.+ ..++.++|||||||++|+|++ |..||.
T Consensus 158 ~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l~el~~~~~~~p~~ 234 (295)
T cd05097 158 RNCLVGNHYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFTLCKEQPYS 234 (295)
T ss_pred hhEEEcCCCcEEecccccccccccCcc-eeccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence 999999999999999999976432211 111223345678999999876 678999999999999999988 667887
Q ss_pred CCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 227 GKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 227 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..+....+..+...+ ..... ..+....+..++.+.+|+.+||..||.+|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~--------------------~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 235 LLSDEQVIENTGEFF--------------------RNQGR---QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ccChHHHHHHHHHhh--------------------hhccc---cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 766544333222111 00000 0011112345788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=313.10 Aligned_cols=249 Identities=26% Similarity=0.418 Sum_probs=201.7
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++.+.||+|+||.||+|.+. .+..||||.+.... .....+.+|+.+++.++|+||+++++++.. ..
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 74 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-----EE 74 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeec-----CC
Confidence 3578999999999999999999875 45789999986432 234668899999999999999999998843 34
Q ss_pred cEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
..|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceecc
Confidence 5899999998 59999997653 68999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
..... ......++..|+|||.+.+ ..++.++||||+||++|+|++ |+.||.+.+....+..+......
T Consensus 155 ~~~~~--~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------- 223 (261)
T cd05034 155 DDEYT--AREGAKFPIKWTAPEAANY--GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM------- 223 (261)
T ss_pred chhhh--hhhccCCCccccCHHHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 21111 1112234568999999986 678999999999999999998 99999887655544443221100
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
+ .....+..+.+++.+||..||.+||+++++++
T Consensus 224 ------------------~-----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 224 ------------------P-----RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ------------------C-----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0 11234678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=317.00 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=198.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCc----EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGE----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~----~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
..+|++.+.||+|+||+||+|....+|. .|++|++... ........+..|+.+++.+.||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---- 80 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---- 80 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC----
Confidence 3679999999999999999999877776 4777777432 222334567889999999999999999998732
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
...++|+||+. |+|.+++... +.+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++.
T Consensus 81 --~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 81 --ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred --CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 24689999998 7999999764 5689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
...... ....+...++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.........+..
T Consensus 159 ~~~~~~-~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--------- 226 (279)
T cd05111 159 LYPDDK-KYFYSEHKTPIKWMALESILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK--------- 226 (279)
T ss_pred ccCCCc-ccccCCCCCcccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC---------
Confidence 533221 112234457778999999876 679999999999999999998 9999987654332222211
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
....+. ...++..+.+++.+||..||.+|||+.|+++
T Consensus 227 ------------------~~~~~~---~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 227 ------------------GERLAQ---PQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ------------------CCcCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 000111 1124567899999999999999999999977
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=311.06 Aligned_cols=243 Identities=25% Similarity=0.429 Sum_probs=200.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++.+.||.|+||.||+|.. .|+.||+|+++.... ..+++.+|+.+++.++|+||+++++++.. ...
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 74 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNP 74 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCC
Confidence 56899999999999999999976 488999999975322 46778999999999999999999999854 355
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 96 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
.|+||||++ ++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc
Confidence 899999998 69999998765 699999999999999999999999999999999999999999999999999986522
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.. .....+..|+|||.+.. ..++.++|||||||++++|++ |..||...+..+....+..
T Consensus 155 ~~------~~~~~~~~~~ape~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~------------ 214 (256)
T cd05039 155 GQ------DSGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK------------ 214 (256)
T ss_pred cc------ccCCCcccccCchhhcC--CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc------------
Confidence 11 12234567999999876 678899999999999999997 9999976654332221110
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.... ......++.+.+||.+||..+|.+|||+.++++
T Consensus 215 ---------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 215 ---------------GYRM---EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ---------------CCCC---CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0000 111345788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=317.67 Aligned_cols=251 Identities=23% Similarity=0.350 Sum_probs=200.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~-----~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
..+|++.+.||+|+||.||+|.. ..++..||+|.+... .......+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 78 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTE--- 78 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec---
Confidence 46789999999999999999964 335678999988643 23445678899999999999999999998854
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeC
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAND---------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 154 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~---------------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~ 154 (508)
....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++
T Consensus 79 --~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 79 --GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG 156 (280)
T ss_pred --CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc
Confidence 345899999998 69999987643 478899999999999999999999999999999999999
Q ss_pred CCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHH
Q 010512 155 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQ 233 (508)
Q Consensus 155 ~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 233 (508)
.++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||......+.
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 233 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY--RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA 233 (280)
T ss_pred CCCCEEECCCCceeEcCCCcee-ecCCCccccccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH
Confidence 9999999999999754322211 11223345688999999877 678999999999999999998 9999976654443
Q ss_pred HHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 234 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 234 l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
+..+.. ..+. .....+++.+.+||.+||+.||.+||++.++++
T Consensus 234 ~~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 234 IECITQ---------------------------GREL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHc---------------------------CccC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 322211 0000 111346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=320.59 Aligned_cols=254 Identities=25% Similarity=0.409 Sum_probs=201.7
Q ss_pred CCCCeEEeeeeeecCceEEEEEEEC-------CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeec
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDT-------HTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIML 86 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~-------~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~ 86 (508)
...+|.+.+.||+|+||.||+|.+. ..+..||+|++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 3578999999999999999999753 234579999986432 234456788999999999 7999999999984
Q ss_pred CCCcCCCccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCC
Q 010512 87 PPSRREFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPK 149 (508)
Q Consensus 87 ~~~~~~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPe 149 (508)
. ...+|+||||+. ++|.+++... ..++...+..++.||+.||.|||++||+||||||+
T Consensus 92 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 92 Q-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred c-----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 3 356899999998 6999998764 24677889999999999999999999999999999
Q ss_pred ceeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCC
Q 010512 150 NILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGK 228 (508)
Q Consensus 150 NILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~ 228 (508)
|||++.++.+||+|||+++........ .......+++.|+|||++.+ ..|+.++|||||||++|+|++ |..||.+.
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred eEEEcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999865332211 11223345678999999876 678999999999999999998 78999876
Q ss_pred ChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 229 NVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 229 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
+..+....+.. .... .....++..+.+||.+||..+|.+|||+.++++.
T Consensus 244 ~~~~~~~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 244 PVEELFKLLKE---------------------------GHRM---DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CHHHHHHHHHc---------------------------CCcC---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 65443332211 0000 1123567889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=321.79 Aligned_cols=252 Identities=26% Similarity=0.422 Sum_probs=199.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECC-------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTH-------TGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLP 87 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~-------tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~ 87 (508)
.++|.+.+.||+|+||.||+|.+.. .+..||+|.++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3689999999999999999998632 345799999874322 34456788999999999 59999999999843
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCc
Q 010512 88 PSRREFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 150 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeN 150 (508)
...+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 90 -----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 90 -----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred -----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 356899999998 6999999753 248889999999999999999999999999999999
Q ss_pred eeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCC
Q 010512 151 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 229 (508)
Q Consensus 151 ILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~ 229 (508)
||++.++.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred EEEcCCCcEEEcccccccccccccccc-ccccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999998643221111 1112234467999999876 678999999999999999999 899998766
Q ss_pred hHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 230 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 230 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.......+.. .... .....++..+.+|+.+||..||.+|||+.++++
T Consensus 242 ~~~~~~~~~~---------------------------~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 242 VEELFKLLRE---------------------------GHRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHHc---------------------------CCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 5443332211 0000 112356778999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=317.45 Aligned_cols=267 Identities=25% Similarity=0.352 Sum_probs=198.8
Q ss_pred CCe-EEeeeeeecCceEEEEEE----ECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 17 SRY-QIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 17 ~rY-~i~~~LG~G~~g~V~~a~----~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
+|| ++++.||+|+||+||++. ...++..||+|.++... .......+.+|+.+|+.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 78 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ--- 78 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence 466 999999999999998764 34578899999986432 223456678999999999999999999987542
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
....+|+||||+. ++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++..
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 2346899999998 6898888764 5999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh-hcCCCChHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTD-LLGTPSTESI 249 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~-~~g~p~~~~~ 249 (508)
..............++..|+|||.+.+ ..++.++|||||||++|+|++|..||...... +..+.. ..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~--- 230 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKE--NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTV--- 230 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcc--cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccch---
Confidence 432221111122345677999999876 67899999999999999999999998543211 111100 0000000
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
......+ ......+ ....++..+.+|+.+||..||++|||++++++
T Consensus 231 -----~~~~~~~---~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 231 -----VRLIELL---ERGMRLP---CPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred -----hhhhhhh---hcCCCCC---CCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000010 0011111 12346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=311.45 Aligned_cols=243 Identities=23% Similarity=0.405 Sum_probs=197.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
..+|++.+.||+|+||.||+|.. .|..||+|.+... .....+.+|+.+++.++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 74 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGG 74 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEc----CCCc
Confidence 35799999999999999999965 4788999998632 234568899999999999999999997643 2346
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 96 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 899999998 69999987654 488999999999999999999999999999999999999999999999999875422
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.. ....++..|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+....+..
T Consensus 155 ~~------~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~------------ 214 (256)
T cd05082 155 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------ 214 (256)
T ss_pred cC------CCCccceeecCHHHHcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc------------
Confidence 11 12234567999999876 678999999999999999997 9999986654332222211
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..+. ...+.+++.+.+|+.+||..||.+|||+.++++
T Consensus 215 ---------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 215 ---------------GYKM---DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ---------------CCCC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0000 112456789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=311.67 Aligned_cols=247 Identities=26% Similarity=0.382 Sum_probs=200.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++++.||+|+||.||+|.+. ++..||+|.+..... ....+.+|+.+++.++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 74 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EP 74 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEcc------CC
Confidence 468999999999999999999864 678899999874332 34578899999999999999999988632 34
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 96 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
.|+||||+. ++|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 799999997 6999988753 3689999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |++||.+.+..+....+.....
T Consensus 155 ~~~~--~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------- 221 (260)
T cd05067 155 NEYT--AREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR--------- 221 (260)
T ss_pred CCcc--cccCCcccccccCHHHhcc--CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC---------
Confidence 2111 1123345678999999876 678899999999999999998 9999987765444333321110
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
. ......+..+.+|+.+||..||++|||++++++
T Consensus 222 ------------------~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 222 ------------------M---PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred ------------------C---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 111345678999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=316.31 Aligned_cols=248 Identities=27% Similarity=0.426 Sum_probs=195.4
Q ss_pred EEeeeeeecCceEEEEEEEC----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 20 QIQEVIGKGSYGVVGSAVDT----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 20 ~i~~~LG~G~~g~V~~a~~~----~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++.+.||.|+||.||+|... ..+..|+||.++. .........+.+|+++++.++||||+++++++.. .+.
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-----~~~ 75 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-----NEP 75 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-----SSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccc-----ccc
Confidence 57899999999999999887 4567899999964 3344457889999999999999999999999963 234
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 96 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
+++|||||. |+|.+++... ..+++.....|+.||+.||.|||+++|+|+||++.|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 899999998 7999999987 6799999999999999999999999999999999999999999999999999987522
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.... ...........|+|||.+.+ ..++.++||||||+++|||++ |+.||.+.+..+....+.+..
T Consensus 156 ~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~---------- 222 (259)
T PF07714_consen 156 KSKY-KNDSSQQLPLRYLAPEVLKD--GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ---------- 222 (259)
T ss_dssp SSSE-EESTTSESGGGGS-HHHHHH--SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE----------
T ss_pred cccc-cccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccc----------
Confidence 2111 11223456678999999977 568999999999999999999 789998776544443332211
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.. .....++..+.++|.+||..||.+|||+.++++
T Consensus 223 -----------------~~---~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 223 -----------------RL---PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp -----------------ET---TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred -----------------cc---eeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 00 011346788999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=309.89 Aligned_cols=245 Identities=30% Similarity=0.479 Sum_probs=203.0
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEecC
Q 010512 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 103 (508)
Q Consensus 25 LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~ 103 (508)
||.|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++.+. ....+|+||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ-----TEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee-----cCCeeEEEEecC
Confidence 6999999999999998999999999875422 2234567889999999999999999998883 446799999999
Q ss_pred C-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcccccc
Q 010512 104 E-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 182 (508)
Q Consensus 104 ~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~ 182 (508)
. ++|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~ 152 (250)
T cd05123 76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---SRTNT 152 (250)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC---CcccC
Confidence 5 7999999988889999999999999999999999999999999999999999999999999998653322 11244
Q ss_pred cccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHh
Q 010512 183 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLG 262 (508)
Q Consensus 183 ~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~ 262 (508)
..++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 153 ~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~----------------------- 207 (250)
T cd05123 153 FCGTPEYLAPEVLLG--KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK----------------------- 207 (250)
T ss_pred CcCCccccChHHhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-----------------------
Confidence 578889999999876 5678899999999999999999999976654222221111
Q ss_pred hcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH---HHHhcCCcc
Q 010512 263 SMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA---EEALADPYF 310 (508)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta---~eiL~hp~f 310 (508)
.. .. .....+..+.+||.+||..||.+||++ +++++||||
T Consensus 208 ---~~--~~---~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 208 ---DP--LR---FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ---CC--CC---CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 00 01 112236889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=311.32 Aligned_cols=246 Identities=23% Similarity=0.360 Sum_probs=197.9
Q ss_pred eeeeecCceEEEEEEECC-CC--cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEE
Q 010512 23 EVIGKGSYGVVGSAVDTH-TG--ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 99 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~-tg--~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV 99 (508)
+.||+|+||+||+|.+.. ++ ..||||.+...... .....+.+|+.+++.++||||+++++++.. ..+|+|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEE
Confidence 468999999999998865 33 36999999754433 456788999999999999999999999853 568999
Q ss_pred EecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCC
Q 010512 100 FELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 176 (508)
Q Consensus 100 ~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~ 176 (508)
|||++ ++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99997 69999998764 6899999999999999999999999999999999999999999999999999875432221
Q ss_pred cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 177 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 177 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~--------------- 216 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRT--RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE--------------- 216 (257)
T ss_pred eecccCCCCCceecCHHHhcc--cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc---------------
Confidence 111123456788999999876 678999999999999999998 99999876654443332210
Q ss_pred HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
....+ .....+..+.+|+.+||..+|.+|||+.++++
T Consensus 217 ---------~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 217 ---------GERLE-----RPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ---------CCcCC-----CCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 00000 11235678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=328.48 Aligned_cols=255 Identities=25% Similarity=0.412 Sum_probs=198.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 89 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~-----~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~ 89 (508)
.++|++.+.||+|+||+||+|.+ ..+++.||||+++... .......+.+|+.+|..+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence 36899999999999999999984 3567899999996432 223456788999999999 689999999987532
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC------------------------------------------------------
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 114 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------------------------------------ 114 (508)
...+|+|||||+ |+|.+++...
T Consensus 84 ---~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 84 ---GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ---CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 346899999998 6999988643
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCccccc
Q 010512 115 -------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 181 (508)
Q Consensus 115 -------------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~ 181 (508)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~ 239 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKG 239 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch-hhcC
Confidence 13677888899999999999999999999999999999999999999999999864322211 1122
Q ss_pred ccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHH
Q 010512 182 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 260 (508)
Q Consensus 182 ~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~ 260 (508)
...++..|+|||++.+ ..++.++|||||||++|+|++ |..||++......+....
T Consensus 240 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---------------------- 295 (343)
T cd05103 240 DARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL---------------------- 295 (343)
T ss_pred CCCCCcceECcHHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHH----------------------
Confidence 3345678999999876 678999999999999999996 999997654221111100
Q ss_pred HhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 261 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 261 l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
........ ....++.+.+++.+||+.||.+|||+.++++|
T Consensus 296 ----~~~~~~~~---~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 296 ----KEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ----hccCCCCC---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00000000 11256789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=317.44 Aligned_cols=250 Identities=23% Similarity=0.388 Sum_probs=197.4
Q ss_pred CeEEeeeeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~-----tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.++||||+++++.+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ----- 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----
Confidence 58899999999999999998753 23578888886432 23345678899999999999999999998843
Q ss_pred CccEEEEEecCC-ccHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCC
Q 010512 93 FKDIYVVFELME-SDLHQVIKAN------------------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 147 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~------------------------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLK 147 (508)
....|+||||+. ++|.+++... ..+++..+..++.|++.||.|||++||+|||||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik 154 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA 154 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence 345899999998 6999887642 247888999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCC
Q 010512 148 PKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFP 226 (508)
Q Consensus 148 PeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~ 226 (508)
|+|||++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++++|++ |..||+
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHcc--CCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999999864332211 11122345678999999876 678999999999999999998 999998
Q ss_pred CCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 227 GKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 227 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
+.........+.... ..+ ....++..+.+|+.+||+.||.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~-------------------------~~~-----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 232 GIAPERLFNLLKTGY-------------------------RME-----RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCCHHHHHHHHhCCC-------------------------CCC-----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 766433322221100 000 11346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=311.17 Aligned_cols=244 Identities=22% Similarity=0.338 Sum_probs=192.5
Q ss_pred eeeecCceEEEEEEEC--CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEe
Q 010512 24 VIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 101 (508)
Q Consensus 24 ~LG~G~~g~V~~a~~~--~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 101 (508)
.||+|+||.||+|... .++..||+|++.... .......+.+|+.+|+.++||||+++++++.. ...|+|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVME 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEE
Confidence 3899999999999765 456679999986432 23345668899999999999999999998732 35799999
Q ss_pred cCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCccc
Q 010512 102 LME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179 (508)
Q Consensus 102 ~~~-g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~ 179 (508)
|++ ++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++............
T Consensus 75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 998 699998875 457899999999999999999999999999999999999999999999999999754332221111
Q ss_pred ccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHH
Q 010512 180 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 258 (508)
Q Consensus 180 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 258 (508)
.+...++..|+|||.+.. ..++.++|||||||++|+|++ |.+||.+....+....+..
T Consensus 155 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------------- 213 (257)
T cd05115 155 RSAGKWPLKWYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ------------------- 213 (257)
T ss_pred cCCCCCCcccCCHHHHcc--CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-------------------
Confidence 122233578999999876 678999999999999999996 9999987654433322211
Q ss_pred HHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 259 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 259 ~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..... ..+.+++++.+||.+||..||++||++.++++
T Consensus 214 --------~~~~~---~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 214 --------GKRLD---CPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred --------CCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01111 11346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=309.94 Aligned_cols=247 Identities=27% Similarity=0.387 Sum_probs=198.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++.+.||+|+||.||+|.+..+ ..||+|++.... .....+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 74 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE------EP 74 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC------CC
Confidence 47899999999999999999987654 469999876432 223567889999999999999999988732 34
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 96 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
.|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||+++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 799999998 59999997643 478999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.........+...
T Consensus 155 ~~~~--~~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~----------- 219 (260)
T cd05069 155 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG----------- 219 (260)
T ss_pred Cccc--ccCCCccchhhCCHHHhcc--CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----------
Confidence 2211 1123346678999999876 678999999999999999999 89999876654443332211
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
...+ .....+..+.+|+.+||..||.+||+++++++
T Consensus 220 ----------------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 220 ----------------YRMP---CPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ----------------CCCC---CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0001 11345788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=319.27 Aligned_cols=252 Identities=26% Similarity=0.406 Sum_probs=199.9
Q ss_pred CCeEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~-----~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~ 90 (508)
++|++.+.||+|+||.||+|.+ ..++..||+|+++... .......+.+|+.+++++ +||||+++++.+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--- 110 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTI--- 110 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec---
Confidence 5899999999999999999975 3356689999987532 233456788999999999 79999999999843
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccc
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 167 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla 167 (508)
.+.+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++
T Consensus 111 --~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 111 --GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred --CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 346899999998 69999997643 3899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCCh
Q 010512 168 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPST 246 (508)
Q Consensus 168 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~ 246 (508)
+........ .......++..|+|||.+.+ ..++.++||||+||++|+|++ |.+||.+......+.....
T Consensus 189 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~------- 258 (302)
T cd05055 189 RDIMNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK------- 258 (302)
T ss_pred ccccCCCce-eecCCCCcccccCCHhhhcc--CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH-------
Confidence 854332211 11122356788999999876 678999999999999999998 9999987653322211100
Q ss_pred HHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 247 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..... ......++.+.+|+.+||..||.+|||+.++++
T Consensus 259 -------------------~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 259 -------------------EGYRM---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred -------------------cCCcC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00000 011245788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=316.31 Aligned_cols=269 Identities=24% Similarity=0.371 Sum_probs=202.3
Q ss_pred CCeEEeeeeeecCceEEEEEEE----CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVD----THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~----~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
.-|++++.||+|+||.||+|.. ..++..||+|.++... .......+.+|+.+|+.++||||+++.+++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~ 79 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTED---G 79 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---C
Confidence 4578999999999999999974 4678999999986432 233456788999999999999999999988543 2
Q ss_pred CccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
...+|+||||++ ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||+++..
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 356899999997 69999987653 5899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
..............++..|+|||++.+ ..++.++|||||||++|+|+++..|+.... . ...+..+....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~ellt~~~~~~~~~--~---~~~~~~~~~~~~~~- 231 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQ--SKFYIASDVWSFGVTLYELLTYCDSESSPM--T---LFLKMIGPTHGQMT- 231 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhcc--CCCCccccchhhhhhhhhhhcCCCCCcccc--c---hhhhhccccccccc-
Confidence 432221112234567778999999876 678999999999999999999876653211 1 11111221111100
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
....... +...... .....++..+.+|+.+||+.||.+|||+.++++
T Consensus 232 ---~~~~~~~---~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 232 ---VTRLVRV---LEEGKRL---PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred ---HHHHHHH---HHcCccC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0001111 1111111 123457889999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=340.81 Aligned_cols=243 Identities=31% Similarity=0.488 Sum_probs=201.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~ 94 (508)
...|++...+|.|+|++|..|.+..++..+++|++.+.. ....+|+.++... +||||+++.+++ .+..
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~ 389 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVY-----EDGK 389 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeeccee-----cCCc
Confidence 456888888999999999999999999999999997541 2234577665555 699999999999 5667
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceee-CCCCcEEEccccccccccC
Q 010512 95 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA-NADCKLKICDFGLARVSFN 172 (508)
Q Consensus 95 ~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl-~~~~~lkL~DFGla~~~~~ 172 (508)
++|+|||++.| .|.+.+.....+. .++..|++||+.|+.|||++||+||||||+|||+ ++.++++|+|||.++....
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred eeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 89999999995 7777777766555 8888999999999999999999999999999999 6899999999999986533
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
. +...+-|..|.|||++.. ..|+.++||||||++||+||+|+.||........+ ..-++.
T Consensus 469 ~------~~tp~~t~~y~APEvl~~--~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei---~~~i~~--------- 528 (612)
T KOG0603|consen 469 S------CDTPALTLQYVAPEVLAI--QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEI---HTRIQM--------- 528 (612)
T ss_pred h------hcccchhhcccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHH---HHhhcC---------
Confidence 2 334577899999999986 79999999999999999999999999765433111 111111
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
..++ ..++..+++||.+||++||.+|+++.+++.||||
T Consensus 529 -----------------~~~s---~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 529 -----------------PKFS---ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -----------------Cccc---cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 1111 4678999999999999999999999999999999
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=323.08 Aligned_cols=252 Identities=26% Similarity=0.421 Sum_probs=199.5
Q ss_pred CCeEEeeeeeecCceEEEEEEECC-------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTH-------TGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPP 88 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~-------tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~ 88 (508)
.+|++++.||+|+||.||+|.+.. .+..||+|.++.. ........+.+|+.+++.+ +||||+++++++..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence 479999999999999999998643 2347999988643 2234456788999999999 79999999999843
Q ss_pred CcCCCccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCce
Q 010512 89 SRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI 151 (508)
Q Consensus 89 ~~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNI 151 (508)
...+|+||||+. |+|.+++.... .++...+..++.||+.||.|||++||+||||||+||
T Consensus 90 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 90 ----DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 356899999998 69999987532 377888899999999999999999999999999999
Q ss_pred eeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCh
Q 010512 152 LANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNV 230 (508)
Q Consensus 152 Ll~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~ 230 (508)
|++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEcCCCcEEECCcccceeccccccc-ccccCCCcCceEcCHHHhcc--CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999864322111 11122334567999999977 678999999999999999998 8899987765
Q ss_pred HHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 231 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 231 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.+....+.. .... .....++..+.+|+.+||..+|.+|||+.+++++
T Consensus 243 ~~~~~~~~~---------------------------~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 243 EELFKLLKE---------------------------GHRM---DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHc---------------------------CCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 443332211 0000 1123456789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=313.66 Aligned_cols=254 Identities=21% Similarity=0.355 Sum_probs=203.0
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECC----CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTH----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~----tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
..++|++.+.||+|+||.||+|.+.. ++..||+|++... ........+.+|+.+|+.++||||+++++++...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-- 80 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-- 80 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence 45789999999999999999999876 3688999988642 3345567788999999999999999999987543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEE
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAN--------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 161 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~--------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL 161 (508)
....+++++|+. ++|.+++... ..+++..+..++.||+.||.|||+++++||||||+||+++.++.+||
T Consensus 81 --~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 81 --GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred --CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEE
Confidence 245799999998 7999988653 35899999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhh
Q 010512 162 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDL 240 (508)
Q Consensus 162 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~ 240 (508)
+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|++++ |++||...+.......+..
T Consensus 159 ~d~g~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~- 234 (280)
T cd05043 159 TDNALSRDLFPMDYHC-LGDNENRPVKWMALESLVN--KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD- 234 (280)
T ss_pred CCCCCcccccCCceEE-eCCCCCcchhccCHHHHhc--CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc-
Confidence 9999998653322111 1122345678999999876 678999999999999999998 9999987654332221111
Q ss_pred cCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 241 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 241 ~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..... ....+++.+.+++.+||..||++|||+.++++
T Consensus 235 --------------------------~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 235 --------------------------GYRLA---QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred --------------------------CCCCC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00000 11245788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=317.65 Aligned_cols=263 Identities=24% Similarity=0.394 Sum_probs=205.5
Q ss_pred CeEEeeeeeecCceEEEEEEEC---CCCcEEEEEEecCccC--ChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcC
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFE--HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~---~tg~~vAIKki~~~~~--~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~ 91 (508)
.|++.+.||+|+||.||+|.+. .++..||||.+++... .......+.+|+.++..+ .||||+++.+.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~---- 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT---- 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec----
Confidence 4899999999999999999864 4678999999864321 122345678999999999 59999999988843
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
...+|+||||+. ++|.+++.....+++..++.++.|+++||.|||+.|++||||||.||+++.++.++|+|||+++..
T Consensus 77 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 77 -DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred -CCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 356899999998 599999988778999999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
...... ......|+..|+|||.+.+....++.++|+||||+++|+|++|..||...........+.
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~------------ 221 (288)
T cd05583 156 LAEEEE--RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS------------ 221 (288)
T ss_pred cccccc--ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHH------------
Confidence 332211 112346889999999987632347889999999999999999999996543211111110
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC---HHHHhcCCcccCCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT---AEEALADPYFHGLA 314 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt---a~eiL~hp~f~~~~ 314 (508)
...... ..+ ....+++.+.+||.+||+.||++||| +.++|+||||+.+.
T Consensus 222 -------~~~~~~---~~~-----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 222 -------RRILKS---KPP-----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred -------HHHHcc---CCC-----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 011100 011 11235688999999999999999998 57789999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=307.55 Aligned_cols=248 Identities=29% Similarity=0.470 Sum_probs=201.3
Q ss_pred eEEeeeeeecCceEEEEEEECCCC----cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 19 YQIQEVIGKGSYGVVGSAVDTHTG----ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~~tg----~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
+++.+.||.|+||.||+|.+..++ ..||+|+++... .......+..|+.+|+.+.|+||+++++++... +
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 74 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----E 74 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----C
Confidence 467889999999999999998766 899999996432 222567788999999999999999999998543 5
Q ss_pred cEEEEEecCC-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~--l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
..|+||||+. ++|.+++..... +++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 6899999998 599999976554 9999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
...... .....++..|+|||.+.+ ..++.++||||+||++|+|++ |.+||.+.+.......+...
T Consensus 155 ~~~~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~---------- 220 (258)
T smart00219 155 DDDYYK--KKGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG---------- 220 (258)
T ss_pred cccccc--cccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC----------
Confidence 332111 112236788999999865 678999999999999999998 88999876544433322210
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
... ......+..+.+++.+||..||.+|||+.++++
T Consensus 221 -----------------~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 221 -----------------YRL---PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred -----------------CCC---CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 000 111236788999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=316.76 Aligned_cols=266 Identities=16% Similarity=0.188 Sum_probs=194.5
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCC---CcEEEEEEecCccCChhHH---------HHHHHHHHHHHhCCCCCcceee
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDA---------TRILREIKLLRLLRHPDIVEIK 82 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~t---g~~vAIKki~~~~~~~~~~---------~~i~~Ei~iL~~L~HpnIv~l~ 82 (508)
..++|++.+.||+|+||+||+|.+..+ +..+|+|+........... .....++..+..+.|+||+.++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 447999999999999999999998777 6677777643221111000 1122344556677899999999
Q ss_pred eeecCCCcCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEc
Q 010512 83 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 162 (508)
Q Consensus 83 ~v~~~~~~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~ 162 (508)
+...... ......|++++++..++.+.+......++..++.++.||+.||.|||+.+|+||||||+|||++.++.++|+
T Consensus 90 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 90 GCGSFKR-CRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred EeeeEec-CCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence 8764322 112245789999888888877766667889999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCc----ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 010512 163 DFGLARVSFNDAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMT 238 (508)
Q Consensus 163 DFGla~~~~~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~ 238 (508)
|||+|+......... .......||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+....+....
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 999998653221110 11123479999999999987 689999999999999999999999998764322211110
Q ss_pred hhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 239 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 239 ~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
. ..++..+.... ...+..++.+.+++..|+..+|.+||+.+++++
T Consensus 247 ~------------------~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 247 K------------------CDFIKRLHEGK-----IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred H------------------HHHHHHhhhhh-----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0 00111111110 012455788999999999999999999999875
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=368.04 Aligned_cols=263 Identities=30% Similarity=0.418 Sum_probs=214.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
-|+.-...||.|.||.||.|.+..||+..|+|-|+--.........+.+|.++|..|+|||+|+++++=... ..+
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR-----ekv 1309 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR-----EKV 1309 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH-----HHH
Confidence 356667789999999999999999999999999864322334455678999999999999999999987543 348
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC-
Q 010512 97 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA- 174 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~- 174 (508)
||.||||+ |+|.+++...+-..+...+.+..|++.|++|||++||+||||||.||+++.+|-+|+.|||.|....+..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 99999998 7999999887778888889999999999999999999999999999999999999999999998765543
Q ss_pred CCcccccccccCccccccccccccc-CCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~-~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
.-......++||+.|||||++.+.. .....++||||||||+.||+||+.||...+..-++ |
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI--M---------------- 1451 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI--M---------------- 1451 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH--H----------------
Confidence 1223356789999999999997742 34567999999999999999999999765432222 1
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
|--.+..+++.| .+++++..|||++||..||++|.++.|+|.|-|-+.-
T Consensus 1452 ------y~V~~gh~Pq~P-----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1452 ------YHVAAGHKPQIP-----ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred ------hHHhccCCCCCc-----hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 111222333322 2378899999999999999999999999999996643
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=314.88 Aligned_cols=252 Identities=22% Similarity=0.321 Sum_probs=199.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~-----~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
.++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.+.||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~--- 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAV--- 79 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC---
Confidence 467999999999999999999874 367899999986432 22334668899999999999999999998843
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCC
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAND----------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 147 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~----------------------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLK 147 (508)
...+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++|++|||||
T Consensus 80 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~ 157 (288)
T cd05050 80 --GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157 (288)
T ss_pred --CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 346899999998 69999986432 36788899999999999999999999999999
Q ss_pred CCceeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCC
Q 010512 148 PKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFP 226 (508)
Q Consensus 148 PeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~ 226 (508)
|+||+++.++.++|+|||+++......... .......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYK-ASENDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred HhheEecCCCceEECccccceecccCcccc-ccCCCccChhhcCHHHHhc--CCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999987543222111 1122344667999999876 679999999999999999997 888887
Q ss_pred CCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 227 GKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 227 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
+.+..+....+.. .... ......+..+.+||.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~---------------------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 235 GMAHEEVIYYVRD---------------------------GNVL---SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCCHHHHHHHHhc---------------------------CCCC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6654333222211 0000 111245788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=310.21 Aligned_cols=250 Identities=25% Similarity=0.413 Sum_probs=200.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC---CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~t---g~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
..+|.+.+.||.|+||.||+|.+..+ ...||||.+.... .......+.+|+.+++.+.||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----- 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE----- 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----
Confidence 35699999999999999999987544 3569999886432 23445678899999999999999999998743
Q ss_pred CccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
...|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||+++..
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 79 -NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeec
Confidence 23689999998 69999997744 5899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
...... ..+...++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.+..+.+..+..
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~---------- 223 (270)
T cd05056 158 EDESYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN---------- 223 (270)
T ss_pred ccccce--ecCCCCccccccChhhhcc--CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc----------
Confidence 332111 1122334568999999876 678999999999999999986 9999987765443332211
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.... ...+.++..+.+|+.+||..+|.+|||+.+++.
T Consensus 224 -----------------~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 224 -----------------GERL---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred -----------------CCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0011 112456789999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=324.03 Aligned_cols=286 Identities=30% Similarity=0.491 Sum_probs=218.1
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-----C---CCcceeeeeecCC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-----H---PDIVEIKHIMLPP 88 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-----H---pnIv~l~~v~~~~ 88 (508)
+||.+++.||-|.|++||+|.|..+.+.||+|+++.. ....+..+.||++|++++ | ..||+|++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 8999999999999999999999999999999999742 233456789999999985 2 3599999999765
Q ss_pred CcCCCccEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhc-CceecCCCCCceeeCCC---------
Q 010512 89 SRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANAD--------- 156 (508)
Q Consensus 89 ~~~~~~~lylV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~-gIiHrDLKPeNILl~~~--------- 156 (508)
. ....++++|+|+++.+|..+|... ..++...++.|++|||.||.|||.. ||||.||||+|||+..+
T Consensus 155 G-pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 155 G-PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred C-CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhh
Confidence 4 567899999999999999999875 3699999999999999999999975 99999999999996421
Q ss_pred --C-----------------------------------------------------------------------------
Q 010512 157 --C----------------------------------------------------------------------------- 157 (508)
Q Consensus 157 --~----------------------------------------------------------------------------- 157 (508)
+
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence 0
Q ss_pred ------------------------------------------------------------------------------cE
Q 010512 158 ------------------------------------------------------------------------------KL 159 (508)
Q Consensus 158 ------------------------------------------------------------------------------~l 159 (508)
++
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 00
Q ss_pred EEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCC------ChHHH
Q 010512 160 KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK------NVVHQ 233 (508)
Q Consensus 160 kL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~------~~~~~ 233 (508)
||+|||-|+-. ...+|.-+.|+.|+|||++.+ ..|++.+||||++|++|||+||..+|.-. .+.+.
T Consensus 394 KIaDlGNACW~------~khFT~DIQTRQYRapEVllG--sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 394 KIADLGNACWV------HKHFTEDIQTRQYRAPEVLLG--SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred EEeeccchhhh------hhhhchhhhhhhccCcceeec--CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 11111111100 001233467899999999998 89999999999999999999999988532 25778
Q ss_pred HHHHHhhcCCCChHHHHHHhhHHHHHHHhh------cccCCCCCCCC------CCC-CCCHHHHHHHHHhccCCCCCCCC
Q 010512 234 LDLMTDLLGTPSTESISRIRNEKARRYLGS------MRKKQPVPFSH------KFP-NADPLALHLLERLLAFDPKDRPT 300 (508)
Q Consensus 234 l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~------~~~~~~~~~~~------~~~-~~~~~~~~Ll~~mL~~DP~~Rpt 300 (508)
+++|..++|..+......-+. -+.|+.. +.+-++.++.. .|+ ....++.+||.-||+++|.+|||
T Consensus 466 iA~i~ELLG~iPr~ia~~Gk~--SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~t 543 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIALGGKY--SRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPT 543 (590)
T ss_pred HHHHHHHHhhccHHHHhcCcc--hHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccccc
Confidence 999999999888776544322 2333332 22222222221 111 12345779999999999999999
Q ss_pred HHHHhcCCcccCCCCC
Q 010512 301 AEEALADPYFHGLANV 316 (508)
Q Consensus 301 a~eiL~hp~f~~~~~~ 316 (508)
|.++|+|||+..+..+
T Consensus 544 A~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 544 AAQCLKHPWLNPVAGP 559 (590)
T ss_pred HHHHhcCccccCCCCC
Confidence 9999999999977654
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=315.92 Aligned_cols=259 Identities=22% Similarity=0.372 Sum_probs=197.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECC----------------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTH----------------TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~----------------tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv 79 (508)
.++|++.+.||+|+||.||+|.+.. ++..||+|++... ........+.+|+.+|+.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3579999999999999999986432 3457999998643 2233456788999999999999999
Q ss_pred eeeeeecCCCcCCCccEEEEEecCC-ccHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCC
Q 010512 80 EIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND-----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 147 (508)
Q Consensus 80 ~l~~v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~-----------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLK 147 (508)
++++++... ...|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+.||+|||||
T Consensus 83 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk 157 (296)
T cd05095 83 RLLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA 157 (296)
T ss_pred eEEEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 999998543 45899999998 69999987643 36677899999999999999999999999999
Q ss_pred CCceeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh--CCCCC
Q 010512 148 PKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT--GKPLF 225 (508)
Q Consensus 148 PeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt--G~~pF 225 (508)
|+|||++.++.++|+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~ 234 (296)
T cd05095 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPY 234 (296)
T ss_pred hheEEEcCCCCEEeccCcccccccCCcce-eccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence 99999999999999999999764332211 11122345678999998776 679999999999999999998 77888
Q ss_pred CCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHh
Q 010512 226 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 305 (508)
Q Consensus 226 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL 305 (508)
...+..+.+..... +........ .......+++.+.+|+.+||+.||.+||++.+++
T Consensus 235 ~~~~~~~~~~~~~~--------------------~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 291 (296)
T cd05095 235 SQLSDEQVIENTGE--------------------FFRDQGRQV---YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIH 291 (296)
T ss_pred cccChHHHHHHHHH--------------------HHhhccccc---cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 76554333221110 000000000 0011234568899999999999999999999987
Q ss_pred c
Q 010512 306 A 306 (508)
Q Consensus 306 ~ 306 (508)
+
T Consensus 292 ~ 292 (296)
T cd05095 292 A 292 (296)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=311.73 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=201.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCc----EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGE----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~----~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
..+|++.+.||+|+||+||+|.+..+|. .||+|.+.... .......+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS---- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence 4789999999999999999999877665 58999886432 23445678899999999999999999999854
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
...++||||+. |+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 81 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 81 --SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred --CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 45899999998 6999998774 4699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
....... .......++..|+|||.+.. ..++.++|+|||||++|+|++ |..||.+.+..+....+..
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------- 226 (279)
T cd05057 159 LDVDEKE-YHAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK--------- 226 (279)
T ss_pred ccCcccc-eecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC---------
Confidence 5422211 11111223567999999876 678999999999999999998 9999987654332222211
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
....+. ....+..+.+++.+||..||.+|||+.++++
T Consensus 227 ------------------~~~~~~---~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 227 ------------------GERLPQ---PPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ------------------CCCCCC---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 111111 1235678999999999999999999999877
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=310.79 Aligned_cols=255 Identities=21% Similarity=0.363 Sum_probs=200.1
Q ss_pred eEEeeeeeecCceEEEEEEEC---CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC-Cc
Q 010512 19 YQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE-FK 94 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~---~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~-~~ 94 (508)
|.+.++||+|+||.||+|... .++..||||++............+.+|+++|+.++||||+++++++....... ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999864 46789999999765555556777899999999999999999999886543221 22
Q ss_pred cEEEEEecCC-ccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccc
Q 010512 95 DIYVVFELME-SDLHQVIKAN------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 167 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla 167 (508)
..+++++|+. |+|.+++... ..++...+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 3578999998 6888776432 24789999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCCh
Q 010512 168 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPST 246 (508)
Q Consensus 168 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~ 246 (508)
+........ .......+++.|++||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus 161 ~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~--~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~------ 231 (273)
T cd05074 161 KKIYSGDYY-RQGCASKLPVKWLALESLAD--NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG------ 231 (273)
T ss_pred ccccCCcce-ecCCCccCchhhcCHhHHhc--CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC------
Confidence 864322211 11122345678999999876 678899999999999999999 89999876543322222110
Q ss_pred HHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 247 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
... ..-+..+..+.+|+.+||..+|++||++.+++.
T Consensus 232 ---------------------~~~---~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 232 ---------------------NRL---KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred ---------------------CcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 011345688999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=310.61 Aligned_cols=242 Identities=25% Similarity=0.382 Sum_probs=190.7
Q ss_pred eeeeecCceEEEEEEECCCCc--EEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCCccEEEE
Q 010512 23 EVIGKGSYGVVGSAVDTHTGE--RVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVV 99 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~--~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV 99 (508)
++||+|+||.||+|.+..+|. .+|+|.++.. ........+.+|+.++..+ +||||+++++++.. .+.+|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv 74 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLA 74 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEE
Confidence 468999999999999988876 4688887632 2233456788999999999 79999999999843 3458999
Q ss_pred EecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEc
Q 010512 100 FELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 162 (508)
Q Consensus 100 ~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~ 162 (508)
|||+. ++|.+++.... .+++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence 99998 69999987543 47889999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhc
Q 010512 163 DFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLL 241 (508)
Q Consensus 163 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~ 241 (508)
|||++....... .......+..|+|||++.. ..++.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 155 dfgl~~~~~~~~----~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~--- 225 (270)
T cd05047 155 DFGLSRGQEVYV----KKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP--- 225 (270)
T ss_pred CCCCccccchhh----hccCCCCccccCChHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh---
Confidence 999986321111 0111233567999999876 678999999999999999997 999997765433222211
Q ss_pred CCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 242 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..... .....++..+.+|+.+||..||.+|||+.+++.
T Consensus 226 ------------------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 226 ------------------------QGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ------------------------CCCCC---CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 00000 111245678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=321.85 Aligned_cols=260 Identities=25% Similarity=0.401 Sum_probs=219.1
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~ 92 (508)
...+|.++.+||+|+||.|.+|..+.|.+.||||++++.. -...+.+--+.|-++|.... -|.++++...|..
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT----- 421 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT----- 421 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh-----
Confidence 3567899999999999999999999999999999997642 22334455567888888775 6788888888844
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
...+|+||||+. |+|-..|+.-+.+.+..+.+++..|+-||-|||++||++||||.+|||++.+|.+||+|||++....
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 455999999998 6999999999999999999999999999999999999999999999999999999999999998533
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.+.. ...+++|||.|+|||++.- .+|+.++|.||+|++|||||.|++||.|++..+....|.+-.-
T Consensus 502 ~~~~---TTkTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv--------- 567 (683)
T KOG0696|consen 502 FDGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV--------- 567 (683)
T ss_pred cCCc---ceeeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC---------
Confidence 2222 2356899999999999974 8999999999999999999999999999998887776654211
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH-----HHHhcCCcccCCCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA-----EEALADPYFHGLAN 315 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta-----~eiL~hp~f~~~~~ 315 (508)
..-...+.++.++.+.+|.+.|.+|..+ .+|-.||||+.+..
T Consensus 568 ----------------------syPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 568 ----------------------SYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred ----------------------cCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence 1113567899999999999999999653 67889999986653
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=334.05 Aligned_cols=236 Identities=28% Similarity=0.416 Sum_probs=195.5
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEe
Q 010512 22 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 101 (508)
Q Consensus 22 ~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 101 (508)
++-||+|+.|.||+++. .++.|||||++.. -..+|+-|++|+||||+.++++|.. ...++||||
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtq-----sPcyCIiME 192 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQ-----SPCYCIIME 192 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecC-----CceeEEeee
Confidence 56799999999999964 5789999998531 1358899999999999999999954 456899999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcccc
Q 010512 102 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 180 (508)
Q Consensus 102 ~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~ 180 (508)
||. |-|..+++....+++.....|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||-++...... ..
T Consensus 193 fCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S----Tk 268 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS----TK 268 (904)
T ss_pred ccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhh----hh
Confidence 998 8999999999999999999999999999999999999999999999999999999999999988643321 12
Q ss_pred cccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHH
Q 010512 181 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 260 (508)
Q Consensus 181 ~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~ 260 (508)
-.++||..|||||++.. .+.+.|+|||||||||||||||..||.+-+. .+.|. ..|+...
T Consensus 269 MSFaGTVaWMAPEvIrn--ePcsEKVDIwSfGVVLWEmLT~EiPYkdVds---sAIIw-GVGsNsL-------------- 328 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRN--EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS---SAIIW-GVGSNSL-------------- 328 (904)
T ss_pred hhhhhhHhhhCHHHhhc--CCcccccceehhHHHHHHHHhcCCCccccch---heeEE-eccCCcc--------------
Confidence 35789999999999998 8999999999999999999999999975432 11111 1111110
Q ss_pred HhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 010512 261 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308 (508)
Q Consensus 261 l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp 308 (508)
..| .-..++..++=||++||.-.|..||++.++|.|-
T Consensus 329 ------~Lp-----vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 329 ------HLP-----VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred ------ccc-----CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 001 1134667788999999999999999999999984
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=305.38 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=199.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
..+|++.+.||.|+||.||+|.+. .+..+|+|++..... ....+.+|+++++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 73 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTE-----RSP 73 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEcc-----CCc
Confidence 468999999999999999999875 477899999864322 23467889999999999999999999843 346
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 96 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
.|+||||+. ++|.+++... +.++++.+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||+++.....
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 74 ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred eEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 899999998 5898888764 46899999999999999999999999999999999999999999999999999754322
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||........+..+..
T Consensus 154 ~~~--~~~~~~~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------- 216 (256)
T cd05112 154 QYT--SSTGTKFPVKWSSPEVFSF--SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA------------- 216 (256)
T ss_pred ccc--ccCCCccchhhcCHhHhcc--CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-------------
Confidence 111 1122335578999999876 678999999999999999998 9999977664433322211
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
...... ....+..+.+|+.+||..||.+|||+.+++++
T Consensus 217 --------------~~~~~~---~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 217 --------------GFRLYK---PRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred --------------CCCCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 000000 11246789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=306.18 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=199.5
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++.+.||+|+||.||+|.+. .+..||+|.+... ......+.+|+.+++.++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~ 73 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------E 73 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------C
Confidence 3578999999999999999999864 4567999988642 2234678899999999999999999998843 4
Q ss_pred cEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
..|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++....
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 5799999998 6999999763 357888999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
..... ......++..|+|||++.. ..++.++|+|||||++|+|++ |.+||++.+..+....+....
T Consensus 154 ~~~~~--~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~--------- 220 (260)
T cd05073 154 DNEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY--------- 220 (260)
T ss_pred CCCcc--cccCCcccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC---------
Confidence 22111 1122345677999999976 678999999999999999998 999998776544433222110
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.. ......+..+.+++.+||..||.+||++.++++
T Consensus 221 ------------------~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 221 ------------------RM---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ------------------CC---CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 00 112356788999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=308.98 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=188.4
Q ss_pred eeeeecCceEEEEEEECC--CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEE
Q 010512 23 EVIGKGSYGVVGSAVDTH--TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~--tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~ 100 (508)
+.||+|+||.||+|.... ....+|+|.+... ........+.+|+.+++.++||||+++++.+.. ....|+||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-----~~~~~lv~ 74 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-----SIPYLLVL 74 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-----CCceEEEE
Confidence 369999999999996432 4567888887542 223344567899999999999999999998843 35689999
Q ss_pred ecCC-ccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 101 ELME-SDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 101 E~~~-g~L~~~i~~~~-----~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
||+. |+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence 9998 69999987643 24677889999999999999999999999999999999999999999999987532221
Q ss_pred CCcccccccccCcccccccccccc-----cCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~-----~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
.. .......++..|+|||++... ...++.++|||||||++|+|++ |.+||......+.+..+....
T Consensus 155 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~------- 226 (269)
T cd05042 155 YY-ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ------- 226 (269)
T ss_pred he-eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhcc-------
Confidence 11 111233556789999987431 1357889999999999999999 789998765444333221100
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
....+........+..+.+++..|+ .||.+|||++++++
T Consensus 227 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 227 ------------------DIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ------------------CccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 0011111222356788899999998 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=303.45 Aligned_cols=243 Identities=24% Similarity=0.413 Sum_probs=193.5
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEec
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 102 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~ 102 (508)
++||+|+||.||+|... ++..||+|+++.... ......+.+|+.+++.++||||+++++++.. ....|+||||
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEEC
Confidence 47999999999999864 688999999875432 2334568899999999999999999999843 3458999999
Q ss_pred CC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcccc
Q 010512 103 ME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 180 (508)
Q Consensus 103 ~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~ 180 (508)
++ ++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......... .
T Consensus 74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--~ 151 (250)
T cd05085 74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS--S 151 (250)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc--C
Confidence 98 6999888754 468999999999999999999999999999999999999999999999999997543221111 1
Q ss_pred cccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHH
Q 010512 181 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259 (508)
Q Consensus 181 ~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 259 (508)
....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~-------------------- 209 (250)
T cd05085 152 GLKQIPIKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-------------------- 209 (250)
T ss_pred CCCCCcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc--------------------
Confidence 11234567999999876 678999999999999999998 9999987664333222211
Q ss_pred HHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 260 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 260 ~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.... .....++..+.+|+.+||..||.+||++.++++
T Consensus 210 -------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 210 -------GYRM---SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred -------CCCC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0000 112346788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=309.51 Aligned_cols=252 Identities=23% Similarity=0.369 Sum_probs=200.5
Q ss_pred CCeEEeeeeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~-----tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
++|++++.||+|+||.||+|+.+. +...||+|.+... ........+.+|+.+|+.++||||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 78 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLCR----- 78 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEEC-----
Confidence 689999999999999999999754 3467999987542 22224567889999999999999999999884
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEE
Q 010512 92 EFKDIYVVFELME-SDLHQVIKAND---------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 161 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~~---------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL 161 (508)
+....|+||||++ ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEE
Confidence 3356899999998 69999998765 6899999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhh
Q 010512 162 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDL 240 (508)
Q Consensus 162 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~ 240 (508)
+|||++....... ........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+......+..+..
T Consensus 159 ~~~~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~- 233 (275)
T cd05046 159 SLLSLSKDVYNSE--YYKLRNALIPLRWLAPEAVQE--DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA- 233 (275)
T ss_pred cccccccccCccc--ccccCCceeEEeecChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc-
Confidence 9999987543221 112234466778999999876 568899999999999999998 7889976543322221110
Q ss_pred cCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 241 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 241 ~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
. ...+. ....++..+.+++.+||..||.+|||+.+++.+
T Consensus 234 --------------------------~-~~~~~-~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 234 --------------------------G-KLELP-VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred --------------------------C-CcCCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0 00011 113467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=304.69 Aligned_cols=244 Identities=26% Similarity=0.419 Sum_probs=194.3
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEec
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 102 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~ 102 (508)
++||.|+||.||+|.+.. ++.||+|++...... .....+.+|+++++.+.||||+++++++.. ....|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-----KQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEec-----CCCeEEEEEc
Confidence 469999999999999877 999999998754332 345678899999999999999999999843 3568999999
Q ss_pred CC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcccc
Q 010512 103 ME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 180 (508)
Q Consensus 103 ~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~ 180 (508)
+. ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++......... ...
T Consensus 74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~ 152 (251)
T cd05041 74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT-VSD 152 (251)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcce-ecc
Confidence 97 6899998653 46899999999999999999999999999999999999999999999999999754321111 000
Q ss_pred cccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHH
Q 010512 181 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259 (508)
Q Consensus 181 ~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 259 (508)
....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.........+...
T Consensus 153 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~------------------- 211 (251)
T cd05041 153 GLKQIPIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG------------------- 211 (251)
T ss_pred ccCcceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-------------------
Confidence 11233567999999876 678999999999999999998 88999776543322222110
Q ss_pred HHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 260 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 260 ~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.... .....+..+.+|+.+||..+|.+|||++|+++
T Consensus 212 --------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 212 --------YRMP---APQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred --------CCCC---CCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0000 11245678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=314.95 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=200.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCc----EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGE----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~----~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
.++|++.+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.+.||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---
Confidence 4678999999999999999999887776 57888876432 223344678999999999999999999988542
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
..++|+||+. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ---~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 82 ---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred ---CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccc
Confidence 3579999998 79999987654 689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
....... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~--------- 226 (303)
T cd05110 159 LEGDEKE-YNADGGKMPIKWMALECIHY--RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK--------- 226 (303)
T ss_pred ccCcccc-cccCCCccccccCCHHHhcc--CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC---------
Confidence 5322211 11223456778999999876 678999999999999999997 8999977653322221110
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
....+ ..+..+..+.+++.+||..||.+||++.++++.
T Consensus 227 ------------------~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 227 ------------------GERLP---QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred ------------------CCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00011 113456789999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=306.89 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=188.4
Q ss_pred eeeeecCceEEEEEEEC--CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEE
Q 010512 23 EVIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~--~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~ 100 (508)
+.||+|+||.||+|... .++..+|+|+++.... ......+.+|+.+++.++||||+++++.+.. ...+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~ 74 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-----VTPYLLVM 74 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCCcEEEE
Confidence 46999999999999754 4567899999864432 2334568899999999999999999998843 34589999
Q ss_pred ecCC-ccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 101 ELME-SDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 101 E~~~-g~L~~~i~~~~-----~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
||++ |+|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 9998 69999986532 35677888999999999999999999999999999999999999999999997532221
Q ss_pred CCcccccccccCccccccccccccc-----CCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~-----~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
. ........++..|+|||++.+.. ..++.++|||||||++|+|++ |.+||+.....+.......
T Consensus 155 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------- 224 (269)
T cd05087 155 Y-YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR--------- 224 (269)
T ss_pred e-eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh---------
Confidence 1 11122346778899999986421 236789999999999999996 9999976554332211100
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
. .....+........+..+.+++.+|+ .||.+|||+++++.
T Consensus 225 --------------~--~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 225 --------------E--QQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred --------------c--ccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 0 00001111111235677899999998 68999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=340.27 Aligned_cols=278 Identities=20% Similarity=0.270 Sum_probs=186.0
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCC----CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC-
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHT----GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS- 89 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~t----g~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~- 89 (508)
..++|++.+.||+|+||.||+|.+..+ +..||||+++.... ......| .++...+.++..+...+....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 457899999999999999999999988 99999999864211 1111111 122222333333333322211
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHhHhcCceecCCCC
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKANDD--------------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKP 148 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~~~--------------------l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKP 148 (508)
......+++||||++ ++|.+++..... .....+..++.||+.||.|||+.||+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 134567899999998 689988875421 12345678999999999999999999999999
Q ss_pred CceeeCC-CCcEEEccccccccccCCCCCcccccccccCccccccccccccc--------------------CCCCcchh
Q 010512 149 KNILANA-DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFF--------------------SKYTPAID 207 (508)
Q Consensus 149 eNILl~~-~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~--------------------~~y~~~~D 207 (508)
+|||++. ++.+||+|||+|+...... ......+++|+.|+|||.+.... ..++.++|
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~--~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGI--NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCcccccccc--ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 9999986 5799999999997543221 11234578999999999763211 12445679
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCC---CCCCCCCHHHH
Q 010512 208 IWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFS---HKFPNADPLAL 284 (508)
Q Consensus 208 IWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~~~~~~~ 284 (508)
|||||||||||+++..+ ..+...++..+....+...... . ..+ ......... ..+...+..+.
T Consensus 362 VwSlGviL~el~~~~~~--~~~~~~~~~~~l~~~~~~~~~~-~--------~~~---~~~~~~~~~~~~~~~d~~~~~~~ 427 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLR--SDSNLIQFNRQLKRNDYDLVAW-R--------KLV---EPRASPDLRRGFEVLDLDGGAGW 427 (566)
T ss_pred cHHHHHHHHHHHhCcCC--CchHHHHHHHHHHhcCCcHHHH-H--------Hhh---ccccchhhhhhhhhccccchHHH
Confidence 99999999999986544 4444444444333333221111 1 110 001111111 11122345677
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 285 HLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 285 ~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
+||.+||++||.+|||+.++|+||||++..
T Consensus 428 dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 428 ELLKSMMRFKGRQRISAKAALAHPYFDREG 457 (566)
T ss_pred HHHHHHccCCcccCCCHHHHhCCcCcCCCC
Confidence 999999999999999999999999998754
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=324.66 Aligned_cols=261 Identities=27% Similarity=0.442 Sum_probs=196.1
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
+.|.-...||+|+||.||+|.-. .|..||||+++...... ..++.+|+.+|.+++|||+|+|+++|.... ...
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~----~~~ 147 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGG----EHR 147 (361)
T ss_pred hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCC----ceE
Confidence 56677789999999999999865 45899999886543321 455999999999999999999999995432 158
Q ss_pred EEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcC---ceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 97 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~g---IiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
+||+|||. |+|.+.+.... +++|.....|+.++++||+|||... |+||||||+|||+|++++.||+|||+|+..
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG 227 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence 99999998 89999998765 8999999999999999999999865 999999999999999999999999999654
Q ss_pred cCCCCCccccccc-ccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHH---HHHHHhhcCCCCh
Q 010512 171 FNDAPSAIFWTDY-VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQ---LDLMTDLLGTPST 246 (508)
Q Consensus 171 ~~~~~~~~~~~~~-~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~---l~~i~~~~g~p~~ 246 (508)
... .. ..... .||.+|+|||++.. +..+.++||||||+++.||++|+.+......... .......
T Consensus 228 ~~~-~~--~~~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~------ 296 (361)
T KOG1187|consen 228 PEG-DT--SVSTTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL------ 296 (361)
T ss_pred Ccc-cc--ceeeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH------
Confidence 321 11 11222 89999999999976 6899999999999999999999988865431111 1111111
Q ss_pred HHHHHHhhHHHHHHHhhcccCCCCCCCCCCC--CCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFP--NADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 247 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
+....+.+.++. .... ..++ ..-..+..+..+|++.+|.+||++.|+++
T Consensus 297 -----~~~~~~~eiiD~---~l~~---~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 297 -----LEEGKLREIVDP---RLKE---GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred -----HHCcchhheeCC---CccC---CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 111111111111 0000 1111 12233668999999999999999999755
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=305.35 Aligned_cols=247 Identities=24% Similarity=0.393 Sum_probs=190.5
Q ss_pred eeeeecCceEEEEEEECC---CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEE
Q 010512 23 EVIGKGSYGVVGSAVDTH---TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 99 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~---tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV 99 (508)
+.||+|+||.||+|.+.. .+..||||++... ........+.+|+.+++.++||||+++++++... .+..|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEE
Confidence 468999999999998653 3467999998532 2234456788999999999999999999987532 2347899
Q ss_pred EecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCc
Q 010512 100 FELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 177 (508)
Q Consensus 100 ~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~ 177 (508)
|||+. ++|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.........
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99998 6999998764 356788889999999999999999999999999999999999999999999997543221100
Q ss_pred -ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 178 -IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 178 -~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
.......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~---------------- 217 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ---------------- 217 (262)
T ss_pred ecccccCcCCccccChhHhcc--CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc----------------
Confidence 11123345678999999876 678999999999999999999 5678876554332221110
Q ss_pred HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..+.... ..++..+.+++.+||..||++||++.++++
T Consensus 218 -----------~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 218 -----------GRRLLQP---EYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred -----------CCCCCCC---CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0011111 134678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=305.99 Aligned_cols=228 Identities=25% Similarity=0.346 Sum_probs=185.6
Q ss_pred cCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEecCC-cc
Q 010512 28 GSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SD 106 (508)
Q Consensus 28 G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~-g~ 106 (508)
|.||.||+|++..+|+.||+|++.... ...+|...+....||||+++++++.. ....|+||||+. ++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVS-----EDSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheec-----CCeEEEEEecCCCCC
Confidence 899999999999999999999996431 22345555566679999999998843 356899999998 69
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcccccccccC
Q 010512 107 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 186 (508)
Q Consensus 107 L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT 186 (508)
|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...... .....++
T Consensus 72 L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------~~~~~~~ 145 (237)
T cd05576 72 LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------CDGEAVE 145 (237)
T ss_pred HHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc------cccCCcC
Confidence 9999988778999999999999999999999999999999999999999999999999987654221 1234567
Q ss_pred cccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhccc
Q 010512 187 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRK 266 (508)
Q Consensus 187 ~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~ 266 (508)
..|+|||.+.+ ..++.++|+||+||++|+|++|..||...... + ..
T Consensus 146 ~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~---------------------------~~ 191 (237)
T cd05576 146 NMYCAPEVGGI--SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I---------------------------NT 191 (237)
T ss_pred ccccCCcccCC--CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c---------------------------cc
Confidence 78999999876 67889999999999999999999887532110 0 00
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH-----HHHhcCCcc
Q 010512 267 KQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA-----EEALADPYF 310 (508)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta-----~eiL~hp~f 310 (508)
..... .-+.+++.+.+||.+||+.||.+||++ +++++||||
T Consensus 192 ~~~~~---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 192 HTTLN---IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ccccC---CcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 00000 112467889999999999999999996 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=327.44 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=199.1
Q ss_pred CCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSR 90 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~-----~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~ 90 (508)
++|.+.+.||+|+||.||+|++. .++..||+|+++... .......+.+|+.+|..+. ||||+++++++..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~--- 112 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTK--- 112 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc---
Confidence 67899999999999999999853 456789999997532 2233457889999999997 9999999999854
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC------------------------------------------------------
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAND------------------------------------------------------ 115 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~------------------------------------------------------ 115 (508)
...+|+|||||. |+|.+++..+.
T Consensus 113 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 113 --GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred --CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 346899999998 69999986532
Q ss_pred --------------------------------------------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCce
Q 010512 116 --------------------------------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI 151 (508)
Q Consensus 116 --------------------------------------------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNI 151 (508)
.+++..+..|+.||+.||.|||+.||+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 356777889999999999999999999999999999
Q ss_pred eeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCh
Q 010512 152 LANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNV 230 (508)
Q Consensus 152 Ll~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~ 230 (508)
|++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.....
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFN--NLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred EEeCCCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcC--CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 9999999999999999864322211 11223457788999999976 678999999999999999998 8899976543
Q ss_pred HHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 231 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 231 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.+.+..... ... .. .....++..+.+|+.+||..||.+||++.++++.
T Consensus 348 ~~~~~~~~~----------------------~~~----~~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 348 NEQFYNAIK----------------------RGY----RM---AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred hHHHHHHHH----------------------cCC----CC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 332211100 000 00 0113467889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=330.71 Aligned_cols=264 Identities=25% Similarity=0.379 Sum_probs=213.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
+-|..++.||-|+||.|+++....|...||+|.+.+.. .....+..+..|-.||..-..+-||+|+-.| .+..+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdn 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDN 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCc
Confidence 34677899999999999999999999999999986531 2223455677899999999999999999988 55667
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+||+|+. ||+-.+|.+.+-|.|+.+++++..|..|+++.|..|+|||||||+|||||.+|.+||.|||||+.+....
T Consensus 704 LYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999998 6999999999999999999999999999999999999999999999999999999999999997642110
Q ss_pred CC---------------------------------------cccccccccCcccccccccccccCCCCcchhhhhHHHHH
Q 010512 175 PS---------------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 215 (508)
Q Consensus 175 ~~---------------------------------------~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il 215 (508)
.. .+.....+||+.|+|||++.. ..|+..+|.||.||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r--~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR--TGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc--cCccccchhhHhhHHH
Confidence 00 001123589999999999987 7899999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCC
Q 010512 216 AEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDP 295 (508)
Q Consensus 216 ~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP 295 (508)
|||+.|++||-.........++.+ ++.++. -....++++++.+||.++.. ++
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~n-----------------w~~~l~----------~~~~~~ls~e~~~li~kLc~-sa 913 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVIN-----------------WRNFLH----------IPYQGNLSKEALDLIQKLCC-SA 913 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeee-----------------hhhccc----------cccccccCHHHHHHHHHHhc-Ch
Confidence 999999999977664333222211 111110 01235788999999998665 88
Q ss_pred CCCCC---HHHHhcCCcccCCCC
Q 010512 296 KDRPT---AEEALADPYFHGLAN 315 (508)
Q Consensus 296 ~~Rpt---a~eiL~hp~f~~~~~ 315 (508)
++|.. ++++-.||||+++..
T Consensus 914 d~RLGkng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 914 DSRLGKNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred hhhhcccchhhhhcCccccccch
Confidence 88864 788999999998753
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=330.99 Aligned_cols=259 Identities=23% Similarity=0.398 Sum_probs=223.5
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.+.+++..||-|+||.|=++.-......+|+|++++. .........+..|-.||-.++.|.||++|..| ++..+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchh
Confidence 6688899999999999999876655556999999764 33344556788999999999999999999988 67788
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|++||-|- |+|+..+...+.+.+..+++++..+++|++|||++|||+|||||+|++++.+|-+||.|||+|+......
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 999999996 7999999999999999999999999999999999999999999999999999999999999999764433
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
. ..++||||.|.|||++.. ...+.++|.||||+++||||+|.|||.+-+.......|.+.+- .+
T Consensus 575 K----TwTFcGTpEYVAPEIILn--KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid--------~i-- 638 (732)
T KOG0614|consen 575 K----TWTFCGTPEYVAPEIILN--KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID--------KI-- 638 (732)
T ss_pred c----eeeecCCcccccchhhhc--cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh--------hh--
Confidence 2 346899999999999987 7889999999999999999999999999999888888765321 00
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCCC
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLAN 315 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt-----a~eiL~hp~f~~~~~ 315 (508)
.| -..++..+.+||+++...+|.+|.. +.+|-+|.||.++..
T Consensus 639 ----------------~~---Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 639 ----------------EF---PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred ----------------hc---ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 00 1245677999999999999999976 899999999998754
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=303.36 Aligned_cols=240 Identities=25% Similarity=0.449 Sum_probs=195.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|++.+.||+|+||.||++. .+++.||+|+++.. .....+.+|+.+++.++||||+++++++.. ...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~ 73 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILH------NGL 73 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCc
Confidence 579999999999999999985 57889999998642 234568899999999999999999998843 236
Q ss_pred EEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 97 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
|+||||+. ++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 99999998 69999997653 5889999999999999999999999999999999999999999999999998754221
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
. .....+..|+|||.+.+ ..++.++|+|||||++|+|++ |++||.+.+.......+..
T Consensus 154 ~------~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------- 212 (254)
T cd05083 154 V------DNSKLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK------------- 212 (254)
T ss_pred C------CCCCCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-------------
Confidence 1 12234567999999876 678999999999999999997 9999987664332222211
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..... ....+++.+.+|+.+||..+|.+||++.+++.
T Consensus 213 --------------~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 213 --------------GYRME---PPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred --------------CCCCC---CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00000 12356788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=306.33 Aligned_cols=238 Identities=20% Similarity=0.282 Sum_probs=184.5
Q ss_pred eeeeecCceEEEEEEECC------------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 23 EVIGKGSYGVVGSAVDTH------------TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~------------tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
+.||+|+||.||+|.... ....||+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~-- 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD-- 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 468999999999997432 2346899987642 223445678899999999999999999998543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCc-------EEE
Q 010512 91 REFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-------LKI 161 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~-------lkL 161 (508)
...++||||++ +.|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. +++
T Consensus 77 ---~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 77 ---VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred ---CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 45799999999 577777765 356999999999999999999999999999999999999987664 899
Q ss_pred ccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHH-hCCCCCCCCChHHHHHHHHhh
Q 010512 162 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEML-TGKPLFPGKNVVHQLDLMTDL 240 (508)
Q Consensus 162 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLl-tG~~pF~~~~~~~~l~~i~~~ 240 (508)
+|||++..... .....++..|+|||++... ..++.++|||||||++|+|+ .|..||.+....+......
T Consensus 154 ~d~g~~~~~~~-------~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-- 223 (262)
T cd05077 154 SDPGIPITVLS-------RQECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYE-- 223 (262)
T ss_pred CCCCCCccccC-------cccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHh--
Confidence 99999865421 1234678899999988642 57899999999999999998 5888887654322111000
Q ss_pred cCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 241 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 241 ~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
. .. ......++.+.+||.+||+.||.+||++.+|+++
T Consensus 224 ----------------------~---~~-----~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 224 ----------------------G---QC-----MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ----------------------c---Cc-----cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0 00 0011234678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=308.12 Aligned_cols=238 Identities=17% Similarity=0.271 Sum_probs=186.4
Q ss_pred eeeeecCceEEEEEEECCCCc-------EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 23 EVIGKGSYGVVGSAVDTHTGE-------RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~-------~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
+.||+|+||.||+|.+..++. .||+|.+... .......+..|+.+|+.+.||||+++++++... ..
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~ 73 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DE 73 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CC
Confidence 469999999999999866544 4888887532 223445678899999999999999999998543 45
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCc--------EEEcccc
Q 010512 96 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--------LKICDFG 165 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~--------lkL~DFG 165 (508)
.++||||+. |+|.+++..++ .+++..+..++.||+.||.|||+.||+||||||+|||++.++. ++++|||
T Consensus 74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 799999998 68999997654 5899999999999999999999999999999999999987765 6999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHhhcCCC
Q 010512 166 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQLDLMTDLLGTP 244 (508)
Q Consensus 166 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG-~~pF~~~~~~~~l~~i~~~~g~p 244 (508)
++..... .....++..|+|||++.+. ..++.++|||||||++|+|++| .+||.............
T Consensus 154 ~~~~~~~-------~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~------ 219 (258)
T cd05078 154 ISITVLP-------KEILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE------ 219 (258)
T ss_pred cccccCC-------chhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH------
Confidence 8865321 1234678899999998752 4578999999999999999998 46765544322211100
Q ss_pred ChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.... .....+..+.+||.+||+.||.+|||++++++.
T Consensus 220 ---------------------~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 220 ---------------------DRHQ-----LPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ---------------------cccc-----CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 0000 011234678999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=305.95 Aligned_cols=245 Identities=28% Similarity=0.408 Sum_probs=193.3
Q ss_pred eeeeecCceEEEEEEECCCC------cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 23 EVIGKGSYGVVGSAVDTHTG------ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg------~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
+.||+|+||.||+|.+...+ ..||||.+..... ......+.+|+.+|+.++||||+++++++.. ....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 74 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQ 74 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCe
Confidence 46999999999999876543 6899998864321 2345678899999999999999999999854 3458
Q ss_pred EEEEecCC-ccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC-----cEEEcc
Q 010512 97 YVVFELME-SDLHQVIKAN-------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-----KLKICD 163 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~-------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~-----~lkL~D 163 (508)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+++|+||||+||+++.++ .++|+|
T Consensus 75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence 99999998 6999998642 2478899999999999999999999999999999999999887 899999
Q ss_pred ccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcC
Q 010512 164 FGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLG 242 (508)
Q Consensus 164 FGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g 242 (508)
||++.......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||+..+..+....+..
T Consensus 155 fg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~--- 228 (269)
T cd05044 155 FGLARDIYKSDYYR-KEGEGLLPVRWMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA--- 228 (269)
T ss_pred cccccccccccccc-cCcccCCCccccCHHHHcc--CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc---
Confidence 99997543222111 1122345678999999976 678999999999999999998 9999987665443332211
Q ss_pred CCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 243 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 243 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.... ......+..+.+||.+||..+|.+||++.++++
T Consensus 229 ------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 229 ------------------------GGRL---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ------------------------CCcc---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0000 112345678999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=303.59 Aligned_cols=236 Identities=19% Similarity=0.278 Sum_probs=186.8
Q ss_pred eeeeecCceEEEEEEECCCC----------cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 23 EVIGKGSYGVVGSAVDTHTG----------ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg----------~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
+.||+|+||.||+|.+..++ ..|++|.+.... .....+.+|+.+|+.++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR----- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-----
Confidence 46999999999999998777 458888765322 115678899999999999999999998854
Q ss_pred CccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC-------cEEEcc
Q 010512 93 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-------KLKICD 163 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~-------~lkL~D 163 (508)
...|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 73 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 73 -DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 34699999998 69999998765 789999999999999999999999999999999999999888 799999
Q ss_pred ccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcC
Q 010512 164 FGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLG 242 (508)
Q Consensus 164 FGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g 242 (508)
||++..... .....++..|+|||++.+....++.++|||||||++++|++ |..||...+.........
T Consensus 152 fg~a~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---- 220 (259)
T cd05037 152 PGIPITVLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---- 220 (259)
T ss_pred CCccccccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh----
Confidence 999986432 12345667899999987622378899999999999999999 577886543211111000
Q ss_pred CCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 243 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 243 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.....+. .....+.+||.+||..||.+|||+.++++
T Consensus 221 ---------------------~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 221 ---------------------DQHRLPM-------PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ---------------------cCCCCCC-------CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000010 11267899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=306.70 Aligned_cols=270 Identities=24% Similarity=0.407 Sum_probs=202.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDT----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~----~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
...|++.+.||+|+||.||+|... .++..||||+++..... .....+.+|+++++.+.||||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~-- 79 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPG-- 79 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCC--
Confidence 357889999999999999999854 35889999999754332 34667899999999999999999999875422
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..
T Consensus 80 -~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 80 -GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred -CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 356899999997 69999997754 699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
...............++..|+|||.+.+ ..++.++|||||||++++|++|..||....... ....+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~~~~~- 230 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRT--SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGIAQGQM- 230 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHcc--CCCCcccchHHHhhhhheeeccCCCcccccchh-----ccccccccccc-
Confidence 5422221111122345567999999876 678899999999999999999998885532111 11111110000
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
........+ ......+. ...++..+.+|+.+||..||.+|||+.++++
T Consensus 231 ---~~~~~~~~~---~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 231 ---IVTRLLELL---KEGERLPR---PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred ---cHHHHHHHH---HcCCcCCC---CccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000111111 11111111 1345678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=302.63 Aligned_cols=250 Identities=28% Similarity=0.472 Sum_probs=199.7
Q ss_pred CeEEeeeeeecCceEEEEEEECC-CCcEEEEEEecCcc--------CChhHHHHHHHHHHHHHh-CCCCCcceeeeeecC
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTH-TGERVAIKKINDVF--------EHVSDATRILREIKLLRL-LRHPDIVEIKHIMLP 87 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~-tg~~vAIKki~~~~--------~~~~~~~~i~~Ei~iL~~-L~HpnIv~l~~v~~~ 87 (508)
.|++.+.||+|+||.||+|.+.. ++..+|+|.+.... .......++.+|+.+++. ++||||+++++++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~- 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL- 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence 48899999999999999999987 78899999885321 222344567789998865 79999999999984
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHh-cCceecCCCCCceeeCCCCcEEE
Q 010512 88 PSRREFKDIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKI 161 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~Qil~aL~yLHs-~gIiHrDLKPeNILl~~~~~lkL 161 (508)
..+..|+||||++ ++|.+++.. ...+++..++.++.|++.||.|||+ .||+|+||||.||+++.++.++|
T Consensus 80 ----~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 80 ----ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred ----cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEE
Confidence 3457999999998 588877642 3468999999999999999999996 68999999999999999999999
Q ss_pred ccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Q 010512 162 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 241 (508)
Q Consensus 162 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~ 241 (508)
+|||++....... ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|++||...+.......+....
T Consensus 156 ~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~ 229 (269)
T cd08528 156 TDFGLAKQKQPES----KLTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229 (269)
T ss_pred ecccceeeccccc----ccccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc
Confidence 9999998643322 2345678899999999986 678999999999999999999999997655433332221100
Q ss_pred CCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 242 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
. .+. .....++.+.+||.+||+.||++||++.|+..+
T Consensus 230 ~-------------------------~~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 230 Y-------------------------EPL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred C-------------------------CcC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 0 010 112456889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=306.06 Aligned_cols=237 Identities=19% Similarity=0.273 Sum_probs=183.5
Q ss_pred eeeecCceEEEEEEECCC------------------------CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcc
Q 010512 24 VIGKGSYGVVGSAVDTHT------------------------GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79 (508)
Q Consensus 24 ~LG~G~~g~V~~a~~~~t------------------------g~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv 79 (508)
.||+|+||.||+|....+ ...||+|++... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 599999999999974321 246889988532 223345678899999999999999
Q ss_pred eeeeeecCCCcCCCccEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC
Q 010512 80 EIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC 157 (508)
Q Consensus 80 ~l~~v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~ 157 (508)
++++++... ...|+||||++ ++|..++.. .+.+++..+..++.||++||.|||++||+||||||+|||++.++
T Consensus 80 ~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 80 FVHGVCVRG-----SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred eEEEEEEeC-----CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 999998543 45799999999 588888865 45789999999999999999999999999999999999997653
Q ss_pred -------cEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHH-hCCCCCCCCC
Q 010512 158 -------KLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEML-TGKPLFPGKN 229 (508)
Q Consensus 158 -------~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLl-tG~~pF~~~~ 229 (508)
.+|++|||++...... ....++..|+|||.+.+. ..++.++|||||||++|+|+ +|..||.+..
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cccCccceeeecCCccccccccc-------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 3899999988643211 223577889999988653 56899999999999999995 6899997654
Q ss_pred hHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 230 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 230 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.......+ .. ....+ ...++.+.+||.+||+.||.+|||+.++|++
T Consensus 227 ~~~~~~~~------------------------~~---~~~~~-----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 227 PSEKERFY------------------------EK---KHRLP-----EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred hHHHHHHH------------------------Hh---ccCCC-----CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 32211110 00 00000 1234678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=300.55 Aligned_cols=250 Identities=20% Similarity=0.290 Sum_probs=186.1
Q ss_pred eeeecCceEEEEEEECC--CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEe
Q 010512 24 VIGKGSYGVVGSAVDTH--TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 101 (508)
Q Consensus 24 ~LG~G~~g~V~~a~~~~--tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 101 (508)
.||+|+||.||+|.... ....+++|.+... ........+.+|+.+++.++||||+++++.+.. ...+|+|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~~~lv~e 75 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-----AIPYLLVFE 75 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEecC-----CCccEEEEe
Confidence 69999999999997533 2345667776532 222345678999999999999999999999854 345899999
Q ss_pred cCC-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCC
Q 010512 102 LME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 176 (508)
Q Consensus 102 ~~~-g~L~~~i~~~----~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~ 176 (508)
|+. |+|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++........
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~- 154 (268)
T cd05086 76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY- 154 (268)
T ss_pred cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh-
Confidence 998 6999998764 2456778889999999999999999999999999999999999999999999864221111
Q ss_pred cccccccccCcccccccccccc-----cCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 177 AIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 177 ~~~~~~~~gT~~Y~APE~l~~~-----~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.......+++..|+|||++... ...++.++|||||||++|+|++ |.+||...+....+..+..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~----------- 223 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK----------- 223 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-----------
Confidence 0112345688999999998531 1245789999999999999997 5788876665443332211
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
... ............++.+.+++..|| .||.+||+++++++
T Consensus 224 ------------~~~--~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 224 ------------DQQ--VKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ------------hcc--cccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 000 000001112346788999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=331.70 Aligned_cols=264 Identities=25% Similarity=0.435 Sum_probs=218.8
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~ 92 (508)
...+.++|.++||.|.||.||+++++.+|...|+|+....... ...+..|..+|+.+. |||++.++++|.-.....
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 4568899999999999999999999999999999998754332 356778999998885 999999999998766566
Q ss_pred CccEEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
.+.+|||||||. |+..++++. ..++.|..+.+|++.++.||.+||.+.++|||||-.|||++.++.|||+|||.+..
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 788999999998 688888875 45799999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCcccccccccccc---cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCh
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 246 (508)
.... .....+.+|||.|||||++... ...|+..+|+||||++..||.-|.||+-+......+-+
T Consensus 173 ldsT---~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~---------- 239 (953)
T KOG0587|consen 173 LDST---VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL---------- 239 (953)
T ss_pred eecc---cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc----------
Confidence 5322 2234678999999999998653 24578899999999999999999999976554332221
Q ss_pred HHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010512 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 247 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~ 311 (508)
++..+| +-.......+..+.+||..||.+|..+||+..++|.|||+.
T Consensus 240 -----------------IpRNPP-PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 240 -----------------IPRNPP-PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred -----------------CCCCCC-ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 122222 11222345678899999999999999999999999999997
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=301.79 Aligned_cols=261 Identities=23% Similarity=0.402 Sum_probs=207.8
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHH-HHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKL-LRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~i-L~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
.+-+..||.|+||+|++-.++.+|+..|||+|..... ..+-++++.|+.. ++.-+.||||+++++... .++.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-----EGdcW 139 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-----EGDCW 139 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-----CCcee
Confidence 3446689999999999999999999999999975433 3556788889865 566679999999999843 46789
Q ss_pred EEEecCCccHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHhHh-cCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 98 VVFELMESDLHQVIK-----ANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 98 lV~E~~~g~L~~~i~-----~~~~l~~~~~~~i~~Qil~aL~yLHs-~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
|.||+|+-+|..+.+ .+..++|...-.|....+.||.||-. .+|||||+||+|||++..|.+||||||.+....
T Consensus 140 iCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 140 ICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred eeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 999999976654432 34579999999999999999999975 589999999999999999999999999997654
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhh-cCCCChHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL-LGTPSTESIS 250 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~-~g~p~~~~~~ 250 (508)
+.-. -+.-.|-+.|||||.+......|+.++|+||||++|||+.||..|+.+=+ .+++++..+ .|.|+.
T Consensus 220 ~SiA----kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~--svfeql~~Vv~gdpp~---- 289 (361)
T KOG1006|consen 220 DSIA----KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD--SVFEQLCQVVIGDPPI---- 289 (361)
T ss_pred HHHH----hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH--HHHHHHHHHHcCCCCe----
Confidence 3322 24457889999999998755569999999999999999999999987633 233333221 232221
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
..+....-..+..+..||..||.+|-.+||...+++++||++-..
T Consensus 290 -------------------l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 290 -------------------LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred -------------------ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 122233345788899999999999999999999999999998543
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=320.77 Aligned_cols=250 Identities=24% Similarity=0.387 Sum_probs=203.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCc---E-EEEEEecC-ccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGE---R-VAIKKIND-VFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~---~-vAIKki~~-~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
++-.+.+.||+|+||.||+|.-+..+. . ||||..+. ..........+++|+++|+.++|||||+++|+.....
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~-- 234 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE-- 234 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC--
Confidence 455677999999999999998765322 3 89999874 2345567788999999999999999999999986543
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
-+|||||+|. |+|.+++++++ .++..+...++++.+.||+|||+++++||||-..|+|+..++.+||+|||+++.
T Consensus 235 ---Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 235 ---PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred ---ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 4899999998 69999999987 499999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHh-hcCCCChH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTD-LLGTPSTE 247 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~-~~g~p~~~ 247 (508)
........ ...--...|+|||.+.. ..|+.++|||||||++||+++ |..||++....+....|.. ...
T Consensus 312 ~~~~~~~~---~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r----- 381 (474)
T KOG0194|consen 312 GSQYVMKK---FLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYR----- 381 (474)
T ss_pred Ccceeecc---ccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCcc-----
Confidence 42111110 01123467999999987 689999999999999999998 8899999887766555521 111
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.+.+ ...+..+..++.+|+..||.+|||+.++.+
T Consensus 382 ----------------------~~~~---~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 382 ----------------------MPIP---SKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ----------------------CCCC---CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 1111 144567888999999999999999999887
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=313.20 Aligned_cols=274 Identities=26% Similarity=0.395 Sum_probs=213.7
Q ss_pred cccccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC-----hhHHHHHHHHHHHHHhCCCCCcceeee
Q 010512 9 FFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-----VSDATRILREIKLLRLLRHPDIVEIKH 83 (508)
Q Consensus 9 ~~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~-----~~~~~~i~~Ei~iL~~L~HpnIv~l~~ 83 (508)
|..--...+||-++.+||+|+|+.||+|.|....+.||+|+-...... ....+...||..|.+.|.||.||++++
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 344446779999999999999999999999999999999975321111 112345779999999999999999999
Q ss_pred eecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhc--CceecCCCCCceeeCCC---C
Q 010512 84 IMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--NVFHRDLKPKNILANAD---C 157 (508)
Q Consensus 84 v~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~--gIiHrDLKPeNILl~~~---~ 157 (508)
+|.-.. ..++-|+|||+| +|.-+++.+..+++.+++.|+.||+.||.||... -|||-||||.|||+... |
T Consensus 535 yfslDt----dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacG 610 (775)
T KOG1151|consen 535 YFSLDT----DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACG 610 (775)
T ss_pred eeeecc----ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccc
Confidence 985432 357999999997 8888898888999999999999999999999876 59999999999997543 7
Q ss_pred cEEEccccccccccCCCCCc----ccccccccCcccccccccccc--cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChH
Q 010512 158 KLKICDFGLARVSFNDAPSA----IFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 231 (508)
Q Consensus 158 ~lkL~DFGla~~~~~~~~~~----~~~~~~~gT~~Y~APE~l~~~--~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~ 231 (508)
.+||.|||++.++..+.... .......||.||++||.+.-. -.+.+.++||||+|||||.++.|+.||..+...
T Consensus 611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ 690 (775)
T KOG1151|consen 611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ 690 (775)
T ss_pred eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence 79999999999876554332 122346799999999987432 246789999999999999999999999654322
Q ss_pred HHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010512 232 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 232 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~ 311 (508)
..+-.-.. +.+...+.|. .-|-+++++++||++||++.-.+|....++-.||||.
T Consensus 691 QdILqeNT------------------------IlkAtEVqFP-~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 691 QDILQENT------------------------ILKATEVQFP-PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred HHHHhhhc------------------------hhcceeccCC-CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 21111000 0000111111 1245789999999999999999999999999999996
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=328.32 Aligned_cols=252 Identities=26% Similarity=0.405 Sum_probs=205.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~-----tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
....+..+.||+|+||.||+|.-.. ....||||.++... .....++|.||+.+|..|+|||||+|++++.
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~---- 559 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCR---- 559 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEc----
Confidence 3557788999999999999997532 34679999997532 2335678999999999999999999999994
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC----------C----CCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAND----------D----LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 155 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~----------~----l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~ 155 (508)
+.+-+|+|||||. |||.++|.... + |+..+...|+.||+.|+.||-++.++||||-..|+||.+
T Consensus 560 -~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 560 -EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGE 638 (774)
T ss_pred -cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceecc
Confidence 4455899999999 99999997432 2 888999999999999999999999999999999999999
Q ss_pred CCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 010512 156 DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQL 234 (508)
Q Consensus 156 ~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l 234 (508)
+..|||+|||+++.......-.. .....-...|||||.|.- .+|+.++||||+||+|||+++ |..||.+.+..+.+
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~-~~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKV-RGNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred ceEEEecccccchhhhhhhhhcc-cCCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 99999999999997543322111 111122357999999975 899999999999999999997 99999998887777
Q ss_pred HHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 235 DLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 235 ~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
+.|.+.- - -..-.+++..+.+|+..||+.+|.+||++.||-.
T Consensus 716 e~i~~g~---------------------------l---L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~ 757 (774)
T KOG1026|consen 716 ECIRAGQ---------------------------L---LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS 757 (774)
T ss_pred HHHHcCC---------------------------c---ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 7665310 0 0112467899999999999999999999998743
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=332.49 Aligned_cols=251 Identities=23% Similarity=0.413 Sum_probs=204.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCC-C----cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHT-G----ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~t-g----~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
..-++.+.||+|+||.||.|.-... | ..||||.+++. ....+...+++|..+|+.++|||||+++++++..
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~--- 767 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS--- 767 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC---
Confidence 4567889999999999999986542 3 35999999753 4456678899999999999999999999999763
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKAN-------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 163 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~-------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~D 163 (508)
...+|++|||+ |||..+|++. ..|+..+...|+.||++|+.||+++++|||||-..|+|++....+||+|
T Consensus 768 --~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 768 --GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred --CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 45799999999 7999999875 2589999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcC
Q 010512 164 FGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLG 242 (508)
Q Consensus 164 FGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g 242 (508)
||+|+........... ..-.-...|||||.+.. ..++.++|||||||++||+++ |..||++.+..+.+......-
T Consensus 846 FGlArDiy~~~yyr~~-~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg- 921 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKH-GEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG- 921 (1025)
T ss_pred cchhHhhhhchheecc-CccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-
Confidence 9999954332211100 01112246999999987 789999999999999999998 899999998776665332210
Q ss_pred CCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 243 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 243 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
+. + .-+.++..+.+++..||+.+|.+||++..|++
T Consensus 922 ------------------------RL--~---~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 ------------------------RL--D---PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ------------------------cc--C---CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 00 0 11356778899999999999999999999998
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.01 Aligned_cols=269 Identities=29% Similarity=0.432 Sum_probs=202.5
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC-cC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RR 91 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~-~~ 91 (508)
.++..-+...+.||+|+||.||+++++.||+.||||.++... +.....+..+|+++|++|+|+|||+++++-.+.. .-
T Consensus 9 ~~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~ 87 (732)
T KOG4250|consen 9 SGENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGL 87 (732)
T ss_pred cCCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCc
Confidence 356677788899999999999999999999999999998643 4556778889999999999999999998753321 01
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeC--CCCc--EEEcc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN--ADCK--LKICD 163 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~---~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~--~~~~--lkL~D 163 (508)
-...-.+|||||. |+|..++.+- ..|++.+...++..+..||.|||.+||+||||||.||++- ++|+ -||+|
T Consensus 88 ~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 88 VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeec
Confidence 1234689999998 6999999753 3699999999999999999999999999999999999863 4454 69999
Q ss_pred ccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHh
Q 010512 164 FGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV----VHQLDLMTD 239 (508)
Q Consensus 164 FGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~----~~~l~~i~~ 239 (508)
||.|+....+. .++..+||+.|.+||++.. ...|+..+|.|||||++|+++||..||-.... .+....+.
T Consensus 168 fG~Arel~d~s----~~~S~vGT~~YLhPel~E~-q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~- 241 (732)
T KOG4250|consen 168 FGAARELDDNS----LFTSLVGTEEYLHPELYER-QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHII- 241 (732)
T ss_pred ccccccCCCCC----eeeeecCchhhcChHHHhh-ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhh-
Confidence 99999764433 4688999999999999974 37899999999999999999999999843221 11211111
Q ss_pred hcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCC---CCH----HHHHHHHHhccCCCCCCCC
Q 010512 240 LLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPN---ADP----LALHLLERLLAFDPKDRPT 300 (508)
Q Consensus 240 ~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~---~~~----~~~~Ll~~mL~~DP~~Rpt 300 (508)
.+.|....+.. ......|+.|+..+|- .++ .+-.+|..||..||.+|-.
T Consensus 242 -tkkp~~v~i~~-----------~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~ 297 (732)
T KOG4250|consen 242 -TKKPSGVAIGA-----------QEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH 297 (732)
T ss_pred -ccCCCceeEee-----------ecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence 12222111110 0112334445544432 222 2346888999999999973
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=280.87 Aligned_cols=242 Identities=39% Similarity=0.652 Sum_probs=197.8
Q ss_pred CceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEecCCc-cH
Q 010512 29 SYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DL 107 (508)
Q Consensus 29 ~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~g-~L 107 (508)
+||.||+|.+..+|+.||+|++........ ...+.+|++.++.++|+||+++++.+... ...++|||++++ +|
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCH
Confidence 589999999998999999999875332211 57788999999999999999999988543 568999999996 99
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcccccccccCc
Q 010512 108 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 187 (508)
Q Consensus 108 ~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~ 187 (508)
.+++.....+++..+..++.+++.+|.|||+.||+|+||+|.||+++.++.++|+|||++....... ......++.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~ 150 (244)
T smart00220 75 FDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTP 150 (244)
T ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCc
Confidence 9999877679999999999999999999999999999999999999999999999999998754332 234457888
Q ss_pred ccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhccc
Q 010512 188 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK-NVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRK 266 (508)
Q Consensus 188 ~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~-~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~ 266 (508)
.|+|||.+.+ ..++.++||||+|+++++|++|..||... +.......+..
T Consensus 151 ~~~~pE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~--------------------------- 201 (244)
T smart00220 151 EYMAPEVLLG--KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK--------------------------- 201 (244)
T ss_pred CCCCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc---------------------------
Confidence 9999999876 67888999999999999999999999763 32222111110
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 267 KQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
...........++..+.+++.+||..||.+||++.++++||||
T Consensus 202 -~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 202 -PKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred -cCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 1111111111266789999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=291.14 Aligned_cols=266 Identities=22% Similarity=0.402 Sum_probs=210.1
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCCc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-VSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~-~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~ 94 (508)
++|.++.+||+|+|..|..++++.|.+.||+|++++...+ ..+..-+..|-.+...- +||.+|.+...|... .
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte-----s 324 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE-----S 324 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc-----c
Confidence 6799999999999999999999999999999999876443 34455566777776655 699999999998554 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
.+++|.||++ |+|--.++....|++++++++...|+.||.|||+.||++||||.+|+|++..|.+||.|+|+++.....
T Consensus 325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 5999999998 688888888889999999999999999999999999999999999999999999999999999864333
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
.. ..++++|||.|.|||++.+ ..|+..+|.|+||++++||+.|+.||.--. ...|...
T Consensus 405 gd---~tstfcgtpnyiapeilrg--eeygfsvdwwalgvlmfemmagrspfdivg-----------m~n~d~n------ 462 (593)
T KOG0695|consen 405 GD---TTSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIVG-----------MDNPDMN------ 462 (593)
T ss_pred Cc---ccccccCCCcccchhhhcc--cccCceehHHHHHHHHHHHHcCCCCcceec-----------CCCcccc------
Confidence 22 2457899999999999998 899999999999999999999999995210 0001110
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC------CHHHHhcCCcccCCCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP------TAEEALADPYFHGLAN 315 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp------ta~eiL~hp~f~~~~~ 315 (508)
...|+..+.-...+- .-...+-.+..+++..|.+||++|. ...++-.|+||+.+..
T Consensus 463 ---tedylfqvilekqir---iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 463 ---TEDYLFQVILEKQIR---IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW 524 (593)
T ss_pred ---hhHHHHHHHhhhccc---ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence 011111110000000 0123455678899999999999995 4789999999996654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.59 Aligned_cols=277 Identities=19% Similarity=0.273 Sum_probs=188.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC----------------CCCcEEEEEEecCccCChh------------HHHHHHHHH
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDT----------------HTGERVAIKKINDVFEHVS------------DATRILREI 67 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~----------------~tg~~vAIKki~~~~~~~~------------~~~~i~~Ei 67 (508)
.++|++.++||+|+||+||+|... ..+..||||+++....... .......|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 568999999999999999999752 3456899999864221100 011233577
Q ss_pred HHHHhCCCCCc-----ceeeeeecCCCc---CCCccEEEEEecCC-ccHHHHHHhC------------------------
Q 010512 68 KLLRLLRHPDI-----VEIKHIMLPPSR---REFKDIYVVFELME-SDLHQVIKAN------------------------ 114 (508)
Q Consensus 68 ~iL~~L~HpnI-----v~l~~v~~~~~~---~~~~~lylV~E~~~-g~L~~~i~~~------------------------ 114 (508)
.++.+++|.++ +++++++..... ...+..|+||||++ ++|.+++...
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77888876654 566666543211 12356899999998 6898887642
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccc
Q 010512 115 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 194 (508)
Q Consensus 115 ~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~ 194 (508)
..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++........ ......+|+.|+|||.
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~--~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF--NPLYGMLDPRYSPPEE 381 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc--CccccCCCcceeChhh
Confidence 12356778899999999999999999999999999999999999999999999754322111 1112245789999998
Q ss_pred cccccC------------------CCC--cchhhhhHHHHHHHHHhCCC-CCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 195 CGSFFS------------------KYT--PAIDIWSIGCIFAEMLTGKP-LFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 195 l~~~~~------------------~y~--~~~DIWSlG~il~eLltG~~-pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
+..... .|+ ...||||+|||+|+|++|.. ||.+....... +.. ......
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~--~~~-----~~~~~~--- 451 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE--LRQ-----YDNDLN--- 451 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH--Hhh-----ccchHH---
Confidence 754210 122 24799999999999999875 77543211110 000 000000
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCC---CCCCCHHHHhcCCcccC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDP---KDRPTAEEALADPYFHG 312 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP---~~Rpta~eiL~hp~f~~ 312 (508)
..+ .. ......++ .+...++.+.||+.+||..+| .+|+|++|+|+||||..
T Consensus 452 --~~r----~~-~~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 452 --RWR----MY-KGQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred --HHH----hh-cccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 000 00 11122232 356778999999999999876 68999999999999963
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=296.54 Aligned_cols=287 Identities=28% Similarity=0.439 Sum_probs=212.1
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECC---CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTH---TGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPS 89 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~---tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~ 89 (508)
.....|.++++||.|+|++||+|.+.. ..+.||+|.|... +...++.+|+.+|..+. +.||+++.+.+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~---- 104 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCF---- 104 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhh----
Confidence 345779999999999999999999987 7899999999753 23567899999999996 89999999988
Q ss_pred cCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC-CcEEEcccccc
Q 010512 90 RREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLA 167 (508)
Q Consensus 90 ~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~-~~lkL~DFGla 167 (508)
+..+.+.+||||++. +..++.. .++..+++.+++.++.||.++|.+||+||||||.|+|.+.. +.-.|+|||+|
T Consensus 105 -rnnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 105 -RNNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred -ccCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhH
Confidence 555679999999995 5555554 37789999999999999999999999999999999999864 67889999999
Q ss_pred ccccCC--------------CC-----------------Cc----------ccccccccCcccccccccccccCCCCcch
Q 010512 168 RVSFND--------------AP-----------------SA----------IFWTDYVATRWYRAPELCGSFFSKYTPAI 206 (508)
Q Consensus 168 ~~~~~~--------------~~-----------------~~----------~~~~~~~gT~~Y~APE~l~~~~~~y~~~~ 206 (508)
...... .+ .. ...-...||++|+|||++.. ...-++++
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k-~~~Qttai 259 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR-CPRQTTAI 259 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh-ccCcCCcc
Confidence 721000 00 00 00113479999999999987 36778999
Q ss_pred hhhhHHHHHHHHHhCCCCC-CCCChHHHHHHHHhhcCCCChHHHHHHh------h----HHHHHHH---hhc-----cc-
Q 010512 207 DIWSIGCIFAEMLTGKPLF-PGKNVVHQLDLMTDLLGTPSTESISRIR------N----EKARRYL---GSM-----RK- 266 (508)
Q Consensus 207 DIWSlG~il~eLltG~~pF-~~~~~~~~l~~i~~~~g~p~~~~~~~~~------~----~~~~~~l---~~~-----~~- 266 (508)
||||.|+|+..+++++.|| ...++.+.+..|..++|..........- . ..+.+.. ..+ .+
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 9999999999999998775 5556666666666666643322211100 0 0011111 111 11
Q ss_pred CCCCCCCCCCC-CCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 267 KQPVPFSHKFP-NADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 267 ~~~~~~~~~~~-~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.++......+. ..+..+.+|+.+||..||.+|+||+++|+||||...
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 11101112222 235589999999999999999999999999999843
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=296.64 Aligned_cols=248 Identities=22% Similarity=0.421 Sum_probs=206.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
.+..+...||-|.||.||.+..+.-.-.||||.++ ++......|+.|..+|+.++|||+|+|+++|... .-+
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK---EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E-----pPF 338 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE-----PPF 338 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhh---hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccC-----CCe
Confidence 44566789999999999999999888899999986 3456788999999999999999999999999643 348
Q ss_pred EEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 97 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
|||+|||. |+|.+++..-. .++.-...+++.||..|+.||..+++|||||-..|+|+.++..||++|||+++++..+
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 99999998 99999998643 4777788889999999999999999999999999999999999999999999998665
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
..... ...-...-|.|||-+.- ..++.++|||+|||+|||+.| |-.||+|-+..+.+.++.+.+.
T Consensus 419 TYTAH--AGAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR---------- 484 (1157)
T KOG4278|consen 419 TYTAH--AGAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR---------- 484 (1157)
T ss_pred ceecc--cCccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc----------
Confidence 53321 11122356899998864 678899999999999999997 8899999886666555543211
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
-.. -.++++...+|+..||+++|.+||++.|+-+
T Consensus 485 -------------M~~-------PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 485 -------------MDG-------PEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred -------------ccC-------CCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 111 1368899999999999999999999988754
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=300.52 Aligned_cols=244 Identities=27% Similarity=0.499 Sum_probs=195.5
Q ss_pred EEeeeeeecCceEEEEEEECC--CC--cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 20 QIQEVIGKGSYGVVGSAVDTH--TG--ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 20 ~i~~~LG~G~~g~V~~a~~~~--tg--~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.+.+.||.|.||.||+|+-.. .| -.||||.-+.... ..+.+.|+.|..+|+.++|||||++++++... -
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~tekflqEa~iMrnfdHphIikLIGv~~e~------P 464 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------P 464 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhhHHHHHHHHHHHHhCCCcchhheeeeeecc------c
Confidence 345679999999999997532 23 3689998875443 34578899999999999999999999999653 3
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 96 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
++||||++. |.|..+++.+. .|+......|++||+.||.|||+.+++||||-..|||+.+...|||+|||++|....+
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 799999999 99999998764 6888999999999999999999999999999999999999999999999999976443
Q ss_pred CCCccccccccc--CcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 174 APSAIFWTDYVA--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 174 ~~~~~~~~~~~g--T~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.. +....| ..-|||||.+.- ..++.++|||.|||++||++. |..||.|-...+.+-.|.+
T Consensus 545 ~y----YkaS~~kLPIKWmaPESINf--RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn----------- 607 (974)
T KOG4257|consen 545 AY----YKASRGKLPIKWMAPESINF--RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN----------- 607 (974)
T ss_pred ch----hhccccccceeecCccccch--hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC-----------
Confidence 22 111122 245999999864 789999999999999999875 9999987554333222211
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..+.|. -+++++.+..|+.+||++||.+||++.++..
T Consensus 608 --------------GeRlP~-----P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 608 --------------GERLPC-----PPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred --------------CCCCCC-----CCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 111222 2578999999999999999999999877643
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=298.72 Aligned_cols=257 Identities=24% Similarity=0.355 Sum_probs=204.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++..+.+.||+|.||.|.+|.-. .+.+||+|+++.. ........+.+||++|.+|+||||+.++++|+... -+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----Pi 610 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----PL 610 (807)
T ss_pred hheehhhhhcCcccceeEEEEec-CceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----ch
Confidence 45688999999999999999753 4699999999743 33344577999999999999999999999997543 48
Q ss_pred EEEEecCC-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 97 YVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~~~--l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
++|+|||+ |+|.+++.++.. +.......++.||+.|++||.+.+++||||.+.|+|++.++++||||||++|-....
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999 899999998743 334555679999999999999999999999999999999999999999999965443
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh--CCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT--GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt--G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
..-.. -...+-...|||||.+.- .+++.++|+|+||+++||+++ ...||......+..+....++..+....
T Consensus 691 ~yy~v-qgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~--- 764 (807)
T KOG1094|consen 691 DYYRV-QGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV--- 764 (807)
T ss_pred Cceee-ecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce---
Confidence 32211 123455578999999876 799999999999999999865 6789977666555555444443332211
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.-..-+-++..+.+|+.+|+..|-.+||+++++..
T Consensus 765 --------------------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 765 --------------------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred --------------------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 11112346678899999999999999999999865
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=312.27 Aligned_cols=246 Identities=32% Similarity=0.468 Sum_probs=189.5
Q ss_pred eeeeeecCceE-EEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCCCccEEEE
Q 010512 22 QEVIGKGSYGV-VGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIYVV 99 (508)
Q Consensus 22 ~~~LG~G~~g~-V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~lylV 99 (508)
.+++|.|+-|+ ||+|.- .|+.||||.+-. .....+.|||..|+.-+ |||||++++.- .+...+||.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIa 581 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIA 581 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEE
Confidence 35789998887 699964 588999998742 23456789999999885 99999998875 334569999
Q ss_pred EecCCccHHHHHHhCC-C---CCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC---CC--cEEEccccccccc
Q 010512 100 FELMESDLHQVIKAND-D---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DC--KLKICDFGLARVS 170 (508)
Q Consensus 100 ~E~~~g~L~~~i~~~~-~---l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~---~~--~lkL~DFGla~~~ 170 (508)
.|+|..+|.+++.... . .........+.|++.||++||+.+|+||||||+||||.. ++ .++|+|||+++..
T Consensus 582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 9999999999998741 1 111345778999999999999999999999999999976 34 5899999999987
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG-~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
..+...-.......||-+|+|||++.. ..-+.++||||+|||+|+.++| ..||...- ..+ ..|.. |..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~--~~~~~avDiFslGCvfyYvltgG~HpFGd~~-~R~-~NIl~--~~~----- 730 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLRE--DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL-ERQ-ANILT--GNY----- 730 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhc--cccCcccchhhcCceEEEEecCCccCCCchH-Hhh-hhhhc--Ccc-----
Confidence 665544444566789999999999987 5567799999999999999986 79995422 111 11211 000
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~ 311 (508)
.+...-+..+..+.|||.+||.+||..||+|.++|.||+|=
T Consensus 731 ---------------------~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 731 ---------------------TLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred ---------------------ceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 01111112222799999999999999999999999999994
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=307.18 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=216.4
Q ss_pred ccccCCCCCeEEeeeeeecCceEEEEEEECCCC---cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeec
Q 010512 10 FTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTG---ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIML 86 (508)
Q Consensus 10 ~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg---~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~ 86 (508)
|+.-..++...|.++||.|.||.||+|+.+..| ..||||.++.. -.......|+.|+.||-++.||||++|.++..
T Consensus 622 FakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 622 FAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 444467788899999999999999999988766 46999999743 34456678999999999999999999999994
Q ss_pred CCCcCCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccc
Q 010512 87 PPSRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 164 (508)
Q Consensus 87 ~~~~~~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DF 164 (508)
. ..-+.||+|||+ |.|..+|..+ +.|+.-+..-+++.|+.|++||-++|++||||-..|||+|.+-..|++||
T Consensus 701 k-----s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDF 775 (996)
T KOG0196|consen 701 K-----SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDF 775 (996)
T ss_pred c-----CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccc
Confidence 3 345899999999 8999999876 46999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCccccccccc--CcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhc
Q 010512 165 GLARVSFNDAPSAIFWTDYVA--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLL 241 (508)
Q Consensus 165 Gla~~~~~~~~~~~~~~~~~g--T~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~ 241 (508)
|++|+..++.+.. .+..-| ...|.|||.+.- .+++.++||||+|+++||.+. |..||-..+..+.+..|.+.+
T Consensus 776 GLSRvledd~~~~--ytt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy 851 (996)
T KOG0196|consen 776 GLSRVLEDDPEAA--YTTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY 851 (996)
T ss_pred cceeecccCCCcc--ccccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc
Confidence 9999765544221 232222 246999999975 799999999999999999875 999988888777777776655
Q ss_pred CCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 242 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
+-|++ .+++..+..|+..||++|-.+||++.||+.
T Consensus 852 RLPpP------------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 852 RLPPP------------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred CCCCC------------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 44432 357788999999999999999999999987
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=298.32 Aligned_cols=255 Identities=25% Similarity=0.401 Sum_probs=207.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECC-CC--cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTH-TG--ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~-tg--~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
++..+.+.||+|.||+|++|.... +| ..||||+++...... ....|++|+.+|.+|+|||+++||++.+..
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~q----- 183 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQ----- 183 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccc-----
Confidence 556778899999999999998764 23 469999997654433 556799999999999999999999999753
Q ss_pred ccEEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 94 KDIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
-+.+|||+++ |+|++.+.+ ...|.-.....|+.||+.|+.||.++++|||||-..|||+-..-.||||||||.+..
T Consensus 184 -p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 184 -PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred -hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceecc
Confidence 3689999999 899999887 345777888899999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
........+....--...|.|||.+.. ..++.++|+|++||++|||++ |..||.|.+..+.+.+|-+.
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~--------- 331 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG--------- 331 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc---------
Confidence 544433222222233456999999987 789999999999999999998 78999999987777665321
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
...+ .-+.++.++.+++..||..+|.+|||+..|.+.-+.
T Consensus 332 ----------------erLp-----RPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 332 ----------------ERLP-----RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred ----------------ccCC-----CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 0111 113467889999999999999999999988654443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=304.02 Aligned_cols=263 Identities=27% Similarity=0.432 Sum_probs=219.6
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
.-.++|+++..+|+|+||.||+|+|+.+++..|+|+++- ....+..-+..||-+++.++||||+.+++.|+...
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkL--ep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d---- 85 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKL--EPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD---- 85 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeec--cCCccccccccceeeeecCCCcChHHHHhhhhhhc----
Confidence 556899999999999999999999999999999999973 33456777889999999999999999999996543
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
.++|+||||+ |+|.+...-.+++++.++.+..+..++||+|||++|-+|||||-.|||+++.|.+|++|||.+..+..
T Consensus 86 -klwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 86 -KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred -CcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh
Confidence 4899999999 58888888888999999999999999999999999999999999999999999999999998875432
Q ss_pred CCCCcccccccccCcccccccccc-cccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCG-SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~-~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
. -....+++||+.|||||+.. +....|+..+|||++|+...|+---++|.-.......+.++.+-.-.|+.
T Consensus 165 t---i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~----- 236 (829)
T KOG0576|consen 165 T---IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT----- 236 (829)
T ss_pred h---hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc-----
Confidence 2 22356789999999999852 22367999999999999999999888887666655555555543322221
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
+. .-...++.+-+|++.+|.++|++|||++.+|.|||..+
T Consensus 237 --------------------lk-Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 237 --------------------LK-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred --------------------cc-CCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 10 11235677889999999999999999999999999864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=324.40 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=185.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
..|...++||+|+||.||+|.+..+|..||||+++.... ....|+.+|+.++|||||++++++... ...
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~ 758 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSE-----KGA 758 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcC-----CCC
Confidence 346667899999999999999999999999999864321 113468899999999999999999543 457
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhH---hcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 97 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLH---s~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
|+|||||+ |+|.+++. .+++..+..++.||++||+||| +.+|+||||||+||+++.++..+++ ||.+.....
T Consensus 759 ~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 99999998 69999985 3889999999999999999999 6699999999999999999888876 665543211
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV-HQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~-~~l~~i~~~~g~p~~~~~~~ 251 (508)
.....+|+.|+|||++.+ ..|+.++|||||||++|||++|+.||...... ..+..+....-.
T Consensus 835 -------~~~~~~t~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------- 897 (968)
T PLN00113 835 -------DTKCFISSAYVAPETRET--KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYS-------- 897 (968)
T ss_pred -------CCCccccccccCcccccC--CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcC--------
Confidence 123478899999999887 68999999999999999999999999532210 001111000000
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.......+.. ...... .........+.+++.+||+.||.+|||+.|+++.
T Consensus 898 --~~~~~~~~~~---~~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 898 --DCHLDMWIDP---SIRGDV-SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred --ccchhheeCc---cccCCC-CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000000000 000000 0001122356789999999999999999999883
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=289.99 Aligned_cols=203 Identities=25% Similarity=0.433 Sum_probs=176.1
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC----C--hhHHHHHHHHHHHHHhCC---CCCcceeee
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE----H--VSDATRILREIKLLRLLR---HPDIVEIKH 83 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~----~--~~~~~~i~~Ei~iL~~L~---HpnIv~l~~ 83 (508)
|.--..|..++.+|.|+||.|+.|+++.+...|+||.|.+..- . ......+-.||+||..|+ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 4445679999999999999999999999999999999865311 0 112234567999999998 999999999
Q ss_pred eecCCCcCCCccEEEEEecCC-c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEE
Q 010512 84 IMLPPSRREFKDIYVVFELME-S-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 161 (508)
Q Consensus 84 v~~~~~~~~~~~lylV~E~~~-g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL 161 (508)
+| ++.+++||+||--+ | +|+++|..+..++|.+++.||+|++-|+++||+.||+|||||-+|+.++.+|.+||
T Consensus 637 fF-----Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 637 FF-----EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred ee-----ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEE
Confidence 99 66678999999887 5 99999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCcccccccccCcccccccccccccCCC-CcchhhhhHHHHHHHHHhCCCCCCC
Q 010512 162 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEMLTGKPLFPG 227 (508)
Q Consensus 162 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y-~~~~DIWSlG~il~eLltG~~pF~~ 227 (508)
+|||.|...... ....++||..|.|||+++| .+| +..-|||++|++||-++....||.+
T Consensus 712 idfgsaa~~ksg-----pfd~f~gtv~~aapevl~g--~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 712 IDFGSAAYTKSG-----PFDVFVGTVDYAAPEVLGG--EKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eeccchhhhcCC-----CcceeeeeccccchhhhCC--CccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999764332 3456899999999999998 455 5778999999999999998888753
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=254.63 Aligned_cols=211 Identities=26% Similarity=0.457 Sum_probs=172.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHh-CCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL-LRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~-L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
+...-+..||+|+||+|-+.++..+|...|+|.+.....+ ..-+++++|+.+..+ ..+|.+|.+++.+ ...++
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~-q~q~r~L~dldi~~r~~~CPf~V~FyGa~-----~regd 119 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS-QEQKRLLMDLDIIMRTVDCPFTVHFYGAL-----FREGD 119 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh-HHHHHHHHhhhhhccCCCCCeEEEeehhh-----hcccc
Confidence 3345567899999999999999999999999999765443 455678899987655 4699999999987 44577
Q ss_pred EEEEEecCCccHHH----HHHhCCCCCHHHHHHHHHHHHHHHHHhHhc-CceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 96 IYVVFELMESDLHQ----VIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 96 lylV~E~~~g~L~~----~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~-gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
++|.||.|..+|.. .++.++..+|..+-+|+..++.||.|||++ .|+|||+||+|||+|.+|++|+||||.+...
T Consensus 120 vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 120 VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 99999999987754 455677899999999999999999999986 8999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCcccccccccccc--cCCCCcchhhhhHHHHHHHHHhCCCCCCC-CChHHHHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEMLTGKPLFPG-KNVVHQLDLM 237 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~--~~~y~~~~DIWSlG~il~eLltG~~pF~~-~~~~~~l~~i 237 (508)
.+.... +-..|-..|||||.+... ...|+.++||||||+.++||.+++.||+. ....+|+..+
T Consensus 200 ~dSiAk----t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 200 VDSIAK----TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred hhhhHH----HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 543322 334577899999998542 24799999999999999999999999964 3344455444
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=271.36 Aligned_cols=269 Identities=25% Similarity=0.326 Sum_probs=198.2
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHh--CCCCCcceeeeeecCCCcCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL--LRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~--L~HpnIv~l~~v~~~~~~~~ 92 (508)
.-.-.+++++||+|.||.||+|. -+++.||||++.. .+.+.+.+|-.|.+. ++|+||+++++.-...+. .
T Consensus 208 ~l~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~-~ 279 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA-D 279 (534)
T ss_pred cCCchhhHHHhhcCccceeehhh--ccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCc-c
Confidence 34556788999999999999995 4579999999963 345667777777655 579999999887544332 2
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhc---------CceecCCCCCceeeCCCCcEEEc
Q 010512 93 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA---------NVFHRDLKPKNILANADCKLKIC 162 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~---------gIiHrDLKPeNILl~~~~~lkL~ 162 (508)
...++||++|-+ |+|.++++.+ .+++....+++.-+++||+|||+- .|+|||||..||||.+|++.-|+
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 457899999998 8999999876 599999999999999999999974 49999999999999999999999
Q ss_pred cccccccccCCCCCcccccccccCcccccccccccccCCCC-----cchhhhhHHHHHHHHHhCCCCCC-CCChHHHHHH
Q 010512 163 DFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYT-----PAIDIWSIGCIFAEMLTGKPLFP-GKNVVHQLDL 236 (508)
Q Consensus 163 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~-----~~~DIWSlG~il~eLltG~~pF~-~~~~~~~l~~ 236 (508)
|||+|..+....+... .-..+||+.|||||++.+. -+.. .++||||+|.|++||++.-..+. +.-..-++..
T Consensus 359 DFGLAl~~~p~~~~~d-~~~qVGT~RYMAPEvLEga-inl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf 436 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGD-THGQVGTRRYMAPEVLEGA-INLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF 436 (534)
T ss_pred ccceeEEecCCCCCcc-hhhhhhhhhhcCHHHHhhh-cccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence 9999998765444332 3347999999999999763 2222 46899999999999998654432 3333333333
Q ss_pred HHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCC--CCCHHHHHHHHHhccCCCCCCCCHHHH
Q 010512 237 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFP--NADPLALHLLERLLAFDPKDRPTAEEA 304 (508)
Q Consensus 237 i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~~~~~~~~Ll~~mL~~DP~~Rpta~ei 304 (508)
-..+-..|+.+.+.... ++++....+...|. ..-..+.+.++.||..||+.|.|+.=+
T Consensus 437 e~evG~hPt~e~mq~~V----------V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 437 EAEVGNHPTLEEMQELV----------VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred hHHhcCCCCHHHHHHHH----------HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 33333455555443321 11222222222222 223457899999999999999998654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=241.05 Aligned_cols=212 Identities=37% Similarity=0.634 Sum_probs=182.0
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEecCC
Q 010512 25 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME 104 (508)
Q Consensus 25 LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~ 104 (508)
||+|++|.||++.+..+|+.+++|++....... ....+.+|+..++.++|++|+++++++... ...++|||++.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCC
Confidence 689999999999998889999999997532221 346788999999999999999999998543 56899999999
Q ss_pred -ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC-CCcEEEccccccccccCCCCCccccc
Q 010512 105 -SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSFNDAPSAIFWT 181 (508)
Q Consensus 105 -g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~-~~~lkL~DFGla~~~~~~~~~~~~~~ 181 (508)
++|.+++... ..+++..+..++.+++++|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~ 151 (215)
T cd00180 75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLK 151 (215)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhh
Confidence 6999998876 57899999999999999999999999999999999999999 89999999999986533221 123
Q ss_pred ccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHH
Q 010512 182 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYL 261 (508)
Q Consensus 182 ~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l 261 (508)
...++..|++||.+... ..++.+.|+|++|+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 45677889999998762 3788999999999999998
Q ss_pred hhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 010512 262 GSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308 (508)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp 308 (508)
..+.+++.+||..||.+||++.++++|+
T Consensus 188 -------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1267899999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=285.70 Aligned_cols=247 Identities=28% Similarity=0.476 Sum_probs=196.4
Q ss_pred EEeeeeeecCceEEEEEEECC-------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcC
Q 010512 20 QIQEVIGKGSYGVVGSAVDTH-------TGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 20 ~i~~~LG~G~~g~V~~a~~~~-------tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~ 91 (508)
.+.+.||+|+||.|++|.-.. ....||||.++..... .+.+.+..|+++|+.+. ||||+.+++.+..
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~---- 373 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ---- 373 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc----
Confidence 677799999999999997431 1457999999765444 67788999999999995 9999999999954
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeC
Q 010512 92 EFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 154 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~ 154 (508)
.+.+++|+||+. |+|..++..+. .++..+...|.+||+.|++||++..++||||-..|||+.
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 466999999999 89999998765 388999999999999999999999999999999999999
Q ss_pred CCCcEEEccccccccccCCCCCcccccccccC--cccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCC-h
Q 010512 155 ADCKLKICDFGLARVSFNDAPSAIFWTDYVAT--RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN-V 230 (508)
Q Consensus 155 ~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT--~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~-~ 230 (508)
.+..+||+|||+|+.......-.. ....++ ..|||||.+.. ..|+.++||||+|++||||++ |..||++-. .
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~--~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRT--KSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred CCCEEEEccccceeccCCCCceEe--cCCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 999999999999995433222110 111222 34999999987 789999999999999999998 889998733 2
Q ss_pred HHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 231 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 231 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.+.+..+.+. .+-.+| ..+++++.++++.||..+|.+||+..++..
T Consensus 529 ~~l~~~l~~G-----------------------~r~~~P-------~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 529 EELLEFLKEG-----------------------NRMEQP-------EHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHHhcC-----------------------CCCCCC-------CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 1222111110 000111 246788999999999999999999999876
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=258.02 Aligned_cols=265 Identities=24% Similarity=0.345 Sum_probs=190.4
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHH--HHhCCCCCcceeeeeecCCC
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKL--LRLLRHPDIVEIKHIMLPPS 89 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~i--L~~L~HpnIv~l~~v~~~~~ 89 (508)
.-.++.+..+++.||+|.||.||+|. ..|+.||||++... +.....||.+| -..|+|+||+.+++.-....
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~--wrGe~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGR--WRGEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecc--ccCCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 34567889999999999999999995 56999999999632 23344555555 45679999999988654332
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhc--------CceecCCCCCceeeCCCCcEE
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--------NVFHRDLKPKNILANADCKLK 160 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~--------gIiHrDLKPeNILl~~~~~lk 160 (508)
..-..+|||++|-+ |+|+|++.. ..++.+.+.++++.++.||++||.. .|.|||||..||||..++..-
T Consensus 279 -gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 279 -GSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred -CceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 33457999999999 899999988 5799999999999999999999964 399999999999999999999
Q ss_pred EccccccccccCCC-CCcccccccccCcccccccccccccC--CCC--cchhhhhHHHHHHHHHhC----------CCCC
Q 010512 161 ICDFGLARVSFNDA-PSAIFWTDYVATRWYRAPELCGSFFS--KYT--PAIDIWSIGCIFAEMLTG----------KPLF 225 (508)
Q Consensus 161 L~DFGla~~~~~~~-~~~~~~~~~~gT~~Y~APE~l~~~~~--~y~--~~~DIWSlG~il~eLltG----------~~pF 225 (508)
|+|+|||-....+. .-....+..+||..|||||++..... .+. .-+||||||.|++|++.. ++||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 99999997654442 22334567899999999999865211 111 358999999999998752 3666
Q ss_pred CCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCC--HHHHHHHHHhccCCCCCCCCHHH
Q 010512 226 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNAD--PLALHLLERLLAFDPKDRPTAEE 303 (508)
Q Consensus 226 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~--~~~~~Ll~~mL~~DP~~Rpta~e 303 (508)
.+--. ..|+.+.+..+. -++..+. .+...|...+ ..+..|++.||..||.-|.||-.
T Consensus 437 yd~Vp-----------~DPs~eeMrkVV------Cv~~~RP----~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALr 495 (513)
T KOG2052|consen 437 YDVVP-----------SDPSFEEMRKVV------CVQKLRP----NIPNRWKSDPALRVMAKLMKECWYANPAARLTALR 495 (513)
T ss_pred ccCCC-----------CCCCHHHHhcce------eecccCC----CCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHH
Confidence 43211 112222211110 0011111 2222232221 23457899999999999999866
Q ss_pred Hhc
Q 010512 304 ALA 306 (508)
Q Consensus 304 iL~ 306 (508)
+-+
T Consensus 496 iKK 498 (513)
T KOG2052|consen 496 IKK 498 (513)
T ss_pred HHH
Confidence 544
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=241.50 Aligned_cols=200 Identities=38% Similarity=0.661 Sum_probs=172.8
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEE
Q 010512 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 98 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 98 (508)
|.+.+.||.|++|.||+|.+..+++.+|+|.+...... .....+.+|+..++.++|+|++++++.+... ...|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEE
Confidence 67889999999999999999988999999999754322 2467788999999999999999999988443 46899
Q ss_pred EEecCCc-cHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCC
Q 010512 99 VFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 176 (508)
Q Consensus 99 V~E~~~g-~L~~~i~~~~~-l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~ 176 (508)
++|++++ +|.+++..... +++..+..++.|++.+|.|||+.+++|+||+|.||+++.++.++|+|||++.........
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999996 99999988766 899999999999999999999999999999999999999999999999999876443211
Q ss_pred cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCC
Q 010512 177 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 227 (508)
Q Consensus 177 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~ 227 (508)
......++..|++||.+.+ ...++.++|+||||+++++|++|+.||++
T Consensus 155 --~~~~~~~~~~~~~pe~~~~-~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 --LLKTVKGTPFYLAPEVLLG-GKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred --cccceeccCCcCCHhHhcC-CCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 1234577889999999842 26788899999999999999999999977
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=299.56 Aligned_cols=208 Identities=16% Similarity=0.208 Sum_probs=149.3
Q ss_pred hCCC-CCcceeeeeecCCC--cCCCccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCC
Q 010512 72 LLRH-PDIVEIKHIMLPPS--RREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 147 (508)
Q Consensus 72 ~L~H-pnIv~l~~v~~~~~--~~~~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLK 147 (508)
.+.| +||+.+++.+.... ......++++||+++++|.++|... ..+++.+++.|++||++||.|||++||+|||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 4455 57777888763221 1123468889999999999999753 469999999999999999999999999999999
Q ss_pred CCceeeCC-------------------CCcEEEccccccccccCCC-------------CCcccccccccCccccccccc
Q 010512 148 PKNILANA-------------------DCKLKICDFGLARVSFNDA-------------PSAIFWTDYVATRWYRAPELC 195 (508)
Q Consensus 148 PeNILl~~-------------------~~~lkL~DFGla~~~~~~~-------------~~~~~~~~~~gT~~Y~APE~l 195 (508)
|+||||+. ++.+||+|||+++...... +........+||++|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 99999965 4456666666665321000 000011225789999999999
Q ss_pred ccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCC
Q 010512 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHK 275 (508)
Q Consensus 196 ~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 275 (508)
.+ ..|+.++|||||||++|||++|.+||..... .+..+.. .. . .+ .
T Consensus 188 ~~--~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~-------------------~~---~---~~-----~ 233 (793)
T PLN00181 188 NG--SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRH-------------------RV---L---PP-----Q 233 (793)
T ss_pred cc--CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHH-------------------hh---c---Ch-----h
Confidence 87 6899999999999999999999888753211 1111100 00 0 00 0
Q ss_pred CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 276 FPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 276 ~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.....+.+.+++.+||.+||.+||++.|+|+||||...
T Consensus 234 ~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 234 ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 01123557789999999999999999999999999764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=274.57 Aligned_cols=247 Identities=25% Similarity=0.398 Sum_probs=198.4
Q ss_pred EEeeeeeecCceEEEEEEECCCC----cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 20 QIQEVIGKGSYGVVGSAVDTHTG----ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 20 ~i~~~LG~G~~g~V~~a~~~~tg----~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
+-.++||+|+||+||+|...-.| .+||||++.. +........++.|+-+|..|.|||+++|++++....
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~-~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------ 771 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE-FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------ 771 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeec-cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence 44678999999999999875445 4688988863 344455678999999999999999999999996543
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 96 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
+-||++||+ |.|.++++.+ +.+..+....|.+||++|+.|||.++++||||-..||||.+-..+||.|||+|+....+
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 789999999 8999999865 57999999999999999999999999999999999999999999999999999986554
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
...- ....-.-.+.|||-|.+.. ..|+.++||||+||.+||++| |..|+.+....+.-+.+.+
T Consensus 852 ~~ey-~~~~gK~pikwmale~i~~--~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~------------- 915 (1177)
T KOG1025|consen 852 EKEY-SAPGGKVPIKWMALESIRI--RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK------------- 915 (1177)
T ss_pred cccc-cccccccCcHHHHHHHhhc--cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc-------------
Confidence 3321 1111122356899998876 799999999999999999998 8999988765333222211
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..+.+ .-+.++-++.-++.+||..|+..||+++++..
T Consensus 916 ------------geRLs-----qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 916 ------------GERLS-----QPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ------------cccCC-----CCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 01111 12457788999999999999999999998765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=246.98 Aligned_cols=249 Identities=27% Similarity=0.431 Sum_probs=189.2
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~ 91 (508)
....+.|.|.+.||+|.||.+.+|.|+.+...+++|-+.+.. .....+.+|..---.|. |.||+.-+++...
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq---- 92 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQ---- 92 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhh----
Confidence 456688999999999999999999999999999999987643 34567888887655554 8999998888653
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeC-CC-CcEEEccccccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-AD-CKLKICDFGLAR 168 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~-~~-~~lkL~DFGla~ 168 (508)
..+.+++++||++ |+|..-+... .+.|...+.++.|+++||.|||+.+++|||||.+||||- .| .+|||||||+.+
T Consensus 93 t~d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 93 TSDAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred cCceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccc
Confidence 3356889999999 8999887764 488999999999999999999999999999999999974 33 469999999987
Q ss_pred cccCCCCCcccccccccCcccccccccccc---cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~ 245 (508)
..... ....--+-.|.+||++... .-...+..|||.||+|+|.+|+|.+||......++ +
T Consensus 172 k~g~t------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-----------~ 234 (378)
T KOG1345|consen 172 KVGTT------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-----------P 234 (378)
T ss_pred ccCce------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-----------h
Confidence 53211 1112234568999987431 12346789999999999999999999974332111 0
Q ss_pred hHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 010512 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR 298 (508)
Q Consensus 246 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~R 298 (508)
. -....++.. +. ......|...++.++.+.++-|..+|++|
T Consensus 235 Y--------~~~~~w~~r---k~-~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 235 Y--------WEWEQWLKR---KN-PALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred H--------HHHHHHhcc---cC-ccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 0 011111111 11 13345667789999999999999999999
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=281.95 Aligned_cols=269 Identities=27% Similarity=0.355 Sum_probs=203.7
Q ss_pred CCe-EEeeeeeecCceEEEEEEECCCCcEEEEEEec----CccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 17 SRY-QIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 17 ~rY-~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~----~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
..| .-..++|.|++|.|+.+....-.+.++.|.+. ...........+..|+-+-..|.|||++....++...
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~--- 393 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI--- 393 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc---
Confidence 344 34578999999988888877767767777654 1111111222367788888999999998887777433
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 92 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 92 ~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
..++-+||||++||+.++...+.++..++..++.||+.||+|||+.||.||||||+|+++..+|.+||+|||.+....
T Consensus 394 --~~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 394 --DGILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred --ccchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeec
Confidence 223444999999999999998899999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCC-cccccccccCcccccccccccccCCCC-cchhhhhHHHHHHHHHhCCCCCCCCChHHHH-HHHHhhcCCCChHH
Q 010512 172 NDAPS-AIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQL-DLMTDLLGTPSTES 248 (508)
Q Consensus 172 ~~~~~-~~~~~~~~gT~~Y~APE~l~~~~~~y~-~~~DIWSlG~il~eLltG~~pF~~~~~~~~l-~~i~~~~g~p~~~~ 248 (508)
..-.. .......+|+..|+|||++.+ ..|+ ..+||||+|+|++.|++|+.||.--...++. ..+.
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~--~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~---------- 539 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTG--KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN---------- 539 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccc--cccCcchhhhhhccceEEEEecCCCccccccccccchhhhc----------
Confidence 33222 244567899999999999988 6777 5689999999999999999999643322111 0000
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
..............+..++...+.+|.+||++||.+|.|+++|++.+||+.+..
T Consensus 540 -------------~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 540 -------------YSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred -------------cccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 000111112222333455677889999999999999999999999999997653
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=225.05 Aligned_cols=165 Identities=21% Similarity=0.265 Sum_probs=127.2
Q ss_pred ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCccccccc
Q 010512 105 SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY 183 (508)
Q Consensus 105 g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~ 183 (508)
|+|.+++.. +.++++..++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||+++..... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--------~~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE--------QS 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc--------cC
Confidence 689999987 456999999999999999999999998 999999999999999 9999865321 12
Q ss_pred ccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHhhcCCCChHHHHHHhhHHHHHHHh
Q 010512 184 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQ-LDLMTDLLGTPSTESISRIRNEKARRYLG 262 (508)
Q Consensus 184 ~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~-l~~i~~~~g~p~~~~~~~~~~~~~~~~l~ 262 (508)
.||+.|+|||++.+ ..|+.++|||||||++|+|++|++||........ +..+..
T Consensus 65 ~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~----------------------- 119 (176)
T smart00750 65 RVDPYFMAPEVIQG--QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN----------------------- 119 (176)
T ss_pred CCcccccChHHhcC--CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHH-----------------------
Confidence 68899999999987 6899999999999999999999999976543211 111111
Q ss_pred hcccCCCCCCCCCCCCCC--HHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010512 263 SMRKKQPVPFSHKFPNAD--PLALHLLERLLAFDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~--~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~ 311 (508)
.+....+... .....++ ..+.+||.+||..||.+|||+.++++|+|+.
T Consensus 120 ~~~~~~~~~~-~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 120 GMPADDPRDR-SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HhccCCcccc-ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 0110000000 0001122 2589999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-26 Score=222.96 Aligned_cols=265 Identities=34% Similarity=0.520 Sum_probs=205.2
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChh-HHHHHHHHHHHHHhCCCC-CcceeeeeecCCCcCCCccE
Q 010512 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS-DATRILREIKLLRLLRHP-DIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~-~~~~i~~Ei~iL~~L~Hp-nIv~l~~v~~~~~~~~~~~l 96 (508)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.+++.+.|+ +|+.+.+.+... ...
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE-----GSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC-----CEE
Confidence 889999999999999999887 7899999976555443 567789999999999988 799999999332 338
Q ss_pred EEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC-cEEEcccccccccc
Q 010512 97 YVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVSF 171 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~-~lkL~DFGla~~~~ 171 (508)
+++++++. +++.+++.... .+++.....++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||+++...
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 99999999 58887777664 799999999999999999999999999999999999999998 79999999998543
Q ss_pred CCCCCc---ccccccccCccccccccccccc-CCCCcchhhhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhhcCCC
Q 010512 172 NDAPSA---IFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV---VHQLDLMTDLLGTP 244 (508)
Q Consensus 172 ~~~~~~---~~~~~~~gT~~Y~APE~l~~~~-~~y~~~~DIWSlG~il~eLltG~~pF~~~~~---~~~l~~i~~~~g~p 244 (508)
...... ......+||.+|+|||.+.+.. ..+....|+||+|++++++++|..||..... ...........+.+
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 332221 1346679999999999987621 4678899999999999999999999877653 22222211111111
Q ss_pred ChHHHHHHhhHHHHHHHhhcccCCCCCCCCCC-CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.......... ......+.+++..++..+|..|.+..+...++|....
T Consensus 234 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 234 ----------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred ----------------------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 0000000000 1223568899999999999999999999998776543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=235.97 Aligned_cols=180 Identities=20% Similarity=0.227 Sum_probs=135.4
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECC-CCcEEEEEEecCccC---ChhHHHHHHHHHHHHHhCCCCCcce-eeeeecCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTH-TGERVAIKKINDVFE---HVSDATRILREIKLLRLLRHPDIVE-IKHIMLPP 88 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~-tg~~vAIKki~~~~~---~~~~~~~i~~Ei~iL~~L~HpnIv~-l~~v~~~~ 88 (508)
-..++|.+.+.||+|+||+||+|++.. ++..||||++..... .......+.+|+.+|+.++|+||+. +++ +
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-~--- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-T--- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-c---
Confidence 356789999999999999999999876 788889998753211 2223556889999999999999985 433 1
Q ss_pred CcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCC-CCCceeeCCCCcEEEccccc
Q 010512 89 SRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDL-KPKNILANADCKLKICDFGL 166 (508)
Q Consensus 89 ~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDL-KPeNILl~~~~~lkL~DFGl 166 (508)
+..|+|||||+| +|. .+.. .. ...++.|+++||.|||++||+|||| ||+|||++.++.+||+|||+
T Consensus 91 -----~~~~LVmE~~~G~~L~-~~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 91 -----GKDGLVRGWTEGVPLH-LARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred -----CCcEEEEEccCCCCHH-HhCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 236999999986 665 2211 11 1468899999999999999999999 99999999999999999999
Q ss_pred cccccCCCCCcc-----cccccccCcccccccccccccC----CCCcchhhh
Q 010512 167 ARVSFNDAPSAI-----FWTDYVATRWYRAPELCGSFFS----KYTPAIDIW 209 (508)
Q Consensus 167 a~~~~~~~~~~~-----~~~~~~gT~~Y~APE~l~~~~~----~y~~~~DIW 209 (508)
|+.......... ..+..++++.|+|||.+..... ..+...|-|
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 997643321111 1245678899999999854212 233446666
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-26 Score=224.88 Aligned_cols=253 Identities=19% Similarity=0.335 Sum_probs=199.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC-----CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHT-----GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~t-----g~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
..|++...++-+|.||.||.|+.+.. .+.|-+|.++. .........++.|--+|..+.|||+..+.++...
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie--- 358 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE--- 358 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeEEEee---
Confidence 35788888999999999999965532 34566776653 2334456778899999999999999999999864
Q ss_pred CCCccEEEEEecCC-ccHHHHHHh------C--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEE
Q 010512 91 REFKDIYVVFELME-SDLHQVIKA------N--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 161 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~------~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL 161 (508)
+...-++++.+++ |+|..++.. + ..++..+...++.|+..|++|||+.||+|.||-..|.+|++.-++||
T Consensus 359 -~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 359 -DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred -ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 3345688999998 899999872 1 24677778889999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhh
Q 010512 162 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDL 240 (508)
Q Consensus 162 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~ 240 (508)
+|=.++|..+........ ...-....||+||.+.. ..|+.++|+||||+++|||++ |+.|+..-+..+....+.+.
T Consensus 438 tDsaLSRDLFP~DYhcLG-DnEnRPvkWMslEal~n--~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG 514 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLG-DNENRPVKWMSLEALQN--SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG 514 (563)
T ss_pred ccchhccccCcccccccC-CCCCCcccccCHHHHhh--hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence 999999987654433211 11123356999999987 799999999999999999998 88999877765555544432
Q ss_pred cCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 241 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 241 ~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
. +-.+| -++++++..++.-||..+|.+||+.+|+..
T Consensus 515 y-----------------------RlaQP-------~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 Y-----------------------RLAQP-------FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred c-----------------------eecCC-------CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 1 11111 268899999999999999999999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-24 Score=221.18 Aligned_cols=255 Identities=20% Similarity=0.216 Sum_probs=188.1
Q ss_pred CeEEeeeeeecCceEEEEEEECCCC-cEEEEEEecCccCChhHHHHHHHHHHHHHhCCC----CCcceeeeeecCCCcCC
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTG-ERVAIKKINDVFEHVSDATRILREIKLLRLLRH----PDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg-~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~H----pnIv~l~~v~~~~~~~~ 92 (508)
+|.+.+.||+|+||.||.|.+..++ ..+|+|......... ...+..|+.+|..+.. .++..+++... ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----ST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--CccchhHHHHHHHHhhhcCCCCCCEEEEecc----CC
Confidence 8999999999999999999988775 678888775432221 1156789999988873 58888888773 12
Q ss_pred CccEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC-----CcEEEcccc
Q 010512 93 FKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-----CKLKICDFG 165 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~-----~~lkL~DFG 165 (508)
...-||||++++.+|.++.... +.++...+..++.|++.+|.+||+.|++||||||+|+++... ..+.|.|||
T Consensus 93 ~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 93 EDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred CceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 3457999999999999988654 479999999999999999999999999999999999999865 359999999
Q ss_pred ccc--cccCCCCC----ccc-ccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 010512 166 LAR--VSFNDAPS----AIF-WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMT 238 (508)
Q Consensus 166 la~--~~~~~~~~----~~~-~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~ 238 (508)
+|+ ........ ... .....||..|+++.+..+ ...+.+.|+||++.++.+|+.|..||.+.........+.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCC--CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 999 43222211 001 234569999999999988 688999999999999999999999997655332222211
Q ss_pred hhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 239 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 239 ~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
... .... .. ......+.....+...+-..+...+|....+..
T Consensus 251 ~~~---------------~~~~--------~~---~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 251 KDP---------------RKLL--------TD---RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred HHh---------------hhhc--------cc---cccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 100 0000 00 011223355666666666678888888776655
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=203.30 Aligned_cols=213 Identities=25% Similarity=0.337 Sum_probs=170.8
Q ss_pred ccccccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCC-CCcceeeeeec
Q 010512 8 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH-PDIVEIKHIML 86 (508)
Q Consensus 8 ~~~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~H-pnIv~l~~v~~ 86 (508)
.-..+...+++|.+++.||+|+||.+|.|....+|+.||||.-..... ...+..|.++.+.|++ ..|..+..+..
T Consensus 6 ~s~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 6 GSLEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred cchhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhcc
Confidence 334567889999999999999999999999999999999998654322 3457789999999985 56766666653
Q ss_pred CCCcCCCccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC---CcEEEc
Q 010512 87 PPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKIC 162 (508)
Q Consensus 87 ~~~~~~~~~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~---~~lkL~ 162 (508)
+..+-.+||++++.+|.+++.- ...++...+.-++-|++.-++|+|..+++||||||+|+|..-+ .++.|+
T Consensus 82 -----e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LI 156 (341)
T KOG1163|consen 82 -----EKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLI 156 (341)
T ss_pred -----ccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEE
Confidence 3345689999999877776653 4569999999999999999999999999999999999997543 469999
Q ss_pred cccccccccCCCCCc-c---cccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChH
Q 010512 163 DFGLARVSFNDAPSA-I---FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 231 (508)
Q Consensus 163 DFGla~~~~~~~~~~-~---~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~ 231 (508)
|||+|+.+....... + .-....||..|.+--...+ ..-+...|+-|+|.++..+.-|..||.|....
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g--~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG--IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhh--hhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 999998764432221 1 1234679999998776665 45567899999999999999999999986543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-25 Score=241.65 Aligned_cols=252 Identities=27% Similarity=0.390 Sum_probs=186.5
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc--CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~--~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.|...+.||++.|=.|.+|.+. .|. |+||++-+.. .......+.+.|++ ...+++||.+.+..+. ...+.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence 7999999999999999999875 455 8899985432 23344556667777 7778999999887765 33456
Q ss_pred EEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc--CC
Q 010512 96 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF--ND 173 (508)
Q Consensus 96 lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~--~~ 173 (508)
.|||-+|...+|++.+..++-|..-+.+.|+.||+.||.-||..||+|+|||.+||||++=+.+.|+||..-+... .+
T Consensus 96 AylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 7999999999999999998889999999999999999999999999999999999999999999999997765432 22
Q ss_pred CCCc--ccccccccCcccccccccccc--------cCC-CCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhc
Q 010512 174 APSA--IFWTDYVATRWYRAPELCGSF--------FSK-YTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLL 241 (508)
Q Consensus 174 ~~~~--~~~~~~~gT~~Y~APE~l~~~--------~~~-y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~ 241 (508)
.+.. .++.+...-.+|.|||.+... ... .+++.||||+||+++||++ |+|||. ..|+-.....-
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~~ 251 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSGN 251 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhccC
Confidence 2211 111122233479999987441 012 5789999999999999987 899994 22221111100
Q ss_pred CCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 242 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.-.. ...+..+ .+...+.||..|++.||.+|.+|++.|+.
T Consensus 252 -~~~~-----------e~~Le~I--------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 -ADDP-----------EQLLEKI--------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred -ccCH-----------HHHHHhC--------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0000 1111111 12357899999999999999999999984
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.6e-23 Score=198.94 Aligned_cols=224 Identities=21% Similarity=0.310 Sum_probs=175.6
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~ 93 (508)
.+-.|+|++.||+|+||+.+.|.+.-+++.||||.-.. .+++.++..|.+..+.|. .++|..++-+- .+.
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr----kS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG 96 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEG 96 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccc----cCCcchHHHHHHHHHHHcCCCCCCceeeec-----ccc
Confidence 45679999999999999999999999999999997543 345667788999999886 58888775544 334
Q ss_pred ccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC-----cEEEcccccc
Q 010512 94 KDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-----KLKICDFGLA 167 (508)
Q Consensus 94 ~~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~-----~lkL~DFGla 167 (508)
.+=.||||+++.+|.++..= ...|+...+.-++.|++.-++|+|++++|+|||||+|+||..-+ .|.|+|||+|
T Consensus 97 ~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 97 KYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred chhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 45579999999766665543 45699999999999999999999999999999999999997543 4899999999
Q ss_pred ccccCCCCCc-cc---ccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhh
Q 010512 168 RVSFNDAPSA-IF---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN---VVHQLDLMTDL 240 (508)
Q Consensus 168 ~~~~~~~~~~-~~---~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~---~~~~l~~i~~~ 240 (508)
+.+....... +. .....||..||+--...+ ..-+...|+-|||-+|...|-|..||.|.. ..+..++|-+-
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG--rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeecccc--chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 9875443332 11 234579999999888777 567889999999999999999999998864 33445555443
Q ss_pred cCCCChHHH
Q 010512 241 LGTPSTESI 249 (508)
Q Consensus 241 ~g~p~~~~~ 249 (508)
-...+.+.+
T Consensus 255 Kr~T~i~~L 263 (449)
T KOG1165|consen 255 KRSTPIEVL 263 (449)
T ss_pred cccCCHHHH
Confidence 333333333
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.7e-24 Score=232.55 Aligned_cols=228 Identities=28% Similarity=0.411 Sum_probs=173.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
...|+.++.|..|+||-||.++|+.|.+.+|+ +|++. .-+ || ||..+. ++
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq-------~li------lR-----nilt~a-----------~n 131 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQ-------NLI------LR-----NILTFA-----------GN 131 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-ccccc-------chh------hh-----cccccc-----------CC
Confidence 46799999999999999999999999999999 66531 111 11 122211 12
Q ss_pred EEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 96 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 96 lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
.++| ||-..+++..++++-+. +.|++|||+.||+|||+||+|++|+.-|.+|+.|||+.........
T Consensus 132 pfvv-----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 132 PFVV-----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ccee-----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 2444 66666666666666554 7789999999999999999999999999999999999976432221
Q ss_pred Cc------------ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC
Q 010512 176 SA------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 243 (508)
Q Consensus 176 ~~------------~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~ 243 (508)
.. ..-...+||+.|+|||++.. ..|+..+|.|++|+|+|+.+.|..||.|+...+.+.......
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr--qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~-- 274 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD-- 274 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhh--hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh--
Confidence 11 11123589999999999987 789999999999999999999999999988766655433211
Q ss_pred CChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCC---CCHHHHhcCCcccCCCCC
Q 010512 244 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR---PTAEEALADPYFHGLANV 316 (508)
Q Consensus 244 p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~R---pta~eiL~hp~f~~~~~~ 316 (508)
+.|.+.....+++++++|.++|+.+|..| ..+-++.+|+||+.+...
T Consensus 275 --------------------------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 275 --------------------------IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred --------------------------ccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 12233334567899999999999999999 457888999999987653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8e-25 Score=229.30 Aligned_cols=241 Identities=25% Similarity=0.403 Sum_probs=196.2
Q ss_pred eeeecCceEEEEEEE---CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCCCccEEEE
Q 010512 24 VIGKGSYGVVGSAVD---THTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIYVV 99 (508)
Q Consensus 24 ~LG~G~~g~V~~a~~---~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~lylV 99 (508)
++|.|+||.|++++. ...|..||+|+.++......+......|-.++..++ ||.+|++...+. ....+|++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafq-----t~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQ-----TDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeec-----cccchhHh
Confidence 479999999988753 346788999998765444444445556888898887 999999988884 44569999
Q ss_pred EecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcc
Q 010512 100 FELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 178 (508)
Q Consensus 100 ~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~ 178 (508)
+++.. |+|+..+.....+++...+.+...++-|++++|+.+|+|||+|++||+++.+|.+++.|||+.+......
T Consensus 76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 99998 5999998888889999999999999999999999999999999999999999999999999998654322
Q ss_pred cccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh-hcCCCChHHHHHHhhHHH
Q 010512 179 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTD-LLGTPSTESISRIRNEKA 257 (508)
Q Consensus 179 ~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~-~~g~p~~~~~~~~~~~~~ 257 (508)
..|||..|||||++.+ ...++|.||+|+++++|++|..||.+ +....|.. -++.|
T Consensus 152 ---~~cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p------------- 207 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMP------------- 207 (612)
T ss_pred ---hcccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCc-------------
Confidence 1289999999999863 67899999999999999999999976 33333322 11111
Q ss_pred HHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCCCC
Q 010512 258 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLANV 316 (508)
Q Consensus 258 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt-----a~eiL~hp~f~~~~~~ 316 (508)
...+..+.+++..|+..+|..|.- +.|+++|+||+.+...
T Consensus 208 -------------------~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 208 -------------------RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred -------------------hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 234577899999999999999965 5899999999876543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-23 Score=200.02 Aligned_cols=177 Identities=12% Similarity=0.124 Sum_probs=134.9
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhH-HHH------HHHHHHHHHhCCCCCcceeeeeecC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSD-ATR------ILREIKLLRLLRHPDIVEIKHIMLP 87 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~-~~~------i~~Ei~iL~~L~HpnIv~l~~v~~~ 87 (508)
..++|+++++||.|+||.||++.+ ++..||||.+......... ... +.+|++.+.++.||+|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 468999999999999999999754 4778999999754433222 222 5789999999999999999988764
Q ss_pred CCcC---CCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcc
Q 010512 88 PSRR---EFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 163 (508)
Q Consensus 88 ~~~~---~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~D 163 (508)
.... ..+..||||||++| +|.++. .+++ ..+.+++.+|..||..||+|||+||.||+++.+| ++|+|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 3221 13458999999997 787763 2333 2466999999999999999999999999999988 99999
Q ss_pred ccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHH
Q 010512 164 FGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEML 219 (508)
Q Consensus 164 FGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLl 219 (508)
||........... + .+... ..|+.++|+||||+.+..+.
T Consensus 178 fg~~~~~~e~~a~-----d----------~~vle--r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKAK-----D----------RIDLE--RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhhH-----H----------HHHHH--hHhcccccccceeEeehHHH
Confidence 9988754221110 0 02222 45778999999999988765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-23 Score=196.32 Aligned_cols=140 Identities=23% Similarity=0.250 Sum_probs=110.0
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhH------------------------HHHHHHHHHHHHhCCCCC
Q 010512 22 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSD------------------------ATRILREIKLLRLLRHPD 77 (508)
Q Consensus 22 ~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~------------------------~~~i~~Ei~iL~~L~Hpn 77 (508)
.+.||+|+||.||+|.+. +|+.||||+++........ .....+|+++|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 578999999999999986 8999999999753221111 122345999999998887
Q ss_pred cceeeeeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHh-HhcCceecCCCCCceeeCC
Q 010512 78 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI-HTANVFHRDLKPKNILANA 155 (508)
Q Consensus 78 Iv~l~~v~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yL-Hs~gIiHrDLKPeNILl~~ 155 (508)
+.....+.. ...||||||++| ++...+.....+++..+..++.|++.+|.|| |+.||+||||||+|||++
T Consensus 81 v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~- 152 (190)
T cd05147 81 IPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence 754333221 123899999996 5544444556899999999999999999999 799999999999999998
Q ss_pred CCcEEEccccccccc
Q 010512 156 DCKLKICDFGLARVS 170 (508)
Q Consensus 156 ~~~lkL~DFGla~~~ 170 (508)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 578999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=201.28 Aligned_cols=240 Identities=20% Similarity=0.278 Sum_probs=153.3
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCC----------CCcceeeeeec
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRH----------PDIVEIKHIML 86 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~H----------pnIv~l~~v~~ 86 (508)
.+...+.||.|+++.||.++|..||+.+|+|++.-.. ......+.+.+|.-....+.+ -.++-.+++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 5677889999999999999999999999999974322 222345666666644444332 12333333332
Q ss_pred CCCc-------C--CC---ccEEEEEecCCccHHHHHHh---CCC----CCHHHHHHHHHHHHHHHHHhHhcCceecCCC
Q 010512 87 PPSR-------R--EF---KDIYVVFELMESDLHQVIKA---NDD----LTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 147 (508)
Q Consensus 87 ~~~~-------~--~~---~~lylV~E~~~g~L~~~i~~---~~~----l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLK 147 (508)
.... . .. -+.+++|+-+.++|.+++.. ... +.......+..|+++.+++||+.||+|+|||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 1100 0 00 13578999999998887642 221 2222334455899999999999999999999
Q ss_pred CCceeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccc------cCCCCcchhhhhHHHHHHHHHhC
Q 010512 148 PKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEMLTG 221 (508)
Q Consensus 148 PeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~------~~~y~~~~DIWSlG~il~eLltG 221 (508)
|+|++++.+|.++|+||+........ ......+..|.+||+.... ...++.+.|.|+||+++|.|++|
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~------~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTR------YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEE------EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred eeeEEEcCCCCEEEcChHHHeecCce------eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999987653211 1113455789999987431 13588899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 010512 222 KPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR 298 (508)
Q Consensus 222 ~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~R 298 (508)
..||....... .....|...- +++...++||..||+.||.+|
T Consensus 247 ~lPf~~~~~~~----------------------------------~~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEA----------------------------------DPEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGS----------------------------------TSGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccc----------------------------------cccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99997543210 0000233333 778899999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=190.44 Aligned_cols=141 Identities=23% Similarity=0.196 Sum_probs=112.3
Q ss_pred EeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChh------------------------HHHHHHHHHHHHHhCCCC
Q 010512 21 IQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS------------------------DATRILREIKLLRLLRHP 76 (508)
Q Consensus 21 i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~------------------------~~~~i~~Ei~iL~~L~Hp 76 (508)
|.+.||+|+||.||+|.+. +|+.||||+++....... ....+.+|+..+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 4578999999999999987 899999999875421100 012345799999999999
Q ss_pred CcceeeeeecCCCcCCCccEEEEEecCCcc-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-cCceecCCCCCceeeC
Q 010512 77 DIVEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILAN 154 (508)
Q Consensus 77 nIv~l~~v~~~~~~~~~~~lylV~E~~~g~-L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs-~gIiHrDLKPeNILl~ 154 (508)
+|.....+... ..||||||++|. +.........++...+..++.|++.+|.+||+ .||+||||||+|||++
T Consensus 80 ~i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~ 152 (190)
T cd05145 80 GVPVPEPILLK-------KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCCCceEEEec-------CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence 88655444321 138999999963 44333344578899999999999999999999 9999999999999999
Q ss_pred CCCcEEEccccccccc
Q 010512 155 ADCKLKICDFGLARVS 170 (508)
Q Consensus 155 ~~~~lkL~DFGla~~~ 170 (508)
++.++|+|||++...
T Consensus 153 -~~~~~liDFG~a~~~ 167 (190)
T cd05145 153 -DGKPYIIDVSQAVEL 167 (190)
T ss_pred -CCCEEEEEcccceec
Confidence 889999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=199.78 Aligned_cols=203 Identities=25% Similarity=0.359 Sum_probs=145.3
Q ss_pred CCCCcceeeeeecCCC----------------------cCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHH
Q 010512 74 RHPDIVEIKHIMLPPS----------------------RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLR 131 (508)
Q Consensus 74 ~HpnIv~l~~v~~~~~----------------------~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~ 131 (508)
+|||||++...|.+.- ......+|+||.....+|.+++-.+. .+.....-++.|+++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~-~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH-RSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC-CchHHHHHHHHHHHH
Confidence 5999999998875321 12345699999999999999997764 677788889999999
Q ss_pred HHHHhHhcCceecCCCCCceeeC--CCC--cEEEccccccccccCCCCCcccc---cccccCcccccccccccccCC---
Q 010512 132 GLKYIHTANVFHRDLKPKNILAN--ADC--KLKICDFGLARVSFNDAPSAIFW---TDYVATRWYRAPELCGSFFSK--- 201 (508)
Q Consensus 132 aL~yLHs~gIiHrDLKPeNILl~--~~~--~lkL~DFGla~~~~~~~~~~~~~---~~~~gT~~Y~APE~l~~~~~~--- 201 (508)
|+.|||.+||.|||||.+|||+. .|+ .+.|+|||.+-......-.-... -+.-|...-||||+....-++
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av 432 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV 432 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence 99999999999999999999974 333 48999999986533221111111 234577889999997542111
Q ss_pred CC-cchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCC
Q 010512 202 YT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNAD 280 (508)
Q Consensus 202 y~-~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 280 (508)
.+ .++|.|+.|.+.||++....||.+...... + .+.| +...+...-..++
T Consensus 433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-------------~---------~r~Y-------qe~qLPalp~~vp 483 (598)
T KOG4158|consen 433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-------------D---------TRTY-------QESQLPALPSRVP 483 (598)
T ss_pred eccchhhhhhhhhhHHHHhccCCcccccchhee-------------c---------hhhh-------hhhhCCCCcccCC
Confidence 12 479999999999999999999976432110 0 0001 1111122234678
Q ss_pred HHHHHHHHHhccCCCCCCCCH---HHHhc
Q 010512 281 PLALHLLERLLAFDPKDRPTA---EEALA 306 (508)
Q Consensus 281 ~~~~~Ll~~mL~~DP~~Rpta---~eiL~ 306 (508)
+.+++|+..+|+.||++|+++ ..+|+
T Consensus 484 p~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 484 PVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred hHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 999999999999999999984 45554
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.1e-21 Score=179.21 Aligned_cols=191 Identities=16% Similarity=0.068 Sum_probs=137.9
Q ss_pred EEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh--hHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCCCccE
Q 010512 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV--SDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 20 ~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~--~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~l 96 (508)
.+...|++|+||+|+.+.. .+.+++.+.+....... .....+.+|+++|++|. |++|.+++++. ..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CE
Confidence 3567899999999998854 68888888775432211 12235789999999996 58899887752 26
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCC-CCCceeeCCCCcEEEccccccccccCCC
Q 010512 97 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDL-KPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 97 ylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDL-KPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
|+||||+.| +|.+.+.. ....++.|++.+|.+||++||+|||| ||+|||++.++.++|+|||+|.......
T Consensus 74 ~lvmeyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred EEEEeeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999999997 56543321 12357889999999999999999999 7999999999999999999998543222
Q ss_pred CCcc--ccc--------ccccCcccccccccccccCCCC-cchhhhhHHHHHHHHHhCCCCCCCCC
Q 010512 175 PSAI--FWT--------DYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKN 229 (508)
Q Consensus 175 ~~~~--~~~--------~~~gT~~Y~APE~l~~~~~~y~-~~~DIWSlG~il~eLltG~~pF~~~~ 229 (508)
.... ... -...++.|++|+.-.-. ...+ ...+.++.|+-+|.++|+..|+-+++
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l-~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVL-KRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh-ccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 1000 000 01256778888764321 2334 56677789999999999998876554
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=179.85 Aligned_cols=136 Identities=21% Similarity=0.250 Sum_probs=107.2
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-----CCCCcceeeeeecCCCcCCCccE
Q 010512 22 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-----RHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 22 ~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-----~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
.+.||+|+||.||. +..++.. +||++.... ......+.+|+.+++.+ .||||+++++++.+.. ..+.+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEE
Confidence 46899999999995 7777776 699986422 22456789999999999 5799999999996542 22444
Q ss_pred E-EEEecCC---ccHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHhHhcCceecCCCCCceeeCC----CCcEEEcccccc
Q 010512 97 Y-VVFELME---SDLHQVIKANDDLTPEHYQFFLYQLLRGL-KYIHTANVFHRDLKPKNILANA----DCKLKICDFGLA 167 (508)
Q Consensus 97 y-lV~E~~~---g~L~~~i~~~~~l~~~~~~~i~~Qil~aL-~yLHs~gIiHrDLKPeNILl~~----~~~lkL~DFGla 167 (508)
| +||||++ ++|.+++... .+++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 5 7899954 6999999764 56666 46688988888 9999999999999999999974 347999995544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-21 Score=200.06 Aligned_cols=258 Identities=24% Similarity=0.371 Sum_probs=171.7
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCC---CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeee-------
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH------- 83 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~t---g~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~------- 83 (508)
.....+.+.+..+.++++.+....-..+ .+.+.-+..+ ..+........+++-.+....|.+..-+.+
T Consensus 241 ~~~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~--~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~ 318 (516)
T KOG1033|consen 241 EESGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRAD--VDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFE 318 (516)
T ss_pred cccccccccccccccccCCchhhhhcccchhhhhccchhhh--ccchhhhhhhhhhhhheeccccCCcccccCCCCchhh
Confidence 3444555666666666666655433222 2233333221 112134455667777776666555444433
Q ss_pred eecCCCcCCCccEEEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcE
Q 010512 84 IMLPPSRREFKDIYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 159 (508)
Q Consensus 84 v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~l 159 (508)
...........++||.|++|. .+|.++|.... ..+....+.++.|+..|++| +|.+|||+||.||+...++.+
T Consensus 319 ~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~ 395 (516)
T KOG1033|consen 319 SSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQL 395 (516)
T ss_pred hccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhh
Confidence 111111122346999999998 79999997543 46778899999999999999 999999999999999999999
Q ss_pred EEccccccccccCCC---CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 010512 160 KICDFGLARVSFNDA---PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 236 (508)
Q Consensus 160 kL~DFGla~~~~~~~---~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~ 236 (508)
||.|||+........ +.....+..+||.|||+||.+.+ ..|+.++||||||+|||||+.- |.. ..+....
T Consensus 396 kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--~~y~~kvdIyaLGlil~EL~~~---f~T--~~er~~t 468 (516)
T KOG1033|consen 396 KIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG--QQYSEKVDIYALGLILAELLIQ---FST--QFERIAT 468 (516)
T ss_pred hhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhh--hhhhhhcchhhHHHHHHHHHHH---hcc--HHHHHHh
Confidence 999999998754433 11223566799999999999998 7999999999999999999972 211 1111111
Q ss_pred HHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 237 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 237 i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
+. .++. ..+...+..-.|...+|+.+||...|.+||++.+.--|+|.
T Consensus 469 ~~------------------------d~r~---g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 469 LT------------------------DIRD---GIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hh------------------------hhhc---CCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 10 0011 11111112223567799999999999999988877777764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.6e-20 Score=181.67 Aligned_cols=147 Identities=18% Similarity=0.138 Sum_probs=113.3
Q ss_pred CCCCeEEeeeeeecCceEEEEEE-ECCCCcEEEEEEecCccCCh--------------------h--HHHHHHHHHHHHH
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAV-DTHTGERVAIKKINDVFEHV--------------------S--DATRILREIKLLR 71 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~-~~~tg~~vAIKki~~~~~~~--------------------~--~~~~i~~Ei~iL~ 71 (508)
.+.-|.+.+.||+|+||.||+|. +..+|..||||+++...... . ....+.+|+.+++
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 34458899999999999999998 67799999999986432100 0 1123568999999
Q ss_pred hCCCCCcceeeeeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcC-ceecCCCCC
Q 010512 72 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN-VFHRDLKPK 149 (508)
Q Consensus 72 ~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~g-IiHrDLKPe 149 (508)
.+.+.. +.+..++.. ...|+||||++| +|.........+....+..++.||+.+|.+||+.| |+||||||+
T Consensus 106 ~L~~~~-i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~ 178 (237)
T smart00090 106 RLYEAG-VPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEY 178 (237)
T ss_pred HHHhcC-CCCCeeeEe------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChh
Confidence 997633 222233311 124899999997 56555444556777778899999999999999999 999999999
Q ss_pred ceeeCCCCcEEEcccccccc
Q 010512 150 NILANADCKLKICDFGLARV 169 (508)
Q Consensus 150 NILl~~~~~lkL~DFGla~~ 169 (508)
||+++ ++.++|+|||++..
T Consensus 179 NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hEEEE-CCCEEEEEChhhhc
Confidence 99999 88999999999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.6e-21 Score=211.09 Aligned_cols=265 Identities=26% Similarity=0.363 Sum_probs=208.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDT-HTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~-~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~ 93 (508)
...|.+.+.||+|+|+.|-.+... .+...+|.|.+............+..|..+-+.+. |.|++.+++.... .
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~-----~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS-----P 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC-----C
Confidence 567999999999999999988764 34567888887655433444556667888888887 9999999888743 4
Q ss_pred ccEEEEEecCC-ccHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHhH-hcCceecCCCCCceeeCCCC-cEEEccccccc
Q 010512 94 KDIYVVFELME-SDLHQVI-KAND-DLTPEHYQFFLYQLLRGLKYIH-TANVFHRDLKPKNILANADC-KLKICDFGLAR 168 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i-~~~~-~l~~~~~~~i~~Qil~aL~yLH-s~gIiHrDLKPeNILl~~~~-~lkL~DFGla~ 168 (508)
...+++++|.. ++++.-+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ .++++|||+|.
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhc
Confidence 45799999987 5888888 5544 6788899999999999999999 99999999999999999999 99999999999
Q ss_pred cccCCCCCccccccccc-CcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChH
Q 010512 169 VSFNDAPSAIFWTDYVA-TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~g-T~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
...............+| ++.|+|||.+.+. ....+..|+||+|+++..+++|..||......+.
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-------------- 238 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-------------- 238 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCccccccccc--------------
Confidence 87653334444567788 9999999998772 3456889999999999999999999865432110
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
.+. .........-...|...+..+.+++.++|..+|..|.+.+++-.++|+..
T Consensus 239 -----------~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 239 -----------RYS-SWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred -----------cce-eecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 000 00111111122345677888999999999999999999999999999987
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1e-19 Score=202.91 Aligned_cols=193 Identities=24% Similarity=0.322 Sum_probs=153.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC---CCCcceeeeeecCCCcCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR---HPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~v~~~~~~~~ 92 (508)
+.+|.|.+.||+|+||.||+|.+.. |+.||+|+-+..... .+.-=.+++.+|+ -+.|+.+...+...
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~---- 766 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW-----EFYICLQVMERLKPQMLPSIMHISSAHVFQ---- 766 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce-----eeeehHHHHHhhchhhhcchHHHHHHHccC----
Confidence 4689999999999999999999876 999999987643322 2222234555555 23444444444322
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC-------CCcEEEccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-------DCKLKICDF 164 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~-------~~~lkL~DF 164 (508)
+.-+||+||.+ |+|.+++..++.+++..+.+|.+|+++-|+.||.++|||+||||+|+||.. ..-|+|+||
T Consensus 767 -~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 767 -NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred -CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 23589999999 999999998888999999999999999999999999999999999999753 234999999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCC
Q 010512 165 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK 222 (508)
Q Consensus 165 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~ 222 (508)
|.+-.+.--.. ...+...++|-.+-.+|...| ..++..+|.|.|..+++.||.|+
T Consensus 846 G~siDm~lfp~-~~~F~~~~~td~f~C~EM~~g--rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 846 GRSIDMKLFPD-GTKFKAVWHTDLFDCIEMREG--RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ccceeeeEcCC-CcEEeeeeccccchhHHHhcC--CCCchhhhhHHHHHHHHHHHHHH
Confidence 99976432222 234566788899999999988 89999999999999999999996
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=5e-19 Score=168.91 Aligned_cols=136 Identities=21% Similarity=0.270 Sum_probs=110.5
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh------hHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 22 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV------SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 22 ~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~------~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++.||+|++|.||+|.. .|..|++|+........ ....++.+|+.++..+.|++|.....++... ..
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~ 73 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----EN 73 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CC
Confidence 36799999999999976 67889999865322211 1124577899999999999987766665332 34
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 96 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 96 lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
.++||||++| +|.+++..... ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||+++.
T Consensus 74 ~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 6999999985 89888865432 7888999999999999999999999999999999 78999999999875
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.4e-19 Score=168.26 Aligned_cols=243 Identities=18% Similarity=0.269 Sum_probs=179.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
+...++-.|.+...|..|+++ ..|..+++|+++.........+.+..|.-.|+-+.||||+.+++.+-.+ .++
T Consensus 190 ~~lnl~tkl~e~hsgelwrgr--wqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnl 262 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGR--WQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNL 262 (448)
T ss_pred hhhhhhhhhccCCCccccccc--ccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCc
Confidence 344566678899999999995 5677888898864433333445677888899999999999999999544 568
Q ss_pred EEEEecCC-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhHhcC--ceecCCCCCceeeCCCCcEEEc--ccccccc
Q 010512 97 YVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKIC--DFGLARV 169 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~~~--l~~~~~~~i~~Qil~aL~yLHs~g--IiHrDLKPeNILl~~~~~lkL~--DFGla~~ 169 (508)
.++..||+ |+|+.++..... .+..++..|+..+++|++|||+.. |----|....+++|++-+.+|. |--++
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs-- 340 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS-- 340 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee--
Confidence 99999999 899999987654 577888999999999999999974 3334578888999998776543 32222
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCC-cchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~-~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
+.. ....-.|.||+||.+.......+ .++|+|||.++++||.|...||..-+..+.--+|
T Consensus 341 -fqe-------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki----------- 401 (448)
T KOG0195|consen 341 -FQE-------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI----------- 401 (448)
T ss_pred -eec-------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh-----------
Confidence 111 12234588999999976322222 5789999999999999999999876644332221
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHh
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 305 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL 305 (508)
.+..++. ..-|++++....|+.-|+.-||.+||.+..++
T Consensus 402 -----------aleglrv-------~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 402 -----------ALEGLRV-------HIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred -----------hhccccc-------cCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 1112222 22367888899999999999999999977654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.8e-18 Score=162.30 Aligned_cols=131 Identities=27% Similarity=0.371 Sum_probs=102.8
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEecCcc-CCh-----hHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 24 VIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHV-----SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 24 ~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~-----~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
.||+|+||.||+|. .+|..|++|+..... ... ....++.+|+++++.+.|+++....-++... ...+
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKT 73 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCE
Confidence 48999999999997 467889999864321 111 1235677899999999988755444333222 2368
Q ss_pred EEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 98 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 98 lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
+||||++| +|.+++..... .++.|++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus 74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999985 88887754321 7899999999999999999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.2e-18 Score=161.51 Aligned_cols=137 Identities=23% Similarity=0.207 Sum_probs=105.7
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChh--------------------HHHHHHHHHHHHHhCCCCC
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS--------------------DATRILREIKLLRLLRHPD 77 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~--------------------~~~~i~~Ei~iL~~L~Hpn 77 (508)
.|.+.+.||+|+||.||+|.+. +|+.||||+++....... ......+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4888999999999999999874 899999998753211000 0123567999999998875
Q ss_pred c--ceeeeeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeC
Q 010512 78 I--VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 154 (508)
Q Consensus 78 I--v~l~~v~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~ 154 (508)
+ ..+++ ....++||||++| +|..+.. ......++.+++.++.++|..||+||||||+||+++
T Consensus 95 i~v~~~~~---------~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~ 159 (198)
T cd05144 95 FPVPKPID---------WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD 159 (198)
T ss_pred CCCCceee---------cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc
Confidence 3 33322 1235899999996 6654432 134567889999999999999999999999999999
Q ss_pred CCCcEEEccccccccc
Q 010512 155 ADCKLKICDFGLARVS 170 (508)
Q Consensus 155 ~~~~lkL~DFGla~~~ 170 (508)
.++.++|+|||++...
T Consensus 160 ~~~~~~liDfg~~~~~ 175 (198)
T cd05144 160 DDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcEEEEECCccccC
Confidence 9999999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.3e-17 Score=179.64 Aligned_cols=138 Identities=24% Similarity=0.331 Sum_probs=107.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEec-CccCC-----hhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEH-----VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~-~~~~~-----~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
..|...+.||+|+||+||++... +..+++|+.. +.... .....++.+|+.+++.++|++|+....+....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-- 408 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP-- 408 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC--
Confidence 44566789999999999999764 4445555432 21111 12235688999999999999998776655432
Q ss_pred CCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 91 REFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 91 ~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
...++||||++| +|.+++. ....++.|++.+|.|||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 409 ---~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 409 ---EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred ---CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 346899999984 8888775 356789999999999999999999999999999 678999999999986
Q ss_pred c
Q 010512 170 S 170 (508)
Q Consensus 170 ~ 170 (508)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 4
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.2e-17 Score=173.33 Aligned_cols=210 Identities=24% Similarity=0.320 Sum_probs=152.8
Q ss_pred HHhCCCCCcceeeeeecCCCcCCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCc-eecCC
Q 010512 70 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANV-FHRDL 146 (508)
Q Consensus 70 L~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gI-iHrDL 146 (508)
|+.+.|.|+.++++.+... ..+++|.+||. |+|.+.+... -.++......+++.|+.||.|||..-| +|+.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence 4678999999999999765 56899999998 8999999873 468888888999999999999998866 99999
Q ss_pred CCCceeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccc--cC---CCCcchhhhhHHHHHHHHHhC
Q 010512 147 KPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF--FS---KYTPAIDIWSIGCIFAEMLTG 221 (508)
Q Consensus 147 KPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~--~~---~y~~~~DIWSlG~il~eLltG 221 (508)
++.|.+++....+||.|||+........ .........-...|.|||++.+. .. .-+.+.||||+|+|++|+++.
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~-~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETA-EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccc-cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998753210 00011112233568999999762 11 146779999999999999999
Q ss_pred CCCCCCCChHHH-HHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 010512 222 KPLFPGKNVVHQ-LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 300 (508)
Q Consensus 222 ~~pF~~~~~~~~-l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt 300 (508)
+.||+....... ...+.. +.........|.-.......+.+..++..||.-+|.+||+
T Consensus 155 ~~~~~~~~~~~~~~eii~~---------------------~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs 213 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILR---------------------VKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPS 213 (484)
T ss_pred cCccccccccCChHHHHHH---------------------HHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCcc
Confidence 999986442111 111111 0010111111111111145567999999999999999999
Q ss_pred HHHHhc
Q 010512 301 AEEALA 306 (508)
Q Consensus 301 a~eiL~ 306 (508)
++++-.
T Consensus 214 ~~~i~~ 219 (484)
T KOG1023|consen 214 IEQIRS 219 (484)
T ss_pred HHHHHh
Confidence 998754
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.8e-17 Score=153.79 Aligned_cols=137 Identities=25% Similarity=0.260 Sum_probs=98.0
Q ss_pred EeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHH----------------------HHHHHHHHHhCCCCC-
Q 010512 21 IQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR----------------------ILREIKLLRLLRHPD- 77 (508)
Q Consensus 21 i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~----------------------i~~Ei~iL~~L~Hpn- 77 (508)
+.+.||+|+||.||+|.+. +|+.||||+++........... ...|...+..+.+..
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999976 8999999998653222111111 135666666665443
Q ss_pred -cceeeeeecCCCcCCCccEEEEEecCCc-cHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-cCceecCCCCCceee
Q 010512 78 -IVEIKHIMLPPSRREFKDIYVVFELMES-DLH-QVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILA 153 (508)
Q Consensus 78 -Iv~l~~v~~~~~~~~~~~lylV~E~~~g-~L~-~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs-~gIiHrDLKPeNILl 153 (508)
+.+++.. ...++||||+++ .+. ..+.... . ...++.++.|++.++.++|. .||+||||||+||++
T Consensus 80 ~~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili 148 (187)
T cd05119 80 PVPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILV 148 (187)
T ss_pred CCCceEec---------CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE
Confidence 3333322 125899999996 221 1121111 1 16788999999999999999 999999999999999
Q ss_pred CCCCcEEEccccccccc
Q 010512 154 NADCKLKICDFGLARVS 170 (508)
Q Consensus 154 ~~~~~lkL~DFGla~~~ 170 (508)
+ ++.++|+|||.+...
T Consensus 149 ~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 149 D-DGKVYIIDVPQAVEI 164 (187)
T ss_pred E-CCcEEEEECcccccc
Confidence 9 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.67 E-value=6e-16 Score=151.21 Aligned_cols=139 Identities=22% Similarity=0.275 Sum_probs=103.8
Q ss_pred eeee-ecCceEEEEEEECCCCcEEEEEEecCcc------C-----ChhHHHHHHHHHHHHHhCCCCCc--ceeeeeecCC
Q 010512 23 EVIG-KGSYGVVGSAVDTHTGERVAIKKINDVF------E-----HVSDATRILREIKLLRLLRHPDI--VEIKHIMLPP 88 (508)
Q Consensus 23 ~~LG-~G~~g~V~~a~~~~tg~~vAIKki~~~~------~-----~~~~~~~i~~Ei~iL~~L~HpnI--v~l~~v~~~~ 88 (508)
.+|| .|+.|+||.+.. .+..+++|.+.... . ......++.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 788888888865 37889999875311 1 11234568899999999998875 5565553322
Q ss_pred CcCCCccEEEEEecCCc--cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccc
Q 010512 89 SRREFKDIYVVFELMES--DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 166 (508)
Q Consensus 89 ~~~~~~~lylV~E~~~g--~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGl 166 (508)
. ......++|||+++| +|.+++.. ..+++.. +.||+.+|.+||++||+||||||.|||++.++.++|+|||.
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 1 111123599999985 78888764 3566543 57899999999999999999999999999999999999998
Q ss_pred ccc
Q 010512 167 ARV 169 (508)
Q Consensus 167 a~~ 169 (508)
++.
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.4e-16 Score=167.53 Aligned_cols=257 Identities=25% Similarity=0.244 Sum_probs=200.0
Q ss_pred CCeEEeeeeee--cCceEEEEEEE--CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcC
Q 010512 17 SRYQIQEVIGK--GSYGVVGSAVD--THTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 17 ~rY~i~~~LG~--G~~g~V~~a~~--~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~ 91 (508)
..+.+.+.+|+ |.+|.||.+.. ..++..+|+|+-+..........+-++|+.-.+.+. |+|.++....+ .
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e 188 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----E 188 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----c
Confidence 45677889999 99999999998 889999999986544444444455567887777775 99999976666 5
Q ss_pred CCccEEEEEecCCccHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHhHhcCceecCCCCCceeeCCC-CcEEEcccc
Q 010512 92 EFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLR----GLKYIHTANVFHRDLKPKNILANAD-CKLKICDFG 165 (508)
Q Consensus 92 ~~~~lylV~E~~~g~L~~~i~~~~~-l~~~~~~~i~~Qil~----aL~yLHs~gIiHrDLKPeNILl~~~-~~lkL~DFG 165 (508)
..+..|+-+|+|+.+|..+...... +++..++..+.+..+ ||..+|+.+++|-|+||.||++..+ ...++.|||
T Consensus 189 ~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 189 GSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred cCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 5567999999999999999887655 888999999999999 9999999999999999999999999 889999999
Q ss_pred ccccccCCCCCcccc--cccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCC--ChHHHHHHHHhhc
Q 010512 166 LARVSFNDAPSAIFW--TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK--NVVHQLDLMTDLL 241 (508)
Q Consensus 166 la~~~~~~~~~~~~~--~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~--~~~~~l~~i~~~~ 241 (508)
+........-..... ....|..-|++||++.+ -++.+.||+|+|.++.+-.+|..++... +.+.++..+.
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~--- 342 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY--- 342 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc---
Confidence 998765443222111 22256678999999876 6889999999999999999987665443 2222222111
Q ss_pred CCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 242 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
...+.+...+..+...+..|+..||..|++++.+++|+++...
T Consensus 343 -----------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 343 -----------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred -----------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 0111223344556669999999999999999999999998743
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.5e-15 Score=133.61 Aligned_cols=131 Identities=23% Similarity=0.196 Sum_probs=107.0
Q ss_pred EeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCC--CCcceeeeeecCCCcCCCccEEE
Q 010512 21 IQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH--PDIVEIKHIMLPPSRREFKDIYV 98 (508)
Q Consensus 21 i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~H--pnIv~l~~v~~~~~~~~~~~lyl 98 (508)
+++.||+|.++.||++.+. +..+++|.+..... ...+.+|+.+++.++| .++.+++..... .+..|+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-----~~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGES-----DGWSYL 70 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-----CCccEE
Confidence 4678999999999999874 37899999864322 4567889999999986 588888777632 256899
Q ss_pred EEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhc---CceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 99 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 99 V~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~---gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
+|||+.| .+..+ +......++.+++.+|++||.. +++|+||+|.||+++.++.++++|||.++.
T Consensus 71 v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 71 LMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9999986 34332 5566778899999999999985 699999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.3e-15 Score=167.61 Aligned_cols=266 Identities=23% Similarity=0.260 Sum_probs=198.8
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
..+.+.+.+.+-+|+++.++.+.-..+|...++|....... ...+.+.+.++-.++-.-.+|.++...--+ ...
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCC
Confidence 45677888899999999999998888887788876543211 111233444444455445566666554432 122
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
...+||++|.. ++|...++.-+..+++.++.++..+..+++|||+..+.|||++|.|+|+..++..++.|||.......
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence 45899999998 69999999888899999999999999999999999999999999999999999999999984433110
Q ss_pred C--------CCC--------------------cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCC
Q 010512 173 D--------APS--------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL 224 (508)
Q Consensus 173 ~--------~~~--------------------~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~p 224 (508)
- ... ...-...+||+.|.+||.+.+ ...+.++|.|++|+++++.++|.+|
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--RRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc--ccCCCcchhhhhhhhhhhhhcCCCC
Confidence 0 000 011123579999999999988 6778899999999999999999999
Q ss_pred CCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHH--
Q 010512 225 FPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE-- 302 (508)
Q Consensus 225 F~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~-- 302 (508)
|...........|. ....+|...-...++.+.+++.++|..+|.+|..+.
T Consensus 1035 ~na~tpq~~f~ni~----------------------------~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~ 1086 (1205)
T KOG0606|consen 1035 FNAETPQQIFENIL----------------------------NRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGA 1086 (1205)
T ss_pred CCCcchhhhhhccc----------------------------cCCCCCCCCccccChhhhhhhhhhhccCchhccCcccc
Confidence 98766433332221 112334344445678899999999999999998877
Q ss_pred -HHhcCCcccCCCC
Q 010512 303 -EALADPYFHGLAN 315 (508)
Q Consensus 303 -eiL~hp~f~~~~~ 315 (508)
++-.|+||+....
T Consensus 1087 ~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1087 AEVKGHPFFQDVDW 1100 (1205)
T ss_pred cccccCCccCCCCc
Confidence 8999999997654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.3e-14 Score=139.25 Aligned_cols=246 Identities=20% Similarity=0.212 Sum_probs=160.4
Q ss_pred EEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHH--HHHHhCCCCCcceeeeeecCCCcCCCccEEEEEecCC-ccHH
Q 010512 32 VVGSAVDTHTGERVAIKKINDVFEHVSDATRILREI--KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLH 108 (508)
Q Consensus 32 ~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei--~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~-g~L~ 108 (508)
.||++.+...|.+|..-.+.-.....-..+.-.+++ .-|-++-|-|||+++.++.+..+++...+.+++|||. |+|.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 356777777777766554421100000001111222 3344556999999999987776667778899999998 7999
Q ss_pred HHHHhC----CCCCHHHHHHHHHHHHHHHHHhHhcC--ceecCCCCCceeeCCCCcEEEccccccccccCCCCCcc--cc
Q 010512 109 QVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI--FW 180 (508)
Q Consensus 109 ~~i~~~----~~l~~~~~~~i~~Qil~aL~yLHs~g--IiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~--~~ 180 (508)
++|++. ..+....+++|+-||+.||.|||+.. |+|+++..+.|++..+|-+|+.---.... ........ ..
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~-h~s~~~~~~~Ek 239 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDST-HPSVNSTREAEK 239 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCcccc-chhhhhhhHhhh
Confidence 988753 35889999999999999999999985 99999999999999998888753211111 00000000 01
Q ss_pred cccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHH
Q 010512 181 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL-FPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259 (508)
Q Consensus 181 ~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~p-F~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 259 (508)
.-..+-++|.|||.=.. .+.+.++|||++|....+|..|..- -.+.+....-..| .+
T Consensus 240 ~~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~i--------------------a~ 297 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTT--TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENI--------------------AN 297 (458)
T ss_pred hccccCCccccCCcCcc--cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhh--------------------hh
Confidence 11245678999987433 5667899999999999999887632 2222211110011 00
Q ss_pred HHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 260 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 260 ~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.+ +.--++.-.+++.+||+-.|..||++.++|.||.+-.++
T Consensus 298 ~i--------------~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh 338 (458)
T KOG1266|consen 298 VI--------------IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH 338 (458)
T ss_pred he--------------eeccCccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence 00 011122235789999999999999999999999976544
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=5e-14 Score=151.40 Aligned_cols=140 Identities=22% Similarity=0.322 Sum_probs=96.1
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh--------------------------------hHHHHH---
Q 010512 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV--------------------------------SDATRI--- 63 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~--------------------------------~~~~~i--- 63 (508)
|+. +.||+|++|.||+|+.+.+|+.||||++++..... ...+.+
T Consensus 122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E 200 (537)
T PRK04750 122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE 200 (537)
T ss_pred cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence 444 78999999999999998889999999996432100 011122
Q ss_pred ---HHHHHHHHhCC----CCCcceeeeeecCCCcCCCccEEEEEecCCc-cHHHH--HHhCC----CCCHHHHHHHHHHH
Q 010512 64 ---LREIKLLRLLR----HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQV--IKAND----DLTPEHYQFFLYQL 129 (508)
Q Consensus 64 ---~~Ei~iL~~L~----HpnIv~l~~v~~~~~~~~~~~lylV~E~~~g-~L~~~--i~~~~----~l~~~~~~~i~~Qi 129 (508)
.+|+..+.+++ +.+.+.+-.+|..- ...-+|||||++| .+.++ +...+ .+.+..+..++.|+
T Consensus 201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 201 LDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred hCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 33444443332 33444444444321 2345899999996 77653 33333 35666677777777
Q ss_pred HHHHHHhHhcCceecCCCCCceeeCCCC----cEEEccccccccc
Q 010512 130 LRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVS 170 (508)
Q Consensus 130 l~aL~yLHs~gIiHrDLKPeNILl~~~~----~lkL~DFGla~~~ 170 (508)
+ ..|++|+|+||.||+++.+| .++++|||++...
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 6 48999999999999999988 9999999998754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.2e-13 Score=140.49 Aligned_cols=140 Identities=22% Similarity=0.264 Sum_probs=94.5
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccCChh--H----------------------H--------------HHHH
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS--D----------------------A--------------TRIL 64 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~--~----------------------~--------------~~i~ 64 (508)
+.||.|++|.||+|+.. +|+.||||+.+....... + . -.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999864 799999999864311100 0 0 0133
Q ss_pred HHHHHHHhC----CCCCcceeeeeecCCCcCCCccEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHhH
Q 010512 65 REIKLLRLL----RHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLR-GLKYIH 137 (508)
Q Consensus 65 ~Ei~iL~~L----~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~-~~l~~~~~~~i~~Qil~-aL~yLH 137 (508)
+|...+.++ +|.+-+.+-.++... ...-+|||||++| +|.++.... .... ...++.+++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~----~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR----TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh----cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH
Confidence 455555554 233334444444321 1235899999986 776665432 1222 2345556655 467889
Q ss_pred hcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 138 TANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 138 s~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
..|++|+|+||.||+++.++.++|+|||++...
T Consensus 275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred hCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999999999999999999999999999998754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=5.3e-12 Score=134.46 Aligned_cols=184 Identities=22% Similarity=0.335 Sum_probs=135.2
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEE
Q 010512 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 98 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 98 (508)
|.+ ...+-++.+..-.|..+.++.+|.|.+.+.... .....+.+-++.|+.|+||||+++++.+ +..+.+||
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~yl 86 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYL 86 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEE
Confidence 454 444444444433566678899999999875332 3445677889999999999999999988 55568999
Q ss_pred EEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhH-hcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCc
Q 010512 99 VFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH-TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 177 (508)
Q Consensus 99 V~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLH-s~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~ 177 (508)
|+|-+.. |..++++ ++...+..-++||+.||.||| ..+++|++|.-.-|+|+..|..||++|.++........
T Consensus 87 vTErV~P-l~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-- 160 (690)
T KOG1243|consen 87 VTERVRP-LETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-- 160 (690)
T ss_pred Eeecccc-HHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--
Confidence 9999863 3333433 337788888999999999997 67899999999999999999999999998865432221
Q ss_pred ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhC
Q 010512 178 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG 221 (508)
Q Consensus 178 ~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG 221 (508)
....+.---.|..|+.+.. -+...|.|-|||++++++.|
T Consensus 161 -~~~~~~~~~s~~~P~~~~~----s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 161 -PAKSLYLIESFDDPEEIDP----SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -ccccchhhhcccChhhcCc----cccchhhhhHHHHHHHHhCc
Confidence 1111222234667776543 12568999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.42 E-value=9.9e-13 Score=123.90 Aligned_cols=139 Identities=21% Similarity=0.244 Sum_probs=100.3
Q ss_pred eeeeeecCceEEEEEEECC------CCcEEEEEEecCc---cCC-----------------hhHHHH----HHHHHHHHH
Q 010512 22 QEVIGKGSYGVVGSAVDTH------TGERVAIKKINDV---FEH-----------------VSDATR----ILREIKLLR 71 (508)
Q Consensus 22 ~~~LG~G~~g~V~~a~~~~------tg~~vAIKki~~~---~~~-----------------~~~~~~----i~~Ei~iL~ 71 (508)
...||.|--+.||.|.... .+..+|||+.+-. +.. ..-... ..+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4679999999999998653 3579999986411 000 011112 238999999
Q ss_pred hCCC--CCcceeeeeecCCCcCCCccEEEEEecCCcc-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHh-HhcCceecCCC
Q 010512 72 LLRH--PDIVEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYI-HTANVFHRDLK 147 (508)
Q Consensus 72 ~L~H--pnIv~l~~v~~~~~~~~~~~lylV~E~~~g~-L~~~i~~~~~l~~~~~~~i~~Qil~aL~yL-Hs~gIiHrDLK 147 (508)
++.. -++..++++. .-+|||||++++ +..-..+...+++.....++.|++.+|..| |..||+|+||+
T Consensus 82 rl~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 9864 4555555542 248999999863 322222233466677788899999999999 89999999999
Q ss_pred CCceeeCCCCcEEEccccccccc
Q 010512 148 PKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 148 PeNILl~~~~~lkL~DFGla~~~ 170 (508)
+.|||+. ++.+.|+|||.+...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 578999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.41 E-value=8.6e-13 Score=121.11 Aligned_cols=127 Identities=17% Similarity=0.131 Sum_probs=93.6
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcc-eeeeeecCCCcCCCccEEEEE
Q 010512 22 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV-EIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 22 ~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv-~l~~v~~~~~~~~~~~lylV~ 100 (508)
++.|+.|.++.||++... |..|++|....... ....+.+|+.+++.+.+.+++ +++.... ..-++||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~-------~~~~lv~ 70 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP-------ETGVLIT 70 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC-------CCCeEEE
Confidence 467899999999999754 78899998754321 122456899999998765544 4443321 1238999
Q ss_pred ecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCc-----eecCCCCCceeeCCCCcEEEcccccccc
Q 010512 101 ELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV-----FHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 101 E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gI-----iHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
|+++| ++... ......++.+++++|+.||+.++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 71 e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 71 EFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred EecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 99997 44322 11123467899999999999985 9999999999999 67899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=7.5e-13 Score=139.53 Aligned_cols=249 Identities=21% Similarity=0.198 Sum_probs=180.5
Q ss_pred CCeEEeeeeeecCceEEEEEEEC-CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCCCc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDT-HTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~-~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~ 94 (508)
.+|..+..||.|.|+.|+.+... .++..|++|-+.+..........-+.|+.+...+. |.++++.+..+. ...
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~-----~~r 339 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS-----QLR 339 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc-----ccc
Confidence 56788999999999999998755 68889999998766555555555677888887775 899998877773 345
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC-CcEEEccccccccccC
Q 010512 95 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVSFN 172 (508)
Q Consensus 95 ~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~-~~lkL~DFGla~~~~~ 172 (508)
+.||-.|||++ ++...+.....+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||.+....-
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence 57899999974 444333334458889999999999999999999999999999999999886 7789999998864211
Q ss_pred CCCCcccccccccCcccc-cccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYR-APELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~-APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
. ......+-+++ ..|++... ..+..+.|++|||.-+.+.++|.+.-...+.... |.
T Consensus 420 ~------~~~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~---i~------------- 476 (524)
T KOG0601|consen 420 S------SGVFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT---IR------------- 476 (524)
T ss_pred e------cccccccccccccchhhccc-cccccccccccccccccccccCcccCccccccee---ee-------------
Confidence 1 11122333444 25555442 6778899999999999999998754322211000 00
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~ 311 (508)
.... ...++....++.+.+.|+..|+..|+.+.++..|.=|.
T Consensus 477 -------------~~~~-----p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 477 -------------SGDT-----PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred -------------cccc-----cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0000 01122335678899999999999999999998887664
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=9.6e-11 Score=107.13 Aligned_cols=143 Identities=23% Similarity=0.295 Sum_probs=105.6
Q ss_pred EeeeeeecCceEEEEEEECCCCcEEEEEEec-CccCCh-----hHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 21 IQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHV-----SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 21 i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~-~~~~~~-----~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
.+.+|-+|+-+.|+++. ..|+.+.||.-. +...++ -...+..+|+++|.++.--.|....=++.+..
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~----- 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY----- 83 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-----
Confidence 67889999999999995 579999998642 222232 23456788999999886444433333332221
Q ss_pred cEEEEEecCCc--cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCc---EEEcccccc
Q 010512 95 DIYVVFELMES--DLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLA 167 (508)
Q Consensus 95 ~lylV~E~~~g--~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~---lkL~DFGla 167 (508)
.-.|+|||++| ++.+++.... .........++.+|-+.|.-||.++|||+||..+||++..++. +.++|||++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 23799999998 8888887642 2333334789999999999999999999999999999987654 589999999
Q ss_pred ccc
Q 010512 168 RVS 170 (508)
Q Consensus 168 ~~~ 170 (508)
...
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.1e-10 Score=105.39 Aligned_cols=131 Identities=21% Similarity=0.291 Sum_probs=94.4
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEe-cCccCChhH-----HHHHHHHHHHHHhCCC--CCcceeeeeecCCCcCCCc
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEHVSD-----ATRILREIKLLRLLRH--PDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki-~~~~~~~~~-----~~~i~~Ei~iL~~L~H--pnIv~l~~v~~~~~~~~~~ 94 (508)
..+++|+-+.++.+.. -|..+++|.- ++...++.- ..+..+|.++|..++- -+...++++.. .
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~-------~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP-------D 72 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC-------C
Confidence 4688999999999943 4556667753 333333322 3456789999998864 34444555442 2
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 95 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 95 ~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
...|||||++| .|.+++... .-.++..+-.-+.-||.+||+|+||.++||++..++ +.++|||++.+.
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 35899999998 556677655 145667777778889999999999999999998664 999999999753
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.7e-10 Score=108.83 Aligned_cols=142 Identities=18% Similarity=0.274 Sum_probs=102.3
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCC--CcceeeeeecCCCcCCCccEEEEE
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP--DIVEIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~Hp--nIv~l~~v~~~~~~~~~~~lylV~ 100 (508)
+.|+.|.++.||++... +|..|++|+....... .....+.+|+.+++.+.+. ++.+++.+.... ...+..|+||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEEE
Confidence 67899999999999764 3688999987543211 1345678999999999763 456666554321 1123568999
Q ss_pred ecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-----------------------------------------
Q 010512 101 ELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT----------------------------------------- 138 (508)
Q Consensus 101 E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs----------------------------------------- 138 (508)
|+++| ++.+.+.. ..+++.....++.+++++|..||+
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99996 45443321 346777777777788888877774
Q ss_pred ---------------cCceecCCCCCceeeCC--CCcEEEcccccccc
Q 010512 139 ---------------ANVFHRDLKPKNILANA--DCKLKICDFGLARV 169 (508)
Q Consensus 139 ---------------~gIiHrDLKPeNILl~~--~~~lkL~DFGla~~ 169 (508)
..++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 56789999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.6e-09 Score=112.49 Aligned_cols=215 Identities=16% Similarity=0.197 Sum_probs=154.2
Q ss_pred CceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEecCC--cc
Q 010512 29 SYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME--SD 106 (508)
Q Consensus 29 ~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~--g~ 106 (508)
--.+.|+|....+|..|++|.++... . ........-+..++++.|+|||.+.+++.... -...-+++|++|.+ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r-~-~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDR-D-QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccc-c-cCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCch
Confidence 34568999999999999999994211 1 11112234568899999999999999998544 23456899999998 48
Q ss_pred HHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 107 LHQVIKA---------------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 107 L~~~i~~---------------~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
|.++.-. +...++..+|.|+.||..||.+||+.|+.-+-|.|.+||++.+.+++|...|...+..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 8876632 2246789999999999999999999999999999999999999999998888776554
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCC-CCCCChHHH-HHHHHhhcCCCChHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL-FPGKNVVHQ-LDLMTDLLGTPSTESI 249 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~p-F~~~~~~~~-l~~i~~~~g~p~~~~~ 249 (508)
.+.. |.+.+ -.+-|.=.||.+++.|.+|..- +..+..... +..|
T Consensus 445 ~d~~-----------------~~le~-----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I------------ 490 (655)
T KOG3741|consen 445 EDPT-----------------EPLES-----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI------------ 490 (655)
T ss_pred CCCC-----------------cchhH-----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh------------
Confidence 3320 12222 2356888999999999999532 211111111 1111
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.+..+.++.++|.-+...++++ -++++++.|
T Consensus 491 --------------------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 491 --------------------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred --------------------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 1234566778888888888876 678888775
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=2e-09 Score=106.80 Aligned_cols=143 Identities=15% Similarity=0.076 Sum_probs=97.7
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEecCccCCh---------hHHHHHHHHHHHHHhCCCCCcce--eeeeecCCCcCC
Q 010512 24 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV---------SDATRILREIKLLRLLRHPDIVE--IKHIMLPPSRRE 92 (508)
Q Consensus 24 ~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~---------~~~~~i~~Ei~iL~~L~HpnIv~--l~~v~~~~~~~~ 92 (508)
.+-......|.++. ..|+.|.||......... .-...+.+|...+..|..-+|.. ++.+........
T Consensus 29 ~v~~~~~rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 29 VFRELEGRRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred EEecCCCceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 33333444466653 367889999764321100 00113678999988885434333 333332211111
Q ss_pred CccEEEEEecCCc--cHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC-------CCcEEE
Q 010512 93 FKDIYVVFELMES--DLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-------DCKLKI 161 (508)
Q Consensus 93 ~~~lylV~E~~~g--~L~~~i~~--~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~-------~~~lkL 161 (508)
...-|||||++++ +|.+++.. ..+.+......++.+++..+.-||.+||+|+|+++.|||++. ++.+.|
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L 186 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSV 186 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence 2346899999996 78888864 345667788899999999999999999999999999999975 467999
Q ss_pred ccccccc
Q 010512 162 CDFGLAR 168 (508)
Q Consensus 162 ~DFGla~ 168 (508)
+||+.++
T Consensus 187 IDl~r~~ 193 (268)
T PRK15123 187 IDLHRAQ 193 (268)
T ss_pred EECCccc
Confidence 9999875
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.7e-09 Score=101.04 Aligned_cols=129 Identities=24% Similarity=0.323 Sum_probs=94.7
Q ss_pred CCCcEEEEEEecCccC-----ChhHHHHHHHHHHHHHhCCCCC--cceeeeeecCCCcCCCccEEEEEecCCc--cHHHH
Q 010512 40 HTGERVAIKKINDVFE-----HVSDATRILREIKLLRLLRHPD--IVEIKHIMLPPSRREFKDIYVVFELMES--DLHQV 110 (508)
Q Consensus 40 ~tg~~vAIKki~~~~~-----~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~~~~~~~~lylV~E~~~g--~L~~~ 110 (508)
..++.|-+|....... ......+..+|...+..|..-. +.+.+.+...... .....|+|+|++++ +|.++
T Consensus 30 ~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~-~~~~s~lite~l~~~~~L~~~ 108 (206)
T PF06293_consen 30 LVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKG-GGYRSYLITEALPGAQDLRDL 108 (206)
T ss_pred ccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCC-CceeEEEEEEeCCCcccHHHH
Confidence 3566777776432211 1123456788998888886433 3344444432221 11346899999986 79999
Q ss_pred HHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC---cEEEcccccccc
Q 010512 111 IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARV 169 (508)
Q Consensus 111 i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~---~lkL~DFGla~~ 169 (508)
+.....++......++.++...++-||.+||+|+|+++.|||++.++ .+.|+||+.++.
T Consensus 109 ~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 109 LQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 88755577888899999999999999999999999999999999987 899999998775
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.9e-09 Score=98.40 Aligned_cols=127 Identities=28% Similarity=0.311 Sum_probs=82.9
Q ss_pred EEEEEEECCCCcEEEEEEecCc----------------cC------Ch--hHHHHHHHHHHHHHhCCCC--Ccceeeeee
Q 010512 32 VVGSAVDTHTGERVAIKKINDV----------------FE------HV--SDATRILREIKLLRLLRHP--DIVEIKHIM 85 (508)
Q Consensus 32 ~V~~a~~~~tg~~vAIKki~~~----------------~~------~~--~~~~~i~~Ei~iL~~L~Hp--nIv~l~~v~ 85 (508)
.||.|.. ..|..+|+|+.+.. +. .. .......+|.+.|..+..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3889976 46789999986310 00 00 1123467899999999865 456665543
Q ss_pred cCCCcCCCccEEEEEecCC--ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-hHhcCceecCCCCCceeeCCCCcEEEc
Q 010512 86 LPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKY-IHTANVFHRDLKPKNILANADCKLKIC 162 (508)
Q Consensus 86 ~~~~~~~~~~lylV~E~~~--g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~y-LHs~gIiHrDLKPeNILl~~~~~lkL~ 162 (508)
.-+|||||++ |.....+... .++.+....++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+
T Consensus 80 ---------~~~ivME~I~~~G~~~~~l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---------RNVIVMEYIGEDGVPLPRLKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---------TTEEEEE--EETTEEGGCHHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE-
T ss_pred ---------CCEEEEEecCCCccchhhHHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEE
Confidence 1289999999 6333333322 12255667788899986665 589999999999999999987 99999
Q ss_pred cccccccc
Q 010512 163 DFGLARVS 170 (508)
Q Consensus 163 DFGla~~~ 170 (508)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=4.8e-10 Score=120.14 Aligned_cols=154 Identities=23% Similarity=0.370 Sum_probs=112.4
Q ss_pred HHHHHHHHhHh-cCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcccccc--------cccCcccccccccccc
Q 010512 128 QLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD--------YVATRWYRAPELCGSF 198 (508)
Q Consensus 128 Qil~aL~yLHs-~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~--------~~gT~~Y~APE~l~~~ 198 (508)
++..|+.|+|. .+++|++|.|++|.++.++.+||+.|+++........ ..+.. ..-...|.|||++.+
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~--~p~~~yd~~lp~~~~~~~~f~apE~~~~- 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE--YPFSEYDPPLPLLLQPHLNFLAPEYLLG- 183 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc--cccccCCCCCChhhccCcccccchhhcc-
Confidence 34489999995 5999999999999999999999999999865433111 11111 123457999999987
Q ss_pred cCCCCcchhhhhHHHHHHHHH-hCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCC
Q 010512 199 FSKYTPAIDIWSIGCIFAEML-TGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFP 277 (508)
Q Consensus 199 ~~~y~~~~DIWSlG~il~eLl-tG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 277 (508)
...+.++|+||+||++|.+. .|+..|.+.+.......-...++ . .. ...-.
T Consensus 184 -~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~---------------------~---~~---~~~s~ 235 (700)
T KOG2137|consen 184 -TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLN---------------------A---GA---FGYSN 235 (700)
T ss_pred -ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccc---------------------c---cc---ccccc
Confidence 67789999999999999998 67777765543222111110000 0 00 01115
Q ss_pred CCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 278 NADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 278 ~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
+++.++++=|.++|..|+.-||++.+++..|||.+
T Consensus 236 ~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D 270 (700)
T KOG2137|consen 236 NLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSD 270 (700)
T ss_pred cCcHHHHHHHHHHhcCCcccCcchhhhhcccccCC
Confidence 67899999999999999999999999999999974
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.2e-07 Score=94.81 Aligned_cols=260 Identities=16% Similarity=0.169 Sum_probs=158.9
Q ss_pred EEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHh-CCCCCcceeeeeecCC----CcCCCc
Q 010512 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL-LRHPDIVEIKHIMLPP----SRREFK 94 (508)
Q Consensus 20 ~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~-L~HpnIv~l~~v~~~~----~~~~~~ 94 (508)
...+.||+|+-+.+|-.-. -+. .+.|++...... ...+ -+..|.. -.||.+-. .+.++. ..+...
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d-~VAKIYh~Pppa--~~aq---k~a~la~~p~~p~~~~--rvaWPqa~L~G~~~~~ 83 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRD-QVAKIYHAPPPA--AQAQ---KVAELAATPDAPLLNY--RVAWPQATLHGGRRGK 83 (637)
T ss_pred CCCccccCCccceeeecch--hhc-hhheeecCCCch--HHHH---HHHHhccCCCCcchhh--hhcccHHHhhCCCccc
Confidence 3457899999999997732 222 345777543211 1111 1122222 24554432 111110 112333
Q ss_pred cEEEEEecCCc--cHHHHHHh---C---CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccc
Q 010512 95 DIYVVFELMES--DLHQVIKA---N---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 166 (508)
Q Consensus 95 ~lylV~E~~~g--~L~~~i~~---~---~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGl 166 (508)
.+-+.|..+.| ....++.. . ....++...+..+.|+.|.+-||.+|..-+|+.++|+|+.+++.+.|.|=..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 47888998875 45555432 1 2367888889999999999999999999999999999999999999998544
Q ss_pred cccccCCCCCcccccccccCcccccccccc-ccc--CCCCcchhhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHhhcC
Q 010512 167 ARVSFNDAPSAIFWTDYVATRWYRAPELCG-SFF--SKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQLDLMTDLLG 242 (508)
Q Consensus 167 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~-~~~--~~y~~~~DIWSlG~il~eLltG-~~pF~~~~~~~~l~~i~~~~g 242 (508)
-.+.. ........+|...|.+||+-. +.. ..-+...|.|.||+++|+||.| +.||.|-.... --+
T Consensus 164 fqi~~----ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~-------~ap 232 (637)
T COG4248 164 FQINA----NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLIS-------DAP 232 (637)
T ss_pred eeecc----CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccC-------CCC
Confidence 33321 122234568999999999743 111 2345678999999999999987 89998743100 001
Q ss_pred CCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCC--CCCCCCHHH
Q 010512 243 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFD--PKDRPTAEE 303 (508)
Q Consensus 243 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~D--P~~Rpta~e 303 (508)
.|.+..|.....-.. -+.-+...+.+.+-.|.-.++.+..|..+|+..- +.-|||++-
T Consensus 233 ~p~E~~Ia~g~f~ya---~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 233 NPLETDIAHGRFAYA---SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred Ccchhhhhcceeeec---hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 111112211110000 0111223344444556677899999999999853 457999754
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=1e-07 Score=90.41 Aligned_cols=142 Identities=15% Similarity=0.154 Sum_probs=102.7
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCc----cCChhHHHHHHHHHHHHHhCCCCC--cceeeeeecCCCcCCCccEEE
Q 010512 25 IGKGSYGVVGSAVDTHTGERVAIKKINDV----FEHVSDATRILREIKLLRLLRHPD--IVEIKHIMLPPSRREFKDIYV 98 (508)
Q Consensus 25 LG~G~~g~V~~a~~~~tg~~vAIKki~~~----~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~~~~~~~~lyl 98 (508)
-|+||.+-|+.... .|..|-+|.-.+. .....-...+.+|+..|..|..-+ +.++. ++-.......-.-+|
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 35689999998753 4557889976421 111234566889999999986433 33333 111000011223689
Q ss_pred EEecCCc--cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCc--EEEcccccccc
Q 010512 99 VFELMES--DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARV 169 (508)
Q Consensus 99 V~E~~~g--~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~--lkL~DFGla~~ 169 (508)
|+|-++| +|.+++... .+.++.....++.++..+|+-||..|+.|+|+-+.|||++.++. +.++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9998884 899888663 35678888999999999999999999999999999999987777 99999987764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=3.6e-08 Score=95.83 Aligned_cols=135 Identities=27% Similarity=0.288 Sum_probs=97.7
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEec-------Ccc---------CChh----HHHHHHHHHHHHHhCCCC--
Q 010512 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-------DVF---------EHVS----DATRILREIKLLRLLRHP-- 76 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~-------~~~---------~~~~----~~~~i~~Ei~iL~~L~Hp-- 76 (508)
+.+...||-|--|.||.|.+. .|.++|||.=+ +.. .+.+ ......+|..+|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 457789999999999999875 79999999621 000 1111 123457899999999754
Q ss_pred CcceeeeeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC
Q 010512 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 155 (508)
Q Consensus 77 nIv~l~~v~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~ 155 (508)
.|.+.++. +.-.+|||+++| .|..+ +++.+....++..|++-+.-+-..||+|+|+.+-||++++
T Consensus 172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 172 KVPKPIAW---------NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCcccc---------ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence 45544332 335899999998 44322 2345556666777777777666899999999999999999
Q ss_pred CCcEEEccccccc
Q 010512 156 DCKLKICDFGLAR 168 (508)
Q Consensus 156 ~~~lkL~DFGla~ 168 (508)
||.+.++||--+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 9999999996553
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.8e-07 Score=87.84 Aligned_cols=144 Identities=17% Similarity=0.234 Sum_probs=91.8
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChh-HHH------HHHHHHHHHHhCCCCCcceeeeeec-
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS-DAT------RILREIKLLRLLRHPDIVEIKHIML- 86 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~-~~~------~i~~Ei~iL~~L~HpnIv~l~~v~~- 86 (508)
..++|.+.+++-......|.+.. -.|..+++|.......... ... ...+++..+..++...+..+.++++
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 45789999999988888887774 4678999998754321111 011 1234455455554333333322221
Q ss_pred --CCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcc
Q 010512 87 --PPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 163 (508)
Q Consensus 87 --~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~D 163 (508)
-...+.....++||||++| .|.+... +++ .+.-.|.+++.-||..|++|+|..|.|+++..+ .++++|
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID 177 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIID 177 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEE
Confidence 1111222345689999998 5544321 333 244567788999999999999999999999855 599999
Q ss_pred cccccc
Q 010512 164 FGLARV 169 (508)
Q Consensus 164 FGla~~ 169 (508)
|+..+.
T Consensus 178 ~~~k~~ 183 (229)
T PF06176_consen 178 TQGKRM 183 (229)
T ss_pred Cccccc
Confidence 987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.1e-07 Score=99.98 Aligned_cols=144 Identities=26% Similarity=0.354 Sum_probs=93.4
Q ss_pred hccccccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh----------------------------h
Q 010512 7 TEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV----------------------------S 58 (508)
Q Consensus 7 ~~~~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~----------------------------~ 58 (508)
.+.|.+|.. ..|+.++-|.||+|+-. +|+.||||+.+...... .
T Consensus 122 ee~F~eF~~-------~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~ 193 (517)
T COG0661 122 EELFSEFEP-------EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVE 193 (517)
T ss_pred HHHHHHcCC-------CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHH
Confidence 356777776 78999999999999865 59999999964221100 0
Q ss_pred HH----H------HHHHHHHHHHhCC----CCCcceeeeeecCCCcCCCccEEEEEecCCc-cHHHH--HHhCCCCC---
Q 010512 59 DA----T------RILREIKLLRLLR----HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQV--IKANDDLT--- 118 (508)
Q Consensus 59 ~~----~------~i~~Ei~iL~~L~----HpnIv~l~~v~~~~~~~~~~~lylV~E~~~g-~L~~~--i~~~~~l~--- 118 (508)
.. + .+.+|...+.+++ ...-+.+=.+|..-+ +.-.|+|||++| .+.+. +++ ..++
T Consensus 194 vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t----~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ 268 (517)
T COG0661 194 VVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYT----TRRVLTMEWIDGIKISDIAALKS-AGIDRKE 268 (517)
T ss_pred HHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhcc----CCcEEEEEeeCCEecccHHHHHh-cCCCHHH
Confidence 00 1 1234555555442 222333444443221 235899999998 55544 444 2344
Q ss_pred --HHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 119 --PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 119 --~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
..-+..++.|++. .|++|.|..|.||+++.+|++.+.|||+....
T Consensus 269 ia~~~~~~f~~q~~~-------dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 269 LAELLVRAFLRQLLR-------DGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred HHHHHHHHHHHHHHh-------cCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 2333334444443 89999999999999999999999999998754
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.6e-06 Score=82.58 Aligned_cols=133 Identities=17% Similarity=0.184 Sum_probs=79.8
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC--cceeeeeecCCCcCCCccEEEEE
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD--IVEIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~~~~~~~~lylV~ 100 (508)
.+||.|..+.||+. .|..+++|...... ....+.+|.++|+.+..-. +.+++++.. ..+..++||
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~-----~~~~~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVE-----DGGRLGLIY 73 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEe-----cCCeeeeee
Confidence 57899999999985 25567888875321 2345788999999986433 355555552 223468899
Q ss_pred ecCCcc--HHHHH---------------------HhC--CCCCHHH-HHHHHHH----------HHHH-HHHhH----hc
Q 010512 101 ELMESD--LHQVI---------------------KAN--DDLTPEH-YQFFLYQ----------LLRG-LKYIH----TA 139 (508)
Q Consensus 101 E~~~g~--L~~~i---------------------~~~--~~l~~~~-~~~i~~Q----------il~a-L~yLH----s~ 139 (508)
|+++|. +...+ +.- ....... ...+..+ +... ..+|. ..
T Consensus 74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~ 153 (226)
T TIGR02172 74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS 153 (226)
T ss_pred eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence 999983 11111 110 0111000 1111111 1111 12222 12
Q ss_pred CceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 140 NVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 140 gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
.++|+|+.|.||+++.++ +.|+||+.+..
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 479999999999999888 99999998763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.1e-06 Score=82.91 Aligned_cols=136 Identities=21% Similarity=0.169 Sum_probs=93.9
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccCChh-----------------HHH-----HHHHHHHHHHhCC--CCCc
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS-----------------DAT-----RILREIKLLRLLR--HPDI 78 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~-----------------~~~-----~i~~Ei~iL~~L~--HpnI 78 (508)
..|+.|--+.||+|.. ..+..||+|+++.....-. ... -..+|..-|+++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 4566777888999964 5689999999852211000 111 1346888888875 3444
Q ss_pred ceeeeeecCCCcCCCccEEEEEecCCccH--HHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-cCceecCCCCCceeeCC
Q 010512 79 VEIKHIMLPPSRREFKDIYVVFELMESDL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANA 155 (508)
Q Consensus 79 v~l~~v~~~~~~~~~~~lylV~E~~~g~L--~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs-~gIiHrDLKPeNILl~~ 155 (508)
.+.+.+. +-.|||||++.+. .-.|+ .-++..+++..+..++++.+.-|-. .|++|+||..-|||+.
T Consensus 133 P~Pi~~~---------~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~- 201 (268)
T COG1718 133 PEPIAFR---------NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH- 201 (268)
T ss_pred CCceeec---------CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-
Confidence 4444443 2389999998431 11111 1134455788899999999988866 9999999999999999
Q ss_pred CCcEEEccccccccc
Q 010512 156 DCKLKICDFGLARVS 170 (508)
Q Consensus 156 ~~~lkL~DFGla~~~ 170 (508)
++.+.|+|||-|...
T Consensus 202 ~~~p~iID~~QaV~~ 216 (268)
T COG1718 202 DGEPYIIDVSQAVTI 216 (268)
T ss_pred CCeEEEEECcccccc
Confidence 889999999988653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.39 E-value=3e-06 Score=81.10 Aligned_cols=139 Identities=21% Similarity=0.230 Sum_probs=80.7
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC--cceeeeeecCCCcCCCccEEEE
Q 010512 22 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD--IVEIKHIMLPPSRREFKDIYVV 99 (508)
Q Consensus 22 ~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~~~~~~~~lylV 99 (508)
++.|+.|..+.||++.... ..+++|..... .....+.+|+.+++.|.... +.+++...... ......|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~--~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD--EFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET--EETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc--cccccceEE
Confidence 4789999999999998754 48999987532 34567889999998886433 44555433221 223347999
Q ss_pred EecCCc-cHHH----------------HH---HhC----CCCCHHH------HHHH---------------HHHHHH-HH
Q 010512 100 FELMES-DLHQ----------------VI---KAN----DDLTPEH------YQFF---------------LYQLLR-GL 133 (508)
Q Consensus 100 ~E~~~g-~L~~----------------~i---~~~----~~l~~~~------~~~i---------------~~Qil~-aL 133 (508)
|++++| .+.. .+ ... .++.... ...+ +..+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 999997 4444 11 111 0111100 0000 111222 23
Q ss_pred HHhH-------hcCceecCCCCCceeeC-CCCcEEEccccccc
Q 010512 134 KYIH-------TANVFHRDLKPKNILAN-ADCKLKICDFGLAR 168 (508)
Q Consensus 134 ~yLH-------s~gIiHrDLKPeNILl~-~~~~lkL~DFGla~ 168 (508)
..++ ...++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3333 24699999999999999 66777899998775
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.36 E-value=3e-06 Score=95.98 Aligned_cols=206 Identities=18% Similarity=0.239 Sum_probs=142.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh
Q 010512 60 ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 138 (508)
Q Consensus 60 ~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs 138 (508)
......|+..+..+.|+|++.++.+-...-... -.+.+..++|.+ ++.+.+..-+..+....+.+..+++.||+|+|+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 334556778889999999999988876542211 234566677874 889999888899999999999999999999999
Q ss_pred cCceecCCCCC---ceeeCCCCcEEEc--cccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHH
Q 010512 139 ANVFHRDLKPK---NILANADCKLKIC--DFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC 213 (508)
Q Consensus 139 ~gIiHrDLKPe---NILl~~~~~lkL~--DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~ 213 (508)
....|.-|... +-.++..+.+.+. ||+.......... .....-+..+.+||.............|+|.+|.
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~----~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK----SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCccc----chhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 96666555544 4445556666666 8887765432221 1223444567788887652223334479999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCC-HHHHHHHHHhcc
Q 010512 214 IFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNAD-PLALHLLERLLA 292 (508)
Q Consensus 214 il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~-~~~~~Ll~~mL~ 292 (508)
.+..+..|..+-... ..+..++ +... ....+++.+|+.
T Consensus 381 l~~~~~~~~~i~~~~------~~~~~~l-----------------------------------~~~~~~~~~d~~~~~~~ 419 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKS------AVPVSLL-----------------------------------DVLSTSELLDALPKCLD 419 (1351)
T ss_pred HHhhhhhcCcccccc------cchhhhh-----------------------------------ccccchhhhhhhhhhcc
Confidence 999999876432110 0000000 1111 157789999999
Q ss_pred CCCCCCCCHHHHhcCCccc
Q 010512 293 FDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 293 ~DP~~Rpta~eiL~hp~f~ 311 (508)
-|+++|+++.+++.|+|.+
T Consensus 420 ~~~~~Rl~~~~ll~~~f~~ 438 (1351)
T KOG1035|consen 420 EDSEERLSALELLTHPFLR 438 (1351)
T ss_pred hhhhhccchhhhhhchhcc
Confidence 9999999999999999976
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.26 E-value=4.5e-06 Score=76.54 Aligned_cols=130 Identities=19% Similarity=0.249 Sum_probs=92.6
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEE
Q 010512 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 98 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 98 (508)
-++.+.||+|.+|+||++. ..|..+|+|+-.. ++....+..|+++|..++-.++..=+-.| +..++
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~----ds~r~~l~kEakiLeil~g~~~~p~vy~y--------g~~~i 89 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGE--WRGGEVALKVRRR----DSPRRNLEKEAKILEILAGEGVTPEVYFY--------GEDFI 89 (201)
T ss_pred hhhhhhhhcccccEEEEee--ccCceEEEEEecC----CcchhhHHHHHHHHHHhhhcCCCceEEEe--------chhhh
Confidence 3556789999999999995 5677999998643 33456788999999999877766433222 22467
Q ss_pred EEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCC-CCceeeCCCCcEEEcccccccc
Q 010512 99 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK-PKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 99 V~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLK-PeNILl~~~~~lkL~DFGla~~ 169 (508)
.|||+.| .|..+.... + +.-+..++++-.-|-..||-|..|. |..+++..++.+.|+||..|+.
T Consensus 90 ~me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 90 RMEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 7999998 666544321 2 2334556666556778899999997 5555555555999999999874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=7e-08 Score=102.77 Aligned_cols=244 Identities=16% Similarity=0.140 Sum_probs=160.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC-cceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD-IVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~Hpn-Iv~l~~v~~~~~~~~~~~ 95 (508)
..|....-+++|+++.++|.+...+...+ .+.+... ....-++++|.+++||| .+..++ +.+...+
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~-----d~~~E~~ 308 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLE-----DYDGEDY 308 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccc-----cCCcccc
Confidence 34566777899999999999877665555 6655321 23345889999999999 333333 3355567
Q ss_pred EEEEEecCCcc--HHHHHH-hCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 96 IYVVFELMESD--LHQVIK-ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 96 lylV~E~~~g~--L~~~i~-~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
.+++++++.+. ....+. ..-.+..-+...+.+.-+++|+|+|+.-=+||| ||+..+ +..+..||+.+.....
T Consensus 309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~ 383 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTR 383 (829)
T ss_pred cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCc
Confidence 89999999843 221111 111233444555677788999999998778999 777654 6889999998876533
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
.. ......+|+.++|||+... ..+....|.|++|.-..+|.-|-+|-.. ....+.. .|..+.... .
T Consensus 384 ~~----~~~t~~~~~~~~~pev~~~--~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~----~g~~p~s~~--L 449 (829)
T KOG0576|consen 384 TM----KPRTAIGTPEPLAPEVIQE--NTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPM----IGNGPNSPM--L 449 (829)
T ss_pred cc----ccccCCCCCCCCCchhhcc--cccccCCCccCCCcchhhcCCCCCCCCC--CccccCC----CCCCCCccc--c
Confidence 32 2355689999999999887 6889999999999887788778776533 1000000 011000000 0
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
.. ...|...+. .++...|+..-|..|++.-.++-|.+|.+
T Consensus 450 ------------~~--~~aw~~~~~------~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 450 ------------TD--KSAWSPVFH------RDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred ------------ch--hhhcCcccc------cCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 00 000111111 15778899999999999999999999975
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.23 E-value=5e-06 Score=89.27 Aligned_cols=146 Identities=27% Similarity=0.399 Sum_probs=89.7
Q ss_pred ccccccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChh--H--------------------------
Q 010512 8 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS--D-------------------------- 59 (508)
Q Consensus 8 ~~~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~--~-------------------------- 59 (508)
++|.+|.. +.||.-+.|.|++|+.+. |+.||||+-+....... +
T Consensus 159 ~if~~f~~-------~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE 230 (538)
T KOG1235|consen 159 DIFSEFDE-------EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDE 230 (538)
T ss_pred HHHHhcCc-------chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHH
Confidence 45666655 679999999999998764 99999998543222110 0
Q ss_pred -HHH------HHHHHHHHH----hCCCCCc---ceeeeeecCCCcCCCccEEEEEecCCc----cHHHHHHhCCCCCHHH
Q 010512 60 -ATR------ILREIKLLR----LLRHPDI---VEIKHIMLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEH 121 (508)
Q Consensus 60 -~~~------i~~Ei~iL~----~L~HpnI---v~l~~v~~~~~~~~~~~lylV~E~~~g----~L~~~i~~~~~l~~~~ 121 (508)
.+. +.+|.+-.. .++|-+. |.+=.+|..-+ ..-.|+||||+| || +.|.+.+ ++...
T Consensus 231 ~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl-~~i~~~g-i~~~~ 304 (538)
T KOG1235|consen 231 IAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDL-DAIDKRG-ISPHD 304 (538)
T ss_pred HHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCH-HHHHHcC-CCHHH
Confidence 011 233443332 2345441 22333333221 235899999996 44 4555543 44443
Q ss_pred HHHHHHHHHHHHH-HhHhcCceecCCCCCceeeCC----CCcEEEccccccccc
Q 010512 122 YQFFLYQLLRGLK-YIHTANVFHRDLKPKNILANA----DCKLKICDFGLARVS 170 (508)
Q Consensus 122 ~~~i~~Qil~aL~-yLHs~gIiHrDLKPeNILl~~----~~~lkL~DFGla~~~ 170 (508)
++.-+.++.. -|=..|++|.|-.|.||+++. ++.+.+.|||+....
T Consensus 305 ---i~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 305 ---ILNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred ---HHHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 3333333322 223478999999999999994 678999999998754
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.05 E-value=4e-05 Score=74.79 Aligned_cols=70 Identities=13% Similarity=0.046 Sum_probs=45.7
Q ss_pred eeeecCc-eEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCCCccEEEEEe
Q 010512 24 VIGKGSY-GVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIYVVFE 101 (508)
Q Consensus 24 ~LG~G~~-g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~lylV~E 101 (508)
.|..|.. ..||++.. .+..+.+|...... ...+.+|+.+++.+. +--+.+++..... .+.-++||+
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~~lv~e 72 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSD-----DGRAWLLTS 72 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEec-----CCccEEEEE
Confidence 4555655 78999954 34678888765321 345678999998885 3334455555532 134689999
Q ss_pred cCCc
Q 010512 102 LMES 105 (508)
Q Consensus 102 ~~~g 105 (508)
+++|
T Consensus 73 ~i~G 76 (244)
T cd05150 73 AVPG 76 (244)
T ss_pred eeCC
Confidence 9987
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.00 E-value=2.7e-05 Score=73.47 Aligned_cols=132 Identities=25% Similarity=0.300 Sum_probs=91.3
Q ss_pred CCeEEeeeeeecCc-eEEEEEEECCCCcEEEEEEecC---c--------cCC-h-------hHHHHHHHHHHHHHhC---
Q 010512 17 SRYQIQEVIGKGSY-GVVGSAVDTHTGERVAIKKIND---V--------FEH-V-------SDATRILREIKLLRLL--- 73 (508)
Q Consensus 17 ~rY~i~~~LG~G~~-g~V~~a~~~~tg~~vAIKki~~---~--------~~~-~-------~~~~~i~~Ei~iL~~L--- 73 (508)
..++.++.||.|.- |.||++.. .|..||+|.+.. . ... . ....-+..|-+...+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 89999999999999 99999964 688999999421 0 000 0 1122356677665555
Q ss_pred CCCCc--ceeeeeecCCC-------------cCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh
Q 010512 74 RHPDI--VEIKHIMLPPS-------------RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 138 (508)
Q Consensus 74 ~HpnI--v~l~~v~~~~~-------------~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs 138 (508)
.+.++ |++++++.-.. ........||.||+...- .++... +.+|++-|..+|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~~~----~~~~~~dl~~~~k 182 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQIRD----IPQMLRDLKILHK 182 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccchhH----HHHHHHHHHHHHH
Confidence 45666 88888874321 011223468999887532 233333 4677788889999
Q ss_pred cCceecCCCCCceeeCCCCcEEEcccccc
Q 010512 139 ANVFHRDLKPKNILANADCKLKICDFGLA 167 (508)
Q Consensus 139 ~gIiHrDLKPeNILl~~~~~lkL~DFGla 167 (508)
.||+-+|+++.|.. .-||+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999987 3478999964
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.00 E-value=6.5e-05 Score=79.05 Aligned_cols=176 Identities=25% Similarity=0.367 Sum_probs=120.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh
Q 010512 59 DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 138 (508)
Q Consensus 59 ~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs 138 (508)
...+++-..++++.+.|+|....+++-.... ....+|||+++.+|.+.++.+. +-... ++ .
T Consensus 25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~----~r~IVV~e~~~~Sled~~~~~~-l~~~s-------~~-------~ 85 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKH----ERVIVVMEHYTMSLEDILKTGN-LKDES-------LL-------A 85 (725)
T ss_pred cHHHHhhhhHHHHhhcCccceeeEeeecCcc----ceEEEEehhhccchHHHHHhcc-cchhh-------hc-------c
Confidence 3556777889999999999999888764332 3389999999999999887654 22111 11 2
Q ss_pred cCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHH
Q 010512 139 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEM 218 (508)
Q Consensus 139 ~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eL 218 (508)
+|+.|- |+ ++++| -++ +. | |- ..++++||||+|.|+.++
T Consensus 86 ~~~~~~-----~~-------~~~td-~~~-------------t~------~--~~-------~~~pKsdVwsl~~i~~el 124 (725)
T KOG1093|consen 86 HGVLHL-----NI-------IYITD-HFL-------------TK------Y--PS-------PIGPKSDVWSLGFIILEL 124 (725)
T ss_pred ccccee-----hh-------hhccc-ccc-------------cc------C--CC-------CCCcchhhhhHHHHHHHH
Confidence 333332 22 23333 111 10 0 11 122599999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 010512 219 LTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR 298 (508)
Q Consensus 219 ltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~R 298 (508)
..|...|......+++..+.++.-.+.....-.... .. .-.++....+++.+|+-..|..|
T Consensus 125 ~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~--~~-----------------~~~~d~~~~~~~~~c~~~~~~ir 185 (725)
T KOG1093|consen 125 YLGISLEAELTESEYLEILLKYYTDDQELLSTAMEH--LI-----------------QLLADKKRLPLLKKCLWLEPIIR 185 (725)
T ss_pred HHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHH--HH-----------------HHhhhHhHHHHhccCCccccccc
Confidence 999999998888888888877765554433221111 00 01245667899999999999999
Q ss_pred CCHHHHhcCCcccCC
Q 010512 299 PTAEEALADPYFHGL 313 (508)
Q Consensus 299 pta~eiL~hp~f~~~ 313 (508)
|...++.+++-|...
T Consensus 186 ~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 186 PLPMELSKRCSFTEV 200 (725)
T ss_pred cchhHHhcCccHHHH
Confidence 999999999999754
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.99 E-value=6e-05 Score=86.60 Aligned_cols=83 Identities=18% Similarity=0.220 Sum_probs=56.1
Q ss_pred EeeeeeecCceEEEEEEECCCC--cEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCc--ceeeeeecCCCcCCCcc
Q 010512 21 IQEVIGKGSYGVVGSAVDTHTG--ERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDI--VEIKHIMLPPSRREFKD 95 (508)
Q Consensus 21 i~~~LG~G~~g~V~~a~~~~tg--~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnI--v~l~~v~~~~~~~~~~~ 95 (508)
-+..|+.|.+..+|+......+ ..+++|+...... ......+.+|+.+|+.|. |++| .+++.++.+. ...+.
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~ 118 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGT 118 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCC
Confidence 3577899999999998765432 4688887643211 122346789999999996 6665 5666655332 12345
Q ss_pred EEEEEecCCcc
Q 010512 96 IYVVFELMESD 106 (508)
Q Consensus 96 lylV~E~~~g~ 106 (508)
.|+||||++|.
T Consensus 119 ~flVME~v~G~ 129 (822)
T PLN02876 119 AFYIMEYLEGR 129 (822)
T ss_pred ceEEEEecCCc
Confidence 78999999874
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00021 Score=67.77 Aligned_cols=128 Identities=21% Similarity=0.262 Sum_probs=89.8
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCcc--------------CChhHHHHHHHHHHHHHhCC------CCCcceee
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVF--------------EHVSDATRILREIKLLRLLR------HPDIVEIK 82 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~--------------~~~~~~~~i~~Ei~iL~~L~------HpnIv~l~ 82 (508)
..||+|+.-.||.--+ ....+||++.... ..........+|+.-...+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 5799999999997633 3446789986543 11123456677887777666 78899999
Q ss_pred eeecCCCcCCCccEEEEEecCC---c----cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC
Q 010512 83 HIMLPPSRREFKDIYVVFELME---S----DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 155 (508)
Q Consensus 83 ~v~~~~~~~~~~~lylV~E~~~---g----~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~ 155 (508)
+...+. -.+-+|+|.+. | +|.+++... .+++ ... ..+-+-..||-.++|+.+||+|.||++..
T Consensus 84 G~veT~-----~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 84 GFVETN-----LGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEEecC-----CceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEe
Confidence 998543 44788888764 3 688888544 4666 333 33344457888999999999999999864
Q ss_pred CC----cEEEcc
Q 010512 156 DC----KLKICD 163 (508)
Q Consensus 156 ~~----~lkL~D 163 (508)
+. .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 32 577887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00012 Score=71.25 Aligned_cols=31 Identities=35% Similarity=0.503 Sum_probs=25.8
Q ss_pred cCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 139 ANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 139 ~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
.+++|+|+.|.|||++.++..-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3589999999999998765557999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.70 E-value=1e-05 Score=93.63 Aligned_cols=155 Identities=17% Similarity=0.121 Sum_probs=117.6
Q ss_pred HHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEEecCC-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhH
Q 010512 63 ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIH 137 (508)
Q Consensus 63 i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~----~~l~~~~~~~i~~Qil~aL~yLH 137 (508)
.+.|..-++...|+++.....-..+ .+....|++++|+. |.++..|.++ .++....+.....+.+.+..-+|
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~p---s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPP---SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCC---CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 4455566677789998876555433 23455799999998 7999998754 24555555555555588888888
Q ss_pred hcC-----ceecCCCCCceeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHH
Q 010512 138 TAN-----VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG 212 (508)
Q Consensus 138 s~g-----IiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG 212 (508)
+.. .+|++||+-|.+|..+..+++.++|+.+..... .......++++.|++|++... -.++.++|+|..|
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~---~sf~Gl~l~sp~~v~qli~N~--ik~t~rsdilr~s 1427 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV---LSFFGLELCSPIYVLQLIKNE--IKFTKRSDILRRS 1427 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCcccccccccccccCch---HhhhhhhhCCHHHHHHHHHHH--HhhhhHHHHHHHH
Confidence 652 699999999999999999999999999843222 223455678889999998776 5788889999999
Q ss_pred HHHHHHHhCCCCC
Q 010512 213 CIFAEMLTGKPLF 225 (508)
Q Consensus 213 ~il~eLltG~~pF 225 (508)
+-+|.+..|.++|
T Consensus 1428 ~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1428 LSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHhcccHHH
Confidence 9999999888776
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00065 Score=65.75 Aligned_cols=72 Identities=11% Similarity=0.181 Sum_probs=45.7
Q ss_pred eeeeeecCceEEEEEEECC-CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCc-ceeeeeecCCCcCCCccEEEE
Q 010512 22 QEVIGKGSYGVVGSAVDTH-TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI-VEIKHIMLPPSRREFKDIYVV 99 (508)
Q Consensus 22 ~~~LG~G~~g~V~~a~~~~-tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~v~~~~~~~~~~~lylV 99 (508)
++.|..|-...||++.... .+..|++|+....... .....+|+.+++.+...++ .+++... . -.+|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~----~~~l 70 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATF-----Q----NGLI 70 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEe-----C----CcEE
Confidence 4678889999999996432 3578999976532111 1223479999998864343 3343322 1 1479
Q ss_pred EecCCc
Q 010512 100 FELMES 105 (508)
Q Consensus 100 ~E~~~g 105 (508)
|||++|
T Consensus 71 ~e~i~G 76 (235)
T cd05157 71 YEFIPG 76 (235)
T ss_pred EEeeCC
Confidence 999986
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00061 Score=69.01 Aligned_cols=155 Identities=17% Similarity=0.170 Sum_probs=88.4
Q ss_pred ccccccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC--cceeeeee
Q 010512 8 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD--IVEIKHIM 85 (508)
Q Consensus 8 ~~~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~ 85 (508)
+++..|+. +....++.++.|....||++.. .+| .+++|+..... ....+..|+.+++.|.... +.+++...
T Consensus 14 ~~l~~y~~-~~~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~ 86 (307)
T TIGR00938 14 SFLDGYDL-GELLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV----KAEELPFFLALTTHLAARGLPVPKPVKSR 86 (307)
T ss_pred HHHHhcCC-CCceeccccCCccccceEEEEe-CCC-cEEEEEecCCC----CHHHHHHHHHHHHHHHHCCCCCCccccCC
Confidence 34556655 3456678888898899999853 334 67789775321 1334567888888885333 33333211
Q ss_pred cCC-CcCCCccEEEEEecCCcc-H-----H------HHH---Hh-CCCC--------CHHHHHH---------------H
Q 010512 86 LPP-SRREFKDIYVVFELMESD-L-----H------QVI---KA-NDDL--------TPEHYQF---------------F 125 (508)
Q Consensus 86 ~~~-~~~~~~~lylV~E~~~g~-L-----~------~~i---~~-~~~l--------~~~~~~~---------------i 125 (508)
... .....+..|+||+|++|. + . ..+ +. ...+ ....... .
T Consensus 87 ~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~ 166 (307)
T TIGR00938 87 DGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHM 166 (307)
T ss_pred CCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHH
Confidence 000 001235578999999862 1 1 111 11 0011 0011000 0
Q ss_pred HHHHHHHHHHhHh-------cCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 126 LYQLLRGLKYIHT-------ANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 126 ~~Qil~aL~yLHs-------~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
...+...++++.. .++||+|+.+.||+++.++.+.|+||+.+..
T Consensus 167 ~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 167 GAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 1122334555532 5899999999999999888778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00025 Score=66.78 Aligned_cols=97 Identities=23% Similarity=0.202 Sum_probs=77.6
Q ss_pred HHHHHHHHhCCC-CCcceeeeeecCCCcCCCccEEEEEecCC-ccHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHhHh
Q 010512 64 LREIKLLRLLRH-PDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQV---IKANDDLTPEHYQFFLYQLLRGLKYIHT 138 (508)
Q Consensus 64 ~~Ei~iL~~L~H-pnIv~l~~v~~~~~~~~~~~lylV~E~~~-g~L~~~---i~~~~~l~~~~~~~i~~Qil~aL~yLHs 138 (508)
..|.-+|+.+++ +++.+++|.+ + -++|.||.+ +++... +..--..++.....++.++++.+.+++.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C--------G-~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC--------G-RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC--------C-CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 358889999986 6999999998 2 266889988 444321 1111246899999999999999999987
Q ss_pred ---cCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 139 ---ANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 139 ---~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
..+.-.|++|+|+-++++|++|++|...+..
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 4588899999999999999999999987764
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00075 Score=68.62 Aligned_cols=150 Identities=16% Similarity=0.140 Sum_probs=80.8
Q ss_pred cccccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCc--ceeeeeec
Q 010512 9 FFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI--VEIKHIML 86 (508)
Q Consensus 9 ~~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnI--v~l~~v~~ 86 (508)
+...|+.+ .-.-.+.|+.|....+|++... +| .+++|++.. .....+..|+.+++.|...++ .+++.
T Consensus 15 ~l~~y~~~-~~~~~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~-----~~~~~l~~~~~~l~~L~~~glpvP~~i~--- 83 (319)
T PRK05231 15 FLAPYDLG-ELLSLKGIAEGIENSNFFLTTT-QG-EYVLTLFER-----LTAEDLPFFLGLMQHLAARGVPVPAPVA--- 83 (319)
T ss_pred HHHhcCCc-hhhccchhccccccceEEEEeC-CC-cEEEEEecc-----CChHHhHHHHHHHHHHHHCCCCCCccee---
Confidence 33455552 3333566788888899998643 33 688998751 123445567777777643332 22221
Q ss_pred CCCc----CCCccEEEEEecCCcc-H-----------HHHHH---h-CCCC--------CHHHH----H-----------
Q 010512 87 PPSR----REFKDIYVVFELMESD-L-----------HQVIK---A-NDDL--------TPEHY----Q----------- 123 (508)
Q Consensus 87 ~~~~----~~~~~lylV~E~~~g~-L-----------~~~i~---~-~~~l--------~~~~~----~----------- 123 (508)
..+. ...+..++++++++|. + ...+. . ...+ ..... .
T Consensus 84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (319)
T PRK05231 84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA 163 (319)
T ss_pred CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence 1110 1134578999999873 1 11111 0 0001 11000 0
Q ss_pred HHHHHHH-HHHHHhH-------hcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 124 FFLYQLL-RGLKYIH-------TANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 124 ~i~~Qil-~aL~yLH-------s~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
..+.+.+ ..+..+. ..++||+|+.|.|||++.+...-|+||+.+..
T Consensus 164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1111111 1122222 23899999999999999665568999998863
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.002 Score=67.59 Aligned_cols=77 Identities=21% Similarity=0.188 Sum_probs=52.9
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCcc----C-ChhHHHHHHHHHHHHHhCC---CCCcceeeeeecCCCcCCC
Q 010512 22 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF----E-HVSDATRILREIKLLRLLR---HPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 22 ~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~----~-~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~v~~~~~~~~~ 93 (508)
.+.||.|.+..||++.+...++.|+||.-.... . ......+...|...|+.+. ..++.+++.+-.
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~------- 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE------- 103 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC-------
Confidence 467999999999999986444689999853211 1 1224567778888888864 245666666531
Q ss_pred ccEEEEEecCCc
Q 010512 94 KDIYVVFELMES 105 (508)
Q Consensus 94 ~~lylV~E~~~g 105 (508)
..-++|||++++
T Consensus 104 ~~~~lVME~L~~ 115 (401)
T PRK09550 104 ELAVTVMEDLSD 115 (401)
T ss_pred CCCEEEEecCCC
Confidence 235899999984
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00051 Score=67.64 Aligned_cols=132 Identities=17% Similarity=0.239 Sum_probs=75.9
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcc-eeeeeecCCCcCCCccEEEEEec
Q 010512 24 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV-EIKHIMLPPSRREFKDIYVVFEL 102 (508)
Q Consensus 24 ~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv-~l~~v~~~~~~~~~~~lylV~E~ 102 (508)
.+..|-.+.+|++. .+|..+++|......... .-...+|..+|+.+..-.++ +++... . -++||||
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~--~-------~~~v~e~ 69 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVN--E-------HWLLVEW 69 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEe--C-------CEEEEEe
Confidence 45678888999986 457788898754321111 01246799999988654332 333222 1 2689999
Q ss_pred CCc-cHH--------------HHHH---hCC----CCCH-HHHHHHHHHH---------HHHHHHhHh--------cCce
Q 010512 103 MES-DLH--------------QVIK---AND----DLTP-EHYQFFLYQL---------LRGLKYIHT--------ANVF 142 (508)
Q Consensus 103 ~~g-~L~--------------~~i~---~~~----~l~~-~~~~~i~~Qi---------l~aL~yLHs--------~gIi 142 (508)
++| .+. +.+. ... +++. ..+..+..++ ...+..+-. ..++
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 986 221 1111 111 1221 1222222222 111222211 2589
Q ss_pred ecCCCCCceeeCCCCcEEEcccccccc
Q 010512 143 HRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 143 HrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
|+|+.|.||+++.++ +.|+||..|..
T Consensus 150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 150 HMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 999999999999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00055 Score=68.74 Aligned_cols=151 Identities=16% Similarity=0.094 Sum_probs=86.6
Q ss_pred ccccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC--cceeeeeecC
Q 010512 10 FTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD--IVEIKHIMLP 87 (508)
Q Consensus 10 ~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~ 87 (508)
...|+.. +..-++.|..|....+|++.. .+..+++|+... .....+..|+.+++.|.+.+ +.+++... .
T Consensus 8 l~~y~~~-~~~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~-~ 78 (296)
T cd05153 8 LADYDLG-ELLSFEGISAGIENTNYFVTT--DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADR-D 78 (296)
T ss_pred HHHcCCC-chhheecccCccccceEEEEe--CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCC-C
Confidence 4455532 333366788888899999854 345788998753 12355778899888886433 33333211 0
Q ss_pred CC--cCCCccEEEEEecCCc-cHH--------HH---H---Hh-CCCCCH--------HHHH------------HHHHHH
Q 010512 88 PS--RREFKDIYVVFELMES-DLH--------QV---I---KA-NDDLTP--------EHYQ------------FFLYQL 129 (508)
Q Consensus 88 ~~--~~~~~~lylV~E~~~g-~L~--------~~---i---~~-~~~l~~--------~~~~------------~i~~Qi 129 (508)
.. ....+..++|+++++| .+. .+ + +. ...+.. .... .....+
T Consensus 79 g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 158 (296)
T cd05153 79 GEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALL 158 (296)
T ss_pred CcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHH
Confidence 00 0112456899999986 210 11 1 10 000000 0000 011112
Q ss_pred HHHHHHhHh-------cCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 130 LRGLKYIHT-------ANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 130 l~aL~yLHs-------~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
..++.++.. .++||+|+.|.|||++.++.+.|+||+.+..
T Consensus 159 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 159 ADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 334444443 4799999999999999887778999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0031 Score=63.68 Aligned_cols=80 Identities=15% Similarity=0.147 Sum_probs=53.6
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCC---CCcceeeeeecCCCcCCCc
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH---PDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~H---pnIv~l~~v~~~~~~~~~~ 94 (508)
+-.-.+.||.|..+.||..... +| .+.+|..+. . .....+.+|...|+.|.. ..+.++++++... ...+
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~-~---~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g 86 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDS-QG-NPMPLMARS-F---STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPG 86 (297)
T ss_pred hhheeeecCCccceeEEEEEcC-CC-CEEEEEecc-c---ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCC
Confidence 3444678999999999999542 23 466676432 1 123567899999999864 3567777766432 1224
Q ss_pred cEEEEEecCCc
Q 010512 95 DIYVVFELMES 105 (508)
Q Consensus 95 ~lylV~E~~~g 105 (508)
.-|||||+++|
T Consensus 87 ~~~LVmE~i~G 97 (297)
T PRK10593 87 PDVLLLERLRG 97 (297)
T ss_pred CeEEEEeccCC
Confidence 47999999985
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0016 Score=66.52 Aligned_cols=139 Identities=24% Similarity=0.303 Sum_probs=98.7
Q ss_pred EEeeeeeecCceEEEEEEECCCCcEEEEEEecCc----------------cCC------h--hHHHHHHHHHHHHHhCCC
Q 010512 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV----------------FEH------V--SDATRILREIKLLRLLRH 75 (508)
Q Consensus 20 ~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~----------------~~~------~--~~~~~i~~Ei~iL~~L~H 75 (508)
+|-..|..|--+.||.|.. ..|..+|||+++-. +.+ + ....-...|++-|++|..
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 4556788999999999974 57888999987421 111 0 011224578888999887
Q ss_pred CCcceeeeeecCCCcCCCccEEEEEecCCccH--HHHHHhCCCCCHHHHHHHHHHHHHHHHHh-HhcCceecCCCCCcee
Q 010512 76 PDIVEIKHIMLPPSRREFKDIYVVFELMESDL--HQVIKANDDLTPEHYQFFLYQLLRGLKYI-HTANVFHRDLKPKNIL 152 (508)
Q Consensus 76 pnIv~l~~v~~~~~~~~~~~lylV~E~~~g~L--~~~i~~~~~l~~~~~~~i~~Qil~aL~yL-Hs~gIiHrDLKPeNIL 152 (508)
-.|....-+++- .-.|||++++++- .-.| +.-.++...+..+-.|++.-+.-| |..+++|.||.=-|+|
T Consensus 226 aGIP~PePIlLk-------~hVLVM~FlGrdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~L 297 (520)
T KOG2270|consen 226 AGIPCPEPILLK-------NHVLVMEFLGRDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLL 297 (520)
T ss_pred cCCCCCCceeee-------cceEeeeeccCCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhhe
Confidence 766554444432 2489999998432 2222 233588888888888888888777 6679999999999999
Q ss_pred eCCCCcEEEccccccc
Q 010512 153 ANADCKLKICDFGLAR 168 (508)
Q Consensus 153 l~~~~~lkL~DFGla~ 168 (508)
+. +|.|.|+|.+-+.
T Consensus 298 yh-dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 298 YH-DGKLYIIDVSQSV 312 (520)
T ss_pred EE-CCEEEEEEccccc
Confidence 86 6789999988664
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0016 Score=65.65 Aligned_cols=72 Identities=15% Similarity=0.099 Sum_probs=45.2
Q ss_pred eeeeeecCceEEEEEEECC------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcc-eeeeeecCCCcCCCc
Q 010512 22 QEVIGKGSYGVVGSAVDTH------TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV-EIKHIMLPPSRREFK 94 (508)
Q Consensus 22 ~~~LG~G~~g~V~~a~~~~------tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv-~l~~v~~~~~~~~~~ 94 (508)
++.|..|-...||++.... +++.|++|+...... ......+|+.+++.+....+. +++..+. .
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~----- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE---LLIDRERELVVFARLSERNLGPKLYGIFP--N----- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc---ceechHHHHHHHHHHHhCCCCCceEEEeC--C-----
Confidence 4567788888999997533 257899998754221 223456898888888643332 3444331 1
Q ss_pred cEEEEEecCCc
Q 010512 95 DIYVVFELMES 105 (508)
Q Consensus 95 ~lylV~E~~~g 105 (508)
.+|++|++|
T Consensus 73 --~~v~e~i~G 81 (302)
T cd05156 73 --GRIEEFIPS 81 (302)
T ss_pred --CchhheeCC
Confidence 357888775
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0053 Score=62.34 Aligned_cols=146 Identities=18% Similarity=0.199 Sum_probs=82.9
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcce--eeeeecCCCcCCCccE
Q 010512 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVE--IKHIMLPPSRREFKDI 96 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~--l~~v~~~~~~~~~~~l 96 (508)
-.+++.+..|..-.+|...+. ++++++. ...............+|..+++.+.--.+.. .++++.... .+..
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~---~g~p 100 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY---LGTP 100 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC---CCCc
Confidence 345555655555556666543 8888888 4322333344566778888888875433332 333332211 3567
Q ss_pred EEEEecCCcc-H------------------HHHHHh---CC-----------CCCHHHHHHHHHHH--------------
Q 010512 97 YVVFELMESD-L------------------HQVIKA---ND-----------DLTPEHYQFFLYQL-------------- 129 (508)
Q Consensus 97 ylV~E~~~g~-L------------------~~~i~~---~~-----------~l~~~~~~~i~~Qi-------------- 129 (508)
|.||++++|. + .+.|.. -. .....++..+..+.
T Consensus 101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 9999999982 1 111110 00 00111111111111
Q ss_pred HHHHHHhHhc--------CceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 130 LRGLKYIHTA--------NVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 130 l~aL~yLHs~--------gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
..-..+|+.+ .++|+|+.+.||+++.++.+-|.||+++...
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 1223344332 3899999999999999988999999999763
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0054 Score=61.32 Aligned_cols=30 Identities=33% Similarity=0.604 Sum_probs=25.7
Q ss_pred CceecCCCCCceeeCCCCcE-EEcccccccc
Q 010512 140 NVFHRDLKPKNILANADCKL-KICDFGLARV 169 (508)
Q Consensus 140 gIiHrDLKPeNILl~~~~~l-kL~DFGla~~ 169 (508)
.++|+|+.|.|||++.++.+ -|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 48999999999999975664 6999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.00076 Score=67.68 Aligned_cols=135 Identities=19% Similarity=0.203 Sum_probs=90.7
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEec--Cc-cC---------------ChhHH--HHHHHHHHHHHhCCC-C
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN--DV-FE---------------HVSDA--TRILREIKLLRLLRH-P 76 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~--~~-~~---------------~~~~~--~~i~~Ei~iL~~L~H-p 76 (508)
-|.++..||-|--+-||.+.+. .|...++|.=. +. +. ..-.. -...+|...|+.|.. .
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 4678889999999999999864 68888888521 00 00 00011 124579999988863 2
Q ss_pred C-cceeeeeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeC
Q 010512 77 D-IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 154 (508)
Q Consensus 77 n-Iv~l~~v~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~ 154 (508)
. |.+.++. ..-++|||++.| .|.++-+-. .+..+...+..-+.-|..+|+||+|..-=||+++
T Consensus 172 fpVPkpiD~---------~RH~Vvmelv~g~Pl~~v~~v~------d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 172 FPVPKPIDH---------NRHCVVMELVDGYPLRQVRHVE------DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCCcccc---------cceeeHHHhhcccceeeeeecC------ChHHHHHHHHHHHHHHHHcCceecccchheeEEe
Confidence 2 3333332 345899999987 555433211 1233444555556678899999999999999999
Q ss_pred CCCcEEEccccccc
Q 010512 155 ADCKLKICDFGLAR 168 (508)
Q Consensus 155 ~~~~lkL~DFGla~ 168 (508)
+++.++++||--+.
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 99999999996543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.028 Score=58.02 Aligned_cols=139 Identities=15% Similarity=0.124 Sum_probs=78.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECC----CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcc-eeeeeecCCCcC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTH----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV-EIKHIMLPPSRR 91 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~----tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv-~l~~v~~~~~~~ 91 (508)
+...+ ..|..|-.-.+|++.... +++.|++|+...... ... .-.+|+.+++.+..-++. ++++.+.
T Consensus 37 ~~~~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~--~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~----- 107 (344)
T PLN02236 37 EALQV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE--LFF-DRDDEIRTFECMSRHGQGPRLLGRFP----- 107 (344)
T ss_pred CcEEE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC--eee-chHHHHHHHHHHHHcCCCCceEEEEC-----
Confidence 34444 456669999999986422 347899998754321 111 225788998888644433 3444441
Q ss_pred CCccEEEEEecCCc-cHH-----------HH---H---HhCC------CCCHHHHHHHHHHHH-----------------
Q 010512 92 EFKDIYVVFELMES-DLH-----------QV---I---KAND------DLTPEHYQFFLYQLL----------------- 130 (508)
Q Consensus 92 ~~~~lylV~E~~~g-~L~-----------~~---i---~~~~------~l~~~~~~~i~~Qil----------------- 130 (508)
. ..|.+|++| +|. .+ + +... ....+.+..++.++.
T Consensus 108 ~----g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~ 183 (344)
T PLN02236 108 N----GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLE 183 (344)
T ss_pred C----ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHH
Confidence 1 246787774 321 11 1 1111 111233334432221
Q ss_pred HHHHH----hH----hcCceecCCCCCceeeCC-CCcEEEccccccc
Q 010512 131 RGLKY----IH----TANVFHRDLKPKNILANA-DCKLKICDFGLAR 168 (508)
Q Consensus 131 ~aL~y----LH----s~gIiHrDLKPeNILl~~-~~~lkL~DFGla~ 168 (508)
..+.. +. ...++|+|+++.|||++. ++.+.|+||..|.
T Consensus 184 ~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 184 DEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11111 11 235899999999999986 4689999998775
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.016 Score=58.45 Aligned_cols=29 Identities=24% Similarity=0.377 Sum_probs=25.6
Q ss_pred cCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 139 ANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 139 ~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
.++||+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.024 Score=57.47 Aligned_cols=30 Identities=17% Similarity=0.135 Sum_probs=27.9
Q ss_pred CceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 140 NVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 140 gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
++||+|+.+.|||++.++.+.++||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.027 Score=58.17 Aligned_cols=81 Identities=16% Similarity=0.059 Sum_probs=52.5
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEecCc-----cCChhHHHHHHHHHHHHHhCC--CC-CcceeeeeecCCCcCCCcc
Q 010512 24 VIGKGSYGVVGSAVDTHTGERVAIKKINDV-----FEHVSDATRILREIKLLRLLR--HP-DIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 24 ~LG~G~~g~V~~a~~~~tg~~vAIKki~~~-----~~~~~~~~~i~~Ei~iL~~L~--Hp-nIv~l~~v~~~~~~~~~~~ 95 (508)
.||.|.-..||++.+...+..|+||.-..- ........+...|...|+... -| .+.+++.+- ...
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D-------~e~ 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD-------TEM 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc-------ccc
Confidence 579999999999997644468999974311 122445667778888887764 34 344454432 123
Q ss_pred EEEEEecCCc--cHHHHH
Q 010512 96 IYVVFELMES--DLHQVI 111 (508)
Q Consensus 96 lylV~E~~~g--~L~~~i 111 (508)
..+|||+++. .|...+
T Consensus 75 ~~~vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 75 AVTVMEDLSHHKIARKGL 92 (370)
T ss_pred ceehHhhCccchHHHHHH
Confidence 4699999963 454444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.068 Score=56.18 Aligned_cols=76 Identities=17% Similarity=0.146 Sum_probs=50.9
Q ss_pred EeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-----ChhHHHHHHHHHHHHHhCC---CCCcceeeeeecCCCcCC
Q 010512 21 IQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-----HVSDATRILREIKLLRLLR---HPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 21 i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-----~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~v~~~~~~~~ 92 (508)
..+.||.|.-..||++.+. +..|+||.-..... ......+...|...|+.+. ...+.+++.+..
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de------ 107 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR------ 107 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC------
Confidence 4678999999999999763 45689997542111 1123455566777777664 246777777663
Q ss_pred CccEEEEEecCCc
Q 010512 93 FKDIYVVFELMES 105 (508)
Q Consensus 93 ~~~lylV~E~~~g 105 (508)
..-++|||++++
T Consensus 108 -d~~vlvME~L~~ 119 (418)
T PLN02756 108 -TMALIGMRYLEP 119 (418)
T ss_pred -CCCEEEEeecCC
Confidence 224889999975
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.041 Score=57.47 Aligned_cols=88 Identities=23% Similarity=0.180 Sum_probs=57.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecC----ccCChhHHHHHHHHHHHHHhCC--CC-CcceeeeeecCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIND----VFEHVSDATRILREIKLLRLLR--HP-DIVEIKHIMLPP 88 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~----~~~~~~~~~~i~~Ei~iL~~L~--Hp-nIv~l~~v~~~~ 88 (508)
.+.+. .+.||.|.-..||++.+...+..|+||.-.. .....-...+...|...|+.+. -| .+.+++.+-
T Consensus 29 ~~~~~-~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D--- 104 (409)
T PRK12396 29 AKGLQ-CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD--- 104 (409)
T ss_pred cccce-eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC---
Confidence 34444 5678999999999998744456799997421 1222455677888999988774 34 344454432
Q ss_pred CcCCCccEEEEEecCCc--cHHHHH
Q 010512 89 SRREFKDIYVVFELMES--DLHQVI 111 (508)
Q Consensus 89 ~~~~~~~lylV~E~~~g--~L~~~i 111 (508)
.....+|||+++. .|...+
T Consensus 105 ----~e~~~~vMEdL~~~~ilR~~L 125 (409)
T PRK12396 105 ----SVMNCCVMEDLSDHTILRTAL 125 (409)
T ss_pred ----cHHhhHHHHhCcccHHHHHHH
Confidence 2335789999863 455554
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.049 Score=55.87 Aligned_cols=139 Identities=14% Similarity=0.172 Sum_probs=76.5
Q ss_pred CCeEEeeeeeecCceEEEEEEECCC---CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcc-eeeeeecCCCcCC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV-EIKHIMLPPSRRE 92 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~t---g~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv-~l~~v~~~~~~~~ 92 (508)
+..++ +.|..|-...+|++..... +..|.+|+...... ..-.-.+|+.+++.+..-++. ++++++ . .
T Consensus 15 ~~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~IdR~~E~~il~~l~~~gl~P~~l~~~-~-~--- 85 (330)
T PLN02421 15 SDFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVIDRERELQAIKYLSAAGFGAKLLGVF-G-N--- 85 (330)
T ss_pred CceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEechHHHHHHHHHHHhcCCCCceeEEe-C-C---
Confidence 34444 4455588888999864322 34899998754221 111234788898888754443 444443 1 1
Q ss_pred CccEEEEEecCCc-cHH--------------HHHH---hCC-C----C-CHHHHHHHHHHH-------------------
Q 010512 93 FKDIYVVFELMES-DLH--------------QVIK---AND-D----L-TPEHYQFFLYQL------------------- 129 (508)
Q Consensus 93 ~~~lylV~E~~~g-~L~--------------~~i~---~~~-~----l-~~~~~~~i~~Qi------------------- 129 (508)
.+|.+|++| .|. ..+. ... + . -...+..++.++
T Consensus 86 ----G~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~ 161 (330)
T PLN02421 86 ----GMIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISF 161 (330)
T ss_pred ----cEeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCH
Confidence 147777764 221 1111 111 0 1 123333333222
Q ss_pred ---HHHHHH----hHhcC----ceecCCCCCceeeCC-CCcEEEccccccc
Q 010512 130 ---LRGLKY----IHTAN----VFHRDLKPKNILANA-DCKLKICDFGLAR 168 (508)
Q Consensus 130 ---l~aL~y----LHs~g----IiHrDLKPeNILl~~-~~~lkL~DFGla~ 168 (508)
..-+.. +.+.+ +||.|+.+.|||++. ++.++++||..|.
T Consensus 162 ~~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 162 EELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 111211 11222 799999999999975 5789999998775
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.044 Score=56.19 Aligned_cols=130 Identities=22% Similarity=0.329 Sum_probs=83.9
Q ss_pred CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhc-CceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 91 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 91 ~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~-gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
.+..+.|++|++-++.+.- ++ .-..+++..|+++.+..++-+... ..=|||+...||||+ +|+|.|+||-++|.
T Consensus 296 de~~y~yl~~kdhgt~is~-ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 296 DETLYLYLHFKDHGTPISI-IK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred CCceEEEEEEecCCceeee-ee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 3446788999988765532 21 235678888999988877777654 689999999999999 99999999999996
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCC--CCCCCCChHHHHHHHHh
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK--PLFPGKNVVHQLDLMTD 239 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~--~pF~~~~~~~~l~~i~~ 239 (508)
...... + .. -..--|-++.| .-+...+||-+ |-.|+.|. ..+|..|..-...++..
T Consensus 371 ~~~q~~--i-sy-----~rldhp~lF~G---~dd~QFeIYrl---Mr~l~~g~wa~F~P~TNvlWL~yLs~~ 428 (488)
T COG5072 371 SYSQGI--I-SY-----NRLDHPDLFNG---VDDYQFEIYRL---MRRLLKGRWAQFEPITNVLWLYYLSHQ 428 (488)
T ss_pred ccCCce--e-ec-----cccCchhhhcC---ccceeeeHHHH---HHHHhcCcHHhcccchhhHHHHHHHHH
Confidence 432211 1 11 11223445544 33667788864 33444454 44555555444444433
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.47 Score=48.51 Aligned_cols=73 Identities=16% Similarity=0.066 Sum_probs=41.7
Q ss_pred ecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC--cceeeeeecCCC--cCCCccEEEEEec
Q 010512 27 KGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD--IVEIKHIMLPPS--RREFKDIYVVFEL 102 (508)
Q Consensus 27 ~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~~--~~~~~~lylV~E~ 102 (508)
.+.-..||++.. .+|..|++|+.+... .....+..|+.++..|.... ++.... .... ....+..+.|+++
T Consensus 35 ~s~eN~vy~v~~-~~~~~~vlKv~r~~~---~~~~~i~~E~~~l~~L~~~gipv~~p~~--~~G~~~~~~~g~~~~l~~~ 108 (325)
T PRK11768 35 NSYENRVYQFGD-EDGRRVVAKFYRPER---WSDAQILEEHAFALELAEAEIPVVAPLA--FNGQTLHEHQGFRFALFPR 108 (325)
T ss_pred ccccceEEEEec-CCCCEEEEEEcCccc---CCHHHHHHHHHHHHHHHHCCCCCCCCcc--CCCCEEEEECCEEEEEEee
Confidence 344667898864 356778888774221 23556778888888875322 222211 1110 0112457889999
Q ss_pred CCc
Q 010512 103 MES 105 (508)
Q Consensus 103 ~~g 105 (508)
++|
T Consensus 109 ~~G 111 (325)
T PRK11768 109 RGG 111 (325)
T ss_pred eCC
Confidence 886
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.14 Score=53.71 Aligned_cols=29 Identities=31% Similarity=0.287 Sum_probs=24.0
Q ss_pred cCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 139 ANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 139 ~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
...||.|+-+.|||.+. +.+.++||..|.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence 45799999999999764 469999997664
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.03 E-value=0.44 Score=56.30 Aligned_cols=31 Identities=42% Similarity=0.574 Sum_probs=26.8
Q ss_pred cCceecCCCCCceeeCCCC--cEE-Ecccccccc
Q 010512 139 ANVFHRDLKPKNILANADC--KLK-ICDFGLARV 169 (508)
Q Consensus 139 ~gIiHrDLKPeNILl~~~~--~lk-L~DFGla~~ 169 (508)
.++||.|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 565 999998864
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.42 E-value=0.56 Score=50.10 Aligned_cols=73 Identities=10% Similarity=0.010 Sum_probs=44.3
Q ss_pred EeeeeeecCceEEEEEEECC--------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcc-eeeeeecCCCcC
Q 010512 21 IQEVIGKGSYGVVGSAVDTH--------TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV-EIKHIMLPPSRR 91 (508)
Q Consensus 21 i~~~LG~G~~g~V~~a~~~~--------tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv-~l~~v~~~~~~~ 91 (508)
-++.|..|-.-.+|++.... .++.|.+++....... .-.-.+|..+++.+..-+|- ++++.+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~---lIdR~~E~~v~~~ls~~gi~P~l~~~f~----- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDE---LYNPISEFEVYKTMSKYRIAPQLLNTFS----- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccc---eeCHHHHHHHHHHHHHCCCCCceEEEeC-----
Confidence 56778888888999987442 2568999987532211 11234688888777644433 3444431
Q ss_pred CCccEEEEEecCCc
Q 010512 92 EFKDIYVVFELMES 105 (508)
Q Consensus 92 ~~~~lylV~E~~~g 105 (508)
-+.|.+|++|
T Consensus 181 ----gg~I~efi~g 190 (442)
T PTZ00296 181 ----GGRIEEWLYG 190 (442)
T ss_pred ----CCEEEEeeCC
Confidence 1456788775
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=93.41 E-value=0.72 Score=46.38 Aligned_cols=75 Identities=15% Similarity=0.118 Sum_probs=44.4
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC---CCCcceeeeeecCCCcCCCc
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR---HPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~v~~~~~~~~~~ 94 (508)
..+-.+.|+.|....+|+.. .++..|.+|+-.. .....+..|..-|+.|. --.+.+++.+.... .
T Consensus 18 ~i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~-----~ 85 (288)
T PF03881_consen 18 KITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD-----D 85 (288)
T ss_dssp ---EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S-----S
T ss_pred ceeeeEecCCCChhheEEEE--CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec-----C
Confidence 44556789999999999986 6788999998652 22345677888888884 23455666665322 2
Q ss_pred cEEEEEecCC
Q 010512 95 DIYVVFELME 104 (508)
Q Consensus 95 ~lylV~E~~~ 104 (508)
.-||||||++
T Consensus 86 ~~fLlle~l~ 95 (288)
T PF03881_consen 86 DAFLLLEFLE 95 (288)
T ss_dssp CCEEEEE---
T ss_pred CceEEEEeec
Confidence 3499999987
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=92.75 E-value=0.024 Score=60.07 Aligned_cols=73 Identities=29% Similarity=0.462 Sum_probs=60.3
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 88 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 88 (508)
.++.++....+|.|+||+|+.+..+..+..||||.|.-. .......+.++|+.-+..+.|++++++...|...
T Consensus 47 ~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlk-n~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~ 119 (516)
T KOG1033|consen 47 EANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLK-NREESRSRVLREVSSLAEFEHPGIKRYFHAWYER 119 (516)
T ss_pred hhccccccccccccCccccCCccccccchhhHHHHhccc-chhhhhhhhhccccchhhhcccchhhheeceecC
Confidence 456788899999999999999999888889999998532 2233456788999999999999999999988654
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.48 E-value=0.085 Score=49.46 Aligned_cols=28 Identities=25% Similarity=0.413 Sum_probs=25.2
Q ss_pred ceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 141 VFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 141 IiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
.+|+|+.|.||++++++ ++|+||+.|..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 59999999999998877 99999998864
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=92.21 E-value=0.2 Score=49.85 Aligned_cols=45 Identities=29% Similarity=0.366 Sum_probs=34.5
Q ss_pred HHHHHHHHHHHhHhc--CceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 125 FLYQLLRGLKYIHTA--NVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 125 i~~Qil~aL~yLHs~--gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
.+..+-.++.-++.. =+||+|+.|+|+|.++.+.++|+||..|..
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 344444445444443 489999999999999999999999988764
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=92.15 E-value=0.12 Score=52.66 Aligned_cols=74 Identities=24% Similarity=0.317 Sum_probs=45.2
Q ss_pred EEEEecCCcc---HHHHHH-hCCC-CCHHHHHHHHHHHHHHHHHh---H-hcCceecCCCCCceeeCCC-----------
Q 010512 97 YVVFELMESD---LHQVIK-ANDD-LTPEHYQFFLYQLLRGLKYI---H-TANVFHRDLKPKNILANAD----------- 156 (508)
Q Consensus 97 ylV~E~~~g~---L~~~i~-~~~~-l~~~~~~~i~~Qil~aL~yL---H-s~gIiHrDLKPeNILl~~~----------- 156 (508)
.|||+++..+ +....- ..|- .-.+-+++++.||+.-.--+ - -.+.+|-||||+|||+-+.
T Consensus 247 IIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~ 326 (434)
T PF05445_consen 247 IIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNR 326 (434)
T ss_pred EEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCe
Confidence 4888887632 221111 1222 23355788889987543223 1 3479999999999997443
Q ss_pred -------CcEEEccccccccc
Q 010512 157 -------CKLKICDFGLARVS 170 (508)
Q Consensus 157 -------~~lkL~DFGla~~~ 170 (508)
-..+|.||.++++.
T Consensus 327 ~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 327 NYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred EEEecccceeeecccCHHHhc
Confidence 22567788888764
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 508 | ||||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-81 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-81 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-76 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-76 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-76 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-76 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-76 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-76 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-76 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-76 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-76 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-76 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-76 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-76 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-75 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-75 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-75 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-74 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-74 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-74 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-74 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-74 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-73 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-73 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-73 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-73 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-69 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-69 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-69 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-69 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-69 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-69 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-69 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-69 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-69 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-69 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-69 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-69 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-69 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-69 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-69 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-69 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-69 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-69 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-69 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-69 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-69 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-69 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-69 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-69 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-69 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-69 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-69 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-69 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-69 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-69 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-69 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-69 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-69 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-69 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-68 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-68 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-68 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-68 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-68 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-68 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-68 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-68 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-68 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-68 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-68 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-68 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-68 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-68 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-68 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-68 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-68 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-68 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-68 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-67 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-67 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-67 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-67 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-67 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-67 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-66 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-66 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-66 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-61 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-60 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-60 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-60 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-60 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-59 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-59 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-54 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-51 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-49 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-49 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-49 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-49 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-49 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-49 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-49 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-49 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-48 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-48 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-48 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-48 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-48 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-48 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-48 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-48 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-48 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-48 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-48 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-48 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-48 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-48 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-47 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-47 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-47 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-47 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-47 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-47 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-46 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-46 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-46 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-46 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-46 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-46 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-46 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-44 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-43 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-43 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-39 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-38 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-38 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-38 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-38 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-38 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-38 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-38 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-38 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-38 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-38 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-38 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-38 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-38 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-38 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-38 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-38 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-38 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-38 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-38 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-38 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-38 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-38 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-38 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-38 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-38 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-38 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-38 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-38 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-37 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-37 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-37 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-37 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-37 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-37 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-37 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-37 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-37 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-37 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-37 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-36 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-36 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-35 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-35 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-35 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-34 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-34 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-34 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-34 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-34 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-34 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-34 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-34 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-34 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-34 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-34 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-34 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-34 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-34 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-34 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-34 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-33 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-33 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-33 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-33 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-33 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-33 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-33 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-33 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-33 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-33 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-33 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-33 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-32 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-32 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-32 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-32 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-30 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-30 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-30 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-30 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-26 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-26 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 8e-26 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-24 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-23 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-22 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-21 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-21 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-21 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-20 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-20 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-20 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-20 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-20 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-20 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-20 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-20 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-20 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-20 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-20 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-20 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-20 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-20 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-20 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-20 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-20 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-20 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-20 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 5e-20 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-20 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-20 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-20 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-19 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-19 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-19 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-19 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-19 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-19 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-19 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-19 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-19 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-19 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-19 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-18 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-18 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-17 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-17 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-17 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-17 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-17 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-16 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-16 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-16 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-16 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-16 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-16 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-16 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-16 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-15 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-15 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-15 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-15 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-14 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-14 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-14 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-14 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-14 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-13 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-11 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 8e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-09 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-09 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-06 |
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 581 bits (1499), Expect = 0.0
Identities = 163/356 (45%), Positives = 225/356 (63%), Gaps = 5/356 (1%)
Query: 1 MQSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA 60
+ E + RY IG+G+YG+V SA D RVAIKKI+ FEH +
Sbjct: 11 AAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYC 69
Query: 61 TRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE 120
R LREIK+L RH +I+ I I+ P+ + KD+Y+V +LME+DL++++K L+ +
Sbjct: 70 QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSND 128
Query: 121 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 180
H +FLYQ+LRGLKYIH+ANV HRDLKP N+L N C LKICDFGLARV+ D F
Sbjct: 129 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188
Query: 181 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL 240
T+YVATRWYRAPE+ + YT +IDIWS+GCI AEML+ +P+FPGK+ + QL+ + +
Sbjct: 189 TEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 247
Query: 241 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 300
LG+PS E ++ I N KAR YL S+ K VP++ FPNAD AL LL+++L F+P R
Sbjct: 248 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 307
Query: 301 AEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQ 356
E+ALA PY + EP + +F+ E L K+ ++E+I+ E + P
Sbjct: 308 VEQALAHPYLEQYYDPSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQPG 361
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 578 bits (1492), Expect = 0.0
Identities = 145/351 (41%), Positives = 217/351 (61%), Gaps = 13/351 (3%)
Query: 11 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 70
Y +S +Q++ ++G+G+YGVV SA TGE VAIKKI F+ A R LREIK+L
Sbjct: 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKIL 63
Query: 71 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLL 130
+ +H +I+ I +I P S F ++Y++ ELM++DLH+VI L+ +H Q+F+YQ L
Sbjct: 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM-LSDDHIQYFIYQTL 122
Query: 131 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI-------FWTDY 183
R +K +H +NV HRDLKP N+L N++C LK+CDFGLAR+ A ++
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 184 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 243
VATRWYRAPE+ + +KY+ A+D+WS GCI AE+ +P+FPG++ HQL L+ ++GT
Sbjct: 183 VATRWYRAPEVMLT-SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241
Query: 244 PSTES-ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 302
P +++ + I + +AR Y+ S+ P FP +P + LL+R+L FDP R TA+
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301
Query: 303 EALADPYFHGLANVDREPSTQPISKLEFEF--ERRKLAKDDVREMIYREIL 351
EAL PY + + EP +PI FEF + L D++++I+ EI
Sbjct: 302 EALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 571 bits (1474), Expect = 0.0
Identities = 133/420 (31%), Positives = 213/420 (50%), Gaps = 53/420 (12%)
Query: 2 QSALETEFFTEYGE----ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV 57
S+ + + + Y I+ +IG+GSYG V A D +T + VAIKK+N +FE +
Sbjct: 7 HSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDL 66
Query: 58 SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDL 117
D RILREI +L L+ I+ + +++P +F ++Y+V E+ +SDL ++ K L
Sbjct: 67 IDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFL 126
Query: 118 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 177
T EH + LY LL G +IH + + HRDLKP N L N DC +K+CDFGLAR ++ +
Sbjct: 127 TEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 178 I-------------------FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEM 218
I T +V TRWYRAPEL YT +IDIWS GCIFAE+
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI-LLQENYTKSIDIWSTGCIFAEL 245
Query: 219 LTG-----------KPLFPG-----------------KNVVHQLDLMTDLLGTPSTESIS 250
L PLFPG K+ QL+++ +++GTP+ + +
Sbjct: 246 LNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLK 305
Query: 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
I + +Y+ ++P+ K+P+ ++LLE +L F+P R T ++AL PY
Sbjct: 306 NINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365
Query: 311 HGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSF 370
+ E + L F+ + L++ +R + +E+ +HP+++ + + +F
Sbjct: 366 KDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPELVIPSVFTIHENNF 424
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 556 bits (1434), Expect = 0.0
Identities = 136/352 (38%), Positives = 209/352 (59%), Gaps = 12/352 (3%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
+ Y+ + +G G+YG V SAVD TG +VAIKK+ F+ A R RE++LL+ +RH
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 77 DIVEIKHIMLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
+++ + + P + +F D Y+V M +DL +++K L + QF +YQ+L+GL+Y
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRY 143
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 195
IH A + HRDLKP N+ N DC+LKI DFGLAR + ++ T YV TRWYRAPE+
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MTGYVVTRWYRAPEVI 197
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
++ +YT +DIWS+GCI AEM+TGK LF G + + QL + + GTP E + R++++
Sbjct: 198 LNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256
Query: 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315
+A+ Y+ + + + F+ NA PLA++LLE++L D + R TA EALA PYF L +
Sbjct: 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316
Query: 316 VDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQ 367
+ EP Q + F+ D+ + + Y+E+L + P E
Sbjct: 317 TEDEPQVQKY---DDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKET 365
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 555 bits (1432), Expect = 0.0
Identities = 135/340 (39%), Positives = 199/340 (58%), Gaps = 12/340 (3%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
Y +G G+YG V SA+D +GE+VAIKK++ F+ A R RE+ LL+ ++H
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 77 DIVEIKHIMLPPSR-REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
+++ + + P S R F D Y+V M++DL +++ + E Q+ +YQ+L+GLKY
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--FSEEKIQYLVYQMLKGLKY 141
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 195
IH+A V HRDLKP N+ N DC+LKI DFGLAR + + T YV TRWYRAPE+
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTGYVVTRWYRAPEVI 195
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
S+ Y +DIWS+GCI AEMLTGK LF GK+ + QL + + G P TE + ++ ++
Sbjct: 196 LSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254
Query: 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315
A+ Y+ S+ + F+ FP A P A LLE++L D R TA +AL P+F +
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314
Query: 316 VDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 355
+ E Q + E KL D+ ++ IY+EI+ + P
Sbjct: 315 PEEETEAQQ--PFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 551 bits (1423), Expect = 0.0
Identities = 123/357 (34%), Positives = 181/357 (50%), Gaps = 20/357 (5%)
Query: 9 FFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIND---------VFEHVSD 59
+ S Y +Q I GSYG V + VD+ G VAIK++ + +
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFL 72
Query: 60 ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD-LT 118
R+LREI+LL HP+I+ ++ I + +Y+V ELM +DL QVI ++
Sbjct: 73 CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVIS 132
Query: 119 PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 178
P+H Q+F+Y +L GL +H A V HRDL P NIL + + ICDF LAR DA
Sbjct: 133 PQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA---- 188
Query: 179 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMT 238
T YV RWYRAPEL F +T +D+WS GC+ AEM K LF G +QL+ +
Sbjct: 189 NKTHYVTHRWYRAPELVMQ-FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247
Query: 239 DLLGTPSTESISRIRNEKARRYL-GSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD 297
+++GTP E + + AR YL S+ ++ P ADP+AL L+ ++L F+P+
Sbjct: 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR 307
Query: 298 RPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYH 354
R + E+AL PYF L + F F+ D+ ++ E+ ++
Sbjct: 308 RISTEQALRHPYFESLFDPLDLTEGLSE---RFHFDESVTDVYDMHKIFTAEVERFN 361
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 550 bits (1418), Expect = 0.0
Identities = 147/351 (41%), Positives = 216/351 (61%), Gaps = 12/351 (3%)
Query: 11 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 70
T + RYQ +G G+YG V +A DT TG RVA+KK++ F+ + A R RE++LL
Sbjct: 23 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 71 RLLRHPDIVEIKHIMLPPSRRE-FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 129
+ ++H +++ + + P E F D+Y+V LM +DL+ ++K LT +H QF +YQ+
Sbjct: 83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQI 141
Query: 130 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
LRGLKYIH+A++ HRDLKP N+ N DC+LKI DFGLAR + + T YVATRWY
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD------EMTGYVATRWY 195
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
RAPE+ ++ Y +DIWS+GCI AE+LTG+ LFPG + + QL L+ L+GTP E +
Sbjct: 196 RAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309
+I +E AR Y+ S+ + + F++ F A+PLA+ LLE++L D R TA +ALA Y
Sbjct: 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314
Query: 310 FHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQE 360
F + D EP P + E R L D+ + + Y E++ + P L +
Sbjct: 315 FAQYHDPDDEPVADPY---DQSLESRDLLIDEWKSLTYDEVISFVPPPLDQ 362
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 549 bits (1416), Expect = 0.0
Identities = 139/386 (36%), Positives = 221/386 (57%), Gaps = 43/386 (11%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-H 75
+Y++ + +GKG+YG+V ++D TGE VA+KKI D F++ +DA R REI +L L H
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
+IV + +++ + +D+Y+VF+ ME+DLH VI+AN L P H Q+ +YQL++ +KY
Sbjct: 69 ENIVNLLNVLRADN---DRDVYLVFDYMETDLHAVIRANI-LEPVHKQYVVYQLIKVIKY 124
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARV------------------SFNDAPSA 177
+H+ + HRD+KP NIL NA+C +K+ DFGL+R + N
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 178 IFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 236
TDYVATRWYRAPE L GS +KYT ID+WS+GCI E+L GKP+FPG + ++QL+
Sbjct: 185 PILTDYVATRWYRAPEILLGS--TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242
Query: 237 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF----------------PNAD 280
+ ++ PS E + I++ A+ + S+++K + S+K + +
Sbjct: 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN 302
Query: 281 PLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKD 340
AL LL++LL F+P R +A +AL P+ N + EP+ I + + K + D
Sbjct: 303 EEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHSID 361
Query: 341 DVREMIYREILEYHPQMLQEYLRGGE 366
D R ++Y EI +++ + +
Sbjct: 362 DYRNLVYSEISRRKRELISNKHQNVQ 387
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 545 bits (1405), Expect = 0.0
Identities = 143/407 (35%), Positives = 205/407 (50%), Gaps = 57/407 (14%)
Query: 6 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILR 65
+++ RY+I+ +IG GSYG V A D VAIKKI VFE + D RILR
Sbjct: 42 MPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR 101
Query: 66 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFF 125
EI +L L H +V++ I++P +F ++YVV E+ +SD ++ + LT H +
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTL 161
Query: 126 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV---------------- 169
LY LL G+KY+H+A + HRDLKP N L N DC +K+CDFGLAR
Sbjct: 162 LYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 170 --------SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT- 220
+ T +V TRWYRAPEL YT AID+WSIGCIFAE+L
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-QENYTEAIDVWSIGCIFAELLNM 280
Query: 221 ----------GKPLFPGKNVV--------------------HQLDLMTDLLGTPSTESIS 250
PLFPG + QL+++ ++LGTPS E I
Sbjct: 281 IKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIE 340
Query: 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
+ E A+RY+ K++ + +FP + A+HLL+R+L F+P R T E LA P+F
Sbjct: 341 ALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF 400
Query: 311 HGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQM 357
+ + E + +L F + + + +R +EI YHP++
Sbjct: 401 KEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYHPEI 446
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 539 bits (1391), Expect = 0.0
Identities = 126/417 (30%), Positives = 208/417 (49%), Gaps = 30/417 (7%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
RYQ + IG G+ G+V +A D VAIKK++ F++ + A R RE+ L++ + H
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 77 DIVEIKHIMLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
+I+ + ++ P + EF+D+Y+V ELM+++L QVI+ +L E + LYQ+L G+K+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKH 179
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 195
+H+A + HRDLKP NI+ +DC LKI DFGLAR A ++ T YV TR+YRAPE+
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYVVTRYYRAPEVI 235
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
Y +DIWS+GCI EM+ K LFPG++ + Q + + + LGTP E + ++
Sbjct: 236 LGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL-QP 292
Query: 256 KARRYLGSMRKKQPVPFSHKFPNA------------DPLALHLLERLLAFDPKDRPTAEE 303
R Y+ + K + F FP++ A LL ++L DP R + ++
Sbjct: 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352
Query: 304 ALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLR 363
AL PY + + P + + + R+ ++ +E+IY+E++ + ++
Sbjct: 353 ALQHPYINVWYDPAEVE-APPPQIYDKQLDEREHTIEEWKELIYKEVMNSEEKTKNGVVK 411
Query: 364 GGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAG 420
G S L + S+ Q + + G
Sbjct: 412 GQPSPSGAAV-------NSSESLPPSSSVNDISSMSTDQTLASDTDSSLEASAGPLG 461
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 530 bits (1367), Expect = 0.0
Identities = 121/356 (33%), Positives = 192/356 (53%), Gaps = 23/356 (6%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
RYQ + IG G+ G+V +A D VAIKK++ F++ + A R RE+ L++ + H
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 77 DIVEIKHIMLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
+I+ + ++ P S EF+D+Y+V ELM+++L QVI+ +L E + LYQ+L G+K+
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKH 142
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 195
+H+A + HRDLKP NI+ +DC LKI DFGLAR A ++ T YV TR+YRAPE+
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYVVTRYYRAPEVI 198
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
Y +DIWS+GCI EM+ G LFPG + + Q + + + LGTP E + ++
Sbjct: 199 LGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL-QP 255
Query: 256 KARRYLGSMRKKQPVPFSHKFPNA------------DPLALHLLERLLAFDPKDRPTAEE 303
R Y+ + K F FP+ A LL ++L D R + +E
Sbjct: 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 315
Query: 304 ALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQ 359
AL PY + + P + + + R+ ++ +E+IY+E+++
Sbjct: 316 ALQHPYINVWYDPSEAE-APPPKIPDKQLDEREHTIEEWKELIYKEVMDLEHHHHH 370
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 520 bits (1342), Expect = 0.0
Identities = 127/315 (40%), Positives = 173/315 (54%), Gaps = 15/315 (4%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 75
SRY + +G G G+V SAVD +RVAIKKI V LREIK++R L H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDH 67
Query: 76 PDIVEIKHIMLPPSRR---------EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 126
+IV++ I+ P + E +Y+V E ME+DL V++ L EH + F+
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP-LLEEHARLFM 126
Query: 127 YQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSFNDAPSAIFWTDYVA 185
YQLLRGLKYIH+ANV HRDLKP N+ N D LKI DFGLAR+ ++ +
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 186 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245
T+WYR+P L S + YT AID+W+ GCIFAEMLTGK LF G + + Q+ L+ + +
Sbjct: 187 TKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245
Query: 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 305
E + + Y+ + + P + P A+ LE++L F P DR TAEEAL
Sbjct: 246 EEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304
Query: 306 ADPYFHGLANVDREP 320
+ PY + EP
Sbjct: 305 SHPYMSIYSFPMDEP 319
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 481 bits (1239), Expect = e-169
Identities = 114/351 (32%), Positives = 180/351 (51%), Gaps = 27/351 (7%)
Query: 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 74
E R+Q++ + G+G++G V + TG VAIKK+ + R L+ ++ L +L
Sbjct: 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAVLH 77
Query: 75 HPDIVEIKHIMLPPSRREFKDIY--VVFELMESDLHQVIK----ANDDLTPEHYQFFLYQ 128
HP+IV+++ R+ +DIY VV E + LH+ + P + FL+Q
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 129 LLRGLKYIH--TANVFHRDLKPKNILAN-ADCKLKICDFGLARVSFNDAPSAIFWTDYVA 185
L+R + +H + NV HRD+KP N+L N AD LK+CDFG A+ P+ Y+
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN----VAYIC 193
Query: 186 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245
+R+YRAPEL YT A+DIWS+GCIFAEM+ G+P+F G N QL + +LG PS
Sbjct: 194 SRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252
Query: 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKF----PNADPLALHLLERLLAFDPKDRPTA 301
E + ++ L + +P+S+ F A LL LL + P++R
Sbjct: 253 REVLRKLNPSHTDVDL---YNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP 309
Query: 302 EEALADPYFHGLAN-VDREPSTQPISKLEFEFERRKL--AKDDVREMIYRE 349
EAL PYF L + + P+ + + + F F ++ + + + R+
Sbjct: 310 YEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 448 bits (1154), Expect = e-156
Identities = 121/386 (31%), Positives = 199/386 (51%), Gaps = 31/386 (8%)
Query: 7 TEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILRE 66
++ T Y +VIG GS+GVV A + E VAIKK+ + D RE
Sbjct: 30 SDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV------LQDKRFKNRE 82
Query: 67 IKLLRLLRHPDIVEIKHIMLPPS-RREFKDIYVVFELMESDLHQVI----KANDDLTPEH 121
++++R+++HP++V++K +++ + +V E + +++ K +
Sbjct: 83 LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLL 142
Query: 122 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVSFNDAPSAIFW 180
+ ++YQLLR L YIH+ + HRD+KP+N+L + LK+ DFG A++ P+
Sbjct: 143 IKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN---- 198
Query: 181 TDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTD 239
Y+ +R+YRAPEL G+ + YT IDIWS GC+ AE++ G+PLFPG++ + QL +
Sbjct: 199 VSYICSRYYRAPELIFGA--TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK 256
Query: 240 LLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKDR 298
+LGTPS E I + + +P PFS F P P A+ L+ RLL + P R
Sbjct: 257 VLGTPSREQIKTMNPNYMEHKF---PQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSAR 313
Query: 299 PTAEEALADPYFHGLANVD-REPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQM 357
TA EAL P+F L + R P+ + + L F + + +L VR + ++ H +
Sbjct: 314 LTAIEALCHPFFDELRTGEARMPNGRELPPL-FNWTKEEL---SVRPDLISRLVPQHAEA 369
Query: 358 LQEYLRGGEQTSFMYPSGVDRFKRQF 383
+ RG + +F P ++ K
Sbjct: 370 -ELLSRGIDVHNFQ-PIPLESLKVTL 393
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 436 bits (1123), Expect = e-151
Identities = 105/392 (26%), Positives = 182/392 (46%), Gaps = 66/392 (16%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 75
+ +Y + + +G GS+G+V D +G+R A+KK+ D RE+ ++++L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDH 59
Query: 76 PDIVEIKHIM---------------------------------LPPSRREFKDIYVVFEL 102
+I+++ + + + K + V+ E
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 103 MESDLHQVI----KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DC 157
+ LH+V+ ++ + ++YQL R + +IH+ + HRD+KP+N+L N+ D
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 158 KLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFA 216
LK+CDFG A+ PS Y+ +R+YRAPEL G+ ++YTP+ID+WSIGC+F
Sbjct: 180 TLKLCDFGSAKKLIPSEPS----VAYICSRFYRAPELMLGA--TEYTPSIDLWSIGCVFG 233
Query: 217 EMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF 276
E++ GKPLF G+ + QL + ++GTP+ E + R+ + +
Sbjct: 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFP---TLKAKDWRKIL 290
Query: 277 PNADP-LALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREP----------STQPI 325
P P LA+ LLE++L ++P R EA+A P+F L N Q I
Sbjct: 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNI 350
Query: 326 SKL-EFEFERRKLAKDDVREMIYREILEYHPQ 356
+L F + +V I + + +
Sbjct: 351 PQLFNFSPYELSIIPGNVLNRILPKNFSPNYK 382
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 427 bits (1099), Expect = e-147
Identities = 110/355 (30%), Positives = 181/355 (50%), Gaps = 28/355 (7%)
Query: 11 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 70
+ + Y +VIG GS+GVV A +GE VAIKK+ D RE++++
Sbjct: 48 PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIM 101
Query: 71 RLLRHPDIVEIKHIMLPPS-RREFKDIYVVFELMESDLHQVIK----ANDDLTPEHYQFF 125
R L H +IV +++ +++ + +V + + +++V + A L + + +
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 161
Query: 126 LYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVSFNDAPSAIFWTDYV 184
+YQL R L YIH+ + HRD+KP+N+L + D LK+CDFG A+ P+ Y+
Sbjct: 162 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN----VSYI 217
Query: 185 ATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 243
+R+YRAPEL G+ + YT +ID+WS GC+ AE+L G+P+FPG + V QL + +LGT
Sbjct: 218 CSRYYRAPELIFGA--TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 275
Query: 244 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKDRPTAE 302
P+ E I + + + P++ F P P A+ L RLL + P R T
Sbjct: 276 PTREQIREMNPNYTEFKF---PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 332
Query: 303 EALADPYFHGLANV-DREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQ 356
EA A +F L + + P+ + L F F ++L + ++ H +
Sbjct: 333 EACAHSFFDELRDPNVKLPNGRDTPAL-FNFTTQEL---SSNPPLATILIPPHAR 383
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 397 bits (1021), Expect = e-136
Identities = 89/316 (28%), Positives = 151/316 (47%), Gaps = 24/316 (7%)
Query: 9 FFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK 68
E+G YQ+ +G+G Y V A++ E+V +K + V +I REIK
Sbjct: 28 HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIK 82
Query: 69 LLRLLR-HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 127
+L LR P+I+ + I+ P V + +D Q+ + LT +F++Y
Sbjct: 83 ILENLRGGPNIITLADIVKDPV--SRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMY 137
Query: 128 QLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 186
++L+ L Y H+ + HRD+KP N++ + KL++ D+GLA + VA+
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVAS 193
Query: 187 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLMTDLLGTPS 245
R+++ PEL + Y ++D+WS+GC+ A M+ K P F G + QL + +LGT
Sbjct: 194 RYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252
Query: 246 TES-ISRIRNEKARRYLGSMRKKQPVPFSHKFPN-----ADPLALHLLERLLAFDPKDRP 299
I + E R+ + + + + P AL L++LL +D + R
Sbjct: 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 312
Query: 300 TAEEALADPYFHGLAN 315
TA EA+ PYF+ +
Sbjct: 313 TAREAMEHPYFYTVVK 328
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 360 bits (927), Expect = e-123
Identities = 104/309 (33%), Positives = 158/309 (51%), Gaps = 12/309 (3%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+Y+ IG+GSYGVV + TG+ VAIKK + + LREI++L+ L+HP+
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYI 136
+V + + R + +++VFE + + + + + +Q L+ + +
Sbjct: 64 LVNLLEVF-----RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LC 195
H N HRD+KP+NIL +K+CDFG AR PS + D VATRWYR+PE L
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFAR-LLTG-PSDYY-DDEVATRWYRSPELLV 175
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
G ++Y P +D+W+IGC+FAE+L+G PL+PGK+ V QL L+ LG
Sbjct: 176 GD--TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233
Query: 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315
+ + + P KFPN AL LL+ L DP +R T E+ L PYF +
Sbjct: 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293
Query: 316 VDREPSTQP 324
++
Sbjct: 294 IEDLAKEHD 302
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 342 bits (880), Expect = e-115
Identities = 97/296 (32%), Positives = 155/296 (52%), Gaps = 12/296 (4%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+Y+ ++G+GSYG+V + TG VAIKK + + +REIKLL+ LRH +
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYI 136
+V + + ++ K Y+VFE ++ + ++ + L + Q +L+Q++ G+ +
Sbjct: 86 LVNLLEVC-----KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC- 195
H+ N+ HRD+KP+NIL + +K+CDFG AR + P ++ D VATRWYRAPEL
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAA-PGEVY-DDEVATRWYRAPELLV 197
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
G KY A+D+W+IGC+ EM G+PLFPG + + QL + LG
Sbjct: 198 GD--VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255
Query: 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311
+ K+ P ++P + + L ++ L DP RP E L +F
Sbjct: 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 320 bits (822), Expect = e-106
Identities = 115/321 (35%), Positives = 166/321 (51%), Gaps = 30/321 (9%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRI--LREIKLLRL 72
A RY+ + +G+G + V A D +T + VAIKKI D LREIKLL+
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 73 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLR 131
L HP+I+ + S I +VF+ ME+DL +IK N LTP H + ++ L+
Sbjct: 69 LSHPNIIGLLDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 191
GL+Y+H + HRDLKP N+L + + LK+ DFGLA+ SF P+ + T V TRWYRA
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGS-PNRAY-THQVVTRWYRA 180
Query: 192 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES-- 248
PE L G+ Y +D+W++GCI AE+L P PG + + QL + + LGTP+ E
Sbjct: 181 PELLFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238
Query: 249 -ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307
+ + + + + +P H F A L L++ L F+P R TA +AL
Sbjct: 239 DMCSLPDYV------TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292
Query: 308 PYFHGLANVDREPSTQPISKL 328
YF P P +L
Sbjct: 293 KYF------SNRPGPTPGCQL 307
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 318 bits (818), Expect = e-106
Identities = 112/328 (34%), Positives = 169/328 (51%), Gaps = 23/328 (7%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
Y + +G+G+Y V T VA+K+I E + T I RE+ LL+ L+H +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHAN 61
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYI 136
IV + I+ + +VFE ++ DL Q + + + + + FL+QLLRGL Y
Sbjct: 62 IVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LC 195
H V HRDLKP+N+L N +LK+ DFGLAR + + P+ + + V T WYR P+ L
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLAR-AKSI-PTKTY-DNEVVTLWYRPPDILL 173
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES---ISRI 252
GS + Y+ ID+W +GCIF EM TG+PLFPG V QL + +LGTP+ E+ I
Sbjct: 174 GS--TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231
Query: 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312
K Y K + P D LL +LL F+ ++R +AE+A+ P+F
Sbjct: 232 EEFKTYNY----PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL- 286
Query: 313 LANVDREPSTQPISKLEFEFERRKLAKD 340
++ P + F + +L K+
Sbjct: 287 --SLGERIHKLPDTTSIFALKEIQLQKE 312
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 317 bits (816), Expect = e-106
Identities = 101/309 (32%), Positives = 142/309 (45%), Gaps = 30/309 (9%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI-----LREIKLLR 71
SRY+ IG G+YG V A D H+G VA+K + + +RE+ LLR
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VPNGGGGGGGLPISTVREVALLR 66
Query: 72 LLR---HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFL 126
L HP++V + + + +VFE ++ DL + L E + +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 127 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 186
Q LRGL ++H + HRDLKP+NIL + +K+ DFGLAR ++ + T V T
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMA---LTPVVVT 182
Query: 187 RWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245
WYRAPE L S Y +D+WS+GCIFAEM KPLF G + QL + DL+G P
Sbjct: 183 LWYRAPEVLLQS---TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239
Query: 246 TES---ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 302
+ + P P P + LL +L F+P R +A
Sbjct: 240 EDDWPRDVSLPRGAFPPR-------GPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF 292
Query: 303 EALADPYFH 311
AL Y H
Sbjct: 293 RALQHSYLH 301
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 316 bits (812), Expect = e-105
Identities = 122/319 (38%), Positives = 172/319 (53%), Gaps = 24/319 (7%)
Query: 2 QSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDAT 61
+ E G +YQ E +G+G+YGVV A D+ G VA+K+I + +
Sbjct: 6 HHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR--LDAEDEGI 62
Query: 62 RI--LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLT 118
+REI LL+ L HP+IV + ++ + +VFE ME DL +V+ L
Sbjct: 63 PSTAIREISLLKELHHPNIVSLIDVIHSERC-----LTLVFEFMEKDLKKVLDENKTGLQ 117
Query: 119 PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 178
+ +LYQLLRG+ + H + HRDLKP+N+L N+D LK+ DFGLAR +F P
Sbjct: 118 DSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR-AFGI-PVRS 175
Query: 179 FWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLM 237
+ T V T WYRAP+ L GS KY+ ++DIWSIGCIFAEM+TGKPLFPG QL +
Sbjct: 176 Y-THEVVTLWYRAPDVLMGS--KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI 232
Query: 238 TDLLGTPSTES---ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFD 294
+LGTP+ + + K R + + + P+S P + LL +L FD
Sbjct: 233 FSILGTPNPREWPQVQELPLWKQRTF----QVFEKKPWSSIIPGFCQEGIDLLSNMLCFD 288
Query: 295 PKDRPTAEEALADPYFHGL 313
P R +A +A+ PYF L
Sbjct: 289 PNKRISARDAMNHPYFKDL 307
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 312 bits (802), Expect = e-104
Identities = 113/300 (37%), Positives = 167/300 (55%), Gaps = 25/300 (8%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRH 75
+Y E IG+G+YGVV A + GE A+KKI E + +REI +L+ L+H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR--LEKEDEGIPSTTIREISILKELKH 59
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLK 134
+IV++ ++ R + +VFE ++ DL +++ L + FL QLL G+
Sbjct: 60 SNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 135 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE- 193
Y H V HRDLKP+N+L N + +LKI DFGLAR +F P + T + T WYRAP+
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLAR-AFGI-PVRKY-THEIVTLWYRAPDV 171
Query: 194 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES---IS 250
L GS KY+ IDIWS+GCIFAEM+ G PLFPG + QL + +LGTP++++ ++
Sbjct: 172 LMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
+ Y + +P+P+ D + LL ++L DP R TA++AL YF
Sbjct: 230 ELPK-----YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 312 bits (801), Expect = e-104
Identities = 112/304 (36%), Positives = 168/304 (55%), Gaps = 25/304 (8%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRH 75
+Y+ E IG+G+YG V A + T E VA+K++ + + LREI LL+ L+H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKH 60
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLK 134
+IV + ++ + + +VFE + DL + + N DL PE + FL+QLL+GL
Sbjct: 61 KNIVRLHDVLHSDKK-----LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 135 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE- 193
+ H+ NV HRDLKP+N+L N + +LK+ +FGLAR +F P + + V T WYR P+
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR-AFGI-PVRCY-SAEVVTLWYRPPDV 172
Query: 194 LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES---I 249
L G+ Y+ +ID+WS GCIFAE+ G+PLFPG +V QL + LLGTP+ E +
Sbjct: 173 LFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309
+++ + K + P + LL+ LL +P R +AEEAL PY
Sbjct: 231 TKLPDYKPYP-----MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285
Query: 310 FHGL 313
F
Sbjct: 286 FSDF 289
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 313 bits (804), Expect = e-103
Identities = 112/340 (32%), Positives = 162/340 (47%), Gaps = 28/340 (8%)
Query: 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRL 72
E S+Y+ IG+G++G V A TG++VA+KK+ E+ + I LREIK+L+L
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKILQL 72
Query: 73 LRHPDIVEIKHIM---LPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQ 128
L+H ++V + I P R IY+VF+ E DL ++ T + +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 129 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY---VA 185
LL GL YIH + HRD+K N+L D LK+ DFGLAR +F+ Y V
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR-AFSL-AKNSQPNRYTNRVV 190
Query: 186 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244
T WYR PE L G Y P ID+W GCI AEM T P+ G HQL L++ L G+
Sbjct: 191 TLWYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248
Query: 245 STES---ISRIRNEKARRYLGSMRKKQPVPFSHKFPN--ADPLALHLLERLLAFDPKDRP 299
+ E + + K Q + DP AL L+++LL DP R
Sbjct: 249 TPEVWPNVDNYELYEKLEL----VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 304
Query: 300 TAEEALADPYFHGL---ANVDREPSTQPISKLEFEFERRK 336
+++AL +F +++ ST S E+ R+
Sbjct: 305 DSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRR 344
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 311 bits (798), Expect = e-103
Identities = 105/329 (31%), Positives = 159/329 (48%), Gaps = 29/329 (8%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDT-HTGERVAIKKINDVFEHVSDATRI--LREIKLLRLL 73
+Y+ IG+G+YG V A D + G VA+K++ + + + +RE+ +LR L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHL 68
Query: 74 R---HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQ 128
HP++V + + + +VFE ++ DL + + E + ++Q
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 129 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 188
LLRGL ++H+ V HRDLKP+NIL + ++K+ DFGLAR ++ + T V T W
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMA---LTSVVVTLW 184
Query: 189 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247
YRAPE L S Y +D+WS+GCIFAEM KPLF G + V QL + D++G P E
Sbjct: 185 YRAPEVLLQS---SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241
Query: 248 S---ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 304
+ + P + D L LL + L F+P R +A A
Sbjct: 242 DWPRDVALPRQAFHSK-------SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 305 LADPYFHGL-ANVDREPSTQPISKLEFEF 332
L+ PYF L + S P S+ E
Sbjct: 295 LSHPYFQDLERCKENLDSHLPPSQNTSEL 323
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = e-103
Identities = 111/309 (35%), Positives = 165/309 (53%), Gaps = 29/309 (9%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLR 74
RY+ +G+G+YG V A+DT T E VAIK+I EH + +RE+ LL+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKELQ 91
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 134
H +I+E+K ++ R ++++FE E+DL + + N D++ + FLYQL+ G+
Sbjct: 92 HRNIIELKSVIHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 135 YIHTANVFHRDLKPKNILANADCK-----LKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
+ H+ HRDLKP+N+L + LKI DFGLAR +F P F T + T WY
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGI-PIRQF-THEIITLWY 203
Query: 190 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248
R PE L GS Y+ ++DIWSI CI+AEML PLFPG + + QL + ++LG P +
Sbjct: 204 RPPEILLGS--RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261
Query: 249 ---ISRIRNEKARRYLGSMRKKQPVPFSHKFPNA-DPLALHLLERLLAFDPKDRPTAEEA 304
++ + + + S K + D L LL +L DP R +A+ A
Sbjct: 262 WPGVTALPD-----WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNA 316
Query: 305 LADPYFHGL 313
L PYF
Sbjct: 317 LEHPYFSHN 325
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 307 bits (788), Expect = e-101
Identities = 107/314 (34%), Positives = 171/314 (54%), Gaps = 31/314 (9%)
Query: 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 74
+S+++ E +G G+Y V ++ TG VA+K++ E + +T I REI L++ L+
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI-REISLMKELK 61
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN------DDLTPEHYQFFLYQ 128
H +IV + ++ ++ + +VFE M++DL + + + L ++F +Q
Sbjct: 62 HENIVRLYDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 129 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 188
LL+GL + H + HRDLKP+N+L N +LK+ DFGLAR +F P F + V T W
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGI-PVNTF-SSEVVTLW 173
Query: 189 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247
YRAP+ L GS Y+ +IDIWS GCI AEM+TGKPLFPG N QL L+ D++GTP+
Sbjct: 174 YRAPDVLMGS--RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231
Query: 248 S---ISRIRNEKARRYLGSMRKKQPVPFSHKFPNA-----DPLALHLLERLLAFDPKDRP 299
++++ Y +++++ P D + L LL +P R
Sbjct: 232 LWPSVTKLPK-----YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL 286
Query: 300 TAEEALADPYFHGL 313
+A++AL P+F
Sbjct: 287 SAKQALHHPWFAEY 300
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 4e-88
Identities = 107/366 (29%), Positives = 168/366 (45%), Gaps = 52/366 (14%)
Query: 16 ASRYQIQ-EVIGKGSYGVVGSAV--DTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 72
++ + +G+G+YG V A D + A+K+I +S + REI LLR
Sbjct: 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG--TGISMSA--CREIALLRE 74
Query: 73 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD---------LTPEHYQ 123
L+HP+++ ++ + L + + ++++F+ E DL +IK + L +
Sbjct: 75 LKHPNVISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 124 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK----LKICDFGLARVSFNDAPSAIF 179
LYQ+L G+ Y+H V HRDLKP NIL + +KI D G AR FN P
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNS-PLKPL 189
Query: 180 --WTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN------- 229
V T WYRAPE L G+ YT AIDIW+IGCIFAE+LT +P+F +
Sbjct: 190 ADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247
Query: 230 --VVHQLDLMTDLLGTPSTES---ISRIRNEKARRYLGSMRKKQPVPF----SHKFPNAD 280
QLD + +++G P+ + I ++ D
Sbjct: 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 307
Query: 281 PLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQP-ISKLEFEFERRKLAK 339
A HLL++LL DP R T+E+A+ DPYF + T + + + +R+
Sbjct: 308 SKAFHLLQKLLTMDPIKRITSEQAMQDPYFL-----EDPLPTSDVFAGCQIPYPKREFLT 362
Query: 340 DDVREM 345
++ +
Sbjct: 363 EEEPDD 368
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 3e-73
Identities = 90/400 (22%), Positives = 152/400 (38%), Gaps = 67/400 (16%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLR-LLRHP 76
+ ++V+G G+ G + VA+K+I +D RE++LLR HP
Sbjct: 25 SFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHP 78
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKY 135
+++ + ++ + Y+ EL + L + ++ D L Q GL +
Sbjct: 79 NVIRYFC-----TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 136 IHTANVFHRDLKPKNIL-----ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 190
+H+ N+ HRDLKP NIL A+ K I DFGL + S + T +
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 191 APE-LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 248
APE L T +DI+S GC+F +++ G F
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL------------------- 234
Query: 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308
+R + + H + D +A L+E+++A DP+ RP+A+ L P
Sbjct: 235 ---------QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285
Query: 309 YFHGLAN-----------VDREPSTQPISKLEFEFERRKLAKDDVREMIYREILE----- 352
+F L +++E PI K + E R + K D RE I +
Sbjct: 286 FFWSLEKQLQFFQDVSDRIEKESLDGPIVK-QLERGGRAVVKMDWRENITVPLQTDLRKF 344
Query: 353 --YHPQMLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEEHY 390
Y +++ LR Y + L + +
Sbjct: 345 RTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGTLPDDF 384
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 9e-67
Identities = 99/331 (29%), Positives = 157/331 (47%), Gaps = 46/331 (13%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 75
A RY++ +VIGKGS+G V A D + VA+K + + + EI++L LR
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAE--EIRILEHLRK 152
Query: 76 PDIVEIKHIMLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRG 132
D +++ F++ I + FEL+ +L+++IK N + + F + +L+
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 133 LKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 190
L +H + H DLKP+NIL +K+ DFG + + Y+ +R+YR
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRV----YTYIQSRFYR 266
Query: 191 APE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
APE + G+ +Y ID+WS+GCI AE+LTG PL PG++ QL M +LLG PS + +
Sbjct: 267 APEVILGA---RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323
Query: 250 SRIRN-------------------EKARRYLGSMRKK----QPVPFSHKFPNA-----DP 281
+ L R + + P S ++ NA DP
Sbjct: 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP 383
Query: 282 LALHLLERLLAFDPKDRPTAEEALADPYFHG 312
L L L++ L +DP R T +AL P+
Sbjct: 384 LFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 4e-66
Identities = 75/321 (23%), Positives = 111/321 (34%), Gaps = 51/321 (15%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP- 76
Y I + IG G V ++ + AIK +N EI L L+
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 77 -DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
I+ + + + IY+V E DL+ +K + P + + +L +
Sbjct: 88 DKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 142
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL- 194
IH + H DLKP N L D LK+ DFG+A +++ V T Y PE
Sbjct: 143 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ-MQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 195 --------CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246
G SK +P D+WS+GCI M GK F
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-----------------I 243
Query: 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306
IS++ + + F + +L+ L DPK R + E LA
Sbjct: 244 NQISKLHAI--------IDPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
Query: 307 DPYFHGLANVDREPSTQPISK 327
PY + P Q
Sbjct: 293 HPYV----QIQTHPVNQMAKG 309
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 3e-64
Identities = 95/346 (27%), Positives = 151/346 (43%), Gaps = 63/346 (18%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI--NDVFEHVSDATRILREIKLLRLL 73
RY+I +IGKGS+G V A D E VAIK I F + + E++LL L+
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-----QIEVRLLELM 107
Query: 74 RHPDIVEIKHIMLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLL 130
D +I+ F++ + +VFE++ +L+ +++ + ++ + F Q+
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 131 RGLKYIHT--ANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTD---- 182
L ++ T ++ H DLKP+NIL +KI DFG S+
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG----------SSCQLGQRIYQ 217
Query: 183 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 242
Y+ +R+YR+PE+ Y AID+WS+GCI EM TG+PLF G N V Q++ + ++LG
Sbjct: 218 YIQSRFYRSPEVL--LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 243 TPS--------------------------TESISRIRNEKARRYLGSMRKKQPVPFSHKF 276
P T+ R R L ++ + +
Sbjct: 276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRR 335
Query: 277 PN------ADPLAL-HLLERLLAFDPKDRPTAEEALADPYFHGLAN 315
AD L L+ R+L +DPK R AL +F A+
Sbjct: 336 AGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 2e-63
Identities = 87/339 (25%), Positives = 141/339 (41%), Gaps = 57/339 (16%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTG-ERVAIKKINDVFEHVSDATRILREIKLLRLLR 74
++RY+I + +G+G++G V +D G VA+K + +V + +A R EI++L L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARS--EIQVLEHLN 69
Query: 75 HPDIVEIKHIMLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLR 131
D + E I +VFEL+ + IK N +H + YQ+ +
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICK 129
Query: 132 GLKYIHTANVFHRDLKPKNIL-------------------ANADCKLKICDFGLARVSFN 172
+ ++H+ + H DLKP+NIL + +K+ DFG
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG------- 182
Query: 173 DAPSAIFWTD----YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 227
SA + + V+TR YRAPE + ++ D+WSIGCI E G +FP
Sbjct: 183 ---SATYDDEHHSTLVSTRHYRAPEVILAL---GWSQPCDVWSIGCILIEYYLGFTVFPT 236
Query: 228 KNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLA---- 283
+ L +M +LG I + R K + + + PL
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFML 296
Query: 284 ---------LHLLERLLAFDPKDRPTAEEALADPYFHGL 313
L++++L +DP R T EAL P+F L
Sbjct: 297 SQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 2e-63
Identities = 68/343 (19%), Positives = 132/343 (38%), Gaps = 65/343 (18%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 75
+ + + +G G++G V + A+K + ++ + + + +I E +L+ +++
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKI--EADILKKIQN 90
Query: 76 PDIVEIKHIMLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRG 132
D + +I+ + + D + ++FE + L+++I N+ E + + ++L+
Sbjct: 91 DD-INNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 133 LKYIHTANVFHRDLKPKNIL-------------------------ANADCKLKICDFGLA 167
L Y+ ++ H DLKP+NIL +K+ DFG
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-- 207
Query: 168 RVSFNDAPSAIFWTD----YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGK 222
A F +D + TR YRAPE + + + D+WS GC+ AE+ TG
Sbjct: 208 --------CATFKSDYHGSIINTRQYRAPEVILNL---GWDVSSDMWSFGCVLAELYTGS 256
Query: 223 PLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYL-------------GSMRKKQP 269
LF + L +M ++ + +Y+ S+ +
Sbjct: 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKH 316
Query: 270 VPFSHKFPNA--DPLALHLLERLLAFDPKDRPTAEEALADPYF 310
V L L +L DP RP+ E L +
Sbjct: 317 VKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 3e-63
Identities = 73/330 (22%), Positives = 115/330 (34%), Gaps = 47/330 (14%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP- 76
Y I + IG G V ++ + AIK +N EI L L+
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 77 -DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
I+ + + IY+V E DL+ +K + P + + +L +
Sbjct: 69 DKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 123
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL- 194
IH + H DLKP N L D LK+ DFG+A +++ V T Y PE
Sbjct: 124 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ-MQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 195 --------CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246
G SK +P D+WS+GCI M GK F
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-----------------I 224
Query: 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306
IS++ + + F + +L+ L DPK R + E LA
Sbjct: 225 NQISKLHAI--------IDPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
Query: 307 DPYFHGLANVDREPSTQPISKLEFEFERRK 336
PY + + + ++++ +
Sbjct: 274 HPYVQIQTHPVNQMAKGTTEEMKYVLGQLV 303
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 2e-62
Identities = 52/343 (15%), Positives = 89/343 (25%), Gaps = 58/343 (16%)
Query: 1 MQSALETEFFTEYGEASR-YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVS 58
ET + + R ++ E + G VV D E A+K S
Sbjct: 45 WPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRS 104
Query: 59 DATRILREIKLLRLLRHPDIVEIK---HIMLPP------------------SRREFKDIY 97
+ R+ L E + ++LP +
Sbjct: 105 ELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYL 164
Query: 98 VVFELMESDLHQVIKANDDLTPEHY-------QFFLYQLLRGLKYIHTANVFHRDLKPKN 150
++ DL + D + QL+R + + + H P N
Sbjct: 165 LLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDN 224
Query: 151 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 210
+ D +L + D P+ Y E + + +T A++ W
Sbjct: 225 LFIMPDGRLMLGDVSALWKVGTRGPA------SSVPVTYAPREFLNASTATFTHALNAWQ 278
Query: 211 IGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPV 270
+G + F + L P T+ +
Sbjct: 279 LGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTD---------------------SL 317
Query: 271 PFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313
F L+ R L FD + R EA+ P F L
Sbjct: 318 AFGS-CTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 2e-62
Identities = 92/350 (26%), Positives = 140/350 (40%), Gaps = 57/350 (16%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTG-ERVAIKKINDVFEHVSDATRILREIKLLRLLR 74
RY+I +G+G++G V +D G +VA+K I +V +A R+ EI +L+ ++
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARL--EINVLKKIK 74
Query: 75 HPDIVEIKHIMLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLR 131
D +L F + + FEL+ + + +K N+ H + YQL
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134
Query: 132 GLKYIHTANVFHRDLKPKNIL-------------------ANADCKLKICDFGLARVSFN 172
L+++H + H DLKP+NIL + + +++ DFG
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG------- 187
Query: 173 DAPSAIFWTD----YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 227
SA F + VATR YR PE + + D+WSIGCI E G LF
Sbjct: 188 ---SATFDHEHHTTIVATRHYRPPEVILEL---GWAQPCDVWSIGCILFEYYRGFTLFQT 241
Query: 228 KNVVHQLDLMTDLLGTPSTESISRIRNEK------ARRYLGSMRKKQPVPFSHKFPNA-- 279
L +M +LG + I R R +K S + +
Sbjct: 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYML 301
Query: 280 -----DPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQP 324
L+ R+L FDP R T EAL P+F GL +R T
Sbjct: 302 QDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSR 351
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 205 bits (522), Expect = 3e-61
Identities = 75/329 (22%), Positives = 112/329 (34%), Gaps = 51/329 (15%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP- 76
Y I + IG G V ++ + AIK +N EI L L+
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 77 -DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
I+ + + + IY+V E DL+ +K + P + + +L +
Sbjct: 116 DKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL- 194
IH + H DLKP N L D LK+ DFG+A +++ V Y PE
Sbjct: 171 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN-QMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 195 --------CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246
G SK +P D+WS+GCI M GK F
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-----------------I 271
Query: 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306
IS++ + + F + +L+ L DPK R + E LA
Sbjct: 272 NQISKLHAI--------IDPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLA 320
Query: 307 DPYFHGLANVDREPSTQPISKLEFEFERR 335
PY + P Q E +
Sbjct: 321 HPYV----QIQTHPVNQMAKGTTEEMKYV 345
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 4e-61
Identities = 75/334 (22%), Positives = 129/334 (38%), Gaps = 49/334 (14%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 75
+RY + +G G + V A D VA+K + + ++A EIKLL+ +
Sbjct: 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAED--EIKLLQRVND 74
Query: 76 PDIVEIKHIMLPPSRR-----EFKDIYV-----VFELMESDLHQVIKANDD--LTPEHYQ 123
D + + + K VFE++ +L +IK + + + +
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 134
Query: 124 FFLYQLLRGLKYIHT-ANVFHRDLKPKNILAN------ADCKLKICDFGLARVSFNDAPS 176
QLL GL Y+H + H D+KP+N+L ++KI D G A + D
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHY 192
Query: 177 AIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV----- 230
T+ + TR YR+PE L G+ + DIWS C+ E++TG LF
Sbjct: 193 ----TNSIQTREYRSPEVLLGA---PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245
Query: 231 -VHQLDLMTDLLGTPSTESISRIR----------NEKARRYLGSMRKKQPVPFSHKFPNA 279
+ + +LLG + + + + L + + +KF
Sbjct: 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 305
Query: 280 DPLAL-HLLERLLAFDPKDRPTAEEALADPYFHG 312
+ + L +L DP+ R A + P+
Sbjct: 306 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 4e-60
Identities = 75/317 (23%), Positives = 118/317 (37%), Gaps = 56/317 (17%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 75
AS ++ V+G+G++G V A + AIKKI + IL E+ LL L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNH 61
Query: 76 PDIVEIKH--------IMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPE-HYQFF 125
+V + + ++ +++ E E L+ +I + + Y
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 126 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW----- 180
Q+L L YIH+ + HRDLKP NI + +KI DFGLA+
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 181 ------TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQL 234
T + T Y A E+ Y ID++S+G IF EM+ P G V+
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDG-TGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVN-- 236
Query: 235 DLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAF 293
++ L + + F F N + ++ L+
Sbjct: 237 -ILKKL-------------------------RSVSIEFPPDFDDNKMKVEKKIIRLLIDH 270
Query: 294 DPKDRPTAEEALADPYF 310
DP RP A L +
Sbjct: 271 DPNKRPGARTLLNSGWL 287
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 2e-58
Identities = 62/308 (20%), Positives = 120/308 (38%), Gaps = 26/308 (8%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+ + +++G+G+ V TG+ AIK N++ + +RE ++L+ L H +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFEVLKKLNHKN 68
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN---DDLTPEHYQFFLYQLLRGL 133
IV++ I + R ++ E L+ V++ L + L ++ G+
Sbjct: 69 IVKLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 134 KYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
++ + HR++KP NI+ + K+ DFG AR +D + T Y
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEY 181
Query: 190 RAPEL------CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF-PGKNVVHQLDLMTDLLG 242
P++ KY +D+WSIG F TG F P + ++M ++
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 243 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 302
+ +IS ++ + S S L +L +L D + +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFD 298
Query: 303 EALADPYF 310
+ A+
Sbjct: 299 QFFAETSD 306
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 2e-58
Identities = 69/327 (21%), Positives = 121/327 (37%), Gaps = 55/327 (16%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
+ ++ + +G+G +GVV A + AIK+I + +++RE+K L L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHP 63
Query: 77 DIVEIKH-------IMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQF---F 125
IV + +Y+ +L +L + +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 126 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV---------SFNDAPS 176
Q+ ++++H+ + HRDLKP NI D +K+ DFGL P+
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 177 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 236
T V T+ Y +PE + Y+ +DI+S+G I E+L P V
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY--PFSTQMERV----- 234
Query: 237 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPK 296
+++ +RN K F F P +++ +L+ P
Sbjct: 235 ----------RTLTDVRNLK---------------FPPLFTQKYPCEYVMVQDMLSPSPM 269
Query: 297 DRPTAEEALADPYFHGLANVDREPSTQ 323
+RP A + + F L + Q
Sbjct: 270 ERPEAINIIENAVFEDLDFPGKTVLRQ 296
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 3e-58
Identities = 87/305 (28%), Positives = 134/305 (43%), Gaps = 49/305 (16%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN------DVFEHVSDATRILREIKLLR 71
Y + + +G G+ G V A + T ++VAI+ I+ A + EI++L+
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 72 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL 130
L HP I++IK+ + +D Y+V ELME +L + N L + + YQ+L
Sbjct: 196 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 131 RGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 187
++Y+H + HRDLKP+N+L DC +KI DFG +++ + T
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTP 305
Query: 188 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246
Y APE L + Y A+D WS+G I L+G P F L
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 354
Query: 247 ESISRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 305
+ I + +Y F + AL L+++LL DPK R T EEAL
Sbjct: 355 DQI------TSGKY----------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 398
Query: 306 ADPYF 310
P+
Sbjct: 399 RHPWL 403
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 5e-58
Identities = 71/296 (23%), Positives = 103/296 (34%), Gaps = 46/296 (15%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLLRH 75
+Q +G GSYG V G A+K+ F D R L E+ ++ +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLK 134
P V ++ + E +Y+ EL L Q +A PE +L L L
Sbjct: 117 PCCVRLEQ-----AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA 171
Query: 135 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 194
++H+ + H D+KP NI + K+ DFGL + Y APEL
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ----EGDPRYMAPEL 227
Query: 195 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254
Y A D++S+G E+ L G QL
Sbjct: 228 LQG---SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL-------------------- 264
Query: 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
+ P F+ + +L +L DPK R TAE LA P
Sbjct: 265 ---------RQGYLPPEFTAGLSSE---LRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 8e-58
Identities = 77/332 (23%), Positives = 133/332 (40%), Gaps = 47/332 (14%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRH 75
+Y + IG+GS+G T G + IK+IN +S R RE+ +L ++H
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEIN--ISRMSSKEREESRREVAVLANMKH 82
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIK-ANDDLTPEHY-QFFLYQLLRG 132
P+IV+ + S E +Y+V + E DL + I L E + Q+
Sbjct: 83 PNIVQYRE-----SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA 137
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 192
LK++H + HRD+K +NI D +++ DFG+ARV + A + T +Y +P
Sbjct: 138 LKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA---RACIGTPYYLSP 194
Query: 193 ELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252
E+C + Y DIW++GC+ E+ T K F + M +L + +I
Sbjct: 195 EICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGS-------MKNL--------VLKI 237
Query: 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312
+ + +S+ + L+ +L +P+DRP+ L +
Sbjct: 238 ISGSFPPV--------SLHYSYDLRS-------LVSQLFKRNPRDRPSVNSILEKGFIAK 282
Query: 313 LANVDREPSTQPISKLEFEFERRKLAKDDVRE 344
P F + +
Sbjct: 283 RIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKR 314
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 3e-57
Identities = 83/308 (26%), Positives = 129/308 (41%), Gaps = 52/308 (16%)
Query: 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRL 72
A Y++ IG GSYG G+ + K+++ + +++A + ++ E+ LLR
Sbjct: 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD--YGSMTEAEKQMLVSEVNLLRE 61
Query: 73 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKA---NDDLTPEHY-QFFLY 127
L+HP+IV ++ R +Y+V E E DL VI E + +
Sbjct: 62 LKHPNIVRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 128 QLLRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 182
QL LK H + V HRDLKP N+ + +K+ DFGLAR+ +D A
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KT 175
Query: 183 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 242
+V T +Y +PE Y DIWS+GC+ E+ P F + +L
Sbjct: 176 FVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFS-------QKEL-- 224
Query: 243 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 302
+IR K RR P +S + ++ R+L RP+ E
Sbjct: 225 ------AGKIREGKFRRI--------PYRYSDELNE-------IITRMLNLKDYHRPSVE 263
Query: 303 EALADPYF 310
E L +P
Sbjct: 264 EILENPLI 271
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 6e-57
Identities = 71/310 (22%), Positives = 111/310 (35%), Gaps = 63/310 (20%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 75
++ E+IG G +G V A G+ IK++ + + RE+K L L H
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNEKAEREVKALAKLDH 63
Query: 76 PDIVEIKH-----------IMLPPSRREFKDIYVVFELMES-DLHQVIK-ANDDLTPEHY 122
+IV SR + K +++ E + L Q I+ + +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 123 -QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 181
Q+ +G+ YIH+ + +RDLKP NI ++KI DFGL ND
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS-- 181
Query: 182 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDL 240
T Y +PE S Y +D++++G I AE+L F
Sbjct: 182 --KGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETSKF---------- 227
Query: 241 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 300
+ +R F K LL++LL+ P+DRP
Sbjct: 228 --------FTDLR-----------DGIISDIFDKKEKT-------LLQKLLSKKPEDRPN 261
Query: 301 AEEALADPYF 310
E L
Sbjct: 262 TSEILRTLTV 271
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-56
Identities = 91/341 (26%), Positives = 139/341 (40%), Gaps = 55/341 (16%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN------DVFEHVSDATRILREIKLLR 71
Y + + +G G+ G V A + T ++VAIK I+ A + EI++L+
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 72 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL 130
L HP I++IK+ + +D Y+V ELME +L + N L + + YQ+L
Sbjct: 71 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 131 RGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 187
++Y+H + HRDLKP+N+L DC +KI DFG +++ + T
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETS---LMRTLCGTP 180
Query: 188 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246
Y APE L + Y A+D WS+G I L+G P F L
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------------ 228
Query: 247 ESISRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 305
+I + K F + AL L+++LL DPK R T EEAL
Sbjct: 229 --KDQITSGK-------------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273
Query: 306 ADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMI 346
P+ E + L E + +
Sbjct: 274 RHPWLQD------EDMKRKFQDLLSEENESTALPQVLAQPS 308
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 6e-56
Identities = 71/364 (19%), Positives = 138/364 (37%), Gaps = 29/364 (7%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+ + +++G+G+ V TG+ AIK N++ + +RE ++L+ L H +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFEVLKKLNHKN 68
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN---DDLTPEHYQFFLYQLLRGL 133
IV++ I + R ++ E L+ V++ L + L ++ G+
Sbjct: 69 IVKLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 134 KYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
++ + HR++KP NI+ + K+ DFG AR +D + T Y
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEY 181
Query: 190 RAPEL------CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF-PGKNVVHQLDLMTDLLG 242
P++ KY +D+WSIG F TG F P + ++M ++
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 243 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 302
+ +IS ++ + S S L +L +L D + +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFD 298
Query: 303 EALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYL 362
+ A+ V S Q ++ + A E++Y++ + QE +
Sbjct: 299 QFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTAT-IFHELVYKQT-KIISSN-QELI 355
Query: 363 RGGE 366
G
Sbjct: 356 YEGR 359
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-54
Identities = 76/303 (25%), Positives = 128/303 (42%), Gaps = 51/303 (16%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLR 74
+ ++I++ IG+G + V A G VA+KK+ +F+ + R ++EI LL+ L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ-IFDLMDAKARADCIKEIDLLKQLN 90
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKA---NDDLTPEHY-QFFLYQL 129
HP++++ S E ++ +V EL ++ DL ++IK L PE + QL
Sbjct: 91 HPNVIKYYA-----SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 130 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
L+++H+ V HRD+KP N+ A +K+ D GL R + +A V T +Y
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPYY 202
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
+PE + Y DIWS+GC+ EM + F G ++ L
Sbjct: 203 MSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLYSLC------------ 247
Query: 250 SRIRNEKARRYLGSMRKKQPVP---FSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306
+I P+P +S + L+ + DP+ RP
Sbjct: 248 KKIEQCDY----------PPLPSDHYSEELRQ-------LVNMCINPDPEKRPDVTYVYD 290
Query: 307 DPY 309
Sbjct: 291 VAK 293
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-53
Identities = 83/319 (26%), Positives = 127/319 (39%), Gaps = 57/319 (17%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 76
RY +GKG + D T E A K + + ++ EI + R L H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
+V ++VV EL L ++ K LT +++L Q++ G +Y
Sbjct: 76 HVVGFHGFFEDN-----DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 130
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT-----DYVATRWYR 190
+H V HRDLK N+ N D ++KI DFGLA + + +Y+
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA--TKVEYDGERKKVLCGTPNYI------ 182
Query: 191 APELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250
APE+ ++ +D+WSIGCI +L GKP F + E+
Sbjct: 183 APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------------KETYL 225
Query: 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
RI+ Y P + P+A L++++L DP RPT E L D +F
Sbjct: 226 RIKK---NEY------SIPKHIN-------PVAASLIQKMLQTDPTARPTINELLNDEFF 269
Query: 311 HGLANVDREPSTQPISKLE 329
P+ PI+ L
Sbjct: 270 ----TSGYIPARLPITCLT 284
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-52
Identities = 85/339 (25%), Positives = 132/339 (38%), Gaps = 61/339 (17%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 76
RY +GKG + D T E A K + + ++ EI + R L H
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
+V ++VV EL L ++ K LT +++L Q++ G +Y
Sbjct: 102 HVVGFHGFFEDNDF-----VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 156
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT-----DYVATRWYR 190
+H V HRDLK N+ N D ++KI DFGLA + + +Y+
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA--TKVEYDGERKKVLCGTPNYI------ 208
Query: 191 APELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250
APE+ ++ +D+WSIGCI +L GKP F + E+
Sbjct: 209 APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------------KETYL 251
Query: 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
RI+ Y P + P+A L++++L DP RPT E L D +F
Sbjct: 252 RIKK---NEY------SIPKHIN-------PVAASLIQKMLQTDPTARPTINELLNDEFF 295
Query: 311 HGLANVDREPSTQPISKLE----FEFERRKLAKDDVREM 345
P+ PI+ L F L + + +
Sbjct: 296 ----TSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPL 330
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 5e-52
Identities = 65/303 (21%), Positives = 110/303 (36%), Gaps = 43/303 (14%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
Y + +G+G + V H G A+K+I D RE + RL HP+
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLFNHPN 87
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRG 132
I+ + L + + +++ + L I+ + LT + + L + RG
Sbjct: 88 ILRLVAYCLRERGAKHE-AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA------IFWTDYVAT 186
L+ IH HRDLKP NIL + + + D G + + W T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 187 RWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245
YRAPEL D+WS+GC+ M+ G+ +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF--------------QK 252
Query: 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 305
+S++ ++ + +P S + +A LL ++ DP RP L
Sbjct: 253 GDSVALA-----------VQNQLSIPQSPRHSSA---LWQLLNSMMTVDPHQRPHIPLLL 298
Query: 306 ADP 308
+
Sbjct: 299 SQL 301
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 7e-52
Identities = 91/320 (28%), Positives = 136/320 (42%), Gaps = 53/320 (16%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
RY I ++GKGS+G V D T + A+K IN D + ILRE++LL+ L HP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 77 DIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 132
+I+++ I +D Y+V EL +L I + + Q+ G
Sbjct: 82 NIMKLFEI--------LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 133 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
+ Y+H N+ HRDLKP+NIL DC +KI DFGL+ + D + T +Y
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK----MKDRIGTAYY 189
Query: 190 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248
APE L G Y D+WS G I +L+G P F GKN +
Sbjct: 190 IAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKN---------------EYDI 230
Query: 249 ISRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307
+ R+ + F ++ A L+ ++L F P R TA + L
Sbjct: 231 LKRV-------------ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277
Query: 308 PYFHGLANVDREPSTQPISK 327
P+ ++ S P +
Sbjct: 278 PWIQKYSSETPTISDLPSLE 297
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-51
Identities = 90/336 (26%), Positives = 141/336 (41%), Gaps = 56/336 (16%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
YQ + +G G+YG V D T AIK I S +++L E+ +L+LL HP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 77 DIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 132
+I+++ F+D Y+V E + +L I + Q+L G
Sbjct: 97 NIMKLYDF--------FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG 148
Query: 133 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
+ Y+H N+ HRDLKP+N+L D +KI DFGL+ V N + + T +Y
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK----MKERLGTAYY 204
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
APE+ KY D+WSIG I +L G P F G+ E +
Sbjct: 205 IAPEV---LRKKYDEKCDVWSIGVILFILLAGYPPFGGQT---------------DQEIL 246
Query: 250 SRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308
++ K F S ++ N A L++++L FD + R +A++AL P
Sbjct: 247 RKVEKGK-------------YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHP 293
Query: 309 YFHGLANVDREPSTQPISKLEFE-----FERRKLAK 339
+ + + P E +KLA+
Sbjct: 294 WIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQ 329
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 1e-51
Identities = 79/342 (23%), Positives = 129/342 (37%), Gaps = 81/342 (23%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN---DVFEHVSDATRILREIKLLRLL 73
+Y ++ IG+GSYGVV A++ T AIK +N + D RI E++L++ L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 74 RHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQF-------- 124
HP+I + + + + I +V EL L + D +
Sbjct: 86 HHPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 125 --------------------------------FLYQLLRGLKYIHTANVFHRDLKPKNIL 152
+ Q+ L Y+H + HRD+KP+N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 153 --ANADCKLKICDFGLARVSFNDAPSAIF-WTDYVATRWYRAPELCGSFFSKYTPAIDIW 209
N ++K+ DFGL++ + + T T ++ APE+ + Y P D W
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 210 SIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQP 269
S G + +L G FPG N ++IS++ +
Sbjct: 261 SAGVLLHLLLMGAVPFPGVN---------------DADTISQV-------------LNKK 292
Query: 270 VPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
+ F + + PLA LL LL + +R A AL P+
Sbjct: 293 LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWI 334
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-51
Identities = 71/299 (23%), Positives = 121/299 (40%), Gaps = 42/299 (14%)
Query: 17 SRY-QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 75
R+ + IG+GS+ V +DT T VA ++ D S+ R E ++L+ L+H
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH 84
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 134
P+IV + + K I +V ELM S L +K + + + + Q+L+GL+
Sbjct: 85 PNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 135 YIHTAN--VFHRDLKPKNILANA-DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 191
++HT + HRDLK NI +KI D GLA + A+ T + A
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPE----FM-A 198
Query: 192 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251
PE+ KY ++D+++ G EM T + + Q+
Sbjct: 199 PEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----------------- 238
Query: 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
Y +P F A P ++E + + +R + ++ L +F
Sbjct: 239 --------YRRVTSGVKPASFDK---VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-51
Identities = 80/321 (24%), Positives = 134/321 (41%), Gaps = 52/321 (16%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRH 75
RY+ Q V+GKGS+G V D TG+ A+K I+ + +D +LRE++LL+ L H
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 76 PDIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLR 131
P+I+++ F+D Y+V E+ +L I + + + Q+L
Sbjct: 86 PNIMKLYEF--------FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 132 GLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 188
G+ Y+H + HRDLKP+N+L + D ++I DFGL+ D + T +
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK----MKDKIGTAY 193
Query: 189 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248
Y APE+ Y D+WS G I +L+G P F G N +
Sbjct: 194 YIAPEV---LHGTYDEKCDVWSTGVILYILLSGCPPFNGAN---------------EYDI 235
Query: 249 ISRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307
+ ++ +K F ++ A L+ ++L + P R +A +AL
Sbjct: 236 LKKV-------------EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282
Query: 308 PYFHGLANVDREPSTQPISKL 328
+ +
Sbjct: 283 EWIQTYTKEQISVDVPSLDNA 303
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-51
Identities = 80/399 (20%), Positives = 140/399 (35%), Gaps = 93/399 (23%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLR-LLRH 75
+ ++++G GS G V + G VA+K++ + L EIKLL H
Sbjct: 15 NLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRML-----IDFCDIALMEIKLLTESDDH 68
Query: 76 PDIVEIKHIMLPPSRREFKD---IYVVFELMESDLHQVIKANDDLTPEHYQF-------F 125
P+++ +Y+ EL +L ++++ +
Sbjct: 69 PNVIRYYCS--------ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 126 LYQLLRGLKYIHTANVFHRDLKPKNIL-------------ANADCKLKICDFGLAR-VSF 171
L Q+ G+ ++H+ + HRDLKP+NIL + ++ I DFGL + +
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 172 NDAPSAIFWTDYVATRWYRAPEL-----CGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLF 225
+ + T +RAPEL + T +IDI+S+GC+F +L+ GK F
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 226 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH 285
K S I + A
Sbjct: 241 GDKY-----------------SRESNIIRGI---------FSLDEMKCLHDRSLIAEATD 274
Query: 286 LLERLLAFDPKDRPTAEEALADPYFHGLA--------------NVDREPSTQPISKLEFE 331
L+ +++ DP RPTA + L P F + +R+P + + K +
Sbjct: 275 LISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSDRLEIENRDPPSALLMKFD-A 333
Query: 332 FERRKLAKDDVREMIYREILE-------YHPQMLQEYLR 363
+ D + ++ YH L + LR
Sbjct: 334 GSDFVIPSGDWTVKFDKTFMDNLERYRKYHSSKLMDLLR 372
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 5e-51
Identities = 73/367 (19%), Positives = 127/367 (34%), Gaps = 104/367 (28%)
Query: 16 ASR----YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLR 71
ASR ++ + +G+G +GVV A + AIK+I + +++RE+K L
Sbjct: 1 ASRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIR-LPNRELAREKVMREVKALA 59
Query: 72 LLRHPDIVEIKH------------------------------------------------ 83
L HP IV +
Sbjct: 60 KLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS 119
Query: 84 ----IMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQ---FFLYQLLRGLKY 135
+ +Y+ +L +L + L + Q+ +++
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND---------APSAIFWTDYVAT 186
+H+ + HRDLKP NI D +K+ DFGL D P+ T V T
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 187 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246
+ Y +PE + Y+ +DI+S+G I E+L V +
Sbjct: 240 KLYMSPEQIHG--NNYSHKVDIFSLGLILFELLY--SFSTQMERVRII------------ 283
Query: 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306
+ +RN K P+ F+ K+P +++ +L+ P +RP A + +
Sbjct: 284 ---TDVRNLKF-----------PLLFTQKYPQ----EHMMVQDMLSPSPTERPEATDIIE 325
Query: 307 DPYFHGL 313
+ F L
Sbjct: 326 NAIFENL 332
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 5e-50
Identities = 87/332 (26%), Positives = 129/332 (38%), Gaps = 64/332 (19%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-----------DVFEHVSDATRILR 65
Y +G G+YG V + + AIK I D I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 66 EIKLLRLLRHPDIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEH 121
EI LL+ L HP+I+++ + F+D Y+V E E +L + I
Sbjct: 96 EISLLKSLDHPNIIKLFDV--------FEDKKYFYLVTEFYEGGELFEQIINRHKFDECD 147
Query: 122 YQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAI 178
+ Q+L G+ Y+H N+ HRD+KP+NIL N+ +KI DFGL+ D
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK--- 204
Query: 179 FWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLM 237
D + T +Y APE L KY D+WS G I +L G P F G+N
Sbjct: 205 -LRDRLGTAYYIAPEVLKK----KYNEKCDVWSCGVIMYILLCGYPPFGGQND------- 252
Query: 238 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPK 296
+ I ++ K F + + N A L++ +L +D
Sbjct: 253 --------QDIIKKVEKGK-------------YYFDFNDWKNISDEAKELIKLMLTYDYN 291
Query: 297 DRPTAEEALADPYFHGLANVDREPSTQPISKL 328
R TAEEAL + AN + + +
Sbjct: 292 KRCTAEEALNSRWIKKYANNINKSDQKTLCGA 323
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-49
Identities = 71/343 (20%), Positives = 130/343 (37%), Gaps = 22/343 (6%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
++++E +G G +G V + TGE+VAIK+ + R EI++++ L HP+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPN 73
Query: 78 IVEIKHIMLPPSRREFKD-IYVVFELMES-DLHQVIKANDD---LTPEHYQFFLYQLLRG 132
+V + + + D + E E DL + + ++ L + L +
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 133 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
L+Y+H + HRDLKP+NI+ KI D G A+ T++V T Y
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE----LCTEFVGTLQY 189
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
APEL KYT +D WS G + E +TG F Q + +
Sbjct: 190 LAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR-EKSNEHIVV 246
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309
+ P P +H L+ +L + + R T +
Sbjct: 247 YDDLTGAVKF-----SSVLPTP-NHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300
Query: 310 FHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILE 352
F L ++ ++ + + +++ + + + +
Sbjct: 301 FQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQ 343
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-49
Identities = 74/317 (23%), Positives = 127/317 (40%), Gaps = 59/317 (18%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRH 75
++I +GKG +G V A + + +A+K + E ++ RE+++ LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 134
P+I+ + +R +Y++ E +++ ++ + ++ +L L
Sbjct: 69 PNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 135 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT-----DYVATRWY 189
Y H+ V HRD+KP+N+L + +LKI DFG + APS+ DY+
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYL----- 174
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
PE+ + +D+WS+G + E L GKP F E+
Sbjct: 175 -PPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---------------ETY 216
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPN-ADPLALHLLERLLAFDPKDRPTAEEALADP 308
RI + FP+ A L+ RLL +P RP E L P
Sbjct: 217 KRISRVE-----------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259
Query: 309 YFHGLANVDREPSTQPI 325
+ AN + + Q
Sbjct: 260 WI--TANSSKPSNCQNK 274
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 7e-49
Identities = 86/302 (28%), Positives = 123/302 (40%), Gaps = 49/302 (16%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
Y ++ IG+GS+G V AV T R A KKI V D R +EI++++ L HP
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK--YFVEDVDRFKQEIEIMKSLDHP 66
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
+I+ + + DIY+V EL +L + + + +L + Y
Sbjct: 67 NIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAY 121
Query: 136 IHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 192
H NV HRDLKP+N L + D LK+ DFGLA F V T +Y +P
Sbjct: 122 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR-FKPGK---MMRTKVGTPYYVSP 177
Query: 193 E-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251
+ L G Y P D WS G + +L G P F ++M I
Sbjct: 178 QVLEG----LYGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVM---------LKI-- 219
Query: 252 IRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
++ F + N P A L+ RLL PK R T+ +AL +F
Sbjct: 220 --------------REGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF 265
Query: 311 HG 312
Sbjct: 266 EK 267
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 8e-49
Identities = 88/307 (28%), Positives = 135/307 (43%), Gaps = 47/307 (15%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
RY I ++GKGS+G V D T + A+K IN D + ILRE++LL+ L HP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
+I+++ I+ + Y+V EL +L I + + Q+ G+ Y
Sbjct: 82 NIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 136 IHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 192
+H N+ HRDLKP+NIL DC +KI DFGL+ + D + T +Y AP
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT----KMKDRIGTAYYIAP 192
Query: 193 E-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251
E L G Y D+WS G I +L+G P F GKN + D++ + +
Sbjct: 193 EVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDIL---------KRV-- 234
Query: 252 IRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
+ F + A L+ ++L F P R TA + L P+
Sbjct: 235 --------------ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280
Query: 311 HGLANVD 317
++ +
Sbjct: 281 QKYSSEE 287
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 8e-49
Identities = 86/319 (26%), Positives = 139/319 (43%), Gaps = 51/319 (15%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
Y ++E +GKG++ VV V TG A K IN D ++ RE ++ R L+HP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
+IV + + +E Y+VF+L+ +L + I A + + + Q+L + Y
Sbjct: 66 NIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 136 IHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 192
H+ + HR+LKP+N+L +K+ DFGLA ND+ W + T Y +P
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSE---AWHGFAGTPGYLSP 176
Query: 193 E-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251
E L Y+ +DIW+ G I +L G P F ++ Q L I
Sbjct: 177 EVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLY---------AQI-- 219
Query: 252 IRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
K + S ++ P A L++ +L +PK R TA++AL P+
Sbjct: 220 --------------KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265
Query: 311 HGLANVDREPSTQPISKLE 329
+RE I + +
Sbjct: 266 -----CNRERVASAIHRQD 279
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-48
Identities = 77/318 (24%), Positives = 129/318 (40%), Gaps = 51/318 (16%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-------DVFEHVSDATRILREIKL 69
Y+ +E++G+G VV + T + A+K I+ E L+E+ +
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 70 LRLL-RHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLY 127
LR + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 77 LRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 128 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 187
LL + +H N+ HRDLKP+NIL + D +K+ DFG + + + T
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ-LDPGE---KLREVCGTP 187
Query: 188 WYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 243
Y APE + S Y +D+WS G I +L G P F + Q+ ++
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLML------ 238
Query: 244 PSTESISRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAE 302
I F S ++ + L+ R L P+ R TAE
Sbjct: 239 ---RMI----------------MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 279
Query: 303 EALADPYFHGLANVDREP 320
EALA P+F +
Sbjct: 280 EALAHPFFQQYVVEEVRH 297
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 3e-48
Identities = 72/302 (23%), Positives = 133/302 (44%), Gaps = 56/302 (18%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 76
+++ ++GKGS+ V A HTG VAIK I+ R+ E+K+ L+HP
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLK 134
I+E+ + + +Y+V E+ + ++++ +K + + F++Q++ G+
Sbjct: 72 SILELYNYFEDSNY-----VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 135 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT-----DYVATRWY 189
Y+H+ + HRDL N+L + +KI DFGLA + P +T +Y+
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA--TQLKMPHEKHYTLCGTPNYI----- 179
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
+PE+ S + D+WS+GC+F +L G+P F V ++
Sbjct: 180 -SPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTV---------------KNTL 221
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPN-ADPLALHLLERLLAFDPKDRPTAEEALADP 308
+++ Y + P+ A L+ +LL +P DR + L P
Sbjct: 222 NKV---VLADY--------------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264
Query: 309 YF 310
+
Sbjct: 265 FM 266
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 7e-48
Identities = 72/317 (22%), Positives = 120/317 (37%), Gaps = 57/317 (17%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRH 75
+ I +GKG +G V A + +A+K + E ++ REI++ LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 134
P+I+ + + R IY++ E +L++ ++ + + F+ +L L
Sbjct: 74 PNILRMYNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128
Query: 135 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT-----DYVATRWY 189
Y H V HRD+KP+N+L +LKI DFG + APS T DY+
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRTMCGTLDYL----- 179
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
PE+ + +D+W G + E L G P F + E+
Sbjct: 180 -PPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT---------------ETH 221
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPN-ADPLALHLLERLLAFDPKDRPTAEEALADP 308
RI N + FP + L+ +LL + P R + + P
Sbjct: 222 RRIVNVDLK-----------------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264
Query: 309 YFHGLANVDREPSTQPI 325
+ + P Q
Sbjct: 265 WVKANSRRVLPPVYQST 281
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 7e-48
Identities = 80/349 (22%), Positives = 142/349 (40%), Gaps = 61/349 (17%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLRL 72
Y E +G G + VV + TG + A K I I RE+ +L+
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 73 LRHPDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQ 128
++HP+++ + + +++ + ++ EL+ +L + + LT E FL Q
Sbjct: 71 IQHPNVITLHEV--------YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 129 LLRGLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFNDAPSAIFWTDYV 184
+L G+ Y+H+ + H DLKP+NI+ ++KI DFGLA + +
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIF 178
Query: 185 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244
T + APE+ + D+WSIG I +L+G F G + + +
Sbjct: 179 GTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETL------- 226
Query: 245 STESISRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEE 303
++S + E F + F N LA + RLL DPK R T ++
Sbjct: 227 --ANVSAVNYE----------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268
Query: 304 ALADPYFHGL---ANVDREPSTQPISKLEFEFERRK---LAKDDVREMI 346
+L P+ + R+ S + K + R+K + + ++
Sbjct: 269 SLQHPWIKPKDTQQALSRKASAVNMEKFKKFAARKKSNNGSGGGLNDIF 317
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-47
Identities = 90/330 (27%), Positives = 141/330 (42%), Gaps = 47/330 (14%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
Y ++E +GKG++ VV V TG A K IN D ++ RE ++ R L+HP
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
+IV + + +E Y+VF+L+ +L + I A + + + Q+L + Y
Sbjct: 89 NIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 143
Query: 136 IHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 192
H+ + HR+LKP+N+L +K+ DFGLA ND+ W + T Y +P
Sbjct: 144 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSE---AWHGFAGTPGYLSP 199
Query: 193 E-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251
E L Y+ +DIW+ G I +L G P F ++ Q L I
Sbjct: 200 EVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLY---------AQI-- 242
Query: 252 IRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
K + S ++ P A L++ +L +PK R TA++AL P+
Sbjct: 243 --------------KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288
Query: 311 HGLANVDREPSTQPISKLEFEFE-RRKLAK 339
V Q +F RRKL
Sbjct: 289 CNRERVASAIHRQDTVDCLKKFNARRKLKG 318
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-47
Identities = 78/385 (20%), Positives = 146/385 (37%), Gaps = 59/385 (15%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLRL 72
Y I E +G G + +V + TG A K I I RE+ +LR
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 73 LRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLR 131
+ HP+I+ + + D+ ++ EL+ +L + + L+ E F+ Q+L
Sbjct: 72 VLHPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 132 GLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 187
G+ Y+HT + H DLKP+NI+ +K+ DFGLA + + + T
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE----FKNIFGTP 182
Query: 188 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247
+ APE+ + D+WSIG I +L+G F G + + +
Sbjct: 183 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETL---------A 228
Query: 248 SISRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEEALA 306
+I+ + + F + F LA + +LL + + R T +EAL
Sbjct: 229 NITAVSYD----------------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272
Query: 307 DPYFHGL---ANVDREPSTQPISKLEFEFERRKLAK-----DDVREMIYREILEYHPQML 358
P+ + + R S + + ++ RR+ + + + H +
Sbjct: 273 HPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWKLSFSIVSLCNHLTRSLMKKVHLRTS 332
Query: 359 QEYLRG--GEQTSFMYPSGVDRFKR 381
++ + + + +R
Sbjct: 333 EDLRNCESDTEENIARRKALHPRRR 357
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-47
Identities = 75/337 (22%), Positives = 133/337 (39%), Gaps = 54/337 (16%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLRL 72
Y I E +G G + +V + TG A K I I RE+ +LR
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 73 LRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLR 131
+ H +++ + + D+ ++ EL+ +L + + L+ E F+ Q+L
Sbjct: 72 VLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 132 GLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 187
G+ Y+HT + H DLKP+NI+ +K+ DFGLA + + + T
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE----FKNIFGTP 182
Query: 188 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247
+ APE+ + D+WSIG I +L+G F G + + +
Sbjct: 183 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETL---------A 228
Query: 248 SISRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEEALA 306
+I+ + + F + F + LA + +LL + + R T +EAL
Sbjct: 229 NITSVSYD----------------FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272
Query: 307 DPYFHGLANVDREPSTQPISKLE----FEFERRKLAK 339
P+ + N + + LE + RR+
Sbjct: 273 HPWITPVDNQQAMVRRESVVNLENFRKQ-YVRRRWKL 308
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-47
Identities = 75/315 (23%), Positives = 129/315 (40%), Gaps = 49/315 (15%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLRL 72
Y++ E +G G + +V TG+ A K I I RE+ +LR
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 73 LRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLR 131
+RHP+I+ + I D+ ++ EL+ +L + + LT + FL Q+L
Sbjct: 65 IRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD 119
Query: 132 GLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 187
G+ Y+H+ + H DLKP+NI+ + ++K+ DFG+A + + T
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----FKNIFGTP 175
Query: 188 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247
+ APE+ + D+WSIG I +L+G F G+ + + +
Sbjct: 176 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGET---KQETL---------T 221
Query: 248 SISRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEEALA 306
+IS + + F + F N LA + RLL DPK R T ++L
Sbjct: 222 NISAVNYD----------------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265
Query: 307 DPYFHGLANVDREPS 321
+ + +
Sbjct: 266 HSWIKAIRRRNVRGE 280
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-47
Identities = 70/319 (21%), Positives = 134/319 (42%), Gaps = 62/319 (19%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN------------------------DV 53
+Y +++ IGKGSYGVV A + + A+K ++
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 54 FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIK 112
+ ++ +EI +L+ L HP++V++ ++ P+ +Y+VFEL+ + +V
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDH---LYMVFELVNQGPVMEVPT 130
Query: 113 ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172
L+ + +F+ L++G++Y+H + HRD+KP N+L D +KI DFG++
Sbjct: 131 -LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF-- 187
Query: 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVV 231
A+ V T + APE ++ A+D+W++G + G+ F +
Sbjct: 188 KGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-- 244
Query: 232 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLL 291
+ L S+I+++ P P+ L+ R+L
Sbjct: 245 -----IMCLH--------SKIKSQALE-----------FP---DQPDIAEDLKDLITRML 277
Query: 292 AFDPKDRPTAEEALADPYF 310
+P+ R E P+
Sbjct: 278 DKNPESRIVVPEIKLHPWV 296
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 5e-47
Identities = 56/343 (16%), Positives = 115/343 (33%), Gaps = 64/343 (18%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN---------------DVFEHVSDATR 62
Y+I + +G + + + A+KK D S
Sbjct: 32 DYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 63 ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEH 121
E++++ +++ + + I+ ++Y+++E ME+ + + + L +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNY 144
Query: 122 YQ--------FFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFN 172
+ +L YIH N+ HRD+KP NIL + + ++K+ DFG +
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES----E 200
Query: 173 DAPSAIFWT-----DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 227
+++ PE + S +DIWS+G M F
Sbjct: 201 YMVDKKIKGSRGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254
Query: 228 KNVVHQLDLMTDLLGTPSTESISRIRNEKAR---RYLGSMRKKQPVPFSHKFPNADPLAL 284
K + +L + IR + + + +
Sbjct: 255 KISLVEL--------------FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDI 300
Query: 285 HLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISK 327
L+ L +P +R T+E+AL + D ++ + K
Sbjct: 301 DFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYK 343
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 6e-47
Identities = 59/319 (18%), Positives = 99/319 (31%), Gaps = 71/319 (22%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL-RLLR 74
+ + E IG G +G V V G AIK+ D LRE+ L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLT---PEHY-QFFLYQL 129
H +V + E + + E L I N + E + L Q+
Sbjct: 70 HSHVVRYFS-----AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 130 LRGLKYIHTANVFHRDLKPKNIL-------------------ANADCKLKICDFGLARVS 170
RGL+YIH+ ++ H D+KP NI A+ KI D G
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT-R 183
Query: 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV 230
+ + A E+ ++ + P DI+++ +PL +
Sbjct: 184 ISSPQV------EEGDSRFLANEVLQENYT-HLPKADIFALALTVVCAAGAEPLPRNGDQ 236
Query: 231 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERL 290
H++ R+ + LL+ +
Sbjct: 237 WHEI------------------------------RQGRLPRIPQVLS---QEFTELLKVM 263
Query: 291 LAFDPKDRPTAEEALADPY 309
+ DP+ RP+A +
Sbjct: 264 IHPDPERRPSAMALVKHSV 282
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-46
Identities = 88/351 (25%), Positives = 139/351 (39%), Gaps = 46/351 (13%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
YQ+ E +GKG++ VV V G+ A IN D ++ RE ++ RLL+HP
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
+IV + + E Y++F+L+ +L + I A + + + Q+L + +
Sbjct: 71 NIVRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 125
Query: 136 IHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 192
H V HR+LKP+N+L +K+ DFGLA + W + T Y +P
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI--EVEGEQQA-WFGFAGTPGYLSP 182
Query: 193 E-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251
E L Y +D+W+ G I +L G P F ++ Q L + I
Sbjct: 183 EVLRK---DPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLY---------QQI-- 225
Query: 252 IRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
K F P A L+ ++L +P R TA EAL P+
Sbjct: 226 --------------KAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271
Query: 311 HGLANVDREPSTQPISKLEFEFE-RRKLAKDDVREMIYREILEYHPQMLQE 360
+ V Q +F RRKL + M+ Q + +
Sbjct: 272 SHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVMLATRNFSVRKQEIIK 322
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-46
Identities = 74/304 (24%), Positives = 128/304 (42%), Gaps = 53/304 (17%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
+ + +G G++G V + +G IK IN +I EI++L+ L HP
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD-RSQVPMEQIEAEIEVLKSLDHP 80
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHY-----QFFLYQLL 130
+I++I + ++ ++Y+V E E +L + I + + + Q++
Sbjct: 81 NIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQA-RGKALSEGYVAELMKQMM 134
Query: 131 RGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 187
L Y H+ +V H+DLKP+NIL + +KI DFGLA + +D T+ T
Sbjct: 135 NALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE----HSTNAAGTA 190
Query: 188 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246
Y APE T DIWS G + +LTG F G + ++
Sbjct: 191 LYMAPEVFKR----DVTFKCDIWSAGVVMYFLLTGCLPFTGTS---LEEVQ--------- 234
Query: 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306
+ + ++ + P A+ LL+++L DP+ RP+A + L
Sbjct: 235 QKA----------------TYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278
Query: 307 DPYF 310
+F
Sbjct: 279 HEWF 282
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 5e-46
Identities = 89/363 (24%), Positives = 156/363 (42%), Gaps = 68/363 (18%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
Y++ + IGKG++ V A TG VAIK I+ + + ++ RE++++++L HP+
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 136
IV++ ++ K +Y++ E ++ + A+ + + + Q++ ++Y
Sbjct: 76 IVKLFEVIETE-----KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW-----YRA 191
H + HRDLK +N+L +AD +KI DFG S F + Y A
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGF---------SNEFTVGGKLDAFCGAPPYAA 181
Query: 192 PELCGSFFS--KYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248
PEL F KY P +D+WS+G I +++G F G+N + +L
Sbjct: 182 PEL----FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-------LKELR------- 223
Query: 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308
R+ +R K +PF + + D +LL+R L +P R T E+ + D
Sbjct: 224 -ERV-----------LRGKYRIPF---YMSTD--CENLLKRFLVLNPIKRGTLEQIMKDR 266
Query: 309 YFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQT 368
+ N E +L+ E D R I + Y + +QE L +
Sbjct: 267 WI----NAGHEE-----DELKPFVEPELDISDQKRIDIMVG-MGYSQEEIQESLSKMKYD 316
Query: 369 SFM 371
Sbjct: 317 EIT 319
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-45
Identities = 83/315 (26%), Positives = 122/315 (38%), Gaps = 46/315 (14%)
Query: 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 74
E + V+GKG+YG+V + D R+AIK+I + + EI L + L+
Sbjct: 20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLK 77
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLL 130
H +IV+ S E I + E + S L + + F+ Q+L
Sbjct: 78 HKNIVQYLG-----SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 131 RGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
GLKY+H + HRD+K N+L N LKI DFG ++ P + T Y
Sbjct: 133 EGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT---ETFTGTLQY 189
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
APE+ Y A DIWS+GC EM TGKP P + M
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP--PFYELGEPQAAM------------ 235
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309
+G + +P + A + + DP R A + L D +
Sbjct: 236 ---------FKVGMFKVHPEIP-----ESMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281
Query: 310 FHGLANVDREPSTQP 324
L ++ TQP
Sbjct: 282 ---LKVSSKKKKTQP 293
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-45
Identities = 70/295 (23%), Positives = 121/295 (41%), Gaps = 39/295 (13%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+ + + +G+G+YG V AV+ T E VA+K ++ V I +EI + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHEN 66
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 136
+V+ + Y+ E +L I+ + + Q F +QL+ G+ Y+
Sbjct: 67 VVKFYGHRREGN-----IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
H + HRD+KP+N+L + LKI DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPELLK 180
Query: 197 SFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
++ +D+WS G + ML G+ + + D + +
Sbjct: 181 R--REFHAEPVDVWSCGIVLTAMLAGELPWDQPS-----DSCQEYS--------DWKEKK 225
Query: 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
P+ D L LL ++L +P R T + D ++
Sbjct: 226 TYL-----------NPWKK----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-45
Identities = 91/361 (25%), Positives = 148/361 (40%), Gaps = 64/361 (17%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 76
Y I+E +G+GS+G V A T ++VA+K I+ + + R+ REI L+LLRHP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 136
I+++ ++ P DI +V E +L I +T + + F Q++ ++Y
Sbjct: 70 HIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW-----YRA 191
H + HRDLKP+N+L + + +KI DFGL S I Y A
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGL---------SNIMTDGNFLKTSCGSPNYAA 175
Query: 192 PELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250
PE+ Y P +D+WS G + ML G+ F + + +
Sbjct: 176 PEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK--------------- 218
Query: 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
++ + P S P A L+ R++ DP R T +E DP+F
Sbjct: 219 KVNSCVYV---------MPDFLS-------PGAQSLIRRMIVADPMQRITIQEIRRDPWF 262
Query: 311 HGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSF 370
NV+ +P+ E + V ++ E + + + E LR E
Sbjct: 263 ----NVNLPDYLRPME----EVQGSYADSRIVSKLG--EAMGFSEDYIVEALRSDENNEV 312
Query: 371 M 371
Sbjct: 313 K 313
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 3e-45
Identities = 78/304 (25%), Positives = 116/304 (38%), Gaps = 49/304 (16%)
Query: 12 EYGEASR-YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 70
EY E Q +G+GS+G V D TG + A+KK+ E E+
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRV-----EELVAC 104
Query: 71 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQ 128
L P IV + + RE + + EL+E S L Q+IK L + ++L Q
Sbjct: 105 AGLSSPRIVPLYG-----AVREGPWVNIFMELLEGGS-LGQLIKQMGCLPEDRALYYLGQ 158
Query: 129 LLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVSFNDAPSAIFWTDY--VA 185
L GL+Y+HT + H D+K N+L ++D + +CDFG A D T
Sbjct: 159 ALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 186 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245
T + APE+ +DIWS C+ ML G + Q L
Sbjct: 219 TETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPW------TQYFRGPLCL---- 266
Query: 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 305
+I +E +P P+ PL ++ L +P R +A E
Sbjct: 267 -----KIASEPPPIR--------EIP-----PSCAPLTAQAIQEGLRKEPVHRASAMELR 308
Query: 306 ADPY 309
Sbjct: 309 RKVG 312
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-45
Identities = 80/338 (23%), Positives = 127/338 (37%), Gaps = 56/338 (16%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN---DVFEHVSDATRILREIKLLRLL 73
Y++ EVIGKG + VV ++ TG++ A+K ++ + RE + +L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 74 RHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVI----KANDDLTPEHYQFFLYQ 128
+HP IVE+ +Y+VFE M+ +DL I A + ++ Q
Sbjct: 84 KHPHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 129 LLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVA 185
+L L+Y H N+ HRD+KP +L +K+ FG+A V
Sbjct: 139 ILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL---VAGGRVG 195
Query: 186 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244
T + APE + Y +D+W G I +L+G F G
Sbjct: 196 TPHFMAPEVVKR---EPYGKPVDVWGCGVILFILLSGCLPFYGTK--------------- 237
Query: 245 STESI-SRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAE 302
E + I K ++ + A L+ R+L DP +R T
Sbjct: 238 --ERLFEGIIKGK-------------YKMNPRQWSHISESAKDLVRRMLMLDPAERITVY 282
Query: 303 EALADPYFHGLANVDREPSTQPISKLEFEFE-RRKLAK 339
EAL P+ + + +F RRKL
Sbjct: 283 EALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKG 320
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-45
Identities = 76/318 (23%), Positives = 125/318 (39%), Gaps = 48/318 (15%)
Query: 18 RYQIQ-EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-H 75
YQ+Q +V+G+G++ V + ++ T + A+K I + +R+ RE+++L + H
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQCQGH 70
Query: 76 PDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLR 131
+++E+ F++ Y+VFE M + I + +
Sbjct: 71 RNVLELIEF--------FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS 122
Query: 132 GLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARV----SFNDAPSAIFWTDYV 184
L ++H + HRDLKP+NIL N +KICDF L S
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 185 ATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 241
+ Y APE+ S Y D+WS+G I +L+G P F G+ +
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242
Query: 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNAD-----PLALHLLERLLAFDPK 296
I+ K + FP+ D A L+ +LL D K
Sbjct: 243 PACQNMLFESIQEGK---------------YE--FPDKDWAHISCAAKDLISKLLVRDAK 285
Query: 297 DRPTAEEALADPYFHGLA 314
R +A + L P+ G A
Sbjct: 286 QRLSAAQVLQHPWVQGCA 303
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 5e-45
Identities = 75/307 (24%), Positives = 125/307 (40%), Gaps = 50/307 (16%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN------DVFEHVSDATRILREIKLL 70
+Y ++VIG+G VV V TG A+K + + RE +L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 71 RLLR-HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQ 128
R + HP I+ + +++VF+LM +L + L+ + + +
Sbjct: 154 RQVAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRS 208
Query: 129 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 188
LL + ++H N+ HRDLKP+NIL + + ++++ DFG + + T
Sbjct: 209 LLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH-LEPGE---KLRELCGTPG 264
Query: 189 YRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244
Y APE L S Y +D+W+ G I +L G P F + Q+ ++
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILML------- 314
Query: 245 STESISRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEE 303
I + F S ++ + L+ RLL DP+ R TAE+
Sbjct: 315 --RMI----------------MEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQ 356
Query: 304 ALADPYF 310
AL P+F
Sbjct: 357 ALQHPFF 363
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 7e-45
Identities = 64/331 (19%), Positives = 117/331 (35%), Gaps = 58/331 (17%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HP 76
R +++ V+ +G + V A D +G A+K++ I++E+ ++ L HP
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL--SNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELME---SDLHQVI---KANDDLTPEHYQFFLYQLL 130
+IV+ L E L + + ++ L+ + YQ
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 131 RGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVA--- 185
R ++++H + HRDLK +N+L + +K+CDFG A + +
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 186 ------TRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLM 237
T YR PE+ +S DIW++GCI + + F +
Sbjct: 207 EITRNTTPMYRTPEII-DLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------ 259
Query: 238 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD 297
RI N G F + L+ +L +P++
Sbjct: 260 -------------RIVN-------GKYSIPPHDTQYTVFHS-------LIRAMLQVNPEE 292
Query: 298 RPTAEEALADPYFHGLANVDREPSTQPISKL 328
R + E + +A PI++L
Sbjct: 293 RLSIAEVVHQL--QEIAAARNVNPKSPITEL 321
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-44
Identities = 74/350 (21%), Positives = 130/350 (37%), Gaps = 53/350 (15%)
Query: 6 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILR 65
++ F+ Y + +G+GS+ + V + + A+K I+ +
Sbjct: 3 DSPFYQHY---DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQK 54
Query: 66 EIKLLRLLR-HPDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPE 120
EI L+L HP+IV++ + F D ++V EL+ +L + IK +
Sbjct: 55 EITALKLCEGHPNIVKLHEV--------FHDQLHTFLVMELLNGGELFERIKKKKHFSET 106
Query: 121 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSA 177
+ + +L+ + ++H V HRDLKP+N+L N + ++KI DFG AR+ D
Sbjct: 107 EASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP- 165
Query: 178 IFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 236
T Y APE L + Y + D+WS+G I ML+G+ F +
Sbjct: 166 --LKTPCFTLHYAAPELLNQ---NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS 220
Query: 237 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDP 295
+++ +I+ F + N A L++ LL DP
Sbjct: 221 AVEIM--------KKIKKGD-------------FSFEGEAWKNVSQEAKDLIQGLLTVDP 259
Query: 296 KDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREM 345
R + + + + P P K
Sbjct: 260 NKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFHAF 309
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-44
Identities = 64/303 (21%), Positives = 121/303 (39%), Gaps = 51/303 (16%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN--DVFEHVSDATRILREIKLLRLLRH 75
+Y + +++G+GSYG V +D+ T R A+K + + + + +EI+LLR LRH
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK--ANDDLTPEHYQFFLYQLLRGL 133
+++++ ++ + + +Y+V E + +++ + QL+ GL
Sbjct: 66 KNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT-----DYVATRW 188
+Y+H+ + H+D+KP N+L LKI G+A A T +
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ---- 178
Query: 189 YRAPELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247
PE+ + ++ +DIWS G + TG F G N+ L
Sbjct: 179 --PPEIA-NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-------KLF------ 222
Query: 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307
I +P + P LL+ +L ++P R + +
Sbjct: 223 --ENIGKGSYA-----------IP-----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264
Query: 308 PYF 310
+F
Sbjct: 265 SWF 267
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-44
Identities = 73/317 (23%), Positives = 125/317 (39%), Gaps = 44/317 (13%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+ + + +G+G+YG V AV+ T E VA+K ++ V I +EI + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHEN 66
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 136
+V+ + Y+ E +L I+ + + Q F +QL+ G+ Y+
Sbjct: 67 VVKFYGHRREGN-----IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
H + HRD+KP+N+L + LKI DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPEL-- 178
Query: 197 SFFS--KYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253
++ +D+WS G + ML G+ + + D +
Sbjct: 179 --LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS-----DSCQEYS--------DWKE 223
Query: 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF-HG 312
+ P+ D L LL ++L +P R T + D ++
Sbjct: 224 KKTYL-----------NPWKK----IDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268
Query: 313 LANVDREPSTQPISKLE 329
L + P E
Sbjct: 269 LKKGAKRPRVTSGGVSE 285
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-44
Identities = 78/331 (23%), Positives = 128/331 (38%), Gaps = 52/331 (15%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
Y I E +G G++GVV V+ TG K IN + D + EI ++ L HP
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHP 108
Query: 77 DIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHY-QFFLYQLLR 131
++ + F+D + ++ E + +L I A D E ++ Q
Sbjct: 109 KLINLHDA--------FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE 160
Query: 132 GLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
GLK++H ++ H D+KP+NI+ +KI DFGLA N P I AT +
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK-LN--PDEIVKVT-TATAEF 216
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
APE+ D+W+IG + +L+G F G++ E++
Sbjct: 217 AAPEIVD--REPVGFYTDMWAIGVLGYVLLSGLSPFAGED---------------DLETL 259
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEEALADP 308
++ F F + P A ++ LL +P+ R T +AL P
Sbjct: 260 QNVKRCD-------------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306
Query: 309 YFHGLANVDREPSTQPISKLEFEFERRKLAK 339
+ G + + + K A
Sbjct: 307 WLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 337
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-44
Identities = 73/332 (21%), Positives = 134/332 (40%), Gaps = 58/332 (17%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
+Y I E +G+G +G+V V+T + + K + +D + +EI +L + RH
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHR 61
Query: 77 DIVEIKHIMLPPSRREFKD---IYVVFELME-SDLH-QVIKANDDLTPEHYQFFLYQLLR 131
+I+ + F+ + ++FE + D+ ++ + +L +++Q+
Sbjct: 62 NILHLHES--------FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 132 GLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
L+++H+ N+ H D++P+NI+ +KI +FG AR + Y
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN----FRLLFTAPEY 169
Query: 190 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248
APE + A D+WS+G + +L+G F + + +
Sbjct: 170 YAPEVHQHDV---VSTATDMWSLGTLVYVLLSGINPFLAET---------------NQQI 211
Query: 249 ISRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEEALAD 307
I I N + F + F A+ ++RLL + K R TA EAL
Sbjct: 212 IENIMNAE-------------YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258
Query: 308 PYFHGLANVDREPSTQPISKLEFEFERRKLAK 339
P+ L ST+ I L+ L K
Sbjct: 259 PW---LKQKIERVSTKVIRTLKHRRYYHTLIK 287
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-44
Identities = 75/301 (24%), Positives = 118/301 (39%), Gaps = 55/301 (18%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 76
Y + + +G G++G V TG +VA+K +N + +I REI+ L+L RHP
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
I+++ ++ P+ D ++V E + +L I + + + Q+L + Y
Sbjct: 72 HIIKLYQVISTPT-----DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW-----YR 190
H V HRDLKP+N+L +A KI DFGL S + Y
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGL---------SNMMSDGEFLRTSCGSPNYA 177
Query: 191 APELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
APE+ Y P +DIWS G I +L G F ++ + L
Sbjct: 178 APEVISG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEH-------VPTLF-------- 220
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309
+IR P + LL +L DP R T ++ +
Sbjct: 221 KKIRGGVFY---------IPEYLN-------RSVATLLMHMLQVDPLKRATIKDIREHEW 264
Query: 310 F 310
F
Sbjct: 265 F 265
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-44
Identities = 77/340 (22%), Positives = 134/340 (39%), Gaps = 62/340 (18%)
Query: 17 SRYQIQ-EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 75
+ Y + + +G+G + VV + TG+ A K + IL EI +L L +
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 76 -PDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHY-----QFF 125
P ++ + + +++ I ++ E ++ + E
Sbjct: 88 CPRVINLHEV--------YENTSEIILILEYAAGGEIFSLCLPELA---EMVSENDVIRL 136
Query: 126 LYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTD 182
+ Q+L G+ Y+H N+ H DLKP+NIL +KI DFG++R A +
Sbjct: 137 IKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK-IGHAC---ELRE 192
Query: 183 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 242
+ T Y APE+ + T A D+W+IG I +LT F G++ +
Sbjct: 193 IMGTPEYLAPEILN--YDPITTATDMWNIGIIAYMLLTHTSPFVGED---NQETY----- 242
Query: 243 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTA 301
+IS++ V +S + F + LA ++ LL +P+ RPTA
Sbjct: 243 ----LNISQVN----------------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTA 282
Query: 302 EEALADPYF--HGLANVDREPSTQPISKLEFEFERRKLAK 339
E L+ + N+ T S+ + R K
Sbjct: 283 EICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSEDK 322
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-44
Identities = 50/353 (14%), Positives = 99/353 (28%), Gaps = 82/353 (23%)
Query: 1 MQSALETEFFTEYGEASR-YQIQEVIGKGSYGVVGSAVDTHTGERVAIK----------- 48
+ +E GE R V+G+ A D TGE +
Sbjct: 56 WNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN 115
Query: 49 ------------KINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96
++ ++ A LR I L++ P ++ + L
Sbjct: 116 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 175
Query: 97 YVVFELMESDLHQVIKANDDLTPEHYQF-------FLYQLLRGLKYIHTANVFHRDLKPK 149
+ ++ M+S+L + + H Q++R L +H + H L+P
Sbjct: 176 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 235
Query: 150 NILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL---------CGSFFS 200
+I+ + + + F +R + PEL +
Sbjct: 236 DIVLDQRGGVFLTGFEHLVRDGAR-------VVSSVSRGFEPPELEARRATISYHRDRRT 288
Query: 201 KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 260
T + D W++G + + + + +
Sbjct: 289 LMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI----------------------- 325
Query: 261 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313
R + +P LLE L + +DR +A+ P + L
Sbjct: 326 ---FRSCKNIP---------QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-44
Identities = 74/331 (22%), Positives = 130/331 (39%), Gaps = 48/331 (14%)
Query: 18 RYQI-QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL-RLLRH 75
YQ+ ++V+G G G V TG++ A+K + D + + +E+ +
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD-------SPKARQEVDHHWQASGG 81
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVI--KANDDLTPEHYQFFLYQLLRG 132
P IV I + + + + ++ E ME +L I + + T + +
Sbjct: 82 PHIVCILDVYENMHHGK-RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 133 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
++++H+ N+ HRD+KP+N+L D LK+ DFG A+ + +A T +Y
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-----LQTPCYTPYY 195
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
APE+ G KY + D+WS+G I +L G P F M
Sbjct: 196 VAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM-----------K 242
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKDRPTAEEALADP 308
RIR + F + A L+ LL DP +R T + + P
Sbjct: 243 RRIRLGQ-------------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289
Query: 309 YFHGLANVDREPSTQPISKLEFEFERRKLAK 339
+ + V + P E + ++ +
Sbjct: 290 WINQSMVVPQTPLHTARVLQEDKDHWDEVKE 320
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-44
Identities = 88/338 (26%), Positives = 136/338 (40%), Gaps = 49/338 (14%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
RY + IG G++GV D T E VA+K I + + REI R LRHP+
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE---RGAAIDENVQREIINHRSLRHPN 77
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 136
IV K ++L P+ + ++ E +L++ I + + +FF QLL G+ Y
Sbjct: 78 IVRFKEVILTPT-----HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 137 HTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 194
H+ + HRDLK +N L + +LKICDFG ++ S + V T Y APE+
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEV 188
Query: 195 CGSFFS--KYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251
+Y D+WS G ML G F ++I R
Sbjct: 189 ----LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY-----------RKTIQR 233
Query: 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311
I + K +P + P HL+ R+ DP R + E +F
Sbjct: 234 ILSVKYS-----------IPDDIRIS---PECCHLISRIFVADPATRISIPEIKTHSWF- 278
Query: 312 GLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYRE 349
L N+ + + + +F+ + + D I E
Sbjct: 279 -LKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISE 315
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-43
Identities = 74/328 (22%), Positives = 118/328 (35%), Gaps = 62/328 (18%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLRL 72
+ Y++ ++GKG +G V + +VAIK I + +SD+ E+ LL
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 73 LR----HPDIVEIKHIMLPPSRREFKDIYVVFELMES--DLHQVIKANDDLTPEHYQFFL 126
+ HP ++ + + +V E DL I L + F
Sbjct: 91 VGAGGGHPGVIRLLDWFETQ-----EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 127 YQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVSFNDAPSAIFWTDYVA 185
Q++ +++ H+ V HRD+K +NIL + K+ DFG + TD+
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG----ALLHDEPY-TDFDG 200
Query: 186 TRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244
TR Y PE +Y +WS+G + +M+ G F
Sbjct: 201 TRVYSPPEWIS--RHQYHALPATVWSLGILLYDMVCGDIPF------------------- 239
Query: 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 304
E I + P S P L+ R LA P RP+ EE
Sbjct: 240 --ERDQEILEAELH---------FPAHVS-------PDCCALIRRCLAPKPSSRPSLEEI 281
Query: 305 LADPYFH-GLANVDREPSTQPISKLEFE 331
L DP+ +V PS + L +
Sbjct: 282 LLDPWMQTPAEDVPLNPSKGGPAPLAWS 309
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-43
Identities = 84/330 (25%), Positives = 131/330 (39%), Gaps = 52/330 (15%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
++++ +G+G+ +V T + A+K + D + EI +L L HP
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK----KTVDKKIVRTEIGVLLRLSHP 108
Query: 77 DIVEIKHIMLPPSRREFKD-IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 134
+I+++K I E I +V EL+ +L I + + Q+L +
Sbjct: 109 NIIKLKEIF------ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVA 162
Query: 135 YIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 191
Y+H + HRDLKP+N+L D LKI DFGL+++ + T Y A
Sbjct: 163 YLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV----LMKTVCGTPGYCA 218
Query: 192 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250
PE L G Y P +D+WS+G I +L G F + +
Sbjct: 219 PEILRG---CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM--------------FR 261
Query: 251 RIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309
RI N + F S + A L+ +L+ DPK R T +AL P+
Sbjct: 262 RILNCE-------------YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308
Query: 310 FHGLANVDREPSTQPISKLEFEFERRKLAK 339
G A + KL+ RRKL
Sbjct: 309 VTGKA-ANFVHMDTAQKKLQEFNARRKLKA 337
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 5e-43
Identities = 73/335 (21%), Positives = 128/335 (38%), Gaps = 59/335 (17%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
Y I E +G G++GVV + TG A K + H SD + +EI+ + +LRHP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHP 214
Query: 77 DIVEIKHIMLPPSRREFKD---IYVVFELME-SDL-HQVIKANDDLTPEHYQFFLYQLLR 131
+V + F+D + +++E M +L +V ++ ++ + ++ Q+ +
Sbjct: 215 TLVNLHDA--------FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 266
Query: 132 GLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
GL ++H N H DLKP+NI+ +LK+ DFGL T +
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS----VKVTTGTAEF 322
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
APE+ D+WS+G + +L+G F G+N E++
Sbjct: 323 AAPEVAE--GKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---------------DDETL 365
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEEALADP 308
+++ F + +LL DP R T +AL P
Sbjct: 366 RNVKSCD-------------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 412
Query: 309 YFHGLANVDREPSTQPISKLEF----EFERRKLAK 339
+ L + I + + + K
Sbjct: 413 W---LTPGNAPGRDSQIPSSRYTKIRDSIKTKYDA 444
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 6e-43
Identities = 80/321 (24%), Positives = 125/321 (38%), Gaps = 56/321 (17%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLLRHP 76
Y+++E IG GSY V + T A+K I+ EI+ LLR +HP
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRDPTEEIEILLRYGQHP 76
Query: 77 DIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 132
+I+ +K + + D +YVV ELM+ +L I + L+ + +
Sbjct: 77 NIITLKDV--------YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKT 128
Query: 133 LKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 188
++Y+H V HRDLKP NIL + ++ICDFG A+ + T
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG---LLMTPCYTAN 185
Query: 189 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247
+ APE L Y A DIWS+G + MLTG F +++
Sbjct: 186 FVAPEVLER---QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA--------- 233
Query: 248 SISRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKDRPTAEEALA 306
RI + K S + + A L+ ++L DP R TA L
Sbjct: 234 ---RIGSGK-------------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277
Query: 307 DPYFHGLANVDREPSTQPISK 327
P+ + + + +
Sbjct: 278 HPWIVHWDQLPQYQLNRQDAP 298
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-42
Identities = 70/305 (22%), Positives = 115/305 (37%), Gaps = 59/305 (19%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLRLL 73
+YQ+ ++G G +G V S + VAIK + + + + TR+ E+ LL+ +
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 74 RH--PDIVEIKHIMLPPSRREFKDIYVVFELMES--DLHQVIKANDDLTPEHYQFFLYQL 129
++ + P ++ E E DL I L E + F +Q+
Sbjct: 104 SSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 158
Query: 130 LRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVSFNDAPSAIFWTDYVATRW 188
L +++ H V HRD+K +NIL + + +LK+ DFG ++ TD+ TR
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG----ALLKDTVY-TDFDGTRV 213
Query: 189 YRAPELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247
Y PE + +Y + +WS+G + +M+ G F E
Sbjct: 214 YSPPEWIR--YHRYHGRSAAVWSLGILLYDMVCGDIPF---------------------E 250
Query: 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307
I + S HL+ LA P DRPT EE
Sbjct: 251 HDEEIIRGQVFF---------RQRVS-------SECQHLIRWCLALRPSDRPTFEEIQNH 294
Query: 308 PYFHG 312
P+
Sbjct: 295 PWMQD 299
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-42
Identities = 46/335 (13%), Positives = 88/335 (26%), Gaps = 70/335 (20%)
Query: 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE------------------ 55
V+G+ A D TGE +
Sbjct: 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 134
Query: 56 -----HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQV 110
+ A LR I L++ P ++ + L + ++ M+S+L
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194
Query: 111 IKANDDLTPEHYQ-------FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 163
+ + H Q++R L +H + H L+P +I+ + + +
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 164 FGLARVSFNDAPSAIFWTDYVATRWYRAPELC---GSFFSKYTPAIDIWSIGCIFAEMLT 220
F A + A A + + T A D W++G +
Sbjct: 255 FEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 221 GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNAD 280
+ + + R + +P
Sbjct: 313 ADLPNTDDAALGGSEWI--------------------------FRSCKNIP--------- 337
Query: 281 PLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315
LLE L + +DR +A+ P + L
Sbjct: 338 QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 372
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-42
Identities = 77/367 (20%), Positives = 136/367 (37%), Gaps = 65/367 (17%)
Query: 6 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILR 65
+ +Y +V+G G G V + T E+ A+K + D + R
Sbjct: 56 KNAIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARR 103
Query: 66 EIKLL-RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQ 123
E++L R + P IV I + K + +V E ++ +L I+ D Q
Sbjct: 104 EVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGD------Q 156
Query: 124 FF--------LYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFN 172
F + + ++Y+H+ N+ HRD+KP+N+L + LK+ DFG A+ + +
Sbjct: 157 AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
Query: 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH 232
T T +Y APE+ G KY + D+WS+G I +L G P F +
Sbjct: 217 HNS----LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNH--- 267
Query: 233 QLDLMTDLLGTPSTESI-SRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERL 290
G + + +RIR + F + L+ L
Sbjct: 268 ---------GLAISPGMKTRIRMGQ-------------YEFPNPEWSEVSEEVKMLIRNL 305
Query: 291 LAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREI 350
L +P R T E + P+ V + P E + + ++ + +
Sbjct: 306 LKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRV 365
Query: 351 LEYHPQM 357
++
Sbjct: 366 DYEQIKI 372
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 3e-41
Identities = 94/450 (20%), Positives = 155/450 (34%), Gaps = 68/450 (15%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 76
Y + + +G G++G V TG +VA+K +N + +I REI+ L+L RHP
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
I+++ ++ P DI++V E + +L I N L + + Q+L G+ Y
Sbjct: 77 HIIKLYQVISTP-----SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW-----YR 190
H V HRDLKP+N+L +A KI DFGL S + Y
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHMNAKIADFGL---------SNMMSDGEFLRTSCGSPNYA 182
Query: 191 APELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
APE+ Y P +DIWS G I +L G F +V
Sbjct: 183 APEVISG--RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK-------------- 226
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309
+I + P + P + LL+ +L DP R T ++ +
Sbjct: 227 -KICDGIFY---------TPQYLN-------PSVISLLKHMLQVDPMKRATIKDIREHEW 269
Query: 310 FHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTS 369
F D P + + + + ++E+ E E + + L
Sbjct: 270 F----KQDLPKYLFPE---DPSYSSTMIDDEALKEVC--EKFECSEEEVLSCLYNRNHQD 320
Query: 370 FM---YPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQNNDYG 426
+ Y +D +R ++ Y H P +
Sbjct: 321 PLAVAYHLIIDN-RRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHT 379
Query: 427 RTADSVAATLQSPPTENANTEEQNGINRPN 456
+ + + +RPN
Sbjct: 380 LDELNPQKSKHQGVRKAKWHLGIRSQSRPN 409
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-41
Identities = 71/354 (20%), Positives = 126/354 (35%), Gaps = 72/354 (20%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN------DVFEHVSDATRILREIKLLR 71
+Y +G G++G V +AVD + V +K I D + ++ EI +L
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 72 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES--DLHQVIKANDDLTPEHYQFFLYQL 129
+ H +I+++ I +V E S DL I + L + QL
Sbjct: 85 RVEHANIIKVLDIFENQ-----GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 130 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
+ + Y+ ++ HRD+K +NI+ D +K+ DFG A F+T + T Y
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYT-FCGTIEY 195
Query: 190 RAPELCGSFFS--KYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246
APE+ Y P +++WS+G ++ + F
Sbjct: 196 CAPEV----LMGNPYRGPELEMWSLGVTLYTLVFEENPF--------------------- 230
Query: 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306
+ P S + L+ LL P+ R T E+ +
Sbjct: 231 CELEET---VEAAI------HPPYLVS-------KELMSLVSGLLQPVPERRTTLEKLVT 274
Query: 307 DPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQE 360
DP+ TQP++ ++ +E ++ LE + L +
Sbjct: 275 DPWV-----------TQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSD 317
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 4e-41
Identities = 71/363 (19%), Positives = 120/363 (33%), Gaps = 45/363 (12%)
Query: 15 EASRYQIQEVIGKG--SYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 72
E Y++ VIGKG V A TGE V +++IN T + E+ + +L
Sbjct: 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKL 82
Query: 73 LRHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKA--NDDLTPEHYQFFLYQ 128
HP+IV + + + +++VV M S +I D + + L
Sbjct: 83 FNHPNIVPYRATFIADN-----ELWVVTSFMAYGS-AKDLICTHFMDGMNELAIAYILQG 136
Query: 129 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG----LARVSFNDAPSAIFWTDYV 184
+L+ L YIH HR +K +IL + D K+ + + F V
Sbjct: 137 VLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 185 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKP----------LF--------- 225
+ +PE+ Y DI+S+G E+ G L
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256
Query: 226 -PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVP--FSHKFPNADPL 282
+ + +L + + +S R P FS F
Sbjct: 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF------ 310
Query: 283 ALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDV 342
H +E+ L +P RP+A L +F + E + + + D
Sbjct: 311 -HHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDH 369
Query: 343 REM 345
+
Sbjct: 370 SGI 372
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-40
Identities = 77/334 (23%), Positives = 130/334 (38%), Gaps = 58/334 (17%)
Query: 17 SRYQI--QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 74
S Y + E++G G +G V +T TG ++A K I + D + EI ++ L
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKEEVKNEISVMNQLD 144
Query: 75 HPDIVEIKHIMLPPSRREF---KDIYVVFELME-SDLHQVIKANDDLTPEHY-QFFLYQL 129
H +++++ F DI +V E ++ +L I E F+ Q+
Sbjct: 145 HANLIQLYDA--------FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI 196
Query: 130 LRGLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 187
G++++H + H DLKP+NIL ++KI DFGLAR + P T
Sbjct: 197 CEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARR-YK--PREKL-KVNFGTP 252
Query: 188 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246
+ APE + F + D+WS+G I +L+G F G N
Sbjct: 253 EFLAPEVVNYDF---VSFPTDMWSVGVIAYMLLSGLSPFLGDN---------------DA 294
Query: 247 ESISRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEEAL 305
E+++ I + + F + A + +LL + R +A EAL
Sbjct: 295 ETLNNILACR-------------WDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEAL 341
Query: 306 ADPYFHGLANVDREPSTQPISKLEFEFERRKLAK 339
P+ + S Q + + + K
Sbjct: 342 KHPWLSD-HKLHSRLSAQKKKNRGSDA-QDFVTK 373
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-40
Identities = 70/342 (20%), Positives = 119/342 (34%), Gaps = 72/342 (21%)
Query: 6 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILR 65
+ +Y +V+G G G V + T E+ A+K + D + R
Sbjct: 12 KNAIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARR 59
Query: 66 EIKLL-RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVI--KANDDLTPEH 121
E++L R + P IV I + K + +V E ++ +L I + + T
Sbjct: 60 EVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTERE 118
Query: 122 YQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAI 178
+ + ++Y+H+ N+ HRD+KP+N+L + LK+ DFG
Sbjct: 119 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------------ 166
Query: 179 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMT 238
A E G KY + D+WS+G I +L G P F + + M
Sbjct: 167 ------------AKETTG---EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM- 210
Query: 239 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKD 297
+RIR + F + L+ LL +P
Sbjct: 211 ----------KTRIRMGQ-------------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 247
Query: 298 RPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAK 339
R T E + P+ V + P E + + +
Sbjct: 248 RMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKE 289
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 78/368 (21%), Positives = 142/368 (38%), Gaps = 79/368 (21%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 75
RY + +G G + V + D + VA+K + EH ++ EI+LL+ +R+
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETAL--DEIRLLKSVRN 92
Query: 76 PDIVEIKHIMLPPSRREFKD-------IYVVFELMESDLHQVIKANDD--LTPEHYQFFL 126
D + M+ +FK I +VFE++ L + I ++ L + +
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 127 YQLLRGLKYIHT-ANVFHRDLKPKNILANAD----------------------------- 156
Q+L+GL Y+HT + H D+KP+NIL + +
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 157 ----------CKLKICDFGLARVSFNDAPSAIF----WTDYVATRWYRAPELCGSFFSKY 202
L+ + +V D +A + +T+ + TR YR+ E+ S Y
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVL--IGSGY 270
Query: 203 TPAIDIWSIGCIFAEMLTGKPLFPGKN------VVHQLDLMTDLLGTPSTESISRIRNEK 256
DIWS C+ E+ TG LF + + L+ +LLG + I +
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV--AGKY 328
Query: 257 ARRYL---GSMRKKQPVPFS---------HKFPNAD-PLALHLLERLLAFDPKDRPTAEE 303
++ + G ++ + +++ + L +L P+ R TA E
Sbjct: 329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAE 388
Query: 304 ALADPYFH 311
L P+ +
Sbjct: 389 CLRHPWLN 396
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-39
Identities = 70/305 (22%), Positives = 121/305 (39%), Gaps = 44/305 (14%)
Query: 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLL 73
A + IG+G+YG V V +G+ +A+K+I + ++L ++ ++R
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSS 78
Query: 74 RHPDIVEIKHIMLPPSRREFKDIYVVFELM----ESDLHQVIKANDDLTPEHY-QFFLYQ 128
P IV+ + D ++ ELM + V DD+ PE
Sbjct: 79 DCPYIVQFYGALFREG-----DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 129 LLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 187
++ L ++ + HRD+KP NIL + +K+CDFG +S S I T R
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG---ISGQLVDS-IAKTRDAGCR 189
Query: 188 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245
Y APE + Y D+WS+G E+ TG+ +P + + + D L
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP------KWNSVFDQL---- 239
Query: 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 305
+++ + + + FS F ++ + L D RP +E L
Sbjct: 240 ----TQVVKGDPPQ----LSNSEEREFSPSF-------INFVNLCLTKDESKRPKYKELL 284
Query: 306 ADPYF 310
P+
Sbjct: 285 KHPFI 289
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-38
Identities = 66/298 (22%), Positives = 111/298 (37%), Gaps = 54/298 (18%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRIL-----REIKLLRLLR 74
+ ++ IGKG +G+V VAIK + RE+ ++ L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVI-KANDDLTPEHYQFFLYQLLRG 132
HP+IV++ +M P +V E + DL+ + + + + G
Sbjct: 82 HPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 133 LKYIHTAN--VFHRDLKPKNIL-----ANADCKLKICDFGLARVSFNDAPSAIFWTDYVA 185
++Y+ N + HRDL+ NI NA K+ DFGL++ S + + +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV------SGLLG 188
Query: 186 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245
+ APE G+ YT D +S I +LTG+ F +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK------------- 235
Query: 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 303
+ I+ IR E R +P + P +++E + DPK RP
Sbjct: 236 IKFINMIREEGLR---------PTIP-----EDCPPRLRNVIELCWSGDPKKRPHFSY 279
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-38
Identities = 62/302 (20%), Positives = 111/302 (36%), Gaps = 43/302 (14%)
Query: 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLL 73
E + + +G G+ G V TG +A+K++ + + RIL ++ +L+
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLKSH 81
Query: 74 RHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRG 132
P IV+ + + D+++ ELM + ++ K PE +++
Sbjct: 82 DCPYIVQCFGTFITNT-----DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 133 LKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 191
L Y+ V HRD+KP NIL + ++K+CDFG +S Y A
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG---ISGRLVDD-KAKDRSAGCAAYMA 192
Query: 192 PE---LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248
PE Y D+WS+G E+ TG+ + E
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK--------------TDFEV 238
Query: 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308
++++ E+ + FS F ++ L D + RP + L
Sbjct: 239 LTKVLQEEPP------LLPGHMGFSGDF-------QSFVKDCLTKDHRKRPKYNKLLEHS 285
Query: 309 YF 310
+
Sbjct: 286 FI 287
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-38
Identities = 79/306 (25%), Positives = 129/306 (42%), Gaps = 39/306 (12%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 75
Y++QEVIG G+ VV +A E+VAIK+I ++ + + +L+EI+ + H
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHH 72
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTP-----EHYQFFL 126
P+IV + ++++V +L+ D+ + I A + L
Sbjct: 73 PNIVSYYTSFVVKD-----ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 127 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR--VSFNDAPSAIFWTDYV 184
++L GL+Y+H HRD+K NIL D ++I DFG++ + D +V
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 185 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244
T + APE+ Y DIWS G E+ TG + H+ M L+ T
Sbjct: 188 GTPCWMAPEVMEQ-VRGYDFKADIWSFGITAIELATGAAPY------HKYPPMKVLMLTL 240
Query: 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 304
+N+ G K+ + F ++ L DP+ RPTA E
Sbjct: 241 --------QNDPPSLETGVQDKEMLKKYGKSFRK-------MISLCLQKDPEKRPTAAEL 285
Query: 305 LADPYF 310
L +F
Sbjct: 286 LRHKFF 291
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 85/354 (24%), Positives = 140/354 (39%), Gaps = 68/354 (19%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLR 74
+ IG GS+G V A D E VAIKK++ + I++E++ L+ LR
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGL 133
HP+ ++ + L ++V E +++ + E + L+GL
Sbjct: 113 HPNTIQYRGCYLREH-----TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGLA-----RVSFNDAPSAIFWTDYVATRW 188
Y+H+ N+ HRD+K NIL + +K+ DFG A SF P +W
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTP---YWM------- 217
Query: 189 YRAPEL-CGSFFSKYTPAIDIWSIGCIFA-EMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246
APE+ +Y +D+WS+G I E+ KP N + L + +P
Sbjct: 218 --APEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQ-NESP-- 271
Query: 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306
+++ +S F N ++ L P+DRPT+E L
Sbjct: 272 ----ALQSGH---------------WSEYFRN-------FVDSCLQKIPQDRPTSEVLLK 305
Query: 307 DPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQE 360
+ V RE I L +R K A ++ + YR++ + QE
Sbjct: 306 HRF------VLRERPPTVIMDL---IQRTKDAVRELDNLQYRKM---KKILFQE 347
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 71/313 (22%), Positives = 124/313 (39%), Gaps = 32/313 (10%)
Query: 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 74
+ ++ +G G+ GVV +G +A K I + + +I+RE+++L
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHECN 89
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGL 133
P IV +I + E M+ L QV+K + + +++GL
Sbjct: 90 SPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 144
Query: 134 KYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFND-APSAIFWTDYVATRWYRA 191
Y+ + HRD+KP NIL N+ ++K+CDFG++ + A S +V TR Y +
Sbjct: 145 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS------FVGTRSYMS 198
Query: 192 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLMTDLLGTPSTESI 249
PE L G + Y+ DIWS+G EM G+ P+ P +L + G +
Sbjct: 199 PERLQG---THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255
Query: 250 SRIRNEKARRYLGSMRKKQPVPFS--HKFPNADPLAL----------HLLERLLAFDPKD 297
+ G + F N P L + + L +P +
Sbjct: 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 315
Query: 298 RPTAEEALADPYF 310
R ++ + +
Sbjct: 316 RADLKQLMVHAFI 328
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 64/297 (21%), Positives = 108/297 (36%), Gaps = 58/297 (19%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
+ + IG GS+G V + G+ VA+K +N E+ +LR RH
Sbjct: 27 TVGQRIGSGSFGTV------YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLK 134
+I+ P + +V + E S L+ + A++ + Q RG+
Sbjct: 81 NILLFMGYSTAP------QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMD 134
Query: 135 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE- 193
Y+H ++ HRDLK NI + D +KI DFGLA + S F + + APE
Sbjct: 135 YLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF-EQLSGSILWMAPEV 193
Query: 194 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN-------VVHQLDLMTDLLGTPST 246
+ + Y+ D+++ G + E++TG+ + N +V + L DL
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR-- 251
Query: 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 303
N L+ L +RP+
Sbjct: 252 ------------------------------SNCPKRMKRLMAECLKKKRDERPSFPR 278
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 67/304 (22%), Positives = 122/304 (40%), Gaps = 46/304 (15%)
Query: 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLL 73
+A + +G+G+YGVV +G+ +A+K+I + + R+L ++ +R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTV 63
Query: 74 RHPDIVEIKHIMLPPSRREFKDIYVVFELM----ESDLHQVIKANDDLTPEHYQFFLYQL 129
P V + D+++ ELM + QVI + + +
Sbjct: 64 DCPFTVTFYGALFREG-----DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 130 LRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 188
++ L+++H+ +V HRD+KP N+L NA ++K+CDFG +S + +
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG---ISGYLVDD-VAKDIDAGCKP 174
Query: 189 YRAPE--LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246
Y APE Y+ DIWS+G E+ + FP + + ++ PS
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPS- 231
Query: 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306
P + KF + + L + K+RPT E +
Sbjct: 232 ----------------------PQLPADKFS---AEFVDFTSQCLKKNSKERPTYPELMQ 266
Query: 307 DPYF 310
P+F
Sbjct: 267 HPFF 270
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-37
Identities = 80/305 (26%), Positives = 129/305 (42%), Gaps = 62/305 (20%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
+Y E IG+G+ G V +A+D TG+ VAI+++N + I+ EI ++R ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNP 77
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
+IV S +++VV E + L V+ + + L+ L++
Sbjct: 78 NIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEF 131
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFNDAPSAIFWTDYVAT 186
+H+ V HRD+K NIL D +K+ DFG R + V T
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM------------VGT 179
Query: 187 RWYRAPELCGSFFSKYTPAIDIWSIGCIFA-EMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245
++ APE+ Y P +DIWS+G I A EM+ G+P + +N + L L+ GTP
Sbjct: 180 PYWMAPEVVTR--KAYGPKVDIWSLG-IMAIEMIEGEPPYLNENPLRALYLIAT-NGTP- 234
Query: 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 305
+ P S F + L R L D + R +A+E L
Sbjct: 235 -------------------ELQNPEKLSAIFRD-------FLNRCLEMDVEKRGSAKELL 268
Query: 306 ADPYF 310
+
Sbjct: 269 QHQFL 273
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 5e-37
Identities = 38/275 (13%), Positives = 81/275 (29%), Gaps = 51/275 (18%)
Query: 18 RYQIQEVIGKGSYGVV-----GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 72
+ ++G+G++ V G D ++ +K + + + ++ L+
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--ANPWEFYIGTQLMERLKP 123
Query: 73 LRHPDIVEIKHIMLPPSRREFKD-IYVVFELME-SDLHQVIK-----ANDDLTPEHYQFF 125
++ F++ +V EL L I + F
Sbjct: 124 SMQHMFMKFYSAH------LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 126 LYQLLRGLKYIHTANVFHRDLKPKNIL-----------ANADCKLKICDFGLARVSFNDA 174
++L ++ +H + H D+KP N + + L + D G +
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237
Query: 175 PSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH- 232
IF T ++ E L + ID + + ML G +
Sbjct: 238 KGTIFTAK-CETSGFQCVEMLSN---KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293
Query: 233 ----------QLDLMTD----LLGTPSTESISRIR 253
LD+ + +L P + +
Sbjct: 294 KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLD 328
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-37
Identities = 53/222 (23%), Positives = 96/222 (43%), Gaps = 22/222 (9%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79
+I E+IGKG +G V GE VAI+ I+ ++ RE+ R RH ++V
Sbjct: 36 EIGELIGKGRFGQVYHG--RWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 80 E-IKHIMLPPSRREFKDIYVVFELME-SDLHQVI-KANDDLTPEHYQFFLYQLLRGLKYI 136
+ M PP + ++ L + L+ V+ A L + ++++G+ Y+
Sbjct: 93 LFMGACMSPP------HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR--APEL 194
H + H+DLK KN+ + + K+ I DFGL +S + W APE+
Sbjct: 147 HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 195 -------CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 229
++ D++++G I+ E+ + F +
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-37
Identities = 82/353 (23%), Positives = 143/353 (40%), Gaps = 70/353 (19%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLR-LLR 74
A +++ E++G G+YG V TG+ AIK ++ + + I +EI +L+
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE---IKQEINMLKKYSH 79
Query: 75 HPDIVEIKHIMLPPSRREFKD-IYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQL 129
H +I + + D +++V E +DL + K N L E + ++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREI 138
Query: 130 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFNDAPSAIFW 180
LRGL ++H V HRD+K +N+L + ++K+ DFG++ R +F
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--------- 189
Query: 181 TDYVATRWYRAPE--LCGSFF-SKYTPAIDIWSIGCIFA-EMLTGKPLFPGKNVVHQLDL 236
+ T ++ APE C + Y D+WS+G I A EM G P +
Sbjct: 190 ---IGTPYWMAPEVIACDENPDATYDFKSDLWSLG-ITAIEMAEGAPPL------CDMHP 239
Query: 237 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPK 296
M L P R++++K +S KF + +E L +
Sbjct: 240 MRALFLIP-RNPAPRLKSKK---------------WSKKFQS-------FIESCLVKNHS 276
Query: 297 DRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYRE 349
RP E+ + P+ D+ Q +L+ +R K + + E Y
Sbjct: 277 QRPATEQLMKHPFIR-----DQPNERQVRIQLKDHIDRTKKKRGEKDETEYEY 324
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-37
Identities = 75/305 (24%), Positives = 126/305 (41%), Gaps = 62/305 (20%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
IG+GS G+V A + H+G +VA+K ++ + E+ ++R +H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHF 102
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
++VE+ S ++++V+ E ++ L ++ L E +L+ L Y
Sbjct: 103 NVVEMYK-----SYLVGEELWVLMEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAY 156
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFNDAPSAIFWTDYVAT 186
+H V HRD+K +IL D ++K+ DFG R S V T
Sbjct: 157 LHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL------------VGT 204
Query: 187 RWYRAPELCGSFFSKYTPAIDIWSIGCIFA-EMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245
++ APE+ S Y +DIWS+G I EM+ G+P + + V + + D P
Sbjct: 205 PYWMAPEVISR--SLYATEVDIWSLG-IMVIEMVDGEPPYFSDSPVQAMKRLRD-SPPP- 259
Query: 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 305
+ K S + LER+L DP++R TA+E L
Sbjct: 260 -------------------KLKNSHKVSPVLRD-------FLERMLVRDPQERATAQELL 293
Query: 306 ADPYF 310
P+
Sbjct: 294 DHPFL 298
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 66/287 (22%), Positives = 117/287 (40%), Gaps = 47/287 (16%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79
I+E IG GS+G V A G VA+K + + H LRE+ +++ LRHP+IV
Sbjct: 40 NIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 80 EIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD---LTPEHYQFFLYQLLRGLKY 135
+ P + +V E + L++++ + L Y + +G+ Y
Sbjct: 98 LFMGAVTQPPN-----LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 136 IHTAN--VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 193
+H N + HR+LK N+L + +K+CDFGL+R+ + S+ T + APE
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS---KSAAGTPEWMAPE 209
Query: 194 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253
+ D++S G I E+ T + + N + ++ +
Sbjct: 210 VLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLN---------------PAQVVAAVG 252
Query: 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 300
+ R +P N +P ++E +P RP+
Sbjct: 253 FKCKR---------LEIP-----RNLNPQVAAIIEGCWTNEPWKRPS 285
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 60/296 (20%), Positives = 105/296 (35%), Gaps = 48/296 (16%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79
EV+GKG +G TGE + +K++ E L+E+K++R L HP+++
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT--FLKEVKVMRCLEHPNVL 70
Query: 80 E-IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYI 136
+ I + + + E ++ L +IK+ D F + G+ Y+
Sbjct: 71 KFIGVLYKDK------RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
H+ N+ HRDL N L + + + DFGLAR+ ++ + + G
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 197 SF---------FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247
+ Y +D++S G + E++ P P T
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD--------------YLPRTM 230
Query: 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 303
R P PN P + R DP+ RP+ +
Sbjct: 231 DFGLNVRGFLDR---------YCP-----PNCPPSFFPITVRCCDLDPEKRPSFVK 272
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-36
Identities = 75/292 (25%), Positives = 119/292 (40%), Gaps = 57/292 (19%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79
+++EV+G+G++GVV A + VAIK+I S+ + E++ L + HP+IV
Sbjct: 11 EVEEVVGRGAFGVVCKA--KWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIV 64
Query: 80 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEHYQFFLYQLLRGLKY 135
++ L P + +V E E L+ V+ + T H + Q +G+ Y
Sbjct: 65 KLYGACLNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 136 IHTAN---VFHRDLKPKNILANADCK-LKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 191
+H+ + HRDLKP N+L A LKICDFG A T+ + + A
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM------TNNKGSAAWMA 171
Query: 192 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251
PE+ S Y+ D++S G I E++T + F I
Sbjct: 172 PEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--------------RIMW 215
Query: 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 303
+ R P+ N L+ R + DP RP+ EE
Sbjct: 216 AVHNGTRP---------PLI-----KNLPKPIESLMTRCWSKDPSQRPSMEE 253
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 77/341 (22%), Positives = 134/341 (39%), Gaps = 73/341 (21%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 75
++I +G G++G V A + TG A K I + + + EI++L H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATCDH 75
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLR 131
P IV++ ++++ E + +++ + LT Q Q+L
Sbjct: 76 PYIVKLLGAYYHDG-----KLWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVVCRQMLE 128
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFNDAPSAIFWTD 182
L ++H+ + HRDLK N+L + +++ DFG++ R SF P +W
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP---YWM- 184
Query: 183 YVATRWYRAPELCGSFFSK---YTPAIDIWSIGCIFA-EMLTGKPLFPGKNVVHQLDLMT 238
APE+ K Y DIWS+G I EM +P P H+L+ M
Sbjct: 185 --------APEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEP--P----HHELNPMR 229
Query: 239 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR 298
LL +++ L P +S +F L+ L +P+ R
Sbjct: 230 VLLKIA--------KSDPPT--L-----LTPSKWSVEF-------RDFLKIALDKNPETR 267
Query: 299 PTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAK 339
P+A + L P+ V S + + +L E + + +
Sbjct: 268 PSAAQLLEHPF------VSSITSNKALRELVAEAKAEVMEE 302
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-35
Identities = 75/300 (25%), Positives = 109/300 (36%), Gaps = 34/300 (11%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79
Q+ + IGKG YG V GE+VA+K E S EI L+RH +I+
Sbjct: 40 QMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFTT-EEASWFRE--TEIYQTVLMRHENIL 94
Query: 80 E-IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
I + +Y++ + E+ L+ +K+ L + Y + GL ++H
Sbjct: 95 GFIAADIKGTGSW--TQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHLH 151
Query: 138 TANVF--------HRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY--VATR 187
T HRDLK KNIL + I D GLA F + + V T+
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK-FISDTNEVDIPPNTRVGTK 210
Query: 188 WYRAPE-LCGSFFSKYTPA---IDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 243
Y PE L S + + D++S G I E+ G +QL +
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG-GIVEEYQLPYHDLVPSD 269
Query: 244 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 303
PS E + I K R P L+ A +P R TA
Sbjct: 270 PSYEDMREIVCIKKLR--------PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-35
Identities = 79/312 (25%), Positives = 120/312 (38%), Gaps = 75/312 (24%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 75
+ E IGKGS+G V +D T + VAIK I D+ E + I +EI +L
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDS 79
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLR 131
P + + L + ++++ E + DL + L L ++L+
Sbjct: 80 PYVTKYYGSYLKDT-----KLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILK 130
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFNDAPSAIFWTD 182
GL Y+H+ HRD+K N+L + ++K+ DFG+A R +F P FW
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTP---FWM- 186
Query: 183 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-EMLTGKPLFPGKNVVHQLDLMTDLL 241
APE+ S Y DIWS+G I A E+ G+P +L M L
Sbjct: 187 --------APEVIKQ--SAYDSKADIWSLG-ITAIELARGEPPH------SELHPMKVLF 229
Query: 242 GTPSTESISRIRNEKARRYLGSMRKKQPV---PFSHKFPNADPLALHLLERLLAFDPKDR 298
P + P +S +E L +P R
Sbjct: 230 LIP--------------------KNNPPTLEGNYSKPLKE-------FVEACLNKEPSFR 262
Query: 299 PTAEEALADPYF 310
PTA+E L +
Sbjct: 263 PTAKELLKHKFI 274
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-34
Identities = 73/299 (24%), Positives = 119/299 (39%), Gaps = 60/299 (20%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATR-ILREIKLLRLLRHPD 77
++E+IG G +G V A G+ VA+K D E +S + +E KL +L+HP+
Sbjct: 10 TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 78 IVEIKHI-MLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
I+ ++ + + P ++ +V E L++V+ + P+ + Q+ RG+ Y
Sbjct: 68 IIALRGVCLKEP------NLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNY 120
Query: 136 IHTAN---VFHRDLKPKNIL--------ANADCKLKICDFGLARVSFNDAPSAIFWTDYV 184
+H + HRDLK NIL ++ LKI DFGLAR +
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGA--- 177
Query: 185 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244
W APE+ + S ++ D+WS G + E+LTG+ F G +
Sbjct: 178 -YAW-MAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGID--------------- 218
Query: 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 303
+ K P+P L+E DP RP+
Sbjct: 219 GLAVAYGVAMNKLA---------LPIP-----STCPEPFAKLMEDCWNPDPHSRPSFTN 263
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-34
Identities = 80/333 (24%), Positives = 140/333 (42%), Gaps = 58/333 (17%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+ + E +G+GSYG V A+ TG+ VAIK++ V + + I++EI +++ P
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQE---IIKEISIMQQCDSPH 85
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRGL 133
+V+ + D+++V E SD+ ++ N LT + L L+GL
Sbjct: 86 VVKYYGSYFKNT-----DLWIVMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGL 138
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGL-ARVSFNDAPSAIFWTDYVATRWYRAP 192
+Y+H HRD+K NIL N + K+ DFG+ +++ A + T ++ AP
Sbjct: 139 EYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV----IGTPFWMAP 194
Query: 193 ELCGSFFSKYTPAIDIWSIGCIFA-EMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251
E+ Y DIWS+G I A EM GKP + + + + ++ P
Sbjct: 195 EVIQE--IGYNCVADIWSLG-ITAIEMAEGKPPYADIHPMRAIFMIPT-NPPP------- 243
Query: 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311
++P +S F +++ L P+ R TA + L P+
Sbjct: 244 -------------TFRKPELWSDNF-------TDFVKQCLVKSPEQRATATQLLQHPF-- 281
Query: 312 GLANVDREPSTQPISKLEFEFERRKLAKDDVRE 344
V + L E KL + + ++
Sbjct: 282 ----VRSAKGVSILRDLINEAMDVKLKRQESQQ 310
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-34
Identities = 43/288 (14%), Positives = 90/288 (31%), Gaps = 50/288 (17%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79
+ + G + G + +K + + E LR+ HP+++
Sbjct: 13 NFLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 80 EIKHIML-PPSRREFKDIYVVFELMES-DLHQVI--KANDDLTPEHYQFFLYQLLRGLKY 135
+ PP+ ++ M L+ V+ N + F + RG+ +
Sbjct: 71 PVLGACQSPPAPH----PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 136 IHTAN--VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 193
+HT + L ++++ + D +I + + + + APE
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS--------PGRMYAPAWVAPE 178
Query: 194 -LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252
L + D+WS + E++T + F + + E ++
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS---------------NMEIGMKV 223
Query: 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 300
E R +P P P L++ + DP RP
Sbjct: 224 ALEGLR---------PTIP-----PGISPHVSKLMKICMNEDPAKRPK 257
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 75/314 (23%), Positives = 125/314 (39%), Gaps = 69/314 (21%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIK--------KINDVFEHVSDATRILREIKLL 70
++ +++G+GS+ V A + T AIK K N V +V RE ++
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKV-PYV------TRERDVM 84
Query: 71 RLLRHPDIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFL 126
L HP V++ F+D +Y ++ +L + I+ +F+
Sbjct: 85 SRLDHPFFVKLYF--------TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT 136
Query: 127 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 186
+++ L+Y+H + HRDLKP+NIL N D ++I DFG A+V ++ A + +V T
Sbjct: 137 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGT 195
Query: 187 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246
Y +PEL + D+W++GCI +++ G P F N
Sbjct: 196 AQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEY--------------- 238
Query: 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDRPT----- 300
+I + FP P A L+E+LL D R
Sbjct: 239 LIFQKIIKLEYD-----------------FPEKFFPKARDLVEKLLVLDATKRLGCEEME 281
Query: 301 -AEEALADPYFHGL 313
A P+F +
Sbjct: 282 GYGPLKAHPFFESV 295
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 72/303 (23%), Positives = 111/303 (36%), Gaps = 40/303 (13%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79
+QE IGKG +G V GE VA+K + R EI +LRH +I+
Sbjct: 45 VLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS--REERSWFR-EAEIYQTVMLRHENIL 99
Query: 80 -----EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGL 133
+ K +++V + E L + +T E GL
Sbjct: 100 GFIAADNKDNGTWT------QLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGL 152
Query: 134 KYIHTANVF--------HRDLKPKNILANADCKLKICDFGLARV-SFNDAPSAIFWTDYV 184
++H V HRDLK KNIL + I D GLA I V
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 185 ATRWYRAPE-LCGSFFSKYTPA---IDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL 240
T+ Y APE L S K+ + DI+++G +F E+ + G + +QL +
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLV 271
Query: 241 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 300
PS E + ++ E+ R +P + A + ++ + R T
Sbjct: 272 PSDPSVEEMRKVVCEQKLR--------PNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323
Query: 301 AEE 303
A
Sbjct: 324 ALR 326
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-33
Identities = 62/305 (20%), Positives = 107/305 (35%), Gaps = 40/305 (13%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79
+ E +GKG YG V + GE VA+K + R E+ +LRH +I+
Sbjct: 11 TLLECVGKGRYGEVWRG--SWQGENVAVKIFSS--RDEKSWFR-ETELYNTVMLRHENIL 65
Query: 80 -----EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGL 133
++ ++++ E L+ ++ L + + GL
Sbjct: 66 GFIASDMTSRHSST------QLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGL 118
Query: 134 KYIHTA--------NVFHRDLKPKNILANADCKLKICDFGLARV-SFNDAPSAIFWTDYV 184
++H + HRDLK KNIL + + I D GLA + S + + V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 185 ATRWYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL 240
T+ Y APE L + +DIW+ G + E+ G ++ +
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN-GIVEDYKPPFYDVV 237
Query: 241 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 300
PS E + ++ +R +P L++ +P R T
Sbjct: 238 PNDPSFEDMRKVVCVDQQR--------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289
Query: 301 AEEAL 305
A
Sbjct: 290 ALRIK 294
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 78/305 (25%), Positives = 127/305 (41%), Gaps = 58/305 (19%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDAT---RILREIKLLRL 72
RY+I + +G G V A DT +VAIK I R RE+
Sbjct: 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFI--PPREKEETLKRFEREVHNSSQ 67
Query: 73 LRHPDIVEIKHIMLPPSRREFKDI-------YVVFELME-SDLHQVIKANDDLTPEHYQF 124
L H +IV + D+ Y+V E +E L + I+++ L+ +
Sbjct: 68 LSHQNIVSMI------------DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAIN 115
Query: 125 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 184
F Q+L G+K+ H + HRD+KP+NIL +++ LKI DFG+A+ + +++ T++V
Sbjct: 116 FTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL---SETSLTQTNHV 172
Query: 185 -ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 243
T Y +PE DI+SIG + EML G+P F G+ V
Sbjct: 173 LGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAV------------ 218
Query: 244 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-TAE 302
SI+ + ++ P + + +++ R D +R T +
Sbjct: 219 ----SIA----------IKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQ 264
Query: 303 EALAD 307
E D
Sbjct: 265 EMKDD 269
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 76/306 (24%), Positives = 129/306 (42%), Gaps = 55/306 (17%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDAT---RILREIKLLRL 72
+ RY++ E++G G V A D VA+K + + D + R RE +
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA--DLARDPSFYLRFRREAQNAAA 68
Query: 73 LRHPDIVEI--------KHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQ 123
L HP IV + LP Y+V E ++ L ++ +TP+
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLP---------YIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 124 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY 183
+ + L + H + HRD+KP NI+ +A +K+ DFG+AR + D+ +++ T
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVTQTAA 178
Query: 184 V-ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 242
V T Y +PE D++S+GC+ E+LTG+P F G
Sbjct: 179 VIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGD-------------- 222
Query: 243 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-TA 301
+P + + +R + P+P S + ++ + LA +P++R TA
Sbjct: 223 SPVSVAYQHVRED-------------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTA 269
Query: 302 EEALAD 307
E AD
Sbjct: 270 AEMRAD 275
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 79/318 (24%), Positives = 128/318 (40%), Gaps = 51/318 (16%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDAT---RILREIKLLRLLR 74
Y+++ ++G+G G V A DT VA+K +++ SD R+ RE + L+
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSE--TLSSDPVFRTRMQREARTAGRLQ 92
Query: 75 HPDIVEIKHIMLPPSRREFKDI-YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRG 132
P +V I H E YV L+ DL +++ L P + Q+
Sbjct: 93 EPHVVPI-H-----DFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSA 146
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT---DYVATRWY 189
L H A HRD+KP+NIL +AD + DFG+A A + T + V T +Y
Sbjct: 147 LDAAHAAGATHRDVKPENILVSADDFAYLVDFGIAS-----ATTDEKLTQLGNTVGTLYY 201
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
APE S T DI+++ C+ E LTG P + G + S+
Sbjct: 202 MAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQL-----------------SV 242
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309
++ + S P ++ R +A +P+DR L+
Sbjct: 243 -------MGAHI----NQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAA 291
Query: 310 FHGLANVDREPSTQPISK 327
LA D++ +T + +
Sbjct: 292 HAALATADQDRATDILRR 309
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 1e-31
Identities = 69/313 (22%), Positives = 117/313 (37%), Gaps = 61/313 (19%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGER-VAIKKINDVFEHVSDATRILREIKLLRLLR 74
A +Y+++ I G G + A+D + R V +K + + + E + L +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA-EAQAMAMAERQFLAEVV 137
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGL 133
HP IV+I + + R Y+V E + L + L +L ++L L
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPAL 195
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 193
Y+H+ + + DLKP+NI+ + +LK+ D G ++ + T ++APE
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI--NSFGYL-----YGTPGFQAPE 247
Query: 194 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253
+ + T A DI+++G A + P G+ V
Sbjct: 248 IVR---TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------------- 283
Query: 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALH-LLERLLAFDPKDRP-TAEEALADPYFH 311
+ + PV + LL R + DP+ R TAEE A
Sbjct: 284 ----------LPEDDPVL-------KTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQ---- 322
Query: 312 GLANVDREPSTQP 324
L V RE Q
Sbjct: 323 -LTGVLREVVAQD 334
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 71/300 (23%), Positives = 116/300 (38%), Gaps = 34/300 (11%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79
Q+ EV +G +G V A E VA+K + + E+ L ++H +I+
Sbjct: 27 QLLEVKARGRFGCVWKA--QLLNEYVAVKIF---PIQDKQSWQNEYEVYSLPGMKHENIL 81
Query: 80 E-IKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
+ I S D++++ E L +KAN ++ + RGL Y+H
Sbjct: 82 QFIGAEKRGTSVD--VDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGLAYLH 138
Query: 138 TA----------NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 187
+ HRD+K KN+L + I DFGLA F SA V TR
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK-FEAGKSAGDTHGQVGTR 197
Query: 188 WYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244
Y APE+ +F ID++++G + E+ + G + L ++ P
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257
Query: 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLAL-HLLERLLAFDPKDRPTAEE 303
S E + + K +R PV + +A L +E D + R +A
Sbjct: 258 SLEDMQEVVVHKKKR---------PVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 68/302 (22%), Positives = 125/302 (41%), Gaps = 49/302 (16%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDI 78
+I IGKGS+G V T + A+K +N ++ + +E+++++ L HP +
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 79 VEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 134
V + + F+D +++V +L+ DL ++ N E + F+ +L+ L
Sbjct: 78 VNLWY--------SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALD 129
Query: 135 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE- 193
Y+ + HRD+KP NIL + + I DF +A + + T+ Y APE
Sbjct: 130 YLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM----AGTKPYMAPEM 185
Query: 194 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253
+ Y+ A+D WS+G E+L G+ + ++ T S E +
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS------------STSSKEIVHTFE 233
Query: 254 NEKARRYLGSMRKKQPVPFSHKFPNA-DPLALHLLERLLAFDPKDR-PTAEEALADPYFH 311
+P+A + LL++LL +P R + PY +
Sbjct: 234 TTVVT-----------------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276
Query: 312 GL 313
+
Sbjct: 277 DI 278
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 65/303 (21%), Positives = 118/303 (38%), Gaps = 52/303 (17%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 82
V+G+G +G V + TG+ A KK+N + + E K+L + IV +
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 83 HIMLPPSRREFKDIYVVFELMES-DL----HQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
+ + + +V +M D+ + V + N F+ Q++ GL+++H
Sbjct: 252 YAFETKTD-----LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGLAR--VSFNDAPSAIFWTDYVATRWYRAPELC 195
N+ +RDLKP+N+L + D ++I D GLA + Y T + APEL
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-----YAGTPGFMAPELL 361
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
+Y ++D +++G EM+ + F + + + R+ +
Sbjct: 362 LG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ-----------RVLEQ 408
Query: 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYF 310
V + KF P + E LL DP+ R + + P F
Sbjct: 409 -------------AVTYPDKFS---PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452
Query: 311 HGL 313
+
Sbjct: 453 RDI 455
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 66/306 (21%), Positives = 113/306 (36%), Gaps = 55/306 (17%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 82
VIG+G++ V TG+ A+K +N + + E +L I ++
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 83 HIMLPPSRREFKD---IYVVFELMES-DL-HQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
F+D +Y+V E DL + K + + E +F+L +++ + +H
Sbjct: 128 F--------AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGLAR--VSFNDAPSAIFWTDYVATRWYRAPEL- 194
HRD+KP NIL + +++ DFG + S + V T Y +PE+
Sbjct: 180 RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA----VGTPDYLSPEIL 235
Query: 195 ----CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250
G Y P D W++G EM G+ F + E+
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---------------ETYG 280
Query: 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR---PTAEEALAD 307
+I + K+ + A ++RLL P+ R A +
Sbjct: 281 KI-----------VHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328
Query: 308 PYFHGL 313
P+F GL
Sbjct: 329 PFFFGL 334
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-29
Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 32/228 (14%)
Query: 6 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDAT 61
T+F E + + +GKG++G V +TGE VA+KK+
Sbjct: 4 PTQF-----EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLR 56
Query: 62 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTP 119
REI++L+ L+H +IV+ K + RR ++ ++ E + L ++ + + +
Sbjct: 57 DFEREIEILKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDH 113
Query: 120 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179
+ Q+ +G++Y+ T HRDL +NIL + ++KI DFGL +V D
Sbjct: 114 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF--- 170
Query: 180 WTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 220
+ WY APE SK++ A D+WS G + E+ T
Sbjct: 171 ---FKVKEPGESPIFWY-APE--SLTESKFSVASDVWSFGVVLYELFT 212
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 69/307 (22%), Positives = 123/307 (40%), Gaps = 49/307 (15%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPD 77
++I +VIG+G++G V + + A+K +N ++ E +L
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 78 IVEIKHIMLPPSRREFKD---IYVVFELMES-DL-HQVIKANDDLTPEHYQFFLYQLLRG 132
I + + F+D +Y+V + DL + K D L E +F+L +++
Sbjct: 136 ITTLHY--------AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA 187
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 192
+ +H + HRD+KP NIL + + +++ DFG D + V T Y +P
Sbjct: 188 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSV-AVGTPDYISP 245
Query: 193 EL---CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
E+ +Y P D WS+G EML G+ F +++V E+
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---------------ETY 290
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR---PTAEEALA 306
+I M K+ F + + A L+ RL+ + R E+
Sbjct: 291 GKI-----------MNHKERFQFPTQVTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKK 338
Query: 307 DPYFHGL 313
P+F G+
Sbjct: 339 HPFFSGI 345
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-28
Identities = 69/299 (23%), Positives = 114/299 (38%), Gaps = 47/299 (15%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 82
V+GKG +G V + TG+ A KK+ + L E ++L + +V +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 83 HIMLPPSRREFKDIYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 139
+ + +V LM DL H F+ ++ GL+ +H
Sbjct: 251 YAYETKDA-----LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 140 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFF 199
+ +RDLKP+NIL + ++I D GLA V T Y APE+ +
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKN-- 359
Query: 200 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259
+YT + D W++GC+ EM+ G+ F + + + + ++
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-----------LVKEV---- 404
Query: 260 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYFHGL 313
P +S +F A L +LL DP +R +A E P F L
Sbjct: 405 ---------PEEYSERFSPQ---ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 32/228 (14%)
Query: 6 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDAT 61
T+F E + + +GKG++G V +TGE VA+KK+
Sbjct: 35 PTQF-----EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLR 87
Query: 62 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTP 119
REI++L+ L+H +IV+ K + RR ++ ++ E + L ++ + + +
Sbjct: 88 DFEREIEILKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDH 144
Query: 120 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179
+ Q+ +G++Y+ T HRDL +NIL + ++KI DFGL +V D
Sbjct: 145 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK----- 199
Query: 180 WTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 220
Y WY APE SK++ A D+WS G + E+ T
Sbjct: 200 -EYYKVKEPGESPIFWY-APE--SLTESKFSVASDVWSFGVVLYELFT 243
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-28
Identities = 71/303 (23%), Positives = 112/303 (36%), Gaps = 55/303 (18%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKI-------NDVFEHVSDATRILREIKLLRLLRHP 76
+IG+G +G V TG+ A+K + + +L + P
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD---CP 252
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
IV + + P + + + +LM DLH + + + +F+ +++ GL++
Sbjct: 253 FIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 195
+H V +RDLKP NIL + ++I D GLA P A V T Y APE+
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYMAPEVL 362
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
Y + D +S+GC+ ++L G F R
Sbjct: 363 QK-GVAYDSSADWFSLGCMLFKLLRGHSPF-------------------------RQHKT 396
Query: 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYF 310
K + + M V F P LLE LL D R A+E P+F
Sbjct: 397 KDKHEIDRMTLTMAVELPDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
Query: 311 HGL 313
L
Sbjct: 454 RSL 456
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 6e-28
Identities = 70/312 (22%), Positives = 123/312 (39%), Gaps = 49/312 (15%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79
++ E+IG+G YG V + VA+K + + + + I + L+ H +I
Sbjct: 16 KLLELIGRGRYGAVYKG--SLDERPVAVKVFSF--ANRQNFIN-EKNIYRVPLMEHDNIA 70
Query: 80 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 138
+ + +V E + L + + + + + RGL Y+HT
Sbjct: 71 RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH-SVTRGLAYLHT 129
Query: 139 ANVF---------HRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY-----V 184
HRDL +N+L D I DFGL+ + D V
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 185 ATRWYRAPE-LCGSF----FSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVV-HQLDLM 237
T Y APE L G+ +D++++G I+ E+ LFPG++V +Q+
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249
Query: 238 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNA---DPLALHLLERLL--- 291
T++ P+ E + + + + +R P KFP A + LA+ L+ +
Sbjct: 250 TEVGNHPTFEDMQVLVSREKQR---------P-----KFPEAWKENSLAVRSLKETIEDC 295
Query: 292 -AFDPKDRPTAE 302
D + R TA+
Sbjct: 296 WDQDAEARLTAQ 307
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-28
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 30/216 (13%)
Query: 20 QIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLL 73
+ +G+G +G V +TGE+VA+K + + +EI++LR L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK---PESGGNHIADLKKEIEILRNL 80
Query: 74 RHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLR 131
H +IV+ K I + I ++ E + S L + + N + + + + Q+ +
Sbjct: 81 YHENIVKYKGIC---TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK 137
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT----- 186
G+ Y+ + HRDL +N+L ++ ++KI DFGL + D Y
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY------YTVKDDRDS 191
Query: 187 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 220
WY APE SK+ A D+WS G E+LT
Sbjct: 192 PVFWY-APE--CLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 69/287 (24%), Positives = 114/287 (39%), Gaps = 46/287 (16%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPD 77
Y++ +VIG+G++G V T + A+K ++ SD+ E ++ P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 78 IVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGL 133
+V++ + F+D +Y+V E M DL ++ N D+ + +F+ +++ L
Sbjct: 131 VVQLFY--------AFQDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLAL 181
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 193
IH+ HRD+KP N+L + LK+ DFG N T V T Y +PE
Sbjct: 182 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM-KMNKEGMVRCDT-AVGTPDYISPE 239
Query: 194 --LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251
Y D WS+G EML G F ++V + S+
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---------------GTYSK 284
Query: 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR 298
I M K + F + A +L+ L D + R
Sbjct: 285 I-----------MNHKNSLTF-PDDNDISKEAKNLICAFLT-DREVR 318
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 74/312 (23%), Positives = 127/312 (40%), Gaps = 55/312 (17%)
Query: 6 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDAT 61
T F E + +GKG++G V +TG VA+K++
Sbjct: 17 PTIF-----EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH--SGPDQQR 69
Query: 62 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTP 119
REI++L+ L IV+ + + P R + + +V E + S L ++ + L
Sbjct: 70 DFQREIQILKALHSDFIVKYRGVSYGPGR---QSLRLVMEYLPSGCLRDFLQRHRARLDA 126
Query: 120 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179
+ Q+ +G++Y+ + HRDL +NIL ++ +KI DFGLA++ D
Sbjct: 127 SRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD------ 180
Query: 180 WTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT--GKPLFPGKN 229
D YV WY APE + ++ D+WS G + E+ T K P
Sbjct: 181 -KDYYVVREPGQSPIFWY-APE--SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236
Query: 230 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH-LLE 288
+ + D + + + E+ +R + P A P +H L++
Sbjct: 237 FLRMMGCERD--VPALSRLLELL--EEGQR----LPA----------PPACPAEVHELMK 278
Query: 289 RLLAFDPKDRPT 300
A P+DRP+
Sbjct: 279 LCWAPSPQDRPS 290
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 51/233 (21%), Positives = 97/233 (41%), Gaps = 34/233 (14%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATRILREIKLLRLLRH 75
+ +V+G G++G V + GE+ VAIK++ + IL E ++ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVDN 76
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 133
P + + I L + + ++ +LM L ++ + D + ++ + Q+ +G+
Sbjct: 77 PHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------- 186
Y+ + HRDL +N+L +KI DFGLA++ +
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-------EKEYHAEGGKVPI 183
Query: 187 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 235
+W A E YT D+WS G E++T G + G + L+
Sbjct: 184 KWM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 54/231 (23%), Positives = 98/231 (42%), Gaps = 37/231 (16%)
Query: 20 QIQEVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+ + +G G +GVV G + VA+K I E +E + + L HP
Sbjct: 11 TLLKELGSGQFGVVKLGKWKGQY---DVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPK 64
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLKY 135
+V+ + + IY+V E + + L ++++ L P Y + G+ +
Sbjct: 65 LVKFYGVCS-----KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------RW 188
+ + HRDL +N L + D +K+ DFG+ R +D YV++ +W
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD--------QYVSSVGTKFPVKW 171
Query: 189 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 235
APE + KY+ D+W+ G + E+ + GK + VV ++
Sbjct: 172 S-APE--VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 53/235 (22%), Positives = 101/235 (42%), Gaps = 40/235 (17%)
Query: 20 QIQEVIGKGSYGVV--GSAVDTHTGE-RVAIKKINDVFEHVSDATRI--LREIKLLRLLR 74
+ ++G+G +G V G + + VA+K + + + + E +++ L
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLD 71
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRG 132
HP IV++ I+ +++ EL +L ++ N + L + Q+ +
Sbjct: 72 HPHIVKLIGIIEEEP------TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 125
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------ 186
+ Y+ + N HRD+ +NIL + +K+ DFGL+R ++ DY
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE--------DYYKASVTRLP 177
Query: 187 -RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 235
+W +PE S F ++T A D+W E+L+ GK F V+ L+
Sbjct: 178 IKWM-SPE---SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 55/235 (23%), Positives = 105/235 (44%), Gaps = 37/235 (15%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
+ ++ +G G YG V V VA+K + E + L+E +++ ++HP
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 69
Query: 77 DIVEIKHIML--PPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLR 131
++V++ + PP Y++ E M +L ++ + +++ + Q+
Sbjct: 70 NLVQLLGVCTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWTDYV 184
++Y+ N HRDL +N L + +K+ DFGL+R+ D +A I WT
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT--- 179
Query: 185 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 235
APE ++K++ D+W+ G + E+ T G +PG + V L+
Sbjct: 180 ------APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 40/235 (17%)
Query: 20 QIQEVIGKGSYGVV--GSAVDTHTGE-RVAIKKINDVFEHVSDATRI--LREIKLLRLLR 74
++ IG+G +G V G + VAIK SD+ R L+E +R
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFD 74
Query: 75 HPDIVEIKHIML-PPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLR 131
HP IV++ ++ P ++++ EL +L ++ L + YQL
Sbjct: 75 HPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 127
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT----- 186
L Y+ + HRD+ +N+L +++ +K+ DFGL+R + Y
Sbjct: 128 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKASKGKL 179
Query: 187 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 235
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 180 PIKWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 58/231 (25%), Positives = 105/231 (45%), Gaps = 35/231 (15%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLR 74
++ + IGKG +G V + G +VA+K I + DAT L E ++ LR
Sbjct: 21 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKN------DATAQAFLAEASVMTQLR 72
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLR 131
H ++V++ +++ E +Y+V E M L +++ L + F +
Sbjct: 73 HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 128
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF---WTDYVATRW 188
++Y+ N HRDL +N+L + D K+ DFGL + + + + WT
Sbjct: 129 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------- 181
Query: 189 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 235
APE K++ D+WS G + E+ + G+ +P K+VV +++
Sbjct: 182 --APE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 37/231 (16%)
Query: 20 QIQEVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+ IG G +G+V G ++ +VAIK I E + E +++ L HP
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKD---KVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPK 64
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKY 135
+V++ + L E I +V E ME L ++ E + G+ Y
Sbjct: 65 LVQLYGVCL-----EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------RW 188
+ A V HRDL +N L + +K+ DFG+ R +D Y ++ +W
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--------QYTSSTGTKFPVKW 171
Query: 189 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 235
+PE FS+Y+ D+WS G + E+ + GK + ++ VV +
Sbjct: 172 A-SPE--VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 57/234 (24%), Positives = 95/234 (40%), Gaps = 34/234 (14%)
Query: 20 QIQEVIGKGSYGVVGSAV---DTHTGERVAIKKI-NDVFEHVSDATRILREIKLLRLLRH 75
++ E +G GS+GVV + VA+K + DV +RE+ + L H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 133
+++ + ++L P + +V EL L ++ + + Q+ G+
Sbjct: 81 RNLIRLYGVVLTPP------MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------- 186
Y+ + HRDL +N+L +KI DFGL R + YV
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH------YVMQEHRKVPF 188
Query: 187 RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 235
W APE S ++ A D W G EM T G+ + G N ++H++D
Sbjct: 189 AWC-APE---SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 58/229 (25%), Positives = 87/229 (37%), Gaps = 35/229 (15%)
Query: 6 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDAT 61
T F + +G+G +G V + TGE VA+K +
Sbjct: 25 PTVF-----HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK---ADAGPQH 76
Query: 62 RI--LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLT 118
R +EI +LR L H I++ K + +V E + L + + +
Sbjct: 77 RSGWKQEIDILRTLYHEHIIKYKGCCEDAGA---ASLQLVMEYVPLGSLRDYLPRHS-IG 132
Query: 119 PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 178
F Q+ G+ Y+H + HRDL +N+L + D +KI DFGLA+
Sbjct: 133 LAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH---- 188
Query: 179 FWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 220
Y WY APE K+ A D+WS G E+LT
Sbjct: 189 --EYYRVREDGDSPVFWY-APE--CLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 55/227 (24%), Positives = 97/227 (42%), Gaps = 25/227 (11%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRHPD 77
+ E IG+G++G V S VA+K E + + L+E ++L+ HP+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARILKQYSHPN 173
Query: 78 IVEIKHIML--PPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGL 133
IV + + P IY+V EL++ D ++ L + + G+
Sbjct: 174 IVRLIGVCTQKQP-------IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGM 226
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 193
+Y+ + HRDL +N L LKI DFG++R + +A V +W APE
Sbjct: 227 EYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT-APE 285
Query: 194 LCGSF-FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 235
+ + +Y+ D+WS G + E + G +P + ++
Sbjct: 286 ---ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 56/228 (24%), Positives = 100/228 (43%), Gaps = 29/228 (12%)
Query: 22 QEVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79
+ +G G++G V G + VA+K + + + +L E +++ L +P IV
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 80 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 138
+ I S +V E+ E L++ ++ N + ++ ++Q+ G+KY+
Sbjct: 82 RMIGICEAES------WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 139 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------RWYRA 191
+N HRDL +N+L KI DFGL++ D Y A +WY A
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE------NYYKAQTHGKWPVKWY-A 188
Query: 192 PELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 235
PE + K++ D+WS G + E + G+ + G V L+
Sbjct: 189 PE--CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 50/236 (21%), Positives = 93/236 (39%), Gaps = 34/236 (14%)
Query: 17 SRYQIQEVIGKGSYGVV--GSAVDTHTGER--VAIKKINDVFEHVSDATRILREIKLLRL 72
+ + +V+G G +G V G + + V IK I D + + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAIGS 71
Query: 73 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLL 130
L H IV + + S + +V + + L ++ + L P+ + Q+
Sbjct: 72 LDHAHIVRLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 131 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT---- 186
+G+ Y+ + HR+L +N+L + ++++ DFG+A + D +
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-------DKQLLYSEAK 178
Query: 187 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 235
+W A E F KYT D+WS G E++T G + G V L+
Sbjct: 179 TPIKWM-ALE--SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 52/233 (22%), Positives = 101/233 (43%), Gaps = 33/233 (14%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
+ ++ +G G YG V V VA+K + E + L+E +++ ++HP
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 276
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLRGL 133
++V++ + Y++ E M +L ++ + +++ + Q+ +
Sbjct: 277 NLVQLLGVCT-----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 331
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND-------APSAIFWTDYVAT 186
+Y+ N HR+L +N L + +K+ DFGL+R+ D A I WT
Sbjct: 332 EYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----- 386
Query: 187 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 235
APE ++K++ D+W+ G + E+ T G +PG V L+
Sbjct: 387 ----APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGER---VAIKKINDVFEHVSDATRI--LREIKL 69
+A+ I +V+G G +G V S ++ VAIK + ++ R L E +
Sbjct: 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASI 99
Query: 70 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLY 127
+ HP+I+ ++ ++ + K + +V E ME+ L ++ +D T L
Sbjct: 100 MGQFDHPNIIRLEGVVT-----KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 128 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT- 186
+ G+KY+ HRDL +NIL N++ K+ DFGL RV +D Y
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-----EAAYTTRG 209
Query: 187 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 235
RW +PE + K+T A D+WS G + E+++ G+ + + V+ +D
Sbjct: 210 GKIPIRWT-SPE--AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-25
Identities = 50/231 (21%), Positives = 92/231 (39%), Gaps = 37/231 (16%)
Query: 20 QIQEVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+ +G G +GVV G + VAIK I E + E K++ L H
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQY---DVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEK 80
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKY 135
+V++ + + + I+++ E M + L ++ + + ++Y
Sbjct: 81 LVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------RW 188
+ + HRDL +N L N +K+ DFGL+R +D +Y ++ RW
Sbjct: 136 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--------EYTSSVGSKFPVRW 187
Query: 189 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 235
PE +SK++ DIW+ G + E+ + GK + +
Sbjct: 188 S-PPE--VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 33/233 (14%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGER---VAIKKINDVFEHVSDATRI--LREIKLLRLLR 74
I+++IG G G V G+R VAIK + ++ R L E ++
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEASIMGQFD 108
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRG 132
HP+I+ ++ ++ + +V E ME+ L ++ +D T L + G
Sbjct: 109 HPNIIRLEGVVT-----RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------ 186
++Y+ HRDL +N+L +++ K+ DFGL+RV +D +A Y T
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA-----YTTTGGKIPI 218
Query: 187 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 235
RW APE F ++ A D+WS G + E+L G+ + V+ ++
Sbjct: 219 RWT-APE--AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 49/241 (20%), Positives = 94/241 (39%), Gaps = 33/241 (13%)
Query: 17 SRYQIQEVIGKGSYGVV--GSAVDTHTGE-RVAIKKINDVFEHVSDATRILREIKLLRLL 73
+ + +++G+G +G V G+ +VA+K + + L E ++
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 74 RHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN------DDLTPEHYQFFL 126
HP+++ + + + S + V+ M+ DLH + + + + F+
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 127 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD-YVA 185
+ G++Y+ N HRDL +N + D + + DFGL++ I+ D Y
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK--------IYSGDYYRQ 205
Query: 186 T-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQL 234
+W A E YT D+W+ G E+ T G +PG + L
Sbjct: 206 GRIAKMPVKWI-AIE--SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262
Query: 235 D 235
Sbjct: 263 L 263
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 61/238 (25%), Positives = 111/238 (46%), Gaps = 36/238 (15%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATRI--LREIKLL 70
S Q+VIG G +G V + + + VAIK + ++ R+ L E ++
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIM 100
Query: 71 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQ 128
H +I+ ++ ++ ++K + ++ E ME+ L + ++ D + L
Sbjct: 101 GQFSHHNIIRLEGVIS-----KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 129 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-- 186
+ G+KY+ N HRDL +NIL N++ K+ DFGL+RV +D Y +
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EATYTTSGG 210
Query: 187 ----RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 235
RW APE + + K+T A D+WS G + E++T G+ + + V+ ++
Sbjct: 211 KIPIRWT-APE---AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 35/233 (15%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
+++ +G+G +G V T RVAIK + L+E ++++ LRH
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHE 239
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGL 133
+V++ ++ + IY+V E M L +K L Q+ G+
Sbjct: 240 KLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 293
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------- 186
Y+ N HRDL+ NIL + K+ DFGLAR+ ++ +Y A
Sbjct: 294 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--------EYTARQGAKFPI 345
Query: 187 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 235
+W APE + + ++T D+WS G + E+ T G+ +PG + V+ Q++
Sbjct: 346 KWT-APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 51/233 (21%), Positives = 97/233 (41%), Gaps = 34/233 (14%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATRILREIKLLRLLRH 75
+ +V+G G++G V + GE+ VAIK++ + IL E ++ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVDN 76
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 133
P + + I L + + ++ +LM L ++ + D + ++ + Q+ +G+
Sbjct: 77 PHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------- 186
Y+ + HRDL +N+L +KI DFGLA++ +
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-------EKEYHAEGGKVPI 183
Query: 187 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 235
+W A E YT D+WS G E++T G + G + L+
Sbjct: 184 KWM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 59/240 (24%), Positives = 105/240 (43%), Gaps = 35/240 (14%)
Query: 15 EASRYQIQEVIGKGSYGVV--GSAVDTHTGE-RVAIKKINDVFEHVSDATRILREIKLLR 71
+ EVIG+G +G V G+ +D + A+K +N + + + ++ L E +++
Sbjct: 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMK 81
Query: 72 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQL 129
HP+++ + I L VV M+ DL I+ + T + F Q+
Sbjct: 82 DFSHPNVLSLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137
Query: 130 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT--- 186
+G+KY+ + HRDL +N + + +K+ DFGLAR ++ +Y +
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEYYSVHNK 189
Query: 187 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 235
+W A E K+T D+WS G + E++T G P +P N + L
Sbjct: 190 TGAKLPVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 246
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 29/228 (12%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLR 74
++ + IGKG +G V + G +VA+K I + DAT L E ++ LR
Sbjct: 193 KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKN------DATAQAFLAEASVMTQLR 244
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLR 131
H ++V++ +++ E +Y+V E M L +++ L + F +
Sbjct: 245 HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 300
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 191
++Y+ N HRDL +N+L + D K+ DFGL + + + + +W A
Sbjct: 301 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWT-A 354
Query: 192 PELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 235
PE K++ D+WS G + E+ + G+ +P K+VV +++
Sbjct: 355 PE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 66/293 (22%), Positives = 116/293 (39%), Gaps = 68/293 (23%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIK--------KINDVFEHVSDATRILREIKLL 70
+ + +G GS+G V +G A+K K+ + EH + RIL+ +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-EHTLNEKRILQAV--- 98
Query: 71 RLLRHPDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFL 126
P +V+++ FKD +Y+V E + ++ ++ + H +F+
Sbjct: 99 ---NFPFLVKLEF--------SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYA 147
Query: 127 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 186
Q++ +Y+H+ ++ +RDLKP+N+L + +++ DFG A+ WT T
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WT-LCGT 201
Query: 187 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246
APE+ S Y A+D W++G + EM G P F +
Sbjct: 202 PEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--------------- 244
Query: 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR 298
+ +I + K R FP + LL LL D R
Sbjct: 245 QIYEKIVSGKVR-----------------FPSHFSSDLKDLLRNLLQVDLTKR 280
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 54/242 (22%), Positives = 100/242 (41%), Gaps = 34/242 (14%)
Query: 17 SRYQIQEVIGKGSYGVV--GSAVDTHTGE-RVAIKKINDVFEHVSDATRILREIKLLRLL 73
++ + ++GKG +G V +VA+K + SD LRE ++
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 74 RHPDIVEIKHIMLPP-SRREFKDIYVVFELMES-DLHQVIKAN------DDLTPEHYQFF 125
HP + ++ + L ++ V+ M+ DLH + A+ +L + F
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 126 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY-- 183
+ + G++Y+ + N HRDL +N + D + + DFGL+R I+ DY
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK--------IYSGDYYR 194
Query: 184 ------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQ 233
+ +W A E + YT D+W+ G E++T G+ + G + +
Sbjct: 195 QGCASKLPVKWL-ALE--SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251
Query: 234 LD 235
L
Sbjct: 252 LI 253
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 76/308 (24%), Positives = 125/308 (40%), Gaps = 66/308 (21%)
Query: 24 VIGKGSYG---VVGSAVDTHTGERVAIKKIN--DVFEHVSDATRILREIKLLRLLRHPDI 78
V+GKG YG V +TG+ A+K + + + D E +L ++HP I
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 79 VEIKHIMLPPSRREFKDIYVVF------ELMESDLHQVIKANDDLTPEHYQFFLYQLLRG 132
V++ + + +Y++ EL + ++ + F+L ++
Sbjct: 84 VDLIYAFQTGGK-----LYLILEYLSGGELF---MQ--LEREGIFMEDTACFYLAEISMA 133
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 192
L ++H + +RDLKP+NI+ N +K+ DFGL + S +D + T Y AP
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT---HTFCGTIEYMAP 190
Query: 193 E-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251
E L S + A+D WS+G + +MLTG P F G+N ++I +
Sbjct: 191 EILMR---SGHNRAVDWWSLGALMYDMLTGAPPFTGENR---------------KKTIDK 232
Query: 252 IRNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR----PT-AEEAL 305
I K P A LL++LL + R P A E
Sbjct: 233 ILKCKLN-----------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQ 275
Query: 306 ADPYFHGL 313
A P+F +
Sbjct: 276 AHPFFRHI 283
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 37/293 (12%), Positives = 68/293 (23%), Gaps = 69/293 (23%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDAT---RILREIKLLRL 72
RY++ G A+DT +VA+ ++ + V L L
Sbjct: 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVD--PQGVLPDDVLQETLSRTLRLSR 87
Query: 73 LRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLR 131
+ P + + ++ + VV E + L +V + +P + L
Sbjct: 88 IDKPGVARVLDVVHTRAG-----GLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAA 140
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 191
H A V P + + D + +
Sbjct: 141 AADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-----------------------TMP 177
Query: 192 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251
P DI IG +L + P V L
Sbjct: 178 DA---------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ------- 221
Query: 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 304
P+ + + + R + D R +
Sbjct: 222 -----------------PIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 62/236 (26%), Positives = 101/236 (42%), Gaps = 41/236 (17%)
Query: 17 SRYQIQEVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 74
++ E +G G +G V G +VA+K + + L E L++ L+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHT---KVAVKSLK---QGSMSPDAFLAEANLMKQLQ 66
Query: 75 HPDIVEIKHIML-PPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLL 130
H +V + ++ P IY++ E ME+ L +K LT Q+
Sbjct: 67 HQRLVRLYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 131 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT---- 186
G+ +I N HRDL+ NIL + KI DFGLAR+ ++ +Y A
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN--------EYTAREGAK 171
Query: 187 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 235
+W APE + +T D+WS G + E++T G+ +PG V+ L+
Sbjct: 172 FPIKWT-APE--AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 35/233 (15%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
+++ +G+G +G V T RVAIK + L+E ++++ LRH
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHE 322
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGL 133
+V++ ++ + IY+V E M L +K L Q+ G+
Sbjct: 323 KLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 376
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------- 186
Y+ N HRDL+ NIL + K+ DFGLAR+ ++ +Y A
Sbjct: 377 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--------EYTARQGAKFPI 428
Query: 187 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 235
+W APE + + ++T D+WS G + E+ T G+ +PG + V+ Q++
Sbjct: 429 KWT-APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (258), Expect = 2e-24
Identities = 74/318 (23%), Positives = 128/318 (40%), Gaps = 83/318 (26%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIK--------KINDVFEHVSDATRILREIKLL 70
+QI +G GS+G V H G A+K ++ V EH +D +L +
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQV-EHTNDERLMLSIV--- 63
Query: 71 RLLRHPDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFL 126
HP I+ + F+D I+++ + +E +L +++ + +F+
Sbjct: 64 ---THPFIIRMWG--------TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA 112
Query: 127 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT----- 181
++ L+Y+H+ ++ +RDLKP+NIL + + +KI DFG A+ + +T
Sbjct: 113 AEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTP 167
Query: 182 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 241
DY+ APE+ + Y +ID WS G + EML G F N +
Sbjct: 168 DYI------APEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---------- 209
Query: 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR-- 298
++ +I N + R FP + LL RL+ D R
Sbjct: 210 -----KTYEKILNAELR-----------------FPPFFNEDVKDLLSRLITRDLSQRLG 247
Query: 299 ---PTAEEALADPYFHGL 313
E+ P+F +
Sbjct: 248 NLQNGTEDVKNHPWFKEV 265
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 72/299 (24%), Positives = 124/299 (41%), Gaps = 52/299 (17%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 82
++GKG++G V + TG A+K + +V + + E ++L+ RHP + +K
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 83 HIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 141
+ R + V E +L + T E +F+ +++ L+Y+H+ +V
Sbjct: 72 YAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 142 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFS 200
+RD+K +N++ + D +KI DFGL + +D + + T Y APE L +
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED---N 180
Query: 201 KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 260
Y A+D W +G + EM+ G+ F ++ I E+ R
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---------------ERLFELILMEEIR-- 223
Query: 261 LGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR-----PTAEEALADPYFHGL 313
FP P A LL LL DPK R A+E + +F +
Sbjct: 224 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 67/243 (27%), Positives = 104/243 (42%), Gaps = 41/243 (16%)
Query: 15 EASRYQIQEVIGKGSYGVV--GSAVDTHTGE-RVAIKKINDVFEHVSDATRILREIKLLR 71
E VIGKG +GVV G +D + AIK ++ + E LRE L+R
Sbjct: 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM-QQVEAFLREGLLMR 77
Query: 72 LLRHPDIVEIKHIML---PPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFL 126
L HP+++ + IML +V+ M DL Q I++ + T + F
Sbjct: 78 GLNHPNVLALIGIMLPPEGL-------PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFG 130
Query: 127 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 186
Q+ RG++Y+ HRDL +N + + +K+ DFGLAR I +Y +
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD--------ILDREYYSV 182
Query: 187 ----------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVH 232
+W A E ++T D+WS G + E+LT G P + + + H
Sbjct: 183 QQHRHARLPVKWT-ALE--SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH 239
Query: 233 QLD 235
L
Sbjct: 240 FLA 242
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 57/240 (23%), Positives = 105/240 (43%), Gaps = 35/240 (14%)
Query: 15 EASRYQIQEVIGKGSYGVV--GSAVDTHTGE-RVAIKKINDVFEHVSDATRILREIKLLR 71
+ EVIG+G +G V G+ +D + A+K +N + + + ++ L E +++
Sbjct: 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMK 145
Query: 72 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQL 129
HP+++ + I L VV M+ DL I+ + T + F Q+
Sbjct: 146 DFSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201
Query: 130 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT--- 186
+G+K++ + HRDL +N + + +K+ DFGLAR ++ ++ +
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEFDSVHNK 253
Query: 187 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 235
+W A E K+T D+WS G + E++T G P +P N + L
Sbjct: 254 TGAKLPVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 37/233 (15%)
Query: 21 IQEVIGKGSYGVVGSAVDTHTGER--VAIK--KINDVFEHVSDATRILREIKLLRLLRHP 76
+G G++G V V ++ VAIK K + ++RE +++ L +P
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE---MMREAQIMHQLDNP 70
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLK 134
IV + + + + +V E+ LH+ + + + + L+Q+ G+K
Sbjct: 71 YIVRLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 124
Query: 135 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------R 187
Y+ N HRDL +N+L KI DFGL++ D Y A +
Sbjct: 125 YLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLK 178
Query: 188 WYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 235
WY APE F K++ D+WS G E L+ G+ + V+ ++
Sbjct: 179 WY-APE---CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 74/299 (24%), Positives = 127/299 (42%), Gaps = 51/299 (17%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 82
++GKG++G V + TG A+K + +V + L E ++L+ RHP + +K
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 83 HIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-N 140
+ R + V E +L + + + +F+ +++ L Y+H+ N
Sbjct: 215 YSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 269
Query: 141 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 200
V +RDLK +N++ + D +KI DFGL + D + + T Y APE+ +
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVLED--N 324
Query: 201 KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 260
Y A+D W +G + EM+ G+ F ++ + + +L I E+ R
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFEL-----------ILMEEIR-- 367
Query: 261 LGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR-----PTAEEALADPYFHGL 313
FP P A LL LL DPK R A+E + +F G+
Sbjct: 368 ---------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 79
++++ +G G +G V A +VA+K + L E +++ L+H +V
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 80 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGLKYI 136
++ ++ + IY++ E M L +K+++ F Q+ G+ +I
Sbjct: 247 KLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------RWY 189
N HRDL+ NIL +A KI DFGLARV ++ +Y A +W
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN--------EYTAREGAKFPIKWT 352
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 235
APE F +T D+WS G + E++T G+ +PG V+ L+
Sbjct: 353 -APE--AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 67/302 (22%), Positives = 118/302 (39%), Gaps = 61/302 (20%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKI-------NDVFEHVSDATRILREIKLLRLLRHP 76
++GKGS+G V A T + AIK + +D E T + + + L HP
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC----TMVEKRV-LSLAWEHP 78
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
+ + ++ V E + DL I++ F+ +++ GL++
Sbjct: 79 FLTHMFCTFQTKEN-----LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 133
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLAR--VSFNDAPSAIFWTDYVATRWYRAPE 193
+H+ + +RDLK NIL + D +KI DFG+ + + + + + T Y APE
Sbjct: 134 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-----FCGTPDYIAPE 188
Query: 194 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253
+ KY ++D WS G + EML G+ F G++ + + IR
Sbjct: 189 ILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE----EELFH-----------SIR 231
Query: 254 NEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR-PTAEEALADPYFH 311
+ +P + A LL +L +P+ R + P F
Sbjct: 232 MDNPF-----------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 274
Query: 312 GL 313
+
Sbjct: 275 EI 276
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 2e-23
Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 40/235 (17%)
Query: 20 QIQEVIGKGSYGVV--GSAVDTHTGE-RVAIKKINDVFEHVSDATRI--LREIKLLRLLR 74
++ IG+G +G V G + VAIK SD+ R L+E +R
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK---NCTSDSVREKFLQEALTMRQFD 449
Query: 75 HPDIVEIKHIML-PPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLR 131
HP IV++ ++ P ++++ EL +L ++ L + YQL
Sbjct: 450 HPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT----- 186
L Y+ + HRD+ +N+L +++ +K+ DFGL+R + Y
Sbjct: 503 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKASKGKL 554
Query: 187 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 235
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 555 PIKWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 63/310 (20%), Positives = 114/310 (36%), Gaps = 73/310 (23%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKI-------NDVFEHVSDATRILREIKLLRLLRHP 76
V+GKGS+G V + T E A+K + +D E T + + + L + P
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVEC----TMVEKRV-LALPGKPP 81
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFE------LMESDLHQVIKANDDLTPEHYQFFLYQLL 130
+ ++ R +Y V E LM H I+ H F+ ++
Sbjct: 82 FLTQLHSCFQTMDR-----LYFVMEYVNGGDLM---YH--IQQVGRFKEPHAVFYAAEIA 131
Query: 131 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 190
GL ++ + + +RDLK N++ +++ +KI DFG+ + + D + + T Y
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT---KTFCGTPDYI 188
Query: 191 APE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
APE + Y ++D W+ G + EML G+ F G++ E
Sbjct: 189 APEIIAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---------------DELF 230
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR----PT-AEE 303
I +P + A+ + + L+ P R P +
Sbjct: 231 QSIMEHNVA-----------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERD 273
Query: 304 ALADPYFHGL 313
+F +
Sbjct: 274 IKEHAFFRYI 283
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 61/305 (20%), Positives = 113/305 (37%), Gaps = 63/305 (20%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKI-------NDVFEHVSDATRILREIKLLRLLRHP 76
V+GKGS+G V + T E A+K + +D E T + + + L + P
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVEC----TMVEKRV-LALPGKPP 402
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
+ ++ R +Y V E + DL I+ H F+ ++ GL +
Sbjct: 403 FLTQLHSCFQTMDR-----LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 457
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-L 194
+ + + +RDLK N++ +++ +KI DFG+ + + D + + T Y APE +
Sbjct: 458 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT---KTFCGTPDYIAPEII 514
Query: 195 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254
Y ++D W+ G + EML G+ F G++ E I
Sbjct: 515 AY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---------------DELFQSIME 556
Query: 255 EKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR-----PTAEEALADP 308
+P + A+ + + L+ P R +
Sbjct: 557 HNVA-----------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 599
Query: 309 YFHGL 313
+F +
Sbjct: 600 FFRYI 604
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 72/306 (23%), Positives = 117/306 (38%), Gaps = 64/306 (20%)
Query: 24 VIGKGSYG---VVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVE 80
V+G+GS+G +V + + A+K + V D R E +L + HP IV+
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 81 IKHIMLPPSRREFKDIYVVF------ELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 134
+ + + +Y++ +L + T E +F+L +L L
Sbjct: 91 LHYAFQTEGK-----LYLILDFLRGGDLF---TR--LSKEVMFTEEDVKFYLAELALALD 140
Query: 135 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE- 193
++H+ + +RDLKP+NIL + + +K+ DFGL++ S + A + T Y APE
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA---YSFCGTVEYMAPEV 197
Query: 194 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253
+ +T + D WS G + EMLTG F GK+ I
Sbjct: 198 VNR---RGHTQSADWWSFGVLMFEMLTGTLPFQGKDR----KETMT-----------MIL 239
Query: 254 NEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR-----PTAEEALAD 307
K P P A LL L +P +R EE
Sbjct: 240 KAKLG-----------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282
Query: 308 PYFHGL 313
+F +
Sbjct: 283 SFFSTI 288
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 31/230 (13%)
Query: 21 IQEVIGKGSYGVVGSAVDTHTGER--VAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 78
+G G++G V V ++ VAIK + E +D ++RE +++ L +P I
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYI 398
Query: 79 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYI 136
V + + + + +V E+ LH+ + + + + L+Q+ G+KY+
Sbjct: 399 VRLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 452
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------RWY 189
N HR+L +N+L KI DFGL++ D Y A +WY
Sbjct: 453 EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLKWY 506
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 235
APE F K++ D+WS G E L+ G+ + V+ ++
Sbjct: 507 -APE--CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 73/303 (24%), Positives = 114/303 (37%), Gaps = 60/303 (19%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIK-LLRLLRHPDIVEI 81
VIGKGS+G V A A+K + + I+ E LL+ ++HP +V +
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 82 KHIMLPPSRREFKDIYVVF------ELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
+ +Y V EL H ++ +F+ ++ L Y
Sbjct: 105 HFSFQTADK-----LYFVLDYINGGELF---YH--LQRERCFLEPRARFYAAEIASALGY 154
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 195
+H+ N+ +RDLKP+NIL ++ + + DFGL + + + T + T Y APE+
Sbjct: 155 LHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--ST-FCGTPEYLAPEVL 211
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
Y +D W +G + EML G P F +N M D I N+
Sbjct: 212 HK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT----AEMYD-----------NILNK 254
Query: 256 KARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR----PTAEEALADPYF 310
+ N A HLLE LL D R E + +F
Sbjct: 255 PLQ-----------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297
Query: 311 HGL 313
+
Sbjct: 298 SLI 300
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 38/239 (15%), Positives = 78/239 (32%), Gaps = 40/239 (16%)
Query: 20 QIQEVIGKGSYGVVGSAVDTHTGE-------RVAIKKINDVFEHVSDATRILREIKLLRL 72
E +G+G++ + V G+ V +K ++ + S++ ++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES--FFEAASMMSK 68
Query: 73 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLL 130
L H +V + + + +V E ++ L +K N + + QL
Sbjct: 69 LSHKHLVLNYGVCV-----CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 131 RGLKYIHTANVFHRDLKPKNILANADCKL--------KICDFGLARVSFNDAPSAIFWTD 182
+ ++ + H ++ KNIL + K+ D G++ + D
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--------VLPKD 175
Query: 183 Y--VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 235
W PE C A D WS G E+ + G + + +
Sbjct: 176 ILQERIPWV-PPE-CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 63/280 (22%), Positives = 109/280 (38%), Gaps = 39/280 (13%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIK-LLRLLRHPDIVEI 81
VIG+GSY V T A+K + ++ D + E + HP +V +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 82 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 140
SR ++ V E + DL ++ L EH +F+ ++ L Y+H
Sbjct: 76 HSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130
Query: 141 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFF 199
+ +RDLK N+L +++ +K+ D+G+ + + + + T Y APE L G
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRG--- 184
Query: 200 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259
Y ++D W++G + EM+ G+ F D I ++ R
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------QNTEDYLFQVILEKQIR- 237
Query: 260 YLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR 298
P + A +L+ L DPK+R
Sbjct: 238 ----------------IPRSLSVKAASVLKSFLNKDPKER 261
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 64/285 (22%), Positives = 110/285 (38%), Gaps = 58/285 (20%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKI-------NDVFEHVSDATRILREIKLLRLLRHP 76
V+GKGS+G V A TG+ A+K + +D E T + I L HP
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVEC----TMTEKRI-LSLARNHP 84
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
+ ++ P R ++ V E + DL I+ + +F+ +++ L +
Sbjct: 85 FLTQLFCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-L 194
+H + +RDLK N+L + + K+ DFG+ + + + + T Y APE L
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT---ATFCGTPDYIAPEIL 196
Query: 195 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254
Y PA+D W++G + EML G F +N + I N
Sbjct: 197 QE---MLYGPAVDWWAMGVLLYEMLCGHAPFEAENE---------------DDLFEAILN 238
Query: 255 EKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR 298
++ +P A +L+ + +P R
Sbjct: 239 DEVV-----------------YPTWLHEDATGILKSFMTKNPTMR 266
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 6e-22
Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 56/255 (21%)
Query: 17 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 69
++ +G+G++G V + + VA+K + D + A R RE +L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAEL 70
Query: 70 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN-------------- 114
L L+H IV+ + + + +VFE M+ DL++ ++A+
Sbjct: 71 LTNLQHEHIVKFYGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 115 --DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172
+L Q+ G+ Y+ + + HRDL +N L A+ +KI DFG++R
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD--- 182
Query: 173 DAPSAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKP 223
++ TDY RW PE + K+T D+WS G I E+ T GK
Sbjct: 183 -----VYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFTYGKQ 234
Query: 224 LFPGKN---VVHQLD 235
+ + V+ +
Sbjct: 235 PWFQLSNTEVIECIT 249
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 65/309 (21%), Positives = 127/309 (41%), Gaps = 60/309 (19%)
Query: 24 VIGKGSYG---VVGSAVDTHTGERVAIK---------KINDVFEHVSDATRILREIKLLR 71
V+G G+YG +V TG+ A+K K EH ++L I+
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT-EHTRTERQVLEHIR--- 116
Query: 72 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL 130
+ P +V + + ++ ++++ + + +L + + T Q ++ +++
Sbjct: 117 --QSPFLVTLHYAFQTETK-----LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 169
Query: 131 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 190
L+++H + +RD+K +NIL +++ + + DFGL++ D + + + T Y
Sbjct: 170 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERAYD-FCGTIEYM 227
Query: 191 APELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250
AP++ S + A+D WS+G + E+LTG F + ++
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR----------- 276
Query: 251 RIRNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR----PT-AEEA 304
RI + +P LA L++RLL DPK R P A+E
Sbjct: 277 RILKSEPP-----------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI 319
Query: 305 LADPYFHGL 313
+F +
Sbjct: 320 KEHLFFQKI 328
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 61/250 (24%), Positives = 98/250 (39%), Gaps = 60/250 (24%)
Query: 15 EASRYQIQ--EVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LR 65
E +R +I +G+GS+G+V G A E RVAIK +N E S RI L
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN 77
Query: 66 EIKLLRLLRHPDIVEIKHIML--PPSRREFKDIYVVFELMES-DLHQVIKAN-------- 114
E +++ +V + ++ P V+ ELM DL +++
Sbjct: 78 EASVMKEFNCHHVVRLLGVVSQGQP-------TLVIMELMTRGDLKSYLRSLRPAMANNP 130
Query: 115 --DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172
+ ++ G+ Y++ HRDL +N + D +KI DFG+ R
Sbjct: 131 VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--- 187
Query: 173 DAPSAIFWTDYVATRWYR------------APELCGSFFSKYTPAIDIWSIGCIFAEMLT 220
I+ TDY YR +PE +T D+WS G + E+ T
Sbjct: 188 -----IYETDY-----YRKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIAT 235
Query: 221 -GKPLFPGKN 229
+ + G +
Sbjct: 236 LAEQPYQGLS 245
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 58/254 (22%), Positives = 102/254 (40%), Gaps = 55/254 (21%)
Query: 17 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 69
++ +G+G++G V + + VA+K + + S++ R RE +L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAEL 96
Query: 70 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD------------ 116
L +L+H IV + E + + +VFE M DL++ ++++
Sbjct: 97 LTMLQHQHIVRFFGVCT-----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 117 ---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173
L Q+ G+ Y+ + HRDL +N L +KI DFG++R
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD---- 207
Query: 174 APSAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPL 224
I+ TDY RW PE + K+T D+WS G + E+ T GK
Sbjct: 208 ----IYSTDYYRVGGRTMLPIRWM-PPE--SILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
Query: 225 FPGKN---VVHQLD 235
+ + + +
Sbjct: 261 WYQLSNTEAIDCIT 274
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 62/280 (22%), Positives = 109/280 (38%), Gaps = 39/280 (13%)
Query: 24 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIK-LLRLLRHPDIVEI 81
VIG+GSY V T A++ + ++ D + E + HP +V +
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 82 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 140
SR ++ V E + DL ++ L EH +F+ ++ L Y+H
Sbjct: 119 HSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173
Query: 141 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFF 199
+ +RDLK N+L +++ +K+ D+G+ + + + + T Y APE L G
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRG--- 227
Query: 200 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259
Y ++D W++G + EM+ G+ F D I ++ R
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------QNTEDYLFQVILEKQIR- 280
Query: 260 YLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR 298
P + A +L+ L DPK+R
Sbjct: 281 ----------------IPRSLSVKAASVLKSFLNKDPKER 304
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 54/236 (22%), Positives = 93/236 (39%), Gaps = 51/236 (21%)
Query: 17 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 69
S + E +G+ +G V G GE VAIK + + R E L
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEAML 65
Query: 70 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN-------------- 114
L+HP++V + ++ + + + ++F DLH+ +
Sbjct: 66 RARLQHPNVVCLLGVVT-----KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 115 --DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172
L P + + Q+ G++Y+ + +V H+DL +N+L +KI D GL R
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE--- 177
Query: 173 DAPSAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 220
++ DY RW APE + K++ DIWS G + E+ +
Sbjct: 178 -----VYAADYYKLLGNSLLPIRWM-APE--AIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 60/252 (23%), Positives = 107/252 (42%), Gaps = 52/252 (20%)
Query: 17 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 69
R ++ + +G+G++G V A VA+K + E + + + E+K+
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 83
Query: 70 L-RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN------------- 114
L + H ++V +L + + V+ E + +L +++
Sbjct: 84 LIHIGHHLNVVN----LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 115 ---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171
D LT EH + +Q+ +G++++ + HRDL +NIL + +KICDFGLAR
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD-- 197
Query: 172 NDAPSAIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GK 222
I+ YV +W APE F YT D+WS G + E+ + G
Sbjct: 198 ------IYKDPDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLLWEIFSLGA 248
Query: 223 PLFPGKNVVHQL 234
+PG + +
Sbjct: 249 SPYPGVKIDEEF 260
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 52/249 (20%), Positives = 89/249 (35%), Gaps = 49/249 (19%)
Query: 17 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 69
+ +G G++G V G +VA+K + E S+ + L E +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALI 86
Query: 70 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQ 128
+ H +IV + L + +++ ELM DL ++ + +
Sbjct: 87 ISKFNHQNIVRCIGVSL-----QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 129 LL-------RGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVSFNDAPSAI 178
LL G +Y+ + HRD+ +N L KI DFG+AR I
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--------I 193
Query: 179 FWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 229
+ Y +W PE +T D WS G + E+ + G +P K+
Sbjct: 194 YRASYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250
Query: 230 ---VVHQLD 235
V+ +
Sbjct: 251 NQEVLEFVT 259
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 52/249 (20%), Positives = 89/249 (35%), Gaps = 49/249 (19%)
Query: 17 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 69
+ +G G++G V G +VA+K + E S+ + L E +
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALI 127
Query: 70 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQ 128
+ H +IV + L + +++ ELM DL ++ + +
Sbjct: 128 ISKFNHQNIVRCIGVSL-----QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 129 LL-------RGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVSFNDAPSAI 178
LL G +Y+ + HRD+ +N L KI DFG+AR I
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--------I 234
Query: 179 FWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 229
+ Y +W PE +T D WS G + E+ + G +P K+
Sbjct: 235 YRAGYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291
Query: 230 ---VVHQLD 235
V+ +
Sbjct: 292 NQEVLEFVT 300
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 87.2 bits (215), Expect = 5e-19
Identities = 51/349 (14%), Positives = 92/349 (26%), Gaps = 75/349 (21%)
Query: 10 FTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI------NDVFEHVSDATRI 63
F+ + Q E IG+G +G V + HT VAIK I H I
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEI 70
Query: 64 LREIKLLRLL---------RHPDIVEIKHIML-------------------------PPS 89
L EI + + L R + + + P
Sbjct: 71 LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130
Query: 90 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF-HRDLKP 148
+ +++V E + + + L+QL L + F HRDL
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHW 190
Query: 149 KNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 208
N+L K+ + S + + + + YT +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSS------------TIPSCGLQVSII------DYTLSRLE 232
Query: 209 WSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK-------ARRYL 261
+F ++ + LF G +Q D + L+ + +
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDG-DYQFD-IYRLMKKENNNRWGEYHPYSNVLWLHYLTDKM 290
Query: 262 GSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
+ + +L F +A + L
Sbjct: 291 LKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 9e-19
Identities = 55/251 (21%), Positives = 95/251 (37%), Gaps = 73/251 (29%)
Query: 17 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 69
+ + IG+G++G V A E VA+K + E S + RE L
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAAL 103
Query: 70 LRLLRHPDIVEIKHIML--PPSRREFKDIYVVFELMES-DLHQVIKANDD---------- 116
+ +P+IV++ + P + ++FE M DL++ +++
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKP-------MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156
Query: 117 --------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 162
L+ Q+ G+ Y+ HRDL +N L + +KI
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 216
Query: 163 DFGLARVSFNDAPSAIFWTDYVATRWYR------------APELCGS-FFSKYTPAIDIW 209
DFGL+R I+ DY Y+ PE S F+++YT D+W
Sbjct: 217 DFGLSRN--------IYSADY-----YKADGNDAIPIRWMPPE---SIFYNRYTTESDVW 260
Query: 210 SIGCIFAEMLT 220
+ G + E+ +
Sbjct: 261 AYGVVLWEIFS 271
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 79/270 (29%)
Query: 17 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 69
+ + +G+G +G V +A VA+K + E+ S + L E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNV 79
Query: 70 LRLLRHPDIVEIKHIML------PPSRREFKDIYVVFELMES-DLHQVIKAN-------- 114
L+ + HP +++ + P + ++ E + L ++ +
Sbjct: 80 LKQVNHPHVIK----LYGACSQDGP-------LLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 115 ----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 158
LT F +Q+ +G++Y+ + HRDL +NIL K
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK 188
Query: 159 LKICDFGLARVSFNDAPSAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIW 209
+KI DFGL+R ++ D YV +W A E S F YT D+W
Sbjct: 189 MKISDFGLSRD--------VYEEDSYVKRSQGRIPVKWM-AIE---SLFDHIYTTQSDVW 236
Query: 210 SIGCIFAEMLT--GKPLFPG---KNVVHQL 234
S G + E++T G P +PG + + + L
Sbjct: 237 SFGVLLWEIVTLGGNP-YPGIPPERLFNLL 265
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 57/255 (22%), Positives = 97/255 (38%), Gaps = 61/255 (23%)
Query: 17 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 69
+ Q + +G G++G V +A + +VA+K + + + E+K+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKI 102
Query: 70 L-RLLRHPDIVEIKHIML------PPSRREFKDIYVVFELME---------------SDL 107
+ L +H +IV +L P + V+ E
Sbjct: 103 MSHLGQHENIVN----LLGACTHGGP-------VLVITEYCCYGDLLNFLRRKSRVLETD 151
Query: 108 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 167
AN + F Q+ +G+ ++ + N HRD+ +N+L KI DFGLA
Sbjct: 152 PAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
Query: 168 RVSFNDAPSAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 220
R ND ++Y+ +W APE F YT D+WS G + E+ +
Sbjct: 212 RDIMND-------SNYIVKGNARLPVKWM-APE--SIFDCVYTVQSDVWSYGILLWEIFS 261
Query: 221 -GKPLFPGKNVVHQL 234
G +PG V +
Sbjct: 262 LGLNPYPGILVNSKF 276
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 61/264 (23%), Positives = 108/264 (40%), Gaps = 72/264 (27%)
Query: 17 SRYQIQEVIGKGSYGVV--GSAVDTHTGE-----RVAIKKINDVFEHVSDATRI--LREI 67
+ + + +G+G++G V AV + VA+K + + ++ + E+
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 91
Query: 68 KLL-RLLRHPDIVEIKHIML------PPSRREFKDIYVVFELMES-DLHQVIKAN----- 114
+++ + +H +I+ +L P +YV+ E +L + ++A
Sbjct: 92 EMMKMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLRARRPPGM 140
Query: 115 -----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 163
+ +T + YQL RG++Y+ + HRDL +N+L + +KI D
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD 200
Query: 164 FGLARVSFNDAPSAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCI 214
FGLAR I D Y T +W APE + F YT D+WS G +
Sbjct: 201 FGLARD--------INNIDYYKKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVL 248
Query: 215 FAEMLT-GK---PLFPGKNVVHQL 234
E+ T G P P + + L
Sbjct: 249 MWEIFTLGGSPYPGIPVEELFKLL 272
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 65/260 (25%), Positives = 95/260 (36%), Gaps = 67/260 (25%)
Query: 17 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 69
+R + +G G++G V +A + VA+K + R + E+K+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKV 79
Query: 70 L-RLLRHPDIVEIKHIML------PPSRREFKDIYVVFELMES-DLHQVIKAN------- 114
L L H +IV +L P V+ E DL ++
Sbjct: 80 LSYLGNHMNIVN----LLGACTIGGP-------TLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 115 -----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 163
L E F YQ+ +G+ ++ + N HRDL +NIL KICD
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188
Query: 164 FGLARVSFNDAPSAIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 215
FGLAR I YV +W APE F YT D+WS G
Sbjct: 189 FGLARD--------IKNDSNYVVKGNARLPVKWM-APESI--FNCVYTFESDVWSYGIFL 237
Query: 216 AEMLT-GKPLFPGKNVVHQL 234
E+ + G +PG V +
Sbjct: 238 WELFSLGSSPYPGMPVDSKF 257
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 61/261 (23%), Positives = 107/261 (40%), Gaps = 72/261 (27%)
Query: 20 QIQEVIGKGSYGVV--GSAVDTHTGE-----RVAIKKINDVFEHVSDATRI--LREIKLL 70
+ + +G+G +G V AV + VA+K + + ++ + E++++
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMM 140
Query: 71 -RLLRHPDIVEIKHIML------PPSRREFKDIYVVFELMES-DLHQVIKAN-------- 114
+ +H +I+ +L P +YV+ E +L + ++A
Sbjct: 141 KMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLRARRPPGMEYS 189
Query: 115 --------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 166
+ +T + YQL RG++Y+ + HRDL +N+L + +KI DFGL
Sbjct: 190 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 249
Query: 167 ARVSFNDAPSAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCIFAE 217
AR I D Y T +W APE + F YT D+WS G + E
Sbjct: 250 ARD--------INNIDYYKKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLMWE 297
Query: 218 MLT-GKPLFPG---KNVVHQL 234
+ T G +PG + + L
Sbjct: 298 IFTLGGSPYPGIPVEELFKLL 318
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 61/264 (23%), Positives = 108/264 (40%), Gaps = 72/264 (27%)
Query: 17 SRYQIQEVIGKGSYGVV--GSAVDTHTGE-----RVAIKKINDVFEHVSDATRI--LREI 67
R + + +G+G++G V A+ + +VA+K + ++ + E+
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEM 125
Query: 68 KLL-RLLRHPDIVEIKHIML------PPSRREFKDIYVVFELMES-DLHQVIKAN----- 114
+++ + +H +I+ +L P +YV+ E +L + ++A
Sbjct: 126 EMMKMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLQARRPPGL 174
Query: 115 -----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 163
+ L+ + YQ+ RG++Y+ + HRDL +N+L D +KI D
Sbjct: 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 234
Query: 164 FGLARVSFNDAPSAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCI 214
FGLAR I D Y T +W APE + F YT D+WS G +
Sbjct: 235 FGLARD--------IHHIDYYKKTTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVL 282
Query: 215 FAEMLT-GK---PLFPGKNVVHQL 234
E+ T G P P + + L
Sbjct: 283 LWEIFTLGGSPYPGVPVEELFKLL 306
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 9e-18
Identities = 54/231 (23%), Positives = 87/231 (37%), Gaps = 62/231 (26%)
Query: 17 SRYQIQEVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLL-R 71
+ + Q+VIG+G++G V AIK++ E+ S E+++L +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCK 81
Query: 72 LLRHPDIVEIKHIML------PPSRREFKDIYVVFELMES-DLHQVIKAN---------- 114
L HP+I+ +L +Y+ E +L ++ +
Sbjct: 82 LGHHPNIIN----LLGACEHRGY-------LYLAIEYAPHGNLLDFLRKSRVLETDPAFA 130
Query: 115 ------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 168
L+ + F + RG+ Y+ HRDL +NIL + KI DFGL+R
Sbjct: 131 IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
Query: 169 VSFNDAPSAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIG 212
+ YV RW A E +S YT D+WS G
Sbjct: 191 --GQEV--------YVKKTMGRLPVRWM-AIE--SLNYSVYTTNSDVWSYG 228
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 7e-17
Identities = 39/167 (23%), Positives = 68/167 (40%), Gaps = 30/167 (17%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRIL-REIKLLRLLR 74
+++ + IG G++G + + +T E VAIK E + L E + + L
Sbjct: 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLG 62
Query: 75 H-PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL------- 126
I ++ + K +V EL+ L + D F L
Sbjct: 63 SGDGIPQVYY-----FGPCGKYNAMVLELLGPSLEDLFDLCD------RTFSLKTVLMIA 111
Query: 127 YQLLRGLKYIHTANVFHRDLKPKNIL-----ANADCKLKICDFGLAR 168
QL+ ++Y+H+ N+ +RD+KP+N L + I DF LA+
Sbjct: 112 IQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 65/266 (24%), Positives = 103/266 (38%), Gaps = 74/266 (27%)
Query: 17 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 69
+ +V+G G++G V +A +VA+K + E + R + E+K+
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKM 101
Query: 70 L-RLLRHPDIVEIKHIML------PPSRREFKDIYVVFELME------------------ 104
+ +L H +IV +L P IY++FE
Sbjct: 102 MTQLGSHENIVN----LLGACTLSGP-------IYLIFEYCCYGDLLNYLRSKREKFSED 150
Query: 105 ------SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 158
+ + + LT E F YQ+ +G++++ + HRDL +N+L
Sbjct: 151 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV 210
Query: 159 LKICDFGLARVSFNDAPSAIFWTD-YVAT-------RWYRAPELCGSFF-SKYTPAIDIW 209
+KICDFGLAR I YV +W APE S F YT D+W
Sbjct: 211 VKICDFGLARD--------IMSDSNYVVRGNARLPVKWM-APE---SLFEGIYTIKSDVW 258
Query: 210 SIGCIFAEMLT-GKPLFPGKNVVHQL 234
S G + E+ + G +PG V
Sbjct: 259 SYGILLWEIFSLGVNPYPGIPVDANF 284
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 16/159 (10%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-SDATRILREIKLLRLLR 74
+RY++ IG GS+G + D GE VAIK E V + ++ E K+ ++++
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQ 62
Query: 75 H-PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRG 132
I I+ E +V EL+ L + + + Q++
Sbjct: 63 GGVGIPTIRW-----CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISR 117
Query: 133 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLAR 168
++YIH+ N HRD+KP N L + I DFGLA+
Sbjct: 118 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 33/168 (19%), Positives = 71/168 (42%), Gaps = 21/168 (12%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
++ + + IG G +G++ A T+ E+ A + E+ + + E+K + + D
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK--VEY-QENGPLFSELKFYQRVAKKD 94
Query: 78 IVE-------IKHIMLP-------PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ 123
++ + ++ +P + ++V E + DL ++ N
Sbjct: 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVL 154
Query: 124 FFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLAR 168
++L L+YIH H D+K N+L N D ++ + D+GL+
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-QVYLADYGLSY 201
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-15
Identities = 36/167 (21%), Positives = 68/167 (40%), Gaps = 30/167 (17%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRIL-REIKLLRLLR 74
Y++ IG+GS+GV+ + ++VAIK FE L E + +LL
Sbjct: 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLRDEYRTYKLLA 63
Query: 75 H-PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL------- 126
I + + +E +V +L+ L ++ +F +
Sbjct: 64 GCTGIPNVYY-----FGQEGLHNVLVIDLLGPSLEDLLDLCG------RKFSVKTVAMAA 112
Query: 127 YQLLRGLKYIHTANVFHRDLKPKNIL-----ANADCKLKICDFGLAR 168
Q+L ++ IH ++ +RD+KP N L + + + DFG+ +
Sbjct: 113 KQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 55/235 (23%), Positives = 90/235 (38%), Gaps = 76/235 (32%)
Query: 24 VIGKGSYGVV--GSAVDTHTGERVAIKKINDV-------FEHVSDATRILREIKLLRLLR 74
+IG G +G V G D G +VA+K+ F EI+ L R
Sbjct: 46 LIGHGVFGKVYKGVLRD---GAKVALKRRTPESSQGIEEF---------ETEIETLSFCR 93
Query: 75 HPDIV-------EIKHIMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHY 122
HP +V E ++L +++ M + L+ ++ E
Sbjct: 94 HPHLVSLIGFCDERNEMIL------------IYKYMENGNLKRHLYGSDLPTMSMSWE-- 139
Query: 123 QFFLYQLL-------RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175
Q L RGL Y+HT + HRD+K NIL + + KI DFG+++
Sbjct: 140 -----QRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194
Query: 176 SAIFWTDYVATRW-----YRAPELCGSFFS--KYTPAIDIWSIGCIFAEMLTGKP 223
+ +++T Y PE +F + T D++S G + E+L +
Sbjct: 195 T------HLSTVVKGTLGYIDPE----YFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 39/159 (24%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-SDATRILREIKLLRLLR 74
+++++ IG GS+G + + T E VAIK E+V + ++L E K+ R+L+
Sbjct: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKIYRILQ 60
Query: 75 -HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRG 132
I ++ E +V +L+ L + L+ + Q++
Sbjct: 61 GGTGIPNVRW-----FGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
Query: 133 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLAR 168
++++H+ + HRD+KP N L ++ I DFGLA+
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 18/140 (12%)
Query: 103 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 162
+E + D LT EH + +Q+ +G++++ + HRDL +NIL + +KIC
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 235
Query: 163 DFGLARVSFNDAPSAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 215
DFGLAR + D DYV +W APE F YT D+WS G +
Sbjct: 236 DFGLARDIYKD-------PDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLL 285
Query: 216 AEMLT-GKPLFPGKNVVHQL 234
E+ + G +PG + +
Sbjct: 286 WEIFSLGASPYPGVKIDEEF 305
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 5e-13
Identities = 60/231 (25%), Positives = 94/231 (40%), Gaps = 67/231 (29%)
Query: 24 VIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSD--ATRILREIKLLRLLRHPDIV 79
+G+G +GVV G V+ VA+KK+ + + ++ + +EIK++ +H ++V
Sbjct: 38 KMGEGGFGVVYKGY-VN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 80 -------EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLL-- 130
+ + L V+ M N L L L
Sbjct: 94 ELLGFSSDGDDLCL------------VYVYMP---------NGSL-----LDRLSCLDGT 127
Query: 131 ----------------RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174
G+ ++H + HRD+K NIL + KI DFGLAR S A
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 175 PSAIFWTDYVA-TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKP 223
+ + T + T Y APE L G + TP DI+S G + E++TG P
Sbjct: 188 QTVM--TSRIVGTTAYMAPEALRG----EITPKSDIYSFGVVLLEIITGLP 232
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 69.1 bits (168), Expect = 2e-12
Identities = 62/416 (14%), Positives = 124/416 (29%), Gaps = 111/416 (26%)
Query: 37 VDTHTGE-RVAIKKINDVFE----------HVSDATR-ILREIKLLRLLRHPDIVEIKHI 84
+D TGE + K I VFE V D + IL + EI HI
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSK------------EEIDHI 54
Query: 85 MLPPSRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQL--------LRGLK 134
++ +F + S ++++ + L Y+F + + +
Sbjct: 55 IMSKDAVS--GTLRLFWTLLSKQEEMVQKFVEEVLRIN-YKFLMSPIKTEQRQPSMMTRM 111
Query: 135 YIHTANVFHRD-----------LKPKNILANADCKLK----ICDFG--------LARVSF 171
YI + + D L+P L A +L+ + G +A
Sbjct: 112 YIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVC 171
Query: 172 NDA------PSAIFWTDYVATRWYRAPE--------LCGSFFSKYTPAIDIWSIGCIFAE 217
IFW + + +PE L +T D S +
Sbjct: 172 LSYKVQCKMDFKIFW---LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH 228
Query: 218 MLTGKP--LFPGKNVVHQLDLMTDLLGTPSTESI------SRI----RNEKARRYLGSMR 265
+ + L K + L ++ ++ + ++ +I R ++ +L +
Sbjct: 229 SIQAELRRLLKSKPYENCLLVLLNVQ---NAKAWNAFNLSCKILLTTRFKQVTDFLSAAT 285
Query: 266 KKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA-DPYFHGL--ANVDREPST 322
H LL + L P+D P E L +P + ++ +T
Sbjct: 286 TTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP--REVLTTNPRRLSIIAESIRDGLAT 343
Query: 323 QPISKLEFEFER-RKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVD 377
++ + + D + +I + P ++ ++P
Sbjct: 344 ---------WDNWKHVNCDKLTTIIESSLNVLEPAEYRKMF----DRLSVFPPSAH 386
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 2e-10
Identities = 71/489 (14%), Positives = 140/489 (28%), Gaps = 150/489 (30%)
Query: 19 YQIQEVIGKGSYGVVGS-----AVDTHTGERVAIKKINDVF-----EHVSDATRILREIK 68
+++ GV+GS A+D +V K +F S T + K
Sbjct: 145 LELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQK 204
Query: 69 LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQ----VIKANDDL-TPEHYQ 123
LL + H R + L++S ++ V+ ++ + +
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLRIHSIQAELR-RLLKSKPYENCLLVL---LNVQNAKAWN 260
Query: 124 FFLYQ--------------LLRGLKYIHTANVFHRD-LKP---KNILANADCKLKICDFG 165
F L H + H L P K++L L
Sbjct: 261 AFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKY---LDCRPQD 317
Query: 166 LARVSFNDAPSAI--FWT---DYVATRW--YRAPELCGSFFSKYTPAIDIWSIGCI---- 214
L R P + D +A W ++ K T I+ S+ +
Sbjct: 318 LPREVLTTNPRRLSIIAESIRDGLA-TWDNWKHVN-----CDKLTTIIES-SLNVLEPAE 370
Query: 215 ----FAEMLTGKPLFPGKNVVHQLDLMTDLLGT----PSTESISRIRNEKARRYLGSMRK 266
F + L+ +FP + + T LL + + N+ + S+ +
Sbjct: 371 YRKMF-DRLS---VFP-PSA----HIPTILLSLIWFDVIKSDVMVVVNKLHKY---SLVE 418
Query: 267 KQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL-------------------AD 307
KQP + ++ + L ++ ++ D
Sbjct: 419 KQPKESTI--------SIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLD 470
Query: 308 PYF------HGLANVDREPSTQPISK--LEFEFERRKLAKD---------------DVRE 344
YF H L N++ L+F F +K+ D ++
Sbjct: 471 QYFYSHIGHH-LKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLK- 528
Query: 345 MIYRE-ILEYHPQM------LQEYLRGGEQTSFMYPSGVDRFKR--QFAHLEEH---YGK 392
Y+ I + P+ + ++L E+ + + A + E + +
Sbjct: 529 -FYKPYICDNDPKYERLVNAILDFLPKIEENLICSK-----YTDLLRIALMAEDEAIFEE 582
Query: 393 GERSTPLQR 401
+ +QR
Sbjct: 583 AHKQ--VQR 589
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 36/174 (20%), Positives = 72/174 (41%), Gaps = 30/174 (17%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+++ IG+G +G + A D ++ E V V SD + E+K + P+
Sbjct: 36 AWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 78 IVE-------IKHIMLPP-------SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ 123
++ +K++ +P + +++ + SDL ++ +AN +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA------KR 148
Query: 124 FFL-------YQLLRGLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLAR 168
F ++L L+YIH H D+K N+L ++ + D+GLA
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 23/174 (13%), Positives = 62/174 (35%), Gaps = 30/174 (17%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTG--------ERVAIKKINDVFEHVSDATRILREIKL 69
+++++ + + G++ A T T ++ ++K + R+ E
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-----LDAKD--GRLFNEQNF 95
Query: 70 L-RLLRHPDIVEIKHIMLPPS----------RREFKDIYVVFELMESDLHQVIKANDDLT 118
R + + + K + P + K ++V + L + +
Sbjct: 96 FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHV 155
Query: 119 -PEHYQFFL-YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI--CDFGLAR 168
E + +LL L+++H H ++ +NI + + + ++ +G A
Sbjct: 156 LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 49/219 (22%), Positives = 94/219 (42%), Gaps = 43/219 (19%)
Query: 24 VIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV-- 79
++G+G +G V G D G VA+K++ + + + E++++ + H +++
Sbjct: 37 ILGRGGFGKVYKGRLAD---GTLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRL 92
Query: 80 -----EIKHIMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLT-PEHYQFFLYQ 128
+L V+ M S L + ++ L P+ + L
Sbjct: 93 RGFCMTPTERLL------------VYPYMANGSVASCLRERPESQPPLDWPKRQRIAL-G 139
Query: 129 LLRGLKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVA 185
RGL Y+H + HRD+K NIL + + + + DFGLA++ + + + T
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVT-TAVRG 197
Query: 186 TRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEMLTGK 222
T + APE G K + D++ G + E++TG+
Sbjct: 198 TIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQ 232
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 508 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.34 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.2 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.11 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.85 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.59 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.48 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.28 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.28 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.19 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.13 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.86 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.66 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.52 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.48 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.16 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.14 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.12 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.11 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.07 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.01 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.9 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.82 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.81 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.81 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.28 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.27 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.16 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.58 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-70 Score=567.94 Aligned_cols=342 Identities=49% Similarity=0.881 Sum_probs=300.3
Q ss_pred cccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCC-C
Q 010512 11 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP-S 89 (508)
Q Consensus 11 ~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~-~ 89 (508)
..|..+++|++++.||+|+||+||+|+++.||+.||||++++........+++.+|+++|+.|+|||||++++++... .
T Consensus 48 ~~~~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 127 (398)
T 4b99_A 48 VTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVP 127 (398)
T ss_dssp CCCCCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred CCCCCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccc
Confidence 345677899999999999999999999999999999999987766667778899999999999999999999998654 3
Q ss_pred cCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 90 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 90 ~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
+.+.+++|||||||+|+|.+++...+++++.+++.|++||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 128 ~~~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 128 YGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp TTTCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred cccCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 34567899999999999999999999999999999999999999999999999999999999999999999999999986
Q ss_pred ccCCC-CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 170 SFNDA-PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 170 ~~~~~-~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
..... ......+.++||++|||||++.+. ..|+.++||||+|||+|||++|++||++.+..+++..|....|+|+...
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 53322 222335678999999999998762 5679999999999999999999999999999999999999999999998
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccch
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKL 328 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~ 328 (508)
+..+.......++..++...+.++...++++++.+++||.+||.+||.+|||++|+|+||||+...+++.++...+ .+
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~~~--~~ 364 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAP--PF 364 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCCSS--CC
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCCCC--CC
Confidence 8887777788888888888888888889999999999999999999999999999999999999887777766543 45
Q ss_pred hhHHHHhhcCHHHHHHHHHHHHHHhCh
Q 010512 329 EFEFERRKLAKDDVREMIYREILEYHP 355 (508)
Q Consensus 329 ~~~~~~~~~~~~~~~~~i~~ei~~~~~ 355 (508)
++.++...+..++++++++.|+.++|.
T Consensus 365 ~~~~~~~~~~~~~~k~~i~~ei~~~~~ 391 (398)
T 4b99_A 365 DFAFDREALTRERIKEAIVAEIEDFHA 391 (398)
T ss_dssp CCHHHHSCCCHHHHHHHHHHHHHHHHH
T ss_pred CCccchhhcCHHHHHHHHHHHHHHHHH
Confidence 677888889999999999999988775
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-63 Score=497.99 Aligned_cols=261 Identities=26% Similarity=0.451 Sum_probs=225.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+++|+.|+|||||++++++. +.+
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~ 105 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDE 105 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence 457999999999999999999999999999999997532 22234577899999999999999999999994 456
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
++|||||||+ |+|.++|.+.+.+++.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 106 ~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 7999999998 599999999899999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
.. .......+||+.|||||++.+ ..|+.++||||||||+|+|++|++||.+.+....+..|...-
T Consensus 186 ~~-~~~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~------------ 250 (311)
T 4aw0_A 186 SK-QARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE------------ 250 (311)
T ss_dssp TT-CCCBCCCCSCGGGCCHHHHHH--SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------------
T ss_pred CC-cccccCcccCcccCCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------------
Confidence 22 223456899999999999987 789999999999999999999999999988766665554310
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHH------HhcCCcccCCCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE------ALADPYFHGLAN 315 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~e------iL~hp~f~~~~~ 315 (508)
..+ ...+++.+++||.+||++||.+|||++| +++||||+++..
T Consensus 251 ----------------~~~---p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw 299 (311)
T 4aw0_A 251 ----------------YDF---PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 299 (311)
T ss_dssp ----------------CCC---CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred ----------------CCC---CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence 111 1357899999999999999999999988 589999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-62 Score=502.38 Aligned_cols=259 Identities=26% Similarity=0.437 Sum_probs=219.7
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
..-++|++++.||+|+||+||+|+++.+|+.||||++++.........++.+|+.+|+.|+|||||++++++. +.
T Consensus 21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-----~~ 95 (350)
T 4b9d_A 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-----EN 95 (350)
T ss_dssp SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-----EC
Confidence 3457999999999999999999999999999999999876556666788999999999999999999999994 44
Q ss_pred ccEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 94 KDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
+.+|||||||+ |+|.++|...+ .+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 96 ~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 175 (350)
T 4b9d_A 96 GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175 (350)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceee
Confidence 67999999998 69999997643 5799999999999999999999999999999999999999999999999999864
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
... ....+..+||+.|||||++.+ ..|+.++||||||||+|||++|++||.+.+..+.+..|....
T Consensus 176 ~~~---~~~~~~~~GT~~YmAPE~l~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--------- 241 (350)
T 4b9d_A 176 NST---VELARACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS--------- 241 (350)
T ss_dssp CHH---HHHHHHHHSCCTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC---------
T ss_pred cCC---cccccccCCCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC---------
Confidence 221 112356789999999999987 789999999999999999999999999988776665553210
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
+......+++.+.+||.+||++||.+|||++|+|+||||+.
T Consensus 242 ---------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 242 ---------------------FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp ---------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred ---------------------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 11123467899999999999999999999999999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-62 Score=498.51 Aligned_cols=256 Identities=29% Similarity=0.498 Sum_probs=221.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
.+|++++.||+|+||+||+|+++.||+.||||+++.... .....+.+|+.+|+.|+|||||++++++. +.+.+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~ 146 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDEL 146 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence 579999999999999999999999999999999975332 23456789999999999999999999994 44579
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 97 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
|||||||+ |+|.+++.. +++++.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 147 ~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp EEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 99999998 599998876 4699999999999999999999999999999999999999999999999999987543322
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
..+..+||++|||||++.+ ..|+.++||||||||+|||++|++||.+.+..+.+..|....
T Consensus 226 ---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-------------- 286 (346)
T 4fih_A 226 ---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-------------- 286 (346)
T ss_dssp ---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS--------------
T ss_pred ---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC--------------
Confidence 2456899999999999987 789999999999999999999999999988777666554311
Q ss_pred HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.+....+..+++.+.+||.+||++||.+|||++|+|+||||+..
T Consensus 287 --------------~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 287 --------------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp --------------CCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred --------------CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 01112234678999999999999999999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-62 Score=484.70 Aligned_cols=255 Identities=31% Similarity=0.530 Sum_probs=206.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
-++|++++.||+|+||+||+|+++.+|+.||||++++... ......++.+|+.+|+.++|||||++++++. +..
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-----SKD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECC
Confidence 3689999999999999999999999999999999975432 2233567899999999999999999999994 446
Q ss_pred cEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 95 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 95 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
.+|||||||+|+|.+++..++++++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 87 ~~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 87 EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 79999999999999999999999999999999999999999999999999999999999999999999999998643322
Q ss_pred CCcccccccccCcccccccccccccCCC-CcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y-~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
..+..+||+.|||||++.+ ..| +.++||||+||++|+|++|++||.+.+....+..|...
T Consensus 167 ----~~~~~~GT~~Y~APE~~~~--~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~------------- 227 (275)
T 3hyh_A 167 ----FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG------------- 227 (275)
T ss_dssp ------------CTTSCHHHHSS--SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------------
T ss_pred ----ccCCeeECcccCChhhhcC--CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-------------
Confidence 2356799999999999987 454 68999999999999999999999988765554444321
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
. ..+ ...+++.+.+||.+||++||.+|||++|+|+||||+.
T Consensus 228 --------------~-~~~---p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 228 --------------V-YTL---PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp --------------C-CCC---CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred --------------C-CCC---CCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 0 111 1357899999999999999999999999999999973
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-61 Score=509.97 Aligned_cols=346 Identities=41% Similarity=0.739 Sum_probs=287.2
Q ss_pred cccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 11 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 11 ~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
..+...++|++++.||+|+||+||+|++..+|+.||||++.+........+++.+|+.+|+.++||||+++++++.....
T Consensus 47 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 47 SDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp SSCCSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred CcCccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence 45677899999999999999999999999999999999998777777778899999999999999999999999987665
Q ss_pred CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 91 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 91 ~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
.....+|+||||++++|.+++.....+++.+++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 127 ~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 127 EKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp TTCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred ccCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 66778999999999999999998888999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCC------------------------cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh------
Q 010512 171 FNDAPS------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT------ 220 (508)
Q Consensus 171 ~~~~~~------------------------~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt------ 220 (508)
...... ....+.++||++|+|||++... ..|+.++||||||||+|||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 322111 1134667999999999987542 679999999999999999998
Q ss_pred -----CCCCCCCCC--------------------hHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCC
Q 010512 221 -----GKPLFPGKN--------------------VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHK 275 (508)
Q Consensus 221 -----G~~pF~~~~--------------------~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 275 (508)
|+++|++.+ ..+++..|.+++|+|+.+.+..+.......++..++......+...
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 889998876 3688999999999999999999999999999999998888889999
Q ss_pred CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccchhhHHHHhhcCHHHHHHHHHHHHHHhCh
Q 010512 276 FPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 355 (508)
Q Consensus 276 ~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ei~~~~~ 355 (508)
++.+++.+.+||.+||.+||.+|||++|+|+||||+++.....++.......+.+. +...+..++++++++.|+..++|
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~~ 444 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYHP 444 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSC-TTSCCCHHHHHHHHHHHHTTTCT
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhCc
Confidence 99999999999999999999999999999999999998876655543322222221 23567889999999999999998
Q ss_pred hhH
Q 010512 356 QML 358 (508)
Q Consensus 356 ~~~ 358 (508)
++.
T Consensus 445 ~~~ 447 (458)
T 3rp9_A 445 EIQ 447 (458)
T ss_dssp TCC
T ss_pred ccc
Confidence 643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-60 Score=501.36 Aligned_cols=346 Identities=37% Similarity=0.694 Sum_probs=297.6
Q ss_pred ccccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC
Q 010512 10 FTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 89 (508)
Q Consensus 10 ~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 89 (508)
+..+...++|++++.||+|+||+||+|++..+|+.||||+++.........+++.+|+.+|+.++||||+++++++....
T Consensus 19 ~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 98 (432)
T 3n9x_A 19 IKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD 98 (432)
T ss_dssp GGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred CCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 45678899999999999999999999999999999999999877777777889999999999999999999999998765
Q ss_pred cCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 90 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 90 ~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
......+|+||||++++|.+++.....+++.+++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 99 ~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 99 LLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp TTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 55567899999999999999999888899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCC-------------------cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh----------
Q 010512 170 SFNDAPS-------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT---------- 220 (508)
Q Consensus 170 ~~~~~~~-------------------~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt---------- 220 (508)
....... ....+.++||++|+|||++... ..|+.++||||||||+|+|++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 257 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhcccccccccc
Confidence 5432211 0224678999999999987542 679999999999999999997
Q ss_pred -CCCCCCCCC-----------------hHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHH
Q 010512 221 -GKPLFPGKN-----------------VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPL 282 (508)
Q Consensus 221 -G~~pF~~~~-----------------~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 282 (508)
|.++|++.+ ..+++..|.+++|+|+.+.+..+.......++...+...+.++...++.+++.
T Consensus 258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 337 (432)
T 3n9x_A 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD 337 (432)
T ss_dssp GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence 677787765 47889999999999999999999999999999998888888888888999999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccchhhHHHHhhcCHHHHHHHHHHHHHHhChhh
Q 010512 283 ALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQM 357 (508)
Q Consensus 283 ~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ei~~~~~~~ 357 (508)
+.+||.+||++||.+|||++|+|+||||+++.....++.........+. +...++.+++++++++|+..++|++
T Consensus 338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~~~~ 411 (432)
T 3n9x_A 338 GINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPEL 411 (432)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSC-TTCCCCHHHHHHHHHHHHHHHCTTC
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChh-hcccCCHHHHHHHHHHHHHHhCccc
Confidence 9999999999999999999999999999999877666543322222221 2256889999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-61 Score=479.44 Aligned_cols=262 Identities=26% Similarity=0.380 Sum_probs=219.0
Q ss_pred CCCCCe-EEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 14 GEASRY-QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 14 ~~~~rY-~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
...+|| ++.+.||+|+||+||+|++..+|..||||++...........++.+|+.+|+.|+|||||++++++.... ..
T Consensus 22 ~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~ 100 (290)
T 3fpq_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KG 100 (290)
T ss_dssp CTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TT
T ss_pred CCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CC
Confidence 445666 7888999999999999999999999999999866556666788999999999999999999999985422 23
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcC--ceecCCCCCceeeCC-CCcEEEccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANA-DCKLKICDFGLAR 168 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~g--IiHrDLKPeNILl~~-~~~lkL~DFGla~ 168 (508)
...+|||||||+ |+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++. +|.+||+|||+|+
T Consensus 101 ~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 456899999998 699999999889999999999999999999999999 999999999999985 7999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
..... ..+..+||+.|||||++.+ .|+.++||||||||+|||++|++||.+.+...++...... +
T Consensus 181 ~~~~~-----~~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~------ 245 (290)
T 3fpq_A 181 LKRAS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-G------ 245 (290)
T ss_dssp GCCTT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-T------
T ss_pred eCCCC-----ccCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-C------
Confidence 54221 2356799999999999864 6999999999999999999999999876554433221110 0
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
..+. ......++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 246 ------------------~~~~---~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 246 ------------------VKPA---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ------------------CCCG---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ------------------CCCC---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 0011 112346789999999999999999999999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-61 Score=500.59 Aligned_cols=256 Identities=29% Similarity=0.498 Sum_probs=222.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|++++.||+|+||+||+|+++.+|+.||||+++.... .....+.+|+.+|+.|+|||||+++++|.. .+.+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~ 223 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDEL 223 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CCEE
Confidence 579999999999999999999999999999999975322 234568899999999999999999999954 4579
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 97 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
|||||||+ |+|.+++.. +.+++.+++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 224 ~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 224 WVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp EEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred EEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 99999998 599998875 4699999999999999999999999999999999999999999999999999987543322
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
..+..+||++|||||++.+ ..|+.++||||||||+|||++|++||.+.+....+..|....
T Consensus 303 ---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-------------- 363 (423)
T 4fie_A 303 ---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-------------- 363 (423)
T ss_dssp ---CBCCCEECTTTCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--------------
T ss_pred ---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC--------------
Confidence 2467899999999999987 789999999999999999999999999988777666554311
Q ss_pred HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.+....+..+++.+.+||.+||++||.+|||++|+|+||||+..
T Consensus 364 --------------~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 364 --------------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp --------------CCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred --------------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 01112345688999999999999999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-61 Score=487.41 Aligned_cols=258 Identities=28% Similarity=0.437 Sum_probs=215.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC---CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~---~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
+++|++++.||+|+||+||+|++. .+++.||||++++.........++.+|+.+|+.|+|||||++++++. +
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~ 97 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ-----T 97 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE-----E
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----E
Confidence 468999999999999999999884 47899999999765433334456889999999999999999999994 4
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
.+.+|||||||+ |+|.+++.+.+.+++.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 467999999998 6999999998999999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
... ...+..+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|...
T Consensus 178 ~~~---~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~----------- 241 (304)
T 3ubd_A 178 DHE---KKAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA----------- 241 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred CCC---ccccccccCcccCCHHHhcc--CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC-----------
Confidence 322 12356799999999999987 78999999999999999999999999998877666555321
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLA 314 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt-----a~eiL~hp~f~~~~ 314 (508)
. .. ....+++.+.+||.+||++||.+||| ++|+++||||+++.
T Consensus 242 ---------------~--~~---~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 242 ---------------K--LG---MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp ---------------C--CC---CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred ---------------C--CC---CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence 0 01 11357899999999999999999998 58999999998763
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-59 Score=480.64 Aligned_cols=335 Identities=41% Similarity=0.760 Sum_probs=286.2
Q ss_pred cccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC-
Q 010512 11 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS- 89 (508)
Q Consensus 11 ~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~- 89 (508)
+.+...++|++++.||+|+||+||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++....
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 19 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp SEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred ceeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 3567789999999999999999999999999999999999776666666788999999999999999999999997642
Q ss_pred cCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 90 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 90 ~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
......+|+||||++++|.+++.. ..+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 99 LDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cccCceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 233466899999998899999876 5799999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
... ..+.+++|++|+|||++.+. ..|+.++||||+|||+|+|++|++||.+.+..+++..|...+|+|+.+.+
T Consensus 178 ~~~------~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 178 ADS------EMTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CCS------SCCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccc------ccCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 432 13567899999999998762 57999999999999999999999999999999999999999999999999
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccchh
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLE 329 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~~ 329 (508)
..+.......++..++......+...++.+++.+.+||.+||.+||.+|||++|+|+||||+.+.+...++..+ .++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~---~~~ 327 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ---KYD 327 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC---CCC
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCC---CCC
Confidence 99998889999999888888888888999999999999999999999999999999999999988777666544 355
Q ss_pred hHHHHhhcCHHHHHHHHHHHHHHhChh
Q 010512 330 FEFERRKLAKDDVREMIYREILEYHPQ 356 (508)
Q Consensus 330 ~~~~~~~~~~~~~~~~i~~ei~~~~~~ 356 (508)
+.++......++++++++.++..++|.
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (367)
T 1cm8_A 328 DSFDDVDRTLDEWKRVTYKEVLSFKPP 354 (367)
T ss_dssp CC-----CCHHHHHHHHHHHHHTCCC-
T ss_pred CChhhhcCCHHHHHHHHHHHHHHhccc
Confidence 667777888999999999999998876
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-60 Score=481.88 Aligned_cols=258 Identities=27% Similarity=0.371 Sum_probs=216.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.+.|++.+.||+|+||+||+|+++.+|+.||||+++.... ..+|+.+|+.|+|||||++++++. +.+.
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~-----~~~~ 124 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVR-----EGPW 124 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEE-----ETTE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEE-----ECCE
Confidence 3579999999999999999999999999999999974321 247999999999999999999994 4467
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC-cEEEccccccccccCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVSFND 173 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~-~lkL~DFGla~~~~~~ 173 (508)
+|||||||+ |+|.++|...+.+++..++.|+.||+.||.|||++||+||||||+|||++.+| .+||+|||+|+.....
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999998 69999999988999999999999999999999999999999999999999998 6999999999875433
Q ss_pred CCCc--ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 174 APSA--IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 174 ~~~~--~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.... ......+||+.|||||++.+ ..|+.++||||||||+|||++|++||.+.+....+..|..
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~------------ 270 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS------------ 270 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH------------
T ss_pred CcccceecCCccccCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc------------
Confidence 2211 11234689999999999987 7899999999999999999999999988765444433322
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHH-------------hcCCcccCCCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA-------------LADPYFHGLAN 315 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~ei-------------L~hp~f~~~~~ 315 (508)
.+.++....+.+++.+.+||.+||++||.+|||+.|+ |+|||+.....
T Consensus 271 ----------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 271 ----------------EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp ----------------SCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred ----------------CCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 1122233456789999999999999999999999997 67999987643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-59 Score=483.20 Aligned_cols=287 Identities=26% Similarity=0.423 Sum_probs=223.7
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEEC---CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 89 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~---~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~ 89 (508)
...++|++++.||+|+||+||+|+++ .+++.||||++.+. ....++.+|+++|+.+ .||||+++++++.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~--- 90 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFR--- 90 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEE---
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEE---
Confidence 45688999999999999999999875 46889999998643 2346788999999998 5999999999994
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC-CcEEEcccccc
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLA 167 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~-~~lkL~DFGla 167 (508)
+.+++|||||||+ |+|.+++. .+++.+++.|++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|
T Consensus 91 --~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 91 --KNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp --ETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred --ECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 4467999999998 69999883 59999999999999999999999999999999999999887 79999999999
Q ss_pred ccccCCCC-------------------------CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCC
Q 010512 168 RVSFNDAP-------------------------SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK 222 (508)
Q Consensus 168 ~~~~~~~~-------------------------~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~ 222 (508)
+....... .....+..+||++|||||++.+. ..|+.++||||+|||+|+|++|+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTC
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCC
Confidence 86432211 01123456899999999999762 46999999999999999999999
Q ss_pred CCC-CCCChHHHHHHHHhhcCCCChHHHHHHhh--------------HHHHHHHhhcccCC---------CCCCCCCCCC
Q 010512 223 PLF-PGKNVVHQLDLMTDLLGTPSTESISRIRN--------------EKARRYLGSMRKKQ---------PVPFSHKFPN 278 (508)
Q Consensus 223 ~pF-~~~~~~~~l~~i~~~~g~p~~~~~~~~~~--------------~~~~~~l~~~~~~~---------~~~~~~~~~~ 278 (508)
+|| .+.+..+++..|..++|++.......... ......+....... .......+..
T Consensus 245 ~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 324 (361)
T 4f9c_A 245 YPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE 324 (361)
T ss_dssp SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred CCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence 887 67788899999999998754433221100 00000111111000 0111234567
Q ss_pred CCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 279 ADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 279 ~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
++++++|||.+||++||.+|||++|+|+||||+++
T Consensus 325 is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 325 VPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 89999999999999999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=481.57 Aligned_cols=337 Identities=40% Similarity=0.740 Sum_probs=268.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~ 94 (508)
.++|++++.||+|+||+||+|.+..+|+.||||++.+.........++.+|+.+|+.+. ||||+++++++... +..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~ 84 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDR 84 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCC
Confidence 47899999999999999999999999999999999877777778888999999999997 99999999999653 235
Q ss_pred cEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 95 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 95 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
.+|+|||||+++|.+++.. ..+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 85 DVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp CEEEEEECCSEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEEEEecccCcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 7999999999999999987 479999999999999999999999999999999999999999999999999998643211
Q ss_pred ------------------CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 010512 175 ------------------PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 236 (508)
Q Consensus 175 ------------------~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~ 236 (508)
......+.++||++|+|||++.+. ..|+.++||||||||+|+|++|++||++.+..+++..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 111234567999999999998762 5799999999999999999999999999999999999
Q ss_pred HHhhcCCCChHHHHHHhhHHHHHHHhhcccCC---CCCCCCCCC-------------CCCHHHHHHHHHhccCCCCCCCC
Q 010512 237 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQ---PVPFSHKFP-------------NADPLALHLLERLLAFDPKDRPT 300 (508)
Q Consensus 237 i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~---~~~~~~~~~-------------~~~~~~~~Ll~~mL~~DP~~Rpt 300 (508)
|...+|.|..+.+..+.......++..+.... ...+...++ .+++.+.+||.+||++||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 99999999998887766555555554443322 223333333 67899999999999999999999
Q ss_pred HHHHhcCCcccCCCCCCCCCCCCCccchhhHHHHhhcCHHHHHHHHHHHHHHhChhhH
Q 010512 301 AEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQML 358 (508)
Q Consensus 301 a~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ei~~~~~~~~ 358 (508)
++|+|+||||+.+.+...++.........+. .......++++++++.++.++++++.
T Consensus 323 ~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (388)
T 3oz6_A 323 ANDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHSIDDYRNLVYSEISRRKRELI 379 (388)
T ss_dssp HHHHTTSTTTTTTCCGGGCCCCSSCCCCC-------CCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHhCCHHHHHhcCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhhhhhh
Confidence 9999999999998887776665443322222 23467789999999999998887644
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-59 Score=480.30 Aligned_cols=335 Identities=43% Similarity=0.806 Sum_probs=281.4
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC-c
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-R 90 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~-~ 90 (508)
.|...++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++.... .
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 103 (367)
T 2fst_X 24 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 103 (367)
T ss_dssp EEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred ccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcc
Confidence 466779999999999999999999999999999999999876666667788999999999999999999999997542 2
Q ss_pred CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 91 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 91 ~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
.....+|+|||+++++|.+++.. ..+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 104 EEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp GGCCCCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred ccCCeEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 34567899999999999998876 57999999999999999999999999999999999999999999999999999864
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.. ..+.++||++|+|||++.+. ..|+.++||||||||+|+|++|++||++.+..+++..|...+|+|..+.+.
T Consensus 183 ~~------~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 183 AD------EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp --------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred cc------cCCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 32 13557899999999998762 578999999999999999999999999999999999999999999999999
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccchhh
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEF 330 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~~~ 330 (508)
.+.....+.++..+.......+...++++++.+.+||.+||.+||.+|||++|+|+||||+.+..+..++...+ +.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~---~~~ 332 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YDQ 332 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCCC---CCG
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCCC---CCc
Confidence 99999999999888888777888888899999999999999999999999999999999999887766655443 455
Q ss_pred HHHHhhcCHHHHHHHHHHHHHHhChhh
Q 010512 331 EFERRKLAKDDVREMIYREILEYHPQM 357 (508)
Q Consensus 331 ~~~~~~~~~~~~~~~i~~ei~~~~~~~ 357 (508)
.++...+..+++++++|.|+..++|..
T Consensus 333 ~~~~~~~~~~~~~~~~~~e~~~~~~~~ 359 (367)
T 2fst_X 333 SLESRDLLIDEWKSLTYDEVISFVPPP 359 (367)
T ss_dssp GGSSCCCCHHHHHHHHHHHHHHCCCCC
T ss_pred chhhccCCHHHHHHHHHHHHHHhccCc
Confidence 566678889999999999999998864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-57 Score=485.51 Aligned_cols=332 Identities=36% Similarity=0.673 Sum_probs=266.0
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc-CC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-RE 92 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-~~ 92 (508)
...++|++++.||+|+||+||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++..... .+
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 44689999999999999999999999999999999998766666778889999999999999999999999976532 34
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 93 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
...+|||||||+++|.+.+.. .+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 139 ~~~~~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 139 FQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CCEEEEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CCeEEEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 567999999999999888854 499999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
. ...+..+||++|+|||++.+ ..|+.++||||||||+|+|++|++||++.+..+++..|...+|+|..+.+..+
T Consensus 217 ~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 217 S----FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp C----CCC----CCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred C----cccCCCcccccccCHHHHcC--CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 2 23466899999999999987 68999999999999999999999999999999999999999999999988776
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCC------------CHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNA------------DPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREP 320 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~------------~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~ 320 (508)
. .....++...+......+...++.. ++.+.+||.+||.+||.+|||++|+|+||||+.+.++..+.
T Consensus 291 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~ 369 (464)
T 3ttj_A 291 Q-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE 369 (464)
T ss_dssp C-HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHS
T ss_pred c-hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCccccc
Confidence 4 4455666555444444443333332 56799999999999999999999999999999776543222
Q ss_pred CCCCccchhhHHHHhhcCHHHHHHHHHHHHHHhCh
Q 010512 321 STQPISKLEFEFERRKLAKDDVREMIYREILEYHP 355 (508)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~ei~~~~~ 355 (508)
.. +.......++......+++++++++++.....
T Consensus 370 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 403 (464)
T 3ttj_A 370 AP-PPQIYDKQLDEREHTIEEWKELIYKEVMNSEE 403 (464)
T ss_dssp CC-C-----------CCCHHHHHHHHHHHHHC---
T ss_pred CC-CCccCCcchhhccCCHHHHHHHHHHHHHHhhh
Confidence 11 11234455666778889999999999876544
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-57 Score=456.15 Aligned_cols=262 Identities=25% Similarity=0.416 Sum_probs=199.9
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc-------
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR------- 90 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~------- 90 (508)
+|++++.||+|+||+||+|+++.+|+.||||+++.. ......+++.+|+.+|+.|+|||||++++++.....
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC-SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 599999999999999999999999999999999643 233445678999999999999999999999864321
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccc
Q 010512 91 REFKDIYVVFELME-SDLHQVIKANDD---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 166 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~~---l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGl 166 (508)
....++|||||||+ |+|.+++..... ..+..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 12345899999998 699999987654 44567899999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCc---------ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 010512 167 ARVSFNDAPSA---------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLM 237 (508)
Q Consensus 167 a~~~~~~~~~~---------~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i 237 (508)
|+......... ...+..+||+.|||||++.+ ..|+.++||||||||+|||++ ||.+. .+....+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~ 237 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTL 237 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcC--CCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHH
Confidence 98754332211 12345789999999999987 789999999999999999996 77542 2222222
Q ss_pred HhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 238 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 238 ~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
........+ ..++..++.+.+||.+||++||.+|||+.|+|+||||+++.
T Consensus 238 ~~~~~~~~p---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 238 TDVRNLKFP---------------------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHTTCCC---------------------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHhcCCCC---------------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 221111111 11123356788999999999999999999999999998764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-56 Score=458.54 Aligned_cols=340 Identities=48% Similarity=0.842 Sum_probs=291.0
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
.+...++|++++.||+|+||.||+|.+..++..||||++.. .........+.+|+++|+.++||||+++++++......
T Consensus 22 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP-FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 100 (364)
T ss_dssp BCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-TTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred eccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecc-ccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence 35677899999999999999999999999999999999974 23444567889999999999999999999999776555
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 92 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 92 ~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
....+|+||||++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~~iv~e~~~~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 101 QMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp TCCCEEEEEECCSEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEcccCcCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 56779999999999999998764 69999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
............+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...+|.|..+.+..
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 333333334567899999999987652 5689999999999999999999999999999999999999999999999988
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccchhhH
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFE 331 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~ 331 (508)
+.+.....+....+.....++...++.+++.+.+||.+||++||.+|||++|+|+||||+.......++.... .+.+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~--~~~~~ 336 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFD 336 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSS--CCCCC
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCC--cCCcc
Confidence 8888888888888877777888888899999999999999999999999999999999998765544443322 33445
Q ss_pred HHHhhcCHHHHHHHHHHHHHHhChh
Q 010512 332 FERRKLAKDDVREMIYREILEYHPQ 356 (508)
Q Consensus 332 ~~~~~~~~~~~~~~i~~ei~~~~~~ 356 (508)
.+...+..++++++++.++..++|.
T Consensus 337 ~~~~~~~~~~~~~~~~~e~~~~~~~ 361 (364)
T 3qyz_A 337 MELDDLPKEKLKELIFEETARFQPG 361 (364)
T ss_dssp -----CCHHHHHHHHHHHTGGGCC-
T ss_pred cccccCCHHHHHHHHHHHHHHhhhh
Confidence 5667788999999999998888764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=481.15 Aligned_cols=260 Identities=26% Similarity=0.415 Sum_probs=226.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|++++.||+|+||+||+|+++.+|+.||||++... ...+...+.+|+.+|+.|+|||||+++++|. +...+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-----~~~~~ 229 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEM 229 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----CSSEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEE
Confidence 6899999999999999999999999999999999643 3445677899999999999999999999994 44679
Q ss_pred EEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC--CcEEEccccccccccC
Q 010512 97 YVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVSFN 172 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~--~~lkL~DFGla~~~~~ 172 (508)
|||||||+ |+|+++|.. .+.+++.+++.|++||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 99999998 699999864 4579999999999999999999999999999999999999865 8999999999987533
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
.. .....+||++|||||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+++..|......+
T Consensus 310 ~~----~~~~~~GT~~y~APEv~~~--~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~-------- 375 (573)
T 3uto_A 310 KQ----SVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM-------- 375 (573)
T ss_dssp TS----EEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC--------
T ss_pred CC----ceeeeEECccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCC--------
Confidence 22 2456799999999999988 789999999999999999999999999998877776665432211
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 316 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~ 316 (508)
....++.+++.+++||.+||++||.+|||++|+|+||||+....+
T Consensus 376 -------------------~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 376 -------------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp -------------------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred -------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 122345788999999999999999999999999999999876543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-55 Score=440.29 Aligned_cols=258 Identities=24% Similarity=0.297 Sum_probs=208.3
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++.+.||+|+||+||+|+.. ..||||+++.........+.+.+|+.+|+.|+|||||++++++.. +
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~ 104 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------D 104 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------S
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------C
Confidence 3478999999999999999999754 359999997655556667889999999999999999999998742 3
Q ss_pred cEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 95 DIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
.+|||||||+ |+|.++|... .++++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 4799999998 7999999764 5799999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcccccccccCcccccccccccc-cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
... ....+..+||+.|||||++.+. ...|+.++|||||||++|||++|++||.+.+....+..+..-
T Consensus 185 ~~~-~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~----------- 252 (307)
T 3omv_A 185 WSG-SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR----------- 252 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHT-----------
T ss_pred CCc-ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhc-----------
Confidence 222 1224557899999999998642 246999999999999999999999999987655444332210
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
......+....+++++.+.+|+.+||+.||.+|||+.|++++
T Consensus 253 --------------~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 253 --------------GYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp --------------TCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred --------------CCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 011122334456788999999999999999999999987653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-55 Score=478.82 Aligned_cols=260 Identities=26% Similarity=0.373 Sum_probs=212.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHH---HHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRIL---REIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~---~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
-++|+++++||+|+||+||+|+++.||+.||||++++... .......+. +++.+++.++|||||+++++|.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~----- 262 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH----- 262 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE-----
Confidence 3689999999999999999999999999999999964321 111122233 4466777889999999999994
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
+..++|||||||. |+|.++|...+.+++..+++|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 4467999999998 699999999999999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.... ....+||+.|||||++.+. ..|+.++||||||||+|||++|++||.+.+..+....+...
T Consensus 343 ~~~~-----~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i---------- 406 (689)
T 3v5w_A 343 SKKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---------- 406 (689)
T ss_dssp SSCC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH----------
T ss_pred CCCC-----CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh----------
Confidence 4322 3457999999999999641 57999999999999999999999999765432221111100
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLA 314 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt-----a~eiL~hp~f~~~~ 314 (508)
+ . .+. .....+++.+.+||.+||++||.+|++ ++||++||||+++.
T Consensus 407 ----------~----~-~~~---~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 407 ----------L----T-MAV---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp ----------H----H-CCC---CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred ----------c----C-CCC---CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence 0 0 011 112457899999999999999999998 89999999999865
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=446.70 Aligned_cols=333 Identities=41% Similarity=0.756 Sum_probs=281.8
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc-
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR- 90 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~- 90 (508)
.|...++|++.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 37 ~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 116 (371)
T 4exu_A 37 AWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 116 (371)
T ss_dssp EEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSS
T ss_pred eecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCc
Confidence 4667789999999999999999999999999999999998766666667889999999999999999999999965432
Q ss_pred CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 91 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 91 ~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
.....+|+||||++++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 117 ~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 117 RNFYDFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp TTCCCCEEEEECCCEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred ccceeEEEEEccccccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 1223459999999999988874 45999999999999999999999999999999999999999999999999999854
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
... ....+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....|.+..+.+.
T Consensus 195 ~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 195 DAE------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccC------cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 221 3456899999999998762 578999999999999999999999999999999999999999999999888
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccchhh
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEF 330 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~~~ 330 (508)
.+.......+...+.......+...++.+++.+.+||.+||++||.+|||++|+|+||||+.+..+..+...+. .+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~--~~~~ 345 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ--PFDD 345 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS--CCCC
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCccccccccc--CcCc
Confidence 88777777777777776666666677889999999999999999999999999999999998776544332221 1222
Q ss_pred HHHHhhcCHHHHHHHHHHHHHHhCh
Q 010512 331 EFERRKLAKDDVREMIYREILEYHP 355 (508)
Q Consensus 331 ~~~~~~~~~~~~~~~i~~ei~~~~~ 355 (508)
..+..++..+++++.+++++.+++|
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (371)
T 4exu_A 346 SLEHEKLTVDEWKQHIYKEIVNFSP 370 (371)
T ss_dssp TTSSCCCCHHHHHHHHHHHHHHCCC
T ss_pred chhhcccchHHHHHHHHHHHHhccc
Confidence 3345677889999999999998875
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-55 Score=438.36 Aligned_cols=263 Identities=22% Similarity=0.321 Sum_probs=214.8
Q ss_pred cccccCCCCCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeee
Q 010512 9 FFTEYGEASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 83 (508)
Q Consensus 9 ~~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~-----~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~ 83 (508)
-|......++|.+.+.||+|+||+||+|.+. .+|..||||+++.. .....+.+.+|+.+|++|+|||||++++
T Consensus 5 ~~~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g 82 (299)
T 4asz_A 5 TFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYG 82 (299)
T ss_dssp GSCCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hhhcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEE
Confidence 3444556678999999999999999999865 36889999999753 3445677999999999999999999999
Q ss_pred eecCCCcCCCccEEEEEecCC-ccHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCC
Q 010512 84 IMLPPSRREFKDIYVVFELME-SDLHQVIKAN-------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPK 149 (508)
Q Consensus 84 v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~-------------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPe 149 (508)
++.. .+.+|||||||+ |+|.++|... ..+++..+..|+.||+.||.|||+++|+||||||+
T Consensus 83 ~~~~-----~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~ 157 (299)
T 4asz_A 83 VCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATR 157 (299)
T ss_dssp EECS-----SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEee-----CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHh
Confidence 9954 456999999998 7999999764 36999999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCC
Q 010512 150 NILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGK 228 (508)
Q Consensus 150 NILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~ 228 (508)
|||++.++.+||+|||+|+....... .......+||+.|||||++.+ ..|+.++|||||||++|||+| |++||.+.
T Consensus 158 NILl~~~~~~Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~--~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~ 234 (299)
T 4asz_A 158 NCLVGENLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQL 234 (299)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGC-EEETTTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred hEEECCCCcEEECCcccceecCCCCc-eeecCceecChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999986533221 112234579999999999987 789999999999999999998 89999988
Q ss_pred ChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 010512 229 NVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308 (508)
Q Consensus 229 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp 308 (508)
+..+.+..+.... ..+ ....+++.+.+|+.+||+.||.+|||+.+++ +
T Consensus 235 ~~~~~~~~i~~~~-------------------------~~~-----~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~ 282 (299)
T 4asz_A 235 SNNEVIECITQGR-------------------------VLQ-----RPRTCPQEVYELMLGCWQREPHMRKNIKGIH--T 282 (299)
T ss_dssp CHHHHHHHHHHTC-------------------------CCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--H
T ss_pred CHHHHHHHHHcCC-------------------------CCC-----CCccchHHHHHHHHHHcCCChhHCcCHHHHH--H
Confidence 7665554443210 001 1135788999999999999999999999994 4
Q ss_pred cccCC
Q 010512 309 YFHGL 313 (508)
Q Consensus 309 ~f~~~ 313 (508)
|++.+
T Consensus 283 ~L~~~ 287 (299)
T 4asz_A 283 LLQNL 287 (299)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=436.67 Aligned_cols=337 Identities=42% Similarity=0.792 Sum_probs=276.0
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
.+...++|++.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+|+.++||||+++++++......
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence 456789999999999999999999999999999999999642 3344566788999999999999999999998766555
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 92 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 92 ~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
....+|+||||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 85 NFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp TCCCEEEEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 5678999999999999999876 469999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCc-------ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC
Q 010512 172 NDAPSA-------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244 (508)
Q Consensus 172 ~~~~~~-------~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p 244 (508)
...... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+....|.|
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 322111 112346899999999987542 578999999999999999999999999999999999999988887
Q ss_pred ChH-HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCC
Q 010512 245 STE-SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQ 323 (508)
Q Consensus 245 ~~~-~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~ 323 (508)
... ....+.......++..++......+...++.+++.+.+||.+||..||.+|||+.|+|+||||+.......++..+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~ 322 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGE 322 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCCC
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccccC
Confidence 633 2333334445555555555555555556678899999999999999999999999999999999887766555555
Q ss_pred Cccch--hhHHHHhhcCHHHHHHHHHHHHH
Q 010512 324 PISKL--EFEFERRKLAKDDVREMIYREIL 351 (508)
Q Consensus 324 ~~~~~--~~~~~~~~~~~~~~~~~i~~ei~ 351 (508)
++... ++......++.++++++++.|++
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 2b9h_A 323 PIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352 (353)
T ss_dssp CCCGGGGGGGCCSSCCCHHHHHHHHHHHHT
T ss_pred CCCcceeeecchhhcCCHHHHHHHHHHHhh
Confidence 54433 34444567889999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=437.72 Aligned_cols=332 Identities=41% Similarity=0.756 Sum_probs=282.0
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc-C
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-R 91 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-~ 91 (508)
+...++|.+.+.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++..... .
T Consensus 20 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 20 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred cccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 455789999999999999999999999999999999998765555667788999999999999999999999965432 1
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 92 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 92 ~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
....+|+||||++++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 100 ~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 100 NFYDFYLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp GCCCCEEEEECCSEEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred cceeEEEEeccccCCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 223569999999999988774 359999999999999999999999999999999999999999999999999997542
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.. ....+||++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+++..+....|.|..+.+..
T Consensus 178 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 178 AE------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp ------------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred CC------ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 21 2456899999999998762 5789999999999999999999999999999999999999999999998888
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccchhhH
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFE 331 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~ 331 (508)
+.......++..++......+...++.+++.+.+||.+||..||.+|||++++|+||||+.+.....+...+ ..+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~--~~~~~~ 328 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQ--QPFDDS 328 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCS--SCCCCT
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCC--CCCccc
Confidence 887777788887777777777788889999999999999999999999999999999999876554433322 123344
Q ss_pred HHHhhcCHHHHHHHHHHHHHHhCh
Q 010512 332 FERRKLAKDDVREMIYREILEYHP 355 (508)
Q Consensus 332 ~~~~~~~~~~~~~~i~~ei~~~~~ 355 (508)
.+...++.+++++.|++++.++.|
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 3coi_A 329 LEHEKLTVDEWKQHIYKEIVNFSP 352 (353)
T ss_dssp TTTCCCCHHHHHHHHHHHHHTCCC
T ss_pred hhhccCCHHHHHHHHHHHHHhhcc
Confidence 456678899999999999987664
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-54 Score=436.98 Aligned_cols=251 Identities=23% Similarity=0.328 Sum_probs=203.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~-----~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
..+|.+.+.||+|+||+||+|+.. .++..||||+++.. .....+.+.+|+.+|+.|+|||||++++++..
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--- 114 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTE--- 114 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE---
Confidence 467999999999999999999864 46889999999743 34456789999999999999999999999943
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeC
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAN---------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 154 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~---------------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~ 154 (508)
...+|||||||+ |+|.+++... +++++.++..|+.||+.||.|||+++|+||||||+|||++
T Consensus 115 --~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 115 --GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp --SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred --CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 456999999998 7999999753 3589999999999999999999999999999999999999
Q ss_pred CCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHH
Q 010512 155 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQ 233 (508)
Q Consensus 155 ~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 233 (508)
.++.+||+|||+|+....... ....+..+||+.|||||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+.
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~--~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~ 269 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269 (329)
T ss_dssp TTTEEEECCCC-----------------CCCCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH
T ss_pred CCCcEEEcccccceeccCCCc-ceecCcccccccccChhhhcC--CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999986533221 112345689999999999987 789999999999999999998 8999998876655
Q ss_pred HHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 234 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 234 l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
+..+.... ..+ ....+++.+.+|+.+||+.||.+|||+.|+++
T Consensus 270 ~~~i~~g~-------------------------~~~-----~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 270 IDCITQGR-------------------------ELE-----RPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp HHHHHHTC-------------------------CCC-----CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred HHHHHcCC-------------------------CCC-----CcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 54443210 011 11357899999999999999999999999987
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-54 Score=433.77 Aligned_cols=253 Identities=22% Similarity=0.345 Sum_probs=209.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~-----~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
.+++++++.||+|+||+||+|.. ..+++.||||+++... .....+.+.+|+.+|++|+|||||++++++..
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--- 100 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK--- 100 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE---
Confidence 36789999999999999999985 3467899999997543 23345779999999999999999999999954
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceee
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA 153 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl 153 (508)
.+.+|||||||+ |+|.++|... ..+++..+..|+.||++||.|||+++|+||||||+|||+
T Consensus 101 --~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 101 --DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp --SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred --CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 356899999998 7999999753 358999999999999999999999999999999999999
Q ss_pred CCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHH
Q 010512 154 NADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVH 232 (508)
Q Consensus 154 ~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~ 232 (508)
++++.+||+|||+|+....... ....+..+||+.|||||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~--~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~ 255 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADY-YKLLGNSLLPIRWMAPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 255 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGC-BCSSSSSCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred CCCCCEEECCcccceeccCCCc-eeEecccccCCcccCHHHHhC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999986533221 122345689999999999987 789999999999999999998 899999988765
Q ss_pred HHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 233 QLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 233 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.+..+... ...+ ....+++.+.+|+.+||+.||.+|||+.||+++
T Consensus 256 ~~~~i~~~---------------------------~~~~---~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 256 VVEMIRNR---------------------------QVLP---CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHTT---------------------------CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcC---------------------------CCCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 55444321 1111 123578899999999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=441.24 Aligned_cols=331 Identities=36% Similarity=0.666 Sum_probs=254.6
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC-cCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RRE 92 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~-~~~ 92 (508)
...++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++.... ...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 3458999999999999999999999999999999999866555666778899999999999999999999997543 233
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 93 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
...+|+|||||+++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 102 FQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp CCEEEEEEECCSEEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred ccceEEEEEcCCCCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 45799999999999999886 3599999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+++..+...+|.|..+.+..+
T Consensus 180 ~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 180 S----FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp --------------CTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred c----cccCCceecCCccCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 2 12345789999999999987 68999999999999999999999999999999999999999999988877665
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCC------------CCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPN------------ADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREP 320 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~------------~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~ 320 (508)
.. ....++...+......+...++. .++.+.+||.+||.+||.+|||++|+|+||||+.+.++....
T Consensus 254 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~ 332 (371)
T 2xrw_A 254 QP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAE 332 (371)
T ss_dssp CH-HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHT
T ss_pred hh-HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccC
Confidence 43 23333333222221111111111 156789999999999999999999999999998765432111
Q ss_pred CCCCccchhhHHHHhhcCHHHHHHHHHHHHHHhC
Q 010512 321 STQPISKLEFEFERRKLAKDDVREMIYREILEYH 354 (508)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~ei~~~~ 354 (508)
...+. ......+.+....++++++++.++..+.
T Consensus 333 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (371)
T 2xrw_A 333 APPPK-IPDKQLDEREHTIEEWKELIYKEVMDLE 365 (371)
T ss_dssp CCCCC-CCTTTTCCCCCCHHHHHHHHHHHHHHHC
T ss_pred CCCCC-CCChhhccccCcHHHHHHHHHHHHHHHh
Confidence 11110 1112223456678899999999987653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-53 Score=426.37 Aligned_cols=294 Identities=39% Similarity=0.661 Sum_probs=239.2
Q ss_pred ccccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC
Q 010512 10 FTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 89 (508)
Q Consensus 10 ~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 89 (508)
.+.-+..++|++++.||+|+||+||+|.+. +|+.||+|++............+.+|+.+|+.++||||+++++++.
T Consensus 14 ~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--- 89 (311)
T 3niz_A 14 LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH--- 89 (311)
T ss_dssp -CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred eeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc---
Confidence 355678899999999999999999999985 5999999999765444445677889999999999999999999994
Q ss_pred cCCCccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 90 RREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 90 ~~~~~~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
....+|+|||||+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 90 --~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 167 (311)
T 3niz_A 90 --SERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR 167 (311)
T ss_dssp --CSSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred --cCCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCce
Confidence 345699999999999999887754 59999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
...... ...+..+||++|+|||++.+. ..|+.++|||||||++|+|++|++||++.+..+.+..+...+|.+....
T Consensus 168 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 243 (311)
T 3niz_A 168 AFGIPV---RSYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE 243 (311)
T ss_dssp ETTSCC---C---CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTT
T ss_pred ecCCCc---ccccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHH
Confidence 653222 123456889999999998752 5689999999999999999999999999999999999999999888766
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
+.......... ..........++....+.+++.+.+||.+||++||.+|||++|+|+||||+++.
T Consensus 244 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 244 WPQVQELPLWK-QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp SGGGTTSHHHH-SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hhhhhccchhh-hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 55433211100 001111122233344567889999999999999999999999999999999763
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=418.80 Aligned_cols=287 Identities=38% Similarity=0.625 Sum_probs=236.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++. ....+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence 6899999999999999999999999999999999765555556678899999999999999999999984 34579
Q ss_pred EEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 97 YVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 97 ylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
|+||||++++|.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 99999999988877765 5689999999999999999999999999999999999999999999999999998653222
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCC-CCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~-~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
......+||+.|+|||++.+. ..|+.++|||||||++|+|++|. ++|.+.+..+++..+...++.+....+.....
T Consensus 156 --~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 156 --RCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred --ccccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 123456899999999998762 45899999999999999999876 45888888889999999999888765543321
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.. .+...........+....+.+++.+.+||.+||+.||.+|||++|+|+||||+++.
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 233 LP--DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp ST--TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cc--cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 00 00000000111222344567899999999999999999999999999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=424.66 Aligned_cols=260 Identities=27% Similarity=0.494 Sum_probs=225.4
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
...++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+++|+.++||||+++++++. ..
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~ 86 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----TE 86 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----EC
Confidence 4457899999999999999999999999999999999876666667788999999999999999999999984 34
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
+.+|+|||||+ ++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred CEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 57999999997 69999999888999999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcccccccccCcccccccccccccCCC-CcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y-~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.. .....+||++|+|||++.+ ..+ +.++|||||||++|+|++|++||.+.+.......+...
T Consensus 167 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----------- 229 (328)
T 3fe3_A 167 GG----KLDAFCGAPPYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG----------- 229 (328)
T ss_dssp SC----GGGTTSSSGGGCCHHHHHT--CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred CC----ccccccCCcceeCcccccC--CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------
Confidence 22 2456789999999999987 455 58999999999999999999999988865555444321
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
....+ ..+++.+.+||.+||.+||.+|||++|+|+||||+....
T Consensus 230 ---------------~~~~p-----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 230 ---------------KYRIP-----FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp ---------------CCCCC-----TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred ---------------CCCCC-----CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 01111 246789999999999999999999999999999987654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-53 Score=418.64 Aligned_cols=284 Identities=38% Similarity=0.655 Sum_probs=233.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|++++.||+|+||+||+|.+ .+|+.||||++............+.+|+.+|+.++||||+++++++.. ...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-----CCeE
Confidence 6899999999999999999998 689999999997544333344678899999999999999999999954 3569
Q ss_pred EEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 97 YVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 97 ylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
|+||||++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 999999999999999864 679999999999999999999999999999999999999999999999999998653221
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...++.+....+.....
T Consensus 155 --~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (288)
T 1ob3_A 155 --RKYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE- 230 (288)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG-
T ss_pred --cccccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc-
Confidence 123456889999999998752 5689999999999999999999999999999999988888888876654433211
Q ss_pred HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
...+...+....+.++......+++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 231 -LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp -STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred -ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 00111112223344455566788999999999999999999999999999999985
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=431.09 Aligned_cols=255 Identities=25% Similarity=0.409 Sum_probs=209.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC-----CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCC-CCcceeeeeecCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHT-----GERVAIKKINDVFEHVSDATRILREIKLLRLLRH-PDIVEIKHIMLPPS 89 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~t-----g~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~H-pnIv~l~~v~~~~~ 89 (508)
.++|++++.||+|+||+||+|.+..+ ++.||||+++.. ......+.+.+|+.+|+++.| ||||++++++...
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~- 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-
Confidence 36899999999999999999987643 468999999753 333456779999999999975 8999999998543
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCcee
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL 152 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNIL 152 (508)
...+|||||||+ |+|.++|... ..+++.++..|+.||++||.|||+++|+||||||+|||
T Consensus 141 ---~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp ---TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ---CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 245899999998 7999999753 34899999999999999999999999999999999999
Q ss_pred eCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChH
Q 010512 153 ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVV 231 (508)
Q Consensus 153 l~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~ 231 (508)
++.++.+||+|||+|+....... ....+..+||+.|||||++.+ ..|+.++|||||||++|||+| |++||++.+..
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~--~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eCCCCCEEECcchhhhhcccCCC-ceeeccccccccccCHHHHhc--CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999986543322 222345689999999999987 789999999999999999998 99999987643
Q ss_pred HHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 232 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 232 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
..+..+.. ... ..+ ....+++.+.+|+.+||+.||.+|||+.|+++|
T Consensus 295 ~~~~~~i~----------------------~g~--~~~-----~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 295 EEFCRRLK----------------------EGT--RMR-----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHH----------------------HTC--CCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHH----------------------cCC--CCC-----CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 33322111 000 011 113468999999999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=424.27 Aligned_cols=332 Identities=37% Similarity=0.665 Sum_probs=263.6
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC---------hhHHHHHHHHHHHHHhCCCCCcceeeee
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH---------VSDATRILREIKLLRLLRHPDIVEIKHI 84 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~---------~~~~~~i~~Ei~iL~~L~HpnIv~l~~v 84 (508)
...++|++++.||+|+||.||+|.+.. |..||||++...... ......+.+|+.+|+.++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 567899999999999999999999864 999999999643221 2234778999999999999999999999
Q ss_pred ecCCCcCCCccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcc
Q 010512 85 MLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 163 (508)
Q Consensus 85 ~~~~~~~~~~~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~D 163 (508)
+..........+|+||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 8765444556799999999999999987654 699999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC
Q 010512 164 FGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 243 (508)
Q Consensus 164 FGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~ 243 (508)
||+++...... ......||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.
T Consensus 178 fg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 178 FNLAREDTADA----NKTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp TTC-------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cCccccccccc----ccceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99997543222 23456899999999998752 57899999999999999999999999999999999999999999
Q ss_pred CChHHHHHHhhHHHHHHHhhcccC-CCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCC
Q 010512 244 PSTESISRIRNEKARRYLGSMRKK-QPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPST 322 (508)
Q Consensus 244 p~~~~~~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~ 322 (508)
|....+..........++...... ....+....+..++.+.+||.+||+.||.+|||+.|+|+||||+++..+......
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~ 332 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEG 332 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTT
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccccc
Confidence 998887776666666665443332 2333444556788999999999999999999999999999999987653222111
Q ss_pred CCccchhhHHHHhhcCHHHHHHHHHHHHHHhC
Q 010512 323 QPISKLEFEFERRKLAKDDVREMIYREILEYH 354 (508)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~i~~ei~~~~ 354 (508)
. ...+.++....+..++++.++.|+.+++
T Consensus 333 ~---~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 361 (362)
T 3pg1_A 333 L---SERFHFDESVTDVYDMHKIFTAEVERFN 361 (362)
T ss_dssp C---CCCCCCCTTCCCHHHHHHHHHHHHHHHC
T ss_pred c---ccccChhhhhhhHHHHHHHHHHHHHHhc
Confidence 1 1122334456677888999999988765
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-52 Score=415.15 Aligned_cols=289 Identities=36% Similarity=0.660 Sum_probs=231.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++. ....
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCe
Confidence 46899999999999999999999999999999999765555555677889999999999999999999984 3456
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+||||+++ +|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 8999999995 677777777889999999999999999999999999999999999999999999999999998653222
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
. .....+||++|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++............
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 157 D---YYDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp ------------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred c---ccCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 1 23456899999999998752 5789999999999999999999999999999999999888888776654332211
Q ss_pred HHHHHHHhhcccCCC---CCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCC
Q 010512 255 EKARRYLGSMRKKQP---VPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 316 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~ 316 (508)
. .+........+ .++...++++++.+.+||.+||..||.+|||++|+|+||||+++.+.
T Consensus 233 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 233 N---QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp C---GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred c---cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 1 11111111111 11122346789999999999999999999999999999999987654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=423.41 Aligned_cols=268 Identities=28% Similarity=0.454 Sum_probs=228.9
Q ss_pred ccccccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh----hHHHHHHHHHHHHHhCCCCCcceeee
Q 010512 8 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV----SDATRILREIKLLRLLRHPDIVEIKH 83 (508)
Q Consensus 8 ~~~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~----~~~~~i~~Ei~iL~~L~HpnIv~l~~ 83 (508)
+.|..-...++|++++.||+|+||+||+|++..+|..||||++++..... .....+.+|+.+|+.++||||+++++
T Consensus 3 ~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~ 82 (361)
T 2yab_A 3 ETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHD 82 (361)
T ss_dssp -CCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ccccCCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEE
Confidence 44556667789999999999999999999999999999999997543221 23567889999999999999999999
Q ss_pred eecCCCcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC----c
Q 010512 84 IMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----K 158 (508)
Q Consensus 84 v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~----~ 158 (508)
++. ....+|+||||++ |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 83 ~~~-----~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~ 157 (361)
T 2yab_A 83 VYE-----NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH 157 (361)
T ss_dssp EEE-----CSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCC
T ss_pred EEE-----eCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccC
Confidence 994 3457999999997 69999998888999999999999999999999999999999999999998877 7
Q ss_pred EEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 010512 159 LKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMT 238 (508)
Q Consensus 159 lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~ 238 (508)
+||+|||++....... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+....+..|.
T Consensus 158 vkl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~ 231 (361)
T 2yab_A 158 IKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231 (361)
T ss_dssp EEECCCSSCEECCTTC----CCCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred EEEEecCCceEcCCCC----ccccCCCCccEECchHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999998654322 2345689999999999987 689999999999999999999999999988777666665
Q ss_pred hhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 239 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 239 ~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
......... .++.+++.+.+||.+||..||.+|||++|+|+||||+..
T Consensus 232 ~~~~~~~~~---------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 232 AVSYDFDEE---------------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp TTCCCCCHH---------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred hcCCCCCch---------------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 432222211 134578899999999999999999999999999999854
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=418.67 Aligned_cols=289 Identities=35% Similarity=0.587 Sum_probs=232.5
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC---ChhHHHHHHHHHHHHHhCC---CCCcceeeeeecCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE---HVSDATRILREIKLLRLLR---HPDIVEIKHIMLPP 88 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~---~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~v~~~~ 88 (508)
..++|++++.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 35799999999999999999999999999999999864321 1112345667887777765 99999999998765
Q ss_pred CcCCCccEEEEEecCCccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccc
Q 010512 89 SRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 166 (508)
Q Consensus 89 ~~~~~~~lylV~E~~~g~L~~~i~~~~~--l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGl 166 (508)
.......+|+||||++++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 4333446899999999999999987654 99999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCh
Q 010512 167 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246 (508)
Q Consensus 167 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 246 (508)
++...... ..+..+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+++..+...++.+..
T Consensus 167 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 167 ARIYSYQM----ALTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp TTTSTTCC----CSGGGGCCCSSCCHHHHHT--SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred ccccCCCc----ccCCccccccccCchHHcC--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 98653222 2356789999999999977 67999999999999999999999999999999999999988888776
Q ss_pred HHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 247 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
..+....... ...+....+.++....+.+++.+.+||.+||++||.+|||+.|+|+||||++.
T Consensus 241 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 241 DDWPRDVSLP----RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TTSCSSCSSC----GGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hhccchhhcc----ccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 5433211000 00111222233334456788999999999999999999999999999999863
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-52 Score=420.50 Aligned_cols=290 Identities=34% Similarity=0.613 Sum_probs=220.7
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++++.||+|+||.||+|.+..+|+.||||+++... .......+.+|+.+|+.++||||+++++++. ..+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 76 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIH-----TEN 76 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC-----CTT
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEE-----ECC
Confidence 3578999999999999999999999999999999996433 2233466789999999999999999999994 345
Q ss_pred cEEEEEecCCccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 95 DIYVVFELMESDLHQVIKAN------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 95 ~lylV~E~~~g~L~~~i~~~------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
.+|+||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 77 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 77 KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156 (317)
T ss_dssp EEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred eEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccce
Confidence 79999999999999998753 359999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
....... .....+||+.|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+++..+.+.+|.+....
T Consensus 157 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 157 AFGIPVN---TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp ETTSCCC---CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred ecCCCcc---cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence 6532221 23456899999999998752 4689999999999999999999999999999999999999999887665
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCC-----CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCC
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPF-----SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 316 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~-----~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~ 316 (508)
+..+... ..+...+....+..+ ......+++.+.+||.+||+.||.+|||++|+|+||||++....
T Consensus 233 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 233 WPSVTKL--PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp CGGGGGC--TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hhhhhhh--hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 4432210 000000000001100 01123578899999999999999999999999999999976543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=422.15 Aligned_cols=289 Identities=35% Similarity=0.624 Sum_probs=231.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|++++.||+|+||+||+|.+..+|+.||||+++..... .....+.+|+.+|+.++||||+++++++.. ...+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEE
Confidence 6899999999999999999999999999999999643211 111235579999999999999999999943 4568
Q ss_pred EEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 97 YVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 97 ylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
|+||||++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 76 TLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred EEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 9999999999999988754 59999999999999999999999999999999999999999999999999998543221
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
......+||++|+|||++.+. ..|+.++|||||||++|+|++|++||++.+..+++..+...+|.|....+......
T Consensus 155 --~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 155 --KTYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ----------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred --cccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 123456889999999998752 56899999999999999999999999999999999999999999887766544322
Q ss_pred HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCC
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 316 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~ 316 (508)
...... ..+......+....+.+++.+.+||.+||++||.+|||++|+|+||||.++...
T Consensus 232 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 232 EEFKTY-NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HHHHHT-CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred hhhccc-ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 111110 111111222223346788999999999999999999999999999999987653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=418.91 Aligned_cols=279 Identities=37% Similarity=0.620 Sum_probs=224.5
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
-...++|++++.||+|+||+||+|++..+|+.||||+++...........+.+|+.+|+.++||||+++++++. .
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~ 104 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-----H 104 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----E
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----c
Confidence 34557999999999999999999999999999999999765444444567789999999999999999999984 3
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeC-----CCCcEEEcccccc
Q 010512 93 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-----ADCKLKICDFGLA 167 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~-----~~~~lkL~DFGla 167 (508)
...+|+||||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 105 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 105 NHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp TTEEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred CCEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 45699999999999999999998999999999999999999999999999999999999994 4556999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChH
Q 010512 168 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 168 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
+...... ......+||+.|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+..+++..+...++.|...
T Consensus 185 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 185 RAFGIPI---RQFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260 (329)
T ss_dssp HHHC--------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cccCCcc---cccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence 8653221 123456789999999998762 458999999999999999999999999999999999998888887765
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCC-------------CCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFP-------------NADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-------------~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.+..... . ..+...++ .+++.+.+||.+||++||.+|||++|+|+||||++..
T Consensus 261 ~~~~~~~---------~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 261 TWPGVTA---------L-----PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp TSTTGGG---------S-----TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhhhh---------h-----hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 4432211 0 01111111 1678999999999999999999999999999998753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=428.37 Aligned_cols=288 Identities=36% Similarity=0.647 Sum_probs=234.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc-CCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-~~~~ 94 (508)
..+|++++.||+|+||+||+|.+..++. ||+|++..... ...+|+.+|+.++||||+++++++..... ....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 4579999999999999999999987766 89998853221 12379999999999999999999865432 3344
Q ss_pred cEEEEEecCCccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeC-CCCcEEEcccccccc
Q 010512 95 DIYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDFGLARV 169 (508)
Q Consensus 95 ~lylV~E~~~g~L~~~i~----~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~-~~~~lkL~DFGla~~ 169 (508)
.+|+|||||++++...+. ....+++..++.|++||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 588999999987766554 356799999999999999999999999999999999999999 799999999999987
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
...... ...++||++|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+++..+...+|+|..+.+
T Consensus 192 ~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAGEP----NVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp CCTTCC----CCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccCCCC----CcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 543322 2457899999999998762 56999999999999999999999999999999999999999999998877
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCC-CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCC
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDR 318 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~ 318 (508)
........ ....+...+.++...+ +.+++.+.+||.+||++||.+|||+.|+|+||||+++.....
T Consensus 267 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 333 (394)
T 4e7w_A 267 KTMNPNYM---EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEA 333 (394)
T ss_dssp HHHCGGGS---SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCC
T ss_pred HhhChhhh---hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccc
Confidence 65432110 0111122223333333 348899999999999999999999999999999998876543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-51 Score=427.32 Aligned_cols=288 Identities=35% Similarity=0.628 Sum_probs=233.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC-cCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~-~~~~~~ 95 (508)
.+|++++.||+|+||+||+|++..+|+.||||++.... ....+|+.+|+.|+||||+++++++.... ..+..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 47999999999999999999999999999999986421 12347999999999999999999986432 123445
Q ss_pred EEEEEecCCccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC-CcEEEccccccccc
Q 010512 96 IYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVS 170 (508)
Q Consensus 96 lylV~E~~~g~L~~~i~----~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~-~~lkL~DFGla~~~ 170 (508)
+++||||++++|.+++. ....+++..++.|++||+.||.|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 78999999998877664 35679999999999999999999999999999999999999965 56899999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
..... ...++||++|+|||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..|.+.+|+|..+.+.
T Consensus 208 ~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 208 VRGEP----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CTTCC----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCC----ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 43322 2457899999999998762 479999999999999999999999999999999999999999999987765
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCC-CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDR 318 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~ 318 (508)
...... .. ..++.....+|...+ +.+++.+.+||.+||.+||.+|||+.|+|+||||+.+.....
T Consensus 283 ~~~~~~-~~--~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 348 (420)
T 1j1b_A 283 EMNPNY-TE--FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV 348 (420)
T ss_dssp HHCSCC-CC--CCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred hhChhh-hh--hccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccc
Confidence 432100 00 000111111121112 357899999999999999999999999999999998776543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=428.79 Aligned_cols=261 Identities=28% Similarity=0.464 Sum_probs=223.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++++.||+|+||+||+|.+..+|+.||+|++............+.+|+.+|+.++||||+++++++. +.+.
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~~~ 84 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS-----EEGH 84 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE-----CSSE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE-----ECCE
Confidence 46799999999999999999999999999999999765544556677899999999999999999999994 4467
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeC---CCCcEEEcccccccccc
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARVSF 171 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~---~~~~lkL~DFGla~~~~ 171 (508)
+|+|||||. |+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999998 59999999999999999999999999999999999999999999999998 46789999999997653
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+....+..+....
T Consensus 165 ~~~---~~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~---------- 229 (444)
T 3soa_A 165 GEQ---QAWFGFAGTPGYLSPEVLRK--DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA---------- 229 (444)
T ss_dssp TTC---CBCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC----------
T ss_pred CCC---ceeecccCCcccCCHHHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC----------
Confidence 322 22456789999999999987 689999999999999999999999999887665555443211
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.......++.+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 230 -----------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 230 -----------------YDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp -----------------CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred -----------------CCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 111223456789999999999999999999999999999999753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=422.77 Aligned_cols=286 Identities=33% Similarity=0.667 Sum_probs=231.1
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc----
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR---- 90 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~---- 90 (508)
..++|++++.||+|+||+||+|.+..+|+.||||++..... ...+|+.+|+.++||||+++++++.....
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 35789999999999999999999999999999999864322 12379999999999999999999865322
Q ss_pred -----------------------------CCCccEEEEEecCCccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHhH
Q 010512 91 -----------------------------REFKDIYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIH 137 (508)
Q Consensus 91 -----------------------------~~~~~lylV~E~~~g~L~~~i~----~~~~l~~~~~~~i~~Qil~aL~yLH 137 (508)
....++|+|||||+++|.+.+. ....+++..++.+++||+.||.|||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp -------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 2345689999999998877765 3567999999999999999999999
Q ss_pred hcCceecCCCCCceeeC-CCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHH
Q 010512 138 TANVFHRDLKPKNILAN-ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA 216 (508)
Q Consensus 138 s~gIiHrDLKPeNILl~-~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~ 216 (508)
++||+||||||+|||++ .++.+||+|||+|+....... ....+||+.|+|||++.+. ..|+.++||||+||++|
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHH
T ss_pred HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHH
Confidence 99999999999999998 688999999999986533222 3456889999999998762 46899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCC-CCCCHHHHHHHHHhccCCC
Q 010512 217 EMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDP 295 (508)
Q Consensus 217 eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~Ll~~mL~~DP 295 (508)
+|++|++||.+.+..+++..+...+|+|..+.+......... ...+......+...+ ...++.+.+||.+||++||
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE---VRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC-----CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccccc---ccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 999999999999999999999999999998876654321000 000111111122222 3478899999999999999
Q ss_pred CCCCCHHHHhcCCcccCCC
Q 010512 296 KDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 296 ~~Rpta~eiL~hp~f~~~~ 314 (508)
.+|||+.|+|+||||+.+.
T Consensus 311 ~~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 311 DLRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp GGSCCHHHHHTSGGGHHHH
T ss_pred hhCCCHHHHhcCHHHHHHH
Confidence 9999999999999998654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=414.00 Aligned_cols=306 Identities=34% Similarity=0.531 Sum_probs=238.7
Q ss_pred hccccccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeec
Q 010512 7 TEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIML 86 (508)
Q Consensus 7 ~~~~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~ 86 (508)
..+....+..++|++++.||+|+||+||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 86 (351)
T 3mi9_A 7 SVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 86 (351)
T ss_dssp -CCCTTSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cccccccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheee
Confidence 33334446779999999999999999999999999999999999765444444567789999999999999999999986
Q ss_pred CCCc---CCCccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEc
Q 010512 87 PPSR---REFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 162 (508)
Q Consensus 87 ~~~~---~~~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~ 162 (508)
.... ...+.+|+||||++++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~ 166 (351)
T 3mi9_A 87 TKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLA 166 (351)
T ss_dssp EC--------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEEC
T ss_pred ccccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEc
Confidence 5321 114568999999999998888764 579999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCC-CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Q 010512 163 DFGLARVSFNDAP-SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 241 (508)
Q Consensus 163 DFGla~~~~~~~~-~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~ 241 (508)
|||+++....... ........+||++|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+...++..+....
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 245 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 9999986542221 22234567899999999998752 568999999999999999999999999999999999999988
Q ss_pred CCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF--PNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 242 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
+.+....+...........+.... .....+...+ ...++.+.+||.+||++||.+|||++|+|+||||....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 246 GSITPEVWPNVDNYELYEKLELVK-GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp CCCCTTTSTTGGGCGGGTSSCCCS-SCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred CCCChhhccccccchhhccccccc-ccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 887766544332110000000000 0000000000 01367899999999999999999999999999998643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=411.84 Aligned_cols=258 Identities=26% Similarity=0.452 Sum_probs=219.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
.++|++++.||+|+||.||+|+++.+|+.||||++++... .......+.+|+.+|+.++||||+++++++.. ..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-----~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-----SS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-----CC
Confidence 3689999999999999999999999999999999965321 22345678899999999999999999999954 45
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
.+|+||||++ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 6999999998 599999998889999999999999999999999999999999999999999999999999999853222
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......+...
T Consensus 159 ~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------- 220 (337)
T 1o6l_A 159 G---ATMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------- 220 (337)
T ss_dssp T---CCBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------
T ss_pred C---CcccccccChhhCChhhhcC--CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------
Confidence 2 12356789999999999987 68999999999999999999999999887765544433210
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 314 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~~ 314 (508)
. ..+ ...+++.+.+||.+||+.||.+|| +++|+++||||.++.
T Consensus 221 -------------~--~~~---p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 221 -------------E--IRF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp -------------C--CCC---CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred -------------C--CCC---CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 0 011 135689999999999999999999 999999999998753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-51 Score=418.43 Aligned_cols=258 Identities=24% Similarity=0.421 Sum_probs=216.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~ 93 (508)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.+ +||||+++++++.. .
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-----~ 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT-----P 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-----C
Confidence 478999999999999999999999999999999997532 1223456688999999988 69999999999944 4
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
..+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 56999999998 59999999888999999999999999999999999999999999999999999999999999985322
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|....
T Consensus 177 ~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~----------- 240 (353)
T 3txo_A 177 NG---VTTATFCGTPDYIAPEILQE--MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE----------- 240 (353)
T ss_dssp ------------CCGGGCCHHHHHH--HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred CC---ccccccCCCcCeEChhhcCC--CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 21 22345789999999999987 679999999999999999999999999988766665553210
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH------HHHhcCCcccCCC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA------EEALADPYFHGLA 314 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta------~eiL~hp~f~~~~ 314 (508)
..+ ...+++.+.+||.+||++||.+||++ +++++||||+++.
T Consensus 241 -----------------~~~---p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 241 -----------------VVY---PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp -----------------CCC---CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred -----------------CCC---CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence 001 12367899999999999999999999 9999999998753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=415.37 Aligned_cols=275 Identities=23% Similarity=0.235 Sum_probs=195.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
+.+|.+.+.||+|+||+||+|++ +|+.||||+++.. ........+|+..+..++|||||++++++.... .....
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~ 75 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQ 75 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceE
Confidence 46899999999999999999986 6899999999642 112223345777778899999999999986432 12346
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhc--------CceecCCCCCceeeCCCCcEEEccccc
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--------NVFHRDLKPKNILANADCKLKICDFGL 166 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~--------gIiHrDLKPeNILl~~~~~lkL~DFGl 166 (508)
+|||||||+ |+|.+++... +++++.+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 899999998 7999999765 699999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCCCC-cccccccccCccccccccccccc----CCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Q 010512 167 ARVSFNDAPS-AIFWTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 241 (508)
Q Consensus 167 a~~~~~~~~~-~~~~~~~~gT~~Y~APE~l~~~~----~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~ 241 (508)
|+........ .......+||++|||||++.+.. ..|+.++||||||||+|||+||.+||........-. .....
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~-~~~~~ 233 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLVP 233 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TTTSC
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc-hhccc
Confidence 9875433221 11233568999999999987521 146789999999999999999998875433211000 00000
Q ss_pred CCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 242 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..+..+.+ ...+..-...+..+.......+...+.+|+.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~--------~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 234 SDPSVEEM--------RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SSCCHHHH--------HHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccchHHHH--------HHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 01111111 1111100001111111111123346789999999999999999999987
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=413.38 Aligned_cols=256 Identities=31% Similarity=0.508 Sum_probs=214.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
.++|++.+.||+|+||+||+|.+..+|+.||||++.+.... ......+.+|+.+|+.++||||+++++++.. ..
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-----PT 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CC
Confidence 47899999999999999999999999999999999643211 1223568899999999999999999999954 35
Q ss_pred cEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 95 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 95 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
.+|+||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 83 DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 69999999999999999988899999999999999999999999999999999999999999999999999998643222
Q ss_pred CCcccccccccCcccccccccccccCCC-CcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y-~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
.....+||+.|+|||++.+ ..| +.++|||||||++|+|++|+.||.+.+.....
T Consensus 163 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~------------------- 217 (336)
T 3h4j_B 163 ----FLKTSCGSPNYAAPEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF------------------- 217 (336)
T ss_dssp ----TTCCCTTSTTTSCGGGSCC--SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-------------------
T ss_pred ----ccccccCCcCcCCHHHHcC--CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-------------------
Confidence 2345689999999999987 454 78999999999999999999999875421110
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.............+++.+.+||.+||..||.+|||++|+++||||+..
T Consensus 218 ------------~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 218 ------------KKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp ------------CCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred ------------HHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 000001111223478999999999999999999999999999999753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=415.18 Aligned_cols=260 Identities=29% Similarity=0.486 Sum_probs=222.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++.+.||+|+||+||+|.+..+|..||+|+++...........+.+|+.+|+.++||||+++++++. +...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence 35799999999999999999999999999999999765555566778999999999999999999999994 3456
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC---cEEEcccccccccc
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARVSF 171 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~---~lkL~DFGla~~~~ 171 (508)
+|+|||||. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 899999998 59999998888899999999999999999999999999999999999998754 59999999998653
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+....+..+.....
T Consensus 183 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~--------- 247 (362)
T 2bdw_A 183 DSE----AWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY--------- 247 (362)
T ss_dssp TCC----SCCCSCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---------
T ss_pred CCc----ccccCCCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC---------
Confidence 222 2345789999999999987 6899999999999999999999999998876555544432111
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
......+..+++.+.+||.+||..||.+|||+.++|+||||...
T Consensus 248 ------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 248 ------------------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp ------------------CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred ------------------CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 11112345678999999999999999999999999999999753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=416.86 Aligned_cols=298 Identities=23% Similarity=0.310 Sum_probs=222.2
Q ss_pred cCCCCCeEEeeeeeec--CceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 13 YGEASRYQIQEVIGKG--SYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G--~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
.+..++|++++.||+| +||.||+|++..+|+.||||+++...........+.+|+.+|+.++||||+++++++..
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--- 97 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--- 97 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE---
Confidence 3677899999999999 99999999999999999999998665555666788899999999999999999999953
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccc
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 167 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla 167 (508)
.+.+|+|||||+ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 98 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 98 --DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp --TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred --CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccc
Confidence 456999999998 6999999876 67999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCC----cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc--
Q 010512 168 RVSFNDAPS----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL-- 241 (508)
Q Consensus 168 ~~~~~~~~~----~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~-- 241 (508)
......... .......+||+.|+|||++.+....|+.++||||||||+|+|++|++||.+.+....+..+....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 754322111 11123358999999999997633578999999999999999999999999877655543322110
Q ss_pred ------CCCChHHHHHHh----hHHHHHHHhh---cccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 010512 242 ------GTPSTESISRIR----NEKARRYLGS---MRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308 (508)
Q Consensus 242 ------g~p~~~~~~~~~----~~~~~~~l~~---~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp 308 (508)
..+......... .......+.. .+.....+.......+++.+.+||.+||++||.+|||++|+|+||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 000000000000 0000000000 000011111223456789999999999999999999999999999
Q ss_pred cccCCCC
Q 010512 309 YFHGLAN 315 (508)
Q Consensus 309 ~f~~~~~ 315 (508)
||+++..
T Consensus 336 ~f~~~~~ 342 (389)
T 3gni_B 336 FFKQIKR 342 (389)
T ss_dssp GGGGC--
T ss_pred HHHHHhh
Confidence 9998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=406.18 Aligned_cols=261 Identities=28% Similarity=0.456 Sum_probs=222.7
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh----hHHHHHHHHHHHHHhCCCCCcceeeeeecCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV----SDATRILREIKLLRLLRHPDIVEIKHIMLPPS 89 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~----~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 89 (508)
...++|++.+.||+|+||.||+|.+..+|..||+|+++...... .....+.+|+.+|+.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 85 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-- 85 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--
Confidence 44578999999999999999999999999999999997543221 235678899999999999999999999943
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC----cEEEccc
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDF 164 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~----~lkL~DF 164 (508)
...+|+||||++ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 86 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 86 ---KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp ---SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred ---CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 456999999997 69999998888899999999999999999999999999999999999999887 7999999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC
Q 010512 165 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244 (508)
Q Consensus 165 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p 244 (508)
|+++...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+....+..+.......
T Consensus 163 g~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 236 (326)
T 2y0a_A 163 GLAHKIDFGN----EFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236 (326)
T ss_dssp TTCEECCTTS----CCCCCCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC
T ss_pred CCCeECCCCC----ccccccCCcCcCCceeecC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc
Confidence 9998653222 1345689999999999986 689999999999999999999999999888766665554332221
Q ss_pred ChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
.. ..++.+++.+.+||.+||..||.+|||++|+|+||||+.
T Consensus 237 ~~---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 237 ED---------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp CH---------------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred Cc---------------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 11 112456788999999999999999999999999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=405.90 Aligned_cols=258 Identities=25% Similarity=0.429 Sum_probs=221.8
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++.+.||+|+||+||+|.+..+|+.||+|++... ......+.+|+.+|+.++||||+++++++. +..
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~ 74 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFE-----SME 74 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETT
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCC
Confidence 457999999999999999999999999999999998632 334566889999999999999999999994 345
Q ss_pred cEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC--CCcEEEccccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVS 170 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~--~~~lkL~DFGla~~~ 170 (508)
.+|+|||||+ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 6999999998 59999997654 7999999999999999999999999999999999999997 789999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+......+...
T Consensus 155 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--- 225 (321)
T 1tki_A 155 KPGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE--- 225 (321)
T ss_dssp CTTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH---
T ss_pred CCCC----ccccccCChhhcCcHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChh---
Confidence 3322 2345689999999999987 678999999999999999999999999988776666655433222211
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.++.+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 226 ------------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 226 ------------------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ------------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ------------------------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 234678899999999999999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=400.79 Aligned_cols=259 Identities=28% Similarity=0.457 Sum_probs=218.9
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
...++|++++.||+|+||+||+|.+..+|+.||||++..... .....+.+|+.+|+.++||||+++++++.. .
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~ 89 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLV-----G 89 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-----C
Confidence 455789999999999999999999999999999999864332 235668899999999999999999999854 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
..+|+||||++ ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 56899999997 6999998765 699999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+....+..+.... .
T Consensus 169 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~--------- 233 (297)
T 3fxz_A 169 EQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-T--------- 233 (297)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHHC--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-S---------
T ss_pred ccc---ccCCccCCcCccChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-C---------
Confidence 222 2345689999999999987 689999999999999999999999998887655544432210 0
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.. ......+++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 234 ---------------~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 234 ---------------PE---LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp ---------------CC---CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ---------------CC---CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 00 01123467889999999999999999999999999999854
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=403.61 Aligned_cols=302 Identities=41% Similarity=0.641 Sum_probs=234.7
Q ss_pred cccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC-
Q 010512 11 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS- 89 (508)
Q Consensus 11 ~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~- 89 (508)
..+...++|++++.||+|+||.||+|.+..+|+.||||++.. ........+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 82 (320)
T 2i6l_A 5 HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL--TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS 82 (320)
T ss_dssp -CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEEC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred ccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEec--CChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence 456678999999999999999999999999999999999864 23455678899999999999999999999985432
Q ss_pred --------cCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeC-CCCcEE
Q 010512 90 --------RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLK 160 (508)
Q Consensus 90 --------~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~-~~~~lk 160 (508)
......+|+||||++|+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 83 QLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp BCCC----CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred ccccccccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence 133467899999999999998864 5799999999999999999999999999999999999997 567999
Q ss_pred EccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhh
Q 010512 161 ICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL 240 (508)
Q Consensus 161 L~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~ 240 (508)
|+|||+++................+|++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999998654322222233456789999999988652 57899999999999999999999999999988888888887
Q ss_pred cCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 010512 241 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 317 (508)
Q Consensus 241 ~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~ 317 (508)
.+.+.......+... ...++.........++....+.+++.+.+||.+||+.||.+|||++|+|+||||+....+.
T Consensus 241 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 241 IPVVHEEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp SCCCCHHHHHHHHTT-SCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred cCCCchhhhhhhhhc-CcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence 777666554432211 0111111112222333344567899999999999999999999999999999998765433
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=419.64 Aligned_cols=281 Identities=32% Similarity=0.551 Sum_probs=231.8
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC------CCCCcceeeeeecCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL------RHPDIVEIKHIMLPP 88 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L------~HpnIv~l~~v~~~~ 88 (508)
...+|++++.||+|+||+||+|.+..+|+.||||+++.. ......+.+|+.+|+.+ .|+||+++++++..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~- 170 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF- 170 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-
Confidence 457899999999999999999999999999999999642 33456677899988887 56799999999843
Q ss_pred CcCCCccEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCc--EEEccc
Q 010512 89 SRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--LKICDF 164 (508)
Q Consensus 89 ~~~~~~~lylV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~--lkL~DF 164 (508)
...+|+||||++++|.+++.... .+++..++.|+.||+.||.|||++||+||||||+|||++.++. +||+||
T Consensus 171 ----~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 171 ----RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp ----TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred ----CCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 35699999999999999998764 4999999999999999999999999999999999999999987 999999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC
Q 010512 165 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244 (508)
Q Consensus 165 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p 244 (508)
|+++..... ....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||++.+..+++..+...+|.|
T Consensus 247 G~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p 318 (429)
T 3kvw_A 247 GSSCYEHQR------VYTYIQSRFYRAPEVILG--ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP 318 (429)
T ss_dssp TTCEETTCC------CCSSCSCGGGCCHHHHHT--BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ccceecCCc------ccccCCCCCccChHHHhC--CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 999754221 245689999999999987 689999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHhhHHHHHHHhhcccCC-----------------------------CCCCCCC-CCCCCHHHHHHHHHhccCC
Q 010512 245 STESISRIRNEKARRYLGSMRKKQ-----------------------------PVPFSHK-FPNADPLALHLLERLLAFD 294 (508)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~~~~~~-----------------------------~~~~~~~-~~~~~~~~~~Ll~~mL~~D 294 (508)
+...+..... ...++..-.... ...+... ....++.+.+||.+||++|
T Consensus 319 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~d 396 (429)
T 3kvw_A 319 SQKLLDASKR--AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD 396 (429)
T ss_dssp CHHHHHTBTT--HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSS
T ss_pred CHHHHHhhhh--hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCC
Confidence 9887765432 222221110000 0000000 1134788999999999999
Q ss_pred CCCCCCHHHHhcCCcccCC
Q 010512 295 PKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 295 P~~Rpta~eiL~hp~f~~~ 313 (508)
|.+|||++|+|+||||+..
T Consensus 397 P~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 397 PAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp TTTSCCHHHHHTSTTTC--
T ss_pred hhhCCCHHHHhCChhhccC
Confidence 9999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=412.84 Aligned_cols=290 Identities=37% Similarity=0.604 Sum_probs=228.9
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh---hHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV---SDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~---~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
...++|++++.||+|+||.||+|.+..+|+.||||+++...... .....+.+|+.+|+.++||||+++++++..
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 83 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--- 83 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC---
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee---
Confidence 34688999999999999999999999999999999996432211 112467899999999999999999999943
Q ss_pred CCCccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 91 REFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 91 ~~~~~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
...+|+||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 84 --~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 84 --KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp --TTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred --CCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 45689999999999999887653 699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
..... ...+..+||++|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+..+++..+....+.+....+
T Consensus 162 ~~~~~---~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 162 FGSPN---RAYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp TTSCC---CCCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccCCc---ccCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence 53222 123556899999999998652 46899999999999999999999999999999999999888888776544
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
...... ..+ .........++...+..+++.+.+||.+||..||.+|||++|+|+||||.+...
T Consensus 238 ~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 238 PDMCSL--PDY-VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp SSTTSS--TTC-CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hhhccC--ccc-ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 322110 000 000111122222334677899999999999999999999999999999987543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=411.07 Aligned_cols=288 Identities=34% Similarity=0.615 Sum_probs=231.3
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
|...++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++. .
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~ 95 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----K 95 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----E
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----c
Confidence 45568999999999999999999999999999999999765555555667889999999999999999999984 4
Q ss_pred CccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 93 FKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 93 ~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
...+|+||||+++ .|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred CCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 4568999999996 566666667789999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.... .....+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....|.........
T Consensus 176 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 176 APGE---VYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred CCcc---ccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 3221 23456899999999998762 4789999999999999999999999999999999988888888776654332
Q ss_pred HhhHHHHHHHhhcc---cCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 252 IRNEKARRYLGSMR---KKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 252 ~~~~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
..... ...... .....+....++.+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 252 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 252 FNKNP---VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHHCG---GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hhhcc---ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 21100 000000 00111122234578899999999999999999999999999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=403.66 Aligned_cols=255 Identities=25% Similarity=0.462 Sum_probs=219.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
.++|++++.||+|+||.||+|++..+|+.||+|++++... .......+.+|+.+|+.++||||+++++++. +..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-----eCC
Confidence 3679999999999999999999999999999999964321 1223566789999999999999999999994 345
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
.+|+||||++ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 7999999998 599999999889999999999999999999999999999999999999999999999999999864321
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+....+..+...
T Consensus 160 ------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------- 218 (318)
T 1fot_A 160 ------TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------------- 218 (318)
T ss_dssp ------BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-------------
T ss_pred ------cccccCCccccCHhHhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence 234689999999999987 68999999999999999999999999988765555444321
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 314 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~~ 314 (508)
. ..+ .+.+++.+.+||.+||..||.+|| +++++++||||+++.
T Consensus 219 -------------~--~~~---p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 219 -------------E--LRF---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp -------------C--CCC---CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred -------------C--CCC---CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 0 001 134678999999999999999999 999999999998754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=410.31 Aligned_cols=259 Identities=25% Similarity=0.416 Sum_probs=219.6
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~ 92 (508)
..++|++.+.||+|+||.||+|+++.+|+.||||++++... .......+.+|..+|+.+ +||||+++++++..
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~----- 89 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT----- 89 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-----
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe-----
Confidence 45789999999999999999999999999999999975321 122355678899999876 89999999999944
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
...+|+||||++ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 456999999997 6999999988889999999999999999999999999999999999999999999999999998542
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+....+..|...
T Consensus 170 ~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------- 233 (345)
T 1xjd_A 170 LGD---AKTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD----------- 233 (345)
T ss_dssp CTT---CCBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred cCC---CcccCCCCCcccCChhhhcC--CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC-----------
Confidence 221 12356789999999999987 68999999999999999999999999988765555444221
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHH-HHhcCCcccCCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE-EALADPYFHGLA 314 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~-eiL~hp~f~~~~ 314 (508)
.+ .+ ...+++.+.+||.+||..||.+||++. ++++||||+++.
T Consensus 234 ----------------~~-~~---p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 234 ----------------NP-FY---PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp ----------------CC-CC---CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred ----------------CC-CC---CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 00 01 124689999999999999999999998 999999998764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=389.07 Aligned_cols=264 Identities=30% Similarity=0.483 Sum_probs=225.3
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++.+.||+|+||.||+|.+..+|..||+|++............+.+|+.+++.++||||+++++++. ...
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 78 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EES 78 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-----cCC
Confidence 458999999999999999999999999999999999766556666778899999999999999999999984 345
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCc---EEEccccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLARVS 170 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~---lkL~DFGla~~~ 170 (508)
..|+||||+. ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 6899999998 599999988888999999999999999999999999999999999999987665 999999999765
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 159 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-------- 224 (284)
T 3kk8_A 159 NDSE----AWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY-------- 224 (284)
T ss_dssp CSSC----BCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--------
T ss_pred ccCc----cccCCCCCcCCcCchhhcC--CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccc--------
Confidence 3322 2345689999999999987 6789999999999999999999999988776555444432111
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 316 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~ 316 (508)
......+..+++.+.+||.+||+.||.+|||++|+|+||||++....
T Consensus 225 -------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 271 (284)
T 3kk8_A 225 -------------------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV 271 (284)
T ss_dssp -------------------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCG
T ss_pred -------------------cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhH
Confidence 11122345678999999999999999999999999999999875543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=406.57 Aligned_cols=281 Identities=22% Similarity=0.419 Sum_probs=229.5
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-----CCCcceeeeeecC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-----HPDIVEIKHIMLP 87 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-----HpnIv~l~~v~~~ 87 (508)
....++|++++.||+|+||+||+|.+..+|+.||||+++. .......+.+|+.+|+.+. ||||+++++++..
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 3456899999999999999999999999999999999963 2344566788999999997 9999999999854
Q ss_pred CCcCCCccEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC----------
Q 010512 88 PSRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---------- 155 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~---------- 155 (508)
...+|+||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 108 -----~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 108 -----YDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp -----TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred -----CCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence 35699999999889999998764 5999999999999999999999999999999999999975
Q ss_pred ---------------CCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh
Q 010512 156 ---------------DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 220 (508)
Q Consensus 156 ---------------~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt 220 (508)
++.+||+|||+++..... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILN--LGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHH
T ss_pred hcccccccccccccCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHcC--CCCCCccchHHHHHHHHHHHH
Confidence 788999999999864321 235689999999999987 689999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCC-----------------CCCCHHH
Q 010512 221 GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF-----------------PNADPLA 283 (508)
Q Consensus 221 G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-----------------~~~~~~~ 283 (508)
|++||.+.+..+.+..+....+.++...+..........++... .....+.... ...++.+
T Consensus 255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 332 (360)
T 3llt_A 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKD--ELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332 (360)
T ss_dssp SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETT--TTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcc--cceecCcccccchhhhhhhhhcccccccchHHHH
Confidence 99999999999999999998888877665443211111110000 0000010000 1124678
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010512 284 LHLLERLLAFDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 284 ~~Ll~~mL~~DP~~Rpta~eiL~hp~f~ 311 (508)
.+||.+||++||.+|||+.|+|+||||+
T Consensus 333 ~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 333 CDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 8999999999999999999999999995
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=404.04 Aligned_cols=267 Identities=22% Similarity=0.387 Sum_probs=215.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~ 93 (508)
.++|++++.||+|+||.||+|+++.+|+.||||++++... .......+.+|+.+|+.+ +||||+++++++.. .
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----E 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-----C
Confidence 3679999999999999999999999999999999976433 334566788999999988 89999999999944 4
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
..+|+||||++ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 56999999998 69999999888899999999999999999999999999999999999999999999999999985322
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.......... .....
T Consensus 163 ~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----------~~~~~-- 225 (345)
T 3a8x_A 163 PG---DTTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD----------QNTED-- 225 (345)
T ss_dssp TT---CCBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-----------------CHH--
T ss_pred CC---CcccccCCCccccCccccCC--CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc----------cccHH--
Confidence 21 12356789999999999987 689999999999999999999999996532111000 00000
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH------HHHhcCCcccCCC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA------EEALADPYFHGLA 314 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta------~eiL~hp~f~~~~ 314 (508)
....... .. ...+ ...+++.+.+||.+||..||.+||++ +++++||||+++.
T Consensus 226 --~~~~~i~----~~-~~~~---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 226 --YLFQVIL----EK-QIRI---PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp --HHHHHHH----HC-CCCC---CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred --HHHHHHH----cC-CCCC---CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 0000011 01 1111 13578999999999999999999995 8999999998754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=423.70 Aligned_cols=268 Identities=23% Similarity=0.393 Sum_probs=222.6
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
..++|+++++||+|+||+||+|++..+|+.||||++++... .......+.+|+.+|..++||||+++++++. +.
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-----~~ 146 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ-----DD 146 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE-----CS
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eC
Confidence 34789999999999999999999999999999999964211 1112233778999999999999999999994 44
Q ss_pred ccEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 94 KDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
..+|+|||||. |+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence 56999999997 699999987 5689999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCcccccccccCcccccccccccc---cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
.... ...+..+||++|+|||++... ...|+.++|||||||++|||++|++||.+.+..+.+..|....
T Consensus 227 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------- 297 (437)
T 4aw2_A 227 EDGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK------- 297 (437)
T ss_dssp TTSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-------
T ss_pred cCCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc-------
Confidence 3221 223456899999999998621 2578999999999999999999999999988777666554210
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHhcCCcccCCCC
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD--RPTAEEALADPYFHGLAN 315 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~--Rpta~eiL~hp~f~~~~~ 315 (508)
....+......+++.+.+||.+||..+|.+ |++++|+++||||+++..
T Consensus 298 -------------------~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w 347 (437)
T 4aw2_A 298 -------------------ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW 347 (437)
T ss_dssp -------------------HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred -------------------ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCH
Confidence 001222334568999999999999999988 999999999999998754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=398.19 Aligned_cols=266 Identities=27% Similarity=0.447 Sum_probs=225.3
Q ss_pred ccccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh----hHHHHHHHHHHHHHhCCCCCcceeeeee
Q 010512 10 FTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV----SDATRILREIKLLRLLRHPDIVEIKHIM 85 (508)
Q Consensus 10 ~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~----~~~~~i~~Ei~iL~~L~HpnIv~l~~v~ 85 (508)
+..-...++|++.+.||+|+||.||+|.+..+|+.||||+++...... .....+.+|+.+|+.++||||+++++++
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (321)
T 2a2a_A 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY 84 (321)
T ss_dssp CBCSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 334445678999999999999999999999999999999997543221 1356788999999999999999999998
Q ss_pred cCCCcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC----cEE
Q 010512 86 LPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLK 160 (508)
Q Consensus 86 ~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~----~lk 160 (508)
.. ...+|+||||++ ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 85 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~k 159 (321)
T 2a2a_A 85 EN-----RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159 (321)
T ss_dssp EC-----SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred ec-----CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEE
Confidence 43 456999999997 69999999888899999999999999999999999999999999999999988 799
Q ss_pred EccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhh
Q 010512 161 ICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL 240 (508)
Q Consensus 161 L~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~ 240 (508)
|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 160 l~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 233 (321)
T 2a2a_A 160 LIDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233 (321)
T ss_dssp ECCCTTCEECCTTC----CCCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred EccCccceecCccc----cccccCCCCCccCcccccC--CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 99999998654322 1345679999999999987 68999999999999999999999999988876666655443
Q ss_pred cCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 241 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 241 ~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
....... .+...++.+.+||.+||..||.+|||++|+|+||||...
T Consensus 234 ~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 234 SYDFDEE---------------------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp CCCCCHH---------------------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred ccccChh---------------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 2222211 123567889999999999999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=412.61 Aligned_cols=267 Identities=22% Similarity=0.386 Sum_probs=213.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-VSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~-~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~ 93 (508)
.++|+++++||+|+||+||+|+++.+++.||||++++.... ......+.+|+.+|+.+ +||||+++++++.. .
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-----~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----E 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-----S
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-----C
Confidence 46899999999999999999999999999999999764322 23345678899999887 89999999999954 4
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
..+|+|||||. |+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 56999999998 59999999888999999999999999999999999999999999999999999999999999985322
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+....+.... .....
T Consensus 206 ~~---~~~~~~~gt~~Y~aPE~l~~--~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-------~~~~~---- 269 (396)
T 4dc2_A 206 PG---DTTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDY---- 269 (396)
T ss_dssp TT---CCBCCCCBCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------CCHHH----
T ss_pred CC---CccccccCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-------hhHHH----
Confidence 22 12356789999999999987 7899999999999999999999999975432111000 00000
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH------HHHhcCCcccCCC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA------EEALADPYFHGLA 314 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta------~eiL~hp~f~~~~ 314 (508)
.....+ .. ... ....+++.+.+||.+||+.||.+||++ +|+++||||+++.
T Consensus 270 ---~~~~i~----~~-~~~---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 270 ---LFQVIL----EK-QIR---IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp ---HHHHHH----HC-CCC---CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred ---HHHHHh----cc-ccC---CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence 000000 01 111 113578999999999999999999985 8999999998764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=406.52 Aligned_cols=257 Identities=22% Similarity=0.389 Sum_probs=220.7
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
...++|++++.||+|+||.||+|++..+|+.||||++++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 112 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD----- 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----
Confidence 34578999999999999999999999999999999996432 112345678899999999999999999999953
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
...+|+||||++ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 113 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc
Confidence 456999999997 6999999988889999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.. ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+....+..|...
T Consensus 193 ~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------- 253 (350)
T 1rdq_E 193 GR------TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----------- 253 (350)
T ss_dssp SC------BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred CC------cccccCCccccCHHHhcC--CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC-----------
Confidence 21 234689999999999987 68999999999999999999999999988765555444321
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLA 314 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt-----a~eiL~hp~f~~~~ 314 (508)
. ..+ ...+++.+.+||.+||+.||.+||+ ++++++||||+++.
T Consensus 254 ---------------~--~~~---p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~ 301 (350)
T 1rdq_E 254 ---------------K--VRF---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp ---------------C--CCC---CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred ---------------C--CCC---CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence 0 011 1356899999999999999999998 99999999998653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=406.78 Aligned_cols=259 Identities=22% Similarity=0.403 Sum_probs=219.4
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~ 92 (508)
..++|++++.||+|+||.||+|++..+|+.||||++++... .......+.+|..+|..+ +||||+++++++..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~----- 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----- 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-----
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-----
Confidence 35789999999999999999999999999999999975321 123356678999999988 79999999999943
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
...+|+||||++ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 457999999998 5999999988889999999999999999999999999999999999999999999999999998532
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..|...
T Consensus 173 ~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------- 236 (353)
T 2i0e_A 173 WDG---VTTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH----------- 236 (353)
T ss_dssp CTT---CCBCCCCSCGGGCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred cCC---cccccccCCccccChhhhcC--CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-----------
Confidence 221 12345789999999999987 68999999999999999999999999988766555444321
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 314 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~~ 314 (508)
.. .+ ...+++.+.+||.+||..||.+|| +++++++||||+++.
T Consensus 237 ---------------~~--~~---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~ 284 (353)
T 2i0e_A 237 ---------------NV--AY---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284 (353)
T ss_dssp ---------------CC--CC---CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred ---------------CC--CC---CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence 00 11 135789999999999999999999 479999999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=399.02 Aligned_cols=260 Identities=28% Similarity=0.454 Sum_probs=210.7
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEEC---CCCcEEEEEEecCccC--ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFE--HVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 88 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~---~tg~~vAIKki~~~~~--~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 88 (508)
-..++|++++.||+|+||.||+|++. .+|+.||||++++... .......+.+|+.+|+.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 92 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT- 92 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC-
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc-
Confidence 34578999999999999999999985 6899999999975422 22345567899999999999999999999944
Q ss_pred CcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccc
Q 010512 89 SRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 167 (508)
Q Consensus 89 ~~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla 167 (508)
.+.+|+|||||+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 93 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 93 ----GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp ----SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred ----CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 456999999998 699999998888999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChH
Q 010512 168 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 168 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
+....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+....
T Consensus 169 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~------ 237 (327)
T 3a62_A 169 KESIHDGT---VTHTFCGTIEYMAPEILMR--SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK------ 237 (327)
T ss_dssp -------------CTTSSCCTTSCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC------
T ss_pred cccccCCc---cccccCCCcCccCHhhCcC--CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC------
Confidence 75432221 2345689999999999987 688999999999999999999999999887665554443210
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCC
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 314 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~~ 314 (508)
. ...+.+++.+.+||.+||..||.+|| +++++++||||+++.
T Consensus 238 --------------------~-----~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 238 --------------------L-----NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp --------------------C-----CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred --------------------C-----CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 0 01134678999999999999999999 899999999998753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=418.48 Aligned_cols=292 Identities=34% Similarity=0.586 Sum_probs=215.5
Q ss_pred CCCCeEE-eeeeeecCceEEEEEEEC--CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 15 EASRYQI-QEVIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 15 ~~~rY~i-~~~LG~G~~g~V~~a~~~--~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
..+.|++ .++||+|+||+||+|++. .+++.||||++..... ...+.+|+.+|+.|+||||+++++++...
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~--- 90 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSH--- 90 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEET---
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecC---
Confidence 3456887 458999999999999965 5789999999975322 24578999999999999999999998642
Q ss_pred CCccEEEEEecCCccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceee----CCCCc
Q 010512 92 EFKDIYVVFELMESDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCK 158 (508)
Q Consensus 92 ~~~~lylV~E~~~g~L~~~i~~~---------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl----~~~~~ 158 (508)
....+|+||||++++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 91 ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp TTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred CCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence 23569999999999999888632 249999999999999999999999999999999999999 67789
Q ss_pred EEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCCh--------
Q 010512 159 LKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV-------- 230 (508)
Q Consensus 159 lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~-------- 230 (508)
+||+|||+++...............+||++|+|||++.+. ..|+.++||||||||+|+|++|++||.+.+.
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 9999999998754332222334567899999999998762 4589999999999999999999999987664
Q ss_pred -HHHHHHHHhhcCCCChHHHHHHhhHH-HHHHHhhcccCCCCC------CCCCCCCCCHHHHHHHHHhccCCCCCCCCHH
Q 010512 231 -VHQLDLMTDLLGTPSTESISRIRNEK-ARRYLGSMRKKQPVP------FSHKFPNADPLALHLLERLLAFDPKDRPTAE 302 (508)
Q Consensus 231 -~~~l~~i~~~~g~p~~~~~~~~~~~~-~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~ 302 (508)
.+++..|...+|.|....+..+.... ............... +.......++.+.+||.+||.+||.+|||++
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 47888999999999887665542210 011111111100000 0011223467899999999999999999999
Q ss_pred HHhcCCcccCCC
Q 010512 303 EALADPYFHGLA 314 (508)
Q Consensus 303 eiL~hp~f~~~~ 314 (508)
|+|+||||.+..
T Consensus 330 e~L~hp~f~~~~ 341 (405)
T 3rgf_A 330 QAMQDPYFLEDP 341 (405)
T ss_dssp HHHTSGGGTSSS
T ss_pred HHhcChhhccCC
Confidence 999999998654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=422.99 Aligned_cols=258 Identities=31% Similarity=0.499 Sum_probs=216.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|++++.||+|+||+||+|++..++..||||++.+..........+.+|+.+|+.++||||+++++++. ....+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~ 111 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKRNY 111 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCEE
Confidence 4799999999999999999999999999999999765444444677889999999999999999999994 34569
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC---CcEEEccccccccccC
Q 010512 97 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVSFN 172 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~---~~lkL~DFGla~~~~~ 172 (508)
|+|||||. |+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 99999998 5999999888889999999999999999999999999999999999999764 4599999999986543
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
.. .....+||++|+|||++.+ .|+.++||||+||++|+|++|.+||.+.+....+..+......
T Consensus 192 ~~----~~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--------- 255 (494)
T 3lij_A 192 QK----KMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT--------- 255 (494)
T ss_dssp TB----CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---------
T ss_pred Cc----cccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 22 2355689999999999864 6899999999999999999999999988876665555432111
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.....+..+++.+.+||.+||++||.+|||+.|+|+||||+..
T Consensus 256 ------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 256 ------------------FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp ------------------CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred ------------------CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 1122345788999999999999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=410.22 Aligned_cols=262 Identities=25% Similarity=0.424 Sum_probs=217.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
.++|++++.||+|+||.||+|.+..+|+.||||++++.. ........+.+|+.+|+.++||||+++++++.. ..
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD-----EE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----CC
Confidence 478999999999999999999999999999999996432 122345678899999999999999999999953 45
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
.+|+|||||. |+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 6999999997 699999999889999999999999999999999999999999999999999999999999999865332
Q ss_pred CCCcccccccccCcccccccccccc-cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
. .....+||+.|+|||++.+. ...|+.++|||||||++|+|++|++||.+.+.......+..
T Consensus 169 ~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~------------- 231 (384)
T 4fr4_A 169 T----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT------------- 231 (384)
T ss_dssp C----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH-------------
T ss_pred C----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH-------------
Confidence 2 23567899999999998642 14589999999999999999999999986543221111110
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-HHHHhcCCcccCCC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-AEEALADPYFHGLA 314 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt-a~eiL~hp~f~~~~ 314 (508)
... . .. .....+++.+.+||.+||..||.+||+ ++++++||||+++.
T Consensus 232 -------~~~----~-~~---~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 232 -------FET----T-VV---TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp -------HHH----C-CC---CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred -------Hhh----c-cc---CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 000 0 00 112356889999999999999999998 99999999998754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=423.35 Aligned_cols=262 Identities=33% Similarity=0.528 Sum_probs=221.7
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++++.||+|+||+||+|.+..+|+.||||++.+..........+.+|+.+|+.++||||+++++++. ...
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~ 94 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSS 94 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cCC
Confidence 347899999999999999999999999999999999754333345677899999999999999999999994 345
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeC---CCCcEEEccccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARVS 170 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~---~~~~lkL~DFGla~~~ 170 (508)
.+|+|||||. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 6999999998 69999998888999999999999999999999999999999999999995 4567999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.... .....+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+.......
T Consensus 175 ~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------ 241 (486)
T 3mwu_A 175 QQNT----KMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF------ 241 (486)
T ss_dssp CCC--------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS------
T ss_pred CCCC----ccCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------
Confidence 3322 2345689999999999875 59999999999999999999999999988766665554321111
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
....+..+++.+.+||.+||..||.+|||+.++|+||||+....
T Consensus 242 ---------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 242 ---------------------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp ---------------------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred ---------------------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 11223567899999999999999999999999999999987643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=400.62 Aligned_cols=264 Identities=27% Similarity=0.380 Sum_probs=214.2
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++++.||+|+||+||+|++..+|+.||||++..... ......+.+|+.+++.++||||+++++++. ...
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~ 78 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRR-----EGN 78 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCC
Confidence 45789999999999999999999999999999999864322 223356789999999999999999999984 345
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
..|+|||||+ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred eEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 6899999998 599999988888999999999999999999999999999999999999999999999999999865322
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
.. .......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+.........
T Consensus 159 ~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~--------------- 221 (323)
T 3tki_A 159 NR-ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW--------------- 221 (323)
T ss_dssp TE-ECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHH---------------
T ss_pred Cc-ccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---------------
Confidence 21 1223457899999999999762 334789999999999999999999998765432211100
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.. . ......+..+++.+.+||.+||..||.+|||++|+|+||||+...
T Consensus 222 -------~~---~---~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 222 -------KE---K---KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp -------HT---T---CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred -------hc---c---cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 00 0 011112345789999999999999999999999999999998643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=396.70 Aligned_cols=291 Identities=35% Similarity=0.597 Sum_probs=235.5
Q ss_pred CCCCeEEeeeeeecCceEEEEEEEC-CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC---CCCCcceeeeeecCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDT-HTGERVAIKKINDVFEHVSDATRILREIKLLRLL---RHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~-~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L---~HpnIv~l~~v~~~~~~ 90 (508)
..++|++++.||+|+||.||+|.+. .+|+.||+|+++...........+.+|+.+++.+ .||||+++++++.....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3478999999999999999999995 6789999999975433322233456777777766 89999999999863322
Q ss_pred CCCccEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 91 REFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 91 ~~~~~lylV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
.....+|+||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 3456799999999999999998754 49999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+...++.+....
T Consensus 169 ~~~~~----~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 169 IYSFQ----MALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCCGG----GGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccCC----CCccccccccceeCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 64321 12345689999999999987 6799999999999999999999999999999999988888888776654
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
+....... ...+......++....+.+++.+.+||.+||..||.+|||+.++|+||||+++..
T Consensus 243 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 243 WPRDVALP----RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp SCTTCSSC----GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred Cccccccc----hhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 43211000 0011112223344455778999999999999999999999999999999997754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=403.78 Aligned_cols=260 Identities=27% Similarity=0.446 Sum_probs=212.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc---CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF---EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~---~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
.++|++.+.||+|+||+||+|.+..+|+.||||+++... ........+.+|+.+|+.++||||+++++++. .
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~ 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS-----S 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----E
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence 468999999999999999999999999999999986321 11123567889999999999999999999984 3
Q ss_pred CccEEEEEecCC-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCc---EEEccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDF 164 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~----~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~---lkL~DF 164 (508)
.+.+|+|||||+ ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+||
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 457999999998 6998877543 35899999999999999999999999999999999999987655 999999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC
Q 010512 165 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244 (508)
Q Consensus 165 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p 244 (508)
|+++...... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+. ..+..+.......
T Consensus 178 g~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~~~~~ 251 (351)
T 3c0i_A 178 GVAIQLGESG---LVAGGRVGTPHFMAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKM 251 (351)
T ss_dssp TTCEECCTTS---CBCCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHTCCCC
T ss_pred cceeEecCCC---eeecCCcCCcCccCHHHHcC--CCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcCCCCC
Confidence 9998654322 12345689999999999987 6799999999999999999999999987532 2222222111111
Q ss_pred ChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
. ...++.+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 252 ~---------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 252 N---------------------------PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp C---------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred C---------------------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 1 11224578899999999999999999999999999999853
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=405.18 Aligned_cols=262 Identities=30% Similarity=0.445 Sum_probs=203.6
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
...++|++++.||+|+||+||+|++..+|+.||||++..... ....+.+|+.+++.++||||+++++++.. .
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~ 88 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILT-----P 88 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEee-----C
Confidence 456899999999999999999999999999999999975322 23567899999999999999999999954 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCc--EEEccccccccc
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVS 170 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~--lkL~DFGla~~~ 170 (508)
..+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 89 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 89 THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 56999999997 699999988888999999999999999999999999999999999999988765 999999999743
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCc-chhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~-~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
.... .....+||++|+|||++.+ ..++. ++|||||||++|+|++|++||.+.+.......+..
T Consensus 169 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---------- 232 (361)
T 3uc3_A 169 VLHS----QPKSTVGTPAYIAPEVLLR--QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ---------- 232 (361)
T ss_dssp ----------------CTTSCHHHHHC--SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH----------
T ss_pred cccC----CCCCCcCCCCcCChhhhcC--CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH----------
Confidence 2221 1245689999999999977 56654 48999999999999999999987543222111110
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
..+. ..... .....+++.+.+||.+||..||.+|||+.|+|+||||....
T Consensus 233 ---------~~~~---~~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 282 (361)
T 3uc3_A 233 ---------RILS---VKYSI---PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282 (361)
T ss_dssp ---------HHHT---TCCCC---CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred ---------HHhc---CCCCC---CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence 0000 00000 11235789999999999999999999999999999997543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=403.68 Aligned_cols=292 Identities=35% Similarity=0.617 Sum_probs=224.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc--CCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR--REF 93 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~--~~~ 93 (508)
.++|++.+.||+|+||+||+|.+..+|+.||||++..... ...+..+|++.++.++||||+++++++..... ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 3689999999999999999999999999999999854322 23355678888999999999999999865322 223
Q ss_pred ccEEEEEecCCccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHhH--hcCceecCCCCCceeeCC-CCcEEEccccc
Q 010512 94 KDIYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIH--TANVFHRDLKPKNILANA-DCKLKICDFGL 166 (508)
Q Consensus 94 ~~lylV~E~~~g~L~~~i~----~~~~l~~~~~~~i~~Qil~aL~yLH--s~gIiHrDLKPeNILl~~-~~~lkL~DFGl 166 (508)
..+|+||||++++|...+. ....+++..++.++.||+.||.||| +.||+||||||+|||++. ++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 4588999999998776554 4567999999999999999999999 999999999999999997 89999999999
Q ss_pred cccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCh
Q 010512 167 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246 (508)
Q Consensus 167 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 246 (508)
++....... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+...++..+...++.+..
T Consensus 179 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3e3p_A 179 AKKLSPSEP----NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253 (360)
T ss_dssp CBCCCTTSC----CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ceecCCCCC----cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence 986543222 2456889999999998652 55899999999999999999999999999999999999999999988
Q ss_pred HHHHHHhhHHHHHHHhhcccCCCCCCCC----CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCC
Q 010512 247 ESISRIRNEKARRYLGSMRKKQPVPFSH----KFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDR 318 (508)
Q Consensus 247 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~----~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~ 318 (508)
+.+..+....... ........++.. .....++.+.+||.+||++||.+|||+.|+|+||||+++.....
T Consensus 254 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 254 EVLRKLNPSHTDV---DLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT 326 (360)
T ss_dssp HHHHHHCTTCCCG---GGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred HHHHhcccchhhc---cccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence 7766543211000 000111112211 22236788999999999999999999999999999998876443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=414.90 Aligned_cols=265 Identities=24% Similarity=0.356 Sum_probs=218.9
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
..++|++++.||+|+||+||+|+++.+|+.||+|++++... .......+.+|+.+|+.++||||+++++++. +.
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~ 141 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-----DD 141 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----EC
Confidence 45789999999999999999999999999999999964211 1112234778999999999999999999994 44
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
..+|+|||||+ |+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CEEEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 57999999997 6999998764 699999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCccccccccccccc--CCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~--~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.. .......+||+.|+|||++.+.. ..|+.++|||||||++|+|++|++||.+.+....+..|.....
T Consensus 221 ~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-------- 290 (410)
T 3v8s_A 221 EG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN-------- 290 (410)
T ss_dssp TS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--------
T ss_pred CC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc--------
Confidence 22 11234678999999999997621 1288999999999999999999999999887766665543100
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHhcCCcccCCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD--RPTAEEALADPYFHGLA 314 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~--Rpta~eiL~hp~f~~~~ 314 (508)
... + .....+++.+.+||.+||..+|.+ ||+++||++||||+++.
T Consensus 291 ----------------~~~--~-p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 291 ----------------SLT--F-PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp ----------------HCC--C-CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred ----------------ccc--C-CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 000 0 112457899999999999999988 99999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=418.45 Aligned_cols=258 Identities=26% Similarity=0.444 Sum_probs=210.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
.++|++++.||+|+||.||+|.+..+|+.||||+++... ........+.+|+.+|+.++||||+++++++. ..+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-----~~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----THD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-----ETT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-----eCC
Confidence 368999999999999999999999999999999997532 22334566789999999999999999999994 345
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-cCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs-~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
.+|+|||||+ |+|.+++.....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+|+....
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 6999999998 5999999888899999999999999999999998 9999999999999999999999999999985332
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......+...
T Consensus 302 ~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------ 364 (446)
T 4ejn_A 302 DG---ATMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------------ 364 (446)
T ss_dssp --------CCSSSCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred CC---cccccccCCccccCHhhcCC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC------------
Confidence 22 12456789999999999987 78999999999999999999999999988765555444321
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 314 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~~ 314 (508)
.. . ....+++.+.+||.+||++||.+|| |++|+|+||||+++.
T Consensus 365 --------------~~--~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 365 --------------EI--R---FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp --------------CC--C---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred --------------CC--C---CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence 00 0 1134679999999999999999999 999999999999764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=391.89 Aligned_cols=261 Identities=25% Similarity=0.467 Sum_probs=208.7
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC------------------------hhHHHHHHHHHHHH
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH------------------------VSDATRILREIKLL 70 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~------------------------~~~~~~i~~Ei~iL 70 (508)
..++|++.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+|
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 357899999999999999999999999999999999643211 11235688999999
Q ss_pred HhCCCCCcceeeeeecCCCcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCC
Q 010512 71 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPK 149 (508)
Q Consensus 71 ~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPe 149 (508)
+.++||||+++++++... ....+|+||||++ ++|.+++ ....+++..++.++.||+.||.|||++||+||||||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HTCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HhCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 999999999999998642 2357899999998 5776654 3457999999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccC-CCCcchhhhhHHHHHHHHHhCCCCCCCC
Q 010512 150 NILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS-KYTPAIDIWSIGCIFAEMLTGKPLFPGK 228 (508)
Q Consensus 150 NILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~-~y~~~~DIWSlG~il~eLltG~~pF~~~ 228 (508)
|||++.++.+||+|||+++...... ......+||+.|+|||++.+... .++.++|||||||++|+|++|+.||.+.
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSD---ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSS---CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HEEECCCCCEEEecCCCcccccccc---ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999998653322 12345689999999999876211 1478899999999999999999999877
Q ss_pred ChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 010512 229 NVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308 (508)
Q Consensus 229 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp 308 (508)
+.......+... ... + ...+.+++.+.+||.+||..||.+|||+.|+|+||
T Consensus 244 ~~~~~~~~~~~~--------------------------~~~--~-~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 244 RIMCLHSKIKSQ--------------------------ALE--F-PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp SHHHHHHHHHHC--------------------------CCC--C-CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred cHHHHHHHHhcc--------------------------cCC--C-CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 654333222110 000 0 11246789999999999999999999999999999
Q ss_pred ccc
Q 010512 309 YFH 311 (508)
Q Consensus 309 ~f~ 311 (508)
||+
T Consensus 295 ~~~ 297 (298)
T 2zv2_A 295 WVT 297 (298)
T ss_dssp HHH
T ss_pred ccc
Confidence 995
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=405.70 Aligned_cols=259 Identities=27% Similarity=0.437 Sum_probs=219.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++++.||+|+||+||+|.+..+|+.||+|++... .......+.+|+.+|+.++||||+++++++. +...
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 122 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYE 122 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCE
Confidence 46899999999999999999999999999999999643 2334567889999999999999999999994 3456
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC--CCcEEEcccccccccc
Q 010512 96 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVSF 171 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~--~~~lkL~DFGla~~~~ 171 (508)
+|+|||||. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 999999998 69999987654 7999999999999999999999999999999999999974 4779999999998653
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+....
T Consensus 203 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~---------- 266 (387)
T 1kob_A 203 PDE----IVKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD---------- 266 (387)
T ss_dssp TTS----CEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC----------
T ss_pred CCc----ceeeeccCCCccCchhccC--CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence 322 1344589999999999987 689999999999999999999999999887665554443211
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.......+..+++.+.+||.+||..||.+|||+.|+|+||||++..
T Consensus 267 -----------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 267 -----------------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp -----------------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred -----------------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 1111233457889999999999999999999999999999998643
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=413.87 Aligned_cols=268 Identities=22% Similarity=0.348 Sum_probs=219.1
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
..++|++++.||+|+||.||+|+++.+|+.||||++++... .......+.+|+.+|..++||||+++++++. +.
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-----~~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ-----DE 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE-----CS
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eC
Confidence 45789999999999999999999999999999999964211 1122344778999999999999999999994 34
Q ss_pred ccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 94 KDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
..+|+|||||. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 57999999997 6999999875 479999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCcccccccccCcccccccccccc-----cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCh
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~-----~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 246 (508)
.... ......+||+.|+|||++... ...|+.++|||||||++|||++|++||.+.+....+..|.....
T Consensus 214 ~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---- 287 (412)
T 2vd5_A 214 ADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE---- 287 (412)
T ss_dssp TTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH----
T ss_pred CCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc----
Confidence 3221 122346899999999998631 14689999999999999999999999999887666655542100
Q ss_pred HHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCC---CCHHHHhcCCcccCCCCC
Q 010512 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR---PTAEEALADPYFHGLANV 316 (508)
Q Consensus 247 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~R---pta~eiL~hp~f~~~~~~ 316 (508)
...+......+++.+.+||.+||. ||.+| |+++|+++||||+++...
T Consensus 288 ----------------------~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~ 337 (412)
T 2vd5_A 288 ----------------------HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWD 337 (412)
T ss_dssp ----------------------HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred ----------------------CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 001111224678999999999999 99998 599999999999987543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=402.83 Aligned_cols=257 Identities=29% Similarity=0.448 Sum_probs=212.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~ 94 (508)
.++|++.+.||+|+||+||+|.++.+|+.||||++++.... ..+|+.+|.++ +||||+++++++. +..
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~ 89 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYD-----DGK 89 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEE-----CSS
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEE-----cCC
Confidence 46799999999999999999999999999999999754322 34688888887 7999999999994 446
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC----CcEEEcccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD----CKLKICDFGLARV 169 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~----~~lkL~DFGla~~ 169 (508)
.+|+|||||+ |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+..+ +.+||+|||+++.
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 7999999998 6999999988899999999999999999999999999999999999998543 3599999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhhcCCCCh
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN---VVHQLDLMTDLLGTPST 246 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~---~~~~l~~i~~~~g~p~~ 246 (508)
...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.. ....+..+.
T Consensus 170 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~-------- 236 (342)
T 2qr7_A 170 LRAENG---LLMTPCYTANFVAPEVLER--QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG-------- 236 (342)
T ss_dssp CBCTTC---CBCCSSCCSSCCCHHHHHH--HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH--------
T ss_pred CcCCCC---ceeccCCCccccCHHHhcC--CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc--------
Confidence 543221 2345689999999999987 578999999999999999999999997642 222222111
Q ss_pred HHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 247 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
..........++.+++.+.+||.+||..||.+|||+.++|+||||.++..
T Consensus 237 -------------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~ 286 (342)
T 2qr7_A 237 -------------------SGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286 (342)
T ss_dssp -------------------HCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred -------------------cCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence 11111222345678999999999999999999999999999999987543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=396.71 Aligned_cols=263 Identities=25% Similarity=0.459 Sum_probs=192.9
Q ss_pred CeEEe---eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCCC
Q 010512 18 RYQIQ---EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 18 rY~i~---~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~ 93 (508)
+|++. +.||+|+||+||+|.+..+|+.||||++.+ .....+.+|+.+|+.+. ||||+++++++. +.
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~ 78 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHEVFH-----DQ 78 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG-----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh-----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cC
Confidence 46664 789999999999999999999999999964 23456789999999997 999999999994 44
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC---cEEEcccccccc
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARV 169 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~---~lkL~DFGla~~ 169 (508)
..+|+|||||+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 56899999998 59999999998999999999999999999999999999999999999998766 799999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
..... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..... ....
T Consensus 159 ~~~~~---~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--------~~~~--- 222 (325)
T 3kn6_A 159 KPPDN---QPLKTPCFTLHYAAPELLNQ--NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC--------TSAV--- 222 (325)
T ss_dssp CCC---------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C--------CCHH---
T ss_pred cCCCC---CcccccCCCcCccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc--------ccHH---
Confidence 43322 22355688999999999987 68999999999999999999999999875431100 0000
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
..+..+...........+..+++.+.+||.+||..||.+|||++|+++||||++...
T Consensus 223 ---------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 223 ---------EIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp ---------HHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred ---------HHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 001111111111111223457899999999999999999999999999999987543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=405.66 Aligned_cols=259 Identities=27% Similarity=0.449 Sum_probs=211.9
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHH-HHhCCCCCcceeeeeecCCCcCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKL-LRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~i-L~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
..++|++++.||+|+||.||+|+++.+++.||||++++... .......+.+|..+ ++.++||||+++++++..
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~----- 110 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT----- 110 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-----
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-----
Confidence 34789999999999999999999999999999999975432 22344567778877 577899999999999944
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
...+|+||||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 457999999998 5999999988889999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+.......|...
T Consensus 191 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------- 254 (373)
T 2r5t_A 191 EHNS---TTSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK----------- 254 (373)
T ss_dssp CCCC---CCCSBSCCCCCCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS-----------
T ss_pred cCCC---ccccccCCccccCHHHhCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-----------
Confidence 2221 2356789999999999987 68999999999999999999999999988766555444320
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH----HHHhcCCcccCCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA----EEALADPYFHGLA 314 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta----~eiL~hp~f~~~~ 314 (508)
+.. ..+.+++.+.+||.+||+.||.+||++ +++++||||+++.
T Consensus 255 -----------------~~~---~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 255 -----------------PLQ---LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp -----------------CCC---CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred -----------------ccC---CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 011 124578999999999999999999986 7999999998764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=418.07 Aligned_cols=263 Identities=30% Similarity=0.437 Sum_probs=220.8
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh-----------hHHHHHHHHHHHHHhCCCCCcceee
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-----------SDATRILREIKLLRLLRHPDIVEIK 82 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~-----------~~~~~i~~Ei~iL~~L~HpnIv~l~ 82 (508)
...++|++++.||+|+||+||+|.+..++..||||++....... .....+.+|+.+|+.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35688999999999999999999999999999999997543221 2356788999999999999999999
Q ss_pred eeecCCCcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC---c
Q 010512 83 HIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---K 158 (508)
Q Consensus 83 ~v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~---~ 158 (508)
+++. +...+|+|||||+ |+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 113 ~~~~-----~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 113 DVFE-----DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEEE-----CSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred EEEE-----cCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence 9994 4467999999998 59999998888999999999999999999999999999999999999999876 6
Q ss_pred EEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 010512 159 LKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMT 238 (508)
Q Consensus 159 lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~ 238 (508)
+||+|||+++...... .....+||+.|+|||++.+ .|+.++||||+||++|+|++|.+||.+.+....+..+.
T Consensus 188 ~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 260 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY----KLRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260 (504)
T ss_dssp EEECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEEEECCCCEEcCCCC----ccccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999998653322 2355689999999999864 68999999999999999999999999988777666665
Q ss_pred hhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 239 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 239 ~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
........ ..++.+++.+.+||.+||++||.+|||++|+|+||||+....
T Consensus 261 ~~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 261 KGKYYFDF---------------------------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp HCCCCCCH---------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred cCCCCCCc---------------------------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 42221111 113467899999999999999999999999999999987543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=393.15 Aligned_cols=252 Identities=27% Similarity=0.299 Sum_probs=206.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++++.||+|+||+||+|++..+|+.||||++..............+|+..+..+ +||||+++++++. +.+.
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence 579999999999999999999999999999999876655555666667777766555 8999999999984 4467
Q ss_pred EEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred EEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9999999999999988764 469999999999999999999999999999999999999999999999999997653222
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...... +.. +....
T Consensus 212 ----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~--~~~~~-------- 271 (311)
T 3p1a_A 212 ----AGEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQ--GYLPP-------- 271 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTT--TCCCH--------
T ss_pred ----CCcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---Hhc--cCCCc--------
Confidence 1244579999999999875 689999999999999999999776654322111 111 00000
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
.....+++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 272 -------------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 272 -------------------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp -------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred -------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 112356789999999999999999999999999999974
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=418.38 Aligned_cols=261 Identities=30% Similarity=0.483 Sum_probs=223.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
.++|++.+.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.+|+.++||||+++++++. ...
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE-----DKG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence 4689999999999999999999999999999999965432 2345677899999999999999999999994 346
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceee---CCCCcEEEccccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVS 170 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl---~~~~~lkL~DFGla~~~ 170 (508)
.+|+|||||. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 7999999998 6999999998899999999999999999999999999999999999999 56789999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+.......
T Consensus 180 ~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------ 246 (484)
T 3nyv_A 180 EASK----KMKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF------ 246 (484)
T ss_dssp CCCC----SHHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------
T ss_pred cccc----ccccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence 3322 2345689999999999865 68999999999999999999999999988766665554321111
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
....+..+++.+.+||.+||++||.+|||+.|+|+||||+....
T Consensus 247 ---------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 247 ---------------------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp ---------------------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred ---------------------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 11223467899999999999999999999999999999987543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=394.96 Aligned_cols=284 Identities=31% Similarity=0.591 Sum_probs=223.9
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCc
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSR 90 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~ 90 (508)
+++..++|++++.||+|+||+||+|++..+|+.||||+++. .....+.+|+.+|+.++ ||||+++++++..+.
T Consensus 31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~- 104 (330)
T 3nsz_A 31 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPV- 104 (330)
T ss_dssp CCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT-
T ss_pred cccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCC-
Confidence 56677899999999999999999999999999999999963 23467889999999997 999999999996532
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC-cEEEccccccc
Q 010512 91 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLAR 168 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~-~lkL~DFGla~ 168 (508)
....|+||||+. ++|.+++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 105 --~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 105 --SRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp --TCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred --CCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 356899999998 58888774 489999999999999999999999999999999999999777 89999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCC-CCCChHHHHHHHHhhcCCCChH
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF-PGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF-~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
....... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.|| .+.+..+++..+...++.+...
T Consensus 180 ~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 254 (330)
T 3nsz_A 180 FYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 254 (330)
T ss_dssp ECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred EcCCCCc----cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhh
Confidence 6533222 3456899999999998762 57899999999999999999999888 4556677777777666643221
Q ss_pred HHHH-Hh---hHHHHHHHhhcccCCCCCCCC-----CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 248 SISR-IR---NEKARRYLGSMRKKQPVPFSH-----KFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 248 ~~~~-~~---~~~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.... .. .......+ .......+.. ....+++.+.+||.+||++||.+|||++|+|+||||+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 255 DYIDKYNIELDPRFNDIL---GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHHHTTCCCCTHHHHHH---CCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hHHHHhccccccchhhhh---hhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 1100 00 00001111 1111111111 1123789999999999999999999999999999999764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=415.61 Aligned_cols=261 Identities=29% Similarity=0.476 Sum_probs=220.4
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
+....++|.+++.||+|+||.||+|.+..+|+.||||+++.... .......+.+|+.+|+.++||||+++++++..
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--- 87 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST--- 87 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC---
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE---
Confidence 33456899999999999999999999999999999999964321 11235678899999999999999999999954
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 91 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
...+|+|||||+ ++|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 88 --~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 88 --PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 165 (476)
T ss_dssp --SSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred --CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhh
Confidence 356999999997 69999998888999999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
..... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......+.....
T Consensus 166 ~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------- 233 (476)
T 2y94_A 166 MSDGE----FLRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF------- 233 (476)
T ss_dssp CCTTC----CBCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-------
T ss_pred ccccc----cccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-------
Confidence 53322 23456899999999999872 2347899999999999999999999998776555544432110
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.....+++.+.+||.+||..||.+|||++|+++||||+..
T Consensus 234 ------------------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 234 ------------------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ------------------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 0112467899999999999999999999999999999863
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=383.96 Aligned_cols=257 Identities=30% Similarity=0.476 Sum_probs=209.7
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++.+.||+|+||+||+|.+..+|..||+|++..... ......+.+|+++|+.++||||+++++++. ...
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 93 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYH 93 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCC
Confidence 45789999999999999999999999999999999975432 234577889999999999999999999994 345
Q ss_pred cEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceee---CCCCcEEEccccc
Q 010512 95 DIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGL 166 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl---~~~~~lkL~DFGl 166 (508)
.+|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~ 173 (285)
T 3is5_A 94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGL 173 (285)
T ss_dssp EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence 6999999998 599988854 3679999999999999999999999999999999999999 4568899999999
Q ss_pred cccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCh
Q 010512 167 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246 (508)
Q Consensus 167 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 246 (508)
+....... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 174 a~~~~~~~----~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~------ 240 (285)
T 3is5_A 174 AELFKSDE----HSTNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK------ 240 (285)
T ss_dssp CCC--------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------
T ss_pred ceecCCcc----cCcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC------
Confidence 97643322 1345679999999999864 6899999999999999999999999887754433222110
Q ss_pred HHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 247 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
...+.......++.+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 241 ----------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 241 ----------------------EPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ----------------------CCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ----------------------CcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 01111223346899999999999999999999999999999974
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=380.48 Aligned_cols=258 Identities=31% Similarity=0.477 Sum_probs=220.5
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+|+.++||||+++++++. ...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~ 79 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNT 79 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCC
Confidence 34689999999999999999999999999999999975433 23567889999999999999999999994 345
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceee---CCCCcEEEccccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVS 170 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl---~~~~~lkL~DFGla~~~ 170 (508)
.+|+||||++ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 80 DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 6899999998 5999999888889999999999999999999999999999999999999 78899999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.......+.......+..
T Consensus 160 ~~~~----~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--- 229 (277)
T 3f3z_A 160 KPGK----MMRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK--- 229 (277)
T ss_dssp CTTS----CBCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH---
T ss_pred cCcc----chhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch---
Confidence 3322 2345679999999999875 48999999999999999999999999887766665554432222221
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.+..+++.+.+||.+||+.||.+|||+.++|+||||++.
T Consensus 230 ------------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 230 ------------------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp ------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred ------------------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 123567899999999999999999999999999999753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=399.15 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=202.8
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++.+.||+|+||.||+|.+..+++.||||+++... ....+.+|+.+|+.++||||+++++++.. ..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~ 121 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFET-----PT 121 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEec-----CC
Confidence 3467999999999999999999999999999999997432 34567789999999999999999999954 45
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC---CCcEEEccccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVS 170 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~---~~~lkL~DFGla~~~ 170 (508)
.+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 6999999998 699999988888999999999999999999999999999999999999976 889999999999864
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhcCCCChHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH-QLDLMTDLLGTPSTESI 249 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~-~l~~i~~~~g~p~~~~~ 249 (508)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+... .+..+..
T Consensus 202 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~---------- 265 (349)
T 2w4o_A 202 EHQV----LMKTVCGTPGYCAPEILRG--CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN---------- 265 (349)
T ss_dssp ---------------CGGGSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT----------
T ss_pred Cccc----ccccccCCCCccCHHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh----------
Confidence 3221 2345689999999999987 689999999999999999999999997665433 2222211
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.........++.++..+.+||.+||..||.+|||+.|+|+||||.+..
T Consensus 266 -----------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 266 -----------------CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp -----------------TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred -----------------CCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 111112234567889999999999999999999999999999998653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=391.15 Aligned_cols=284 Identities=31% Similarity=0.523 Sum_probs=228.9
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEE-CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC------cceeeeeec
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVD-THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD------IVEIKHIML 86 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~-~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~Hpn------Iv~l~~v~~ 86 (508)
...++|++++.||+|+||.||+|.+ ..+|+.||||+++.. ......+.+|+.+++.++|++ |+++++++.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 3467999999999999999999998 568999999999642 334567889999999987654 899999884
Q ss_pred CCCcCCCccEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC---------
Q 010512 87 PPSRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--------- 155 (508)
Q Consensus 87 ~~~~~~~~~lylV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~--------- 155 (508)
..+.+|+||||++++|.+++...+ ++++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 88 -----~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 88 -----HHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp -----ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred -----cCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence 345799999999999999998775 6899999999999999999999999999999999999987
Q ss_pred ----------CCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCC
Q 010512 156 ----------DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 225 (508)
Q Consensus 156 ----------~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF 225 (508)
++.+||+|||+++..... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILA--LGWSQPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhC--CCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 668999999999864321 234689999999999987 68999999999999999999999999
Q ss_pred CCCChHHHHHHHHhhcCCCChHHHHHHhhHH--------------HHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhc
Q 010512 226 PGKNVVHQLDLMTDLLGTPSTESISRIRNEK--------------ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLL 291 (508)
Q Consensus 226 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~--------------~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL 291 (508)
++.+..+.+..+...++..+...+....... ...+..... .....+.......++.+.+||.+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~L 313 (339)
T 1z57_A 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRAC-KPLKEFMLSQDVEHERLFDLIQKML 313 (339)
T ss_dssp CCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHC-CCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcC-cchhhhcccchhhHHHHHHHHHHHh
Confidence 9999999998898888887776554332100 000000000 0000111112234567899999999
Q ss_pred cCCCCCCCCHHHHhcCCcccCCC
Q 010512 292 AFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 292 ~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
..||.+|||+.|+|+||||+.+.
T Consensus 314 ~~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 314 EYDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp CSSTTTSCCHHHHTTSGGGGGGG
T ss_pred CcCcccccCHHHHhcCHHHHHHh
Confidence 99999999999999999998754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=382.25 Aligned_cols=262 Identities=26% Similarity=0.357 Sum_probs=217.9
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
.....|++.+.||+|+||+||+|.+..++..||+|++............+.+|+.+|+.++||||+++++++.... ...
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 101 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGK 101 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSC
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCC
Confidence 4456789999999999999999999999999999999866666667788999999999999999999999885432 234
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcC--ceecCCCCCceeeC-CCCcEEEcccccccc
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARV 169 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~g--IiHrDLKPeNILl~-~~~~lkL~DFGla~~ 169 (508)
..+|+||||++ ++|.+++.....+++..++.++.||+.||.|||+.| |+||||||+|||++ .++.+||+|||++..
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 66899999997 599999998888999999999999999999999999 99999999999998 789999999999975
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+......
T Consensus 182 ~~~~-----~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--------- 244 (290)
T 1t4h_A 182 KRAS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS--------- 244 (290)
T ss_dssp CCTT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT---------
T ss_pred cccc-----ccccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc---------
Confidence 4322 1244679999999998864 5899999999999999999999999875543332211100
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
...+ .......++.+.+||.+||..||.+|||++++|+||||++
T Consensus 245 ----------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 245 ----------------GVKP---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----------------TCCC---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----------------cCCc---cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 0000 1112345688999999999999999999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=400.10 Aligned_cols=281 Identities=32% Similarity=0.525 Sum_probs=227.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCC-----cceeeeeecCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPD-----IVEIKHIMLPPS 89 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-Hpn-----Iv~l~~v~~~~~ 89 (508)
.++|++.+.||+|+||+||+|.+..+|+.||||+++.. ......+.+|+.+++.++ |++ |+.+++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 127 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-- 127 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--
Confidence 47999999999999999999999999999999999742 334566788999998886 553 8899888843
Q ss_pred cCCCccEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhH--hcCceecCCCCCceeeC--CCCcEEEcc
Q 010512 90 RREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIH--TANVFHRDLKPKNILAN--ADCKLKICD 163 (508)
Q Consensus 90 ~~~~~~lylV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLH--s~gIiHrDLKPeNILl~--~~~~lkL~D 163 (508)
...+|+||||++++|.+++... ..+++..++.++.||+.||.||| ..||+||||||+|||++ .++.+||+|
T Consensus 128 ---~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 128 ---RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp ---TTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred ---CCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 3569999999999999999876 46999999999999999999999 47999999999999995 478899999
Q ss_pred ccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC
Q 010512 164 FGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 243 (508)
Q Consensus 164 FGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~ 243 (508)
||+++..... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+++..+...+|.
T Consensus 205 FG~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 276 (382)
T 2vx3_A 205 FGSSCQLGQR------IYQYIQSRFYRSPEVLLG--MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276 (382)
T ss_dssp CTTCEETTCC------CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred ccCceecccc------cccccCCccccChHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999865321 245689999999999987 67999999999999999999999999999999999999999999
Q ss_pred CChHHHHHHhhHHHHHHHhhcccCCC---------CCCCC-CC------------------C-------CCCHHHHHHHH
Q 010512 244 PSTESISRIRNEKARRYLGSMRKKQP---------VPFSH-KF------------------P-------NADPLALHLLE 288 (508)
Q Consensus 244 p~~~~~~~~~~~~~~~~l~~~~~~~~---------~~~~~-~~------------------~-------~~~~~~~~Ll~ 288 (508)
|+...+.... ..+.++..++.... ..+.. .. . ...+.+.+||.
T Consensus 277 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 354 (382)
T 2vx3_A 277 PPAHILDQAP--KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLIL 354 (382)
T ss_dssp CCHHHHTTCT--THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHH
T ss_pred CCHHHHHhhH--HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHH
Confidence 9887665432 23334333322100 00000 00 0 00147899999
Q ss_pred HhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 289 RLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 289 ~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
+||++||.+|||++|+|+||||++..
T Consensus 355 ~mL~~dP~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 355 RMLDYDPKTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp HHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred HhcCCChhhCCCHHHHhcCcccccCC
Confidence 99999999999999999999998653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=400.01 Aligned_cols=283 Identities=27% Similarity=0.417 Sum_probs=225.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC--------CCCcceeeeeecC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR--------HPDIVEIKHIMLP 87 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~--------HpnIv~l~~v~~~ 87 (508)
.++|++++.||+|+||+||+|++..+|+.||||+++.. ......+.+|+.+|+.++ |+||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 48999999999999999999999999999999999642 344567889999999996 7889999999853
Q ss_pred CCcCCCccEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhc-CceecCCCCCceeeCCCC-------
Q 010512 88 PSRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADC------- 157 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~-gIiHrDLKPeNILl~~~~------- 157 (508)
.. .....+|+||||++++|.+.+... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 113 ~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 113 SG-VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EE-TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred cC-CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 21 134579999999999988888765 4699999999999999999999998 999999999999999875
Q ss_pred ------------------------------------------cEEEccccccccccCCCCCcccccccccCccccccccc
Q 010512 158 ------------------------------------------KLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 195 (508)
Q Consensus 158 ------------------------------------------~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l 195 (508)
.+||+|||+++..... .+..+||+.|+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCHHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCChhh
Confidence 7999999999865322 3456899999999999
Q ss_pred ccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCC
Q 010512 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN------VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQP 269 (508)
Q Consensus 196 ~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~------~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~ 269 (508)
.+ ..|+.++|||||||++|+|++|++||.+.+ ..+++..+...+|.++...+...... ..++........
T Consensus 266 ~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~ 341 (397)
T 1wak_A 266 IG--SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS--KEFFTKKGDLKH 341 (397)
T ss_dssp HT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTG--GGTBCTTSSBSS
T ss_pred cC--CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccc--ccccCCcccccc
Confidence 87 679999999999999999999999998765 56778888888998887665332110 000000000000
Q ss_pred C----CC---------CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 270 V----PF---------SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 270 ~----~~---------~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
. ++ .......++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0 00 0001123456889999999999999999999999999973
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=394.07 Aligned_cols=275 Identities=24% Similarity=0.332 Sum_probs=218.6
Q ss_pred ccccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCC
Q 010512 10 FTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 88 (508)
Q Consensus 10 ~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 88 (508)
.+.-...++|++.+.||+|+||.||+|.+..+|+.||||+++.... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 84 (311)
T 3ork_A 5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84 (311)
T ss_dssp CCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred CCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence 3444567899999999999999999999999999999999976433 334456788999999999999999999998543
Q ss_pred CcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccc
Q 010512 89 SRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 167 (508)
Q Consensus 89 ~~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla 167 (508)
. ......|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 85 ~-~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 85 T-PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp E-TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred C-CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 2 12234699999997 699999998889999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChH
Q 010512 168 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 168 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
+...............+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~---- 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI---- 237 (311)
T ss_dssp ------------------CCTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC----
T ss_pred ccccccccccccccccCcCcccCCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC----
Confidence 865433322222345679999999999987 68999999999999999999999999988765554433221111
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
+.......+++.+.+||.+||+.||.+||++.++|.|+|++...
T Consensus 238 -----------------------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 238 -----------------------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp -----------------------CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred -----------------------CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 11112345788999999999999999999999999999997543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=383.11 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=214.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
.++|++.+.||+|+||+||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++. +..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DAT 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----cCC
Confidence 3689999999999999999999999999999999864321 1223456889999999999999999999994 345
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
.+|+||||++ ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 6899999998 699999988888999999999999999999999999999999999999999999999999998643222
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 163 -----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------- 224 (279)
T 3fdn_A 163 -----RRTDLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----------- 224 (279)
T ss_dssp ----------CCCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-----------
T ss_pred -----cccccCCCCCccCHhHhcc--CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC-----------
Confidence 1245689999999999987 6889999999999999999999999998776555444432110
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.....+++.+.+||.+||..||.+|||+.|+|+||||+...
T Consensus 225 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 225 --------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred --------------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 01124678899999999999999999999999999998654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=395.66 Aligned_cols=268 Identities=28% Similarity=0.447 Sum_probs=214.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc---CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF---EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~---~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
.++|++.+.||+|+||+||+|.+..++..||||++.... ........+.+|+.+|+.++||||+++++++. +
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~ 99 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE-----D 99 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc-----c
Confidence 478999999999999999999999999999999986431 13345678899999999999999999999994 3
Q ss_pred CccEEEEEecCC-ccHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHH
Q 010512 93 FKDIYVVFELME-SDLHQVIKA----------------------------------------NDDLTPEHYQFFLYQLLR 131 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~----------------------------------------~~~l~~~~~~~i~~Qil~ 131 (508)
...+|+|||||+ |+|.+++.. ...+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 456999999997 699998842 112467888999999999
Q ss_pred HHHHhHhcCceecCCCCCceeeCCCC--cEEEccccccccccCCCC-CcccccccccCcccccccccccccCCCCcchhh
Q 010512 132 GLKYIHTANVFHRDLKPKNILANADC--KLKICDFGLARVSFNDAP-SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 208 (508)
Q Consensus 132 aL~yLHs~gIiHrDLKPeNILl~~~~--~lkL~DFGla~~~~~~~~-~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DI 208 (508)
||.|||++||+||||||+|||++.++ .+||+|||+++....... .........||+.|+|||++.+....|+.++||
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 99999999999999999999998776 899999999986533221 111234568999999999987544678999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHH
Q 010512 209 WSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLE 288 (508)
Q Consensus 209 WSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~ 288 (508)
|||||++|+|++|+.||.+.+..+.+..+...... .....+..+++.+.+||.
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~li~ 312 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC---------------------------FENPNYNVLSPLARDLLS 312 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------------------------TTSGGGGGSCHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccc---------------------------cCCcccccCCHHHHHHHH
Confidence 99999999999999999988876655544321111 111122346889999999
Q ss_pred HhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 289 RLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 289 ~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
+||..||.+|||+.++|+||||+++.+
T Consensus 313 ~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 313 NLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HHcCCChhHCCCHHHHhcChhhccChH
Confidence 999999999999999999999997654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=387.92 Aligned_cols=262 Identities=25% Similarity=0.400 Sum_probs=206.1
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc------
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR------ 90 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~------ 90 (508)
++|++++.||+|+||.||+|++..+|+.||||+++... .......+.+|+.+|+.++||||+++++++.....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 57999999999999999999999999999999997432 33456778999999999999999999998854321
Q ss_pred ----------------------------------------------CCCccEEEEEecCC-ccHHHHHHhCCC---CCHH
Q 010512 91 ----------------------------------------------REFKDIYVVFELME-SDLHQVIKANDD---LTPE 120 (508)
Q Consensus 91 ----------------------------------------------~~~~~lylV~E~~~-g~L~~~i~~~~~---l~~~ 120 (508)
.....+|+|||||+ ++|.+++..... .++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 11234899999998 599999987653 5666
Q ss_pred HHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCc---------ccccccccCccccc
Q 010512 121 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA---------IFWTDYVATRWYRA 191 (508)
Q Consensus 121 ~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~---------~~~~~~~gT~~Y~A 191 (508)
.+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......... ......+||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 789999999999999999999999999999999999999999999998764432111 12345689999999
Q ss_pred ccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCC
Q 010512 192 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVP 271 (508)
Q Consensus 192 PE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~ 271 (508)
||++.+ ..|+.++|||||||++|+|++|..|+.. ....+........
T Consensus 245 PE~~~~--~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~-------------------------- 291 (332)
T 3qd2_B 245 PEQIHG--NNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKF-------------------------- 291 (332)
T ss_dssp HHHHHC--CCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCC--------------------------
T ss_pred hHHhcC--CCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCC--------------------------
Confidence 999987 6899999999999999999998766421 1111111111110
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 272 FSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 272 ~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
...+...++.+.+||.+||+.||.+|||++|+|+||||+++
T Consensus 292 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 292 -PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp -CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred -CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 01112335678999999999999999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=387.55 Aligned_cols=281 Identities=26% Similarity=0.385 Sum_probs=208.7
Q ss_pred CCCCeEEe-eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCC
Q 010512 15 EASRYQIQ-EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 15 ~~~rY~i~-~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~ 92 (508)
..++|++. +.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.+|+++ +||||+++++++..
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~----- 82 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEE----- 82 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----
Confidence 45789996 78999999999999999999999999996542 23456788999999885 79999999999843
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCc---EEEccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLAR 168 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~---lkL~DFGla~ 168 (508)
.+.+|+||||++ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 83 EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred CCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 456999999998 699999998888999999999999999999999999999999999999998876 9999999997
Q ss_pred cccCCCC----CcccccccccCcccccccccccc---cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Q 010512 169 VSFNDAP----SAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 241 (508)
Q Consensus 169 ~~~~~~~----~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~ 241 (508)
....... ........+||+.|+|||++.+. ...|+.++|||||||++|+|++|++||.+.+..+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---- 238 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR---- 238 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC------
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc----
Confidence 6432111 11112345799999999998641 135789999999999999999999999876532100000
Q ss_pred CCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 242 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
+...... .......+...........+..+++.+.+||.+||..||.+|||++|+|+||||++..
T Consensus 239 ~~~~~~~--------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 239 GEACPAC--------QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp --CCHHH--------HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred cccchhH--------HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 0000000 0000011111111111112345788999999999999999999999999999998754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=390.94 Aligned_cols=264 Identities=25% Similarity=0.413 Sum_probs=220.3
Q ss_pred CCCCCeEEe-eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcC
Q 010512 14 GEASRYQIQ-EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 14 ~~~~rY~i~-~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~ 91 (508)
...++|.+. +.||+|+||+||+|.+..+|+.||||+++...........+.+|+.+++.+. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~----- 99 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE----- 99 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE-----
Confidence 345678888 8999999999999999999999999999866555555678899999999995 699999999994
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC---CCcEEEcccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFG 165 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~---~~~lkL~DFG 165 (508)
....+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 4456999999998 5999888553 57999999999999999999999999999999999999998 7899999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC
Q 010512 166 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245 (508)
Q Consensus 166 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~ 245 (508)
+++...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 180 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-- 251 (327)
T 3lm5_A 180 MSRKIGHAC----ELREIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD-- 251 (327)
T ss_dssp GCEEC-------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--
T ss_pred cccccCCcc----ccccccCCcCccCCeeecC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccc--
Confidence 998653322 1245689999999999987 68999999999999999999999999988766655544332211
Q ss_pred hHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 246 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
.....+..+++.+.+||.+||+.||.+|||++++|+||||+++..
T Consensus 252 -------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 252 -------------------------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp -------------------------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred -------------------------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 112334567899999999999999999999999999999997654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=392.79 Aligned_cols=261 Identities=27% Similarity=0.360 Sum_probs=208.1
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCC--CCcceeeeeecCCCcCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH--PDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~H--pnIv~l~~v~~~~~~~~ 92 (508)
..++|++++.||+|+||.||+|.+ .++..||||+++...........+.+|+.+|+.++| |||+++++++..
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~----- 80 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----- 80 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-----
Confidence 457899999999999999999987 468999999997655555566788999999999987 999999999854
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 93 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
...+|+|||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 81 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 81 DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp SSEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred CCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 45699999988899999999999999999999999999999999999999999999999997 67899999999986533
Q ss_pred CCCCcccccccccCcccccccccccc---------cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHhhcC
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV-HQLDLMTDLLG 242 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~---------~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~-~~l~~i~~~~g 242 (508)
... .......+||+.|+|||++.+. ...|+.++|||||||++|+|++|+.||.+.... ..+..+.
T Consensus 160 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---- 234 (343)
T 3dbq_A 160 DTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---- 234 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH----
T ss_pred ccc-cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh----
Confidence 221 1123456899999999998531 146889999999999999999999999764321 1111111
Q ss_pred CCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 243 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 243 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
...... ......++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 235 ----------------------~~~~~~---~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 235 ----------------------DPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp ----------------------CTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred ----------------------cCCccc---CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 011111 111234678999999999999999999999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=382.57 Aligned_cols=259 Identities=28% Similarity=0.441 Sum_probs=217.3
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++.+.||+|+||.||+|.+..+|+.||+|+++... ......+.+|+.+|+.++||||+++++++. ...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 79 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STT 79 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCC
Confidence 3468999999999999999999999999999999997432 223456889999999999999999999984 345
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceee---CCCCcEEEccccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVS 170 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl---~~~~~lkL~DFGla~~~ 170 (508)
.+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 80 HYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred EEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 6899999998 6999999888889999999999999999999999999999999999999 77899999999999753
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+....
T Consensus 160 ~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--------- 223 (304)
T 2jam_A 160 QNG-----IMSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY--------- 223 (304)
T ss_dssp CCB-----TTHHHHSCCCBCCTTTBSS--CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC---------
T ss_pred CCC-----ccccccCCCCccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC---------
Confidence 221 1244579999999999987 689999999999999999999999998877655544443211
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.......+..+++.+.+||.+||..||.+|||++++|+||||++..
T Consensus 224 ------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 224 ------------------YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp ------------------CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred ------------------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 0111123456789999999999999999999999999999998653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=394.38 Aligned_cols=262 Identities=26% Similarity=0.394 Sum_probs=218.0
Q ss_pred ccccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhHHHHHHHHHHHHHhCCCCCcceeeeeecCC
Q 010512 10 FTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPP 88 (508)
Q Consensus 10 ~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 88 (508)
|.......+|++++.||+|+||+||+|++..+|+.||||++...... ......+.+|+.+|+.++||||+++++++..
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 125 (348)
T 1u5q_A 47 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR- 125 (348)
T ss_dssp CCCSCHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-
T ss_pred hcccchhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-
Confidence 33334456799999999999999999999999999999999754322 3345678899999999999999999999854
Q ss_pred CcCCCccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccc
Q 010512 89 SRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 167 (508)
Q Consensus 89 ~~~~~~~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla 167 (508)
...+|+||||+.|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 126 ----~~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 201 (348)
T 1u5q_A 126 ----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA 201 (348)
T ss_dssp ----TTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred ----CCeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCc
Confidence 356899999999999888864 567999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccc-cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCh
Q 010512 168 RVSFNDAPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246 (508)
Q Consensus 168 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 246 (508)
+.... ....+||+.|+|||++.+. ...|+.++|||||||++|+|++|++||.+.+....+..+...
T Consensus 202 ~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~------ 268 (348)
T 1u5q_A 202 SIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------ 268 (348)
T ss_dssp BSSSS-------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------
T ss_pred eecCC-------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc------
Confidence 76422 2346899999999998531 257899999999999999999999999887765544333211
Q ss_pred HHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 247 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
..+. .....+++.+.+||.+||+.||.+|||++++|+||||..
T Consensus 269 --------------------~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 269 --------------------ESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp --------------------CCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred --------------------CCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 0111 112356788999999999999999999999999999975
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=385.79 Aligned_cols=255 Identities=29% Similarity=0.508 Sum_probs=214.4
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEE
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 97 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 97 (508)
.|...+.||+|+||.||+|++..+|+.||||++.... ......+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~ 118 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLV-----GEELW 118 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEEE
Confidence 4889999999999999999999999999999996432 2345678899999999999999999999854 35689
Q ss_pred EEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCC
Q 010512 98 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 176 (508)
Q Consensus 98 lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~ 176 (508)
+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 119 lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 196 (321)
T 2c30_A 119 VLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP- 196 (321)
T ss_dssp EEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred EEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-
Confidence 9999998 588888754 5799999999999999999999999999999999999999999999999999986543222
Q ss_pred cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHH
Q 010512 177 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256 (508)
Q Consensus 177 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 256 (508)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 197 --~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~--------------- 257 (321)
T 2c30_A 197 --KRKSLVGTPYWMAPEVISR--SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP--------------- 257 (321)
T ss_dssp --CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS---------------
T ss_pred --ccccccCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---------------
Confidence 2345689999999999987 688999999999999999999999998877655443332210
Q ss_pred HHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 257 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
+ +.......+++.+.+||.+||+.||.+|||+.++|+||||...
T Consensus 258 ------------~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 258 ------------P-PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp ------------C-CCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred ------------C-CCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 0 0011123467889999999999999999999999999999754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=399.29 Aligned_cols=257 Identities=28% Similarity=0.413 Sum_probs=212.1
Q ss_pred CCeEE--eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 17 SRYQI--QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 17 ~rY~i--~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
+.|.+ .+.||+|+||.||+|.+..+|..||+|+++.. .......+.+|+.+|+.++||||+++++++.. ..
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~ 159 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFES-----KN 159 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CC
Confidence 44555 67899999999999999999999999999743 23456778999999999999999999999943 45
Q ss_pred cEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceee--CCCCcEEEccccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA--NADCKLKICDFGLARVS 170 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl--~~~~~lkL~DFGla~~~ 170 (508)
.+|+|||||+ ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++..
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 6999999998 5999888764 469999999999999999999999999999999999999 56789999999999875
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+......
T Consensus 240 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~------- 306 (373)
T 2x4f_A 240 KPRE----KLKVNFGTPEFLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD------- 306 (373)
T ss_dssp CTTC----BCCCCCSSCTTCCHHHHTT--CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-------
T ss_pred CCcc----ccccccCCCcEeChhhccC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-------
Confidence 4322 1344579999999999976 68999999999999999999999999998877666555432111
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.....++.+++.+.+||.+||+.||.+|||+.|+|+||||.+.
T Consensus 307 --------------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 307 --------------------LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp --------------------SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred --------------------CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 1112345678999999999999999999999999999999753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=378.03 Aligned_cols=260 Identities=28% Similarity=0.476 Sum_probs=217.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh----hHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV----SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~----~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
++|++.+.||+|+||.||+|.+..+|+.||+|+++...... .....+.+|+.+|+.++||||+++++++..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN----- 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-----
Confidence 57999999999999999999999999999999987542221 235778999999999999999999999954
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC----cEEEcccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGLA 167 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~----~lkL~DFGla 167 (508)
...+|+||||++ ++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 456899999997 69999998888899999999999999999999999999999999999999887 8999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChH
Q 010512 168 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 168 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+.........
T Consensus 160 ~~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 232 (283)
T 3bhy_A 160 HKIEAGN----EFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE- 232 (283)
T ss_dssp EECC------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH-
T ss_pred eeccCCC----cccccCCCcCccCcceecC--CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc-
Confidence 8653322 1345679999999999987 68999999999999999999999999988766655544332221111
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
..++..++.+.+||.+||..||.+|||+.++|+||||+.+.
T Consensus 233 --------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 233 --------------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp --------------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred --------------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 11245678899999999999999999999999999998654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=389.16 Aligned_cols=283 Identities=31% Similarity=0.519 Sum_probs=227.3
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCC-cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC------cceeeeeecC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTG-ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD------IVEIKHIMLP 87 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg-~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~Hpn------Iv~l~~v~~~ 87 (508)
..++|++++.||+|+||+||+|.+..++ ..||||+++.. ......+.+|+.+|+.++|++ ++.+.+++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~- 92 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN- 92 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE-
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee-
Confidence 4589999999999999999999998877 68999999642 334567788999999998766 888888873
Q ss_pred CCcCCCccEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceee------------
Q 010512 88 PSRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA------------ 153 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl------------ 153 (508)
..+.+|+||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 93 ----~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 93 ----FHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp ----ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred ----eCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence 345799999999999998887754 69999999999999999999999999999999999999
Q ss_pred -------CCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCC
Q 010512 154 -------NADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFP 226 (508)
Q Consensus 154 -------~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~ 226 (508)
+.++.+||+|||+++..... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH------HTTIVATRHYRPPEVILE--LGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC------CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccCCCcEEEeecCcccccccc------ccCCcCCCcccCCeeeec--CCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 56789999999999864321 244689999999999987 689999999999999999999999999
Q ss_pred CCChHHHHHHHHhhcCCCChHHHHHHhhHH--------------HHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 010512 227 GKNVVHQLDLMTDLLGTPSTESISRIRNEK--------------ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLA 292 (508)
Q Consensus 227 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~--------------~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~ 292 (508)
+.+..+.+..+...++.++...+....... ...++..... ............++.+.+||.+||.
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK-PLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCC-cccccccccchhHHHHHHHHHHHhc
Confidence 999999999999998888776654432110 0000000000 0000001112234678899999999
Q ss_pred CCCCCCCCHHHHhcCCcccCCC
Q 010512 293 FDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 293 ~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.||.+|||+.|+|+||||+++.
T Consensus 320 ~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 320 FDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp SSTTTSCCHHHHTTSGGGGGCC
T ss_pred CChhhCcCHHHHhcChhhcCCC
Confidence 9999999999999999999764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=398.71 Aligned_cols=260 Identities=28% Similarity=0.377 Sum_probs=208.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC--CCCcceeeeeecCCCcCCCc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR--HPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~--HpnIv~l~~v~~~~~~~~~~ 94 (508)
.+|++++.||+|+||+||+|.+.. |+.||||+++...........+.+|+.+|+.|+ ||||+++++++.. ..
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-----CC
Confidence 469999999999999999999865 999999999765555556778999999999997 5999999999854 34
Q ss_pred cEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 95 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 95 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
.+|||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus 130 ~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 130 YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 599999977789999999988999999999999999999999999999999999999995 6899999999998653322
Q ss_pred CCcccccccccCcccccccccccc---------cCCCCcchhhhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhhcCCC
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV-VHQLDLMTDLLGTP 244 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~---------~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~-~~~l~~i~~~~g~p 244 (508)
. .......+||+.|+|||++.+. ...|+.++||||||||+|+|++|++||.+... ...+..+..
T Consensus 209 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~----- 282 (390)
T 2zmd_A 209 T-SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID----- 282 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC-----
T ss_pred c-cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC-----
Confidence 1 1123456899999999998641 13689999999999999999999999976432 112211110
Q ss_pred ChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
......+ ....+..+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 283 ---------------------~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 283 ---------------------PNHEIEF---PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp ---------------------TTSCCCC---CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ---------------------ccccCCC---CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 0111111 12346789999999999999999999999999999854
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=400.96 Aligned_cols=264 Identities=27% Similarity=0.424 Sum_probs=205.3
Q ss_pred CCCCCeEEe-eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHH-HhCCCCCcceeeeeecCCCcC
Q 010512 14 GEASRYQIQ-EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL-RLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 14 ~~~~rY~i~-~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL-~~L~HpnIv~l~~v~~~~~~~ 91 (508)
...++|.+. ++||+|+||+||+|.+..+|+.||||+++. ...+.+|+.++ +.++||||+++++++.... .
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY-A 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-T
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeecc-c
Confidence 345678887 799999999999999999999999999863 23567899887 5568999999999884311 2
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC---CCcEEEcccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFG 165 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~---~~~lkL~DFG 165 (508)
+...+|||||||+ |+|.+++...+ .+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 2457899999998 59999998754 5999999999999999999999999999999999999998 7899999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC
Q 010512 166 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245 (508)
Q Consensus 166 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~ 245 (508)
+++...... ..+..+||+.|+|||++.+ ..|+.++||||||||+|+|++|++||.+.+.....
T Consensus 210 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----------- 272 (400)
T 1nxk_A 210 FAKETTSHN----SLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------- 272 (400)
T ss_dssp TCEECC---------------CTTCCGGGSCC--CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-----------
T ss_pred cccccCCCC----ccccCCCCCCccCHhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-----------
Confidence 998643221 2356789999999999977 78999999999999999999999999876532100
Q ss_pred hHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 246 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
......+ ...........+..+++.+.+||.+||..||.+|||++|+|+||||.+..
T Consensus 273 ~~~~~~i------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 273 PGMKTRI------------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp CSHHHHH------------HHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred HHHHHHH------------HcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 0000000 00011111223467889999999999999999999999999999998643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=379.46 Aligned_cols=259 Identities=23% Similarity=0.380 Sum_probs=198.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++++.||+|+||+||+|.+..+|+.||||+++...........+..+...++.++||||+++++++.. .+.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----~~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-----EGD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-----cCC
Confidence 478999999999999999999999999999999997543333333444455566888999999999999954 356
Q ss_pred EEEEEecCCccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhc-CceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 96 IYVVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 96 lylV~E~~~g~L~~~i~~----~~~l~~~~~~~i~~Qil~aL~yLHs~-gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
+|+||||++++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 81 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 899999999988777653 56799999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCccccccccccc--ccCCCCcchhhhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhhcCCCChH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN-VVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~--~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~-~~~~l~~i~~~~g~p~~~ 247 (508)
..... .....||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+.. ....+..+..
T Consensus 161 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------- 228 (290)
T 3fme_A 161 VDDVA----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE-------- 228 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH--------
T ss_pred ccccc----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc--------
Confidence 33221 233479999999999731 12578999999999999999999999997633 2222211111
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
...+ ......+++.+.+||.+||+.||.+|||+.|+++||||+.
T Consensus 229 ------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 229 ------------------EPSP---QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp ------------------SCCC---CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ------------------cCCC---CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 0011 0112356889999999999999999999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=377.86 Aligned_cols=265 Identities=29% Similarity=0.421 Sum_probs=223.7
Q ss_pred ccccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCC
Q 010512 10 FTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 88 (508)
Q Consensus 10 ~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 88 (508)
.......++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 86 (294)
T 2rku_A 8 LVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED- 86 (294)
T ss_dssp EEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred eeCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-
Confidence 3445677899999999999999999999999999999999865432 33456678899999999999999999999843
Q ss_pred CcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccc
Q 010512 89 SRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 167 (508)
Q Consensus 89 ~~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla 167 (508)
...+|+||||++ ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 87 ----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 162 (294)
T 2rku_A 87 ----NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162 (294)
T ss_dssp ----SSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ----CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCc
Confidence 456899999998 699999988888999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChH
Q 010512 168 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 168 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 163 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------- 230 (294)
T 2rku_A 163 TKVEYDGE---RKKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------- 230 (294)
T ss_dssp EECCSTTC---CBCCCCSCCSSCCHHHHTT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------
T ss_pred eecccCcc---ccccccCCCCcCCcchhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-------
Confidence 86532221 1344679999999999987 67899999999999999999999999887654443322110
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
.. .....+++.+.+||.+||..||.+|||++++++||||.....
T Consensus 231 -------------------~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 231 -------------------EY-----SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp -------------------CC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred -------------------cC-----CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence 00 111356789999999999999999999999999999986544
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=426.41 Aligned_cols=259 Identities=22% Similarity=0.393 Sum_probs=221.3
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~ 92 (508)
..++|+++++||+|+||.||+|.+..+|+.||||++++.. ........+.+|+.+|..+ +||+|+.+++++. +
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~-----~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----T 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB-----C
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE-----e
Confidence 3478999999999999999999999999999999997531 1223356678899999987 6999999999984 4
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
...+||||||++ |+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 457999999998 6999999988899999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.... .....+||+.|+|||++.+ ..|+.++||||||||+|||++|++||.+.+..+.+..|...
T Consensus 494 ~~~~---~~~~~~GT~~Y~APE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~----------- 557 (674)
T 3pfq_A 494 WDGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH----------- 557 (674)
T ss_dssp CTTC---CBCCCCSCSSSCCHHHHTC--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS-----------
T ss_pred cCCc---ccccccCCCcccCHhhhcC--CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-----------
Confidence 2221 2356789999999999987 78999999999999999999999999998876666555321
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCH-----HHHhcCCcccCCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA-----EEALADPYFHGLA 314 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta-----~eiL~hp~f~~~~ 314 (508)
. .. ....+++.+.+||.+||+.||.+||++ +||++||||+++.
T Consensus 558 ---------------~--~~---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 558 ---------------N--VA---YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp ---------------C--CC---CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred ---------------C--CC---CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 0 01 113578999999999999999999997 9999999999764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=380.67 Aligned_cols=267 Identities=23% Similarity=0.403 Sum_probs=217.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC--ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE--HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~--~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
.++|++.+.||+|+||.||+|.+..+|..||+|+++.... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---EK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CC
Confidence 4789999999999999999999999999999999974321 123456789999999999999999999998542 23
Q ss_pred ccEEEEEecCCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 94 KDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 94 ~~lylV~E~~~g~L~~~i~~--~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
..+|+||||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 81 QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp -CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 56899999999888888876 3569999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.... ........||+.|+|||++.+....++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 161 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~----------- 228 (305)
T 2wtk_C 161 PFAA-DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG----------- 228 (305)
T ss_dssp TTCS-SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-----------
T ss_pred cccc-ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC-----------
Confidence 3222 1223456799999999998763234578999999999999999999999887754444333210
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 317 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~ 317 (508)
.. .....+++.+.+||.+||..||.+|||++|+++||||+......
T Consensus 229 ---------------~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 229 ---------------SY-----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp ---------------CC-----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred ---------------CC-----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence 00 11235678999999999999999999999999999998765433
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=406.55 Aligned_cols=254 Identities=17% Similarity=0.216 Sum_probs=202.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHH---HHHHhCCCCCcceee-------ee
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREI---KLLRLLRHPDIVEIK-------HI 84 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~-~~~~~~~~~i~~Ei---~iL~~L~HpnIv~l~-------~v 84 (508)
.++|++.+.||+|+||+||+|++..+|+.||||+++.. .........+.+|+ ++|+.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 47899999999999999999999999999999999743 22334567788999 455556899999998 44
Q ss_pred ecCCCc-------CCCc-----cEEEEEecCCccHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHhHhcCceecC
Q 010512 85 MLPPSR-------REFK-----DIYVVFELMESDLHQVIKANDDLTP-------EHYQFFLYQLLRGLKYIHTANVFHRD 145 (508)
Q Consensus 85 ~~~~~~-------~~~~-----~lylV~E~~~g~L~~~i~~~~~l~~-------~~~~~i~~Qil~aL~yLHs~gIiHrD 145 (508)
+..... .+.+ ..|+||||++|+|.+++...+.+++ ..+..|+.||+.||.|||++||+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 433210 0111 3799999999999999987655555 78888999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccC-----------CCCcchhhhhHHHH
Q 010512 146 LKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS-----------KYTPAIDIWSIGCI 214 (508)
Q Consensus 146 LKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~-----------~y~~~~DIWSlG~i 214 (508)
|||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+ . .|+.++|||||||+
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~--~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEAR--RATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHH--HTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcc--cccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999985321 2345678 99999999986 4 79999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCC
Q 010512 215 FAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFD 294 (508)
Q Consensus 215 l~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~D 294 (508)
+|+|++|+.||.+.+....... .....+.+++.+.+||.+||..|
T Consensus 303 l~elltg~~Pf~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~li~~~L~~d 347 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSEW-----------------------------------IFRSCKNIPQPVRALLEGFLRYP 347 (377)
T ss_dssp HHHHHHSSCCC------CCSGG-----------------------------------GGSSCCCCCHHHHHHHHHHTCSS
T ss_pred HHHHHHCCCCCcccccccchhh-----------------------------------hhhhccCCCHHHHHHHHHHcCCC
Confidence 9999999999976542111100 01122567899999999999999
Q ss_pred CCCCCCHHHHhcCCcccCC
Q 010512 295 PKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 295 P~~Rpta~eiL~hp~f~~~ 313 (508)
|.+|||+.++|+||||+++
T Consensus 348 p~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 348 KEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp GGGCCCHHHHHTSHHHHHH
T ss_pred chhCCCHHHHhhChHHHHH
Confidence 9999999999999999754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=378.49 Aligned_cols=258 Identities=23% Similarity=0.381 Sum_probs=217.9
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
-..++|++.+.||+|+||.||+|.+..++..||||++..... .......+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 85 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD----- 85 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-----
Confidence 345789999999999999999999999999999999864321 11224578899999999999999999999843
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
...+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 456899999998 5999999988889999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 166 ~~~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----------- 227 (284)
T 2vgo_A 166 SLR-----RRTMCGTLDYLPPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV----------- 227 (284)
T ss_dssp SSC-----BCCCCSCGGGCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-----------
T ss_pred ccc-----cccccCCCCcCCHHHhcc--CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc-----------
Confidence 221 234679999999999987 67899999999999999999999999887654443333210
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.. ...+.++..+.+||.+||..||.+|||++++++||||+...
T Consensus 228 ---------------~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 228 ---------------DL-----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp ---------------CC-----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred ---------------cc-----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 00 11135678999999999999999999999999999998644
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=390.30 Aligned_cols=259 Identities=28% Similarity=0.484 Sum_probs=216.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC--h----hHHHHHHHHHHHHHhC-CCCCcceeeeeecCCC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH--V----SDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 89 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~--~----~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~ 89 (508)
++|++.+.||+|+||.||+|.+..+|+.||||++...... . .....+.+|+.+++.+ +||||+++++++.
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--- 170 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE--- 170 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE---
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe---
Confidence 5799999999999999999999999999999998654321 1 1245678999999999 7999999999984
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
.....|+||||++ ++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 171 --~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 171 --SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp --BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred --eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 3456999999998 5999999888889999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccc----cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~----~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p 244 (508)
...... .....+||+.|+|||++.+. ...|+.++|||||||++|+|++|..||.+.+....+..+......+
T Consensus 249 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 324 (365)
T 2y7j_A 249 HLEPGE----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF 324 (365)
T ss_dssp ECCTTC----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred ccCCCc----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 654322 23456899999999998641 1358899999999999999999999998877665555443322111
Q ss_pred ChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010512 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~ 311 (508)
.. ..+...++.+.+||.+||..||.+|||++++|+||||+
T Consensus 325 ~~---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 325 SS---------------------------PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp CH---------------------------HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred CC---------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 11 11235678899999999999999999999999999996
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=404.92 Aligned_cols=260 Identities=32% Similarity=0.524 Sum_probs=204.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC------hhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH------VSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 89 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~------~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 89 (508)
.++|++.+.||+|+||+||+|.+..+++.||||++...... ......+.+|+.+|+.++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 47899999999999999999999999999999999653211 1122347899999999999999999999732
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC---cEEEcccc
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFG 165 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~---~lkL~DFG 165 (508)
..+|+|||||+ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 212 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 ----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp ----SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred ----CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence 34799999998 69999998888999999999999999999999999999999999999997654 59999999
Q ss_pred ccccccCCCCCcccccccccCccccccccccc-ccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHH-HHHHhhcCC
Q 010512 166 LARVSFNDAPSAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQL-DLMTDLLGT 243 (508)
Q Consensus 166 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~-~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l-~~i~~~~g~ 243 (508)
+++...... .....+||+.|+|||++.+ ....|+.++|||||||++|+|++|++||.+......+ ..+....
T Consensus 288 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~-- 361 (419)
T 3i6u_A 288 HSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK-- 361 (419)
T ss_dssp TTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC--
T ss_pred cceecCCCc----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC--
Confidence 998653221 2345789999999999853 1256889999999999999999999999875432211 1121111
Q ss_pred CChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 244 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 244 p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
.......+..+++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 362 -------------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 362 -------------------------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp -------------------------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred -------------------------CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 11111223457889999999999999999999999999999974
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=375.26 Aligned_cols=251 Identities=22% Similarity=0.278 Sum_probs=207.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++++.||+|+||+||+|.+..+|+.||||+++...........+.+|+..+..+ +||||+++++++.. ...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----~~~ 85 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----DDH 85 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----TTE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence 679999999999999999999999999999999986655556677889999999999 89999999999843 456
Q ss_pred EEEEEecCC-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC--------------
Q 010512 96 IYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-------------- 156 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~----~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~-------------- 156 (508)
+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 899999998 5999999764 679999999999999999999999999999999999999844
Q ss_pred -----CcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChH
Q 010512 157 -----CKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 231 (508)
Q Consensus 157 -----~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~ 231 (508)
..+||+|||++...... ....||+.|+|||++.+. ..++.++|||||||++|+|++|.+|+......
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 237 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH
T ss_pred ccCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhHH
Confidence 47999999999865322 224689999999999762 46678999999999999999999877543221
Q ss_pred HHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010512 232 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 232 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~ 311 (508)
. .+. . .. +......+++.+.+||.+||..||.+|||+.++|+||||.
T Consensus 238 ~---~~~-----------------------~----~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 284 (289)
T 1x8b_A 238 H---EIR-----------------------Q----GR---LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284 (289)
T ss_dssp H---HHH-----------------------T----TC---CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred H---HHH-----------------------c----CC---CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence 1 110 0 00 1112245789999999999999999999999999999998
Q ss_pred CC
Q 010512 312 GL 313 (508)
Q Consensus 312 ~~ 313 (508)
+.
T Consensus 285 ~~ 286 (289)
T 1x8b_A 285 SA 286 (289)
T ss_dssp --
T ss_pred hh
Confidence 53
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=393.36 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=210.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh------hHHHHHHHHHHHHHhCCCCCcceeeeeecCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV------SDATRILREIKLLRLLRHPDIVEIKHIMLPPS 89 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~------~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 89 (508)
.++|++++.||+|+||+||+|++..+|+.||||+++...... .....+.+|+.+|+.++||||+++++++.
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~--- 99 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE--- 99 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE---
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence 368999999999999999999999999999999997543211 12345678999999999999999999994
Q ss_pred cCCCccEEEEEecCC-c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccc
Q 010512 90 RREFKDIYVVFELME-S-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 167 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla 167 (508)
..+.+|+||||+. | +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 100 --~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 100 --NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp --CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred --eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 4457999999986 5 99999999889999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCC-CcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCh
Q 010512 168 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246 (508)
Q Consensus 168 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y-~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 246 (508)
+...... .....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+....
T Consensus 178 ~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------- 236 (335)
T 3dls_A 178 AYLERGK----LFYTFCGTIEYCAPEVLMG--NPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------- 236 (335)
T ss_dssp EECCTTC----CBCEECSCGGGCCHHHHTT--CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------
T ss_pred eECCCCC----ceeccCCCccccChhhhcC--CCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------
Confidence 8653322 2345689999999999987 444 88999999999999999999999652210
Q ss_pred HHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 247 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
..... .....+++.+.+||.+||..||.+|||++++|+||||++
T Consensus 237 -----------------~~~~~-----~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 237 -----------------VEAAI-----HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp -----------------TTTCC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred -----------------Hhhcc-----CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 00000 111236889999999999999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=385.24 Aligned_cols=263 Identities=29% Similarity=0.422 Sum_probs=222.8
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
.....++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++..
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 112 (335)
T 2owb_A 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--- 112 (335)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred CcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---
Confidence 4456789999999999999999999999999999999987543 233456678899999999999999999999943
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 91 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
...+|+||||++ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 113 --~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 113 --NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp --SSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred --CCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 456999999998 69999998888899999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 191 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------- 256 (335)
T 2owb_A 191 VEYDGE---RKKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--------- 256 (335)
T ss_dssp CCSTTC---CBCCCCSCCSSCCHHHHHT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT---------
T ss_pred cccCcc---cccccCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC---------
Confidence 532221 1344679999999999987 67899999999999999999999999887654443332210
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
.. .....+++.+.+||.+||..||.+|||++|+|+||||.....
T Consensus 257 -----------------~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 257 -----------------EY-----SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp -----------------CC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred -----------------CC-----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 00 011346788999999999999999999999999999986543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=376.19 Aligned_cols=265 Identities=28% Similarity=0.434 Sum_probs=219.6
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC-------hhHHHHHHHHHHHHHhCC-CCCcceeeeee
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-------VSDATRILREIKLLRLLR-HPDIVEIKHIM 85 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~-------~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~ 85 (508)
+..++|++.+.||+|+||.||+|.+..+|+.||||+++..... ......+.+|+.+|+.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 4568999999999999999999999999999999999643211 122456789999999996 99999999998
Q ss_pred cCCCcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccc
Q 010512 86 LPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 164 (508)
Q Consensus 86 ~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DF 164 (508)
. ....+|+||||++ ++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus 94 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 94 E-----TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp E-----CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred c-----cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecc
Confidence 4 3456999999998 699999998888999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccc----cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhh
Q 010512 165 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL 240 (508)
Q Consensus 165 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~----~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~ 240 (508)
|++....... ......||+.|+|||++.+. ...++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 169 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (298)
T 1phk_A 169 GFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244 (298)
T ss_dssp TTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred cchhhcCCCc----ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence 9998653322 23456799999999998521 246889999999999999999999999887765544433321
Q ss_pred cCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 241 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 241 ~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.. ......++.++..+.+||.+||..||.+|||+.++|+||||++..
T Consensus 245 ~~---------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 245 NY---------------------------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp CC---------------------------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred Cc---------------------------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 10 111122345788999999999999999999999999999998653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=417.18 Aligned_cols=263 Identities=26% Similarity=0.403 Sum_probs=216.4
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
-..++|+++++||+|+||.||+|.+..+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++..
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----- 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET----- 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-----
Confidence 34578999999999999999999999999999999996431 112234567899999999999999999999943
Q ss_pred CccEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
...+|+|||||+ |+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccccee
Confidence 457999999997 69999998754 499999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
..... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......+.
T Consensus 336 ~~~~~----~~~~~~GT~~Y~APEvl~~--~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~----------- 398 (576)
T 2acx_A 336 VPEGQ----TIKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE----------- 398 (576)
T ss_dssp CCTTC----CEECCCSCGGGCCHHHHTT--CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH-----------
T ss_pred cccCc----cccccCCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH-----------
Confidence 53322 2345689999999999987 689999999999999999999999998764211111110
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCC
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 314 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~~ 314 (508)
..+... +..+ ...+++.+.+||.+||+.||.+|| +++|+++||||+++.
T Consensus 399 ---------~~i~~~----~~~~---p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 399 ---------RLVKEV----PEEY---SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp ---------HHHHHC----CCCC---CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred ---------HHhhcc----cccC---CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence 001111 1111 245789999999999999999999 899999999999754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=378.97 Aligned_cols=266 Identities=27% Similarity=0.332 Sum_probs=213.9
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
...++|++++.||+|+||.||+|.+..++..||+|++..... ......++.+|+.+++.++||||+++++++. .
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~ 82 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE-----E 82 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE-----C
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee-----e
Confidence 346799999999999999999999999999999999864332 3345677899999999999999999999984 4
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
.+.+|+||||++ ++|.+++...+++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 83 DDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred CCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 467999999998 5999999988899999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..........
T Consensus 163 ~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~------------ 226 (294)
T 4eqm_A 163 ETSL--TQTNHVLGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ------------ 226 (294)
T ss_dssp --------------CCSSCCHHHHHT--CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS------------
T ss_pred cccc--cccCccccCccccCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh------------
Confidence 2221 12344679999999999987 6789999999999999999999999998775443322211
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
...+.......+.+++.+.++|.+||..||.+||+..+.+.+.|..-+.
T Consensus 227 --------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 227 --------------DSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp --------------SCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred --------------ccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 1111111122356789999999999999999999777777777765443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=374.17 Aligned_cols=260 Identities=27% Similarity=0.411 Sum_probs=214.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|++++.||+|+||.||+|.+..+|+.||||+++.... ......+.+|+.+++.++||||+++++++. .....
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 80 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 80 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEE
Confidence 579999999999999999999999999999999964322 234567889999999999999999999984 34568
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 97 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
|+||||++ ++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999998 59999998777899999999999999999999999999999999999999999999999999986432221
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHhhcCCCChHHHHHHhh
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQ-LDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~-l~~i~~~~g~p~~~~~~~~~~ 254 (508)
........||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+.... +..+..
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------------- 223 (276)
T 2yex_A 161 -ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--------------- 223 (276)
T ss_dssp -ECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT---------------
T ss_pred -hhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh---------------
Confidence 1123456899999999999762 3347899999999999999999999987653221 111110
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
. ......+..+++.+.+||.+||..||.+|||++|+++||||++.
T Consensus 224 ------------~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 224 ------------K--KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp ------------T--CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ------------c--ccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 0 00111234578899999999999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=391.49 Aligned_cols=285 Identities=22% Similarity=0.324 Sum_probs=218.9
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
...++|++++.||+|+||+||+|.+..+|..||+|++... ........+.+|+.+|+.++||||+++++++.. .
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 103 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----D 103 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----T
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----C
Confidence 3457899999999999999999999999999999999754 234456778999999999999999999999853 4
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhc-CceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~-gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
+.+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++....
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 56999999998 59999999888899999999999999999999996 99999999999999999999999999997543
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhh-cCCCChHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL-LGTPSTESIS 250 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~-~g~p~~~~~~ 250 (508)
... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......+... .+.+......
T Consensus 184 ~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3eqc_A 184 DSM-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256 (360)
T ss_dssp HHC---------CCCCTTCCHHHHTT--CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------
T ss_pred ccc-----ccCCCCCCCeECHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCC
Confidence 221 234689999999999987 68999999999999999999999999987755443322111 1111100000
Q ss_pred HH--------------hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 251 RI--------------RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 251 ~~--------------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.. ........+.......+.. .....+++.+.+||.+||++||.+|||++|+|+||||++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp -----------------CCCHHHHHHHHHHSCCCC--CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccCCCcccccccCCCCcccchhhhhHHhccCCCC--CCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 00 0000001111111111111 1123468899999999999999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=375.61 Aligned_cols=257 Identities=27% Similarity=0.464 Sum_probs=191.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-----SN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-----SS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-----CC
Confidence 4689999999999999999999999999999999964321 11224678899999999999999999999843 45
Q ss_pred cEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 95 DIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
.+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 6899999997 5999999875 5799999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+....+..+.
T Consensus 165 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------------- 225 (278)
T 3cok_A 165 PHE---KHYTLCGTPNYISPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV-------------- 225 (278)
T ss_dssp --------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC--------------
T ss_pred CCC---cceeccCCCCcCCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh--------------
Confidence 221 1234679999999999987 678999999999999999999999998765322221110
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
... ......+++.+.+||.+||..||.+|||++++|+||||...
T Consensus 226 -------------~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 226 -------------LAD----YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp -------------SSC----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred -------------hcc----cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 000 01123467899999999999999999999999999999753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=377.06 Aligned_cols=260 Identities=33% Similarity=0.528 Sum_probs=219.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++.. ...
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SSS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-----CCe
Confidence 468999999999999999999999999999999997655545567788999999999999999999999843 456
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC---CcEEEcccccccccc
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVSF 171 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~---~~lkL~DFGla~~~~ 171 (508)
+|+||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 899999997 6999999888889999999999999999999999999999999999999764 469999999998653
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 176 ~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------- 239 (287)
T 2wei_A 176 QNT----KMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY--------- 239 (287)
T ss_dssp CCS----SCSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred CCC----ccccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 322 1234578999999999875 589999999999999999999999998776554443322110
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
. .....+..+++.+.+||.+||..||.+|||+.++|+||||++..
T Consensus 240 -----------------~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 240 -----------------A-FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp -----------------C-CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred -----------------C-CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 0 00112346789999999999999999999999999999998653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=408.86 Aligned_cols=262 Identities=24% Similarity=0.348 Sum_probs=214.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
.++|+++++||+|+||.||+|+++.+|+.||||++++... .......+.+|+.+|+.++||||+++++++.. ..
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-----KT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-----CC
Confidence 4789999999999999999999999999999999964321 11234678899999999999999999999843 45
Q ss_pred cEEEEEecCC-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~----~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
.+|+|||||+ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 6999999998 6999998764 3699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......+.
T Consensus 339 ~~~~~~---~~~~~~GT~~Y~APE~l~~--~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~----------- 402 (543)
T 3c4z_A 339 LKAGQT---KTKGYAGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK----------- 402 (543)
T ss_dssp CCTTCC---CBCCCCSCTTTSCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHH-----------
T ss_pred ccCCCc---ccccccCCccccChhhhcC--CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHH-----------
Confidence 533221 1345689999999999987 689999999999999999999999998764211100000
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCC
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLA 314 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt-----a~eiL~hp~f~~~~ 314 (508)
...+. . ... ....+++.+.+||.+||+.||.+||+ ++++++||||+++.
T Consensus 403 --------~~i~~---~--~~~---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 403 --------QRVLE---Q--AVT---YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp --------HHHHH---C--CCC---CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred --------HHHhh---c--ccC---CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence 00000 0 011 11457899999999999999999996 58999999999754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=388.23 Aligned_cols=287 Identities=24% Similarity=0.363 Sum_probs=224.7
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-----------CCCcceeee
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-----------HPDIVEIKH 83 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-----------HpnIv~l~~ 83 (508)
..++|++++.||+|+||+||+|.+..+|+.||||++.. .......+.+|+.+++.+. ||||+++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 35799999999999999999999999999999999964 2334566789999999886 899999999
Q ss_pred eecCCCcCCCccEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhc-CceecCCCCCceeeC------
Q 010512 84 IMLPPSRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILAN------ 154 (508)
Q Consensus 84 v~~~~~~~~~~~lylV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~-gIiHrDLKPeNILl~------ 154 (508)
++.... .....+++|||+++++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++
T Consensus 94 ~~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 94 HFNHKG-PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEEEE-TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred HhhccC-CCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence 986432 223468999999988999999873 4599999999999999999999998 999999999999994
Q ss_pred CCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCC-----
Q 010512 155 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN----- 229 (508)
Q Consensus 155 ~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~----- 229 (508)
.++.+||+|||+++..... .+..+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CcceEEEcccccccccCCC------CCCCCCCccccCcHHHhC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 4457999999999865322 244589999999999987 679999999999999999999999998765
Q ss_pred -hHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCC-------------CCCCCCCHHHHHHHHHhccCCC
Q 010512 230 -VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFS-------------HKFPNADPLALHLLERLLAFDP 295 (508)
Q Consensus 230 -~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-------------~~~~~~~~~~~~Ll~~mL~~DP 295 (508)
....+..+...+|.++...+...... ..++............ ......++.+.+||.+||+.||
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYT--RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTH--HHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchh--hhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 55677788888898887665443221 1111110000000000 0112345678899999999999
Q ss_pred CCCCCHHHHhcCCcccCCCC
Q 010512 296 KDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 296 ~~Rpta~eiL~hp~f~~~~~ 315 (508)
.+|||++|+|+||||++...
T Consensus 323 ~~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 323 RKRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp TTCBCHHHHHTCGGGTTCTT
T ss_pred cccCCHHHHhhChhhhcccC
Confidence 99999999999999997654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=371.78 Aligned_cols=256 Identities=28% Similarity=0.468 Sum_probs=207.2
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
..++|++.+.||+|+||.||+|.+..+|+.||||+++.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 83 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-----P 83 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----S
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----C
Confidence 45789999999999999999999999999999999864321 12234578899999999999999999999844 4
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
..+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 56899999997 59999998888899999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcccccccccCcccccccccccccCCC-CcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y-~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.. ......||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 164 ~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------- 227 (276)
T 2h6d_A 164 GE----FLRTSCGSPNYAAPEVISG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV---------- 227 (276)
T ss_dssp -----------------CCTGGGTT--SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred Cc----ceecccCCccccCHHHHcC--CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc----------
Confidence 21 1234578999999999986 344 689999999999999999999998776544433332100
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
. .....++..+.+||.+||+.||.+|||++++++||||++
T Consensus 228 ----------------~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 228 ----------------F-----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp ----------------C-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred ----------------c-----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence 0 011245788999999999999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=393.94 Aligned_cols=269 Identities=17% Similarity=0.138 Sum_probs=194.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhC--CCCCcceee-------eeec
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL--RHPDIVEIK-------HIML 86 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L--~HpnIv~l~-------~v~~ 86 (508)
.+|++.+.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 449999999999999999999999999999999976543 233455677785555444 699988755 3332
Q ss_pred CCCcC------------CCccEEEEEecCCccHHHHHHhCC-CCCHHHH------HHHHHHHHHHHHHhHhcCceecCCC
Q 010512 87 PPSRR------------EFKDIYVVFELMESDLHQVIKAND-DLTPEHY------QFFLYQLLRGLKYIHTANVFHRDLK 147 (508)
Q Consensus 87 ~~~~~------------~~~~lylV~E~~~g~L~~~i~~~~-~l~~~~~------~~i~~Qil~aL~yLHs~gIiHrDLK 147 (508)
..... ....+|||||||+++|.+++...+ .+.+... ..++.||+.||+|||++||+|||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 21110 114589999999999999998643 3444444 5677999999999999999999999
Q ss_pred CCceeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCC
Q 010512 148 PKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 227 (508)
Q Consensus 148 PeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~ 227 (508)
|+|||++.++.+||+|||+++..... .....+|+.|+|||++.+....|+.++|||||||++|+|++|+.||.+
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGTR------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTCE------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred HHHEEECCCCCEEEEecceeeecCCC------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999864211 124567799999999975335789999999999999999999999987
Q ss_pred CChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 228 KNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 228 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
......- ..... ...............+.+++.+.+||.+||+.||.+|||+.++|+|
T Consensus 296 ~~~~~~~-----~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 296 VTPGIKG-----SWKRP-----------------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp CCTTCTT-----CCCBC-----------------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred cCccccc-----chhhh-----------------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 6421000 00000 0000001111112235789999999999999999999999999999
Q ss_pred CcccCC
Q 010512 308 PYFHGL 313 (508)
Q Consensus 308 p~f~~~ 313 (508)
|||+++
T Consensus 354 p~f~~~ 359 (371)
T 3q60_A 354 PEFLQL 359 (371)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=372.90 Aligned_cols=260 Identities=28% Similarity=0.446 Sum_probs=216.1
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++++.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 80 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNT 80 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGT
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCc
Confidence 45789999999999999999999999999999999976555556677899999999999999999999987532 235
Q ss_pred cEEEEEecCC-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhHhcC-----ceecCCCCCceeeCCCCcEEEccc
Q 010512 95 DIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDF 164 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~----~~l~~~~~~~i~~Qil~aL~yLHs~g-----IiHrDLKPeNILl~~~~~lkL~DF 164 (508)
.+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 6899999998 5999998753 34999999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC
Q 010512 165 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244 (508)
Q Consensus 165 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p 244 (508)
|+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 161 g~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~---- 231 (279)
T 2w5a_A 161 GLARILNHDT---SFAKTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG---- 231 (279)
T ss_dssp CHHHHC---C---HHHHHHHSCCTTCCHHHHHC--C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----
T ss_pred chheeecccc---ccccccCCCccccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc----
Confidence 9998653221 11234578999999999987 68999999999999999999999999887654433333211
Q ss_pred ChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
.. ......+++.+.+||.+||..||.+|||++|+|+|+|+..
T Consensus 232 -----------------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 232 -----------------------KF---RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp -----------------------CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred -----------------------cc---ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 00 0112356789999999999999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=378.90 Aligned_cols=260 Identities=32% Similarity=0.522 Sum_probs=208.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC------ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE------HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 89 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~------~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 89 (508)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 86 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 86 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence 4689999999999999999999999999999999965321 11223457899999999999999999999843
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCc---EEEcccc
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFG 165 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~---lkL~DFG 165 (508)
..+|+||||++ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 87 ----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 87 ----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp ----SSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred ----CceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 23799999998 599999988889999999999999999999999999999999999999987665 9999999
Q ss_pred ccccccCCCCCcccccccccCccccccccccc-ccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHhhcCC
Q 010512 166 LARVSFNDAPSAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQ-LDLMTDLLGT 243 (508)
Q Consensus 166 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~-~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~-l~~i~~~~g~ 243 (508)
+++..... .......||+.|+|||++.+ ....++.++|||||||++|+|++|..||.+...... ...+......
T Consensus 163 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (322)
T 2ycf_A 163 HSKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238 (322)
T ss_dssp TCEECCCC----HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC
T ss_pred cceecccc----cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc
Confidence 99865321 12244679999999999742 125789999999999999999999999976543211 1112111000
Q ss_pred CChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 244 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 244 p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
.....+..+++.+.+||.+||..||.+|||++++|+||||++
T Consensus 239 ---------------------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 239 ---------------------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp ---------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred ---------------------------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 011122456789999999999999999999999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=374.52 Aligned_cols=265 Identities=23% Similarity=0.372 Sum_probs=212.8
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
.....++|++++.||+|+||.||+|.+..+|..||+|++... .......+.+|+.+|+.++||||+++++++..
T Consensus 14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 87 (302)
T 2j7t_A 14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYH---- 87 (302)
T ss_dssp SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee----
Confidence 456678999999999999999999999999999999998643 23346778899999999999999999999854
Q ss_pred CCccEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
.+.+|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 88 -~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 88 -DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp -C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred -CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 346899999998 588888765 56799999999999999999999999999999999999999999999999999864
Q ss_pred ccCCCCCcccccccccCccccccccccc---ccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCh
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 246 (508)
..... .......||+.|+|||++.. ....++.++|||||||++|+|++|..||.+.+....+..+....
T Consensus 167 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----- 238 (302)
T 2j7t_A 167 NLKTL---QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD----- 238 (302)
T ss_dssp HHHHH---HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-----
T ss_pred ccccc---cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC-----
Confidence 32111 11234579999999999841 11578899999999999999999999998877554443332110
Q ss_pred HHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 247 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.+ .......++..+.+||.+||..||.+|||+.++++||||+++.
T Consensus 239 ---------------------~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 239 ---------------------PP--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp ---------------------CC--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ---------------------Cc--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 00 0011134678899999999999999999999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=391.79 Aligned_cols=264 Identities=23% Similarity=0.376 Sum_probs=211.5
Q ss_pred CCeEEeeeeeecCceEEEEEEEC---CCCcEEEEEEecCccC--ChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFE--HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~---~tg~~vAIKki~~~~~--~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~ 90 (508)
++|++++.||+|+||+||+|++. .+|+.||||+++.... .......+.+|+.+|+.+ .||||+++++++..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--- 130 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--- 130 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE---
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee---
Confidence 68999999999999999999984 5899999999974321 122334567899999999 69999999999843
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 91 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
...+|+|||||+ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 131 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 131 --ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp --TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred --CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 456899999998 59999999888899999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
..... .......+||+.|+|||++.+....++.++|||||||++|+|++|+.||...+.......+..
T Consensus 209 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~---------- 276 (355)
T 1vzo_A 209 FVADE--TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---------- 276 (355)
T ss_dssp CCGGG--GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH----------
T ss_pred cccCC--CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH----------
Confidence 43221 112345689999999999976334688999999999999999999999976542211111110
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCC
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 314 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~~ 314 (508)
..+. ... .....+++.+.+||.+||..||.+|| |++|+++||||+.+.
T Consensus 277 ---------~~~~---~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 277 ---------RILK---SEP-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp ---------HHHH---CCC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred ---------HHhc---cCC-----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 0010 011 11245778999999999999999999 999999999998753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=374.31 Aligned_cols=257 Identities=28% Similarity=0.467 Sum_probs=209.8
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++++.||+|+||.||+|.+..+|+.||||++... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 97 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NT 97 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch----HHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CC
Confidence 457899999999999999999999999999999999643 234668899999999999999999999853 35
Q ss_pred cEEEEEecCCc-cHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 95 DIYVVFELMES-DLHQVIK-ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 95 ~lylV~E~~~g-~L~~~i~-~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
.+|+||||+++ +|.+++. ....+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 68999999985 9999987 456799999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 178 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------ 240 (314)
T 3com_A 178 TMA---KRNTVIGTPFWMAPEVIQE--IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN------------ 240 (314)
T ss_dssp TBS---CBCCCCSCGGGCCHHHHSS--SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------------
T ss_pred hcc---ccCccCCCCCccChhhcCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC------------
Confidence 221 2345679999999999987 67899999999999999999999999877654433222110
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.+..+ .....+++.+.+||.+||..||.+|||+.++|+||||++.
T Consensus 241 ---------------~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 241 ---------------PPPTF-RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp ---------------CCCCC-SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred ---------------CCccc-CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 00000 1122457889999999999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=374.34 Aligned_cols=255 Identities=25% Similarity=0.392 Sum_probs=205.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++.+.||+|+||+||+|.+ +|..||||++............+.+|+.+|+.++||||+++++++.. ...
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~ 108 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-----PPN 108 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----TTC
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCc
Confidence 47899999999999999999976 58899999998665555666789999999999999999999999943 355
Q ss_pred EEEEEecCC-ccHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHhHhcC--ceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 96 IYVVFELME-SDLHQVIKANDD---LTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~---l~~~~~~~i~~Qil~aL~yLHs~g--IiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
+|+||||++ ++|.+++...+. +++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 899999998 599999987653 999999999999999999999999 99999999999999999999999999975
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 189 ~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~-------- 255 (309)
T 3p86_A 189 KASTF---LSSKSAAGTPEWMAPEVLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC-------- 255 (309)
T ss_dssp ----------------CCTTSCHHHHTT--CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC--------
T ss_pred ccccc---cccccCCCCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--------
Confidence 43221 12345689999999999987 678999999999999999999999998877554443332110
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc--CCccc
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA--DPYFH 311 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~--hp~f~ 311 (508)
.. ......+++.+.+||.+||..||.+|||+.++++ .++++
T Consensus 256 ------------------~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 256 ------------------KR---LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp ------------------CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred ------------------CC---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00 0112457899999999999999999999999998 45544
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=377.71 Aligned_cols=273 Identities=27% Similarity=0.409 Sum_probs=194.6
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
...++|++.+.||+|+||+||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 85 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-----K 85 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEES-----S
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEee-----c
Confidence 446899999999999999999999999999999999864321 2335668899999999999999999999954 3
Q ss_pred ccEEEEEecCC-ccHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccc
Q 010512 94 KDIYVVFELME-SDLHQVIKA--------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 164 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~--------~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DF 164 (508)
..+|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEec
Confidence 46899999997 699999874 456999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCC--CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC
Q 010512 165 GLARVSFNDAP--SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 242 (508)
Q Consensus 165 Gla~~~~~~~~--~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g 242 (508)
|++........ .........||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+......
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-- 242 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN-- 242 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS--
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc--
Confidence 99976532211 11122346799999999998652 46899999999999999999999999887654443222110
Q ss_pred CCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 243 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 243 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.+.. .............+++.+.+||.+||..||.+|||+.++++||||++..
T Consensus 243 ~~~~-------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 243 DPPS-------------------LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp SCCC-------------------TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred CCCc-------------------cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 0000 0000111233456789999999999999999999999999999998754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=374.03 Aligned_cols=265 Identities=24% Similarity=0.407 Sum_probs=210.8
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCc-C
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSR-R 91 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~-~ 91 (508)
...++|++++.||+|+||.||+|.+..+|+.||||++.... .....+.+|+.+++.+ +||||+++++++..... .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 56689999999999999999999999999999999986432 2346788999999999 79999999999865321 1
Q ss_pred CCccEEEEEecCCc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 92 EFKDIYVVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 92 ~~~~lylV~E~~~g-~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
....+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 14578999999984 999999864 479999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccc---cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~ 245 (508)
....... ......||+.|+|||++... ...++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 178 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----- 249 (326)
T 2x7f_A 178 QLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN----- 249 (326)
T ss_dssp ----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-----
T ss_pred ecCcCcc---ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-----
Confidence 6432211 12446799999999998621 156889999999999999999999999877654443322110
Q ss_pred hHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 246 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
..+ ......+++.+.+||.+||..||.+|||++++++||||++.
T Consensus 250 ---------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 250 ---------------------PAP---RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp ---------------------CCC---CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred ---------------------ccc---cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 001 11124568899999999999999999999999999999853
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=377.27 Aligned_cols=255 Identities=24% Similarity=0.344 Sum_probs=209.9
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCc---EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~---~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
-..++|++.+.||+|+||.||+|.+..+|. .||||+++... .......+.+|+.+|+.++||||+++++++.
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---- 120 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVT---- 120 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC----
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE----
Confidence 456889999999999999999999986655 59999997532 3445677899999999999999999999983
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
....+|+||||++ ++|.+++... +.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 121 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 121 -RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp -GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred -eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 4456899999997 5999999765 579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChH
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
................+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~----- 272 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR----- 272 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC-----
T ss_pred ccccCccceeeccCCCCcccccCHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC-----
Confidence 76443333323344567889999999987 689999999999999999999 9999988776555444332110
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
. .....+++.+.+||.+||..||.+|||+.++++
T Consensus 273 ----------------------~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 273 ----------------------L---PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ----------------------C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------C---CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0 112357889999999999999999999999987
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=377.73 Aligned_cols=279 Identities=22% Similarity=0.355 Sum_probs=211.7
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
....++|++.+.||+|+||+||+|.+..+|+.||||+++.... ......+.+|+.+|+.++||||+++++++....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 80 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT--- 80 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---
Confidence 3456899999999999999999999999999999999975322 233566789999999999999999999986532
Q ss_pred CccEEEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceee----CCCCcEEEccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDF 164 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl----~~~~~lkL~DF 164 (508)
...+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Df 160 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccC
Confidence 346899999998 69999998654 39999999999999999999999999999999999999 78888999999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccc------cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHH-HHHHH
Q 010512 165 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH-QLDLM 237 (508)
Q Consensus 165 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~------~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~-~l~~i 237 (508)
|+++...... .....+||+.|+|||++... ...|+.++|||||||++|+|++|+.||....... ....+
T Consensus 161 g~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 161 GAARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp TTCEECCTTC----CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred CCceecCCCC----ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 9998654332 13456799999999998521 2578999999999999999999999997543211 11122
Q ss_pred HhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCC-------CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCc
Q 010512 238 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSH-------KFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309 (508)
Q Consensus 238 ~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-------~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~ 309 (508)
...+...+...+..+.. ....+..|.. ....+++.+.+||.+||+.||.+|||++|+|+||-
T Consensus 237 ~~~~~~~p~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 237 YKIITGKPSGAISGVQK----------AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHHHCCTTCCEEEEC----------STTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HHHhcCCCcccchhhhc----------ccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 21111111100000000 0000111111 11234567889999999999999999999999875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=370.48 Aligned_cols=257 Identities=27% Similarity=0.416 Sum_probs=216.5
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
...++|++++.||+|+||.||+|.+..+|+.||||+++.... ......+.+|+.+++.++||||+++++++.. .
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 92 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----D 92 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----C
Confidence 445789999999999999999999999999999999965432 2346778999999999999999999999853 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
..+|+||||++ ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 56899999998 489988864 5799999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+..
T Consensus 172 ~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------- 233 (303)
T 3a7i_A 172 TQ---IKRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK------------- 233 (303)
T ss_dssp TB---CCBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------------
T ss_pred cc---cccCccCCCcCccCHHHHhc--CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc-------------
Confidence 22 12345689999999999987 6889999999999999999999999987665443322211
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
..+ ......++..+.+||.+||..||.+|||+.++|+||||..
T Consensus 234 --------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 234 --------------NNP---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp --------------SCC---CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred --------------CCC---CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 111 1122457889999999999999999999999999999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=377.23 Aligned_cols=269 Identities=22% Similarity=0.356 Sum_probs=196.7
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCc---EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 89 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~---~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 89 (508)
....++|++.+.||+|+||+||+|.+..++. .||||+++...........+.+|+.+++.++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3556889999999999999999999887765 8999999765545566788999999999999999999999986543
Q ss_pred cC-CCccEEEEEecCC-ccHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEE
Q 010512 90 RR-EFKDIYVVFELME-SDLHQVIKAND------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 161 (508)
Q Consensus 90 ~~-~~~~lylV~E~~~-g~L~~~i~~~~------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL 161 (508)
.. .....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEE
Confidence 21 1223599999998 59999986532 5999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhh
Q 010512 162 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDL 240 (508)
Q Consensus 162 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~ 240 (508)
+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+...
T Consensus 179 ~Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 255 (323)
T 3qup_A 179 ADFGLSRKIYSGDYY-RQGCASKLPVKWLALESLAD--NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255 (323)
T ss_dssp CCCCC------------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred eeccccccccccccc-cccccccCcccccCchhhcC--CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence 999999865332211 11234467889999999987 689999999999999999999 99999887765544433221
Q ss_pred cCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-------HHHHhcCCcccCC
Q 010512 241 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-------AEEALADPYFHGL 313 (508)
Q Consensus 241 ~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt-------a~eiL~hp~f~~~ 313 (508)
. . ....+.+++.+.+||.+||..||.+||| +++++.|||+...
T Consensus 256 ~---------------------------~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 256 N---------------------------R---LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp C---------------------------C---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred C---------------------------C---CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 0 0 1112457789999999999999999999 7888999999764
Q ss_pred C
Q 010512 314 A 314 (508)
Q Consensus 314 ~ 314 (508)
.
T Consensus 306 ~ 306 (323)
T 3qup_A 306 S 306 (323)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=376.39 Aligned_cols=263 Identities=25% Similarity=0.417 Sum_probs=192.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHH-HHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~-iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
.++|++++.||+|+||.||+|.+..+|+.||||+++... .......+.+|+. +++.++||||+++++++.. .+
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~~ 94 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-----EG 94 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-----SS
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-----CC
Confidence 478999999999999999999999999999999997543 2334455667776 7788899999999999954 35
Q ss_pred cEEEEEecCCccHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHhHhc-CceecCCCCCceeeCCCCcEEEccccccc
Q 010512 95 DIYVVFELMESDLHQVIKA-----NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 95 ~lylV~E~~~g~L~~~i~~-----~~~l~~~~~~~i~~Qil~aL~yLHs~-gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
.+|+||||++++|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 6899999999998888764 56799999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccccccccccc--ccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCh
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 246 (508)
...... ......||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+.+... ..+.
T Consensus 175 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~-------- 240 (327)
T 3aln_A 175 QLVDSI----AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQLT-------- 240 (327)
T ss_dssp C----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------C--------
T ss_pred eccccc----ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHHH--------
Confidence 653322 1234579999999999832 11568999999999999999999999997643210 0000
Q ss_pred HHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 247 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.......+.........+++.+.+||.+||..||.+|||+.++++||||...
T Consensus 241 ---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 241 ---------------QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp ---------------CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ---------------HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 0011111111122335688999999999999999999999999999999753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=380.05 Aligned_cols=252 Identities=25% Similarity=0.406 Sum_probs=208.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-------CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDT-------HTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLP 87 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~-------~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~ 87 (508)
.++|++.+.||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+|+.+ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 368999999999999999999874 35678999999754 2334567789999999999 89999999999843
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCc
Q 010512 88 PSRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 150 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeN 150 (508)
.+.+|+||||++ |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 159 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 159 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred -----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 456899999998 59999998753 47999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCC
Q 010512 151 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 229 (508)
Q Consensus 151 ILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~ 229 (508)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..|+.++|||||||++|+|++ |..||.+.+
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEECCCCCEEEccccCCcccCcccce-ecccCCCcccceECHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999999865332211 12234567889999999987 689999999999999999999 999998876
Q ss_pred hHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 230 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 230 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.......+... ... .....+++.+.+||.+||..||.+|||+.|+++
T Consensus 311 ~~~~~~~~~~~---------------------------~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 311 VEELFKLLKEG---------------------------HRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp GGGHHHHHHTT---------------------------CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcC---------------------------CCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 54443332211 000 112357789999999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=363.81 Aligned_cols=263 Identities=28% Similarity=0.407 Sum_probs=202.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC------
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS------ 89 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~------ 89 (508)
.++|++++.||+|+||.||+|.+..+|+.||||++.. .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 3579999999999999999999999999999999963 2344567889999999999999999999885431
Q ss_pred --cCCCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccc
Q 010512 90 --RREFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 165 (508)
Q Consensus 90 --~~~~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFG 165 (508)
......+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 123467899999998 59999998654 58899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC-----------CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCC-ChHHH
Q 010512 166 LARVSFNDAP-----------SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK-NVVHQ 233 (508)
Q Consensus 166 la~~~~~~~~-----------~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~-~~~~~ 233 (508)
++........ .........||+.|+|||++.+. ..++.++|||||||++|+|++ ||... +....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 9986532210 01123456799999999998762 478999999999999999998 44321 11111
Q ss_pred HHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 234 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 234 l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
+..+. ..............++.+.+||.+||..||.+|||+.++|+||||..
T Consensus 238 ~~~~~---------------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 238 LKKLR---------------------------SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHH---------------------------STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHhcc---------------------------ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 11111 11111111223456788999999999999999999999999999974
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=378.36 Aligned_cols=273 Identities=19% Similarity=0.318 Sum_probs=212.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChh---------------HHHHHHHHHHHHHhCCCCCcce
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS---------------DATRILREIKLLRLLRHPDIVE 80 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~---------------~~~~i~~Ei~iL~~L~HpnIv~ 80 (508)
.++|++++.||+|+||.||+|.+ +|+.||||++........ ....+.+|+.+|+.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 47999999999999999999998 899999999864322111 1277889999999999999999
Q ss_pred eeeeecCCCcCCCccEEEEEecCCc-cHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHhHh-cCceecCCCCCc
Q 010512 81 IKHIMLPPSRREFKDIYVVFELMES-DLHQV------IKA--NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKN 150 (508)
Q Consensus 81 l~~v~~~~~~~~~~~lylV~E~~~g-~L~~~------i~~--~~~l~~~~~~~i~~Qil~aL~yLHs-~gIiHrDLKPeN 150 (508)
+++++.. .+.+|+||||+++ +|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus 108 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp CSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred EEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 9999954 3579999999985 99888 655 5679999999999999999999999 999999999999
Q ss_pred eeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCc-chhhhhHHHHHHHHHhCCCCCCCCC
Q 010512 151 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEMLTGKPLFPGKN 229 (508)
Q Consensus 151 ILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~-~~DIWSlG~il~eLltG~~pF~~~~ 229 (508)
||++.++.+||+|||++...... ......||+.|+|||++.+. ..++. ++|||||||++|+|++|..||.+.+
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEcCCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999865332 23556899999999999862 25666 9999999999999999999998876
Q ss_pred h-HHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 010512 230 V-VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308 (508)
Q Consensus 230 ~-~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp 308 (508)
. ......+.......+... .. + ...............+++.+.+||.+||..||.+|||++|+|+||
T Consensus 257 ~~~~~~~~i~~~~~~~~~~~-~~--------~---~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 257 SLVELFNNIRTKNIEYPLDR-NH--------F---LYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp CSHHHHHHHTSCCCCCCCSS-SS--------S---TTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred cHHHHHHHHhccCcCCccch-hh--------h---hccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 5 444433322111000000 00 0 000000001112256789999999999999999999999999999
Q ss_pred cccCC
Q 010512 309 YFHGL 313 (508)
Q Consensus 309 ~f~~~ 313 (508)
||++.
T Consensus 325 ~f~~~ 329 (348)
T 2pml_X 325 WLADT 329 (348)
T ss_dssp GGTTC
T ss_pred cccCC
Confidence 99864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=382.87 Aligned_cols=257 Identities=21% Similarity=0.311 Sum_probs=210.2
Q ss_pred CCCeEEeeeeeecCceEEEEEE-----ECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAV-----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~-----~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
.++|++++.||+|+||+||+|. +..++..||||+++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--- 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--- 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec---
Confidence 4789999999999999999999 5567889999999643 334455678899999999999999999999854
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC---cE
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAND-------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KL 159 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~-------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~---~l 159 (508)
....|+|||||. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 146 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 146 --SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred --CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 345799999997 59999998643 489999999999999999999999999999999999999655 49
Q ss_pred EEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 010512 160 KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMT 238 (508)
Q Consensus 160 kL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~ 238 (508)
||+|||+++........ .......||+.|+|||++.+ ..|+.++|||||||++|+|++ |.+||.+.+....+..+.
T Consensus 224 kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYY-RKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp EECCCHHHHHHHHHSSC-TTCCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred EECCCcccccccccccc-ccCCCcCCcccEECHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999854322111 11234578999999999977 689999999999999999998 999999887655554443
Q ss_pred hhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010512 239 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 239 ~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~ 311 (508)
... .. .....+++.+.+||.+||+.||.+|||+.++++|.++.
T Consensus 301 ~~~---------------------------~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SGG---------------------------RM---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTC---------------------------CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCC---------------------------CC---CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 211 00 11235678899999999999999999999999998864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=367.24 Aligned_cols=262 Identities=21% Similarity=0.327 Sum_probs=194.2
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++++.||+|+||.||+|.+..+|+.||||++............+..+..+++.++||||+++++++.. ..
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~~ 97 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-----NT 97 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-----CC
Confidence 4578999999999999999999999999999999997543332233334445567888999999999999954 35
Q ss_pred cEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhc-CceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 95 DIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 95 ~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~-gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
.+|+||||+++.+..+... ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 98 DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 6999999997666666654 56799999999999999999999995 999999999999999999999999999976433
Q ss_pred CCCCcccccccccCccccccccccc---ccCCCCcchhhhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhhcCCCChHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN-VVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~---~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~-~~~~l~~i~~~~g~p~~~~ 248 (508)
.. ......||+.|+|||++.+ ....++.++|||||||++|+|++|+.||.+.. ....+..+..
T Consensus 178 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------- 244 (318)
T 2dyl_A 178 DK----AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--------- 244 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH---------
T ss_pred Cc----cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc---------
Confidence 22 1234579999999999852 12568899999999999999999999997643 2222222211
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
..+ +.......+++.+.+||.+||..||.+|||++++|+||||+++
T Consensus 245 ------------------~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 245 ------------------EEP-PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp ------------------SCC-CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred ------------------cCC-CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 000 1111223578999999999999999999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=375.37 Aligned_cols=267 Identities=26% Similarity=0.405 Sum_probs=189.3
Q ss_pred ccccCCCCCeEEee-eeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHH-HHHHhCCCCCcceeeeeecC
Q 010512 10 FTEYGEASRYQIQE-VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREI-KLLRLLRHPDIVEIKHIMLP 87 (508)
Q Consensus 10 ~~~~~~~~rY~i~~-~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei-~iL~~L~HpnIv~l~~v~~~ 87 (508)
...+...++|++.+ +||+|+||+||+|.+..+|+.||||++... ....+|+ ..++.+.||||+++++++..
T Consensus 21 ~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 21 PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-------HHHHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 44677889999965 699999999999999999999999998642 1122333 44677899999999999854
Q ss_pred CCcCCCccEEEEEecCCc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC---CcEEE
Q 010512 88 PSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKI 161 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~g-~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~---~~lkL 161 (508)
.. .....+|+|||||+| +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||
T Consensus 94 ~~-~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl 172 (336)
T 3fhr_A 94 MH-HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKL 172 (336)
T ss_dssp EE-TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEE
T ss_pred cc-CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEE
Confidence 21 224568999999985 9999998764 69999999999999999999999999999999999999864 55999
Q ss_pred ccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Q 010512 162 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 241 (508)
Q Consensus 162 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~ 241 (508)
+|||+++...... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.........+..
T Consensus 173 ~Dfg~~~~~~~~~-----~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-- 243 (336)
T 3fhr_A 173 TDFGFAKETTQNA-----LQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR-- 243 (336)
T ss_dssp CCCTTCEEC-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred eccccceeccccc-----cccCCCCcCccChhhhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH--
Confidence 9999998643221 244678999999999976 6789999999999999999999999976553221111000
Q ss_pred CCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 242 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.+...........+..+++.+.+||.+||..||.+|||++|+|+||||++..
T Consensus 244 ---------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 244 ---------------------RIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp ----------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred ---------------------hhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 0000111111223457889999999999999999999999999999998644
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=376.28 Aligned_cols=255 Identities=25% Similarity=0.422 Sum_probs=208.7
Q ss_pred CCCeEEeeeeeecCceEEEEEE-----ECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAV-----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 89 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~-----~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~ 89 (508)
.++|++.+.||+|+||.||+|. +..+++.||||+++.. ........+.+|+.+|+.+ +||||+++++++...
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~- 98 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 98 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-
Confidence 4789999999999999999998 5667899999999753 2334556789999999999 789999999998543
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCC----------------------------------------------------
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKANDD---------------------------------------------------- 116 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~~~---------------------------------------------------- 116 (508)
...+|+|||||. |+|.+++.....
T Consensus 99 ---~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 99 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp ---TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ---CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 245899999998 599999986543
Q ss_pred --------------CCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCcccccc
Q 010512 117 --------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 182 (508)
Q Consensus 117 --------------l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~ 182 (508)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~ 254 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGD 254 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-CEEC--
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-chhccc
Confidence 89999999999999999999999999999999999999999999999999986533322 222345
Q ss_pred cccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHH
Q 010512 183 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYL 261 (508)
Q Consensus 183 ~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l 261 (508)
..||+.|+|||++.+ ..|+.++|||||||++|+|++ |.+||.+.+....+......
T Consensus 255 ~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~--------------------- 311 (359)
T 3vhe_A 255 ARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE--------------------- 311 (359)
T ss_dssp CEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH---------------------
T ss_pred cCCCceeEChhhhcC--CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc---------------------
Confidence 678999999999987 789999999999999999998 99999887643332221110
Q ss_pred hhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 262 GSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.... .....+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 312 -----~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 312 -----GTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp -----TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CCCC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 0000 1123467899999999999999999999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=362.97 Aligned_cols=257 Identities=28% Similarity=0.399 Sum_probs=203.9
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEE
Q 010512 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 98 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 98 (508)
|....+||+|+||.||+|.+..++..||||++... .......+.+|+.+++.++||||+++++++.. .+.+|+
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 96 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKI 96 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEE
Confidence 33445999999999999999999999999999653 23345678899999999999999999999843 456899
Q ss_pred EEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC-CCcEEEccccccccccCC
Q 010512 99 VFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSFND 173 (508)
Q Consensus 99 V~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~-~~~lkL~DFGla~~~~~~ 173 (508)
||||++ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999997 69999998652 4678999999999999999999999999999999999988 899999999999865332
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
.. ......||+.|+|||++.+....++.++|||||||++|+|++|+.||.+...........
T Consensus 177 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--------------- 238 (295)
T 2clq_A 177 NP---CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV--------------- 238 (295)
T ss_dssp -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH---------------
T ss_pred CC---cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh---------------
Confidence 21 124567999999999987632348899999999999999999999996543221110000
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
... ... ......+++.+.+||.+||..||.+|||++++|+||||+..
T Consensus 239 ------~~~---~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 239 ------GMF---KVH----PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp ------HHH---CCC----CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred ------ccc---ccc----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 000 000 11224578899999999999999999999999999999854
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=367.67 Aligned_cols=262 Identities=27% Similarity=0.357 Sum_probs=206.9
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC--CCCcceeeeeecCCCcCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR--HPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~--HpnIv~l~~v~~~~~~~~ 92 (508)
..++|++++.||+|+||.||+|.+. +|+.||||+++...........+.+|+.+|+.++ ||||+++++++..
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~----- 99 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----- 99 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC-----
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec-----
Confidence 4467999999999999999999985 5899999999765555556778899999999997 5999999999854
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 93 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
...+|+|||+..++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 100 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 100 DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 178 (313)
T ss_dssp SSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC---
T ss_pred CCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccC
Confidence 35699999987789999999988999999999999999999999999999999999999996 58999999999986533
Q ss_pred CCCCcccccccccCcccccccccccc---------cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHhhcC
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV-HQLDLMTDLLG 242 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~---------~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~-~~l~~i~~~~g 242 (508)
... ........||+.|+|||++.+. ...++.++|||||||++|+|++|..||.+.... ..+..+
T Consensus 179 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~----- 252 (313)
T 3cek_A 179 DTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI----- 252 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH-----
T ss_pred ccc-cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH-----
Confidence 221 1122345799999999998641 136889999999999999999999999764321 111111
Q ss_pred CCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 243 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 243 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
+ ....... .....+..+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 253 ------------------~---~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 253 ------------------I---DPNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp ------------------H---CTTSCCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred ------------------H---hcccccC---CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 0 0011111 112347889999999999999999999999999999854
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=364.82 Aligned_cols=260 Identities=23% Similarity=0.405 Sum_probs=209.6
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++.+.||+|+||+||+|.+..+|+.||+|++.. ........+.+|+.+|+.++||||+++++++.. ..
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 80 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DK 80 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TT
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CC
Confidence 45789999999999999999999999999999999854 344566788999999999999999999999953 45
Q ss_pred cEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 95 DIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
.+|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred eeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 6899999998 599999987 56799999999999999999999999999999999999999999999999999987533
Q ss_pred CCCCc-----------ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Q 010512 173 DAPSA-----------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 241 (508)
Q Consensus 173 ~~~~~-----------~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~ 241 (508)
..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||+........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~------- 231 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD------- 231 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT-------
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH-------
Confidence 22211 11125689999999999987 78999999999999999999999998754321000
Q ss_pred CCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 242 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
... . ....+.. ...+.+++.+.+||.+||+.||.+|||+.++++ |++.+
T Consensus 232 --~~~-~--------~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l 280 (310)
T 3s95_A 232 --FGL-N--------VRGFLDR----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL 280 (310)
T ss_dssp --SSB-C--------HHHHHHH----------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred --Hhh-h--------hhccccc----------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence 000 0 0000000 011356678999999999999999999999998 66543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=357.54 Aligned_cols=250 Identities=24% Similarity=0.404 Sum_probs=207.7
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++++.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.+|+.++||||+++++++. +..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~ 78 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQA 78 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSS
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc---CHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCC
Confidence 3478999999999999999999986 577899999975433 2456889999999999999999999984 345
Q ss_pred cEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 95 DIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
.+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 6899999998 5999999764 4689999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.. ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+.....
T Consensus 159 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~--------- 225 (269)
T 4hcu_A 159 DQ--YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR--------- 225 (269)
T ss_dssp HH--HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---------
T ss_pred cc--cccccCcccccccCCHHHhcC--CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc---------
Confidence 21 112234567889999999986 689999999999999999999 9999988776555444322110
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
. ......++.+.+||.+||+.||.+|||+.++++|
T Consensus 226 ------------------~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 226 ------------------L---YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ------------------C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------C---CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0 0112457889999999999999999999999985
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=365.45 Aligned_cols=253 Identities=23% Similarity=0.383 Sum_probs=209.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~-----~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
.++|++.+.||+|+||.||+|.+ ..++..||||+++.. ........+.+|+.+|+.++||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---- 96 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACS---- 96 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC----
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe----
Confidence 47899999999999999999998 345689999999743 23455678899999999999999999999984
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHhHhcCceecC
Q 010512 91 REFKDIYVVFELME-SDLHQVIKANDD------------------------LTPEHYQFFLYQLLRGLKYIHTANVFHRD 145 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~~------------------------l~~~~~~~i~~Qil~aL~yLHs~gIiHrD 145 (508)
....+|+||||++ ++|.+++..... +++..+..++.||+.||.|||++||+|||
T Consensus 97 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 97 -QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred -cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 3456899999998 699999987543 89999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCC
Q 010512 146 LKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPL 224 (508)
Q Consensus 146 LKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~p 224 (508)
|||+|||++.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDS-YVKRSQGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSC-EECSSCCCSCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cchheEEEcCCCCEEEcccccccccccccc-ceeccCCCCcccccChhhhcC--CCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999986533221 112234567889999999987 679999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHH
Q 010512 225 FPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 304 (508)
Q Consensus 225 F~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~ei 304 (508)
|.+.+.......+... .. ......+++.+.+||.+||..||.+|||+.++
T Consensus 253 ~~~~~~~~~~~~~~~~---------------------------~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 302 (314)
T 2ivs_A 253 YPGIPPERLFNLLKTG---------------------------HR---MERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302 (314)
T ss_dssp STTCCGGGHHHHHHTT---------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHhhcC---------------------------Cc---CCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9887654443332210 00 11224678999999999999999999999999
Q ss_pred hcC
Q 010512 305 LAD 307 (508)
Q Consensus 305 L~h 307 (508)
+++
T Consensus 303 ~~~ 305 (314)
T 2ivs_A 303 SKD 305 (314)
T ss_dssp HHH
T ss_pred HHH
Confidence 874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=370.36 Aligned_cols=258 Identities=19% Similarity=0.236 Sum_probs=205.9
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~ 92 (508)
-..++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+|+.| +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~----- 76 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPC----- 76 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEec-----
Confidence 356899999999999999999999999999999999864322 23577899999999 89999999999843
Q ss_pred CccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCc-----EEEccccc
Q 010512 93 FKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-----LKICDFGL 166 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~-----lkL~DFGl 166 (508)
....|+||||++++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++. +||+|||+
T Consensus 77 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 77 GKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred CCccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 456899999998899999987 467999999999999999999999999999999999999999887 99999999
Q ss_pred cccccCCCCCcc----cccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC
Q 010512 167 ARVSFNDAPSAI----FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 242 (508)
Q Consensus 167 a~~~~~~~~~~~----~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g 242 (508)
++.......... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..+.
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~- 233 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG--KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG- 233 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH-
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcC--CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH-
Confidence 987543322111 1245689999999999987 689999999999999999999999998854332222211110
Q ss_pred CCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 243 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 243 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..... .+........ +.+.+||..||..||.+||+++++++
T Consensus 234 -----------~~~~~-----------~~~~~~~~~~-p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 234 -----------DTKRA-----------TPIEVLCENF-PEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp -----------HHHHH-----------SCHHHHTTTC-HHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -----------hhhcc-----------CCHHHHhccC-hHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 00000 0000011122 38999999999999999999999876
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=360.86 Aligned_cols=255 Identities=17% Similarity=0.231 Sum_probs=208.2
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~ 93 (508)
..++|++.+.||+|+||+||+|.+..+|+.||||++.... ....+.+|+.+++.+ +|+||+.+++++. ..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~ 78 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EG 78 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ET
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CC
Confidence 4678999999999999999999999999999999986432 223577899999999 7999999999883 44
Q ss_pred ccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCc-----EEEcccccc
Q 010512 94 KDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-----LKICDFGLA 167 (508)
Q Consensus 94 ~~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~-----lkL~DFGla 167 (508)
...|+||||++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 79 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 79 LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 5689999999889999998754 5999999999999999999999999999999999999988776 999999999
Q ss_pred ccccCCCCCc----ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHhh
Q 010512 168 RVSFNDAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV---HQLDLMTDL 240 (508)
Q Consensus 168 ~~~~~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~---~~l~~i~~~ 240 (508)
+......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.. ..+..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 8754432211 12345689999999999987 67999999999999999999999999875432 222222110
Q ss_pred cCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 241 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 241 ~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.. ..+.....+.+++.+.+||.+||..||.+|||++++++
T Consensus 237 ~~--------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 237 KQ--------------------------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HH--------------------------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cc--------------------------CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 00 00111123457889999999999999999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=373.56 Aligned_cols=252 Identities=27% Similarity=0.430 Sum_probs=210.4
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh----hHHHHHHHHHHHHHhCC--CCCcceeeeeecC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV----SDATRILREIKLLRLLR--HPDIVEIKHIMLP 87 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~----~~~~~i~~Ei~iL~~L~--HpnIv~l~~v~~~ 87 (508)
...++|++.+.||+|+||.||+|.+..+|+.||||+++...... .....+.+|+.+|+.+. ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 45689999999999999999999999999999999996542221 12245678999999996 5999999999953
Q ss_pred CCcCCCccEEEEEecCC--ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeC-CCCcEEEccc
Q 010512 88 PSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDF 164 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~--g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~-~~~~lkL~DF 164 (508)
...+|+|||++. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 120 -----~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 120 -----PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp -----SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred -----CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 456899999997 69999999888999999999999999999999999999999999999999 7899999999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC
Q 010512 165 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244 (508)
Q Consensus 165 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p 244 (508)
|+++..... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+. +.
T Consensus 195 g~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~------ 256 (320)
T 3a99_A 195 GSGALLKDT-----VYTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------II------ 256 (320)
T ss_dssp TTCEECCSS-----CBCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH------
T ss_pred ccccccccc-----cccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhh------hh------
Confidence 999865332 13456799999999998762 3347889999999999999999999965321 00
Q ss_pred ChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
. .. . .....+++.+.+||.+||..||.+|||++++++||||++.
T Consensus 257 -----------------~---~~--~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 257 -----------------R---GQ--V---FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp -----------------H---CC--C---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -----------------c---cc--c---cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 0 00 0 0123578899999999999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=364.57 Aligned_cols=271 Identities=22% Similarity=0.375 Sum_probs=206.4
Q ss_pred CCCCeEEeeeeeecCceEEEEEE----ECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~----~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
..++|++++.||+|+||+||+|+ +..+|+.||||++... .......+.+|+.+|+.++||||+++++++...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 83 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA-- 83 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH--
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 45899999999999999999998 6678999999999742 344567789999999999999999999998532
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
....+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 84 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 84 -GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp -HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred -CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 2245899999997 69999998754 59999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
................+|..|+|||++.+ ..++.++|||||||++|+|++|..||..... . .....+......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~---~~~~~~~~~~~~ 235 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPPA--E---FMRMIGNDKQGQ 235 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH--H---HHHHHCTTCCTH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcC--CCCChHHHHHHHHHHHHHHHhcccccCCChH--H---HHhhhcCccccc
Confidence 75433322222334567888999999987 6899999999999999999999999864321 1 111122211111
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.. .......+......+ ....+++.+.+||.+||..||.+|||+.|+++
T Consensus 236 ~~------~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 236 MI------VFHLIELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HH------HHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hh------HHHHHHHHhccCcCC---CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 10 011111111111111 12467899999999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=355.59 Aligned_cols=250 Identities=21% Similarity=0.332 Sum_probs=207.1
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++++.||+|+||.||+|.+. ++..||+|+++.... ....+.+|+.+|+.++||||+++++++. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~ 76 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCS-----KEY 76 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSS
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCC
Confidence 3578999999999999999999876 577899999975332 2456889999999999999999999983 445
Q ss_pred cEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 95 DIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
.+|+||||++ ++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 6899999997 68999998754 599999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+....
T Consensus 157 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---------- 222 (268)
T 3sxs_A 157 DQY--VSSVGTKFPVKWSAPEVFHY--FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH---------- 222 (268)
T ss_dssp TCE--EECCSCCCCGGGCCHHHHHH--SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC----------
T ss_pred hhh--hcccCCCcCcccCCHHHHhc--cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC----------
Confidence 321 12234567788999999977 678999999999999999999 999998877654443332110
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.. ......++.+.+||.+||+.||.+|||+.+++++
T Consensus 223 -----------------~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 223 -----------------RL---YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp -----------------CC---CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------------CC---CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 0112357889999999999999999999999984
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=372.61 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=209.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECC-------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTH-------TGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLP 87 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~-------tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~ 87 (508)
.++|++.+.||+|+||+||+|.+.. .+..||||+++.. ........+.+|+.+++.+ +||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3789999999999999999999754 3468999999754 3345567889999999999 89999999999943
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCc
Q 010512 88 PSRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 150 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeN 150 (508)
.+.+|+||||++ |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 147 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 147 -----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred -----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 456899999998 59999998754 49999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCC
Q 010512 151 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 229 (508)
Q Consensus 151 ILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~ 229 (508)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTT-CCCTTCCCGGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEcCCCcEEEcccCccccccccccc-ccccCCCCCcceeCHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999865332211 12344567899999999987 789999999999999999999 999998877
Q ss_pred hHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 230 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 230 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.......+.... .. .....+++.+.+||.+||+.||.+|||+.|++++
T Consensus 299 ~~~~~~~~~~~~---------------------------~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 299 VEELFKLLKEGH---------------------------RM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHHTTC---------------------------CC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCC---------------------------CC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 554443332210 00 1123578899999999999999999999999984
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=368.61 Aligned_cols=253 Identities=22% Similarity=0.289 Sum_probs=208.6
Q ss_pred CCCCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 89 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~-----~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 89 (508)
..++|++++.||+|+||.||+|.+. .++..||||+++... .......+.+|+.+|+.++||||+++++++..
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 121 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV-- 121 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc--
Confidence 4578999999999999999999987 456899999997532 33456678999999999999999999999843
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHhHhcCceec
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKAN------------------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHR 144 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHr 144 (508)
...+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||
T Consensus 122 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 122 ---GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred ---CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 456899999998 5999999864 569999999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCC
Q 010512 145 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKP 223 (508)
Q Consensus 145 DLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~ 223 (508)
||||+|||++.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCcc-ccccCCCcccceecChhhhcc--CCcCcccccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999986432211 111234578899999999987 679999999999999999999 999
Q ss_pred CCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHH
Q 010512 224 LFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 303 (508)
Q Consensus 224 pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~e 303 (508)
||.+.+.......+... .. ......+++.+.+||.+||..||.+|||+.+
T Consensus 276 p~~~~~~~~~~~~~~~~---------------------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 325 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRDG---------------------------NI---LACPENCPLELYNLMRLCWSKLPADRPSFCS 325 (343)
T ss_dssp TTTTSCHHHHHHHHHTT---------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cCCCCChHHHHHHHhCC---------------------------Cc---CCCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 99887754444333210 00 0112357789999999999999999999999
Q ss_pred Hhc
Q 010512 304 ALA 306 (508)
Q Consensus 304 iL~ 306 (508)
+++
T Consensus 326 ~~~ 328 (343)
T 1luf_A 326 IHR 328 (343)
T ss_dssp HHH
T ss_pred HHH
Confidence 987
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=357.87 Aligned_cols=250 Identities=20% Similarity=0.315 Sum_probs=205.3
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++++.||+|+||+||+|.+. ++..||||+++.... ....+.+|+.+|+.++||||+++++++. ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~ 92 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQR 92 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSS
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC---CHHHHHHHHHHHhcCCCCCEeeEEEEEe-----cCC
Confidence 3478999999999999999999876 678899999975432 2456889999999999999999999984 345
Q ss_pred cEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 95 DIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
.+|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 6999999997 699999987 45799999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.. ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+......
T Consensus 173 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------- 240 (283)
T 3gen_A 173 DE--YTSSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-------- 240 (283)
T ss_dssp HH--HHSTTSTTSCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--------
T ss_pred cc--cccccCCccCcccCCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC--------
Confidence 21 111234467788999999987 679999999999999999998 99999887765554444321110
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
......++.+.+||.+||+.||.+|||+.++++|
T Consensus 241 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 241 ----------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ----------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0112457889999999999999999999999985
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=358.21 Aligned_cols=252 Identities=25% Similarity=0.412 Sum_probs=198.6
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCC---CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~t---g~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
...++|++.+.||+|+||.||+|.+..+ +..||||+++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 87 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--- 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc---
Confidence 3457999999999999999999998653 567999998643 334456678999999999999999999999832
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
+.+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 88 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 88 ---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp ---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred ---CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence 34799999998 59999998654 69999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChH
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
....... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+...
T Consensus 165 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~------- 233 (281)
T 1mp8_A 165 YMEDSTY--YKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG------- 233 (281)
T ss_dssp ----------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-------
T ss_pred ccCcccc--cccccCCCcccccChhhccc--CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC-------
Confidence 6533221 11233467789999999976 689999999999999999996 99999887765544433211
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
... ...+.+++.+.+||.+||..||.+|||+.++++
T Consensus 234 --------------------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 234 --------------------ERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp --------------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 011 122467899999999999999999999999987
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=358.68 Aligned_cols=255 Identities=21% Similarity=0.311 Sum_probs=208.2
Q ss_pred CCCCCeEEee-eeeecCceEEEEEE--ECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 14 GEASRYQIQE-VIGKGSYGVVGSAV--DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 14 ~~~~rY~i~~-~LG~G~~g~V~~a~--~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
...++|++.+ .||+|+||+||+|. +..++..||||+++...........+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 89 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--- 89 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC---
Confidence 4457899998 99999999999994 46678999999997654444556789999999999999999999999832
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 91 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
..+|+||||++ ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 90 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 90 ---ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp ---SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred ---CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 35899999998 69999999988899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
...............+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-------- 236 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-------- 236 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--------
T ss_pred eccCCCcccccccCCCCceeeChHHhcc--CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------
Confidence 5433322222233456789999999976 678999999999999999999 99999887754433332210
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
... .....+++.+.+||.+||..||.+|||+.++++
T Consensus 237 -------------------~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 237 -------------------ERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp -------------------CCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------------CCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 112457899999999999999999999999987
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=372.49 Aligned_cols=276 Identities=22% Similarity=0.241 Sum_probs=210.0
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
+-..++|++++.||+|+||+||+|.+. ++.||||++... ........+|+.+|+.++||||+++++++.... ..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~ 93 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SV 93 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SS
T ss_pred ccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CC
Confidence 345678999999999999999999875 799999999642 233455677999999999999999999986533 12
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhc----------CceecCCCCCceeeCCCCcEEE
Q 010512 93 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA----------NVFHRDLKPKNILANADCKLKI 161 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~----------gIiHrDLKPeNILl~~~~~lkL 161 (508)
...+|+|||||+ |+|.+++... .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred CceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 346899999998 5999999765 599999999999999999999999 9999999999999999999999
Q ss_pred ccccccccccCCCCCcccccccccCcccccccccccc---cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 010512 162 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMT 238 (508)
Q Consensus 162 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~ 238 (508)
+|||+++........ ......+||+.|+|||++.+. ...++.++|||||||++|+|++|++||.+...........
T Consensus 173 ~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 173 ADFGLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp CCCTTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred ccCCcccccccccCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 999999865433221 223456899999999998752 1245678899999999999999999998765433333333
Q ss_pred hhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCC--CCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 239 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFP--NADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 239 ~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
...+.+....+... .. .......+...+. ..++.+.+||.+||+.||.+|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~--------~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 252 EIGQHPSLEDMQEV--------VV--HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHCSSCCHHHHHHH--------HT--TSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccCCchhhhhhh--------hh--cccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 33334443332211 11 1111111111111 22456899999999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=366.01 Aligned_cols=251 Identities=27% Similarity=0.438 Sum_probs=202.0
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh----hHHHHHHHHHHHHHhC----CCCCcceeeeeec
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV----SDATRILREIKLLRLL----RHPDIVEIKHIML 86 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~----~~~~~i~~Ei~iL~~L----~HpnIv~l~~v~~ 86 (508)
..++|++.+.||+|+||.||+|.+..+|+.||||+++...... .....+.+|+.+++.+ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 4578999999999999999999999999999999996532211 1233456799999999 8999999999984
Q ss_pred CCCcCCCccEEEEEec-CC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeC-CCCcEEEcc
Q 010512 87 PPSRREFKDIYVVFEL-ME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICD 163 (508)
Q Consensus 87 ~~~~~~~~~lylV~E~-~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~-~~~~lkL~D 163 (508)
. .+..|+|||+ +. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|
T Consensus 109 ~-----~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 109 T-----QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp ---------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred c-----CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEE
Confidence 3 3568999999 55 69999999888899999999999999999999999999999999999999 889999999
Q ss_pred ccccccccCCCCCcccccccccCcccccccccccccCCC-CcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC
Q 010512 164 FGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 242 (508)
Q Consensus 164 FGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y-~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g 242 (508)
||+++...... .....||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+... +..
T Consensus 184 fg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~--- 247 (312)
T 2iwi_A 184 FGSGALLHDEP-----YTDFDGTRVYSPPEWISR--HQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILE--- 247 (312)
T ss_dssp CSSCEECCSSC-----BCCCCSCTTTSCHHHHHH--SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH---
T ss_pred cchhhhcccCc-----ccccCCcccccCceeeec--CCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhh---
Confidence 99998654322 345679999999999876 344 4689999999999999999999965211 000
Q ss_pred CCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 243 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 243 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
. . . .....+++.+.+||.+||..||.+|||++|+|+||||+...
T Consensus 248 --------------------~---~--~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 248 --------------------A---E--L---HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp --------------------T---C--C---CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred --------------------h---c--c---CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 0 0 0 11235788999999999999999999999999999998654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=354.50 Aligned_cols=251 Identities=23% Similarity=0.332 Sum_probs=204.9
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHH-----HHHHHHHHHHHhCCCCCcceeeeeecCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA-----TRILREIKLLRLLRHPDIVEIKHIMLPP 88 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~-----~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 88 (508)
-..++|++.+.||+|+||+||+|.+..+++.||||++.......... ..+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 44589999999999999999999999999999999986543322221 6788999999999999999999998532
Q ss_pred CcCCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcC--ceecCCCCCceeeCCCCc-----E
Q 010512 89 SRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCK-----L 159 (508)
Q Consensus 89 ~~~~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~g--IiHrDLKPeNILl~~~~~-----l 159 (508)
.++||||+. ++|.+.+... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++. +
T Consensus 96 -------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 96 -------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp -------TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred -------CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeE
Confidence 279999998 7998888765 47999999999999999999999999 999999999999988876 9
Q ss_pred EEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHH--HHHH
Q 010512 160 KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQ--LDLM 237 (508)
Q Consensus 160 kL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~--l~~i 237 (508)
||+|||+++.... ......||+.|+|||++.+....++.++|||||||++|+|++|+.||.+.+.... ...+
T Consensus 169 kl~Dfg~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 242 (287)
T 4f0f_A 169 KVADFGLSQQSVH------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242 (287)
T ss_dssp EECCCTTCBCCSS------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred EeCCCCccccccc------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence 9999999974322 1345689999999999854335688999999999999999999999986553221 1111
Q ss_pred HhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 238 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 238 ~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.. .... ......+++.+.+||.+||+.||.+|||++++++
T Consensus 243 ~~--------------------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 243 RE--------------------------EGLR---PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HH--------------------------SCCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hc--------------------------cCCC---CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 10 0000 1122467899999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=362.53 Aligned_cols=261 Identities=20% Similarity=0.301 Sum_probs=201.9
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECC---CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTH---TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~---tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
-..++|++.+.||+|+||.||+|.+.. ++..||+|+++...........+.+|+.+|+.++||||+++++++.....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 345789999999999999999998765 56689999997655555666788999999999999999999999976543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcc
Q 010512 91 REFKDIYVVFELME-SDLHQVIKA------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 163 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~------~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~D 163 (508)
......|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECS
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEee
Confidence 33446799999998 599999853 34699999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcC
Q 010512 164 FGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLG 242 (508)
Q Consensus 164 FGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g 242 (508)
||+++....... ........+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+....
T Consensus 191 fg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~- 266 (313)
T 3brb_A 191 FGLSKKIYSGDY-YRQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH- 266 (313)
T ss_dssp CSCC-----------------CCGGGSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-
T ss_pred cCcceecccccc-cCcccccCCCccccCchhhcC--CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC-
Confidence 999986533221 111234467889999999987 689999999999999999999 899998877544443332110
Q ss_pred CCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 243 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 243 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.. .....+++.+.+||.+||..||.+|||+.+++++
T Consensus 267 --------------------------~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 267 --------------------------RL---KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp --------------------------CC---CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------------------CC---CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 1124577899999999999999999999999873
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=361.92 Aligned_cols=256 Identities=27% Similarity=0.370 Sum_probs=200.5
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
...++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----- 105 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI----- 105 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----
Confidence 345889999999999999999999999999999999975433 23345678899999999999999999999843
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
.+.+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 106 DGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp TTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 456899999998 4999999988889999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 186 ~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------------ 249 (309)
T 2h34_A 186 DEKL--TQLGNTVGTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ------------ 249 (309)
T ss_dssp -------------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS------------
T ss_pred cccc--ccccccCCCcCccCHHHHcC--CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc------------
Confidence 3221 12345679999999999987 6889999999999999999999999987654321111111
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-CHHHHhc
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-TAEEALA 306 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-ta~eiL~ 306 (508)
.........+.+++.+.+||.+||..||.+|| |++++++
T Consensus 250 ----------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 250 ----------------AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ----------------CCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ----------------CCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 11111223456788999999999999999999 7887775
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=384.76 Aligned_cols=258 Identities=28% Similarity=0.402 Sum_probs=194.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.+|.+.++||+|+||+|+. ....+|+.||||++..... ..+.+|+.+|+.+ +||||+++++++. +...
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~~~~ 92 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEK-----DRQF 92 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEE-----ETTE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCE
Confidence 4699999999999999764 3456899999999964322 2246899999999 7999999999984 4456
Q ss_pred EEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC-----CCcEEEcccccccc
Q 010512 96 IYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-----DCKLKICDFGLARV 169 (508)
Q Consensus 96 lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~-----~~~lkL~DFGla~~ 169 (508)
+|||||||+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||+|+.
T Consensus 93 ~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 93 QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 89999999999999998764 4666677899999999999999999999999999999953 23588999999987
Q ss_pred ccCCCCCcccccccccCcccccccccccc-cCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
...........+..+||++|+|||++.+. ...++.++|||||||++|+|++ |.+||....... ...+. +.
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-~~~~~---~~---- 244 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-ANILL---GA---- 244 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-HHHHT---TC----
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-HHHHh---cc----
Confidence 54333222234567899999999998742 2567889999999999999999 899996544322 11111 10
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
............+..+.+||.+||+.||.+|||++++|+||||.++
T Consensus 245 --------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 245 --------------------CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp --------------------CCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred --------------------CCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 0001111112234568899999999999999999999999999754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=357.05 Aligned_cols=258 Identities=24% Similarity=0.301 Sum_probs=200.3
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
-..++|++.+.||+|+||+||+|.+. ..||+|+++...........+.+|+.+|+.++||||++++++...
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------ 91 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------ 91 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC------
Confidence 45688999999999999999999754 359999998666666667889999999999999999999996532
Q ss_pred ccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 94 KDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
..+++||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 34799999998 6999998643 569999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCcccccccccccc-cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.... ........||+.|+|||++... ...++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 172 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---------- 240 (289)
T 3og7_A 172 RWSG-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR---------- 240 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH----------
T ss_pred cccc-cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc----------
Confidence 2221 1223456799999999998621 256889999999999999999999999886654443322210
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
......+......+++.+.+||.+||..||.+|||+.++++
T Consensus 241 ---------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 241 ---------------GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp ---------------TSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------cccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11122333445578899999999999999999999999987
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=366.89 Aligned_cols=255 Identities=21% Similarity=0.344 Sum_probs=201.2
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEE----EEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERV----AIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 88 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~v----AIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 88 (508)
.-..++|++++.||+|+||+||+|++..+|..| |+|.++... .......+.+|+.+|+.++||||+++++++...
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 345678999999999999999999998887754 777775322 223456789999999999999999999999642
Q ss_pred CcCCCccEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccc
Q 010512 89 SRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 166 (508)
Q Consensus 89 ~~~~~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGl 166 (508)
..++|++|+. |+|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 90 ------~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 163 (327)
T 3poz_A 90 ------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp ------SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred ------CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcc
Confidence 3789999998 799999987 45799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCC
Q 010512 167 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPS 245 (508)
Q Consensus 167 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~ 245 (508)
++........ .......+|+.|+|||++.+ ..|+.++|||||||++|+|++ |+.||.+.+.......+....
T Consensus 164 a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~---- 236 (327)
T 3poz_A 164 AKLLGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---- 236 (327)
T ss_dssp HHHHTTTCC--------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC----
T ss_pred eeEccCCccc-ccccCCCccccccChHHhcc--CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC----
Confidence 9875433221 12234567889999999987 789999999999999999999 999998876544333222110
Q ss_pred hHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 246 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.. ...+.++..+.+|+.+||+.||.+|||+.+++++
T Consensus 237 -----------------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 237 -----------------------RL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -----------------------CC---CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -----------------------CC---CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 00 1123567889999999999999999999999975
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=375.55 Aligned_cols=252 Identities=23% Similarity=0.379 Sum_probs=206.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++.+.||+|+||.||+|.+..+|..||||+++.. ........+.+|+.+|+.++||||+++++++.. ...
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 186 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQP 186 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-----SSS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-----CCC
Confidence 46899999999999999999999999999999998743 233344568899999999999999999999943 356
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 96 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
+|+|||||+ |+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 899999998 69999997654 6999999999999999999999999999999999999999999999999999864321
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
... .......+++.|+|||++.+ ..|+.++|||||||++|||++ |..||++.+.......+...
T Consensus 267 ~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~------------ 331 (377)
T 3cbl_A 267 VYA-ASGGLRQVPVKWTAPEALNY--GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG------------ 331 (377)
T ss_dssp EEE-CCSSCCEEEGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT------------
T ss_pred cee-ecCCCCCCCcCcCCHhHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------------
Confidence 110 00112235678999999986 679999999999999999998 99999887754443332211
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
...+ ....+++.+.+||.+||+.||.+|||++++++
T Consensus 332 ---------------~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 332 ---------------GRLP---CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ---------------CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCC---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0111 11346788999999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=357.03 Aligned_cols=251 Identities=22% Similarity=0.409 Sum_probs=211.7
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
-..++|++.+.||+|+||+||+|.+..++..||||++... ......+.+|+.+++.++||||+++++++. ..
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~ 81 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----RE 81 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cC
Confidence 4568899999999999999999999999999999999642 335677889999999999999999999984 34
Q ss_pred ccEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 94 KDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
..+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 56899999998 6999999874 35999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||++.+.......+....
T Consensus 162 ~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~-------- 229 (288)
T 3kfa_A 162 TGDTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-------- 229 (288)
T ss_dssp CSSSS--EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC--------
T ss_pred cCCcc--ccccCCccccCcCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC--------
Confidence 43221 22344567889999999987 689999999999999999999 999998877544433332110
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
. ......+++.+.+||.+||..||.+|||+.++++
T Consensus 230 -------------------~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 230 -------------------R---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp -------------------C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------C---CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 0 0112457889999999999999999999999987
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=374.45 Aligned_cols=254 Identities=25% Similarity=0.393 Sum_probs=196.6
Q ss_pred CCCCeEEeeeeeecCceEEEEEEEC---CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~---~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
..++|++.+.||+|+||.||+|++. .++..||||+++... .......+.+|+.+|+.++||||+++++++..
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---- 117 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK---- 117 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee----
Confidence 3468999999999999999999876 467789999997532 34456678999999999999999999999843
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
...+|+|||||+ ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 118 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 118 -SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred -CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 456899999997 69999998754 699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
...............+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+....
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~------- 267 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY------- 267 (373)
T ss_dssp -----------------CTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE-------
T ss_pred cccCCccceeccCCCcCCCccChhhhcc--CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------
Confidence 5433222211223346788999999987 689999999999999999998 999998777554443332111
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
. .+ ....++..+.+||.+||+.||.+||++.++++
T Consensus 268 ----------------~--~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 268 ----------------R--LP-----PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ----------------E--CC-----CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------C--CC-----CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 0 00 11356788999999999999999999999887
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=362.40 Aligned_cols=257 Identities=23% Similarity=0.357 Sum_probs=202.6
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCC----cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTG----ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 88 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg----~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 88 (508)
-...++|++.+.||+|+||+||+|.+..++ ..||||+++... .......+.+|+.+++.++||||+++++++.
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-- 116 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-- 116 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe--
Confidence 345689999999999999999999886553 469999997432 3345567889999999999999999999984
Q ss_pred CcCCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccc
Q 010512 89 SRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 166 (508)
Q Consensus 89 ~~~~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGl 166 (508)
....+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 117 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 117 ---KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp ---SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred ---cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCc
Confidence 3456999999998 5999999765 5799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCC
Q 010512 167 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPS 245 (508)
Q Consensus 167 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~ 245 (508)
++................+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~---- 267 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF---- 267 (333)
T ss_dssp -----------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC----
T ss_pred chhhccccccccccCCCCccccccCchhccc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC----
Confidence 9875433222222233456889999999976 689999999999999999998 999998776544443332210
Q ss_pred hHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 246 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.. .....+++.+.+||.+||..||.+||++.+++++
T Consensus 268 -----------------------~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 268 -----------------------RL---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp -----------------------CC---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -----------------------cC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 1123567889999999999999999999999873
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=359.47 Aligned_cols=253 Identities=27% Similarity=0.410 Sum_probs=208.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 89 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~-----~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~ 89 (508)
.++|++.+.||+|+||.||+|.+ ..++..||||+++.. ........+.+|+.+|+.+ +||||+++++++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 98 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence 47899999999999999999985 467889999999743 2334567789999999999 89999999999943
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCc
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKAND------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 150 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~~------------------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeN 150 (508)
.+..|+||||++ |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 99 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 99 ---GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ---SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ---CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 456899999998 59999998754 48999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCC
Q 010512 151 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 229 (508)
Q Consensus 151 ILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~ 229 (508)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+..
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EEEcCCCCEEEccccccccccccccc-eeccCCCCcceeeChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999999999999865433221 22334567889999999977 689999999999999999998 999998766
Q ss_pred hHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 230 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 230 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
....+..+... ... . .....+++.+.+||.+||..||.+|||+.++++
T Consensus 253 ~~~~~~~~~~~----------------------~~~----~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 253 VDSKFYKMIKE----------------------GFR----M---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp SSHHHHHHHHH----------------------TCC----C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhHHHHHhcc----------------------CCC----C---CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 43333222110 000 0 112356789999999999999999999999997
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=362.54 Aligned_cols=253 Identities=21% Similarity=0.367 Sum_probs=208.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~-----~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
.++|++.+.||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 99 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--- 99 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS---
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc---
Confidence 478999999999999999999876 46789999999743 233455678899999999999999999999843
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcE
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAN----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 159 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~----------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~l 159 (508)
....|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 100 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 100 --GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred --CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 456899999998 5999998752 357999999999999999999999999999999999999999999
Q ss_pred EEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 010512 160 KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMT 238 (508)
Q Consensus 160 kL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~ 238 (508)
||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 178 kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp EECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred EECcCccccccccccc-cccccCCCCCCCccChhhhcc--CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 9999999986432221 112234567899999999987 679999999999999999999 899998877544443332
Q ss_pred hhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 239 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 239 ~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.. . .......+++.+.+||.+||..||.+|||+.++++|
T Consensus 255 ~~---------------------------~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 255 EG---------------------------G---LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TT---------------------------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cC---------------------------C---cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 10 0 011224678899999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=357.22 Aligned_cols=272 Identities=24% Similarity=0.390 Sum_probs=210.4
Q ss_pred CCCCCeEEeeeeeecCceEEEEEE----ECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 89 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~----~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 89 (508)
-...+|++++.||+|+||.||+|+ +..+|+.||||+++... .......+.+|+.+|+.++||||+++++++....
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 345679999999999999999998 67799999999997543 2334577889999999999999999999986532
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccc
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 167 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla 167 (508)
...+|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 97 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 97 ---GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp ----CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred ---CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence 256899999998 599999954 457999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChH
Q 010512 168 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 168 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
.................||..|+|||++.+ ..++.++|||||||++|+|++|..||... ...+....+.....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~ 246 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQ--SKFYIASDVWSFGVTLHELLTYCDSDSSP-----MALFLKMIGPTHGQ 246 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSH-----HHHHHHHHCSCCGG
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecC--CCCCcchhHHHHHHHHHHHHHccCCCcch-----hhHHhhccCCcccc
Confidence 876444332223445678899999999977 67889999999999999999999886432 12222222222221
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.. .......+......+ ..+.+++.+.+||.+||..||.+|||+.++++
T Consensus 247 ~~-------~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 247 MT-------VTRLVNTLKEGKRLP---CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp GH-------HHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred cC-------HHHHHHHHhccCCCC---CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 11 111111122222211 22467899999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=365.71 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=206.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 89 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~-----~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~ 89 (508)
.++|++.+.||+|+||.||+|.+ ..++..||||+++... .......+.+|+.+|+.+ +||||+++++++..
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 120 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 120 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence 47899999999999999999997 3467789999997432 223456788999999999 89999999999844
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHhHhcCceecC
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKAND-----------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRD 145 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~~-----------------------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrD 145 (508)
.+.+|+||||++ |+|.+++.... .+++..+..++.||+.||.|||++||+|||
T Consensus 121 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 121 ---SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ---CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 356899999998 59999998653 279999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCC
Q 010512 146 LKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPL 224 (508)
Q Consensus 146 LKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~p 224 (508)
|||+|||++.++.+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCcc-ceeccCccCccCccCHHHhcc--CCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999986543322 122344578899999999977 689999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHH
Q 010512 225 FPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 304 (508)
Q Consensus 225 F~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~ei 304 (508)
|.+.+....+..+.. ..... .....+++.+.+||.+||..||.+|||+.++
T Consensus 275 ~~~~~~~~~~~~~~~--------------------------~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 325 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQ--------------------------NGFKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 325 (344)
T ss_dssp STTCCCSHHHHHHHH--------------------------TTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cccCCcHHHHHHHHh--------------------------cCCCC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 987664333222111 00000 1123467899999999999999999999999
Q ss_pred hcCCc
Q 010512 305 LADPY 309 (508)
Q Consensus 305 L~hp~ 309 (508)
++|..
T Consensus 326 ~~~l~ 330 (344)
T 1rjb_A 326 TSFLG 330 (344)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=354.34 Aligned_cols=258 Identities=20% Similarity=0.243 Sum_probs=206.8
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
....++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+|+.+++.++|++++..+..+.. .
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~ 76 (296)
T 3uzp_A 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGA----E 76 (296)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEE----E
T ss_pred ceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccC----C
Confidence 3457899999999999999999999999999999999864322 2357899999999999988877766632 3
Q ss_pred CccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceee---CCCCcEEEccccccc
Q 010512 93 FKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLAR 168 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl---~~~~~lkL~DFGla~ 168 (508)
....|+||||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 77 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 77 GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CCceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 356899999998899999974 4579999999999999999999999999999999999999 478899999999998
Q ss_pred cccCCCCCc----ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHhhc
Q 010512 169 VSFNDAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV---HQLDLMTDLL 241 (508)
Q Consensus 169 ~~~~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~---~~l~~i~~~~ 241 (508)
......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.. ..+..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-- 232 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-- 232 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH--
T ss_pred cccccccccccccccccccccccccCChhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc--
Confidence 754432211 11245689999999999987 67999999999999999999999999874421 12221111
Q ss_pred CCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 242 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.... .+.......+++.+.+||.+||+.||.+|||++++++
T Consensus 233 -------------~~~~-----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 233 -------------KKMS-----------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -------------HHHH-----------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -------------cccC-----------CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 0000 0001112456789999999999999999999999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=358.36 Aligned_cols=261 Identities=20% Similarity=0.237 Sum_probs=202.5
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
....++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.++|++++..+..+.. .
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~ 76 (296)
T 4hgt_A 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGA----E 76 (296)
T ss_dssp ------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEE----E
T ss_pred cccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecC----C
Confidence 3567899999999999999999999999999999998754322 2347789999999999988887776642 3
Q ss_pred CccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceee---CCCCcEEEccccccc
Q 010512 93 FKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLAR 168 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl---~~~~~lkL~DFGla~ 168 (508)
....|+||||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 77 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 77 GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CCceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 356899999998899999985 4579999999999999999999999999999999999999 788999999999998
Q ss_pred cccCCCCCc----ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC
Q 010512 169 VSFNDAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244 (508)
Q Consensus 169 ~~~~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p 244 (508)
......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------- 227 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY------- 227 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH-------
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcC--CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhh-------
Confidence 754432211 12235689999999999987 67999999999999999999999999875432111111
Q ss_pred ChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..+...... .+.......+++.+.+||.+||+.||.+|||++++++
T Consensus 228 -----~~~~~~~~~-----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 228 -----ERISEKKMS-----------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -----HHHHHHHHH-----------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -----hhhhccccc-----------chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 000000000 0111122456789999999999999999999999987
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=365.70 Aligned_cols=274 Identities=23% Similarity=0.350 Sum_probs=213.8
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEE----ECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecC
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLP 87 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~----~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~ 87 (508)
.+-..++|++++.||+|+||.||+|+ +..++..||||++... .......+.+|+.+|+.++||||+++++++..
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 95 (327)
T 3lxl_A 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYG 95 (327)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence 34556899999999999999999998 5778999999999743 34456678999999999999999999999864
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccc
Q 010512 88 PSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 165 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFG 165 (508)
. ....+|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 96 ~---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 96 P---GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp S---SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGG
T ss_pred C---CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccc
Confidence 3 3456899999996 699999987 4569999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC
Q 010512 166 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245 (508)
Q Consensus 166 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~ 245 (508)
+++................||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ . .........
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~-~~~~~~~~~ 248 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSD--NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL-R-MMGCERDVP 248 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-H-HCC----CC
T ss_pred cceecccCCccceeeccCCccccccCHHHhcc--CCCChHHhHHHHHHHHHHHHhCCCCCccccchhh-h-hcccccccc
Confidence 99876443332233345678899999999987 6789999999999999999999999965332111 0 000000000
Q ss_pred hHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 246 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
. .......+......+ ..+.+++.+.+||.+||..||.+|||+.+++++
T Consensus 249 --~--------~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 249 --A--------LSRLLELLEEGQRLP---APPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp --H--------HHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --c--------HHHHHHHhhcccCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 011111111111111 234678999999999999999999999999763
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=354.71 Aligned_cols=257 Identities=22% Similarity=0.324 Sum_probs=210.2
Q ss_pred CCCCCeEEee-eeeecCceEEEEEEEC--CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 14 GEASRYQIQE-VIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 14 ~~~~rY~i~~-~LG~G~~g~V~~a~~~--~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
-..++|.+.+ .||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 81 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--- 81 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC---
Confidence 3456788887 9999999999999864 47889999999753 334566788999999999999999999999832
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
..+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 82 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 158 (287)
T 1u59_A 82 ---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK 158 (287)
T ss_dssp ---SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred ---CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccccee
Confidence 34899999998 5999998654 469999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChH
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
................+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~------- 229 (287)
T 1u59_A 159 ALGADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG------- 229 (287)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-------
T ss_pred eeccCcceeeccccccccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC-------
Confidence 75433222222234467899999999976 678999999999999999998 99999887654443333210
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCc
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~ 309 (508)
.. ....+.+++.+.+||.+||..||.+|||+.++++|.+
T Consensus 230 --------------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 230 --------------------KR---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp --------------------CC---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred --------------------Cc---CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 00 1122467899999999999999999999999998654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=362.08 Aligned_cols=259 Identities=22% Similarity=0.348 Sum_probs=190.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCC---cC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPS---RR 91 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~---~~ 91 (508)
..+|++.+.||+|+||.||+|.+..+|+.||||++.. ........+.+|+.+|+.+. ||||+++++++.... ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS--NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecC--CchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 3589999999999999999999999999999999853 23445667889999999996 999999999985321 13
Q ss_pred CCccEEEEEecCCccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHhHhcC--ceecCCCCCceeeCCCCcEEEccccc
Q 010512 92 EFKDIYVVFELMESDLHQVIKA---NDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGL 166 (508)
Q Consensus 92 ~~~~lylV~E~~~g~L~~~i~~---~~~l~~~~~~~i~~Qil~aL~yLHs~g--IiHrDLKPeNILl~~~~~lkL~DFGl 166 (508)
....+|+||||++|+|.+++.. .+.+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+
T Consensus 105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 3456899999999999998865 567999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCc---------ccccccccCccccccccccc-ccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 010512 167 ARVSFNDAPSA---------IFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 236 (508)
Q Consensus 167 a~~~~~~~~~~---------~~~~~~~gT~~Y~APE~l~~-~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~ 236 (508)
++......... .......||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+......+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 98654322111 01124569999999999831 125788999999999999999999999976442211100
Q ss_pred HHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCc
Q 010512 237 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309 (508)
Q Consensus 237 i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~ 309 (508)
.... ......++.+.+||.+||+.||.+|||+.|+++|.+
T Consensus 265 ------------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 265 ------------------------------KYSI---PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -------------------------------CCC---CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred ------------------------------cccC---CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 0000 112345567899999999999999999999999754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=350.02 Aligned_cols=249 Identities=14% Similarity=0.187 Sum_probs=206.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++.+.||+|+||+||+|.+. |..||||+++...........+.+|+.+|+.++||||+++++++.... ...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---APH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---SSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---CCC
Confidence 478999999999999999999874 889999999866555566778999999999999999999999986532 256
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcC--ceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 96 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~g--IiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||+.| |+||||||+|||++.++.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 899999998 59999998765 4899999999999999999999999 999999999999999999999999987642
Q ss_pred cCCCCCcccccccccCcccccccccccc-cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
. .....||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 164 ~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--------- 226 (271)
T 3kmu_A 164 Q--------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE--------- 226 (271)
T ss_dssp S--------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHS---------
T ss_pred c--------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhc---------
Confidence 1 1335789999999998762 123344899999999999999999999887755443332210
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
... ......+++.+.+||.+||+.||.+|||++++++
T Consensus 227 -----------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 227 -----------------GLR---PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -----------------CCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 0122457899999999999999999999999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=361.17 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=207.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-------CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDT-------HTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLP 87 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~-------~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~ 87 (508)
.++|++.+.||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+|+.+ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 479999999999999999999975 46789999999753 2344567789999999999 89999999999843
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCc
Q 010512 88 PSRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 150 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeN 150 (508)
.+.+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 113 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 113 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp -----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred -----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 456899999998 59999998654 38999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCC
Q 010512 151 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 229 (508)
Q Consensus 151 ILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~ 229 (508)
||++.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSS-EECCSCCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEcCCCCEEEcccccccccccccc-ccccCCCCcccceeChHHhcC--CCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 9999999999999999986533221 111234467889999999977 678999999999999999999 999998877
Q ss_pred hHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 230 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 230 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.......+... .. ......+++.+.+||.+||..||.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~---------------------------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 265 VEELFKLLKEG---------------------------HR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHHHT---------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcC---------------------------CC---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 54443333211 00 01124578899999999999999999999999973
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=365.40 Aligned_cols=256 Identities=21% Similarity=0.324 Sum_probs=204.7
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcE----EEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecC
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLP 87 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~----vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~ 87 (508)
..-..++|++++.||+|+||+||+|.+..+|.. ||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 344568899999999999999999999888876 7777765322 1222345678999999999999999999883
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccc
Q 010512 88 PSRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 165 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFG 165 (508)
...+|+||||+. |+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 86 -----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 160 (325)
T 3kex_A 86 -----GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFG 160 (325)
T ss_dssp -----BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCS
T ss_pred -----CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCC
Confidence 245899999998 6999999875 579999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCC
Q 010512 166 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTP 244 (508)
Q Consensus 166 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p 244 (508)
+++....... ........||..|+|||++.+ ..|+.++|||||||++|+|++ |..||.+.+.......+...
T Consensus 161 ~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---- 233 (325)
T 3kex_A 161 VADLLPPDDK-QLLYSEAKTPIKWMALESIHF--GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG---- 233 (325)
T ss_dssp GGGGSCCCTT-CCC-----CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT----
T ss_pred cccccCcccc-cccccCCCCcccccChHHhcc--CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC----
Confidence 9987543322 222345678889999999987 689999999999999999999 99999887654433333211
Q ss_pred ChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.... ....+++.+.+||.+||..||.+|||+.++++|
T Consensus 234 -----------------------~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 234 -----------------------ERLA---QPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp -----------------------CBCC---CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred -----------------------CCCC---CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000 112345678899999999999999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=363.27 Aligned_cols=258 Identities=21% Similarity=0.305 Sum_probs=206.5
Q ss_pred CCCCeEEeeeeeecCceEEEEEE-----ECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAV-----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 89 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~-----~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 89 (508)
..++|++++.||+|+||.||+|. +..++..||||++... ........+.+|+.+|+.++||||+++++++..
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 104 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-- 104 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC--
Confidence 45799999999999999999998 5678899999999643 234456678899999999999999999999854
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC---Cc
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKAND-------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CK 158 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~~-------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~---~~ 158 (508)
....|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+ ..
T Consensus 105 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 105 ---SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp ---SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred ---CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence 345799999996 69999998753 48999999999999999999999999999999999999954 46
Q ss_pred EEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 010512 159 LKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLM 237 (508)
Q Consensus 159 lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i 237 (508)
+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+
T Consensus 182 ~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 258 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYY-RKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258 (327)
T ss_dssp EEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred EEECcccccccccccccc-ccCCCcCCCcceeCHhHhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence 999999999864332211 11234578899999999977 689999999999999999998 99999887755444333
Q ss_pred HhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010512 238 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 238 ~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~ 311 (508)
.... . ......+++.+.+||.+||..||.+|||+.++++|.|+-
T Consensus 259 ~~~~---------------------------~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TSGG---------------------------R---MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HTTC---------------------------C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCC---------------------------C---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 2210 0 011245778999999999999999999999999998864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=348.45 Aligned_cols=248 Identities=27% Similarity=0.440 Sum_probs=194.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC--hhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH--VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~--~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
.++|++.+.||+|+||.||+|.+. |..||||+++..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-----E 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-----C
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-----C
Confidence 478999999999999999999874 889999998653222 2235678899999999999999999999943 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcC---ceecCCCCCceeeCC--------CCcEEE
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN---VFHRDLKPKNILANA--------DCKLKI 161 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~g---IiHrDLKPeNILl~~--------~~~lkL 161 (508)
+.+|+||||++ ++|.+++. ...+++..+..++.||+.||.|||++| |+||||||+|||++. ++.+||
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred CceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 56899999998 58888774 557999999999999999999999999 999999999999986 678999
Q ss_pred ccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Q 010512 162 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 241 (508)
Q Consensus 162 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~ 241 (508)
+|||++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 158 ~Dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-- 228 (271)
T 3dtc_A 158 TDFGLAREWHRTT-----KMSAAGAYAWMAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM-- 228 (271)
T ss_dssp CCCCC------------------CCGGGSCHHHHHH--CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT--
T ss_pred ccCCccccccccc-----ccCCCCccceeCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc--
Confidence 9999998643222 234579999999999987 6799999999999999999999999988765443322211
Q ss_pred CCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 242 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
..... .....+++.+.+||.+||..||.+|||+.|+++|
T Consensus 229 ------------------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 229 ------------------------NKLAL---PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ------------------------SCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCC---CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 01111 1124567899999999999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=359.46 Aligned_cols=261 Identities=23% Similarity=0.314 Sum_probs=198.5
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHh--CCCCCcceeeeeecCCCcC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL--LRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~--L~HpnIv~l~~v~~~~~~~ 91 (508)
...++|++++.||+|+||+||+|.+ +|+.||||++.. .....+.+|..++.. ++||||+++++++.... .
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~ 76 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSS-----RDEKSWFRETELYNTVMLRHENILGFIASDMTSR-H 76 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-T
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecc-----ccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-C
Confidence 3567999999999999999999987 689999999863 234556677777777 78999999999875422 3
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhH--------hcCceecCCCCCceeeCCCCcEEEc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH--------TANVFHRDLKPKNILANADCKLKIC 162 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLH--------s~gIiHrDLKPeNILl~~~~~lkL~ 162 (508)
....+|+||||++ |+|.+++.. ..+++..+..++.||+.||.||| +.||+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred CCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 3456899999998 599999954 57999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccCCCCCc-ccccccccCcccccccccccccC----CCCcchhhhhHHHHHHHHHhC----------CCCCCC
Q 010512 163 DFGLARVSFNDAPSA-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEMLTG----------KPLFPG 227 (508)
Q Consensus 163 DFGla~~~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~----~y~~~~DIWSlG~il~eLltG----------~~pF~~ 227 (508)
|||+++......... ......+||+.|+|||++.+... .++.++|||||||++|+|++| .+||.+
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999998654332211 11234589999999999876211 455799999999999999999 888865
Q ss_pred CCh----HHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHH
Q 010512 228 KNV----VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 303 (508)
Q Consensus 228 ~~~----~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~e 303 (508)
... ...+..+ ..........+........++.+.+||.+||+.||.+|||+.+
T Consensus 236 ~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~ 292 (301)
T 3q4u_A 236 VVPNDPSFEDMRKV-----------------------VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALR 292 (301)
T ss_dssp TSCSSCCHHHHHHH-----------------------HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred cCCCCcchhhhhHH-----------------------HhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHH
Confidence 321 1111111 1000111111110011224567999999999999999999999
Q ss_pred Hhc
Q 010512 304 ALA 306 (508)
Q Consensus 304 iL~ 306 (508)
+++
T Consensus 293 i~~ 295 (301)
T 3q4u_A 293 IKK 295 (301)
T ss_dssp HHH
T ss_pred HHH
Confidence 986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=358.52 Aligned_cols=256 Identities=25% Similarity=0.419 Sum_probs=208.8
Q ss_pred CCCCeEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPP 88 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~-----~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~ 88 (508)
..++|++.+.||+|+||+||+|.+ ..+++.||||+++... .......+.+|+.+|+.+ +||||+++++++...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 347999999999999999999984 4578999999997542 334556789999999999 699999999998543
Q ss_pred CcCCCccEEEEEecCC-ccHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCce
Q 010512 89 SRREFKDIYVVFELME-SDLHQVIKANDD----------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI 151 (508)
Q Consensus 89 ~~~~~~~lylV~E~~~-g~L~~~i~~~~~----------------l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNI 151 (508)
...+|+||||++ ++|.+++..... +++..+..++.||+.||.|||++||+||||||+||
T Consensus 104 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 104 ----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ----TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ----CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 245899999998 599999987654 89999999999999999999999999999999999
Q ss_pred eeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCCh
Q 010512 152 LANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNV 230 (508)
Q Consensus 152 Ll~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~ 230 (508)
|++.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred EECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhcc--ccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999986543322 222345678899999999987 689999999999999999998 9999987653
Q ss_pred HHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 231 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 231 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
...+..... . .... .....+++.+.+||.+||..||.+|||+.++++|
T Consensus 257 ~~~~~~~~~----------------------~----~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 257 DEEFCRRLK----------------------E----GTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp SHHHHHHHH----------------------H----TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHhc----------------------c----CccC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 322211110 0 0000 1123467899999999999999999999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=347.69 Aligned_cols=249 Identities=24% Similarity=0.384 Sum_probs=206.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++.+.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 77 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAP 77 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSS
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCC
Confidence 478999999999999999999986 678999999975433 23578899999999999999999999843 356
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 96 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 899999998 6999999875 46899999999999999999999999999999999999999999999999999864321
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
. ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+....
T Consensus 158 ~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~----------- 222 (267)
T 3t9t_A 158 Q--YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF----------- 222 (267)
T ss_dssp H--HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-----------
T ss_pred c--ccccccccccccccChhhhcC--CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC-----------
Confidence 1 111234567889999999986 688999999999999999999 899998877554443332210
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.. ......++.+.+||.+||..||.+|||+.+++++
T Consensus 223 ----------------~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 223 ----------------RL---YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ----------------CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------cC---CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 0112457889999999999999999999999873
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=366.78 Aligned_cols=267 Identities=16% Similarity=0.158 Sum_probs=202.0
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECC---CCcEEEEEEecCccCChh---------HHHHHHHHHHHHHhCCCCCcceee
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTH---TGERVAIKKINDVFEHVS---------DATRILREIKLLRLLRHPDIVEIK 82 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~---tg~~vAIKki~~~~~~~~---------~~~~i~~Ei~iL~~L~HpnIv~l~ 82 (508)
..++|++.+.||+|+||.||+|.+.. ++..||||++........ ....+.+|+.+++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 45789999999999999999999987 889999999864321110 112356788999999999999999
Q ss_pred eeecCCCcCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC--cEE
Q 010512 83 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC--KLK 160 (508)
Q Consensus 83 ~v~~~~~~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~--~lk 160 (508)
+++.... .....+|+||||++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEF-KGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEES-SSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred ccccccc-CCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 9986522 2346799999999779999998877899999999999999999999999999999999999999887 999
Q ss_pred EccccccccccCCCC----CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCC--hHHHH
Q 010512 161 ICDFGLARVSFNDAP----SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN--VVHQL 234 (508)
Q Consensus 161 L~DFGla~~~~~~~~----~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~--~~~~l 234 (508)
|+|||+++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.. .....
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 999999986532211 1112245689999999999987 689999999999999999999999996532 22111
Q ss_pred HHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 235 DLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 235 ~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..........+.... .. .....+++.+.+||.+||..||.+|||++++++
T Consensus 272 ~~~~~~~~~~~~~~~---------~~-------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 272 TAKTNLLDELPQSVL---------KW-------------APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHTTTHHHH---------HH-------------SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhhcccccHHHH---------hh-------------ccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 111111111111000 00 001257789999999999999999999999988
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=361.54 Aligned_cols=253 Identities=21% Similarity=0.350 Sum_probs=201.1
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEE----EEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERV----AIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 89 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~v----AIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 89 (508)
-..++|++++.||+|+||+||+|.+..+|+.| |+|.+... ........+.+|+.+|+.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-
Confidence 45688999999999999999999998888755 66666532 2234567789999999999999999999998643
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccc
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 167 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla 167 (508)
..++|++++. |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 90 -----~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 90 -----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp -----SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred -----CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 3789999998 6999999874 57999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCCh
Q 010512 168 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPST 246 (508)
Q Consensus 168 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~ 246 (508)
+....... ........+|+.|+|||++.+ ..|+.++|||||||++|+|++ |.+||.+.+.......+....
T Consensus 165 ~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~----- 236 (327)
T 3lzb_A 165 KLLGAEEK-EYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----- 236 (327)
T ss_dssp ----------------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-----
T ss_pred eEccCccc-cccccCCCccccccCHHHHcC--CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-----
Confidence 86533222 112234567889999999987 789999999999999999999 999998876544433332110
Q ss_pred HHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 247 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.. ...+.+++.+.+||.+||..||.+|||+.|+++
T Consensus 237 ----------------------~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 237 ----------------------RL---PQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ----------------------CC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CC---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 00 112346788999999999999999999999997
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=355.02 Aligned_cols=246 Identities=17% Similarity=0.277 Sum_probs=201.1
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCC-------cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTG-------ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLP 87 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg-------~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~ 87 (508)
..++|++.+.||+|+||+||+|.+..++ ..||+|++... .......+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 3578999999999999999999998877 47999999643 23445778999999999999999999999954
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCc-------
Q 010512 88 PSRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK------- 158 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~-g~L~~~i~~~~~-l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~------- 158 (508)
....|+||||++ ++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 84 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 84 -----GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp -----TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred -----CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc
Confidence 345799999998 699999987654 999999999999999999999999999999999999998887
Q ss_pred -EEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhC-CCCCCCCChHHHHHH
Q 010512 159 -LKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQLDL 236 (508)
Q Consensus 159 -lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG-~~pF~~~~~~~~l~~ 236 (508)
+||+|||++..... .....||+.|+|||++.+. ..++.++|||||||++|+|++| .+||...+.......
T Consensus 159 ~~kl~Dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~ 230 (289)
T 4fvq_A 159 FIKLSDPGISITVLP-------KDILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230 (289)
T ss_dssp EEEECCCCSCTTTSC-------HHHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred eeeeccCcccccccC-------ccccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH
Confidence 99999999864321 1235688999999998752 5689999999999999999995 566665543322221
Q ss_pred HHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 237 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 237 i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
... ... .....++.+.+||.+||+.||.+|||+.++++|
T Consensus 231 ~~~-------------------------~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 231 YED-------------------------RHQ-------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHT-------------------------TCC-------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhc-------------------------cCC-------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 110 000 112335668999999999999999999999983
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=370.03 Aligned_cols=269 Identities=16% Similarity=0.149 Sum_probs=202.3
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCC-----CcEEEEEEecCccCChhH---------HHHHHHHHHHHHhCCCCCcce
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHT-----GERVAIKKINDVFEHVSD---------ATRILREIKLLRLLRHPDIVE 80 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~t-----g~~vAIKki~~~~~~~~~---------~~~i~~Ei~iL~~L~HpnIv~ 80 (508)
..++|++.+.||+|+||+||+|.+..+ ++.||||++......... ...+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 345899999999999999999998764 588999998643211000 012345666777888999999
Q ss_pred eeeeecCCCcCCCccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeC--CCC
Q 010512 81 IKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN--ADC 157 (508)
Q Consensus 81 l~~v~~~~~~~~~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~--~~~ 157 (508)
+++++.... .....+|||||||+++|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEE-TTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeecc-CCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 999986532 223568999999988999999876 6799999999999999999999999999999999999999 889
Q ss_pred cEEEccccccccccCCCCC----cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHH
Q 010512 158 KLKICDFGLARVSFNDAPS----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQ 233 (508)
Q Consensus 158 ~lkL~DFGla~~~~~~~~~----~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~ 233 (508)
.+||+|||+++........ .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+......
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 9999999999865332111 111234569999999999987 6799999999999999999999999986432222
Q ss_pred HHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 234 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 234 l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
........ . .......+.... ...++++.+.+||..||..||.+||++.++++
T Consensus 270 ~~~~~~~~----------~-~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 270 YVRDSKIR----------Y-RENIASLMDKCF---------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHH----------H-HHCHHHHHHHHS---------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHH----------h-hhhHHHHHHHhc---------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 21111100 0 000111111100 01356789999999999999999999999887
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=359.17 Aligned_cols=254 Identities=24% Similarity=0.378 Sum_probs=207.0
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCc-----EEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGE-----RVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPP 88 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~-----~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~ 88 (508)
..++|++.+.||+|+||.||+|.+..++. .||+|+++... .......+.+|+.+|+.+ +||||+++++++..
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 121 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTH- 121 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec-
Confidence 34789999999999999999999977664 89999997532 334567789999999999 89999999999843
Q ss_pred CcCCCccEEEEEecCC-ccHHHHHHh--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceee
Q 010512 89 SRREFKDIYVVFELME-SDLHQVIKA--------------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA 153 (508)
Q Consensus 89 ~~~~~~~lylV~E~~~-g~L~~~i~~--------------~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl 153 (508)
.+.+|+||||++ |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 122 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 122 ----GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp ----SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred ----CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 456899999998 599999875 2458999999999999999999999999999999999999
Q ss_pred CCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHH
Q 010512 154 NADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVH 232 (508)
Q Consensus 154 ~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~ 232 (508)
+.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.....
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSN-YIVKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTT-SEECSSCEECGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred CCCCeEEECccccccccccccc-eeecCCCCCCccccCHHHhcc--CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 9999999999999986543322 122334567889999999987 689999999999999999998 999998766433
Q ss_pred HHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 233 QLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 233 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.+..+... .... ......++.+.+||.+||+.||.+|||+.++++
T Consensus 275 ~~~~~~~~--------------------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 275 KFYKLVKD--------------------------GYQM---AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHHH--------------------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhc--------------------------CCCC---CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 33222110 0000 011345788999999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=377.96 Aligned_cols=262 Identities=27% Similarity=0.386 Sum_probs=193.9
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~ 92 (508)
...+.|.+.++||+|+||+||.+ ...+|+.||||++... ....+.+|+.+|+.+ +||||+++++++. .
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~ 80 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSET-----T 80 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEE-----C
T ss_pred hhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEe-----c
Confidence 45577888999999999999875 4568999999998632 235678999999876 8999999999984 3
Q ss_pred CccEEEEEecCCccHHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC---------
Q 010512 93 FKDIYVVFELMESDLHQVIKANDDL-------TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--------- 156 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~~~~l-------~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~--------- 156 (508)
...+|||||||+|+|.+++...... ++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~ 160 (434)
T 2rio_A 81 DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT 160 (434)
T ss_dssp SSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred CCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccccc
Confidence 4569999999999999999876433 223456799999999999999999999999999999754
Q ss_pred ----CcEEEccccccccccCCCCC-cccccccccCcccccccccccc-----cCCCCcchhhhhHHHHHHHHHh-CCCCC
Q 010512 157 ----CKLKICDFGLARVSFNDAPS-AIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEMLT-GKPLF 225 (508)
Q Consensus 157 ----~~lkL~DFGla~~~~~~~~~-~~~~~~~~gT~~Y~APE~l~~~-----~~~y~~~~DIWSlG~il~eLlt-G~~pF 225 (508)
+.+||+|||+++........ .......+||+.|+|||++.+. ...++.++|||||||++|+|++ |..||
T Consensus 161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 48999999999875433211 1123456899999999998651 2468999999999999999999 99999
Q ss_pred CCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHh
Q 010512 226 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 305 (508)
Q Consensus 226 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL 305 (508)
.+..... ...+.... ..... .......+++.+.+||.+||+.||.+|||+.++|
T Consensus 241 ~~~~~~~-~~i~~~~~------------------------~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil 294 (434)
T 2rio_A 241 GDKYSRE-SNIIRGIF------------------------SLDEM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294 (434)
T ss_dssp CSTTTHH-HHHHHTCC------------------------CCCCC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCchhhH-HHHhcCCC------------------------Ccccc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHH
Confidence 7654322 11111000 00000 0000112457799999999999999999999999
Q ss_pred cCCcccC
Q 010512 306 ADPYFHG 312 (508)
Q Consensus 306 ~hp~f~~ 312 (508)
+||||..
T Consensus 295 ~hp~f~~ 301 (434)
T 2rio_A 295 RHPLFWP 301 (434)
T ss_dssp TSGGGSC
T ss_pred hCCccCC
Confidence 9999964
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=350.89 Aligned_cols=251 Identities=23% Similarity=0.368 Sum_probs=203.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECC---CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTH---TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~---tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
.++|++.+.||+|+||+||+|.+.. ++..||+|++... ........+.+|+.+|+.++||||+++++++..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 84 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE----- 84 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----
Confidence 4789999999999999999998653 4457999998753 234456778999999999999999999999843
Q ss_pred CccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
...|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred -CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 23699999998 6999999764 46999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+....
T Consensus 164 ~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~-------- 231 (281)
T 3cc6_A 164 EDEDY--YKASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-------- 231 (281)
T ss_dssp -----------CCCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC--------
T ss_pred ccccc--cccccCCCCcceeCchhhcc--CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC--------
Confidence 33221 11234467889999999976 689999999999999999998 999998766544433332110
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.. .....+++.+.+||.+||..||.+|||+.+++++
T Consensus 232 -----------------~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 232 -----------------RL-----PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp -----------------CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CC-----CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 00 1123467899999999999999999999999973
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=351.39 Aligned_cols=255 Identities=23% Similarity=0.359 Sum_probs=203.8
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCC---CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~t---g~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
...+|++.+.||+|+||+||+|.+..+ +..||+|+++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 97 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR---- 97 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc----
Confidence 346799999999999999999997543 346999998752 344556778999999999999999999999753
Q ss_pred CCccEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 92 EFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 92 ~~~~lylV~E~~~g-~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
..+..|+||||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 98 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 98 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred CCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccc
Confidence 23568999999984 999999764 4689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCC-CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChH
Q 010512 170 SFNDAP-SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 170 ~~~~~~-~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
...... .........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~------ 249 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR------ 249 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC------
T ss_pred ccccchhccccccCCCCCccccChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC------
Confidence 533221 1112344578899999999987 689999999999999999999 678888766544433322110
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.. .....+++.+.+||.+||..||.+|||+.++++
T Consensus 250 ---------------------~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 250 ---------------------RL---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp ---------------------CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 011346788999999999999999999999987
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=353.96 Aligned_cols=255 Identities=25% Similarity=0.424 Sum_probs=196.4
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 13 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 13 ~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
+...++|++.+.||+|+||.||+|.+..+|..||||++... .........+.+|+.+|+.++||||+++++++..
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 103 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE---- 103 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----
Confidence 44557899999999999999999999999999999999753 2334456778899999999999999999999853
Q ss_pred CCccEEEEEecCCc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccc
Q 010512 92 EFKDIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 166 (508)
Q Consensus 92 ~~~~lylV~E~~~g-~L~~~i~~----~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGl 166 (508)
.+.+|+||||+++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 104 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 104 -DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 182 (310)
T ss_dssp -TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--
T ss_pred -CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccc
Confidence 3568999999984 99998864 45699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChH--HHHHHHHhhcCCC
Q 010512 167 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV--HQLDLMTDLLGTP 244 (508)
Q Consensus 167 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~--~~l~~i~~~~g~p 244 (508)
+........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... .....+.
T Consensus 183 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------ 251 (310)
T 2wqm_A 183 GRFFSSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------ 251 (310)
T ss_dssp -------------------CCSSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHH------
T ss_pred eeeecCCCc---cccccCCCeeEeChHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhh------
Confidence 986433221 1234579999999999987 68999999999999999999999999764321 1111110
Q ss_pred ChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.. ...+ .....+++.+.+||.+||..||.+|||+.++++
T Consensus 252 ------------------~~-~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 252 ------------------QC-DYPP----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp ------------------TT-CSCC----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------cc-cCCC----CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 0001 112457889999999999999999999999997
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=362.34 Aligned_cols=250 Identities=25% Similarity=0.382 Sum_probs=203.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEE--EEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERV--AIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~v--AIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~ 92 (508)
.++|++.+.||+|+||.||+|++..+|..+ |||.++.. ........+.+|+.+|+.+ +||||+++++++. .
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~ 97 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----H 97 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----E
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeee-----e
Confidence 378999999999999999999999888865 99998643 2233456788999999999 8999999999984 3
Q ss_pred CccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC
Q 010512 93 FKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 155 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~ 155 (508)
.+.+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 177 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence 456999999997 59999998654 6999999999999999999999999999999999999999
Q ss_pred CCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 010512 156 DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQL 234 (508)
Q Consensus 156 ~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l 234 (508)
++.+||+|||+++...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.....
T Consensus 178 ~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~ 251 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251 (327)
T ss_dssp GGCEEECCTTCEESSCEEC----CC----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred CCeEEEcccCcCccccccc----cccCCCCCccccChhhhcc--ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH
Confidence 9999999999997432111 1233467889999999976 678999999999999999998 99999887754433
Q ss_pred HHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 235 DLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 235 ~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
..+.. .... .....+++.+.+||.+||..||.+|||+++++++
T Consensus 252 ~~~~~---------------------------~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 252 EKLPQ---------------------------GYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHGGG---------------------------TCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhc---------------------------CCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 32211 1000 1123567899999999999999999999999984
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=348.55 Aligned_cols=253 Identities=26% Similarity=0.391 Sum_probs=203.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCc---EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~---~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
-+|.+.+.||+|+||+||+|.+..++. .||+|++... ........+.+|+.+|+.++||||+++++++....
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 95 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE---- 95 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----
Confidence 467888999999999999999765544 8999999752 33445677899999999999999999999995432
Q ss_pred ccEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 94 KDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
...|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 33589999997 799999987 4568999999999999999999999999999999999999999999999999998543
Q ss_pred CCCC-CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 172 NDAP-SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 172 ~~~~-~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
.... .........+|+.|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-------- 245 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQT--YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR-------- 245 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTT--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC--------
T ss_pred CCcccccccCcCCCCCccccChhhhcc--CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC--------
Confidence 2211 1112234578899999999987 689999999999999999999 556676665544433332211
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.. .....+++.+.+||.+||..||.+|||+.++++
T Consensus 246 -------------------~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 246 -------------------RL---PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp -------------------CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CC---CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 00 112346788999999999999999999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=365.63 Aligned_cols=257 Identities=12% Similarity=0.160 Sum_probs=201.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC--------CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceee-----
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHT--------GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK----- 82 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~t--------g~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~----- 82 (508)
.++|++.+.||+|+||.||+|.+..+ ++.||||++... ..+.+|+.+|+.++||||++++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 57999999999999999999999874 889999998642 3577999999999999999843
Q ss_pred ----------eeecCCCcCCCccEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCc
Q 010512 83 ----------HIMLPPSRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 150 (508)
Q Consensus 83 ----------~v~~~~~~~~~~~lylV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeN 150 (508)
+++.. ....+|+||||++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 114 ~~~~~i~~~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N 189 (352)
T 2jii_A 114 TPLLAIPTCMGFGVH----QDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189 (352)
T ss_dssp CTTCSCCCCCEEEEE----TTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred CCccCccchhhcccc----CCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence 33321 24678999999988999999986 689999999999999999999999999999999999
Q ss_pred eeeCCCC--cEEEccccccccccCCCCC----cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCC
Q 010512 151 ILANADC--KLKICDFGLARVSFNDAPS----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL 224 (508)
Q Consensus 151 ILl~~~~--~lkL~DFGla~~~~~~~~~----~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~p 224 (508)
||++.++ .+||+|||+++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--CGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999998 8999999999865332111 112244589999999999987 6899999999999999999999999
Q ss_pred CCCCC-hHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHH
Q 010512 225 FPGKN-VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 303 (508)
Q Consensus 225 F~~~~-~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~e 303 (508)
|.+.. ....+..... .+.... .........+..+++.+.+||.+||..||.+|||+++
T Consensus 268 f~~~~~~~~~~~~~~~-------------------~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 326 (352)
T 2jii_A 268 WTNCLPNTEDIMKQKQ-------------------KFVDKP--GPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAM 326 (352)
T ss_dssp TGGGTTCHHHHHHHHH-------------------HHHHSC--CCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred cccCCcCHHHHHHHHH-------------------hccCCh--hhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHH
Confidence 98754 2221111100 000000 0000011122457899999999999999999999999
Q ss_pred Hhc
Q 010512 304 ALA 306 (508)
Q Consensus 304 iL~ 306 (508)
+++
T Consensus 327 l~~ 329 (352)
T 2jii_A 327 LRN 329 (352)
T ss_dssp HHH
T ss_pred HHH
Confidence 987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=364.13 Aligned_cols=270 Identities=23% Similarity=0.320 Sum_probs=207.1
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
...++|++.+.||+|+||.||+|.+ .+|..||||++... .......+.+|+.+|+.++||||+++++++. ..
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 107 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCD-----ER 107 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECC-----CT
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CC
Confidence 3458999999999999999999986 47899999998653 2345677899999999999999999999984 34
Q ss_pred ccEEEEEecCC-ccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 94 KDIYVVFELME-SDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~----~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
+.+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 56899999998 69998886543 58999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..
T Consensus 188 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~--------- 255 (321)
T 2qkw_B 188 KGTELDQ-THLSTVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW--------- 255 (321)
T ss_dssp ECSSSSC-CCCBCCCEEETTTCCHHHHHH--CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH---------
T ss_pred ccccccc-cccccccCCCccccCHHHhcC--CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH---------
Confidence 6432221 112344579999999999977 6899999999999999999999999976543211110000
Q ss_pred HHHHhhHHHHHHHhhcccC-CCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCc
Q 010512 249 ISRIRNEKARRYLGSMRKK-QPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~ 309 (508)
.... .....+... .+.......+..+..+.+|+.+||+.||.+|||+.|+++|..
T Consensus 256 ----~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 256 ----AVES--HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp ----THHH--HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----hhhc--cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 0000 000000000 000111112234567889999999999999999999998543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=358.65 Aligned_cols=262 Identities=24% Similarity=0.411 Sum_probs=204.0
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++++.||+|+||.||+|.+..+|+.||||++.. ........+.+|+.+++.++||||+++++++.... ....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 103 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKH 103 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec--CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCc
Confidence 35789999999999999999999999999999999854 33455677889999999999999999999986321 2345
Q ss_pred cEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
.+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 7899999998 599998875 46799999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCc------ccccccccCcccccccccccc-cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC
Q 010512 170 SFNDAPSA------IFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 242 (508)
Q Consensus 170 ~~~~~~~~------~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g 242 (508)
........ .......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||...... +
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----------~ 253 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK----------G 253 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT----------T
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc----------c
Confidence 42211110 012335679999999998652 123788999999999999999999999431100 0
Q ss_pred CCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 243 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 243 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.. ...... ..... ...+.+++.+.+||.+||+.||.+|||+.+++++
T Consensus 254 ---~~---------~~~~~~---~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 254 ---DS---------VALAVQ---NQLSI---PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp ---SC---------HHHHHH---CC--C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---ch---------hhHHhh---ccCCC---CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 00 000000 00001 1124578899999999999999999999999995
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=349.59 Aligned_cols=249 Identities=28% Similarity=0.374 Sum_probs=204.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC------
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS------ 89 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~------ 89 (508)
..+|++++.||+|+||.||+|.+..+|+.||+|+++... ..+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 357999999999999999999999999999999996432 34678999999999999999999874311
Q ss_pred -----cCCCccEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEE
Q 010512 90 -----RREFKDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 161 (508)
Q Consensus 90 -----~~~~~~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL 161 (508)
......+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 122456899999999 4999999764 57999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Q 010512 162 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 241 (508)
Q Consensus 162 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~ 241 (508)
+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ...
T Consensus 164 ~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~------- 228 (284)
T 2a19_B 164 GDFGLVTSLKNDG----KRTRSKGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETS--KFF------- 228 (284)
T ss_dssp CCCTTCEESSCCS----CCCCCCSCCTTSCHHHHHC--SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHH-------
T ss_pred Ccchhheeccccc----cccccCCcccccChhhhcc--CCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHH-------
Confidence 9999998654322 1244679999999999987 678999999999999999999998873210 000
Q ss_pred CCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010512 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 242 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~ 311 (508)
.. ..... ....+++.+.+||.+||..||.+|||+.|+++|.|.-
T Consensus 229 ----------------~~----~~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 229 ----------------TD----LRDGI------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp ----------------HH----HHTTC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------------HH----hhccc------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00 00000 1134678899999999999999999999999998864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=379.55 Aligned_cols=249 Identities=21% Similarity=0.406 Sum_probs=208.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
..+|++.+.||+|+||.||+|.+..++..||||+++... .....+.+|+.+|+.++||||+++++++.. ...
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~ 290 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPP 290 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSS
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCc
Confidence 467999999999999999999999999999999997532 235678999999999999999999999943 356
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 96 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
+|||||||. |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 899999998 7999999864 4589999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
... .......+|..|+|||++.+ ..|+.++|||||||++|+|++ |..||++.+.......+...
T Consensus 371 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~----------- 435 (495)
T 1opk_A 371 DTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD----------- 435 (495)
T ss_dssp CCE--ECCTTCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-----------
T ss_pred Cce--eecCCCcCCcceeCHhHHhc--CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----------
Confidence 221 11233456788999999986 689999999999999999999 99999987754443332211
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
... .....+++.+.+||.+||+.||.+|||+.++++
T Consensus 436 ----------------~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 436 ----------------YRM---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ----------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCC---CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 000 112357889999999999999999999999987
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=362.04 Aligned_cols=271 Identities=20% Similarity=0.305 Sum_probs=205.6
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
...++|++.+.||+|+||.||+|.+ .+|..||||++...... .....+.+|+.+++.++||||+++++++.. .
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 99 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMT-----P 99 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECC-----S
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEec-----C
Confidence 4568999999999999999999975 46899999999753221 122358899999999999999999999954 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHhHhc---CceecCCCCCceeeCCCCcEEEcccc
Q 010512 94 KDIYVVFELME-SDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHTA---NVFHRDLKPKNILANADCKLKICDFG 165 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~----~l~~~~~~~i~~Qil~aL~yLHs~---gIiHrDLKPeNILl~~~~~lkL~DFG 165 (508)
...|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 45799999998 59999998643 499999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhh
Q 010512 166 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN-----VVHQLDLMTDL 240 (508)
Q Consensus 166 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~-----~~~~l~~i~~~ 240 (508)
+++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... .......+...
T Consensus 180 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 180 LAKLMDYKDT--HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp SCEECCSSSS--CEECCCCSCGGGCCHHHHHH--SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cccccCcccc--cccccccCCcCccCHHHhcc--CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9986533222 22345679999999999977 678999999999999999999999995211 11111111111
Q ss_pred cCCCChHHHHHHhhHHHHHHHhhcccCCCCCC-CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 241 LGTPSTESISRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 241 ~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
+..... ........ .......+..+.+|+.+||+.||.+|||+.++++|-.-.++
T Consensus 256 ~~~~~~------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 256 LKEKKL------------------EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TSSCCS------------------TTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred hhchhh------------------hhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 000000 00000000 01112234678999999999999999999999998765444
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=345.18 Aligned_cols=247 Identities=25% Similarity=0.380 Sum_probs=205.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++++.||+|+||.||+|.+. ++..||||+++.... ....+.+|+.+|+.++||||+++++++.. +.
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 81 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EP 81 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcC------CC
Confidence 478999999999999999999975 577899999975332 35678899999999999999999999842 34
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 96 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 799999997 69999986543 699999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+....
T Consensus 162 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~---------- 227 (279)
T 1qpc_A 162 NEY--TAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---------- 227 (279)
T ss_dssp SCE--ECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----------
T ss_pred ccc--ccccCCCCccCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc----------
Confidence 221 12234567889999999976 678999999999999999999 999998877654443332110
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.. .....+++.+.+||.+||..||.+|||+.++++
T Consensus 228 -----------------~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 228 -----------------RM---VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp -----------------CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CC---CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 112356789999999999999999999999987
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=370.92 Aligned_cols=244 Identities=23% Similarity=0.383 Sum_probs=202.6
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++.+.||+|+||.||+|.+. |..||||+++... ....+.+|+.+|+.++||||+++++++... ..
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~ 260 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KG 260 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT----TS
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC----CC
Confidence 3478999999999999999999874 7899999997532 356788999999999999999999998543 23
Q ss_pred cEEEEEecCC-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~--l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
.+|||||||+ |+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 6899999998 699999987543 7999999999999999999999999999999999999999999999999998542
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.. .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||++.+..+.+..+...
T Consensus 341 ~~------~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~---------- 402 (450)
T 1k9a_A 341 ST------QDTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---------- 402 (450)
T ss_dssp ------------CCCTTTSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT----------
T ss_pred cc------ccCCCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC----------
Confidence 21 122367889999999987 689999999999999999998 99999876654433332211
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
... .....+++.+.+||.+||..||.+|||+.++++
T Consensus 403 -----------------~~~---~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 403 -----------------YKM---DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp -----------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 000 112457899999999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=386.62 Aligned_cols=246 Identities=22% Similarity=0.314 Sum_probs=202.2
Q ss_pred eeeeecCceEEEEEEE--CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccEEEEE
Q 010512 23 EVIGKGSYGVVGSAVD--THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~--~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~ 100 (508)
+.||+|+||+||+|.+ ..++..||||+++...........+.+|+.+|+.++||||+++++++.. ..+|+||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence 4899999999999954 5677899999998765555567889999999999999999999999842 3479999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCccc
Q 010512 101 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 179 (508)
Q Consensus 101 E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~ 179 (508)
|||. |+|.+++.....+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus 449 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 449 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred EccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 9998 699999998889999999999999999999999999999999999999999999999999999876443322222
Q ss_pred ccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHH
Q 010512 180 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 258 (508)
Q Consensus 180 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 258 (508)
.+...+|+.|+|||++.+ ..|+.++|||||||++|+|++ |+.||.+.+.......+....
T Consensus 529 ~~~~~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~----------------- 589 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE----------------- 589 (635)
T ss_dssp ------CGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----------------
T ss_pred ccCCCCceeeeChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence 344567889999999976 689999999999999999998 999999887655544443211
Q ss_pred HHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 259 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 259 ~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.. .....+++.+.+||.+||..||.+|||++++++
T Consensus 590 ----------~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 590 ----------RM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ----------CC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------CC---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 00 112357889999999999999999999999976
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=374.39 Aligned_cols=259 Identities=18% Similarity=0.187 Sum_probs=197.6
Q ss_pred ccCCCC-CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCC-CCcce--------
Q 010512 12 EYGEAS-RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRH-PDIVE-------- 80 (508)
Q Consensus 12 ~~~~~~-rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~H-pnIv~-------- 80 (508)
+.+... .|.+.++||+|+||+||+|.+..+|+.||||+++... ........+.+|+.+++.+.| .|+..
T Consensus 72 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~ 151 (413)
T 3dzo_A 72 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151 (413)
T ss_dssp SSSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred cCCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence 444443 4899999999999999999999999999999987332 222335678899999999987 32211
Q ss_pred -eeeeecC------------CCcCCCccEEEEEecCCccHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHhHhcC
Q 010512 81 -IKHIMLP------------PSRREFKDIYVVFELMESDLHQVIKA-------NDDLTPEHYQFFLYQLLRGLKYIHTAN 140 (508)
Q Consensus 81 -l~~v~~~------------~~~~~~~~lylV~E~~~g~L~~~i~~-------~~~l~~~~~~~i~~Qil~aL~yLHs~g 140 (508)
..++... ........++++|+++.++|.+++.. ...+++..+..++.||+.||.|||++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 231 (413)
T 3dzo_A 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 231 (413)
T ss_dssp CCCEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cchhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 1111111 00011335789999999999988851 234788889999999999999999999
Q ss_pred ceecCCCCCceeeCCCCcEEEccccccccccCCCCCcccccccccCccccccccccc--------ccCCCCcchhhhhHH
Q 010512 141 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS--------FFSKYTPAIDIWSIG 212 (508)
Q Consensus 141 IiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--------~~~~y~~~~DIWSlG 212 (508)
|+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++.+ ....|+.++||||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 999999999999999999999999998764221 345678 99999999831 115688899999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 010512 213 CIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLA 292 (508)
Q Consensus 213 ~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~ 292 (508)
|++|+|++|+.||.+.+....... .......+++.+.+||.+||.
T Consensus 305 vil~elltg~~Pf~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~li~~~l~ 349 (413)
T 3dzo_A 305 LAIYWIWCADLPNTDDAALGGSEW-----------------------------------IFRSCKNIPQPVRALLEGFLR 349 (413)
T ss_dssp HHHHHHHHSSCCCCTTGGGSCSGG-----------------------------------GGSSCCCCCHHHHHHHHHHTC
T ss_pred HHHHHHHHCCCCCCCcchhhhHHH-----------------------------------HHhhcccCCHHHHHHHHHHcc
Confidence 999999999999987553211100 011223567999999999999
Q ss_pred CCCCCCCCHHHHhcCCcccC
Q 010512 293 FDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 293 ~DP~~Rpta~eiL~hp~f~~ 312 (508)
.||.+|||+.++|+||||+.
T Consensus 350 ~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 350 YPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp SSGGGSCCHHHHTTSHHHHH
T ss_pred CChhhCcCHHHHHhCHHHHH
Confidence 99999999999999999964
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=371.99 Aligned_cols=247 Identities=25% Similarity=0.402 Sum_probs=205.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++.+.||+|+||.||+|.+. ++..||||+++... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------~~ 256 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EP 256 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC------Cc
Confidence 468999999999999999999885 57889999997532 246778999999999999999999999842 35
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 96 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
+|+|||||. |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 799999998 6999999754 3689999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.. ........+|..|+|||++.. ..|+.++|||||||++|||++ |+.||++.+..+.+..+.....
T Consensus 337 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~--------- 403 (454)
T 1qcf_A 337 NE--YTAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR--------- 403 (454)
T ss_dssp HH--HHTTCSSSSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC---------
T ss_pred Cc--eeccCCCcccccccCHHHhcc--CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 11 111223456788999999976 689999999999999999999 9999998776555444332110
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.+ ....+++.+.+||.+||..||.+|||++++++
T Consensus 404 ----------------~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 404 ----------------MP-----RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ----------------CC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CC-----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 01 11356789999999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=356.18 Aligned_cols=269 Identities=24% Similarity=0.362 Sum_probs=206.1
Q ss_pred CCCe-EEeeeeeecCceEEEEEE----ECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 16 ASRY-QIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 16 ~~rY-~i~~~LG~G~~g~V~~a~----~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
.++| ++++.||+|+||+||+|. +..+|+.||||+++.. ........+.+|+.+|+.++||||+++++++...
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 105 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA-- 105 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC--
Confidence 4556 999999999999997774 4568999999999754 3344567789999999999999999999998643
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 91 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
....+|+||||++ ++|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 106 -~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 106 -GAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp -TTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred -CCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 2356899999998 5999998765 499999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
...............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-----~~~~~~~~~~~~- 255 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKE--YKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-----FLELIGIAQGQM- 255 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-----HHHHHCSCCHHH-
T ss_pred ccccccccccccCCCCCceeeChHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCcccccchh-----hhhhhcccccch-
Confidence 6443322222345578899999999987 67889999999999999999999999653211 111111111111
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
........+......+ ....+++.+.+||.+||..||.+|||+.++++
T Consensus 256 ------~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 256 ------TVLRLTELLERGERLP---RPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp ------HHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------hHHHHHHHHhcccCCC---CCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0011111111111111 22467899999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=349.90 Aligned_cols=258 Identities=22% Similarity=0.338 Sum_probs=200.6
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECC-CCc--EEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecC
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTH-TGE--RVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLP 87 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~-tg~--~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~ 87 (508)
..-..++|++++.||+|+||+||+|.+.. ++. .||||+++.... .......+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 34556899999999999999999998643 333 699999875432 33456778999999999999999999999854
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccc
Q 010512 88 PSRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 165 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFG 165 (508)
. ..++||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 93 ~------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg 166 (291)
T 1u46_A 93 P------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG 166 (291)
T ss_dssp S------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred C------CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccc
Confidence 2 3799999998 6999998764 569999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCC
Q 010512 166 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTP 244 (508)
Q Consensus 166 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p 244 (508)
++.................+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---- 240 (291)
T 1u46_A 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE---- 240 (291)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS----
T ss_pred ccccccccccchhhhccCCCCceeeCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc----
Confidence 99876443322222334567889999999977 678999999999999999999 99999887765444333211
Q ss_pred ChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.... .....++..+.+||.+||..||.+|||+.++++
T Consensus 241 ----------------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 241 ----------------------GERL---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp ----------------------CCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCC---CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0000 112457899999999999999999999999998
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=346.17 Aligned_cols=244 Identities=22% Similarity=0.383 Sum_probs=196.8
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++.+.||+|+||.||+|.+ +|..||||+++.. .....+.+|+.+++.++||||+++++++... .+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~ 88 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KG 88 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CC
Confidence 348999999999999999999986 4889999998642 2456788999999999999999999997542 24
Q ss_pred cEEEEEecCCc-cHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 95 DIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 95 ~lylV~E~~~g-~L~~~i~~~~~--l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
.+|+||||+++ +|.+++...+. +++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 68999999985 99999986543 8999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.. .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus 169 ~~------~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~----------- 229 (278)
T 1byg_A 169 ST------QDTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----------- 229 (278)
T ss_dssp -------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-----------
T ss_pred cc------ccCCCccccccCHHHhCC--CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----------
Confidence 22 123467889999999977 689999999999999999998 9999987665443332211
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
... ......+++.+.+||.+||..||.+|||+.++++
T Consensus 230 ----------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 230 ----------------GYK---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ----------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCC---CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 000 1122457899999999999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=352.49 Aligned_cols=268 Identities=23% Similarity=0.314 Sum_probs=206.2
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc--CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 89 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~--~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 89 (508)
.|.....|...+.||+|+||+||+|.+ ++..||||++.... ........+.+|+.+|+.++||||+++++++..
T Consensus 26 ~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 101 (307)
T 2nru_A 26 NFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-- 101 (307)
T ss_dssp TTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec--
Confidence 456666777789999999999999975 68899999997532 233446778999999999999999999999843
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccc
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKA---NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 165 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~---~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFG 165 (508)
...+|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 102 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg 178 (307)
T 2nru_A 102 ---GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFG 178 (307)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred ---CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecc
Confidence 356899999997 699999874 3469999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC
Q 010512 166 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245 (508)
Q Consensus 166 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~ 245 (508)
+++....... ........||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+....+..+........
T Consensus 179 ~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 254 (307)
T 2nru_A 179 LARASEKFAQ-TVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEE 254 (307)
T ss_dssp TCEECCSCSS-CEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTS
T ss_pred cccccccccc-cccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhh
Confidence 9986533222 122344679999999999875 588999999999999999999999987654332222211100000
Q ss_pred hHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 246 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
. ....++. ..+.......+..+.+|+.+||..||.+|||+.++++
T Consensus 255 ~---------~~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 255 K---------TIEDYID-------KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp C---------CHHHHSC-------SSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred h---------hhhhhcc-------ccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0 0001100 0011111233466889999999999999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=368.25 Aligned_cols=272 Identities=23% Similarity=0.370 Sum_probs=206.5
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
...++|++.+.||+|+||+||+|++..+|+.||||+++.... ......+.+|+.+|+.++||||+++++++.... .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~ 81 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---T 81 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---T
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---C
Confidence 456899999999999999999999999999999999975322 233566789999999999999999999986532 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceee----CCCCcEEEcccc
Q 010512 94 KDIYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFG 165 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl----~~~~~lkL~DFG 165 (508)
..+|+|||||+ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 46899999997 69999997643 39999999999999999999999999999999999999 778889999999
Q ss_pred ccccccCCCCCcccccccccCcccccccccccc------cCCCCcchhhhhHHHHHHHHHhCCCCCCCCCh----HHHHH
Q 010512 166 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV----VHQLD 235 (508)
Q Consensus 166 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~------~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~----~~~l~ 235 (508)
+++...... .....+||+.|+|||++.+. ...|+.++|||||||++|+|++|+.||.+... ...+.
T Consensus 162 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 162 AARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp GCEECCCGG----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred CceEccCCC----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 998653321 23456799999999998531 13578899999999999999999999965331 22222
Q ss_pred HHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCC-------CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 236 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSH-------KFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 236 ~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-------~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.+.. +.|.. .+..+.. ....+..|.. ....+++.+.+||.+||++||.+|||+.++++
T Consensus 238 ~~~~--~~p~~-~~~~~~~----------~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 238 KIIT--GKPSG-AISGVQK----------AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHHH--SCCTT-CCEEEEC----------STTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred HHhc--CCCcc-cchhhee----------ccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 2211 12211 0000000 0000111111 11234567889999999999999999999865
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=347.52 Aligned_cols=246 Identities=26% Similarity=0.413 Sum_probs=193.1
Q ss_pred ccCCCCCeEEe-eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHH-HhCCCCCcceeeeeecCCC
Q 010512 12 EYGEASRYQIQ-EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL-RLLRHPDIVEIKHIMLPPS 89 (508)
Q Consensus 12 ~~~~~~rY~i~-~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL-~~L~HpnIv~l~~v~~~~~ 89 (508)
.....++|.+. +.||+|+||.||+|.+..+|+.||||++.. ...+.+|+.++ +.++||||+++++++....
T Consensus 12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 84 (299)
T 3m2w_A 12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY 84 (299)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence 34556789888 789999999999999999999999999853 23567899888 6678999999999985311
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC---CCcEEEcc
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICD 163 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~---~~~lkL~D 163 (508)
.....+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 85 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 85 -AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp -TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred -CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 22456899999998 59999998764 6999999999999999999999999999999999999998 78899999
Q ss_pred ccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC
Q 010512 164 FGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 243 (508)
Q Consensus 164 FGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~ 243 (508)
||++.... + ..|+.++|||||||++|+|++|++||.+.+.......+..
T Consensus 164 fg~a~~~~-------------------------~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~---- 212 (299)
T 3m2w_A 164 FGFAKETT-------------------------G--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT---- 212 (299)
T ss_dssp CTTCEECT-------------------------T--CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC----
T ss_pred cccccccc-------------------------c--ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH----
Confidence 99886421 1 3578899999999999999999999976553221100000
Q ss_pred CChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 244 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 244 p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
.............+..+++.+.+||.+||..||.+|||+.|+|+||||.+...
T Consensus 213 -------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 213 -------------------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp -------------------SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred -------------------HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 00000000001112467899999999999999999999999999999986543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=363.22 Aligned_cols=254 Identities=22% Similarity=0.358 Sum_probs=195.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCC---CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~t---g~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
.+|++.+.||+|+||+||+|.+..+ +..||+|.++.. ........+.+|+.+|+.++||||+++++++... .
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~ 163 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----E 163 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----S
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----C
Confidence 4689999999999999999987543 346899998753 3345667899999999999999999999987532 2
Q ss_pred ccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 94 KDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
+..|+||||++ |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 45799999998 5999999865 458999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCC-cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 172 NDAPS-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 172 ~~~~~-~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
..... ....+...+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~--------- 312 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--------- 312 (373)
T ss_dssp --------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT---------
T ss_pred ccccccccccCCCCCcccccChHHhcC--CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC---------
Confidence 32211 112234567889999999987 689999999999999999999 78899876644333222110
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
... .....+++.+.+||.+||..||.+|||+.+++++
T Consensus 313 ------------------~~~---~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 313 ------------------RRL---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp ------------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 0113467889999999999999999999999873
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=347.59 Aligned_cols=243 Identities=29% Similarity=0.436 Sum_probs=193.7
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++.+.||+|+||+||+|.+. ++.||||++.. ......+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------- 72 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACLN------- 72 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------
Confidence 3468999999999999999999874 78999999863 2345678899999999999999999998742
Q ss_pred cEEEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhHh---cCceecCCCCCceeeCCCCc-EEEccccc
Q 010512 95 DIYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHT---ANVFHRDLKPKNILANADCK-LKICDFGL 166 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~Qil~aL~yLHs---~gIiHrDLKPeNILl~~~~~-lkL~DFGl 166 (508)
..|+||||++ ++|.+++.... .+++..+..++.||++||.|||+ +||+||||||+|||++.++. +||+|||+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence 3699999998 59999998765 37899999999999999999999 89999999999999998887 79999999
Q ss_pred cccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCh
Q 010512 167 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246 (508)
Q Consensus 167 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 246 (508)
+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............
T Consensus 153 ~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--------- 215 (307)
T 2eva_A 153 ACDIQTH------MTNNKGSAAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW--------- 215 (307)
T ss_dssp ------------------CCTTSSCHHHHTC--CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH---------
T ss_pred ccccccc------cccCCCCCceEChhhhCC--CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH---------
Confidence 9754221 234579999999999987 68999999999999999999999999754321110000
Q ss_pred HHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 247 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
. ...... ......+++.+.+||.+||..||.+|||++++++
T Consensus 216 ------------~----~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 216 ------------A----VHNGTR---PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp ------------H----HHTTCC---CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------H----HhcCCC---CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0 000011 1123467889999999999999999999999988
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=356.47 Aligned_cols=281 Identities=22% Similarity=0.269 Sum_probs=200.1
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHH--HHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILR--EIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~--Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
-..++|++++.||+|+||+||+|.+ +|+.||||+++.. ....+.. |+..+..++||||+++++.+......
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 3458999999999999999999976 6899999998632 2233334 44445568999999999865433334
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhc---------CceecCCCCCceeeCCCCcEEE
Q 010512 92 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA---------NVFHRDLKPKNILANADCKLKI 161 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~---------gIiHrDLKPeNILl~~~~~lkL 161 (508)
....+|+|||||+ |+|.+++... .+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred CCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 4557899999997 6999999765 468999999999999999999999 9999999999999999999999
Q ss_pred ccccccccccCCCC-----CcccccccccCccccccccccccc-----CCCCcchhhhhHHHHHHHHHhCC-CCCCCCCh
Q 010512 162 CDFGLARVSFNDAP-----SAIFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNV 230 (508)
Q Consensus 162 ~DFGla~~~~~~~~-----~~~~~~~~~gT~~Y~APE~l~~~~-----~~y~~~~DIWSlG~il~eLltG~-~pF~~~~~ 230 (508)
+|||+++....... ........+||+.|+|||++.+.. ..++.++|||||||++|+|++|. ++|++...
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999986543211 112233568999999999987521 24667899999999999999996 45555442
Q ss_pred HHHHHHHH-hhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCC---CCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 231 VHQLDLMT-DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFP---NADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 231 ~~~l~~i~-~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~---~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
......+. .....+....+. ..+.. ......+...++ .+++.+.+||.+||..||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQ--------VLVSR--EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHH--------HHHTT--SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHH--------hhhcc--cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 22111111 112222222211 11111 111122222222 24567999999999999999999999955
Q ss_pred ------CCcccC
Q 010512 307 ------DPYFHG 312 (508)
Q Consensus 307 ------hp~f~~ 312 (508)
++|-++
T Consensus 312 ~L~~ll~~~~~~ 323 (336)
T 3g2f_A 312 RMAELMMIWERN 323 (336)
T ss_dssp HHHHHHHCCCC-
T ss_pred HHHHHHHHHHhc
Confidence 677654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=350.61 Aligned_cols=271 Identities=22% Similarity=0.366 Sum_probs=208.8
Q ss_pred CCCCeEEeeeeeecCceEEEEEE----ECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~----~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
..++|++++.||+|+||.||+|. +..+|+.||||++... .......+.+|+.+|+.++||||+++++++....
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 115 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG- 115 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC-
Confidence 45679999999999999999998 5678999999999753 3445677899999999999999999999986432
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
...+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 116 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 116 --RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred --CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 246899999998 5999999876 469999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
................+|..|+|||++.+ ..++.++|||||||++|+|++|..||.... . .+....+......
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~~~~~~~--~---~~~~~~~~~~~~~ 266 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPP--A---EFMRMIGNDKQGQ 266 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHHTTCGGGSHH--H---HHHHHHCTTCCTH
T ss_pred hccccccccccccCCCCceeEECchhhcC--CCCCchhhHHHHHHHHHHHHhcCCCCCCCH--H---HHHHhhccccchh
Confidence 75443322122234567888999999987 678999999999999999999999885321 1 1112222222111
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.. ....... +......+ ....+++.+.+||.+||..||.+|||+.++++
T Consensus 267 ~~---~~~~~~~---~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 267 MI---VFHLIEL---LKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HH---HHHHHHH---HHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hh---HHHHHHH---hhcCCCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 10 0011111 11111111 12467899999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=367.94 Aligned_cols=247 Identities=26% Similarity=0.395 Sum_probs=200.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++.+.||+|+||.||+|.+.. +..||||+++.... ....+.+|+.+|+.++||||+++++++.. ..
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~ 252 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 252 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cc
Confidence 4679999999999999999999864 46799999975332 34678899999999999999999999843 35
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 96 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
+|+|||||+ |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 799999998 6999999643 4699999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.... ......+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+....
T Consensus 333 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~---------- 398 (452)
T 1fmk_A 333 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---------- 398 (452)
T ss_dssp ------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----------
T ss_pred Ccee--cccCCcccccccCHhHHhc--CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 2211 1233457789999999986 689999999999999999999 999999877655444332211
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..+ ..+.+++.+.+||.+||..||.+|||++++++
T Consensus 399 ---------------~~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 399 ---------------RMP-----CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp ---------------CCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCC-----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 001 11357789999999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=369.66 Aligned_cols=260 Identities=19% Similarity=0.247 Sum_probs=204.3
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
...++|++++.||+|+||.||+|.+..+|+.||||+++..... ..+.+|+.+++.|+|++++..+..+. ...
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~----~~~ 75 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFG----VEG 75 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEE----EET
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEE----eeC
Confidence 3568999999999999999999999999999999988643322 34778999999999865555444442 234
Q ss_pred ccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceee---CCCCcEEEcccccccc
Q 010512 94 KDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARV 169 (508)
Q Consensus 94 ~~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl---~~~~~lkL~DFGla~~ 169 (508)
...||||||+.++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 76 ~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 56899999998899999985 5679999999999999999999999999999999999999 6889999999999987
Q ss_pred ccCCCCCc----ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC
Q 010512 170 SFNDAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245 (508)
Q Consensus 170 ~~~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~ 245 (508)
........ ......+||+.|+|||++.+ ..++.++||||||||+|+|++|+.||.+.........+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~------ 227 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK------ 227 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHH------
T ss_pred ccCCccccccccccccccCCCccccCHHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHH------
Confidence 54432211 11235689999999999987 6899999999999999999999999987654222222111
Q ss_pred hHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 246 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
+........+. .....+++.+.+||.+||..||.+||+++++++
T Consensus 228 ------i~~~~~~~~~~-----------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 228 ------ISEKKVATSIE-----------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp ------HHHHHHHSCHH-----------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ------HhhccccccHH-----------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11111100000 111356788999999999999999999998876
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=359.56 Aligned_cols=245 Identities=15% Similarity=0.178 Sum_probs=194.9
Q ss_pred CCCeEEeeeeeecCceEEEEE-----EECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC---CCCcceeeeeecC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSA-----VDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR---HPDIVEIKHIMLP 87 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a-----~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~v~~~ 87 (508)
.++|++.+.||+|+||+||+| .+..+++.||||+++.. ....+.+|+.+++.++ |+||+.+++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 477999999999999999999 46778999999999642 3456778888888887 8999999999954
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC------
Q 010512 88 PSRREFKDIYVVFELME-SDLHQVIKA-----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA------ 155 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~-g~L~~~i~~-----~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~------ 155 (508)
.+..|+|||||+ |+|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++.
T Consensus 139 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 139 -----QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp -----SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred -----CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence 345899999998 799999974 457999999999999999999999999999999999999998
Q ss_pred -----CCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCCh
Q 010512 156 -----DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV 230 (508)
Q Consensus 156 -----~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~ 230 (508)
++.+||+|||+|+...... .....+..+||++|+|||++.+ ..|+.++|||||||++|+|++|+.||.....
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFP-KGTIFTAKCETSGFQCVEMLSN--KPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSC-TTEEECCSSCTTSCCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred ccccccCCEEEeeCchhhhhhccC-CCceeeeecCCCCCCChHHhcC--CCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 8999999999997643222 2223456789999999999987 6799999999999999999999999954321
Q ss_pred HHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 010512 231 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308 (508)
Q Consensus 231 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp 308 (508)
... ... ..+.. . ..++.+.+++..||..+|.+|++..+.|.+.
T Consensus 291 ~~~-----------------------------~~~----~~~~~-~-~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 291 GEC-----------------------------KPE----GLFRR-L-PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp TEE-----------------------------EEC----SCCTT-C-SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred Cce-----------------------------eec----hhccc-c-CcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 000 000 00000 0 1356788999999999999997655555533
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=378.51 Aligned_cols=252 Identities=22% Similarity=0.339 Sum_probs=201.0
Q ss_pred CCCeEEee-eeeecCceEEEEEEEC--CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 16 ASRYQIQE-VIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 16 ~~rY~i~~-~LG~G~~g~V~~a~~~--~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
..+|.+.+ .||+|+||.||+|.+. .++..||||+++... .......+.+|+++|+.++||||+++++++..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----- 407 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----- 407 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-----
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-----
Confidence 45666666 8999999999999875 356789999997542 23456789999999999999999999999853
Q ss_pred CccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
..+|+|||||. |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 34899999998 6999998754 46999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
..............+|+.|+|||++.+ ..|+.++|||||||++|||++ |+.||.+.+..+....+...
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~--------- 555 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--------- 555 (613)
T ss_dssp C--------------CCTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT---------
T ss_pred cCCCceeeeccCCCCccceeCHhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---------
Confidence 332221111223346689999999976 689999999999999999998 99999987765544433221
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
... .....+++.+.+||.+||..||.+|||+.++++
T Consensus 556 ------------------~~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 556 ------------------KRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp ------------------CCC---CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred ------------------CCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 001 112357899999999999999999999999854
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=350.01 Aligned_cols=263 Identities=25% Similarity=0.328 Sum_probs=192.4
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHh--CCCCCcceeeeeecCCCcCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL--LRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~--L~HpnIv~l~~v~~~~~~~~ 92 (508)
..++|++++.||+|+||.||+|.+. |+.||||++... ......+|..++.. ++||||+++++++.... ..
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~ 106 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGT-GS 106 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GG
T ss_pred cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CC
Confidence 3478999999999999999999875 899999998532 23444556666555 48999999999986542 22
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhc--------CceecCCCCCceeeCCCCcEEEcc
Q 010512 93 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--------NVFHRDLKPKNILANADCKLKICD 163 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~--------gIiHrDLKPeNILl~~~~~lkL~D 163 (508)
...+|+||||++ |+|.+++... .+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred CCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 357899999998 5999999765 699999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCC-cccccccccCcccccccccccccCCCCc------chhhhhHHHHHHHHHhC----------CCCCC
Q 010512 164 FGLARVSFNDAPS-AIFWTDYVATRWYRAPELCGSFFSKYTP------AIDIWSIGCIFAEMLTG----------KPLFP 226 (508)
Q Consensus 164 FGla~~~~~~~~~-~~~~~~~~gT~~Y~APE~l~~~~~~y~~------~~DIWSlG~il~eLltG----------~~pF~ 226 (508)
||+++........ .......+||+.|+|||++.+ ..++. ++|||||||++|+|++| +.||.
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE--SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTT--CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhccc--ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999765332221 111235689999999999976 34444 39999999999999999 66665
Q ss_pred CCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 227 GKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 227 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..... .+.... ..............+.......+++.+.+||.+||+.||.+|||+.++++
T Consensus 264 ~~~~~-----------~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (337)
T 3mdy_A 264 DLVPS-----------DPSYED--------MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324 (337)
T ss_dssp TTSCS-----------SCCHHH--------HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhcCC-----------CCchhh--------hHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence 43210 001000 00111000001111100011234567899999999999999999999998
Q ss_pred C
Q 010512 307 D 307 (508)
Q Consensus 307 h 307 (508)
|
T Consensus 325 ~ 325 (337)
T 3mdy_A 325 T 325 (337)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=390.41 Aligned_cols=280 Identities=25% Similarity=0.343 Sum_probs=211.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC-cCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~-~~~~~ 94 (508)
.++|++.+.||+|+||+||+|.+..+|+.||||+++.. ........+.+|+.+|+.++||||+++++++.... .....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 37899999999999999999999999999999998753 33455677899999999999999999999875422 12356
Q ss_pred cEEEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCc---EEEcccccc
Q 010512 95 DIYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLA 167 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~---lkL~DFGla 167 (508)
..|+|||||+ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 7899999997 69999998754 6999999999999999999999999999999999999997765 999999999
Q ss_pred ccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChH
Q 010512 168 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 168 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......+... .......
T Consensus 172 ~~~~~~~----~~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~---i~~~~~~ 242 (676)
T 3qa8_A 172 KELDQGE----LCTEFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK---VREKSNE 242 (676)
T ss_dssp CBTTSCC----CCCCCCSCCTTCSSCSSCC--SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT---CC-----
T ss_pred ccccccc----ccccccCCcccCChHHhcc--CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh---hhcccch
Confidence 8653322 2345689999999999987 78999999999999999999999999875433221100 0000000
Q ss_pred HHHHHhhHHHHHHHhhcccC-----CCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 248 SISRIRNEKARRYLGSMRKK-----QPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.+ ......... .........+.+++.+.+||.+||.+||.+|||+.++|+||||+.+.
T Consensus 243 ~~---------~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~ 305 (676)
T 3qa8_A 243 HI---------VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305 (676)
T ss_dssp -C---------CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred hh---------hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence 00 000000000 00011122334678899999999999999999999999999998654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=371.11 Aligned_cols=247 Identities=26% Similarity=0.392 Sum_probs=204.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++.+.||+|+||.||+|.+.. +..||||+++.... ....+.+|+.+|+.|+||||+++++++.. ..
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~ 335 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 335 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee------cc
Confidence 4689999999999999999999864 46799999975332 34678999999999999999999999843 45
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 96 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
+|||||||. |+|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 899999998 5999999643 4699999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.. ........+|..|+|||++.+ ..|+.++|||||||++|+|++ |+.||.+....+.+..+....
T Consensus 416 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~---------- 481 (535)
T 2h8h_A 416 NE--YTARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---------- 481 (535)
T ss_dssp HH--HHTTCSTTSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC----------
T ss_pred Cc--eecccCCcCcccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 11 111223456788999999986 689999999999999999999 999999877655444332211
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
..+ ....++..+.+||.+||..||.+|||++++++
T Consensus 482 -----------------~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 482 -----------------RMP---CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp -----------------CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 001 12357788999999999999999999999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=361.95 Aligned_cols=255 Identities=18% Similarity=0.157 Sum_probs=192.2
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC------ChhHHHHHHHHHHHHHhCC---------CCCc
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE------HVSDATRILREIKLLRLLR---------HPDI 78 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~------~~~~~~~i~~Ei~iL~~L~---------HpnI 78 (508)
-..++|++++.||+|+||+||+|++ +|+.||||+++.... .......+.+|+.+|+.++ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3457899999999999999999987 789999999975432 2233477889999999886 7777
Q ss_pred ceeeeeecCCC-------------------------cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHH
Q 010512 79 VEIKHIMLPPS-------------------------RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRG 132 (508)
Q Consensus 79 v~l~~v~~~~~-------------------------~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~a 132 (508)
+++.+++.... ......+|||||||. |++.+.+.. ..+++..++.++.||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 77776643110 012567999999997 556555543 568999999999999999
Q ss_pred HHHhH-hcCceecCCCCCceeeCCCC--------------------cEEEccccccccccCCCCCcccccccccCccccc
Q 010512 133 LKYIH-TANVFHRDLKPKNILANADC--------------------KLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 191 (508)
Q Consensus 133 L~yLH-s~gIiHrDLKPeNILl~~~~--------------------~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~A 191 (508)
|.||| ++||+||||||+|||++.++ .+||+|||+|+.... ...+||+.|+|
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------~~~~gt~~y~a 245 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------GIVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------TEEECCCCTTC
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------CcEEEeecccC
Confidence 99999 99999999999999999987 899999999986532 23489999999
Q ss_pred ccccccccCCCCcchhhhhHHHH-HHHHHhCCCCCCCCChHH-HHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCC
Q 010512 192 PELCGSFFSKYTPAIDIWSIGCI-FAEMLTGKPLFPGKNVVH-QLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQP 269 (508)
Q Consensus 192 PE~l~~~~~~y~~~~DIWSlG~i-l~eLltG~~pF~~~~~~~-~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~ 269 (508)
||++.+ .. +.++||||+|++ .++++.|..||.+..... ....+. .... ...
T Consensus 246 PE~~~g--~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~-----------------------~~~~-~~~ 298 (336)
T 2vuw_A 246 EDLFTG--DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKML-----------------------KQMT-FKT 298 (336)
T ss_dssp SGGGCC--CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHH-----------------------HTCC-CSS
T ss_pred hhhhcC--CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhh-----------------------hhhc-cCc
Confidence 999987 33 889999998777 777888999985321111 111111 0000 011
Q ss_pred CCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHh-cCCccc
Q 010512 270 VPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL-ADPYFH 311 (508)
Q Consensus 270 ~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL-~hp~f~ 311 (508)
......++.+++.+.+||.+||++| |++|+| +||||+
T Consensus 299 ~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 299 KCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp CCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred ccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 1111122345788999999999987 999999 999995
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=348.01 Aligned_cols=264 Identities=21% Similarity=0.274 Sum_probs=205.0
Q ss_pred ccccC-CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCC
Q 010512 10 FTEYG-EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 88 (508)
Q Consensus 10 ~~~~~-~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 88 (508)
..+|. ..++|++.+.||+|+||.||+|.+.. .||+|+++...........+.+|+.+++.++||||+++++++..
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 100 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS- 100 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-
Confidence 34553 34899999999999999999998754 49999997554444444567789999999999999999999954
Q ss_pred CcCCCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccc
Q 010512 89 SRREFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 166 (508)
Q Consensus 89 ~~~~~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGl 166 (508)
...+|+||||++ ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+
T Consensus 101 ----~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 101 ----PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp ----SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred ----CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCC
Confidence 345999999998 69999997754 699999999999999999999999999999999999998 78999999999
Q ss_pred cccccCCCC--CcccccccccCcccccccccccc-------cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 010512 167 ARVSFNDAP--SAIFWTDYVATRWYRAPELCGSF-------FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLM 237 (508)
Q Consensus 167 a~~~~~~~~--~~~~~~~~~gT~~Y~APE~l~~~-------~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i 237 (508)
++....... .........||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+.......+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 255 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 876422111 11123345699999999998642 145889999999999999999999999887754443333
Q ss_pred HhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 238 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 238 ~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
... ..+. .....++..+.+||.+||..||.+|||+.++++ .++.+
T Consensus 256 ~~~--------------------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l 300 (319)
T 2y4i_B 256 GTG--------------------------MKPN---LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKL 300 (319)
T ss_dssp HTT--------------------------CCCC---CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC
T ss_pred ccC--------------------------CCCC---CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHH
Confidence 211 0000 111246778999999999999999999999998 55444
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=345.50 Aligned_cols=262 Identities=24% Similarity=0.307 Sum_probs=198.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHh--CCCCCcceeeeeecCCCcCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL--LRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~--L~HpnIv~l~~v~~~~~~~~~ 93 (508)
.++|++.+.||+|+||.||+|.+ +|+.||||+++. .....+.+|+.+++. ++||||+++++++.... ...
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc-----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-Ccc
Confidence 46899999999999999999987 589999999863 234567889999988 78999999999986543 223
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhH--------hcCceecCCCCCceeeCCCCcEEEccc
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH--------TANVFHRDLKPKNILANADCKLKICDF 164 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLH--------s~gIiHrDLKPeNILl~~~~~lkL~DF 164 (508)
..+|+||||++ |+|.+++... .+++..+..++.||+.||.||| +.||+||||||+|||++.++.+||+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred ceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 47999999998 5999999764 6999999999999999999999 899999999999999999999999999
Q ss_pred cccccccCCCCCc-ccccccccCcccccccccccccC----CCCcchhhhhHHHHHHHHHhC----------CCCCCCCC
Q 010512 165 GLARVSFNDAPSA-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEMLTG----------KPLFPGKN 229 (508)
Q Consensus 165 Gla~~~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~----~y~~~~DIWSlG~il~eLltG----------~~pF~~~~ 229 (508)
|++.......... .......||+.|+|||++.+... .++.++|||||||++|+|++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 9998654332211 12345689999999999876211 233789999999999999999 67876542
Q ss_pred hHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 230 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF--PNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 230 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.. .+....+ ...+. .......+...+ ..++..+.+||.+||..||.+|||+.++++|
T Consensus 272 ~~-----------~~~~~~~--------~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 272 PS-----------DPSVEEM--------RKVVC--EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CS-----------SCCHHHH--------HHHHT--TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cC-----------cccHHHH--------HHHHH--HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 10 0000000 00000 000011111111 1234578899999999999999999999984
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=371.04 Aligned_cols=250 Identities=25% Similarity=0.420 Sum_probs=204.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC---CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~t---g~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 92 (508)
.++|++.+.||+|+||.||+|.+..+ +..||||+++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----- 462 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 462 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----
Confidence 46899999999999999999998653 567999998643 334455778999999999999999999999832
Q ss_pred CccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
+.+|+||||++ |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred -CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 34799999998 69999998654 6999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
..... .......+|+.|+|||++.+ ..|+.++|||||||++|+|++ |.+||.+.+..+.+..+...
T Consensus 542 ~~~~~--~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~--------- 608 (656)
T 2j0j_A 542 EDSTY--YKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--------- 608 (656)
T ss_dssp CC------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT---------
T ss_pred CCCcc--eeccCCCCCcceeCHHHhcC--CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---------
Confidence 33221 11233467889999999976 689999999999999999997 99999987765554443221
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
... ...+.+++.+.+||.+||..||.+|||+.++++
T Consensus 609 ------------------~~~---~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 609 ------------------ERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ------------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCC---CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 001 112457899999999999999999999999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=327.07 Aligned_cols=228 Identities=17% Similarity=0.104 Sum_probs=185.2
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
..++|++.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+++.++||||+++++++.. .
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~ 103 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----R 103 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----T
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----C
Confidence 457899999999999999999999999999999999765433 3445778999999999999999999999843 4
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
+.+|+||||++ ++|.+++... ..+.++..++.||+.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred CcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 56999999998 5999998543 5677889999999999999999999999999999999999999998543
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
|++ .++.++|||||||++|+|++|+.||.+.+....+.....
T Consensus 175 ----------------~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~------------- 216 (286)
T 3uqc_A 175 ----------------TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER------------- 216 (286)
T ss_dssp ----------------CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB-------------
T ss_pred ----------------ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH-------------
Confidence 332 378899999999999999999999988663221100000
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.....+.......+.+++.+.+||.+||+.||.+| |+.|+++
T Consensus 217 -----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 217 -----------DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp -----------CTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred -----------HhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 00011111122335678999999999999999999 9999998
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=374.96 Aligned_cols=246 Identities=25% Similarity=0.361 Sum_probs=198.6
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECC-CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTH-TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~-tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
..++|++.+.||+|+||+||+|.+.. +|+.||||++... ........+.+|+.+|+.++||||+++++++........
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 34899999999999999999999976 7999999998642 233445678899999999999999999999865432222
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
...||||||++ ++|.+++.. .+++..+..|+.||+.||.|||++||+||||||+|||++.+ .+||+|||+++....
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred ceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 33799999998 588887654 79999999999999999999999999999999999999975 999999999986432
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
. ...+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.... +.+....
T Consensus 234 ~-------~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~~~~---- 289 (681)
T 2pzi_A 234 F-------GYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPEDDP---- 289 (681)
T ss_dssp C-------SCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCTTCH----
T ss_pred C-------CccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCcccccc----------ccccccc----
Confidence 1 34679999999999875 4589999999999999999999998753210 0010000
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~ 311 (508)
....++.+.+||.+||..||.+||+..+++.|+|+.
T Consensus 290 -----------------------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 290 -----------------------VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp -----------------------HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -----------------------ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 001246788999999999999999999999998875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=314.72 Aligned_cols=186 Identities=18% Similarity=0.137 Sum_probs=133.8
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEecCccCC--------hhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCCc
Q 010512 24 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH--------VSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 24 ~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~--------~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..+.|+.|.+..++....|+.||+|++.+.... ....+++.+|+++|+++ .|+||+++++++ ++.+
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence 356788888888888788999999999653211 22345688999999999 699999999999 5567
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
.+||||||++| +|.++|...+++++. .|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 79999999995 999999999888875 47899999999999999999999999999999999999999999865332
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCC
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKP 223 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~ 223 (508)
. ...+..+||+.|||||++.+ .+..++|+||+|+++++|.+|..
T Consensus 393 ~---~~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 393 C---SWPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC--------------------CCCCTTHH
T ss_pred C---ccccCceechhhccHHHhCC---CCCCcccccccccchhhhccccc
Confidence 2 22456789999999999976 56778999999999988876643
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.8e-29 Score=267.89 Aligned_cols=189 Identities=21% Similarity=0.270 Sum_probs=142.2
Q ss_pred EEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC-h-----hHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-V-----SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 20 ~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~-~-----~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
...++||+|+||+||+| ...+..+|+|++...... . ...+++.+|+.+|+.++||||+++..+... .
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-----~ 411 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD-----L 411 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-----T
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-----C
Confidence 44679999999999999 456889999987542221 1 123457899999999999999944444332 1
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
...|||||||+ ++|.+++.. +..++.||++||.|||++||+||||||+|||++. .+||+|||+++....
T Consensus 412 ~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 412 DNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp TTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred CccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 34599999998 699999865 5789999999999999999999999999999998 999999999987533
Q ss_pred CCCCc----ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCC
Q 010512 173 DAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 225 (508)
Q Consensus 173 ~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF 225 (508)
..... ......+||+.|||||++......|+..+|+||..+-..+.+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 21110 012356899999999999765457888999999998888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-25 Score=220.27 Aligned_cols=161 Identities=18% Similarity=0.181 Sum_probs=123.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh----------------hHHHHHHHHHHHHHhCCCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV----------------SDATRILREIKLLRLLRHPDIV 79 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~----------------~~~~~i~~Ei~iL~~L~HpnIv 79 (508)
...|.+.+.||+|+||.||+|.+ .+|+.||||+++...... .....+.+|+.+|+.++ | +
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 34566779999999999999999 889999999996421110 13456889999999999 4 6
Q ss_pred eeeeeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCc
Q 010512 80 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 158 (508)
Q Consensus 80 ~l~~v~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~ 158 (508)
++.+++.. +..|+|||||+| +|.+ +. ......++.||+.||.|||++||+||||||+|||++ ++.
T Consensus 165 ~v~~~~~~------~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~ 230 (282)
T 1zar_A 165 AVPKVYAW------EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG 230 (282)
T ss_dssp SSCCEEEE------ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE
T ss_pred CcCeEEec------cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc
Confidence 66665421 346999999985 8887 31 234567999999999999999999999999999999 999
Q ss_pred EEEccccccccccCCCCCcccccccccCccccccccccc--------ccCCCCcchhhhh
Q 010512 159 LKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS--------FFSKYTPAIDIWS 210 (508)
Q Consensus 159 lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--------~~~~y~~~~DIWS 210 (508)
+||+|||+|+. +..|+|||++.+ +...|+..+|+|.
T Consensus 231 vkl~DFG~a~~----------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 231 IWIIDFPQSVE----------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp EEECCCTTCEE----------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EEEEECCCCeE----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99999999863 245789998743 0123555556654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=6.2e-22 Score=194.08 Aligned_cols=140 Identities=17% Similarity=0.145 Sum_probs=109.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcE--EEEEEecCccCCh----------------------hHHHHHHHHHHHHHh
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGER--VAIKKINDVFEHV----------------------SDATRILREIKLLRL 72 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~--vAIKki~~~~~~~----------------------~~~~~i~~Ei~iL~~ 72 (508)
.-|++.+.||+|+||.||+|.+..+|.. ||||+++...... .....+.+|+.+|+.
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 4589999999999999999998778999 9999875421110 112357899999999
Q ss_pred CCCCCcc--eeeeeecCCCcCCCccEEEEEecCC--c----cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhH-hcCcee
Q 010512 73 LRHPDIV--EIKHIMLPPSRREFKDIYVVFELME--S----DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH-TANVFH 143 (508)
Q Consensus 73 L~HpnIv--~l~~v~~~~~~~~~~~lylV~E~~~--g----~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLH-s~gIiH 143 (508)
|.|++|. .+++. ...||||||++ | .|.++... .++..+..++.||+.||.||| +.||+|
T Consensus 127 l~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givH 194 (258)
T 1zth_A 127 AKEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVH 194 (258)
T ss_dssp HHHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEEC
T ss_pred HHhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 9988652 33322 23599999995 3 67665432 345678899999999999999 999999
Q ss_pred cCCCCCceeeCCCCcEEEccccccccc
Q 010512 144 RDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 144 rDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=3.9e-18 Score=175.64 Aligned_cols=137 Identities=16% Similarity=0.164 Sum_probs=98.0
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC------------hhHH--------HHHHHHHHHHHhCCCCC
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH------------VSDA--------TRILREIKLLRLLRHPD 77 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~------------~~~~--------~~i~~Ei~iL~~L~Hpn 77 (508)
-|+|.+.||.|+||.||+|.+. +|+.||||+++..... .... ....+|...|.+|.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4999999999999999999975 7999999987532100 0000 11235677777775544
Q ss_pred cceeeeeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC
Q 010512 78 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 156 (508)
Q Consensus 78 Iv~l~~v~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~ 156 (508)
+....-+.. ...+|||||++| .|.++. .......++.||+.+|.|||.+|||||||||.|||++.+
T Consensus 175 v~vp~p~~~-------~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 175 FPVPEPIAQ-------SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE 241 (397)
T ss_dssp CSCCCEEEE-------ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE
T ss_pred CCCCeeeec-------cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC
Confidence 432211111 123799999996 664432 223456788999999999999999999999999999988
Q ss_pred Cc----------EEEccccccc
Q 010512 157 CK----------LKICDFGLAR 168 (508)
Q Consensus 157 ~~----------lkL~DFGla~ 168 (508)
+. +.|+||+-+.
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCE
T ss_pred CCcccccccccceEEEEeCCcc
Confidence 73 8899998764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=3.7e-12 Score=123.85 Aligned_cols=138 Identities=13% Similarity=0.099 Sum_probs=106.5
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ 95 (508)
..|++...++.|+.+.||++.. .|..|++|........ ....+.+|+.+|+.|. +..+.+++++.. ..+.
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~ 84 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGW 84 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCc
Confidence 3589999999999999999964 3689999998642211 1235789999999995 667778888773 2356
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh------------------------------------
Q 010512 96 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT------------------------------------ 138 (508)
Q Consensus 96 lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs------------------------------------ 138 (508)
.|+|||+++| +|.+.+ .+......++.++.++|..||+
T Consensus 85 ~~lv~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred eEEEEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 8999999997 676542 1223345788999999999998
Q ss_pred -----------------------cCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 139 -----------------------ANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 139 -----------------------~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876556799999775
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.20 E-value=2.5e-11 Score=120.93 Aligned_cols=184 Identities=18% Similarity=0.257 Sum_probs=120.5
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCc--ceeeeeecCCCcCCCccEEE
Q 010512 22 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDI--VEIKHIMLPPSRREFKDIYV 98 (508)
Q Consensus 22 ~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnI--v~l~~v~~~~~~~~~~~lyl 98 (508)
++.++.|....||++. ..+++|+... ......+.+|+.+|+.+. +..| .+++.... ........|+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~--~~~~~~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGM--PSETYQMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECC--CCSSCSCSCE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecC--CCCCCCcceE
Confidence 4569999999999873 4588998642 234567889999999884 3332 33333221 1122234589
Q ss_pred EEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh---------------------------------------
Q 010512 99 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT--------------------------------------- 138 (508)
Q Consensus 99 V~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs--------------------------------------- 138 (508)
||++++| .|..... ..++.++...++.|+.+.|+.||+
T Consensus 94 vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp EEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred EEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9999997 5544332 247888888889999999988886
Q ss_pred -------------------cCceecCCCCCceeeCC--CCcEEEccccccccccCCCCCcccccccccCccc---ccccc
Q 010512 139 -------------------ANVFHRDLKPKNILANA--DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY---RAPEL 194 (508)
Q Consensus 139 -------------------~gIiHrDLKPeNILl~~--~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y---~APE~ 194 (508)
..++|+|++|.||+++. ++.+.|+||+.+...... .+......+ ..|+.
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-------~Dl~~~~~~~~~~~~~~ 244 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-------NDFISLMEDDEEYGMEF 244 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-------HHHHTTCCTTTSCCHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-------HHHHHHHhhccccCHHH
Confidence 13799999999999998 456789999998753211 111111111 22322
Q ss_pred cccccCCC------------CcchhhhhHHHHHHHHHhCCCCC
Q 010512 195 CGSFFSKY------------TPAIDIWSIGCIFAEMLTGKPLF 225 (508)
Q Consensus 195 l~~~~~~y------------~~~~DIWSlG~il~eLltG~~pF 225 (508)
.......| ....+.|++|.+++.+.+|.++|
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11110111 12368999999999999998776
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.18 E-value=5.8e-11 Score=114.45 Aligned_cols=134 Identities=15% Similarity=0.067 Sum_probs=96.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC--cceeeeeecCCCcCCCc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD--IVEIKHIMLPPSRREFK 94 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~~~~~~~ 94 (508)
..|.+..+.+.|..+.||++.. .+|..|++|..... ....+.+|+.+|+.+.+.+ +.+++.+... .+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~ 88 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AG 88 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SS
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CC
Confidence 4567665555677799999954 56788999997542 1234678999999986544 4557776632 24
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcC---------------------------------
Q 010512 95 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--------------------------------- 140 (508)
Q Consensus 95 ~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~g--------------------------------- 140 (508)
..|+|||+++| +| . . ...+ ...++.++.+.|..||+..
T Consensus 89 ~~~~v~e~i~G~~l-~-~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 89 RDWLLLGEVPGQDL-L-S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp CEEEEEECCSSEET-T-T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred CCEEEEEecCCccc-C-c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 58999999997 55 3 1 1122 2356777888888888753
Q ss_pred -------------------------ceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 141 -------------------------VFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 141 -------------------------IiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
++|+|++|.|||++.++.+.|+|||.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776667999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.11 E-value=2.1e-10 Score=116.90 Aligned_cols=144 Identities=15% Similarity=0.207 Sum_probs=104.7
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEec--CccCChhHHHHHHHHHHHHHhCC--CCCcceeeeeecCCCcCCCc
Q 010512 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN--DVFEHVSDATRILREIKLLRLLR--HPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~--~~~~~~~~~~~i~~Ei~iL~~L~--HpnIv~l~~v~~~~~~~~~~ 94 (508)
..-++.|+.|.++.||++... +..+++|+.. .... ......+.+|+.+|+.|. +..+.+++.++... ...+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g 114 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIG 114 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTS
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccC
Confidence 344678999999999999753 5688899875 2211 112346788999999997 45577787776433 1224
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-----------------------------------
Q 010512 95 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT----------------------------------- 138 (508)
Q Consensus 95 ~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs----------------------------------- 138 (508)
..|+|||+++| .+.+. ....+++.....++.+++++|..||+
T Consensus 115 ~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp SCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred CeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 57999999997 44221 12347888889999999999999997
Q ss_pred -----------------------cCceecCCCCCceeeCCCCc--EEEcccccccc
Q 010512 139 -----------------------ANVFHRDLKPKNILANADCK--LKICDFGLARV 169 (508)
Q Consensus 139 -----------------------~gIiHrDLKPeNILl~~~~~--lkL~DFGla~~ 169 (508)
.+++|+|++|.|||++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999998754 68999999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=5.9e-07 Score=89.47 Aligned_cols=134 Identities=22% Similarity=0.209 Sum_probs=91.7
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCC---CcceeeeeecCCCcCCCccEEE
Q 010512 22 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP---DIVEIKHIMLPPSRREFKDIYV 98 (508)
Q Consensus 22 ~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~Hp---nIv~l~~v~~~~~~~~~~~lyl 98 (508)
++.++.|....||++ |..+++|+-. .......+.+|+.+|+.|.+. .+.+++.+... ..+..|+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~----~~g~~~~ 90 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR----SDGNPFV 90 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC----TTSCEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc----CCCceEE
Confidence 456899999999998 5668888853 223456788999999999753 23444444421 2345689
Q ss_pred EEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhc--------------------------------------
Q 010512 99 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-------------------------------------- 139 (508)
Q Consensus 99 V~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~-------------------------------------- 139 (508)
||++++| .|..... ..++......+..|+.+.|..||+.
T Consensus 91 v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 91 GYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp EEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred EEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9999997 5544221 2245555555556666555555542
Q ss_pred ----------------------CceecCCCCCceeeCC---CCcE-EEccccccccc
Q 010512 140 ----------------------NVFHRDLKPKNILANA---DCKL-KICDFGLARVS 170 (508)
Q Consensus 140 ----------------------gIiHrDLKPeNILl~~---~~~l-kL~DFGla~~~ 170 (508)
.++|+|++|.|||++. ++.+ .|+||+.+...
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999997 4665 89999988753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1.6e-06 Score=84.07 Aligned_cols=132 Identities=18% Similarity=0.209 Sum_probs=90.3
Q ss_pred eeeecCce-EEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCCCccEEEEEe
Q 010512 24 VIGKGSYG-VVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIYVVFE 101 (508)
Q Consensus 24 ~LG~G~~g-~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~lylV~E 101 (508)
.+..|..| .||+......+..+++|.-.. .....+.+|..+|+.|. +--+.+++.+.. +.+..|+|||
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~-----~~~~~~lvme 100 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIR-----TPDDAWLLTT 100 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEEEEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEE-----ECCeEEEEEE
Confidence 45556555 699988777778899998642 34566889999999885 323555666653 2345799999
Q ss_pred cCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhc-----------------------------------------
Q 010512 102 LMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA----------------------------------------- 139 (508)
Q Consensus 102 ~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~----------------------------------------- 139 (508)
+++| ++.+..... ......+..++...|.-||+.
T Consensus 101 ~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred eeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 9997 555544321 122334455555555555532
Q ss_pred -----------------CceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 140 -----------------NVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 140 -----------------gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
.++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 179999999999999877677999998763
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=3.7e-06 Score=86.54 Aligned_cols=78 Identities=17% Similarity=0.074 Sum_probs=48.9
Q ss_pred EeeeeeecCceEEEEEEECCCCcEEEEEEecCccC--C---hhHHHHHHHHHHHHHhCCC--CC-cceeeeeecCCCcCC
Q 010512 21 IQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE--H---VSDATRILREIKLLRLLRH--PD-IVEIKHIMLPPSRRE 92 (508)
Q Consensus 21 i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~--~---~~~~~~i~~Ei~iL~~L~H--pn-Iv~l~~v~~~~~~~~ 92 (508)
-.+.||.|..+.||++.+..++..|++|....... . .....++.+|..+|+.+.. |. +.+++.+. .
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-~----- 107 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-T----- 107 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-T-----
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-C-----
Confidence 35689999999999997666678999998653211 0 1123456789999988742 33 33454432 1
Q ss_pred CccEEEEEecCCc
Q 010512 93 FKDIYVVFELMES 105 (508)
Q Consensus 93 ~~~lylV~E~~~g 105 (508)
...++|||+++|
T Consensus 108 -~~~~lvmE~l~g 119 (397)
T 2olc_A 108 -EMAVTVMEDLSH 119 (397)
T ss_dssp -TTTEEEECCCTT
T ss_pred -CccEEEEEeCCC
Confidence 224899999986
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.19 E-value=6.6e-06 Score=82.17 Aligned_cols=30 Identities=20% Similarity=0.324 Sum_probs=27.4
Q ss_pred cCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 139 ANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 139 ~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
.++||+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999775
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=7.8e-06 Score=82.67 Aligned_cols=85 Identities=8% Similarity=0.144 Sum_probs=53.1
Q ss_pred eEEeeee-eecCceEEEEEEECC------CCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCC---CCcceeeeeecC
Q 010512 19 YQIQEVI-GKGSYGVVGSAVDTH------TGERVAIKKINDVFE-HVSDATRILREIKLLRLLRH---PDIVEIKHIMLP 87 (508)
Q Consensus 19 Y~i~~~L-G~G~~g~V~~a~~~~------tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~H---pnIv~l~~v~~~ 87 (508)
....+.| +.|....+|++.... ++..+++|....... .......+.+|+.+|+.|.. ..+.+++.+...
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4456778 899999999986430 266888987643210 00011346788888888852 345666666533
Q ss_pred CCcCCCccEEEEEecCCc
Q 010512 88 PSRREFKDIYVVFELMES 105 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~g 105 (508)
.. ..+..|+|||+++|
T Consensus 102 ~~--~~g~~~~v~e~l~G 117 (357)
T 3ats_A 102 GD--VLGTPFFLMDYVEG 117 (357)
T ss_dssp ST--TTSSCEEEEECCCC
T ss_pred CC--ccCCceEEEEecCC
Confidence 21 12346899999986
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00034 Score=72.43 Aligned_cols=32 Identities=16% Similarity=0.313 Sum_probs=28.2
Q ss_pred HhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 137 HTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 137 Hs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
+...++|+|++|.|||++.++ +.|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 456799999999999999876 99999998875
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00071 Score=66.58 Aligned_cols=131 Identities=14% Similarity=0.097 Sum_probs=73.0
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCc-ceeeeeecCCCcCCCccEEEEE
Q 010512 22 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI-VEIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 22 ~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~v~~~~~~~~~~~lylV~ 100 (508)
++.|+.|....+|++ ..|++|+....... .....+|+.+++.+..-++ .+++... . ..-++|+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~--~-----~~~~~v~ 86 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVD--P-----ATGVMVT 86 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--T-----TTCCEEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEE--C-----CCCEEEE
Confidence 788999999999999 45888987532111 1112468888877753333 3444432 1 1137899
Q ss_pred ecC-Cc-cHH-----H----------HH---HhCC-CC----C-HHHHHHHHHH--------------HHHHHHHhH---
Q 010512 101 ELM-ES-DLH-----Q----------VI---KAND-DL----T-PEHYQFFLYQ--------------LLRGLKYIH--- 137 (508)
Q Consensus 101 E~~-~g-~L~-----~----------~i---~~~~-~l----~-~~~~~~i~~Q--------------il~aL~yLH--- 137 (508)
||+ +| .|. + .+ +..+ .+ . ...+..+..+ +...+..+.
T Consensus 87 e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l 166 (301)
T 3dxq_A 87 RYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSAL 166 (301)
T ss_dssp ECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHH
T ss_pred eecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHH
Confidence 999 65 221 1 01 1111 01 1 1112222111 111111111
Q ss_pred -----hcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 138 -----TANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 138 -----s~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
...++|+|+.|.||+ ..++.+.|+||..+..
T Consensus 167 ~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 167 AAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 123899999999999 5677899999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00072 Score=66.92 Aligned_cols=152 Identities=14% Similarity=0.125 Sum_probs=82.0
Q ss_pred ccccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCc--ceeeeeecC
Q 010512 10 FTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI--VEIKHIMLP 87 (508)
Q Consensus 10 ~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnI--v~l~~v~~~ 87 (508)
...|+. +...-++.|+.|....||++... +| .+++|..... .....+..|+.+++.|...++ .+++... .
T Consensus 16 l~~~~~-~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~ 87 (322)
T 2ppq_A 16 LTQYDV-GSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRK-D 87 (322)
T ss_dssp HTTBCC-CCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBT-T
T ss_pred HHhCCC-CcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCcccCCC-C
Confidence 344665 34445677888999999999753 33 6889988642 112345678888887753222 2222210 0
Q ss_pred CC--cCCCccEEEEEecCCcc-H-----H------HH---HHh-CCC--------CCHHHHHHHH---------------
Q 010512 88 PS--RREFKDIYVVFELMESD-L-----H------QV---IKA-NDD--------LTPEHYQFFL--------------- 126 (508)
Q Consensus 88 ~~--~~~~~~lylV~E~~~g~-L-----~------~~---i~~-~~~--------l~~~~~~~i~--------------- 126 (508)
.. ....+..++||++++|. + . .. ++. ... .........+
T Consensus 88 g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~ 167 (322)
T 2ppq_A 88 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR 167 (322)
T ss_dssp CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred CCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhH
Confidence 00 00124568999999862 1 0 01 111 111 1111111100
Q ss_pred HHHHHHHHHhHh-------cCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 127 YQLLRGLKYIHT-------ANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 127 ~Qil~aL~yLHs-------~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
..+...+..+.. .+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 168 ~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 168 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 113344555542 3699999999999999775568999997753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0021 Score=64.01 Aligned_cols=76 Identities=16% Similarity=0.086 Sum_probs=55.2
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC---CCCcceeeeeecCCCcCCCc
Q 010512 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR---HPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 18 rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~v~~~~~~~~~~ 94 (508)
.-.-.+.|+.|....+|++.. .+..|++|.... .....+.+|...|+.|. ...+.+++..... .+
T Consensus 37 ~i~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g 104 (312)
T 3jr1_A 37 FIKHKEKLYSGEMNEIWLIND--EVQTVFVKINER-----SYRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QG 104 (312)
T ss_dssp CCCEEEEECCSSSSEEEEEES--SSCEEEEEEEEG-----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SS
T ss_pred ceeeeEEeCCccceeeeEEEE--CCCeEEEEeCCc-----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CC
Confidence 334467899999999999964 467888998653 23566788999998884 2456666666532 24
Q ss_pred cEEEEEecCCc
Q 010512 95 DIYVVFELMES 105 (508)
Q Consensus 95 ~lylV~E~~~g 105 (508)
..|+|||+++|
T Consensus 105 ~~~lvme~l~G 115 (312)
T 3jr1_A 105 HSFLLLEALNK 115 (312)
T ss_dssp EEEEEEECCCC
T ss_pred ceEEEEEeccC
Confidence 68999999985
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.00097 Score=66.47 Aligned_cols=31 Identities=26% Similarity=0.470 Sum_probs=27.3
Q ss_pred cCceecCCCCCceeeCCC----CcEEEcccccccc
Q 010512 139 ANVFHRDLKPKNILANAD----CKLKICDFGLARV 169 (508)
Q Consensus 139 ~gIiHrDLKPeNILl~~~----~~lkL~DFGla~~ 169 (508)
..++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999875 6799999998874
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0056 Score=57.40 Aligned_cols=97 Identities=19% Similarity=0.115 Sum_probs=65.9
Q ss_pred cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHh-HhcCceecCCCCCceeeCCCCcEEEccccccccccCCCCCccccccc
Q 010512 106 DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYI-HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY 183 (508)
Q Consensus 106 ~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yL-Hs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~ 183 (508)
+|.+++.. +.+++++++|.+++|.+.+|.-+ +.+.-..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence 78888876 56899999999999999998776 222222344557899999999988764 2111
Q ss_pred ccCcccccccccccccCCCCcchhhhhHHHHHHHHHhC
Q 010512 184 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG 221 (508)
Q Consensus 184 ~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG 221 (508)
.....+.|||... ...+.+.=|||||+++|.-+--
T Consensus 98 ~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp ---------CCSS---SSSCHHHHHHHHHHHHHHHHTT
T ss_pred ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhhc
Confidence 0113456888763 3557889999999999998863
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0055 Score=59.68 Aligned_cols=77 Identities=12% Similarity=0.002 Sum_probs=52.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCC---CcceeeeeecCCCcCCC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP---DIVEIKHIMLPPSRREF 93 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~Hp---nIv~l~~v~~~~~~~~~ 93 (508)
.+..-++.+|.|..+.||++.. .+|+.|.+|+-..... .....+.+|+..|+.|.-- -+.+++...
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-------- 83 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-------- 83 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--------
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEecc--------
Confidence 4566788999999999999975 4789999998653211 1223467899999988532 233444332
Q ss_pred ccEEEEEecCCc
Q 010512 94 KDIYVVFELMES 105 (508)
Q Consensus 94 ~~lylV~E~~~g 105 (508)
.-++|||++++
T Consensus 84 -~~~lv~e~l~~ 94 (288)
T 3f7w_A 84 -DRTLAMEWVDE 94 (288)
T ss_dssp -TTEEEEECCCC
T ss_pred -CceEEEEeecc
Confidence 23899999873
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0028 Score=62.76 Aligned_cols=138 Identities=17% Similarity=0.129 Sum_probs=77.8
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC--cceeeeeecCCC--cCCCccEEE
Q 010512 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD--IVEIKHIMLPPS--RREFKDIYV 98 (508)
Q Consensus 23 ~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~~--~~~~~~lyl 98 (508)
..|+ |....||++.. .+|+.+++|..+... .....+..|+.+++.|.... +.+++.. ... ....+..|+
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~---~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFA 104 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC---CCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEE
Confidence 4566 88899998853 356679999986321 12456677888888885322 3333332 110 011345688
Q ss_pred EEecCCc-cH-----HH------HH---H---hCC------CCCHHHH----HH------------------HHHHHHHH
Q 010512 99 VFELMES-DL-----HQ------VI---K---AND------DLTPEHY----QF------------------FLYQLLRG 132 (508)
Q Consensus 99 V~E~~~g-~L-----~~------~i---~---~~~------~l~~~~~----~~------------------i~~Qil~a 132 (508)
||++++| .+ .. .+ + ... .++.... .. .+.+++..
T Consensus 105 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 184 (328)
T 1zyl_A 105 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA 184 (328)
T ss_dssp EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHH
Confidence 9999986 21 11 11 1 110 1222111 11 11122222
Q ss_pred HHHh----HhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 133 LKYI----HTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 133 L~yL----Hs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
+.-+ ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 185 l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 185 VTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 2211 234589999999999999 5 899999987753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0054 Score=63.71 Aligned_cols=72 Identities=13% Similarity=0.091 Sum_probs=48.5
Q ss_pred EeeeeeecCceEEEEEEECC-------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCc-ceeeeeecCCCcCC
Q 010512 21 IQEVIGKGSYGVVGSAVDTH-------TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI-VEIKHIMLPPSRRE 92 (508)
Q Consensus 21 i~~~LG~G~~g~V~~a~~~~-------tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~v~~~~~~~~ 92 (508)
-++.|+.|....||++.... .+..|++|+.... . ....+.+|+.+++.|...++ .++++.+. +
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~-----~ 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E--TESHLVAESVIFTLLSERHLGPKLYGIFS-----G 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C--CHHHHHHHHHHHHHHHHTTSSSCEEEEET-----T
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--C--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC-----C
Confidence 35678899999999997642 3578999987431 1 11345579999988864333 45665541 1
Q ss_pred CccEEEEEecCCc
Q 010512 93 FKDIYVVFELMES 105 (508)
Q Consensus 93 ~~~lylV~E~~~g 105 (508)
.+|+||++|
T Consensus 148 ----g~v~e~l~G 156 (429)
T 1nw1_A 148 ----GRLEEYIPS 156 (429)
T ss_dssp ----EEEECCCCE
T ss_pred ----CEEEEEeCC
Confidence 389999985
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.90 E-value=0.002 Score=65.31 Aligned_cols=73 Identities=8% Similarity=-0.009 Sum_probs=42.8
Q ss_pred EeeeeeecCceEEEEEEECC--------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC-cceeeeeecCCCcC
Q 010512 21 IQEVIGKGSYGVVGSAVDTH--------TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD-IVEIKHIMLPPSRR 91 (508)
Q Consensus 21 i~~~LG~G~~g~V~~a~~~~--------tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~Hpn-Iv~l~~v~~~~~~~ 91 (508)
-++.|+.|....+|++.... .+..|++|+..... .......+|..+|+.|...+ +.++++.. .
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--- 108 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--- 108 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T---
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C---
Confidence 35678889999999997543 13688888865321 11112357888888885333 33555543 1
Q ss_pred CCccEEEEEecCCc
Q 010512 92 EFKDIYVVFELMES 105 (508)
Q Consensus 92 ~~~~lylV~E~~~g 105 (508)
-++||+|++|
T Consensus 109 ----~~~v~e~i~G 118 (369)
T 3c5i_A 109 ----GGRIEEWLYG 118 (369)
T ss_dssp ----TEEEEECCCS
T ss_pred ----CcEEEEEecC
Confidence 1689999986
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0051 Score=62.90 Aligned_cols=139 Identities=12% Similarity=0.165 Sum_probs=81.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECC-------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC-cceeeeeecCC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTH-------TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD-IVEIKHIMLPP 88 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~-------tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~Hpn-Iv~l~~v~~~~ 88 (508)
+..+ ++.|..|-...+|++.... ++..|.+|+..... .....+.+|..+++.|..-+ ..++++.+
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--- 123 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVF--- 123 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEE---
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEc---
Confidence 3444 3568889999999997532 35789999863321 12345568999998885322 34555554
Q ss_pred CcCCCccEEEEEecCCc-cHH--------------HHH---HhCC-----CC--CHHHHHHHHHHHHH------------
Q 010512 89 SRREFKDIYVVFELMES-DLH--------------QVI---KAND-----DL--TPEHYQFFLYQLLR------------ 131 (508)
Q Consensus 89 ~~~~~~~lylV~E~~~g-~L~--------------~~i---~~~~-----~l--~~~~~~~i~~Qil~------------ 131 (508)
.+ .+||||++| .|. ..+ +... .. -+..+..|+.|+-.
T Consensus 124 --~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~ 197 (379)
T 3feg_A 124 --PE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLL 197 (379)
T ss_dssp --TT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHH
T ss_pred --CC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhh
Confidence 11 289999986 221 111 1111 11 23556666655432
Q ss_pred -------HHHHhH----h----cCceecCCCCCceeeCCC----CcEEEccccccc
Q 010512 132 -------GLKYIH----T----ANVFHRDLKPKNILANAD----CKLKICDFGLAR 168 (508)
Q Consensus 132 -------aL~yLH----s----~gIiHrDLKPeNILl~~~----~~lkL~DFGla~ 168 (508)
.+..|. . ..++|+|+.+.|||++.+ +.+.|+||..|.
T Consensus 198 ~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 198 EMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 233332 2 258999999999999876 789999998775
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0043 Score=62.22 Aligned_cols=31 Identities=19% Similarity=0.326 Sum_probs=27.7
Q ss_pred cCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 139 ANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 139 ~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3689999999999999888899999988764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.018 Score=60.38 Aligned_cols=72 Identities=17% Similarity=0.186 Sum_probs=46.4
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCc-ceeeeeecCCCcCCCccEEEEE
Q 010512 22 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI-VEIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 22 ~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~v~~~~~~~~~~~lylV~ 100 (508)
++.|+.|-...+|++.....+..|++|+.........+ ..+|..+|+.|...++ .++++++. . .+||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id---R~~E~~vl~~L~~~gl~P~ll~~~~--~-------G~v~ 180 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN---REREKKISCILYNKNIAKKIYVFFT--N-------GRIE 180 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC---HHHHHHHHHHHTTSSSBCCEEEEET--T-------EEEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC---HHHHHHHHHHHHhcCCCCCEEEEeC--C-------eEEE
Confidence 46788999999999987544578999987432211111 2579999999975554 45666551 1 2599
Q ss_pred ecCCc
Q 010512 101 ELMES 105 (508)
Q Consensus 101 E~~~g 105 (508)
||++|
T Consensus 181 e~I~G 185 (458)
T 2qg7_A 181 EFMDG 185 (458)
T ss_dssp ECCCS
T ss_pred EeeCC
Confidence 99985
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.27 E-value=0.16 Score=52.55 Aligned_cols=73 Identities=11% Similarity=0.008 Sum_probs=46.5
Q ss_pred EeeeeeecCceEEEEEEECC-------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC-cceeeeeecCCCcCC
Q 010512 21 IQEVIGKGSYGVVGSAVDTH-------TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD-IVEIKHIMLPPSRRE 92 (508)
Q Consensus 21 i~~~LG~G~~g~V~~a~~~~-------tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~Hpn-Iv~l~~v~~~~~~~~ 92 (508)
-++.|..|-...+|++.... .+..|++++........ -...+|..+++.|..-+ ..++++.+.
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~---idR~~E~~~l~~L~~~gi~P~l~~~~~------ 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF---YDSKVELDVFRYLSNINIAPNIIADFP------ 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC---CCHHHHHHHHHHHHHTTSSCCEEEEET------
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh---cCHHHHHHHHHHHHhcCCCCCEEEEcC------
Confidence 34567889999999997652 15789999864322111 12357888888885323 344554331
Q ss_pred CccEEEEEecCCc
Q 010512 93 FKDIYVVFELMES 105 (508)
Q Consensus 93 ~~~lylV~E~~~g 105 (508)
-++||+|++|
T Consensus 145 ---~~~I~efI~G 154 (424)
T 3mes_A 145 ---EGRIEEFIDG 154 (424)
T ss_dssp ---TEEEEECCCS
T ss_pred ---CCEEEEEeCC
Confidence 1789999986
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.16 E-value=0.24 Score=50.64 Aligned_cols=29 Identities=31% Similarity=0.421 Sum_probs=24.8
Q ss_pred ceecCCCCCceee------CCCCcEEEcccccccc
Q 010512 141 VFHRDLKPKNILA------NADCKLKICDFGLARV 169 (508)
Q Consensus 141 IiHrDLKPeNILl------~~~~~lkL~DFGla~~ 169 (508)
++|+|+.+.|||+ +++..+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999998 4467799999988764
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.58 E-value=0.068 Score=55.99 Aligned_cols=63 Identities=16% Similarity=0.116 Sum_probs=17.5
Q ss_pred EEeeeeeecCceEEEEEEECCCCcEEEE------EEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeee
Q 010512 20 QIQEVIGKGSYGVVGSAVDTHTGERVAI------KKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIM 85 (508)
Q Consensus 20 ~i~~~LG~G~~g~V~~a~~~~tg~~vAI------Kki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~ 85 (508)
.+.+.|| ||.||++.......+||+ |..+...........+.+|..+++.++|||+++.+.+.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 3455666 999999987655568888 66653333333445678899999999999999987765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 508 | ||||
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-98 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-92 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-90 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-80 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-79 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-76 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-74 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-73 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-72 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-72 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-71 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-71 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-68 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-68 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-68 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-68 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-67 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-67 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-66 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-66 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-66 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-66 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-66 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-64 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-63 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-63 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-62 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-59 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-59 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-59 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-57 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-56 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-55 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-53 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-51 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-50 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-50 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-50 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-50 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-50 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-49 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-46 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-44 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-43 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-40 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-24 |
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 299 bits (766), Expect = 1e-98
Identities = 161/341 (47%), Positives = 220/341 (64%), Gaps = 5/341 (1%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 75
RY IG+G+YG+V SA D RVAIKKI+ FEH + R LREIK+L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP-FEHQTYCQRTLREIKILLRFRH 65
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
+I+ I I+ P+ + KD+Y+V LM +DL++++K L+ +H +FLYQ+LRGLKY
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKY 124
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 195
IH+ANV HRDLKP N+L N C LKICDFGLARV+ D F T+YVATRWYRAPE+
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
+ YT +IDIWS+GCI AEML+ +P+FPGK+ + QL+ + +LG+PS E ++ I N
Sbjct: 185 LNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315
KAR YL S+ K VP++ FPNAD AL LL+++L F+P R E+ALA PY +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 316 VDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQ 356
EP + +F+ E L K+ ++E+I+ E + P
Sbjct: 304 PSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQPG 342
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 282 bits (721), Expect = 6e-92
Identities = 148/346 (42%), Positives = 217/346 (62%), Gaps = 12/346 (3%)
Query: 11 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 70
T + RYQ +G G+YG V +A DT TG RVA+KK++ F+ + A R RE++LL
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 71 RLLRHPDIVEIKHIMLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 129
+ ++H +++ + + P S EF D+Y+V LM +DL+ ++K LT +H QF +YQ+
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQI 130
Query: 130 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
LRGLKYIH+A++ HRDLKP N+ N DC+LKI DFGLAR + ++ T YVATRWY
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MTGYVATRWY 184
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
RAPE+ + + Y +DIWS+GCI AE+LTG+ LFPG + + QL L+ L+GTP E +
Sbjct: 185 RAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309
+I +E AR Y+ S+ + + F++ F A+PLA+ LLE++L D R TA +ALA Y
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303
Query: 310 FHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 355
F + D EP P + FE R L D+ + + Y E++ + P
Sbjct: 304 FAQYHDPDDEPVADPY---DQSFESRDLLIDEWKSLTYDEVISFVP 346
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 277 bits (710), Expect = 3e-90
Identities = 137/346 (39%), Positives = 212/346 (61%), Gaps = 12/346 (3%)
Query: 11 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 70
T + + Y+ + +G G+YG V SAVD TG +VAIKK+ F+ A R RE++LL
Sbjct: 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 71
Query: 71 RLLRHPDIVEIKHIMLPPSRRE-FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 129
+ +RH +++ + + P + F D Y+V M +DL +++K ++ L + QF +YQ+
Sbjct: 72 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQM 130
Query: 130 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
L+GL+YIH A + HRDLKP N+ N DC+LKI DFGLAR + ++ T YV TRWY
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM------TGYVVTRWY 184
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
RAPE+ + + +YT +DIWS+GCI AEM+TGK LF G + + QL + + GTP E +
Sbjct: 185 RAPEVILN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309
R+++++A+ Y+ + + + F+ NA PLA++LLE++L D + R TA EALA PY
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303
Query: 310 FHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 355
F L + + EP Q K + F+ D+ + + Y+E+L + P
Sbjct: 304 FESLHDTEDEPQVQ---KYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 251 bits (641), Expect = 8e-80
Identities = 120/354 (33%), Positives = 194/354 (54%), Gaps = 23/354 (6%)
Query: 11 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 70
+ + RYQ + IG G+ G+V +A D VAIKK++ F++ + A R RE+ L+
Sbjct: 11 STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70
Query: 71 RLLRHPDIVEIKHIMLPPSR-REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 129
+ + H +I+ + ++ P EF+D+Y+V ELM+++L QVI+ D E + LYQ+
Sbjct: 71 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYLLYQM 128
Query: 130 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
L G+K++H+A + HRDLKP NI+ +DC LKI DFGLAR + T YV TR+Y
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM----MTPYVVTRYY 184
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
RAPE+ Y +DIWS+GCI EM+ K LFPG++ + Q + + + LGTP E +
Sbjct: 185 RAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNA------------DPLALHLLERLLAFDPKD 297
++ R Y+ + K + F FP++ A LL ++L DP
Sbjct: 243 KKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 298 RPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREIL 351
R + ++AL PY + + E P + + + R+ ++ +E+IY+E++
Sbjct: 302 RISVDDALQHPYINVWYDPA-EVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM 354
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (634), Expect = 2e-79
Identities = 106/303 (34%), Positives = 153/303 (50%), Gaps = 7/303 (2%)
Query: 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 74
E S+Y+ IG+G++G V A TG++VA+KK+ E LREIK+L+LL+
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 67
Query: 75 HPDIVEIKHIMLPPSRREFKD---IYVVFELMESDLHQV-IKANDDLTPEHYQFFLYQLL 130
H ++V + I + + IY+VF+ E DL + T + + LL
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 127
Query: 131 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VSFNDAPSAIFWTDYVATRWY 189
GL YIH + HRD+K N+L D LK+ DFGLAR S +T+ V T WY
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
R PEL Y P ID+W GCI AEM T P+ G HQL L++ L G+ + E
Sbjct: 188 RPPELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 250 SRIRNEKARRYLGSMR-KKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308
+ N + L ++ +K+ V K DP AL L+++LL DP R +++AL
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 309 YFH 311
+F
Sbjct: 307 FFW 309
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (618), Expect = 2e-76
Identities = 105/331 (31%), Positives = 170/331 (51%), Gaps = 21/331 (6%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
Y +VIG GS+GVV A +GE VAIKK+ D RE++++R L H +
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRKLDHCN 74
Query: 78 IVEIKHIMLPPSRREFKD-IYVVFELMESDLHQVI----KANDDLTPEHYQFFLYQLLRG 132
IV +++ ++ + + +V + + +++V +A L + + ++YQL R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 133 LKYIHTANVFHRDLKPKNILANADCKL-KICDFGLARVSFNDAPSAIFWTDYVATRWYRA 191
L YIH+ + HRD+KP+N+L + D + K+CDFG A+ P Y+ +R+YRA
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP----NVSYICSRYYRA 190
Query: 192 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251
PEL YT +ID+WS GC+ AE+L G+P+FPG + V QL + +LGTP+ E I
Sbjct: 191 PELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 252 IRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
+ ++ P++ F P P A+ L RLL + P R T EA A +F
Sbjct: 250 MNPNYTEFKFPQIKAH---PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 311 HGLANVDREPSTQPISKLEFEFERRKLAKDD 341
L + + + + F F ++L+ +
Sbjct: 307 DELRDPNVKLPNGRDTPALFNFTTQELSSNP 337
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (599), Expect = 2e-74
Identities = 103/310 (33%), Positives = 154/310 (49%), Gaps = 22/310 (7%)
Query: 23 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDAT---RILREIKLLRLLRHPDIV 79
+ +G+G + V A D +T + VAIKKI + LREIKLL+ L HP+I+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 80 EIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 138
+ S +I +VF+ ME+D + + LTP H + ++ L+GL+Y+H
Sbjct: 64 GLLDAFGHKS-----NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 139 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 198
+ HRDLKP N+L + + LK+ DFGLA+ + + +T V TRWYRAPEL
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA---YTHQVVTRWYRAPELL-FG 174
Query: 199 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 258
Y +D+W++GCI AE+L P PG + + QL + + LGTP+ E + +
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 259 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDR 318
+ +P H F A L L++ L F+P R TA +AL YF
Sbjct: 235 VT---FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF------SN 285
Query: 319 EPSTQPISKL 328
P P +L
Sbjct: 286 RPGPTPGCQL 295
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 9e-73
Identities = 103/305 (33%), Positives = 151/305 (49%), Gaps = 16/305 (5%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGER-VAIKKINDVFEHVSDATRILREIKLLRLL--- 73
+Y+ IG+G+YG V A D G R VA+K++ +RE+ +LR L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 74 RHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLR 131
HP++V + + + +VFE ++ DL + + + E + ++QLLR
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 191
GL ++H+ V HRDLKP+NIL + ++K+ DFGLAR+ T V T WYRA
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA----LTSVVVTLWYRA 183
Query: 192 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251
PE+ S Y +D+WS+GCIFAEM KPLF G + V QL + D++G P E R
Sbjct: 184 PEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311
+ + K P + D L LL + L F+P R +A AL+ PYF
Sbjct: 242 DVALPRQAF----HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
Query: 312 GLANV 316
L
Sbjct: 298 DLERC 302
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 1e-72
Identities = 115/313 (36%), Positives = 167/313 (53%), Gaps = 21/313 (6%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+Q E IG+G+YGVV A + TGE VA+KKI E + +REI LL+ L HP+
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKY 135
IV++ ++ ++ +Y+VFE + DL + + A+ + + +L+QLL+GL +
Sbjct: 63 IVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 195
H+ V HRDLKP+N+L N + +K+ DFGLAR +T V T WYRAPE+
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR---TYTHEVVTLWYRAPEIL 174
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
Y+ A+DIWS+GCIFAEM+T + LFPG + + QL + LGTP
Sbjct: 175 LG-CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP--GVT 231
Query: 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315
Y S K FS P D LL ++L +DP R +A+ ALA P+F +
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV-- 289
Query: 316 VDREPSTQPISKL 328
T+P+ L
Sbjct: 290 ------TKPVPHL 296
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (586), Expect = 5e-72
Identities = 64/308 (20%), Positives = 119/308 (38%), Gaps = 28/308 (9%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
++ +G G+ GVV +G +A K I+ + + +I+RE+++L P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQIIRELQVLHECNSPY 65
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 136
IV +I + E M+ L QV+K + + +++GL Y+
Sbjct: 66 IVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 137 HTAN-VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 195
+ + HRD+KP NIL N+ ++K+CDFG++ + +V TR Y +PE
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-----NSFVGTRSYMSPERL 175
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
+ Y+ DIWS+G EM G+ P + + + + E+ R R
Sbjct: 176 --QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 256 KARRYLGSMRKKQPVPFSHKFPNA-------------DPLALHLLERLLAFDPKDRPTAE 302
M + P+ + + L +P +R +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 303 EALADPYF 310
+ + +
Sbjct: 294 QLMVHAFI 301
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 226 bits (576), Expect = 4e-71
Identities = 106/294 (36%), Positives = 159/294 (54%), Gaps = 13/294 (4%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+Y E IG+G+YGVV A + + GE A+KKI E + +REI +L+ L+H +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 136
IV++ ++ K + +VFE + + + L + FL QLL G+ Y
Sbjct: 62 IVKLYDVI-----HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
H V HRDLKP+N+L N + +LKI DFGLAR +T + T WYRAP++
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK---YTHEIVTLWYRAPDVLM 173
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256
KY+ IDIWS+GCIFAEM+ G PLFPG + QL + +LGTP++++ + +
Sbjct: 174 G-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT--E 230
Query: 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
+Y + +P+P+ D + LL ++L DP R TA++AL YF
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 9e-71
Identities = 105/294 (35%), Positives = 151/294 (51%), Gaps = 11/294 (3%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+Y+ E IG+G+YG V A + T E VA+K++ + + LREI LL+ L+H +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
IV + ++ + K V + N DL PE + FL+QLL+GL + H
Sbjct: 63 IVRLHDVL----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 197
+ NV HRDLKP+N+L N + +LK+ +FGLAR ++ V T WYR P++
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC---YSAEVVTLWYRPPDVLFG 175
Query: 198 FFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256
Y+ +ID+WS GCIFAE+ PLFPG +V QL + LLGTP+ E + K
Sbjct: 176 -AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT--K 232
Query: 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
Y + P + LL+ LL +P R +AEEAL PYF
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 1e-68
Identities = 71/295 (24%), Positives = 120/295 (40%), Gaps = 37/295 (12%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+ + + +G+G+YG V AV+ T E VA+K + D+ V I +EI + ++L H +
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHEN 64
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMESDLH-QVIKANDDLTPEHYQFFLYQLLRGLKYI 136
+V+ + Y+ E I+ + + Q F +QL+ G+ Y+
Sbjct: 65 VVKFYGHRREGNI-----QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
H + HRD+KP+N+L + LKI DFGLA V F T Y APEL
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256
+ +D+WS G + ML G+ + + Q
Sbjct: 179 R-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--------------------- 216
Query: 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311
K+ + + + D L LL ++L +P R T + D +++
Sbjct: 217 -------SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 220 bits (562), Expect = 1e-68
Identities = 80/326 (24%), Positives = 135/326 (41%), Gaps = 43/326 (13%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
Y ++V+G G++ V A D T + VAIK I + EI +L ++HP+
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPN 68
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 136
IV + I +Y++ +L+ +L I T ++Q+L +KY+
Sbjct: 69 IVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 123
Query: 137 HTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 193
H + HRDLKP+N+L + D K+ I DFGL+++ + + T Y APE
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL----STACGTPGYVAPE 179
Query: 194 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253
+ Y+ A+D WSIG I +L G P F +N +
Sbjct: 180 VLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE------------------ 219
Query: 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313
+ K + S + + A + L+ DP+ R T E+AL P+ G
Sbjct: 220 ---------QILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270
Query: 314 ANVDREPSTQPISKLEFEFERRKLAK 339
+D+ +++ F + K +
Sbjct: 271 TALDKNIHQSVSEQIKKNFAKSKWKQ 296
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 3e-68
Identities = 69/293 (23%), Positives = 119/293 (40%), Gaps = 40/293 (13%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+Y E IG+G+ G V +A+D TG+ VAI+++N + I+ EI ++R ++P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
IV +++VV E + + + + L+ L+++H
Sbjct: 79 IVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 138 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 197
+ V HRD+K NIL D +K+ DFG + + V T ++ APE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTR 190
Query: 198 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 257
Y P +DIWS+G + EM+ G+P + +N + L L+
Sbjct: 191 --KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------------------- 228
Query: 258 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
P + L R L D + R +A+E L +
Sbjct: 229 --------ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 219 bits (558), Expect = 6e-68
Identities = 91/312 (29%), Positives = 153/312 (49%), Gaps = 26/312 (8%)
Query: 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLR 71
E+G YQ+ +G+G Y V A++ E+V +K + V + +I REIK+L
Sbjct: 30 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILE 84
Query: 72 LLR-HPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQL 129
LR P+I+ + I+ P R +VFE + +D Q+ + LT +F++Y++
Sbjct: 85 NLRGGPNIITLADIVKDPVSRT---PALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEI 138
Query: 130 LRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVSFNDAPSAIFWTDYVATRW 188
L+ L Y H+ + HRD+KP N++ + + KL++ D+GLA + VA+R+
Sbjct: 139 LKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE----YNVRVASRY 194
Query: 189 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLMTDLLGTPSTE 247
++ PEL + Y ++D+WS+GC+ A M+ K P F G + QL + +LGT
Sbjct: 195 FKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253
Query: 248 SISRIRNEKARRYLGSMRKKQP------VPFSHKFPNADPLALHLLERLLAFDPKDRPTA 301
N + + + S P AL L++LL +D + R TA
Sbjct: 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313
Query: 302 EEALADPYFHGL 313
EA+ PYF+ +
Sbjct: 314 REAMEHPYFYTV 325
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 217 bits (554), Expect = 2e-67
Identities = 76/350 (21%), Positives = 135/350 (38%), Gaps = 53/350 (15%)
Query: 7 TEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILR 65
E F + + IG GS+G V A D E VAIKK++ + I++
Sbjct: 5 AELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 66 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQF 124
E++ L+ LRHP+ ++ + L ++V E S + L
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKKPLQEVEIAA 119
Query: 125 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 184
+ L+GL Y+H+ N+ HRD+K NIL + +K+ DFG A + +V
Sbjct: 120 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFV 172
Query: 185 ATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 243
T ++ APE + +Y +D+WS+G E+ KP N + L +
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------ 226
Query: 244 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 303
+ + P S + + ++ L P+DRPT+E
Sbjct: 227 --------------------AQNESPALQSGHWS---EYFRNFVDSCLQKIPQDRPTSEV 263
Query: 304 ALADPYFHGLANVDREPSTQPISKLEFEF----ERRKLAKDDVREMIYRE 349
L + + P T + ++ E L +++++++E
Sbjct: 264 LLKHRFV-----LRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKILFQE 308
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 9e-67
Identities = 71/333 (21%), Positives = 140/333 (42%), Gaps = 48/333 (14%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
+Y I E +G+G +G+V V+T + + K + +D + +EI +L + RH +
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRN 62
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLKY 135
I+ + +++ ++FE + D+ + I + +L +++Q+ L++
Sbjct: 63 ILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117
Query: 136 IHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 193
+H+ N+ H D++P+NI+ +KI +FG AR + +T Y APE
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT----APEYYAPE 173
Query: 194 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253
+ + A D+WS+G + +L+G F + ++
Sbjct: 174 VHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE------------------ 213
Query: 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313
++ + F A+ ++RLL + K R TA EAL P+
Sbjct: 214 ---------NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ- 263
Query: 314 ANVDREPSTQPISKLEFEFERRKLAKDDVREMI 346
++R ST+ I L+ L K D+ ++
Sbjct: 264 -KIER-VSTKVIRTLKHRRYYHTLIKKDLNMVV 294
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 213 bits (543), Expect = 3e-66
Identities = 74/306 (24%), Positives = 124/306 (40%), Gaps = 49/306 (16%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA-------TRILREIKLL 70
Y+ +E++G+G VV + T + A+K I+ A L+E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 71 RLLR-HPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQ 128
R + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 64 RKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 118
Query: 129 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 188
LL + +H N+ HRDLKP+NIL + D +K+ DFG + + T
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----REVCGTPS 174
Query: 189 YRAPELC----GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244
Y APE+ Y +D+WS G I +L G P F + + L +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM-------- 226
Query: 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 304
+ S ++ + L+ R L P+ R TAEEA
Sbjct: 227 -------------------IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
Query: 305 LADPYF 310
LA P+F
Sbjct: 268 LAHPFF 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 215 bits (548), Expect = 5e-66
Identities = 74/333 (22%), Positives = 127/333 (38%), Gaps = 45/333 (13%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
Y I E +G G++GVV + TG A K + H SD + +EI+ + +LRHP
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPT 84
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVI-KANDDLTPEHYQFFLYQLLRGLKY 135
+V + + ++ +++E M +L + + ++ ++ + ++ Q+ +GL +
Sbjct: 85 LVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 139
Query: 136 IHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 193
+H N H DLKP+NI+ +LK+ DFGL T + APE
Sbjct: 140 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH----LDPKQSVKVTTGTAEFAAPE 195
Query: 194 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253
+ D+WS+G + +L+G F G+N L
Sbjct: 196 VA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN----------------- 236
Query: 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313
++ F + +LL DP R T +AL P+
Sbjct: 237 ----------VKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP- 285
Query: 314 ANVDREPSTQPISKLEFEFERRKLAKDDVREMI 346
N S P S+ + K D E +
Sbjct: 286 GNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPL 318
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 5e-66
Identities = 67/316 (21%), Positives = 113/316 (35%), Gaps = 50/316 (15%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
++I +G G++G V A + T A K I+ + + + EI +L HP+
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPN 70
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVI--KANDDLTPEHYQFFLYQLLRGLKY 135
IV++ +++++ E + + LT Q Q L L Y
Sbjct: 71 IVKLLDAF-----YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNY 125
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 195
+H + HRDLK NIL D +K+ DFG++ + ++ T ++ APE+
Sbjct: 126 LHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDSFIGTPYWMAPEVV 182
Query: 196 GSFFSK---YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252
SK Y D+WS+G EM +P N + L +
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-------------- 228
Query: 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312
K P + L++ L + R T + L P+
Sbjct: 229 --------------KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV-- 272
Query: 313 LANVDREPSTQPISKL 328
S +PI +L
Sbjct: 273 -----TVDSNKPIREL 283
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 214 bits (547), Expect = 6e-66
Identities = 75/326 (23%), Positives = 129/326 (39%), Gaps = 48/326 (14%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
Y I E +G G++GVV V+ TG K IN + D + EI ++ L HP
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHPK 87
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLKY 135
++ + + ++ ++ E + +L I A D ++ ++ Q GLK+
Sbjct: 88 LINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 142
Query: 136 IHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 193
+H ++ H D+KP+NI+ +KI DFGLA D AT + APE
Sbjct: 143 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV----KVTTATAEFAAPE 198
Query: 194 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253
+ D+W+IG + +L+G F G++ + L +
Sbjct: 199 IVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV---------------- 240
Query: 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313
++ F + P A ++ LL +P+ R T +AL P+ G
Sbjct: 241 -----------KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG- 288
Query: 314 ANVDREPSTQPISKLEFEFERRKLAK 339
D T I + R+K+ +
Sbjct: 289 ---DHSNLTSRIPSSRYNKIRQKIKE 311
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 6e-66
Identities = 69/296 (23%), Positives = 118/296 (39%), Gaps = 45/296 (15%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRH 75
++I +GKG +G V A + + +A+K + E ++ RE+++ LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLK 134
P+I+ + +R +Y++ E +++ ++ + ++ +L L
Sbjct: 66 PNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120
Query: 135 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 194
Y H+ V HRD+KP+N+L + +LKI DFG + APS+ T T Y PE+
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTT-LCGTLDYLPPEM 175
Query: 195 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254
+ +D+WS+G + E L GKP F +
Sbjct: 176 IEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------- 216
Query: 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
R + P A L+ RLL +P RP E L P+
Sbjct: 217 ---------SRVEFTFP-----DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 1e-64
Identities = 79/304 (25%), Positives = 118/304 (38%), Gaps = 48/304 (15%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 75
A Y++ IG GSYG G+ + K+++ ++ ++ E+ LLR L+H
Sbjct: 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 62
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD----LTPEHYQFFLYQLL 130
P+IV ++ + +Y+V E E DL VI L E + QL
Sbjct: 63 PNIVRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 131 RGLKYIH-----TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVA 185
LK H V HRDLKP N+ + +K+ DFGLAR+ +D A +V
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KAFVG 176
Query: 186 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245
T +Y +PE Y DIWS+GC+ E+ P F +
Sbjct: 177 TPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG---------- 224
Query: 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 305
+IR K RR ++ R+L RP+ EE L
Sbjct: 225 -----KIREGKFRRI---------------PYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
Query: 306 ADPY 309
+P
Sbjct: 265 ENPL 268
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 1e-63
Identities = 78/351 (22%), Positives = 140/351 (39%), Gaps = 46/351 (13%)
Query: 18 RYQI-QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLLRH 75
Y++ +V+G G G V + T E+ A+K + D + RE++ R +
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQC 64
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRG 132
P IV I + K + +V E ++ +L I+ D T + +
Sbjct: 65 PHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 133 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 189
++Y+H+ N+ HRD+KP+N+L + LK+ DFG A+ + S T T +Y
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSHNSLTTPCYTPYY 179
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
APE+ G KY + D+WS+G I +L G P F + + M +
Sbjct: 180 VAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI-------- 229
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 309
R Q + ++ L+ LL +P R T E + P+
Sbjct: 230 ---------------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 274
Query: 310 FHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQE 360
V + P L+ + ER + K+++ + ++Y +++
Sbjct: 275 IMQSTKVPQTPLHTSRV-LKEDKERWEDVKEEMTSALATMRVDYEQIKIKK 324
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 2e-63
Identities = 69/296 (23%), Positives = 119/296 (40%), Gaps = 41/296 (13%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 78
+ IG+GS+ V +DT T VA ++ D S+ R E ++L+ L+HP+I
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 79 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 137
V + + K I +V ELM S L +K + + + + Q+L+GL+++H
Sbjct: 71 VRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 138 TAN--VFHRDLKPKNIL-ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 194
T + HRDLK NI +KI D GLA + F + T + APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-----FAKAVIGTPEFMAPEM 184
Query: 195 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254
+ KY ++D+++ G EM T + + Q+
Sbjct: 185 ---YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-------------------- 221
Query: 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310
R V + A P ++E + + +R + ++ L +F
Sbjct: 222 --------YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 2e-62
Identities = 72/304 (23%), Positives = 121/304 (39%), Gaps = 47/304 (15%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 76
++ +++G+GS+ V A + T AIK + + + RE ++ L HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
V++ + +Y + +L + I+ +F+ +++ L+Y
Sbjct: 69 FFVKLYFTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 195
+H + HRDLKP+NIL N D ++I DFG A+V ++ A +V T Y +PEL
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA-RANSFVGTAQYVSPELL 182
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
+ D+W++GCI +++ G P F N +
Sbjct: 183 TE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------------------ 222
Query: 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA------LADPY 309
K F KF P A L+E+LL D R EE A P+
Sbjct: 223 ----------IKLEYDFPEKFF---PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
Query: 310 FHGL 313
F +
Sbjct: 270 FESV 273
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 3e-59
Identities = 63/293 (21%), Positives = 104/293 (35%), Gaps = 38/293 (12%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
+ + + IG GS+G V VA+K +N E+ +LR RH
Sbjct: 8 GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLK 134
+I+ + +V + E S L+ + + Q +G+
Sbjct: 65 NILLFMGYS------TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 135 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE- 193
Y+H ++ HRDLK NI + D +KI DFGLA V + S F + + APE
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMAPEV 177
Query: 194 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253
+ + Y+ D+++ G + E++TG+ + N Q+ M
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--------------- 222
Query: 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306
R S N L+ L +RP + LA
Sbjct: 223 ----------GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 4e-59
Identities = 74/304 (24%), Positives = 115/304 (37%), Gaps = 47/304 (15%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLRLL 73
Y E +G G + VV + TG + A K I I RE+ +L+ +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 74 RHPDIVEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRG 132
+HP+++ + + D+ ++ EL+ L + + LT E FL Q+L G
Sbjct: 71 QHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 133 LKYIHTANVFHRDLKPKNILANAD----CKLKICDFGLARVSFNDAPSAIFWTDYVATRW 188
+ Y+H+ + H DLKP+NI+ ++KI DFGLA + T
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPE 181
Query: 189 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248
+ APE+ D+WSIG I +L+G F G L +
Sbjct: 182 FVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV----------- 228
Query: 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308
F N LA + RLL DPK R T +++L P
Sbjct: 229 ----------------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 272
Query: 309 YFHG 312
+
Sbjct: 273 WIKP 276
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 194 bits (493), Expect = 6e-59
Identities = 72/293 (24%), Positives = 119/293 (40%), Gaps = 33/293 (11%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 76
RY++ E++G G V A D VA+K + D+ S R RE + L HP
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 135
IV + + Y+V E ++ L ++ +TP+ + + L +
Sbjct: 68 AIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 136 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 195
H + HRD+KP NI+ +A +K+ DFG+AR + S + T Y +PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 196 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
D++S+GC+ E+LTG+P F G + V
Sbjct: 187 RG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV----------------- 227
Query: 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-TAEEALAD 307
++ P+P S + ++ + LA +P++R TA E AD
Sbjct: 228 ----------REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 2e-57
Identities = 69/307 (22%), Positives = 118/307 (38%), Gaps = 57/307 (18%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLR 71
S+YQ+ ++G G +G V S + VAIK + + + + TR+ E+ LL+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 72 LLR--HPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLY 127
+ ++ + P ++ E E DL I L E + F +
Sbjct: 63 KVSSGFSGVIRLLDWFERPDS-----FVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 128 QLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVSFNDAPSAIFWTDYVAT 186
Q+L +++ H V HRD+K +NIL + + +LK+ DFG + + +TD+ T
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGT 172
Query: 187 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246
R Y PE + + + +WS+G + +M+ G F +
Sbjct: 173 RVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------------- 216
Query: 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306
+ V F + HL+ LA P DRPT EE
Sbjct: 217 -------------------IRGQVFFRQRVS---SECQHLIRWCLALRPSDRPTFEEIQN 254
Query: 307 DPYFHGL 313
P+ +
Sbjct: 255 HPWMQDV 261
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 1e-56
Identities = 65/300 (21%), Positives = 113/300 (37%), Gaps = 45/300 (15%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLL-RLLRH 75
+ + +++GKGS+G V A T + AIK + DV D + E ++L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLK 134
P + + ++ V E + DL I++ F+ +++ GL+
Sbjct: 63 PFLTHMFCTFQTKEN-----LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 117
Query: 135 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 194
++H+ + +RDLK NIL + D +KI DFG+ + + + T Y APE+
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPEI 174
Query: 195 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254
KY ++D WS G + EML G+ F G++
Sbjct: 175 LLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH------------------- 213
Query: 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE-EALADPYFHGL 313
+ + A LL +L +P+ R + P F +
Sbjct: 214 ---------SIRMDNPFYPRWLE---KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 4e-55
Identities = 68/302 (22%), Positives = 125/302 (41%), Gaps = 48/302 (15%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPD 77
+ +++GKG++G V + TG A+K + +V + + E ++L+ RHP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYI 136
+ +K+ R + V E L + T E +F+ +++ L+Y+
Sbjct: 67 LTALKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
H+ +V +RD+K +N++ + D +KI DFGL + +D + + T Y APE+
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF---CGTPEYLAPEVLE 178
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256
+ Y A+D W +G + EM+ G+ F ++ +L+
Sbjct: 179 D--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------------------- 217
Query: 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFH 311
+ + F P A LL LL DPK R A+E + +F
Sbjct: 218 ---------LMEEIRFPRTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
Query: 312 GL 313
+
Sbjct: 266 SI 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 181 bits (460), Expect = 5e-53
Identities = 69/306 (22%), Positives = 116/306 (37%), Gaps = 49/306 (16%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLRLL 73
+ + +IG+G +G V TG+ A+K ++ + + + A + L+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 74 RHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRG 132
P IV + + P + + + +LM DLH + + + +F+ +++ G
Sbjct: 65 DCPFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 119
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 192
L+++H V +RDLKP NIL + ++I D GLA P A T Y AP
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG-----THGYMAP 174
Query: 193 ELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252
E+ Y + D +S+GC+ ++L G F + ++
Sbjct: 175 EVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--------------- 218
Query: 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALAD 307
M V F P LLE LL D R A+E
Sbjct: 219 ----------RMTLTMAVELPDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265
Query: 308 PYFHGL 313
P+F L
Sbjct: 266 PFFRSL 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 179 bits (454), Expect = 8e-53
Identities = 65/302 (21%), Positives = 117/302 (38%), Gaps = 51/302 (16%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPD 77
+QI +G GS+G V H G A+K + ++ + E +L ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKYI 136
I+ + ++ + I+++ + +E + P +F+ ++ L+Y+
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
H+ ++ +RDLKP+NIL + + +KI DFG A+ + T Y APE+
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVS 174
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256
+ Y +ID WS G + EML G F N + + +
Sbjct: 175 T--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------------------- 213
Query: 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYFH 311
+ + P P + LL RL+ D R E+ P+F
Sbjct: 214 -------LNAELRFP-----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261
Query: 312 GL 313
+
Sbjct: 262 EV 263
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 6e-51
Identities = 58/293 (19%), Positives = 111/293 (37%), Gaps = 52/293 (17%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
++ + IGKG +G V + G +VA+K I + + A L E ++ LRH
Sbjct: 7 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND----ATAQAFLAEASVMTQLRHS 60
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGL 133
++V++ +++ E +Y+V E M L +++ L + F + +
Sbjct: 61 NLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 193
+Y+ N HRDL +N+L + D K+ DFGL + + + + APE
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST------QDTGKLPVKWTAPE 170
Query: 194 LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252
K++ D+WS G + E+ + G+ +P + + + R+
Sbjct: 171 AL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---------------KDVVPRV 213
Query: 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 305
K P P +++ D RP+ +
Sbjct: 214 EKG----------YKMDAP-----DGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-50
Identities = 67/304 (22%), Positives = 112/304 (36%), Gaps = 30/304 (9%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 75
A +QE IGKG +G V GE VA+K + + EI +LRH
Sbjct: 2 ARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRH 56
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 134
+I+ + + +++V + E L + +T E GL
Sbjct: 57 ENILGFIAADNKDNGT-WTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLA 114
Query: 135 YIHTA--------NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-IFWTDYVA 185
++H + HRDLK KNIL + I D GLA + + I V
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 186 TRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 241
T+ Y APE+ + + DI+++G +F E+ + G + +QL +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233
Query: 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA 301
PS E + ++ E+ R +P + A + ++ + R TA
Sbjct: 234 SDPSVEEMRKVVCEQKLRP--------NIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285
Query: 302 EEAL 305
Sbjct: 286 LRIK 289
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 4e-50
Identities = 61/327 (18%), Positives = 129/327 (39%), Gaps = 47/327 (14%)
Query: 1 MQSALETEFFTEYGE---ASRYQIQEVIGKGSYGVVGSAVDTH---TGERVAIKKIN--D 52
++ L T T + E +++ +V+G G+YG V TG+ A+K +
Sbjct: 5 VKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKAT 64
Query: 53 VFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVI 111
+ + E ++L +R + + L + + ++++ + + +L +
Sbjct: 65 IVQKAKTTEHTRTERQVLEHIRQSPFL----VTLHYAFQTETKLHLILDYINGGELFTHL 120
Query: 112 KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171
+ T Q ++ +++ L+++H + +RD+K +NIL +++ + + DFGL++ F
Sbjct: 121 SQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EF 179
Query: 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 231
+ + + + G S + A+D WS+G + E+LTG F
Sbjct: 180 VADETERAYDFCGTIEYMAPDIVRGG-DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 238
Query: 232 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLL 291
+ + ++ + P P LA L++RLL
Sbjct: 239 NSQAEI----------------------SRRILKSEPPYP-----QEMSALAKDLIQRLL 271
Query: 292 AFDPKDRP-----TAEEALADPYFHGL 313
DPK R A+E +F +
Sbjct: 272 MKDPKKRLGCGPRDADEIKEHLFFQKI 298
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 6e-50
Identities = 59/294 (20%), Positives = 111/294 (37%), Gaps = 45/294 (15%)
Query: 24 VIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 81
+G G++G V G + VA+K + + + +L E +++ L +P IV +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 82 KHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 140
I E + +V E+ E L++ ++ N + ++ ++Q+ G+KY+ +N
Sbjct: 74 IGIC------EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 141 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 200
HRDL +N+L KI DFGL++ D T + APE
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--Y 185
Query: 201 KYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 259
K++ D+WS G + E + G+ + G +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM----------------------- 222
Query: 260 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE---ALADPYF 310
+ K + + P L+ +D ++RP L + Y+
Sbjct: 223 ----LEKGERMGCPAGCP---REMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (436), Expect = 7e-50
Identities = 55/301 (18%), Positives = 107/301 (35%), Gaps = 49/301 (16%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 76
++ + +G GS+G V +G A+K ++ + L E ++L+ + P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 136
+V+++ + V+ + ++ ++ + H +F+ Q++ +Y+
Sbjct: 102 FLVKLEFSF----KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
H+ ++ +RDLKP+N+L + +++ DFG A+ T APE+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPEALAPEIIL 211
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 256
S Y A+D W++G + EM G P F + +
Sbjct: 212 S--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE--------------------- 248
Query: 257 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYFH 311
V F F LL LL D R + +F
Sbjct: 249 -------KIVSGKVRFPSHFS---SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
Query: 312 G 312
Sbjct: 299 T 299
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 172 bits (437), Expect = 8e-50
Identities = 66/340 (19%), Positives = 116/340 (34%), Gaps = 47/340 (13%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
+RY + +G G + V A D VA+K + EIKLL+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDA 69
Query: 77 DIVE------------IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQF 124
D + + H + + + + +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 125 FLYQLLRGLKYIHTA-NVFHRDLKPKNILANAD------CKLKICDFGLARVSFNDAPSA 177
QLL GL Y+H + H D+KP+N+L ++KI D G A
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---- 185
Query: 178 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV------V 231
+T+ + TR YR+PE+ + + DIWS C+ E++TG LF
Sbjct: 186 --YTNSIQTREYRSPEVL--LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
Query: 232 HQLDLMTDLLGTPSTESISRIRNEK----ARRYLGSMRKKQPVPFSHKF-------PNAD 280
+ + +LLG + + + + +R L ++ K + P +
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301
Query: 281 PLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREP 320
L +L DP+ R A + P+ ++
Sbjct: 302 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR 341
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (432), Expect = 9e-50
Identities = 54/304 (17%), Positives = 96/304 (31%), Gaps = 44/304 (14%)
Query: 18 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 77
RY++ IG GS+G + D GE VAIK +H ++ E K+ ++++
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGV 63
Query: 78 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 136
+ E +V EL+ S + + + Q++ ++YI
Sbjct: 64 GIPTIRW----CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 137 HTANVFHRDLKPKNILAN---ADCKLKICDFGLARVSFNDAPSAIFW----TDYVATRWY 189
H+ N HRD+KP N L + I DFGLA+ + + T Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 190 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249
+ + + D+ S+G + G + G +
Sbjct: 180 ASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-------------- 223
Query: 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE---EALA 306
+Y KK P L + D+P +
Sbjct: 224 ---------KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
Query: 307 DPYF 310
+ +
Sbjct: 275 NLFH 278
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 169 bits (430), Expect = 1e-49
Identities = 49/298 (16%), Positives = 95/298 (31%), Gaps = 43/298 (14%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 75
Y++ IG+GS+GV+ + ++VAIK SDA ++ E + +LL
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLAG 59
Query: 76 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLK 134
+ + +E +V +L+ L ++ + + Q+L ++
Sbjct: 60 CTGIPNVYYFG----QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115
Query: 135 YIHTANVFHRDLKPKNILANADC-----KLKICDFGLARVSFNDAPSAIFW----TDYVA 185
IH ++ +RD+KP N L + + DFG+ + + +
Sbjct: 116 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 186 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245
T Y + + + D+ ++G +F L G + G
Sbjct: 176 TARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK----------- 222
Query: 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 303
+ RI KKQ P + P +
Sbjct: 223 -QKYERI-----------GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDY 268
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-49
Identities = 70/314 (22%), Positives = 115/314 (36%), Gaps = 55/314 (17%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
+++ +G+G +G V T RVAIK + L+E ++++ LRH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHE 72
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELME---SDLHQVIKANDDLTPEHYQFFLYQLLRGL 133
+V++ ++ + IY+V E M + L Q+ G+
Sbjct: 73 KLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 193
Y+ N HRDL+ NIL + K+ DFGLAR+ ++ +A + APE
Sbjct: 127 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR--QGAKFPIKWTAPE 184
Query: 194 LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252
++T D+WS G + E+ T G+ +PG LD + P
Sbjct: 185 AALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP-- 240
Query: 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA--DPYF 310
L+ + +P++RPT E A + YF
Sbjct: 241 ----------------------------ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
Query: 311 HGLANVDREPSTQP 324
EP QP
Sbjct: 273 -----TSTEPQYQP 281
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (428), Expect = 3e-49
Identities = 61/307 (19%), Positives = 112/307 (36%), Gaps = 46/307 (14%)
Query: 7 TEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGER---VAIKKINDVFEHVSDATRI 63
F + + S +I++VIG G +G V S G+R VAIK + +
Sbjct: 16 VREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDF 74
Query: 64 LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEH 121
L E ++ HP+++ ++ ++ + + ++ E ME+ +D T
Sbjct: 75 LSEASIMGQFDHPNVIHLEGVVTKSTP-----VMIITEFMENGSLDSFLRQNDGQFTVIQ 129
Query: 122 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 181
L + G+KY+ N HRDL +NIL N++ K+ DFGL+R +D + +
Sbjct: 130 LVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS 189
Query: 182 --DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMT 238
+ AP + K+T A D+WS G + E+++ G+ + ++ +
Sbjct: 190 ALGGKIPIRWTAP--EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE 247
Query: 239 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR 298
P L+ D R
Sbjct: 248 QDYRLPPPMDCP------------------------------SALHQLMLDCWQKDRNHR 277
Query: 299 PTAEEAL 305
P + +
Sbjct: 278 PKFGQIV 284
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 7e-49
Identities = 63/295 (21%), Positives = 106/295 (35%), Gaps = 44/295 (14%)
Query: 18 RYQIQEVIGKGSYGVVGSAV---DTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLL 73
++ E +G GS+GVV + VA+K + DV +RE+ + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 74 RHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLR 131
H +++ + ++ + +V EL S L ++ K + Q+
Sbjct: 69 DHRNLIRLYGVV------LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 191
G+ Y+ + HRDL +N+L +KI DFGL R + + + A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 192 PELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250
PE + ++ A D W G EM T G+ + G N L
Sbjct: 183 PESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH--------------- 225
Query: 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 305
+I E R P P + +++ + A P+DRPT
Sbjct: 226 KIDKEGERL---------PRP-----EDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-47
Identities = 63/300 (21%), Positives = 108/300 (36%), Gaps = 50/300 (16%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
++ E +G G +G V + +VA+K + + L E L++ L+H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQ 68
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMESDL---HQVIKANDDLTPEHYQFFLYQLLRGL 133
+V + ++ + IY++ E ME+ + LT Q+ G+
Sbjct: 69 RLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 134 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 193
+I N HRDL+ NIL + KI DFGLAR + + APE
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPE 180
Query: 194 LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252
+ +T D+WS G + E++T G+ +PG + +
Sbjct: 181 AI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------- 225
Query: 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA--DPYF 310
R +P N L+ P+DRPT + + + +F
Sbjct: 226 ----------GYRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 4e-47
Identities = 66/321 (20%), Positives = 122/321 (38%), Gaps = 69/321 (21%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGER-----VAIKKINDVFEHVSDATRILREIKLL- 70
+ +V+G G++G V +A + VA+K + + + S+ ++ E+K++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMT 95
Query: 71 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD------------- 116
+L H +IV + IY++FE DL +++ +
Sbjct: 96 QLGSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 117 ----------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 166
LT E F YQ+ +G++++ + HRDL +N+L +KICDFGL
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 167 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLF 225
AR +D+ + + + APE F YT D+WS G + E+ + G +
Sbjct: 211 ARDIMSDSNY-VVRGNARLPVKWMAPESL--FEGIYTIKSDVWSYGILLWEIFSLGVNPY 267
Query: 226 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH 285
PG V + ++ + A
Sbjct: 268 PGIPVDANFYKL--------------------------IQNGFKMDQP---FYATEEIYI 298
Query: 286 LLERLLAFDPKDRPTAEEALA 306
+++ AFD + RP+ +
Sbjct: 299 IMQSCWAFDSRKRPSFPNLTS 319
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 5e-47
Identities = 60/309 (19%), Positives = 116/309 (37%), Gaps = 48/309 (15%)
Query: 18 RYQIQEV-IGKGSYGVVGSAVDTHTGER--VAIKKINDVFEHVSDATRILREIKLLRLLR 74
I ++ +G G++G V V ++ VAIK + E +D ++RE +++ L
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLD 67
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRG 132
+P IV + + + + + +V E+ LH+ + +++ + L+Q+ G
Sbjct: 68 NPYIVRLIGVC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 192
+KY+ N HRDL +N+L KI DFGL++ D + + AP
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
Query: 193 ELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251
E K++ D+WS G E L+ G+ + +
Sbjct: 182 ECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF--------------- 224
Query: 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE---ALADP 308
+ + + + P P L+ + +DRP +
Sbjct: 225 ------------IEQGKRMECP---PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
Query: 309 YFHGLANVD 317
Y+ + V+
Sbjct: 270 YYSLASKVE 278
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 7e-47
Identities = 51/292 (17%), Positives = 101/292 (34%), Gaps = 46/292 (15%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 78
+ +G G +GVV VAIK I E + E K++ L H +
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKL 61
Query: 79 VEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 136
V++ + + + I+++ E M L+ + + + + ++Y+
Sbjct: 62 VQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
+ HRDL +N L N +K+ DFGL+R +D ++ + PE+
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS--SVGSKFPVRWSPPEVLM 174
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
SK++ DIW+ G + E+ + GK + +
Sbjct: 175 Y--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH------------------- 213
Query: 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307
+ + + H ++ +RPT + L++
Sbjct: 214 --------IAQGLRLYRPHLAS---EKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (408), Expect = 2e-46
Identities = 54/290 (18%), Positives = 110/290 (37%), Gaps = 40/290 (13%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
+ ++ +G G YG V V VA+K + E + L+E +++ ++HP
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 73
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 136
++V++ + ++ + + L + +++ + Q+ ++Y+
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYL 131
Query: 137 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 196
N HRDL +N L + +K+ DFGL+R+ D +A + APE
Sbjct: 132 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA--HAGAKFPIKWTAPESLA 189
Query: 197 SFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255
+K++ D+W+ G + E+ T G +PG ++ +L
Sbjct: 190 Y--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL------------------- 228
Query: 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 305
+ K + P L+ ++P DRP+ E
Sbjct: 229 --------LEKDYRMERPEGCP---EKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 8e-46
Identities = 63/292 (21%), Positives = 109/292 (37%), Gaps = 46/292 (15%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 76
S + IG G +G+V ++VAIK I E + E +++ L HP
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHP 60
Query: 77 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHY-QFFLYQLLRGLK 134
+V++ + L + I +VFE ME L ++ L + G+
Sbjct: 61 KLVQLYGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 135 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 194
Y+ A V HRDL +N L + +K+ DFG+ R +D T + +PE+
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEV 173
Query: 195 CGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253
FS+Y+ D+WS G + E+ + GK + ++ ++ ++
Sbjct: 174 F--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-------------- 217
Query: 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 305
R +P A ++ P+DRP L
Sbjct: 218 ---------GFRLYKP-------RLASTHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-44
Identities = 59/298 (19%), Positives = 115/298 (38%), Gaps = 43/298 (14%)
Query: 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATRILREIKLL 70
S Q+VIG G +G V + + + VAIK + + L E ++
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIM 63
Query: 71 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQ 128
H +I+ ++ ++ ++K + ++ E ME + + + + + + L
Sbjct: 64 GQFSHHNIIRLEGVI-----SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118
Query: 129 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 188
+ G+KY+ N HRDL +NIL N++ K+ DFGL+RV +D + +
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 189 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248
+ APE K+T A D+WS G + E++T + H++
Sbjct: 179 WTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-------------- 222
Query: 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306
+ ++ +P P L+ + + RP + ++
Sbjct: 223 ------------MKAINDGFRLPTPMDCP---SAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 5e-44
Identities = 57/296 (19%), Positives = 109/296 (36%), Gaps = 44/296 (14%)
Query: 18 RYQIQEVIGKGSYGVVGSAVD---THTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 74
EVIG+G +G V A+K +N + + + ++ L E +++
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFS 86
Query: 75 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ--FFLYQLLRG 132
HP+++ + I L VV M+ + N+ P F Q+ +G
Sbjct: 87 HPNVLSLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 142
Query: 133 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VSFNDAPSAIFWTDYVATRWYRA 191
+K++ + HRDL +N + + +K+ DFGLAR + + S T + A
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 192 PELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250
E + K+T D+WS G + E++T G P +P N
Sbjct: 203 LESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-------------- 246
Query: 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306
+ + + + P+ ++ + + RP+ E ++
Sbjct: 247 -------------LLQGRRLLQPEYCPDP---LYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 7e-44
Identities = 55/297 (18%), Positives = 108/297 (36%), Gaps = 43/297 (14%)
Query: 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATRILREIKLLR 71
+ ++ +V+G G++G V + GE+ VAIK++ + ++ IL E ++
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMA 66
Query: 72 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLR 131
+ +P + + I L + + + L V + D++ ++ + Q+ +
Sbjct: 67 SVDNPHVCRLLGICLTSTVQ----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 191
G+ Y+ + HRDL +N+L +KI DFGLA++ + A
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL-LGAEEKEYHAEGGKVPIKWMA 181
Query: 192 PELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250
E YT D+WS G E++T G + G ++
Sbjct: 182 LESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK----------- 228
Query: 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307
++ P P P ++ + D RP E + +
Sbjct: 229 --------------GERLPQP-----PICTIDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 2e-43
Identities = 62/297 (20%), Positives = 108/297 (36%), Gaps = 47/297 (15%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGER---VAIKKINDVFEHVSDATRILREIKLLRLL 73
R ++ IG+G +G V + VAIK + S + L+E +R
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMRQF 65
Query: 74 RHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLR 131
HP IV++ ++ ++++ EL + L + YQL
Sbjct: 66 DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 132 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 191
L Y+ + HRD+ +N+L +++ +K+ DFGL+R + + + + + A
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKWMA 177
Query: 192 PELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250
PE ++T A D+W G E+L G F G +
Sbjct: 178 PESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-------------- 221
Query: 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307
+ + +P PN P L+ + A+DP RP E A
Sbjct: 222 -------------IENGERLPMP---PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 4e-43
Identities = 64/311 (20%), Positives = 110/311 (35%), Gaps = 63/311 (20%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGER--VAIKKINDVFEHVSDATRILREIKLL-RLL 73
+ + Q+VIG+G++G V A G R AIK++ + D E+++L +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLG 68
Query: 74 RHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD---------------- 116
HP+I+ + +Y+ E +L ++ +
Sbjct: 69 HHPNIINLLGACEHRGY-----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 117 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 176
L+ + F + RG+ Y+ HRDL +NIL + KI DFGL+R
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183
Query: 177 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLD 235
T + A E S YT D+WS G + E+++ G + G +
Sbjct: 184 ----TMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237
Query: 236 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDP 295
+ R ++P N D L+ + P
Sbjct: 238 KLPQ-----------------------GYRLEKP-------LNCDDEVYDLMRQCWREKP 267
Query: 296 KDRPTAEEALA 306
+RP+ + L
Sbjct: 268 YERPSFAQILV 278
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (386), Expect = 4e-43
Identities = 54/320 (16%), Positives = 104/320 (32%), Gaps = 70/320 (21%)
Query: 17 SRYQIQEVIGKGSYGVV-----GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLR 71
+ + IG+G++G V + VA+K + + RE L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMA 71
Query: 72 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD-------------- 116
+P+IV++ + + ++FE M DL++ +++
Sbjct: 72 EFDNPNIVKLLGVCAVGKP-----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 117 ----------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 166
L+ Q+ G+ Y+ HRDL +N L + +KI DFGL
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 167 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLF 225
+R ++ D + RW + ++YT D+W+ G + E+ + G +
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFY---NRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 226 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH 285
G + +R + P +
Sbjct: 244 YGMAHEEVIYY---------------------------VRDGNILACPENCP---LELYN 273
Query: 286 LLERLLAFDPKDRPTAEEAL 305
L+ + P DRP+
Sbjct: 274 LMRLCWSKLPADRPSFCSIH 293
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 6e-43
Identities = 66/315 (20%), Positives = 114/315 (36%), Gaps = 64/315 (20%)
Query: 17 SRYQIQEVIGKGSYGVVGSA-----VDTHTGERVAIKKINDVFEHVSDATRILREIKLL- 70
+R + +G G++G V A + + VA+K + H+++ ++ E+K+L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSELKVLS 81
Query: 71 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD------------- 116
L H +IV + V+ E DL ++ D
Sbjct: 82 YLGNHMNIVNLLGACTIGGP-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 117 -----LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171
L E F YQ+ +G+ ++ + N HRDL +NIL KICDFGLAR
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNV 230
ND+ + + +W + YT D+WS G E+ + G +PG V
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFN---CVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 231 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERL 290
+ M +++ + P +++
Sbjct: 254 DSKFYKM--------------------------IKEGFRMLSPEHAP---AEMYDIMKTC 284
Query: 291 LAFDPKDRPTAEEAL 305
DP RPT ++ +
Sbjct: 285 WDADPLKRPTFKQIV 299
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 2e-41
Identities = 59/317 (18%), Positives = 115/317 (36%), Gaps = 65/317 (20%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTHTGE-------RVAIKKINDVFEHVSDATRILREIKL 69
R + + +G+G++G V A + +VA+K + D + ++ E+++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEM 71
Query: 70 L-RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIK--------------- 112
+ + +H +I+ + + +YV+ E +L + ++
Sbjct: 72 MKMIGKHKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126
Query: 113 -ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171
+ L+ + YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNV 230
+ + +W L YT D+WS G + E+ T G +PG V
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 231 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERL 290
L +++ + N ++
Sbjct: 244 EELFKL---------------------------LKEGHRMDKPSNCTNE---LYMMMRDC 273
Query: 291 LAFDPKDRPTAEEALAD 307
P RPT ++ + D
Sbjct: 274 WHAVPSQRPTFKQLVED 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-40
Identities = 54/307 (17%), Positives = 104/307 (33%), Gaps = 56/307 (18%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLR 71
+ + +G+GS+G+V V RVAIK +N+ + L E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMK 78
Query: 72 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD----------LTPE 120
+V + ++ V+ ELM DL +++ +
Sbjct: 79 EFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 121 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 180
++ G+ Y++ HRDL +N + D +KI DFG+ R +
Sbjct: 134 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYRKG 192
Query: 181 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQLDLMTD 239
+ + +PE +T D+WS G + E+ T + + G + L + +
Sbjct: 193 GKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250
Query: 240 LLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP 299
P N + L+ ++PK RP
Sbjct: 251 -------------------------GGLLDKP-----DNCPDMLFELMRMCWQYNPKMRP 280
Query: 300 TAEEALA 306
+ E ++
Sbjct: 281 SFLEIIS 287
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-40
Identities = 60/312 (19%), Positives = 111/312 (35%), Gaps = 59/312 (18%)
Query: 17 SRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLR 71
R ++ + +G+G++G V A T T VA+K + + H + L+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 72 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAN---------------- 114
+ H ++V + P + V+ E + +L +++
Sbjct: 73 IGHHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 115 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174
D LT EH + +Q+ +G++++ + HRDL +NIL + +KICDFGLAR + D
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
Query: 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQ 233
+ +W + YT D+WS G + E+ + +PG + +
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 234 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAF 293
R+ + P +
Sbjct: 246 F-----------------------------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 276
Query: 294 DPKDRPTAEEAL 305
+P RPT E +
Sbjct: 277 EPSQRPTFSELV 288
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 98.3 bits (244), Expect = 2e-24
Identities = 25/203 (12%), Positives = 59/203 (29%), Gaps = 27/203 (13%)
Query: 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI--------NDVFEHVSDATRILREIKLL 70
I +++G+G V + +K +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 71 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLL 130
+ +++ + +P ++ V+ EL+++ ++ E+ L +L
Sbjct: 61 ARNEFRALQKLQGLAVPK-VYAWEGNAVLMELIDAKELYRVR------VENPDEVLDMIL 113
Query: 131 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VSFNDAPSAIFWTDYVATRWY 189
+ + + H DL N+L ++ + I DF + V + ++
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVL-VSEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 190 RAPELCGSFFSKYTPAIDIWSIG 212
Y DI S
Sbjct: 173 S---------RTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 508 | |||
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.39 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.93 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.68 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.96 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.76 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.7 |
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-62 Score=498.99 Aligned_cols=334 Identities=41% Similarity=0.771 Sum_probs=280.4
Q ss_pred cccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 11 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 11 ~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
+.|...++|++++.||+|+||+||+|+++.+|+.||||++++........+.+.+|+++|+.++|||||++++++.....
T Consensus 12 ~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~ 91 (346)
T d1cm8a_ 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91 (346)
T ss_dssp SEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred ceeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence 34667899999999999999999999999999999999998766666677889999999999999999999999976532
Q ss_pred -CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 91 -REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 91 -~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
....++|+|||||+++|..+++. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 92 ~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 92 LDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ccccceEEEEEecccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceec
Confidence 23456899999998888887764 5799999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
.... .+..+||++|+|||++.+. ..++.++||||+||++|+|++|++||.+.+..+++..+....+.++.+.+
T Consensus 171 ~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 171 ADSE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CCSS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cCCc------cccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 5322 3567899999999998762 56789999999999999999999999999999999999999999999998
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccchh
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLE 329 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~~ 329 (508)
..........+...........+...++++++.+++||.+||.+||.+|||++|+|+||||+.+.+...++..+ +++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~---~~~ 320 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ---KYD 320 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC---CCC
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCC---CCC
Confidence 88877777777777777777888888899999999999999999999999999999999999988766665443 344
Q ss_pred hHHHHhhcCHHHHHHHHHHHHHHhCh
Q 010512 330 FEFERRKLAKDDVREMIYREILEYHP 355 (508)
Q Consensus 330 ~~~~~~~~~~~~~~~~i~~ei~~~~~ 355 (508)
..++......+++++++++|+++++|
T Consensus 321 ~~~~~~~~~~~e~k~~~~~e~~~~~~ 346 (346)
T d1cm8a_ 321 DSFDDVDRTLDEWKRVTYKEVLSFKP 346 (346)
T ss_dssp CC-----CCHHHHHHHHHHHHHTCCC
T ss_pred CchhhhhcCHHHHHHHHHHHhhcCCC
Confidence 45566667889999999999998876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-60 Score=486.79 Aligned_cols=340 Identities=47% Similarity=0.827 Sum_probs=283.4
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
.|..++||++++.||+|+||+||+|+++.+|+.||||++++. ......+++.+|+.+|+.|+||||+++++++......
T Consensus 3 ~~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81 (345)
T ss_dssp CCCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred ccCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh-cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccc
Confidence 466788999999999999999999999999999999999743 3445567889999999999999999999999776555
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 92 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 92 ~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
....+|+||++++|+|.+++... ++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~~~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 82 QMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp TCCCEEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 55678888888889999999765 69999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
............+||+.|+|||++... ..|+.++||||+||++|+|++|++||.+.+..++...+...++.+.......
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred CCCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 443333334567899999999998652 6788999999999999999999999999999999999999999998887766
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccchhhH
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFE 331 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~ 331 (508)
...................++...++.+++.+++||.+||++||.+|||++|+|+||||+.......++..+. ...+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~--~~~~~ 317 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFD 317 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSS--CC---
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccccC--ccCCC
Confidence 6666666666667777777777788899999999999999999999999999999999997766554443332 23445
Q ss_pred HHHhhcCHHHHHHHHHHHHHHhChh
Q 010512 332 FERRKLAKDDVREMIYREILEYHPQ 356 (508)
Q Consensus 332 ~~~~~~~~~~~~~~i~~ei~~~~~~ 356 (508)
.+...+..++++++++.|...++|+
T Consensus 318 ~~~~~~~~~~l~~l~~~e~~~~~~~ 342 (345)
T d1pmea_ 318 MELDDLPKEKLKELIFEETARFQPG 342 (345)
T ss_dssp -----CCHHHHHHHHHHHSGGGSTT
T ss_pred hhhhhCCHHHHHHHHHHHHHhcCCC
Confidence 5667788899999999999888885
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-60 Score=483.74 Aligned_cols=333 Identities=44% Similarity=0.819 Sum_probs=284.9
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc-
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR- 90 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~- 90 (508)
.|..++||++++.||+|+||+||+|++..+|+.||||++++.........++.+|+.+|+.|+|||||++++++.....
T Consensus 13 ~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~ 92 (348)
T d2gfsa1 13 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 92 (348)
T ss_dssp EEEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSST
T ss_pred cccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccc
Confidence 3556789999999999999999999999999999999998776666777889999999999999999999999875432
Q ss_pred CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 91 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 91 ~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
++...+|+++++++|+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++...
T Consensus 93 ~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 93 EEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp TTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred ccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc
Confidence 23345666666666899998854 57999999999999999999999999999999999999999999999999999753
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.. ......||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......|....+.+..+...
T Consensus 172 ~~------~~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 172 DD------EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp TG------GGSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred Cc------ccccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 21 23456899999999997762 467899999999999999999999999999999999999999999988887
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCccchhh
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEF 330 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~~~~~~~~~~~ 330 (508)
.........+...........+...+.++++.+++||.+||.+||.+|||++|+|+||||+++.+++.++...+ +.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~---~~~ 321 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YDQ 321 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCC---CCC
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCC---CCC
Confidence 77777777777766666666677777889999999999999999999999999999999999888777776554 345
Q ss_pred HHHHhhcCHHHHHHHHHHHHHHhCh
Q 010512 331 EFERRKLAKDDVREMIYREILEYHP 355 (508)
Q Consensus 331 ~~~~~~~~~~~~~~~i~~ei~~~~~ 355 (508)
.++......+++++++++|+.++.|
T Consensus 322 ~~~~~~~~~~~~k~~~~~e~~~~~p 346 (348)
T d2gfsa1 322 SFESRDLLIDEWKSLTYDEVISFVP 346 (348)
T ss_dssp GGGGCCCCHHHHHHHHHHHHHTCCC
T ss_pred cccchhcCHHHHHHHHHHHhhccCC
Confidence 6677888999999999999998876
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-60 Score=469.81 Aligned_cols=260 Identities=27% Similarity=0.406 Sum_probs=215.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++++.||+|+||+||+|+++.+|+.||||+++.... ....+.+.+|+.+|+.++|||||++++++. +.+.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~-----~~~~ 77 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNI 77 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeec-----cCce
Confidence 3579999999999999999999999999999999965322 223456889999999999999999999994 4457
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|||||||+ |+|.+++..++.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred eEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999998754322
Q ss_pred CCcccccccccCcccccccccccccCC-CCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~-y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
. ....+..+||+.|||||++.+ .. ++.++|||||||++|+|++|++||.+.+...+......
T Consensus 158 ~-~~~~~~~~GT~~Y~APE~~~~--~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~-------------- 220 (271)
T d1nvra_ 158 R-ERLLNKMCGTLPYVAPELLKR--REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-------------- 220 (271)
T ss_dssp E-ECCBCCCCSCGGGSCTHHHHC--SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH--------------
T ss_pred c-cccccceeeCcCccCHhHhcC--CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh--------------
Confidence 2 223456799999999999976 44 46889999999999999999999987654322211110
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
........++.+++.+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 221 --------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 221 --------------EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp --------------TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred --------------cCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 001112224567899999999999999999999999999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-60 Score=465.05 Aligned_cols=253 Identities=25% Similarity=0.443 Sum_probs=219.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++|||||++++++. +.+.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----ECCE
Confidence 57999999999999999999999999999999986432 12233567889999999999999999999995 3456
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|||||||+ |+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred EEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 999999998 699999998889999999999999999999999999999999999999999999999999999754322
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
.....+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+...-
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~------------- 220 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE------------- 220 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-------------
T ss_pred ----cccccCCCCcccCHHHHcC--CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 1345689999999999987 689999999999999999999999999888766555443210
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
..+ ...+++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 221 ---------------~~~---p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 221 ---------------FTF---PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp ---------------CCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred ---------------CCC---CccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 011 1347899999999999999999999999999999964
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-59 Score=465.36 Aligned_cols=256 Identities=28% Similarity=0.466 Sum_probs=219.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++++.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|+.+|+.++|||||++++++.. .+.
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~ 91 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLV-----GDE 91 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCE
Confidence 4689999999999999999999999999999999974332 235678999999999999999999999954 456
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|||||||+ |+|.+++..+ .+++.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 92 ~~ivmEy~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEEecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999998 6999887664 69999999999999999999999999999999999999999999999999998753322
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+....
T Consensus 171 ~---~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~------------- 232 (293)
T d1yhwa1 171 S---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG------------- 232 (293)
T ss_dssp C---CBCCCCSCGGGCCHHHHSS--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-------------
T ss_pred c---cccccccCCCccChhhhcC--CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence 2 2356789999999999987 789999999999999999999999999888766655443210
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
.... ...+.+++.+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 233 ------------~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 233 ------------TPEL---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ------------SCCC---SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ------------CCCC---CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 0001 122457899999999999999999999999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-59 Score=460.33 Aligned_cols=258 Identities=29% Similarity=0.469 Sum_probs=210.3
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
.+++|++++.||+|+||+||+|+++.+|+.||||+++.........+.+.+|+++|+.++|||||++++++... ...
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~ 78 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNT 78 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCC
Confidence 35789999999999999999999999999999999987655666677899999999999999999999998643 235
Q ss_pred cEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhcC-----ceecCCCCCceeeCCCCcEEEccc
Q 010512 95 DIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDF 164 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~Qil~aL~yLHs~g-----IiHrDLKPeNILl~~~~~lkL~DF 164 (508)
.+|||||||+ |+|.+++.. +..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+||
T Consensus 79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF 158 (269)
T d2java1 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158 (269)
T ss_dssp CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence 6899999998 699998864 467999999999999999999999976 999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC
Q 010512 165 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244 (508)
Q Consensus 165 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p 244 (508)
|+|+....... ..+..+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....|...
T Consensus 159 G~a~~~~~~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~---- 229 (269)
T d2java1 159 GLARILNHDTS---FAKAFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG---- 229 (269)
T ss_dssp HHHHHC--------------CCCSCCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT----
T ss_pred cceeecccCCC---ccccCCCCcccCCHHHHcC--CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC----
Confidence 99987543221 2356789999999999987 68999999999999999999999999988765554444221
Q ss_pred ChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcc
Q 010512 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 310 (508)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f 310 (508)
. +......+++.+.+||.+||+.||.+|||++|+|+|||+
T Consensus 230 -----------------------~---~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 230 -----------------------K---FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp -----------------------C---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -----------------------C---CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 0 111123578999999999999999999999999999995
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-59 Score=469.87 Aligned_cols=284 Identities=36% Similarity=0.577 Sum_probs=228.7
Q ss_pred EEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh---hHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 20 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV---SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 20 ~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~---~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
+.+++||+|+||+||+|+++.+|+.||||+++...... .....+.+|+.+|+.++|||||++++++.. .+++
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-----~~~~ 75 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-----KSNI 75 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----TTCC
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-----CCce
Confidence 35789999999999999999999999999996543221 123468899999999999999999999944 4569
Q ss_pred EEEEecCCccHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 97 YVVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 97 ylV~E~~~g~L~~~i-~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
|||||||.+++...+ ..+..+++..++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 76 ~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 76 SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp EEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred eehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 999999997555444 4456799999999999999999999999999999999999999999999999999986533222
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
.....+||++|+|||++.+. ..|+.++||||+||++|+|++|.+||.+.+..+++..|...+|+|..+.+......
T Consensus 156 ---~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 156 ---AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp ---CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred ---cccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence 23457899999999998752 57899999999999999999999999999999999999999999887654332110
Q ss_pred HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
. ...........++...++.+++.+++||.+||++||.+|||++|+|+||||++...
T Consensus 232 ~---~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 232 P---DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp T---TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred c---hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 0 00011112223334445678999999999999999999999999999999986543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-59 Score=466.50 Aligned_cols=260 Identities=27% Similarity=0.468 Sum_probs=219.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
+++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++||||+++++++. +.+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~ 81 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDE 81 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE-----CSS
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE-----ECC
Confidence 467999999999999999999999999999999996432 12234567899999999999999999999994 446
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
.+|||||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC
Confidence 7999999998 599999999899999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
.. ....+..+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..|...
T Consensus 162 ~~-~~~~~~~~GT~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~------------- 225 (288)
T d1uu3a_ 162 SK-QARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL------------- 225 (288)
T ss_dssp ---------CCCCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-------------
T ss_pred Cc-ccccccccCCccccCceeecc--CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC-------------
Confidence 22 222456789999999999987 78999999999999999999999999988866655544321
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHH------HhcCCcccCCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE------ALADPYFHGLA 314 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~e------iL~hp~f~~~~ 314 (508)
. ..+ ...+++.+.+||.+||++||.+|||++| +++||||+++.
T Consensus 226 --------------~-~~~---p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 226 --------------E-YDF---PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp --------------C-CCC---CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred --------------C-CCC---CccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence 0 111 1357899999999999999999999988 58899999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-58 Score=456.08 Aligned_cols=259 Identities=27% Similarity=0.398 Sum_probs=217.4
Q ss_pred CCCCe-EEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 15 EASRY-QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 15 ~~~rY-~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
..+|| ++.+.||+|+||+||+|++..++..||+|++..........+.+.+|+++|+.++|||||++++++.... ...
T Consensus 6 ~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~ 84 (270)
T d1t4ha_ 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGK 84 (270)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSC
T ss_pred CCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccC
Confidence 34566 7888999999999999999999999999999766556666778999999999999999999999985432 234
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcC--ceecCCCCCceeeC-CCCcEEEcccccccc
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARV 169 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~g--IiHrDLKPeNILl~-~~~~lkL~DFGla~~ 169 (508)
..+|||||||+ |+|.+++.+...+++..++.|+.||++||+|||++| |+||||||+|||++ .++.+||+|||+|+.
T Consensus 85 ~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 85 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred CEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 67899999998 699999998889999999999999999999999999 99999999999997 478999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHH-HHHhhcCCCChHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD-LMTDLLGTPSTES 248 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~-~i~~~~g~p~~~~ 248 (508)
.... .....+||+.|||||++.+ .|+.++|||||||++|+|++|++||.+......+. .+.. +.
T Consensus 165 ~~~~-----~~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~--~~----- 229 (270)
T d1t4ha_ 165 KRAS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS--GV----- 229 (270)
T ss_dssp CCTT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT--TC-----
T ss_pred ccCC-----ccCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc--CC-----
Confidence 4221 2345789999999999865 69999999999999999999999998765443332 2211 00
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~ 311 (508)
.+. ......++.+.+||.+||++||++|||++|+|+||||+
T Consensus 230 -------------------~~~---~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 230 -------------------KPA---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp -------------------CCG---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred -------------------CCc---ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 111 11234678899999999999999999999999999995
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.3e-59 Score=466.14 Aligned_cols=260 Identities=29% Similarity=0.456 Sum_probs=207.4
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++++.||+|+||+||+|+++.+|+.||||++.+.... .....+.+|+.+|+.++|||||++++++. +.+
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~ 80 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYE-----SGG 80 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECC
Confidence 446799999999999999999999999999999999754332 22356789999999999999999999994 446
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeC---CCCcEEEccccccccc
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARVS 170 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~---~~~~lkL~DFGla~~~ 170 (508)
.+|||||||+ |+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||+. .++.+||+|||+|+..
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 7999999998 69999999988999999999999999999999999999999999999984 5789999999999864
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.... .....+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+.......+...
T Consensus 161 ~~~~----~~~~~~GT~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~---------- 224 (307)
T d1a06a_ 161 DPGS----VLSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA---------- 224 (307)
T ss_dssp ----------------CTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTT----------
T ss_pred cCCC----eeeeeeeCccccCcHHHcC--CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhcc----------
Confidence 3222 2345789999999999987 68999999999999999999999999988766655544321
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
........++.+++.+.+||.+||++||.+|||++|+|+||||++.
T Consensus 225 -----------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 225 -----------------EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp -----------------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred -----------------CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 1111223346789999999999999999999999999999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-59 Score=473.75 Aligned_cols=283 Identities=22% Similarity=0.355 Sum_probs=217.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++++.||+|+||+||+|++..+|+.||||+++... ......++.+|+.+|+.++|||||++++++.. ...
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~ 78 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE 78 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-----SSE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCE
Confidence 468999999999999999999999999999999997543 33455778999999999999999999999954 456
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-cCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs-~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
+|||||||+ |+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999 5999999988899999999999999999999997 59999999999999999999999999999865332
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhcCCCChHHHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH-QLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~-~l~~i~~~~g~p~~~~~~~~ 252 (508)
. .+..+||++|||||++.+ ..|+.++||||+|||+|||++|+.||.+.+... +...+....|.+........
T Consensus 159 ~-----~~~~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 159 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp T-----C---CCSSCCCCHHHHHC--SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred c-----cccccCCccccCchHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 1 345799999999999988 789999999999999999999999998766432 22223333333221110000
Q ss_pred hh--------------HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 253 RN--------------EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 253 ~~--------------~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.. ......+.......+... .....++++.+||.+||++||.+|||++|+|+||||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKL--PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCC--CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 00 000011111111111111 112367899999999999999999999999999999753
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-58 Score=472.85 Aligned_cols=329 Identities=36% Similarity=0.663 Sum_probs=255.6
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc-CC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-RE 92 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-~~ 92 (508)
...++|+++++||+|+||+||+|++..||+.||||++++...+.....++.+|+.+|++++||||+++++++..... +.
T Consensus 14 ~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred eecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 34579999999999999999999999999999999998776666677789999999999999999999999975432 34
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 93 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 93 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
..++|+|||||.+++.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++....
T Consensus 94 ~~~~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 94 FQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CCEEEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CceeEEEEeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 57899999999998887764 5699999999999999999999999999999999999999999999999999886533
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
.. ..+..++|+.|+|||++.+ ..|++++||||+||++|+|++|++||.+.+...++..+...++.+..+.+...
T Consensus 172 ~~----~~~~~~~t~~y~aPE~l~~--~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 172 SF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp -------------CCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred cc----ccccccccccccChhhhcC--CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 22 3456789999999999987 68999999999999999999999999999999999999999999988877665
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCC------------CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCCCCC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKF------------PNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREP 320 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~------------~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~~~~ 320 (508)
.. ....+...........+...+ ...++.+.+||.+||.+||.+||||+|+|+||||+.+.++..+.
T Consensus 246 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~ 324 (355)
T d2b1pa1 246 QP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE 324 (355)
T ss_dssp CH-HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHT
T ss_pred hh-hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCccccc
Confidence 43 333333333222222111111 12356789999999999999999999999999999765432222
Q ss_pred CCCCccchhhHHHHhhcCHHHHHHHHHHHHHH
Q 010512 321 STQPISKLEFEFERRKLAKDDVREMIYREILE 352 (508)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~ei~~ 352 (508)
...+ ...+.+.+++....++++++|+.|+++
T Consensus 325 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (355)
T d2b1pa1 325 APPP-QIYDKQLDEREHTIEEWKELIYKEVMN 355 (355)
T ss_dssp CCCC--------CCCCCCHHHHHHHHHHHHHC
T ss_pred CCCC-CCCCcchhhhhcCHHHHHHHHHHHhcC
Confidence 2211 233445566778889999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-58 Score=457.87 Aligned_cols=262 Identities=29% Similarity=0.455 Sum_probs=224.8
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC----hhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH----VSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 89 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~----~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 89 (508)
...++|++++.||+|+||+||+|+++.+|+.||||++++.... ....+.+.+|+.+|+.|+|||||++++++.
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--- 83 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE--- 83 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE---
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE---
Confidence 4557899999999999999999999999999999999653221 223577899999999999999999999994
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC----cEEEccc
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDF 164 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~----~lkL~DF 164 (508)
+...+|||||||+ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 84 --~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 84 --NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp --CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred --ECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecch
Confidence 4467999999998 69999999888999999999999999999999999999999999999999876 4999999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC
Q 010512 165 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 244 (508)
Q Consensus 165 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p 244 (508)
|+|+...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..|.......
T Consensus 162 G~a~~~~~~~----~~~~~~~t~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1jksa_ 162 GLAHKIDFGN----EFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235 (293)
T ss_dssp TTCEECTTSC----BCSCCCCCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC
T ss_pred hhhhhcCCCc----cccccCCCCcccCHHHHcC--CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 9998653322 2345689999999999987 689999999999999999999999999988877776665432222
Q ss_pred ChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 245 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
... .++.+++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 236 ~~~---------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 236 EDE---------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp CHH---------------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred Cch---------------------------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 211 124578899999999999999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-58 Score=462.54 Aligned_cols=288 Identities=39% Similarity=0.635 Sum_probs=235.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|++++.||+|+||+||+|.+..+|+.||||+++..........++.+|+++|+.++|||||++++++. +..++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~-----~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc-----cccce
Confidence 5899999999999999999999999999999999754433334567899999999999999999999994 44579
Q ss_pred EEEEecCCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 97 YVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 97 ylV~E~~~g~L~~~i~~--~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
|+|||||.+++.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99999999887777654 3569999999999999999999999999999999999999999999999999998753322
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
......+||+.|+|||++... ..++.++||||+||++|+|++|+.||.+.+..+++..+....|.+....+.....
T Consensus 157 ---~~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 ---RTYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp ---BCTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ---ccceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 224567899999999998762 4568999999999999999999999999999999999998888887665543221
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
. ..+...........+...++.+++.+.+||.+||.+||.+|||++|+|+||||+++..
T Consensus 233 ~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 233 M--PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp S--TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred c--cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 0 1111111112222233345678899999999999999999999999999999987754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-58 Score=466.77 Aligned_cols=256 Identities=25% Similarity=0.446 Sum_probs=222.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++||||+++++++. +...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSSE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec-----cccc
Confidence 57999999999999999999999999999999997532 12234677889999999999999999999994 4467
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+|||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999998 6999999999999999999999999999999999999999999999999999999999999998643322
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
. .....+||++|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..+...
T Consensus 160 ~---~~~~~~GT~~Y~aPE~~~~--~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~-------------- 220 (337)
T d1o6la_ 160 A---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------------- 220 (337)
T ss_dssp C---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------
T ss_pred c---ccccceeCHHHhhhhhccC--CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--------------
Confidence 2 2456799999999999988 78999999999999999999999999998866555444321
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCC
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGL 313 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~ 313 (508)
. .. ....+++.+.+||.+||++||.+|+ +++|+++||||+++
T Consensus 221 -------------~-~~---~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 221 -------------E-IR---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp -------------C-CC---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred -------------C-CC---CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 0 11 1235789999999999999999999 49999999999865
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-58 Score=459.25 Aligned_cols=259 Identities=24% Similarity=0.357 Sum_probs=217.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.+.|++++.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|+++|+.++|||||++++++.. .+.
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~ 83 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENN 83 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCe
Confidence 35799999999999999999999999999999999753 23445678899999999999999999999953 456
Q ss_pred EEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 96 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
+|||||||+ |+|.+++.. ..++++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 84 LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 999999998 699998765 457999999999999999999999999999999999999999999999999999754221
Q ss_pred CCCcccccccccCcccccccccccc---cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
. ......+||+.|+|||++... ...|+.++|||||||++|+|++|++||.+.+..+.+..+...
T Consensus 164 ~---~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~---------- 230 (288)
T d2jfla1 164 I---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS---------- 230 (288)
T ss_dssp H---HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS----------
T ss_pred c---ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC----------
Confidence 1 123457899999999998531 256899999999999999999999999988776665544321
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
.+ +.....+.+++.+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 231 -----------------~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 231 -----------------EP-PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp -----------------CC-CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred -----------------CC-CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 00 011122457899999999999999999999999999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.8e-58 Score=468.31 Aligned_cols=260 Identities=26% Similarity=0.422 Sum_probs=223.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|++++.||+|+||+||+|+++.+|+.||||++... .....+.+.+|+.+|+.|+|||||++++++. +.+.+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~ 98 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEM 98 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----ETTEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence 5899999999999999999999999999999999653 3445677899999999999999999999994 44679
Q ss_pred EEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC--CCcEEEccccccccccC
Q 010512 97 YVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVSFN 172 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~--~~~lkL~DFGla~~~~~ 172 (508)
|||||||+ |+|.+++.. .+.+++.+++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+....
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 99999998 699999854 457999999999999999999999999999999999999964 57899999999986533
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
.. .....+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|......+.
T Consensus 179 ~~----~~~~~~gT~~Y~aPEv~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~------- 245 (350)
T d1koaa2 179 KQ----SVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD------- 245 (350)
T ss_dssp TS----CEEEECSCTTTCCHHHHHT--CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC-------
T ss_pred cc----ccceecCcccccCHHHHcC--CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------
Confidence 22 2355789999999999987 7899999999999999999999999999887777766654322211
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 316 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~ 316 (508)
...++.+++.+.+||.+||.+||.+|||++|+|+||||+....+
T Consensus 246 --------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 246 --------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp --------------------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred --------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 12234678999999999999999999999999999999876543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-58 Score=461.01 Aligned_cols=290 Identities=35% Similarity=0.603 Sum_probs=237.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC-CcEEEEEEecCccCChhHHHHHHHHHHHHHhC---CCCCcceeeeeecCCCcC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHT-GERVAIKKINDVFEHVSDATRILREIKLLRLL---RHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~t-g~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L---~HpnIv~l~~v~~~~~~~ 91 (508)
.++|++++.||+|+||+||+|++..+ ++.||||+++...........+.+|+.+|+.| +||||+++++++......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47999999999999999999999766 66799999975444433344566788877766 799999999998654444
Q ss_pred CCccEEEEEecCCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 92 EFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 92 ~~~~lylV~E~~~g~L~~~i~~--~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
....+|+|||||++++..+... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 5578999999999766555443 35699999999999999999999999999999999999999999999999999975
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
.... ......+||+.|+|||++.+ ..|+.++||||+||++|||++|++||.+.+..+++..|...+|.|....+
T Consensus 166 ~~~~----~~~~~~~gT~~Y~APE~~~~--~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 166 YSFQ----MALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCGG----GGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hccc----ccCCCcccChhhcCcchhcC--CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 4322 23456789999999999987 78999999999999999999999999999999999999999999887654
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCC
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 315 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~ 315 (508)
....... ..........+.......+++.+.+||.+||++||.+|||++|+|+||||+++..
T Consensus 240 ~~~~~~~----~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 240 PRDVALP----RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp CTTCSSC----GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccch----hhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 3211100 0111223334444556778999999999999999999999999999999997643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-57 Score=465.88 Aligned_cols=258 Identities=27% Similarity=0.440 Sum_probs=223.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++++.||+|+||+||+|++..+|+.||||+++.. ...+...+.+|+.+|+.|+|||||++++++. +...
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~ 100 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYE 100 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCE
Confidence 35799999999999999999999999999999999753 2344567889999999999999999999994 4467
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeC--CCCcEEEcccccccccc
Q 010512 96 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN--ADCKLKICDFGLARVSF 171 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~--~~~~lkL~DFGla~~~~ 171 (508)
+|||||||+ |+|.+++...+ ++++.+++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+...
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC
Confidence 999999998 69998876654 699999999999999999999999999999999999998 57899999999998754
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
... ......||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..|.....
T Consensus 181 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--------- 245 (352)
T d1koba_ 181 PDE----IVKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW--------- 245 (352)
T ss_dssp TTS----CEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC---------
T ss_pred CCC----ceeeccCcccccCHHHHcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------
Confidence 322 2355689999999999987 7899999999999999999999999999887776666543221
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
......++.+++.+.+||.+||++||.+|||++|+|+||||++.
T Consensus 246 ------------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 246 ------------------EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp ------------------CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ------------------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 11223456789999999999999999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-57 Score=458.32 Aligned_cols=256 Identities=26% Similarity=0.383 Sum_probs=217.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..+|++++.||+|+||+||+|++..+|+.||||+++..... ....+.+.+|+.+|+.|+|||||++++++.. ..
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~ 88 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EH 88 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TT
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CC
Confidence 45699999999999999999999999999999999754332 3345678999999999999999999999954 35
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
.+|||||||.+ +|..++..++++++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 69999999995 6666677778899999999999999999999999999999999999999999999999999985422
Q ss_pred CCCcccccccccCcccccccccccc-cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
....+||+.|||||++.+. ...|+.++|||||||++|+|++|.+||.+.+..+.+..+...
T Consensus 168 ------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~------------ 229 (309)
T d1u5ra_ 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------------ 229 (309)
T ss_dssp ------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------------
T ss_pred ------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC------------
Confidence 2346899999999998652 246899999999999999999999999988766555444321
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
..+.. ....+++.+.+||.+||+.||.+|||++|+|+||||..
T Consensus 230 --------------~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 230 --------------ESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp --------------CCCCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred --------------CCCCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 11111 12356899999999999999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.7e-57 Score=455.47 Aligned_cols=254 Identities=25% Similarity=0.449 Sum_probs=220.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+.+|+.+|+.++|||||++++++. +...
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-----eCCe
Confidence 46999999999999999999999999999999996432 12234577889999999999999999999995 4467
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
+|+|||||. |+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 999999998 589999999999999999999999999999999999999999999999999999999999999875322
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
.+..+||+.|||||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-------------- 216 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-------------- 216 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--------------
T ss_pred -----cccccCcccccCHHHHcC--CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--------------
Confidence 245789999999999987 68999999999999999999999999998876655544321
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCC
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 314 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~~ 314 (508)
.. ...+.+++.+.+||.+||.+||.+|+ |++++|+||||+++.
T Consensus 217 ------------~~-----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 217 ------------EL-----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp ------------CC-----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred ------------CC-----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence 00 11135789999999999999999996 999999999998753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.3e-57 Score=450.90 Aligned_cols=284 Identities=38% Similarity=0.657 Sum_probs=235.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
+||++++.||+|+||+||+|+++ +|+.||||+++..........++.+|+.+|+.++||||+++++.+.. .+.+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc-----CCce
Confidence 68999999999999999999985 88999999997654444446788999999999999999999999954 4569
Q ss_pred EEEEecCCccHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 97 YVVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 97 ylV~E~~~g~L~~~i-~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
|+|||++.+++...+ ...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|........
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 999999997655555 4467899999999999999999999999999999999999999999999999999987533221
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHhhH
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 255 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 255 (508)
.....+||+.|+|||++.+. ..++.++||||+||++|+|++|++||.+.+..+++..+...+|.+....+.....
T Consensus 156 ---~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~- 230 (286)
T d1ob3a_ 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE- 230 (286)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG-
T ss_pred ---ccceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh-
Confidence 23456799999999998763 5689999999999999999999999999999999999999999887766543321
Q ss_pred HHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 256 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 256 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
...+........+.++....+.+++.+.|||.+||++||++|||++|+|+||||++
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 231 -LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp -STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred -hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 11122223334455556667789999999999999999999999999999999973
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-57 Score=461.89 Aligned_cols=254 Identities=21% Similarity=0.370 Sum_probs=220.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
-++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+++|+.++|||||++++++. ...
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~ 114 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc-----ccc
Confidence 368999999999999999999999999999999996432 22234567899999999999999999999994 445
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
.+|+||||+. |+|.+++...+.+++.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 115 ~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 6999999998 699999998889999999999999999999999999999999999999999999999999999865321
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
....+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..|....
T Consensus 195 ------~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------------ 254 (350)
T d1rdqe_ 195 ------TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK------------ 254 (350)
T ss_dssp ------BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------
T ss_pred ------cccccCccccCCHHHHcC--CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC------------
Confidence 245689999999999987 789999999999999999999999999988766655543211
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGL 313 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~ 313 (508)
+ .....+++.+.+||.+||.+||.+|+ |++++++||||++.
T Consensus 255 ---------------~----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 255 ---------------V----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp ---------------C----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred ---------------C----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 0 11235789999999999999999995 99999999999865
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-56 Score=443.64 Aligned_cols=262 Identities=28% Similarity=0.442 Sum_probs=222.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh-------hHHHHHHHHHHHHHhCC-CCCcceeeeeecC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-------SDATRILREIKLLRLLR-HPDIVEIKHIMLP 87 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~-------~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~ 87 (508)
.++|++++.||+|+||+||+|++..+|+.||||++++..... ....++.+|+.+|+.|+ ||||+++++++.
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~- 80 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE- 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE-
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc-
Confidence 368999999999999999999999999999999996543221 12346889999999997 999999999994
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccc
Q 010512 88 PSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 166 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGl 166 (508)
+.+.+|||||||+ |+|.++|..++++++..++.|+.||++||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 81 ----~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 81 ----TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp ----CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ----cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence 4467999999998 69999999988999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCcccccccccccc----cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC
Q 010512 167 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 242 (508)
Q Consensus 167 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~----~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g 242 (508)
++...... ..+..+||+.|+|||++.+. ...|+.++||||+||++|+|++|+.||.+.+.......+...
T Consensus 157 a~~~~~~~----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~-- 230 (277)
T d1phka_ 157 SCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG-- 230 (277)
T ss_dssp CEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--
T ss_pred eeEccCCC----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC--
Confidence 98753322 23567899999999998531 245789999999999999999999999998876655544321
Q ss_pred CCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 243 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 243 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
........++++++++++||.+||+.||.+|||++|+|+||||+..
T Consensus 231 -------------------------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 231 -------------------------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp -------------------------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred -------------------------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 1111122345788999999999999999999999999999999853
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-56 Score=457.24 Aligned_cols=287 Identities=35% Similarity=0.605 Sum_probs=235.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCC-cCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~-~~~~~~ 95 (508)
-+|+.+++||+|+||+||+|++..+|+.||||+++.... ...+|+.+|+.|+||||+++++++.... ..+..+
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 379999999999999999999999999999999965322 2247999999999999999999986542 234567
Q ss_pred EEEEEecCCccHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC-cEEEccccccccc
Q 010512 96 IYVVFELMESDLHQVI----KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVS 170 (508)
Q Consensus 96 lylV~E~~~g~L~~~i----~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~-~lkL~DFGla~~~ 170 (508)
+|||||||++++...+ .....+++.+++.|++||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 8999999997665544 3456799999999999999999999999999999999999999875 8999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.... .....+||+.|+|||++.+. ..|+.++||||+||++|||++|++||.+.+..+++..|.+.+|++..+.+.
T Consensus 174 ~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 174 VRGE----PNVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CTTS----CCCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cCCc----ccccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 4322 23457899999999998752 579999999999999999999999999999999999999999999988776
Q ss_pred HHhhHHHHHHHhhcccCCCCCCC-CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFS-HKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 317 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~~~~ 317 (508)
......... ........++. ...+..++.+.+||.+||.+||.+|||+.|+|+||||+.+.+..
T Consensus 249 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 313 (350)
T d1q5ka_ 249 EMNPNYTEF---KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313 (350)
T ss_dssp HHCC---CC---CCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred hhccchhhc---cccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCC
Confidence 543321111 11111122221 23456899999999999999999999999999999999876543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-56 Score=451.21 Aligned_cols=256 Identities=25% Similarity=0.438 Sum_probs=221.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
-+||++++.||+|+||+||+|+++.+|+.||||+++.. ..+...+.+|+++|+.++|||||++++++. +.+.
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~ 75 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFE-----SMEE 75 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCE
Confidence 46899999999999999999999999999999999753 234456889999999999999999999994 4467
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC--CcEEEcccccccccc
Q 010512 96 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVSF 171 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~--~~lkL~DFGla~~~~ 171 (508)
+|||||||+ |+|.++|...+ .+++.+++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 76 ~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 999999998 59999998765 79999999999999999999999999999999999999854 589999999998653
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
... .....++|+.|+|||.+.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..|......++..
T Consensus 156 ~~~----~~~~~~~t~~y~ape~~~~--~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~---- 225 (321)
T d1tkia_ 156 PGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE---- 225 (321)
T ss_dssp TTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH----
T ss_pred cCC----cccccccccccccchhccC--CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChh----
Confidence 322 2345689999999999987 689999999999999999999999999998877777665433222221
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
.++.+++.+.+||.+||.+||.+|||++|+|+||||++
T Consensus 226 -----------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 226 -----------------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp -----------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred -----------------------hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 23457889999999999999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.3e-56 Score=456.88 Aligned_cols=260 Identities=25% Similarity=0.360 Sum_probs=213.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC----ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE----HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~----~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
-++|+++++||+|+||+||+|++..+|+.||||++.+... ......+..+|+.+++.++|||||++++++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~---- 78 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT---- 78 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE----
Confidence 3679999999999999999999999999999999864321 11112223345777788889999999999944
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 170 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~ 170 (508)
.+.+|||||||+ |+|.+++.....+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 79 -~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 79 -PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred -CCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 456999999998 699999999889999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 171 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 171 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.... ....+||+.|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+....+....
T Consensus 158 ~~~~-----~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~--------- 222 (364)
T d1omwa3 158 SKKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--------- 222 (364)
T ss_dssp SSSC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS---------
T ss_pred CCCc-----ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---------
Confidence 3322 3456899999999998642 578999999999999999999999998765433322111110
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCcccCCC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLA 314 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpt-----a~eiL~hp~f~~~~ 314 (508)
..+. .....+++.+.+||.+||++||.+||| ++|+++||||+++.
T Consensus 223 ----------------~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 223 ----------------TMAV---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp ----------------SCCC---CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred ----------------cCCC---CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence 1111 122467899999999999999999999 89999999999764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-56 Score=449.90 Aligned_cols=297 Identities=35% Similarity=0.561 Sum_probs=230.1
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc---
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR--- 90 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~--- 90 (508)
...+||++++.||+|+||+||+|++..+|+.||||++...........++.+|+++|+.++||||+++++++.....
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 45689999999999999999999999999999999997655555556778999999999999999999999865421
Q ss_pred CCCccEEEEEecCCccHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 91 REFKDIYVVFELMESDLHQVIK-ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 91 ~~~~~lylV~E~~~g~L~~~i~-~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
.....+|+|||||.+++...+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 2235689999999976665544 456799999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCC-CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 170 SFNDAP-SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 170 ~~~~~~-~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
...... ........+||++|+|||++.+. ..|+.++||||+||++|+|++|++||.+.+....+..+...++.+..+.
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 432221 11223456899999999998762 5789999999999999999999999999999999999999999887765
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccC
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKF--PNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 312 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~ 312 (508)
+...........+..... ....+...+ ...++.++|||.+||++||++|||++|+|+||||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 246 WPNVDNYELYEKLELVKG-QKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp STTCCCC-------CCSS-CCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred ccccchhhhhhhhccccc-ccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 444332221111111110 000000000 023678899999999999999999999999999985
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-56 Score=447.77 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=218.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHH-hCCCCCcceeeeeecCCCcCCCc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLR-LLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~-~~~~~~~~i~~Ei~iL~-~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.++. .++|||||++++++.. .+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-----~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-----KE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-----SS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-----CC
Confidence 57999999999999999999999999999999996432 12233456677877765 7899999999999944 46
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 95 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
.+|||||||+ |+|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 6999999998 699999999889999999999999999999999999999999999999999999999999999864332
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
. ...+..+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..|.. +
T Consensus 157 ~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~----------- 218 (320)
T d1xjda_ 157 D---AKTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--D----------- 218 (320)
T ss_dssp T---CCBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--C-----------
T ss_pred c---ccccccCCCCCcCCHHHHcC--CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--C-----------
Confidence 2 22456789999999999987 7899999999999999999999999999887665554432 0
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHH-HHhcCCcccCC
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE-EALADPYFHGL 313 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~-eiL~hp~f~~~ 313 (508)
.+ . ....+++.+.+||.+||+.||.+|||++ ++++||||+++
T Consensus 219 --------------~~-~---~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 219 --------------NP-F---YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp --------------CC-C---CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred --------------CC-C---CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 11 1 1135789999999999999999999995 89999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-55 Score=434.14 Aligned_cols=287 Identities=36% Similarity=0.583 Sum_probs=236.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
+||++++.||+|+||+||+|++..+|+.||||+++..........++.+|+.+|+.++||||+++++++.. ..++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-----~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc-----ccce
Confidence 58999999999999999999999999999999997655555667889999999999999999999999954 4568
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCCC
Q 010512 97 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 175 (508)
Q Consensus 97 ylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~~ 175 (508)
++|++++.+ +|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+.......
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999995 7777778788999999999999999999999999999999999999999999999999999987543322
Q ss_pred CcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHhhcCCCChHHHHHHhh
Q 010512 176 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL-FPGKNVVHQLDLMTDLLGTPSTESISRIRN 254 (508)
Q Consensus 176 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~p-F~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 254 (508)
......+++.|+|||++.+. ..++.++||||+||++|+|++|+.| |.+.+..+++..+....+.+....+.....
T Consensus 157 ---~~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 157 ---CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ---cceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 23455788999999998762 4578999999999999999998866 677888888888888888877654332211
Q ss_pred HHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 255 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 255 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
. ..+................+..++.+.+||.+||++||.+||||+|+|+||||+++.
T Consensus 233 ~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 233 L--PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp S--TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred c--ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 0 000000001112233445567889999999999999999999999999999998764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.1e-55 Score=433.83 Aligned_cols=267 Identities=25% Similarity=0.379 Sum_probs=214.4
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
..++|++.+.||+|+||+||+|++..+|+.||||+++.... +.....++.+|+++|+.++||||+++++++.... ...
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~ 83 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG 83 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSS
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCC
Confidence 46899999999999999999999999999999999976543 3445567899999999999999999999986533 233
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
..+|||||||+ ++|.+++...+++++.+++.|+.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 45899999999 59999999888999999999999999999999999999999999999999999999999999986544
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
...........+||+.|+|||++.+ ..|+.++||||||||+|+|++|++||.+.+..+.+..+..
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~------------- 228 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR------------- 228 (277)
T ss_dssp ---------------TTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-------------
T ss_pred ccccccccccccCcccccCHHHHcC--CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh-------------
Confidence 4433344566789999999999987 6899999999999999999999999998876655443322
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCccc
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 311 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~ 311 (508)
..+.+.....+++++.+.+||.+||++||.+||+..+.|.|+|.+
T Consensus 229 --------------~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 229 --------------EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp --------------CCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred --------------cCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 122233344567899999999999999999999544445566653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-56 Score=437.34 Aligned_cols=250 Identities=27% Similarity=0.440 Sum_probs=209.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh----hHHHHHHHHHHHHHhCC--CCCcceeeeeecCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV----SDATRILREIKLLRLLR--HPDIVEIKHIMLPPS 89 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~----~~~~~i~~Ei~iL~~L~--HpnIv~l~~v~~~~~ 89 (508)
.++|++.+.||+|+||+||+|++..+|+.||||++++..... ....++.+|+.+|+.++ |||||++++++.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~--- 79 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--- 79 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE---
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe---
Confidence 578999999999999999999999999999999997532211 12344678999999997 899999999994
Q ss_pred cCCCccEEEEEecCC--ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC-CcEEEccccc
Q 010512 90 RREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGL 166 (508)
Q Consensus 90 ~~~~~~lylV~E~~~--g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~-~~lkL~DFGl 166 (508)
..+.+|+||||+. +++.+++..+..+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 80 --~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 80 --RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp --CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred --eCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccc
Confidence 4456999999997 4888999888899999999999999999999999999999999999999855 7999999999
Q ss_pred cccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCh
Q 010512 167 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246 (508)
Q Consensus 167 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 246 (508)
|+..... ..+..+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+. +..
T Consensus 158 a~~~~~~-----~~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~------- 218 (273)
T d1xwsa_ 158 GALLKDT-----VYTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR------- 218 (273)
T ss_dssp CEECCSS-----CBCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH-------
T ss_pred ceecccc-----cccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCchH------Hhh-------
Confidence 9864322 24567899999999998762 3456789999999999999999999975321 100
Q ss_pred HHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 247 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.. .. ..+.+++++.+||.+||++||.+|||++|+|+||||+++
T Consensus 219 -------------------~~--~~---~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 219 -------------------GQ--VF---FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp -------------------CC--CC---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -------------------cc--cC---CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 00 01 123578999999999999999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-56 Score=449.59 Aligned_cols=262 Identities=26% Similarity=0.409 Sum_probs=210.1
Q ss_pred CCCCeEEee-eeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHH-hCCCCCcceeeeeecCCCcCC
Q 010512 15 EASRYQIQE-VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLR-LLRHPDIVEIKHIMLPPSRRE 92 (508)
Q Consensus 15 ~~~rY~i~~-~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~-~L~HpnIv~l~~v~~~~~~~~ 92 (508)
..++|+|++ +||+|+||+||+|++..+|+.||||++++ ...+.+|+.++. .++|||||+++++|.... ..
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~ 80 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY-AG 80 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TT
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cC
Confidence 456899875 69999999999999999999999999963 245678999865 558999999999985321 23
Q ss_pred CccEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC---CCcEEEccccc
Q 010512 93 FKDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGL 166 (508)
Q Consensus 93 ~~~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~---~~~lkL~DFGl 166 (508)
...+|||||||+ |+|.++|... ..+++.+++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence 467999999998 6999999875 36999999999999999999999999999999999999986 46799999999
Q ss_pred cccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCh
Q 010512 167 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 246 (508)
Q Consensus 167 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 246 (508)
|+...... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|++||.+.+.......+....
T Consensus 161 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i----- 229 (335)
T d2ozaa1 161 AKETTSHN----SLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----- 229 (335)
T ss_dssp CEECCCCC----CCCCCSCCCSSCCCCCCCG--GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC-----
T ss_pred eeeccCCC----ccccccCCcccCCcHHHcC--CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH-----
Confidence 98654332 2355789999999999987 689999999999999999999999998876544333222111
Q ss_pred HHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 247 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 247 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
...........++.+++.+.+||.+||++||.+|||+.|+|+||||...
T Consensus 230 ------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 230 ------------------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp ------------------CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred ------------------hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 0011101111223578999999999999999999999999999999753
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.1e-54 Score=437.70 Aligned_cols=287 Identities=31% Similarity=0.571 Sum_probs=225.4
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCc
Q 010512 12 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSR 90 (508)
Q Consensus 12 ~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~ 90 (508)
+|+..++|++++.||+|+||+||+|++..+|+.||||+++.. ..+++.+|+.+|+.+. ||||+++++++...
T Consensus 30 ~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~-- 102 (328)
T d3bqca1 30 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDP-- 102 (328)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT--
T ss_pred CCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEec--
Confidence 577889999999999999999999999999999999999642 3467889999999996 99999999998643
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCC-cEEEccccccc
Q 010512 91 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLAR 168 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~-~lkL~DFGla~ 168 (508)
....+|+|||||. ++|..+ .+.+++..++.+++||+.||.|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 103 -~~~~~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 103 -VSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp -TTCSEEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred -CCCceeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccce
Confidence 3357999999999 577654 34699999999999999999999999999999999999998765 59999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhhcCCCChH
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK-NVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~-~~~~~l~~i~~~~g~p~~~ 247 (508)
...... .....++|+.|+|||++.+. ..|+.++||||+||++|+|++|+.||... +..++...+...+|.+...
T Consensus 179 ~~~~~~----~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~ 253 (328)
T d3bqca1 179 FYHPGQ----EYNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253 (328)
T ss_dssp ECCTTC----CCCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred eccCCC----cccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhh
Confidence 654332 23567899999999998763 56899999999999999999999998654 4566777787777765433
Q ss_pred HHHHHhhHH-HHHHHhhcccCCCCCC-----CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCCC
Q 010512 248 SISRIRNEK-ARRYLGSMRKKQPVPF-----SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 248 ~~~~~~~~~-~~~~l~~~~~~~~~~~-----~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~~ 314 (508)
.+....... ...+...........+ ......+++++.+||++||.+||.+|||++|+|+||||+.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 322110000 0000011111111111 112235789999999999999999999999999999998754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=422.49 Aligned_cols=258 Identities=23% Similarity=0.299 Sum_probs=208.4
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
..++|++.+.||+|+||+||+|+.. ..||||+++.........+.+.+|+.+|++++|||||++++++.. .
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~ 76 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------P 76 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------S
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------c
Confidence 3578999999999999999999743 369999997665556677889999999999999999999998743 3
Q ss_pred cEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 95 DIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
.+|||||||+ |+|.+++... ..+++..+..|+.||++||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 4799999999 6999999764 5699999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCcccccccccccc-cCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
... ....+...||+.|||||++.+. ...|+.++|||||||++|||++|+.||.+.+...++..+..-
T Consensus 157 ~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~----------- 224 (276)
T d1uwha_ 157 WSG-SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR----------- 224 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH-----------
T ss_pred cCC-cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc-----------
Confidence 222 2234567899999999998652 245899999999999999999999999987655544332211
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
...+..+.....++++.+.+||.+||..||.+|||+.|++++
T Consensus 225 --------------~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 225 --------------GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp --------------TSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 011112223345678999999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=421.99 Aligned_cols=255 Identities=22% Similarity=0.345 Sum_probs=206.7
Q ss_pred eEEe-eeeeecCceEEEEEEEC--CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 19 YQIQ-EVIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 19 Y~i~-~~LG~G~~g~V~~a~~~--~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
+.+. +.||+|+||+||+|.+. .+++.||||+++....+.....++.+|+.+|++++|||||++++++.. +.
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~ 81 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ES 81 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SS
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CC
Confidence 3443 47999999999999854 466889999997655555566789999999999999999999999843 24
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 96 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
.|||||||+ |+|.+++.....+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 82 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161 (277)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccc
Confidence 799999998 6999999998899999999999999999999999999999999999999999999999999998764443
Q ss_pred CCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHHh
Q 010512 175 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 253 (508)
Q Consensus 175 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 253 (508)
..........||+.|+|||++.+ ..|+.++|||||||++|||++ |++||.+.+..+....+..
T Consensus 162 ~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~-------------- 225 (277)
T d1xbba_ 162 NYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-------------- 225 (277)
T ss_dssp SEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT--------------
T ss_pred cccccccccCCCceecCchhhcC--CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc--------------
Confidence 33333345679999999999987 689999999999999999997 8999998876554443322
Q ss_pred hHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHH---hcCCccc
Q 010512 254 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA---LADPYFH 311 (508)
Q Consensus 254 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~ei---L~hp~f~ 311 (508)
....+ ....+++.+.+||.+||+.||.+|||++++ |+|+|+.
T Consensus 226 -------------~~~~~---~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 226 -------------GERMG---CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp -------------TCCCC---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -------------CCCCC---CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 01111 113578999999999999999999999998 4666653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-52 Score=420.20 Aligned_cols=256 Identities=24% Similarity=0.363 Sum_probs=199.6
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCc---EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~---~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
...++|++.+.||+|+||+||+|.++.+|+ .||||++... ......+.+.+|+.+|++|+|||||++++++..
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--- 98 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK--- 98 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee---
Confidence 445789999999999999999999987765 6899988643 234456779999999999999999999999944
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
.+.+|+|||||+ |+|.+++... +.+++.++..|+.||++||.|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 99 --~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 99 --STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred --CCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccce
Confidence 356899999998 6999988774 469999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCc--ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCC
Q 010512 169 VSFNDAPSA--IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPS 245 (508)
Q Consensus 169 ~~~~~~~~~--~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~ 245 (508)
......... .......||+.|||||++.+ ..|+.++|||||||++|||++ |++||.+.+..+.+..+....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~---- 250 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY---- 250 (299)
T ss_dssp -------------------CGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC----
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhc--CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----
Confidence 754332221 11223568999999999987 789999999999999999998 899999887655554443211
Q ss_pred hHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 246 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
..+ ....+++.+.+||.+||+.||.+|||+.|++++
T Consensus 251 ---------------------~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 251 ---------------------RLP-----PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ---------------------CCC-----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------------------CCC-----CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 011 123578899999999999999999999998873
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.9e-53 Score=420.37 Aligned_cols=263 Identities=20% Similarity=0.396 Sum_probs=214.1
Q ss_pred hccccccCC-CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeee
Q 010512 7 TEFFTEYGE-ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIM 85 (508)
Q Consensus 7 ~~~~~~~~~-~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~ 85 (508)
...|.+|.. .++|++.+.||+|+||+||+|++..+|+.||||+++... ...+++.+|+.+|+.++|||||++++++
T Consensus 6 ~p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~ 82 (287)
T d1opja_ 6 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVC 82 (287)
T ss_dssp STTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccE
Confidence 344556643 478999999999999999999999999999999997533 3356789999999999999999999999
Q ss_pred cCCCcCCCccEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEc
Q 010512 86 LPPSRREFKDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 162 (508)
Q Consensus 86 ~~~~~~~~~~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~ 162 (508)
.. .+.+|||||||+ |+|.+++... ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 83 ~~-----~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~ 157 (287)
T d1opja_ 83 TR-----EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 157 (287)
T ss_dssp CS-----SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred ee-----CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEc
Confidence 43 456899999998 7999998764 468999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCC-CCCCCCChHHHHHHHHhhc
Q 010512 163 DFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLMTDLL 241 (508)
Q Consensus 163 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~-~pF~~~~~~~~l~~i~~~~ 241 (508)
|||+|+....... ...+...||+.|+|||++.+ ..|+.++|||||||++|||++|. +||.+.+.......+..
T Consensus 158 DFG~a~~~~~~~~--~~~~~~~g~~~y~aPE~~~~--~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~-- 231 (287)
T d1opja_ 158 DFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-- 231 (287)
T ss_dssp CCCCTTTCCSSSS--EEETTEEECGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT--
T ss_pred cccceeecCCCCc--eeeccccccccccChHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc--
Confidence 9999986543222 22344568999999999987 78999999999999999999965 45555554333222211
Q ss_pred CCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCcccCC
Q 010512 242 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 313 (508)
Q Consensus 242 g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp~f~~~ 313 (508)
.... .....+++.+.+||.+||+.||.+|||++|+++ +|+.+
T Consensus 232 -------------------------~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~ 273 (287)
T d1opja_ 232 -------------------------DYRM---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM 273 (287)
T ss_dssp -------------------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred -------------------------CCCC---CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence 0111 112457899999999999999999999999976 55443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=411.55 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=199.2
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 94 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 94 (508)
.+++|++++.||+|+||+||+|++. ++..||||+++.... ..+.+.+|+++|+.++|||||++++++.. .+
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~ 73 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QA 73 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SS
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC---cHHHHHHHHHHHHhcCCCCcccccceecc-----CC
Confidence 3578999999999999999999976 577899999975332 34578999999999999999999999954 34
Q ss_pred cEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 95 DIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 95 ~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
.+|+|||||+ |+|.+++... ..++++.+..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccC
Confidence 5899999998 7999988765 5689999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.... ......||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+..+.....
T Consensus 154 ~~~~--~~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~--------- 220 (263)
T d1sm2a_ 154 DQYT--SSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR--------- 220 (263)
T ss_dssp -------------CTTSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC---------
T ss_pred CCce--eecceecCcccCChHHhcC--CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC---------
Confidence 3221 2234679999999999987 689999999999999999999 5788877776555544432110
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
. . ....+++.+.+||.+||+.||.+|||++|+++|
T Consensus 221 ----------------~--~---~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 221 ----------------L--Y---KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ----------------C--C---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------C--C---CccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 0 0 113467899999999999999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-53 Score=417.72 Aligned_cols=258 Identities=22% Similarity=0.360 Sum_probs=213.6
Q ss_pred CCCCeEEeee-eeecCceEEEEEEECC--CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 15 EASRYQIQEV-IGKGSYGVVGSAVDTH--TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 15 ~~~rY~i~~~-LG~G~~g~V~~a~~~~--tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
..++|.+.+. ||+|+||+||+|.++. ++..||||+++.. ......+++.+|+++|+.++|||||++++++..
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---- 80 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---- 80 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES----
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc----
Confidence 3467899985 9999999999998754 4558999999753 344566789999999999999999999999843
Q ss_pred CCccEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
+.+|||||||+ |+|.+++.. +..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 81 --~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 81 --EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp --SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred --CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhc
Confidence 24899999999 699998765 45799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
...............||+.|+|||++.+ ..|+.++|||||||++|||++ |++||.+.+..+.+..+...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~-------- 228 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-------- 228 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT--------
T ss_pred ccccccccccccccccCccccChHHHhC--CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------
Confidence 6543333333345678999999999987 689999999999999999998 99999987765554444321
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHH---hcCCccc
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA---LADPYFH 311 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~ei---L~hp~f~ 311 (508)
... ...+.+++.+.+||.+||+.||.+|||+.++ |+|+|+.
T Consensus 229 -------------------~~~---~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 229 -------------------KRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp -------------------CCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------------CCC---CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 011 1124678999999999999999999999888 6788875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=422.96 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=206.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCc-----EEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGE-----RVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~-----~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~ 90 (508)
++|+++++||+|+||+||+|++..+++ .||+|++.... .......+.+|+.+|+.+ +|||||++++++..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~--- 112 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL--- 112 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee---
Confidence 689999999999999999999876543 79999986432 233456788999999998 89999999999943
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHhHhcCceecCC
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAND-----------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDL 146 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~-----------------------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDL 146 (508)
.+.+|+|||||+ |+|.++|.... .+++..++.|+.||+.||+|||++||+||||
T Consensus 113 --~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 113 --SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred --CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 456899999998 69999997642 4899999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCC
Q 010512 147 KPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLF 225 (508)
Q Consensus 147 KPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF 225 (508)
||+|||++.++.+||+|||+|+....... ........||+.|||||++.+ ..|+.++|||||||++|||++ |++||
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred chhccccccCCeEEEeeccccccccCCCc-eeeeccccCCCccCChHHHcC--CCCCcceeccchhHHHHHHHhCCCCCC
Confidence 99999999999999999999987544332 223345678999999999987 789999999999999999997 89999
Q ss_pred CCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHh
Q 010512 226 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 305 (508)
Q Consensus 226 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL 305 (508)
.+.+....+..+..- ....+ ....+++.+.+||.+||+.||.+|||++||+
T Consensus 268 ~~~~~~~~~~~~~~~--------------------------~~~~~---~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~ 318 (325)
T d1rjba_ 268 PGIPVDANFYKLIQN--------------------------GFKMD---QPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318 (325)
T ss_dssp TTCCCSHHHHHHHHT--------------------------TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCHHHHHHHHHhc--------------------------CCCCC---CCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 987655444333210 00111 1135789999999999999999999999999
Q ss_pred cC
Q 010512 306 AD 307 (508)
Q Consensus 306 ~h 307 (508)
+|
T Consensus 319 ~~ 320 (325)
T d1rjba_ 319 SF 320 (325)
T ss_dssp HH
T ss_pred HH
Confidence 85
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=413.12 Aligned_cols=253 Identities=25% Similarity=0.373 Sum_probs=208.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++++.||+|+||+||+|+++ ++..||||+++.... ..+.+.+|+.+|++++|||||++++++.. +.
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~ 81 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EP 81 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeecc------CC
Confidence 368999999999999999999975 678899999975332 34678999999999999999999998743 34
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 96 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
+|+|||||+ |+|.+++... .++++..+..|+.||++||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccC
Confidence 799999998 7998877543 3699999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG-~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
.. ....+...||+.|+|||++.+ ..|+.++|||||||++|||+|| .+||.+.+..+.+..+...
T Consensus 162 ~~--~~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~----------- 226 (272)
T d1qpca_ 162 NE--YTAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG----------- 226 (272)
T ss_dssp SC--EECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----------
T ss_pred Cc--cccccccCCcccccChHHHhC--CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-----------
Confidence 22 122345679999999999986 6899999999999999999995 6677766654444333221
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc--CCcccC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA--DPYFHG 312 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~--hp~f~~ 312 (508)
.... ....+++.+.+||.+||+.||.+|||++++++ |+||..
T Consensus 227 ----------------~~~~---~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 227 ----------------YRMV---RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ----------------CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------------CCCC---CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 0000 11357889999999999999999999999998 788853
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=403.94 Aligned_cols=249 Identities=20% Similarity=0.310 Sum_probs=210.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
+++|++++.||+|+||+||+|+++ ++..||||++++... ....+++|+.++++++||||+++++++.. .+.
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-----~~~ 73 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRP 73 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECC-----SSS
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEee-----CCc
Confidence 578999999999999999999984 788999999975433 34578999999999999999999999943 456
Q ss_pred EEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 96 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
+|+||||++ |+|.+++.. ...+++..+..|+.||++||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 74 ~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 74 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp EEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred eEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 999999998 788888765 457999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
... ......||+.|+|||++.+ ..|+.++|||||||++|||++ |+.||.+.+..+....+.....
T Consensus 154 ~~~--~~~~~~~t~~y~aPE~~~~--~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~---------- 219 (258)
T d1k2pa_ 154 EYT--SSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR---------- 219 (258)
T ss_dssp SCC--CCCCSCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC----------
T ss_pred Cce--eecccCCCCCcCCcHHhcC--CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC----------
Confidence 221 2345679999999999987 789999999999999999998 8999998887665544432110
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
. + ....+++.+.+||.+||+.||.+|||++++|+|
T Consensus 220 ---------------~--~---~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 220 ---------------L--Y---RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ---------------C--C---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------C--C---CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1 1 113567889999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=423.14 Aligned_cols=264 Identities=23% Similarity=0.383 Sum_probs=215.1
Q ss_pred CCeEEeeeeeecCceEEEEEEE---CCCCcEEEEEEecCcc--CChhHHHHHHHHHHHHHhCCC-CCcceeeeeecCCCc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVD---THTGERVAIKKINDVF--EHVSDATRILREIKLLRLLRH-PDIVEIKHIMLPPSR 90 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~---~~tg~~vAIKki~~~~--~~~~~~~~i~~Ei~iL~~L~H-pnIv~l~~v~~~~~~ 90 (508)
++|++++.||+|+||+||+|.+ ..+|+.||||++++.. ........+.+|+++|++++| |||+++++++.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~---- 99 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ---- 99 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE----
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec----
Confidence 6799999999999999999987 4579999999997532 122335567899999999977 89999999984
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 91 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
+...+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 100 -~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 100 -TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp -ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred -cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 4456999999998 69999999998999999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCChHHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 249 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~~~~~ 249 (508)
...... .......||+.|+|||.+.+....++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 179 ~~~~~~--~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~--------- 247 (322)
T d1vzoa_ 179 FVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR--------- 247 (322)
T ss_dssp CCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH---------
T ss_pred hccccc--ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh---------
Confidence 533221 223457899999999999764346788999999999999999999999887644333322210
Q ss_pred HHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCcccCCC
Q 010512 250 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 314 (508)
Q Consensus 250 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rp-----ta~eiL~hp~f~~~~ 314 (508)
.. .... .....+++.+.+||.+||.+||.+|| |++|+|+||||+++.
T Consensus 248 ----------~~---~~~~-----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 248 ----------IL---KSEP-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp ----------HH---HCCC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred ----------cc---cCCC-----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 00 0011 11235789999999999999999999 589999999998754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-51 Score=404.39 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=197.3
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCC----cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTG----ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg----~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
.+++|++.++||+|+||.||+|..+.++ ..||||+++.. ........+.+|+.+|+.++|||||++++++..
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~--- 80 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--- 80 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec---
Confidence 4578999999999999999999887654 47999999753 233445678999999999999999999999943
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccc
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 168 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~ 168 (508)
...+|+|||||. +++.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 81 --~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 81 --YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp --SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred --CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhh
Confidence 356899999998 5777777654 579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHhhcCCCChH
Q 010512 169 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQLDLMTDLLGTPSTE 247 (508)
Q Consensus 169 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG-~~pF~~~~~~~~l~~i~~~~g~p~~~ 247 (508)
................||+.|+|||++.+ ..|+.++|||||||++|||++| .+||.+.+..+.+..+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~------- 229 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG------- 229 (283)
T ss_dssp ---------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-------
T ss_pred cccCCCccceEeccCCCCccccCHHHHcc--CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc-------
Confidence 76443333223345678999999999987 7899999999999999999995 5556555543333333211
Q ss_pred HHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 248 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 248 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
...+ ....+++.+.+||.+||..||.+|||+.|+++
T Consensus 230 --------------------~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 230 --------------------FRLP---TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp --------------------CCCC---CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------------------CCCC---CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 1111 11356788999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=405.45 Aligned_cols=250 Identities=25% Similarity=0.417 Sum_probs=198.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCC---CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~t---g~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
++|++++.||+|+||+||+|++..+ +..||||+++.. ........+.+|+.+|+.++|||||++++++..
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 79 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 79 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 6899999999999999999998654 457999998643 334455678999999999999999999999842
Q ss_pred ccEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccccc
Q 010512 94 KDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 171 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~ 171 (508)
+.+|+|||||. |+|.+++.. ...+++..+..++.||++||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 35899999998 688887765 4579999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHH
Q 010512 172 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 250 (508)
Q Consensus 172 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~ 250 (508)
.... ...+...||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+..+...
T Consensus 160 ~~~~--~~~~~~~gt~~y~apE~l~~--~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~---------- 225 (273)
T d1mp8a_ 160 DSTY--YKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---------- 225 (273)
T ss_dssp -------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT----------
T ss_pred CCcc--eeccceecCcccchhhHhcc--CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC----------
Confidence 3222 12345678999999999987 789999999999999999998 89999988766555444321
Q ss_pred HHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 251 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 251 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
... ...+++++.+.+||.+||..||.+|||++|+++|
T Consensus 226 -----------------~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 226 -----------------ERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp -----------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCC---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111 1235678999999999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=409.02 Aligned_cols=253 Identities=22% Similarity=0.357 Sum_probs=202.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCc----EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGE----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 91 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~----~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 91 (508)
..+|+++++||+|+||+||+|.+..+|+ +||+|+++.. ......+.+.+|+.+|+.++|||||++++++...
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--- 83 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 83 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS---
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence 3679999999999999999999988876 5888888643 2233467799999999999999999999999643
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 92 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 92 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
..++||+++. |+|.+.+... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ---~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 84 ---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp ---SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred ---CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeecccccee
Confidence 3678888887 7898877764 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHH
Q 010512 170 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 248 (508)
Q Consensus 170 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~ 248 (508)
...... ........||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+....+....
T Consensus 161 ~~~~~~-~~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~------- 230 (317)
T d1xkka_ 161 LGAEEK-EYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------- 230 (317)
T ss_dssp TTTTCC---------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC-------
T ss_pred cccccc-cccccccccCccccChHHHhc--CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-------
Confidence 543322 222344578999999999987 689999999999999999998 899998877554433332210
Q ss_pred HHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 010512 249 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 308 (508)
Q Consensus 249 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~hp 308 (508)
..+ ..+.+++.+.+||.+||..||.+|||+.|+++|.
T Consensus 231 ------------------~~~-----~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 231 ------------------RLP-----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp ------------------CCC-----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ------------------CCC-----CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 011 1135788999999999999999999999999873
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=400.52 Aligned_cols=254 Identities=26% Similarity=0.383 Sum_probs=204.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCcc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 95 (508)
.++|++.+.||+|+||.||+|+++.+ ..||||+++.... ..+.+.+|+.+|++++|||||++++++.. +.
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~ 85 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 85 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEec------CC
Confidence 47899999999999999999998755 5799999975433 34678999999999999999999998842 24
Q ss_pred EEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccC
Q 010512 96 IYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 172 (508)
Q Consensus 96 lylV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~ 172 (508)
+|+|||||. |+|..++.. ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence 799999999 688877754 35799999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHhhcCCCChHHHHH
Q 010512 173 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQLDLMTDLLGTPSTESISR 251 (508)
Q Consensus 173 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG-~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~ 251 (508)
... ...+...||+.|+|||++.+ ..++.++|||||||++|||++| .+||.+.+..+.+..+....
T Consensus 166 ~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~---------- 231 (285)
T d1fmka3 166 NEY--TARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---------- 231 (285)
T ss_dssp ------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----------
T ss_pred CCc--eeeccccccccccChHHHhC--CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC----------
Confidence 222 12344679999999999987 7899999999999999999995 56677666555554443211
Q ss_pred HhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc--CCcccCC
Q 010512 252 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA--DPYFHGL 313 (508)
Q Consensus 252 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~--hp~f~~~ 313 (508)
.. ...+.+++.+.+||.+||+.||++|||++++++ ++||...
T Consensus 232 -----------------~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 232 -----------------RM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp -----------------CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -----------------CC---CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 11 122467889999999999999999999999998 8899764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=400.28 Aligned_cols=259 Identities=22% Similarity=0.325 Sum_probs=203.4
Q ss_pred cccCCCCCeEEeeeeeecCceEEEEEEECC-CC--cEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeeeec
Q 010512 11 TEYGEASRYQIQEVIGKGSYGVVGSAVDTH-TG--ERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIML 86 (508)
Q Consensus 11 ~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~-tg--~~vAIKki~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~ 86 (508)
|++...++|++++.||+|+||.||+|+... ++ ..||||++++... .....+.+.+|+.+|+.++||||+++++++.
T Consensus 2 t~~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ceEEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 566667889999999999999999998643 33 4799999975433 3344567899999999999999999999995
Q ss_pred CCCcCCCccEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccc
Q 010512 87 PPSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 164 (508)
Q Consensus 87 ~~~~~~~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DF 164 (508)
. ..+|+|||||+ |+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 82 ~------~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~Df 155 (273)
T d1u46a_ 82 T------PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF 155 (273)
T ss_dssp S------SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred e------cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccc
Confidence 3 24799999998 688877655 457999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCC
Q 010512 165 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGT 243 (508)
Q Consensus 165 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~ 243 (508)
|+++................||.+|+|||++.+ ..|+.++|||||||++|||++ |++||.+.+..+.+..+...
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~--- 230 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE--- 230 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS---
T ss_pred hhhhhcccCCCcceecCccccCcccCCHHHHhC--CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC---
Confidence 999976554443333455678899999999987 789999999999999999998 89999998876665554321
Q ss_pred CChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 244 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 244 p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.... ...+.+++.+.+||.+||..||++|||+.++++
T Consensus 231 -----------------------~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 231 -----------------------GERL---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp -----------------------CCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCC---CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0011 122467899999999999999999999999874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=401.93 Aligned_cols=254 Identities=25% Similarity=0.402 Sum_probs=197.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~-----tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~ 90 (508)
++|++++.||+|+||.||+|.+.. +++.||||+++... .....+.+.+|+.++.++ +|+||+.+++++...
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-- 89 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 89 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC--
Confidence 689999999999999999999753 45789999997432 334556778888888776 689999999988543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceee
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA 153 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl 153 (508)
...+|+|||||+ |+|.+++... ..+++..+..++.||++||.|||++||+||||||+|||+
T Consensus 90 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 90 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp --TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred --CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 346899999998 7999999753 248999999999999999999999999999999999999
Q ss_pred CCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhC-CCCCCCCChHH
Q 010512 154 NADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVH 232 (508)
Q Consensus 154 ~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG-~~pF~~~~~~~ 232 (508)
+.++.+||+|||+|+....... ....+..+||+.|+|||++.+ ..|+.++|||||||++|||++| .+||.+.+...
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp CGGGCEEECC------CCSCTT-SCCTTSCCCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred CCCCcEEEccCcchhhcccccc-ccccCceeeCccccchhHhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999986543322 223455789999999999987 7899999999999999999986 57898766443
Q ss_pred HHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 233 QLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 233 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.+..+.. ..... .....+++.+.+||.+||+.||.+|||++|+++|
T Consensus 245 ~~~~~~~--------------------------~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 245 EFCRRLK--------------------------EGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHH--------------------------HTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHh--------------------------cCCCC---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3322211 00001 1123578899999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-49 Score=398.04 Aligned_cols=252 Identities=21% Similarity=0.284 Sum_probs=207.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~-----~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
.++|++++.||+|+||+||+|+.+ .++..||||+++.. .......++.+|+.+|+.++||||+++++++..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--- 87 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAV--- 87 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeecc---
Confidence 357999999999999999999865 35689999999753 233445679999999999999999999999954
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHhHhcCceecC
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAND------------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRD 145 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~~------------------------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrD 145 (508)
...+++||||++ |+|.+++.... .+++..+..|+.||+.||+|||++||+|||
T Consensus 88 --~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 88 --GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred --CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 356899999998 79999986532 388999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCC-CC
Q 010512 146 LKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PL 224 (508)
Q Consensus 146 LKPeNILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~-~p 224 (508)
|||+|||++.++.+||+|||+|+...... .....+...||+.|+|||++.+ ..|+.++|||||||++|||++|. +|
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~--~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSAD-YYKADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGG-CBC----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred EcccceEECCCCcEEEccchhheeccCCc-cccccCCCCcCcCcCCHHHHcc--CCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999998653322 2222345678999999999987 78999999999999999999985 78
Q ss_pred CCCCChHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHH
Q 010512 225 FPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 304 (508)
Q Consensus 225 F~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~ei 304 (508)
|.+.+..+.+..+.+. .. ......+++.+.+||.+||+.||.+|||+.||
T Consensus 243 ~~~~~~~e~~~~v~~~---------------------------~~---~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev 292 (301)
T d1lufa_ 243 YYGMAHEEVIYYVRDG---------------------------NI---LACPENCPLELYNLMRLCWSKLPADRPSFCSI 292 (301)
T ss_dssp TTTSCHHHHHHHHHTT---------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHHHcC---------------------------CC---CCCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 9887766555444321 10 11124678899999999999999999999999
Q ss_pred hc
Q 010512 305 LA 306 (508)
Q Consensus 305 L~ 306 (508)
++
T Consensus 293 ~~ 294 (301)
T d1lufa_ 293 HR 294 (301)
T ss_dssp HH
T ss_pred HH
Confidence 76
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=389.40 Aligned_cols=242 Identities=22% Similarity=0.386 Sum_probs=196.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
++|++++.||+|+||.||+|++ +|..||||++++. ...+.+.+|+++|++++||||+++++++... .+.+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~ 76 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGL 76 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CC
T ss_pred HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEec----CCcE
Confidence 5799999999999999999987 4789999999642 3456789999999999999999999998643 2347
Q ss_pred EEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCC
Q 010512 97 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 173 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~ 173 (508)
|+||||++ |+|.+++.... .+++..+..|+.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence 99999998 69999986543 5899999999999999999999999999999999999999999999999999864322
Q ss_pred CCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcCCCChHHHHHH
Q 010512 174 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 174 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~~~~~~~ 252 (508)
.....+|..|+|||++.+ ..|+.++|||||||++|||++ |++||.+.+..+.+..+..
T Consensus 157 ------~~~~~~~~~y~aPE~l~~--~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~------------- 215 (262)
T d1byga_ 157 ------QDTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------- 215 (262)
T ss_dssp -----------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-------------
T ss_pred ------CccccccccCCChHHHhC--CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-------------
Confidence 233568899999999987 689999999999999999998 7899987765554443321
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.... ...+.+++.+.+||.+||..||.+|||+.++++
T Consensus 216 --------------~~~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 216 --------------GYKM---DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp --------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCC---CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 0111 112356799999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-49 Score=392.68 Aligned_cols=252 Identities=25% Similarity=0.409 Sum_probs=204.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCC-------cEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTG-------ERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLP 87 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg-------~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~ 87 (508)
.++|++++.||+|+||.||+|++..++ ..||||+++... .......+.+|+..+.++ +|||||++++++..
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 479999999999999999999876554 479999997543 334557788999999888 79999999999953
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCc
Q 010512 88 PSRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 150 (508)
Q Consensus 88 ~~~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeN 150 (508)
...+|+|||||+ |+|.++|.... .+++..+..++.||+.||+|||+.||+||||||+|
T Consensus 91 -----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 91 -----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp -----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred -----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 456899999998 79999997542 48999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCC
Q 010512 151 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 229 (508)
Q Consensus 151 ILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~ 229 (508)
||++.++.+||+|||+++........ ......+||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eeecCCCCeEeccchhhccccccccc-cccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 99999999999999999876543322 22455689999999999987 789999999999999999998 799998877
Q ss_pred hHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 230 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 230 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
.......+.. ....+ ....+++.+.+||.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~~~i~~---------------------------~~~~~---~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 243 VEELFKLLKE---------------------------GHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHT---------------------------TCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHc---------------------------CCCCC---CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 5544333321 11111 11357889999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-49 Score=396.90 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=202.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCc--EEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCCcCCC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGE--RVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~--~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~ 93 (508)
++|++.++||+|+||+||+|+++.+|. .||||+++... .....+.+.+|+++|+.+ +|||||++++++.. .
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~ 83 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----R 83 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----T
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-----C
Confidence 689999999999999999999988886 47788875432 223456789999999999 69999999999953 4
Q ss_pred ccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCC
Q 010512 94 KDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 156 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~ 156 (508)
+.+|+|||||+ |+|.++|..+ ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence 56999999999 7999999754 569999999999999999999999999999999999999999
Q ss_pred CcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCC-CCCCCCChHHHHH
Q 010512 157 CKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLD 235 (508)
Q Consensus 157 ~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~-~pF~~~~~~~~l~ 235 (508)
+.+||+|||+|+....... .....||..|+|||.+.+ ..|+.++||||||||+|||++|. +||.+.+..+.+.
T Consensus 164 ~~~kl~DfG~a~~~~~~~~----~~~~~gt~~y~aPE~l~~--~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~ 237 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237 (309)
T ss_dssp GCEEECCTTCEESSCEECC----C----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred CceEEcccccccccccccc----ccceecCCcccchHHhcc--CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999985432221 234578999999999987 78999999999999999999965 6888777555443
Q ss_pred HHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 236 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 236 ~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
.+.+ .... .....+++.+.+||.+||..||++|||++|+++|
T Consensus 238 ~i~~---------------------------~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 238 KLPQ---------------------------GYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HGGG---------------------------TCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHh---------------------------cCCC---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3321 1111 1123578999999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.4e-49 Score=392.24 Aligned_cols=266 Identities=19% Similarity=0.235 Sum_probs=205.6
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 14 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 14 ~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
..+++|++++.||+|+||+||+|++..+|+.||||++..... ..++.+|+++++.++|+|++..+..+. ...
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~ 75 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCG----AEG 75 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEE----EET
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEE----ecC
Confidence 456899999999999999999999999999999999865322 234678999999999887666655543 234
Q ss_pred ccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC---CCcEEEcccccccc
Q 010512 94 KDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARV 169 (508)
Q Consensus 94 ~~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~---~~~lkL~DFGla~~ 169 (508)
...|+||||++++|.+.+.. ...+++..+..++.||+.||+|||++||+||||||+|||++. +..+||+|||+|+.
T Consensus 76 ~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 76 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred CEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 56899999999988777665 457999999999999999999999999999999999998764 45799999999997
Q ss_pred ccCCCCCc----ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC
Q 010512 170 SFNDAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 245 (508)
Q Consensus 170 ~~~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~p~ 245 (508)
........ ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.........+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~---- 229 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS---- 229 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH----
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhC--CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh----
Confidence 64332211 12345689999999999987 689999999999999999999999998766544332221110
Q ss_pred hHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHH---HHhcCCcccC
Q 010512 246 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE---EALADPYFHG 312 (508)
Q Consensus 246 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~---eiL~hp~f~~ 312 (508)
... ...+.....+++++.+.+||.+||+.||.+||+++ ++|+|+|.+.
T Consensus 230 --------~~~-----------~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 230 --------EKK-----------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp --------HHH-----------HHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred --------ccc-----------CCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 000 00111122346789999999999999999999987 4577887653
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=391.04 Aligned_cols=257 Identities=22% Similarity=0.365 Sum_probs=212.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCc
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 90 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~-----tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 90 (508)
.++|++.+.||+|+||+||+|.+.. ++..||||+++.. ........+.+|+.+|++++||||+++++++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--- 94 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--- 94 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS---
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec---
Confidence 4899999999999999999998752 4678999999753 344455678999999999999999999999943
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcE
Q 010512 91 REFKDIYVVFELME-SDLHQVIKAN----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 159 (508)
Q Consensus 91 ~~~~~lylV~E~~~-g~L~~~i~~~----------~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~l 159 (508)
...+++|||||. |+|.+++... ..+++..+..++.||++||.|||+++|+||||||+|||++.++++
T Consensus 95 --~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 95 --GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred --CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence 346899999998 7999988642 247899999999999999999999999999999999999999999
Q ss_pred EEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHH
Q 010512 160 KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQLDLMT 238 (508)
Q Consensus 160 kL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG-~~pF~~~~~~~~l~~i~ 238 (508)
||+|||+|+....... ....+..+||+.|+|||.+.+ ..|+.++|||||||++|||++| .+||.+.+..+.+..+.
T Consensus 173 Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~--~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~ 249 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249 (308)
T ss_dssp EECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred EEeecccceeccCCcc-eeeccceecccccCCHHHHcc--CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999986543322 222345579999999999987 7899999999999999999998 58898887766555443
Q ss_pred hhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc------CCccc
Q 010512 239 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA------DPYFH 311 (508)
Q Consensus 239 ~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~------hp~f~ 311 (508)
+.. .. ...+.+++.+.+||.+||+.||.+|||++++++ +|+|+
T Consensus 250 ~~~---------------------------~~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 250 EGG---------------------------LL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298 (308)
T ss_dssp TTC---------------------------CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred hCC---------------------------CC---CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence 210 00 112356789999999999999999999999998 56654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=388.61 Aligned_cols=253 Identities=27% Similarity=0.406 Sum_probs=209.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeeeecCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 89 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~-----~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~ 89 (508)
.++|++.+.||+|+||.||+|+. ..++..||||+++.. ........+.+|+.+++.+ +|||||++++++..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-- 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc-cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee--
Confidence 37999999999999999999985 357789999999753 3445666789999999999 69999999999943
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCc
Q 010512 90 RREFKDIYVVFELME-SDLHQVIKAND------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 150 (508)
Q Consensus 90 ~~~~~~lylV~E~~~-g~L~~~i~~~~------------------~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeN 150 (508)
...+|+|||||+ |+|.+++.... .+++..+..|+.||+.||+|||++||+||||||+|
T Consensus 99 ---~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 99 ---GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ---SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ---CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 355899999998 69999987543 58999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHh-CCCCCCCCC
Q 010512 151 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 229 (508)
Q Consensus 151 ILl~~~~~lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~ 229 (508)
||++.++.+||+|||+++...... .....+..+||+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCT-TSEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccccCcccccccchheeccCCC-cceEeeecccChHHcCHHHhcC--CCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999998754332 2233456789999999999987 789999999999999999998 778887776
Q ss_pred hHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 230 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 230 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
....+..+..- ..+ + . ....+++.+.+||.+||+.||.+|||++++|+
T Consensus 253 ~~~~~~~~i~~----------------------~~~---~-~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 253 VDSKFYKMIKE----------------------GFR---M-L---SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SSHHHHHHHHH----------------------TCC---C-C---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhc----------------------CCC---C-C---CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 55444333210 000 0 0 11346789999999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=381.69 Aligned_cols=251 Identities=21% Similarity=0.315 Sum_probs=199.2
Q ss_pred EEeeeeeecCceEEEEEEECCCC---cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCCCcCCCccE
Q 010512 20 QIQEVIGKGSYGVVGSAVDTHTG---ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 96 (508)
Q Consensus 20 ~i~~~LG~G~~g~V~~a~~~~tg---~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 96 (508)
.+.++||+|+||+||+|++..++ ..||||++++ ..+.....++.+|+++|++++||||+++++++... .+.+
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~ 104 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSP 104 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECC-CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCce
Confidence 34679999999999999986643 3699999974 34556678899999999999999999999997532 2468
Q ss_pred EEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEccccccccccCCC
Q 010512 97 YVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 174 (508)
Q Consensus 97 ylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~DFGla~~~~~~~ 174 (508)
|+|||||+ |+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||+++++.+||+|||+++......
T Consensus 105 ~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999 68988887543 57888999999999999999999999999999999999999999999999998754332
Q ss_pred CC-cccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHhhcCCCChHHHHHH
Q 010512 175 PS-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV-HQLDLMTDLLGTPSTESISRI 252 (508)
Q Consensus 175 ~~-~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~-~~l~~i~~~~g~p~~~~~~~~ 252 (508)
.. ........||+.|+|||++.+ ..|+.++|||||||++|||++|..||...... +....+..
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~------------- 249 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------------- 249 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT-------------
T ss_pred cccceecccccccccccChHHHhc--CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-------------
Confidence 22 222345679999999999987 68999999999999999999977666543321 11111110
Q ss_pred hhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 010512 253 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 307 (508)
Q Consensus 253 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~h 307 (508)
..... ..+.+++.+.+||.+||..||++|||+.|+++|
T Consensus 250 --------------g~~~~---~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 250 --------------GRRLL---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp --------------TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CCCCC---CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01111 113567899999999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-47 Score=389.43 Aligned_cols=282 Identities=24% Similarity=0.346 Sum_probs=212.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-----------CCCcceeeeee
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-----------HPDIVEIKHIM 85 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-----------HpnIv~l~~v~ 85 (508)
+||++++.||+|+||+||+|++..+|+.||||++++. ......+.+|+++|+.+. |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 6799999999999999999999999999999999743 233456788999998885 47788898887
Q ss_pred cCCCcCCCccEEEEEecCC--ccHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHhHh-cCceecCCCCCceeeCCCCc--
Q 010512 86 LPPSRREFKDIYVVFELME--SDLHQVIK--ANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCK-- 158 (508)
Q Consensus 86 ~~~~~~~~~~lylV~E~~~--g~L~~~i~--~~~~l~~~~~~~i~~Qil~aL~yLHs-~gIiHrDLKPeNILl~~~~~-- 158 (508)
... .....++||.++. ++...... ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.
T Consensus 90 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 90 NHK---GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEE---ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred eec---cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 432 2244566666664 34433333 34579999999999999999999998 89999999999999987653
Q ss_pred ----EEEccccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCC-----
Q 010512 159 ----LKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN----- 229 (508)
Q Consensus 159 ----lkL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~----- 229 (508)
++|+|||.+...... ....+||+.|+|||++.+ ..|+.++||||+||++++|++|+.||...+
T Consensus 167 ~~~~~kl~dfg~s~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp TEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeeEeecccccccccc------cccccccccccChhhccc--cCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence 999999999754321 244689999999999987 789999999999999999999999997543
Q ss_pred -hHHHHHHHHhhcCCCChHHHHHHhhHHHHHHHhhcccC---CCCC----------CCCCCCCCCHHHHHHHHHhccCCC
Q 010512 230 -VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKK---QPVP----------FSHKFPNADPLALHLLERLLAFDP 295 (508)
Q Consensus 230 -~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~l~~~~~~---~~~~----------~~~~~~~~~~~~~~Ll~~mL~~DP 295 (508)
..+.+..+...+|+++...+...... ..+....... .... ........++.+.+||.+||.+||
T Consensus 239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 239 KDDDHIAQIIELLGELPSYLLRNGKYT--RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTH--HHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred chhHHHHHHHHHhCCCCHHHhhccccc--ccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 34566777788898877665432211 1111110000 0000 001112346789999999999999
Q ss_pred CCCCCHHHHhcCCcccCCC
Q 010512 296 KDRPTAEEALADPYFHGLA 314 (508)
Q Consensus 296 ~~Rpta~eiL~hp~f~~~~ 314 (508)
.+|||++|+|+||||+...
T Consensus 317 ~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 317 RKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp TTCBCHHHHHTCGGGTTCT
T ss_pred hHCcCHHHHhcCcccCCCC
Confidence 9999999999999998654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.7e-47 Score=381.31 Aligned_cols=258 Identities=17% Similarity=0.228 Sum_probs=205.6
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCC-CCcceeeeeecCCCcCCC
Q 010512 15 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH-PDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 15 ~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~H-pnIv~l~~v~~~~~~~~~ 93 (508)
.+++|+|++.||+|+||+||+|++..+|+.||||+++.... ...+.+|+++++.|+| +||+.+++++. ..
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~ 73 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EG 73 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ET
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEee-----cC
Confidence 36899999999999999999999999999999999864322 2346789999999976 89999998883 44
Q ss_pred ccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCC-----CCcEEEcccccc
Q 010512 94 KDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-----DCKLKICDFGLA 167 (508)
Q Consensus 94 ~~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~-----~~~lkL~DFGla 167 (508)
...|+||||++++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|
T Consensus 74 ~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 74 LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred CccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccccee
Confidence 5689999999999999987754 6999999999999999999999999999999999999974 578999999999
Q ss_pred ccccCCCCCc----ccccccccCcccccccccccccCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC
Q 010512 168 RVSFNDAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 243 (508)
Q Consensus 168 ~~~~~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~~g~ 243 (508)
+......... ......+||+.|||||++.+ ..|+.++|||||||++|+|++|..||.+.........+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~---- 227 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER---- 227 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH----
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcC--CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH----
Confidence 8754332211 12345689999999999987 6899999999999999999999999987653322211111
Q ss_pred CChHHHHHHhhHHHHHHHhhcccCCCCCCCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 244 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 244 p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
+...+. ..+.....+++++.+.+|+..|+..+|.+||+.+.+.+
T Consensus 228 --------i~~~~~-----------~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 228 --------IGEKKQ-----------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp --------HHHHHH-----------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred --------HHhccC-----------CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 000000 01111223457789999999999999999999877654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=383.64 Aligned_cols=271 Identities=23% Similarity=0.264 Sum_probs=195.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHH--HHHHHHHHhCCCCCcceeeeeecCCCcCCC
Q 010512 16 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRHPDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 16 ~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i--~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 93 (508)
+.+|.+.+.||+|+||.||+|+. +|+.||||+++.. ..... .+|+..+..++|||||++++++.... ...
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~-----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~ 73 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTW 73 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc-----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-Ccc
Confidence 56899999999999999999975 6899999999632 22333 34556667889999999999997543 233
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh--------cCceecCCCCCceeeCCCCcEEEccc
Q 010512 94 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT--------ANVFHRDLKPKNILANADCKLKICDF 164 (508)
Q Consensus 94 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs--------~gIiHrDLKPeNILl~~~~~lkL~DF 164 (508)
..+|+|||||+ |+|.+++.+. .+++.....++.|++.||.|||+ +||+||||||+|||++.++.+||+||
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 46899999998 6999999875 69999999999999999999996 59999999999999999999999999
Q ss_pred cccccccCCCCC-cccccccccCcccccccccccccC----CCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 010512 165 GLARVSFNDAPS-AIFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTD 239 (508)
Q Consensus 165 Gla~~~~~~~~~-~~~~~~~~gT~~Y~APE~l~~~~~----~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~ 239 (508)
|+++........ .......+||+.|+|||++.+... .++.++|||||||++|||++|.+||........ .....
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~-~~~~~ 231 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL-PYYDL 231 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC-TTTTT
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc-chhhc
Confidence 999876443322 122345789999999999875211 267799999999999999999988754331110 00000
Q ss_pred hcCCCChHHHHHHhhHHHHHHHhhcccCCCCCCCCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 010512 240 LLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF--PNADPLALHLLERLLAFDPKDRPTAEEALA 306 (508)
Q Consensus 240 ~~g~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~~~~~~~Ll~~mL~~DP~~Rpta~eiL~ 306 (508)
....+....+ ...+.. .....++...+ ......+.+|+.+||+.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~~--------~~~~~~--~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 232 VPSDPSVEEM--------RKVVCE--QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SCSSCCHHHH--------HHHHTT--SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccccchHHHH--------HHHHhc--cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 0111111111 111110 00001111111 112345889999999999999999999987
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=3.5e-26 Score=211.96 Aligned_cols=171 Identities=16% Similarity=0.088 Sum_probs=121.8
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC----------------hhHHHHHHHHHHHHHhCCCCCcceee
Q 010512 19 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH----------------VSDATRILREIKLLRLLRHPDIVEIK 82 (508)
Q Consensus 19 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~----------------~~~~~~i~~Ei~iL~~L~HpnIv~l~ 82 (508)
|.+.++||+|+||+||+|++. +|+.||||+++..... ........+|+..|.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 578999999999999999985 7999999987532110 01123356789999999999999887
Q ss_pred eeecCCCcCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhcCceecCCCCCceeeCCCCcEEEc
Q 010512 83 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 162 (508)
Q Consensus 83 ~v~~~~~~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs~gIiHrDLKPeNILl~~~~~lkL~ 162 (508)
+... .++||||+++... ..++...+..++.||+.||.|||++||+||||||+|||++.+ .++|+
T Consensus 81 ~~~~---------~~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 81 AWEG---------NAVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EEET---------TEEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEEC
T ss_pred EecC---------CEEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEE
Confidence 7641 2799999996422 125666678899999999999999999999999999999965 59999
Q ss_pred cccccccccCCCCCcccccccccCcccccccccccccCCCCcchhhhhHHHH
Q 010512 163 DFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 214 (508)
Q Consensus 163 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~i 214 (508)
|||+|.......... .....+. .-.+.+ ...|+.++|+||+.--
T Consensus 145 DFG~a~~~~~~~~~~-~l~rd~~----~~~~~f---~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGWRE-ILERDVR----NIITYF---SRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTHHH-HHHHHHH----HHHHHH---HHHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCcHH-HHHHHHH----HHHHHH---cCCCCCcccHHHHHHH
Confidence 999997542211100 0000000 001111 1468899999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.39 E-value=6.7e-07 Score=83.96 Aligned_cols=139 Identities=14% Similarity=0.116 Sum_probs=87.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeeeecCCCcCCCcc
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD 95 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ 95 (508)
..|++.+..+.|+.+.||++. ..+..+.+|+....... ....+.+|...|+.|. +--+.+++.+. ...+.
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~ 84 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGW 84 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCc
Confidence 467777776666668999984 45677889987543222 2334678999988875 33345555554 23356
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh------------------------------------
Q 010512 96 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT------------------------------------ 138 (508)
Q Consensus 96 lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~Qil~aL~yLHs------------------------------------ 138 (508)
.|+||++++| .+.+.... ......++.++.+.++.||+
T Consensus 85 ~~lv~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred eEEEEEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 7999999997 44333211 11112223333333333332
Q ss_pred -----------------------cCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 139 -----------------------ANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 139 -----------------------~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1279999999999999776667999998763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.93 E-value=1.6e-05 Score=79.52 Aligned_cols=77 Identities=18% Similarity=0.052 Sum_probs=47.7
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCcc----C-ChhHHHHHHHHHHHHHhCC-C--CCcceeeeeecCCCcCCC
Q 010512 22 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF----E-HVSDATRILREIKLLRLLR-H--PDIVEIKHIMLPPSRREF 93 (508)
Q Consensus 22 ~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~----~-~~~~~~~i~~Ei~iL~~L~-H--pnIv~l~~v~~~~~~~~~ 93 (508)
.+.||.|....||++.+..+|+.|++|.-.... . ......+..+|...|+.+. + ..+.+++.+..
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~------- 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT------- 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET-------
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC-------
Confidence 456899999999999988788899999753211 1 1123345667888887763 2 23445544321
Q ss_pred ccEEEEEecCCc
Q 010512 94 KDIYVVFELMES 105 (508)
Q Consensus 94 ~~lylV~E~~~g 105 (508)
...++|||++++
T Consensus 104 ~~~~lvmE~L~~ 115 (392)
T d2pula1 104 EMAVTVMEDLSH 115 (392)
T ss_dssp TTTEEEECCCTT
T ss_pred CCCEEEEeccCC
Confidence 224789999975
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.68 E-value=4.3e-05 Score=70.71 Aligned_cols=71 Identities=8% Similarity=-0.013 Sum_probs=45.9
Q ss_pred eeeecC-ceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC--cceeeeeecCCCcCCCccEEEEE
Q 010512 24 VIGKGS-YGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD--IVEIKHIMLPPSRREFKDIYVVF 100 (508)
Q Consensus 24 ~LG~G~-~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~~~~~~~~lylV~ 100 (508)
.+..|. -+.||++.. ..|..+.+|..... ....+.+|+..|+.|.... +.+++.+... .+..|+||
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-----~~~~~~v~ 85 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLL 85 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEE
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCcc-----CHhHHHHHHHHHHHHHhcCCCCCceeeeccc-----ccceEEEE
Confidence 445554 468899864 45667888876432 2234677888888775333 4556655532 34579999
Q ss_pred ecCCc
Q 010512 101 ELMES 105 (508)
Q Consensus 101 E~~~g 105 (508)
++++|
T Consensus 86 ~~i~G 90 (255)
T d1nd4a_ 86 GEVPG 90 (255)
T ss_dssp ECCSS
T ss_pred Eeeec
Confidence 99986
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.96 E-value=0.0013 Score=63.28 Aligned_cols=74 Identities=15% Similarity=0.052 Sum_probs=45.4
Q ss_pred cCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecCC--CcCCCccEEEEEecCCc
Q 010512 28 GSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP--SRREFKDIYVVFELMES 105 (508)
Q Consensus 28 G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~--~~~~~~~lylV~E~~~g 105 (508)
+.--.||++.. .+|..|++|+.+... .....+..|+..|..|...+|.-..-+.... .....+..+.|+++++|
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp~~---~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cccceeEEEEc-CCCCEEEEEEeCCCC---CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 44568999965 578899999875321 2346678899999888643332111111111 11224557889999875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.76 E-value=0.0015 Score=62.06 Aligned_cols=155 Identities=14% Similarity=0.072 Sum_probs=79.3
Q ss_pred ccccccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeeeecC
Q 010512 8 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLP 87 (508)
Q Consensus 8 ~~~~~~~~~~rY~i~~~LG~G~~g~V~~a~~~~tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~ 87 (508)
.+...|+.+ +..-.+.|..|---+.|++... +| .|++|++... .....+..|+.+|..|...++.-..-+...
T Consensus 10 ~~l~~Y~lg-~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~----~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~ 82 (316)
T d2ppqa1 10 NFLTQYDVG-SLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRK 82 (316)
T ss_dssp HHHTTBCCC-CEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred HHHHhCCCC-CceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCC----CCHHHHHHHHHHHHhhhhccccccccceec
Confidence 345567664 4555667778888889999754 34 5889988532 123455668888888754333211111100
Q ss_pred CC---cCCCccEEEEEecCCcc------HHH------HH---Hh-CC--------CCCHH------------------HH
Q 010512 88 PS---RREFKDIYVVFELMESD------LHQ------VI---KA-ND--------DLTPE------------------HY 122 (508)
Q Consensus 88 ~~---~~~~~~lylV~E~~~g~------L~~------~i---~~-~~--------~l~~~------------------~~ 122 (508)
.. .......+.++.++.|. ... .+ .. .. ..... ..
T Consensus 83 ~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (316)
T d2ppqa1 83 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 162 (316)
T ss_dssp TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred CCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhH
Confidence 00 00112345555555431 100 00 00 00 01111 11
Q ss_pred HHHHHHHHHHHHHhHh----cCceecCCCCCceeeCCCCcEEEcccccccc
Q 010512 123 QFFLYQLLRGLKYIHT----ANVFHRDLKPKNILANADCKLKICDFGLARV 169 (508)
Q Consensus 123 ~~i~~Qil~aL~yLHs----~gIiHrDLKPeNILl~~~~~lkL~DFGla~~ 169 (508)
...+..+...+.-.+. .|+||+|+.++||+++.+...-|+||+.+..
T Consensus 163 ~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 163 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 1122223333333322 4799999999999999887778999998863
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.70 E-value=0.0035 Score=61.82 Aligned_cols=75 Identities=15% Similarity=0.113 Sum_probs=49.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECC-------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC-cceeeeeecCC
Q 010512 17 SRYQIQEVIGKGSYGVVGSAVDTH-------TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD-IVEIKHIMLPP 88 (508)
Q Consensus 17 ~rY~i~~~LG~G~~g~V~~a~~~~-------tg~~vAIKki~~~~~~~~~~~~i~~Ei~iL~~L~Hpn-Iv~l~~v~~~~ 88 (508)
+..+| +.|+.|-.-.+|++.... .++.|.+++.... . ......+|..+++.+.-.+ ..++++++..
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~---~~idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E---TESHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-c---hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 34444 678999999999997643 3467877776421 1 2234568999999886334 3467666621
Q ss_pred CcCCCccEEEEEecCCc
Q 010512 89 SRREFKDIYVVFELMES 105 (508)
Q Consensus 89 ~~~~~~~lylV~E~~~g 105 (508)
.+|+||++|
T Consensus 117 --------g~I~efi~g 125 (395)
T d1nw1a_ 117 --------GRLEEYIPS 125 (395)
T ss_dssp --------EEEECCCCE
T ss_pred --------ceEEEEecc
Confidence 688999986
|